PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Rad, R; Rad, L; Wang, W; Cadinanos, J; Vassiliou, G; Rice, S; Campos, LS; Yusa, K; Banerjee, R; Li, MA; de la Rosa, J; Strong, A; Lu, D; Ellis, P; Conte, N; Yang, FT; Liu, PT; Bradley, A				Rad, Roland; Rad, Lena; Wang, Wei; Cadinanos, Juan; Vassiliou, George; Rice, Stephen; Campos, Lia S.; Yusa, Kosuke; Banerjee, Ruby; Li, Meng Amy; de la Rosa, Jorge; Strong, Alexander; Lu, Dong; Ellis, Peter; Conte, Nathalie; Yang, Fang Tang; Liu, Pentao; Bradley, Allan			PiggyBac Transposon Mutagenesis: A Tool for Cancer Gene Discovery in Mice	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; SLEEPING-BEAUTY; CHROMOSOMAL TRANSPOSITION; TRANSGENIC MICE; MOUSE; NETWORKS; SCREENS; SYSTEM	Transposons are mobile DNA segments that can disrupt gene function by inserting in or near genes. Here, we show that insertional mutagenesis by the PiggyBac transposon can be used for cancer gene discovery in mice. PiggyBac transposition in genetically engineered transposon-transposase mice induced cancers whose type (hematopoietic versus solid) and latency were dependent on the regulatory elements introduced into transposons. Analysis of 63 hematopoietic tumors revealed that PiggyBac is capable of genome-wide mutagenesis. The PiggyBac screen uncovered many cancer genes not identified in previous retroviral or Sleeping Beauty transposon screens, including Spic, which encodes a PU.1-related transcription factor, and Hdac7, a histone deacetylase gene. PiggyBac and Sleeping Beauty have different integration preferences. To maximize the utility of the tool, we engineered 21 mouse lines to be compatible with both transposon systems in constitutive, tissue-or temporal-specific mutagenesis. Mice with different transposon types, copy numbers, and chromosomal locations support wide applicability.	[Rad, Roland; Rad, Lena; Wang, Wei; Cadinanos, Juan; Vassiliou, George; Rice, Stephen; Campos, Lia S.; Yusa, Kosuke; Banerjee, Ruby; Li, Meng Amy; Strong, Alexander; Lu, Dong; Ellis, Peter; Conte, Nathalie; Yang, Fang Tang; Liu, Pentao; Bradley, Allan] Wellcome Trust Sanger Inst, Hinxton Cambridge CB10 1SA, England; [Cadinanos, Juan; de la Rosa, Jorge] IMOMA, Oviedo 33193, Spain	Wellcome Trust Sanger Institute	Bradley, A (corresponding author), Wellcome Trust Sanger Inst, Genome Campus, Hinxton Cambridge CB10 1SA, England.	abradley@sanger.ac.uk	Wilson, Matthew H/K-3193-2013; Yang, Fan/GYU-4249-2022	Conte, Nathalie/0000-0002-1010-3121; Yang, Fengtang/0000-0002-3573-2354; Vassiliou, George/0000-0003-4337-8022; Cadinanos, Juan/0000-0001-7561-7759; Bradley, Allan/0000-0002-2349-8839; de la Rosa, Jorge/0000-0002-0201-2078	Wellcome Trust; Deutsche Forschungsgemeinschaft; Fundacion Maria Cristina Masaveu Peterson	Wellcome Trust(Wellcome TrustEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fundacion Maria Cristina Masaveu Peterson	We thank the research support facility team, B. L. Ng, B. Fu, and Y. Hooks for technical assistance; N. Carter and C. Lopez-Otin for experimental resources; L. Wessels, J. ten Hoeve, and J. de Ridder for software used in data analysis; D. Saur for technical advice; and H. Prosser for reagents. The work was supported by the Wellcome Trust. R. R. and J. R. are recipients of a fellowship from the Deutsche Forschungsgemeinschaft and the Fundacion Maria Cristina Masaveu Peterson, respectively.	Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bronson SK, 1996, P NATL ACAD SCI USA, V93, P9067, DOI 10.1073/pnas.93.17.9067; Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; Collier LS, 2009, CANCER RES, V69, P8429, DOI 10.1158/0008-5472.CAN-09-1760; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; de Ridder J, 2006, PLOS COMPUT BIOL, V2, P1530, DOI 10.1371/journal.pcbi.0020166; Dequiedt F, 2003, IMMUNITY, V18, P687, DOI 10.1016/S1074-7613(03)00109-2; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Hoemann CD, 2000, MOL CELL BIOL, V20, P3831, DOI 10.1128/MCB.20.11.3831-3842.2000; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Ivics Z, 2009, NAT METHODS, V6, P415, DOI [10.1038/NMETH.1332, 10.1038/nmeth.1332]; Keng VW, 2005, NAT METHODS, V2, P763, DOI 10.1038/NMETH795; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Kool J, 2009, NAT REV CANCER, V9, P389, DOI 10.1038/nrc2647; Liang Q, 2009, GENESIS, V47, P404, DOI 10.1002/dvg.20508; Luo GB, 1998, P NATL ACAD SCI USA, V95, P10769, DOI 10.1073/pnas.95.18.10769; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Uren AG, 2008, CELL, V133, P727, DOI 10.1016/j.cell.2008.03.021; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Willis TG, 1998, BLOOD, V91, P1873, DOI 10.1182/blood.V91.6.1873.1873_1873_1881	23	161	181	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2010	330	6007					1104	1107		10.1126/science.1193004	http://dx.doi.org/10.1126/science.1193004			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	20947725	Green Accepted			2022-12-01	WOS:000284374700044
J	Zhou, AW; Carrell, RW; Murphy, MP; Wei, ZQ; Yan, YH; Stanley, PLD; Stein, PE; Pipkin, FB; Read, RJ				Zhou, Aiwu; Carrell, Robin W.; Murphy, Michael P.; Wei, Zhenquan; Yan, Yahui; Stanley, Peter L. D.; Stein, Penelope E.; Pipkin, Fiona Broughton; Read, Randy J.			A redox switch in angiotensinogen modulates angiotensin release	NATURE			English	Article							OXIDATIVE STRESS; NITRIC-OXIDE; RENIN; HYPERTENSION; PREECLAMPSIA; SYSTEM; KIDNEY; MODEL	Blood pressure is critically controlled by angiotensins(1), which are vasopressor peptides specifically released by the enzyme renin from the tail of angiotensinogen-a non-inhibitory member of the serpin family of protease inhibitors(2,3). Although angiotensinogen has long been regarded as a passive substrate, the crystal structures solved here to 2.1 angstrom resolution show that the angiotensin cleavage site is inaccessibly buried in its amino-terminal tail. The conformational rearrangement that makes this site accessible for proteolysis is revealed in our 4.4 angstrom structure of the complex of human angiotensinogen with renin. The co-ordinated changes involved are seen to be critically linked by a conserved but labile disulphide bridge. Here we show that the reduced unbridged form of angiotensinogen is present in the circulation in a near 40:60 ratio with the oxidized sulphydryl-bridged form, which preferentially interacts with receptor-bound renin. We propose that this redox-responsive transition of angiotensinogen to a form that will more effectively release angiotensin at a cellular level contributes to the modulation of blood pressure. Specifically, we demonstrate the oxidative switch of angiotensinogen to its more active sulphydryl-bridged form in the maternal circulation in pre-eclampsia-the hypertensive crisis of pregnancy that threatens the health and survival of both mother and child.	[Carrell, Robin W.; Stein, Penelope E.] Univ Cambridge, Cambridge Inst Med Res, Dept Med, Cambridge CB2 0XY, England; [Zhou, Aiwu; Wei, Zhenquan; Yan, Yahui; Stanley, Peter L. D.; Read, Randy J.] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 0XY, England; [Murphy, Michael P.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England; [Pipkin, Fiona Broughton] Univ Nottingham, City Hosp, Dept Obstet & Gynaecol, Nottingham NG5 1PB, England	University of Cambridge; University of Cambridge; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham	Carrell, RW (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Med, Hills Rd, Cambridge CB2 0XY, England.	awz20@cam.ac.uk; rwc1000@cam.ac.uk	Read, Randy J/L-1418-2013; Murphy, Michael P/C-2120-2009	Read, Randy J/0000-0001-8273-0047; Murphy, Michael P/0000-0003-1115-9618; ZHOU, Aiwu/0000-0002-2555-5091	British Heart Foundation; Wellcome Trust; Isaac Newton Trust of the University of Cambridge; UK Medical Research Council with Daresbury SRS; UK Medical Research Council; Diamond Light Source; MRC [MC_U105663142] Funding Source: UKRI; British Heart Foundation [PG/09/072/27945] Funding Source: researchfish; Medical Research Council [MC_U105663142] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Isaac Newton Trust of the University of Cambridge; UK Medical Research Council with Daresbury SRS(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diamond Light Source; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the British Heart Foundation, the Wellcome Trust, the Isaac Newton Trust of the University of Cambridge and the UK Medical Research Council, with the support of the Daresbury SRS and Diamond Light Source. We acknowledge the assistance of G. Bunkoczi in data processing, H. Hong for the HPLC measurements of angiotensin, and T. Prime for analysing S-nitrosothiols.	Brandes N, 2009, ANTIOXID REDOX SIGN, V11, P997, DOI [10.1089/ars.2008.2285, 10.1089/ARS.2008.2285]; Burton GJ, 2004, J SOC GYNECOL INVEST, V11, P342, DOI 10.1016/j.jsgi.2004.03.003; Dahm CC, 2006, J BIOL CHEM, V281, P10056, DOI 10.1074/jbc.M512203200; DEALWIS CG, 1994, J MOL BIOL, V236, P342, DOI 10.1006/jmbi.1994.1139; Dickson ME, 2006, HYPERTENSION, V48, P14, DOI 10.1161/01.HYP.0000227932.13687.60; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fyhrquist F, 2008, J INTERN MED, V264, P224, DOI 10.1111/j.1365-2796.2008.01981.x; Gimenez-Roqueplo AP, 1998, J BIOL CHEM, V273, P34480, DOI 10.1074/jbc.273.51.34480; Harrison DG, 2009, MED CLIN N AM, V93, P621, DOI 10.1016/j.mcna.2009.02.015; Hoffmann DS, 2008, HYPERTENSION, V51, P1058, DOI 10.1161/HYPERTENSIONAHA.107.107219; Hubel CA, 1999, P SOC EXP BIOL MED, V222, P222, DOI 10.1046/j.1525-1373.1999.d01-139.x; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; INOUE I, 1995, J BIOL CHEM, V270, P11430, DOI 10.1074/jbc.270.19.11430; Inoue I, 1997, J CLIN INVEST, V99, P1786, DOI 10.1172/JCI119343; Kilicdag EB, 2005, HYPERTENS PREGNANCY, V24, P147, DOI 10.1081/PRG-200059863; KIM HS, 1995, P NATL ACAD SCI USA, V92, P2735, DOI 10.1073/pnas.92.7.2735; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mistry HD, 2008, HYPERTENSION, V52, P881, DOI 10.1161/HYPERTENSIONAHA.108.116103; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myatt L, 2010, PLACENTA, V31, pS66, DOI 10.1016/j.placenta.2009.12.021; Nasir UM, 1998, BIOSCI BIOTECH BIOCH, V62, P338, DOI 10.1271/bbb.62.338; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Powell NA, 2005, BIOORG MED CHEM LETT, V15, P4713, DOI 10.1016/j.bmcl.2005.07.063; Sedeek M, 2008, AM J HYPERTENS, V21, P1152, DOI 10.1038/ajh.2008.239; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; STEIN PE, 1989, BIOCHEM J, V262, P103, DOI 10.1042/bj2620103; Streatfeild-James RMA, 1998, FEBS LETT, V436, P267, DOI 10.1016/S0014-5793(98)01145-4; Wilcox CS, 2005, AM J PHYSIOL-REG I, V289, pR913, DOI 10.1152/ajpregu.00250.2005	30	161	170	1	38	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 4	2010	468	7320					108	111		10.1038/nature09505	http://dx.doi.org/10.1038/nature09505			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674YF	20927107	Green Accepted, Green Submitted			2022-12-01	WOS:000283786900045
J	Sachedina, N; Donaldson, LJ				Sachedina, Nabihah; Donaldson, Liam J.			Paediatric mortality related to pandemic influenza A H1N1 infection in England: an observational population-based study	LANCET			English	Article							VIRUS-INFECTION; UNITED-STATES; CHILDREN; DEATHS	Background Young people (aged 0-18 years) have been disproportionately affected by pandemic influenza A H1N1 infection. We aimed to analyse paediatric mortality to inform clinical and public health policies for future influenza seasons and pandemics. Methods All paediatric deaths related to pandemic influenza A H1N1 infection from June 26,2009, to March 22,2010 in England were identified through daily reporting systems and cross-checking of records and were validated by confirmation of influenza infection by laboratory results or death certificates. Clinicians responsible for each individual child provided detailed information about past medical history, presentation, and clinical course of the acute illness. Case estimates of influenza A H1N1 were obtained from the Health Protection Agency. The primary outcome measures were population mortality rates and case-fatality rates. Findings 70 paediatric deaths related to pandemic influenza A H1N1 were reported. Childhood mortality rate was 6 per million population. The rate was highest for children aged less than 1 year. Mortality rates were higher for Bangladeshi children (47 deaths per million population [95% CI 17-103]) and Pakistani children (36 deaths per million population [18-64]) than for white British children (4 deaths per million [3-6]). 15 (21%) children who died were previously healthy; 45 (64%) had severe pre-existing disorders. The highest age-standardised mortality rate for a preexisting disorder was for chronic neurological disease (1536 per million population). 19 (27%) deaths occurred before inpatient admission. Children in this subgroup were significantly more likely to have been healthy or had only mild pre-existing disorders than those who died after admission (p=0-0109). Overall, 45 (64%) children had received oseltamivir: seven within 48 h of symptom onset. Interpretation Vaccination priority should be for children at increased risk of severe illness or death from influenza. This group might include those with specified pre-existing disorders and those in some ethnic minority groups. Early pre-hospital supportive and therapeutic care is also important.	[Donaldson, Liam J.] Natl Patient Safety Agcy, London W1T 5HD, England; [Sachedina, Nabihah; Donaldson, Liam J.] Dept Hlth, London SE1 6TE, England		Donaldson, LJ (corresponding author), Natl Patient Safety Agcy, 4-8 Maple St, London W1T 5HD, England.	liam.donaldson@npsa.nhs.uk			Department of Health	Department of Health	We thank the many clinicians in England who supplied the clinical information about their patients; Matthew Mak, Emma Stanton, Paul Rutter, and Tara Fajeyisan for their work in the validation of all deaths; Oliver Mytton for assistance with data analysis; and lain Yardley for assistance in editing the manuscript. This work was done as part of the public health response to pandemic influenza in England. The costs of the study were small and met from the Chief Medical Officer's budget within the Department of Health without the need for additional funding.	Bhat N, 2005, NEW ENGL J MED, V353, P2559, DOI 10.1056/NEJMoa051721; Butland BK, 2006, THORAX, V61, P383, DOI 10.1136/thx.2005.043646; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Castrodale L., 2009, Morbidity and Mortality Weekly Report, V58, P1341; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P941; Cunha BA, 2009, CLIN INFECT DIS, V49, P1454, DOI 10.1086/644496; Donaldson LJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5213; Johnson BF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007671; Libster R, 2010, NEW ENGL J MED, V362, P45, DOI 10.1056/NEJMoa0907673; Lister P, 2009, LANCET, V374, P605, DOI 10.1016/S0140-6736(09)61513-0; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; O'Riordan S, 2010, CAN MED ASSOC J, V182, P39, DOI 10.1503/cmaj.091724; Office for National Statistics, MID2007 POP EST ETHN; Office for National Statistics, 20029 ONS; Office for National Statistics, MID2008 POP EST ENGL; Pitman RJ, 2007, J INFECTION, V54, P530, DOI 10.1016/j.jinf.2006.09.017; Saklad M., 1941, ANESTHESIOLOGY, V2, P281, DOI DOI 10.1097/00000542-194105000-00004; Shun-Shin M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3172; To KKW, 2010, J MED VIROL, V82, P1, DOI 10.1002/jmv.21664; Turner SJ, 2008, J BIOL, V8, P69; van 't Klooster TM, 2010, EUROSURV, V15; WHO, WHO GUID PHARM MAN P; Wright Peter F, 2009, N Engl J Med, V361, pe112, DOI 10.1056/NEJMopv0910749	24	105	107	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2010	376	9755					1846	1852		10.1016/S0140-6736(10)61195-6	http://dx.doi.org/10.1016/S0140-6736(10)61195-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696KG	21030071	Green Accepted			2022-12-01	WOS:000285439700033
J	Janssen, BJC; Robinson, RA; Perez-Branguli, F; Bell, CH; Mitchell, KJ; Siebold, C; Jones, EY				Janssen, Bert J. C.; Robinson, Ross A.; Perez-Branguli, Francesc; Bell, Christian H.; Mitchell, Kevin J.; Siebold, Christian; Jones, E. Yvonne			Structural basis of semaphorin-plexin signalling	NATURE			English	Article							CRYSTAL-STRUCTURE; RECEPTOR; BINDING; MODEL; TRANSMEMBRANE; FAMILY; LIGAND; MET; GLYCOSYLATION; DIMERIZATION	Cell-cell signalling of semaphorin ligands through interaction with plexin receptors is important for the homeostasis and morphogenesis of many tissues and is widely studied for its role in neural connectivity, cancer, cell migration and immune responses(1). SEMA4D and Sema6A exemplify two diverse vertebrate, membrane-spanning semaphorin classes (4 and 6) that are capable of direct signalling through members of the two largest plexin classes, B and A, respectively(2,3). In the absence of any structural information on the plexin ectodomain or its interaction with semaphorins the extracellular specificity and mechanism controlling plexin signalling has remained unresolved. Here we present crystal structures of cognate complexes of the semaphorin-binding regions of plexins B1 and A2 with semaphorin ectodomains (human PLXNB1(1-2)-SEMA4D(ecto) and murine PlxnA2(1-4)-Sema6A(ecto)), plus unliganded structures of PlxnA2(1-4) and Sema6A(ecto). These structures, together with biophysical and cellular assays of wild-type and mutant proteins, reveal that semaphorin dimers independently bind two plexin molecules and that signalling is critically dependent on the avidity of the resulting bivalent 2: 2 complex (monomeric semaphorin binds plexin but fails to trigger signalling). In combination, our data favour a cell-cell signalling mechanism involving semaphorin-stabilized plexin dimerization, possibly followed by clustering, which is consistent with previous functional data. Furthermore, the shared generic architecture of the complexes, formed through conserved contacts of the amino-terminal seven-bladed beta-propeller (sema) domains of both semaphorin and plexin, suggests that a common mode of interaction triggers all semaphorin-plexin based signalling, while distinct insertions within or between blades of the sema domains determine binding specificity.	[Janssen, Bert J. C.; Robinson, Ross A.; Bell, Christian H.; Siebold, Christian; Jones, E. Yvonne] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England; [Perez-Branguli, Francesc; Mitchell, Kevin J.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin 2, Ireland; [Perez-Branguli, Francesc; Mitchell, Kevin J.] Trinity Coll Dublin, Inst Neurosci, Dublin 2, Ireland	University of Oxford; Wellcome Centre for Human Genetics; Trinity College Dublin; Trinity College Dublin	Jones, EY (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England.	yvonne@strubi.ox.ac.uk	Jones, Yvonne/N-8111-2019; Janssen, Bert/I-3338-2016; Jones, Yvonne/J-2293-2016	Jones, Yvonne/0000-0002-3834-1893; Janssen, Bert/0000-0002-8101-8370; Jones, Yvonne/0000-0002-3834-1893; Robinson, Ross/0000-0002-1482-0910; Siebold, Christian/0000-0002-6635-3621; Mitchell, Kevin/0000-0002-3433-4530	Human Frontier Science Program; Science Foundation Ireland; Wellcome Trust; Cancer Research UK; Cancer Research UK [10976] Funding Source: researchfish; Medical Research Council [G0900084, G0700232, G9900061] Funding Source: researchfish; MRC [G0900084, G9900061, G0700232] Funding Source: UKRI	Human Frontier Science Program(Human Frontier Science Program); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the staff of European Synchrotron Radiation Facility beamline ID 23-1 and Diamond beamline IO3 for assistance with data collection, the Molecular Cytogenetics and Microscopy Core facility of the Wellcome Trust Centre for Human Genetics, T. S. Walter for help with crystallization, G. Sutton for help with MALS experiments, A. F. Sonnen for help with AUC experiments, W. Lu for help with tissue culture, J. M. Grimes for assistance with figures and A. R. Aricescu and D. I. Stuart for critical reading of the manuscript. This work was funded by Cancer Research UK and the UK Medical Research Council. B. J. C. J. is funded by the Human Frontier Science Program, K. J. M. by a Science Foundation Ireland grant, C. H. B. and C. S. by the Wellcome Trust and E.Y.J. by Cancer Research UK.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Antipenko A, 2003, NEURON, V39, P589, DOI 10.1016/S0896-6273(03)00502-6; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Capparuccia L, 2009, J CELL SCI, V122, P1723, DOI 10.1242/jcs.030197; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gherardi E, 2006, P NATL ACAD SCI USA, V103, P4046, DOI 10.1073/pnas.0509040103; Gherardi E, 2004, CURR OPIN STRUC BIOL, V14, P669, DOI 10.1016/j.sbi.2004.10.010; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; He HW, 2009, P NATL ACAD SCI USA, V106, P15610, DOI 10.1073/pnas.0906923106; Kerjan G, 2005, NAT NEUROSCI, V8, P1516, DOI 10.1038/nn1555; Klostermann A, 1998, J BIOL CHEM, V273, P7326, DOI 10.1074/jbc.273.13.7326; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Koppel AM, 1997, NEURON, V19, P531, DOI 10.1016/S0896-6273(00)80369-4; Koppel AM, 1998, J BIOL CHEM, V273, P15708, DOI 10.1074/jbc.273.25.15708; Korostylev A, 2008, DEVELOPMENT, V135, P3333, DOI 10.1242/dev.019760; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leslie A.G.W., 1992, JOINT CCP4 ESF EMACB; Liu HL, 2010, CELL, V142, P749, DOI 10.1016/j.cell.2010.07.040; Love CA, 2003, NAT STRUCT BIOL, V10, P843, DOI 10.1038/nsb977; Mayo CJ, 2005, STRUCTURE, V13, P175, DOI 10.1016/j.str.2004.12.010; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merte J, 2010, J NEUROSCI, V30, P5767, DOI 10.1523/JNEUROSCI.5061-09.2010; Muller KM, 1998, ANAL BIOCHEM, V261, P149, DOI 10.1006/abio.1998.2725; Niemann HH, 2007, CELL, V130, P235, DOI 10.1016/j.cell.2007.05.037; O'Callaghan CA, 1999, ANAL BIOCHEM, V266, P9, DOI 10.1006/abio.1998.2930; Oinuma I, 2004, J NEUROSCI, V24, P11473, DOI 10.1523/JNEUROSCI.3257-04.2004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Renaud J, 2008, NAT NEUROSCI, V11, P440, DOI 10.1038/nn2064; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Suto F, 2007, NEURON, V53, P535, DOI 10.1016/j.neuron.2007.01.028; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tong Y, 2007, J BIOL CHEM, V282, P37215, DOI 10.1074/jbc.M703800200; Tong YF, 2009, J BIOL CHEM, V284, P35962, DOI 10.1074/jbc.M109.056275; Toyofuku T, 2005, NAT NEUROSCI, V8, P1712, DOI 10.1038/nn1596; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Turner LJ, 2006, METHOD ENZYMOL, V406, P665, DOI 10.1016/S0076-6879(06)06052-6; Walter TS, 2005, ACTA CRYSTALLOGR D, V61, P651, DOI 10.1107/S0907444905007808; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8	54	161	183	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 28	2010	467	7319					1118	U132		10.1038/nature09468	http://dx.doi.org/10.1038/nature09468			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671XW	20877282	Green Accepted			2022-12-01	WOS:000283548600050
J	Chi, P; Chen, Y; Zhang, L; Guo, XY; Wongvipat, J; Shamu, T; Fletcher, JA; Dewell, S; Maki, RG; Zheng, DY; Antonescu, CR; Allis, CD; Sawyers, CL				Chi, Ping; Chen, Yu; Zhang, Lei; Guo, Xingyi; Wongvipat, John; Shamu, Tambudzai; Fletcher, Jonathan A.; Dewell, Scott; Maki, Robert G.; Zheng, Deyou; Antonescu, Cristina R.; Allis, C. David; Sawyers, Charles L.			ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours	NATURE			English	Article							INTERSTITIAL-CELLS; GENE-EXPRESSION; MOUSE MODEL; MUTATIONS; CAJAL; INHIBITION; GIST	Gastrointestinal stromal tumour (GIST) is the most common human sarcoma and is primarily defined by activating mutations in the KIT or PDGFRA receptor tyrosine kinases(1,2). KIT is highly expressed in interstitial cells of Cajal (ICCs)-the presumed cell of origin for GIST-as well as in haematopoietic stem cells, melanocytes, mast cells and germ cells(2,3). Yet, families harbouring germline activating KIT mutations and mice with knock-in Kit mutations almost exclusively develop ICC hyperplasia and GIST(4-7), suggesting that the cellular context is important for KIT to mediate oncogenesis. Here we show that the ETS family member ETV1 is highly expressed in the subtypes of ICCs sensitive to oncogenic KIT mediated transformation(8), and is required for their development. In addition, ETV1 is universally highly expressed in GISTs and is required for growth of imatinib-sensitive and resistant GIST cell lines. Transcriptome profiling and global analyses of ETV1-binding sites suggest that ETV1 is a master regulator of an ICC-GIST-specific transcription network mainly through enhancer binding. The ETV1 transcriptional program is further regulated by activated KIT, which prolongs ETV1 protein stability and cooperates with ETV1 to promote tumorigenesis. We propose that GIST arises from ICCs with high levels of endogenous ETV1 expression that, when coupled with an activating KIT mutation, drives an oncogenic ETS transcriptional program. This differs from other ETS-dependent tumours such as prostate cancer, melanoma and Ewing sarcoma where genomic translocation or amplification drives aberrant ETS expression(9-11). It also represents a novel mechanism of oncogenic transcription factor activation.	[Chi, Ping; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Chi, Ping; Chen, Yu; Maki, Robert G.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Chen, Yu; Wongvipat, John; Shamu, Tambudzai; Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Zhang, Lei; Antonescu, Cristina R.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Guo, Xingyi; Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA; [Fletcher, Jonathan A.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Dewell, Scott] Rockefeller Univ, Genom Resource Ctr, New York, NY USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Sawyers, Charles L.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Brigham & Women's Hospital; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute	Sawyers, CL (corresponding author), Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA.	alliscd@rockefeller.edu; sawyersc@mskcc.org	Pillay, Nischalan/F-9536-2012; Maki, Robert G/J-9145-2019; Zhang, Lei/GYQ-7446-2022; Sawyers, Charles/G-5327-2016; Maki, Robert G./AAI-2793-2020; ravegnini, gloria/K-1330-2016	Maki, Robert G/0000-0002-9853-2528; ravegnini, gloria/0000-0002-7774-402X; Shamu, Tambudzai/0000-0001-8944-8079; Zheng, Deyou/0000-0003-4354-5337	National Cancer Institute [K08CA140946, 5F32CA130372, CA47179, CA148260]; US National Institute of Mental Health [R21MH087840]; National Cancer Institute-American Society of Clinical Oncology Cancer Foundation Clinical Investigator Team; American Society of Clinical Oncology; Doris Duke; Charles H Revson; Charles A. Dana foundations; Rockefeller University; American Cancer Society [CCE-106841, P01CA47179]; Life Raft Group; GIST; Shuman Family Fund for GIST Research; Cycle for Survival; Albert Einstein College of Medicine; National Institutes of Health [GM40922]; Starr Cancer Consortium; NATIONAL CANCER INSTITUTE [RC2CA148260, P30CA008748, P01CA047179, F32CA130372, P50CA140146, K08CA140946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH087840] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Cancer Institute-American Society of Clinical Oncology Cancer Foundation Clinical Investigator Team; American Society of Clinical Oncology; Doris Duke(Doris Duke Charitable Foundation (DDCF)); Charles H Revson; Charles A. Dana foundations; Rockefeller University; American Cancer Society(American Cancer Society); Life Raft Group; GIST; Shuman Family Fund for GIST Research; Cycle for Survival; Albert Einstein College of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by the National Cancer Institute (K08CA140946, to Y.C.), (5F32CA130372, to P. C.), (CA47179, to C. R. A. and R. G. M.), (CA148260, to R. G. M.), US National Institute of Mental Health (R21MH087840, to D.Z.), National Cancer Institute-American Society of Clinical Oncology Cancer Foundation Clinical Investigator Team Leadership Supplemental Award (to R. G. M.), American Society of Clinical Oncology Young Investigator Award (to P. C.), the Doris Duke (to C. L. S.), Charles H Revson (to Y.C.) and Charles A. Dana (to Y.C.) foundations, The Rockefeller University Fund (to C. D. A.), American Cancer Society Mentored Research Scholar Grant CCE-106841 (to C. R. A.), P01CA47179 (to C. R. A. and R. G. M.), the Life Raft Group (to C. R. A.), the GIST Cancer Research Fund (to C. R. A.), the Shuman Family Fund for GIST Research (to P. C., C. R. A. and R. G. M.), Cycle for Survival (to R. G. M.), Startup Funds from the Albert Einstein College of Medicine (to D.Z.), National Institutes of Health (GM40922, to C. D. A.) and the Starr Cancer Consortium (to P. C., Y.C., C. L. S. and C. D. A.). We thank the International Genomics Consortium for generating ExpO data. We thank G. Wang, P. Iaquinta, and H. Hieronymus for discussions, and especially T. M. Jessell and J. N. Betley for providing and breeding Etv1<SUP>-/-</SUP> mice.	Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Antonescu CR, 2006, SEMIN DIAGN PATHOL, V23, P63, DOI 10.1053/j.semdp.2006.08.003; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bauer S, 2006, CANCER RES, V66, P9153, DOI 10.1158/0008-5472.CAN-06-0165; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Chen H, 2007, PHYSIOL GENOMICS, V31, P492, DOI 10.1152/physiolgenomics.00113.2007; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Jane-Valbuena J, 2010, CANCER RES, V70, P2075, DOI 10.1158/0008-5472.CAN-09-3092; Kindblom LG, 1998, AM J PATHOL, V152, P1259; Kwon JG, 2009, GASTROENTEROLOGY, V136, P630, DOI 10.1053/j.gastro.2008.10.031; Mertens F, 2009, SEMIN ONCOL, V36, P312, DOI 10.1053/j.seminoncol.2009.06.004; Miettinen M, 2006, ARCH PATHOL LAB MED, V130, P1466; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Nakai N, 2008, J PATHOL, V214, P302, DOI 10.1002/path.2296; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Ostrowski J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-413; Rubin BP, 2005, CANCER RES, V65, P6631, DOI 10.1158/0008-5472.CAN-05-0891; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Segal NH, 2003, AM J PATHOL, V163, P691, DOI 10.1016/S0002-9440(10)63696-6; Sommer G, 2003, P NATL ACAD SCI USA, V100, P6706, DOI 10.1073/pnas.1037763100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Ward SM, 2001, AM J PHYSIOL-GASTR L, V281, pG602, DOI 10.1152/ajpgi.2001.281.3.G602; Yamaguchi U, 2008, J CLIN ONCOL, V26, P4100, DOI 10.1200/JCO.2007.14.2331; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	33	213	226	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2010	467	7317					849	U117		10.1038/nature09409	http://dx.doi.org/10.1038/nature09409			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20927104	Green Accepted			2022-12-01	WOS:000282898700068
J	Jeste, DV; Harris, JC				Jeste, Dilip V.; Harris, James C.			Wisdom-A Neuroscience Perspective	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SELF		[Jeste, Dilip V.] Univ Calif San Diego, Sam & Rose Stein Inst Res Aging, La Jolla, CA 92093 USA; [Jeste, Dilip V.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Jeste, Dilip V.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Harris, James C.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Harris, James C.] Johns Hopkins Univ, Sch Med, Dept Behav Sci & Pediat, Baltimore, MD 21205 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Johns Hopkins University; Johns Hopkins University	Jeste, DV (corresponding author), Univ Calif San Diego, Sam & Rose Stein Inst Res Aging, 9500 Gilman Dr,Mail Code 0664, La Jolla, CA 92093 USA.	djeste@ucsd.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH080002] Funding Source: NIH RePORTER; NIMH NIH HHS [MH080002] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ARDELT M, 1997, J GERONTOL B-PSYCHOL, V52, P15, DOI DOI 10.1093/GERONB/52B.1.P15; Cato MA, 2004, J INT NEUROPSYCH SOC, V10, P453, DOI 10.1017/S1355617704103123; Feder A, 2009, NAT REV NEUROSCI, V10, P446, DOI 10.1038/nrn2649; Grossmann I, 2010, P NATL ACAD SCI USA, V107, P7246, DOI 10.1073/pnas.1001715107; Jeste DV, 2008, PSYCHIATRY, V71, P197, DOI 10.1521/psyc.2008.71.3.197; Lou HC, 2010, HUM BRAIN MAPP, V31, P185, DOI 10.1002/hbm.20855; Meeks TW, 2009, ARCH GEN PSYCHIAT, V66, P355, DOI 10.1001/archgenpsychiatry.2009.8; Miller BL, 2001, NEUROLOGY, V57, P817, DOI 10.1212/WNL.57.5.817; Parisi JM, 2009, EDUC GERONTOL, V35, P867, DOI 10.1080/03601270902782453; Sternberg R. J., 2005, HDB WISDOM PSYCHOL P	10	22	25	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2010	304	14					1602	1603		10.1001/jama.2010.1458	http://dx.doi.org/10.1001/jama.2010.1458			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662OE	20940386				2022-12-01	WOS:000282816500025
J	Mohammadi, D				Mohammadi, Dara			Public health insecticide development: a status of hiatus	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Mohammadi, D (corresponding author), The Lancet, London NW1 7BY, England.							Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004	1	0	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 9	2010	376	9748					1207	1207		10.1016/S0140-6736(10)61859-4	http://dx.doi.org/10.1016/S0140-6736(10)61859-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	664ZT	20934581				2022-12-01	WOS:000283003500010
J	Hazen, TC; Dubinsky, EA; DeSantis, TZ; Andersen, GL; Piceno, YM; Singh, N; Jansson, JK; Probst, A; Borglin, SE; Fortney, JL; Stringfellow, WT; Bill, M; Conrad, ME; Tom, LM; Chavarria, KL; Alusi, TR; Lamendella, R; Joyner, DC; Spier, C; Baelum, J; Auer, M; Zemla, ML; Chakraborty, R; Sonnenthal, EL; D'haeseleer, P; Holman, HYN; Osman, S; Lu, ZM; Van Nostrand, JD; Deng, Y; Zhou, JZ; Mason, OU				Hazen, Terry C.; Dubinsky, Eric A.; DeSantis, Todd Z.; Andersen, Gary L.; Piceno, Yvette M.; Singh, Navjeet; Jansson, Janet K.; Probst, Alexander; Borglin, Sharon E.; Fortney, Julian L.; Stringfellow, William T.; Bill, Markus; Conrad, Mark E.; Tom, Lauren M.; Chavarria, Krystle L.; Alusi, Thana R.; Lamendella, Regina; Joyner, Dominique C.; Spier, Chelsea; Baelum, Jacob; Auer, Manfred; Zemla, Marcin L.; Chakraborty, Romy; Sonnenthal, Eric L.; D'haeseleer, Patrik; Holman, Hoi-Ying N.; Osman, Shariff; Lu, Zhenmei; Van Nostrand, Joy D.; Deng, Ye; Zhou, Jizhong; Mason, Olivia U.			Deep-Sea Oil Plume Enriches Indigenous Oil-Degrading Bacteria	SCIENCE			English	Article							PETROLEUM-HYDROCARBONS; GEN.-NOV.; CRUDE-OIL; COMMUNITIES; TEMPERATURES; ANTARCTICA; GEOCHIP; SPILL	The biological effects and expected fate of the vast amount of oil in the Gulf of Mexico from the Deepwater Horizon blowout are unknown owing to the depth and magnitude of this event. Here, we report that the dispersed hydrocarbon plume stimulated deep-sea indigenous gamma-Proteobacteria that are closely related to known petroleum degraders. Hydrocarbon-degrading genes coincided with the concentration of various oil contaminants. Changes in hydrocarbon composition with distance from the source and incubation experiments with environmental isolates demonstrated faster-than-expected hydrocarbon biodegradation rates at 5 degrees C. Based on these results, the potential exists for intrinsic bioremediation of the oil plume in the deep-water column without substantial oxygen drawdown.	[Hazen, Terry C.; Dubinsky, Eric A.; DeSantis, Todd Z.; Andersen, Gary L.; Piceno, Yvette M.; Singh, Navjeet; Jansson, Janet K.; Probst, Alexander; Borglin, Sharon E.; Fortney, Julian L.; Stringfellow, William T.; Bill, Markus; Conrad, Mark E.; Tom, Lauren M.; Chavarria, Krystle L.; Alusi, Thana R.; Lamendella, Regina; Joyner, Dominique C.; Baelum, Jacob; Auer, Manfred; Zemla, Marcin L.; Chakraborty, Romy; Sonnenthal, Eric L.; Holman, Hoi-Ying N.; Osman, Shariff; Zhou, Jizhong; Mason, Olivia U.] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; [Stringfellow, William T.; Spier, Chelsea] Univ Pacific, Ecol Engn Res Program, Stockton, CA 95211 USA; [Lu, Zhenmei; Van Nostrand, Joy D.; Deng, Ye; Zhou, Jizhong] Univ Oklahoma, Norman, OK 73072 USA; [D'haeseleer, Patrik] Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Livermore, CA 94550 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of the Pacific; University of Oklahoma System; University of Oklahoma - Norman; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Hazen, TC (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, MS 70A-3317,1 Cyclotron Rd, Berkeley, CA 94720 USA.	tchazen@lbl.gov	Van Nostrand, Joy D/F-1740-2016; Chakraborty, Romy/D-9230-2015; Deng, Ye/X-4358-2019; Bælum, Jacob/I-2353-2013; Bill, Markus/D-8478-2013; Piceno, Yvette/I-6738-2016; Stringfellow, William T/O-4389-2015; Tom, Lauren/E-9739-2015; Jansson, Janet/H-5478-2018; Probst, Alexander J/K-2813-2016; Dubinsky, Eric A/D-3787-2015; Holman, Hoi-Ying/N-8451-2014; Mason, Olivia/AAP-2627-2021; 1.4, ALS Beamline/I-1886-2014; Hazen, Terry C/C-1076-2012; 吴, 昊/AAB-1620-2020; Andersen, Gary/G-2792-2015; Sonnenthal, Eric LLoyd/A-4336-2009; Borglin, Sharon E/I-1013-2016; Lu, Zhenmei/I-3218-2014; Conrad, Mark E/G-2767-2010; 5.4, ALS Beamline/I-2863-2014	Van Nostrand, Joy D/0000-0001-9548-6450; Chakraborty, Romy/0000-0001-9326-554X; Deng, Ye/0000-0002-7584-0632; Bælum, Jacob/0000-0002-1022-6586; Bill, Markus/0000-0001-7002-2174; Piceno, Yvette/0000-0002-7915-4699; Stringfellow, William T/0000-0003-3189-5604; Jansson, Janet/0000-0002-5487-4315; Dubinsky, Eric A/0000-0002-9420-6661; Holman, Hoi-Ying/0000-0002-7534-2625; Hazen, Terry C/0000-0002-2536-9993; Andersen, Gary/0000-0002-1618-9827; Sonnenthal, Eric LLoyd/0000-0003-2987-3481; Conrad, Mark E/0000-0001-9509-7324; D'haeseleer, Patrik/0000-0003-0007-8150; Probst, Alexander/0000-0002-9392-6544	University of California at Berkeley, Energy Biosciences Institute under U.S. Department of Energy [DE-AC02-05CH11231]; University of Oklahoma Research Foundation; British Petroleum; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy	University of California at Berkeley, Energy Biosciences Institute under U.S. Department of Energy; University of Oklahoma Research Foundation; British Petroleum; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by a subcontract from the University of California at Berkeley, Energy Biosciences Institute, to Lawrence Berkeley National Laboratory under U.S. Department of Energy contract DE-AC02-05CH11231 and by the University of Oklahoma Research Foundation. The Energy Biosciences Institute is funded by British Petroleum. The SR-FTIR work was conducted at the infrared beamline at the Advanced Light Source, which is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy. We thank T. Pollard, K. Keller, M. Carrera, P. Willems, P. Carragher, P. Collinson, S. Lisiecki, P. Vaishampayan, R. Graham, J. Wong, N. Duncan, D. Long, and N. Tam for logistical and technical support. We also thank the captain, crew, and science teams aboard the R/V Ocean Veritas and the R/V Brooks McCall. The National Center for Biotechnology Information accession numbers of the 16S rRNA genes retrieved from clone library analyses are HM587888, HM587889, and HM587890. Sequences for 16S rRNA are also available at greengenes.lbl.gov.	Aries E, 2001, ORG GEOCHEM, V32, P891, DOI 10.1016/S0146-6380(01)00052-3; Atlas R, 2009, MICROB BIOTECHNOL, V2, P213, DOI 10.1111/j.1751-7915.2008.00079.x; Brakstad OG, 2006, BIODEGRADATION, V17, P71, DOI 10.1007/s10532-005-3342-8; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Gentile G, 2006, ENVIRON MICROBIOL, V8, P2150, DOI 10.1111/j.1462-2920.2006.01097.x; He ZL, 2007, ISME J, V1, P67, DOI 10.1038/ismej.2007.2; He ZL, 2010, ISME J, V4, P1167, DOI 10.1038/ismej.2010.46; Judson RS, 2010, ENVIRON SCI TECHNOL, V44, P5979, DOI 10.1021/es102150z; Kovac N, 2002, MAR CHEM, V78, P205, DOI 10.1016/S0304-4203(02)00033-6; Macnaughton SJ, 1999, APPL ENVIRON MICROB, V65, P3566; Meyers R.A., 2015, ENCY ANAL CHEM, DOI [DOI 10.1002/9780470027318.A0117.PUB2, 10.1002/9780470027318.a0117.pub2]; Pfiffner SM, 2006, GEOMICROBIOL J, V23, P431, DOI 10.1080/01490450600875712; ROBINSON N, 2000, WEARCHECK TECH B; Schlosser A, 2008, INT J SYST EVOL MICR, V58, P2122, DOI 10.1099/ijs.0.65767-0; Socrates G., 2002, INFRARED RAMAN CHARA; Venosa AD, 2007, MAR POLLUT BULL, V54, P545, DOI 10.1016/j.marpolbul.2006.12.013; Yakimov MM, 2007, CURR OPIN BIOTECH, V18, P257, DOI 10.1016/j.copbio.2007.04.006; Yakimov MM, 2004, FEMS MICROBIOL ECOL, V49, P419, DOI 10.1016/j.femsec.2004.04.018; Yakimov MM, 2003, INT J SYST EVOL MICR, V53, P779, DOI 10.1099/ijs.0.02366-0	19	818	858	16	900	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					204	208		10.1126/science.1195979	http://dx.doi.org/10.1126/science.1195979			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20736401	Green Submitted			2022-12-01	WOS:000282644600037
J	Kuehne, SA; Cartman, ST; Heap, JT; Kelly, ML; Cockayne, A; Minton, NP				Kuehne, Sarah A.; Cartman, Stephen T.; Heap, John T.; Kelly, Michelle L.; Cockayne, Alan; Minton, Nigel P.			The role of toxin A and toxin B in Clostridium difficile infection	NATURE			English	Article							DIARRHEA; STRAIN; RESISTANT; GENOME	Clostridium difficile infection is the leading cause of healthcare-associated diarrhoea in Europe and North America(1,2). During infection, C. difficile produces two key virulence determinants, toxin A and toxin B. Experiments with purified toxins have indicated that toxin A alone is able to evoke the symptoms of C. difficile infection, but toxin B is unable to do so unless it is mixed with toxin A or there is prior damage to the gut mucosa(3). However, a recent study indicated that toxin B is essential for C. difficile virulence and that a strain producing toxin A alone was avirulent(4). This creates a paradox over the individual importance of toxin A and toxin B. Here we show that isogenic mutants of C. difficile producing either toxin A or toxin B alone can cause fulminant disease in the hamster model of infection. By using a gene knockout system(5,6) to inactivate the toxin genes permanently, we found that C. difficile producing either one or both toxins showed cytotoxic activity in vitro that translated directly into virulence in vivo. Furthermore, by constructing the first ever double-mutant strain of C. difficile, in which both toxin genes were inactivated, we were able to completely attenuate virulence. Our findings re-establish the importance of both toxin A and toxin B and highlight the need to continue to consider both toxins in the development of diagnostic tests and effective countermeasures against C. difficile.	[Kuehne, Sarah A.; Cartman, Stephen T.; Heap, John T.; Kelly, Michelle L.; Cockayne, Alan; Minton, Nigel P.] Univ Nottingham, NIHR Biomed Res Unit, Nottingham Digest Dis Ctr, Sch Mol Med Sci,Ctr Biomol Sci,Clostridia Res Grp, Nottingham NG7 2RD, England	University of Nottingham	Minton, NP (corresponding author), Univ Nottingham, NIHR Biomed Res Unit, Nottingham Digest Dis Ctr, Sch Mol Med Sci,Ctr Biomol Sci,Clostridia Res Grp, Nottingham NG7 2RD, England.	nigel.minton@nottingham.ac.uk	Kuehne, Sarah/AAV-3481-2021	Kuehne, Sarah/0000-0001-6790-8433; Minton, Nigel/0000-0002-9277-1261	UK Medical Research Council [G0601176]; European Union [HEALTH-F3-2008-223585]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F003390/1]; Biotechnology and Biological Sciences Research Council [BB/F003390/1] Funding Source: researchfish; Medical Research Council [G0601176] Funding Source: researchfish; BBSRC [BB/F003390/1] Funding Source: UKRI; MRC [G0601176] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	S.A.K., S.T.C., A.C. and N.P.M. acknowledge the financial support of the UK Medical Research Council (G0601176). Support for M.L.K. was provided by the European Union (HEALTH-F3-2008-223585) and for J.T.H. by the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/F003390/1). We thank C. von-Eichel Streiber for supplying the neutralizing antibody serums and Y. Mahida for the Vero cells. We are also grateful to A. Olling and R. Gerhard for methodological advice on western blots.	Alfa MJ, 2000, J CLIN MICROBIOL, V38, P2706, DOI 10.1128/JCM.38.7.2706-2714.2000; Cartman ST, 2010, APPL ENVIRON MICROB, V76, P1103, DOI 10.1128/AEM.02525-09; Chaves-Olarte E, 2003, J BIOL CHEM, V278, P7956, DOI 10.1074/jbc.M209244200; Drudy D, 2007, INFECT CONT HOSP EP, V28, P932, DOI 10.1086/519181; Drudy D, 2007, INT J INFECT DIS, V11, P5, DOI 10.1016/j.ijid.2006.04.003; Du Tim, 2004, Can J Infect Dis, V15, P83; Elliott B, 2007, INTERN MED J, V37, P561, DOI 10.1111/j.1445-5994.2007.01403.x; HACHLER H, 1987, ANTIMICROB AGENTS CH, V31, P1039, DOI 10.1128/AAC.31.7.1039; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2010, J MICROBIOL METH, V80, P49, DOI 10.1016/j.mimet.2009.10.018; Heap JT, 2009, J MICROBIOL METH, V78, P79, DOI 10.1016/j.mimet.2009.05.004; Hussain HA, 2005, J MED MICROBIOL, V54, P137, DOI 10.1099/jmm.0.45790-0; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; KIM PH, 1987, INFECT IMMUN, V55, P2984, DOI 10.1128/IAI.55.12.2984-2992.1987; LYERLY DM, 1985, INFECT IMMUN, V47, P349, DOI 10.1128/IAI.47.2.349-352.1985; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; O'Connor JR, 2006, MOL MICROBIOL, V61, P1335, DOI 10.1111/j.1365-2958.2006.05315.x; Poutanen SM, 2004, CAN MED ASSOC J, V171, P51, DOI 10.1503/cmaj.1031189; Sambrook JF., 2001, MOL CLONING LAB MANU; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Stabler RA, 2008, J MED MICROBIOL, V57, P771, DOI 10.1099/jmm.0.47743-0; TORRES J, 1992, TOXICON, V30, P419, DOI 10.1016/0041-0101(92)90538-G; TORRES JF, 1991, J MED MICROBIOL, V35, P40, DOI 10.1099/00222615-35-1-40; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; WILLIAMS DR, 1990, J GEN MICROBIOL, V136, P819, DOI 10.1099/00221287-136-5-819	26	579	602	1	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2010	467	7316					711	U97		10.1038/nature09397	http://dx.doi.org/10.1038/nature09397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659NE	20844489	Green Submitted			2022-12-01	WOS:000282572500039
J	Drake, JM; Griffen, BD				Drake, John M.; Griffen, Blaine D.			Early warning signals of extinction in deteriorating environments	NATURE			English	Article							REGIME SHIFTS; POPULATIONS; STOCHASTICITY; ECOSYSTEMS; SYSTEM; TIMES	During the decline to extinction, animal populations may present dynamical phenomena not exhibited by robust populations(1,2). Some of these phenomena, such as the scaling of demographic variance, are related to small size(3-6) whereas others result from density-dependent nonlinearities(7). Although understanding the causes of population extinction has been a central problem in theoretical biology for decades(8), the ability to anticipate extinction has remained elusive(9). Here we argue that the causes of a population's decline are central to the predictability of its extinction. Specifically, environmental degradation may cause a tipping point in population dynamics, corresponding to a bifurcation in the underlying population growth equations, beyond which decline to extinction is almost certain. In such cases, imminent extinction will be signalled by critical slowing down (CSD). We conducted an experiment with replicate laboratory populations of Daphnia magna to test this hypothesis. We show that populations crossing a transcritical bifurcation, experimentally induced by the controlled decline in environmental conditions, show statistical signatures of CSD after the onset of environmental deterioration and before the critical transition. Populations in constant environments did not have these patterns. Four statistical indicators all showed evidence of the approaching bifurcation as early as 110 days (similar to 8 generations) before the transition occurred. Two composite indices improved predictability, and comparative analysis showed that early warning signals based solely on observations in deteriorating environments without reference populations for standardization were hampered by the presence of transient dynamics before the onset of deterioration, pointing to the importance of reliable baseline data before environmental deterioration begins. The universality of bifurcations in models of population dynamics suggests that this phenomenon should be general(10-12).	[Drake, John M.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Griffen, Blaine D.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University System of Georgia; University of Georgia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Drake, JM (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.	jdrake@uga.edu	Drake, John/D-6622-2012; Griffen, Blaine/AAC-6384-2021	Drake, John/0000-0003-4646-1235	Odum School of Ecology, University of Georgia; University of South Carolina	Odum School of Ecology, University of Georgia; University of South Carolina	G. Fussman, A. Hastings, A. Kramer, R. Hall, A. Park and T. Stratmann provided comments on earlier versions of this paper. A. Silletti assisted with the preparation of the manuscript. This research was supported by funding from the Odum School of Ecology, a University of Georgia Faculty Research Grant and funding from the University of South Carolina.	BAILLIE JEM, 2004, 2004 IUCN RED LIST T, P10; Becks L, 2005, NATURE, V435, P1226, DOI 10.1038/nature03627; Biggs R, 2009, P NATL ACAD SCI USA, V106, P826, DOI 10.1073/pnas.0811729106; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dakos V, 2010, THEOR ECOL-NETH, V3, P163, DOI 10.1007/s12080-009-0060-6; Drake JM, 2005, PLOS BIOL, V3, P1300, DOI 10.1371/journal.pbio.0030222; Drake JM, 2006, ECOLOGY, V87, P2215, DOI 10.1890/0012-9658(2006)87[2215:ETIEP]2.0.CO;2; Fagan WF, 2006, ECOL LETT, V9, P51, DOI 10.1111/j.1461-0248.2005.00845.x; Fussmann GF, 2000, SCIENCE, V290, P1358, DOI 10.1126/science.290.5495.1358; Guttal V, 2008, ECOL LETT, V11, P450, DOI 10.1111/j.1461-0248.2008.01160.x; HALLAM TG, 1981, J THEOR BIOL, V93, P303, DOI 10.1016/0022-5193(81)90106-5; Hastings A, 2010, ECOL LETT, V13, P464, DOI 10.1111/j.1461-0248.2010.01439.x; Jagers P, 2002, J APPL PROBAB, V39, P395, DOI 10.1017/S0021900200022609; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; KENDALL DG, 1948, ANN MATH STAT, V19, P1, DOI 10.1214/aoms/1177730285; Lande R, 1998, OIKOS, V83, P353, DOI 10.2307/3546849; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Ludwig D, 1996, AM NAT, V147, P506, DOI 10.1086/285863; Ludwig D, 1999, ECOLOGY, V80, P298, DOI 10.2307/176998; McSharry PE, 2003, NAT MED, V9, P241, DOI 10.1038/nm0303-241; Melbourne BA, 2008, NATURE, V454, P100, DOI 10.1038/nature06922; Oborny B, 2005, OIKOS, V109, P291; Saether, 2003, STOCHASTIC POPULATIO, DOI [10.1093/acprof:oso/9780198525257.001.0001, DOI 10.1093/ACPROF:OSO/9780198525257.001.0001]; Scheffer M., 2009, CRITICAL TRANSITIONS; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Takimoto G, 2009, POPUL ECOL, V51, P419, DOI 10.1007/s10144-009-0148-2; VAN NES EH, 2007, AM NAT, V169, P738; WISSEL C, 1984, OECOLOGIA, V65, P101, DOI 10.1007/BF00384470	30	348	363	5	234	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2010	467	7314					456	459		10.1038/nature09389	http://dx.doi.org/10.1038/nature09389			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KO	20827269				2022-12-01	WOS:000282090200042
J	Lowe, AJ; Carlin, JB; Bennett, CM; Hosking, CS; Allen, KJ; Robertson, CF; Axelrad, C; Abramson, MJ; Hill, DJ; Dharmage, SC				Lowe, Adrian J.; Carlin, John B.; Bennett, Catherine M.; Hosking, Clifford S.; Allen, Katrina J.; Robertson, Colin F.; Axelrad, Christine; Abramson, Michael J.; Hill, David J.; Dharmage, Shyamali C.			Paracetamol use in early life and asthma: prospective birth cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GLUTATHIONE LEVELS; MEDICATION USE; RISK; ACETAMINOPHEN; CHILDREN; ASSOCIATION; INFECTIONS; IBUPROFEN; DISEASE; SENSITIZATION	Objective To determine if use of paracetamol in early life is an independent risk factor for childhood asthma. Design Prospective birth cohort study. Setting Melbourne Atopy Cohort Study. Participants 620 children with a family history of allergic disease, with paracetamol use prospectively documented on 18 occasions from birth to 2 years of age, followed until age 7 years. Main outcome measures The primary outcome was childhood asthma, ascertained by questionnaire at 6 and 7 years. Secondary outcomes were infantile wheeze, allergic rhinitis, eczema, and skin prick test positivity. Results Paracetamol had been used in 51% (295/575) of children by 12 weeks of age and in 97% (556/575) by 2 years. Between 6 and 7 years, 80% (495/620) were followed up; 30% (148) had current asthma. Increasing frequency of paracetamol use was weakly associated with increased risk of childhood asthma (crude odds ratio 1.18, 95% confidence interval 1.00 to 1.39, per doubling of days of use). However, after adjustment for frequency of respiratory infections, this association essentially disappeared (odds ratio 1.08, 0.91 to 1.29). Paracetamol use for non-respiratory causes was not associated with asthma (crude odds ratio 0.95, 0.81 to 1.12). Conclusions In children with a family history of allergic diseases, no association was found between early paracetamol use and risk of subsequent allergic disease after adjustment for respiratory infections or when paracetamol use was restricted to non-respiratory tract infections. These findings suggest that early paracetamol use does not increase the risk of asthma.	[Lowe, Adrian J.; Carlin, John B.; Allen, Katrina J.; Robertson, Colin F.; Axelrad, Christine; Hill, David J.; Dharmage, Shyamali C.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Lowe, Adrian J.; Carlin, John B.; Bennett, Catherine M.; Dharmage, Shyamali C.] Univ Melbourne, Sch Pop Hlth, Ctr Mol Environm Genet & Anal Epidemiol, Carlton, Vic 3053, Australia; [Hosking, Clifford S.] John Hunter Childrens Hosp New Lambton, Dept Paediat, Newcastle, NSW 2305, Australia; [Abramson, Michael J.] Monash Univ, Alfred Hosp, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; Monash University	Lowe, AJ (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.	lowe.adrian@gmail.com	Allen, Katrina/I-4361-2018; Carlin, John B/B-3492-2012; Abramson, Michael/AAQ-2671-2020; Carlin, John/AAG-4332-2020	Allen, Katrina/0000-0002-1921-4493; Carlin, John B/0000-0002-2694-9463; Abramson, Michael/0000-0002-9954-0538; Carlin, John/0000-0002-2694-9463; Bennett, Catherine/0000-0001-9581-1612; Dharmage, Shyamali/0000-0001-6063-1937; Lowe, Adrian/0000-0002-4691-8162	Dairy Australia; CRC for Asthma; National Health and Medical Research Council; Nestec, a subsidiary of Nestle Australia; GlaxoSmithKline; Reckitt Benckiser	Dairy Australia(Dairy Australia); CRC for Asthma(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Nestec, a subsidiary of Nestle Australia(Nestle SA); GlaxoSmithKline(GlaxoSmithKline); Reckitt Benckiser	Dairy Australia, CRC for Asthma, and VicHealth supported AJL during his PhD, when the work presented in the manuscript was first developed. AJL, SCD, and KJA are supported by the National Health and Medical Research Council. Nestec, a subsidiary of Nestle Australia, provided staff funding for the first six years of the study. The funding bodies had no role in the design, analysis, conduct, or reporting of the study. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that (1) DJH has received support from Nestec (a subsidiary of Nestle Australia) for the submitted work; (2) within the previous 3 years, SCD has received a grant from GlaxoSmithKline for unrelated work, MJA received funding from Reckitt Benckiser for an unrelated research project, CFR is on the GlaxoSmithKline Pediatric Asthma Scientific Board, and MJA is on the GlaxoSmithKline Scientific Advisory Committee for the Australian Asthma Study, and these companies might have an interest in the submitted work; (3) all authors their spouses, partners, or children have no other financial relationships that may be relevant to the submitted work; and (4) all authors have no non-financial interests that may be relevant to the submitted work.	AAS K, 1973, INT ARCH ALLER A IMM, V45, P57, DOI 10.1159/000231002; Barr RG, 2008, LANCET, V372, P1011, DOI 10.1016/S0140-6736(08)61417-8; Barr RG, 2004, AM J RESP CRIT CARE, V169, P836, DOI 10.1164/rccm.200304-596OC; Beasley R, 2008, LANCET, V372, P1039, DOI 10.1016/S0140-6736(08)61445-2; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Celedon JC, 2004, CLIN EXP ALLERGY, V34, P1011, DOI 10.1111/j.1365-2222.2004.01994.x; Cohet C, 2004, J EPIDEMIOL COMMUN H, V58, P852, DOI 10.1136/jech.2003.019182; Dimova S, 2005, INT J BIOCHEM CELL B, V37, P1727, DOI 10.1016/j.biocel.2005.03.005; Eneli I, 2005, CHEST, V127, P604, DOI 10.1378/chest.127.2.604; Farquhar H, 2009, J ALLERGY CLIN IMMUN, V124, P649, DOI 10.1016/j.jaci.2009.07.037; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; KOGAN MD, 1994, JAMA-J AM MED ASSOC, V272, P1025, DOI 10.1001/jama.272.13.1025; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Lesko SM, 1999, PEDIATRICS, V104, part. no., DOI 10.1542/peds.104.4.e39; Lesko SM, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e20; Lowe AJ, 2007, CLIN EXP ALLERGY, V37, P1624, DOI 10.1111/j.1365-2222.2007.02822.x; Lowe AJ, 2007, CLIN EXP ALLERGY, V37, P536, DOI 10.1111/j.1365-2222.2007.02691.x; Lowe A, 2009, LANCET, V373, P120, DOI 10.1016/S0140-6736(09)60030-1; Lowe AJ, 2006, J ALLERGY CLIN IMMUN, V117, P682, DOI 10.1016/j.jaci.2005.10.027; McKeever TM, 2005, AM J RESP CRIT CARE, V171, P966, DOI 10.1164/rccm.200409-1269OC; Merkus PJFM, 1996, PEDIATR PULM, V21, P383, DOI 10.1002/(SICI)1099-0496(199606)21:6<383::AID-PPUL6>3.0.CO;2-M; MICHELI L, 1994, ENVIRON HEALTH PERSP, V102, P63, DOI 10.1289/ehp.94102s963; Oddy WH, 2002, EUR RESPIR J, V19, P899, DOI 10.1183/09031936.02.00103602; Perzanowski MS, 2010, THORAX, V65, P118, DOI 10.1136/thx.2009.121459; Rebordosa C, 2008, INT J EPIDEMIOL, V37, P583, DOI 10.1093/ije/dyn070; Rockenbauer M, 2001, EPIDEMIOLOGY, V12, P461, DOI 10.1097/00001648-200107000-00017; Shaheen SO, 2002, THORAX, V57, P958, DOI 10.1136/thorax.57.11.958; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5	29	73	74	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 15	2010	341								c4616	10.1136/bmj.c4616	http://dx.doi.org/10.1136/bmj.c4616			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653LV	20843914	Green Submitted, Green Published, hybrid			2022-12-01	WOS:000282093800015
J	Quanstrum, KH; Hayward, RA				Quanstrum, Kerianne H.; Hayward, Rodney A.			Lessons from the Mammography Wars	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BREAST-CANCER; PREVENTION		[Quanstrum, Kerianne H.; Hayward, Rodney A.] Univ Michigan, Robert Wood Johnson Fdn, Clin Scholars Program, Ann Arbor, MI 48109 USA; [Quanstrum, Kerianne H.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Hayward, Rodney A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Hayward, Rodney A.] VA Ann Arbor Healthcare Syst, VA Hlth Serv Res & Dev Ctr Excellence, Dept Vet Affairs VA, Ann Arbor, MI USA	Robert Wood Johnson Foundation (RWJF); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Quanstrum, KH (corresponding author), Univ Michigan, Robert Wood Johnson Fdn, Clin Scholars Program, Ann Arbor, MI 48109 USA.							Berg AO, 2002, ANN INTERN MED, V137, P344, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00011; BRYNER J, NEW MAMMOGRAM GUIDEL; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Hayward RA, 2005, HEALTH AFFAIR, V24, P1571, DOI 10.1377/hlthaff.24.6.1571; Hayward RA, 2010, ANN INTERN MED, V152, P69, DOI 10.7326/0003-4819-152-2-201001190-00004; Lee CH, 2010, J AM COLL RADIOL, V7, P18, DOI 10.1016/j.jacr.2009.09.022; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; SMITH A, 1911, WEALTH NATIONS 1, P207; Vickers AJ, 2010, SEMIN ONCOL, V37, P31, DOI 10.1053/j.seminoncol.2009.12.004; WALKER EP, USPSTF MEMBERS DEFEN; Zulman DM, 2008, MILBANK Q, V86, P557, DOI 10.1111/j.1468-0009.2008.00534.x	11	89	89	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 9	2010	363	11					1076	1079		10.1056/NEJMsb1002538	http://dx.doi.org/10.1056/NEJMsb1002538			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	647HS	20825322				2022-12-01	WOS:000281609700014
J	Zenilman, A				Zenilman, Ariela			The Hands That Guide Me	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												azenilm1@binghamton.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2010	304	10					1049	1049		10.1001/jama.2010.1291	http://dx.doi.org/10.1001/jama.2010.1291			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646RM	20823426				2022-12-01	WOS:000281559800001
J	Oh, DY; Talukdar, S; Bae, EJ; Imamura, T; Morinaga, H; Fan, WQ; Li, PP; Lu, WJ; Watkins, SM; Olefsky, JM				Oh, Da Young; Talukdar, Saswata; Bae, Eun Ju; Imamura, Takeshi; Morinaga, Hidetaka; Fan, WuQiang; Li, Pingping; Lu, Wendell J.; Watkins, Steven M.; Olefsky, Jerrold M.			GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects	CELL			English	Article							FREE FATTY-ACIDS; PROTEIN-COUPLED RECEPTORS; BETA-ARRESTIN; ADIPOSE-TISSUE; OBESITY; INFLAMMATION; RESISTANCE; ACTIVATION; SECRETION; CELLS	Omega-3 fatty acids (omega-3 FAs), DHA and EPA, exert anti-inflammatory effects, but the mechanisms are poorly understood. Here, we show that the G protein-coupled receptor 120 (GPR120) functions as an omega-3 FA receptor/sensor. Stimulation of GPR120 with omega-3 FAs or a chemical agonist causes broad anti-inflammatory effects in monocytic RAW 264.7 cells and in primary intraperitoneal macrophages. All of these effects are abrogated by GPR120 knock-down. Since chronic macrophage-mediated tissue inflammation is a key mechanism for insulin resistance in obesity, we fed obese WT and GPR120 knockout mice a high-fat diet with or without omega-3 FA supplementation. The omega-3 FA treatment inhibited inflammation and enhanced systemic insulin sensitivity in WT mice, but was without effect in GPR120 knockout mice. In conclusion, GPR120 is a functional omega-3 FA receptor/sensor and mediates potent insulin sensitizing and antidiabetic effects in vivo by repressing macrophage-induced tissue inflammation.	[Oh, Da Young; Talukdar, Saswata; Bae, Eun Ju; Morinaga, Hidetaka; Fan, WuQiang; Li, Pingping; Lu, Wendell J.; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Imamura, Takeshi] Shiga Univ Med Sci, Div Pharmacol, Otsu, Shiga 5202192, Japan; [Watkins, Steven M.] Tethys Biosci, W Sacramento, CA 95691 USA	University of California System; University of California San Diego; Shiga University of Medical Science	Olefsky, JM (corresponding author), Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA.	jolefsky@ucsd.edu	Eckhardt, Erik/G-1567-2010; OH, DA YOUNG/B-2369-2008; Li, Pingping/F-1109-2019	Li, Pingping/0000-0003-0679-270X; Talukdar, Saswata/0000-0003-3042-0025	National Institutes of Health [NIDDK DK033651, DK063491, DK 074868]; NICHD/NIH [U54 HD 012303-25]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD012303, U54HD012303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK074868, P30DK063491, R01DK033651, R37DK033651] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Jachelle M. Ofrecio and Sarah Nalbandian for their help with animal maintenance and Elizabeth J. Hansen for editorial assistance. We are grateful to Dr. Robert Lefkowitz (Howard Hughes Medical Institute, Duke University) for the gift of FLAG-tagged serial mutant beta-arrestin2 constructs and to Dr. Maziyar Saberi at NGM Bio Inc. (San Francisco, CA) for GLP-1 measurements. We thank the Flow Cytometry Resource and Neal Sekiya for assistance with FACS analysis at the VA San Diego hospital, the UCSD Histology Core lab for technical help with processing liver specimens, and UCSD Microscope Resource for microscopy analysis. This study was funded in part by the National Institutes of Health grants NIDDK DK033651 (J.M.O.), DK063491 (J.M.O.), DK 074868 (J.M.O.), and the Eunice Kennedy Shriver NICHD/NIH through a cooperative agreement U54 HD 012303-25 as part of the specialized Cooperative Centers Program in Reproduction and Infertility Research.	Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; BARON AD, 1988, AM J PHYSIOL, V255, pE769, DOI 10.1152/ajpendo.1988.255.6.E769; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909; Calder PC, 2005, BIOCHEM SOC T, V33, P423, DOI 10.1042/BST0330423; Cen B, 2001, MOL PHARMACOL, V59, P758, DOI 10.1124/mol.59.4.758; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Gotoh C, 2007, BIOCHEM BIOPH RES CO, V354, P591, DOI 10.1016/j.bbrc.2007.01.028; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Imamura T, 1999, MOL CELL BIOL, V19, P6765; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jucker BM, 1999, DIABETES, V48, P134, DOI 10.2337/diabetes.48.1.134; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Lee JY, 2003, J LIPID RES, V44, P479, DOI 10.1194/jlr.M200361-JLR200; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Luttrell LM, 2002, J CELL SCI, V115, P455; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Miller WE, 2001, CURR OPIN CELL BIOL, V13, P139, DOI 10.1016/S0955-0674(00)00190-3; Neschen S, 2007, DIABETES, V56, P1034, DOI 10.2337/db06-1206; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Oh DY, 2005, MOL ENDOCRINOL, V19, P722, DOI 10.1210/me.2004-0220; Polozova A, 2007, J MOL NEUROSCI, V33, P56, DOI 10.1007/s12031-007-0039-y; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Schulte G, 2003, CELL SIGNAL, V15, P813, DOI 10.1016/S0898-6568(03)00058-5; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Tazoe H, 2008, J PHYSIOL PHARMACOL, V59, P251; Ulloa-Aguirre A, 1999, ARCH MED RES, V30, P420, DOI 10.1016/S0188-0128(99)00041-X; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	36	1643	1714	14	276	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2010	142	5					687	698		10.1016/j.cell.2010.07.041	http://dx.doi.org/10.1016/j.cell.2010.07.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	646FL	20813258	Bronze, Green Accepted			2022-12-01	WOS:000281523200013
J	Liu, HR; Jin, L; Koh, SBS; Atanasov, I; Schein, S; Wu, L; Zhou, ZH				Liu, Hongrong; Jin, Lei; Koh, Sok Boon S.; Atanasov, Ivo; Schein, Stan; Wu, Lily; Zhou, Z. Hong			Atomic Structure of Human Adenovirus by Cryo-EM Reveals Interactions Among Protein Networks	SCIENCE			English	Article							CRYOELECTRON MICROSCOPY STRUCTURE; RESOLUTION; HEXON; VECTORS; TYPE-2; DNA; IX; BACTERIOPHAGE-PRD1; VISUALIZATION; ORGANIZATION	Construction of a complex virus may involve a hierarchy of assembly elements. Here, we report the structure of the whole human adenovirus virion at 3.6 angstroms resolution by cryo-electron microscopy (cryo-EM), revealing in situ atomic models of three minor capsid proteins (IIIa, VIII, and IX), extensions of the (penton base and hexon) major capsid proteins, and interactions within three protein-protein networks. One network is mediated by protein IIIa at the vertices, within group-of-six (GOS) tiles-a penton base and its five surrounding hexons. Another is mediated by ropes (protein IX) that lash hexons together to form group-of-nine (GON) tiles and bind GONs to GONs. The third, mediated by IIIa and VIII, binds each GOS to five surrounding GONs. Optimization of adenovirus for cancer and gene therapy could target these networks.	[Liu, Hongrong; Jin, Lei; Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Liu, Hongrong; Jin, Lei; Atanasov, Ivo; Schein, Stan; Wu, Lily; Zhou, Z. Hong] Univ Calif Los Angeles, Calif Nanosyst Inst, Los Angeles, CA 90095 USA; [Liu, Hongrong] Xiangtan Univ, Inst Modern Phys, Xiangtan 411105, Hunan, Peoples R China; [Koh, Sok Boon S.; Wu, Lily] Univ Calif Los Angeles, Sch Med, Inst Mol Med IMED, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Schein, Stan] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Schein, Stan] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Chinese Academy of Sciences; Xiangtan University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Zhou, ZH (corresponding author), Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA.	Hong.Zhou@ucla.edu	Schein, Stan/G-4942-2018; Zhou, Z Hong/HDN-0747-2022		National Institutes of Health [GM071940, AI069015, CA101904, 1S10RR23057]; National Natural Scientific Foundation of China [10874144]; Congressionally Directed Medical Research Programs [W81XWH-06-1-055]; NATIONAL CANCER INSTITUTE [R01CA101904] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Congressionally Directed Medical Research Programs(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Berk for advice; W. H. Hui for imaging, C.-O. Yun and O.-J. Kwon for providing the Ad-Delta E1B19/55 virus sample, and X. Zhang and P. Ge for discussion. This project is supported in part by grants from the National Institutes of Health (GM071940 and AI069015 to Z.H.Z.) and (CA101904 to L.W.). We acknowledge use of facilities at the Electron Imaging Center for NanoMachines supported in part by NIH (1S10RR23057). H.L. thanks the National Natural Scientific Foundation of China for support (10874144). S.B.K. was supported by Congressionally Directed Medical Research Programs W81XWH-06-1-055 predoctoral training program. Our structure and atomic model have been deposited in the EM Data Bank and the Protein Data Bank with accession numbers EMD-5172 and 3IYN, respectively.	Abrescia NGA, 2004, NATURE, V432, P68, DOI 10.1038/nature03056; Berk A.J., 2007, FIELDS VIROLOGY, VII, P2356; BOUDIN ML, 1980, VIROLOGY, V101, P144, DOI 10.1016/0042-6822(80)90491-2; BURNETT RM, 1985, J MOL BIOL, V185, P125, DOI 10.1016/0022-2836(85)90187-1; Cockburn JJB, 2004, NATURE, V432, P122, DOI 10.1038/nature03053; COLBY WW, 1981, J VIROL, V39, P977, DOI 10.1128/JVI.39.3.977-980.1981; CROWTHER R A, 1972, Journal of Molecular Biology, V68, P181, DOI 10.1016/0022-2836(72)90273-2; Deng BB, 2007, J VIROL, V81, P3640, DOI 10.1128/JVI.02254-06; EVERITT E, 1975, VIROLOGY, V67, P197, DOI 10.1016/0042-6822(75)90417-1; Everts M, 2004, CURR GENE THER, V4, P337; Fabry CMS, 2009, J VIROL, V83, P1135, DOI 10.1128/JVI.01808-08; Fabry CMS, 2005, EMBO J, V24, P1645, DOI 10.1038/sj.emboj.7600653; Jiang W, 2006, NATURE, V439, P612, DOI 10.1038/nature04487; LAVER WG, 1968, J MOL BIOL, V37, P379, DOI 10.1016/0022-2836(68)90109-5; Lehmberg E, 1999, J CHROMATOGR B, V732, P411, DOI 10.1016/S0378-4347(99)00316-3; Liang YY, 2002, J STRUCT BIOL, V137, P292, DOI 10.1016/S1047-8477(02)00014-X; Marsh MP, 2006, J VIROL, V80, P11881, DOI 10.1128/JVI.01471-06; Matthews DA, 1998, J GEN VIROL, V79, P1671, DOI 10.1099/0022-1317-79-7-1671; McGrath WJ, 2003, BBA-PROTEINS PROTEOM, V1648, P1, DOI 10.1016/S1570-9639(03)00024-4; Ostapchuk P, 2005, J CELL BIOCHEM, V96, P25, DOI 10.1002/jcb.20523; Perez-Berna AJ, 2009, J MOL BIOL, V392, P547, DOI 10.1016/j.jmb.2009.06.057; PRAGE L, 1972, VIROLOGY, V49, P745, DOI 10.1016/0042-6822(72)90531-4; Roberts DM, 2006, NATURE, V441, P239, DOI 10.1038/nature04721; ROBERTS MM, 1986, SCIENCE, V232, P1148, DOI 10.1126/science.3704642; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Russell WC, 2009, J GEN VIROL, V90, P1, DOI 10.1099/vir.0.003087-0; Rux JJ, 2003, J VIROL, V77, P9553, DOI 10.1128/JVI.77.17.9553-9566.2003; Saban SD, 2006, J VIROL, V80, P12049, DOI 10.1128/JVI.01652-06; Sargent KL, 2004, GENE THER, V11, P504, DOI 10.1038/sj.gt.3302107; Silvestry M, 2009, J VIROL, V83, P7375, DOI 10.1128/JVI.00331-09; Smith AC, 2009, J VIROL, V83, P2025, DOI 10.1128/JVI.01644-08; SMITH KO, 1965, J BACTERIOL, V90, P254, DOI 10.1128/JB.90.1.254-261.1965; STEWART PL, 1991, CELL, V67, P145, DOI 10.1016/0092-8674(91)90578-M; STEWART PL, 1993, EMBO J, V12, P2589, DOI 10.1002/j.1460-2075.1993.tb05919.x; Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013; van Raaij MJ, 1999, NATURE, V401, P935, DOI 10.1038/44880; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Wiethoff CM, 2005, J VIROL, V79, P1992, DOI 10.1128/JVI.79.4.1992-2000.2005; Yan M, 2010, NAT NANOTECHNOL, V5, P48, DOI [10.1038/NNANO.2009.341, 10.1038/nnano.2009.341]; Zubieta C, 2005, MOL CELL, V17, P121, DOI 10.1016/j.molcel.2004.11.041	40	263	276	3	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 27	2010	329	5995					1038	1043		10.1126/science.1187433	http://dx.doi.org/10.1126/science.1187433			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642WZ	20798312	Green Accepted			2022-12-01	WOS:000281253500030
J	Frieden, TR; Collins, FS				Frieden, Thomas R.; Collins, Francis S.			Intentional Infection of Vulnerable Populations in 1946-1948 Another Tragic History Lesson	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Frieden, Thomas R.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Collins, Francis S.] NIH, Bethesda, MD 20892 USA	Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA	Frieden, TR (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS D-14, Atlanta, GA 30333 USA.	txf2@cdc.gov		Frieden, Thomas/0000-0002-4759-2256				[Anonymous], 1979, BELMONT REPORT ETHIC; Lederer S.E., 1995, SUBJECTED SCI HUMAN; MAGNUSON HJ, 1956, MEDICINE, V35, P33, DOI 10.1097/00005792-195602000-00002; MAHONEY J F, 1946, Am J Syph Gonorrhea Vener Dis, V30, P1; Office of Human Subjects Research National Institutes of Health, REG ETH GUID; Reverby Susan M., 2009, EXAMINING TUSKEGEE I; SUSAN M, REVERBY FACULTY PAGE; *US DEP HHS, INF 1946 1948 US PUB	8	24	24	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 10	2010	304	18					2063	2064		10.1001/jama.2010.1554	http://dx.doi.org/10.1001/jama.2010.1554			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	677OB	20937719	Green Published			2022-12-01	WOS:000284000600028
J	Bodin, K; Ellmerich, S; Kahan, MC; Tennent, GA; Loesch, A; Gilbertson, JA; Hutchinson, WL; Mangione, PP; Gallimore, JR; Millar, DJ; Minogue, S; Dhillon, AP; Taylor, GW; Bradwell, AR; Petrie, A; Gillmore, JD; Bellotti, V; Botto, M; Hawkins, PN; Pepys, MB				Bodin, Karl; Ellmerich, Stephan; Kahan, Melvyn C.; Tennent, Glenys A.; Loesch, Andrzej; Gilbertson, Janet A.; Hutchinson, Winston L.; Mangione, Palma P.; Gallimore, J. Ruth; Millar, David J.; Minogue, Shane; Dhillon, Amar P.; Taylor, Graham W.; Bradwell, Arthur R.; Petrie, Aviva; Gillmore, Julian D.; Bellotti, Vittorio; Botto, Marina; Hawkins, Philip N.; Pepys, Mark B.			Antibodies to human serum amyloid P component eliminate visceral amyloid deposits	NATURE			English	Article							PHARMACOLOGICAL DEPLETION; AL AMYLOIDOSIS; COMPLEMENT; FIBRILS; MICE	Accumulation of amyloid fibrils in the viscera and connective tissues causes systemic amyloidosis, which is responsible for about one in a thousand deaths in developed countries(1). Localized amyloid can also have serious consequences; for example, cerebral amyloid angiopathy is an important cause of haemorrhagic stroke. The clinical presentations of amyloidosis are extremely diverse and the diagnosis is rarely made before significant organ damage is present(1). There is therefore a major unmet need for therapy that safely promotes the clearance of established amyloid deposits. Over 20 different amyloid fibril proteins are responsible for different forms of clinically significant amyloidosis and treatments that substantially reduce the abundance of the respective amyloid fibril precursor proteins can arrest amyloid accumulation(1). Unfortunately, control of fibril-protein production is not possible in some forms of amyloidosis and in others it is often slow and hazardous(1). There is no therapy that directly targets amyloid deposits for enhanced clearance. However, all amyloid deposits contain the normal, non-fibrillar plasma glycoprotein, serum amyloid P component (SAP)(2,3). Here we show that administration of anti-human-SAP antibodies to mice with amyloid deposits containing human SAP triggers a potent, complement-dependent, macrophage-derived giant cell reaction that swiftly removes massive visceral amyloid deposits without adverse effects. Anti-SAP-antibody treatment is clinically feasible because circulating human SAP can be depleted in patients by the bis-D-proline compound CPHPC4, thereby enabling injected anti-SAP antibodies to reach residual SAP in the amyloid deposits. The unprecedented capacity of this novel combined therapy to eliminate amyloid deposits should be applicable to all forms of systemic and local amyloidosis.	[Bodin, Karl; Ellmerich, Stephan; Kahan, Melvyn C.; Tennent, Glenys A.; Loesch, Andrzej; Gilbertson, Janet A.; Hutchinson, Winston L.; Mangione, Palma P.; Gallimore, J. Ruth; Millar, David J.; Taylor, Graham W.; Gillmore, Julian D.; Bellotti, Vittorio; Hawkins, Philip N.; Pepys, Mark B.] UCL, Ctr Amyloidosis & Acute Phase Prot, Div Med, London NW3 2PF, England; [Mangione, Palma P.; Bellotti, Vittorio] Univ Pavia, Dipartimento Biochim, I-27100 Pavia, Italy; [Minogue, Shane] UCL, Ctr Mol Cell Biol, Div Med, London NW3 2PF, England; [Dhillon, Amar P.] UCL, Dept Histopathol, London NW3 2PF, England; [Bradwell, Arthur R.] Univ Birmingham, Sch Med, Dept Immun & Infect, Birmingham B15 2TT, W Midlands, England; [Bradwell, Arthur R.] Binding Site Ltd, Birmingham B14 4ZB, W Midlands, England; [Petrie, Aviva] UCL Eastman Dent Inst, Biostat Unit, London WC1X 8LD, England; [Botto, Marina] Univ London Imperial Coll Sci Technol & Med, Fac Med, Rheumatol Sect, London W12 0NN, England	University of London; University College London; University of Pavia; University of London; University College London; University of London; University College London; University of Birmingham; University of London; University College London; Imperial College London	Pepys, MB (corresponding author), UCL, Ctr Amyloidosis & Acute Phase Prot, Div Med, Royal Free Campus,Rowland Hill St, London NW3 2PF, England.	m.pepys@ucl.ac.uk	Bellotti, Vittorio/A-6201-2014	Bellotti, Vittorio/0000-0001-8678-662X; Taylor, Graham/0000-0002-9672-8463; Bradwell, Arthur/0000-0002-1562-1606; Mangione, Palma/0000-0003-0260-1400	Medical Research Council [G97900510]; University College London; Erik and Edith Fernstroms Foundation for Medical Research; Swedish Research Council; Medical Research Council [G0901596, G7900510] Funding Source: researchfish; National Centre for the Replacement [G0800737/1] Funding Source: researchfish; MRC [G7900510, G0901596] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University College London(General Electric); Erik and Edith Fernstroms Foundation for Medical Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by Medical Research Council Programme Grant G97900510 to M.B.P. and P.N.H. and by the University College London Amyloidosis Research Fund. K.B. was supported by the Erik and Edith Fernstroms Foundation for Medical Research and a Postdoctoral Fellowship from the Swedish Research Council. K.B. dedicates his work to his late father, Gunnar Bodin. We thank S. Gordon, S. Wood, S. Kolstoe, J. Raynes, P. Simons and R. Al-Shawi for information, advice, reagents and support, and B. Jones for processing the manuscript.	Argiles A, 2002, NEPHROL DIAL TRANSPL, V17, P1136, DOI 10.1093/ndt/17.6.1136; Botto M, 1997, NAT MED, V3, P855, DOI 10.1038/nm0897-855; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; BREATHNACH SM, 1981, NATURE, V293, P652, DOI 10.1038/293652a0; DEBEER FC, 1982, J IMMUNOL METHODS, V50, P17, DOI 10.1016/0022-1759(82)90300-3; DYCK RF, 1980, J EXP MED, V152, P1162, DOI 10.1084/jem.152.5.1162; Gillmore JD, 2010, BRIT J HAEMATOL, V148, P760, DOI 10.1111/j.1365-2141.2009.08036.x; HAWKINS PN, 1990, CLIN EXP IMMUNOL, V81, P325; HAWKINS PN, 1988, J EXP MED, V167, P903, DOI 10.1084/jem.167.3.903; KLAUS GGB, 1979, IMMUNOLOGY, V38, P687; Lachmann HJ, 2007, NEW ENGL J MED, V356, P2361, DOI 10.1056/NEJMoa070265; Lachmann HJ, 2003, BRIT J HAEMATOL, V122, P78, DOI 10.1046/j.1365-2141.2003.04433.x; Nakamura Y, 1999, PATHOL INT, V49, P898, DOI 10.1046/j.1440-1827.1999.00962.x; Pepys MB, 2006, ANNU REV MED, V57, P223, DOI 10.1146/annurev.med.57.121304.131243; PEPYS MB, 1979, CLIN EXP IMMUNOL, V38, P284; Pepys MB, 2002, NATURE, V417, P254, DOI 10.1038/417254a; Pepys MB, 1997, AMYLOID, V4, P274, DOI 10.3109/13506129709003838; Solomon A, 2003, CANCER BIOTHER RADIO, V18, P853, DOI 10.1089/108497803322702824; Solomon A, 2003, CLIN CANCER RES, V9, p3831S; TENNENT GA, 1995, P NATL ACAD SCI USA, V92, P4299, DOI 10.1073/pnas.92.10.4299; van Rooijen N, 2010, METHODS MOL BIOL, V605, P189, DOI 10.1007/978-1-60327-360-2_13; Verine J, 2007, HUM PATHOL, V38, P1798, DOI 10.1016/j.humpath.2007.04.013; WALL JS, 2010, BLOOD           0603, DOI DOI 10.1182/BLOOD-2010-03-273797; WEISS SW, 1973, AM J PATHOL, V72, P447; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; ZUCKERFRANKLIN D, 1970, J ULTRA MOL STRUCT R, V32, P247, DOI 10.1016/S0022-5320(70)80005-3	26	238	246	0	32	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 4	2010	468	7320					93	97		10.1038/nature09494	http://dx.doi.org/10.1038/nature09494			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674YF	20962779	Green Accepted			2022-12-01	WOS:000283786900042
J	Goldberg, EE; Kohn, JR; Lande, R; Robertson, KA; Smith, SA; Igic, B				Goldberg, Emma E.; Kohn, Joshua R.; Lande, Russell; Robertson, Kelly A.; Smith, Stephen A.; Igic, Boris			Species Selection Maintains Self-Incompatibility	SCIENCE			English	Article							MATING SYSTEMS; POLYMORPHISM; EVOLUTION; DIVERSIFICATION; FERTILIZATION; SPECIATION; DIVERSITY; PLANTS; RATES	Identifying traits that affect rates of speciation and extinction and, hence, explain differences in species diversity among clades is a major goal of evolutionary biology. Detecting such traits is especially difficult when they undergo frequent transitions between states. Self-incompatibility, the ability of hermaphrodites to enforce outcrossing, is frequently lost in flowering plants, enabling self-fertilization. We show, however, that in the nightshade plant family (Solanaceae), species with functional self-incompatibility diversify at a significantly higher rate than those without it. The apparent short-term advantages of potentially self-fertilizing individuals are therefore offset by strong species selection, which favors obligate outcrossing.	[Goldberg, Emma E.; Robertson, Kelly A.; Igic, Boris] Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA; [Kohn, Joshua R.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Lande, Russell] Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot SL5 7PY, Berks, England; [Smith, Stephen A.] Natl Evolutionary Synth Ctr, Durham, NC 27705 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California San Diego; Imperial College London; The National Evolutionary Synthesis Center	Igic, B (corresponding author), Univ Illinois, Dept Biol Sci, 840 W Taylor St,M-C 067, Chicago, IL 60607 USA.	boris@uic.edu	Smith, Stephen/AAE-8623-2019	Smith, Stephen/0000-0003-2035-9531; Goldberg, Emma/0000-0002-7311-9606	NSF [DEB-0919089]; Division Of Environmental Biology [0919089] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank R. FitzJohn, A. Mooers, R. Olmstead, T. Paape, L. Popovic, D. L. Shade, and R. Ree for help and discussions. Data are deposited in the Dryad database with accession no. 1888. Funded by NSF grant DEB-0919089 to B.I.	Barrett SCH, 2003, PHILOS T R SOC B, V358, P991, DOI 10.1098/rstb.2003.1301; Busch JW, 2008, TRENDS PLANT SCI, V13, P128, DOI 10.1016/j.tplants.2008.01.002; Darwin C, 1903, MORE LETT C DARWIN R; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; FitzJohn RG, 2009, SYST BIOL, V58, P595, DOI 10.1093/sysbio/syp067; Franklin-Tong V. E., 2008, P237, DOI 10.1007/978-3-540-68486-2_11; Glemin S, 2006, P ROY SOC B-BIOL SCI, V273, P3011, DOI 10.1098/rspb.2006.3657; Goldberg EE, 2008, EVOLUTION, V62, P2727, DOI 10.1111/j.1558-5646.2008.00505.x; Goodwillie C, 2005, ANNU REV ECOL EVOL S, V36, P47, DOI 10.1146/annurev.ecolsys.36.091704.175539; GOULD SJ, 1982, SCIENCE, V216, P380, DOI 10.1126/science.7041256; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Igic B, 2006, P NATL ACAD SCI USA, V103, P1359, DOI 10.1073/pnas.0506283103; Igic B, 2004, NEW PHYTOL, V161, P97, DOI 10.1046/j.1469-8137.2003.00952.x; Igic B, 2008, INT J PLANT SCI, V169, P93, DOI 10.1086/523362; Igic B, 2006, EVOLUTION, V60, P1098, DOI 10.1111/j.0014-3820.2006.tb01186.x; IOERGER TR, 1990, P NATL ACAD SCI USA, V87, P9732, DOI 10.1073/pnas.87.24.9732; Jablonski D, 2008, ANNU REV ECOL EVOL S, V39, P501, DOI 10.1146/annurev.ecolsys.39.110707.173510; KAROLY K, 1994, AM NAT, V144, P677, DOI 10.1086/285700; Lewontin R.C., 1970, ANNU REV ECOL SYST, V1, P1, DOI [DOI 10.1146/ANNUREV.ES.01.110170.000245, 10.1146/annurev.es.01.110170.000245]; Maddison WP, 2007, SYST BIOL, V56, P701, DOI 10.1080/10635150701607033; Maddison WP, 2006, EVOLUTION, V60, P1743, DOI 10.1554/05-666.1; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Olmstead RG, 2007, ACTA HORTIC, P255, DOI 10.17660/ActaHortic.2007.745.11; Porcher E, 2005, EVOLUTION, V59, P46, DOI 10.1111/j.0014-3820.2005.tb00893.x; Rabosky DL, 2010, TRENDS ECOL EVOL, V25, P68, DOI 10.1016/j.tree.2009.07.002; Schoen DJ, 2008, INT J PLANT SCI, V169, P119, DOI 10.1086/523356; SCHOEN DJ, 1991, P NATL ACAD SCI USA, V88, P4494, DOI 10.1073/pnas.88.10.4494; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; STEBBINS GL, 1974, FLOWERING PLANTS; Steinbachs JE, 2002, MOL BIOL EVOL, V19, P825, DOI 10.1093/oxfordjournals.molbev.a004139; Williams G. C., 1992, NATURAL SELECTION DO; ZAVADA MS, 1986, AM NAT, V128, P538, DOI 10.1086/284586	32	323	328	5	200	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					493	495		10.1126/science.1194513	http://dx.doi.org/10.1126/science.1194513			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966249				2022-12-01	WOS:000283329100036
J	Radu, A; Pichon, C; Camparo, P; Antoine, M; Allory, Y; Couvelard, A; Fromont, G; Hai, MTV; Ghinea, N				Radu, Aurelian; Pichon, Christophe; Camparo, Philippe; Antoine, Martine; Allory, Yves; Couvelard, Anne; Fromont, Gaelle; Hai, Mai Thu Vu; Ghinea, Nicolae			Expression of Follicle-Stimulating Hormone Receptor in Tumor Blood Vessels.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CELL-PROLIFERATION; PROSTATE-CANCER; BREAST-CANCER; FSH; LOCALIZATION; CARCINOMAS; PROTEINS	Background: In adult humans, the follicle-stimulating hormone (FSH) receptor is expressed only in the granulosa cells of the ovary and the Sertoli cells of the testis. It is minimally expressed by the endothelial cells of gonadal blood vessels. Methods: We used immunohistochemical and immunoblotting techniques involving four separate FSH-receptor-specific monoclonal antibodies that recognize different FSH receptor epitopes and in situ hybridization to detect FSH receptor in tissue samples from patients with a wide range of tumors. Immunoelectron microscopy was used to detect FSH receptor in mouse tumors. Results: In all 1336 patients examined, FSH receptor was expressed by endothelial cells in tumors of all grades, including early T1 tumors. The tumors were located in the prostate, breast, colon, pancreas, urinary bladder, kidney, lung, liver, stomach, testis, and ovary. In specimens obtained during surgery performed to remove tumors, the FSH receptor was not expressed in the normal tissues located more than 10 mm from the tumors. The tumor lymphatic vessels did not express FSH receptor. The endothelial cells that expressed FSH receptor were located at the periphery of the tumors in a layer that was approximately 10 mm thick; this layer extended both into and outside of the tumor. Immunoelectron microscopy in mice with xenograft tumors, after perfusion with anti-FSH-receptor antibodies coupled to colloidal gold, showed that the FSH receptor is exposed on the luminal endothelial surface and can bind and internalize circulating ligands. Conclusions: FSH receptor is selectively expressed on the surface of the blood vessels of a wide range of tumors. (Funded by INSERM.) N Engl J Med 2010;363:1621-30.	[Allory, Yves; Hai, Mai Thu Vu; Ghinea, Nicolae] Univ Paris Est, INSERM, U955, Eq 07, Creteil, France; [Radu, Aurelian] Mt Sinai Sch Med, New York, NY USA; [Pichon, Christophe] INSERM, U753, Villejuif, France; [Camparo, Philippe] Val de Grace Hosp, Paris, France; [Antoine, Martine] Tenon Hosp, Paris, France; [Couvelard, Anne] Beaujon Hosp, Clichy, France; [Fromont, Gaelle] Ctr Hosp Univ Poitiers, Poitiers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Icahn School of Medicine at Mount Sinai; Institut National de la Sante et de la Recherche Medicale (Inserm); Val-de-Grace Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Poitiers; Universite de Poitiers	Ghinea, N (corresponding author), Univ Paris Est, INSERM, U955, Eq 07, 8 Rue Gen Sarrail, Creteil, France.	nicolae.ghinea@inserm.fr	fromont, gaelle/N-8708-2016; Ghinea, Nicolae/G-3188-2013	Anne, Couvelard/0000-0002-6316-1210	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	Supported by INSERM.	Alam H, 2009, ENDOCRINOLOGY, V150, P915, DOI 10.1210/en.2008-0850; Begum R, 2003, HISTOPATHOLOGY, V43, P244, DOI 10.1046/j.1365-2559.2003.01714.x; Belien JAM, 1999, J PATHOL, V189, P309; Ben-Josef E, 1999, J UROLOGY, V161, P970, DOI 10.1016/S0022-5347(01)61831-7; BOCKERS TM, 1994, CELL TISSUE RES, V278, P595; Castro-Fernandez C, 2004, ENDOCRINE, V25, P49, DOI 10.1385/ENDO:25:1:49; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Eble J.N., 2004, WHO CLASSIFICATION T; Fernebro J, 2007, APMIS, V115, P707, DOI 10.1111/j.1600-0463.2007.apm_650.x; FOX SB, 1993, CANCER RES, V53, P4161; Green FL, 2006, AM JOINT COMMITTEE C; Hai MTV, 2004, BIOL CELL, V96, P133, DOI 10.1016/j.biolcel.2003.11.008; Macklon NS, 1998, MATURITAS, V30, P181, DOI 10.1016/S0378-5122(98)00072-3; Mariani S, 2006, J UROLOGY, V175, P2072, DOI 10.1016/S0022-5347(06)00273-4; Ohashi K, 1997, VIRCHOWS ARCH, V430, P107, DOI 10.1007/BF01008031; Plant TM, 2001, ENDOCR REV, V22, P764, DOI 10.1210/er.22.6.764; Rodins K, 2002, CLIN CANCER RES, V8, P1075; Shoji M, 1999, AM J PATHOL, V154, P909, DOI 10.1016/S0002-9440(10)65338-2; Simoni M, 1997, ENDOCR REV, V18, P739, DOI 10.1210/er.18.6.739; SPRENGEL R, 1990, MOL ENDOCRINOL, V4, P525, DOI 10.1210/mend-4-4-525; Vannier B, 1996, BIOCHEMISTRY-US, V35, P1358, DOI 10.1021/bi952290f; Zeng HY, 2003, J BIOL CHEM, V278, P20738, DOI 10.1074/jbc.M209712200	22	216	236	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 21	2010	363	17					1621	1630		10.1056/NEJMoa1001283	http://dx.doi.org/10.1056/NEJMoa1001283			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	668BD	20961245				2022-12-01	WOS:000283242700006
J	Levy, DL; Heald, R				Levy, Daniel L.; Heald, Rebecca			Nuclear Size Is Regulated by Importin alpha and Ntf2 in Xenopus	CELL			English	Article							SYSTEMS-ANALYSIS; PROTEIN IMPORT; EGG EXTRACTS; PORE COMPLEX; TRANSPORT; ENVELOPE; RAN; LAMINA; CELLS; ORGANIZATION	The size of the nucleus varies among different cell types, species, and disease states, but mechanisms of nuclear size regulation are poorly understood. We investigated nuclear scaling in the pseudotetraploid frog Xenopus laevis and its smaller diploid relative Xenopus tropicalis, which contains smaller cells and nuclei. Nuclear scaling was recapitulated in vitro using egg extracts, demonstrating that titratable cytoplasmic factors determine nuclear size to a greater extent than DNA content. Nuclear import rates correlated with nuclear size, and varying the concentrations of two transport factors, importin alpha and Ntf2, was sufficient to account for nuclear scaling between the two species. Both factors modulated lamin B3 import, with importin alpha increasing overall import rates and Ntf2 reducing import based on cargo size. Importin alpha also contributes to nuclear size changes during early X. laevis development. Thus, nuclear transport mechanisms are physiological regulators of both interspecies and developmental nuclear scaling.	[Levy, Daniel L.; Heald, Rebecca] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Heald, R (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	bheald@berkeley.edu	Levy, Daniel/AAA-7205-2019	Levy, Daniel/0000-0002-7853-3275; Heald, Rebecca/0000-0001-6671-6528	NIH [DP1 OD000818]; American Cancer Society [PF-09-041-01-DDC]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000818] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Steve Bird, Mary Dasso, Dirk Gorlich, David Halpin, Richard Harland, Petr Kalab, Jan Liphardt, Alan Lowe, Andreas Merdes, Jon Soderholm, and Karsten Weis for reagents. We acknowledge Steve Bird and Saori Haigo for conducting the initial nuclear scaling experiments in egg extracts; Saori Haigo, Esther Kieserman, and Richard Harland's laboratory for help with Xenopus embryos; and Abby Dernburg for use of the Marianas SDC microscope. We thank members of the Heald lab for helpful advice; Rose Loughlin, Jeff Tang, Karsten Weis, and David Weisblat for constructive comments on the manuscript; and Favian Hernandez for artwork. R.H. is supported by the NIH Director's Pioneer Award (DP1 OD000818) and The Miller Institute for Basic Research in Science. D. L. L. acknowledges support from an American Cancer Society postdoctoral fellowship (PF-09-041-01-DDC).	AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0; Brown KS, 2007, J CELL BIOL, V176, P765, DOI 10.1083/jcb.200610043; Cavalier-Smith T, 2005, ANN BOT-LONDON, V95, P147, DOI 10.1093/aob/mci010; Clarkson WD, 1996, J MOL BIOL, V263, P517, DOI 10.1006/jmbi.1996.0594; D'Angelo MA, 2006, SCIENCE, V312, P440, DOI 10.1126/science.1124196; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Fankhauser G, 1939, J HERED, V30, P379, DOI 10.1093/oxfordjournals.jhered.a104767; Feldherr C, 1998, J CELL SCI, V111, P1889; Goldberg MW, 2008, J CELL SCI, V121, P215, DOI 10.1242/jcs.022020; Gorlich D, 2003, EMBO J, V22, P1088, DOI 10.1093/emboj/cdg113; Grammer TC, 2005, MECH DEVELOP, V122, P263, DOI 10.1016/j.mod.2004.11.003; Hachet V, 2004, EMBO J, V23, P1526, DOI 10.1038/sj.emboj.7600154; HALL MN, 2004, CELL GROWTH CONTROL; HEALD R, 1990, CELL, V61, P579, DOI 10.1016/0092-8674(90)90470-Y; HEITLINGER E, 1991, J CELL BIOL, V113, P485, DOI 10.1083/jcb.113.3.485; HORNER HA, 1983, J CELL SCI, V63, P135; JENKINS H, 1993, J CELL SCI, V106, P275; Jorgensen P, 2007, MOL BIOL CELL, V18, P3523, DOI 10.1091/mbc.E06-10-0973; Lemaitre JM, 1998, J CELL BIOL, V142, P1159, DOI 10.1083/jcb.142.5.1159; LOEWINGER L, 1988, EMBO J, V7, P2301, DOI 10.1002/j.1460-2075.1988.tb03073.x; LOWE AR, 2010, NATURE IN PRESS, DOI DOI 10.10.1038/NATURE09285; Madrid AS, 2006, CHROMOSOMA, V115, P98, DOI 10.1007/s00412-005-0043-3; Manor U, 2008, SEMIN CELL DEV BIOL, V19, P502, DOI 10.1016/j.semcdb.2008.07.006; Maresca Thomas J., 2006, V322, P459; Marshall WF, 2008, SEMIN CELL DEV BIOL, V19, P520, DOI 10.1016/j.semcdb.2008.07.007; Marshall WF, 2002, TRENDS CELL BIOL, V12, P414, DOI 10.1016/S0962-8924(02)02341-3; MAUL GG, 1977, J CELL BIOL, V73, P748, DOI 10.1083/jcb.73.3.748; Montorzi M, 2000, MOL REPROD DEV, V55, P75, DOI 10.1002/(SICI)1098-2795(200001)55:1<75::AID-MRD10>3.0.CO;2-Z; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Neumann FR, 2007, J CELL BIOL, V179, P593, DOI 10.1083/jcb.200708054; NEWPORT JW, 1990, J CELL BIOL, V111, P2247, DOI 10.1083/jcb.111.6.2247; NIEUWKOOP PD, 1967, NORMAL TABLE XENOPOU; Prufert K, 2004, J CELL SCI, V117, P6105, DOI 10.1242/jcs.01532; Riddick G, 2005, J CELL BIOL, V168, P1027, DOI 10.1083/jcb.200409024; Riddick G, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100160; Sive H. L., 2000, EARLY DEV XENOPUS LA; Smith A, 1998, CURR BIOL, V8, P1403, DOI 10.1016/S0960-9822(98)00023-2; Smith AE, 2002, SCIENCE, V295, P488, DOI 10.1126/science.1064732; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Theerthagiri G, 2010, J CELL BIOL, V189, P1129, DOI 10.1083/jcb.200912045; Webster M, 2009, J CELL SCI, V122, P1477, DOI 10.1242/jcs.037333; Wilson NF, 2008, SEMIN CELL DEV BIOL, V19, P494, DOI 10.1016/j.semcdb.2008.07.005; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430	43	156	159	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					288	298		10.1016/j.cell.2010.09.012	http://dx.doi.org/10.1016/j.cell.2010.09.012			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946986	Green Accepted, Bronze			2022-12-01	WOS:000283052200017
J	Shoemaker, CJ; Eyler, DE; Green, R				Shoemaker, Christopher J.; Eyler, Daniel E.; Green, Rachel			Dom34:Hbs1 Promotes Subunit Dissociation and Peptidyl-tRNA Drop-Off to Initiate No-Go Decay	SCIENCE			English	Article							YEAST TRANSLATION INITIATION; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNAS; TERMINATION; RIBOSOME; RELEASE; ELONGATION; ERF1; RECONSTITUTION; DEGRADATION	No-go decay (NGD) is one of several messenger RNA (mRNA) surveillance systems dedicated to the removal of defective mRNAs from the available pool. Two interacting factors, Dom34 and Hbs1, are genetically implicated in NGD in yeast. Using a reconstituted yeast translation system, we show that Dom34: Hbs1 interacts with the ribosome to promote subunit dissociation and peptidyl-tRNA drop-off. Our data further indicate that these recycling activities are shared by the homologous translation termination factor complex eRF1:eRF3, suggesting a common ancestral function. Because Dom34: Hbs1 activity exhibits no dependence on either peptide length or A-site codon identity, we propose that this quality-control system functions broadly to recycle ribosomes throughout the translation cycle whenever stalls occur.	[Green, Rachel] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University	Green, R (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA.	ragreen@jhmi.edu			Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM059425] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059425] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; Algire MA, 2002, RNA, V8, P382, DOI 10.1017/S1355838202029527; Alkalaeva EZ, 2006, CELL, V125, P1125, DOI 10.1016/j.cell.2006.04.035; Atkinson GC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-290; Carr-Schmid A, 2002, MOL CELL BIOL, V22, P2564, DOI 10.1128/MCB.22.8.2564-2574.2002; Cole SE, 2009, MOL CELL, V34, P440, DOI 10.1016/j.molcel.2009.04.017; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Frolova L, 1996, RNA, V2, P334; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; Gandhi R, 2008, J BIOL CHEM, V283, P32218, DOI 10.1074/jbc.M803785200; Gartmann M, 2010, J BIOL CHEM, V285, P14848, DOI 10.1074/jbc.C109.096057; Graille M, 2008, J BIOL CHEM, V283, P7145, DOI 10.1074/jbc.M708224200; Khoshnevis S, 2010, EMBO REP, V11, P214, DOI 10.1038/embor.2009.272; Kolitz SE, 2009, RNA, V15, P138, DOI 10.1261/rna.1318509; Kurata S, 2010, P NATL ACAD SCI USA, V107, P10854, DOI 10.1073/pnas.1006247107; Lee HH, 2007, MOL CELL, V27, P938, DOI 10.1016/j.molcel.2007.07.019; Passos DO, 2009, MOL BIOL CELL, V20, P3025, DOI 10.1091/mbc.E09-01-0028; PELTZ SW, 1993, GENE DEV, V7, P1737, DOI 10.1101/gad.7.9.1737; Pisarev AV, 2007, CELL, V131, P286, DOI 10.1016/j.cell.2007.08.041; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Si K, 1999, MOL CELL BIOL, V19, P1416; Soudet J, 2010, EMBO J, V29, P80, DOI 10.1038/emboj.2009.307; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; VOGEL Z, 1971, EUR J BIOCHEM, V21, P582, DOI 10.1111/j.1432-1033.1971.tb01504.x; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8; Zavialov AV, 2005, MOL CELL, V18, P675, DOI 10.1016/j.molcel.2005.05.016	28	221	229	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 15	2010	330	6002					369	372		10.1126/science.1192430	http://dx.doi.org/10.1126/science.1192430			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947765	Green Accepted			2022-12-01	WOS:000282986700041
J	McGuire, AL; Evans, BJ; Caulfield, T; Burke, W				McGuire, Amy L.; Evans, Barbara J.; Caulfield, Timothy; Burke, Wylie			Regulating Direct-to-Consumer Personal Genome Testing	SCIENCE			English	Editorial Material							DISEASE; RISK		[McGuire, Amy L.] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA; [Evans, Barbara J.] Univ Houston, Ctr Law, Hlth Law & Policy Inst, Houston, TX 77204 USA; [Caulfield, Timothy] Univ Alberta, Hlth Law Inst, Edmonton, AB T6G 2H5, Canada; [Burke, Wylie] Univ Washington, Sch Med, Dept Bioeth & Humanities, Seattle, WA 98195 USA	Baylor College of Medicine; University of Houston System; University of Houston; University of Alberta; University of Washington; University of Washington Seattle	McGuire, AL (corresponding author), Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA.	amcguire@bcm.edu			NHGRI NIH HHS [R01HG004333, P50HG3374-06] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004333, P50HG003374] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		American College of Medical Genetics, STAT DIR TO CONS GEN; American Medical Association, DIR TO CONS GEN TEST; Chao S, 2008, ALZ DIS ASSOC DIS, V22, P94, DOI 10.1097/WAD.0b013e31815a9dcc; Collins FS, 2001, JAMA-J AM MED ASSOC, V286, P2322, DOI 10.1001/jama.286.18.2322; *DEP HLTH HUM GEN, 2009, COMM FRAM PRINC DIR; European Commission, 2010, EUR EC, V39, P1, DOI DOI 10.2791/49877; Evans BJ, 2010, NOTRE DAME LAW REV, V85, P419; *FDA, FDA CDRH PUBL M OV L; *FDA, 2010, OV DEV REG; Fed. Trade Comm, 2006, AT HOM GEN TESTS HLT; *FTC, COMM ACT; *GAO, 2006, NUTR TEST TESTS PURC; *GAPP, GAPP KNOWL BAS; Green RC, 2009, NEW ENGL J MED, V361, P245, DOI 10.1056/NEJMoa0809578; Heshka JT, 2008, GENET MED, V10, P19, DOI 10.1097/GIM.0b013e31815f524f; Hunter DJ, 2008, NEW ENGL J MED, V358, P105, DOI 10.1056/NEJMp0708162; Javitt GH, 2007, FOOD DRUG LAW J, V62, P617; McGuire AL, 2008, JAMA-J AM MED ASSOC, V300, P2669, DOI 10.1001/jama.2008.803; National Center for Biotechnology Information, GENETESTS; National Institutes of Health, GEN TEST REG; Secretary's Advisory Committee On Genetics Health And Society (SACGHS), 2008, US SYST OV GEN TEST; United States Government Accountability Office (GAO), 2010, DIR TO CONS GEN TEST; Wright C., 2009, BAN DIRECT TO CONSUM	23	34	35	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					181	182		10.1126/science.1194006	http://dx.doi.org/10.1126/science.1194006			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	660LP	20929761				2022-12-01	WOS:000282644600025
J	Hoerauf, A				Hoerauf, Achim			Microflora, Helminths, and the Immune System -- Who Controls Whom?.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Clin, Bonn, Germany	University of Bonn	Hoerauf, A (corresponding author), Univ Clin, Bonn, Germany.							Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hayes KS, 2010, SCIENCE, V328, P1391, DOI 10.1126/science.1187703; Kefalakes H, 2009, EUR J CLIN PHARMACOL, V65, P963, DOI 10.1007/s00228-009-0719-3; Zapater P, 2009, GASTROENTEROLOGY, V137, P1669, DOI 10.1053/j.gastro.2009.07.058	4	4	4	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2010	363	15					1476	1478		10.1056/NEJMcibr1007689	http://dx.doi.org/10.1056/NEJMcibr1007689			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	659NV	20925552				2022-12-01	WOS:000282575100016
J	Pavri, R; Gazumyan, A; Jankovic, M; Di Virgilio, M; Klein, I; Ansarah-Sobrinho, C; Resch, W; Yamane, A; San-Martin, BR; Barreto, V; Nieland, TJ; Root, DE; Casellas, R; Nussenzweig, MC				Pavri, Rushad; Gazumyan, Anna; Jankovic, Mila; Di Virgilio, Michela; Klein, Isaac; Ansarah-Sobrinho, Camilo; Resch, Wolfgang; Yamane, Arito; San-Martin, Bernardo Reina; Barreto, Vasco; Nieland, Thomas J.; Root, David E.; Casellas, Rafael; Nussenzweig, Michel C.			Activation-Induced Cytidine Deaminase Targets DNA at Sites of RNA Polymerase II Stalling by Interaction with Spt5	CELL			English	Article							CLASS-SWITCH RECOMBINATION; SINGLE-STRANDED-DNA; TRANSCRIPTION ELONGATION-FACTOR; ANTIBODY DIVERSIFICATION ENZYME; PROTEIN-KINASE-A; CENTER B-CELLS; SOMATIC HYPERMUTATION; C-MYC; IMMUNOGLOBULIN GENES; P-TEFB	Activation-induced cytidine deaminase (AID) initiates antibody gene diversification by creating U:G mismatches. However, AID is not specific for antibody genes; Off-target lesions can activate oncogenes or cause chromosome translocations. Despite its importance in these transactions little is known about how AID finds its targets. We performed an shRNA screen to identify factors required for class switch recombination (CSR) of antibody loci. We found that Spt5, a factor associated with stalled RNA polymerase II (Pol II) and single stranded DNA (ssDNA), is required for CSR. Spt5 interacts with AID, it facilitates association between AID and Pol II, and AID recruitment to its Ig and non-Ig targets. ChIP-seq experiments reveal that Spt5 colocalizes with AID and stalled Pol II. Further, Spt5 accumulation at sites of Pol II stalling is predictive of AID-induced mutation. We propose that AID is targeted to sites of Pol II stalling in part via its association with Spt5.	[Pavri, Rushad; Gazumyan, Anna; Jankovic, Mila; Di Virgilio, Michela; Klein, Isaac; San-Martin, Bernardo Reina; Barreto, Vasco; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Gazumyan, Anna; Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Ansarah-Sobrinho, Camilo; Resch, Wolfgang; Yamane, Arito; Casellas, Rafael] NCI, Natl Inst Arthrit & Musculoskeletal & Skin Dis NI, Ctr Canc Res, Bethesda, MD 20892 USA; [San-Martin, Bernardo Reina] Univ Strasbourg, INSERM U964, CNRS UMR7104, IGBMC, F-67404 Illkirch Graffenstaden, France; [Barreto, Vasco] Inst Gulbenkian Ciencias, Lab Epigenet Soma, P-2780156 Oeiras, Portugal; [Nieland, Thomas J.] MIT, Broad Inst, RNAi Platform, Cambridge, MA 02142 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Instituto Gulbenkian de Ciencia; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	casellar@mail.nih.gov; nussen@mail.rockefeller.edu	Yamane, Arito/A-2959-2013; Di Virgilio, Michela/AAE-9298-2022; Barreto, Vasco M./H-2306-2018; Barreto, Vasco/D-4275-2012; Reina-San-Martin, Bernardo/I-9484-2016; Nussenzweig, Michel/AAE-7292-2019	Barreto, Vasco M./0000-0002-0010-8607; Barreto, Vasco/0000-0002-0010-8607; Reina-San-Martin, Bernardo/0000-0003-2083-6166; Resch, Wolfgang/0000-0001-7594-5963; Pavri, Rushad/0000-0002-6191-6333; Di Virgilio, Michela/0000-0001-5189-0793	Cancer Research Institute; NIH [AI037526]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037526] Funding Source: NIH RePORTER	Cancer Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Nussenzweig lab for helpful discussions, Klara Velinzon for FACS sorting, and Tom Eisenreich and David Bosque for animal management. We thank Drs Jayanta Chaudhuri and Urszula Nowak for ChIP protocols and anti-AID antibody, Dr. Sohail Malik for generously providing purified recombinant DSIF and Dr. Alan Derr for assistance with informatics. M.D.V. is a fellow of the American-Italian Cancer Foundation. R.P was a recipient of The Irvington Institute Postdoctoral Fellowship of the Cancer Research Institute. The work was supported by NIH grant (AI037526) to M.C.N.M.C.N. is a Howard Hughes Medical Institute Investigator.	Amir-Zilberstein L, 2008, J BIOL CHEM, V283, P1317, DOI 10.1074/jbc.M706767200; Andrulis ED, 2002, NATURE, V420, P837, DOI 10.1038/nature01181; Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Conticello SG, 2008, MOL CELL, V31, P474, DOI 10.1016/j.molcel.2008.07.009; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Daniel JA, 2010, SCIENCE, V329, P917, DOI 10.1126/science.1187942; Daniels GA, 1995, NUCLEIC ACIDS RES, V23, P5006, DOI 10.1093/nar/23.24.5006; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Ding BJ, 2010, J BIOL CHEM, V285, P5317, DOI 10.1074/jbc.M109.082818; GIARDINA C, 1992, GENE DEV, V6, P2190, DOI 10.1101/gad.6.11.2190; Gilmour DS, 2009, CHROMOSOMA, V118, P1, DOI 10.1007/s00412-008-0182-4; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; Kim JB, 2001, J BIOL CHEM, V276, P12317, DOI 10.1074/jbc.M010908200; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Lefebvre B, 2002, MOL CELL BIOL, V22, P1446, DOI 10.1128/MCB.22.5.1446-1459.2002; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Lis JT, 2007, NATURE, V450, P198, DOI 10.1038/nature06324; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; McBride KM, 2008, J EXP MED, V205, P2585, DOI 10.1084/jem.20081319; McBride KM, 2006, P NATL ACAD SCI USA, V103, P8798, DOI 10.1073/pnas.0603272103; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193; Nakamura Y, 2008, CANCER GENET CYTOGEN, V182, P144, DOI 10.1016/j.cancergencyto.2008.01.013; Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; Pasqualucci L, 2006, P NATL ACAD SCI USA, V103, P395, DOI 10.1073/pnas.0509969103; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Pei Y, 2002, J BIOL CHEM, V277, P19639, DOI 10.1074/jbc.M200015200; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Rajagopal D, 2009, J EXP MED, V206, P1237, DOI 10.1084/jem.20082514; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Raschke EE, 1999, J IMMUNOL, V163, P4375; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Rohwer F, 1996, J IMMUNOL, V157, P643; Ronai D, 2007, J EXP MED, V204, P181, DOI 10.1084/jem.20062032; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Shen HM, 2009, J EXP MED, V206, P1057, DOI 10.1084/jem.20082678; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95, DOI 10.1002/j.1460-2075.1986.tb04182.x; Storb U, 2007, ADV EXP MED BIOL, V596, P83; SWANSON MS, 1991, MOL CELL BIOL, V11, P4286, DOI 10.1128/MCB.11.8.4286; Tian M, 2000, J BIOL CHEM, V275, P24163, DOI 10.1074/jbc.M003343200; Vuong BQ, 2009, NAT IMMUNOL, V10, P420, DOI 10.1038/ni.1708; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wang LL, 2009, J EXP MED, V206, P1817, DOI 10.1084/jem.20081678; Wang M, 2010, J EXP MED, V207, P141, DOI 10.1084/jem.20092238; Wen YX, 1999, GENE DEV, V13, P1774, DOI 10.1101/gad.13.14.1774; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yamaguchi Y, 1999, J BIOL CHEM, V274, P8085, DOI 10.1074/jbc.274.12.8085; YANCOPOULOS GD, 1986, EMBO J, V5, P3259, DOI 10.1002/j.1460-2075.1986.tb04637.x; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	87	267	273	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 1	2010	143	1					122	133		10.1016/j.cell.2010.09.017	http://dx.doi.org/10.1016/j.cell.2010.09.017			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	656UC	20887897	Green Accepted, Bronze			2022-12-01	WOS:000282362000019
J	Vannini, A; Ringel, R; Kusser, AG; Berninghausen, O; Kassavetis, GA; Cramer, P				Vannini, Alessandro; Ringel, Rieke; Kusser, Anselm G.; Berninghausen, Otto; Kassavetis, George A.; Cramer, Patrick			Molecular Basis of RNA Polymerase III Transcription Repression by Maf1	CELL			English	Article							ELECTRON-MICROSCOPY; STRUCTURAL BIOLOGY; SUBCOMPLEX; PROTEIN; SUBUNIT; COMPLEX; TFIIF; DEPHOSPHORYLATION; TERMINATION; INITIATION	RNA polymerase III (Pol III) transcribes short RNAs required for cell growth. Under stress conditions, the conserved protein Maf1 rapidly represses Pol III transcription. We report the crystal structure of Maf1 and cryo-electron microscopic structures of Pol III, an active Pol III-DNA-RNA complex, and a repressive Pol III-Maf1 complex. Binding of DNA and RNA causes ordering of the Pol III-specific sub-complex C82/34/31 that is required for transcription initiation. Maf1 binds the Pol III clamp and rearranges C82/34/31 at the rim of the active center cleft. This impairs recruitment of Pol III to a complex of promoter DNA with the initiation factors Brf1 and TBP and thus prevents closed complex formation. Maf1 does however not impair binding of a DNA-RNA scaffold and RNA synthesis. These results explain how Maf1 specifically represses transcription initiation from Pol III promoters and indicate that Maf1 also prevents reinitiation by binding Pol III during transcription elongation.	[Vannini, Alessandro; Ringel, Rieke; Kusser, Anselm G.; Berninghausen, Otto; Cramer, Patrick] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Vannini, Alessandro; Ringel, Rieke; Kusser, Anselm G.; Berninghausen, Otto; Cramer, Patrick] Univ Munich, Dept Biochem, CIPSM, D-81377 Munich, Germany; [Kassavetis, George A.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of Munich; University of Munich; University of California System; University of California San Diego	Cramer, P (corresponding author), Univ Munich, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@genzentrum.lmu.de	Vannini, Alessandro/N-4528-2014; Vannini, Alessandro/E-6988-2011	Vannini, Alessandro/0000-0001-7212-5425	European Molecular Biology Organization; European Union [MEIF-CT-2006-040653]; Deutsche Forschungsgemeinschaft; Nanosystems Initiative Munich; Elitenetzwerk Bayern; Jung-Stiftung;  [SFB646];  [TR5]	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Nanosystems Initiative Munich; Elitenetzwerk Bayern; Jung-Stiftung; ; 	We thank R. Beckmann, T. Becker, C. Ungewickel, J. Burger, and T. Mielke for help with E.M. We thank A. Imhof (Zentrallabor fur Proteinanalytik) and T. Frohlich (Laboratory for Functional Genome Analysis) for mass spectrometry. We acknowledge the crystallization facility at the department of E. Conti at the Max Planck Institute of Biochemistry, Martinsried. We thank D. Deak for help with figure preparation. A.V. was supported by a European Molecular Biology Organization long-term fellowship and by the European Union training program Marie Curie (MEIF-CT-2006-040653). P.C. was supported by the Deutsche Forschungsgemeinschaft, the SFB646, the TR5, the Nanosystems Initiative Munich, the Elitenetzwerk Bayern, and the Jung-Stiftung. A.V. prepared Pol III complexes, A.V. and A.G.K. determined EM structures, R.R. prepared and crystallized Maf1, R.R. and A.V. determined the Maf1 X-ray structure, R.R. and A.V. conducted functional assays, G.A.K. advised on Pol III preparation, A.V., R.R., A.G.K., and P.C. wrote the manuscript, and P.C. designed and supervised research.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andrau JC, 1999, J MOL BIOL, V288, P511, DOI 10.1006/jmbi.1999.2724; Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; BARDELEBEN C, 1994, J MOL BIOL, V235, P1193, DOI 10.1006/jmbi.1994.1073; BARTHOLOMEW B, 1993, MOL CELL BIOL, V13, P942, DOI 10.1128/MCB.13.2.942; Boguta M, 1997, GENE, V185, P291, DOI 10.1016/S0378-1119(96)00669-5; Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; Brun I, 1997, EMBO J, V16, P5730, DOI 10.1093/emboj/16.18.5730; Cabart P, 2008, J BIOL CHEM, V283, P36108, DOI 10.1074/jbc.M807538200; Carter R, 2009, MOL BIOL EVOL, V26, P2515, DOI 10.1093/molbev/msp164; Chedin S, 1998, GENE DEV, V12, P3857, DOI 10.1101/gad.12.24.3857; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Cramer P, 2008, ANNU REV BIOPHYS, V37, P337, DOI 10.1146/annurev.biophys.37.032807.130008; Damsma GE, 2009, J BIOL CHEM, V284, P31658, DOI 10.1074/jbc.M109.022764; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Desai N, 2005, J BIOL CHEM, V280, P6455, DOI 10.1074/jbc.M412375200; Eichner J, 2010, EMBO J, V29, P706, DOI 10.1038/emboj.2009.386; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P., 2007, SCALA SCALE TOGETHER; Fernandez-Tornero C, 2007, MOL CELL, V25, P813, DOI 10.1016/j.molcel.2007.02.016; Ferri ML, 2000, MOL CELL BIOL, V20, P488, DOI 10.1128/MCB.20.2.488-495.2000; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Geiduschek EP, 2006, CURR BIOL, V16, pR849, DOI 10.1016/j.cub.2006.08.071; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; Geiger SR, 2010, MOL CELL, V39, P583, DOI 10.1016/j.molcel.2010.07.028; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Jasiak AJ, 2006, MOL CELL, V23, P71, DOI 10.1016/j.molcel.2006.05.013; Juo ZS, 2003, NATURE, V422, P534, DOI 10.1038/nature01534; Kassavetis GA, 2005, P NATL ACAD SCI USA, V102, P15406, DOI 10.1073/pnas.0507653102; Kassavetis GA, 2003, J BIOL CHEM, V278, P17912, DOI 10.1074/jbc.M300743200; Kassavetis GA, 2010, J BIOL CHEM, V285, P2695, DOI 10.1074/jbc.M109.074013; KHOO B, 1994, GENE DEV, V8, P2879, DOI 10.1101/gad.8.23.2879; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Landrieux E, 2006, EMBO J, V25, P118, DOI 10.1038/sj.emboj.7600915; Lannutti BJ, 1996, BIOCHEMISTRY-US, V35, P9821, DOI 10.1021/bi960525x; Lee J, 2009, J BIOL CHEM, V284, P12604, DOI 10.1074/jbc.C900020200; LESLIE AGW, 1986, CCP4 NEWSLETTER, V18, P33; Lorenzen K, 2007, STRUCTURE, V15, P1237, DOI 10.1016/j.str.2007.07.016; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Moir RD, 2006, P NATL ACAD SCI USA, V103, P15044, DOI 10.1073/pnas.0607129103; Oficjalska-Pham D, 2006, MOL CELL, V22, P623, DOI 10.1016/j.molcel.2006.04.008; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Pluta K, 2001, MOL CELL BIOL, V21, P5031, DOI 10.1128/MCB.21.15.5031-5040.2001; Reina JH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000134; Roberts DN, 2006, MOL CELL, V22, P633, DOI 10.1016/j.molcel.2006.04.009; SADHALE PP, 1994, MOL CELL BIOL, V14, P6164, DOI 10.1128/MCB.14.9.6164; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Shor B, 2010, J BIOL CHEM, V285, P15380, DOI 10.1074/jbc.M109.071639; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THUILLIER V, 1995, EMBO J, V14, P351, DOI 10.1002/j.1460-2075.1995.tb07009.x; Upadhya R, 2002, MOL CELL, V10, P1489, DOI 10.1016/S1097-2765(02)00787-6; Wang ZX, 1997, GENE DEV, V11, P1315, DOI 10.1101/gad.11.10.1315; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; WERNER M, 1993, J BIOL CHEM, V268, P20721; WERNER M, 1992, MOL CELL BIOL, V12, P1087, DOI 10.1128/MCB.12.3.1087; Willis IM, 2004, PROG NUCLEIC ACID RE, V77, P323, DOI 10.1016/S0079-6603(04)77009-9	60	120	122	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2010	143	1					59	70		10.1016/j.cell.2010.09.002	http://dx.doi.org/10.1016/j.cell.2010.09.002			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	656UC	20887893	Bronze, Green Submitted, Green Accepted			2022-12-01	WOS:000282362000014
J	Barreda, VD; Palazzesi, L; Telleria, MC; Katinas, L; Crisci, JV; Bremer, K; Passalia, MG; Corsolini, R; Brizuela, RR; Bechis, F				Barreda, V. D.; Palazzesi, L.; Telleria, M. C.; Katinas, L.; Crisci, J. V.; Bremer, K.; Passalia, M. G.; Corsolini, R.; Rodriguez Brizuela, R.; Bechis, F.			Eocene Patagonia Fossils of the Daisy Family	SCIENCE			English	Article							ASTERACEAE; DIVERSITY; POLLEN		[Barreda, V. D.; Palazzesi, L.; Rodriguez Brizuela, R.] Museo Argentino Ciencias Nat Bernardino Rivadavia, Div Paleobot, Secc Paleopalinol, Buenos Aires, DF, Argentina; [Barreda, V. D.; Palazzesi, L.; Telleria, M. C.; Katinas, L.; Crisci, J. V.; Passalia, M. G.; Bechis, F.] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Telleria, M. C.; Crisci, J. V.] Museo La Plata, Lab Sistemat & Biol Evolut, La Plata, Argentina; [Telleria, M. C.] Museo Argentino Ciencias Nat Bernardino Rivadavia, Lab Actuopalinol, Buenos Aires, DF, Argentina; [Katinas, L.; Crisci, J. V.] Museo La Plata, Div Plantas Vasc, La Plata, Argentina; [Bremer, K.] Stockholm Univ, SE-10691 Stockholm, Sweden; [Passalia, M. G.] Inst Invest Biodiversidad & Medioambiente, Lab Palinol & Paleobot, San Carlos De Bariloche, Rio Negro, Argentina; [Corsolini, R.] Museo Lago Gutierrez Dr Rosendo Pascual Geol & Pa, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Bechis, F.] Univ Nacl Rio Negro, Inst Invest Diversidad Cultural & Proc Cambio, San Carlos De Bariloche, Rio Negro, Argentina	Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); National University of La Plata; Museo La Plata; Stockholm University	Barreda, VD (corresponding author), Museo Argentino Ciencias Nat Bernardino Rivadavia, Div Paleobot, Secc Paleopalinol, Ave Angel Gallardo 470,C1405DJR, Buenos Aires, DF, Argentina.	vbarreda@macn.gov.ar		Barreda, Viviana Dora/0000-0002-1560-1277; Palazzesi, Luis/0000-0001-8026-4679	CONICET; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); NSF; Direct For Biological Sciences [0919071] Funding Source: National Science Foundation	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank P. C. Hoch for the critical reading of the manuscript. Financial support was provided by grants of CONICET, Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), and NSF.	Barreda V, 2007, BOT REV, V73, P31, DOI 10.1663/0006-8101(2007)73[31:PVTDTP]2.0.CO;2; Barreda V, 2010, REV PALAEOBOT PALYNO, V160, P102, DOI 10.1016/j.revpalbo.2010.02.004; Barreda V, 2009, REV PALAEOBOT PALYNO, V154, P22, DOI 10.1016/j.revpalbo.2008.11.005; Blackmore S, 2010, PLANT SYST EVOL, V284, P17, DOI 10.1007/s00606-009-0232-2; Telleria MC, 2010, PLANT SYST EVOL, V285, P75, DOI 10.1007/s00606-009-0257-6; Funk VA, 2005, BIOL SKRIFTER, V55, P343; Graham A., 1996, P KEW INT COMPOSITAE, P123; Kim KJ, 2005, MOL BIOL EVOL, V22, P1783, DOI 10.1093/molbev/msi174; Macphail M. K., 1994, Papers and Proceedings of the Royal Society of Tasmania, V128, P1; Martinez-Millan M, 2010, BOT REV, V76, P83, DOI 10.1007/s12229-010-9040-1; Scott L, 2006, REV PALAEOBOT PALYNO, V142, P47, DOI 10.1016/j.revpalbo.2006.07.010; Wilf P, 2005, AM NAT, V165, P634, DOI 10.1086/430055; Zavada MS, 2000, GRANA, V39, P39, DOI 10.1080/00173130150503795; Zhao Zaiming, 2006, Lundellia, V9, P51	14	67	72	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2010	329	5999					1621	1621		10.1126/science.1193108	http://dx.doi.org/10.1126/science.1193108			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20929840				2022-12-01	WOS:000282098100032
J	Barclay, S; Maher, J				Barclay, Stephen; Maher, Jane			Spotlight: Palliative Care Beyond Cancer Having the difficult conversations about the end of life	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEDICAL-CARE; GOOD DOCTOR; DEATH; COMMUNICATION; ONCOLOGISTS; PREFERENCES; FAMILIES; ILLNESS; DIE		[Barclay, Stephen] Inst Publ Hlth, Gen Pract & Primary Care Res Unit,, Cambridge CB2 2SR, England; [Maher, Jane] Mt Vernon Canc Ctr, London, England	University of Cambridge; Mount Vernon Cancer Centre	Barclay, S (corresponding author), Inst Publ Hlth, Gen Pract & Primary Care Res Unit,, Cambridge CB2 2SR, England.	sigb2@medschl.cam.ac.uk		Barclay, Stephen/0000-0002-4505-7743				[Anonymous], 2005, MORT STAT; Barclay S, 2009, BRIT J GEN PRACT, V59, P642, DOI 10.3399/bjgp09X454052; Berry SR, 2008, J CLIN ONCOL, V26, P157, DOI 10.1200/JCO.2007.12.3224; BUCKMAN R, 1992, BREAK BAD NEWS, DOI [10.3138/j.ctt1h1hrxp, DOI 10.3138/J.CTT1H1HRXP]; Christakis N A, 1998, Hosp J, V13, P71; Christakis NA, 1998, ARCH INTERN MED, V158, P2389, DOI 10.1001/archinte.158.21.2389; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Cleland John G F, 2002, Heart Fail Rev, V7, P229, DOI 10.1023/A:1020024122726; Coulter A, 2002, BRIT MED J, V325, P668, DOI 10.1136/bmj.325.7366.668; Dale J, 2009, QUAL SAF HEALTH CARE, V18, P174, DOI 10.1136/qshc.2007.024836; ELLERSHAW J., 2003, CARE DYING PATHWAY E; FORD S, 1994, BRIT J CANCER, V70, P767, DOI 10.1038/bjc.1994.393; Gattellari M, 2002, J CLIN ONCOL, V20, P503, DOI 10.1200/JCO.20.2.503; Glare P, 2003, BRIT MED J, V327, P195, DOI 10.1136/bmj.327.7408.195; Heffner JE, 2000, CHEST, V117, P1474, DOI 10.1378/chest.117.5.1474; Hurwitz B, 2002, BMJ-BRIT MED J, V325, P667, DOI 10.1136/bmj.325.7366.667; Kirk P, 2004, BMJ-BRIT MED J, V328, P1343, DOI 10.1136/bmj.38103.423576.55; Koedoot CG, 2004, EUR J CANCER, V40, P225, DOI 10.1016/j.ejca.2003.10.008; Lynn J, 2001, JAMA-J AM MED ASSOC, V285, P925, DOI 10.1001/jama.285.7.925; MACKILLOP WJ, 1988, BRIT J CANCER, V58, P355, DOI 10.1038/bjc.1988.218; *MACM CANC SUPP, 2004, UNCL MILL; Maltoni M, 2002, HEMATOL ONCOL CLIN N, V16, P715, DOI 10.1016/S0889-8588(02)00024-2; Murray SA, 2005, BRIT MED J, V330, P611, DOI 10.1136/bmj.330.7492.611; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; Murtagh FEM, 2004, CLIN MED, V4, P39, DOI 10.7861/clinmedicine.4-1-39; Quirt CF, 1997, LUNG CANCER-J IASLC, V18, P1, DOI 10.1016/S0169-5002(97)00048-2; TODD CJ, 1984, SOC SCI MED, V18, P667, DOI 10.1016/0277-9536(84)90295-8; Wenrich MD, 2001, ARCH INTERN MED, V161, P868, DOI 10.1001/archinte.161.6.868; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665	29	28	29	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2010	341								c4862	10.1136/bmj.c4862	http://dx.doi.org/10.1136/bmj.c4862			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653MO	20847022				2022-12-01	WOS:000282095800006
J	Lee, BH; Lee, MJ; Park, S; Oh, DC; Elsasser, S; Chen, PC; Gartner, C; Dimova, N; Hanna, J; Gygi, SP; Wilson, SM; King, RW; Finley, D				Lee, Byung-Hoon; Lee, Min Jae; Park, Soyeon; Oh, Dong-Chan; Elsasser, Suzanne; Chen, Ping-Chung; Gartner, Carlos; Dimova, Nevena; Hanna, John; Gygi, Steven P.; Wilson, Scott M.; King, Randall W.; Finley, Daniel			Enhancement of proteasome activity by a small-molecule inhibitor of USP14	NATURE			English	Article							DEUBIQUITINATING ENZYME USP14; 26S PROTEASOME; ATAXIA MICE; UBIQUITIN; DEGRADATION; PROTEINS; SUBUNIT; SURVIVAL; SYSTEM; STRESS	Proteasomes, the primary mediators of ubiquitin-protein conjugate degradation, are regulated through complex and poorly understood mechanisms. Here we show that USP14, a proteasome-associated deubiquitinating enzyme, can inhibit the degradation of ubiquitin-protein conjugates both in vitro and in cells. A catalytically inactive variant of USP14 has reduced inhibitory activity, indicating that inhibition is mediated by trimming of the ubiquitin chain on the substrate. A high-throughput screen identified a selective small-molecule inhibitor of the deubiquitinating activity of human USP14. Treatment of cultured cells with this compound enhanced degradation of several proteasome substrates that have been implicated in neurodegenerative disease. USP14 inhibition accelerated the degradation of oxidized proteins and enhanced resistance to oxidative stress. Enhancement of proteasome activity through inhibition of USP14 may offer a strategy to reduce the levels of aberrant proteins in cells under proteotoxic stress.	[Lee, Byung-Hoon; Lee, Min Jae; Park, Soyeon; Elsasser, Suzanne; Gartner, Carlos; Dimova, Nevena; Hanna, John; Gygi, Steven P.; King, Randall W.; Finley, Daniel] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Oh, Dong-Chan] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Oh, Dong-Chan] Seoul Natl Univ, Coll Pharm, Inst Nat Prod Res, Seoul 151742, South Korea; [Chen, Ping-Chung; Wilson, Scott M.] Univ Alabama, Civitan Int Res Ctr, Evelyn F McKnight Brain Inst, Dept Neurobiol, Birmingham, AL 35294 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Seoul National University (SNU); University of Alabama System; University of Alabama Birmingham	King, RW (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	randy_king@hms.harvard.edu; daniel_finley@hms.harvard.edu	Lee, Min Jae/C-9814-2015	Lee, Min Jae/0000-0002-3252-6467; Lee, Byung-Hoon/0000-0002-7101-0471; Wilson, Scott/0000-0001-9376-9430; King, Randall/0000-0001-7882-8180	National Institutes of Health [DK082906, GM65592, GM66492, NS047533]; Harvard Technology Development Accelerator Fund; Merck Co.; Johnson Johnson; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK082906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066492, R01GM067945, R01GM065592, R56GM066492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057098, R01NS047533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Technology Development Accelerator Fund; Merck Co.(Merck & Company); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Gordon, J. Y. Suk and N. Bays for advice and assistance, and members of the Finley laboratory for comments on the manuscript. We thank C. Shamu and the staff of the ICCB facility at Harvard Medical School, where the HT screen was carried out. We also thank N. Hathaway for ubiquitinated cyclin B, L. Huang for the tagged proteasome cell line, R. Baker for anti-USP14 antibody, G. DeMartino for anti-UCH37 antibody, K. Wilkinson and K. Walters for DUB enzymes, as well as C. Seong, M. Kim, S. M. Lim and D. Waterman for assistance in some experiments. For plasmids, we thank K. Walters, M. Sowa, W. Harper, V. Lee, F. Baralle, H. Paulson, Y. T. Kwon, M. Masucci, M.-K. Kwak, P. Coffino and C. Kahana. This work was supported by grants from the National Institutes of Health (DK082906 to D. F., GM65592 to D. F., GM66492 to R.W.K. and NS047533 to S.M.W.); the Harvard Technology Development Accelerator Fund (D.F.); Merck & Co. (D.F. and R.W.K.); and Johnson & Johnson (D.F. and R.W.K.).	Ahmed EK, 2007, ANN NY ACAD SCI, V1119, P88, DOI 10.1196/annals.1404.020; Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Anderson C, 2005, J NEUROCHEM, V95, P724, DOI 10.1111/j.1471-4159.2005.03409.x; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Catic A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000679; Chauhan D, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S1; Chen PC, 2009, J NEUROSCI, V29, P10909, DOI 10.1523/JNEUROSCI.2635-09.2009; Chernova TA, 2003, J BIOL CHEM, V278, P52102, DOI 10.1074/jbc.M310283200; Chondrogianni N, 2005, J BIOL CHEM, V280, P11840, DOI 10.1074/jbc.M413007200; Chondrogianni N, 2003, J BIOL CHEM, V278, P28026, DOI 10.1074/jbc.M301048200; Crimmins S, 2006, J NEUROSCI, V26, P11423, DOI 10.1523/JNEUROSCI.3600-06.2006; Crimmins S, 2009, DEV BIOL, V325, P33, DOI 10.1016/j.ydbio.2008.09.021; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; David DC, 2002, J NEUROCHEM, V83, P176, DOI 10.1046/j.1471-4159.2002.01137.x; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hanna J, 2007, CELL, V129, P747, DOI 10.1016/j.cell.2007.03.042; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hinault MP, 2006, J MOL NEUROSCI, V30, P249, DOI 10.1385/JMN:30:3:249; Hoyt MA, 2005, METHOD ENZYMOL, V398, P399, DOI 10.1016/S0076-6879(05)98033-6; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Jacobson AD, 2009, J BIOL CHEM, V284, P35485, DOI 10.1074/jbc.M109.052928; JORDAN MA, 1991, CANCER RES, V51, P2212; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Kobayashi H, 2005, J BIOL CHEM, V280, P10468, DOI 10.1074/jbc.M409969200; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Kwong LK, 2008, NEUROSIGNALS, V16, P41, DOI 10.1159/000109758; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lehman NL, 2009, ACTA NEUROPATHOL, V118, P329, DOI 10.1007/s00401-009-0560-x; LI X, 1995, CYTOMETRY, V20, P172, DOI 10.1002/cyto.990200210; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muchamuel T, 2009, NAT MED, V15, P781, DOI 10.1038/nm.1978; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Saeki Y, 2005, METHOD ENZYMOL, V399, P215, DOI 10.1016/S0076-6879(05)99014-9; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Shabek N, 2009, P NATL ACAD SCI USA, V106, P11907, DOI 10.1073/pnas.0905746106; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Spires-Jones TL, 2009, TRENDS NEUROSCI, V32, P150, DOI 10.1016/j.tins.2008.11.007; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Todi SV, 2007, J BIOL CHEM, V282, P29348, DOI 10.1074/jbc.M704126200; Tonoki A, 2009, MOL CELL BIOL, V29, P1095, DOI 10.1128/MCB.01227-08; Varshavsky A, 2000, BIOL CHEM, V381, P779, DOI 10.1515/BC.2000.101; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Wilson SM, 2002, NAT GENET, V32, P420, DOI 10.1038/ng1006; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	64	681	712	5	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 9	2010	467	7312					179	U63		10.1038/nature09299	http://dx.doi.org/10.1038/nature09299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647KB	20829789	Green Accepted			2022-12-01	WOS:000281616300028
J	Lazzeri, M; Guazzoni, G				Lazzeri, Massimo; Guazzoni, Giorgio			Focal therapy meets prostate cancer	LANCET			English	Editorial Material							MORTALITY		[Lazzeri, Massimo; Guazzoni, Giorgio] Univ Vita Salute San Raffaele, Hosp San Raffaele, Dept Urol, I-20127 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Lazzeri, M (corresponding author), Univ Vita Salute San Raffaele, Hosp San Raffaele, Dept Urol, I-20127 Milan, Italy.	lazzeri.m@tiscali.it	Lazzeri, Massimo/K-5004-2016; Lazzeri, Massimo/AAB-6955-2021	Lazzeri, Massimo/0000-0002-4411-3715; Lazzeri, Massimo/0000-0002-4411-3715; Guazzoni, Giorgio Ferruccio/0000-0002-5713-8313				Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Barkun JS, 2009, LANCET, V374, P1089, DOI 10.1016/S0140-6736(09)61083-7; Carter HB, 2007, J UROLOGY, V178, P2359, DOI 10.1016/j.juro.2007.08.039; Ellis DS, 2007, UROLOGY, V70, P9, DOI 10.1016/j.urology.2007.07.036; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Klotz L, 2008, NAT CLIN PRACT UROL, V5, P2, DOI 10.1038/ncpuro0993; Lindner U, 2009, J UROLOGY, V182, P1371, DOI 10.1016/j.juro.2009.06.035; Loughlin KR, 2010, J UROLOGY, V183, P871, DOI 10.1016/j.juro.2009.11.011; Mulhall JP, 2009, J UROLOGY, V181, P462, DOI 10.1016/j.juro.2008.10.047; Onik G, 2008, UROL ONCOL-SEMIN ORI, V26, P500, DOI 10.1016/j.urolonc.2008.03.004; Quinn M, 2002, BJU INT, V90, P162, DOI 10.1046/j.1464-410X.2002.2822.x; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084	12	19	20	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2010	376	9746					1036	1037		10.1016/S0140-6736(10)60594-6	http://dx.doi.org/10.1016/S0140-6736(10)60594-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	657KM	20870082				2022-12-01	WOS:000282411600009
J	Luxton, GWG; Gomes, ER; Folker, ES; Vintinner, E; Gundersen, GG				Luxton, G. W. Gant; Gomes, Edgar R.; Folker, Eric S.; Vintinner, Erin; Gundersen, Gregg G.			Linear Arrays of Nuclear Envelope Proteins Harness Retrograde Actin Flow for Nuclear Movement	SCIENCE			English	Article							MICROFILAMENT BUNDLES BENEATH; NEURONAL MIGRATION; MYOSIN-II; F-ACTIN; CENTROSOME; GROWTH; DYNEIN; ROLES; NEUROGENESIS; FIBROBLASTS	Nuclei move to specific locations to polarize migrating and differentiating cells. Many nuclear movements are microtubule-dependent. However, nuclear movement to reorient the centrosome in migrating fibroblasts occurs through an unknown actin-dependent mechanism. We found that linear arrays of outer (nesprin2G) and inner (SUN2) nuclear membrane proteins assembled on and moved with retrogradely moving dorsal actin cables during nuclear movement in polarizing fibroblasts. Inhibition of nesprin2G, SUN2, or actin prevented nuclear movement and centrosome reorientation. The coupling of actin cables to the nuclear membrane for nuclear movement via specific membrane proteins indicates that, like plasma membrane integrins, nuclear membrane proteins assemble into actin-dependent arrays for force transduction.	[Luxton, G. W. Gant; Gomes, Edgar R.; Folker, Eric S.; Vintinner, Erin; Gundersen, Gregg G.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Gomes, Edgar R.] Univ Paris 06, INSERM, UMR S 787, F-75634 Paris, France; [Gomes, Edgar R.] Grp Hosp Pitie Salpetriere, Inst Myol, F-75013 Paris, France	Columbia University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Gundersen, GG (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA.	ggg1@columbia.edu	Luxton, GW Gant/A-7212-2017; Gomes, Edgar/ABH-7441-2020; Gomes, Edgar r/D-9000-2015	Gomes, Edgar/0000-0002-6941-4872; Gomes, Edgar r/0000-0002-6941-4872; Folker, Eric/0000-0003-1619-7330; Luxton, GW Gant/0000-0002-6180-8906	Dystonia Medical Research Foundation; American Heart Association; Muscular Dystrophy Association; Association pour la Recherche sur le Cancer; Ligue Nacionale contre le Cancer; NIH [GM06929, NS059352]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099481, R01GM062939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059352, R56NS059352] Funding Source: NIH RePORTER	Dystonia Medical Research Foundation; American Heart Association(American Heart Association); Muscular Dystrophy Association(Muscular Dystrophy Association); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nacionale contre le Cancer; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank W. Dauer, H. Herrmann, E. Marcantonio, G. Morris, S. Shackleton, R. Wedlich-Soldner, and H. Worman for providing reagents; members of the Dauer, Hirano, and Worman labs for helpful discussions; and Y. Zhao for analysis. This work was supported by a Dystonia Medical Research Foundation Fellowship (G.W.G.L.), an American Heart Association fellowship (E.S.F.), a Muscular Dystrophy Association grant (E.R.G.), an Association pour la Recherche sur le Cancer grant (E.R.G.), a Ligue Nacionale contre le Cancer grant (E.R.G.), a Dystonia Medical Research Foundation grant (G.G.G.), and NIH (GM06929 and NS059352) grants (G.G.G.).	Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Goulding MB, 2007, J CELL BIOL, V178, P1177, DOI 10.1083/jcb.200703159; HEATH JP, 1981, CELL BIOL INT REP, V5, P975, DOI 10.1016/0309-1651(81)90214-9; HEATH JP, 1983, J CELL SCI, V60, P331; Ketelaar T, 2002, PLANT CELL, V14, P2941, DOI 10.1105/tpc.005892; King MC, 2008, CELL, V134, P427, DOI 10.1016/j.cell.2008.06.022; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Lei K, 2009, P NATL ACAD SCI USA, V106, P10207, DOI 10.1073/pnas.0812037106; Luke Y, 2008, J CELL SCI, V121, P1887, DOI 10.1242/jcs.019075; Naumanen P, 2008, J MICROSC-OXFORD, V231, P446, DOI 10.1111/j.1365-2818.2008.02057.x; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Ramos-Garcia SL, 2009, EUKARYOT CELL, V8, P1880, DOI 10.1128/EC.00062-09; Reinsch S, 1998, J CELL SCI, V111, P2283; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Schmoranzer J, 2009, CURR BIOL, V19, P1065, DOI 10.1016/j.cub.2009.05.065; Solecki DJ, 2009, NEURON, V63, P63, DOI 10.1016/j.neuron.2009.05.028; Starr DA, 2002, SCIENCE, V298, P406, DOI 10.1126/science.1075119; Starr DA, 2009, J CELL SCI, V122, P577, DOI 10.1242/jcs.037622; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Wilhelmsen K, 2006, J CELL SCI, V119, P5021, DOI 10.1242/jcs.03295; Zhang XC, 2007, DEVELOPMENT, V134, P901, DOI 10.1242/dev.02783; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018	26	326	333	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 20	2010	329	5994					956	959		10.1126/science.1189072	http://dx.doi.org/10.1126/science.1189072			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640WN	20724637	Green Accepted			2022-12-01	WOS:000281084800038
J	Nakagawa, K; Hirota, Y; Sawada, N; Yuge, N; Watanabe, M; Uchino, Y; Okuda, N; Shimomura, Y; Suhara, Y; Okano, T				Nakagawa, Kimie; Hirota, Yoshihisa; Sawada, Natsumi; Yuge, Naohito; Watanabe, Masato; Uchino, Yuri; Okuda, Naoko; Shimomura, Yuka; Suhara, Yoshitomo; Okano, Toshio			Identification of UBIAD1 as a novel human menaquinone-4 biosynthetic enzyme	NATURE			English	Article							DIETARY PHYLLOQUINONE; GENE; VITAMIN-K-2; CONVERSION; ACCUMULATION; METABOLISM; MUTATIONS; TISSUES; RATS	Vitamin K occurs in the natural world in several forms, including a plant form, phylloquinone (PK), and a bacterial form, menaquinones (MKs). In many species, including humans, PK is a minor constituent of hepatic vitamin K content, with most hepatic vitamin K content comprising long-chain MKs. Menaquinone-4 (MK-4) is ubiquitously present in extrahepatic tissues, with particularly high concentrations in the brain, kidney and pancreas of humans and rats(1-3). It has consistently been shown that PK is endogenously converted to MK-4 (refs 4-8). This occurs either directly within certain tissues or by interconversion to menadione (K-3), followed by prenylation to MK-4 (refs 9-12). No previous study has sought to identify the human enzyme responsible for MK-4 biosynthesis. Previously we provided evidence for the conversion of PK and K3 into MK-4 in mouse cerebra(13). However, the molecular mechanisms for these conversion reactions are unclear. Here we identify a human MK-4 biosynthetic enzyme. We screened the human genome database for prenylation enzymes and found UbiA prenyltransferase containing 1 (UBIAD1), a human homologue of Escherichia coli prenyltransferase menA. We found that short interfering RNA against the UBIAD1 gene inhibited the conversion of deuterium-labelled vitamin K derivatives into deuterium-labelled-MK-4 (MK-4-d(7)) in human cells. We confirmed that the UBIAD1 gene encodes an MK-4 biosynthetic enzyme through its expression and conversion of deuterium-labelled vitamin K derivatives into MK-4-d(7) in insect cells infected with UBIAD1 baculovirus. Converted MK-4-d(7) was chemically identified by H-2-NMR analysis. MK-4 biosynthesis by UBIAD1 was not affected by the vitamin K antagonist warfarin. UBIAD1 was localized in endoplasmic reticulum and ubiquitously expressed in several tissues of mice. Our results show that UBIAD1 is a human MK-4 biosynthetic enzyme; this identification will permit more effective decisions to be made about vitamin K intake and bone health.	[Nakagawa, Kimie; Hirota, Yoshihisa; Sawada, Natsumi; Yuge, Naohito; Watanabe, Masato; Uchino, Yuri; Okuda, Naoko; Shimomura, Yuka; Suhara, Yoshitomo; Okano, Toshio] Kobe Pharmaceut Univ, Dept Hyg Sci, Higashinada Ku, Kobe, Hyogo 6588558, Japan	Kobe Pharmaceutical University	Okano, T (corresponding author), Kobe Pharmaceut Univ, Dept Hyg Sci, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	t-okano@kobepharma-u.ac.jp	Hirota, Yoshihisa/R-6741-2019	Hirota, Yoshihisa/0000-0002-6462-9479; Suhara, Yoshitomo/0000-0002-4770-2910	Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank M. Sugiura and A. Takeuchi for technical support with <SUP>2</SUP>H-NMR analysis and LC-APCI-MS/MS analysis. This work was supported in part by priority areas from the Ministry of Education, Culture, Sports, Science and Technology (to K.N. and T.O.).	BILLETER M, 1960, BIOCHEM Z, V333, P430; Booth SL, 1998, J NUTR, V128, P785, DOI 10.1093/jn/128.5.785; Davidson RT, 1998, J NUTR, V128, P220, DOI 10.1093/jn/128.2.220; DIALAMEH G H, 1970, Biochimica et Biophysica Acta, V223, P332; GUILLAUMONT M, 1992, INT J VITAM NUTR RES, V62, P15; Ichikawa T, 2006, J BIOL CHEM, V281, P16927, DOI 10.1074/jbc.M600896200; Igarashi M, 2007, MOL CELL BIOL, V27, P7947, DOI 10.1128/MCB.00813-07; Lin E. C. C., 1987, ESCHERICHIA COLI SAL, P202; Lopez-Martin JM, 2007, HUM MOL GENET, V16, P1091, DOI 10.1093/hmg/ddm058; MARTIUS C, 1961, AM J CLIN NUTR, V9, P97, DOI 10.1093/ajcn/9.4.97; MARTIUS C, 1959, BIOCHEM Z, V331, P1; MEGANATHAN R, 1996, ESCHERICHIA COLI SAL, P642; Okano T, 2008, J BIOL CHEM, V283, P11270, DOI 10.1074/jbc.M702971200; Orr A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000685; Ronden JE, 1998, BBA-GEN SUBJECTS, V1379, P69, DOI 10.1016/S0304-4165(97)00089-5; Shearer M.J., 1988, CURRENT ADV VITAMIN, P437; Shearer MJ, 2008, THROMB HAEMOSTASIS, V100, P530, DOI 10.1160/TH08-03-0147; Spronk HMH, 2003, J VASC RES, V40, P531, DOI 10.1159/000075344; Suhara Y, 2009, BIOORG MED CHEM LETT, V19, P1054, DOI 10.1016/j.bmcl.2009.01.021; Suvarna K, 1998, J BACTERIOL, V180, P2782, DOI 10.1128/JB.180.10.2782-2787.1998; Tabb MM, 2003, J BIOL CHEM, V278, P43919, DOI 10.1074/jbc.M303136200; TAGGART WV, 1969, BIOCHEMISTRY-US, V8, P1141, DOI 10.1021/bi00831a047; Thijssen HHW, 2006, BRIT J NUTR, V95, P260, DOI 10.1079/BJN20051630; Thijssen HHW, 1996, BRIT J NUTR, V75, P121, DOI 10.1079/BJN19960115; THIJSSEN HHW, 1994, BRIT J NUTR, V72, P415, DOI 10.1079/BJN19940043; Thijssen HHW, 1996, J NUTR, V126, P537, DOI 10.1093/jn/126.2.537; WALLACE BJ, 1977, BIOCHIM BIOPHYS ACTA, V461, P84, DOI 10.1016/0005-2728(77)90071-8; Weiss JS, 2008, AM J MED GENET A, V146A, P271, DOI 10.1002/ajmg.a.32201; Weiss JS, 2007, INVEST OPHTH VIS SCI, V48, P5007, DOI 10.1167/iovs.07-0845; [No title captured]	30	214	234	3	58	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 4	2010	468	7320					117	+		10.1038/nature09464	http://dx.doi.org/10.1038/nature09464			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674YF	20953171				2022-12-01	WOS:000283786900047
J	Margolis, SS; Salogiannis, J; Lipton, DM; Mandel-Brehm, C; Wills, ZP; Mardinly, AR; Hu, LD; Greer, PL; Bikoff, JB; Ho, HYH; Soskis, MJ; Sahin, M; Greenberg, ME				Margolis, Seth S.; Salogiannis, John; Lipton, David M.; Mandel-Brehm, Caleigh; Wills, Zachary P.; Mardinly, Alan R.; Hu, Linda; Greer, Paul L.; Bikoff, Jay B.; Ho, Hsin-Yi Henry; Soskis, Michael J.; Sahin, Mustafa; Greenberg, Michael E.			EphB-Mediated Degradation of the RhoA GEF Ephexin5 Relieves a Developmental Brake on Excitatory Synapse Formation	CELL			English	Article							DENDRITIC SPINE MORPHOGENESIS; GROWTH CONE; TYROSINE PHOSPHORYLATION; ANGELMAN SYNDROME; EXCHANGE FACTORS; STRUCTURAL BASIS; IN-VIVO; RECEPTORS; SYNAPTOGENESIS; ACTIVATION	The mechanisms that promote excitatory synapse formation and maturation have been extensively studied. However, the molecular events that limit excitatory synapse development so that synapses form at the right time and place and in the correct numbers are less well understood. We have identified a RhoA guanine nucleotide exchange factor, Ephexin5, which negatively regulates excitatory synapse development until EphrinB binding to the EphB receptor tyrosine kinase triggers Ephexin5 phosphorylation, ubiquitination, and degradation. The degradation of Ephexin5 promotes EphB-dependent excitatory synapse development and is mediated by Ube3A, a ubiquitin ligase that is mutated in the human cognitive disorder Angelman syndrome and duplicated in some forms of Autism Spectrum Disorders (ASDs). These findings suggest that aberrant EphB/Ephexin5 signaling during the development of synapses may contribute to the abnormal cognitive function that occurs in Angelman syndrome and, possibly, ASDs.	[Margolis, Seth S.; Salogiannis, John; Lipton, David M.; Mandel-Brehm, Caleigh; Wills, Zachary P.; Mardinly, Alan R.; Hu, Linda; Greer, Paul L.; Bikoff, Jay B.; Ho, Hsin-Yi Henry; Soskis, Michael J.; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Sahin, Mustafa] Harvard Univ, Sch Med, Childrens Hosp Boston, FM Kirby Neurobiol Ctr,Dept Neurol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	michael_greenberg@hms.harvard.edu	Salogiannis, John/AAX-3128-2021; SAHIN, MUSTAFA/I-8653-2019; Bikoff, Jay/N-8107-2018	Salogiannis, John/0000-0002-1988-7284; SAHIN, MUSTAFA/0000-0001-7044-2953; Wills, Zachary/0000-0001-9822-6742; Mardinly, Alan/0000-0001-9891-6719; mandel-brehm, caleigh/0000-0001-7764-6529	National Institute of Neurological Disorders and Stroke [RO1 5R01NS045500]; NRSA [5T32AG00222-15]; Edward R. and Anne G. Lefler postdoctoral fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000222] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward R. and Anne G. Lefler postdoctoral fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Thompson, Y. Zhou, and H. Ye for assistance in generating mice; E. Griffith, J. Zieg, S. Cohen, I. Spiegel, M. Andzelm, and the Greenberg lab for critical discussions. This work was supported by National Institute of Neurological Disorders and Stroke grant RO1 5R01NS045500 (M.E.G); NRSA Training grant 5T32AG00222-15 (S.S.M.); and Edward R. and Anne G. Lefler postdoctoral fellowship (S.S.M.).	Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Fasen K, 2008, TRAFFIC, V9, P251, DOI 10.1111/j.1600-0854.2007.00679.x; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Kayser MS, 2008, NEURON, V59, P56, DOI 10.1016/j.neuron.2008.05.007; Kayser MS, 2006, J NEUROSCI, V26, P12152, DOI 10.1523/JNEUROSCI.3072-06.2006; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Lai KO, 2009, CURR OPIN NEUROBIOL, V19, P275, DOI 10.1016/j.conb.2009.04.009; Lim BK, 2008, NAT NEUROSCI, V11, P160, DOI 10.1038/nn2033; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Ogita H, 2003, CIRC RES, V93, P23, DOI 10.1161/01.RES.0000079310.81429.C8; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Sharfe N, 2003, J IMMUNOL, V170, P6024, DOI 10.4049/jimmunol.170.12.6024; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Yashiro K, 2009, NAT NEUROSCI, V12, P777, DOI 10.1038/nn.2327; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	33	171	180	3	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 29	2010	143	3					442	455		10.1016/j.cell.2010.09.038	http://dx.doi.org/10.1016/j.cell.2010.09.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672RF	21029865	Green Accepted, Bronze			2022-12-01	WOS:000283603900017
J	Pang, SS; Berry, R; Chen, ZJ; Kjer-Nielsen, L; Perugini, MA; King, GF; Wang, C; Chew, SH; La Gruta, NL; Williams, NK; Beddoe, T; Tiganis, T; Cowieson, NP; Godfrey, DI; Purcell, AW; Wilce, MCJ; McCluskey, J; Rossjohn, J				Pang, Siew Siew; Berry, Richard; Chen, Zhenjun; Kjer-Nielsen, Lars; Perugini, Matthew A.; King, Glenn F.; Wang, Christina; Chew, Sock Hui; La Gruta, Nicole L.; Williams, Neal K.; Beddoe, Travis; Tiganis, Tony; Cowieson, Nathan P.; Godfrey, Dale I.; Purcell, Anthony W.; Wilce, Matthew C. J.; McCluskey, James; Rossjohn, Jamie			The structural basis for autonomous dimerization of the pre-T-cell antigen receptor	NATURE			English	Article							ANALYTICAL ULTRACENTRIFUGATION; SEDIMENTATION-VELOCITY; ALPHA; TCR; BETA; SELECTION; ANGSTROM; OPINION; CHAINS; PHENIX	The pre-T-cell antigen receptor (pre-TCR), expressed by immature thymocytes, has a pivotal role in early T-cell development, including TCR beta-selection, survival and proliferation of CD4(-)CD8(-) double-negative thymocytes, and subsequent ab T-cell lineage differentiation(1-3). Whereas alpha beta TCR ligation by the peptide-loaded major histocompatibility complex initiates T-cell signalling(4), preTCR-induced signalling occurs by means of a ligand-independent dimerization event(5). The pre-TCR comprises an invariant a-chain (pre-T alpha) that pairs with any TCR beta-chain (TCR beta) following successful TCR beta-gene rearrangement(6). Here we provide the basis of pre-T alpha-TCR beta assembly and pre-TCR dimerization. The pre-T alpha chain comprised a single immunoglobulin-like domain that is structurally distinct from the constant (C) domain of the TCR alpha-chain(7); nevertheless, the mode of association between pre-T alpha and TCRb mirrored that mediated by the C alpha-C beta domains of the abTCR. The pre-TCR had a propensity to dimerize in solution, and the molecular envelope of the pre-TCR dimer correlated well with the observed head-to-tail pre-TCR dimer. This mode of pre-TCR dimerization enabled the pre-T alpha domain to interact with the variable (V) beta domain through residues that are highly conserved across the V beta and joining (J) beta gene families, thus mimicking the interactions at the core of the alpha beta TCR's V alpha-V beta interface. Disruption of this pre-T alpha-V beta dimer interface abrogated pre-TCR dimerization in solution and impaired pre-TCR expression on the cell surface. Accordingly, we provide a mechanism of pre-TCR self-association that allows the pre-T alpha chain to simultaneously 'sample' the correct folding of both the V and C domains of any TCR beta-chain, regardless of its ultimate specificity, which represents a critical checkpoint in T-cell development. This unusual dual-chaperone-like sensing function of pre-T alpha represents a unique mechanism in nature whereby developmental quality control regulates the expression and signalling of an integral membrane receptor complex.	[Chen, Zhenjun; Kjer-Nielsen, Lars; La Gruta, Nicole L.; Godfrey, Dale I.; McCluskey, James] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Pang, Siew Siew; Berry, Richard; Wang, Christina; Chew, Sock Hui; Williams, Neal K.; Beddoe, Travis; Tiganis, Tony; Cowieson, Nathan P.; Wilce, Matthew C. J.; Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, Prot Crystallog Unit, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Perugini, Matthew A.; Purcell, Anthony W.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Perugini, Matthew A.; Purcell, Anthony W.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [King, Glenn F.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, St Lucia, Qld 4072, Australia	University of Melbourne; Monash University; University of Melbourne; University of Melbourne; University of Queensland	McCluskey, J (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	jamesm1@unimelb.edu.au; jamie.rossjohn@monash.edu	Purcell, Anthony/AAH-1942-2019; Beddoe, Travis/F-3415-2014; Rossjohn, Jamie/F-9032-2013; McCluskey, James/A-1291-2007; King, Glenn F/J-5059-2012; Tiganis, Tony/AAV-3495-2020	Purcell, Anthony/0000-0003-0532-8331; Beddoe, Travis/0000-0003-4550-2277; Rossjohn, Jamie/0000-0002-2020-7522; McCluskey, James/0000-0002-8597-815X; King, Glenn F/0000-0002-2308-2200; Tiganis, Tony/0000-0002-8065-9942; berry, richard/0000-0001-7043-0469; La Gruta, Nicole/0000-0001-5358-9363; Godfrey, Dale/0000-0002-3009-5472	Australian Research Council; National Health and Medical Research Council of Australia	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	We thank S. Turner for discussions; S. Ramarathinam for technical assistance; the staff at the Australian synchrotron (MX and SAXS/WAXS beamlines) and Berkeley Advanced Light Source (SIBYLS beamline) for assistance with data collection; and T. Caradoc-Davies for advice on processing of merohedral twinned X-ray data. This research was supported by grants from the Australian Research Council and the National Health and Medical Research Council of Australia. A.W.P., T.T. and M.C.J.W. are supported by NHMRC Senior Research Fellowships, and D.I.G. is supported by an NHMRC Principal Research Fellowship. M.A.P. is supported by an ARC Future Fellowship and J.R. is supported by an ARC Federation Fellowship.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allison TJ, 2001, NATURE, V411, P820, DOI 10.1038/35081115; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; Borowski C, 2004, J EXP MED, V199, P607, DOI 10.1084/jem.20031973; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P423, DOI 10.1007/s00249-009-0418-0; Burger R, 1999, LEUKEMIA RES, V23, P19, DOI 10.1016/S0145-2126(98)00133-7; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Dave VP, 2009, IMMUNOL REV, V232, P22, DOI 10.1111/j.1600-065X.2009.00835.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; HIRANO T, 1979, J IMMUNOL, V123, P1133; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Kjer-Nielsen L, 2002, STRUCTURE, V10, P1521, DOI 10.1016/S0969-2126(02)00878-X; Kuhns MS, 2007, IMMUNITY, V26, P357, DOI 10.1016/j.immuni.2007.01.015; Melchers F, 2005, NAT REV IMMUNOL, V5, P578, DOI 10.1038/nri1649; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/NMETH.1192, 10.1038/nmeth.1192]; Saint-Ruf C, 2000, NATURE, V406, P524, DOI 10.1038/35020093; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; von Boehmer H, 2005, NAT REV IMMUNOL, V5, P571, DOI 10.1038/nri1636; Yamasaki S, 2006, NAT IMMUNOL, V7, P67, DOI 10.1038/ni1290; Yamasaki S, 2007, TRENDS IMMUNOL, V28, P39, DOI 10.1016/j.it.2006.11.006; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	30	59	66	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2010	467	7317					844	U110		10.1038/nature09448	http://dx.doi.org/10.1038/nature09448			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944746				2022-12-01	WOS:000282898700067
J	Feng, MY; Grice, DM; Faddy, HM; Nguyen, N; Leitch, S; Wang, YY; Muend, S; Kenny, PA; Sukumar, S; Roberts-Thomson, SJ; Monteith, GR; Rao, R				Feng, Mingye; Grice, Desma M.; Faddy, Helen M.; Nguyen, Nguyen; Leitch, Sharon; Wang, Yingyu; Muend, Sabina; Kenny, Paraic A.; Sukumar, Saraswati; Roberts-Thomson, Sarah J.; Monteith, Gregory R.; Rao, Rajini			Store-Independent Activation of Orai1 by SPCA2 in Mammary Tumors	CELL			English	Article							GENE-EXPRESSION SIGNATURE; YEAST SECRETORY PATHWAY; BREAST-CANCER; CELL-PROLIFERATION; PLASMA-MEMBRANE; CRAC CHANNEL; CALCIUM-TRANSPORT; ION SELECTIVITY; I-CRAC; CA2+	Ca(2+) is an essential and ubiquitous second messenger. Changes in cytosolic Ca(2+) trigger events critical for tumorigenesis, such as cellular motility, proliferation, and apoptosis. Weshow that an isoform of Secretory Pathway Ca(2+)-ATPase, SPCA2, is upregulated in breast cancer-derived cells and human breast tumors, and suppression of SPCA2 attenuates basal Ca(2+) levels and tumorigenicity. Contrary to its conventional role in Golgi Ca(2+) sequestration, expression of SPCA2 increased Ca(2+) influx by a mechanism dependent on the store-operated Ca(2+) channel Orai1. Unexpectedly, SPCA2-Orai1 signaling was independent of ER Ca(2+) stores or STIM1 and STIM2 sensors and uncoupled from Ca(2+)-ATPase activity of SPCA2. Binding of the SPCA2 amino terminus to Orai1 enabled access of its carboxyl terminus to Orai1 and activation of Ca(2+) influx. Our findings reveal a signaling pathway in which the Orai1-SPCA2 complex elicits constitutive store-independent Ca(2+) signaling that promotes tumorigenesis.	[Feng, Mingye; Leitch, Sharon; Muend, Sabina; Rao, Rajini] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Nguyen, Nguyen; Sukumar, Saraswati] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Grice, Desma M.; Faddy, Helen M.; Roberts-Thomson, Sarah J.; Monteith, Gregory R.] Univ Queensland, Sch Pharm, Brisbane, Qld 4072, Australia; [Kenny, Paraic A.] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Wang, Yingyu] Johns Hopkins Univ, Dept Mech Engn, Whiting Sch Engn, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; University of Queensland; Yeshiva University; Albert Einstein College of Medicine; Johns Hopkins University	Rao, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	rrao@jhmi.edu	Monteith, Gregory/B-1626-2008; Faddy, Helen M/A-6541-2015; Roberts-Thomson, Sarah/W-5676-2019; Feng, Mingye/E-2302-2013; Grice, Desma M/A-7730-2011; Roberts-Thomson, Sarah J/B-4282-2011	Monteith, Gregory/0000-0002-4345-530X; Roberts-Thomson, Sarah/0000-0001-8202-5786; Roberts-Thomson, Sarah J/0000-0001-8202-5786; Faddy, Helen/0000-0002-3446-8248	National Institution of Health [GM62142]; National Health and Medical Research [569644]; Cancer Council Queensland; Department of Defense-Center of Excellence [W81XWH-04-1-0595]; Albert Einstein College of Medicine; American Heart Association [0815058E]; American Psychological Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062142] Funding Source: NIH RePORTER	National Institution of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research; Cancer Council Queensland(Cancer Council Queensland); Department of Defense-Center of Excellence(United States Department of Defense); Albert Einstein College of Medicine; American Heart Association(American Heart Association); American Psychological Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Paul Worley and Dr. Guo Huang (Johns Hopkins University) for kind gifts of plasmids expressing Orai1, STIM1, and NFAT. This work was supported by grant GM62142 from the National Institution of Health to R.R., 569644 from the National Health and Medical Research and Cancer Council Queensland to G.R.M. and S.J.R.-T., Department of Defense-Center of Excellence Grant W81XWH-04-1-0595 to S.S., laboratory startup funds from the Albert Einstein College of Medicine to P.A.K., American Heart Association Pre-doctoral fellowship 0815058E to M.F., and American Psychological Association scholarship to H.M.F. and D.M.	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Aittoniemi J, 2009, PHILOS T R SOC B, V364, P257, DOI 10.1098/rstb.2008.0142; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BOS JL, 1989, CANCER RES, V49, P4682; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Cahalan MD, 2007, CELL CALCIUM, V42, P133, DOI 10.1016/j.ceca.2007.03.002; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Clementi E, 1996, CELL CALCIUM, V19, P269, DOI 10.1016/S0143-4160(96)90068-8; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Cook SJ, 2006, CELL CALCIUM, V39, P101, DOI 10.1016/j.ceca.2005.10.014; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Cullen PJ, 2002, NAT REV MOL CELL BIO, V3, P339, DOI 10.1038/nrm808; Donovan S, 2002, BBA-REV CANCER, V1602, P23, DOI 10.1016/S0304-419X(01)00041-5; Downward J, 1996, CANCER SURV, V27, P87; Durr G, 1998, MOL BIOL CELL, V9, P1149, DOI 10.1091/mbc.9.5.1149; Faddy HM, 2008, BIOCHEM BIOPH RES CO, V369, P977, DOI 10.1016/j.bbrc.2008.03.003; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; GARSIDE VC, 2010, EXP CELL RES, DOI DOI 10.10.106/J.YEXCR.2010.06.014; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Huster D, 2003, J BIOL CHEM, V278, P32212, DOI 10.1074/jbc.M305408200; Lecchi S, 2005, BIOCHEMISTRY-US, V44, P16624, DOI 10.1021/bi051555f; Lee WJ, 2006, BBA-REV CANCER, V1765, P235, DOI 10.1016/j.bbcan.2005.12.001; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Mamillapalli R, 2008, J BIOL CHEM, V283, P24435, DOI 10.1074/jbc.M801738200; Matsumoto Y, 2002, SCIENCE, V295, P499, DOI 10.1126/science.1065693; Missiaen L, 2007, CELL CALCIUM, V41, P405, DOI 10.1016/j.ceca.2006.11.001; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Morgan MP, 2005, J MAMMARY GLAND BIOL, V10, P181, DOI 10.1007/s10911-005-5400-6; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Reinhardt TA, 2004, J BIOL CHEM, V279, P42369, DOI 10.1074/jbc.M407788200; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vanoevelen J, 2005, J BIOL CHEM, V280, P22800, DOI 10.1074/jbc.M501026200; Vig M, 2007, CELL CALCIUM, V42, P157, DOI 10.1016/j.ceca.2007.03.008; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wei Y, 1999, BIOCHEMISTRY-US, V38, P14534, DOI 10.1021/bi9911233; Wei Y, 2000, J BIOL CHEM, V275, P23927, DOI 10.1074/jbc.M002618200; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Xiang MH, 2005, J BIOL CHEM, V280, P11608, DOI 10.1074/jbc.M413116200; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108	50	206	208	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 1	2010	143	1					84	98		10.1016/j.cell.2010.08.040	http://dx.doi.org/10.1016/j.cell.2010.08.040			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	656UC	20887894	Green Accepted, Bronze			2022-12-01	WOS:000282362000016
J	Moyle, LC; Nakazato, T				Moyle, Leonie C.; Nakazato, Takuya			Hybrid Incompatibility "Snowballs" Between Solanum Species	SCIENCE			English	Article							MALE-STERILITY; GENETICS; EPISTASIS; EVOLUTION; DOMINANCE; LOCI	Among the reproductive barriers that can isolate species, hybrid sterility is frequently due to dysfunctional interactions between loci that accumulate between differentiating lineages. Theory describing the evolution of these incompatibilities has generated the prediction, still empirically untested, that loci underlying hybrid incompatibility should accumulate faster than linearly with time-the "snowball effect." We evaluated the accumulation of quantitative trait loci (QTL) between species in the plant group Solanum and found evidence for a faster-than-linear accumulation of hybrid seed sterility QTL, thus empirically evaluating and confirming this theoretical prediction. In comparison, loci underlying traits unrelated to hybrid sterility show no evidence for an accelerating rate of accumulation between species.	[Moyle, Leonie C.; Nakazato, Takuya] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Nakazato, Takuya] Univ Memphis, Memphis, TN 38152 USA	Indiana University System; Indiana University Bloomington; University of Memphis	Moyle, LC (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	lmoyle@indiana.edu			National Science Foundation [DEB-0532097, DEB-0849157]	National Science Foundation(National Science Foundation (NSF))	M. Fryska, E. Graham, E. Lines, and K. Wolt contributed to collection of the data. C. Muir drew Figure 1. M. Hahn, C. Muir, and M. Turelli provided comments on the manuscript. Supported by National Science Foundation grants DEB-0532097 and DEB-0849157 (LCM).	Burnham K.P., 2002, MODEL SELECTION MULT, DOI DOI 10.1007/B97636; CABOT EL, 1994, GENETICS, V137, P175; Chang AS, 2010, EVOLUTION, V64, P253, DOI 10.1111/j.1558-5646.2009.00823.x; Cohen J., 2013, STAT POWER ANAL BEHA, DOI 10.4324/9780203771587; Coyne J.A., 2004, SPECIATION; Dobzhansky T, 1936, GENETICS, V21, P113; Gourbiere S, 2010, EVOLUTION, V64, P1, DOI 10.1111/j.1558-5646.2009.00844.x; Johnson Norman A., 2006, P374; Kondrashov AS, 2003, EVOLUTION, V57, P151; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Mendelson TC, 2004, EVOLUTION, V58, P1424; Moyle LC, 2006, MOL BIOL EVOL, V23, P973, DOI 10.1093/molbev/msj112; Moyle LC, 2005, GENETICS, V169, P355, DOI 10.1534/genetics.104.029546; Moyle LC, 2008, GENETICS, V179, P1437, DOI 10.1534/genetics.107.083618; Muller H., 1942, BIOL S, V6, P71; ORR HA, 1995, GENETICS, V139, P1805; Orr HA, 2001, EVOLUTION, V55, P1085; Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718; Tao Y, 2003, GENETICS, V164, P1399; Turelli M, 2000, GENETICS, V154, P1663; Turelli M, 2007, GENETICS, V176, P1059, DOI 10.1534/genetics.106.065979; UNCKLESS R, COMMUNICATION; Zar J.H., 2010, BIOSTAT ANAL, V5th	23	148	148	1	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2010	329	5998					1521	1523		10.1126/science.1193063	http://dx.doi.org/10.1126/science.1193063			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650RK	20847271				2022-12-01	WOS:000281869000041
J	Vermeulen, M; Eberl, HC; Matarese, F; Marks, H; Denissov, S; Butter, F; Lee, KK; Olsen, JV; Hyman, AA; Stunnenberg, HG; Mann, M				Vermeulen, Michiel; Eberl, H. Christian; Matarese, Filomena; Marks, Hendrik; Denissov, Sergei; Butter, Falk; Lee, Kenneth K.; Olsen, Jesper V.; Hyman, Anthony A.; Stunnenberg, Henk G.; Mann, Matthias			Quantitative Interaction Proteomics and Genome-wide Profiling of Epigenetic Histone Marks and Their Readers	CELL			English	Article							CHROMATIN MODIFICATIONS; BAC TRANSGENEOMICS; MOLECULAR-BASIS; TUDOR DOMAIN; PWWP DOMAIN; METHYLATION; H3; COMPLEXES; BINDING; LYSINE-4	Trimethyl-lysine (me3) modifications on histones are the most stable epigenetic marks and they control chromatin-mediated regulation of gene expression. Here, we determine proteins that bind these marks by high-accuracy, quantitative mass spectrometry. These chromatin "readers'' are assigned to complexes by interaction proteomics of full-length BAC-GFP-tagged proteins. ChIP-Seq profiling identifies their genomic binding sites, revealing functional properties. Among the main findings, the human SAGA complex binds to H3K4me3 via a double Tudor-domain in the C terminus of Sgf29, and the PWWP domain is identified as a putative H3K36me3 binding motif. The ORC complex, including LRWD1, binds to the three most prominent transcriptional repressive lysine methylation sites. Our data reveal a highly adapted interplay between chromatin marks and their associated protein complexes. Reading specific trimethyl-lysine sites by specialized complexes appears to be a widespread mechanism to mediate gene expression.	[Vermeulen, Michiel; Eberl, H. Christian; Butter, Falk; Olsen, Jesper V.; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Matarese, Filomena; Marks, Hendrik; Denissov, Sergei; Stunnenberg, Henk G.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Fac Sci, Dept Mol Biol, NL-6525 GA Nijmegen, Netherlands; [Lee, Kenneth K.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Olsen, Jesper V.] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark	Max Planck Society; Radboud University Nijmegen; Stowers Institute for Medical Research; Max Planck Society; University of Copenhagen	Vermeulen, M (corresponding author), Univ Med Ctr Utrecht, Dept Physiol Chem, Utrecht, Netherlands.	m.vermeulen-3@umcutrecht.nl; h.stunnenberg@ncmls.ru.nl; mmann@biochem.mpg.de	Hyman, Tony/F-1923-2011; Vermeulen, Michiel/C-8883-2013; Hyman, Anthony A/B-3917-2017; Mann, Matthias/A-3454-2013; Stunnenberg, Hendrik G./D-6875-2012; Olsen, Jesper/ABH-4638-2020; Marks, Hendrik/E-2801-2012	Vermeulen, Michiel/0000-0003-0836-6894; Hyman, Anthony A/0000-0003-3664-154X; Mann, Matthias/0000-0003-1292-4799; Stunnenberg, Hendrik G./0000-0002-0066-1576; Olsen, Jesper/0000-0002-4747-4938; Marks, Hendrik/0000-0002-4198-3731; Butter, Falk/0000-0002-7197-7279; Eberl, H. Christian/0000-0002-4159-5958	Max-Planck Society for the Advancement of Science, HEROIC; European Union [LSHG-CT-2005-018883]	Max-Planck Society for the Advancement of Science, HEROIC(Max Planck Society); European Union(European Commission)	Eva Janssen-Megens, Kees-Jan Francois, and Yan Tan helped with the sequencing, the MPI core facility expressed and purified recombinant proteins, and Dr. F. Tashiro kindly provided Sgf29 antibody. This work was supported by the Max-Planck Society for the Advancement of Science, HEROIC, an Integrated Project funded by the European Union under the 6th Framework Program (LSHG-CT-2005-018883) and by Interaction Proteome (LSHG-CT-2003-505520). M. V. received a fellowship of the Dutch Cancer Society (KWF/NKB) and a grant from the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research.	Butter F, 2010, EMBO REP, V11, P305, DOI 10.1038/embor.2010.6; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Denissov S, 2007, EMBO J, V26, P944, DOI 10.1038/sj.emboj.7601550; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fischle W, 2008, J BIOL CHEM, V283, P19626, DOI 10.1074/jbc.M802655200; Franz H, 2009, J BIOL CHEM, V284, P35049, DOI 10.1074/jbc.M109.052332; Garcia BA, 2007, CURR OPIN CHEM BIOL, V11, P66, DOI 10.1016/j.cbpa.2006.11.022; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Hughes-Davies L, 2003, CELL, V115, P523, DOI 10.1016/S0092-8674(03)00930-9; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Hurd PJ, 2009, J BIOL CHEM, V284, P16575, DOI 10.1074/jbc.M109.005421; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lee N, 2009, MOL CELL BIOL, V29, P1401, DOI 10.1128/MCB.01643-08; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Mandel S, 2007, DEV BIOL, V303, P814, DOI 10.1016/j.ydbio.2006.11.039; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Mateescu B, 2004, EMBO REP, V5, P490, DOI 10.1038/sj.embor.7400139; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Moshkin YM, 2009, MOL CELL, V35, P782, DOI 10.1016/j.molcel.2009.07.020; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; Nagy Z, 2010, CELL MOL LIFE SCI, V67, P611, DOI 10.1007/s00018-009-0199-8; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Prasanth SG, 2004, EMBO J, V23, P2651, DOI 10.1038/sj.emboj.7600255; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Ringrose L, 2004, MOL CELL, V16, P641, DOI 10.1016/j.molcel.2004.10.015; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Tyteca S, 2006, EMBO J, V25, P1680, DOI 10.1038/sj.emboj.7601066; VAN OEVELEN C, 2008, MOL CELL, V32, P359; Vermeulen M, 2008, CURR OPIN BIOTECH, V19, P331, DOI 10.1016/j.copbio.2008.06.001; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Vermeulen M, 2009, CURR OPIN CELL BIOL, V21, P761, DOI 10.1016/j.ceb.2009.09.003; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Wang Y, 2009, MOL CELL, V33, P428, DOI 10.1016/j.molcel.2009.02.002; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Winter S, 2008, CELL CYCLE, V7, P1336, DOI 10.4161/cc.7.10.5946; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	56	552	577	2	88	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2010	142	6					967	980		10.1016/j.cell.2010.08.020	http://dx.doi.org/10.1016/j.cell.2010.08.020			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650NA	20850016	Bronze			2022-12-01	WOS:000281855000018
J	Dosenbach, NUF; Nardos, B; Cohen, AL; Fair, DA; Power, JD; Church, JA; Nelson, SM; Wig, GS; Vogel, AC; Lessov-Schlaggar, CN; Barnes, KA; Dubis, JW; Feczko, E; Coalson, RS; Pruett, JR; Barch, DM; Petersen, SE; Schlaggar, BL				Dosenbach, Nico U. F.; Nardos, Binyam; Cohen, Alexander L.; Fair, Damien A.; Power, Jonathan D.; Church, Jessica A.; Nelson, Steven M.; Wig, Gagan S.; Vogel, Alecia C.; Lessov-Schlaggar, Christina N.; Barnes, Kelly Anne; Dubis, Joseph W.; Feczko, Eric; Coalson, Rebecca S.; Pruett, John R., Jr.; Barch, Deanna M.; Petersen, Steven E.; Schlaggar, Bradley L.			Prediction of Individual Brain Maturity Using fMRI	SCIENCE			English	Article							RESTING HUMAN BRAIN; FUNCTIONAL CONNECTIVITY; COGNITIVE CONTROL; PATTERN-ANALYSIS; CHILDREN; CORTEX; REPRESENTATIONS; NETWORKS; ABILITY; HUMANS	Group functional connectivity magnetic resonance imaging (fcMRI) studies have documented reliable changes in human functional brain maturity over development. Here we show that support vector machine-based multivariate pattern analysis extracts sufficient information from fcMRI data to make accurate predictions about individuals' brain maturity across development. The use of only 5 minutes of resting-state fcMRI data from 238 scans of typically developing volunteers (ages 7 to 30 years) allowed prediction of individual brain maturity as a functional connectivity maturation index. The resultant functional maturation curve accounted for 55% of the sample variance and followed a nonlinear asymptotic growth curve shape. The greatest relative contribution to predicting individual brain maturity was made by the weakening of short-range functional connections between the adult brain's major functional networks.	[Dosenbach, Nico U. F.; Nardos, Binyam; Cohen, Alexander L.; Power, Jonathan D.; Church, Jessica A.; Nelson, Steven M.; Wig, Gagan S.; Vogel, Alecia C.; Barnes, Kelly Anne; Dubis, Joseph W.; Coalson, Rebecca S.; Petersen, Steven E.; Schlaggar, Bradley L.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Fair, Damien A.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97239 USA; [Nelson, Steven M.; Barch, Deanna M.; Petersen, Steven E.] Washington Univ, Dept Psychol, St Louis, MO 63130 USA; [Wig, Gagan S.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Wig, Gagan S.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Lessov-Schlaggar, Christina N.; Feczko, Eric; Pruett, John R., Jr.; Barch, Deanna M.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Coalson, Rebecca S.; Barch, Deanna M.; Petersen, Steven E.; Schlaggar, Bradley L.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Petersen, Steven E.; Schlaggar, Bradley L.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Schlaggar, Bradley L.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA	Washington University (WUSTL); Oregon Health & Science University; Washington University (WUSTL); Harvard University; Harvard University; Massachusetts General Hospital; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Dosenbach, NUF (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	ndosenbach@wustl.edu; schlaggarb@neuro.wustl.edu	Barch, Deanna M/G-8638-2013; Petersen, Steve/ABF-1368-2020; Cohen, Alexander/A-6865-2009; Cohen, Alexander Li/H-6594-2019; Church-Lang, Jessica/L-2659-2016; Kennedy, Kristen M/B-4699-2008; Church, Jessica/E-2836-2010; Schlaggar, Bradley/AAZ-4153-2020; Nelson, Steven/C-1003-2009	Cohen, Alexander/0000-0001-6557-5866; Cohen, Alexander Li/0000-0001-6557-5866; Church-Lang, Jessica/0000-0003-1369-9116; Kennedy, Kristen M/0000-0001-5373-9026; Power, Jonathan/0000-0002-6922-100X	NIH [NS55582, NS053425, HD057076, NS00169011, NS51281, NS32979, NS41255, NS46424, DA027046]; John Merck Scholars Fund; Burroughs-Wellcome Fund; Dana Foundation; Ogle Family Fund; McDonnell Center; Simons Foundation; American Hearing Research Foundation; Diabetes Research Center at Washington University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057076] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [K12EY016336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH062130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032979, R21NS041255, K02NS053425, R01NS046424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA027046] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Merck Scholars Fund; Burroughs-Wellcome Fund(Burroughs Wellcome Fund); Dana Foundation; Ogle Family Fund; McDonnell Center; Simons Foundation; American Hearing Research Foundation; Diabetes Research Center at Washington University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants NS55582, NS053425, HD057076, and NS00169011 (B.L.S.); NS51281, NS32979, NS41255, and NS46424 (S.E.P.); DA027046 (C.N.L.-S.); EY16336 (J.R.P.); and MH62130 (D.M.B.) and by the John Merck Scholars Fund (B.L.S.), Burroughs-Wellcome Fund (B.L.S.), Dana Foundation (B.L.S.), Ogle Family Fund (B.L.S.), McDonnell Center (S.E.P. and B.L.S.), Simons Foundation (S.E.P.), American Hearing Research Foundation (J. E. C. Lieu), and Diabetes Research Center at Washington University (T. G. Hershey). We thank J. E. C. Lieu, C. E. Pizoli, and T. G. Hershey for providing data and F. M. Miezin, J. Harwell, A. Z. Snyder, and H. M. Lugar for help with data analysis.	Akaike H., 1973, 2 INT S INF THEOR, P267; [Anonymous], 2009, PSYCHOL SCI, V20, P1364, DOI 10.1111/j.1467-9280.2009.02460.x; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Craik FIM, 2006, TRENDS COGN SCI, V10, P131, DOI 10.1016/j.tics.2006.01.007; Crone EA, 2006, P NATL ACAD SCI USA, V103, P9315, DOI 10.1073/pnas.0510088103; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Johnson JD, 2009, NEURON, V63, P697, DOI 10.1016/j.neuron.2009.08.011; Johnson MH, 2001, NAT REV NEUROSCI, V2, P475, DOI 10.1038/35081509; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; POLYN SM, 1963, SCIENCE, V310, P2005; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Schlaggar BL, 2002, SCIENCE, V296, P1476, DOI 10.1126/science.1069464; Schurger A, 2010, SCIENCE, V327, P97, DOI 10.1126/science.1180029; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Shen H, 2010, NEUROIMAGE, V49, P3110, DOI 10.1016/j.neuroimage.2009.11.011; Somerville LH, 2010, CURR OPIN NEUROBIOL, V20, P236, DOI 10.1016/j.conb.2010.01.006; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Tsoularis A, 2002, MATH BIOSCI, V179, P21, DOI 10.1016/S0025-5564(02)00096-2; Velanova K, 2009, J NEUROSCI, V29, P12558, DOI 10.1523/JNEUROSCI.1579-09.2009; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198	37	1351	1379	16	265	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2010	329	5997					1358	1361		10.1126/science.1194144	http://dx.doi.org/10.1126/science.1194144			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647YR	20829489	Green Accepted			2022-12-01	WOS:000281657300043
J	Ito, T; Yokoyama, S				Ito, Takuhiro; Yokoyama, Shigeyuki			Two enzymes bound to one transfer RNA assume alternative conformations for consecutive reactions	NATURE			English	Article							STRUCTURAL BASIS; SYNTHETASE; AMIDOTRANSFERASE; CRYSTALLOGRAPHY; RECRUITMENT; GLUTAMINE	In most bacteria and all archaea, glutamyl-tRNA synthetase (GluRS) glutamylates both tRNA(Glu) and tRNA(Gln), and then Glu-tRNA(Gln) is selectively converted to Gln-tRNA(Gln) by a tRNAdependent amidotransferase(1,2). The mechanisms by which the two enzymes recognize their substrate tRNA(s), and how they cooperate with each other in Gln-tRNA(Gln) synthesis, remain to be determined. Here we report the formation of the 'glutamine transamidosome' from the bacterium Thermotoga maritima, consisting of tRNA(Gln), GluRS and the heterotrimeric amidotransferase GatCAB, and its crystal structure at 3.35 angstrom resolution. The anticodon-binding body of GluRS recognizes the common features of tRNA(Gln) and tRNA(Glu), whereas the tail body of GatCAB recognizes the outer corner of the L-shaped tRNA(Gln) in a tRNA(Gln)-specific manner. GluRS is in the productive form, as its catalytic body binds to the amino-acid-acceptor arm of tRNA(Gln). In contrast, GatCAB is in the non-productive form: the catalytic body of GatCAB contacts that of GluRS and is located near the acceptor stem of tRNA(Gln), in an appropriate site to wait for the completion of Glu-tRNA(Gln) formation by GluRS. We identified the hinges between the catalytic and anticodon-binding bodies of GluRS and between the catalytic and tail bodies of GatCAB, which allow both GluRS and GatCAB to adopt the productive and non-productive forms. The catalytic bodies of the two enzymes compete for the acceptor arm of tRNA(Gln) and therefore cannot assume their productive forms simultaneously. The transition from the present glutamylation state, with the productive GluRS and the non-productive GatCAB, to the putative amidation state, with the nonproductive GluRS and the productive GatCAB, requires an intermediate state with the two enzymes in their non-productive forms, for steric reasons. The proposed mechanism explains how the transamidosome efficiently performs the two consecutive steps of Gln-tRNA(Gln) formation, with a low risk of releasing the unstable intermediate Glu-tRNA(Gln).	[Ito, Takuhiro; Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Bunkyo Ku, Tokyo 1130033, Japan; [Ito, Takuhiro; Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Struct Biol Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Ito, Takuhiro; Yokoyama, Shigeyuki] RIKEN Syst & Struct Biol Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	University of Tokyo; University of Tokyo; RIKEN	Yokoyama, S (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	yokoyama@biochem.s.u-tokyo.ac.jp	Ito, Takuhiro/N-6893-2015; Yokoyama, Shigeyuki/N-6911-2015	Ito, Takuhiro/0000-0003-3704-5205; Yokoyama, Shigeyuki/0000-0003-3133-7338	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank S. Sekine for discussions and help with data collection, S. Goto-Ito for reading the manuscript, and S. Takahashi, N. Kiyasu and R. Matsunaga for help with sample preparation. We are grateful to the staff of the beamline BL41XU in the SPring-8 and the beamline AR-NE3A in the Photon Factory for their support during data collection. This work was supported by the Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT), a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and MEXT, and the Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from MEXT.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bailly M, 2007, MOL CELL, V28, P228, DOI 10.1016/j.molcel.2007.08.017; Bailly M, 2006, NUCLEIC ACIDS RES, V34, P6083, DOI 10.1093/nar/gkl622; Becker HD, 1998, P NATL ACAD SCI USA, V95, P12832, DOI 10.1073/pnas.95.22.12832; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Curnow AW, 1998, P NATL ACAD SCI USA, V95, P12838, DOI 10.1073/pnas.95.22.12838; Curnow AW, 1997, P NATL ACAD SCI USA, V94, P11819, DOI 10.1073/pnas.94.22.11819; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ito T, 2010, ACTA CRYSTALLOGR D, V66, P813, DOI 10.1107/S0907444910019086; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nakamura A, 2010, NUCLEIC ACIDS RES, V38, P672, DOI 10.1093/nar/gkp955; Nakamura A, 2006, SCIENCE, V312, P1954, DOI 10.1126/science.1127156; Oshikane H, 2006, SCIENCE, V312, P1950, DOI 10.1126/science.1128470; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RAMPIAS T, NUCL ACIDS IN PRESS; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; Sekine S, 2003, EMBO J, V22, P676, DOI 10.1093/emboj/cdg053; Sekine S, 2001, NAT STRUCT BIOL, V8, P203, DOI 10.1038/84927; Tumbula DL, 2000, NATURE, V407, P106, DOI 10.1038/35024120; WILCOX M, 1968, P NATL ACAD SCI USA, V61, P229, DOI 10.1073/pnas.61.1.229; Wu J, 2009, J MOL BIOL, V391, P703, DOI 10.1016/j.jmb.2009.06.014	24	44	46	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP	2010	467	7315					612	U143		10.1038/nature09411	http://dx.doi.org/10.1038/nature09411			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655TT	20882017				2022-12-01	WOS:000282273100044
J	Weber, TS; Deutsch, C				Weber, Thomas S.; Deutsch, Curtis			Ocean nutrient ratios governed by plankton biogeography	NATURE			English	Article							ANTARCTIC CIRCUMPOLAR CURRENT; GLACIAL SOUTHERN-OCEAN; ELEMENTAL STOICHIOMETRY; MARINE-PHYTOPLANKTON; COMMUNITY STRUCTURE; NITROGEN-FIXATION; PACIFIC-OCEAN; CO2; DENITRIFICATION; PHOSPHORUS	The major nutrients nitrate and phosphate have one of the strongest correlations in the sea, with a slope similar to the average nitrogen (N) to phosphorus (P) content of plankton biomass (N/P = 16:1). The processes through which this global relationship emerges despite the wide range of N/P ratios at the organism level are not known. Here we use an ocean circulation model and observed nutrient distributions to show that the N/P ratio of biological nutrient removal varies across latitude in Southern Ocean surface waters, from 12: 1 in the polar ocean to 20: 1 in the sub-Antarctic zone. These variations are governed by regional differences in the species composition of the plankton community. The covariation of dissolved nitrate and phosphate is maintained by ocean circulation, which mixes the shallow subsurface nutrients between distinct biogeographic provinces. Climate-driven shifts in these marine biomes may alter the mean N/P ratio and the associated carbon export by Southern Ocean ecosystems.	[Weber, Thomas S.; Deutsch, Curtis] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Weber, TS (corresponding author), Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA.	tweber@atmos.ucla.edu	Deutsch, Curtis A/D-1703-2011		National Science Foundation; Gordon and Betty Moore Foundation; UCLA	National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); UCLA	We thank S. Khatiwala for providing the transport matrix. This work was funded by grants from the National Science Foundation and the Gordon and Betty Moore Foundation. Additional support for T.S.W. was provided by a Pauley Fellowship from UCLA.	ANDERSON LA, 1994, GLOBAL BIOGEOCHEM CY, V8, P65, DOI 10.1029/93GB03318; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Arrigo KR, 1999, SCIENCE, V283, P365, DOI 10.1126/science.283.5400.365; BROECKER WS, 1982, PROG OCEANOGR, V11, P151, DOI 10.1016/0079-6611(82)90007-6; Brzezinski MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014349; CODISPOTI LA, 1985, MAR CHEM, V16, P277, DOI 10.1016/0304-4203(85)90051-9; CODISPOTI LA, 1989, LIFE SCI R, V44, P377; Dentener F, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002672; Elderfield H, 2000, NATURE, V405, P305, DOI 10.1038/35012507; Falkowski PG, 2000, J PHYCOL, V36, P3, DOI 10.1046/j.1529-8817.2000.99161.x; Finkel ZV, 2006, LIMNOL OCEANOGR, V51, P2690, DOI 10.4319/lo.2006.51.6.2690; Fu FX, 2007, J PHYCOL, V43, P485, DOI 10.1111/j.1529-8817.2007.00355.x; Garcia H. E., 2006, WORLD OCEAN ATLAS 20; Geider RJ, 2002, EUR J PHYCOL, V37, P1, DOI 10.1017/S0967026201003456; Green SE, 2006, DEEP-SEA RES PT II, V53, P620, DOI 10.1016/j.dsr2.2006.01.022; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Jin X, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002532; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; KARL DM, 2001, ENCY OCEAN SCI, P1876; Khatiwala S, 2005, OCEAN MODEL, V9, P51, DOI 10.1016/j.ocemod.2004.04.002; Klausmeier CA, 2004, NATURE, V429, P171, DOI 10.1038/nature02454; KOPCZYNSKA EE, 1986, POLAR BIOL, V6, P161, DOI 10.1007/BF00274879; Le Quere C, 2007, SCIENCE, V316, P1735, DOI 10.1126/science.1136188; Longhurst A, 1995, PROG OCEANOGR, V36, P77, DOI 10.1016/0079-6611(95)00015-1; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Price NM, 2005, LIMNOL OCEANOGR, V50, P1159, DOI 10.4319/lo.2005.50.4.1159; Quigg A, 2003, NATURE, V425, P291, DOI 10.1038/nature01953; REDFIELD AC, 1958, AM SCI, V46, P205; Sarmiento JL, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002134; SARMIENTO JL, 1984, NATURE, V308, P621, DOI 10.1038/308621a0; Schlitzer R, 2002, DEEP-SEA RES PT II, V49, P1623, DOI 10.1016/S0967-0645(02)00004-8; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, P80; TAKAHASHI T, 1985, J GEOPHYS RES-OCEANS, V90, P6907, DOI 10.1029/JC090iC04p06907; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759	35	191	197	4	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP	2010	467	7315					550	554		10.1038/nature09403	http://dx.doi.org/10.1038/nature09403			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655TT	20882009				2022-12-01	WOS:000282273100030
J	Matsuzaki, Y; Ogawa-Ohnishi, M; Mori, A; Matsubayashi, Y				Matsuzaki, Yo; Ogawa-Ohnishi, Mari; Mori, Ayaka; Matsubayashi, Yoshikatsu			Secreted Peptide Signals Required for Maintenance of Root Stem Cell Niche in Arabidopsis	SCIENCE			English	Article							PHYTOSULFOKINE; PROLIFERATION; PROTEINS; GENES	Stem cells are maintained in the niche by intercellular interactions and signaling networks. In this work, we study extracellular signals required for maintenance of the root stem cell niche in higher plants. We identify a family of functionally redundant homologous peptides that are secreted, tyrosine-sulfated, and expressed mainly in the stem cell area and the innermost layer of central columella cells. We name these peptides root meristem growth factors (RGFs). RGFs are required for maintenance of the root stem cell niche and transit amplifying cell proliferation in Arabidopsis. RGF1 defines expression levels and patterns of the stem cell transcription factor PLETHORA, mainly at the posttranscriptional level. The RGFs function independently of the auxin pathway. These peptide signals play a crucial role in postembryonic root development.	[Matsuzaki, Yo; Ogawa-Ohnishi, Mari; Mori, Ayaka; Matsubayashi, Yoshikatsu] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University	Matsubayashi, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	matsu@agr.nagoya-u.ac.jp	MATSUBAYASHI, Yoshikatsu/AAA-9705-2019	Matsubayashi, Yoshikatsu/0000-0002-2669-2119	Ministry of Education, Culture, Sports, Science, and Technology [19060010]; Japan Society for the Promotion of Science [19GS0315]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank P. Doerner for providing the CYCB1; 1: GUS seeds, T. Guilfoyle for the DR5:GUS seeds, and B. Scheres for the plt1-4 plt2-2 seeds. This research was supported by a Grant-in-Aid for Scientific Research for Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology (no. 19060010) and a Grant-in-Aid for Creative Scientific Research from the Japan Society for the Promotion of Science (no. 19GS0315).	Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Amano Y, 2007, P NATL ACAD SCI USA, V104, P18333, DOI 10.1073/pnas.0706403104; Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238; Colon-Carmona A, 1999, PLANT J, V20, P503, DOI 10.1046/j.1365-313x.1999.00620.x; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; Komori R, 2009, P NATL ACAD SCI USA, V106, P15067, DOI 10.1073/pnas.0902801106; Matsubayashi Y, 1996, P NATL ACAD SCI USA, V93, P7623, DOI 10.1073/pnas.93.15.7623; Matsubayashi Y, 2006, PLANT PHYSIOL, V142, P45, DOI 10.1104/pp.106.081109; Moore KL, 2003, J BIOL CHEM, V278, P24243, DOI 10.1074/jbc.R300008200; Sarkar AK, 2007, NATURE, V446, P811, DOI 10.1038/nature05703; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963	11	274	309	6	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 27	2010	329	5995					1065	1067		10.1126/science.1191132	http://dx.doi.org/10.1126/science.1191132			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642WZ	20798316				2022-12-01	WOS:000281253500037
J	Kaida, D; Berg, MG; Younis, I; Kasim, M; Singh, LN; Wan, L; Dreyfuss, G				Kaida, Daisuke; Berg, Michael G.; Younis, Ihab; Kasim, Mumtaz; Singh, Larry N.; Wan, Lili; Dreyfuss, Gideon			U1 snRNP protects pre-mRNAs from premature cleavage and polyadenylation	NATURE			English	Article							DISEASE GENE-PRODUCT; MAMMALIAN-CELLS; MINOR CLASS; SPLICEOSOME; COMPLEX; SMN; TRANSCRIPTION; DEFICIENCY; INSIGHTS	In eukaryotes, U1 small nuclear ribonucleoprotein (snRNP) forms spliceosomes in equal stoichiometry with U2, U4, U5 and U6 snRNPs; however, its abundance in human far exceeds that of the other snRNPs. Here we used antisense morpholino oligonucleotide to U1 snRNA to achieve functional U1 snRNP knockdown in HeLa cells, and identified accumulated unspliced pre-mRNAs by genomic tiling microarrays. In addition to inhibiting splicing, U1 snRNP knockdown caused premature cleavage and polyadenylation in numerous pre-mRNAs at cryptic polyadenylation signals, frequently in introns near (<5 kilobases) the start of the transcript. This did not occur when splicing was inhibited with U2 snRNA antisense morpholino oligonucleotide or the U2-snRNP-inactivating drug spliceostatin A unless U1 antisense morpholino oligonucleotide was also included. We further show that U1 snRNA-pre-mRNA base pairing was required to suppress premature cleavage and polyadenylation from nearby cryptic polyadenylation signals located in introns. These findings reveal a critical splicing-independent function for U1 snRNP in protecting the transcriptome, which we propose explains its overabundance.	[Kaida, Daisuke; Berg, Michael G.; Younis, Ihab; Kasim, Mumtaz; Singh, Larry N.; Wan, Lili; Dreyfuss, Gideon] Univ Penn, Sch Med, Howard Hughes Med Inst, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania	Dreyfuss, G (corresponding author), Univ Penn, Sch Med, Howard Hughes Med Inst, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	gdreyfuss@hhmi.upenn.edu	Younis, Ihab/M-1849-2019; Dreyfuss, Gideon/D-1218-2013; Singh, Larry N./AAG-6880-2021	Younis, Ihab/0000-0003-3329-5979; Dreyfuss, Gideon/0000-0001-8129-8774; Singh, Larry N./0000-0002-2478-5864; Kaida, Daisuke/0000-0003-4014-5231	Association Francaise Contre les Myopathies (AFM)	Association Francaise Contre les Myopathies (AFM)(Association Francaise contre les Myopathies)	We are grateful to the members of our laboratory, especially J. Yong and J. Bachorik, for discussions and comments on this manuscript. We thank M. Yoshida for providing spliceostatin A. We also thank D. A. Baldwin and H. Rodriguez at the Microarray Core Facility at the University of Pennsylvania School of Medicine for help with the tiling array. This work was supported by the Association Francaise Contre les Myopathies (AFM). G.D. is an Investigator of the Howard Hughes Medical Institute.	Baserga S., 1993, RNA WORLD, P359; Calvo O, 2003, GENE DEV, V17, P1321, DOI 10.1101/gad.1093603; Cifuentes-Diaz Carmen, 2002, Semin Pediatr Neurol, V9, P145, DOI 10.1053/spen.2002.33801; Danckwardt S, 2008, EMBO J, V27, P482, DOI 10.1038/sj.emboj.7601932; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Fortes P, 2003, P NATL ACAD SCI USA, V100, P8264, DOI 10.1073/pnas.1332669100; Friend K, 2007, MOL CELL, V28, P240, DOI 10.1016/j.molcel.2007.09.026; Gabanella F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000921; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gromak N, 2006, MOL CELL BIOL, V26, P3986, DOI 10.1128/MCB.26.10.3986-3996.2006; Gu MG, 2005, CURR OPIN STRUC BIOL, V15, P99, DOI 10.1016/j.sbi.2005.01.009; Gunderson SI, 1998, MOL CELL, V1, P255, DOI 10.1016/S1097-2765(00)80026-X; Hall SL, 1996, SCIENCE, V271, P1716, DOI 10.1126/science.271.5256.1716; Iannaccone Susan T, 2004, Curr Neurol Neurosci Rep, V4, P74, DOI 10.1007/s11910-004-0016-6; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Kambach C, 1999, CURR OPIN STRUC BIOL, V9, P222, DOI 10.1016/S0959-440X(99)80032-3; Kataoka N, 2004, J BIOL CHEM, V279, P7009, DOI 10.1074/jbc.M307692200; Konig H, 2007, CELL, V131, P718, DOI 10.1016/j.cell.2007.09.043; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Kramer A, 2005, BIOCHEM SOC T, V33, P439; Kyburz A, 2006, MOL CELL, V23, P195, DOI 10.1016/j.molcel.2006.05.037; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; Matter N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni041; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Tarn WY, 1996, CELL, V84, P801, DOI 10.1016/S0092-8674(00)81057-0; Vagner S, 2000, RNA, V6, P178, DOI 10.1017/S1355838200991854; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wan LL, 2005, MOL CELL BIOL, V25, P5543, DOI 10.1128/MCB.25.13.5543-5551.2005; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	42	406	415	3	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2010	468	7324					664	U81		10.1038/nature09479	http://dx.doi.org/10.1038/nature09479			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	20881964	Green Accepted			2022-12-01	WOS:000284836700034
J	Rubinson, EH; Gowda, ASP; Spratt, TE; Gold, B; Eichman, BF				Rubinson, Emily H.; Gowda, A. S. Prakasha; Spratt, Thomas E.; Gold, Barry; Eichman, Brandt F.			An unprecedented nucleic acid capture mechanism for excision of DNA damage	NATURE			English	Article							HUMAN AP ENDONUCLEASE-1; CRYSTAL-STRUCTURE; BASE EXCISION; HEAT REPEATS; SUBSTRATE-SPECIFICITY; GLYCOSYLASE-I; ALKYLATED DNA; REPAIR; RECOGNITION; 3-METHYLADENINE	DNA glycosylases that remove alkylated and deaminated purine nucleobases are essential DNA repair enzymes that protect the genome, and at the same time confound cancer alkylation therapy, by excising cytotoxic N3-methyladenine bases formed by DNA-targeting anticancer compounds. The basis for glycosylase specificity towards N3- and N7-alkylpurines is believed to result from intrinsic instability of the modified bases and not from direct enzyme functional group chemistry. Here we present crystal structures of the recently discovered Bacillus cereus AlkD glycosylase in complex with DNAs containing alkylated, mismatched and abasic nucleotides. Unlike other glycosylases, AlkD captures the extrahelical lesion in a solvent-exposed orientation, providing an illustration for how hydrolysis of N3- and N7-alkylated bases may be facilitated by increased lifetime out of the DNA helix. The structures and supporting biochemical analysis of base flipping and catalysis reveal how the HEAT repeats of AlkD distort the DNA backbone to detect non-Watson-Crick base pairs without duplex intercalation.	[Rubinson, Emily H.; Eichman, Brandt F.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [Rubinson, Emily H.; Eichman, Brandt F.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Gowda, A. S. Prakasha; Spratt, Thomas E.] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Gold, Barry] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA	Vanderbilt University; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Eichman, BF (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37232 USA.	brandt.eichman@vanderbilt.edu		Eichman, Brandt/0000-0002-0965-2297; ALADAHALLI SANNE GOWDA, PRAKASHA GOWDA/0000-0002-0055-7103; Spratt, Thomas/0000-0002-6805-3729	US Department of Energy Office of Basic Energy Sciences; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; American Cancer Society; NIH [RO1 CA29088]; Vanderbilt Training Program in Molecular Toxicology; NATIONAL CANCER INSTITUTE [P30CA068485, R01CA029088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267, T32ES007028] Funding Source: NIH RePORTER	US Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Training Program in Molecular Toxicology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank J. Stivers for providing the pyrene phosphoramidite, Z. Warzak and LS-CAT beamline staff at the Advanced Photon Source (APS) for assistance with X-ray data collection, and T. Ellenberger, J. Stivers and P. O'Brien for comments on the manuscript. Use of the APS was supported by the US Department of Energy Office of Basic Energy Sciences. Use of LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor. This research was supported by a grant from the American Cancer Society (to B.F.E.) and the NIH (RO1 CA29088 to B.G.). E.H.R. was supported in part by the Vanderbilt Training Program in Molecular Toxicology. Additional support for local crystallography facilities was provided by the Vanderbilt Center in Molecular Toxicology and the Vanderbilt-Ingram Cancer Center.	ABOULELA F, 1985, NUCLEIC ACIDS RES, V13, P4811, DOI 10.1093/nar/13.13.4811; Adams PD, 2007, NATO SCI SER II-MATH, V245, P101, DOI 10.1007/978-1-4020-6316-9_9; Alseth I, 2006, MOL MICROBIOL, V59, P1602, DOI 10.1111/j.1365-2958.2006.05044.x; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Asaeda A, 2000, BIOCHEMISTRY-US, V39, P1959, DOI 10.1021/bi9917075; Baldwin MR, 2009, BIOCHEMISTRY-US, V48, P6022, DOI 10.1021/bi900517y; Banerjee A, 2006, SCIENCE, V311, P1153, DOI 10.1126/science.1120288; Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; Bennett MT, 2006, J AM CHEM SOC, V128, P12510, DOI 10.1021/ja0634829; Brown PJ, 2008, CANCER LETT, V260, P48, DOI 10.1016/j.canlet.2007.10.015; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Dalhus B, 2007, NUCLEIC ACIDS RES, V35, P2451, DOI 10.1093/nar/gkm039; Dinner AR, 2001, NATURE, V413, P752, DOI 10.1038/35099587; Drohat AC, 2002, NAT STRUCT BIOL, V9, P659, DOI 10.1038/nsb829; Eichman BF, 2003, EMBO J, V22, P4898, DOI 10.1093/emboj/cdg505; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ezaz-Nikpay K, 1994, Chem Biol, V1, P235, DOI 10.1016/1074-5521(94)90016-7; EZAZNIKPAY K, 1992, J AM CHEM SOC, V114, P6562, DOI 10.1021/ja00042a048; Friedberg EC, 2006, DNA REPAIR, V5, P986, DOI 10.1016/j.dnarep.2006.05.005; Ganguly M, 2010, J PHYS CHEM B, V114, P7656, DOI 10.1021/jp101004k; Gates KS, 2004, CHEM RES TOXICOL, V17, P839, DOI 10.1021/tx049965c; Hecht SS, 1999, MUTAT RES-FUND MOL M, V424, P127, DOI 10.1016/S0027-5107(99)00014-7; Holt S, 1998, CARCINOGENESIS, V19, P1763, DOI 10.1093/carcin/19.10.1763; HUNTER WN, 1987, J BIOL CHEM, V262, P9962; Irani RJ, 2002, NUCLEOS NUCLEOT NUCL, V21, P737, DOI 10.1081/NCN-120016477; Jiang YL, 2003, BIOCHEMISTRY-US, V42, P1922, DOI 10.1021/bi027014x; Jiang YL, 2001, J BIOL CHEM, V276, P42347, DOI 10.1074/jbc.M106594200; Jones BN, 2008, METHOD ENZYMOL, V448, P23, DOI 10.1016/S0076-6879(08)02602-5; LARSON K, 1985, MUTAT RES, V150, P77, DOI 10.1016/0027-5107(85)90103-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lau AY, 1998, CELL, V95, P249, DOI 10.1016/S0092-8674(00)81755-9; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; Lee S, 2008, J AM CHEM SOC, V130, P11570, DOI 10.1021/ja8025328; Li L, 2009, CHEM RES TOXICOL, V22, P1464, DOI 10.1021/tx9001572; Lyons DM, 2009, J AM CHEM SOC, V131, P17742, DOI 10.1021/ja908378y; Maher RL, 2007, J BIOL CHEM, V282, P30577, DOI 10.1074/jbc.M704341200; Maher RL, 2007, DNA REPAIR, V6, P71, DOI 10.1016/j.dnarep.2006.09.001; Maiti A, 2009, J BIOL CHEM, V284, P36680, DOI 10.1074/jbc.M109.062356; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Metz AH, 2007, EMBO J, V26, P2411, DOI 10.1038/sj.emboj.7601649; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Mol CD, 2002, J MOL BIOL, V315, P373, DOI 10.1006/jmbi.2001.5264; Neuwald AF, 2000, GENOME RES, V10, P1445, DOI 10.1101/gr.147400; O'Brien PJ, 2004, J BIOL CHEM, V279, P26876, DOI 10.1074/jbc.M403860200; O'Brien PJ, 2004, J BIOL CHEM, V279, P9750, DOI 10.1074/jbc.M312232200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parikh SS, 2000, P NATL ACAD SCI USA, V97, P5083, DOI 10.1073/pnas.97.10.5083; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Plosky BS, 2008, NUCLEIC ACIDS RES, V36, P2152, DOI 10.1093/nar/gkn058; Rubinson EH, 2008, J MOL BIOL, V381, P13, DOI 10.1016/j.jmb.2008.05.078; SHUKER DEG, 1987, CARCINOGENESIS, V8, P959, DOI 10.1093/carcin/8.7.959; SHUKER DEG, 1992, CHEM RES TOXICOL, V5, P450, DOI 10.1021/tx00028a001; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Singer B., 1983, MOL BIOL MUTAGENS CA; Stivers JT, 2008, CHEM-EUR J, V14, P786, DOI 10.1002/chem.200701501; Stivers JT, 2004, PROG NUCLEIC ACID RE, V77, P37, DOI 10.1016/S0079-6603(04)77002-6; Stivers JT, 2003, CHEM REV, V103, P2729, DOI 10.1021/cr010219b; Tubbs JL, 2009, NATURE, V459, P808, DOI 10.1038/nature08076; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Williams DR, 2008, STRUCTURE, V16, P468, DOI 10.1016/j.str.2007.12.014; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Yang CG, 2009, CHEMBIOCHEM, V10, P417, DOI 10.1002/cbic.200800580	65	62	64	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 18	2010	468	7322					406	U309		10.1038/nature09428	http://dx.doi.org/10.1038/nature09428			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681KP	20927102	Green Accepted			2022-12-01	WOS:000284313100036
J	Graham, AL; Hayward, AD; Watt, KA; Pilkington, JG; Pemberton, JM; Nussey, DH				Graham, Andrea L.; Hayward, Adam D.; Watt, Kathryn A.; Pilkington, Jill G.; Pemberton, Josephine M.; Nussey, Daniel H.			Fitness Correlates of Heritable Variation in Antibody Responsiveness in a Wild Mammal	SCIENCE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; FEMALE SOAY SHEEP; AUTOIMMUNE-DISEASE; SUSCEPTIBILITY; AUTOANTIBODIES; POPULATION; TOLERANCE; PREVALENCE; MODEL; AGE	A functional immune system is important for survival in natural environments, where individuals are frequently exposed to parasites. Yet strong immune responses may have fitness costs if they deplete limited energetic resources or cause autoimmune disease. We have found associations between fitness and heritable self-reactive antibody responsiveness in a wild population of Soay sheep. The occurrence of self-reactive antibodies correlated with overall antibody responsiveness and was associated with reduced reproduction in adults of both sexes. However, in females, the presence of self-reactive antibodies was positively associated with adult survival during harsh winters. Our results highlight the complex effects of natural selection on immune responsiveness and suggest that fitness trade-offs may maintain immunoheterogeneity, including genetic variation in autoimmune susceptibility.	[Graham, Andrea L.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Graham, Andrea L.; Hayward, Adam D.; Watt, Kathryn A.; Pilkington, Jill G.; Pemberton, Josephine M.; Nussey, Daniel H.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [Graham, Andrea L.; Watt, Kathryn A.] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh EH9 3JT, Midlothian, Scotland; [Graham, Andrea L.; Nussey, Daniel H.] Univ Edinburgh, Sch Biol Sci, Ctr Immun Infect & Evolut, Edinburgh EH9 3JT, Midlothian, Scotland	Princeton University; University of Edinburgh; University of Edinburgh; University of Edinburgh	Graham, AL (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	algraham@princeton.edu	Graham, Andrea/GON-8450-2022; Hayward, Adam/B-7659-2016; Graham, Andrea L./P-7296-2019; Graham, Andrea L./A-8808-2010; Nussey, Daniel H/F-4155-2010; Pemberton, Josephine M/F-3100-2010	Hayward, Adam/0000-0001-6953-7509; Graham, Andrea L./0000-0002-6580-2755; Graham, Andrea L./0000-0002-6580-2755; 	Biotechnology and Biological Sciences Research Council; Natural Environment Research Council; Wellcome Trust; Science and Technology Directorate, U.S. Department of Homeland Security; Fogarty International Center; Biotechnology and Biological Sciences Research Council [BB/H021868/1] Funding Source: researchfish; Natural Environment Research Council [NE/G004854/1, NE/E01237X/1] Funding Source: researchfish; BBSRC [BB/H021868/1] Funding Source: UKRI; NERC [NE/E01237X/1, NE/G004854/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust(Wellcome TrustEuropean Commission); Science and Technology Directorate, U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Biotechnology and Biological Sciences and Natural Environment Research Councils; the Wellcome Trust; and the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, U.S. Department of Homeland Security, and the Fogarty International Center. Thanks to the National Trust for Scotland and Scottish National Heritage for permission to work on St. Kilda; the Ministry of Defense, QinetiQ, Amey, and Eurest Support Services staff on St. Kilda and Benbecula for logistical support; T. Clutton-Brock, M. Crawley, B. Grenfell, and many field volunteers for the data set and samples; F. Howison, N. Sanderson, K. Fairlie-Clarke, J. Matthews, and A. Nisbet for laboratory assistance; and A. Read, B. Grenfell, T. Little, D. Gray, R. Mellanby, S. Caserta, B. Craig, T. Coulson, J. Slate, R. Maizels, W. Craigens, and members of the Wild Evolution Group for discussions.	Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Attanasio R, 2001, CLIN EXP IMMUNOL, V123, P361, DOI 10.1046/j.1365-2249.2001.01454.x; Clatworthy MR, 2007, P NATL ACAD SCI USA, V104, P7169, DOI 10.1073/pnas.0608889104; Clutton-Brock T.H., 2004, SOAY SHEEP DYNAMICS; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; CluttonBrock TH, 1996, J ANIM ECOL, V65, P675, DOI 10.2307/5667; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; COVELLI V, 1989, J IMMUNOL, V142, P1224; Devalapalli AP, 2006, SCAND J IMMUNOL, V64, P125, DOI 10.1111/j.1365-3083.2006.01785.x; Dighiero G, 1999, IMMUNOL TODAY, V20, P423, DOI 10.1016/S0167-5699(99)01509-1; Falconer DS, 1996, INTRO QUANTITATIVE G; Frank S., 2002, IMMUNOLOGY EVOLUTION; Graham AL, 2005, ANNU REV ECOL EVOL S, V36, P373, DOI 10.1146/annurev.ecolsys.36.102003.152622; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; Grindstaff JL, 2003, P ROY SOC B-BIOL SCI, V270, P2309, DOI 10.1098/rspb.2003.2485; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Kumar KR, 2006, SCIENCE, V312, P1665, DOI 10.1126/science.1125893; Lazzaro BP, 2009, PHILOS T R SOC B, V364, P15, DOI 10.1098/rstb.2008.0141; Lee YH, 2009, LUPUS, V18, P727, DOI 10.1177/0961203309104020; Liang KP, 2007, J RHEUMATOL, V34, P1203; Limaye N, 2008, GENES IMMUN, V9, P61, DOI 10.1038/sj.gene.6364446; Lipsky PE, 2001, NAT IMMUNOL, V2, P764, DOI 10.1038/ni0901-764; Lleo A, 2010, AUTOIMMUN REV, V9, pA259, DOI 10.1016/j.autrev.2009.12.002; Marrow P, 1996, PHILOS T R SOC B, V351, P17, DOI 10.1098/rstb.1996.0002; Nilsson BO, 2006, J AUTOIMMUN, V27, P281, DOI 10.1016/j.jaut.2006.10.002; Njemini R, 2002, CLIN EXP IMMUNOL, V127, P99, DOI 10.1046/j.1365-2249.2002.01713.x; Rioux JD, 2009, P NATL ACAD SCI USA, V106, P18680, DOI 10.1073/pnas.0909307106; Rolff J, 2003, SCIENCE, V301, P472, DOI 10.1126/science.1080623; Smee NM, 2007, JAVMA-J AM VET MED A, V230, P1180, DOI 10.2460/javma.230.8.1180; Tavecchia G, 2005, J ANIM ECOL, V74, P201, DOI 10.1111/j.1365-2656.2005.00916.x; Trowsdale J, 2006, NAT IMMUNOL, V7, P241, DOI 10.1038/ni1317; Viney ME, 2005, TRENDS ECOL EVOL, V20, P665, DOI 10.1016/j.tree.2005.10.003; Wood JD, 1998, DIGEST DIS SCI, V43, P1443, DOI 10.1023/A:1018842210330	33	152	153	3	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 29	2010	330	6004					662	665		10.1126/science.1194878	http://dx.doi.org/10.1126/science.1194878			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672KB	21030656				2022-12-01	WOS:000283580600046
J	Iwashyna, TJ; Ely, EW; Smith, DM; Langa, KM				Iwashyna, Theodore J.; Ely, E. Wesley; Smith, Dylan M.; Langa, Kenneth M.			Long-term Cognitive Impairment and Functional Disability Among Survivors of Severe Sepsis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DISABLED OLDER WOMEN; INTENSIVE-CARE-UNIT; QUALITY-OF-LIFE; MORTALITY; DELIRIUM; DECLINE; STATES; DEMENTIA; HEALTH; HOSPITALIZATION	Context Cognitive impairment and functional disability are major determinants of caregiving needs and societal health care costs. Although the incidence of severe sepsis is high and increasing, the magnitude of patients' long-term cognitive and functional limitations after sepsis is unknown. Objective To determine the change in cognitive impairment and physical functioning among patients who survive severe sepsis, controlling for their presepsis functioning. Design, Setting, and Patients A prospective cohort involving 1194 patients with 1520 hospitalizations for severe sepsis drawn from the Health and Retirement Study, a nationally representative survey of US residents (1998-2006). A total of 9223 respondents had a baseline cognitive and functional assessment and had linked Medicare claims; 516 survived severe sepsis and 4517 survived a nonsepsis hospitalization to at least 1 follow-up survey and are included in the analysis. Main Outcome Measures Personal interviews were conducted with respondents or proxies using validated surveys to assess the presence of cognitive impairment and to determine the number of activities of daily living (ADLs) and instrumental ADLs (IADLs) for which patients needed assistance. Results Survivors' mean age at hospitalization was 76.9 years. The prevalence of moderate to severe cognitive impairment increased 10.6 percentage points among patients who survived severe sepsis, an odds ratio (OR) of 3.34 (95% confidence interval [CI], 1.53-7.25) in multivariable regression. Likewise, a high rate of new functional limitations was seen following sepsis: in those with no limits before sepsis, a mean 1.57 new limitations (95% CI, 0.99-2.15); and for those with mild to moderate limitations before sepsis, a mean of 1.50 new limitations (95% CI, 0.87-2.12). In contrast, nonsepsis general hospitalizations were associated with no change in moderate to severe cognitive impairment (OR, 1.15; 95% CI, 0.80-1.67; P for difference vs sepsis=.01) and with the development of fewer new limitations (mean among those with no limits before hospitalization, 0.48; 95% CI, 0.39-0.57; P for difference vs sepsis <.001 and mean among those with mild to moderate limits, 0.43; 95% CI, 0.23-0.63; P for difference=.001). The declines in cognitive and physical function persisted for at least 8 years. Conclusions Severe sepsis in this older population was independently associated with substantial and persistent new cognitive impairment and functional disability among survivors. The magnitude of these new deficits was large, likely resulting in a pivotal downturn in patients' ability to live independently. JAMA. 2010; 304(16): 1787-1794	[Iwashyna, Theodore J.; Langa, Kenneth M.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Ely, E. Wesley] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Ely, E. Wesley] VA Tennessee Valley Geriatr Res & Educ Clin Ctr, Nashville, TN USA; [Smith, Dylan M.] SUNY Stony Brook, Med Ctr, Dept Prevent Med, Stony Brook, NY 11794 USA; [Langa, Kenneth M.] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Langa, Kenneth M.] Ann Arbor Vet Affairs Hlth Serv, Res & Dev Serv Ctr Excellence, Ann Arbor, MI USA	University of Michigan System; University of Michigan; Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; University of Michigan System; University of Michigan	Iwashyna, TJ (corresponding author), 3A23 300 NIB,SPC 5419,300 N Ingalls, Ann Arbor, MI 48109 USA.	tiwashyn@umich.edu	Ely, E. Wesley/Z-2018-2019	Ely, E. Wesley/0000-0003-3957-2172; Iwashyna, Theodore/0000-0002-4226-9310; Langa, Kenneth/0000-0002-2798-1836	National Institutes of Health [K08 HL091249, R01 AG027010, R01 AG030155, AG027472]; Society of Critical Care Medicine; Michigan Institute for Clinical and Health Research [UL1RR024986]; National Institute on Aging [U01 AG09740]; Veterans Affairs Merit Award; Tennessee Valley Geriatric Research, Education and Clinical Center; National Institute of Diabetes and Digestive and Kidney Disease [P60 DK-20572]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL091249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030155, R01AG027010, U01AG009740, R01AG027472, K23AG001023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Society of Critical Care Medicine; Michigan Institute for Clinical and Health Research; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs Merit Award(US Department of Veterans Affairs); Tennessee Valley Geriatric Research, Education and Clinical Center; National Institute of Diabetes and Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants K08 HL091249, R01 AG027010, and R01 AG030155 from the National Institutes of Health; the Society of Critical Care Medicine's 2010 Vision Grant; and by pilot support from grant UL1RR024986 from the Michigan Institute for Clinical and Health Research. Grant U01 AG09740 from the National Institute on Aging provided funding for the Health and Retirement Study, which is performed at the Institute for Social Research, University of Michigan. Dr Ely was supported by grant AG027472 from the National Institutes of Health, by the Veterans Affairs Merit Award, and by the Tennessee Valley Geriatric Research, Education and Clinical Center. Consultative support was provided by the Measurement Core of the Michigan Diabetes Center through grant P60 DK-20572 from the National Institute of Diabetes and Digestive and Kidney Disease.	Allison PaulD., 2009, FIXED EFFECTS REGRES; Alzheimer's Association, 2006, EARL ONS DEM NAT CHA; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Banaszak-Holl J, 2004, ALZ DIS ASSOC DIS, V18, P83, DOI 10.1097/01.wad.0000126619.80941.91; Boyd CM, 2005, J GERONTOL A-BIOL, V60, P888, DOI 10.1093/gerona/60.7.888; Boyd CM, 2009, J AM GERIATR SOC, V57, P1757, DOI 10.1111/j.1532-5415.2009.02455.x; Boyd CM, 2008, J AM GERIATR SOC, V56, P2171, DOI 10.1111/j.1532-5415.2008.02023.x; Callahan Leigh Ann, 2009, Crit Care Med, V37, pS354, DOI 10.1097/CCM.0b013e3181b6e439; CHELLURI L, 1993, JAMA-J AM MED ASSOC, V269, P3119, DOI 10.1001/jama.269.24.3119; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Fonda S, 2004, DOCUMENTATION PHYS F; Fong TG, 2009, NEUROLOGY, V72, P1570, DOI 10.1212/WNL.0b013e3181a4129a; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Fried TR, 2001, ARCH INTERN MED, V161, P2602, DOI 10.1001/archinte.161.21.2602; Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1; Health and Retirement Study, 2008, SAMPL SIZ RESP RAT; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Herzog AR, 1997, J GERONTOL B-PSYCHOL, V52, P37, DOI 10.1093/geronb/52B.Special_Issue.37; Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95; Hopkins RO, 2005, AM J RESP CRIT CARE, V171, P340, DOI 10.1164/rccm.200406-763OC; Iwashyna TJ, 2010, ANN INTERN MED, V153, P204, DOI 10.7326/0003-4819-153-3-201008030-00013; Jackson JC, 2004, NEUROPSYCHOL REV, V14, P87, DOI 10.1023/B:NERV.0000028080.39602.17; Jorm AF, 2004, INT PSYCHOGERIATR, V16, P275, DOI 10.1017/S1041610204000390; Kaarlola A, 2006, CRIT CARE MED, V34, P2120, DOI 10.1097/01.CCM.0000227656.31911.2E; Kuo HK, 2005, LANCET NEUROL, V4, P371, DOI 10.1016/S1474-4422(05)70099-5; Kuo HK, 2004, J GERONTOL A-BIOL, V59, P1191, DOI 10.1093/gerona/59.11.1191; Langa KM, 2008, ALZHEIMERS DEMENT, V4, P134, DOI 10.1016/j.jalz.2008.01.001; Langa KM, 2005, NEUROEPIDEMIOLOGY, V25, P181, DOI 10.1159/000087448; Langa KM, 2001, J GEN INTERN MED, V16, P770, DOI 10.1046/j.1525-1497.2001.10123.x; Langa KM, 2004, JAMA-J AM MED ASSOC, V292, P2901, DOI 10.1001/jama.292.23.2901; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; McConnell S, 2008, EVALUATION REV, V32, P157, DOI 10.1177/0193841X07309115; Mehta KM, 2003, J GERONTOL A-BIOL, V58, P461; MIKKELSEN ME, 2008, AM THOR SOC MAY 21 T; Needham DM, 2008, JAMA-J AM MED ASSOC, V300, P1685, DOI 10.1001/jama.300.14.1685; Ofstedal MB., 2005, DOCUMENTATION COGNIT, DOI DOI 10.1371/journal.pone.0144722; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rozzini R, 2005, J GERONTOL A-BIOL, V60, P1180, DOI 10.1093/gerona/60.9.1180; Saint S, 2002, AM J RESP CRIT CARE, V165, P1475, DOI 10.1164/rccm.2110035; Schweickert WD, 2007, CHEST, V131, P1541, DOI 10.1378/chest.06-2065; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Sharshar T, 2009, CRIT CARE MED, V37, P3047, DOI 10.1097/CCM.0b013e3181b027e9; SPRUNG CL, 1990, CRIT CARE MED, V18, P801, DOI 10.1097/00003246-199008000-00001; WELSH KA, 1993, NEUROPSY NEUROPSY BE, V6, P103; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d; Yaffe K, 2002, JAMA-J AM MED ASSOC, V287, P2090, DOI 10.1001/jama.287.16.2090; Yende Sachin, 2007, Curr Infect Dis Rep, V9, P382, DOI 10.1007/s11908-007-0059-3; Ziegler-Graham K, 2008, ALZHEIMERS DEMENT, V4, P316, DOI 10.1016/j.jalz.2008.05.2479; Zivin K, 2010, AM J GERIAT PSYCHIAT, V18, P1036, DOI 10.1097/JGP.0b013e3181dba6d2	51	1399	1476	5	97	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 27	2010	304	16					1787	1794		10.1001/jama.2010.1553	http://dx.doi.org/10.1001/jama.2010.1553			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671JZ	20978258	Bronze, Green Accepted			2022-12-01	WOS:000283501300019
J	Bettencourt, L; West, G				Bettencourt, Luis; West, Geoffrey			A unified theory of urban living	NATURE			English	Editorial Material							GENERAL-MODEL; CITIES; GROWTH		[Bettencourt, Luis; West, Geoffrey] Los Alamos Natl Lab, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory	Bettencourt, L (corresponding author), Los Alamos Natl Lab, Los Alamos, NM 87545 USA.		Bettencourt, Luis/R-9861-2019	Limb, Melanie Ruth/0000-0002-6258-3366				[Anonymous], 2010, GLOBAL SUSTAINABILIT; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; BETTENCOURT LMA, PLOS ONE IN PRESS; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Brown M.A., 2009, POLICY SOC, V27, P285, DOI [10.1016/j.polsoc.2009.01.001, DOI 10.1016/J.POLSOC.2009.01.001]; Dodman D, 2009, ENVIRON URBAN, V21, P185, DOI 10.1177/0956247809103016; Jacobs Jane, 1961, DEATH LIFE GREAT AM; UN-Habitat, 2010, STAT WORLDS CIT 2010; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122	10	455	467	9	165	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 21	2010	467	7318					912	913		10.1038/467912a	http://dx.doi.org/10.1038/467912a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	668FT	20962823				2022-12-01	WOS:000283254700015
J	Jacobson, SG; Cideciyan, AV				Jacobson, Samuel G.; Cideciyan, Artur V.			Treatment Possibilities for Retinitis Pigmentosa.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jacobson, Samuel G.; Cideciyan, Artur V.] Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Jacobson, SG (corresponding author), Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA.		Cideciyan, Artur V/A-1075-2007	Cideciyan, Artur V/0000-0002-2018-0905; Jacobson, Samuel/0000-0003-2122-169X				Bramall AN, 2010, ANNU REV NEUROSCI, V33, P441, DOI 10.1146/annurev-neuro-060909-153227; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Cideciyan AV, 2010, PROG RETIN EYE RES, V29, P398, DOI 10.1016/j.preteyeres.2010.04.002; Flannery JG, 2006, NEURON, V50, P1, DOI 10.1016/j.neuron.2006.03.027; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297	5	55	60	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 21	2010	363	17					1669	1671		10.1056/NEJMcibr1007685	http://dx.doi.org/10.1056/NEJMcibr1007685			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	668BD	20961252				2022-12-01	WOS:000283242700014
J	Chandra, A; Acosta, JD				Chandra, Anita; Acosta, Joie D.			Disaster Recovery Also Involves Human Recovery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Chandra, Anita; Acosta, Joie D.] RAND Corp, Arlington, VA 22202 USA	RAND Corporation	Chandra, A (corresponding author), RAND Corp, 1200 S Hayes St, Arlington, VA 22202 USA.	Anita_Chandra@rand.org						ACOSTA J, 2010, NAVIGATING LONG ROAD; Chandra A., 2009, ROLE NONGOVERNMENTAL; CHANDRA A, 2010, COMMUNITY RESILIENCE; *EM MED FDN, 2009, DEV NAT STAND ALL HA; Kates R.W., 1977, RECONSTRUCTION FOLLO, P1; NAVARRO M, 2010, NY TIMES        0617, pA19; PFEFFERBAUM BJ, 2009, HELPING FAMILIES COM, P265; U.S. Department of Health & Human Services, 2009, NAT HLTH SEC STRAT; *US DEP HOM SEC, 2010, NAT DIS REC IN PRESS; *US GOV ACC OFF, 2009, GAO09561	10	22	22	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2010	304	14					1608	1609		10.1001/jama.2010.1456	http://dx.doi.org/10.1001/jama.2010.1456			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662OE	20940389				2022-12-01	WOS:000282816500028
J	Camilli, R; Reddy, CM; Yoerger, DR; Van Mooy, BAS; Jakuba, MV; Kinsey, JC; McIntyre, CP; Sylva, SP; Maloney, JV				Camilli, Richard; Reddy, Christopher M.; Yoerger, Dana R.; Van Mooy, Benjamin A. S.; Jakuba, Michael V.; Kinsey, James C.; McIntyre, Cameron P.; Sylva, Sean P.; Maloney, James V.			Tracking Hydrocarbon Plume Transport and Biodegradation at Deepwater Horizon	SCIENCE			English	Article							OIL	The Deepwater Horizon blowout is the largest offshore oil spill in history. We present results from a subsurface hydrocarbon survey using an autonomous underwater vehicle and a ship-cabled sampler. Our findings indicate the presence of a continuous plume of oil, more than 35 kilometers in length, at approximately 1100 meters depth that persisted for months without substantial biodegradation. Samples collected from within the plume reveal monoaromatic petroleum hydrocarbon concentrations in excess of 50 micrograms per liter. These data indicate that monoaromatic input to this plume was at least 5500 kilograms per day, which is more than double the total source rate of all natural seeps of the monoaromatic petroleum hydrocarbons in the northern Gulf of Mexico. Dissolved oxygen concentrations suggest that microbial respiration rates within the plume were not appreciably more than 1 micromolar oxygen per day.	[Camilli, Richard; Yoerger, Dana R.; Kinsey, James C.] Woods Hole Oceanog Inst, Dept Appl Ocean Phys & Engn, Woods Hole, MA 02543 USA; [Reddy, Christopher M.; Van Mooy, Benjamin A. S.; McIntyre, Cameron P.; Sylva, Sean P.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Jakuba, Michael V.] Univ Sydney, Australian Ctr Field Robot, Sydney, NSW 2006, Australia; [Maloney, James V.] Monitor Instruments Co, Cheswick, PA 15024 USA	Woods Hole Oceanographic Institution; Woods Hole Oceanographic Institution; University of Sydney	Camilli, R (corresponding author), Woods Hole Oceanog Inst, Dept Appl Ocean Phys & Engn, Woods Hole, MA 02543 USA.	rcamilli@whoi.edu	McIntyre, Cameron P/D-1222-2016; Sylva, Sean/D-4400-2014	McIntyre, Cameron P/0000-0001-8517-9836; Sylva, Sean/0000-0002-4727-440X; Reddy, Christopher/0000-0002-7814-2071	NSF [OCE-1045025, OCE-0537173, OCE-1043976, OCE-1045670, OCE-0644290]; U.S. Coast Guard [HSCG3210CR0020]; NASA [NNX09AB76G]	NSF(National Science Foundation (NSF)); U.S. Coast Guard; NASA(National Aeronautics & Space Administration (NASA))	This research was supported by NSF grants OCE-1045025 (RAPID Response Research) and OCE-0537173 (National Oceanographic Partnership Program for TETHYS development) to R. C., OCE-1043976 (RAPID) to C. M. R., OCE-1045670 (RAPID) to B. A. S. V. M., and OCE-0644290 [NSF Ocean Sciences (OCE)-Submersible] for Sentry development and integration to D.R.Y.; by U.S. Coast Guard HSCG3210CR0020 to R. C.; and by NASA Astrobiology Science and Technology for Exploring Planets (ASTEP) NNX09AB76G for integrating technology with Sentry to D.R.Y. We thank the officers and crew of the R/V Endeavor and J. Parker and J. Kusek of the U. S. Coast Guard for assistance during marine operations at the Deepwater Horizon well site. We thank K. Keteles (U. S. Environmental Protection Agency); D. Hollander and E. Goddard (Univ. of South Florida); and A. Billings, A. Duester, S. McCue, D. Torres, M. Swartz, C. Murphy, R. Catanach, and J. Fenwick (Woods Hole Oceanographic Institution) for logistics, operations, experimental, and administrative support. We acknowledge J. Ledwell, C. German, R. Munier, and especially J. Farrington for valuable discussions and guidance.	Camilli R., 2007, Oceans 2007, P1; Camilli R, 2009, MAR POLLUT BULL, V58, P1505, DOI 10.1016/j.marpolbul.2009.05.016; Camilli R, 2009, ENVIRON SCI TECHNOL, V43, P5014, DOI 10.1021/es803717d; Chen FH, 2004, J MARINE SYST, V45, P189, DOI 10.1016/j.jmarsys.2003.11.005; Dasanayaka LK, 2009, J HYDRO-ENVIRON RES, V2, P243, DOI 10.1016/j.jher.2009.01.004; GARCIA HE, 2006, WORLD OCEAN ATLAS 20, V3, P342; German CR, 2008, DEEP-SEA RES PT I, V55, P203, DOI 10.1016/j.dsr.2007.11.004; German CR, 1998, EARTH PLANET SC LETT, V156, P267, DOI 10.1016/S0012-821X(98)00020-X; Gillis J., 2010, NY TIMES, pA1; GOLDENBERG S, 2010, GUARDIAN        0701, P26; *INT JOINT AN GROU, REV PREL DAT EX SUBS; Johansen O, 2003, MAR POLLUT BULL, V47, P360, DOI 10.1016/S0025-326X(03)00202-9; Johansen O, 2000, SPILL SCI TECHNOL B, V6, P103, DOI 10.1016/S1353-2561(00)00042-6; Kvenvolden KA, 2003, GEO-MAR LETT, V23, P140, DOI 10.1007/s00367-003-0135-0; Mau S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031344; *MONT BAY AQ RES I, DAT REP NOAA SHIP GO; OUDOT C, 1988, LIMNOL OCEANOGR, V33, P146, DOI 10.4319/lo.1988.33.1.0146; Rabalais NN, 2010, BIOGEOSCIENCES, V7, P585, DOI 10.5194/bg-7-585-2010; *SEA BIRD EL, 2010, 64 SEA BIRD EL; Simecek-Beatty D, 2007, OIL SPILL ENVIRONMENTAL FORENSICS: FINGERPRINTING AND SOURCE IDENTIFICATION, P405, DOI 10.1016/B978-012369523-9.50017-3; STEVENSON LH, 1991, DICT ENV SCI, P294; *UN COMM DEEPW HOR, 2010, US SCI TEAMS REF EST; Valentine DL, 2010, NAT GEOSCI, V3, P345, DOI 10.1038/NGEO848; WANG ZD, 1995, ANAL CHEM, V67, P3491, DOI 10.1021/ac00115a018; Winkler L.W., 1888, BER DTSCH CHEM GES, V21, P2843, DOI DOI 10.1002/CBER.188802102122	25	576	598	9	409	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2010	330	6001					201	204		10.1126/science.1195223	http://dx.doi.org/10.1126/science.1195223			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20724584				2022-12-01	WOS:000282644600036
J	Shiels, MS; Pfeiffer, RM; Engels, EA				Shiels, Meredith S.; Pfeiffer, Ruth M.; Engels, Eric A.			Age at Cancer Diagnosis Among Persons With AIDS in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; HIV-INFECTED INDIVIDUALS; HODGKIN LYMPHOMA; CROHNS-DISEASE; HEPATOCELLULAR-CARCINOMA; GENETIC ANTICIPATION; LUNG-CANCER; RISK; PEOPLE	Background: Studies have reported young ages at cancer diagnosis in HIV-infected persons and have suggested that HIV accelerates carcinogenesis. However, these comparisons did not account for differences in population age structures. Objective: To compare ages at diagnosis for non-AIDS-defining types of cancer that occur in both the AIDS and general populations, after adjustment for differences in age and other demographic characteristics between these populations. Design: Registry linkage study. Setting: 15 HIV/AIDS and cancer registry databases in the United States. Participants: 212 055 persons with AIDS enrolled in the U. S. HIV/AIDS Cancer Match Study from 1996 to 2007. Measurements: Comparison of age-at-diagnosis distributions for various types of cancer in both the AIDS and general populations, after adjustment for age and other demographic characteristics. Results: The proportion of person-time contributed by older persons (age >= 65 years) was far smaller in the AIDS population (1.5%) than in the general population (12.5%). Reflecting this difference, the ages at diagnosis for most types of cancer were approximately 20 years younger among persons with AIDS. However, after adjustment for differences in the populations at risk, the median ages at diagnosis in the AIDS and general populations did not differ for most types of cancer (for example, colon, prostate, or breast cancer; all P > 0.100). In contrast, ages at diagnosis of lung (median, 50 vs. 54 years) and anal cancer (median, 42 vs. 45 years) were significantly younger in persons with AIDS than expected in the general population (P < 0.001), and the age at diagnosis of Hodgkin lymphoma was significantly older (median, 42 vs. 40 years; P < 0.001). Limitations: Information on other cancer risk factors, including cigarette smoking, was not available. Analysis was restricted to non-Hispanic white and black persons who had AIDS, which could limit the generalizability of the findings to other racial and ethnic groups or to persons with HIV but not AIDS. Conclusion: For most types of cancer, the age at diagnosis is similar in the AIDS and general populations, after adjustment for the ages of the populations at risk. Modest age differences remained for a few types of cancer, which may indicate either acceleration of carcinogenesis by HIV or earlier exposure to cancer risk factors.	[Shiels, Meredith S.] NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, NIH, Rockville, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Shiels, MS (corresponding author), NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, NIH, 6120 Execut Blvd,EPS 7059, Rockville, MD 20892 USA.	shielsms@mail.nih.gov	Pfeiffer, Ruth M/F-4748-2011		National Cancer Institute; NATIONAL CANCER INSTITUTE [Z01CP010150, ZIACP010150] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant Support: By the intramural research program of the National Cancer Institute.	Alshafie MT, 1997, BRIT J SURG, V84, P1068, DOI 10.1002/bjs.1800840808; [Anonymous], HIV AIDS SURV REP 20; Bhavan Kavita P, 2008, Curr HIV/AIDS Rep, V5, P150, DOI 10.1007/s11904-008-0023-3; Biggar RJ, 2006, BLOOD, V108, P3786, DOI 10.1182/blood-2006-05-024109; Brau N, 2007, J HEPATOL, V47, P527, DOI 10.1016/j.jhep.2007.06.010; Brock MV, 2006, JAIDS-J ACQ IMM DEF, V43, P47, DOI 10.1097/01.qai.0000232260.95288.93; BROWN GW, 1950, P 2 BERK S MATH STAT, P159; Carbone A, 2009, CURR OPIN HIV AIDS, V4, P3, DOI 10.1097/COH.0b013e32831a722b; *CDCP, 1992, MMWR-MORBID MORTAL W, V41; Chapman C, 2009, CLIN COLORECTAL CANC, V8, P215, DOI 10.3816/CCC.2009.n.036; Clifford GM, 2009, BLOOD, V113, P5737, DOI 10.1182/blood-2009-02-204172; Clifford GM, 2005, JNCI-J NATL CANCER I, V97, P425, DOI 10.1093/jnci/dji072; Crum-Cianflone NF, 2010, AIDS, V24, P535, DOI 10.1097/QAD.0b013e328331f6e2; D'Souza G, 2008, J GEN INTERN MED, V23, P1452, DOI 10.1007/s11606-008-0698-6; Demopoulos BP, 2003, ARCH PATHOL LAB MED, V127, P589; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150; Engels EA, 2008, INT J CANCER, V123, P187, DOI 10.1002/ijc.23487; Engels EA, 2006, AIDS, V20, P1645, DOI 10.1097/01.aids.0000238411.75324.59; Frisch M, 2001, JAMA-J AM MED ASSOC, V285, P1736, DOI 10.1001/jama.285.13.1736; Frisch M, 1996, LANCET, V347, P1551, DOI 10.1016/S0140-6736(96)90703-5; Goedert JJ, 2006, BRIT J CANCER, V95, P642, DOI 10.1038/sj.bjc.6603282; Grandbastien B, 1998, GUT, V42, P170, DOI 10.1136/gut.42.2.170; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Horner MJ, 2009, SEER CANC STAT REV 1; Long JL, 2008, AIDS, V22, P489, DOI 10.1097/QAD.0b013e3282f47082; Mani H, 2009, CLIN LYMPHOMA MYELOM, V9, P206, DOI 10.3816/CLM.2009.n.042; Mofenson Lynne M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Picco MF, 2001, ANN INTERN MED, V134, P1124, DOI 10.7326/0003-4819-134-12-200106190-00013; Polito JMII, 1996, LANCET, V347, P798, DOI 10.1016/S0140-6736(96)90870-3; Puoti M, 2004, AIDS, V18, P2285, DOI 10.1097/00002030-200411190-00009; Shiels MS, 2009, JAIDS-J ACQ IMM DEF, V52, P611, DOI 10.1097/QAI.0b013e3181b327ca; Silverberg MJ, 2006, AIDS, V20, P1531, DOI 10.1097/01.aids.0000237369.41617.0f; Silverberg MJ, 2009, AIDS, V23, P2337, DOI 10.1097/QAD.0b013e3283319184; Tobias C, 2007, AIDS PATIENT CARE ST, V21, pS3, DOI 10.1089/apc.2007.9992; U.S. (United States). Census Bureau, 2009, ANN EST RES POP SEX; WHO, 2022, INT CLASSIFICATION D	39	154	157	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 5	2010	153	7					452	+		10.7326/0003-4819-153-7-201010050-00008	http://dx.doi.org/10.7326/0003-4819-153-7-201010050-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658VG	20921544	Green Accepted			2022-12-01	WOS:000282517000004
J	McKenna, NJ; O'Malley, BW				McKenna, Neil J.; O'Malley, Bert W.			SnapShot: NR Coregulators	CELL			English	Editorial Material							REPRESSION; DISEASE		[McKenna, Neil J.; O'Malley, Bert W.] Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine	McKenna, NJ (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.			McKenna, Neil/0000-0001-6689-0104	NIDDK NIH HHS [U19-DK62434] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Lee YH, 2009, MOL ENDOCRINOL, V23, P425, DOI 10.1210/me.2008-0380; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Manavathi Bramanandam, 2007, Nucl Recept Signal, V5, pe010, DOI 10.1621/nrs.05010; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; O'Malley BW, 2007, MOL ENDOCRINOL, V21, P1009, DOI 10.1210/me.2007-0012; ONATE SA, 1995, SCIENCE, V270, P1354; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; White R, 2008, FEBS LETT, V582, P39, DOI 10.1016/j.febslet.2007.11.017	11	12	13	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 1	2010	143	1					172	U176		10.1016/j.cell.2010.09.032	http://dx.doi.org/10.1016/j.cell.2010.09.032			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	656UC	20887900	Bronze			2022-12-01	WOS:000282362000024
J	Moresi, V; Williams, AH; Meadows, E; Flynn, JM; Potthoff, MJ; McAnally, J; Shelton, JM; Backs, J; Klein, WH; Richardson, JA; Bassel-Duby, R; Olson, EN				Moresi, Viviana; Williams, Andrew H.; Meadows, Eric; Flynn, Jesse M.; Potthoff, Matthew J.; McAnally, John; Shelton, John M.; Backs, Johannes; Klein, William H.; Richardson, James A.; Bassel-Duby, Rhonda; Olson, Eric N.			Myogenin and Class II HDACs Control Neurogenic Muscle Atrophy by Inducing E3 Ubiquitin Ligases	CELL			English	Article							DEPENDENT CARDIAC-HYPERTROPHY; RING FINGER 1; SKELETAL-MUSCLE; SATELLITE CELLS; SOLEUS MUSCLE; GENE; DENERVATION; EXPRESSION; RAT; PROTEIN	Maintenance of skeletal muscle structure and function requires innervation by motor neurons, such that denervation causes muscle atrophy. We show that myogenin, an essential regulator of muscle development, controls neurogenic atrophy. Myogenin is upregulated in skeletal muscle following denervation and regulates expression of the E3 ubiquitin ligases MuRF1 and atrogin-1, which promote muscle proteolysis and atrophy. Deletion of myogenin from adult mice diminishes expression of MuRF1 and atrogin-1 in denervated muscle and confers resistance to atrophy. Mice lacking histone deacetylases (HDACs) 4 and 5 in skeletal muscle fail to upregulate myogenin and also preserve muscle mass following denervation. Conversely, forced expression of myogenin in skeletal muscle of HDAC mutant mice restores muscle atrophy following denervation. Thus, myogenin plays a dual role as both a regulator of muscle development and an inducer of neurogenic atrophy. These findings reveal a specific pathway for muscle wasting and potential therapeutic targets for this disorder.	[Moresi, Viviana; Williams, Andrew H.; Potthoff, Matthew J.; McAnally, John; Backs, Johannes; Richardson, James A.; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Shelton, John M.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Richardson, James A.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Meadows, Eric; Flynn, Jesse M.; Klein, William H.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center	Olson, EN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu	Moresi, Viviana/N-7977-2013	Moresi, viviana/0000-0003-1912-0339; Potthoff, Matthew/0000-0001-9158-5128	National Institutes of Health; Robert A. Welch Foundation [I-0025]; Muscular Dystrophy Association; Deutsche Forschungsgemeinschaft [BA 2258/1-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL053351, R01HL093039, R01HL077439] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Muscular Dystrophy Association(Muscular Dystrophy Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Marco Sandri for scientific input, Cheryl Nolen and Svetlana Bezprozvannaya for technical assistance, Jose Cabrera for graphics, and Jennifer Brown for editorial assistance. Work in the laboratory of E.N.O. was supported by grants from the National Institutes of Health and the Robert A. Welch Foundation (grant number I-0025). W.H.K. was supported by a grant from the Muscular Dystrophy Association and the Robert A. Welch Foundation. J.B. was supported by the Deutsche Forschungsgemeinschaft (BA 2258/1-1).	Attaix D, 2005, ESSAYS BIOCHEM, V41, P173, DOI 10.1042/EB0410173; Attaix Didier, 2008, Curr Opin Support Palliat Care, V2, P262, DOI 10.1097/SPC.0b013e3283196ac2; Backs J, 2008, MOL CELL BIOL, V28, P3437, DOI 10.1128/MCB.01611-07; Beehler BC, 2006, EXP BIOL MED, V231, P335; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Charrel RN, 2008, LANCET INFECT DIS, V8, P5, DOI 10.1016/S1473-3099(07)70296-7; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Cohen TJ, 2007, J BIOL CHEM, V282, P33752, DOI 10.1074/jbc.M706268200; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dona M, 2003, BIOCHEM BIOPH RES CO, V312, P1132, DOI 10.1016/j.bbrc.2003.11.032; Eley HL, 2007, J BIOL CHEM, V282, P7087, DOI 10.1074/jbc.M610378200; Glass DJ, 2003, TRENDS MOL MED, V9, P344, DOI 10.1016/S1471-4914(03)00138-2; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Grifone R, 2004, MOL CELL BIOL, V24, P6253, DOI 10.1128/MCB.24.14.6253-6267.2004; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Heanue TA, 1999, GENE DEV, V13, P3231, DOI 10.1101/gad.13.24.3231; HERBISON GJ, 1979, ARCH PHYS MED REHAB, V60, P401; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; Hughes SM, 1999, J CELL BIOL, V145, P633, DOI 10.1083/jcb.145.3.633; Hyatt JPK, 2003, AM J PHYSIOL-CELL PH, V285, pC1161, DOI 10.1152/ajpcell.00128.2003; Ishido M, 2004, AM J PHYSIOL-CELL PH, V287, pC484, DOI 10.1152/ajpcell.00080.2004; Kardon G, 2002, DEV DYNAM, V224, P350, DOI 10.1002/dvdy.10107; Kedar V, 2004, P NATL ACAD SCI USA, V101, P18135, DOI 10.1073/pnas.0404341102; Knapp JR, 2006, DEVELOPMENT, V133, P601, DOI 10.1242/dev.02249; KOTHARY R, 1989, DEVELOPMENT, V105, P707; Laclef C, 2003, DEVELOPMENT, V130, P2239, DOI 10.1242/dev.00440; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; Li HH, 2007, J CLIN INVEST, V117, P3211, DOI 10.1172/JCI31757; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Lu JR, 1999, P NATL ACAD SCI USA, V96, P552, DOI 10.1073/pnas.96.2.552; Mammucari C, 2008, AUTOPHAGY, V4, P524, DOI 10.4161/auto.5905; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; MEDINA R, 1995, BIOCHEM J, V307, P631, DOI 10.1042/bj3070631; Mercer SE, 2005, J BIOL CHEM, V280, P25788, DOI 10.1074/jbc.M413594200; MERLIE JP, 1994, J BIOL CHEM, V269, P2461; MIDRIO M, 1992, PFLUG ARCH EUR J PHY, V420, P446, DOI 10.1007/BF00374618; Moriscot AS, 2010, J STRUCT BIOL, V170, P344, DOI 10.1016/j.jsb.2010.02.001; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; NWOYE L, 1982, AM J PHYSIOL, V242, pR401, DOI 10.1152/ajpregu.1982.242.3.R401; OGILVIE RW, 1990, STAIN TECHNOL, V65, P231, DOI 10.3109/10520299009105613; Patterson MF, 2006, AM J PHYSIOL-CELL PH, V291, pC518, DOI 10.1152/ajpcell.00013.2006; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Rana ZA, 2004, ACTA PHYSIOL SCAND, V181, P233, DOI 10.1111/j.1365-201X.2004.01282.x; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Sato Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1748, DOI 10.1271/bbb.90085; Spencer JA, 2000, J CELL BIOL, V150, P771, DOI 10.1083/jcb.150.4.771; Tang HB, 2006, P NATL ACAD SCI USA, V103, P16977, DOI 10.1073/pnas.0601565103; Tang HB, 2009, MOL BIOL CELL, V20, P1120, DOI 10.1091/mbc.E08-07-0759; Tawa NE, 1997, J CLIN INVEST, V100, P197, DOI 10.1172/JCI119513; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Willis MS, 2009, AM J PHYSIOL-HEART C, V296, pH997, DOI 10.1152/ajpheart.00660.2008	63	304	323	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2010	143	1					35	45		10.1016/j.cell.2010.09.004	http://dx.doi.org/10.1016/j.cell.2010.09.004			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	656UC	20887891	Bronze, Green Accepted			2022-12-01	WOS:000282362000012
J	Park, CY; Shcheglovitov, A; Dolmetsch, R				Park, Chan Young; Shcheglovitov, Aleksandr; Dolmetsch, Ricardo			The CRAC Channel Activator STIM1 Binds and Inhibits L-Type Voltage-Gated Calcium Channels	SCIENCE			English	Article							MEDIUM SPINY NEURONS; T-LYMPHOCYTES; SKELETAL-MUSCLE; PLASMA-MEMBRANE; CA2+ CHANNELS; STORE; ENTRY; ORAI1; INFLUX; SENSOR	Voltage-and store-operated calcium (Ca2+) channels are the major routes of Ca2+ entry in mammalian cells, but little is known about how cells coordinate the activity of these channels to generate coherent calcium signals. We found that STIM1 (stromal interaction molecule 1), the main activator of store-operated Ca2+ channels, directly suppresses depolarization-induced opening of the voltage-gated Ca2+ channel Ca(V)1.2. STIM1 binds to the C terminus of Ca(V)1.2 through its Ca2+ release-activated Ca2+ activation domain, acutely inhibits gating, and causes long-term internalization of the channel from the membrane. This establishes a previously unknown function for STIM1 and provides a molecular mechanism to explain the reciprocal regulation of these two channels in cells.	[Park, Chan Young; Shcheglovitov, Aleksandr; Dolmetsch, Ricardo] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Park, Chan Young] UNIST, Sch Nanobiotechnol & Chem Engn, Ulsan 689798, South Korea	Stanford University; Ulsan National Institute of Science & Technology (UNIST)	Dolmetsch, R (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	ricardo.dolmetsch@stanford.edu	Tuluc, Petronel/C-2527-2011; Park, Chan Young/F-5696-2010	Park, Chan Young/0000-0002-5183-3665	NIH [DP1OD003889, R21MH087898]; Simons Fund for Autism Research; California Institute for Regenerative Medicine [TG 01159]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH087898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048564] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003889] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Fund for Autism Research; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by NIH grants DP1OD003889 and R21MH087898, the Simons Fund for Autism Research, the California Institute for Regenerative Medicine grant TG 01159. We thank A. Budzillo for help with experiments, and R. Lewis and A. Nigh for feedback on the manuscript.	BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Calin-Jageman I, 2008, J NEUROCHEM, V105, P573, DOI 10.1111/j.1471-4159.2008.05286.x; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; FANGER CM, 1995, J CELL BIOL, V131, P655, DOI 10.1083/jcb.131.3.655; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Green EM, 2007, NEURON, V55, P615, DOI 10.1016/j.neuron.2007.07.024; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; HESS P, 1988, CAN J PHYSIOL PHARM, V66, P1218, DOI 10.1139/y88-201; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; Kotturi MF, 2005, MOL IMMUNOL, V42, P1461, DOI 10.1016/j.molimm.2005.01.014; Kotturi MF, 2003, J BIOL CHEM, V278, P46949, DOI 10.1074/jbc.M309268200; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lyfenko AD, 2008, J PHYSIOL-LONDON, V586, P4815, DOI 10.1113/jphysiol.2008.160481; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Soboloff J, 2006, BBA-MOL CELL RES, V1763, P1161, DOI 10.1016/j.bbamcr.2006.09.023; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Tsien Richard W., 1995, Trends in Neurosciences, V18, P52, DOI 10.1016/0166-2236(95)93867-W; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	29	240	243	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2010	330	6000					101	105		10.1126/science.1191027	http://dx.doi.org/10.1126/science.1191027			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20929812				2022-12-01	WOS:000282334500045
J	Heinig, M; Petretto, E; Wallace, C; Bottolo, L; Rotival, M; Lu, H; Li, YY; Sarwar, R; Langley, SR; Bauerfeind, A; Hummel, O; Lee, YA; Paskas, S; Rintisch, C; Saar, K; Cooper, J; Buchan, R; Gray, EE; Cyster, JG; Erdmann, J; Hengstenberg, C; Maouche, S; Ouwehand, WH; Rice, CM; Samani, NJ; Schunkert, H; Goodall, AH; Schulz, H; Roider, HG; Vingron, M; Blankenberg, S; Munzel, T; Zeller, T; Szymczak, S; Ziegler, A; Tiret, L; Smyth, DJ; Pravenec, M; Aitman, TJ; Cambien, F; Clayton, D; Todd, JA; Hubner, N; Cook, SA				Heinig, Matthias; Petretto, Enrico; Wallace, Chris; Bottolo, Leonardo; Rotival, Maxime; Lu, Han; Li, Yoyo; Sarwar, Rizwan; Langley, Sarah R.; Bauerfeind, Anja; Hummel, Oliver; Lee, Young-Ae; Paskas, Svetlana; Rintisch, Carola; Saar, Kathrin; Cooper, Jason; Buchan, Rachel; Gray, Elizabeth E.; Cyster, Jason G.; Erdmann, Jeanette; Hengstenberg, Christian; Maouche, Seraya; Ouwehand, Willem H.; Rice, Catherine M.; Samani, Nilesh J.; Schunkert, Heribert; Goodall, Alison H.; Schulz, Herbert; Roider, Helge G.; Vingron, Martin; Blankenberg, Stefan; Muenzel, Thomas; Zeller, Tanja; Szymczak, Silke; Ziegler, Andreas; Tiret, Laurence; Smyth, Deborah J.; Pravenec, Michal; Aitman, Timothy J.; Cambien, Francois; Clayton, David; Todd, John A.; Hubner, Norbert; Cook, Stuart A.		Cardiogenics Consortium	A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk	NATURE			English	Article							GENOME-WIDE ASSOCIATION; TRANSCRIPTION FACTORS; MOLECULAR NETWORKS; GENE-EXPRESSION; DISEASE; INFLAMMATION; RESPONSES; IFIH1; SNPS; RAT	Combined analyses of gene networks and DNA sequence variation can provide new insights into the aetiology of common diseases that may not be apparent from genome-wide association studies alone. Recent advances in rat genomics are facilitating systems-genetics approaches(1,2). Here we report the use of integrated genome-wide approaches across seven rat tissues to identify gene networks and the loci underlying their regulation. We defined an interferon regulatory factor 7 (IRF7(3))-driven inflammatory network (IDIN) enriched for viral response genes, which represents a molecular biomarker for macrophages and which was regulated in multiple tissues by a locus on rat chromosome 15q25. We show that Epstein-Barr virus induced gene 2 (Ebi2, also known as Gpr183), which lies at this locus and controls B lymphocyte migration(4,5), is expressed in macrophages and regulates the IDIN. The human orthologous locus on chromosome 13q32 controlled the human equivalent of the IDIN, which was conserved in monocytes. IDIN genes were more likely to associate with susceptibility to type 1 diabetes (T1D)-amacrophage-associated autoimmune disease-than randomly selected immune response genes (P = 8.85 x 10(-6)). The human locus controlling the IDIN was associated with the risk of T1D at single nucleotide polymorphism rs9585056 (P = 7.0 x 10(-10); odds ratio, 1.15), which was one of five single nucleotide polymorphisms in this region associated with EBI2 (GPR183) expression. These data implicate IRF7 network genes and their regulatory locus in the pathogenesis of T1D.	[Heinig, Matthias; Bauerfeind, Anja; Hummel, Oliver; Lee, Young-Ae; Paskas, Svetlana; Rintisch, Carola; Saar, Kathrin; Schulz, Herbert; Hubner, Norbert] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Heinig, Matthias; Roider, Helge G.; Vingron, Martin] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Petretto, Enrico; Bottolo, Leonardo; Lu, Han; Li, Yoyo; Sarwar, Rizwan; Langley, Sarah R.; Buchan, Rachel; Aitman, Timothy J.; Cook, Stuart A.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Med Res Council,Clin Sci Ctr, London W12 0NN, England; [Petretto, Enrico; Bottolo, Leonardo] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Epidemiol & Biostat, London W2 1PG, England; [Wallace, Chris; Cooper, Jason; Smyth, Deborah J.; Clayton, David; Todd, John A.] Univ Cambridge, Cambridge Inst Med Res, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab, Cambridge CB2 0XY, England; [Rotival, Maxime; Maouche, Seraya; Tiret, Laurence; Cambien, Francois] Univ Paris 06, INSERM, UMRS 937, F-75013 Paris, France; [Rotival, Maxime; Maouche, Seraya; Tiret, Laurence; Cambien, Francois] Sch Med, F-75013 Paris, France; [Lee, Young-Ae] Charite, D-13353 Berlin, Germany; [Gray, Elizabeth E.; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Gray, Elizabeth E.; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Erdmann, Jeanette; Schunkert, Heribert] Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany; [Hengstenberg, Christian] Univ Regensburg, Klin & Poliklin Innere Med 2, D-93053 Regensburg, Germany; [Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge CB2 0PT, England; [Ouwehand, Willem H.] Natl Hlth Serv Blood & Transplant, Cambridge CB2 0PT, England; [Ouwehand, Willem H.; Rice, Catherine M.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Samani, Nilesh J.; Goodall, Alison H.] Univ Leicester, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Samani, Nilesh J.; Goodall, Alison H.] Glenfield Hosp, Leicester NIHR Biomed Res Unit Cardiovasc Dis, Leicester LE3 9QP, Leics, England; [Blankenberg, Stefan; Muenzel, Thomas; Zeller, Tanja] Johannes Gutenberg Univ Mainz, Med Klin & Poliklin, D-55131 Mainz, Germany; [Szymczak, Silke; Ziegler, Andreas] Univ Lubeck, Inst Med Biometrie & Stat, Univ Klinikum Schleswig Holstein, D-23562 Lubeck, Germany; [Pravenec, Michal] Acad Sci Czech Republic, Inst Physiol, Prague 14220 4, Czech Republic; [Pravenec, Michal] Ctr Appl Genom, Prague 14220 4, Czech Republic; [Hubner, Norbert] Charite, CC4, D-10117 Berlin, Germany; [Cook, Stuart A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Max Planck Society; Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Imperial College London; University of Cambridge; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; University of Regensburg; University of Cambridge; NHS Blood & Transplant (NHSBT); Wellcome Trust Sanger Institute; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Johannes Gutenberg University of Mainz; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Imperial College London	Hubner, N (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	nhuebner@mdc-berlin.de; stuart.cook@csc.mrc.ac.uk	Hengstenberg, Christian/U-5485-2019; Erdmann, Jeanette/A-4417-2009; Pravenec, Michal/B-1666-2012; Erdmann, Jeanette/P-7513-2014; Langley, Sarah R/E-4481-2019; Szymczak, Silke/C-6625-2013; Cook, Stuart/G-9567-2011; Cambien, Francois/AAP-9751-2020; Munzel, Thomas/A-2912-2014; Todd, John/A-3542-2010; Ziegler, Andreas/G-4246-2012	Pravenec, Michal/0000-0001-9197-5871; Erdmann, Jeanette/0000-0002-4486-6231; Munzel, Thomas/0000-0001-5503-4150; Matvienko-Sikar, Karen/0000-0003-2777-6581; smyth, deborah/0000-0002-6330-2669; Todd, John/0000-0003-2740-8148; Paskas, Svetlana/0000-0002-1206-5376; Bottolo, Leonardo/0000-0002-6381-2327; Aitman, Timothy/0000-0002-7875-4502; Ziegler, Andreas/0000-0002-8386-5397; Wallace, Chris/0000-0001-9755-1703; Buchan, Rachel/0000-0003-2490-9289; Maouche, Seraya/0000-0001-8186-1635; Goodall, Alison/0000-0002-7883-9645; Saar, Kathrin/0000-0002-4483-1557; Heinig, Matthias/0000-0002-5612-1720; Szymczak, Silke/0000-0002-8897-9035; Ouwehand, Willem/0000-0002-7744-1790; Zeller, Tanja/0000-0003-3379-2641; Schmitz, Gerd/0000-0002-1325-1007; Rotival, Maxime/0000-0003-2519-8044; Cook, Stuart/0000-0001-6628-194X	German National Genome Research Network; Helmholtz Association Alliance on Systems Biology; EURATools [LSHG-CT-2005-019015]; European Union [LSHM-CT-2006-037593]; PHC ALLIANCE [19419PH]; UK National Institute for Health Research Biomedical Research Unit (Royal Brompton and Harefield NHS Trusts, University Hospitals of Leicester NHS Trusts); Biomedical Research Centre (Imperial College NHS Trust); British Heart Foundation; Grant Agency of the Czech Republic [P301/10/0290]; Ministry of Education of the Czech Republic [1M6837805002]; Fondation Leducq; Medical Research Council UK; Research Councils UK; Juvenile Diabetes Research Foundation International; National Institute for Health Research (UK); National Institute of Diabetes and Digestive and Kidney Diseases (USA); Wellcome Trust; European Community [HEALTH-F4-2010-241504]; MRC [MC_U120085815, MC_U120061454, MC_U120097112] Funding Source: UKRI; Medical Research Council [MC_U120097112, MC_U120061454, MC_U120085815] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10275] Funding Source: researchfish	German National Genome Research Network; Helmholtz Association Alliance on Systems Biology; EURATools; European Union(European Commission); PHC ALLIANCE; UK National Institute for Health Research Biomedical Research Unit (Royal Brompton and Harefield NHS Trusts, University Hospitals of Leicester NHS Trusts); Biomedical Research Centre (Imperial College NHS Trust); British Heart Foundation(British Heart Foundation); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Fondation Leducq(Leducq Foundation); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Research Councils UK(UK Research & Innovation (UKRI)); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); National Institute for Health Research (UK)(National Institute for Health Research (NIHR)); National Institute of Diabetes and Digestive and Kidney Diseases (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We acknowledge funding from the German National Genome Research Network (NGFN-Plus 'Genetics of Heart Failure'), the Helmholtz Association Alliance on Systems Biology (MSBN), EURATools (LSHG-CT-2005-019015), European Union FP6 (LSHM-CT-2006-037593), PHC ALLIANCE 2009 (19419PH), UK National Institute for Health Research Biomedical Research Unit (Royal Brompton and Harefield NHS Trusts, University Hospitals of Leicester NHS Trusts) and Biomedical Research Centre (Imperial College NHS Trust) awards, the British Heart Foundation, grant P301/10/0290 from the Grant Agency of the Czech Republic, grant 1M6837805002 from the Ministry of Education of the Czech Republic, the Fondation Leducq, the Medical Research Council UK, Research Councils UK, the Juvenile Diabetes Research Foundation International, National Institute for Health Research (UK), National Institute of Diabetes and Digestive and Kidney Diseases (USA), and the Wellcome Trust. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. HEALTH-F4-2010-241504 (EURATRANS). O. Burren performed T1DBase analyses.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Atanur SS, 2010, GENOME RES, V20, P791, DOI 10.1101/gr.103499.109; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Breitling R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000232; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Cooper JD, 2009, GENES IMMUN, V10, pS85, DOI 10.1038/gene.2009.97; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; HOLNESS CL, 1993, BLOOD, V81, P1607; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Li Q, 2008, P NATL ACAD SCI USA, V105, P12439, DOI 10.1073/pnas.0806439105; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Petretto E, 2008, NAT GENET, V40, P546, DOI 10.1038/ng.134; Petretto E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000737; Plagnol V, 2009, BIOSTATISTICS, V10, P327, DOI 10.1093/biostatistics/kxn039; Roider HG, 2009, BIOINFORMATICS, V25, P435, DOI 10.1093/bioinformatics/btn627; Saar K, 2008, NAT GENET, V40, P560, DOI 10.1038/ng.124; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; VON HERRATH M, 2009, NATURE, V459, P518; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	29	213	221	0	23	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2010	467	7314					460	464		10.1038/nature09386	http://dx.doi.org/10.1038/nature09386			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KO	20827270	Green Accepted, Green Published			2022-12-01	WOS:000282090200043
J	FitzGerald, JM; Quon, BS				FitzGerald, J. Mark; Quon, Bradley S.			The impact of asthma guidelines	LANCET			English	Editorial Material							MAINTENANCE TREATMENT; MANAGEMENT		[FitzGerald, J. Mark; Quon, Bradley S.] Univ British Columbia, Vancouver Coastal Hlth Res Inst, Ctr Lung Res, Vancouver, BC V7V 2J3, Canada	University of British Columbia; Vancouver Coastal Health Research Institute	FitzGerald, JM (corresponding author), Univ British Columbia, Vancouver Coastal Hlth Res Inst, Ctr Lung Res, Vancouver, BC V7V 2J3, Canada.	markf@interchange.ubc.ca						Bahadori K, 2010, J ASTHMA ALLERGY, V3, P33; Bahadori Katayoun, 2009, BMC Pulm Med, V9, P24, DOI 10.1186/1471-2466-9-24; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Ernst P, 2006, ANN INTERN MED, V145, P692, DOI 10.7326/0003-4819-145-9-200611070-00012; FitzGerald JM, 2004, THORAX, V59, P550, DOI 10.1136/thx.2003.014936; HARGREAVE FE, 1990, J ALLERGY CLIN IMMUN, V85, P1098, DOI 10.1016/0091-6749(90)90056-A; *INT UN TUB LUNG D, 2010, ASTHM DRUG FAC; Lemiere C, 2002, CAN MED ASSOC J, V167, P1008; Lougheed MD, 2010, CAN RESPIR J, V17, P15, DOI 10.1155/2010/827281; *LUNG ASS ONT, 2009, ASTHM CME ONL EV BAS; Poureslami Iraj M, 2007, MedGenMed, V9, P40; Public Health Agency of Canada, 2007, LIF BREATH RESP DIS; QUON B, 2009, COCHRANE DB SYST REV, V1; Thier Sara L, 2008, Manag Care, V17, P48	14	10	11	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 4	2010	376	9743					751	753		10.1016/S0140-6736(10)61159-2	http://dx.doi.org/10.1016/S0140-6736(10)61159-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	650EC	20816530				2022-12-01	WOS:000281831000008
J	Arana, A; Wentworth, CE; Ayuso-Mateos, JL; Arellano, FM				Arana, Alejandro; Wentworth, Charles E.; Ayuso-Mateos, Jose L.; Arellano, Felix M.			Suicide-Related Events in Patients Treated with Antiepileptic Drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMORBIDITY SURVEY REPLICATION; RISK-FACTORS; BIPOLAR DISORDER; EPILEPSY; ANTIDEPRESSANTS; UK; PREVENTION; VALIDATION; ALGORITHM; DEATH	BACKGROUND A previous meta-analysis of data from clinical trials showed an association between antiepileptic drugs and suicidality (suicidal ideation, behavior, or both). We used observational data to examine the association between the use or nonuse of antiepileptic drugs and suicide-related events (attempted suicides and completed suicides) in patients with epilepsy, depression, or bipolar disorder. METHODS We used data collected as part of the clinical care of patients who were representative of the general population in the United Kingdom to identify patients with epilepsy, depression, or bipolar disorder and to determine whether they received antiepileptic drugs. We estimated the incidence rate of suicide-related events and used logistic regression to compute odds ratios, controlling for confounding factors. RESULTS In a cohort of 5,130,795 patients, the incidence of suicide-related events per 100,000 person-years was 15.0 (95% confidence interval [CI], 14.6 to 15.5) among patients without epilepsy, depression, bipolar disorder, or antiepileptic-drug treatment, 38.2 (95% CI, 26.3 to 53.7) among patients with epilepsy who did not receive antiepileptic drugs, and 48.2 (95% CI, 39.4 to 58.5) among patients with epilepsy who received antiepileptic drugs. In adjusted analyses, the use of antiepileptic drugs was not associated with an increased risk of suicide-related events among patients with epilepsy (odds ratio, 0.59; 95% CI, 0.35 to 0.98) or bipolar disorder (1.13; 95% CI, 0.35 to 3.61) but was significantly associated with an increased risk among patients with depression (1.65; 95% CI, 1.24 to 2.19) and those who did not have epilepsy, depression, or bipolar disorder (2.57; 95% CI, 1.78 to 3.71). CONCLUSIONS The current use of antiepileptic drugs was not associated with an increased risk of suicide-related events among patients with epilepsy, but it was associated with an increased risk of such events among patients with depression and among those who did not have epilepsy, depression, or bipolar disorder.	[Arana, Alejandro; Arellano, Felix M.] Risk MR Pharmacovigilance Serv, Zaragoza 50001, Spain; [Ayuso-Mateos, Jose L.] Univ Autonoma Madrid, Hosp Univ Princesa, Dept Psychiat, Madrid, Spain; [Ayuso-Mateos, Jose L.] Inst Salud Carlos III, Ctr Invest Biomed Red Salud Mental, Madrid, Spain; [Wentworth, Charles E.; Arellano, Felix M.] RiskMR, Bridgewater, NJ USA	Autonomous University of Madrid; Hospital de La Princesa; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III	Arana, A (corresponding author), Risk MR Pharmacovigilance Serv, Jeronimo Zurita 14,1-D, Zaragoza 50001, Spain.	arana.riskmr@gmail.com		ARANA, Alejandro/0000-0002-1593-3124; Ayuso-Mateos, Jose Luis/0000-0002-7544-826X				American Foundation for Suicide Prevention, RISK FACT SUIC; ARCLLANO FM, 2009, J ALLERGY CLIN IMMUN, V123, P1111; Arellano FM, 2006, PHARMACOEPIDEM DR S, V15, P861, DOI 10.1002/pds.1343; Bell GS, 2009, CNS DRUGS, V23, P281, DOI 10.2165/00023210-200923040-00002; Blumer D, 2002, EPILEPSY BEHAV, V3, P232, DOI 10.1016/S1525-5050(02)00006-9; Braden JB, 2008, J PAIN, V9, P1106, DOI 10.1016/j.jpain.2008.06.004; Christensen J, 2007, LANCET NEUROL, V6, P693, DOI 10.1016/S1474-4422(07)70175-8; DeLeo D., 2002, WORLD REPORT VIOLENC, P183; Gibbons RD, 2007, AM J PSYCHIAT, V164, P1044, DOI 10.1176/appi.ajp.164.7.1044; Gibbons RD, 2009, ARCH GEN PSYCHIAT, V66, P1354, DOI 10.1001/archgenpsychiatry.2009.159; Goodwin FK, 2003, JAMA-J AM MED ASSOC, V290, P1467, DOI 10.1001/jama.290.11.1467; Hall GC, 2009, PHARMACOEPIDEM DR S, V18, P120, DOI 10.1002/pds.1686; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Hesdorffer DC, 2006, ANN NEUROL, V59, P35, DOI 10.1002/ana.20685; Hippisley-Cox J, 2008, HEART, V94, P34, DOI 10.1136/hrt.2007.134890; Jick H, 2004, JAMA-J AM MED ASSOC, V292, P338, DOI 10.1001/jama.292.3.338; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Mortensen PB, 2000, LANCET, V355, P9, DOI 10.1016/S0140-6736(99)06376-X; Moscicki EK, 2001, CLIN NEUROSCI RES, V1, P310, DOI 10.1016/S1566-2772(01)00032-9; MOSCICKI EK, 1985, SUICIDE PREVENTION Y, P22; NHS Centre for Coding and Classification, 1996, READ COD VERS 3; Nilsson L, 2002, EPILEPSIA, V43, P644, DOI 10.1046/j.1528-1157.2002.40001.x; *OFF NAT STAT, 2009, SUIC UK SUIC RAT CON; Patorno E, 2010, JAMA-J AM MED ASSOC, V303, P1401, DOI 10.1001/jama.2010.410; Posner K, 2007, AM J PSYCHIAT, V164, P1035, DOI 10.1176/appi.ajp.164.7.1035; Qin P, 2005, BMJ-BRIT MED J, V331, P23, DOI 10.1136/bmj.38488.462037.8F; Vigo DV, 2009, HARVARD REV PSYCHIAT, V17, P231, DOI 10.1080/10673220903129814; VONKORFF M, 1992, J CLIN EPIDEMIOL, V45, P197, DOI 10.1016/0895-4356(92)90016-G	28	119	127	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2010	363	6					542	551		10.1056/NEJMoa0909801	http://dx.doi.org/10.1056/NEJMoa0909801			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634BB	20818889	Bronze			2022-12-01	WOS:000280552700008
J	Dhingra, N; Jha, P; Sharma, VP; Cohen, AA; Jotkar, RM; Rodriguez, PS; Bassani, DG; Suraweera, W; Laxminarayan, R; Peto, R				Dhingra, Neeraj; Jha, Prabhat; Sharma, Vinod P.; Cohen, Alan A.; Jotkar, Raju M.; Rodriguez, Peter S.; Bassani, Diego G.; Suraweera, Wilson; Laxminarayan, Ramanan; Peto, Richard		Million Death Study Collaborators	Adult and child malaria mortality in India: a nationally representative mortality survey	LANCET			English	Article							VERBAL AUTOPSIES; DEATHS; BURDEN; VALIDATION; FRACTIONS; DISEASES; SMOKING; AFRICA; HEALTH; RATES	Background National malaria death rates are difficult to assess because reliably diagnosed malaria is likely to be cured, and deaths in the community from undiagnosed malaria could be misattributed in retrospective enquiries to other febrile causes of death, or vice-versa. We aimed to estimate plausible ranges of malaria mortality in India, the most populous country where the disease remains common. Methods Full-time non-medical field workers interviewed families or other respondents about each of 122 000 deaths during 2001-03 in 6671 randomly selected areas of India, obtaining a half-page narrative plus answers to specific questions about the severity and course of any fevers. Each field report was sent to two of 130 trained physicians, who independently coded underlying causes, with discrepancies resolved either via anonymous reconciliation or adjudication. Findings Of all coded deaths at ages 1 month to 70 years, 2681 (3.6%) of 75 342 were attributed to malaria. Of these, 2419 (90%) were in rural areas and 2311 (86%) were not in any health-care facility. Death rates attributed to malaria correlated geographically with local malaria transmission rates derived independently from the Indian malaria control programme. The adjudicated results show 205 000 malaria deaths per year in India before age 70 years (55 000 in early childhood, 30 000 at ages 5-14 years, 120 000 at ages 15-69 years); 1.8% cumulative probability of death from malaria before age 70 years. Plausible lower and upper bounds (on the basis of only the initial coding) were 125 000-277 000. Malaria accounted for a substantial minority of about 1.3 million unattended rural fever deaths attributed to infectious diseases in people younger than 70 years. Interpretation Despite uncertainty as to which unattended febrile deaths are from malaria, even the lower bound greatly exceeds the WHO estimate of only 15 000 malaria deaths per year in India (5000 early childhood, 10 000 thereafter). This low estimate should be reconsidered, as should the low WHO estimate of adult malaria deaths worldwide.	[Dhingra, Neeraj; Jha, Prabhat; Cohen, Alan A.; Jotkar, Raju M.; Rodriguez, Peter S.; Bassani, Diego G.; Suraweera, Wilson] St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 2C5, Canada; [Dhingra, Neeraj; Jha, Prabhat; Cohen, Alan A.; Jotkar, Raju M.; Rodriguez, Peter S.; Bassani, Diego G.; Suraweera, Wilson] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5B 2C5, Canada; [Dhingra, Neeraj] Natl AIDS Control Org, New Delhi, India; [Sharma, Vinod P.] Indian Inst Technol, Ctr Rural Dev & Technol, New Delhi, India; [Jotkar, Raju M.] St Johns Res Inst, Bangalore, Karnataka, India; [Laxminarayan, Ramanan] Resources Future Inc, Washington, DC 20036 USA; [Peto, Richard] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Peto, Richard] Univ Oxford, Epidemiol Studies Unit, Oxford, England	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; St. John's National Academy of Health Sciences; St. John's Research Institute; Resources for the Future; University of Oxford; University of Oxford	Jha, P (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 2C5, Canada.	prabhatjha@utoronto.ca	Bassani, Diego/G-2827-2015; Suraweera, Wilson MG/O-8962-2014; Laxminarayan, Ramanan/ABD-5050-2021	Bassani, Diego/0000-0001-6704-3820; Suraweera, Wilson/0000-0001-9673-5746; Rodriguez, Peter/0000-0003-2272-9962; Cohen, Alan/0000-0003-4113-3988; Jha, Prabhat/0000-0001-7067-8341	Fogarty International Center of the US National Institutes of Health [R01 TW05991-01]; Canadian Institute of Health Research (CIHR) [IEG-53506]; Li Ka Shing Knowledge Institute; UK Medical Research Council; Keenan Research Centre at St Michael's Hospital, University of Toronto; MRC [MC_U137686857] Funding Source: UKRI; Medical Research Council [MC_U137686857] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [R01TW005991] Funding Source: NIH RePORTER	Fogarty International Center of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Li Ka Shing Knowledge Institute(University of Toronto); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Keenan Research Centre at St Michael's Hospital, University of Toronto; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The Registrar General of India established the SRS in 1971, has continued it ever since, and is collaborating with several of the authors on the ongoing Million Death Study. External funding is from the Fogarty International Center of the US National Institutes of Health (grant R01 TW05991-01), Canadian Institute of Health Research (CIHR; IEG-53506), Li Ka Shing Knowledge Institute and Keenan Research Centre at St Michael's Hospital, University of Toronto (CGHR support), and UK Medical Research Council (CTSU support). Additional support was provided by the Disease Control Priorities Network, University of Washington. PI le supported by the Canada Research Chair programme. The opinions expressed in this paper are those of the authors and do not necessarily represent those of the Government of India. We thank David Fisman, Hellen Gelband, Adrianna Murphy, and Torn Peto for comments, and Brendon Pezzack for graphics.	Adjuik M, 2006, B WORLD HEALTH ORGAN, V84, P181, DOI 10.2471/BLT.05.026492; Anker M, 1997, INT J EPIDEMIOL, V26, P1090, DOI 10.1093/ije/26.5.1090; Bawah AA, 2007, AM J TROP MED HYG, V77, P145, DOI 10.4269/ajtmh.2007.77.145; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Bhat PNM, 2002, POP STUD-J DEMOG, V56, P119, DOI 10.1080/00324720215930; *CENTR BUR HLTH IN, 2007, NAT HLTH PROF 2007; Chandramohan D, 1998, TROP MED INT HEALTH, V3, P436, DOI 10.1046/j.1365-3156.1998.00255.x; Chaturvedi HK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-301; Cohen AA, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-1; Diamond-Smith Nadia, 2009, Malar J, V8, P24, DOI 10.1186/1475-2875-8-24; Gajalakshmi V, 2003, LANCET, V362, P507, DOI 10.1016/S0140-6736(03)14109-8; Gajalakshmi V, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-7; Gogoi S. C., 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P526; Gupta E, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-92; Hamer DH, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-210; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; *INT I POP SCI, 2002, NAT FAM HLTH SURV 2; *INT I POP SCI, 2006, DLHS2 INT I POP SCI; Jain V, 2008, AM J TROP MED HYG, V79, P636; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Jha P, 2001, NATL MED J INDIA, V14, P129; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Jha P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c621; Joshi R, 2006, INT J EPIDEMIOL, V35, P1522, DOI 10.1093/ije/dyl168; Kleinschmidt I, 2000, INT J EPIDEMIOL, V29, P355, DOI 10.1093/ije/29.2.355; Kumar A, 2007, AM J TROP MED HYG, V77, P69, DOI 10.4269/ajtmh.2007.77.69; Kumar R, 2006, Indian J Public Health, V50, P90; Maude GH, 1997, INT J EPIDEMIOL, V26, P1097, DOI 10.1093/ije/26.5.1097; *NIMR NVBDCP, 2007, IN DEPTH REV MAL NAT; Nosten F, 2007, AM J TROP MED HYG, V77, P181, DOI 10.4269/ajtmh.2007.77.181; *REG GEN IND, 2005, MED CERT CAUS DEATH; *REG GEN IND, 2005, SAMPL REG SYST STAT; Registrar General of India and Center for Global Health Research, 2009, CAUS DEATH IND 2001; Reuben Rachel, 1997, Indian Journal of Pediatrics, V64, P243, DOI 10.1007/BF02752458; Rowe AK, 2006, INT J EPIDEMIOL, V35, P691, DOI 10.1093/ije/dyl027; Runsewe-Abiodun Iyabo T, 2006, BMC Pediatr, V6, P19, DOI 10.1186/1471-2431-6-19; Sarkar J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-133; Sharma SK, 2004, ANN TROP MED PARASIT, V98, P459, DOI 10.1179/000349804225003569; SIVANANDAN V, 2004, ASSESSMENT COMPLETEN; Smith D. L., 2009, SHRINKING MALARIA MA, P108; SNOW RW, 1992, LANCET, V340, P351, DOI 10.1016/0140-6736(92)91414-4; Talisuna A, 2009, LANCET, V374, P1224, DOI 10.1016/S0140-6736(09)61767-0; Tripathy R, 2007, PEDIATRICS, V120, pE454, DOI 10.1542/peds.2006-3171; United Nations Department of Economic and Social Affairs Population Division, 2008, WORLD POP PROSP; World Health Organization, 2008, WORLD MAL REP 2008; World Health Organization, 1994, INT STAT CLASS DIS R; World Health Organization, 2020, GLOBAL REPORT EPIDEM; [No title captured]	48	191	195	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 20	2010	376	9754					1768	1774		10.1016/S0140-6736(10)60831-8	http://dx.doi.org/10.1016/S0140-6736(10)60831-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	690EI	20970179	Green Accepted			2022-12-01	WOS:000284984900032
J	Vikstrom, I; Carotta, S; Luthje, K; Peperzak, V; Jost, PJ; Glaser, S; Busslinger, M; Bouillet, P; Strasser, A; Nutt, SL; Tarlinton, DM				Vikstrom, Ingela; Carotta, Sebastian; Luethje, Katja; Peperzak, Victor; Jost, Philipp J.; Glaser, Stefan; Busslinger, Meinrad; Bouillet, Philippe; Strasser, Andreas; Nutt, Stephen L.; Tarlinton, David M.			Mcl-1 Is Essential for Germinal Center Formation and B Cell Memory	SCIENCE			English	Article							PROSURVIVAL BCL-2 PROTEINS; ANTIBODY-FORMING-CELLS; AFFINITY MATURATION; SOMATIC HYPERMUTATION; CLONAL SELECTION; IMMUNE-RESPONSE; EXPRESSION; RECRUITMENT; MICE; FAS	Lymphocyte survival during immune responses is controlled by the relative expression of pro- and anti-apoptotic molecules, regulating the magnitude, quality, and duration of the response. We investigated the consequences of deleting genes encoding the anti-apoptotic molecules Mcl1 and Bcl2l1 (Bcl-xL) from B cells using an inducible system synchronized with expression of activation-induced cytidine deaminase (Aicda) after immunization. This revealed Mcl1 and not Bcl2l1 to be indispensable for the formation and persistence of germinal centers (GCs). Limiting Mcl1 expression reduced the magnitude of the GC response with an equivalent, but not greater, effect on memory B cell formation and no effect on persistence. Our results identify Mcl1 as the main anti-apoptotic regulator of activated B cell survival and suggest distinct mechanisms controlling survival of GC and memory B cells.	[Vikstrom, Ingela; Carotta, Sebastian; Luethje, Katja; Peperzak, Victor; Jost, Philipp J.; Glaser, Stefan; Bouillet, Philippe; Strasser, Andreas; Nutt, Stephen L.; Tarlinton, David M.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Busslinger, Meinrad] Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria; [Bouillet, Philippe; Strasser, Andreas; Nutt, Stephen L.; Tarlinton, David M.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3050, Australia	Walter & Eliza Hall Institute; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Melbourne	Tarlinton, DM (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia.	tarlinto@wehi.edu.au	Jost, Philipp J./S-4962-2016; Bouillet, Philippe/E-1241-2013; Nutt, Stephen L/C-9256-2013; Busslinger, Meinrad J./J-1249-2016; Strasser, Andreas/C-7581-2013	Jost, Philipp J./0000-0003-2454-0362; Bouillet, Philippe/0000-0002-9012-6058; Nutt, Stephen L/0000-0002-0020-6637; Busslinger, Meinrad J./0000-0002-9111-9351; Strasser, Andreas/0000-0002-5020-4891; Tarlinton, David/0000-0001-9928-686X	National Health and Medical Research Council (NHMRC) Australia [356202, 461221]; Leukemia and Lymphoma Society [7413]; NIH [CA43540, CA80188]; NHMRC; Pfizer Australia; Olle Engkvist Byggmastare Foundation; Wenner-Gren Foundation; German Academic Exchange Service; Charles and Sylvia Viertel Charitable Foundation; Boehringer Ingelheim; NATIONAL CANCER INSTITUTE [R01CA080188, R01CA043540] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC) Australia(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Pfizer Australia(PfizerPfizer Australia); Olle Engkvist Byggmastare Foundation; Wenner-Gren Foundation; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Charles and Sylvia Viertel Charitable Foundation; Boehringer Ingelheim(Boehringer Ingelheim); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the National Health and Medical Research Council (NHMRC) Australia (356202 to D. M. T. and S.L.N. and 461221 to P. B. and A. S.), the Leukemia and Lymphoma Society (SCOR grant 7413), and the NIH (CA43540 and CA80188). D. M. T. and A. S. are supported by fellowships from the NHMRC; S.L.N. by a Pfizer Australia Research Fellowship; I. V. by the Olle Engkvist Byggmastare and Wenner-Gren Foundations; K. L. by a fellowship from the German Academic Exchange Service; P. B. by the Charles and Sylvia Viertel Charitable Foundation; and M. B. by Boehringer Ingelheim. DNA sequence data are available in GenBank (accession number HM804028-HM804084). We are indebted to the facilities of our respective institutes, particularly those responsible for animal husbandry and flow cytometry. We also acknowledge the assistance of L. O'Reilly for Western blot antibodies and the many helpful discussions with members of the Walter and Eliza Hall Institute B Cell Program. Author contributions are as follows: I. V. and D. M. T. designed the research; I. V., K. L., S. G., V. P., S. C., and P.J. performed experiments and contributed to interpretation and discussion; M. B., P. B., A. S., and S.L.N. contributed to the design of experiments, interpretation of results, and drafting the manuscript; I. V., K. L., and V. P. analyzed data and prepared figures; and I. V. and D. M. T. wrote the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; ALLEN D, 1987, IMMUNOL REV, V96, P5, DOI 10.1111/j.1600-065X.1987.tb00506.x; Carrington EM, 2010, P NATL ACAD SCI USA, V107, P10967, DOI 10.1073/pnas.1005256107; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cho-Vega JH, 2004, HUM PATHOL, V35, P1095, DOI 10.1016/j.humpath.2004.04.018; CUMANO A, 1986, EMBO J, V5, P2459, DOI 10.1002/j.1460-2075.1986.tb04522.x; Fischer SF, 2007, BLOOD, V110, P3978, DOI 10.1182/blood-2007-05-091306; Haberman AM, 2003, NAT REV IMMUNOL, V3, P757, DOI 10.1038/nri1178; Hao ZY, 2008, IMMUNITY, V29, P615, DOI 10.1016/j.immuni.2008.07.016; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Ridderstad A, 1998, J IMMUNOL, V160, P4688; ROES J, 1993, J EXP MED, V177, P45, DOI 10.1084/jem.177.1.45; SMITH KGC, 1994, IMMUNITY, V1, P803, DOI 10.1016/S1074-7613(94)80022-7; Smith KGC, 2000, J EXP MED, V191, P475, DOI 10.1084/jem.191.3.475; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Takahashi Y, 1999, J EXP MED, V190, P399, DOI 10.1084/jem.190.3.399; Takahashi Y, 2001, IMMUNITY, V14, P181, DOI 10.1016/S1074-7613(01)00100-5; Tarlinton D, 2006, NAT REV IMMUNOL, V6, P785, DOI 10.1038/nri1938; Toyama H, 2002, IMMUNITY, V17, P329, DOI 10.1016/S1074-7613(02)00387-4; Wagner KU, 2000, DEVELOPMENT, V127, P4949; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Yokoyama T, 2002, IMMUNOL LETT, V81, P107, DOI 10.1016/S0165-2478(02)00003-2	34	156	157	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2010	330	6007					1095	1099		10.1126/science.1191793	http://dx.doi.org/10.1126/science.1191793			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	20929728	Green Accepted			2022-12-01	WOS:000284374700041
J	Payne, D				Payne, David			Nutrition Sticky labels	BRITISH MEDICAL JOURNAL			English	Editorial Material							OSTEOARTHRITIS; GLUCOSAMINE		[Payne, David] BMJ, London WC1H 9JR, England		Payne, D (corresponding author), BMJ, London WC1H 9JR, England.	dpayne@bmj.com						*ALL NAT HLTH, 2009, NEUT OUR FREED SPEEC; BOWLER N, 2010, BBC NEWS        0707; Wandel S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4675; Wilkens P, 2010, JAMA-J AM MED ASSOC, V304, P45, DOI 10.1001/jama.2010.893; 1999, MIRROR          1004; 2010, C BRUSS 26 27 MAY; 2010, R LEHMANS J BLO 0712; NUTR HLTH CLAIMS EUR	8	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 26	2010	341								c5861	10.1136/bmj.c5861	http://dx.doi.org/10.1136/bmj.c5861			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	674YE	20978067				2022-12-01	WOS:000283786800026
J	Schultz, PH; Hermalyn, B; Colaprete, A; Ennico, K; Shirley, M; Marshall, WS				Schultz, Peter H.; Hermalyn, Brendan; Colaprete, Anthony; Ennico, Kimberly; Shirley, Mark; Marshall, William S.			The LCROSS Cratering Experiment	SCIENCE			English	Article							WATER; IMPACTS; SURFACE	As its detached upper-stage launch vehicle collided with the surface, instruments on the trailing Lunar Crater Observation and Sensing Satellite (LCROSS) Shepherding Spacecraft monitored the impact and ejecta. The faint impact flash in visible wavelengths and thermal signature imaged in the mid-infrared together indicate a low-density surface layer. The evolving spectra reveal not only OH within sunlit ejecta but also other volatile species. As the Shepherding Spacecraft approached the surface, it imaged a 25- to-30-meter-diameter crater and evidence of a high-angle ballistic ejecta plume still in the process of returning to the surface-an evolution attributed to the nature of the impactor.	[Schultz, Peter H.; Hermalyn, Brendan] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Colaprete, Anthony; Ennico, Kimberly; Shirley, Mark; Marshall, William S.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Marshall, William S.] Univ Space Res Assoc, Mountain View, CA 94043 USA	Brown University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Universities Space Research Association (USRA)	Schultz, PH (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.	peter_schultz@brown.edu	Ennico, Kimberly/L-9606-2014		LCROSS Project; NASA's Exploration Systems Mission Directorate (ESMD); NASA Science Mission Directorate (SMD); NASA	LCROSS Project; NASA's Exploration Systems Mission Directorate (ESMD); NASA Science Mission Directorate (SMD)(National Aeronautics & Space Administration (NASA)); NASA(National Aeronautics & Space Administration (NASA))	We thank the LCROSS Project and NASA's Exploration Systems Mission Directorate (ESMD) and NASA Science Mission Directorate (SMD; Planetary Geology and Geophysics) for support. We are also very grateful to the NASA Ames Vertical Gun Range technical team and the Thermophysics Facilities Branch at NASA Ames for their continued support in experiments. B. H. was supported through a NASA Rhode Island Space Grant fellowship for part of this study.	Anderson JLB, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002075; Clark RN, 2009, SCIENCE, V326, P562, DOI 10.1126/science.1178105; Colaprete A, 2010, SCIENCE, V330, P463, DOI 10.1126/science.1186986; Ernst CA, 2007, ICARUS, V190, P334, DOI 10.1016/j.icarus.2007.03.030; ERNST CM, 2005, LUN PLAN SCI C, V36, P1475; Feldman WC, 1998, SCIENCE, V281, P1496, DOI 10.1126/science.281.5382.1496; Gladstone GR, 2010, SCIENCE, V330, P472, DOI 10.1126/science.1186474; HARRIS RS, 2007, 1360 LPI; Hermalyn B., 2010, LUNAR PLANET SCI, P41; Hermalyn B, 2010, ICARUS, V209, P866, DOI 10.1016/j.icarus.2010.05.025; HODGES RR, 1973, J GEOPHYS RES, V78, P8055, DOI 10.1029/JA078i034p08055; HOUSEN KR, 1983, J GEOPHYS RES, V88, P2485, DOI 10.1029/JB088iB03p02485; Korycansky DG, 2009, METEORIT PLANET SCI, V44, P603, DOI 10.1111/j.1945-5100.2009.tb00755.x; Ong L, 2010, ICARUS, V207, P578, DOI 10.1016/j.icarus.2009.12.012; Paige DA, 2010, SCIENCE, V330, P479, DOI 10.1126/science.1187726; Pieters CM, 2009, SCIENCE, V326, P568, DOI 10.1126/science.1178658; POTTER AE, 1988, SCIENCE, V241, P675, DOI 10.1126/science.241.4866.675; Schultz PH, 2007, ICARUS, V190, P295, DOI 10.1016/j.icarus.2007.06.006; Schultz PH, 2006, NATURE, V444, P184, DOI 10.1038/nature05303; SCHULTZ PH, 2006, WORKSH LUN CRAT OBS; SCHULTZ PH, 2009, EOS T AGU, V90; Sunshine JM, 2009, SCIENCE, V326, P565, DOI 10.1126/science.1179788	22	112	114	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					468	472		10.1126/science.1187454	http://dx.doi.org/10.1126/science.1187454			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966243				2022-12-01	WOS:000283329100029
J	Sharma, M; Yi, MG; Dong, H; Qin, HJ; Peterson, E; Busath, DD; Zhou, HX; Cross, TA				Sharma, Mukesh; Yi, Myunggi; Dong, Hao; Qin, Huajun; Peterson, Emily; Busath, David D.; Zhou, Huan-Xiang; Cross, Timothy A.			Insight into the Mechanism of the Influenza A Proton Channel from a Structure in a Lipid Bilayer	SCIENCE			English	Article							M2 ION-CHANNEL; VIRUS; TRANSMEMBRANE; SELECTIVITY; AMANTADINE; STATE; HISTIDINE; PROTEIN; MODEL; CONDUCTANCE	The M2 protein from the influenza A virus, an acid-activated proton-selective channel, has been the subject of numerous conductance, structural, and computational studies. However, little is known at the atomic level about the heart of the functional mechanism for this tetrameric protein, a His(37)-Trp(41) cluster. We report the structure of the M2 conductance domain (residues 22 to 62) in a lipid bilayer, which displays the defining features of the native protein that have not been attainable from structures solubilized by detergents. We propose that the tetrameric His(37)-Trp(41) cluster guides protons through the channel by forming and breaking hydrogen bonds between adjacent pairs of histidines and through specific interactions of the histidines with the tryptophan gate. This mechanism explains the main observations on M2 proton conductance.	[Yi, Myunggi; Dong, Hao; Zhou, Huan-Xiang] Florida State Univ, Dept Phys, Tallahassee, FL 32306 USA; [Sharma, Mukesh; Qin, Huajun; Cross, Timothy A.] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Sharma, Mukesh; Cross, Timothy A.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Yi, Myunggi; Dong, Hao; Zhou, Huan-Xiang; Cross, Timothy A.] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Peterson, Emily; Busath, David D.] Brigham Young Univ, Dept Physiol & Dev Biol, Provo, UT 84602 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University; Brigham Young University	Zhou, HX (corresponding author), Florida State Univ, Dept Phys, Tallahassee, FL 32306 USA.	hzhou4@fsu.edu; cross@magnet.fsu.edu	Zhou, Huan-Xiang/AAH-9836-2020; Dong, Hao/H-2054-2011; Sharma, Mukesh/F-8328-2010; zhou, huan/GYJ-4398-2022; Zhou, Huan-Xiang/M-5170-2016	Zhou, Huan-Xiang/0000-0001-9020-0302; Sharma, Mukesh/0000-0003-3036-1846; Zhou, Huan-Xiang/0000-0001-9020-0302; Cross, Timothy/0000-0002-9413-0505	National Institute of Allergy and Infectious Diseases [AI023007]; NSF Division of Materials Research [0654118]; State of Florida [0654118]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023007] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NSF Division of Materials Research(National Science Foundation (NSF)); State of Florida; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Institute of Allergy and Infectious Diseases grant AI023007. The spectroscopy was conducted at the National High Magnetic Field Laboratory supported by Cooperative Agreement 0654118 between the NSF Division of Materials Research and the State of Florida. T.A.C., H.-X.Z., D.D.B., M.S., and M.Y. have applied for a patent on the mechanism reported here. The structure (an ensemble of eight models) has been deposited in the Protein Data Bank with accession code 2L0J.	Acharya R, 2010, P NATL ACAD SCI USA, V107, P15075, DOI 10.1073/pnas.1007071107; Cady SD, 2008, P NATL ACAD SCI USA, V105, P1483, DOI 10.1073/pnas.0711500105; Cady SD, 2010, NATURE, V463, P689, DOI 10.1038/nature08722; Chizhmakov IV, 2003, J PHYSIOL-LONDON, V546, P427, DOI 10.1113/jphysiol.2002.028910; Chizhmakov IV, 1996, J PHYSIOL-LONDON, V494, P329, DOI 10.1113/jphysiol.1996.sp021495; Cross TA, 2011, TRENDS BIOCHEM SCI, V36, P117, DOI 10.1016/j.tibs.2010.07.005; GUBAREVA L, 2009, MMWR-MORBID MORTAL W, V58, P1; Hu J, 2006, P NATL ACAD SCI USA, V103, P6865, DOI 10.1073/pnas.0601944103; Hu J, 2007, BIOPHYS J, V92, P4335, DOI 10.1529/biophysj.106.090183; KRAUSE JA, 1991, ACTA CRYSTALLOGR B, V47, P506, DOI 10.1107/S0108768191000915; Lau TL, 2008, J BIOL CHEM, V283, P16162, DOI 10.1074/jbc.M801748200; Li C, 2007, BBA-BIOMEMBRANES, V1768, P3162, DOI 10.1016/j.bbamem.2007.08.025; Lin TI, 2001, J VIROL, V75, P3647, DOI 10.1128/JVI.75.8.3647-3656.2001; Ma CL, 2009, P NATL ACAD SCI USA, V106, P12283, DOI 10.1073/pnas.0905726106; Mould JA, 2000, J BIOL CHEM, V275, P8592, DOI 10.1074/jbc.275.12.8592; Nishimura K, 2002, BIOCHEMISTRY-US, V41, P13170, DOI 10.1021/bi0262799; Okada A, 2001, BIOCHEMISTRY-US, V40, P6053, DOI 10.1021/bi0028441; Pinto LH, 1997, P NATL ACAD SCI USA, V94, P11301, DOI 10.1073/pnas.94.21.11301; QUICK A, 1976, CAN J CHEM, V54, P2465, DOI 10.1139/v76-350; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Song XJ, 2001, MAGN RESON CHEM, V39, pS37, DOI 10.1002/mrc.957; Song XJ, 2001, MAGN RESON CHEM, V39, pS30, DOI 10.1002/mrc.956; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Takeda M, 2002, J VIROL, V76, P1391, DOI 10.1128/JVI.76.3.1391-1399.2002; Tang YJ, 2002, J BIOL CHEM, V277, P39880, DOI 10.1074/jbc.M206582200; Tatara W, 2003, J PHYS CHEM A, V107, P7827, DOI 10.1021/jp030065z; Tian CL, 2003, PROTEIN SCI, V12, P2597, DOI 10.1110/ps.03168503; Venkataraman P, 2005, J BIOL CHEM, V280, P21463, DOI 10.1074/jbc.M412406200; Yi M, 2008, J PHYS CHEM B, V112, P7977, DOI 10.1021/jp800171m; Yi MG, 2009, P NATL ACAD SCI USA, V106, P13311, DOI 10.1073/pnas.0906553106	31	364	365	6	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					509	512		10.1126/science.1191750	http://dx.doi.org/10.1126/science.1191750			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966252	Green Accepted			2022-12-01	WOS:000283329100041
J	Lahtela, J; Nousiainen, HO; Stefanovic, V; Tallila, J; Viskari, H; Karikoski, R; Gentile, M; Saloranta, C; Varilo, T; Salonen, R; Kestila, M				Lahtela, Jenni; Nousiainen, Heidi O.; Stefanovic, Vedran; Tallila, Jonna; Viskari, Heli; Karikoski, Riitta; Gentile, Massimiliano; Saloranta, Carola; Varilo, Teppo; Salonen, Riitta; Kestila, Marjo			Brief Report: Mutant CHUK and Severe Fetal Encasement Malformation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BARTSOCAS-PAPAS-SYNDROME; KAPPA-B-KINASE; IKK-ALPHA; EPIDERMAL DIFFERENTIATION; MICE LACKING; SKIN; MORPHOGENESIS; CANCER	We report an autosomal recessive lethal syndrome characterized by multiple fetal malformations, the most obvious anomalies being the defective face and seemingly absent limbs, which are bound to the trunk and encased under the skin. We identified the molecular defect that causes this syndrome, using a combined strategy of gene-expression arrays, candidate-gene analysis, clinical studies, and genealogic investigations. A point mutation in two affected fetuses led to the loss of the conserved helix-loop-helix ubiquitous kinase (CHUK), also known as I(kappa)B kinase (alpha). CHUK has an essential role in the development of skin epidermis and its derivatives, along with various other morphogenetic events. (Funded by the Academy of Finland and others.).	[Kestila, Marjo] Natl Inst Hlth & Welf, Publ Hlth Genom Unit, Biomedicum Helsinki, Helsinki 00251, Finland; [Stefanovic, Vedran] Helsinki Univ Hosp, Dept Obstet & Gynecol, Helsinki, Finland; [Karikoski, Riitta] Helsinki Univ Hosp, Dept Pathol, Helsinki, Finland; [Saloranta, Carola] Helsinki Univ Hosp, Dept Clin Genet, Helsinki, Finland; [Gentile, Massimiliano] Univ Helsinki, Biomedicum Genom, Helsinki, Finland; [Varilo, Teppo] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Salonen, Riitta] Vaestoliitto, Dept Med Genet, Helsinki, Finland	Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki	Kestila, M (corresponding author), Natl Inst Hlth & Welf, Publ Hlth Genom Unit, Biomedicum Helsinki, POB 104, Helsinki 00251, Finland.	marjo.kestila@thl.fi	Stefanovic, Vedran/L-8905-2013; Gentile, Massimo/R-3270-2016	Stefanovic, Vedran/0000-0001-5230-1698; Gentile, Massimo/0000-0002-5256-0726; Lahtela, Jenni Salla Pauliina/0000-0001-5664-0021; Varilo, Teppo/0000-0002-5839-8854	Academy of Finland [211124, 118468]; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	Supported by grants (211124 and 118468) from the Academy of Finland and by grants from the Sigrid Juselius Foundation (all to Dr. Kestil).	BARTSOCAS CS, 1972, J MED GENET, V9, P222, DOI 10.1136/jmg.9.2.222; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Davis George E., 2007, Birth Defects Research, V81, P270, DOI 10.1002/bdrc.20107; Descargues P, 2008, EMBO J, V27, P2639, DOI 10.1038/emboj.2008.196; Gareus R, 2007, NAT CELL BIOL, V9, P461, DOI 10.1038/ncb1560; HENNEKAM RCM, 1994, AM J MED GENET, V53, P102, DOI 10.1002/ajmg.1320530203; Hu YL, 2001, NATURE, V410, P710, DOI 10.1038/35070605; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Karin M, 2008, CELL RES, V18, P334, DOI 10.1038/cr.2008.30; Lanford, 1987, P GREENWOOD GENET CT, V6, P10; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; Sil AK, 2004, NATURE, V428, P660, DOI 10.1038/nature02421; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; VARILO T, 1999, THESIS U HELINSKI HE; Veenstra-Knol HE, 2003, AM J MED GENET A, V123A, P243, DOI 10.1002/ajmg.a.20308; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	18	43	45	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 21	2010	363	17					1631	1637		10.1056/NEJMoa0911698	http://dx.doi.org/10.1056/NEJMoa0911698			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	668BD	20961246				2022-12-01	WOS:000283242700007
J	Roignant, JY; Treisman, JE				Roignant, Jean-Yves; Treisman, Jessica E.			Exon Junction Complex Subunits Are Required to Splice Drosophila MAP Kinase, a Large Heterochromatic Gene	CELL			English	Article							OSKAR MESSENGER-RNA; RECEPTOR TYROSINE KINASE; MAGO-NASHI; SIGNALING PATHWAY; BINDING PROTEIN; CORE COMPLEX; CELL-DEATH; NONSENSE; EXPRESSION; TRANSLATION	The exon junction complex (EJC) is assembled on spliced mRNAs upstream of exon-exon junctions and can regulate their subsequent translation, localization, or degradation. We isolated mutations in Drosophila mago nashi (mago), which encodes a core EJC subunit, based on their unexpectedly specific effects on photoreceptor differentiation. Loss of Mago prevents epidermal growth factor receptor signaling, due to a large reduction in MAPK mRNA levels. MAPK expression also requires the EJC subunits Y14 and eIF4AIII and EJC-associated splicing factors. Mago depletion does not affect the transcription or stability of MAPK mRNA but alters its splicing pattern. MAPK expression from an exogenous promoter requires Mago only when the template includes introns. MAPK is the primary functional target of mago in eye development; in cultured cells, Mago knockdown disproportionately affects other large genes located in heterochromatin. These data support a nuclear role for EJC components in splicing a specific subset of introns.	[Roignant, Jean-Yves; Treisman, Jessica E.] NYU Sch Med, Kimmel Ctr Biol & Med, Dept Cell Biol, Skirball Inst, New York, NY 10016 USA	New York University	Treisman, JE (corresponding author), NYU Sch Med, Kimmel Ctr Biol & Med, Dept Cell Biol, Skirball Inst, 540 1st Ave, New York, NY 10016 USA.	jessica.treisman@med.nyu.edu		Roignant, Jean-Yves/0000-0003-1395-2150; Treisman, Jessica/0000-0002-7453-107X	National Institutes of Health [EY13777]; NATIONAL EYE INSTITUTE [R01EY013777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Robert Boswell, Barry Dickson, Anne Ephrussi, Ruth Lehmann, James Skeath, Daniel St Johnston, Marc Therrien, the Developmental Studies Hybridoma Bank, the Drosophila Genomics Resource Center, and the Bloomington Drosophila stock center for reagents. We also thank Antonio-Javier Lopez for searching for recursive splice sites in MAPK pre-mRNA and Madeline Crosby for providing a list of heterochromatic genes. We are grateful to the NYU Cancer Institute Genomics Facility and Laura Hogan for assistance with qRT-PCR and deep sequencing and to Stuart Brown and Zuojian Tang for bio-informatics analysis. The manuscript was improved by the critical comments of Sergio Astigarraga, Ines Carrrera, Kerstin Hofmeyer, Kevin Legent, Sylvie Ozon Rickman, Hyung Don Ryoo, Josie Steinhauer, Andrea Zamparini, and Jiri Zavadil. This work was supported by the National Institutes of Health (grant EY13777 to J.E.T.).	Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006; BOSWELL RE, 1991, DEVELOPMENT, V113, P373; Burnette JM, 2005, GENETICS, V170, P661, DOI 10.1534/genetics.104.039701; Carrera I, 2008, MOL CELL BIOL, V28, P5238, DOI 10.1128/MCB.00747-08; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; CHENG J, 1994, MOL CELL BIOL, V14, P6317, DOI 10.1128/MCB.14.9.6317; Ciapponi L, 2001, GENE DEV, V15, P1540, DOI 10.1101/gad.886301; Degot S, 2004, J BIOL CHEM, V279, P33702, DOI 10.1074/jbc.M402754200; Diem MD, 2007, NAT STRUCT MOL BIOL, V14, P1173, DOI 10.1038/nsmb1321; Dimitri P, 2003, MOL BIOL EVOL, V20, P503, DOI 10.1093/molbev/msg048; Dostie J, 2002, CURR BIOL, V12, P1060, DOI 10.1016/S0960-9822(02)00902-8; EBERL DF, 1993, GENETICS, V134, P277; Fox-Walsh KL, 2005, P NATL ACAD SCI USA, V102, P16176, DOI 10.1073/pnas.0508489102; Gatfield D, 2003, EMBO J, V22, P3960, DOI 10.1093/emboj/cdg371; Gehring NH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000120; Gehring NH, 2009, CELL, V137, P536, DOI 10.1016/j.cell.2009.02.042; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; Golembo M, 1996, DEVELOPMENT, V122, P223; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Hachet O, 2001, CURR BIOL, V11, P1666, DOI 10.1016/S0960-9822(01)00508-5; Halfar K, 2001, DEVELOPMENT, V128, P1687; HAY BA, 1994, DEVELOPMENT, V120, P2121; Herold N, 2009, MOL CELL BIOL, V29, P281, DOI 10.1128/MCB.01415-08; HOU XS, 1995, CELL, V81, P63, DOI 10.1016/0092-8674(95)90371-2; Ideue T, 2007, GENE DEV, V21, P1993, DOI 10.1101/gad.1557907; Janody F, 2004, GENETICS, V166, P187, DOI 10.1534/genetics.166.1.187; Karim FD, 1998, DEVELOPMENT, V125, P1; Kataoka N, 2001, EMBO J, V20, P6424, DOI 10.1093/emboj/20.22.6424; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lee MH, 2007, PLOS GENET, V3, P2540, DOI 10.1371/journal.pgen.0030233; Li C, 2003, MOL CELL BIOL, V23, P7363, DOI 10.1128/MCB.23.20.7363-7376.2003; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Martin-Blanco E, 1999, DEVELOPMENT, V126, P5739; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; Miura GI, 2006, DEV CELL, V10, P167, DOI 10.1016/j.devcel.2005.11.017; Mohr SE, 2001, GENE DEV, V15, P2886; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NEWMARK PA, 1994, DEVELOPMENT, V120, P1303; Newmark PA, 1997, DEVELOPMENT, V124, P3197; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Nykamp K, 2008, RNA, V14, P1378, DOI 10.1261/rna.1066008; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; Parma DH, 2007, DEV BIOL, V308, P507, DOI 10.1016/j.ydbio.2007.06.007; Ponicsan SL, 2010, CURR OPIN GENET DEV, V20, P149, DOI 10.1016/j.gde.2010.01.004; Queenan AM, 1997, DEVELOPMENT, V124, P3871; Reichert VL, 2002, GENE DEV, V16, P2778, DOI 10.1101/gad.1030602; Roignant JY, 2009, INT J DEV BIOL, V53, P795, DOI 10.1387/ijdb.072483jr; Roignant JY, 2006, GENE DEV, V20, P795, DOI 10.1101/gad.1390506; Schwartz S, 2010, EMBO J, V29, P1629, DOI 10.1038/emboj.2010.71; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; Shepard S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007853; Silver DL, 2010, NAT NEUROSCI, V13, P551, DOI 10.1038/nn.2527; Smith CD, 2007, SCIENCE, V316, P1586, DOI 10.1126/science.1139815; Srivastava M, 2007, CELL DEATH DIFFER, V14, P92, DOI 10.1038/sj.cdd.4401931; Stalder L, 2008, TRENDS CELL BIOL, V18, P315, DOI 10.1016/j.tcb.2008.04.005; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; Trembley JH, 2005, MOL CELL BIOL, V25, P1446, DOI 10.1128/MCB.25.4.1446-1457.2005; van Eeden FJM, 2001, J CELL BIOL, V154, P511, DOI 10.1083/jcb.200105056; Wiegand HL, 2003, P NATL ACAD SCI USA, V100, P11327, DOI 10.1073/pnas.1934877100; Yang LH, 2003, DEV CELL, V4, P359, DOI 10.1016/S1534-5807(03)00059-5; Yu J, 2002, GENOME RES, V12, P1185, DOI 10.1101/gr.224602; Zhai RG, 2003, P NATL ACAD SCI USA, V100, P10860, DOI 10.1073/pnas.1832753100; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P11574, DOI 10.1073/pnas.0704946104	70	90	94	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					238	250		10.1016/j.cell.2010.09.036	http://dx.doi.org/10.1016/j.cell.2010.09.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946982	Green Accepted, Bronze			2022-12-01	WOS:000283052200013
J	Wieseler, B; McGauran, N; Kaiser, T				Wieseler, Beate; McGauran, Natalie; Kaiser, Thomas			Finding studies on reboxetine: a tale of hide and seek	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRIALS; REGISTRATION; PUBLICATION; DEPRESSION; GABAPENTIN; DOCUMENTS		[Wieseler, Beate; McGauran, Natalie; Kaiser, Thomas] Inst Qual & Efficiency Hlth Care, D-51105 Cologne, Germany		Wieseler, B (corresponding author), Inst Qual & Efficiency Hlth Care, Dillenburger Strasse 27, D-51105 Cologne, Germany.	beate.wieseler@iqwig.de		Wieseler, Beate/0000-0002-3519-754X; Kaiser, Thomas/0000-0003-0795-538X				Eyding D, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4737; *FDA, 2010, IMPR SAF IMP FOOD ME; Hill KP, 2008, ANN INTERN MED, V149, P251, DOI 10.7326/0003-4819-149-4-200808190-00006; *I QUAL EFF HLTH C, 2009, A0520C I QUAL EFF HL; *I QUAL EFF HLTH C, 2008, GEN METH VERS 3 0; Krleza-Jeric K, 2005, BMJ-BRIT MED J, V330, P956, DOI 10.1136/bmj.330.7497.956; McGauran N, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-37; Page ME, 2003, CNS DRUG REV, V9, P327; Preskorn Sheldon H, 2004, J Psychiatr Pract, V10, P57, DOI 10.1097/00131746-200401000-00006; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Stafford N, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2521; Steinman MA, 2006, ANN INTERN MED, V145, P284, DOI 10.7326/0003-4819-145-4-200608150-00008; Turner EH, 2008, SCIENCE, V322, P44, DOI 10.1126/science.322.5898.44c; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1; Wood AJJ, 2009, NEW ENGL J MED, V360, P824, DOI 10.1056/NEJMsr0806582	17	21	21	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 12	2010	341								c4942	10.1136/bmj.c4942	http://dx.doi.org/10.1136/bmj.c4942			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	663KN	20940211				2022-12-01	WOS:000282886900011
J	Hutchison, WD; Burkness, EC; Mitchell, PD; Moon, RD; Leslie, TW; Fleischer, SJ; Abrahamson, M; Hamilton, KL; Steffey, KL; Gray, ME; Hellmich, RL; Kaster, LV; Hunt, TE; Wright, RJ; Pecinovsky, K; Rabaey, TL; Flood, BR; Raun, ES				Hutchison, W. D.; Burkness, E. C.; Mitchell, P. D.; Moon, R. D.; Leslie, T. W.; Fleischer, S. J.; Abrahamson, M.; Hamilton, K. L.; Steffey, K. L.; Gray, M. E.; Hellmich, R. L.; Kaster, L. V.; Hunt, T. E.; Wright, R. J.; Pecinovsky, K.; Rabaey, T. L.; Flood, B. R.; Raun, E. S.			Areawide Suppression of European Corn Borer with Bt Maize Reaps Savings to Non-Bt Maize Growers	SCIENCE			English	Article							PEST-MANAGEMENT; INSECT RESISTANCE; TRANSGENIC CROPS; LEPIDOPTERA; PYRALIDAE; TOXIN; POPULATIONS; CRAMBIDAE; EVOLUTION; BOLLWORM	Transgenic maize engineered to express insecticidal proteins from the bacterium Bacillus thuringiensis (Bt) has become widely adopted in U. S. agriculture. In 2009, Bt maize was planted on more than 22.2 million hectares, constituting 63% of the U. S. crop. Using statistical analysis of per capita growth rate estimates, we found that areawide suppression of the primary pest Ostrinia nubilalis (European corn borer) is associated with Bt maize use. Cumulative benefits over 14 years are an estimated $3.2 billion for maize growers in Illinois, Minnesota, and Wisconsin, with more than $2.4 billion of this total accruing to non-Bt maize growers. Comparable estimates for Iowa and Nebraska are $3.6 billion in total, with $1.9 billion for non-Bt maize growers. These results affirm theoretical predictions of pest population suppression and highlight economic incentives for growers to maintain non-Bt maize refugia for sustainable insect resistance management.	[Hutchison, W. D.; Burkness, E. C.; Moon, R. D.] Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA; [Mitchell, P. D.] Univ Wisconsin, Dept Agr & Appl Econ, Madison, WI 53706 USA; [Leslie, T. W.] Long Isl Univ, Dept Biol, Brooklyn, NY 11201 USA; [Fleischer, S. J.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Abrahamson, M.] Minnesota Dept Agr, St Paul, MN 55107 USA; [Hamilton, K. L.] Wisconsin Dept Agr Trade & Consumer Protect, Madison, WI 53718 USA; [Steffey, K. L.; Gray, M. E.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Hellmich, R. L.] ARS, USDA, Corn Insects & Crop Genet Res Unit, Genet Lab, Ames, IA 50011 USA; [Kaster, L. V.] Syngenta Seeds Inc, Slater, IA 50244 USA; [Hunt, T. E.] Univ Nebraska, Dept Entomol, NEREC, Haskell Agr Lab, Concord, NE 68728 USA; [Wright, R. J.] Univ Nebraska, Dept Entomol, Lincoln, NE 68583 USA; [Pecinovsky, K.] Iowa State Univ, Nashua, IA 50658 USA; [Rabaey, T. L.] Gen Mills Inc, Le Sueur, MN 56058 USA; [Flood, B. R.] Del Monte Foods, Rochelle, IL 61068 USA; [Raun, E. S.] Pest Management Co, Lincoln, NE 68506 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison; Long Island University-Brooklyn Campus; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA); Syngenta; University of Nebraska System; University of Nebraska System; University of Nebraska Lincoln; Iowa State University	Hutchison, WD (corresponding author), Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA.	hutch002@umn.edu	Fleischer, Shelby/AAN-1392-2020; Fleischer, Shelby/AAD-6663-2020; Moon, Roger/ABA-7225-2020	Hutchison, William D./0000-0001-9605-2996	University of Minnesota	University of Minnesota(University of Minnesota System)	This study is part of a large-scale monitoring program for O. nubilalis via cooperating members of USDA Multistate Project NC-205, "Ecology and Management of European Corn Borer and Other Lepidopteran Pests of Corn." Support was also provided by personnel with state departments of agriculture, agricultural experiment stations, and cooperative extension, and a grant from the Rapid Agricultural Response Fund, University of Minnesota. We acknowledge numerous growers who permitted data collection from commercial maize fields over the past 50 years. We thank J. Dyer, L. Lewis, B. Gunnarson, and R. Ritland for technical support, and Y. Carriere, J. Chapman, J.-Z. Zhou, and J. P. Chavas for reviews of earlier versions of the manuscript. P. D. M. also provides limited private economic consulting services to agencies, universities, and private companies, which in the past 3 years has included small projects for Monsanto, Pioneer Hi-Bred International, and Syngenta on topics unrelated to this paper. Mention of a proprietary product does not constitute an endorsement or a recommendation for its use by the universities associated with this research or the USDA.	ALSTAD DN, 1995, SCIENCE, V268, P1894, DOI 10.1126/science.268.5219.1894; Bartels DW, 1997, J ECON ENTOMOL, V90, P449, DOI 10.1093/jee/90.2.449; Brookes G., 2008, AgBioForum, V11, P21; Burkness EC, 2002, CROP PROT, V21, P157, DOI 10.1016/S0261-2194(01)00080-1; Burnham KP., 2002, MODEL SELECTION MULT, V2; Carriere Y, 2003, P NATL ACAD SCI USA, V100, P1519, DOI 10.1073/pnas.0436708100; Goldberger J., 2005, AgBioForum, V8, P151; Hellmich RL, 1999, J ECON ENTOMOL, V92, P1014, DOI 10.1093/jee/92.5.1014; HILL RE, 1979, ENVIRON ENTOMOL, V8, P91, DOI 10.1093/ee/8.1.91; Hurley TM, 2004, AM J AGR ECON, V86, P345, DOI 10.1111/j.0092-5853.2004.00583.x; HUTCHISON W, 2008, MINNESOTA FRUIT 0606; Lewis LC, 2009, BIOL CONTROL, V48, P223, DOI 10.1016/j.biocontrol.2008.10.009; LEWIS P, 2001, 200007A SAP US EPA, P5; MASON CE, 1996, NCR327 IOW STAT U; Mitchell PD, 2002, J AGR RESOUR ECON, V27, P390; O'Rourke ME, 2010, ECOL APPL, V20, P1228, DOI 10.1890/09-0067.1; Onstad DW, 1999, J ECON ENTOMOL, V92, P1256, DOI 10.1093/jee/92.6.1256; OSTLIE KR, 1997, NCR602 U MINN; Pereira EJG, 2008, B ENTOMOL RES, V98, P621, DOI 10.1017/S0007485308005920; Pilcher CD, 2002, J ECON ENTOMOL, V95, P878, DOI 10.1603/0022-0493-95.5.878; Reardon BJ, 2006, J ECON ENTOMOL, V99, P1641, DOI 10.1603/0022-0493-99.5.1641; Royama T., 1992, ANAL POPULATION ECOL; Shelton AM, 2006, ANNU REV ENTOMOL, V51, P285, DOI 10.1146/annurev.ento.51.110104.150959; Sibly RM, 2005, SCIENCE, V309, P607, DOI 10.1126/science.1110760; Sisterson MS, 2004, J ECON ENTOMOL, V97, P1413, DOI 10.1603/0022-0493-97.4.1413; Storer Nicholas P., 2008, V5, P273, DOI 10.1007/978-1-4020-8373-0_10; Tabashnik BE, 2008, P NATL ACAD SCI USA, V105, P19029, DOI 10.1073/pnas.0810763106; USDA-ARS, AD GEN ENG CROPS US; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550	29	458	488	2	224	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					222	225		10.1126/science.1190242	http://dx.doi.org/10.1126/science.1190242			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20929774	Green Published			2022-12-01	WOS:000282644600042
J	Bisgaard, H; Hermansen, MN; Bonnelykke, K; Stokholm, J; Baty, F; Skytt, NL; Aniscenko, J; Kebadze, T; Johnston, SL				Bisgaard, Hans; Hermansen, Mette Northman; Bonnelykke, Klaus; Stokholm, Jakob; Baty, Florent; Skytt, Nanna Lassen; Aniscenko, Julia; Kebadze, Tatiana; Johnston, Sebastian L.			Association of bacteria and viruses with wheezy episodes in young children: prospective birth cohort study	BRITISH MEDICAL JOURNAL			English	Article							PLACEBO-CONTROLLED TRIAL; ORAL PREDNISOLONE; VIRAL-INFECTIONS; DOUBLE-BLIND; 1ST YEAR; ASTHMA; EXACERBATIONS; INFANCY; LIFE; CLARITHROMYCIN	Objective To study the association between wheezy symptoms in young children and the presence of bacteria in the airways. Design Birth cohort study. Setting Clinical research unit in Copenhagen. Participants Children of asthmatic mothers, from age 4 weeks to 3 years, with planned visits and acute admissions to the research clinic. Main outcome measure Frequency of bacteria and virus carriage in airway aspirates during wheezy episodes and at planned visits without respiratory symptoms. Results 984 samples (361 children) were analysed for bacteria, 844 (299 children) for viruses, and 696 (277 children) for both viruses and bacteria. Wheezy episodes were associated with both bacterial infection (odds ratio 2.9, 95% confidence interval 1.9 to 4.3; P<0.001) and virus infection (2.8, 1.7 to 4.4; P<0.001). The associations of bacteria and viruses were independent of each other. Conclusion Acute wheezy episodes in young children were significantly associated with bacterial infections similar to but independent of the association with virus infections.	[Bisgaard, Hans; Hermansen, Mette Northman; Bonnelykke, Klaus; Stokholm, Jakob; Baty, Florent; Skytt, Nanna Lassen] Copenhagen Prospect Studies Asthma Childhood, DK-2820 Gentofte, Copenhagen, Denmark; [Bisgaard, Hans; Hermansen, Mette Northman; Bonnelykke, Klaus; Stokholm, Jakob; Baty, Florent; Skytt, Nanna Lassen] Univ Copenhagen, DK-2820 Gentofte, Copenhagen, Denmark; [Bisgaard, Hans; Hermansen, Mette Northman; Bonnelykke, Klaus; Stokholm, Jakob; Baty, Florent; Skytt, Nanna Lassen] Danish Pediat Asthma Ctr, DK-2820 Gentofte, Copenhagen, Denmark; [Bisgaard, Hans; Hermansen, Mette Northman; Bonnelykke, Klaus; Stokholm, Jakob; Baty, Florent; Skytt, Nanna Lassen] Copenhagen Univ Hosp, DK-2820 Gentofte, Copenhagen, Denmark; [Aniscenko, Julia; Kebadze, Tatiana; Johnston, Sebastian L.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, MRC & Asthma UK Ctr Allerg Mech Asthma, Dept Resp Med, London SW7 2AZ, England; [Aniscenko, Julia; Kebadze, Tatiana; Johnston, Sebastian L.] Univ London Imperial Coll Sci Technol & Med, Ctr Resp Infect, London SW7 2AZ, England	University of Copenhagen; University of Copenhagen; Imperial College London; University of London; King's College London; Imperial College London	Bisgaard, H (corresponding author), Copenhagen Prospect Studies Asthma Childhood, Ledreborg Alle 34, DK-2820 Gentofte, Copenhagen, Denmark.	Bisgaard@copsac.com	Johnston, Sebastian Lennox/I-2423-2012; Kronow, Joern/B-1054-2011; Bisgaard, Hans/N-4761-2016	Johnston, Sebastian Lennox/0000-0003-3009-9200; Bisgaard, Hans/0000-0003-4131-7592; Bonnelykke, Klaus/0000-0003-2003-1018; Stokholm, Jakob/0000-0003-4989-9769	Copenhagen Prospective Study on Asthma in Childhood; Lundbeck Foundation; Pharmacy Foundation; Augustinus Foundation; Danish Medical Research Council; Danish Pediatric Asthma Centre; Lundbeck Foundation [R16-2007-1694] Funding Source: researchfish	Copenhagen Prospective Study on Asthma in Childhood; Lundbeck Foundation(Lundbeckfonden); Pharmacy Foundation; Augustinus Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Pediatric Asthma Centre; Lundbeck Foundation(Lundbeckfonden)	The Copenhagen Prospective Study on Asthma in Childhood is funded by private and public research funds (seewww.copsac.com). The study is supported by the Lundbeck Foundation, the Pharmacy Foundation of 1991, Augustinus Foundation, the Danish Medical Research Council, and the Danish Pediatric Asthma Centre. The funding agencies had no role in the study design; the conduct of the study; data collection and management; data analysis; or the preparation, review, or approval of the manuscript.	Andersen ZJ, 2008, THORAX, V63, P710, DOI 10.1136/thx.2007.085480; ANIANSSON G, 1992, J INFECT DIS, V165, pS38, DOI 10.1093/infdis/165-Supplement_1-S38; [Anonymous], 2005, NIH PUBL, V05-4772; Bisgaard H, 2004, ANN ALLERG ASTHMA IM, V93, P381, DOI 10.1016/S1081-1206(10)61398-1; Bisgaard H, 2006, NEW ENGL J MED, V354, P1998, DOI 10.1056/NEJMoa054692; Bisgaard H, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050131; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bisgaard H, 2007, PEDIATR PULM, V42, P723, DOI 10.1002/ppul.20644; Bush A, 2009, NEW ENGL J MED, V360, P409, DOI 10.1056/NEJMe0808951; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Ducharme FM, 2009, NEW ENGL J MED, V360, P339, DOI 10.1056/NEJMoa0808907; Fonseca-Aten M, 2006, ANN ALLERG ASTHMA IM, V97, P457, DOI 10.1016/S1081-1206(10)60935-0; Hahn DL, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010011; Harrison LM, 1999, FEMS IMMUNOL MED MIC, V25, P19, DOI 10.1111/j.1574-695X.1999.tb01323.x; Johnston SL, 2006, NEW ENGL J MED, V354, P1589, DOI 10.1056/NEJMoa044080; Johnston SL, 2006, J ALLERGY CLIN IMMUN, V117, P1233, DOI 10.1016/j.jaci.2006.03.035; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kocevar VS, 2004, CHEST, V125, P1680, DOI 10.1378/chest.125.5.1680; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Kusel MMH, 2006, PEDIATR INFECT DIS J, V25, P680, DOI 10.1097/01.inf.0000226912.88900.a3; Lemanske RF, 2005, J ALLERGY CLIN IMMUN, V116, P571, DOI 10.1016/j.jaci.2005.06.024; Lund B, 2001, CLIN MICROBIOL INFEC, V7, P230, DOI 10.1046/j.1469-0691.2001.00242.x; Murray P.R., 2003, MANUAL CLIN MICROBIO, V8th; Oommen A, 2003, LANCET, V362, P1433, DOI 10.1016/S0140-6736(03)14685-5; Panickar J, 2009, NEW ENGL J MED, V360, P329, DOI 10.1056/NEJMoa0804897; Peacock SJ, 2003, J CLIN MICROBIOL, V41, P5718, DOI 10.1128/JCM.41.12.5718-5725.2003; Tahan F, 2007, EUR RESPIR J, V29, P91, DOI 10.1183/09031936.00029206; Talbot TR, 2005, NEW ENGL J MED, V352, P2082, DOI 10.1056/NEJMoa044113; Watson K, 2006, PEDIATR INFECT DIS J, V25, P782, DOI 10.1097/01.inf.0000232705.49634.68	29	220	229	1	12	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 4	2010	341								c4978	10.1136/bmj.c4978	http://dx.doi.org/10.1136/bmj.c4978			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	663IZ	20921080	hybrid, Green Published			2022-12-01	WOS:000282878600001
J	Robert, S; Kleine-Vehn, J; Barbez, E; Sauer, M; Paciorek, T; Baster, P; Vanneste, S; Zhang, J; Simon, S; Covanova, M; Hayashi, K; Dhonukshe, P; Yang, Z; Bednarek, SY; Jones, AM; Luschnig, C; Aniento, F; Zazimalova, E; Friml, J				Robert, Stephanie; Kleine-Vehn, Juergen; Barbez, Elke; Sauer, Michael; Paciorek, Tomasz; Baster, Pawel; Vanneste, Steffen; Zhang, Jing; Simon, Sibu; Covanova, Milada; Hayashi, Kenichiro; Dhonukshe, Pankaj; Yang, Zhenbiao; Bednarek, Sebastian Y.; Jones, Alan M.; Luschnig, Christian; Aniento, Fernando; Zazimalova, Eva; Friml, Jiri			ABP1 Mediates Auxin Inhibition of Clathrin-Dependent Endocytosis in Arabidopsis	CELL			English	Article							OF-FUNCTION MUTATION; BOX PROTEIN TIR1; BINDING PROTEIN-1; CELL EXPANSION; ENDOPLASMIC-RETICULUM; TRANSFERRIN RECEPTOR; PLASMA-MEMBRANE; EFFLUX CARRIER; TYRPHOSTIN A23; TRANSPORT	Spatial distribution of the plant hormone auxin regulates multiple aspects of plant development. These self-regulating auxin gradients are established by the action of PIN auxin transporters, whose activity is regulated by their constitutive cycling between the plasma membrane and endosomes. Here, we show that auxin signaling by the auxin receptor AUXIN-BINDING PROTEIN 1 (ABP1) inhibits the clathrin-mediated internalization of PIN proteins. ABP1 acts as a positive factor in clathrin recruitment to the plasma membrane, thereby promoting endocytosis. Auxin binding to ABP1 interferes with this action and leads to the inhibition of clathrin-mediated endocytosis. Our study demonstrates that ABP1 mediates a nontranscriptional auxin signaling that regulates the evolutionarily conserved process of clathrin-mediated endocytosis and suggests that this signaling may be essential for the developmentally important feedback of auxin on its own transport.	[Robert, Stephanie; Kleine-Vehn, Juergen; Barbez, Elke; Sauer, Michael; Paciorek, Tomasz; Baster, Pawel; Vanneste, Steffen; Zhang, Jing; Friml, Jiri] VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Robert, Stephanie; Kleine-Vehn, Juergen; Barbez, Elke; Sauer, Michael; Paciorek, Tomasz; Baster, Pawel; Vanneste, Steffen; Zhang, Jing; Friml, Jiri] Univ Ghent, Dept Plant Biotechnol & Genet, B-9052 Ghent, Belgium; [Simon, Sibu; Covanova, Milada; Zazimalova, Eva] ASCR, Inst Expt Bot, Prague 16502 6, Czech Republic; [Hayashi, Kenichiro] Okayama Univ Sci, Dept Biochem, Okayama 7000005, Japan; [Dhonukshe, Pankaj] Univ Utrecht, Dept Biol, NL-3584 CH Utrecht, Netherlands; [Yang, Zhenbiao] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Yang, Zhenbiao] Univ Calif Riverside, Ctr Plant Cell Biol, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Bednarek, Sebastian Y.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Jones, Alan M.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Jones, Alan M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Luschnig, Christian] Univ Nat Resources & Appl Life Sci, BOKU, Inst Appl Genet & Cell Biol, A-1190 Vienna, Austria; [Aniento, Fernando] Univ Valencia, Dept Bioquim & Biol Mol, Burjassot 46100, Spain	Flanders Institute for Biotechnology (VIB); Ghent University; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Okayama University of Science; Utrecht University; University of California System; University of California Riverside; University of California System; University of California Riverside; University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Natural Resources & Life Sciences, Vienna; University of Valencia	Friml, J (corresponding author), VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium.	jiri.friml@psb.vib-ugent.be	Barbez, Elke/AAP-2131-2021; Vanneste, Steffen/K-8353-2013; Friml, Jiri/D-9511-2012; Robert, Stéphanie/K-7604-2012; Company, Fernando Aniento/G-9781-2015; Kleine-Vehn, Jürgen/C-8984-2014; Hayashi, Ken-ichiro/AAP-3513-2021; Sauer, Michael/F-6519-2014; Simon, Sibu/A-2614-2012; Sauer, Michael/G-3424-2011; Covanova, Milada/F-7473-2014; Eva, Zazimalova/G-7432-2014; Robert, Stephanie/ABB-8265-2020	Vanneste, Steffen/0000-0002-9948-9672; Friml, Jiri/0000-0002-8302-7596; Robert, Stéphanie/0000-0002-0013-3239; Company, Fernando Aniento/0000-0003-3553-585X; Kleine-Vehn, Jürgen/0000-0002-4354-3756; Hayashi, Ken-ichiro/0000-0002-9812-2801; Sauer, Michael/0000-0002-4014-9825; Eva, Zazimalova/0000-0002-8325-7092; Robert, Stephanie/0000-0002-0013-3239; Luschnig, Christian/0000-0003-2099-9280; Barbez, Elke/0000-0002-5531-7916	Research Foundation Flanders; Ministry of Education of the Czech Republic [LC06034]; Ministerio de Educacion y Ciencia [BFU2005-00071]; Agency for Innovation by Science and Technology; HFSP long-term; Marie Curie IEF; National Institute of General Medical Sciences [GM65989]; Department of Energy [DE-FG02-05er15671]; National Science Foundation [MCB0718202, 0723515]; NWO-VENI;  [ATLF 142-2007]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065989, R01GM081451, R01GM100130] Funding Source: NIH RePORTER	Research Foundation Flanders(FWO); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Ministerio de Educacion y Ciencia(Spanish Government); Agency for Innovation by Science and Technology; HFSP long-term; Marie Curie IEF(European Commission); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); NWO-VENI(Netherlands Organization for Scientific Research (NWO)); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the anonymous reviewer for helpful comments and Martine De Cock for help in preparing the manuscript. We are very grateful to X.Y. Chen, M. Estelle, T. Gaude, N. Geldner, O. Leyser, C. Perrot-Rechen-mann, and J.W. Reed for sharing published materials and Drs. Jin-Gui Chen and Ming-Jing Wu for generating abp1 mutants. This work was supported by the Odysseus program of the Research Foundation Flanders, the Ministry of Education of the Czech Republic (project LC06034), and the Ministerio de Educacion y Ciencia (grant BFU2005-00071). E.B. is indebted to the Agency for Innovation by Science and Technology for a predoctoral fellowship and S.V. to EMBO for a long-term fellowship (ATLF 142-2007). M.S. was supported by HFSP long-term and Marie Curie IEF fellowships. A.M.J is supported by grants from The National Institute of General Medical Sciences (GM65989), The Department of Energy (DE-FG02-05er15671), and The National Science Foundation (MCB0718202, 0723515). P.D. is supported by NWO-VENI grant.	Abas L, 2006, NAT CELL BIOL, V8, P249, DOI 10.1038/ncb1369; Badescu GO, 2006, TRENDS PLANT SCI, V11, P217, DOI 10.1016/j.tplants.2006.03.001; Banbury AN, 2003, J BIOL CHEM, V278, P12022, DOI 10.1074/jbc.M211966200; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Braun N, 2008, PLANT CELL, V20, P2746, DOI 10.1105/tpc.108.059048; Chen JG, 2001, GENE DEV, V15, P902, DOI 10.1101/gad.866201; Collings DA, 2008, J EXP BOT, V59, P361, DOI 10.1093/jxb/erm324; Dharmasiri N, 2004, TRENDS PLANT SCI, V9, P302, DOI 10.1016/j.tplants.2004.04.003; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dhonukshe P, 2008, NATURE, V456, P962, DOI 10.1038/nature07409; Dhonukshe P, 2007, CURR BIOL, V17, P520, DOI 10.1016/j.cub.2007.01.052; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Henderson J, 1997, PLANTA, V202, P313, DOI 10.1007/s004250050133; HERTEL R, 1972, PLANTA, V107, P325, DOI 10.1007/BF00386394; JONES AM, 1993, PLANT PHYSIOL, V101, P595, DOI 10.1104/pp.101.2.595; Jones AM, 1998, SCIENCE, V282, P1114, DOI 10.1126/science.282.5391.1114; JONES AM, 1994, ANNU REV PLANT PHYS, V45, P393, DOI 10.1146/annurev.pp.45.060194.002141; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kepinski S, 2002, PLANT CELL, V14, pS81, DOI 10.1105/tpc.010447; Kim YW, 2001, PLANT PHYSIOL, V127, P1243, DOI 10.1104/pp.010450; Kleine-Vehn J, 2008, P NATL ACAD SCI USA, V105, P17812, DOI 10.1073/pnas.0808073105; Knox K, 2003, DEVELOPMENT, V130, P5769, DOI 10.1242/dev.00659; Konopka CA, 2008, PLANT CELL, V20, P1363, DOI 10.1105/tpc.108.059428; Lau S, 2009, TRENDS PLANT SCI, V14, P182, DOI 10.1016/j.tplants.2009.01.004; Leblanc N, 1997, PLANT MOL BIOL, V33, P679, DOI 10.1023/A:1005757815212; Leyser O, 2006, CURR BIOL, V16, pR424, DOI 10.1016/j.cub.2006.05.014; LIU SH, 1995, CELL, V83, P257, DOI 10.1016/0092-8674(95)90167-1; LOBLER M, 1985, J BIOL CHEM, V260, P9848; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; Napier RM, 2002, PLANT MOL BIOL, V49, P339, DOI 10.1023/A:1015259130955; Ortiz-Zapater E, 2006, PLANT J, V48, P757, DOI 10.1111/j.1365-313X.2006.02909.x; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Pan JW, 2009, PLANT CELL, V21, P568, DOI 10.1105/tpc.108.061465; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Petrasek J, 2009, DEVELOPMENT, V136, P2675, DOI 10.1242/dev.030353; Robinson DG, 2008, PLANT PHYSIOL, V147, P1482, DOI 10.1104/pp.108.120105; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Sauer M, 2006, NAT PROTOC, V1, P98, DOI 10.1038/nprot.2006.15; Schenck D, 2010, PLANT PHYSIOL, V152, P1183, DOI 10.1104/pp.109.149591; Shimomura S, 1999, PLANTA, V209, P118, DOI 10.1007/s004250050613; Sieberer T, 2000, CURR BIOL, V10, P1595, DOI 10.1016/S0960-9822(00)00861-7; Swarup K, 2008, NAT CELL BIOL, V10, P946, DOI 10.1038/ncb1754; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; TIAN HC, 1995, J BIOL CHEM, V270, P26962, DOI 10.1074/jbc.270.45.26962; Tian Q, 2002, PLANT CELL, V14, P301, DOI 10.1105/tpc.010283; TIMPTE C, 1994, GENETICS, V138, P1239; Tromas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006648; Ueda T, 2001, EMBO J, V20, P4730, DOI 10.1093/emboj/20.17.4730; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Vieten A, 2007, TRENDS PLANT SCI, V12, P160, DOI 10.1016/j.tplants.2007.03.006; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Woo EJ, 2002, EMBO J, V21, P2877, DOI 10.1093/emboj/cdf291; Xu TD, 2010, CELL, V143, P99, DOI 10.1016/j.cell.2010.09.003; Yang HB, 2009, PLANT J, V59, P179, DOI 10.1111/j.1365-313X.2009.03856.x; ZAZIMALOVA E, 1985, PLANT GROWTH REGUL, V3, P15, DOI 10.1007/BF00123542	61	300	317	0	119	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2010	143	1					111	121		10.1016/j.cell.2010.09.027	http://dx.doi.org/10.1016/j.cell.2010.09.027			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	656UC	20887896	Green Accepted, Bronze, Green Published			2022-12-01	WOS:000282362000018
J	Rosen, CJ; Khosla, S				Rosen, Clifford J.; Khosla, Sundeep			Placebo-Controlled Fracture Trials in Osteoporosis - Proceeding with Caution	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RISK; PREVENTION; DENSITY; WOMEN		[Rosen, Clifford J.] Maine Med Ctr, Res Inst, Scarborough, ON, Canada; [Khosla, Sundeep] Mayo Clin, Coll Med, Rochester, MN USA	Mayo Clinic	Rosen, CJ (corresponding author), Maine Med Ctr, Res Inst, Scarborough, ON, Canada.		Khosla, Sundeep/AAE-6170-2020	Khosla, Sundeep/0000-0002-2936-4372	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027065] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR027065] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Cauley JA, 2003, JAMA-J AM MED ASSOC, V290, P1729, DOI 10.1001/jama.290.13.1729; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; European Medicines Agency, 2005, GUID EV NEW MED PROD; Food and Drug Administration Division of Metabolic and Endocrine Drug Products, 1994, GUID PRECL CLIN EV A; Fost N, 2003, J BONE MINER RES, V18, P1110, DOI 10.1359/jbmr.2003.18.6.1110; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Silverman SL, 2008, J BONE MINER RES, V23, P159, DOI 10.1359/JBMR.070905	8	16	16	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2010	363	14					1365	1367		10.1056/NEJMsb1002227	http://dx.doi.org/10.1056/NEJMsb1002227			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	655TD	20879887	Green Accepted			2022-12-01	WOS:000282271500014
J	Acar, M; Pando, BF; Arnold, FH; Elowitz, MB; van Oudenaarden, A				Acar, Murat; Pando, Bernardo F.; Arnold, Frances H.; Elowitz, Michael B.; van Oudenaarden, Alexander			A General Mechanism for Network-Dosage Compensation in Gene Circuits	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; BINDING; YEAST; ROBUSTNESS; PROTEIN; REPRESSION; SYSTEMS; GAL80P; MEMORY; SIGNAL	Coping with variations in network dosage is crucial for maintaining optimal function in gene networks. We explored how network structure facilitates network-level dosage compensation. By using the yeast galactose network as a model, we combinatorially deleted one of the two copies of its four regulatory genes and found that network activity was robust to the change in network dosage. A mathematical analysis revealed that a two-component genetic circuit with elements of opposite regulatory activity (activator and inhibitor) constitutes a minimal requirement for network-dosage invariance. Specific interaction topologies and a one-to-one interaction stoichiometry between the activating and inhibiting agents were additional essential elements facilitating dosage invariance. This mechanism of network-dosage invariance could represent a general design for gene network structure in cells.	[Acar, Murat; Elowitz, Michael B.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Pando, Bernardo F.; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [Arnold, Frances H.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Arnold, Frances H.] CALTECH, Div Biochem & Mol Biophys, Pasadena, CA 91125 USA; [Elowitz, Michael B.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Elowitz, Michael B.] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; [van Oudenaarden, Alexander] MIT, Dept Biol, Cambridge, MA 02139 USA	California Institute of Technology; Massachusetts Institute of Technology (MIT); California Institute of Technology; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; Massachusetts Institute of Technology (MIT)	Acar, M (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	acar@caltech.edu	Acar, Murat/AIB-8244-2022; van Oudenaarden, Alexander/AAA-1705-2019	Arnold, Frances H./0000-0002-4027-364X	Center for Biological Circuit Design at Caltech; NIH; NSF; Packard Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068664, R01GM079771, R01GM068957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028299] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003936] Funding Source: NIH RePORTER	Center for Biological Circuit Design at Caltech; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to thank J. J. Collins, M. Thattai, and H. Youk for helpful discussions and/or comments on the manuscript. M. A. was supported by a fellowship grant from the Center for Biological Circuit Design at Caltech. B. F. P. and A.v.O were supported by grants from NIH and NSF. Work in the Elowitz laboratory was supported by the Packard Foundation, NSF, and NIH. Work in the Arnold laboratory was supported by NIH.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Alon U., 2020, An introduction to systems biology: design principles of biological circuits ed., V2nd edn, P249; Bardwell L, 1998, GENE DEV, V12, P2887, DOI 10.1101/gad.12.18.2887; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Buchler NE, 2008, J MOL BIOL, V384, P1106, DOI 10.1016/j.jmb.2008.09.079; Di Talia S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000221; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; Fell D., 1997, UNDERSTANDING CONTRO; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; LIU YJ, 1995, MOL GEN GENET, V248, P182, DOI 10.1007/BF02190799; Melcher K, 2001, EMBO J, V20, P841, DOI 10.1093/emboj/20.4.841; Mizutani A, 2003, EMBO J, V22, P2178, DOI 10.1093/emboj/cdg220; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Peng G, 2000, MOL CELL BIOL, V20, P5140, DOI 10.1128/MCB.20.14.5140-5148.2000; Peng G, 2002, P NATL ACAD SCI USA, V99, P8548, DOI 10.1073/pnas.142100099; Ramsey SA, 2006, NAT GENET, V38, P1082, DOI 10.1038/ng1869; Rancati G, 2008, CELL, V135, P879, DOI 10.1016/j.cell.2008.09.039; SAVAGEAU MA, 1974, NATURE, V252, P546, DOI 10.1038/252546a0; Shinar G, 2007, P NATL ACAD SCI USA, V104, P19931, DOI 10.1073/pnas.0706792104; SuzukiFujimoto T, 1996, MOL CELL BIOL, V16, P2504; Timson DJ, 2002, BIOCHEM J, V363, P515, DOI 10.1042/0264-6021:3630515; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	28	74	75	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1656	1660		10.1126/science.1190544	http://dx.doi.org/10.1126/science.1190544			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20929850	Green Accepted			2022-12-01	WOS:000282098100045
J	Fleming, SM; Weil, RS; Nagy, Z; Dolan, RJ; Rees, G				Fleming, Stephen M.; Weil, Rimona S.; Nagy, Zoltan; Dolan, Raymond J.; Rees, Geraint			Relating Introspective Accuracy to Individual Differences in Brain Structure	SCIENCE			English	Article							PREFRONTAL CORTEX; CONFIDENCE; MEMORY; DISCRIMINATION; INSIGHTS; DECISION; ANATOMY; CHOICE	The ability to introspect about self-performance is key to human subjective experience, but the neuroanatomical basis of this ability is unknown. Such accurate introspection requires discriminating correct decisions from incorrect ones, a capacity that varies substantially across individuals. We dissociated variation in introspective ability from objective performance in a simple perceptual-decision task, allowing us to determine whether this interindividual variability was associated with a distinct neural basis. We show that introspective ability is correlated with gray matter volume in the anterior prefrontal cortex, a region that shows marked evolutionary development in humans. Moreover, interindividual variation in introspective ability is also correlated with white-matter microstructure connected with this area of the prefrontal cortex. Our findings point to a focal neuroanatomical substrate for introspective ability, a substrate distinct from that supporting primary perception.	[Fleming, Stephen M.; Weil, Rimona S.; Nagy, Zoltan; Dolan, Raymond J.; Rees, Geraint] UCL, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England; [Weil, Rimona S.; Rees, Geraint] UCL, Inst Cognit Neurosci, London WC1N 3AR, England	University of London; University College London; University of London; University College London	Fleming, SM (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, 12 Queen Sq, London WC1N 3BG, England.	s.fleming@fil.ion.ucl.ac.uk	Fleming, Steve/A-9584-2010; Weil, Rimona S/B-6151-2009; Nagy, Zoltan/AAI-2485-2019; Rees, Geraint/C-1493-2008	Nagy, Zoltan/0000-0001-6611-6362; Rees, Geraint/0000-0002-9623-7007; Weil, Rimona/0000-0002-5092-6325; Fleming, Stephen/0000-0003-0233-4891; Dolan, Ray/0000-0001-9356-761X	Wellcome Trust; University College London; Medical Research Council; Medical Research Council [G0500743] Funding Source: researchfish; MRC [G0500743] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); University College London(General Electric); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by the Wellcome Trust (G. R., R.J.D., Z.N.), the University College London four-year Ph.D. program in neuroscience (S.M.F.), and the Medical Research Council (R. S. W.). We thank T. Sharot, G. Ridgway, and C. Frith for comments on earlier drafts of this manuscript.	Burgin GH, 2007, IEEE T EVOLUT COMPUT, V11, P290, DOI 10.1109/TEVC.2007.899730; Carreiras M, 2009, NATURE, V461, P983, DOI 10.1038/nature08461; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Cleeremans A, 2007, NEURAL NETWORKS, V20, P1032, DOI 10.1016/j.neunet.2007.09.011; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; DEL CUL A, 2009, BRAIN 9, V132, P2531; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Fleming SM, 2010, CONSCIOUS COGN, V19, P352, DOI 10.1016/j.concog.2009.11.002; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Fuentemilla L, 2009, J NEUROSCI, V29, P8698, DOI 10.1523/JNEUROSCI.5270-08.2009; Galvin SJ, 2003, PSYCHON B REV, V10, P843, DOI 10.3758/BF03196546; Graziano M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004909; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Kornbrot DE, 2006, PERCEPT PSYCHOPHYS, V68, P393, DOI 10.3758/BF03193685; Kunimoto C, 2001, CONSCIOUS COGN, V10, P294, DOI 10.1006/ccog.2000.0494; Lau HC, 2008, PROG BRAIN RES, V168, P35, DOI 10.1016/S0079-6123(07)68004-2; Lau HC, 2006, P NATL ACAD SCI USA, V103, P18763, DOI 10.1073/pnas.0607716103; METCALFE J, 2008, HDB METAMEMORY MEMOR, P27; Metcalfe J, 1996, METACOGNITION KNOWIN; Park HJ, 2008, HUM BRAIN MAPP, V29, P503, DOI 10.1002/hbm.20314; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Rounis E, 2010, COGN NEUROSCI-UK, V1, P165, DOI 10.1080/17588921003632529; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Shimamura AP, 2000, CONSCIOUS COGN, V9, P313, DOI 10.1006/ccog.2000.0450; Simons JS, 2010, CEREB CORTEX, V20, P479, DOI 10.1093/cercor/bhp116; Smith CD, 2007, NEUROBIOL AGING, V28, P1075, DOI 10.1016/j.neurobiolaging.2006.05.018; Szczepanowski R, 2007, J VISION, V7, DOI 10.1167/7.4.10; Titchener E. B., 1909, LECT EXPT PSYCHOL TH; Tuch DS, 2005, P NATL ACAD SCI USA, V102, P12212, DOI 10.1073/pnas.0407259102; Washburn DA, 2005, J GEN PSYCHOL, V132, P446, DOI 10.3200/GENP.132.4.446-461	31	482	485	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2010	329	5998					1541	1543		10.1126/science.1191883	http://dx.doi.org/10.1126/science.1191883			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650RK	20847276	Green Accepted, Green Published			2022-12-01	WOS:000281869000047
J	McKenna, NJ; O'Malley, BW				McKenna, Neil J.; O'Malley, Bert W.			SnapShot: Nuclear Receptors II	CELL			English	Editorial Material							SYSTEM		[McKenna, Neil J.; O'Malley, Bert W.] Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine	McKenna, NJ (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.			McKenna, Neil/0000-0001-6689-0104	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434] Funding Source: NIH RePORTER; NIDDK NIH HHS [U19-DK62434] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Auwerx J, 1999, CELL, V97, P161; Benoit G, 2006, PHARMACOL REV, V58, P798, DOI 10.1124/pr.58.4.10; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Duez H, 2009, J APPL PHYSIOL, V107, P1972, DOI 10.1152/japplphysiol.00570.2009; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Kim KW, 2009, MOL CELL ENDOCRINOL, V300, P132, DOI 10.1016/j.mce.2008.09.026; PEAREN MA, MOL ENDOCRINOL, DOI DOI 10.10.1210/ME.2010-0015; TREMBLAY AM, 2007, NUCL RECEPT SIGNAL, V3, pE9; Yin Lei, 2010, Nucl Recept Signal, V8, pe001, DOI 10.1621/nrs.08001	9	5	5	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 17	2010	142	6					986	U155		10.1016/j.cell.2010.08.041	http://dx.doi.org/10.1016/j.cell.2010.08.041			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650NA	20850017	Bronze			2022-12-01	WOS:000281855000021
J	Aigouy, B; Farhadifar, R; Staple, DB; Sagner, A; Roper, JC; Julicher, F; Eaton, S				Aigouy, Benoit; Farhadifar, Reza; Staple, Douglas B.; Sagner, Andreas; Roeper, Jens-Christian; Juelicher, Frank; Eaton, Suzanne			Cell Flow Reorients the Axis of Planar Polarity in the Wing Epithelium of Drosophila	CELL			English	Article							TISSUE MORPHOGENESIS; PROLIFERATION CONTROL; CADHERIN SUPERFAMILY; FAT; SHAPE; GENE; MUTATIONS; EXTENSION; MECHANISM; PACKING	Planar cell polarity (PCP) proteins form polarized cortical domains that govern polarity of external structures such as hairs and cilia in both vertebrate and invertebrate epithelia. The mechanisms that globally orient planar polarity are not understood, and are investigated here in the Drosophila wing using a combination of experiment and theory. Planar polarity arises during growth and PCP domains are initially oriented toward the well-characterized organizer regions that control growth and patterning. At pupal stages, the wing hinge contracts, subjecting wing-blade epithelial cells to anisotropic tension in the proximal-distal axis. This results in precise patterns of oriented cell elongation, cell rearrangement and cell division that elongate the blade proximo-distally and realign planar polarity with the proximal-distal axis. Mutation of the atypical Cadherin Dachsous perturbs the global polarity pattern by altering epithelial dynamics. This mechanism utilizes the cellular movements that sculpt tissues to align planar polarity with tissue shape.	[Farhadifar, Reza; Staple, Douglas B.; Juelicher, Frank] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Aigouy, Benoit; Sagner, Andreas; Roeper, Jens-Christian; Eaton, Suzanne] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society; Max Planck Society	Julicher, F (corresponding author), Max Planck Inst Phys Komplexer Syst, Noethnitzer Str 38, D-01187 Dresden, Germany.	julicher@pks.mpg.de; eaton@mpi-cbg.de	Julicher, Frank/B-1828-2009; /AAG-7913-2021; Eaton, Suzanne/D-7698-2017; Sagner, Andreas/AAF-6235-2020	Julicher, Frank/0000-0003-4731-9185; Eaton, Suzanne/0000-0002-8319-284X; Sagner, Andreas/0000-0001-5698-8191	Max Planck Gesellschaft; Fondation pour la Recherche Medicale; Boehringer Ingelheim Fonds	Max Planck Gesellschaft(Max Planck Society); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	This work represents a truly collaborative effort. Each author has contributed significantly to the findings and regular group discussions guided the development of the ideas presented here. The manuscript was written jointly by all authors. S.E., A.S., J.R., R.F., and F.J. were supported by the Max Planck Gesellschaft. B.A. was funded by the Fondation pour la Recherche Medicale. D.S. acknowledges the Natural Sciences and Engineering Research Council of Canada and the German Academic Exchange Service. J.R. was supported by a predoctoral fellowship from the Boehringer Ingelheim Fonds. We thank Tony Hyman and Stephan Grill for use of the laser cutting microscope. We are grateful to Stephan Grill, Ewa Paluch, Elisabeth Knust, and Carl-Philipp Heisenberg for critical comments on the manuscript. We thank David Strutt, Seth S.Blair, VDRC and the Bloomington Stock Center for providing fly stocks, Barry Dickson for DNA constructs, Julia Gabel for help with cloning, Sven Ssykor for transgenic injections.	Adler PN, 1998, DEVELOPMENT, V125, P959; Amonlirdviman K, 2005, SCIENCE, V307, P423, DOI 10.1126/science.1105471; Axelrod JD, 2009, SEMIN CELL DEV BIOL, V20, P964, DOI 10.1016/j.semcdb.2009.08.001; Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; BRYANT PJ, 1988, DEV BIOL, V129, P541, DOI 10.1016/0012-1606(88)90399-5; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000628; Butler LC, 2009, NAT CELL BIOL, V11, P859, DOI 10.1038/ncb1894; Casal J, 2006, DEVELOPMENT, V133, P4561, DOI 10.1242/dev.02641; Chen WS, 2008, CELL, V133, P1093, DOI 10.1016/j.cell.2008.04.048; Cho E, 2004, DEVELOPMENT, V131, P4489, DOI 10.1242/dev.01315; CLARK HF, 1995, GENE DEV, V9, P1530, DOI 10.1101/gad.9.12.1530; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; Classen Anne-Kathrin, 2008, V420, P265, DOI 10.1007/978-1-59745-583-1_16; Cortes S, 2006, BIOPHYS CHEM, V120, P168, DOI 10.1016/j.bpc.2005.11.002; Daga RR, 2008, J CELL SCI, V121, P1973, DOI 10.1242/jcs.011825; De Gennes P.G., 1993, INT SERIES MONOGRAPH, V83; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Garoia F, 2005, MECH DEVELOP, V122, P175, DOI 10.1016/j.mod.2004.10.007; Garoia F, 2000, MECH DEVELOP, V94, P95, DOI 10.1016/S0925-4773(00)00306-3; Haase SB, 2007, CURR BIOL, V17, pR249, DOI 10.1016/j.cub.2007.02.003; Ishikawa HO, 2008, SCIENCE, V321, P401, DOI 10.1126/science.1158159; Joanny JF, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/422; KELLER R, 1992, DEV DYNAM, V193, P199, DOI 10.1002/aja.1001930302; Keller R, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015007; Lawrence PA, 2007, NAT REV GENET, V8, P555, DOI 10.1038/nrg2125; Le Garrec JF, 2006, DEV DYNAM, V235, P235, DOI 10.1002/dvdy.20617; Lopez-Schier H, 2004, DEV CELL, V7, P401, DOI 10.1016/j.devcel.2004.07.018; Ma D, 2003, NATURE, V421, P543, DOI 10.1038/nature01366; Ma D, 2008, P NATL ACAD SCI USA, V105, P18800, DOI 10.1073/pnas.0808868105; Matakatsu H, 2004, DEVELOPMENT, V131, P3785, DOI 10.1242/dev.01254; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Shimada Y, 2006, DEV CELL, V10, P209, DOI 10.1016/j.devcel.2005.11.016; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Strauss B, 2006, DEVELOPMENT, V133, P3883, DOI 10.1242/dev.02578; Strutt H, 2005, BIOESSAYS, V27, P1218, DOI 10.1002/bies.20318; Strutt H, 2002, DEV CELL, V3, P851, DOI 10.1016/S1534-5807(02)00363-5; Strutt H, 2008, CURR BIOL, V18, P1555, DOI 10.1016/j.cub.2008.08.063; Tree DRP, 2002, CELL, V109, P371, DOI 10.1016/S0092-8674(02)00715-8; Tree DRP, 2002, SEMIN CELL DEV BIOL, V13, P217, DOI 10.1016/S1084-9521(02)00042-3; Uemura T, 2003, J BIOCHEM, V134, P625, DOI 10.1093/jb/mvg186; VILLANO JL, 1995, DEVELOPMENT, V121, P2767; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; VINSON CR, 1987, NATURE, V329, P549, DOI 10.1038/329549a0; Vladar EK, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002964; Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622; Wu J, 2008, DEV CELL, V15, P462, DOI 10.1016/j.devcel.2008.08.004; Wu J, 2009, TRENDS CELL BIOL, V19, P295, DOI 10.1016/j.tcb.2009.04.003; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050; Zeidler MP, 2000, DEV BIOL, V228, P181, DOI 10.1006/dbio.2000.9940	53	465	468	1	50	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 3	2010	142	5					773	786		10.1016/j.cell.2010.07.042	http://dx.doi.org/10.1016/j.cell.2010.07.042			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	646FL	20813263	Bronze			2022-12-01	WOS:000281523200020
J	Nowak, MA; Tarnita, CE; Wilson, EO				Nowak, Martin A.; Tarnita, Corina E.; Wilson, Edward O.			The evolution of eusociality	NATURE			English	Article							DIVISION-OF-LABOR; GROUP-SELECTION; KIN SELECTION; SOCIAL INTERACTIONS; INCLUSIVE FITNESS; COOPERATION; ALTRUISM; POLYMORPHISM; HYMENOPTERA; MULTILEVEL	Eusociality, in which some individuals reduce their own lifetime reproductive potential to raise the offspring of others, underlies the most advanced forms of social organization and the ecologically dominant role of social insects and humans. For the past four decades kin selection theory, based on the concept of inclusive fitness, has been the major theoretical attempt to explain the evolution of eusociality. Here we show the limitations of this approach. We argue that standard natural selection theory in the context of precise models of population structure represents a simpler and superior approach, allows the evaluation of multiple competing hypotheses, and provides an exact framework for interpreting empirical observations.	[Nowak, Martin A.; Tarnita, Corina E.] Harvard Univ, Dept Math, Dept Organism & Evolutionary Biol, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Wilson, Edward O.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	Harvard University; Harvard University	Nowak, MA (corresponding author), Harvard Univ, Dept Math, Dept Organism & Evolutionary Biol, Program Evolutionary Dynam, Cambridge, MA 02138 USA.	martin_nowak@harvard.edu	Chapuisat, Michel/T-8686-2017; Nowak, Martin A/A-6977-2008	Chapuisat, Michel/0000-0001-7207-199X; Alizon, Samuel/0000-0002-0779-9543	John Templeton Foundation; NSF/NIH [R01GM078986]; Bill and Melinda Gates Foundation [37874]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078986] Funding Source: NIH RePORTER	John Templeton Foundation; NSF/NIH(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. M. Horton for advice and help in preparing the manuscript. M.A.N. and C.E.T. gratefully acknowledge support from the John Templeton Foundation, the NSF/NIH joint program in mathematical biology (NIH grant R01GM078986), the Bill and Melinda Gates Foundation (Grand Challenges grant 37874), and J. Epstein.	Abouheif E, 2002, SCIENCE, V297, P249, DOI 10.1126/science.1071468; Antal T, 2009, P NATL ACAD SCI USA, V106, P8597, DOI 10.1073/pnas.0902528106; Bonabeau E, 1996, P ROY SOC B-BIOL SCI, V263, P1565, DOI 10.1098/rspb.1996.0229; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; Cole BJ, 1999, SCIENCE, V285, P891, DOI 10.1126/science.285.5429.891; Costa J., 2006, OTHER INSECT SOC; Cowan D.P., 1991, P33; Doebeli M, 2006, J EVOLUTION BIOL, V19, P1386, DOI 10.1111/j.1420-9101.2006.01157.x; Duffy J. Emmett, 2007, P387; Fletcher JA, 2004, J THEOR BIOL, V228, P303, DOI 10.1016/j.jtbi.2004.01.004; Fletcher JA, 2006, TRENDS ECOL EVOL, V21, P597, DOI 10.1016/j.tree.2006.08.008; Fletcher JA, 2009, P ROY SOC B-BIOL SCI, V276, P13, DOI 10.1098/rspb.2008.0829; Foster KR, 2005, TRENDS ECOL EVOL, V20, P363, DOI 10.1016/j.tree.2005.05.005; Frank SA., 1998, FDN SOCIAL EVOLUTION, DOI [10.1515/9780691206820, DOI 10.1515/9780691206820]; Gadagkar R, 2001, SOCIAL BIOL ROPALIDI; Grafen A, 2007, J EVOLUTION BIOL, V20, P2278, DOI 10.1111/j.1420-9101.2007.01413.x; Grafen A., 1984, BEHAV ECOLOGY EVOLUT, P62; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Holldobler B., 1990, pi; Hughes WOH, 2004, EVOLUTION, V58, P1251, DOI 10.1111/j.0014-3820.2004.tb01704.x; Hunt JH, 2007, P NATL ACAD SCI USA, V104, P14020, DOI 10.1073/pnas.0705660104; Hunt JH, 2005, SCIENCE, V308, P264, DOI 10.1126/science.1109724; Hunt JH, 2007, EVOLUTION SOCIAL WAS; Jeanson R, 2005, ANIM BEHAV, V70, P1183, DOI 10.1016/j.anbehav.2005.03.004; Johns PM, 2009, P NATL ACAD SCI USA, V106, P17452, DOI 10.1073/pnas.0907961106; Jones JC, 2004, SCIENCE, V305, P402, DOI 10.1126/science.1096340; Khila A, 2010, PHILOS T R SOC B, V365, P617, DOI 10.1098/rstb.2009.0257; Linksvayer TA, 2005, Q REV BIOL, V80, P317, DOI 10.1086/432266; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2006, P ROY SOC B-BIOL SCI, V273, P2249, DOI 10.1098/rspb.2006.3576; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Pepper JW, 2002, AM NAT, V160, P205, DOI 10.1086/341018; Queller DC, 1998, BIOSCIENCE, V48, P165, DOI 10.2307/1313262; Rheindt FE, 2005, INSECT SOC, V52, P163, DOI 10.1007/s00040-004-0787-4; ROBINSON GE, 1989, WESTV STUD, P61; Ross KG, 1998, P NATL ACAD SCI USA, V95, P14232, DOI 10.1073/pnas.95.24.14232; Rousset F.., 2004, GENETIC STRUCTURE SE; SAKAGAMI S. F., 1960, INSECTES SOCIAUX, V7, P57, DOI 10.1007/BF02225757; Sakagami S. F., 1987, Animal societies: theories and facts., P1; Schwander T, 2005, BEHAV ECOL SOCIOBIOL, V59, P215, DOI 10.1007/s00265-005-0027-6; Swenson W, 2000, P NATL ACAD SCI USA, V97, P9110, DOI 10.1073/pnas.150237597; Tarnita CE, 2009, J THEOR BIOL, V259, P570, DOI 10.1016/j.jtbi.2009.03.035; Tarnita CE, 2009, P NATL ACAD SCI USA, V106, P8601, DOI 10.1073/pnas.0903019106; Taylor PD, 2007, NATURE, V447, P469, DOI 10.1038/nature05784; Thorne BL, 2003, P NATL ACAD SCI USA, V100, P12808, DOI 10.1073/pnas.2133530100; Toth AL, 2007, SCIENCE, V318, P441, DOI 10.1126/science.1146647; Traulsen A, 2006, P NATL ACAD SCI USA, V103, P10952, DOI 10.1073/pnas.0602530103; Traulsen A, 2010, EVOLUTION, V64, P316, DOI 10.1111/j.1558-5646.2009.00899.x; van Veelen M, 2009, J THEOR BIOL, V259, P589, DOI 10.1016/j.jtbi.2009.04.019; Wade MJ, 2010, NATURE, V463, pE8, DOI 10.1038/nature08809; WADE MJ, 1976, P NATL ACAD SCI USA, V73, P4604, DOI 10.1073/pnas.73.12.4604; Wcislo WT, 1997, INSECT SOC, V44, P199, DOI 10.1007/s000400050041; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; West-Eberhard Mary Jane, 2003, pi; Wilson DS, 2008, AM SCI, V96, P380, DOI 10.1511/2008.74.1; Wilson DS, 2007, Q REV BIOL, V82, P327, DOI 10.1086/522809; Wilson E.O., 1975, P1; Wilson E.O., 1971, INSECT SOC; Wilson EO, 2008, BIOSCIENCE, V58, P17, DOI 10.1641/B580106; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P13367, DOI 10.1073/pnas.0505858102; Wolf JB, 2001, J EVOLUTION BIOL, V14, P347, DOI 10.1046/j.1420-9101.2001.00277.x	61	666	694	7	1043	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2010	466	7310					1057	1062		10.1038/nature09205	http://dx.doi.org/10.1038/nature09205			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20740005	Green Accepted			2022-12-01	WOS:000281203600030
J	Soria, C; Estermann, FE; Espantman, KC; O'Shea, CC				Soria, Conrado; Estermann, Fanny E.; Espantman, Kristen C.; O'Shea, Clodagh C.			Heterochromatin silencing of p53 target genes by a small viral protein	NATURE			English	Article							EARLY REGION 4; ADENOVIRUS MUTANT; TUMOR-SUPPRESSOR; CELLS; REPLICATION; METHYLATION; EXPRESSION; E1A; TRANSCRIPTION; ONYX-015	The transcription factor p53 (also known as TP53) guards against tumour and virus replication and is inactivated in almost all cancers. p53-activated transcription of target genes is thought to be synonymous with the stabilization of p53 in response to oncogenes and DNA damage. During adenovirus replication, the degradation of p53 by E1B-55k is considered essential for p53 inactivation, and is the basis for p53-selective viral cancer therapies. Here we reveal a dominant epigenetic mechanism that silences p53-activated transcription, irrespective of p53 phosphorylation and stabilization. We show that another adenoviral protein, E4-ORF3, inactivates p53 independently of E1B-55k by forming a nuclear structure that induces de novo H3K9me3 heterochromatin formation at p53 target promoters, preventing p53-DNA binding. This suppressive nuclear web is highly selective in silencing p53 promoters and operates in the backdrop of global transcriptional changes that drive oncogenic replication. These findings are important for understanding how high levels of wild-type p53 might also be inactivated in cancer as well as the mechanisms that induce aberrant epigenetic silencing of tumour-suppressor loci. Our study changes the longstanding definition of how p53 is inactivated in adenovirus infection and provides key insights that could enable the development of true p53-selective oncolytic viral therapies.	[Soria, Conrado; Estermann, Fanny E.; Espantman, Kristen C.; O'Shea, Clodagh C.] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA	Salk Institute	O'Shea, CC (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	oshea@salk.edu			Alliance of Cancer Gene Therapy; American Cancer Society; Sontag Foundation; Beckman Foundation; National Cancer Institute [R01CA137094]; NATIONAL CANCER INSTITUTE [R01CA137094] Funding Source: NIH RePORTER	Alliance of Cancer Gene Therapy; American Cancer Society(American Cancer Society); Sontag Foundation; Beckman Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Fitzpatrick and the Waitt Advanced Biophotonics Center for assistance with imaging and analysis, J. Karlseder, I. Verma, T. Hunter, R. Shaw and the O'Shea laboratory for critical reading of this manuscript, L. Haro, S. Panda, R. O'Sullivan and A. Rodriguez for advice and protocols, and P. Branton and D. Ornelles for viruses. C.C.O. acknowledges funding from the Alliance of Cancer Gene Therapy, the American Cancer Society, the Sontag Foundation and the Beckman Foundation. This work was supported by R01CA137094 from the National Cancer Institute.	Bachman KE, 2003, CANCER CELL, V3, P89, DOI 10.1016/S1535-6108(02)00234-9; BARKER DD, 1987, VIROLOGY, V156, P107, DOI 10.1016/0042-6822(87)90441-7; Berk AJ, 2005, ONCOGENE, V24, P7673, DOI 10.1038/sj.onc.1209040; Berriz GF, 2003, BIOINFORMATICS, V19, P2502, DOI 10.1093/bioinformatics/btg363; Bischoff JR, 1996, SCIENCE, V274, P373, DOI 10.1126/science.274.5286.373; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; CUTT JR, 1987, J VIROL, V61, P543, DOI 10.1128/JVI.61.2.543-552.1987; DEBBAS M, 1993, GENE DEV, V7, P546, DOI 10.1101/gad.7.4.546; Doucas V, 1996, GENE DEV, V10, P196, DOI 10.1101/gad.10.2.196; Downey T, 2006, METHOD ENZYMOL, V411, P256, DOI 10.1016/S0076-6879(06)11013-7; Eberhardy SR, 2001, J BIOL CHEM, V276, P48562, DOI 10.1074/jbc.M109014200; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x; HALBERT DN, 1985, J VIROL, V56, P250, DOI 10.1128/JVI.56.1.250-257.1985; Harada JN, 2002, J VIROL, V76, P9194, DOI 10.1128/JVI.76.18.9194-9206.2002; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; HUANG MM, 1989, J VIROL, V63, P2605, DOI 10.1128/JVI.63.6.2605-2615.1989; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johnson L, 2002, CANCER CELL, V1, P325, DOI 10.1016/S1535-6108(02)00060-0; JONES N, 1979, P NATL ACAD SCI USA, V76, P3665, DOI 10.1073/pnas.76.8.3665; Khuri FR, 2000, NAT MED, V6, P879, DOI 10.1038/78638; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Lane DP, 2005, COLD SH Q B, V70, P489, DOI 10.1101/sqb.2005.70.049; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; Levine AJ, 2009, VIROLOGY, V384, P285, DOI 10.1016/j.virol.2008.09.034; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; LOWE SW, 1993, GENE DEV, V7, P535, DOI 10.1101/gad.7.4.535; Maehara K, 2005, J CELL BIOL, V168, P553, DOI 10.1083/jcb.200411093; Marcellus RC, 1996, J VIROL, V70, P6207, DOI 10.1128/JVI.70.9.6207-6215.1996; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; McCormick F, 2003, CANCER BIOL THER, V2, pS157; O'Shea CC, 2005, ONCOGENE, V24, P7640, DOI 10.1038/sj.onc.1209047; O'Shea CC, 2005, CANCER CELL, V8, P61, DOI 10.1016/j.ccr.2005.06.009; O'Shea CC, 2004, CANCER CELL, V6, P611, DOI 10.1016/j.ccr.2004.11.012; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Ries SJ, 2000, NAT MED, V6, P1128, DOI 10.1038/80466; Shepard RN, 2003, J VIROL, V77, P8593, DOI 10.1128/JVI.77.15.8593-8595.2003; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang N, 2003, NANO LETT, V3, P475, DOI 10.1021/nl034019m; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; Yan B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r78; Yondola MA, 2007, J VIROL, V81, P4264, DOI 10.1128/JVI.02629-06	58	105	111	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2010	466	7310					1076	U85		10.1038/nature09307	http://dx.doi.org/10.1038/nature09307			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20740008	Green Accepted			2022-12-01	WOS:000281203600033
J	Huang, CS; Sadre-Bazzaz, K; Shen, Y; Deng, BB; Zhou, ZH; Tong, LA				Huang, Christine S.; Sadre-Bazzaz, Kianoush; Shen, Yang; Deng, Binbin; Zhou, Z. Hong; Tong, Liang			Crystal structure of the alpha(6)beta(6) holoenzyme of propionyl-coenzyme A carboxylase	NATURE			English	Article							ACETYL-COA CARBOXYLASE; BIOTIN CARBOXYLASE; CARBOXYLTRANSFERASE DOMAIN; PYRUVATE-CARBOXYLASE; FUNCTIONAL-ANALYSIS; CATALYTIC-ACTIVITY; MCCB MUTATIONS; A CARBOXYLASE; ACIDEMIA; SUBUNIT	Propionyl-coenzyme A carboxylase (PCC), a mitochondrial biotin-dependent enzyme, is essential for the catabolism of the amino acids Thr, Val, Ile and Met, cholesterol and fatty acids with an odd number of carbon atoms. Deficiencies in PCC activity in humans are linked to the disease propionic acidaemia, an autosomal recessive disorder that can be fatal in infants(1-4). The holoenzyme of PCC is an alpha(6)beta(6) dodecamer, with a molecular mass of 750 kDa. The alpha-subunit contains the biotin carboxylase (BC) and biotin carboxyl carrier protein (BCCP) domains, whereas the beta-subunit supplies the carboxyltransferase (CT) activity. Here we report the crystal structure at 3.2-angstrom resolution of a bacterial PCC alpha(6)beta(6) holoenzyme as well as cryo-electron microscopy (cryo-EM) reconstruction at 15-angstrom resolution demonstrating a similar structure for human PCC. The structure defines the overall architecture of PCC and reveals unexpectedly that the alpha-subunits are arranged as monomers in the holoenzyme, decorating a central beta(6) hexamer. A hitherto unrecognized domain in the alpha-subunit, formed by residues between the BC and BCCP domains, is crucial for interactions with the beta-subunit. We have named it the BT domain. The structure reveals for the first time the relative positions of the BC and CT active sites in the holoenzyme. They are separated by approximately 55 angstrom, indicating that the entire BCCP domain must translocate during catalysis. The BCCP domain is located in the active site of the beta-subunit in the current structure, providing insight for its involvement in the CT reaction. The structural information establishes a molecular basis for understanding the large collection of disease-causing mutations in PCC and is relevant for the holoenzymes of other biotin-dependent carboxylases, including 3-methylcrotonyl-CoA carboxylase (MCC)(5-7) and eukaryotic acetyl-CoA carboxylase (ACC)(8,9).	[Huang, Christine S.; Sadre-Bazzaz, Kianoush; Shen, Yang; Tong, Liang] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Deng, Binbin; Zhou, Z. Hong] Univ Texas Houston, Sch Med, Dept Pathol & Lab Med, Houston, TX 77030 USA; [Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA	Columbia University; University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California Los Angeles	Tong, LA (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ltong@columbia.edu	Zhou, Z Hong/HDN-0747-2022	Tong, Liang/0000-0002-0563-6468; Huang, Christine/0000-0003-4082-3880	National Institutes of Health [DK067238, GM071940, AI069015, GM08281]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071940, T32GM008281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Whalen and H. Robinson for access to the X29A beamline at the National Synchrotron Light Source; J. Schwanof and R. Abramowitz for access to the X4A beamline; M. Sampat for help during the initial stages of the project; and W. W. Cleland for discussions. This research was supported in part by National Institutes of Health grants DK067238 (to L. T.), GM071940 and AI069015 (to Z.H.Z.). C. S. H. was also supported by a National Institutes of Health training program in molecular biophysics (GM08281).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bilder P, 2006, BIOCHEMISTRY-US, V45, P1712, DOI 10.1021/bi0520479; Blanchard CZ, 1999, BIOCHEMISTRY-US, V38, P3393, DOI 10.1021/bi982660a; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chou CY, 2009, J BIOL CHEM, V284, P11690, DOI 10.1074/jbc.M805783200; Cronan JE, 2002, PROG LIPID RES, V41, P407, DOI 10.1016/S0163-7827(02)00007-3; Deodato F, 2006, AM J MED GENET C, V142C, P104, DOI 10.1002/ajmg.c.30090; Desviat LR, 2006, J HUM GENET, V51, P992, DOI 10.1007/s10038-006-0068-3; Desviat LR, 2003, MOL GENET METAB, V80, P315, DOI 10.1016/S1096-7192(03)00130-6; Desviat LR, 2004, MOL GENET METAB, V83, P28, DOI 10.1016/j.ymgme.2004.08.001; Diacovich L, 2004, BIOCHEMISTRY-US, V43, P14027, DOI 10.1021/bi049065v; Hall PR, 2003, EMBO J, V22, P2334, DOI 10.1093/emboj/cdg244; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Janiyani K, 2001, J BIOL CHEM, V276, P29864, DOI 10.1074/jbc.M104102200; Jiang H, 2005, J BIOL CHEM, V280, P27719, DOI 10.1074/jbc.M413281200; Jogl G, 2001, ACTA CRYSTALLOGR D, V57, P1127, DOI 10.1107/S0907444901006783; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lin TW, 2006, P NATL ACAD SCI USA, V103, P3072, DOI 10.1073/pnas.0510580103; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muro S, 2001, MOL GENET METAB, V74, P476, DOI 10.1006/mgme.2001.3254; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perez-Cerda C, 2003, BBA-MOL BASIS DIS, V1638, P43, DOI 10.1016/S0925-4439(03)00039-5; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rodriguez-Pombo P, 2005, BBA-MOL BASIS DIS, V1740, P489, DOI 10.1016/j.bbadis.2004.10.009; Shen Y, 2004, MOL CELL, V16, P881, DOI 10.1016/j.molcel.2004.11.034; Shen Y, 2006, MOL CELL, V22, P807, DOI 10.1016/j.molcel.2006.04.026; Sloane V, 2004, J BIOL CHEM, V279, P15772, DOI 10.1074/jbc.M311982200; St Maurice M, 2007, SCIENCE, V317, P1076, DOI 10.1126/science.1144504; Stadler SC, 2006, HUM MUTAT, V27, P748, DOI 10.1002/humu.20349; Stucki M, 2009, J BIOL CHEM, V284, P28953, DOI 10.1074/jbc.M109.050674; Thoden JB, 2000, J BIOL CHEM, V275, P16183, DOI 10.1074/jbc.275.21.16183; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; WALDROP GL, 1994, BIOCHEMISTRY-US, V33, P10249, DOI 10.1021/bi00200a004; Weatherly SC, 2004, BIOCHEM J, V380, P105, DOI 10.1042/BJ20031960; Wendt KS, 2003, EMBO J, V22, P3493, DOI 10.1093/emboj/cdg358; Xiang S, 2008, NAT STRUCT MOL BIOL, V15, P295, DOI 10.1038/nsmb.1393; Zhang HL, 2003, SCIENCE, V299, P2064, DOI 10.1126/science.1081366	39	64	70	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2010	466	7309					1001	U135		10.1038/nature09302	http://dx.doi.org/10.1038/nature09302			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640ED	20725044	Green Accepted			2022-12-01	WOS:000281030300040
J	Mulder, AM; Yoshioka, C; Beck, AH; Bunner, AE; Milligan, RA; Potter, CS; Carragher, B; Williamson, JR				Mulder, Anke M.; Yoshioka, Craig; Beck, Andrea H.; Bunner, Anne E.; Milligan, Ronald A.; Potter, Clinton S.; Carragher, Bridget; Williamson, James R.			Visualizing Ribosome Biogenesis: Parallel Assembly Pathways for the 30S Subunit	SCIENCE			English	Article							ESCHERICHIA-COLI; RNA; PROTEINS; RECONSTITUTION; LANDSCAPE; COMPLEXES; DYNAMICS	Ribosomes are self-assembling macromolecular machines that translate DNA into proteins, and an understanding of ribosome biogenesis is central to cellular physiology. Previous studies on the Escherichia coli 30S subunit suggest that ribosome assembly occurs via multiple parallel pathways rather than through a single rate-limiting step, but little mechanistic information is known about this process. Discovery single-particle profiling (DSP), an application of time-resolved electron microscopy, was used to obtain more than 1 million snapshots of assembling 30S subunits, identify and visualize the structures of 14 assembly intermediates, and monitor the population flux of these intermediates over time. DSP results were integrated with mass spectrometry data to construct the first ribosome-assembly mechanism that incorporates binding dependencies, rate constants, and structural characterization of populated intermediates.	[Beck, Andrea H.; Bunner, Anne E.; Williamson, James R.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Beck, Andrea H.; Bunner, Anne E.; Williamson, James R.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Beck, Andrea H.; Bunner, Anne E.; Williamson, James R.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Mulder, Anke M.; Yoshioka, Craig; Milligan, Ronald A.; Potter, Clinton S.; Carragher, Bridget] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Williamson, JR (corresponding author), Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA.	jrwill@scripps.edu	Yoshioka, Craig/ABH-3720-2020; Williamson, James/AAL-2104-2021; Williamson, James R/B-2891-2009	Williamson, James/0000-0002-8772-468X; Williamson, James R/0000-0002-8772-468X; Bunner, Anne/0000-0002-0305-1300; Carragher, Bridget/0000-0002-0624-5020	NIH [RR175173, R37-GM-53757, GM-52468]; NSF; NIH through the National Center for Research Resources [RR175173, RR023093]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573, R01RR023093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053757, R37GM052468, R01GM052468] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NIH through the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH (grants RR175173, R37-GM-53757, and GM-52468) and the NSF (graduate research fellowship to A. M. M.). The EM data collection and analysis were conducted at the National Resource for Automated Molecular Microscopy, which is supported by the NIH through the National Center for Research Resources P41 program (grants RR175173 and RR023093). We thank N. R. Voss and members of the Automated Molecular Imaging and Williamson laboratories for critical discussion of experiments. MAP, structure factors, and layer-line data have been deposited at EMDB with accession code EMD-1783.	Adilakshmi T, 2008, NATURE, V455, P1268, DOI 10.1038/nature07298; Bunner AE, 2010, J MOL BIOL, V398, P1, DOI 10.1016/j.jmb.2010.02.036; Bunner AE, 2010, P NATL ACAD SCI USA, V107, P5417, DOI 10.1073/pnas.0912007107; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Frank J, 2006, 3 DIMENSIONAL ELECT; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; MANDIYAN V, 1991, P NATL ACAD SCI USA, V88, P8174, DOI 10.1073/pnas.88.18.8174; MIZUSHIMA S, 1970, NATURE, V226, P1214, DOI 10.1038/2261214a0; NIERHAUS KH, 1974, P NATL ACAD SCI USA, V71, P4713, DOI 10.1073/pnas.71.12.4713; NOMURA M, 1973, SCIENCE, V179, P864, DOI 10.1126/science.179.4076.864; PAULING L, 1968, P NATL ACAD SCI USA, V60, P59, DOI 10.1073/pnas.60.1.59; POWERS T, 1993, J MOL BIOL, V232, P362, DOI 10.1006/jmbi.1993.1396; Ruiz Teresa, 2006, V319, P403; SERDYUK IN, 1983, J MOL BIOL, V169, P409, DOI 10.1016/S0022-2836(83)80058-8; Sharma MR, 2005, MOL CELL, V18, P319, DOI 10.1016/j.molcel.2005.03.028; Talkington MWT, 2005, NATURE, V438, P628, DOI 10.1038/nature04261; Zhang W, 2008, STRUCTURE, V16, P1770, DOI 10.1016/j.str.2008.10.011	17	144	148	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 29	2010	330	6004					673	677		10.1126/science.1193220	http://dx.doi.org/10.1126/science.1193220			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672KB	21030658	Green Accepted			2022-12-01	WOS:000283580600049
J	Moreno, JD				Moreno, Jonathan D.			Long shadow of the stem-cell ruling	NATURE			English	Editorial Material									Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Moreno, JD (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.								0	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 28	2010	467	7319					1031	1032		10.1038/4671031a	http://dx.doi.org/10.1038/4671031a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	671XW	20981069				2022-12-01	WOS:000283548600013
J	Ripatti, S; Tikkanen, E; Orho-Melander, M; Havulinna, AS; Silander, K; Sharma, A; Guiducci, C; Perola, M; Jula, A; Sinisalo, J; Lokki, ML; Nieminen, MS; Melander, O; Salomaa, V; Peltonen, L; Kathiresan, S				Ripatti, Samuli; Tikkanen, Emmi; Orho-Melander, Marju; Havulinna, Aki S.; Silander, Kaisa; Sharma, Amitabh; Guiducci, Candace; Perola, Markus; Jula, Antti; Sinisalo, Juha; Lokki, Marja-Liisa; Nieminen, Markku S.; Melander, Olle; Salomaa, Veikko; Peltonen, Leena; Kathiresan, Sekar			A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses	LANCET			English	Article							HOSPITAL DISCHARGE REGISTER; CARDIOVASCULAR EVENTS; PREDICTIVE ABILITY; ROC CURVE; RECLASSIFICATION; STATISTICS; MARKER; AREA	Background Comparison of patients with coronary heart disease and controls in genome-wide association studies has revealed several single nucleotide polymorphisms (SNPs) associated with coronary heart disease. We aimed to establish the external validity of these findings and to obtain more precise risk estimates using a prospective cohort design. Methods We tested 13 recently discovered SNPs for association with coronary heart disease in a case-control design including participants differing from those in the discovery samples (3829 participants with prevalent coronary heart disease and 48 897 controls free of the disease) and a prospective cohort design including 30 725 participants free of cardiovascular disease from Finland and Sweden. We modelled the 13 SNPs as a multilocus genetic risk score and used Cox proportional hazards models to estimate the association of genetic risk score with incident coronary heart disease. For case-control analyses we analysed associations between individual SNPs and quintiles of genetic risk score using logistic regression. Findings In prospective cohort analyses, 1264 participants had a first coronary heart disease event during a median 10.7 years' follow-up (IQR 6.7-13.6). Genetic risk score was associated with a first coronary heart disease event. When compared with the bottom quintile of genetic risk score, participants in the top quintile were at 1.66-times increased risk of coronary heart disease in a model adjusting for traditional risk factors (95% CI 1.35-2.04, p value for linear trend=7.3x10(-10)). Adjustment for family history did not change these estimates. Genetic risk score did not improve C index over traditional risk factors and family history (p=0.19), nor did it have a significant effect on net reclassification improvement (2.2%, p=0.18); however, it did have a small effect on integrated discrimination index (0.004, p=0.0006). Results of the case-control analyses were similar to those of the prospective cohort analyses. Interpretation Using a genetic risk score based on 13 SNPs associated with coronary heart disease, we can identify the 20% of individuals of European ancestry who are at roughly 70% increased risk of a first coronary heart disease event. The potential clinical use of this panel of SNPs remains to be defined.	[Ripatti, Samuli; Tikkanen, Emmi; Silander, Kaisa; Peltonen, Leena] Univ Helsinki, FIMM, FIM-00014 Helsinki, Finland; [Ripatti, Samuli; Tikkanen, Emmi; Havulinna, Aki S.; Silander, Kaisa; Perola, Markus; Jula, Antti; Salomaa, Veikko; Peltonen, Leena] Natl Inst Hlth & Welf, Helsinki, Finland; [Orho-Melander, Marju; Sharma, Amitabh; Melander, Olle] Lund Univ, Dept Clin Sci Malmo, Malmo, Sweden; [Guiducci, Candace; Peltonen, Leena; Kathiresan, Sekar] Broad Inst, Cambridge, MA USA; [Sinisalo, Juha; Nieminen, Markku S.] Helsinki Univ Cent Hosp, Dept Med, Div Cardiol, Helsinki, Finland; [Lokki, Marja-Liisa] Univ Helsinki, Haartman Inst, Transplantat Lab, FIM-00014 Helsinki, Finland; [Peltonen, Leena] Wellcome Trust Sanger Inst, Hinxton, England; [Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Kathiresan, Sekar] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA	University of Helsinki; Finland National Institute for Health & Welfare; Lund University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Wellcome Trust Sanger Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Ripatti, S (corresponding author), Univ Helsinki, FIMM, POB 20, FIM-00014 Helsinki, Finland.	samuli.ripatti@fimm.fi	Havulinna, Aki/AAM-4769-2021; Ripatti, Samuli/H-9446-2014	Ripatti, Samuli/0000-0002-0504-1202; Perola, Markus/0000-0003-4842-1667; Melander, Olle/0000-0002-2581-484X; Sinisalo, Juha/0000-0002-0169-5137	Merck; Daiichi Sankyo; Alnylam; Pfizer; Wellcome Trust [WT089062/Z/097Z, WT089061/Z/09/Z]; US National Institutes of Health [R01 HL087676]; Donovan Family Foundation; Center of Excellence for Complex Disease Genetics of the Academy of Finland [213506, 129680]; Biocentrum Helsinki Foundation; Nordic Center of Excellence in Disease Genetics; Academy of Finland [129494]; Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation; Finnish Academy [129322]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087676] Funding Source: NIH RePORTER	Merck(Merck & Company); Daiichi Sankyo(Daiichi Sankyo Company Limited); Alnylam; Pfizer(Pfizer); Wellcome Trust(Wellcome TrustEuropean Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donovan Family Foundation; Center of Excellence for Complex Disease Genetics of the Academy of Finland(Academy of Finland); Biocentrum Helsinki Foundation; Nordic Center of Excellence in Disease Genetics; Academy of Finland(Academy of Finland); Finnish Foundation for Cardiovascular Research; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Academy(Academy of Finland); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	SK has received consultancy fees from Merck and Daiichi Sankyo and grants from Alnylam and Pfizer. All other authors declare that they have no conflicts of interest.; We wish to dedicate this paper to the memory of Leena Peltonen, who passed away on March 11, 2010. This work was supported by the Wellcome Trust (WT089062/Z/097Z, WT089061/Z/09/Z), US National Institutes of Health (R01 HL087676), and the Donovan Family Foundation. We thank David Altshuler for guidance and helpful suggestions regarding study design and analyses. LP was supported by the Center of Excellence for Complex Disease Genetics of the Academy of Finland (grants 213506, 129680), the Biocentrum Helsinki Foundation, and The Nordic Center of Excellence in Disease Genetics. VS is supported by the Academy of Finland (grant number 129494), the Finnish Foundation for Cardiovascular Research, and the Sigrid Juselius Foundation. JS was funded by Finnish Foundation for Cardiovascular Research, Special governmental subsidy for health sciences research (EVO). MP was supported by Finnish Foundation for Cardiovascular Research and Finnish Academy Salve Program, grant number 129322	Antolini L, 2004, COMMUN STAT-THEOR M, V33, P2117, DOI 10.1081/STA-200026579; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Cook NR, 2008, STAT MED, V27, P191, DOI 10.1002/sim.2987; Erdmann J, 2009, NAT GENET, V41, P280, DOI 10.1038/ng.307; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Healy DG, 2006, LANCET NEUROL, V5, P701, DOI 10.1016/S1474-4422(06)70524-5; Heistaro S., 2008, METHODOLOGY REPORT H; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kattainen A, 2006, EUR HEART J, V27, P296, DOI 10.1093/eurheartj/ehi630; Langholz B, 1996, STAT SCI, V11, P35; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; Musunuru K, 2010, ANNU REV GENOM HUM G, V11, P91, DOI 10.1146/annurev-genom-082509-141637; Olkin I, 2014, STAT METHODS METAANA; Pajunen P, 2005, EUR J CARDIOV PREV R, V12, P132, DOI 10.1097/00149831-200504000-00007; Paynter NP, 2010, JAMA-J AM MED ASSOC, V303, P631, DOI 10.1001/jama.2010.119; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Persson M, 2007, ARTERIOSCL THROM VAS, V27, P1411, DOI 10.1161/ATVBAHA.107.142679; SAMANI NJ, 2007, NEW ENGL J MED, V357, P1; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Steyerberg EW, 2010, ANN INTERN MED, V152, P195, DOI 10.7326/0003-4819-152-3-201002020-00019; Tolonen H, 2007, EUR J CARDIOV PREV R, V14, P380, DOI 10.1097/01.hjr.0000239466.26132.f2; VARTIAINEN E, 2009, INT J EPIDEMIOL, V12, P1; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249	29	397	417	0	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 23	2010	376	9750					1393	1400		10.1016/S0140-6736(10)61267-6	http://dx.doi.org/10.1016/S0140-6736(10)61267-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672ZO	20971364	Green Published			2022-12-01	WOS:000283627500034
J	Mega, JL; Close, SL; Wiviott, SD; Shen, L; Walker, JR; Simon, T; Antman, EM; Braunwald, E; Sabatine, MS				Mega, Jessica L.; Close, Sandra L.; Wiviott, Stephen D.; Shen, Lei; Walker, Joseph R.; Simon, Tabassome; Antman, Elliott M.; Braunwald, Eugene; Sabatine, Marc S.			Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis	LANCET			English	Article							PERCUTANEOUS CORONARY INTERVENTION; OF-FUNCTION POLYMORPHISM; DUODENAL ENTEROCYTES; PLATELET INHIBITION; STENT THROMBOSIS; P-GLYCOPROTEIN; MDR1 GENE; EXPRESSION; RESPONSIVENESS; THROMBOLYSIS	Background Clopidogrel and prasugrel are subject to efflux via P-glycoprotein (encoded by ABCB1, also known as MDR1). ABCB1 polymorphisms, particularly 3435C -> T, may affect drug transport and efficacy. We aimed to assess the effect of this polymorphism by itself and alongside variants in CYP2C/9 on cardiovascular outcomes in patients treated with clopidogrel or prasugrel in TRITON-TIMI 38. We also assessed the effect of genotype on the pharmacodynamic and pharmacoldnetic properties of these drugs in healthy individuals. Methods We genotyped ABCB1 in 2932 patients with acute coronary syndromes undergoing percutaneous intervention who were treated with clopidogrel (n=1471) or prasugrel (n=1461) in the TRITON -> TIMI 38 trial. We evaluated the association between ABCB1 3435C -> T and rates of the primary efficacy endpoint (cardiovascular death, myocardial infarction, or stroke) until 15 months. We then assessed the combined effect of ABCB13435C -> T genotype and reduced-function alleles of CYP2C19. 321 healthy individuals were also genotyped, and we tested the association of genetic variants with reduction in maximum platelet aggregation and plasma concentrations of active drug metabolites. Findings In patients treated with clopidogrel, ABCB1 3435C -> T genotype was significantly associated with the risk of cardiovascular death, myocardial infarction, or stroke (p=0.0064). TT homozygotes had a 72% increased risk of the primary endpoint compared with CT/CC individuals (Kaplan-Meier event rates 12.9% [52 of 414] vs 7.8% [80 of 1057 participants]; HR 1.72, 95% CI 1.22-2.44, p=0.002). ABCB1 3435C -> T and CYP2C19 genotypes were significant, independent predictors of the primary endpoint, and 681 (47%) of the 1454 genotyped patients taking clopidogrel who were either CYP2C19 reduced-function allele carriers, ABCB1 3435 TT homozygotes, or both were at increased risk of the primary endpoint (HR 1.97, 95% CI 1.38-2.82, p=0.0002). In healthy participants, 3435 TT homozygotes had an absolute reduction in maximum platelet aggregation with clopidogrel that was 7.3 percentage points less than for CT/CC individuals (p=0.0127). ABCB1 genotypes were not significantly associated with clinical or pharmacological outcomes in patients with an acute coronary syndrome or healthy individuals treated with prasugrel, respectively. Interpretation Individuals with the ABCB1 3435 TT genotype have reduced platelet inhibition and are at increased risk of recurrent ischaemic events during clopidogrel treatment. In patients with acute coronary syndromes who have undergone percutaneous intervention, when both ABCB1 and CYP2C19 are taken into account, nearly half of the population carries a genotype associated with increased risk of major adverse cardiovascular events while on standard doses of clopidogrel.	[Mega, Jessica L.; Wiviott, Stephen D.; Antman, Elliott M.; Braunwald, Eugene] Brigham & Womens Hosp, TIMI Study Grp, Div Cardiovasc, Boston, MA 02115 USA; [Mega, Jessica L.; Wiviott, Stephen D.; Antman, Elliott M.; Braunwald, Eugene; Sabatine, Marc S.] Harvard Univ, Sch Med, Boston, MA USA; [Close, Sandra L.] Indiana Univ, Indianapolis, IN 46204 USA; [Close, Sandra L.; Shen, Lei] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Walker, Joseph R.] Daiichi Sankyo Inc, Edison, NJ USA; [Simon, Tabassome] Univ Paris 06, AP HP, F-75252 Paris 05, France	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Indiana University System; Indiana University-Purdue University Indianapolis; Eli Lilly; Daiichi Sankyo Company Limited; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite	Mega, JL (corresponding author), Brigham & Womens Hosp, TIMI Study Grp, Div Cardiovasc, 350 Longwood Ave, Boston, MA 02115 USA.	jmega@partners.org; msabatine@partners.org	Sabatine, Marc/AAJ-6751-2020	Sabatine, Marc/0000-0002-0691-3359; SIMON, Tabassome/0000-0002-4550-0450	Daiichi Sankyo; Eli Lilly; Sanofi-Aventis; Bristol-Myers Squibb; AstraZeneca; Schering-Plough/Merck; Johnson Johnson; Bayer Healthcare; National Institutes of Health [K99/R00 HL098461-01]; ARENA; Medco; Portola; Schering-Plough; Servier; Pfizer; Caisse d'Assurance Maladie; Merck; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL098461, R00HL098461] Funding Source: NIH RePORTER	Daiichi Sankyo(Daiichi Sankyo Company Limited); Eli Lilly(Eli Lilly); Sanofi-Aventis(Sanofi-Aventis); Bristol-Myers Squibb(Bristol-Myers Squibb); AstraZeneca(AstraZeneca); Schering-Plough/Merck(Merck & CompanySchering Plough Corporation); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARENA(Australian Renewable Energy Agency (ARENA)); Medco; Portola; Schering-Plough(Merck & CompanySchering Plough Corporation); Servier(Servier); Pfizer(Pfizer); Caisse d'Assurance Maladie; Merck(Merck & Company); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The TIMI Study Group receives research grant support from Daiichi Sankyo, Eli Lilly, Sanofi-Aventis, Bristol-Myers Squibb, AstraZeneca, Schering-Plough/Merck, Johnson & Johnson, and Bayer Healthcare. Additionally, JLM is supported in part by grant K99/R00 HL098461-01 from the National Institutes of Health and reports consulting fees from Sanofi-Aventis, Bristol-Myers Squibb, and AstraZeneca. SDW reports consulting fees from Sanofi-Aventis, Bristol-Myers Squibb, AstraZeneca, ARENA, Medco, and Portola, and lecture fees for CME from Schering-Plough, Daiichi Sanity, Eli Lilly, Novartis, and AstraZeneca. TS reports research grant support from Servier, Pfizer, Daiichi Sankyo, Eli Lilly, Sanofi-Aventis, AstraZeneca, and Caisse d'Assurance Maladie and consulting fees from Eli Lilly, Daiichi Sankyo, Sanofi-Aventis, Bristol-Myers Squibb, and AstraZeneca. EMA has no additional relationships to disclose. EB reports consulting fees from Daiichi Sankyo and lecture fees from Schering-Plough and Merck. MSS reports consulting fees from AstraZeneca, Bristol-Myers Squibb, Sanofi-Aventis, Daiichi Sanity, and Eli Lilly and lecture fees from Bristol-Myers Squibb, Sanofi-Aventis, and Eli Lilly. JRW is an employee of Daiichi Sanity and holds equity ownership or stock options therein. SLC is a former employee of Eli Lilly and holds equity ownership or stock options therein. LS is an employee of Eli Lilly and holds equity ownership or stock options therein.	Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; Anderson JL, 2009, J AM COLL CARDIOL, V53, pA27; Brandt JT, 2007, J THROMB HAEMOST, V5, P2429, DOI 10.1111/j.1538-7836.2007.02775.x; Collet JP, 2009, LANCET, V373, P309, DOI 10.1016/S0140-6736(08)61845-0; Dumaual C, 2007, PHARMACOGENOMICS, V8, P293, DOI 10.2217/14622416.8.3.293; Farid NA, 2007, RAPID COMMUN MASS SP, V21, P169, DOI 10.1002/rcm.2813; Fontana P, 2007, J THROMB HAEMOST, V5, P2153, DOI 10.1111/j.1538-7836.2007.02722.x; Giusti B, 2009, AM J CARDIOL, V103, P806, DOI 10.1016/j.amjcard.2008.11.048; Gladding P, 2008, JACC-CARDIOVASC INTE, V1, P620, DOI 10.1016/j.jcin.2008.09.008; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Hochholzer W, 2006, J AM COLL CARDIOL, V48, P1742, DOI 10.1016/j.jacc.2006.06.065; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663; Mega JL, 2009, CIRCULATION, V119, P2553, DOI 10.1161/CIRCULATIONAHA.109.851949; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Moriya Y, 2002, BIOL PHARM BULL, V25, P1356, DOI 10.1248/bpb.25.1356; Nakamura T, 2002, CLIN PHARMACOL THER, V71, P297, DOI 10.1067/mcp.2002.122055; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Sibbing D, 2009, EUR HEART J, V30, P916, DOI 10.1093/eurheartj/ehp041; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Taubert D, 2006, CLIN PHARMACOL THER, V80, P486, DOI 10.1016/j.clpt.2006.07.007; Trenk D, 2008, J AM COLL CARDIOL, V51, P1925, DOI 10.1016/j.jacc.2007.12.056; Wiviott SD, 2008, LANCET, V371, P1353, DOI 10.1016/S0140-6736(08)60422-5; Wiviott SD, 2007, CIRCULATION, V116, P2923, DOI 10.1161/CIRCULATIONAHA.107.740324; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Wiviott SD, 2006, AM HEART J, V152, P627, DOI 10.1016/j.ahj.2006.04.012; Zhou SF, 2008, CURR DRUG METAB, V9, P738, DOI 10.2174/138920008786049302	29	469	506	0	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 16	2010	376	9749					1312	1319		10.1016/S0140-6736(10)61273-1	http://dx.doi.org/10.1016/S0140-6736(10)61273-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671RX	20801494	Green Accepted			2022-12-01	WOS:000283528600033
J	Smoot, GF				Smoot, George F.			Thinking in aeons	NATURE			English	Editorial Material									Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Smoot, GF (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA.								0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2010	467	7317					S12	S12		10.1038/467S12a	http://dx.doi.org/10.1038/467S12a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	663PB	20944612	Bronze			2022-12-01	WOS:000282898700011
J	Wiegand, KC; Shah, SP; Al-Agha, OM; Zhao, YJ; Tse, K; Zeng, T; Senz, J; McConechy, MK; Anglesio, MS; Kalloger, SE; Yang, W; Heravi-Moussavi, A; Giuliany, R; Chow, C; Fee, J; Zayed, A; Prentice, L; Melnyk, N; Turashvili, G; Delaney, AD; Madore, J; Yip, S; McPherson, AW; Ha, G; Bell, L; Fereday, S; Tam, A; Galletta, L; Tonin, PN; Provencher, D; Miller, D; Jones, SJM; Moore, RA; Morin, GB; Oloumi, A; Boyd, N; Aparicio, SA; Shih, IM; Mes-Masson, AM; Bowtell, DD; Hirst, M; Gilks, B; Marra, MA; Huntsman, DG				Wiegand, Kimberly C.; Shah, Sohrab P.; Al-Agha, Osama M.; Zhao, Yongjun; Tse, Kane; Zeng, Thomas; Senz, Janine; McConechy, Melissa K.; Anglesio, Michael S.; Kalloger, Steve E.; Yang, Winnie; Heravi-Moussavi, Alireza; Giuliany, Ryan; Chow, Christine; Fee, John; Zayed, Abdalnasser; Prentice, Leah; Melnyk, Nataliya; Turashvili, Gulisa; Delaney, Allen D.; Madore, Jason; Yip, Stephen; McPherson, Andrew W.; Ha, Gavin; Bell, Lynda; Fereday, Sian; Tam, Angela; Galletta, Laura; Tonin, Patricia N.; Provencher, Diane; Miller, Dianne; Jones, Steven J. M.; Moore, Richard A.; Morin, Gregg B.; Oloumi, Arusha; Boyd, Niki; Aparicio, Samuel A.; Shih, Ie-Ming; Mes-Masson, Anne-Marie; Bowtell, David D.; Hirst, Martin; Gilks, Blake; Marra, Marco A.; Huntsman, David G.			ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLEAR-CELL CARCINOMA; DISTINCT-HISTOLOGIC-TYPE; GRADE SEROUS CARCINOMA; POOR-PROGNOSIS; MECHANISMS; EXPRESSION; RESISTANCE; CANCER; COMPONENT; STAGE	BACKGROUND Ovarian clear-cell and endometrioid carcinomas may arise from endometriosis, but the molecular events involved in this transformation have not been described. METHODS We sequenced the whole transcriptomes of 18 ovarian clear-cell carcinomas and 1 ovarian clear-cell carcinoma cell line and found somatic mutations in ARID1A (the AT-rich interactive domain 1A [SWI-like] gene) in 6 of the samples. ARID1A encodes BAF250a, a key component of the SWI-SNF chromatin remodeling complex. We sequenced ARID1A in an additional 210 ovarian carcinomas and a second ovarian clear-cell carcinoma cell line and measured BAF250a expression by means of immunohistochemical analysis in an additional 455 ovarian carcinomas. RESULTS ARID1A mutations were seen in 55 of 119 ovarian clear-cell carcinomas (46%), 10 of 33 endometrioid carcinomas (30%), and none of the 76 high-grade serous ovarian carcinomas. Seventeen carcinomas had two somatic mutations each. Loss of the BAF250a protein correlated strongly with the ovarian clear-cell carcinoma and endometrioid carcinoma subtypes and the presence of ARID1A mutations. In two patients, ARID1A mutations and loss of BAF250a expression were evident in the tumor and contiguous atypical endometriosis but not in distant endometriotic lesions. CONCLUSIONS These data implicate ARID1A as a tumor-suppressor gene frequently disrupted in ovarian clear-cell and endometrioid carcinomas. Since ARID1A mutation and loss of BAF250a can be seen in the preneoplastic lesions, we speculate that this is an early event in the transformation of endometriosis into cancer.	[Huntsman, David G.] BC Canc Agcy, Ctr Translat & Appl Genom, Vancouver, BC, Canada; [Zhao, Yongjun; Tse, Kane; Zeng, Thomas; Delaney, Allen D.; Tam, Angela; Jones, Steven J. M.; Moore, Richard A.; Morin, Gregg B.; Hirst, Martin; Marra, Marco A.] Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Fee, John; Turashvili, Gulisa; Oloumi, Arusha; Aparicio, Samuel A.] BC Canc Res Ctr, Vancouver, BC, Canada; [Chow, Christine; Gilks, Blake; Huntsman, David G.] Genet Pathol Evaluat Ctr, Vancouver, BC, Canada; [Wiegand, Kimberly C.; Miller, Dianne; Morin, Gregg B.; Aparicio, Samuel A.; Gilks, Blake; Marra, Marco A.; Huntsman, David G.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Morin, Gregg B.; Marra, Marco A.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [Madore, Jason; Provencher, Diane; Mes-Masson, Anne-Marie] CHU Montreal, Hop Notre Dame, Inst Canc Montreal, Ctr Rech, Montreal, PQ, Canada; [Tonin, Patricia N.] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Provencher, Diane; Mes-Masson, Anne-Marie] Univ Montreal, Montreal, PQ, Canada; [Fereday, Sian; Galletta, Laura; Bowtell, David D.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Bowtell, David D.] Univ Melbourne, Melbourne, Vic, Australia; [Shih, Ie-Ming] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	British Columbia Cancer Agency; British Columbia Cancer Agency; University of British Columbia; Simon Fraser University; Universite de Montreal; McGill University; Universite de Montreal; Peter Maccallum Cancer Center; University of Melbourne; Johns Hopkins University	Huntsman, DG (corresponding author), BC Canc Agcy, Ctr Translat & Appl Genom, Rm 3427,600 W 10th Ave, Vancouver, BC, Canada.	dhuntsma@bccancer.bc.ca	Ha, Gavin/N-1984-2019; Hirst, Martin/B-7684-2016; Jones, Steven J/C-3621-2009; Bowtell, David/H-1007-2016; Huntsman, David/ABE-6082-2020; Morin, Gregg B/E-9123-2012; Marra, Marco A/B-5987-2008; sdsd, shihieih/ABE-6190-2020; Yip, Stephen/E-9994-2012	Ha, Gavin/0000-0001-7578-7272; Jones, Steven J/0000-0003-3394-2208; Bowtell, David/0000-0001-9089-7525; Morin, Gregg B/0000-0001-8949-4374; Marra, Marco A/0000-0001-7146-7175; Yip, Stephen/0000-0002-8514-9861; Turashvili, Gulisa/0000-0001-6125-5865; Fereday, Sian/0000-0002-8559-8579; Madore, Jason/0000-0002-3499-474X; Anglesio, Michael/0000-0003-1639-5003; Aparicio, Samuel/0000-0002-0487-9599; Mes-Masson, Anne-Marie/0000-0002-6498-266X	British Columbia (BC) Cancer Foundation; Vancouver General Hospital (VGH)-University of British Columbia Hospital Foundation; Canadian Institutes of Health Research (CIHR); Genome Canada; OvCaRe; Michael Smith Foundation for Health Research (MSFHR); CIHR [STP-53912]; Canadian Breast Cancer Foundation; Canada Research Chair in Molecular Oncology; Sanofi-Aventis, Canada; Ovarian Cancer Canada; U.S. Army Medical Research and Materiel Command [DAMD17-O1-1-0729]; Cancer Council Tasmania; Cancer Foundation of Western Australia; National Health and Medical Research Council of Australia; National Cancer Institute, National Institutes of Health [RO1CA103937, RO1CA129080]; NATIONAL CANCER INSTITUTE [R01CA129080, R01CA103937] Funding Source: NIH RePORTER	British Columbia (BC) Cancer Foundation; Vancouver General Hospital (VGH)-University of British Columbia Hospital Foundation; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); OvCaRe; Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Canada Research Chair in Molecular Oncology(Canada Research Chairs); Sanofi-Aventis, Canada(Sanofi-Aventis); Ovarian Cancer Canada; U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Cancer Council Tasmania(Cancer Council Tasmania); Cancer Foundation of Western Australia(Cancer Council Western Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the British Columbia (BC) Cancer Foundation and the Vancouver General Hospital (VGH)-University of British Columbia Hospital Foundation (to the OvCaRe ovarian cancer research team in Vancouver) and the Canadian Institutes of Health Research (CIHR). The Michael Smith Genome Sciences Centre (MSGSC), with which many of the authors are affiliated, is funded by Genome Canada, and OvCaRe and the MSGSC are also funded by the Michael Smith Foundation for Health Research (MSFHR). Salary support is provided by MSFHR to Drs. Shah, Marra, Jones, and Huntsman; by the CIHR Training Program for Clinician Scientists in Molecular Oncologic Pathology to Drs. Al-Agha and Turashvili (STP-53912); by the CIHR Bioinformatics Training Program for Health Research to Mr. McPherson and Mr. Ha; by the Canadian Breast Cancer Foundation to Dr. Shah; and a Canada Research Chair in Molecular Oncology to Dr. Aparicio. The Genetic Pathology Evaluation Centre, which constructed the tissue microarrays, has received nondirected research grants from Sanofi-Aventis, Canada. The contributing tumor banks were supported by OvCaRe and Ovarian Cancer Canada (VGH, Banque de Tissus et de Donnees of the Reseau de Recherche sur le Cancer of the Fonds de la Recherche en Sante du Quebec, affiliated with the Canadian Tumor Repository Network), and by a grant (DAMD17-O1-1-0729) from the U.S. Army Medical Research and Materiel Command; grants from the Cancer Council Tasmania, the Cancer Foundation of Western Australia, and the National Health and Medical Research Council of Australia to AOCS; and grants from the National Cancer Institute, National Institutes of Health (RO1CA103937 and RO1CA129080).	Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Crotzer DR, 2007, GYNECOL ONCOL, V105, P404, DOI 10.1016/j.ygyno.2006.12.024; Dagan T, 2002, MOL BIOL EVOL, V19, P1022, DOI 10.1093/oxfordjournals.molbev.a004161; DeCristofaro MF, 2001, J CELL PHYSIOL, V186, P136; Dent J, 2003, BRIT J CANCER, V88, P1578, DOI 10.1038/sj.bjc.6600896; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; GILKS CB, 2009, J ONCOL         1230; Goff BA, 1996, GYNECOL ONCOL, V60, P412, DOI 10.1006/gyno.1996.0065; Goya R, 2010, BIOINFORMATICS, V26, P730, DOI 10.1093/bioinformatics/btq040; Huang JM, 2007, GENE CHROMOSOME CANC, V46, P745, DOI 10.1002/gcc.20459; Itamochi H, 2008, CANCER SCI, V99, P653, DOI 10.1111/j.1349-7006.2008.00747.x; JEMAL A, 2010, CA CANC J CLIN  0707; Kobel M, 2010, INT J GYNECOL PATHOL, V29, P203, DOI 10.1097/PGP.0b013e3181c042b6; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Kobel M, 2009, AM J SURG PATHOL, V33, P14, DOI 10.1097/PAS.0b013e3181788546; Kozmik Z, 2001, GENOMICS, V73, P140, DOI 10.1006/geno.2001.6477; Kuo KT, 2009, AM J PATHOL, V174, P1597, DOI 10.2353/ajpath.2009.081000; LAU DHM, 1991, CANCER RES, V51, P5181; Mitelman F, 1997, CANCER GENET CYTOGEN, V95, P1, DOI 10.1016/S0165-4608(96)00252-X; Mitelman F, 1997, NAT GENET, V15, P417, DOI 10.1038/ng0497supp-417; Ness RB, 2003, AM J OBSTET GYNECOL, V189, P280, DOI 10.1067/mob.2003.408; Press JZ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-17; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Sato N, 2000, CANCER RES, V60, P7052; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Suehiro Y, 2000, ONCOLOGY-BASEL, V59, P50, DOI 10.1159/000012137; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.3.CO;2-X; Tavassoli F.A., 2003, PATHOLOGY GENETICS T, V4; Vigano P, 2006, HUM REPROD UPDATE, V12, P77, DOI 10.1093/humupd/dmi037; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Wang XM, 2004, INT J CANCER, V112, P636, DOI 10.1002/ijc.20450	35	1110	1164	4	136	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 14	2010	363	16					1532	1543		10.1056/NEJMoa1008433	http://dx.doi.org/10.1056/NEJMoa1008433			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	663KP	20942669	Green Accepted			2022-12-01	WOS:000282887100007
J	Field, GD; Gauthier, JL; Sher, A; Greschner, M; Machado, TA; Jepson, LH; Shlens, J; Gunning, DE; Mathieson, K; Dabrowski, W; Paninski, L; Litke, AM; Chichilnisky, EJ				Field, Greg D.; Gauthier, Jeffrey L.; Sher, Alexander; Greschner, Martin; Machado, Timothy A.; Jepson, Lauren H.; Shlens, Jonathon; Gunning, Deborah E.; Mathieson, Keith; Dabrowski, Wladyslaw; Paninski, Liam; Litke, Alan M.; Chichilnisky, E. J.			Functional connectivity in the retina at the resolution of photoreceptors	NATURE			English	Article							LATERAL GENICULATE-NUCLEUS; CELL RECEPTIVE-FIELDS; MACAQUE MONKEY RETINA; MIDGET GANGLION-CELLS; PRIMATE RETINA; COLOR-VISION; CONE INPUTS; BIPOLAR CELLS; S-CONE; PHYSIOLOGICAL-BASIS	To understand a neural circuit requires knowledge of its connectivity. Here we report measurements of functional connectivity between the input and ouput layers of the macaque retina at single-cell resolution and the implications of these for colour vision. Multi-electrode technology was used to record simultaneously from complete populations of the retinal ganglion cell types (midget, parasol and small bistratified) that transmit high-resolution visual signals to the brain. Fine-grained visual stimulation was used to identify the location, type and strength of the functional input of each cone photoreceptor to each ganglion cell. The populations of ON and OFF midget and parasol cells each sampled the complete population of long- and middle-wavelength-sensitive cones. However, only OFF midget cells frequently received strong input from short-wavelength-sensitive cones. ON and OFF midget cells showed a small non-randomtendency to selectively sample from either long- or middle-wavelength-sensitive cones to a degree not explained by clumping in the cone mosaic. These measurements reveal computations in a neural circuit at the elementary resolution of individual neurons.	[Field, Greg D.; Gauthier, Jeffrey L.; Greschner, Martin; Machado, Timothy A.; Jepson, Lauren H.; Shlens, Jonathon; Chichilnisky, E. J.] Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA; [Sher, Alexander; Litke, Alan M.] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Gunning, Deborah E.; Mathieson, Keith] Univ Glasgow, Dept Phys & Astron, Glasgow G12 8QQ, Lanark, Scotland; [Dabrowski, Wladyslaw] AGH Univ Sci & Technol, Fac Phys & Appl Comp Sci, PL-2330059 Krakow, Poland; [Paninski, Liam] Columbia Univ, Dept Stat, New York, NY 10027 USA; [Paninski, Liam] Columbia Univ, Ctr Theoret Neurosci, New York, NY 10027 USA	Salk Institute; University of California System; University of California Santa Cruz; University of Glasgow; AGH University of Science & Technology; Columbia University; Columbia University	Chichilnisky, EJ (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ej@salk.edu	Field, Greg/AAI-1428-2021; Gunning, Deborah/P-5825-2015; Mathieson, Keith/G-6308-2011; Dabrowski, Wladyslaw/AAS-6369-2020	Field, Greg/0000-0001-5942-2679; Mathieson, Keith/0000-0002-9517-8076; Dabrowski, Wladyslaw/0000-0001-9061-9568; Gauthier, Jeffrey/0000-0002-0509-8532; Chichilnisky, E.J./0000-0002-5613-0248; Sher, Alexander/0000-0001-6655-6456; Machado, Tim/0000-0003-3762-1460	Helen Hay Whitney Foundation; German Research Foundation; National Institutes of Health (NIH) National Research Service [NS054519-01]; Chapman Foundation; Miller Institute for Basic Research in Science; Polish Ministry of Science and Higher Education; Burroughs Wellcome Fund Career Award at Scientific Interface; Engineering and Physical Sciences Research Council; Royal Society of Edinburgh; McKnight Foundation; NSF [PHY-0750525]; Sloan Research Fellowship; NIH [EY13150]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS054519] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/E039731/1, EP/G042446/1] Funding Source: researchfish; EPSRC [EP/E039731/1, EP/G042446/1] Funding Source: UKRI	Helen Hay Whitney Foundation; German Research Foundation(German Research Foundation (DFG)); National Institutes of Health (NIH) National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chapman Foundation; Miller Institute for Basic Research in Science; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Burroughs Wellcome Fund Career Award at Scientific Interface(Burroughs Wellcome Fund); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society of Edinburgh; McKnight Foundation; NSF(National Science Foundation (NSF)); Sloan Research Fellowship(Alfred P. Sloan Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Helen Hay Whitney Foundation (G.D.F.), German Research Foundation (M.G.), National Institutes of Health (NIH) National Research Service Award (NS054519-01) and Chapman Foundation (J.L.G.), Miller Institute for Basic Research in Science (J.S.), Polish Ministry of Science and Higher Education (W.D.), Burroughs Wellcome Fund Career Award at Scientific Interface (A.S.), Engineering and Physical Sciences Research Council (D.E.G.), Royal Society of Edinburgh (K.M.), McKnight Foundation (A.M.L. and E.J.C.), NSF Grant PHY-0750525 (A.M.L.), a Sloan Research Fellowship and NIH Grant EY13150 (E.J.C). We thank C. K. Hulse for technical assistance; M. I. Grivich, D. Petrusca, A. Grillo, P. Grybos, P. Hottowy and S. Kachiguine for technical development; H. Fox, M. Taffe, E. Callaway and K. Osborn for providing access to retinas; S. Barry for machining; F. Rieke and T. Sejnowski for providing comments on the manuscript. We thank the San Diego Supercomputer Center and the National Science Foundation (Cooperative Agreements 05253071 and 0438741) for large-scale data storage.	BAYLOR DA, 1987, J PHYSIOL-LONDON, V390, P145, DOI 10.1113/jphysiol.1987.sp016691; Buzas P, 2006, J NEUROSCI, V26, P11148, DOI 10.1523/JNEUROSCI.3237-06.2006; Calkins DJ, 1999, NEURON, V24, P313, DOI 10.1016/S0896-6273(00)80846-6; CALKINS DJ, 1994, NATURE, V371, P70, DOI 10.1038/371070a0; Chatterjee S, 2002, NEURON, V35, P1135, DOI 10.1016/S0896-6273(02)00874-7; Chichilnisky EJ, 1999, NAT NEUROSCI, V2, P889, DOI 10.1038/13189; Chichilnisky EJ, 2002, J NEUROSCI, V22, P2737, DOI 10.1523/JNEUROSCI.22-07-02737.2002; Dacey D, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P281; Dacey DM, 2000, ANNU REV NEUROSCI, V23, P743, DOI 10.1146/annurev.neuro.23.1.743; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; DACEY DM, 1993, J NEUROSCI, V13, P5334, DOI 10.1523/JNEUROSCI.13-12-05334.1993; DEMONASTERIO FM, 1975, J PHYSIOL-LONDON, V251, P197, DOI 10.1113/jphysiol.1975.sp011087; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P241, DOI 10.1113/jphysiol.1984.sp015499; DEVALOIS RL, 1966, J OPT SOC AM, V56, P966, DOI 10.1364/JOSA.56.000966; DeVries SH, 1997, J NEUROPHYSIOL, V78, P2048, DOI 10.1152/jn.1997.78.4.2048; Diggle PJ, 1983, STAT ANAL SPATIAL PO; Diller L, 2004, J NEUROSCI, V24, P1079, DOI 10.1523/JNEUROSCI.3828-03.2004; Field GD, 2007, J NEUROSCI, V27, P13261, DOI 10.1523/JNEUROSCI.3437-07.2007; Frechette ES, 2005, J NEUROPHYSIOL, V94, P119, DOI 10.1152/jn.01175.2004; Gegenfurtner KR, 2003, NAT REV NEUROSCI, V4, P563, DOI 10.1038/nrn1138; Ghosh KK, 1996, J COMP NEUROL, V366, P76, DOI 10.1002/(SICI)1096-9861(19960226)366:1<76::AID-CNE6>3.0.CO;2-H; Hofer H, 2005, J NEUROSCI, V25, P9669, DOI 10.1523/JNEUROSCI.2414-05.2005; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; JACOBS GH, 1965, NATURE, V206, P487, DOI 10.1038/206487a0; Jusuf PR, 2006, J NEUROSCI, V26, P3908, DOI 10.1523/JNEUROSCI.4891-05.2006; KAISER PK, 1990, J PHYSIOL-LONDON, V422, P153, DOI 10.1113/jphysiol.1990.sp017978; Klug K, 2003, J NEUROSCI, V23, P9881; KOUYAMA N, 1992, J NEUROSCI, V12, P1233; LEE BB, 1994, VISION RES, V34, P3081, DOI 10.1016/0042-6989(94)90074-4; Lee BB, 1996, VISION RES, V36, P631, DOI 10.1016/0042-6989(95)00167-0; LEE BB, 1988, J PHYSIOL-LONDON, V404, P323, DOI 10.1113/jphysiol.1988.sp017292; Lee SCS, 2007, J COMP NEUROL, V502, P126, DOI 10.1002/cne.21284; Lennie P., 1991, COMPUTATIONAL MODELS, P71, DOI [10.7551/mitpress/2002.003.0010, DOI 10.7551/MITPRESS/2002.003.0010]; Litke AM, 2004, IEEE T NUCL SCI, V51, P1434, DOI 10.1109/TNS.2004.832706; Martin PR, 2001, NATURE, V410, P933, DOI 10.1038/35073587; Nathans J, 1999, NEURON, V24, P299, DOI 10.1016/S0896-6273(00)80845-4; Neitz J, 2002, NEURON, V35, P783, DOI 10.1016/S0896-6273(02)00818-8; Packer OS, 1996, J NEUROSCI, V16, P2251; REID RC, 1992, NATURE, V356, P716, DOI 10.1038/356716a0; Reid RC, 2002, J NEUROSCI, V22, P6158; Rodieck R, 1998, 1 STEPS SEEING; Roorda A, 1999, NATURE, V397, P520, DOI 10.1038/17383; Sincich LC, 2009, NAT NEUROSCI, V12, P967, DOI 10.1038/nn.2352; Solomon SG, 2007, NAT REV NEUROSCI, V8, P276, DOI 10.1038/nrn2094; Solomon SG, 2005, J NEUROSCI, V25, P4527, DOI 10.1523/JNEUROSCI.3921-04.2005; Sun H, 2006, J NEUROPHYSIOL, V95, P837, DOI 10.1152/jn.00714.2005; Tailby C, 2008, J PHYSIOL-LONDON, V586, P5947, DOI 10.1113/jphysiol.2008.161893; Wachtler T, 2007, J VISION, V7, DOI 10.1167/7.8.6; WASSLE H, 1981, NATURE, V292, P344, DOI 10.1038/292344a0; WASSLE H, 1994, VISION RES, V34, P561, DOI 10.1016/0042-6989(94)90013-2; WIESEL TN, 1966, J NEUROPHYSIOL, V29, P1115, DOI 10.1152/jn.1966.29.6.1115	51	200	206	6	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 7	2010	467	7316					673	U54		10.1038/nature09424	http://dx.doi.org/10.1038/nature09424			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659NE	20930838	Green Accepted			2022-12-01	WOS:000282572500030
J	Koplan, JP; Brownell, KD				Koplan, Jeffrey P.; Brownell, Kelly D.			Response of the Food and Beverage Industry to the Obesity Threat	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Koplan, Jeffrey P.] Emory Univ, Emory Global Hlth Inst, Atlanta, GA 30322 USA; [Brownell, Kelly D.] Yale Univ, Rudd Ctr Food Policy & Obes, New Haven, CT USA	Emory University; Yale University	Koplan, JP (corresponding author), Emory Univ, Emory Global Hlth Inst, 1599 Clifton Rd NE,Ste 6-101, Atlanta, GA 30322 USA.	jkoplan@emory.edu						[Anonymous], PREV CHILDH OB HLTH; Brandt AM, 2007, CIGARETTE CENTURY RI; Brownell KD, 2009, MILBANK Q, V87, P259, DOI 10.1111/j.1468-0009.2009.00555.x; Cashore BW., 2004, GOVERNING MARKETS FO; *COC COL CO, COC COL CO 2009 4 QU; Institute of Medicine, 2006, FOOD MARK CHILDR YOU; Sharma LL, 2010, AM J PUBLIC HEALTH, V100, P240, DOI 10.2105/AJPH.2009.160960; United States Institute of Medicine, 2009, LOCAL GOVT ACTIONS P; World Health Organization, 2006, MARK FOOD NON BEV CH	9	53	53	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2010	304	13					1487	1488		10.1001/jama.2010.1436	http://dx.doi.org/10.1001/jama.2010.1436			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	658SO	20924016				2022-12-01	WOS:000282509900026
J	Middleton, A; Niruban, A; Girling, G; Myint, PK				Middleton, Anna; Niruban, Alagaratnam; Girling, Gill; Myint, Phyo Kyaw			Practice Pointer Communicating in a healthcare setting with people who have hearing loss	BRITISH MEDICAL JOURNAL			English	Editorial Material							OLDER-ADULTS; DEAF; IMPAIRMENT		[Niruban, Alagaratnam; Myint, Phyo Kyaw] Norfolk & Norwich Univ Hosp, Acad Dept Med Elderly, Norwich NR4 7UY, Norfolk, England; [Middleton, Anna] Cardiff Univ, Inst Med Genet, Cardiff CF14 4XN, S Glam, Wales; [Girling, Gill] Norfolk Deaf Assoc, Norwich NR3 4TL, Norfolk, England; [Myint, Phyo Kyaw] Univ E Anglia, Sch Med, Fac Hlth, Hlth & Social Sci Res Inst, Norwich NR4 7TJ, Norfolk, England; [Myint, Phyo Kyaw] Univ Cambridge, Sch Clin Med, Dept Public Hlth & Primary Care, Clin Gerontol Unit, Cambridge CB2 0QQ, England	Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; Cardiff University; University of East Anglia; University of Cambridge	Myint, PK (corresponding author), Norfolk & Norwich Univ Hosp, Acad Dept Med Elderly, Norwich NR4 7UY, Norfolk, England.	Phyo.K.Myint@uea.ac.uk		Middleton, Anna/0000-0003-3103-8098				Baker Holly, 2007, Psychol Health Med, V12, P380, DOI 10.1080/13548500601133466; Barnett S, 2002, FAM MED, V34, P376; Brink P, 2007, GERONTOLOGIST, V47, P633, DOI 10.1093/geront/47.5.633; Dalton DS, 2003, GERONTOLOGIST, V43, P661, DOI 10.1093/geront/43.5.661; Davidhizar Ruth, 2008, J Pract Nurs, V58, P12; Department of Health, 2005, MENT HLTH DEAFN EQ A; FORTNUM H, 2006, EFFECTS GENETIC HEAR, P29; Harmer L, 1999, J Deaf Stud Deaf Educ, V4, P73, DOI 10.1093/deafed/4.2.73; Hickson Louise, 2007, Seminars in Speech and Language, V28, P283, DOI 10.1055/s-2007-986525; Hines J, 2000, Nurs Stand, V14, P33; Iezzoni LI, 2004, ANN INTERN MED, V140, P356, DOI 10.7326/0003-4819-140-5-200403020-00011; JONES B, 1998, EBM, V1, P131; Ladd P., 2003, MULTILINGUAL MATTERS; Mackenzie I, 2009, ANN TROP MED PARASIT, V103, P565, DOI 10.1179/000349809X12459740922372; Mann W J, 1994, Md Med J, V43, P509; Middleton A., 2010, WORKING DEAF PEOPLE; Middleton A, 2010, J EVAL CLIN PRACT, V16, P811, DOI 10.1111/j.1365-2753.2009.01207.x; Middleton A, 2010, SIGN LANG STUD, V10, P170, DOI 10.1353/sls.0.0038; NHS Quality Improvement Scotland, 2005, MAX COMM OLD PEOPL W; *ROYAL NAT I DEAF, 2004, SIMPL CUR; Royal National Institute for the Deaf, 2006, FACTS FIG DEAFN TINN; SAUNDERS GH, 2007, TRENDS AMPLIF, V11, P227; Slaven Antoinette, 2003, Nurs Stand, V18, P39; Steinberg AG, 2006, J GEN INTERN MED, V21, P260, DOI 10.1111/j.1525-1497.2006.00340.x; Steinberg AG, 2002, J WOMEN HEALTH GEN-B, V11, P729, DOI 10.1089/15409990260363689; Stephens D., 2005, IMPACT GENETIC HEARI, P54; Traynor Noel, 2004, Nurs Times, V100, P32; WITTE TN, 2000, J AM BOARD FAM PRACT, V13, P81; World Health O, 2001, INT CLASS FUNCT DIS; Zazove P, 2006, J AM BOARD FAM MED, V19, P141, DOI 10.3122/jabfm.19.2.141	30	16	16	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 29	2010	341								c4672	10.1136/bmj.c4672	http://dx.doi.org/10.1136/bmj.c4672			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	659ND	20880905				2022-12-01	WOS:000282572400008
J	Desser, AS; Gyrd-Hansen, D; Olsen, JA; Grepperud, S; Kristiansen, IS				Desser, Arna S.; Gyrd-Hansen, Dorte; Olsen, Jan Abel; Grepperud, Sverre; Kristiansen, Ivar Sonbo			Societal views on orphan drugs: cross sectional survey of Norwegians aged 40 to 67	BRITISH MEDICAL JOURNAL			English	Article							CHOICE	Objective To determine whether a general societal preference for prioritising treatment of rare diseases over common ones exists and could provide a justification for accepting higher cost effectiveness thresholds for orphan drugs. Design Cross sectional survey using a web based questionnaire. Setting Norway. Participants Random sample of 1547 Norwegians aged 40-67. Main outcome measure Choice between funding treatment for a rare disease versus a common disease and how funds should be allocated if it were not possible to treat all patients, for each of two scenarios: identical treatment costs per patient and higher costs for the rare disease. Respondents rated five statements concerning attitudes to equity on a five point Likert scale (5=completely agree). Results For the equal cost scenario, 11.2% (9.6% to 12.8%) of respondents favoured treating the rare disease, 24.9% (21.7% to 26.0%) the common disease, and 64.9% (62.6% to 67.3%) were indifferent. When the rare disease was four times more costly to treat, the results were, respectively, 7.4% (6.1% to 8.7%), 45.3% (42.8% to 47.8%), and 47.3% (44.8% to 49.8%). Rankings for attitude on a Likert scale indicated strong support for the statements "rare disease patients should have the right to treatment even if more expensive" (mean score 4.5, SD 0.86) and "resources should be used to provide the greatest possible health benefits" (3.9, 1.23). Conclusions Despite strong general support for statements expressing a desire for equal treatment rights for patients with rare diseases, there was little evidence that a societal preference for rarity exists if treatment of patients with rare diseases is at the expense of treatment of those with common diseases.	[Desser, Arna S.; Grepperud, Sverre; Kristiansen, Ivar Sonbo] Univ Oslo, Dept Hlth Mgmt & Hlth Econ, N-0317 Oslo, Norway; [Gyrd-Hansen, Dorte; Kristiansen, Ivar Sonbo] Univ So Denmark, Inst Publ Hlth, Odense, Denmark; [Olsen, Jan Abel] Univ Tromso, Dept Community Med, Tromso, Norway	University of Oslo; University of Southern Denmark; UiT The Arctic University of Tromso	Desser, AS (corresponding author), Univ Oslo, Dept Hlth Mgmt & Hlth Econ, PO Box 1089,Blindern, N-0317 Oslo, Norway.	a.s.desser@medisin.uio.no	Gyrd-Hansen, Dorte/A-3161-2011	Grepperud, Sverre Ole/0000-0002-8658-7345; Gyrd-Hansen, Dorte/0000-0003-1137-2304	Norwegian Research Council; University of Oslo	Norwegian Research Council(Research Council of NorwayEuropean Commission); University of Oslo	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and all authors want to declare (1) Financial support for the submitted work from the Norwegian Research Council and the Health Economics Research Programme (HERO) at the University of Oslo. ISK (2) has received gifts, travel funds, honorariums, consultancy fees or salary from a wide range of public institutions, not for profit organisations or for profit organisations that may have an interest in orphan drug issues. The other authors declare no interests under (2), and all authors declare that they have (3) No spouses, partners, or children with relationships with commercial entities that might have an interest in the submitted work; (4) No non-financial interests that may be relevant to the submitted work.	DENIS A, 2010, J MED EC; Drummond MF, 2007, INT J TECHNOL ASSESS, V23, P36, DOI 10.1017/S0266462307051550; *EUROQOL, 2010, EQ 5D; *HELS OG OMS, 1987, 198723 NOU HELS OG O; Hughes DA, 2005, QJM-INT J MED, V98, P829, DOI 10.1093/qjmed/hci128; McCabe C, 2006, QJM-INT J MED, V99, P341, DOI 10.1093/qjmed/hcl033; McCabe C, 2005, BRIT MED J, V331, P1016, DOI 10.1136/bmj.331.7523.1016; McCabe C, 2007, INT J TECHNOL ASSESS, V23, P397; McKie J, 2003, SOC SCI MED, V56, P2407, DOI 10.1016/S0277-9536(02)00244-7; National Institute for Clinical Excellence, 2004, CIT COUNC REP ULTR D CIT COUNC REP ULTR D; NORD E, 1995, SOC SCI MED, V41, P1429, DOI 10.1016/0277-9536(95)00121-M; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; TVERSKY A, 1992, PSYCHOL SCI, V3, P358, DOI 10.1111/j.1467-9280.1992.tb00047.x; Ubel PA, 1996, NEW ENGL J MED, V334, P1174, DOI 10.1056/NEJM199605023341807	14	66	66	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 22	2010	341								c4715	10.1136/bmj.c4715	http://dx.doi.org/10.1136/bmj.c4715			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	655TK	20861122	Green Published, hybrid, Green Submitted			2022-12-01	WOS:000282272200023
J	Sekulic, N; Bassett, EA; Rogers, DJ; Black, BE				Sekulic, Nikolina; Bassett, Emily A.; Rogers, Danielle J.; Black, Ben E.			The structure of (CENP-A-H4)(2) reveals physical features that mark centromeres	NATURE			English	Article							NUCLEOSOME CORE PARTICLE; SMALL-ANGLE SCATTERING; CENP-A NUCLEOSOMES; ANGSTROM RESOLUTION; CHROMATIN; DNA; HISTONES; SYSTEM; DOMAIN; CRYSTALLOGRAPHY	Centromeres are specified epigenetically, and the histone H3 variant CENP-A is assembled into the chromatin of all active centromeres(1). Divergence from H3 raises the possibility that CENP-A generates unique chromatin features to mark physically centromere location. Here we report the crystal structure of a subnucleosomal heterotetramer, human (CENP-A-H4)(2), that reveals three distinguishing properties encoded by the residues that comprise the CENP-A targeting domain (CATD; ref. 2): (1) a CENP-A-CENP-A interface that is substantially rotated relative to the H3-H3 interface; (2) a protruding loop L1 of the opposite charge as that on H3; and (3) strong hydrophobic contacts that rigidify the CENP-A-H4 interface. Residues involved in the CENP-A-CENP-A rotation are required for efficient incorporation into centromeric chromatin, indicating specificity for an unconventional nucleosome shape. DNA topological analysis indicates that CENP-A-containing nucleosomes are octameric with conventional left-handed DNA wrapping, in contrast to other recent proposals(3-6). Our results indicate that CENP-A marks centromere location by restructuring the nucleosome from within its folded histone core.	[Sekulic, Nikolina; Bassett, Emily A.; Rogers, Danielle J.; Black, Ben E.] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Bassett, Emily A.; Black, Ben E.] Univ Penn, Sch Med, Grad Grp Biochem & Mol Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Black, BE (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	blackbe@mail.med.upenn.edu	Sekulic, Nikolina/N-5550-2016; Sekulic, Nikolina/F-8911-2013	Sekulic, Nikolina/0000-0001-7555-3222; 	NIH [GM82989, GM08275]; Burroughs Wellcome Fund; Rita Allen Foundation; American Cancer Society; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008275, R01GM082989] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Rita Allen Foundation; American Cancer Society(American Cancer Society); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Cleveland for plasmids and steadfast encouragement to pursue a physical understanding of the centromere; S. Wood for generating cleaved histone H2A; K. Gupta for help with collecting data and technical suggestions; and K. Ferguson, G. Van Duyne, M. Lemmon, J. Shorter, L. Jansen, D. Foltz, J. Shah, D. Alvarado, K. Moravcevic and T. Panchenko for discussions and comments on the manuscript. This work was supported by the NIH research grant GM82989, a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund, and a Rita Allen Foundation Scholar Award to B.E.B.N.S. is supported by a postdoctoral fellowship from the American Cancer Society and E.A.B. has been supported by the Penn Structural Biology Training Grant (NIH GM08275) and a predoctoral fellowship from the American Heart Association.	Altaf M, 2007, MOL CELL, V28, P1002, DOI 10.1016/j.molcel.2007.12.002; Bassett EA, 2010, J CELL BIOL, V190, P177, DOI 10.1083/jcb.201001035; BINASTEIN M, 1977, CELL, V11, P609, DOI 10.1016/0092-8674(77)90078-2; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black BE, 2008, CURR OPIN CELL BIOL, V20, P91, DOI 10.1016/j.ceb.2007.11.007; Black BE, 2007, P NATL ACAD SCI USA, V104, P5008, DOI 10.1073/pnas.0700390104; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; Camahort R, 2009, MOL CELL, V35, P794, DOI 10.1016/j.molcel.2009.07.022; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Carruthers LM, 1999, METHOD ENZYMOL, V304, P19; Dalal Y, 2007, PLOS BIOL, V5, P1798, DOI 10.1371/journal.pbio.0050218; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Englander SW, 2006, J AM SOC MASS SPECTR, V17, P1481, DOI 10.1016/j.jasms.2006.06.006; Erhardt S, 2008, J CELL BIOL, V183, P805, DOI 10.1083/jcb.200806038; ESPOSITO F, 1987, NUCLEIC ACIDS RES, V15, P5105, DOI 10.1093/nar/15.13.5105; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Furuyama T, 2009, CELL, V138, P104, DOI 10.1016/j.cell.2009.04.049; Fyodorov DV, 2003, METHOD ENZYMOL, V371, P499; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lu X, 2008, NAT STRUCT MOL BIOL, V15, P1122, DOI 10.1038/nsmb.1489; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lusser A, 2004, NAT METHODS, V1, P19, DOI 10.1038/nmeth709; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Shelby RD, 1997, J CELL BIOL, V136, P501, DOI 10.1083/jcb.136.3.501; Shuaib M, 2010, P NATL ACAD SCI USA, V107, P1349, DOI 10.1073/pnas.0913709107; Silva NCE, 2007, J MOL BIOL, V370, P555, DOI 10.1016/j.jmb.2007.04.064; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; Smith MM, 2002, CURR OPIN CELL BIOL, V14, P279, DOI 10.1016/S0955-0674(02)00331-9; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Vermaak D, 2002, MOL CELL BIOL, V22, P7553, DOI 10.1128/MCB.22.21.7553-7561.2002; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Williams JS, 2009, MOL CELL, V33, P287, DOI 10.1016/j.molcel.2009.01.017; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3	41	164	169	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 16	2010	467	7313					347	U132		10.1038/nature09323	http://dx.doi.org/10.1038/nature09323			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650CF	20739937	Green Accepted			2022-12-01	WOS:000281824900043
J	Lee, K; Gallop, JL; Rambani, K; Kirschner, MW				Lee, Kwonmoo; Gallop, Jennifer L.; Rambani, Komal; Kirschner, Marc W.			Self-Assembly of Filopodia-Like Structures on Supported Lipid Bilayers	SCIENCE			English	Article							N-WASP; ARP2/3 COMPLEX; DENDRITIC NETWORK; BARBED END; ACTIN; PROTEINS; FORMIN; CELLS; MOTILITY; FAMILY	Filopodia are finger-like protrusive structures, containing actin bundles. By incubating frog egg extracts with supported lipid bilayers containing phosphatidylinositol 4,5 bisphosphate, we have reconstituted the assembly of filopodia-like structures (FLSs). The actin assembles into parallel bundles, and known filopodial components localize to the tip and shaft. The filopodia tip complexes self-organize-they are not templated by preexisting membrane microdomains. The F-BAR domain protein toca-1 recruits N-WASP, followed by the Arp2/3 complex and actin. Elongation proteins, Diaphanous-related formin, VASP, and fascin are recruited subsequently. Although the Arp2/3 complex is required for FLS initiation, it is not essential for elongation, which involves formins. We propose that filopodia form via clustering of Arp2/3 complex activators, self-assembly of filopodial tip complexes on the membrane, and outgrowth of actin bundles.	[Lee, Kwonmoo; Gallop, Jennifer L.; Rambani, Komal; Kirschner, Marc W.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Lee, Kwonmoo] MIT, Dept Phys, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	marc@hms.harvard.edu		Lee, Kwonmoo/0000-0001-6838-7094; Gallop, Jennifer Louise/0000-0002-9978-1382	Korea Science and Engineering Foundation (KOSEF); Harvard-MIT; European Molecular Biology Organization; NIH [GM26875]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026875, R37GM026875] Funding Source: NIH RePORTER	Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); Harvard-MIT; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	K. L. was the recipient of a Korea Science and Engineering Foundation (KOSEF) Scholarship and Harvard-MIT Health Sciences and Technology Fellowship. J.L.G was the recipient of an European Molecular Biology Organization Long-Term Fellowship. This work was funded by NIH grant GM26875. We thank G. Bokoch for the gift of the GST-RhoA-N19 plasmid, S. Field for the gift of the pEGFP GFP-PLC delta PH domain plasmid, Weiner for the RhoGDI plasmid, R. Tsien for the mCherry plasmid, A. Alberts for the mDia2 plasmid, and D. Vignjevic for the fascin plasmid. We thank A. Lebensohn for helping extract preparation and valuable discussions and M. Coughlin, T. Walz, and D. Kelly for help with EM. We thank J. Waters, W. Salmon, and Nikon Imaging Center at Harvard Medical School.	Arasada R, 2007, BBA-MOL CELL RES, V1773, P631, DOI 10.1016/j.bbamcr.2007.03.009; Brieher WM, 2004, J CELL BIOL, V165, P233, DOI 10.1083/jcb.200311040; Chan YHM, 2007, CURR OPIN CHEM BIOL, V11, P581, DOI 10.1016/j.cbpa.2007.09.020; Co C, 2007, CELL, V128, P901, DOI 10.1016/j.cell.2006.12.049; Crane JM, 2004, BIOPHYS J, V86, P2965, DOI 10.1016/S0006-3495(04)74347-7; DAVENPORT RW, 1993, NATURE, V361, P721, DOI 10.1038/361721a0; Eisenmann KM, 2007, CURR BIOL, V17, P579, DOI 10.1016/j.cub.2007.03.024; Faix J, 2009, INT J BIOCHEM CELL B, V41, P1656, DOI 10.1016/j.biocel.2009.02.012; GUPTON SL, 2007, SCI STKE, pRE5, DOI DOI 10.1126/STKE.4002007RE5; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Ho HYH, 2001, P NATL ACAD SCI USA, V98, P11306, DOI 10.1073/pnas.211420498; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Johnston SA, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-65; Korobova F, 2008, MOL BIOL CELL, V19, P1561, DOI 10.1091/mbc.E07-09-0964; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Liu AP, 2008, NAT PHYS, V4, P789, DOI 10.1038/nphys1071; Lommel S, 2001, EMBO REP, V2, P850, DOI 10.1093/embo-reports/kve197; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Medalia O, 2007, CURR BIOL, V17, P79, DOI 10.1016/j.cub.2006.11.022; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; MOOSEKER MS, 1982, J CELL BIOL, V95, P223, DOI 10.1083/jcb.95.1.223; Nicholson-Dykstra SM, 2008, CELL MOTIL CYTOSKEL, V65, P904, DOI 10.1002/cm.20312; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Papayannopoulos V, 2005, MOL CELL, V17, P181, DOI 10.1016/j.molcel.2004.11.054; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Sarmiento C, 2008, J CELL BIOL, V180, P1245, DOI 10.1083/jcb.200708123; Schwille P, 2005, PROTEIN-LIPID INTERACTIONS: FROM MEMBRANE DOMAINS TO CELLULAR NETWORKS, P337; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Steffen A, 2006, MOL BIOL CELL, V17, P2581, DOI 10.1091/mbc.E05-11-1088; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Yang C, 2007, PLOS BIOL, V5, P2624, DOI 10.1371/journal.pbio.0050317	39	115	115	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 10	2010	329	5997					1341	1345		10.1126/science.1191710	http://dx.doi.org/10.1126/science.1191710			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647YR	20829485	Green Accepted, Green Published			2022-12-01	WOS:000281657300038
J	Jones, R				Jones, Rachel			Biomarkers: casting the net wide	NATURE			English	Editorial Material							PARKINSONS-DISEASE; HUMAN PLASMA											Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Booij J, 1997, EUR J NUCL MED, V24, P68, DOI 10.1007/BF01728311; COLLINGWOOD JF, 2008, MOV DIS S1, V23; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Oakley AE, 2007, NEUROLOGY, V68, P1820, DOI 10.1212/01.wnl.0000262033.01945.9a; POSNEN MM, 2004, ANN NEUROL, V56, P173	7	18	18	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2010	466	7310					S11	S12		10.1038/466S11a	http://dx.doi.org/10.1038/466S11a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20739930				2022-12-01	WOS:000281203600061
J	Eisele, YS; Obermuller, U; Heilbronner, G; Baumann, F; Kaeser, SA; Wolburg, H; Walker, LC; Staufenbiel, M; Heikenwalder, M; Jucker, M				Eisele, Yvonne S.; Obermueller, Ulrike; Heilbronner, Goetz; Baumann, Frank; Kaeser, Stephan A.; Wolburg, Hartwig; Walker, Lary C.; Staufenbiel, Matthias; Heikenwalder, Mathias; Jucker, Mathias			Peripherally Applied A beta-Containing Inoculates Induce Cerebral beta-Amyloidosis	SCIENCE			English	Article							ALZHEIMER-DISEASE; PATHOGENESIS; DEPOSITION; PRIONS	The intracerebral injection of beta-amyloid-containing brain extracts can induce cerebral beta-amyloidosis and associated pathologies in susceptible hosts. We found that intraperitoneal inoculation with beta-amyloid-rich extracts induced beta-amyloidosis in the brains of beta-amyloid precursor protein transgenic mice after prolonged incubation times.	[Eisele, Yvonne S.; Obermueller, Ulrike; Heilbronner, Goetz; Baumann, Frank; Kaeser, Stephan A.; Jucker, Mathias] Univ Tubingen, Dept Cellular Neurol, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany; [Eisele, Yvonne S.; Obermueller, Ulrike; Heilbronner, Goetz; Baumann, Frank; Kaeser, Stephan A.; Jucker, Mathias] DZNE German Ctr Neurodegenerat Dis, D-72076 Tubingen, Germany; [Heilbronner, Goetz] Univ Tubingen, Grad Sch Cellular & Mol Neurosci, D-72074 Tubingen, Germany; [Wolburg, Hartwig] Univ Tubingen, Dept Pathol, D-72076 Tubingen, Germany; [Walker, Lary C.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Walker, Lary C.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Staufenbiel, Matthias] Novartis Inst Biomed Res, CH-4056 Basel, Switzerland; [Heikenwalder, Mathias] Univ Zurich Hosp, Dept Pathol, Inst Neuropathol, CH-8091 Zurich, Switzerland	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Emory University; Emory University; Novartis; University of Zurich; University Zurich Hospital	Jucker, M (corresponding author), Univ Tubingen, Dept Cellular Neurol, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany.	mathias.jucker@uni-tuebingen.de	Heikenwalder, Mathias/AAA-2269-2020; Walker, L C/J-6541-2015; Eisele, Yvonne/E-7897-2015; Baumann, Frank/F-7737-2016	Walker, L C/0000-0001-9166-3261; Eisele, Yvonne/0000-0002-3868-4327; Jucker, Mathias/0000-0001-9045-1072	Competence Network on Degenerative Dementias [BMBF-01GI0705]; Bundesministerium fur Bildung und Forschung as part of ERA-Net NEURON (MIPROTRAN); Center for Integrative Neuroscience (Deutsche Forschungsgemeinschaft); NIH [RR-00165]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER	Competence Network on Degenerative Dementias; Bundesministerium fur Bildung und Forschung as part of ERA-Net NEURON (MIPROTRAN); Center for Integrative Neuroscience (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank M.-J. Runser, L. Jacobson (Basel), F. Langer, J. Coomaraswamy, S. Grathwohl, N. Varvel, T. Hamaguchi, C. Schafer, A. Bosch, G. Frommer-Kastle, U. Scheurlen (Tubingen) for experimental help and A. Aguzzi (Zurich) for insightful comments. This work was supported by the Competence Network on Degenerative Dementias (BMBF-01GI0705), the Bundesministerium fur Bildung und Forschung as part of ERA-Net NEURON (MIPROTRAN), the Center for Integrative Neuroscience (Deutsche Forschungsgemeinschaft), and NIH RR-00165.	Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Bremer J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007160; Calhoun ME, 1999, P NATL ACAD SCI USA, V96, P14088, DOI 10.1073/pnas.96.24.14088; Eisele YS, 2009, P NATL ACAD SCI USA, V106, P12926, DOI 10.1073/pnas.0903200106; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heikenwalder M, 2005, SCIENCE, V307, P1107, DOI 10.1126/science.1106460; KIMBERLIN RH, 1978, J COMP PATHOL, V88, P39, DOI 10.1016/0021-9975(78)90059-2; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morris JC, 2009, ARCH NEUROL-CHICAGO, V66, P1469, DOI 10.1001/archneurol.2009.269; Prusiner SB, 2004, PRION BIOL DIS; Storandt M, 2009, ARCH NEUROL-CHICAGO, V66, P1476, DOI 10.1001/archneurol.2009.272; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Walker LC, 2006, TRENDS NEUROSCI, V29, P438, DOI 10.1016/j.tins.2006.06.010; Zhang-Nunes SX, 2006, BRAIN PATHOL, V16, P30, DOI 10.1111/j.1750-3639.2006.tb00559.x	15	431	440	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 12	2010	330	6006					980	982		10.1126/science.1194516	http://dx.doi.org/10.1126/science.1194516			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678XY	20966215	Green Accepted			2022-12-01	WOS:000284118000047
J	Nutt, DJ; King, LA; Phillips, LD				Nutt, David J.; King, Leslie A.; Phillips, Lawrence D.		Independent Sci Comm Drugs	Drug harms in the UK: a multicriteria decision analysis	LANCET			English	Article							ILLICIT DRUGS; TOXICITY; MISUSE	Background Proper assessment of the harms caused by the misuse of drugs can inform policy makers in health, policing, and social care. We aimed to apply multicriteria decision analysis (MCDA) modelling to a range of drug harms in the UK. Method Members of the Independent Scientific Committee on Drugs, including two invited specialists, met in a 1-day interactive workshop to score 20 drugs on 16 criteria: nine related to the harms that a drug produces in the individual and seven to the harms to others. Drugs were scored out of 100 points, and the criteria were weighted to indicate their relative importance. Findings MCDA modelling showed that heroin, crack cocaine, and metamfetamine were the most harmful drugs to individuals (part scores 34, 37, and 32, respectively), whereas alcohol, heroin, and crack cocaine were the most harmful to others (46, 21, and 17, respectively). Overall, alcohol was the most harmful drug (overall harm score 72), with heroin (55) and crack cocaine (54) in second and third places. Interpretation These findings lend support to previous work assessing drug harms, and show how the improved scoring and weighting approach of MCDA increases the differentiation between the most and least harmful drugs. However, the findings correlate poorly with present UK drug classification, which is not based simply on considerations of harm.	[Nutt, David J.] Univ London Imperial Coll Sci Technol & Med, Neuropsychopharmacol Unit, London W12 0NN, England; [King, Leslie A.] EMCDDA, Lisbon, Portugal; [Phillips, Lawrence D.] Univ London London Sch Econ & Polit Sci, Dept Management, London WC2A 2AE, England	Imperial College London; University of London; London School Economics & Political Science	Nutt, DJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Neuropsychopharmacol Unit, Burlington Danes Bldg,Du Cane Rd, London W12 0NN, England.	d.nutt@imperial.ac.uk			Centre for Crime and Justice Studies (UK); Facilitations Limited	Centre for Crime and Justice Studies (UK); Facilitations Limited	This study is funded by the Centre for Crime and Justice Studies (UK). Yuji Wu assisted with some of the data analyses.; DJN and LAK received travel expenses to attend the decision conference meeting. LAK is a consultant to the Department of Health and the EMCDDA. LDP is a director of Facilitations Limited, which paid him a consulting fee because it was the company engaged by the Centre for Crime and Justice Studies to run the study and analyse the data.	Academy of Medical Sciences (AMS), 2004, CALL TIM NAT DRINK M; *ADV COUNC MIS DRU, 2010, CONS US MULT DEC AN; [Anonymous], 2010, DRUGS RES OVERVIEW E; Anthony JC, 1994, EXP CLIN PSYCHOPHARM, V2, P244, DOI 10.1037/1064-1297.2.3.244; *BRIT MED ASS, 1987, LIV RISK; Coomber R, 1999, ADDICT RES, V7, P85, DOI 10.3109/16066359909004376; DODGSON J, 2000, MULTICRITERIA ANAL M; Gable RS, 2004, ADDICTION, V99, P686, DOI 10.1111/j.1360-0443.2004.00744.x; *HC HLTH COMM, 2010, 1511 HC HLTH COMM; Horn G., 2008, BRAIN SCI ADDICTION; King LA, 2010, HUM PSYCHOPHARM CLIN, V25, P162, DOI 10.1002/hup.1090; Morton A, 2009, RISK ANAL, V29, P764, DOI 10.1111/j.1539-6924.2008.01192.x; Murphy PI, 2007, LANCET, V369, P1856, DOI 10.1016/S0140-6736(07)60841-1; National Institute for Health and Clinical Excellence (NICE), 2010, ALC US DIS PREV DEV; Nutt D, 2007, LANCET, V369, P1047, DOI 10.1016/S0140-6736(07)60464-4; Phillips LD, 2007, ADVANCES IN DECISION ANALYSIS: FROM FOUNDATIONS TO APPLICATIONS, P375, DOI 10.1017/CBO9780511611308.020; REGANCIRINCIONE P, 1994, ORG BEHAV HUMAN DECI, V58, P246; United Nations Office on Drugs and Crime, 2010, WORLD DRUG REP 2010; van Amsterdam J, 2010, EUR ADDICT RES, V16, P202, DOI 10.1159/000317249; Werb D., 2010, EFFECT DRUG LAW ENFO	20	861	881	4	245	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 6	2010	376	9752					1558	1565		10.1016/S0140-6736(10)61462-6	http://dx.doi.org/10.1016/S0140-6736(10)61462-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	680QE	21036393				2022-12-01	WOS:000284248700033
J	Brennan, KA; Genever, RW				Brennan, K. A.; Genever, R. W.			Practice Pointer Managing Parkinson's disease during surgery	BRITISH MEDICAL JOURNAL			English	Editorial Material							PERIOPERATIVE MANAGEMENT; TRANSDERMAL ROTIGOTINE; INDUCED DYSKINESIAS; PROPOFOL; ANESTHESIA		[Genever, R. W.] Chesterfield Royal Hosp NHS Fdn Trust, Calow S44 5BL, Chesterfield, England; [Brennan, K. A.] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England	University of Sheffield	Genever, RW (corresponding author), Chesterfield Royal Hosp NHS Fdn Trust, Calow S44 5BL, Chesterfield, England.	Richard.Genever@chesterfieldroyal.nhs.uk			Boehringer Ingelheim; Glaxo Smith Kline; Teva; Lundbeck; Orion	Boehringer Ingelheim(Boehringer Ingelheim); Glaxo Smith Kline(GlaxoSmithKline); Teva(Teva Pharmaceutical Industries); Lundbeck(Lundbeck Corporation); Orion	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that RG has received sponsorship to attend medical conferences from Boehringer Ingelheim, Glaxo Smith Kline, Teva and Lundbeck, and Orion. RG has received honoraria for speaking at meetings from Glaxo Smith Kline and Orion. RG has received honoraria for sitting on advisory boards from Glaxo Smith Kline and Boehringer Ingelheim. KB has no relationships with any companies that might have an interest in the submitted work in the previous 3 years; and RG and KB have no non-financial interests that may be relevant to the submitted work.	ANDERSON BJ, 1994, BRIT J NEUROSURG, V8, P387, DOI 10.3109/02688699409029633; Brady M, 2009, COCHRANE DB SYST REV, V7; Davies RG, 2005, BRIT J ANAESTH, V95, P424, DOI 10.1093/bja/aei579; Furuya R, 1998, ANESTHESIOLOGY, V89, P261, DOI 10.1097/00000542-199807000-00035; Iyer SS, 2005, NEUROLOGY, V65, P1507, DOI 10.1212/01.wnl.0000183286.92632.71; Krauss JK, 1996, ANESTH ANALG, V83, P420, DOI 10.1097/00000539-199608000-00037; LeWitt PA, 2007, CLIN NEUROPHARMACOL, V30, P256, DOI 10.1097/wnf.0b013e318154c7c4; MADOPAR CR, 2009, SUMMARY PRODUCT CHAR; Mehta Samir, 2008, Am J Orthop (Belle Mead NJ), V37, P513; Nicholson G, 2002, BRIT J ANAESTH, V89, P904, DOI 10.4103/0019-5049.82658; *PARK UK, GET IT TIM; Pepper PV, 1999, J AM GERIATR SOC, V47, P967, DOI 10.1111/j.1532-5415.1999.tb01292.x; REED AP, 1992, ANESTH ANALG, V75, P850; Schrag A, 2000, BRIT MED J, V321, P21, DOI 10.1136/bmj.321.7252.21; SINEMET CR, 2009, SUMMARY PRODUCT CHAR; STOLTZ M, 2004, BRIT J ANAESTH, V96, P868; Ueda M, 1999, NEUROLOGY, V52, P777, DOI 10.1212/WNL.52.4.777; Wenzelburger R, 2002, BRAIN, V125, P871, DOI 10.1093/brain/awf084; Wullner U, 2010, J NEURAL TRANSM, V117, P855, DOI 10.1007/s00702-010-0425-4	19	29	31	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 1	2010	341								c5718	10.1136/bmj.c5718	http://dx.doi.org/10.1136/bmj.c5718			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	678CD	21041319				2022-12-01	WOS:000284045500010
J	Chandler, VL				Chandler, Vicki L.			Paramutation's Properties and Puzzles	SCIENCE			English	Editorial Material							MAIZE; TRANS; INHERITANCE; EXPRESSION; LOCUS	Paramutation refers to the process by which homologous DNA sequences communicate in trans to establish meiotically heritable expression states. Although mechanisms are unknown, current data are consistent with the hypothesis that the establishment and heritable transmission of specific chromatin states underlies paramutation. Transcribed, noncoding tandem repeats and proteins implicated in RNA-directed transcriptional silencing in plants and yeast are required for paramutation, yet the specific molecules mediating heritable silencing remain to be determined.	Univ Arizona, Dept Plant Sci, Inst BIO5, Tucson, AZ 85719 USA	University of Arizona	Chandler, VL (corresponding author), Univ Arizona, Dept Plant Sci, Inst BIO5, Tucson, AZ 85719 USA.	chandler@ag.arizona.edu						Arteaga-Vazquez M, 2010, P NATL ACAD SCI USA, V107, P12986, DOI 10.1073/pnas.1007972107; Arteaga-Vazquez MA, 2010, CURR OPIN GENET DEV, V20, P156, DOI 10.1016/j.gde.2010.01.008; Bourc'his D, 2010, SCIENCE, V330, P617, DOI 10.1126/science.1194776; Brzeska K, 2010, P NATL ACAD SCI USA, V107, P5516, DOI 10.1073/pnas.1001576107; Chandler VL, 2007, CELL, V128, P641, DOI 10.1016/j.cell.2007.02.007; COE EH, 1966, GENETICS, V53, P1035; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; Haring M, 2010, PLANT J, V63, P366, DOI 10.1111/j.1365-313X.2010.04245.x; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Stam M, 2009, MOL PLANT, V2, P578, DOI 10.1093/mp/ssp020; Suter CM, 2010, TRENDS GENET, V26, P9, DOI 10.1016/j.tig.2009.11.003	12	55	55	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 29	2010	330	6004					628	629		10.1126/science.1191044	http://dx.doi.org/10.1126/science.1191044			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672KB	21030647				2022-12-01	WOS:000283580600035
J	Sawa, S; Cherrier, M; Lochner, M; Satoh-Takayama, N; Fehling, HJ; Langa, F; Di Santo, JP; Eberl, G				Sawa, Shinichiro; Cherrier, Marie; Lochner, Matthias; Satoh-Takayama, Naoko; Fehling, Hans Joerg; Langa, Francina; Di Santo, James P.; Eberl, Gerard			Lineage Relationship Analysis of ROR gamma t(+) Innate Lymphoid Cells	SCIENCE			English	Article							ROR-GAMMA-T; TISSUE-INDUCER CELLS; NATURAL-KILLER-CELLS; PROINFLAMMATORY IL-17(+); NKP46(+) CELLS; HELPER-CELLS; IN-VIVO; DIFFERENTIATION; IMMUNITY; ORGANOGENESIS	Lymphoid tissue-inducer (LTi) cells initiate the development of lymphoid tissues through the activation of local stromal cells in a process similar to inflammation. LTi cells express the nuclear hormone receptor ROR gamma t, which also directs the expression of the proinflammatory cytokine interleukin-17 in T cells. We show here that LTi cells are part of a larger family of proinflammatory ROR gamma t(+) innate lymphoid cells (ILCs) that differentiate from distinct fetal liver ROR gamma t(+) precursors. The fate of ROR gamma t(+) ILCs is determined by mouse age, and after birth, favors the generation of cells involved in intestinal homeostasis and defense. Contrary to ROR gamma t(+) T cells, however, ROR gamma t(+) ILCs develop in the absence of microbiota. Our study indicates that ROR gamma t(+) ILCs evolve to preempt intestinal colonization by microbial symbionts.	[Sawa, Shinichiro; Cherrier, Marie; Lochner, Matthias; Eberl, Gerard] Inst Pasteur, Lymphoid Tissue Dev Unit, F-75724 Paris, France; [Sawa, Shinichiro; Cherrier, Marie; Lochner, Matthias; Eberl, Gerard] CNRS, URA1961, F-75724 Paris, France; [Lochner, Matthias] Hannover Med Sch, Ctr Expt & Clin Infect Res, TWINCORE, Inst Infect Immunol, D-3000 Hannover, Germany; [Lochner, Matthias] Helmholtz Ctr Infect Res, Hannover, Germany; [Satoh-Takayama, Naoko; Di Santo, James P.] Inst Pasteur, Innate Immun Unit, F-75724 Paris, France; [Satoh-Takayama, Naoko; Di Santo, James P.] INSERM, U668, F-75724 Paris, France; [Fehling, Hans Joerg] Univ Clin Ulm, Inst Immunol, Ulm, Germany; Inst Pasteur, Ctr Ingenieurie Genet Murine, F-75724 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Ulm University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Eberl, G (corresponding author), Inst Pasteur, Lymphoid Tissue Dev Unit, F-75724 Paris, France.	gerard.eberl@pasteur.fr	Lochner, Matthias/L-6963-2015; Di Santo, James P/M-4298-2014; Eberl, Gerard/A-1160-2013	Lochner, Matthias/0000-0002-7979-5613; Di Santo, James P/0000-0002-7146-1862; Eberl, Gerard/0000-0002-1119-5638; Cherrier, Marie/0000-0001-5323-4239	Institut Pasteur; Mairie de Paris; Agence Nationale de la Recherche; European Commission; Deutsche Forschungsgemeinschaft [FE-578/3-1]; Schlumberger Foundation	Institut Pasteur(European Commission); Mairie de Paris(Region Ile-de-France); Agence Nationale de la Recherche(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Schlumberger Foundation(Schlumberger)	We thank the members of the Lymphoid Tissue Development lab for discussions and critical reading of the manuscript and L. Polomack, S. Dulauroy, G. Chauveau-Le Friec, and the team of the Centre d'Ingenierie Genetique Murine for technical assistance. We also thank R. Varona for CCR6-deficient mice, I. Gomperts-Boneca for Nod1- and Nod2-deficient mice, and H. Bujard for LC-1-Cre mice. This work was supported by the Institut Pasteur, grants from the Mairie de Paris, the Agence Nationale de la Recherche, and an Excellence Grant from the European Commission. M. L. was supported by the Deutsche Forschungsgemeinschaft and the Schlumberger Foundation. H.J.F. is funded by the Deutsche Forschungsgemeinschaft (FE-578/3-1). The authors have no competing financial interests.	Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Crellin NK, 2010, J EXP MED, V207, P281, DOI 10.1084/jem.20091509; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Lugering A, 2010, CLIN EXP IMMUNOL, V160, P440, DOI 10.1111/j.1365-2249.2010.04103.x; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Mebius RE, 2001, J IMMUNOL, V166, P6593, DOI 10.4049/jimmunol.166.11.6593; Michel ML, 2008, P NATL ACAD SCI USA, V105, P19845, DOI 10.1073/pnas.0806472105; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nishikawa S, 2000, CURR OPIN IMMUNOL, V12, P342, DOI 10.1016/S0952-7915(00)00097-2; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Schonig K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf134; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643; Yoshida H, 2001, J IMMUNOL, V167, P2511, DOI 10.4049/jimmunol.167.5.2511; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	30	379	390	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 29	2010	330	6004					665	669		10.1126/science.1194597	http://dx.doi.org/10.1126/science.1194597			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672KB	20929731				2022-12-01	WOS:000283580600047
J	Sudmant, PH; Kitzman, JO; Antonacci, F; Alkan, C; Malig, M; Tsalenko, A; Sampas, N; Bruhn, L; Shendure, J; Eichler, EE				Sudmant, Peter H.; Kitzman, Jacob O.; Antonacci, Francesca; Alkan, Can; Malig, Maika; Tsalenko, Anya; Sampas, Nick; Bruhn, Laurakay; Shendure, Jay; Eichler, Evan E.		1000 Genomes Project	Diversity of Human Copy Number Variation and Multicopy Genes	SCIENCE			English	Article							HUMAN GENOME; SEGMENTAL DUPLICATIONS; HUMAN-DISEASE; EVOLUTION; SCHIZOPHRENIA; POLYMORPHISMS; CONVERSION; SELECTION; DELETION; 15Q13.3	Copy number variants affect both disease and normal phenotypic variation, but those lying within heavily duplicated, highly identical sequence have been difficult to assay. By analyzing short-read mapping depth for 159 human genomes, we demonstrated accurate estimation of absolute copy number for duplications as small as 1.9 kilobase pairs, ranging from 0 to 48 copies. We identified 4.1 million "singly unique nucleotide" positions informative in distinguishing specific copies and used them to genotype the copy and content of specific paralogs within highly duplicated gene families. These data identify human-specific expansions in genes associated with brain development, reveal extensive population genetic diversity, and detect signatures consistent with gene conversion in the human species. Our approach makes similar to 1000 genes accessible to genetic studies of disease association.	[Sudmant, Peter H.; Kitzman, Jacob O.; Antonacci, Francesca; Alkan, Can; Malig, Maika; Shendure, Jay; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Tsalenko, Anya; Sampas, Nick; Bruhn, Laurakay] Agilent Technol, Santa Clara, CA 95051 USA; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Agilent Technologies; Howard Hughes Medical Institute	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Rosenstiel, Philip/A-5137-2009; Shendure, Jay/AAU-3684-2021; Mills, Ryan E/F-4225-2010; Cooper, David N/H-4384-2011; Khurana, Ekta/C-4933-2013; Myers, Simon R/A-6792-2015; Altshuler, David M/A-4476-2009; Sahinalp, Suleyman Cenk/X-7843-2018; Ye, Kai/B-3640-2012; Dahl, Andreas/E-3783-2017; Chen, Ken/AAU-1432-2021; Alkan, Can/D-2982-2009; Li, Yingrui/K-1064-2015; Antonacci, Francesca/F-5457-2013; Browning, Brian L/A-1178-2010; Wang, Jun/A-7261-2013; Wilson, Richard K./AAF-4139-2019; Tumian, Afidalina/J-4404-2014	Rosenstiel, Philip/0000-0002-9692-8828; Mills, Ryan E/0000-0003-3425-6998; Cooper, David N/0000-0002-8943-8484; Myers, Simon R/0000-0002-2585-9626; Altshuler, David M/0000-0002-7250-4107; Sahinalp, Suleyman Cenk/0000-0002-5050-0682; Dahl, Andreas/0000-0002-2668-8371; Chen, Ken/0000-0003-4013-5279; Alkan, Can/0000-0002-5443-0706; Antonacci, Francesca/0000-0002-5833-6186; Browning, Brian L/0000-0001-6454-6633; Wilson, Richard K./0000-0002-1992-1358; Abyzov, Alexej/0000-0001-5405-6729; Stone, Eric/0000-0002-2725-4209; Kitzman, Jacob/0000-0002-6145-882X; Leinonen, Rasko/0000-0002-2639-7187; Balasubramanian, Shankar/0000-0002-0281-5815; Sebat, Jonathan/0000-0002-9087-526X; Chinwalla, Asif/0000-0001-7831-3996; Sudmant, Peter/0000-0002-9573-8248; MacArthur, Daniel/0000-0002-5771-2290; MCLELLAN, MICHAEL/0000-0002-2703-8784; Aguinaga, Jesus Christ/0000-0003-0664-6219; Keenan, Stephen/0000-0002-9141-7690; Schaffner, Stephen/0000-0001-6699-3568; Clark, Andrew/0000-0001-7159-8511; Zalunin, Vadim/0000-0002-7722-1958; Tumian, Afidalina/0000-0003-2763-6677; Herrero, Javier/0000-0001-7313-717X; Haraksingh, Rajini/0000-0002-6644-8874; Cibulskis, Kristian/0000-0003-1343-1582; Kulesha, Eugene/0000-0002-4285-6232; Radhakrishnan, Rajesh/0000-0001-7170-699X; Clarke, Laura/0000-0002-5989-6898; Shendure, Jay/0000-0002-1516-1865; Hinrichs, Angie/0000-0002-1697-1130; Walter, Klaudia/0000-0003-4448-0301; Keane, Thomas/0000-0001-7532-6898; McLaren, William/0000-0001-6218-1116; Eberle, Michael/0000-0001-8965-1253; Swerdlow, Harold/0000-0002-9510-160X; Keinan, Alon/0000-0002-9760-1122; Sherry, Stephen/0000-0002-7982-076X	Natural Sciences and Engineering Research Council of Canada; NSF; NIH [HG004120]; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, P01HG004120, U54HG003273, ZIAHG000024] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank M. Ventura and M. Ross for sharing unpublished data; C. Lee for technical assistance; C. Campbell, J. Kidd, P. Green, and M. Hoopman for discussion; and T. Brown for manuscript preparation assistance. This work was supported by a Natural Sciences and Engineering Research Council of Canada Fellowship (P. H. S.), an NSF Graduate Research Fellowship (J.O.K.), and NIH grant HG004120 to E. E. E. E. E. E. is an Investigator of the Howard Hughes Medical Institute. E. E. E is on the scientific advisory board for Pacific Biosciences. A. T., N.S., and L. B. are employees of Agilent Technologies. J. S. is a member of the scientific advisory boards of Tandem Technologies, Stratos Genomics, Good Start Genetics, and Adaptive TCR. Sequence and array data are deposited at the NCBI under accessions SRP002878, SRP003500, SRP000031, SRP000032, and GSE24334.	*1000 GEN PROJ, 2010, NATURE          1028, DOI DOI 10.1038/NATURE09534; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Antonacci F, 2009, HUM MOL GENET, V18, P2555, DOI 10.1093/hmg/ddp187; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; Chen LT, 1999, J BIOL CHEM, V274, P26931, DOI 10.1074/jbc.274.38.26931; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cooper GM, 2008, NAT GENET, V40, P1199, DOI 10.1038/ng.236; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Dai L, 2009, AM J MED GENET A, V149A, P302, DOI 10.1002/ajmg.a.32652; Edelmann L, 2007, J MED GENET, V44, P136, DOI 10.1136/jmg.2006.044537; Estivill X, 2002, HUM MOL GENET, V11, P1987, DOI 10.1093/hmg/11.17.1987; Force A, 1999, GENETICS, V151, P1531; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Hageman GS, 2006, ANN MED, V38, P592, DOI 10.1080/07853890601097030; Hirayasu K, 2008, AM J HUM GENET, V82, P1075, DOI 10.1016/j.ajhg.2008.03.012; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Innan H, 2003, P NATL ACAD SCI USA, V100, P8793, DOI 10.1073/pnas.1031592100; Jiang Z, 2007, NAT GENET, V39, P1361, DOI 10.1038/ng.2007.9; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marques-Bonet T, 2009, NATURE, V457, P877, DOI 10.1038/nature07744; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; PALLANCK L, 1995, NATURE, V376, P25, DOI 10.1038/376025a0; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Shinawi M, 2009, NAT GENET, V41, P1269, DOI 10.1038/ng.481; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Urban TJ, 2009, NAT MED, V15, P1110, DOI 10.1038/nm1009-1110; Xue YL, 2008, AM J HUM GENET, V83, P337, DOI 10.1016/j.ajhg.2008.08.004	30	458	480	2	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 29	2010	330	6004					641	646		10.1126/science.1197005	http://dx.doi.org/10.1126/science.1197005			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672KB	21030649	Green Accepted, Green Submitted			2022-12-01	WOS:000283580600039
J	Kong, A; Thorleifsson, G; Gudbjartsson, DF; Masson, G; Sigurdsson, A; Jonasdottir, A; Walters, GB; Jonasdottir, A; Gylfason, A; Kristinsson, KT; Gudjonsson, SA; Frigge, ML; Helgason, A; Thorsteinsdottir, U; Stefansson, K				Kong, Augustine; Thorleifsson, Gudmar; Gudbjartsson, Daniel F.; Masson, Gisli; Sigurdsson, Asgeir; Jonasdottir, Aslaug; Walters, G. Bragi; Jonasdottir, Adalbjorg; Gylfason, Arnaldur; Kristinsson, Kari Th.; Gudjonsson, Sigurjon A.; Frigge, Michael L.; Helgason, Agnar; Thorsteinsdottir, Unnur; Stefansson, Kari			Fine-scale recombination rate differences between sexes, populations and individuals	NATURE			English	Article							HUMAN GENOME; MEIOTIC RECOMBINATION; SEQUENCE VARIANTS; SELECTION; HOTSPOTS; HUMANS; PRDM9; MAP; GENE	Meiotic recombinations contribute to genetic diversity by yielding new combinations of alleles. Recently, high-resolution recombination maps were inferred from high-density single-nucleotide polymorphism (SNP) data using linkage disequilibrium (LD) patterns that capture historical recombination events(1,2). The use of these maps has been demonstrated by the identification of recombination hotspots(2) and associated motifs(3), and the discovery that the PRDM(9) gene affects the proportion of recombinations occurring at hotspots(4-6). However, these maps provide no information about individual or sex differences. Moreover, locus-specific demographic factors like natural selection(7) can bias LD-based estimates of recombination rate. Existing genetic maps based on family data avoid these shortcomings(8), but their resolution is limited by relatively few meioses and a low density of markers. Here we used genome-wide SNP data from(15),257 parent-offspring pairs to construct the first recombination maps based on directly observed recombinations with a resolution that is effective down to 10 kilobases (kb). Comparing male and female maps reveals that about 15% of hot-spots in one sex are specific to that sex. Although male recombinations result in more shuffling of exons within genes, female recombinations generate more new combinations of nearby genes. We discover novel associations between recombination characteristics of individuals and variants in the PRDM9 gene and we identify new recombination hotspots. Comparisons of our maps with two LD-based maps inferred from data of HapMap populations of Utah residents with ancestry from northern and western Europe (CEU) and Yoruba in Ibadan, Nigeria (YRI) reveal population differences previously masked by noise and map differences at regions previously described as targets of natural selection.	[Kong, Augustine; Thorleifsson, Gudmar; Gudbjartsson, Daniel F.; Masson, Gisli; Sigurdsson, Asgeir; Jonasdottir, Aslaug; Walters, G. Bragi; Jonasdottir, Adalbjorg; Gylfason, Arnaldur; Kristinsson, Kari Th.; Gudjonsson, Sigurjon A.; Frigge, Michael L.; Helgason, Agnar; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Helgason, Agnar] Univ Iceland, Dept Anthropol, IS-101 Reykjavik, Iceland; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland	University of Iceland; University of Iceland	Kong, A (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	kong@decode.is; kari.stefansson@decode.is	Walters, G. Bragi/L-4215-2013; Stefansson, Kari/AAE-7187-2019; Helgason, Agnar/K-1522-2015	Walters, G. Bragi/0000-0002-5415-6487; Gudbjartsson, Daniel/0000-0002-5222-9857; Helgason, Agnar/0000-0002-8545-3767; Kong, Augustine/0000-0001-8193-5438; Gudjonsson, Sigurjon A./0000-0001-9314-7412				Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kong A, 2008, SCIENCE, V319, P1398, DOI 10.1126/science.1152422; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Lang MR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000744; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; O'Reilly PF, 2008, GENOME RES, V18, P1304, DOI 10.1101/gr.067181.107; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508	18	385	390	0	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 28	2010	467	7319					1099	1103		10.1038/nature09525	http://dx.doi.org/10.1038/nature09525			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671XW	20981099				2022-12-01	WOS:000283548600046
J	Neafsey, DE; Lawniczak, MKN; Park, DJ; Redmond, SN; Coulibaly, MB; Traore, SF; Sagnon, N; Costantini, C; Johnson, C; Wiegand, RC; Collins, FH; Lander, ES; Wirth, DF; Kafatos, FC; Besansky, NJ; Christophides, GK; Muskavitch, MAT				Neafsey, D. E.; Lawniczak, M. K. N.; Park, D. J.; Redmond, S. N.; Coulibaly, M. B.; Traore, S. F.; Sagnon, N.; Costantini, C.; Johnson, C.; Wiegand, R. C.; Collins, F. H.; Lander, E. S.; Wirth, D. F.; Kafatos, F. C.; Besansky, N. J.; Christophides, G. K.; Muskavitch, M. A. T.			SNP Genotyping Defines Complex Gene-Flow Boundaries Among African Malaria Vector Mosquitoes	SCIENCE			English	Article							ANOPHELES-GAMBIAE S.S.; INCIPIENT SPECIATION; MOLECULAR-FORMS; DIFFERENTIATION; DIVERGENCE; ISLANDS	Mosquitoes in the Anopheles gambiae complex show rapid ecological and behavioral diversification, traits that promote malaria transmission and complicate vector control efforts. A high-density, genome-wide mosquito SNP-genotyping array allowed mapping of genomic differentiation between populations and species that exhibit varying levels of reproductive isolation. Regions near centromeres or within polymorphic inversions exhibited the greatest genetic divergence, but divergence was also observed elsewhere in the genomes. Signals of natural selection within populations were overrepresented among genomic regions that are differentiated between populations, implying that differentiation is often driven by population-specific selective events. Complex genomic differentiation among speciating vector mosquito populations implies that tools for genome-wide monitoring of population structure will prove useful for the advancement of malaria eradication.	[Neafsey, D. E.; Park, D. J.; Johnson, C.; Wiegand, R. C.; Lander, E. S.; Wirth, D. F.; Muskavitch, M. A. T.] Broad Inst, Cambridge, MA 02142 USA; [Lawniczak, M. K. N.; Redmond, S. N.; Kafatos, F. C.; Christophides, G. K.] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Coulibaly, M. B.; Traore, S. F.] Malaria Res & Training Ctr, Bamako, Mali; [Sagnon, N.] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Costantini, C.] Inst Rech Dev, Unite Rech R016, Montpellier, France; [Costantini, C.] Org Coordinat Lutte Endemies Afrique Cent, Yaounde, Cameroon; [Collins, F. H.; Besansky, N. J.] Univ Notre Dame, Notre Dame, IN 46556 USA; [Wirth, D. F.; Muskavitch, M. A. T.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Muskavitch, M. A. T.] Boston Coll, Chestnut Hill, MA 02467 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Imperial College London; Institut de Recherche pour le Developpement (IRD); University of Notre Dame; Harvard University; Harvard T.H. Chan School of Public Health; Boston College	Muskavitch, MAT (corresponding author), Broad Inst, Cambridge, MA 02142 USA.	marc.muskavitch@bc.edu	Coulibaly, Mamadou/AAE-7006-2019; Costantini, Carlo/F-3470-2012	Costantini, Carlo/0000-0003-1016-129X; redmond, seth/0000-0003-2653-760X; Christophides, George/0000-0002-3323-1687; Lawniczak, Mara/0000-0002-3006-2080	Burroughs Wellcome Fund [1008238]; Broad Institute; Wellcome Trust [077229/Z/05/Z]; National Human Genome Research Institute; Harvard School of Public Health Department of Immunology and Infectious Diseases; Biotechnology and Biological Sciences Research Council [BB/E002641/1]; BBSRC [BB/E002641/1] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Broad Institute; Wellcome Trust(Wellcome TrustEuropean Commission); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Harvard School of Public Health Department of Immunology and Infectious Diseases; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by Burroughs Wellcome Fund Request 1008238, the Broad Institute Director's Fund, the Wellcome Trust Programme grant 077229/Z/05/Z to F.C.K. and G.K.C., National Human Genome Research Institute support to E.S.L., the Harvard School of Public Health Department of Immunology and Infectious Diseases, and the DeLuca Professorship from Boston College to M.A.T.M. In addition, M.K.N.L. was supported by a Biotechnology and Biological Sciences Research Council research grant BB/E002641/1 to G.K.C. Sequencing data for array validation have been deposited in the National Center for Biotechnology Information Short Read Archive with accession numbers SRX005397 to SRX005403. SNPs have been submitted to dbSNP Build B133 (ss/rs numbers in progress) and, meanwhile, are listed in the supporting online material. ArrayExpress accession number: A-AFFY-167.	Besansky NJ, 2003, P NATL ACAD SCI USA, V100, P10818, DOI 10.1073/pnas.1434337100; Butlin RK, 2005, MOL ECOL, V14, P2621, DOI 10.1111/j.1365-294X.2005.02617.x; Cassone BJ, 2008, MOL ECOL, V17, P2491, DOI 10.1111/j.1365-294X.2008.03774.x; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; Coluzzi M., 1982, Progress in Clinical and Biological Research, V96, P143; Curtis C.F., 1982, P290; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Enayati A, 2010, ANNU REV ENTOMOL, V55, P569, DOI 10.1146/annurev-ento-112408-085423; Fanello C, 2003, INSECT MOL BIOL, V12, P241, DOI 10.1046/j.1365-2583.2003.00407.x; Koufopanou V, 2002, MOL BIOL EVOL, V19, P239, DOI 10.1093/oxfordjournals.molbev.a004077; Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755; Lehmann T, 2008, INFECT GENET EVOL, V8, P737, DOI 10.1016/j.meegid.2008.06.003; Machado CA, 2002, MOL BIOL EVOL, V19, P472, DOI 10.1093/oxfordjournals.molbev.a004103; Manoukis NC, 2008, P NATL ACAD SCI USA, V105, P2940, DOI 10.1073/pnas.0709806105; Navarro A, 2003, EVOLUTION, V57, P447, DOI 10.1554/0014-3820(2003)057[0447:APIGIP]2.0.CO;2; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Rogers DW, 2008, P NATL ACAD SCI USA, V105, P19390, DOI 10.1073/pnas.0809723105; Slotman M, 2004, GENETICS, V167, P275, DOI 10.1534/genetics.167.1.275; Slotman MA, 2007, MOL ECOL, V16, P639, DOI 10.1111/j.1365-294X.2006.03172.x; Slotman MA, 2006, AM J TROP MED HYG, V74, P641, DOI 10.4269/ajtmh.2006.74.641; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Stump AD, 2005, P NATL ACAD SCI USA, V102, P15930, DOI 10.1073/pnas.0508161102; Takken W, 2002, TROP MED INT HEALTH, V7, P1022, DOI 10.1046/j.1365-3156.2002.00983.x; Tripet F, 2001, MOL ECOL, V10, P1725, DOI 10.1046/j.0962-1083.2001.01301.x; Trung HD, 2005, TROP MED INT HEALTH, V10, P251, DOI 10.1111/j.1365-3156.2004.01378.x; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Via S, 2009, P NATL ACAD SCI USA, V106, P9939, DOI 10.1073/pnas.0901397106; White BJ, 2010, MOL ECOL, V19, P925, DOI 10.1111/j.1365-294X.2010.04531.x; White BJ, 2007, PLOS GENET, V3, P2404, DOI 10.1371/journal.pgen.0030217; Wu CI, 2004, NAT REV GENET, V5, P114, DOI 10.1038/nrg1269	33	134	134	4	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					514	517		10.1126/science.1193036	http://dx.doi.org/10.1126/science.1193036			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966254	Green Published, Green Accepted			2022-12-01	WOS:000283329100043
J	Rosenzweig, C; Solecki, W; Hammer, SA; Mehrotra, S				Rosenzweig, Cynthia; Solecki, William; Hammer, Stephen A.; Mehrotra, Shagun			Cities lead the way in climate-change action	NATURE			English	Editorial Material									[Rosenzweig, Cynthia] Goddard Inst Space Studies, Climate Impacts Grp, New York, NY 10025 USA; [Solecki, William] CUNY, Inst Sustainable Cities, New York, NY 10065 USA; [Hammer, Stephen A.] Joint US China Collaborat Clean Energy, Energy Smart Cities Initiat, Shanghai 200041, Peoples R China; [Mehrotra, Shagun] Columbia Univ, Earth Inst, Climate & Cities Facil, New York, NY 10027 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; City University of New York (CUNY) System; Columbia University	Rosenzweig, C (corresponding author), Goddard Inst Space Studies, Climate Impacts Grp, New York, NY 10025 USA.	crosenzweig@giss.nasa.gov						Bloomberg MR, 2010, ANN NY ACAD SCI, V1196, P1, DOI [10.1111/j.1749-6632.2009.05415.x, 10.1111/j.1749-6632.2009.05415_1.x]; de Sherbinin A., 2011, CHOICE REV ONLINE; Mehrotra S., 2009, 5 URB RES S; Parry M., 2007, CLIMATE CHANGE 2007; United Nations, 2009, WORLD POP PROSP 2009; World Bank, 2010, WORLD DEV REP 2010 D	6	437	442	11	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 21	2010	467	7318					909	911		10.1038/467909a	http://dx.doi.org/10.1038/467909a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	668FT	20962822				2022-12-01	WOS:000283254700014
J	Arii, J; Goto, H; Suenaga, T; Oyama, M; Kozuka-Hata, H; Imai, T; Minowa, A; Akashi, H; Arase, H; Kawaoka, Y; Kawaguchi, Y				Arii, Jun; Goto, Hideo; Suenaga, Tadahiro; Oyama, Masaaki; Kozuka-Hata, Hiroko; Imai, Takahiko; Minowa, Atsuko; Akashi, Hiroomi; Arase, Hisashi; Kawaoka, Yoshihiro; Kawaguchi, Yasushi			Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1	NATURE			English	Article							LIGHT-CHAIN KINASE; CATALYTIC-ACTIVITY; CELL-FUSION; GLYCOPROTEINS GB; MEMBRANE-FUSION; IN-VITRO; PROTEIN; ACTIVATION; ALPHA; US3	Herpes simplex virus-1 (HSV-1), the prototype of the a-herpesvirus family, causes life-long infections in humans. Although generally associated with various mucocutaneous diseases, HSV-1 is also involved in lethal encephalitis(1). HSV-1 entry into host cells requires cellular receptors for both envelope glycoproteins B (gB) and D (gD)(2-4). However, the gB receptors responsible for its broad host range in vitro and infection of critical targets in vivo1 remain unknown. Here we show that non-muscle myosin heavy chain IIA (NMHC-IIA), a subunit of non-muscle myosin IIA (NM-IIA), functions as an HSV-1 entry receptor by interacting with gB. A cell line that is relatively resistant to HSV-1 infection(5) became highly susceptible to infection by this virus when NMHC-IIA was overexpressed. Antibody to NMHC-IIA blocked HSV-1 infection in naturally permissive target cells. Furthermore, knockdown of NMHC-IIA in the permissive cells inhibited HSV-1 infection as well as cell-cell fusion when gB, gD, gH and gL were coexpressed. Cell-surface expression of NMHC-IIA was markedly and rapidly induced during the initiation of HSV-1 entry. A specific inhibitor of myosin light chain kinase, which regulates NM-IIA by phosphorylation(6), reduced the redistribution of NMHC-IIA as well as HSV-1 infection in cell culture and in a murine model for herpes stromal keratitis. NMHC-IIA is ubiquitously expressed in various human tissues and cell types(7) and, therefore, is implicated as a functional gB receptor that mediates broad HSV-1 infectivity both in vitro and in vivo. The identification of NMHC-IIA as an HSV-1 entry receptor and the involvement of NM-IIA regulation in HSV-1 infection provide an insight into HSV-1 entry and identify new targets for antiviral drug development.	[Arii, Jun; Imai, Takahiko; Minowa, Atsuko; Kawaguchi, Yasushi] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis,Div Viral Infect, Dept Infect Dis Control,Minato Ku, Tokyo 1088639, Japan; [Arii, Jun; Akashi, Hiroomi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Microbiol, Bunkyo Ku, Tokyo 1138657, Japan; [Goto, Hideo; Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol,Minato Ku, Tokyo 1088639, Japan; [Suenaga, Tadahiro; Arase, Hisashi] Osaka Univ, Microbial Dis Res Inst, Dept Immunochem, Suita, Osaka 5650871, Japan; [Oyama, Masaaki; Kozuka-Hata, Hiroko] Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo 1088639, Japan; [Arase, Hisashi] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Arase, Hisashi] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Special Pathogens,Minato Ku, Tokyo 1088639, Japan; [Kawaoka, Yoshihiro] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53711 USA; [Kawaoka, Yoshihiro] ERATO Infect Induced Host Responses Project, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Osaka University; University of Tokyo; Osaka University; Japan Science & Technology Agency (JST); University of Tokyo; University of Wisconsin System; University of Wisconsin Madison; Japan Science & Technology Agency (JST)	Kawaguchi, Y (corresponding author), Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis,Div Viral Infect, Dept Infect Dis Control,Minato Ku, Tokyo 1088639, Japan.	ykawagu@ims.u-tokyo.ac.jp	Arase, Hisashi/C-8442-2009	Arase, Hisashi/0000-0002-1153-3166; Kozuka-Hata, Hiroko/0000-0002-9286-6594; Oyama, Masaaki/0000-0001-6478-3735; Kawaguchi, Yasushi/0000-0001-8232-6925	Japan Initiative for Global Research Network on Infectious Diseases; Founding Research Center for Emerging; Ministry of Education, Science, Sports and Culture of Japan; Ministry of Health of Japan; Takeda Science Foundation; ERATO (Japan Science and Technology Agency); Japan Society for the Promotion of Science	Japan Initiative for Global Research Network on Infectious Diseases(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Founding Research Center for Emerging; Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health of Japan; Takeda Science Foundation(Takeda Science Foundation (TSF)); ERATO (Japan Science and Technology Agency)(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank P. G. Spear, L. W. Enquist, Y. Matsuura, N. Mizushima, S. Sugano, R. Adelstein, T. Ichimura, K. Araki-Sasaki, Y. Mori and M. Takahashi for providing reagents, S. Koyama for technical assistance and K. Wells and S. Watson for critical reading of this manuscript. This study was supported by Grants-in-aid for Scientific Research, Grants-in-aid for Scientific Research in Priority Areas, Grants-in-aid for Specially Promoted Research, and contract research funds for the Program of Japan Initiative for Global Research Network on Infectious Diseases and the Program of Founding Research Center for Emerging and Reemerging Infectious Diseases from the Ministry of Education, Science, Sports and Culture of Japan, by Grants-in-aid from the Ministry of Health of Japan, by grants from the Takeda Science Foundation, and by ERATO (Japan Science and Technology Agency). J. A. was supported by research fellowships from the Japan Society for the Promotion of Science by Young Scientists.	[Anonymous], 2007, FIELDS VIROLOGY; Arii J, 2009, J VIROL, V83, P4520, DOI 10.1128/JVI.02601-08; Balliet JW, 2006, J VIROL, V80, P440, DOI 10.1128/JVI.80.1.440-450.2006; Bender FC, 2003, J VIROL, V77, P9542, DOI 10.1128/JVI.77.17.9542-9552.2003; CHAMSAI PT, 1989, VIROLOGY, V170, P468, DOI 10.1016/0042-6822(89)90438-8; Cheshenko N, 2003, J CELL BIOL, V163, P283, DOI 10.1083/jcb.200301084; Demmin GL, 2001, J VIROL, V75, P10856, DOI 10.1128/JVI.75.22.10856-10869.2001; Gallagher PJ, 1997, J MUSCLE RES CELL M, V18, P1, DOI 10.1023/A:1018616814417; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Haraguchi T, 2007, FEBS LETT, V581, P4949, DOI 10.1016/j.febslet.2007.09.028; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kato A, 2008, J VIROL, V82, P6172, DOI 10.1128/JVI.00044-08; Kawaguchi Y, 1997, J VIROL, V71, P1019, DOI 10.1128/JVI.71.2.1019-1024.1997; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; LI DQ, 1994, P NATL ACAD SCI USA, V91, P853, DOI 10.1073/pnas.91.3.853; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nebl T, 2002, J BIOL CHEM, V277, P43399, DOI 10.1074/jbc.M205386200; Okuma K, 1999, VIROLOGY, V254, P235, DOI 10.1006/viro.1998.9530; OLDEN K, 1976, CELL, V8, P383, DOI 10.1016/0092-8674(76)90150-1; Oyama M, 2009, MOL CELL PROTEOMICS, V8, P226, DOI 10.1074/mcp.M800186-MCP200; Pertel PE, 2001, VIROLOGY, V279, P313, DOI 10.1006/viro.2000.0713; Polcicova K, 2005, P NATL ACAD SCI USA, V102, P11462, DOI 10.1073/pnas.0503230102; Sagou K, 2009, J VIROL, V83, P5773, DOI 10.1128/JVI.00103-09; SAITOH M, 1987, J BIOL CHEM, V262, P7796; SARMIENTO M, 1979, J VIROL, V29, P1149, DOI 10.1128/JVI.29.3.1149-1158.1979; Sato MK, 2007, MOL BIOL CELL, V18, P1009, DOI 10.1091/mbc.E06-08-0706; Satoh T, 2008, CELL, V132, P935, DOI 10.1016/j.cell.2008.01.043; Shimizu S, 2006, J PHYSIOL-LONDON, V570, P219, DOI 10.1113/jphysiol.2005.097998; Spear PG, 2006, VIROLOGY, V344, P17, DOI 10.1016/j.virol.2005.09.016; Suenaga T, 2010, P NATL ACAD SCI USA, V107, P866, DOI 10.1073/pnas.0913351107; TOOTHAKER LE, 1991, BLOOD, V78, P1826; Turner A, 1998, J VIROL, V72, P873, DOI 10.1128/JVI.72.1.873-875.1998; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Watanabe T, 2007, MOL BIOL CELL, V18, P605, DOI 10.1091/mbc.E06-07-0590	34	158	173	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2010	467	7317					859	U129		10.1038/nature09420	http://dx.doi.org/10.1038/nature09420			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944748				2022-12-01	WOS:000282898700070
J	Vaaje-Kolstad, G; Westereng, B; Horn, SJ; Liu, ZL; Zhai, H; Sorlie, M; Eijsink, VGH				Vaaje-Kolstad, Gustav; Westereng, Bjorge; Horn, Svein J.; Liu, Zhanliang; Zhai, Hong; Sorlie, Morten; Eijsink, Vincent G. H.			An Oxidative Enzyme Boosting the Enzymatic Conversion of Recalcitrant Polysaccharides	SCIENCE			English	Article							BINDING PROTEIN CBP21; GLYCOSIDE HYDROLASE FAMILY; SERRATIA-MARCESCENS; BIOFUELS	Efficient enzymatic conversion of crystalline polysaccharides is crucial for an economically and environmentally sustainable bioeconomy but remains unfavorably inefficient. We describe an enzyme that acts on the surface of crystalline chitin, where it introduces chain breaks and generates oxidized chain ends, thus promoting further degradation by chitinases. This enzymatic activity was discovered and further characterized by using mass spectrometry and chromatographic separation methods to detect oxidized products generated in the absence or presence of H(2)(18)O or (18)O(2). There are strong indications that similar enzymes exist that work on cellulose. Our findings not only demonstrate the existence of a hitherto unknown enzyme activity but also provide new avenues toward more efficient enzymatic conversion of biomass.	[Vaaje-Kolstad, Gustav; Westereng, Bjorge; Horn, Svein J.; Liu, Zhanliang; Zhai, Hong; Sorlie, Morten; Eijsink, Vincent G. H.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway	Norwegian University of Life Sciences	Eijsink, VGH (corresponding author), Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, POB 5003, N-1432 As, Norway.	vincent.eijsink@umb.no	Westereng, Bjørge/A-1688-2013; Horn, Svein/F-9723-2010; Horn, Svein Jarle/C-6258-2008	Westereng, Bjørge/0000-0002-5141-7231; Horn, Svein Jarle/0000-0002-1590-9001; Vaaje-Kolstad, Gustav/0000-0002-3077-8003	Norwegian Research Council [171991/V40, 164653, 186946/I30, 190877/S60]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	We thank A. C. Bunaes for technical assistance and G. Vriend for helpful discussions. This work was supported by Norwegian Research Council grants 171991/V40, 164653, 186946/I30, and 190877/S60.	Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Davies GJ, 2003, BIOCHEM SOC T, V31, P523, DOI 10.1042/BST0310523; Eijsink VGH, 2008, TRENDS BIOTECHNOL, V26, P228, DOI 10.1016/j.tibtech.2008.02.004; Fetzner S, 2010, APPL MICROBIOL BIOT, V86, P791, DOI 10.1007/s00253-010-2455-0; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Karkehabadi S, 2008, J MOL BIOL, V383, P144, DOI 10.1016/j.jmb.2008.08.016; Moser F, 2008, BIOTECHNOL BIOENG, V100, P1066, DOI 10.1002/bit.21856; REESE ET, 1950, J BACTERIOL, V59, P485, DOI 10.1128/JB.59.4.485-497.1950; Suzuki K, 1998, BIOSCI BIOTECH BIOCH, V62, P128, DOI 10.1271/bbb.62.128; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P28492, DOI 10.1074/jbc.M504468200; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P11313, DOI 10.1074/jbc.M407175200; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010	14	815	853	16	412	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					219	222		10.1126/science.1192231	http://dx.doi.org/10.1126/science.1192231			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20929773				2022-12-01	WOS:000282644600041
J	Tsukahara, T; Tanno, Y; Watanabe, Y				Tsukahara, Tatsuya; Tanno, Yuji; Watanabe, Yoshinori			Phosphorylation of the CPC by Cdk1 promotes chromosome bi-orientation	NATURE			English	Article							SISTER-CHROMATID COHESION; FISSION YEAST; CELL-DIVISION; SCHIZOSACCHAROMYCES-POMBE; AURORA-B; MICROTUBULE ATTACHMENT; PASSENGER COMPLEX; INNER CENTROMERE; MITOTIC SPINDLE; MEIOSIS-I	Successful partition of replicated genomes at cell division requires chromosome attachment to opposite poles of mitotic spindle (bi-orientation). Any defects in this regulation bring about chromosomal instability, which may accelerate tumour progression in humans. To achieve chromosome bi-orientation at prometaphase, the chromosomal passenger complex (CPC), composed of catalytic kinase Aurora B and regulatory components (INCENP, Survivin and Borealin), must be localized to centromeres to phosphorylate kinetochore substrates(1-7). Although the CPC dynamically changes the subcellular localization, the regulation of centromere targeting is largely unknown(1). Here we isolated a fission yeast cyclin B mutant defective specifically in chromosome bi-orientation. Accordingly, we identified Cdk1 (also known as Cdc2)-cyclin-B-dependent phosphorylation of Survivin. Preventing Survivin phosphorylation impairs centromere CPC targeting as well as chromosome bi-orientation, whereas phosphomimetic Survivin suppresses the bi-orientation defect in the cyclin B mutant. Survivin phosphorylation promotes direct binding with shugoshin(8,9), which we now define as a conserved centromeric adaptor of the CPC. In human cells, the phosphorylation of Borealin has a comparable role. Thus, our study resolves the conserved mechanisms of CPC targeting to centromeres, highlighting a key role of Cdk1-cyclin B in chromosome bi-orientation.	[Tsukahara, Tatsuya; Watanabe, Yoshinori] Univ Tokyo, Grad Sch Sci, Grad Program Biophys & Biochem, Tokyo 1130032, Japan; [Tsukahara, Tatsuya; Tanno, Yuji; Watanabe, Yoshinori] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan	University of Tokyo; University of Tokyo	Watanabe, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Grad Program Biophys & Biochem, Tokyo 1130032, Japan.	ywatanab@iam.u-tokyo.ac.jp	Tsukahara, Tatsuya/AAO-1707-2021	Tsukahara, Tatsuya/0000-0002-6928-8562; Watanabe, Yoshinori/0000-0002-5488-4812	Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms); JSPS; MEXT, Japan; Grants-in-Aid for Scientific Research [21000010] Funding Source: KAKEN	Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Hauf for critically reading the manuscript and the Yeast Genetic Resource Center (YGRC) for yeast strains, and all the members of our laboratory, particularly S. A. Kawashima, for their valuable support and discussion. This work was supported in part by Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), JSPS Research Fellowship (to T.T. and Y.T.) and a Grant-in-Aid for Specially Promoted Research, MEXT, Japan (to Y.W.).	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bohnert KA, 2009, MOL BIOL CELL, V20, P3646, DOI 10.1091/mbc.E09-04-0289; Boyarchuk Y, 2007, J CELL BIOL, V176, P919, DOI 10.1083/jcb.200609044; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Chen Q, 2008, CELL RES, V18, P268, DOI 10.1038/cr.2008.11; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; HIRAOKA Y, 1984, CELL, V39, P349, DOI 10.1016/0092-8674(84)90013-8; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Huang HM, 2007, J CELL BIOL, V177, P413, DOI 10.1083/jcb.200701122; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Klein UR, 2006, MOL BIOL CELL, V17, P2547, DOI 10.1091/mbc.E05-12-1133; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Liu ST, 2003, NAT CELL BIOL, V5, P341, DOI 10.1038/ncb953; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; NASMYTH K, 1981, MOL GEN GENET, V182, P119, DOI 10.1007/BF00422777; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Rajagopalan S, 2002, GENETICS, V160, P445; Resnick TD, 2006, DEV CELL, V11, P57, DOI 10.1016/j.devcel.2006.04.021; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; Tanaka TU, 2008, CHROMOSOMA, V117, P521, DOI 10.1007/s00412-008-0173-5; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Vanoosthuyse V, 2007, MOL BIOL CELL, V18, P1657, DOI 10.1091/mbc.E06-10-0890; Watanabe Y, 2005, CURR OPIN CELL BIOL, V17, P590, DOI 10.1016/j.ceb.2005.10.003; Xu Z, 2009, MOL CELL, V35, P426, DOI 10.1016/j.molcel.2009.06.031; Yamagishi Y, 2008, NATURE, V455, P251, DOI 10.1038/nature07217; Yokobayashi S, 2003, MOL CELL BIOL, V23, P3965, DOI 10.1128/MCB.23.11.3965-3973.2003; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013	35	179	183	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 7	2010	467	7316					719	U111		10.1038/nature09390	http://dx.doi.org/10.1038/nature09390			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659NE	20739936				2022-12-01	WOS:000282572500041
J	Xiang, KH; Nagaike, T; Xiang, S; Kilic, T; Beh, MM; Manley, JL; Tong, LA				Xiang, Kehui; Nagaike, Takashi; Xiang, Song; Kilic, Turgay; Beh, Maia M.; Manley, James L.; Tong, Liang			Crystal structure of the human symplekin-Ssu72-CTD phosphopeptide complex	NATURE			English	Article							RNA-POLYMERASE-II; C-TERMINAL DOMAIN; ESS1 PROLYL ISOMERASE; MESSENGER-RNA; TRANSCRIPTION TERMINATION; MACROMOLECULAR STRUCTURES; POLYADENYLATION FACTOR; ANOMALOUS DIFFRACTION; SSU72; PHOSPHATASE	Symplekin (Pta1 in yeast) is a scaffold in the large protein complex that is required for 3'-end cleavage and polyadenylation of eukaryotic messenger RNA precursors (pre-mRNAs)(1-4); it also participates in transcription initiation and termination by RNA polymerase II (Pol II)(5,6). Symplekin mediates interactions between many different proteins in this machinery(1,2,7-9), although the molecular basis for its function is not known. Here we report the crystal structure at 2.4 angstrom resolution of the amino-terminal domain (residues 30-340) of human symplekin in a ternary complex with the Pol II carboxyterminal domain (CTD) Ser 5 phosphatase Ssu72 (refs 7, 10-17) and a CTD Ser 5 phosphopeptide. The N-terminal domain of symplekin has the ARM or HEAT fold, with seven pairs of antiparallel a-helices arranged in the shape of an arc. The structure of Ssu72 has some similarity to that of low-molecular-mass phosphotyrosine protein phosphatase(18,19), although Ssu72 has a unique active-site landscape as well as extra structural features at the C terminus that are important for interaction with symplekin. Ssu72 is bound to the concave face of symplekin, and engineered mutations in this interface can abolish interactions between the two proteins. The CTD peptide is bound in the active site of Ssu72, with the pSer 5-Pro 6 peptide bond in the cis configuration, which contrasts with all other known CTD peptide conformations(20,21). Although the active site of Ssu72 is about 25 angstrom from the interface with symplekin, we found that the symplekin N-terminal domain stimulates Ssu72 CTD phosphatase activity in vitro. Furthermore, the N-terminal domain of symplekin inhibits polyadenylation in vitro, but only when coupled to transcription. Because catalytically active Ssu72 overcomes this inhibition, our results show a role for mammalian Ssu72 in transcription-coupled pre-mRNA 3'-end processing.	[Xiang, Kehui; Nagaike, Takashi; Xiang, Song; Kilic, Turgay; Beh, Maia M.; Manley, James L.; Tong, Liang] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Tong, LA (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ltong@columbia.edu	KILIC, TURGAY/O-4493-2014; Xiang, Song/AAF-6422-2019	KILIC, TURGAY/0000-0003-2233-950X; Xiang, Song/0000-0001-9314-4684; Tong, Liang/0000-0002-0563-6468; Xiang, Kehui/0000-0002-3770-1367; Manley, James/0000-0002-8341-1459	National Institutes of Health [GM077175, GM028983]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077175, R01GM028983] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Forouhar and J. Seetharaman for help with data collection; T. Auperin for initial experiments with symplekin; R. Abramowitz and J. Schwanof for setting up the X4C beamline; S. Myers for setting up the X29A beamline at the National Synchrotron Light Source; M. Heidemann and D. Eick for providing the 3E10 antibody; N. Rao and C. Logan for HeLa nuclear extract and help with in vitro assays; and J. Decatur for characterizing the phosphopeptide by NMR. This research is supported in part by grants from the National Institutes of Health to L.T. (GM077175) and J.L.M. (GM028983).	Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calvo O, 2003, GENE DEV, V17, P1321, DOI 10.1101/gad.1093603; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Dichtl B, 2002, MOL CELL, V10, P1139, DOI 10.1016/S1097-2765(02)00707-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ganem C, 2003, EMBO J, V22, P1588, DOI 10.1093/emboj/cdg141; Ghazy MA, 2009, MOL CELL BIOL, V29, P2296, DOI 10.1128/MCB.01514-08; Hausmann S, 2005, J BIOL CHEM, V280, P37681, DOI 10.1074/jbc.M505292200; He XY, 2003, GENE DEV, V17, P1030, DOI 10.1101/gad.1075203; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Hirose Y, 1998, NATURE, V395, P93, DOI 10.1038/25786; Jogl G, 2001, ACTA CRYSTALLOGR D, V57, P1127, DOI 10.1107/S0907444901006783; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kennedy SA, 2009, J MOL BIOL, V392, P115, DOI 10.1016/j.jmb.2009.06.062; Krishnamurthy S, 2004, MOL CELL, V14, P387, DOI 10.1016/S1097-2765(04)00235-7; Krishnamurthy S, 2009, MOL CELL BIOL, V29, P2925, DOI 10.1128/MCB.01655-08; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Meinhart A, 2003, J BIOL CHEM, V278, P15917, DOI 10.1074/jbc.M301643200; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nedea E, 2003, J BIOL CHEM, V278, P33000, DOI 10.1074/jbc.M304454200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reyes-Reyes M, 2007, MOL CELL BIOL, V27, P926, DOI 10.1128/MCB.01361-06; Rozenblatt-Rosen O, 2009, P NATL ACAD SCI USA, V106, P755, DOI 10.1073/pnas.0812023106; Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028; Singh N, 2009, MOL CELL, V36, P255, DOI 10.1016/j.molcel.2009.08.018; St-Pierre B, 2005, NUCLEIC ACIDS RES, V33, P464, DOI 10.1093/nar/gki171; SU XD, 1994, NATURE, V370, P575, DOI 10.1038/370575a0; TAKAGAKI Y, 1988, CELL, V52, P731, DOI 10.1016/0092-8674(88)90411-4; Takagaki Y, 2000, MOL CELL BIOL, V20, P1515, DOI 10.1128/MCB.20.5.1515-1525.2000; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Xu YX, 2003, GENE DEV, V17, P2765, DOI 10.1101/gad.1135503; ZHANG M, 1994, BIOCHEMISTRY-US, V33, P11097, DOI 10.1021/bi00203a006; Zhang Y, 2006, MOL CELL, V24, P759, DOI 10.1016/j.molcel.2006.10.027; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zhao J, 1999, MOL CELL BIOL, V19, P7733	41	114	117	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 7	2010	467	7316					729	U124		10.1038/nature09391	http://dx.doi.org/10.1038/nature09391			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659NE	20861839	Green Accepted			2022-12-01	WOS:000282572500043
J	Balskus, EP; Walsh, CT				Balskus, Emily P.; Walsh, Christopher T.			The Genetic and Molecular Basis for Sunscreen Biosynthesis in Cyanobacteria	SCIENCE			English	Article							AMINO-ACIDS; MYCOSPORINES; SUPERFAMILY; ORGANISMS; PATHWAY; ENZYMES; GENOME	Ultraviolet UV-A and UV-B radiation is harmful to living systems, causing damage to biological macromolecules. An important strategy for dealing with UV exposure is the biosynthesis of small-molecule sunscreens. Among such metabolites, the mycosporine and mycosporine-like amino acids (MAAs) are remarkable for their wide phylogenetic distribution and their unique chemical structures. Here, we report the identification of a MAA biosynthetic gene cluster in a cyanobacterium and the discovery of analogous pathways in other sequenced organisms. We have expressed the cluster in a heterologous bacterial host and characterized all four biosynthetic enzymes in vitro. In addition to clarifying the origin of the MAAs, these efforts have revealed two unprecedented enzymatic strategies for imine formation.	[Balskus, Emily P.; Walsh, Christopher T.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Walsh, CT (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	christopher_walsh@hms.harvard.edu			NIH [GM-20011]; NIH NRSA [GM-084625]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM084625, R01GM020011, R37GM020011] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the NIH (GM-20011). E. P. B. is the recipient of an NIH NRSA postdoctoral fellowship (GM-084625). We acknowledge Tri-K Industries (Northvale, NJ) for providing a sample of Helioguard 365 containing authentic standards of shinorine and porphyra-334.	Adams NL, 2001, MAR BIOL, V138, P267, DOI 10.1007/s002270000463; Bandaranayake WM, 1998, NAT PROD REP, V15, P159; BENDER SL, 1989, BIOCHEMISTRY-US, V28, P7555, DOI 10.1021/bi00445a009; Cockell CS, 1999, BIOL REV, V74, P311, DOI 10.1017/S0006323199005356; de la Coba F, 2009, J DERMATOL SCI, V55, P161, DOI 10.1016/j.jdermsci.2009.06.004; DEHORTER B, 1980, PHYTOCHEMISTRY, V19, P2311, DOI 10.1016/S0031-9422(00)91017-3; Dunlap WC, 1998, J PHYCOL, V34, P418, DOI 10.1046/j.1529-8817.1998.340418.x; FAVREBONVIN J, 1987, PHYTOCHEMISTRY, V26, P2509, DOI 10.1016/S0031-9422(00)83866-2; FAVREBONVIN J, 1976, CAN J CHEM, V54, P1105, DOI 10.1139/v76-158; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Galperin MY, 1997, PROTEIN SCI, V6, P2639; LEMOYNE F, 1985, Zeitschrift fuer Naturforschung Section C Journal of Biosciences, V40, P612; Mahmud T, 2007, J NAT PROD, V70, P1384, DOI 10.1021/np070210q; Neale PJ, 1998, J PHYCOL, V34, P928, DOI 10.1046/j.1529-8817.1998.340928.x; Oren A, 1997, GEOMICROBIOL J, V14, P231, DOI 10.1080/01490459709378046; Oren A, 2007, FEMS MICROBIOL LETT, V269, P1, DOI 10.1111/j.1574-6968.2007.00650.x; Portwich A, 2003, PHYCOLOGIA, V42, P384, DOI 10.2216/i0031-8884-42-4-384.1; Shick JM, 2002, ANNU REV PHYSIOL, V64, P223, DOI 10.1146/annurev.physiol.64.081501.155802; Singh SP, 2010, GENOMICS, V95, P120, DOI 10.1016/j.ygeno.2009.10.002; Singh SP, 2008, PHOTOCHEM PHOTOBIOL, V84, P1500, DOI 10.1111/j.1751-1097.2008.00376.x; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Starcevic A, 2008, P NATL ACAD SCI USA, V105, P2533, DOI 10.1073/pnas.0707388105; TRIONE EJ, 1966, NATURE, V212, P163, DOI 10.1038/212163a0; WHITE JD, 1989, J AM CHEM SOC, V111, P8970, DOI 10.1021/ja00206a059; Wu X, 2007, CHEMBIOCHEM, V8, P239, DOI 10.1002/cbic.200600446; Yakovleva I, 2004, COMP BIOCHEM PHYS B, V139, P721, DOI 10.1016/j.cbpc.2004.08.016	26	224	236	2	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1653	1656		10.1126/science.1193637	http://dx.doi.org/10.1126/science.1193637			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20813918	Green Accepted, Green Submitted			2022-12-01	WOS:000282098100044
J	Narayan, KMV; Ali, MK; Koplan, JP				Narayan, K. M. Venkat; Ali, Mohammed K.; Koplan, Jeffrey P.			GLOBAL HEALTH Global Noncommunicable Diseases - Where Worlds Meet	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Narayan, K. M. Venkat] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; Emory Univ, Emory Global Hlth Inst, Atlanta, GA USA	Emory University; Rollins School Public Health; Emory University	Narayan, KMV (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.		Ali, Mohammed K/N-9833-2013; Narayan, K.M. Venkat/J-9819-2012	Narayan, K.M. Venkat/0000-0001-8621-5405; Ali, Mohammed/0000-0001-7266-2503				Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; Schiffman M, 2009, NEW ENGL J MED, V360, P1453, DOI 10.1056/NEJMe0901167; World Health Organization, 2009, GLOB HLTH RISKS MORT; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5	5	193	203	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2010	363	13					1196	1198		10.1056/NEJMp1002024	http://dx.doi.org/10.1056/NEJMp1002024			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	652ZA	20860499				2022-12-01	WOS:000282050000002
J	Manel, N; Hogstad, B; Wang, YM; Levy, DE; Unutmaz, D; Littman, DR				Manel, Nicolas; Hogstad, Brandon; Wang, Yaming; Levy, David E.; Unutmaz, Derya; Littman, Dan R.			A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELLS; TRANS-ENHANCEMENT; DC-SIGN; INFECTION; REPLICATION; VECTORS; RNA; DIFFERENTIATION; TRANSDUCTION	Dendritic cells serve a key function in host defence, linking innate detection of microbes to activation of pathogen-specific adaptive immune responses(1,2). Whether there is cell-intrinsic recognition of human immunodeficiency virus (HIV) by host innate pattern-recognition receptors and subsequent coupling to antiviral T-cell responses is not yet known(3). Dendritic cells are largely resistant to infection with HIV-1(4), but facilitate infection of co-cultured T-helper cells through a process of trans-enhancement(5,6). Here we show that, when dendritic cell resistance to infection is circumvented(7,8), HIV-1 induces dendritic cell maturation, an antiviral type I interferon response and activation of T cells. This innate response is dependent on the interaction of newly synthesized HIV-1 capsid with cellular cyclophilin A (CYPA) and the subsequent activation of the transcription factor IRF3. Because the peptidylprolyl isomerase CYPA also interacts with HIV-1 capsid to promote infectivity, our results indicate that capsid conformation has evolved under opposing selective pressures for infectivity versus furtiveness. Thus, a cell-intrinsic sensor for HIV-1 exists in dendritic cells and mediates an antiviral immune response, but it is not typically engaged owing to the absence of dendritic cell infection. The virulence of HIV-1 may be related to evasion of this response, the manipulation of which may be necessary to generate an effective HIV-1 vaccine.	[Manel, Nicolas; Hogstad, Brandon; Littman, Dan R.] NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med,Mol Pathogenesis Program, New York, NY 10016 USA; [Manel, Nicolas] Univ Montpellier 1 & 2, Inst Genet Mol Montpellier, CNRS, UMR5535, F-34070 Montpellier, France; [Hogstad, Brandon; Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Wang, Yaming; Levy, David E.; Unutmaz, Derya; Littman, Dan R.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Wang, Yaming; Levy, David E.] NYU, Sch Med, Inst Canc, New York, NY 10016 USA; [Unutmaz, Derya; Littman, Dan R.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	New York University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Howard Hughes Medical Institute; New York University; New York University; New York University; New York University	Littman, DR (corresponding author), NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med,Mol Pathogenesis Program, New York, NY 10016 USA.	dan.littman@med.nyu.edu	Levy, David/AAG-6202-2019; Manel, Nicolas/E-2128-2011; Levy, David/GPS-4945-2022	Levy, David/0000-0002-7320-7788; Manel, Nicolas/0000-0002-1481-4430; Unutmaz, Derya/0000-0001-8898-6633	EMBO; Cancer Research Institute; Institut National de la Sante et de la Recherche Medicale; Howard Hughes Medical Institute; Helen and Martin Kimmel Center for Biology and Medicine; National Institutes of Health (NIH) [AI33856, AI28900, U54AI57168, R01AI065303]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI084633, U54AI057158, R01AI065303, R01AI028900, R01AI033856, U54AI057168] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); Cancer Research Institute; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Helen and Martin Kimmel Center for Biology and Medicine; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Littman laboratory for valuable discussions and critical reading of the manuscript, and T. Egawa, E. Kurz, X. Gong and L. Kozyhaya for assistance with experiments. We thank S. Hopkins at Scynexis for the gift of the SCY compound, J. Zavadil and the genomic core facility of New York University Medical Center for performing the array studies, M. Emerman, M. Yamashita and W. Sundquist for HIV constructs and critical reading of the manuscript, B. Walker, A. Piechocka-Trocha, D. Kwon, S. M. Vine, N. Bardhwaj and E. Miller for T-cell clones and reagents, and S. Schwab and R. Medzhitov for critical reading of the manuscript. N. M. thanks M. Sitbon, N. Taylor and J.-M. Blanchard for continuous support. The work was supported sequentially by EMBO and Cancer Research Institute fellowships (N.M.), by the Institut National de la Sante et de la Recherche Medicale (N.M.), by the Howard Hughes Medical Institute (D.R.L.), the Helen and Martin Kimmel Center for Biology and Medicine (D.R.L.), and National Institutes of Health (NIH) grants AI33856 (D.R.L.), AI28900 (D.E.L.), U54AI57168 (D.E.L.) and R01AI065303 (D.U.).	Antons AK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002952; Boggiano C, 2007, J VIROL, V81, P2519, DOI 10.1128/JVI.01661-06; CAMERON PU, 1992, SCIENCE, V257, P383, DOI 10.1126/science.1352913; Chatterji U, 2009, J BIOL CHEM, V284, P16998, DOI 10.1074/jbc.M109.007625; de Silva TI, 2008, TRENDS MICROBIOL, V16, P588, DOI 10.1016/j.tim.2008.09.003; Demirov DG, 2002, J VIROL, V76, P105, DOI 10.1128/JVI.76.1.105-117.2002; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Elkon R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-110; Fonteneau JF, 2001, J IMMUNOL METHODS, V258, P111, DOI 10.1016/S0022-1759(01)00477-X; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Griffin SDC, 2001, J VIROL, V75, P12058, DOI 10.1128/JVI.75.24.12058-12069.2001; Honda K, 2003, P NATL ACAD SCI USA, V100, P10872, DOI 10.1073/pnas.1934678100; Hopkins S, 2010, ANTIMICROB AGENTS CH, V54, P660, DOI 10.1128/AAC.00660-09; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kosmrlj A, 2010, NATURE, V465, P350, DOI 10.1038/nature08997; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Langenkamp A, 2002, EUR J IMMUNOL, V32, P2046, DOI 10.1002/1521-4141(200207)32:7<2046::AID-IMMU2046>3.0.CO;2-M; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; MALIM MH, 1988, NATURE, V335, P181, DOI 10.1038/335181a0; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mangeot PE, 2002, MOL THER, V5, P283, DOI 10.1006/mthe.2002.0541; Mangeot PE, 2000, J VIROL, V74, P8307, DOI 10.1128/JVI.74.18.8307-8315.2000; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moris A, 2006, BLOOD, V108, P1643, DOI 10.1182/blood-2006-02-006361; Morner A, 1999, J VIROL, V73, P2343; Neagu MR, 2009, J CLIN INVEST, V119, P3035, DOI 10.1172/JCI39354; Negre D, 2000, GENE THER, V7, P1613, DOI 10.1038/sj.gt.3301292; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Price AJ, 2009, NAT STRUCT MOL BIOL, V16, P1036, DOI 10.1038/nsmb.1667; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; Yamashita M, 2007, PLOS PATHOG, V3, P1502, DOI 10.1371/journal.ppat.0030156; Yoo SH, 1997, J MOL BIOL, V269, P780, DOI 10.1006/jmbi.1997.1051; Zhang HL, 2004, J VIROL, V78, P1718, DOI 10.1128/JVI.78.4.1718-1729.2004	39	326	339	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 9	2010	467	7312					214	U104		10.1038/nature09337	http://dx.doi.org/10.1038/nature09337			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647KB	20829794	Green Accepted			2022-12-01	WOS:000281616300036
J	Muenzner, P; Bachmann, V; Zimmermann, W; Hentschel, J; Hauck, CR				Muenzner, Petra; Bachmann, Verena; Zimmermann, Wolfgang; Hentschel, Jochen; Hauck, Christof R.			Human-Restricted Bacterial Pathogens Block Shedding of Epithelial Cells by Stimulating Integrin Activation	SCIENCE			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; NEISSERIA-GONORRHOEAE; HOST DEFENSES; CARCINOEMBRYONIC ANTIGENS; FOCAL ADHESIONS; ORGAN-CULTURE; OPA PROTEINS; EXPRESSION; INFECTION; RECEPTORS	Colonization of mucosal surfaces is the key initial step in most bacterial infections. One mechanism protecting the mucosa is the rapid shedding of epithelial cells, also termed exfoliation, but it is unclear how pathogens counteract this process. We found that carcinoembryonic antigen (CEA)-binding bacteria colonized the urogenital tract of CEA transgenic mice, but not of wild-type mice, by suppressing exfoliation of mucosal cells. CEA binding triggered de novo expression of the transforming growth factor receptor CD105, changing focal adhesion composition and activating beta(1) integrins. This manipulation of integrin inside-out signaling promotes efficient mucosal colonization and represents a potential target to prevent or cure bacterial infections.	[Muenzner, Petra; Bachmann, Verena; Hentschel, Jochen; Hauck, Christof R.] Univ Konstanz, Fachbereich Biol, Lehrstuhl Zellbiol, D-78457 Constance, Germany; [Zimmermann, Wolfgang] Univ Munich, LIFE Ctr, Tumor Immunol Lab, D-81377 Munich, Germany; [Hentschel, Jochen] Univ Konstanz, Fachbereich Biol, EM Serv, D-78457 Constance, Germany; [Hauck, Christof R.] Univ Konstanz, Konstanz Res Sch Chem Biol, D-78457 Constance, Germany	University of Konstanz; University of Munich; University of Konstanz; University of Konstanz	Hauck, CR (corresponding author), Univ Konstanz, Fachbereich Biol, Lehrstuhl Zellbiol, D-78457 Constance, Germany.	christof.hauck@uni-konstanz.de	Zimmermann, Wolfgang/L-9277-2013		Deutsche Forschungsgemeinschaft [Ha2856/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank M. C. Beckerle for zyxin-deficient fibroblasts and antibodies; M. Chudakov for the mKate cDNA; J. W. Greiner for sending the CEAtg mice; T. F. Meyer for bacterial strains; D. W. Piston for cDNA of mCerulean; A. J. Schaeffer for hVEC cells; D. Vestweber for providing antibody; C. Hentschel, J. Scharrer, and R. Mak'anyengo for assistance with SEM; and B. Planitz for expert animal care. Supported by Deutsche Forschungsgemeinschaft grant Ha2856/6-1 (C.R.H.).	Berger CN, 2004, MOL MICROBIOL, V52, P963, DOI 10.1111/j.1365-2958.2004.04033.x; CHEN T, 1995, J EXP MED, V182, P511, DOI 10.1084/jem.182.2.511; Conley BA, 2004, J BIOL CHEM, V279, P27440, DOI 10.1074/jbc.M312561200; EADESPERNER AM, 1994, CANCER RES, V54, P4169; Guerrero-Esteo M, 1999, EUR J CELL BIOL, V78, P614, DOI 10.1016/S0171-9335(99)80046-6; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Hauck CR, 2003, CURR OPIN MICROBIOL, V6, P43, DOI 10.1016/S1369-5274(03)00004-3; Hill DJ, 2003, MOL MICROBIOL, V48, P117, DOI 10.1046/j.1365-2958.2003.03433.x; Hoffman LM, 2006, J CELL BIOL, V172, P771, DOI 10.1083/jcb.200512115; JERSE AE, 1994, J EXP MED, V179, P911, DOI 10.1084/jem.179.3.911; Kim M, 2009, NATURE, V459, P578, DOI 10.1038/nature07952; MCGEE ZA, 1981, J INFECT DIS, V143, P413, DOI 10.1093/infdis/143.3.413; MELLY MA, 1981, J INFECT DIS, V143, P423, DOI 10.1093/infdis/143.3.423; Merz AJ, 2000, ANNU REV CELL DEV BI, V16, P423, DOI 10.1146/annurev.cellbio.16.1.423; Mosleh IM, 1997, INFECT IMMUN, V65, P3391, DOI 10.1128/IAI.65.8.3391-3398.1997; Muenzner P, 2005, J CELL BIOL, V170, P825, DOI 10.1083/jcb.200412151; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; Mysorekar IU, 2002, J BIOL CHEM, V277, P7412, DOI 10.1074/jbc.M110560200; Pearson JP, 2005, COLONIZATION OF MUCOSAL SURFACES, P3; SWANSON J, 1988, J EXP MED, V168, P2121, DOI 10.1084/jem.168.6.2121; TJIA KF, 1988, GRAEF ARCH CLIN EXP, V226, P341, DOI 10.1007/BF02172964; Toleman M, 2001, CELL MICROBIOL, V3, P33, DOI 10.1046/j.1462-5822.2001.00089.x; VANPUTTEN JPM, 1995, EMBO J, V14, P2144, DOI 10.1002/j.1460-2075.1995.tb07208.x; Virji M, 2000, MOL MICROBIOL, V36, P784, DOI 10.1046/j.1365-2958.2000.01885.x; Virji M, 1996, MOL MICROBIOL, V22, P941, DOI 10.1046/j.1365-2958.1996.01551.x; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Voges M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-117; WHO, 2001, GLOB PREV INC SEL CU; ZAMBRUNO G, 1995, J CELL BIOL, V129, P853, DOI 10.1083/jcb.129.3.853	30	69	71	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 3	2010	329	5996					1197	1201		10.1126/science.1190892	http://dx.doi.org/10.1126/science.1190892			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645SG	20813953	Green Submitted			2022-12-01	WOS:000281485600034
J	Cabernard, C; Prehoda, KE; Doe, CQ				Cabernard, Clemens; Prehoda, Kenneth E.; Doe, Chris Q.			A spindle-independent cleavage furrow positioning pathway	NATURE			English	Article							NONMUSCLE MYOSIN-II; DROSOPHILA NEUROBLASTS; ASYMMETRIC DIVISIONS; CELL-DIVISION; CORTICAL POLARITY; CONTRACTILE RING; PROTEIN COMPLEX; ALPHA-I; CYTOKINESIS; ORIENTATION	The mitotic spindle determines the cleavage furrow site during metazoan cell division(1,2), but whether other mechanisms exist remains unknown. Here we identify a spindle-independent mechanism for cleavage furrow positioning in Drosophila neuroblasts. We show that early and late furrow proteins (Pavarotti, Anillin, and Myosin) are localized to the neuroblast basal cortex at anaphase onset by a Pins cortical polarity pathway, and can induce a basally displaced furrow even in the complete absence of a mitotic spindle. Rotation or displacement of the spindle results in two furrows: an early polarity-induced basal furrow and a later spindle-induced furrow. This spindle-independent cleavage furrow mechanism may be relevant to other highly polarized mitotic cells, such as mammalian neural progenitors.	[Cabernard, Clemens; Doe, Chris Q.] Univ Oregon, Howard Hughes Med Inst, Eugene, OR 97403 USA; [Cabernard, Clemens; Prehoda, Kenneth E.; Doe, Chris Q.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Cabernard, Clemens; Doe, Chris Q.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	Howard Hughes Medical Institute; University of Oregon; University of Oregon; University of Oregon	Doe, CQ (corresponding author), Univ Oregon, Howard Hughes Med Inst, Eugene, OR 97403 USA.	cdoe@uoregon.edu	Cabernard, Clemens/A-9033-2010	Prehoda, Ken/0000-0003-4214-6158; Cabernard, Clemens/0000-0003-3706-6401	National Institutes of Health [GM068032]; American Heart Association; Swiss National Science Foundation; HHMI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); HHMI(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Brand, D. Glover, C.-Y. Lee, M. Peifer, J. Raff, E. Wieschaus, A. Wilde, and the Bloomington and Vienna Drosophila RNAi Center stock centres for fly stocks and/or antibody reagents; R. Andersen, B. Bowerman, M. Goulding and B. Nolan for comments on the manuscript; and T. Gillies and K. Hirono for technical support. This work was supported by the National Institutes of Health (GM068032; to K. P.), the American Heart Association (to C. C. and K. P.), the Swiss National Science Foundation (to C. C.) and HHMI (to C.Q.D.).	Albertson R, 2003, NAT CELL BIOL, V5, P166, DOI 10.1038/ncb922; Barros CS, 2003, DEV CELL, V5, P829, DOI 10.1016/S1534-5807(03)00359-9; Basto R, 2000, NAT CELL BIOL, V2, P939, DOI 10.1038/35046592; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Bonaccorsi S, 2000, NAT CELL BIOL, V2, P54, DOI 10.1038/71378; Bonaccorsi S, 1998, J CELL BIOL, V142, P751, DOI 10.1083/jcb.142.3.751; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Cabernard C, 2009, DEV CELL, V17, P134, DOI 10.1016/j.devcel.2009.06.009; Cai Y, 2003, CELL, V112, P51, DOI 10.1016/S0092-8674(02)01170-4; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; CONRAD GW, 1974, DEV BIOL, V36, P363, DOI 10.1016/0012-1606(74)90058-X; Deng MQ, 2007, DEV CELL, V12, P301, DOI 10.1016/j.devcel.2006.11.008; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; FIELD CM, 1995, J CELL BIOL, V131, P165, DOI 10.1083/jcb.131.1.165; Foe VE, 2008, J CELL BIOL, V183, P457, DOI 10.1083/jcb.200807128; Fuse N, 2003, CURR BIOL, V13, P947, DOI 10.1016/S0960-9822(03)00334-8; Giansanti MG, 2008, CURR BIOL, V18, P303, DOI 10.1016/j.cub.2008.01.058; Giansanti MG, 2001, DEVELOPMENT, V128, P1137; Guan ZH, 2000, P NATL ACAD SCI USA, V97, P8122, DOI 10.1073/pnas.97.14.8122; Hickson GRX, 2006, CURR BIOL, V16, P359, DOI 10.1016/j.cub.2005.12.043; Izumi Y, 2004, J CELL BIOL, V164, P729, DOI 10.1083/jcb.200309162; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kosodo Y, 2008, EMBO J, V27, P3151, DOI 10.1038/emboj.2008.227; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Megraw TL, 2001, CURR BIOL, V11, P116, DOI 10.1016/S0960-9822(01)00017-3; Minestrini G, 2003, MOL BIOL CELL, V14, P4028, DOI 10.1091/mbc.E03-04-0214; Oliferenko S, 2009, GENE DEV, V23, P660, DOI 10.1101/gad.1772009; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Royou A, 2002, J CELL BIOL, V158, P127, DOI 10.1083/jcb.200203148; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Siegrist SE, 2006, DEVELOPMENT, V133, P529, DOI 10.1242/dev.02211; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Silverman-Gavrila RV, 2008, MOL BIOL CELL, V19, P3735, DOI 10.1091/mbc.E08-01-0049; Somers WG, 2003, DEV CELL, V4, P29, DOI 10.1016/S1534-5807(02)00402-1; von Dassow G, 2009, TRENDS CELL BIOL, V19, P165, DOI 10.1016/j.tcb.2009.01.008; WOODS DF, 1989, DEV BIOL, V134, P222, DOI 10.1016/0012-1606(89)90092-4; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Yu FW, 2003, J CELL BIOL, V162, P623, DOI 10.1083/jcb.200303174	41	121	121	4	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 2	2010	467	7311					91	U124		10.1038/nature09334	http://dx.doi.org/10.1038/nature09334			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645MB	20811457	Green Accepted			2022-12-01	WOS:000281461200041
J	Pasternak, B; Hviid, A				Pasternak, Bjorn; Hviid, Anders			Use of Acyclovir, Valacyclovir, and Famciclovir in the First Trimester of Pregnancy and the Risk of Birth Defects	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HERPES-SIMPLEX-VIRUS; GENITAL HERPES; REGISTRATION; INFECTION; ZOSTER; OUTCOMES; SAFETY; TYPE-1; RATES	Context Herpes simplex and herpes zoster infections are common and often treated with antiviral drugs including acyclovir, valacyclovir, and famciclovir. Safety of these antivirals when used in the first trimester of pregnancy is insufficiently documented. Objective To investigate associations between exposure to acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and risk of major birth defects. Design, Setting, and Participants Population-based historical cohort study of 837 795 live-born infants in Denmark from January 1, 1996, to September 30, 2008. Participants had no diagnoses of chromosomal aberrations, genetic syndromes, birth defect syndromes with known causes, or congenital viral infections. Nationwide registries were used to ascertain individual-level information on dispensed antiviral drugs, birth defect diagnoses (categorized according to a standardized classification scheme), and potential confounders. Main Outcome Measure Prevalence odds ratios (PORs) of any major birth defect diagnosed within the first year of life by exposure to antiviral drugs. Results Among 1804 pregnancies exposed to acyclovir, valacyclovir, or famciclovir in the first trimester, 40 infants (2.2%) were diagnosed with a major birth defect compared with 19 920 (2.4%) among the unexposed (adjusted POR, 0.89; 95% confidence interval [CI], 0.65-1.22). For individual antivirals, a major birth defect was diagnosed in 32 of 1561 infants (2.0%) with first-trimester exposure to acyclovir (adjusted POR, 0.82; 95% Cl, 0.57-1.17) and in 7 of 229 infants (3.1%) with first-trimester exposure to valacyclovir (adjusted POR, 1.21; 95% CI, 0.56-2.62). Famciclovir exposure was uncommon (n=26), with 1 infant (3.8%) diagnosed with a birth defect. Exploratory analyses revealed no associations between antiviral drug exposure and 13 different subgroups of birth defects, but the number of exposed cases in each subgroup was small. Conclusion In this large nationwide cohort, exposure to acyclovir or valacyclovir in the first trimester of pregnancy was not associated with an increased risk of major birth defects. JAMA. 2010;304(8):859-866	[Pasternak, Bjorn; Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark	Statens Serum Institut	Pasternak, B (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	bjp@ssi.dk	Pasternak, Bjorn/H-5739-2012; Hviid, Anders/AAH-4319-2020	Pasternak, Bjorn/0000-0002-2097-8466; Hviid, Anders/0000-0002-7509-9127	Danish Medical Research Council; Lundbeck Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden)	This work was supported by grants from the Danish Medical Research Council and the Lundbeck Foundation.	Andersen TF, 1999, DAN MED BULL, V46, P263; BENEDETTI J, 1994, ANN INTERN MED, V121, P847, DOI 10.7326/0003-4819-121-11-199412010-00004; Brown ZA, 1997, NEW ENGL J MED, V337, P509, DOI 10.1056/NEJM199708213370801; Buhimschi CS, 2009, OBSTET GYNECOL, V113, P166, DOI 10.1097/AOG.0b013e31818d6788; Cernik C, 2008, ARCH INTERN MED, V168, P1137, DOI 10.1001/archinte.168.11.1137; CHAHOUD I, 1988, ARCH TOXICOL, V62, P8, DOI 10.1007/BF00316250; *DANM STAT, RES DAT DAT SOURC AV; *EUR NETW, COD EUR SUBGR CONG A; *EUR NETW, MIN AN EXCL; Jepsen P, 2006, INT J RISK SAF MED, V18, P77; Jorgensen Finn Stener, 2003, Ugeskr Laeger, V165, P4409; Knudsen LB, 1998, DAN MED BULL, V45, P320; Kristensen J, 1996, J CLIN EPIDEMIOL, V49, P893, DOI 10.1016/0895-4356(96)00018-2; Larsen H, 2003, SCAND J PUBLIC HEALT, V31, P12, DOI 10.1080/14034940210134194; MOORE HL, 1983, FUND APPL TOXICOL, V3, P560, DOI 10.1016/S0272-0590(83)80105-5; Pedersen CB, 2006, DAN MED BULL, V53, P441; Ratanajamit C, 2003, SCAND J INFECT DIS, V35, P255, DOI 10.1080/00365540310000229; SALTZMAN R, 1994, ANTIMICROB AGENTS CH, V38, P2454, DOI 10.1128/AAC.38.10.2454; Sen P, 2007, BMJ-BRIT MED J, V334, P1048, DOI 10.1136/bmj.39189.504306.55; Smith JS, 2002, J INFECT DIS, V186, pS3, DOI 10.1086/343739; Stone KM, 2004, BIRTH DEFECTS RES A, V70, P201, DOI 10.1002/bdra.20013; Tyring SK, 2002, J INFECT DIS, V186, pS40, DOI 10.1086/342966; *US FDA, 2005, ZOV AC PROD INF; *US FDA, 2008, VALTR VAL PROD INF; *US FDA, 2009, FAMV FAMC PROD INF; Wareham DW, 2007, BMJ-BRIT MED J, V334, P1211, DOI 10.1136/bmj.39206.571042.AE; Wilton LV, 1998, BRIT J OBSTET GYNAEC, V105, P882, DOI 10.1111/j.1471-0528.1998.tb10234.x; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964; Yawn BP, 2007, MAYO CLIN PROC, V82, P1341, DOI 10.4065/82.11.1341	29	114	118	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2010	304	8					859	866		10.1001/jama.2010.1206	http://dx.doi.org/10.1001/jama.2010.1206			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644OY	20736469	Bronze			2022-12-01	WOS:000281389900023
J	Rothwell, PM; Wilson, M; Elwin, CE; Norrving, B; Algra, A; Warlow, CP; Meade, TW				Rothwell, Peter M.; Wilson, Michelle; Elwin, Carl-Eric; Norrving, Bo; Algra, Ale; Warlow, Charles P.; Meade, Tom W.			Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials	LANCET			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; TRANSIENT ISCHEMIC ATTACK; ADENOMA RECURRENCE; PRIMARY PREVENTION; GENE-EXPRESSION; RISK; CYCLOOXYGENASE-2; SURVIVAL; COLON; CHEMOPREVENTION	Background High-dose aspirin (>= 500 mg daily) reduces long-term incidence of colorectal cancer, but adverse effects might limit its potential for long-term prevention. The long-term effectiveness of lower doses (75-300 mg daily) is unknown. We assessed the effects of aspirin on incidence and mortality due to colorectal cancer in relation to dose, duration of treatment, and site of tumour. Methods We followed up four randomised trials of aspirin versus control in primary (Thrombosis Prevention Trial, British Doctors Aspirin Trial) and secondary (Swedish Aspirin Low Dose Trial, UK-TA Aspirin Trial) prevention of vascular events and one trial of different doses of aspirin (Dutch TIA Aspirin Trial) and established the effect of aspirin on risk of colorectal cancer over 20 years during and after the trials by analysis of pooled individual patient data. Results In the four trials of aspirin versus control (mean duration of scheduled treatment 6.0 years), 391 (2.8%) of 14 033 patients had colorectal cancer during a median follow-up of 18.3 years. Allocation to aspirin reduced the 20-year risk of colon cancer (incidence hazard ratio [HR] 0.76, 0.60-0.96, p=0.02; mortality HR 0.65, 0.48-0.88, p=0.005), but not rectal cancer (0.90, 0.63-1.30, p=0.58; 0.80, 0.50-1.28, p=0.35). Where subsite data were available, aspirin reduced risk of cancer of the proximal colon (0.45, 0.28-0.74, p=0.001; 0.34, 0.18-0.66, p=0.001), but not the distal colon (1.10, 0.73-1.64, p=0.66; 1.21, 0.66-2.24, p=0.54; for incidence difference p=0.04, for mortality difference p=0.01). However, benefit increased with scheduled duration of treatment, such that allocation to aspirin of 5 years or longer reduced risk of proximal colon cancer by about 70% (0.35, 0.20-0.63; 0.24, 0.11-0.52; both p<0.0001) and also reduced risk of rectal cancer (0.58, 0.36-0.92, p=0.02; 0.47, 0.26-0.87, p=0.01). There was no increase in benefit at doses of aspirin greater than 75 mg daily, with an absolute reduction of 1.76% (0.61-2.91; p=0.001) in 20-year risk of any fatal colorectal cancer after 5-years scheduled treatment with 75-300 mg daily. However, risk of fatal colorectal cancer was higher on 30 mg versus 283 mg daily on long-term follow-up of the Dutch TIA trial (odds ratio 2.02, 0.70-6.05, p=0.15). Interpretation Aspirin taken for several years at doses of at least 75 mg daily reduced long-term incidence and mortality due to colorectal cancer. Benefit was greatest for cancers of the proximal colon, which are not otherwise prevented effectively by screening with sigmoidoscopy or colonoscopy.	[Rothwell, Peter M.; Wilson, Michelle] Univ Oxford, Dept Clin Neurol, Stroke Prevent Res Unit, Oxford, England; [Elwin, Carl-Eric] Karolinska Inst, Dept Lab Med, Div Clin Pharmacol, Stockholm, Sweden; [Norrving, Bo] Lund Univ, Neurol Sect, Dept Clin Sci, S-22100 Lund, Sweden; [Algra, Ale] Rudolf Magnus Inst Neurosci, Dept Neurol, NL-3508 TA Utrecht, Netherlands; [Algra, Ale] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Warlow, Charles P.] Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh, Midlothian, Scotland; [Meade, Tom W.] Univ London, London Sch Hyg & Trop Med, London, England	University of Oxford; Karolinska Institutet; Lund University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Edinburgh; University of London; London School of Hygiene & Tropical Medicine	Rothwell, PM (corresponding author), John Radcliffe Hosp, Univ Dept Clin Neurol, Stroke Prevent Res Unit, Oxford OX3 9DU, England.	peter.rothwell@clneuro.ox.ac.uk	Rothwell, Peter/ABE-5913-2020; Hug, Balthasar L./G-1568-2010	Rothwell, Peter/0000-0001-9739-9211; Norrving, Bo/0000-0002-8024-5096	Boehringer Ingelheim; Stroke Prevention Research Unit, Oxford, UK; NIHR; MRC [G0701113] Funding Source: UKRI; Medical Research Council [G0701113] Funding Source: researchfish	Boehringer Ingelheim(Boehringer Ingelheim); Stroke Prevention Research Unit, Oxford, UK; NIHR(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	PMR and BN have received honoraria for talks, advisory boards and clinical trial committees from several pharmaceutical companies with an interest in antiplatelet agents, including AstraZeneca, Bayer, Boehringer Ingelheim, Sanofi-BMS, and Servier. AA has received honoraria for advisory boards and research funding from Boehringer Ingelheim. The other authors declare no conflicts of interest.; We thank Richard Peto and Jill Boreham for access to data from the British Doctors Aspirin Trial; Christine Knottenbelt and Marilyn Goulding for their help in accessing long-term follow-up data from the TPT cohort; Birgit Peterson for help in collating data on causes of deaths in the SALT trial cohort; and Ziyah Mehta for help with analysis and production of graphs. The cost of cancer registry and death certificate follow-up of the UK-TIA Aspirin Trial was met by unrestricted research funds from the Stroke Prevention Research Unit, Oxford, UK. PMR is in receipt of an NIHR Senior Investigator Award.	Abela JE, 2009, BIOSCI TRENDS, V3, P158; [Anonymous], 1991, Lancet, V338, P1345; Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Awtry EH, 2000, CIRCULATION, V101, P1206, DOI 10.1161/01.CIR.101.10.1206; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Baron JA, 2006, GASTROENTEROLOGY, V131, P1674, DOI 10.1053/j.gastro.2006.08.079; Barry EL, 2009, CANCER EPIDEM BIOMAR, V18, P2726, DOI 10.1158/1055-9965.EPI-09-0363; BEDENNE L, 1992, CANCER, V69, P883, DOI 10.1002/1097-0142(19920215)69:4<883::AID-CNCR2820690408>3.0.CO;2-B; Benamouzig R, 2003, GASTROENTEROLOGY, V125, P328, DOI 10.1016/S0016-5085(03)00887-4; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Birkenkamp-Demtroder K, 2005, GUT, V54, P374, DOI 10.1136/gut.2003.036848; BREWSTER D, 1995, PUBLIC HEALTH, V109, P285, DOI 10.1016/S0033-3506(95)80206-1; Brewster DH, 2002, EUR J CANCER, V38, P414, DOI 10.1016/S0959-8049(01)00385-9; BUFILL JA, 1990, ANN INTERN MED, V113, P779, DOI 10.7326/0003-4819-113-10-779; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Chan AT, 2009, JAMA-J AM MED ASSOC, V302, P649, DOI 10.1001/jama.2009.1112; Chapple KS, 2000, AM J PATHOL, V156, P545, DOI 10.1016/S0002-9440(10)64759-1; Cole BF, 2009, J NATL CANCER I, V101, P256, DOI 10.1093/jnci/djn485; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Ederer F, 1999, J CLIN EPIDEMIOL, V52, P447, DOI 10.1016/S0895-4356(99)00016-5; Elsaleh H, 2000, LANCET, V355, P1745, DOI 10.1016/S0140-6736(00)02261-3; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; Fasey N, 2002, BRIT J GEN PRACT, V52, P208; Flossmann E, 2007, INT J EPIDEMIOL, V36, P962, DOI 10.1093/ije/dym200; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Friedman GD, 1998, PHARMACOEPIDEM DR S, V7, P99, DOI 10.1002/(SICI)1099-1557(199803/04)7:2<99::AID-PDS320>3.0.CO;2-0; Greving JP, 2008, CIRCULATION, V117, P2875, DOI 10.1161/CIRCULATIONAHA.107.735340; HAWKINS MM, 1992, BRIT J CANCER, V66, P408, DOI 10.1038/bjc.1992.279; Iacopetta B, 2002, INT J CANCER, V101, P403, DOI 10.1002/ijc.10635; JUULMOLLER S, 1992, LANCET, V340, P1421, DOI 10.1016/0140-6736(92)92619-Q; Kelloff GJ, 2004, CLIN CANCER RES, V10, P3908, DOI 10.1158/1078-0432.CCR-03-0789; KOZUKA S, 1975, DIS COLON RECTUM, V18, P494, DOI 10.1007/BF02587218; Leopoldo S, 2008, ANN SURG ONCOL, V15, P1429, DOI 10.1245/s10434-007-9757-1; Levine JS, 2006, NEW ENGL J MED, V355, P2551, DOI 10.1056/NEJMcp063038; Logan RFA, 2008, GASTROENTEROLOGY, V134, P29, DOI 10.1053/j.gastro.2007.10.014; Mahipal A, 2006, CANCER EPIDEM BIOMAR, V15, P1785, DOI 10.1158/1055-9965.EPI-05-0674; Meade TW, 1998, LANCET, V351, P233; Nasir Aejaz, 2004, Clin Colorectal Cancer, V3, P243, DOI 10.3816/CCC.2004.n.005; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; Pollock A M, 1995, Qual Health Care, V4, P184, DOI 10.1136/qshc.4.3.184; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Smalley W, 1999, ARCH INTERN MED, V159, P161, DOI 10.1001/archinte.159.2.161; Sturmer T, 1998, ANN INTERN MED, V128, P713, DOI 10.7326/0003-4819-128-9-199805010-00003; van Wijk I, 2005, LANCET, V365, P2098, DOI 10.1016/S0140-6736(05)66734-7; VANGIJN J, 1991, NEW ENGL J MED, V325, P1261, DOI 10.1056/NEJM199110313251801; Wallace K, 2009, CANCER EPIDEM BIOMAR, V18, P2310, DOI 10.1158/1055-9965.EPI-09-0211; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X	52	930	965	2	108	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 20	2010	376	9754					1741	1750		10.1016/S0140-6736(10)61543-7	http://dx.doi.org/10.1016/S0140-6736(10)61543-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	690EI	20970847				2022-12-01	WOS:000284984900030
J	Long, MA; Jin, DZZ; Fee, MS				Long, Michael A.; Jin, Dezhe Z.; Fee, Michale S.			Support for a synaptic chain model of neuronal sequence generation	NATURE			English	Article							HIPPOCAMPAL PYRAMIDAL NEURONS; IDENTIFIED HVC NEURONS; WHOLE-CELL RECORDINGS; ZEBRA FINCH; TERMINAL DENDRITES; NEURAL ACTIVITY; VOCAL CONTROL; NUCLEUS HVC; IN-VITRO; SONGBIRD	In songbirds, the remarkable temporal precision of song is generated by a sparse sequence of bursts in the premotor nucleus HVC. To distinguish between two possible classes of models of neural sequence generation, we carried out intracellular recordings of HVC neurons in singing zebra finches (Taeniopygia guttata). We found that the subthreshold membrane potential is characterized by a large, rapid depolarization 5-10 ms before burst onset, consistent with a synaptically connected chain of neurons in HVC. We found no evidence for the slow membrane potential modulation predicted by models in which burst timing is controlled by subthreshold dynamics. Furthermore, bursts ride on an underlying depolarization of similar to 10-ms duration, probably the result of a regenerative calcium spike within HVC neurons that could facilitate the propagation of activity through a chain network with high temporal precision. Our results provide insight into the fundamental mechanisms by which neural circuits can generate complex sequential behaviours.	[Long, Michael A.; Fee, Michale S.] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Jin, Dezhe Z.] Penn State Univ, Dept Phys, University Pk, PA 16802 USA	Massachusetts Institute of Technology (MIT); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Fee, MS (corresponding author), MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	fee@mit.edu	Jin, Dezhe/AAE-6788-2020	Fee, Michale/0000-0001-7539-1745	National Institutes of Health [MH067105, DC009280]; Alfred P. Sloan Research Fellowship; National Science Foundation [IOS-0827731]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K99DC009280, R00DC009280] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank M. Wilson, S. Seung, A. Andalman, J. Goldberg and A. Gray for comments on earlier versions of this manuscript. We would also like to thank A. Andalman, D. Aronov and T. Ramee for help with acquisition and analysis software. This work is supported by funding from the National Institutes of Health to M.S.F. (MH067105) and M.A.L. (DC009280), and from the Alfred P. Sloan Research Fellowship and the National Science Foundation to D.Z.J. (IOS-0827731).	Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; AMARI SI, 1972, IEEE T COMPUT, VC 21, P1197, DOI 10.1109/T-C.1972.223477; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; CONNORS BW, 1982, J PHARMACOL EXP THER, V220, P476; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Dutar P, 1998, J NEUROPHYSIOL, V80, P1828, DOI 10.1152/jn.1998.80.4.1828; Fee MS, 2004, ANN NY ACAD SCI, V1016, P153, DOI 10.1196/annals.1298.022; Fiete IR, 2010, NEURON, V65, P563, DOI 10.1016/j.neuron.2010.02.003; Foster DJ, 2007, HIPPOCAMPUS, V17, P1093, DOI 10.1002/hipo.20345; GEORGOPOULOS AP, 1989, SCIENCE, V243, P234, DOI 10.1126/science.2911737; Glaze CM, 2007, J NEUROSCI, V27, P7631, DOI 10.1523/JNEUROSCI.1065-07.2007; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hahnloser RHR, 2006, J NEUROPHYSIOL, V96, P794, DOI 10.1152/jn.01064.2005; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Jin DZ, 2007, J COMPUT NEUROSCI, V23, P283, DOI 10.1007/s10827-007-0032-z; Jun JK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000723; KONISHI M, 1985, ANNU REV NEUROSCI, V8, P125, DOI 10.1146/annurev.ne.08.030185.001013; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Kubota M, 1998, J NEUROPHYSIOL, V80, P914, DOI 10.1152/jn.1998.80.2.914; Larkum ME, 2002, J NEUROSCI, V22, P6991; Lashley K. S., 1951, CEREBRAL MECH BEHAV; Lee AK, 2006, NEURON, V51, P399, DOI 10.1016/j.neuron.2006.07.004; Leonardo A, 2005, J NEUROSCI, V25, P652, DOI 10.1523/JNEUROSCI.3036-04.2005; Lewicki MS, 1996, J NEUROSCI, V16, P5854; Li MR, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011918; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mooney R, 2005, J NEUROSCI, V25, P1952, DOI 10.1523/JNEUROSCI.3726-04.2005; MOONEY R, 1992, J NEUROSCI, V12, P2464; Mooney R, 2000, J NEUROSCI, V20, P5420, DOI 10.1523/JNEUROSCI.20-14-05420.2000; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Rosen MJ, 2003, NEURON, V39, P177, DOI 10.1016/S0896-6273(03)00357-X; Scharff C, 2000, NEURON, V25, P481, DOI 10.1016/S0896-6273(00)80910-1; Shima K, 2007, NATURE, V445, P315, DOI 10.1038/nature05470; Solis MM, 2005, J NEUROSCI, V25, P2811, DOI 10.1523/JNEUROSCI.5285-04.2005; STENT GS, 1978, SCIENCE, V200, P1348, DOI 10.1126/science.663615; VU ET, 1994, J NEUROSCI, V14, P6924; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	46	237	241	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 18	2010	468	7322					394	399		10.1038/nature09514	http://dx.doi.org/10.1038/nature09514			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681KP	20972420	Green Submitted, Green Accepted			2022-12-01	WOS:000284313100034
J	Han, L; Monne, M; Okumura, H; Schwend, T; Cherry, AL; Flot, D; Matsuda, T; Jovine, L				Han, Ling; Monne, Magnus; Okumura, Hiroki; Schwend, Thomas; Cherry, Amy L.; Flot, David; Matsuda, Tsukasa; Jovine, Luca			Insights into Egg Coat Assembly and Egg-Sperm Interaction from the X-Ray Structure of Full-Length ZP3	CELL			English	Article							ZONA-PELLUCIDA DOMAIN; SITE-DIRECTED MUTAGENESIS; MASS-SPECTROMETRY; VITELLINE ENVELOPE; RECEPTOR ACTIVITY; COMBINING SITE; FEMALE MICE; PROTEINS; MOUSE; GLYCOPROTEIN	ZP3, a major component of the zona pellucida (ZP) matrix coating mammalian eggs, is essential for fertilization by acting as sperm receptor. By retaining a propeptide that contains a polymerization-blocking external hydrophobic patch (EHP), we determined the crystal structure of an avian homolog of ZP3 at 2.0 angstrom resolution. The structure unveils the fold of a complete ZP domain module in a homodimeric arrangement required for secretion and reveals how EHP prevents premature incorporation of ZP3 into the ZP. This suggests mechanisms underlying polymerization and how local structural differences, reflected by alternative disulfide patterns, control the specificity of ZP subunit interaction. Close relative positioning of a conserved O-glycan important for sperm binding and the hypervariable, positively selected C-terminal region of ZP3 suggests a concerted role in the regulation of species-restricted gamete recognition. Alternative conformations of the area around the O-glycan indicate how sperm binding could trigger downstream events via intramolecular signaling.	[Han, Ling; Monne, Magnus; Okumura, Hiroki; Schwend, Thomas; Cherry, Amy L.; Jovine, Luca] Karolinska Inst, Dept Biosci & Nutr, SE-14183 Huddinge, Sweden; [Han, Ling; Monne, Magnus; Okumura, Hiroki; Schwend, Thomas; Cherry, Amy L.; Jovine, Luca] Karolinska Inst, Ctr Biosci, SE-14183 Huddinge, Sweden; [Okumura, Hiroki] Meijo Univ, Fac Agr, Dept Appl Biol Chem, Tempaku Ku, Nagoya, Aichi 4688502, Japan; [Flot, David] EMBL Grenoble, F-38042 Grenoble 9, France; [Matsuda, Tsukasa] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Karolinska Institutet; Karolinska Institutet; Meijo University; European Molecular Biology Laboratory (EMBL); Nagoya University	Jovine, L (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Halsovagen 7, SE-14183 Huddinge, Sweden.	luca.jovine@ki.se	Monné, Magnus/D-5642-2012; Jovine, Luca/J-3563-2019; Jovine, Luca/E-8170-2010	Monné, Magnus/0000-0003-2344-3878; Jovine, Luca/0000-0002-2679-6946; Jovine, Luca/0000-0002-2679-6946; Cherry, Amy/0000-0002-8222-1071	Center for Biosciences; Swedish Research Council [2005-5102, 2007-6068]; European Community [ERG 31055]; Scandinavia-Japan Sasakawa Foundation; Japan Society for the Promotion of Science; MEXT; EMBO	Center for Biosciences; Swedish Research Council(Swedish Research CouncilEuropean Commission); European Community(European Commission); Scandinavia-Japan Sasakawa Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); EMBO(European Molecular Biology Organization (EMBO))	We thank CMC Biologics for expression plasmids pDEF38 and pNEF38; the ESRF for provision of synchrotron radiation facilities and Joanne McCarthy for assistance; Pavel Afonine, Ralf Grosse-Kunstleve, and Tom Terwilliger for help with PHENIX; Elmar Krieger and Alessandra Villa for help with molecular dynamics simulations; Hans Hebert for electron microscopy; Hisako Watanabe for help with sperm preparation; Franco Cotelli, Eveline Litscher, Rune Toftgard, and Paul Wassarman for discussions and comments. This work was supported by the Center for Biosciences; the Swedish Research Council (grants 2005-5102 and 2007-6068); the European Community (Marie Curie ERG 31055); the Scandinavia-Japan Sasakawa Foundation; Grant-in-aids from the Japan Society for the Promotion of Science and MEXT; and an EMBO Young Investigator award to L.J. Author Contributions: L.H. expressed proteins and analyzed mutants; M.M. generated constructs, purified and crystallized proteins, carried out model building, and refined the structures; H.O. generated and characterized constructs, expressed proteins, and performed and analyzed sperm binding assays; T.S. performed mass spectrometric analysis; A.L.C. analyzed crystallographic data; D.F. assisted data collection at ESRF; T.M. performed and analyzed sperm binding assays; L.J. directed the research, solved the structure, took part in structure refinement, ran molecular dynamics simulations, and wrote the manuscript with contributions from all other authors. L.J. dedicates this work to Marta, Smilla, and Sofia.	BARRATT CLR, 1993, HUM REPROD S; Bausek N, 2004, BIOL REPROD, V71, P684, DOI 10.1095/biolreprod.104.028605; BLEIL JD, 1980, CELL, V20, P873, DOI 10.1016/0092-8674(80)90334-7; Boja ES, 2005, BIOCHEMISTRY-US, V44, P16445, DOI 10.1021/bi051883f; Boja ES, 2003, J BIOL CHEM, V278, P34189, DOI 10.1074/jbc.M304026200; BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9; Callebaut I, 2007, BIOINFORMATICS, V23, P1871, DOI 10.1093/bioinformatics/btm265; Chalabi S, 2006, BIOCHEMISTRY-US, V45, P637, DOI 10.1021/bi0512804; Chen J, 1998, P NATL ACAD SCI USA, V95, P6193, DOI 10.1073/pnas.95.11.6193; Darie CC, 2004, BIOCHEMISTRY-US, V43, P7459, DOI 10.1021/bi0495937; Fernandes I, 2010, DEV CELL, V18, P64, DOI 10.1016/j.devcel.2009.11.009; FLORMAN HM, 1985, CELL, V41, P313, DOI 10.1016/0092-8674(85)90084-4; Gahlay G, 2010, SCIENCE, V329, P216, DOI 10.1126/science.1188178; Hasegawa A, 2006, REPRODUCTION, V132, P455, DOI 10.1530/rep.1.01016; Jansa SA, 2003, J MOL EVOL, V56, P294, DOI 10.1007/s00239-002-2401-6; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Jovine L, 2004, P NATL ACAD SCI USA, V101, P5922, DOI 10.1073/pnas.0401600101; Kanai S, 2008, MOL REPROD DEV, V75, P847, DOI 10.1002/mrd.20836; Kaul Renuka, 2001, Reprod Biomed Online, V2, P33; KINLOCH RA, 1995, P NATL ACAD SCI USA, V92, P263, DOI 10.1073/pnas.92.1.263; Legan PK, 2005, NAT NEUROSCI, V8, P1035, DOI 10.1038/nn1496; Liu CY, 1996, P NATL ACAD SCI USA, V93, P5431, DOI 10.1073/pnas.93.11.5431; Llorca O, 2007, J MOL BIOL, V365, P694, DOI 10.1016/j.jmb.2006.10.015; McLaughlin EA, 2010, MOL CELL ENDOCRINOL, DOI DOI 10.10.1016/J.MCE.2010.04.004; MILLAR SE, 1989, SCIENCE, V246, P935, DOI 10.1126/science.2479101; Monne M, 2008, NATURE, V456, P653, DOI 10.1038/nature07599; Monne M, 2006, SEMIN REPROD MED, V24, P204, DOI 10.1055/s-2006-948550; Okumura H, 2007, BIOL REPROD, V76, P9, DOI 10.1095/biolreprod.106.056267; Pan JZ, 2000, MOL REPROD DEV, V55, P175, DOI 10.1002/(SICI)1098-2795(200002)55:2&lt;175::AID-MRD6&gt;3.0.CO;2-6; Quesada C, 2004, J BIOL CHEM, V279, P26627, DOI 10.1074/jbc.M401588200; Rankin T, 1996, DEVELOPMENT, V122, P2903; Sanejouand YH, 2004, PROTEINS, V57, P205, DOI 10.1002/prot.20197; Sasanami T, 2003, BIOL REPROD, V68, P1613, DOI 10.1095/biolreprod.102.011841; Sasanami T, 2006, CELLS TISSUES ORGANS, V183, P41, DOI 10.1159/000094905; Schaeffer C, 2009, MOL BIOL CELL, V20, P589, DOI 10.1091/mbc.E08-08-0876; Shur BD, 2008, INT J DEV BIOL, V52, P703, DOI 10.1387/ijdb.082571bs; Sugiyama H, 1999, J BIOCHEM-TOKYO, V125, P469, DOI 10.1093/oxfordjournals.jbchem.a022310; Swann CA, 2007, REPRODUCTION, V133, P697, DOI 10.1530/REP-06-0043; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998; Takeuchi Y, 1999, EUR J BIOCHEM, V260, P736, DOI 10.1046/j.1432-1327.1999.00203.x; Turner LM, 2006, MOL BIOL EVOL, V23, P1656, DOI 10.1093/molbev/msl035; Vo LH, 2000, BIOL REPROD, V62, P766, DOI 10.1095/biolreprod62.3.766; Waclawek M, 1998, BIOL REPROD, V59, P1230, DOI 10.1095/biolreprod59.5.1230; Wassarman PM, 2008, INT J DEV BIOL, V52, P665, DOI 10.1387/ijdb.072524pw; Yasumasu S, 2010, J BIOCHEM, V148, P439, DOI 10.1093/jb/mvq086; Zhao M, 2004, BIOCHEMISTRY-US, V43, P12090, DOI 10.1021/bi048958k	47	107	114	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 29	2010	143	3					404	415		10.1016/j.cell.2010.09.041	http://dx.doi.org/10.1016/j.cell.2010.09.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672RF	20970175	Green Submitted, Bronze			2022-12-01	WOS:000283603900014
J	Pitt, JN; Ferre-D'Amare, AR				Pitt, Jason N.; Ferre-D'Amare, Adrian R.			Rapid Construction of Empirical RNA Fitness Landscapes	SCIENCE			English	Article							IN-VITRO; SELECTION; EVOLUTION; SEQUENCES; RIBOZYMES; MOLECULES; BINDING; LIGANDS	Evolution is an adaptive walk through a hypothetical fitness landscape, which depicts the relationship between genotypes and the fitness of each corresponding phenotype. We constructed an empirical fitness landscape for a catalytic RNA by combining next-generation sequencing, computational analysis, and "serial depletion," an in vitro selection protocol. By determining the reaction rate constant for every point mutant of a catalytic RNA, we demonstrated that abundance in serially depleted pools correlates with biochemical activity (correlation coefficient r = 0.67, standard score Z = 7.4). Therefore, enumeration of each genotype by deep sequencing yielded a fitness landscape containing similar to 10(7) unique sequences, without requiring measurement of the phenotypic fitness for each sequence. High-throughput mapping between genotype and phenotype may apply to artificial selections, host-pathogen interactions, and other biomedically relevant evolutionary phenomena.	[Ferre-D'Amare, Adrian R.] Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; Fred Hutchinson Cancer Center	Ferre-D'Amare, AR (corresponding author), Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, 1100 Fairview Ave N, Seattle, WA 98109 USA.	aferre@fhcrc.org			W.M. Keck Foundation; Howard Hughes Medical Institute (HHMI)	W.M. Keck Foundation(W.M. Keck Foundation); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute)	We thank R. Basom, A. Marty, and the staff of the Fred Hutchison Cancer Research Center Genomics Shared Resource for performing the Illumina sequencing and D. Bartel, B. Fritz, R. Knight, H. Malik, W. Noble, H. Robins, A. Roll-Mecak, and M. Tewari for discussions. This work was supported by the W.M. Keck Foundation and the Howard Hughes Medical Institute (HHMI). A.R.F.-D. is an investigator of the HHMI. Illumina sequence data have been deposited with the National Center for Biotechnology Information Sequence Read Archive with accession code SRA020870.	Carothers JM, 2004, J AM CHEM SOC, V126, P5130, DOI 10.1021/ja031504a; de la Pena M, 2009, RNA, V15, P1949, DOI 10.1261/rna.1889509; Domingo E, 2009, EMBO REP, V10, P444, DOI 10.1038/embor.2009.61; EKLAND EH, 1995, SCIENCE, V269, P364, DOI 10.1126/science.7618102; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fernandez G, 2007, J VIROL, V81, P2485, DOI 10.1128/JVI.01594-06; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Hurst LD, 1996, Q REV BIOL, V71, P317, DOI 10.1086/419442; Huynen MA, 1996, P NATL ACAD SCI USA, V93, P397, DOI 10.1073/pnas.93.1.397; JOYCE GF, 1989, GENE, V82, P83, DOI 10.1016/0378-1119(89)90033-4; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; LEHMAN N, 1993, CURR BIOL, V3, P723, DOI 10.1016/0960-9822(93)90019-K; Pitt JN, 2010, NUCLEIC ACIDS RES, V38, P7908, DOI 10.1093/nar/gkq661; Pitt JN, 2009, J AM CHEM SOC, V131, P3532, DOI 10.1021/ja8067325; Poelwijk FJ, 2007, NATURE, V445, P383, DOI 10.1038/nature05451; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; Schuster P, 2001, BIOL CHEM, V382, P1301, DOI 10.1515/BC.2001.162; Schuster P, 2009, EUR REV, V17, P281, DOI 10.1017/S1062798709000787; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Stich M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-46; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Turk RM, 2010, P NATL ACAD SCI USA, V107, P4585, DOI 10.1073/pnas.0912895107; Vlassov A, 2001, P NATL ACAD SCI USA, V98, P7706, DOI 10.1073/pnas.141041098; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356	26	114	119	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					376	379		10.1126/science.1192001	http://dx.doi.org/10.1126/science.1192001			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947767	Green Accepted			2022-12-01	WOS:000282986700043
J	Shoval, O; Alon, U				Shoval, Oren; Alon, Uri			SnapShot: Network Motifs	CELL			English	Editorial Material							FEEDFORWARD LOOP; GENE-REGULATION; CELL		[Shoval, Oren; Alon, Uri] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Shoval, O (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.							Alon U, 2006, INTRO SYSTEMS BIOL D; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Goentoro L, 2009, MOL CELL, V36, P894, DOI 10.1016/j.molcel.2009.11.018; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6	10	85	86	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 15	2010	143	2					326	U158		10.1016/j.cell.2010.09.050	http://dx.doi.org/10.1016/j.cell.2010.09.050			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946989	Bronze			2022-12-01	WOS:000283052200020
J	Guly, CM; Forrester, JV				Guly, Catherine M.; Forrester, John V.			Investigation and management of uveitis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							REFRACTORY UVEITIS; THERAPY; CYCLOSPORINE; POSTERIOR; INFLIXIMAB; BLINDNESS; ALPHA		[Guly, Catherine M.] Aberdeen Royal Infirm, Aberdeen AB25 2ZN, Scotland; [Forrester, John V.] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland	University of Aberdeen; University of Aberdeen	Guly, CM (corresponding author), Aberdeen Royal Infirm, Aberdeen AB25 2ZN, Scotland.	catherine.guly@doctors.org.uk						[Anonymous], 1999, Am J Ophthalmol, V127, P537; Daniel E, 2010, AM J OPHTHALMOL, V149, P423, DOI 10.1016/j.ajo.2009.09.026; Deuter CME, 2006, RETINA-J RET VIT DIS, V26, P786, DOI 10.1097/01.iae.0000244265.75771.71; Diaz-Llopis M, 2008, J OCUL PHARMACOL TH, V24, P351, DOI 10.1089/jop.2007.0104; Dick A. D., 2008, PRACTICAL MANUAL INT; Durrani OM, 2004, BRIT J OPHTHALMOL, V88, P1159, DOI 10.1136/bjo.2003.037226; Gangaputra S, 2009, OPHTHALMOLOGY, V116, P2188, DOI 10.1016/j.ophtha.2009.04.020; Gilbert RE, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002218, DOI 10.1002/14651858.CD002218]; ISLAM N, 2007, BMJ CLIN EVID, V12, P705; Jabs DA, 2000, AM J OPHTHALMOL, V130, P492, DOI 10.1016/S0002-9394(00)00659-0; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Kempen John H, 2009, BMJ, V339, pb2480, DOI 10.1136/bmj.b2480; Kotter I, 2003, BRIT J OPHTHALMOL, V87, P423, DOI 10.1136/bjo.87.4.423; Lee RWJ, 2010, BRIT J OPHTHALMOL, V94, P269, DOI 10.1136/bjo.2009.176750; Maini R, 2004, BRIT J OPHTHALMOL, V88, P512, DOI 10.1136/bjo.2002.013334; Mansour AM, 2009, AM J OPHTHALMOL, V148, P310, DOI 10.1016/j.ajo.2009.03.023; Murphy CC, 2005, ARCH OPHTHALMOL-CHIC, V123, P634, DOI 10.1001/archopht.123.5.634; NUSSENBLATT RB, 1991, AM J OPHTHALMOL, V112, P138, DOI 10.1016/S0002-9394(14)76692-9; Pavesio C, 2010, OPHTHALMOLOGY, V117, P567, DOI 10.1016/j.ophtha.2009.11.027; Plskova J, 2007, AM J OPHTHALMOL, V144, P55, DOI 10.1016/j.ajo.2007.03.050; Rothova A, 1996, BRIT J OPHTHALMOL, V80, P332, DOI 10.1136/bjo.80.4.332; ROTHOVA A, 1992, BRIT J OPHTHALMOL, V76, P137, DOI 10.1136/bjo.76.3.137; Royal College of Ophthalmologists, 2006, GUID SCREEN UV JUV I; Suhler EB, 2009, ARCH OPHTHALMOL-CHIC, V127, P819, DOI 10.1001/archophthalmol.2009.141; SuttorpSchulten MSA, 1996, BRIT J OPHTHALMOL, V80, P844, DOI 10.1136/bjo.80.9.844; van Kooij B, 2006, OCUL IMMUNOL INFLAMM, V14, P73, DOI 10.1080/09273940500545684; Yamada Y, 2010, BRIT J OPHTHALMOL, V94, P284, DOI 10.1136/bjo.2009.158840; YAZICI H, 1990, NEW ENGL J MED, V322, P281, DOI 10.1056/NEJM199002013220501	28	35	38	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 13	2010	341								c4976	10.1136/bmj.c4976	http://dx.doi.org/10.1136/bmj.c4976			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	668FB	20943722				2022-12-01	WOS:000283252900012
J	Riess, H				Riess, Helen			Empathy in Medicine-A Neurobiological Perspective	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PSYCHOTHERAPY		Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wang Ambulatory Care Ctr,Dept Psychiat, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Riess, H (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wang Ambulatory Care Ctr,Dept Psychiat, 15 Parkman St,Ste 812, Boston, MA 02114 USA.	hriess@partners.org						Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Decety J, 2010, NEUROIMAGE, V50, P1676, DOI 10.1016/j.neuroimage.2010.01.025; GLUCKSMAN ML, 1981, PSYCHOTHER PSYCHOSOM, V36, P185, DOI 10.1159/000287543; Hickson GB, 2002, JAMA-J AM MED ASSOC, V287, P2951, DOI 10.1001/jama.287.22.2951; Hojat M, 2009, ACAD MED, V84, P1182, DOI 10.1097/ACM.0b013e3181b17e55; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Marci Carl, 2005, Am J Psychother, V59, P213; Marci CD, 2007, J NERV MENT DIS, V195, P103, DOI 10.1097/01.nmd.0000253731.71025.fc; Shanafelt TD, 2009, JAMA-J AM MED ASSOC, V302, P1338, DOI 10.1001/jama.2009.1385; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x	10	69	69	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2010	304	14					1604	1605		10.1001/jama.2010.1455	http://dx.doi.org/10.1001/jama.2010.1455			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662OE	20940387				2022-12-01	WOS:000282816500026
J	Telfer, S; Lambin, X; Birtles, R; Beldomenico, P; Burthe, S; Paterson, S; Begon, M				Telfer, Sandra; Lambin, Xavier; Birtles, Richard; Beldomenico, Pablo; Burthe, Sarah; Paterson, Steve; Begon, Mike			Species Interactions in a Parasite Community Drive Infection Risk in a Wildlife Population	SCIENCE			English	Article							COWPOX; HOST; ASSOCIATIONS; COINFECTION; HELMINTH; RODENTS; IMPACT	Most hosts, including humans, are simultaneously or sequentially infected with several parasites. A key question is whether patterns of coinfection arise because infection by one parasite species affects susceptibility to others or because of inherent differences between hosts. We used time-series data from individual hosts in natural populations to analyze patterns of infection risk for a microparasite community, detecting large positive and negative effects of other infections. Patterns remain once variations in host susceptibility and exposure are accounted for. Indeed, effects are typically of greater magnitude, and explain more variation in infection risk, than the effects associated with host and environmental factors more commonly considered in disease studies. We highlight the danger of mistaken inference when considering parasite species in isolation rather than parasite communities.	[Telfer, Sandra; Paterson, Steve; Begon, Mike] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; [Telfer, Sandra; Lambin, Xavier] Univ Aberdeen, Sch Biol Sci, Aberdeen AB24 2TZ, Scotland; [Birtles, Richard] Univ Liverpool, Sch Vet Sci, Liverpool CH64 7TE, Merseyside, England; [Beldomenico, Pablo] Univ Nacl Litoral, Fac Ciencias Vet, RA-3080 Esperanza, Santa Fe, Argentina; [Burthe, Sarah] Ctr Ecol & Hydrol Edinburgh, Penicuik EH26 0QB, Midlothian, Scotland	University of Liverpool; University of Aberdeen; University of Liverpool; National University of the Littoral; UK Centre for Ecology & Hydrology (UKCEH)	Telfer, S (corresponding author), Univ Liverpool, Sch Biol Sci, Crown St, Liverpool L69 7ZB, Merseyside, England.	s.telfer@abdn.ac.uk	Paterson, Steve/D-2154-2009; Lambin, Xavier/E-8284-2011; Burthe, Sarah J/Q-9505-2016	Paterson, Steve/0000-0002-1307-2981; Lambin, Xavier/0000-0003-4643-2653; Burthe, Sarah J/0000-0001-8871-3432; Begon, Mike/0000-0003-1715-5327; BELDOMENICO, Pablo/0000-0001-5039-8975; Telfer, Sandra/0000-0002-9596-0711; Birtles, Richard/0000-0002-4216-5044	Natural Environment Research Council [GR3/13051]; Wellcome Trust [075202/Z/04/Z, 070675/Z/03/Z]; Dorothy Hodgkin Studentship; Natural Environment Research Council [CEH010021] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust(Wellcome TrustEuropean Commission); Dorothy Hodgkin Studentship; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the following for data collection in the field and laboratory and for discussion and comments: R. Anderson, M. Bennett, K. Bown, S. Gebert, C. Glover, A. Goodsall, G. Hutcheson, D. Jones, L. Lukomski, J. Rogers, A. Smith, G. Telford, and D. Tidhar. The work was supported by funding from the Natural Environment Research Council (GR3/13051) and The Wellcome Trust (075202/Z/04/Z; 070675/Z/03/Z). P. B. was supported by a Dorothy Hodgkin Studentship and is currently a career investigator of the Argentine Council for Science and Technology (CONICET). Metadata are available at the Knowledge Network for Biocomplexity (KNB) data repository (http://knb.ecoinformatics.org). After discussion of specific requirements, more detailed data will be made available on request from mbegon@liv.ac.uk or s.telfer@abdn.ac.uk.	Akaike H, 1973, INT S INF THEOR, P267, DOI DOI 10.2307/2334537; Behnke JM, 2008, PARASITOLOGY, V135, P751, DOI 10.1017/S0031182008000334; Belongia EA, 2002, VECTOR-BORNE ZOONOT, V2, P265, DOI 10.1089/153036602321653851; Birtles RJ, 2005, ANN NY ACAD SCI, V1063, P270, DOI 10.1196/annals.1355.044; Booth M, 2006, TRENDS PARASITOL, V22, P359, DOI 10.1016/j.pt.2006.06.007; Burthe S, 2008, J ANIM ECOL, V77, P110, DOI 10.1111/j.1365-2656.2007.01302.x; Chantrey J, 1999, EPIDEMIOL INFECT, V122, P455, DOI 10.1017/S0950268899002423; Cox FEG, 2001, PARASITOLOGY, V122, pS23, DOI 10.1017/S003118200001698X; Graham AL, 2005, J INFECT DIS, V191, P410, DOI 10.1086/426871; Graham AL, 2008, P NATL ACAD SCI USA, V105, P566, DOI 10.1073/pnas.0707221105; Irwin P, 2005, ARTHROPOD BORNE INFE, P63; Jackson JA, 2006, INT J PARASITOL, V36, P1341, DOI 10.1016/j.ijpara.2006.07.003; Johns JL, 2009, INFECT IMMUN, V77, P4070, DOI 10.1128/IAI.00570-09; Jolles AE, 2008, ECOLOGY, V89, P2239, DOI 10.1890/07-0995.1; Lawn SD, 2006, CLIN INFECT DIS, V42, P1040, DOI 10.1086/501018; Lello J, 2004, NATURE, V428, P840, DOI 10.1038/nature02490; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; PURNELL RE, 1977, VET REC, V100, P4, DOI 10.1136/vr.100.1.4; Rodriguez M, 1999, PARASITE IMMUNOL, V21, P177, DOI 10.1046/j.1365-3024.1999.00218.x; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; Swanson SJ, 2006, CLIN MICROBIOL REV, V19, P708, DOI 10.1128/CMR.00011-06; Telfer S, 2008, PARASITOLOGY, V135, P767, DOI 10.1017/S0031182008000395; Telfer S, 2007, PARASITOLOGY, V134, P413, DOI 10.1017/S0031182006001624; Telfer S, 2005, OIKOS, V109, P317, DOI 10.1111/j.0030-1299.2005.13734.x	24	388	398	2	191	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					243	246		10.1126/science.1190333	http://dx.doi.org/10.1126/science.1190333			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20929776	Green Accepted			2022-12-01	WOS:000282644600048
J	Yamagishi, Y; Honda, T; Tanno, Y; Watanabe, Y				Yamagishi, Yuya; Honda, Takashi; Tanno, Yuji; Watanabe, Yoshinori			Two Histone Marks Establish the Inner Centromere and Chromosome Bi-Orientation	SCIENCE			English	Article							SISTER-CHROMATID COHESION; AURORA-B; MITOTIC CHROMOSOME; SHUGOSHIN; KINETOCHORE; SPINDLE; LOCALIZATION; ATTACHMENT; MEIOSIS; CHECKPOINT	For proper partitioning of chromosomes in mitosis, the chromosomal passenger complex (CPC) including Aurora B and survivin must be localized at the center of paired kinetochores, at the site called the inner centromere. It is largely unknown what defines the inner centromere and how the CPC is targeted to this site. Here, we show that the phosphorylation of histone H3-threonine 3 (H3-pT3) mediated by Haspin cooperates with Bub1-mediated histone 2A-serine 121 (H2A-S121) phosphorylation in targeting the CPC to the inner centromere in fission yeast and human cells. H3-pT3 promotes nucleosome binding of survivin, whereas phosphorylated H2A-S121 facilitates the binding of shugoshin, the centromeric CPC adaptor. Haspin colocalizes with cohesin by associating with Pds5, whereas Bub1 localizes at kinetochores. Thus, the inner centromere is defined by intersection of two histone kinases.	[Yamagishi, Yuya; Honda, Takashi; Tanno, Yuji; Watanabe, Yoshinori] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan; [Yamagishi, Yuya; Watanabe, Yoshinori] Univ Tokyo, Grad Sch Sci, Grad Program Biophys & Biochem, Tokyo 1130033, Japan; [Honda, Takashi; Watanabe, Yoshinori] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1130032, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Watanabe, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan.	ywatanab@iam.u-tokyo.ac.jp		Watanabe, Yoshinori/0000-0002-5488-4812	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [21000010] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Hauf for critical reading of the manuscript, the Yeast Genetic Resource Centre for yeast strains, and all the members of our laboratory for their valuable support and discussion. This work was supported in part by Japan Society for the Promotion of Science research fellowships (to Y.Y., T.H., and Y.T.); the Global Center of Excellence Program; and a Grant-in-Aid for Specially Promoted Research (to Y.W.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018; Hamant O, 2005, CURR BIOL, V15, P948, DOI 10.1016/j.cub.2005.04.049; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; KERREBROCK AW, 1995, CELL, V83, P247, DOI 10.1016/0092-8674(95)90166-3; Kiburz BM, 2005, GENE DEV, V19, P3017, DOI 10.1101/gad.1373005; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Morishita J, 2001, GENES CELLS, V6, P743, DOI 10.1046/j.1365-2443.2001.00459.x; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Resnick TD, 2006, DEV CELL, V11, P57, DOI 10.1016/j.devcel.2006.04.021; Rivera T, 2009, CHROMOSOMA, V118, P223, DOI 10.1007/s00412-008-0190-4; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Shintomi K, 2009, GENE DEV, V23, P2224, DOI 10.1101/gad.1844309; Sonoda E, 2001, DEV CELL, V1, P759, DOI 10.1016/S1534-5807(01)00088-0; Tanaka TU, 2008, CHROMOSOMA, V117, P521, DOI 10.1007/s00412-008-0173-5; Tsukahara T, 2010, NATURE, V467, P719, DOI 10.1038/nature09390; Vanoosthuyse V, 2007, MOL BIOL CELL, V18, P1657, DOI 10.1091/mbc.E06-10-0890; Watanabe Y, 2005, CURR OPIN CELL BIOL, V17, P590, DOI 10.1016/j.ceb.2005.10.003; Yamagishi Y, 2008, NATURE, V455, P251, DOI 10.1038/nature07217	27	330	341	4	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					239	243		10.1126/science.1194498	http://dx.doi.org/10.1126/science.1194498			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20929775				2022-12-01	WOS:000282644600047
J	Dzhindzhev, NS; Yu, QAD; Weiskopf, K; Tzolovsky, G; Cunha-Ferreira, I; Riparbelli, M; Rodrigues-Martins, A; Bettencourt-Dias, M; Callaini, G; Glover, DM				Dzhindzhev, Nikola S.; Yu, Quan D.; Weiskopf, Kipp; Tzolovsky, George; Cunha-Ferreira, Ines; Riparbelli, Maria; Rodrigues-Martins, Ana; Bettencourt-Dias, Monica; Callaini, Giuliano; Glover, David M.			Asterless is a scaffold for the onset of centriole assembly	NATURE			English	Article							POLO-BOX DOMAIN; DROSOPHILA; DUPLICATION; PROTEINS; CYTOKINESIS; BIOGENESIS; SUFFICIENT; SUBSTRATE; EMBRYO; CELLS	Centrioles are found in the centrosome core and, as basal bodies, at the base of cilia and flagella. Centriole assembly and duplication is controlled by Polo-like-kinase 4 (Plk4): these processes fail if Plk4 is downregulated and are promoted by Plk4 overexpression(1-7). Here we show that the centriolar protein Asterless (Asl; human orthologue CEP152) provides a conserved molecular platform, the amino terminus of which interacts with the cryptic Polo box of Plk4 whereas the carboxy terminus interacts with the centriolar protein Sas-4 (CPAP in humans). Drosophila Asl and human CEP152 are required for the centrosomal loading of Plk4 in Drosophila and CPAP in human cells, respectively. Depletion of Asl or CEP152 caused failure of centrosome duplication; their overexpression led to de novo centriole formation in Drosophila eggs, duplication of free centrosomes in Drosophila embryos, and centrosome amplification in cultured Drosophila and human cells. Overexpression of a Plk4-binding-deficient mutant of Asl prevented centriole duplication in cultured cells and embryos. However, this mutant protein was able to promote microtubule organizing centre (MTOC) formation in both embryos and oocytes. Such MTOCs had pericentriolar material and the centriolar protein Sas-4, but no centrioles at their core. Formation of such acentriolar MTOCs could be phenocopied by overexpression of Sas-4 in oocytes or embryos. Our findings identify independent functions for Asl as a scaffold for Plk4 and Sas-4 that facilitates self-assembly and duplication of the centriole and organization of pericentriolar material.	[Dzhindzhev, Nikola S.; Yu, Quan D.; Weiskopf, Kipp; Tzolovsky, George; Cunha-Ferreira, Ines; Rodrigues-Martins, Ana; Glover, David M.] Univ Cambridge, Dept Genet, Canc Res UK Cell Cycle Genet Grp, Cambridge CB2 3EH, England; [Tzolovsky, George; Riparbelli, Maria; Rodrigues-Martins, Ana; Glover, David M.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal; [Riparbelli, Maria; Callaini, Giuliano] Univ Siena, Dipartimento Biol Evolut, I-53100 Siena, Italy	University of Cambridge; Instituto Gulbenkian de Ciencia; University of Siena	Dzhindzhev, NS (corresponding author), Univ Cambridge, Dept Genet, Canc Res UK Cell Cycle Genet Grp, Downing St, Cambridge CB2 3EH, England.	nsd23@cam.ac.uk; dmg25@cam.ac.uk	Callaini, Giuliano/T-6353-2018; Bettencourt-Dias, Monica/B-5176-2015	Callaini, Giuliano/0000-0003-2252-0309; Bettencourt-Dias, Monica/0000-0003-1987-5598; Glover, David/0000-0003-0956-0103; Dzhindzhev, Nikola/0000-0001-9866-3600	Cancer Research UK; Fundacao Calouste Gulbenkian; Fundacao para a Ciencia e Tecnologia (FCT); Royal Society; Cancer Research UK [11431] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Fundacao Calouste Gulbenkian(European Commission); Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Royal Society(Royal Society of London); Cancer Research UK(Cancer Research UK)	We thank E. Wegel for technical help. We thank P. Coelho, G. Mao, P. Gonczy, T. Megraw and J. Raff for antibodies. We thank Cancer Research UK for a Programme Grant to D.M.G. and a studentship to Q.D.Y. K.W. was a visiting scholar of the Winston Churchill Foundation of the United States. Fundacao Calouste Gulbenkian, Fundacao para a Ciencia e Tecnologia (FCT) provided support to M.B.-D. and scholarships to I.C.-F. and A.R.-M. The Royal Society provided an International Joint Project Grant for collaboration between M.B.-D. and D.M.G.	Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Blachon S, 2008, GENETICS, V180, P2081, DOI 10.1534/genetics.108.095141; Chang J, 2010, EMBO J, V29, P2395, DOI 10.1038/emboj.2010.118; Cunha-Ferreira I, 2009, CURR BIOL, V19, P43, DOI 10.1016/j.cub.2008.11.037; D'Avino PP, 2006, J CELL SCI, V119, P4402, DOI 10.1242/jcs.03210; D'Avino PP, 2009, METHODS MOL BIOL, V545, P99, DOI 10.1007/978-1-60327-993-2_6; Dobbelaere J, 2008, PLOS BIOL, V6, P1975, DOI 10.1371/journal.pbio.0060224; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Fox JD, 2003, FEBS LETT, V537, P53, DOI 10.1016/S0014-5793(03)00070-X; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Leung GC, 2002, NAT STRUCT BIOL, V9, P719, DOI 10.1038/nsb848; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Mottier-Pavie V, 2009, MOL BIOL CELL, V20, P2605, DOI 10.1091/mbc.E08-11-1115; Peel N, 2007, CURR BIOL, V17, P834, DOI 10.1016/j.cub.2007.04.036; Rodrigues-Martins A, 2007, SCIENCE, V316, P1046, DOI 10.1126/science.1142950; Rodrigues-Martins A, 2007, CURR BIOL, V17, P1465, DOI 10.1016/j.cub.2007.07.034; Rogers GC, 2009, J CELL BIOL, V184, P225, DOI 10.1083/jcb.200808049; Varmark H, 2007, CURR BIOL, V17, P1735, DOI 10.1016/j.cub.2007.09.031; WARN RM, 1986, EXP CELL RES, V163, P201, DOI 10.1016/0014-4827(86)90573-2	24	215	221	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 7	2010	467	7316					714	U104		10.1038/nature09445	http://dx.doi.org/10.1038/nature09445			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659NE	20852615				2022-12-01	WOS:000282572500040
J	Korzhnev, DM; Religa, TL; Banachewicz, W; Fersht, AR; Kay, LE				Korzhnev, Dmitry M.; Religa, Tomasz L.; Banachewicz, Wiktor; Fersht, Alan R.; Kay, Lewis E.			A Transient and Low-Populated Protein-Folding Intermediate at Atomic Resolution	SCIENCE			English	Article							DISPERSION NMR-SPECTROSCOPY; ON-PATHWAY INTERMEDIATE; TIME-SCALE DYNAMICS; RELAXATION DISPERSION; CHEMICAL-SHIFTS; FF DOMAIN; ACCURATE MEASUREMENT; STRUCTURE GENERATION; TRANSITION-STATE; EXCHANGE	Proteins can sample conformational states that are critical for function but are seldom detected directly because of their low occupancies and short lifetimes. In this work, we used chemical shifts and bond-vector orientation constraints obtained from nuclear magnetic resonance relaxation dispersion spectroscopy, in concert with a chemical shift-based method for structure elucidation, to determine an atomic-resolution structure of an "invisible" folding intermediate of a small protein module: the FF domain. The structure reveals non-native elements preventing formation of the native conformation in the carboxyl-terminal part of the protein. This is consistent with the kinetics of folding in which a well-structured intermediate forms rapidly and then rearranges slowly to the native state. The approach introduces a general strategy for structure determination of low-populated and transiently formed protein states.	[Korzhnev, Dmitry M.; Religa, Tomasz L.; Kay, Lewis E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Korzhnev, Dmitry M.; Religa, Tomasz L.; Kay, Lewis E.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Korzhnev, Dmitry M.; Religa, Tomasz L.; Kay, Lewis E.] Univ Toronto, Dept Chem, Toronto, ON M5S 1A8, Canada; [Banachewicz, Wiktor; Fersht, Alan R.] MRC, Ctr Prot Engn, Cambridge CB2 2QH, England	University of Toronto; University of Toronto; University of Toronto; University of Cambridge	Kay, LE (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	kay@pound.med.utoronto.ca	Fersht, Alan R/B-2189-2008		European Molecular Biology Organization [ALTF 827-2006]; Canadian Institutes of Health Research (CIHR); MRC [MC_U105484373] Funding Source: UKRI; Medical Research Council [MC_U105484373] Funding Source: researchfish	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J. Forman-Kay (Hospital for Sick Children, Toronto) for providing laboratory space and useful discussions, P. Jemth (Uppsala Univ.) for providing plasmids for protein expression, R. Vernon (Univ. of Washington, Seattle) for valuable discussions, and R. Muhandiram (Univ. of Toronto) for NMR support. T.L.R. acknowledges the European Molecular Biology Organization (ALTF 827-2006) and the Canadian Institutes of Health Research (CIHR) for postdoctoral fellowships. L.E.K. holds a Canada Research Chair in Biochemistry. This work was supported by a grant from the CIHR to L.E.K. The structural ensembles of the WT FF domain-folding intermediate have been deposited in the Protein Data Bank (PDB; www.rcsb.org) with accession code 2KZG.	Allen M, 2002, J MOL BIOL, V323, P411, DOI 10.1016/S0022-2836(02)00968-3; Auer S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.178104; Baldwin AJ, 2009, NAT CHEM BIOL, V5, P808, DOI 10.1038/nchembio.238; BAX A, 1994, CURR OPIN STRUC BIOL, V4, P738, DOI 10.1016/S0959-440X(94)90173-2; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Brockwell DJ, 2007, CURR OPIN STRUC BIOL, V17, P30, DOI 10.1016/j.sbi.2007.01.003; Capaldi AP, 2002, NAT STRUCT BIOL, V9, P209, DOI 10.1038/nsb757; Cavalli A, 2007, P NATL ACAD SCI USA, V104, P9615, DOI 10.1073/pnas.0610313104; Daggett V, 2003, NAT REV MOL CELL BIO, V4, P497, DOI 10.1038/nrm1126; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Englander SW, 2007, Q REV BIOPHYS, V40, P287, DOI 10.1017/S0033583508004654; Feng HQ, 2005, P NATL ACAD SCI USA, V102, P5026, DOI 10.1073/pnas.0501372102; Fersht A, 1999, STRUCTURE MECH PROTE; Hansen DF, 2008, J PHYS CHEM B, V112, P5898, DOI 10.1021/jp074793o; Hansen DF, 2008, J AM CHEM SOC, V130, P2667, DOI 10.1021/ja078337p; Igumenova TI, 2007, J AM CHEM SOC, V129, P13396, DOI 10.1021/ja0761636; Ishima R, 2004, J BIOMOL NMR, V29, P187, DOI 10.1023/B:JNMR.0000019249.50306.5d; Ishima R, 2003, J BIOMOL NMR, V25, P243, DOI 10.1023/A:1022851228405; Jemth P, 2005, J MOL BIOL, V350, P363, DOI 10.1016/j.jmb.2005.04.067; Jemth P, 2004, P NATL ACAD SCI USA, V101, P6450, DOI 10.1073/pnas.0401732101; Jemth P, 2008, PROTEIN ENG DES SEL, V21, P207, DOI 10.1093/protein/gzm091; Korzhnev DM, 2004, NATURE, V430, P586, DOI 10.1038/nature02655; Korzhnev DM, 2008, ACCOUNTS CHEM RES, V41, P442, DOI 10.1021/ar700189y; Korzhnev DM, 2007, J MOL BIOL, V372, P497, DOI 10.1016/j.jmb.2007.06.012; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; Lundstrom P, 2008, J BIOMOL NMR, V42, P35, DOI 10.1007/s10858-008-9260-4; Lundstrom P, 2009, J AM CHEM SOC, V131, P1915, DOI 10.1021/ja807796a; Lundstrom P, 2007, J BIOMOL NMR, V38, P199, DOI 10.1007/s10858-007-9158-6; MATOUSCHEK A, 1989, NATURE, V340, P122, DOI 10.1038/340122a0; McCully ME, 2010, BIOPHYS J, V99, P1628, DOI 10.1016/j.bpj.2010.06.040; Neudecker P, 2007, P NATL ACAD SCI USA, V104, P15717, DOI 10.1073/pnas.0705097104; Orekhov VY, 2004, J AM CHEM SOC, V126, P1886, DOI 10.1021/ja038620y; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Religa TL, 2005, NATURE, V437, P1053, DOI 10.1038/nature04054; Religa TL, 2007, P NATL ACAD SCI USA, V104, P9272, DOI 10.1073/pnas.0703434104; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2007, J BIOMOL NMR, V38, P289, DOI 10.1007/s10858-007-9166-6; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Skrynnikov NR, 2002, J AM CHEM SOC, V124, P12352, DOI 10.1021/ja0207089; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Vallurupalli P, 2008, P NATL ACAD SCI USA, V105, P11766, DOI 10.1073/pnas.0804221105; Vallurupalli P, 2007, P NATL ACAD SCI USA, V104, P18473, DOI 10.1073/pnas.0708296104; Wensley BG, 2010, NATURE, V463, P685, DOI 10.1038/nature08743; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pW496, DOI 10.1093/nar/gkn305; Wishart DS, 2001, METHOD ENZYMOL, V338, P3	49	236	237	1	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2010	329	5997					1312	1316		10.1126/science.1191723	http://dx.doi.org/10.1126/science.1191723			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647YR	20829478				2022-12-01	WOS:000281657300029
J	Gale, DP; de Jorge, EG; Cook, HT; Martinez-Barricarte, R; Hadjisavvas, A; McLean, AG; Pusey, CD; Pierides, A; Kyriacou, K; Athanasiou, Y; Voskarides, K; Deltas, C; Palmer, A; Fremeaux-Bacchi, V; de Cordoba, SR; Maxwell, PH; Pickering, MC				Gale, Daniel P.; de Jorge, Elena Goicoechea; Cook, H. Terence; Martinez-Barricarte, Ruben; Hadjisavvas, Andreas; McLean, Adam G.; Pusey, Charles D.; Pierides, Alkis; Kyriacou, Kyriacos; Athanasiou, Yiannis; Voskarides, Konstantinos; Deltas, Constantinos; Palmer, Andrew; Fremeaux-Bacchi, Veronique; Rodriguez de Cordoba, Santiago; Maxwell, Patrick H.; Pickering, Matthew C.			Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis	LANCET			English	Article							HEMOLYTIC-UREMIC SYNDROME; TRANSLATIONAL MINIREVIEW SERIES; MACULAR DEGENERATION; LINKAGE ANALYSIS; DISEASE; AGE; DEPOSITS; RISK	Background Complement is a key component of the innate immune system, and variation in genes that regulate its activation is associated with renal and other disease. We aimed to establish the genetic basis for a familial disorder of complement regulation associated with persistent microscopic haematuria, recurrent macroscopic haematuria, glomerulonephritis, and progressive renal failure. Methods We sought patients from the West London Renal and Transplant Centre (London, UK) with unusual renal disease and affected family members as a method of identification of new genetic causes of kidney disease. Two families of Cypriot origin were identified in which renal disease was consistent with autosomal dominant transmission and renal biopsy of at least one individual showed C3 glomerulonephritis. A mutation was identified via a genomewide linkage study and candidate gene analysis. A PCR-based diagnostic test was then developed and used to screen for the mutation in population-based samples and in individuals and families with renal disease. Findings Occurrence of familial renal disease cosegregated with the same mutation in the complement factor H-related protein 5 gene (CFHR5). In a cohort of 84 Cypriots with unexplained renal disease, four had mutation in CFHR5. Overall, we identified 26 individuals with the mutation and evidence of renal disease from 11 ostensibly unrelated kindreds, including the original two families. A mutant CFHR5 protein present in patient serum had reduced affinity for surface-bound complement. We term this renal disease CFHR5 nephropathy. Interpretation CFHR5 nephropathy accounts for a substantial burden of renal disease in patients of Cypriot origin and can be diagnosed with a specific molecular test. The high risk of progressive renal disease in carriers of the CFHR5 mutation implies that isolated microscopic haematuria or recurrent macroscopic haematuria should not be regarded as a benign finding in individuals of Cypriot descent.	[Maxwell, Patrick H.] UCL, Rayne Inst, Div Med, London WC1E 6JF, England; [de Jorge, Elena Goicoechea; Cook, H. Terence; Pickering, Matthew C.] Univ London Imperial Coll Sci Technol & Med, Ctr Complement & Inflammat Res, London, England; [Gale, Daniel P.; McLean, Adam G.; Pusey, Charles D.; Palmer, Andrew] Univ London Imperial Coll Sci Technol & Med, Imperial Coll Kidney & Transplant Inst, London, England; [Martinez-Barricarte, Ruben; Rodriguez de Cordoba, Santiago] CSIC, Ctr Invest Biol, Ctr Invest Biomed Enfermedades Raras, Madrid, Spain; [Martinez-Barricarte, Ruben; Rodriguez de Cordoba, Santiago] Inst Reina Sofia Invest Nefrol, Madrid, Spain; [Hadjisavvas, Andreas; Kyriacou, Kyriacos] Cyprus Inst Neurol & Genet, Dept Electron Microscopy & Pathol, Nicosia, Cyprus; [Pierides, Alkis] Hippocrateon Hosp, Dept Nephrol, Nicosia, Cyprus; [Athanasiou, Yiannis] Nicosia Gen Hosp, Dept Nephrol, Nicosia, Cyprus; [Voskarides, Konstantinos; Deltas, Constantinos] Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus; [Fremeaux-Bacchi, Veronique] Hop Europeen Georges Pompidou, AP HP, Serv Immunol Biol, Paris, France; [Fremeaux-Bacchi, Veronique] Cordeliers Res Ctr, INSERM, UMRS 872, Paris, France	University of London; King's College London; University College London; Imperial College London; Imperial College London; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Hippocrateon Private Hospital; University of Cyprus; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Maxwell, PH (corresponding author), UCL, Rayne Inst, Div Med, 5 Univ St, London WC1E 6JF, England.	p.maxwell@ucl.ac.uk	Barricarte, Ruben Martinez/W-8695-2019; Maxwell, Patrick H/C-5557-2008; Gale, Daniel/D-5594-2013; Deltas, Constantinos/A-4936-2013; Voskarides, Konstantinos/A-4669-2013; Deltas, Constantinos/J-9345-2013; de Cordoba, Santiago Rodriguez/K-6727-2014; de Jorge, Elena Goicoechea/L-4580-2016	Barricarte, Ruben Martinez/0000-0001-7925-449X; Maxwell, Patrick H/0000-0002-0338-2679; Gale, Daniel/0000-0002-9170-1579; Deltas, Constantinos/0000-0001-5549-9169; Voskarides, Konstantinos/0000-0002-3705-3451; Deltas, Constantinos/0000-0001-5549-9169; de Cordoba, Santiago Rodriguez/0000-0001-6401-1874; de Jorge, Elena Goicoechea/0000-0002-4978-2483; Pickering, Matthew/0000-0002-1153-0192	UK Medical Research Council; Wellcome Trust [WT082291MA]; UK National Institute for Health Research Biomedical Research Centre; Cyprus Research Promotion Foundation; Cyprus Research Promotion Foundation [ENISigmaX/0505/02, ENISigmaX/0308/08]; EU; St Peter's Trust; UK National Institute for Health Research; MRC [G0600420] Funding Source: UKRI; Medical Research Council [G0600420] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10315] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); UK National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); Cyprus Research Promotion Foundation; Cyprus Research Promotion Foundation; EU(European Commission); St Peter's Trust; UK National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	DPG is supported by the UK Medical Research Council and EGdJ and MCP are supported by the Wellcome Trust. Additional support was provided by the UK National Institute for Health Research Biomedical Research Centre Funding Scheme and the Cyprus Research Promotion Foundation. No payment was received for the writing of this article. We thank the patients and their families. DPG is supported by a UK Medical Research Council Clinical Research Training Fellowship. MCP is a Wellcome Trust Senior Fellow in Clinical Science (WT082291MA) and EGdJ is funded by this fellowship. CD is supported by the Cyprus Research Promotion Foundation through grants ENI Sigma X/0505/02 and ENI Sigma X/0308/08. Additional support was obtained from the UK National Institute for Health Research Biomedical Research Centre Funding Scheme. PHM is supported by the EU large scale collaborative project Metoxia, the St Peter's Trust, and a Senior Investigator Award from the UK National Institute for Health Research.	BERGER J, 1968, J UROL NEPHROL, V74, P694; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cohen RA, 2003, NEW ENGL J MED, V348, P2330, DOI 10.1056/NEJMcp012694; de Cordoba SR, 2008, CLIN EXP IMMUNOL, V151, P1, DOI 10.1111/j.1365-2249.2007.03574.x; de Jorge EG, 2007, P NATL ACAD SCI USA, V104, P240, DOI 10.1073/pnas.0603420103; Dragon-Durey MA, 2009, J MED GENET, V46, P447, DOI 10.1136/jmg.2008.064766; Fremeaux-Bacchi V, 2008, BLOOD, V112, P4948, DOI 10.1182/blood-2008-01-133702; Genin E, 2004, J MED GENET, V41, P445, DOI 10.1136/jmg.2003.017962; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Hillmen P, 2006, NEW ENGL J MED, V355, P1233, DOI 10.1056/NEJMoa061648; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Loizidou MA, 2008, BREAST CANCER RES TR, V112, P575, DOI 10.1007/s10549-007-9881-4; Markianos K, 2001, AM J HUM GENET, V68, P963, DOI 10.1086/319507; McRae JL, 2005, J IMMUNOL, V174, P6250, DOI 10.4049/jimmunol.174.10.6250; McRae JL, 2001, J BIOL CHEM, V276, P6747, DOI 10.1074/jbc.M007495200; Murphy B, 2002, AM J KIDNEY DIS, V39, P24, DOI 10.1053/ajkd.2002.29873; Narendra U, 2009, MOL VIS, V15, P731; *NAT COLL CTR CHRO, 2008, CHRON KIDN DIS NAT C, P147; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Pickering MC, 2008, CLIN EXP IMMUNOL, V151, P210, DOI 10.1111/j.1365-2249.2007.03574.x; Pickering MC, 2007, J EXP MED, V204, P1249, DOI 10.1084/jem.20070301; Servais A, 2007, J MED GENET, V44, P193, DOI 10.1136/jmg.2006.045328; Smith RJH, 2007, J AM SOC NEPHROL, V18, P2447, DOI 10.1681/ASN.2007030356; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Voskarides K, 2007, J AM SOC NEPHROL, V18, P3004, DOI 10.1681/ASN.2007040444; WHALEY K, 1976, J EXP MED, V144, P1147, DOI 10.1084/jem.144.5.1147	26	227	243	1	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 4	2010	376	9743					794	801		10.1016/S0140-6736(10)60670-8	http://dx.doi.org/10.1016/S0140-6736(10)60670-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	650EC	20800271	Green Published, Green Submitted			2022-12-01	WOS:000281831000030
J	Nikoletopoulou, V; Lickert, H; Frade, JM; Rencurel, C; Giallonardo, P; Zhang, LX; Bibel, M; Barde, YA				Nikoletopoulou, Vassiliki; Lickert, Heiko; Frade, Jose Maria; Rencurel, Chantal; Giallonardo, Patrizia; Zhang, Lixin; Bibel, Miriam; Barde, Yves-Alain			Neurotrophin receptors TrkA and TrkC cause neuronal death whereas TrkB does not	NATURE			English	Article							NERVE GROWTH-FACTOR; EMBRYONIC STEM-CELLS; SYMPATHETIC NEURONS; GENETIC-EVIDENCE; MESSENGER-RNA; P75; EXPRESSION; DEPENDENCE; GANGLIA; MICE	Neurons of the peripheral nervous system have long been known to require survival factors to prevent their death during development. But why they selectively become dependent on secretory molecules has remained a mystery, as is the observation that in the central nervous system, most neurons do not show this dependency. Using engineered embryonic stem cells, we show here that the neurotrophin receptors TrkA and TrkC (tropomyosin receptor kinase A and C, also known as Ntrk1 and Ntrk3, respectively) instruct developing neurons to die, both in vitro and in vivo. By contrast, TrkB (also known as Ntrk2), a closely related receptor primarily expressed in the central nervous system, does not. These results indicate that TrkA and TrkC behave as dependence receptors, explaining why developing sympathetic and sensory neurons become trophic-factor-dependent for survival. We suggest that the expansion of the Trk gene family that accompanied the segregation of the peripheral from the central nervous system generated a novel mechanism of cell number control.	[Nikoletopoulou, Vassiliki; Rencurel, Chantal; Zhang, Lixin; Barde, Yves-Alain] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Lickert, Heiko; Giallonardo, Patrizia] Helmholtz Zentrum Munchen, Inst Stem Cell Res, D-85764 Neuherberg, Germany; [Frade, Jose Maria] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Bibel, Miriam] Novartis Inst BioMed Res, Neurodegenerat Dept, CH-4002 Basel, Switzerland	University of Basel; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Novartis	Nikoletopoulou, V (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.	n.vassiliki@unibas.ch; yves.barde@unibas.ch	Frade, Jose M/E-7913-2013; Barde, Yves/F-6019-2011; Zhang, Li/GWM-7501-2022; Lickert, Heiko/K-9045-2013	Frade, Jose M/0000-0001-7067-2505; Nikoletopoulou, Vassiliki/0000-0003-3646-992X; Barde, Yves/0000-0002-7627-461X	DFG; consortium EuTRACC; Swiss National Foundation	DFG(German Research Foundation (DFG)); consortium EuTRACC; Swiss National Foundation(Swiss National Science Foundation (SNSF))	H.L. is supported by an Emmy-Nother fellowship of the DFG. V.N. and Y.-A.B. thank S. Arber, G. Dechant as well as members of our laboratory for discussions and suggestions.; Tetraploid embryos were generated by P. G. and H. L.; J.M.F. initiated the comparison of the Ngf and TrkA mutant embryos; C. R performed the cloning of the HA-tagged Trk cDNAs; ES lines expressing non-tagged Trk cDNAs from the Mapt locus were generated by M. B.; L.Z. made the first observations with the neuronal differentiation of Trk-expressing ES cells. V.N. and Y.-A.B designed and carried out all other experiments. This work was supported by the consortium EuTRACC and the Swiss National Foundation.	Barbacid M, 1995, ANN NY ACAD SCI, V766, P442, DOI 10.1111/j.1749-6632.1995.tb26693.x; Benito-Gutierrez E, 2005, DEVELOPMENT, V132, P2191, DOI 10.1242/dev.01803; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Bredesen DE, 2005, CELL DEATH DIFFER, V12, P1031, DOI 10.1038/sj.cdd.4401680; Brennan C, 1999, NAT NEUROSCI, V2, P699, DOI 10.1038/11158; Chao MV, 2010, DEV NEUROBIOL, V70, P269, DOI 10.1002/dneu.20779; COUGHLIN MD, 1981, DEV BIOL, V82, P56, DOI 10.1016/0012-1606(81)90428-0; Davies AM, 2003, EMBO J, V22, P2537, DOI 10.1093/emboj/cdg254; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; ERNFORS P, 1989, NEURON, V2, P1605, DOI 10.1016/0896-6273(89)90049-4; ESCANDON E, 1994, J NEUROSCI, V14, P2054; Frade JM, 1999, DEVELOPMENT, V126, P683; GAESE F, 1994, DEVELOPMENT, V120, P1613; Gschwendtner A, 2003, MOL CELL NEUROSCI, V24, P307, DOI 10.1016/S1044-7431(03)00167-2; HAMBURGER V, 1981, J NEUROSCI, V1, P60, DOI 10.1523/JNEUROSCI.01-01-00060.1981; Holland LZ, 2009, NAT REV NEUROSCI, V10, P736, DOI 10.1038/nrn2703; KAHANE N, 1994, J NEUROBIOL, V25, P571, DOI 10.1002/neu.480250509; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Kolbeck R, 1999, J NEUROCHEM, V72, P1930, DOI 10.1046/j.1471-4159.1999.0721930.x; LEE KF, 1994, SCIENCE, V263, P1447, DOI 10.1126/science.8128229; LIU X, 1995, NATURE, V375, P238, DOI 10.1038/375238a0; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Moqrich A, 2004, NAT NEUROSCI, V7, P812, DOI 10.1038/nn1283; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakagawara A, 2001, CANCER LETT, V169, P107, DOI 10.1016/S0304-3835(01)00530-4; Nikoletopoulou V, 2007, CELL STEM CELL, V1, P529, DOI 10.1016/j.stem.2007.08.011; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453; Plachta N, 2007, NAT NEUROSCI, V10, P712, DOI 10.1038/nn1897; Rauskolb S, 2010, J NEUROSCI, V30, P1739, DOI 10.1523/JNEUROSCI.5100-09.2010; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Schecterson LC, 2010, DEV NEUROBIOL, V70, P332, DOI 10.1002/dneu.20767; Sendtner M, 1996, NEUROCHEM RES, V21, P831, DOI 10.1007/BF02532307; Singh KK, 2008, NAT NEUROSCI, V11, P649, DOI 10.1038/nn.2114; Stenqvist A, 2005, EMBO REP, V6, P973, DOI 10.1038/sj.embor.7400512; Tauszig-Delamasure S, 2007, P NATL ACAD SCI USA, V104, P13361, DOI 10.1073/pnas.0701243104; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; von Bartheld CS, 1998, HISTOL HISTOPATHOL, V13, P437, DOI 10.14670/HH-13.437; von Schack D, 2001, NAT NEUROSCI, V4, P977, DOI 10.1038/nn730; Wernig M, 2002, J NEUROSCI RES, V69, P918, DOI 10.1002/jnr.10395; White FA, 1996, J NEUROSCI, V16, P4662; WYATT S, 1993, DEVELOPMENT, V119, P635; WYATT S, 1995, J CELL BIOL, V130, P1435, DOI 10.1083/jcb.130.6.1435; Yano H, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-03-j0003.2001	48	152	157	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2010	467	7311					59	U87		10.1038/nature09336	http://dx.doi.org/10.1038/nature09336			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645MB	20811452	Green Submitted			2022-12-01	WOS:000281461200034
J	Mayer, M; Depken, M; Bois, JS; Julicher, F; Grill, SW				Mayer, Mirjam; Depken, Martin; Bois, Justin S.; Juelicher, Frank; Grill, Stephan W.			Anisotropies in cortical tension reveal the physical basis of polarizing cortical flows	NATURE			English	Article							C-ELEGANS EMBRYOS; CAENORHABDITIS-ELEGANS; EARLY EMBRYOGENESIS; PROTEINS RGA-3; CELL-DIVISION; PAR PROTEINS; GERM-LINE; CYTOKINESIS; MICROFILAMENTS; MORPHOGENESIS	Asymmetric cell divisions are essential for the development of multicellular organisms. To proceed, they require an initially symmetric cell to polarize(1). In Caenorhabditis elegans zygotes, anteroposterior polarization is facilitated by a large-scale flow of the actomyosin cortex(2-4), which directs the asymmetry of the first mitotic division. Cortical flows appear in many contexts of development(5), but their underlying forces and physical principles remain poorly understood. How actomyosin contractility and cortical tension interact to generate large-scale flow is unclear. Here we report on the subcellular distribution of cortical tension in the polarizing C. elegans zygote, which we determined using position- and direction-sensitive laser ablation. We demonstrate that cortical flow is associated with anisotropies in cortical tension and is not driven by gradients in cortical tension, which contradicts previous proposals(5). These experiments, in conjunction with a theoretical description of active cortical mechanics, identify two prerequisites for large-scale cortical flow: a gradient in actomyosin contractility to drive flow and a sufficiently large viscosity of the cortex to allow flow to be long-ranged. We thus reveal the physical requirements of large-scale intracellular cortical flow that ensure the efficient polarization of the C. elegans zygote.	[Mayer, Mirjam; Depken, Martin; Bois, Justin S.; Grill, Stephan W.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Mayer, Mirjam; Depken, Martin; Bois, Justin S.; Juelicher, Frank; Grill, Stephan W.] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany	Max Planck Society; Max Planck Society	Grill, SW (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.	grill@mpi-cbg.de	Grill, Stephan/D-9427-2012; Julicher, Frank/B-1828-2009	Julicher, Frank/0000-0003-4731-9185; Bois, Justin/0000-0001-7137-8746	Boehringer Ingelheim Fonds; Human Frontier Science Program	Boehringer Ingelheim Fonds(Boehringer Ingelheim); Human Frontier Science Program(Human Frontier Science Program)	We thank C. Cowan, N. Goehring, P. Gonczy, J. Howard, T. Hyman, M. Loose, F. Nedelec and K. Oegema for advice and suggestions on the manuscript. We are grateful to E. Munro for scientific advice, worm strains and discussions. M. M. is supported by a predoctoral fellowship from the Boehringer Ingelheim Fonds, and J.S.B. by a postdoctoral fellowship from the Human Frontier Science Program.	BRAY D, 1988, SCIENCE, V239, P883, DOI 10.1126/science.3277283; BRENNER S, 1974, GENETICS, V77, P71; Cheeks RJ, 2004, CURR BIOL, V14, P851, DOI 10.1016/j.cub.2004.05.022; Cowan CR, 2004, NATURE, V431, P92, DOI 10.1038/nature02825; Dai JW, 1999, BIOPHYS J, V77, P1168, DOI 10.1016/S0006-3495(99)76968-7; Daniels BR, 2006, BIOPHYS J, V90, P4712, DOI 10.1529/biophysj.105.080606; Gardel ML, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.088102; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Goldstein B, 1996, DEVELOPMENT, V122, P1467; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; HILL DP, 1988, DEV BIOL, V125, P75, DOI 10.1016/0012-1606(88)90060-7; HIRAMOTO Y, 1970, Biorheology, V6, P201; HIRD SN, 1993, J CELL BIOL, V121, P1343, DOI 10.1083/jcb.121.6.1343; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Humphrey D, 2002, NATURE, V416, P413, DOI 10.1038/416413; HYMAN AA, 1987, J CELL BIOL, V105, P2123, DOI 10.1083/jcb.105.5.2123; Kruse K, 2005, EUR PHYS J E, V16, P5, DOI 10.1140/epje/e2005-00002-5; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Lieleg O, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.108101; Mandato CA, 2001, J CELL BIOL, V154, P785, DOI 10.1083/jcb.200103105; Motegi F, 2006, DEV CELL, V10, P509, DOI 10.1016/j.devcel.2006.03.001; Motegi F, 2006, NAT CELL BIOL, V8, P978, DOI 10.1038/ncb1459; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Munro E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003400; Nance J, 2003, DEVELOPMENT, V130, P5339, DOI 10.1242/dev.00735; PASTERNAK C, 1989, NATURE, V341, P549, DOI 10.1038/341549a0; Raffel M, 2007, EXP FLUID MECH, P1, DOI 10.1007/978-3-540-72308-0; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798; Salbreux G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.058102; Schmutz C, 2007, DEVELOPMENT, V134, P3495, DOI 10.1242/dev.000802; Schonegg S, 2007, P NATL ACAD SCI USA, V104, P14976, DOI 10.1073/pnas.0706941104; Shelton CA, 1996, DEVELOPMENT, V122, P2043; Simha RA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.058101; STROME S, 1986, J CELL BIOL, V103, P2241, DOI 10.1083/jcb.103.6.2241; STROME S, 1983, CELL, V35, P15, DOI 10.1016/0092-8674(83)90203-9; STROME S, 1988, BIOESSAYS, V8, P145, DOI 10.1002/bies.950080504; SVEEN J, 2004, ADV COASTAL OCEAN EN, V9, pCH1; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Velarde N, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-142; Wottawah F, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.098103; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592; Zhang WD, 2005, P NATL ACAD SCI USA, V102, P7186, DOI 10.1073/pnas.0502545102; Zonies S, 2010, DEVELOPMENT, V137, P1669, DOI 10.1242/dev.045823	47	326	334	4	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP	2010	467	7315					617	U150		10.1038/nature09376	http://dx.doi.org/10.1038/nature09376			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655TT	20852613				2022-12-01	WOS:000282273100045
J	Vorosmarty, CJ; McIntyre, PB; Gessner, MO; Dudgeon, D; Prusevich, A; Green, P; Glidden, S; Bunn, SE; Sullivan, CA; Liermann, CR; Davies, PM				Voeroesmarty, C. J.; McIntyre, P. B.; Gessner, M. O.; Dudgeon, D.; Prusevich, A.; Green, P.; Glidden, S.; Bunn, S. E.; Sullivan, C. A.; Liermann, C. Reidy; Davies, P. M.			Global threats to human water security and river biodiversity	NATURE			English	Article							AMERICAN FRESH-WATER; MARINE; VULNERABILITY; INDICATORS; RESOURCES; MAP	Protecting the world's freshwater resources requires diagnosing threats over a broad range of scales, from global to local. Here we present the first worldwide synthesis to jointly consider human and biodiversity perspectives on water security using a spatial framework that quantifies multiple stressors and accounts for downstream impacts. We find that nearly 80% of the world's population is exposed to high levels of threat to water security. Massive investment in water technology enables rich nations to offset high stressor levels without remedying their underlying causes, whereas less wealthy nations remain vulnerable. A similar lack of precautionary investment jeopardizes biodiversity, with habitats associated with 65% of continental discharge classified as moderately to highly threatened. The cumulative threat framework offers a tool for prioritizing policy and management responses to this crisis, and underscores the necessity of limiting threats at their source instead of through costly remediation of symptoms in order to assure global water security for both humans and freshwater biodiversity.	[Voeroesmarty, C. J.; Green, P.] CUNY City Coll, Environm CrossRd Initiat, New York, NY 10035 USA; [McIntyre, P. B.] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Gessner, M. O.] Swiss Fed Inst Technol, Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, CH-8600 Dubendorf, Switzerland; [Gessner, M. O.] Swiss Fed Inst Technol, Inst Integrat Biol IBZ, CH-8600 Dubendorf, Switzerland; [Gessner, M. O.] Leibniz Inst Freshwater Ecol & Inland Fisheries I, D-16775 Stechlin, Germany; [Dudgeon, D.] Univ Hong Kong, Sch Biol Sci, Div Ecol & Biodivers, Hong Kong, Hong Kong, Peoples R China; [Prusevich, A.; Glidden, S.] Univ New Hampshire, Water Syst Anal Grp, Durham, NH 03824 USA; [Bunn, S. E.] Griffith Univ, Australian Rivers Inst, Nathan, Qld 4111, Australia; [Sullivan, C. A.] So Cross Univ, Sch Environm Sci & Management, Lismore, NSW 2480, Australia; [Liermann, C. Reidy] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Davies, P. M.] Univ Western Australia, Ctr Excellence Nat Resource Management, Albany 6330, Australia	City University of New York (CUNY) System; City College of New York (CUNY); University of Michigan System; University of Michigan; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of Hong Kong; University System Of New Hampshire; University of New Hampshire; Griffith University; Southern Cross University; University of Washington; University of Washington Seattle; University of Western Australia	Vorosmarty, CJ (corresponding author), CUNY City Coll, Environm CrossRd Initiat, New York, NY 10035 USA.	contact@riverthreat.net	Quinn, Patrick/B-5489-2010; Bunn, Stuart E/B-9065-2008; Hu, Lile/E-7961-2015; Davies, Peter M/C-3518-2013; Sullivan, Caroline/T-8668-2017	Bunn, Stuart E/0000-0002-6540-3586; Sullivan, Caroline/0000-0001-8486-0523; Gessner, Mark O./0000-0003-2516-7416; Prusevich, Alexander/0000-0002-9529-443X	NASA [NNX07AF28G]; NSF Division of Earth Sciences [0854957]; Global Environment Facility [UPI 00345306]; D.H. Smith Fellowship	NASA(National Aeronautics & Space Administration (NASA)); NSF Division of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Global Environment Facility; D.H. Smith Fellowship	We thank A. DeSherbinin, L. Poff, C. Revenga, J. Melillo and O. Young for comments on the manuscript; D. Allan, R. Abell, J. Bogardi, M. Meybeck, W. Wollheim, R. F. Wright, D. Boswell, R. Lacey, N. Schneider and D. Vorosmarty for advice; and D. Dube and B. Fekete for technical support. Grant support for database and tool development was from NASA Inter-Disciplinary Science Program Grant NNX07AF28G, with additional support from the NSF Division of Earth Sciences (Hydrologic Sciences Program Award #0854957) and Global Environment Facility (UPI 00345306). P.B.M. was supported by a D.H. Smith Fellowship. Financial and logistical support for expert group meetings and communications was from the Global Water System Project (Bonn), DIVERSITAS-freshwaterBIODIVERSITY (Paris), NSF BestNet, and Australian Agency for International Development (AusAID) through the Australian Water Research Facility. Conference facilities were provided by the Swiss Federal Institute of Science & Technology (Eawag) and The City College of New York/CUNY.	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Arthington AH, 2006, ECOL APPL, V16, P1311, DOI 10.1890/1051-0761(2006)016[1311:TCOPEF]2.0.CO;2; ASHLEY R, 2006, INFRASTRUCTURE 2030, pCH5; Balian EV, 2008, HYDROBIOLOGIA, V595, P627, DOI 10.1007/s10750-007-9246-3; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Brown Oli, 2009, RISING TEMPERATURES; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Clausen R, 2008, SOC SCI RES, V37, P1310, DOI 10.1016/j.ssresearch.2007.10.002; *CONV BIOL DIV, 2004, TEXT CONV BIOL DIV; Dinda S, 2004, ECOL ECON, V49, P431, DOI 10.1016/j.ecolecon.2004.02.011; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Esty D.C., 2006, PILOT ENV PERFORMANC; Esty DC, 2005, 2005 ENV SUSTAINABIL; FAO (Food and Agriculture Organization), 2006, WAT MON MAPP EX GLOB; Fekete BM, 2001, WATER RESOUR RES, V37, P1955, DOI 10.1029/2001WR900024; Freyhof J, 2007, HDB EUROPEAN FRESHWA; Gleick PH, 2003, SCIENCE, V302, P1524, DOI 10.1126/science.1089967; *GLOB ENV FAC, 2008, FIN STEW GLOB BIOD; *GLOB WAT SYST PRO, 2004, EOS AGU T, V85, P513; Grey D., 2006, WATER GROWTH DEV THE; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2009, CONSERV LETT, V2, P189, DOI 10.1111/j.1755-263X.2009.00060.x; International Organization of Supreme Audit Institutions (INTOSAI), 2009, INT LAB C 98 SESS GE, P1; Jelks HL, 2008, FISHERIES, V33, P372, DOI 10.1577/1548-8446-33.8.372; Karl T. R., 2009, Global climate change impacts in the United States; MEYBECK M, 2003, PHIL T R SOC LOND B; *MIN ENV PROT, 2009, STAT ENV CHIN 2008; Palmer MA, 2009, SCIENCE, V325, P575, DOI 10.1126/science.1172976; Reid WV, 2005, MILLENNIUM ECOSYSTEM; Ricciardi A, 1999, CONSERV BIOL, V13, P1220, DOI 10.1046/j.1523-1739.1999.98380.x; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Seitzinger SP, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002606; Smith A., 2008, GSA TODAY, V18, P4, DOI DOI 10.1130/GSAT01802A.1; Steffen W, 2007, AMBIO, V36, P614, DOI 10.1579/0044-7447(2007)36[614:TAAHNO]2.0.CO;2; Strayer DL, 2010, J N AM BENTHOL SOC, V29, P344, DOI 10.1899/08-171.1; Sullivan C, 2005, WATER SCI TECHNOL, V51, P69, DOI 10.2166/wst.2005.0111; Tockner K, 2009, RIVERS OF EUROPE, 1ST EDITION, P1; *UN DEV PROGR, 2006, HDR 2006 SCARC POW P; UN Environmental Programme, 2010, UNEPIPBES33; *UNEP GEMS WAT PRO, 2008, WAT QUAL EC HUM HLTH; US-Environmental Protection Agency, 2000, EPA841R02001; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; Vorosmarty CJ, 2005, AMBIO, V34, P230, DOI 10.1639/0044-7447(2005)034[0230:GIOEWS]2.0.CO;2; Vorosmarty CJ, 2002, AQUAT SCI, V64, P328, DOI 10.1007/PL00012590; Vu┬ru┬smarty C.J., 2005, MILLENNIUM ECOSYSTEM, V1, P165; WHO UNICEF, 2010, PROGR SAN DRINK WAT; *WORLD BANK, 2010, COUNTR CLASS; World Commission on Dams, 2000, DAMS DEV A NEW FRAM; *WORLD CONS MON CT, 1998, WCMC BIOD SER, V8; *WORLD WAT ASS PRO, 2009, WAT CHANG WORLD	50	3978	4132	139	2481	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP	2010	467	7315					555	561		10.1038/nature09440	http://dx.doi.org/10.1038/nature09440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655TT	20882010	Green Submitted, Green Accepted			2022-12-01	WOS:000282273100031
J	Berry, MPR; Graham, CM; McNab, FW; Xu, ZH; Bloch, SAA; Oni, T; Wilkinson, KA; Banchereau, R; Skinner, J; Wilkinson, RJ; Quinn, C; Blankenship, D; Dhawan, R; Cush, JJ; Mejias, A; Ramilo, O; Kon, OM; Pascual, V; Banchereau, J; Chaussabel, D; O'Garra, A				Berry, Matthew P. R.; Graham, Christine M.; McNab, Finlay W.; Xu, Zhaohui; Bloch, Susannah A. A.; Oni, Tolu; Wilkinson, Katalin A.; Banchereau, Romain; Skinner, Jason; Wilkinson, Robert J.; Quinn, Charles; Blankenship, Derek; Dhawan, Ranju; Cush, John J.; Mejias, Asuncion; Ramilo, Octavio; Kon, Onn M.; Pascual, Virginia; Banchereau, Jacques; Chaussabel, Damien; O'Garra, Anne			An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis	NATURE			English	Article							GENE-EXPRESSION PATTERNS; MYCOBACTERIUM-TUBERCULOSIS; INFECTION; RESPONSES; IMMUNITY; CELLS	Tuberculosis (TB), caused by infection with Mycobacterium tuberculosis, is a major cause of morbidity and mortality worldwide. Efforts to control it are hampered by difficulties with diagnosis, prevention and treatment(1,2). Most people infected with M. tuberculosis remain asymptomatic, termed latent TB, with a 10% lifetime risk of developing active TB disease. Current tests, however, cannot identify which individuals will develop disease(3). The immune response to M. tuberculosis is complex and incompletely characterized, hindering development of new diagnostics, therapies and vaccines(4,5). Here we identify a whole-blood 393 transcript signature for active TB in intermediate and high-burden settings, correlating with radiological extent of disease and reverting to that of healthy controls after treatment. A subset of patients with latent TB had signatures similar to those in patients with active TB. We also identify a specific 86-transcript signature that discriminates active TB from other inflammatory and infectious diseases. Modular and pathway analysis revealed that the TB signature was dominated by a neutrophil-driven interferon (IFN)-inducible gene profile, consisting of both IFN-gamma and type I IFN-alpha beta signalling. Comparison with transcriptional signatures in purified cells and flow cytometric analysis suggest that this TB signature reflects changes in cellular composition and altered gene expression. Although an IFN-inducible signature was also observed in whole blood of patients with systemic lupus erythematosus (SLE), their complete modular signature differed from TB, with increased abundance of plasma cell transcripts. Our studies demonstrate a hitherto underappreciated role of type I IFN-alpha beta signalling in the pathogenesis of TB, which has implications for vaccine and therapeutic development. Our study also provides a broad range of transcriptional biomarkers with potential as diagnostic and prognostic tools to combat the TB epidemic.	[Berry, Matthew P. R.; Graham, Christine M.; McNab, Finlay W.; O'Garra, Anne] Natl Inst Med Res, MRC, Div Immunoregulat, London NW7 1AA, England; [Wilkinson, Katalin A.; Wilkinson, Robert J.] Natl Inst Med Res, MRC, Div Mycobacterial Res, London NW7 1AA, England; [Bloch, Susannah A. A.; Kon, Onn M.] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Dept Resp Med, London W2 1NY, England; [Oni, Tolu; Wilkinson, Katalin A.; Wilkinson, Robert J.] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Observatory, South Africa; [Oni, Tolu] Univ London Imperial Coll Sci Technol & Med, Wright Fleming Inst, Div Med, London W2 1PG, England; [Xu, Zhaohui; Skinner, Jason; Quinn, Charles; Cush, John J.; Pascual, Virginia; Banchereau, Jacques; Chaussabel, Damien] ANRS Ctr Human Vaccines, INSERM, U899, Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Blankenship, Derek] Baylor Hlth Care Syst, Inst Hlth Care Res & Improvement, Dallas, TX 75206 USA; [Dhawan, Ranju] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Dept Radiol, London W2 1NY, England; [Banchereau, Romain] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Mejias, Asuncion; Ramilo, Octavio] Nationwide Childrens Hosp, Ctr Vaccines & Immun, Res Inst, Columbus, OH 43205 USA	MRC National Institute for Medical Research; MRC National Institute for Medical Research; Imperial College London; University of Cape Town; Imperial College London; Baylor Scott & White Health; Institut National de la Sante et de la Recherche Medicale (Inserm); Baylor Health Care System; Imperial College London; University of Texas System; University of Texas Southwestern Medical Center Dallas; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	O'Garra, A (corresponding author), Natl Inst Med Res, MRC, Div Immunoregulat, Mill Hill, London NW7 1AA, England.	aogarra@nimr.mrc.ac.uk	Mejias, Maria Asuncion/E-3659-2011; Wilkinson, Katalin/AAQ-7713-2021; Mejias, Asuncion/AAC-5998-2019; Pascual, Virginia/ABD-3099-2020; Wilkinson, Katalin/AAF-6805-2020; Chaussabel, Damien/AAX-1909-2020	Wilkinson, Katalin/0000-0002-9796-2040; Mejias, Asuncion/0000-0002-5983-8006; Chaussabel, Damien/0000-0002-6131-7242; Wilkinson, Robert/0000-0002-2753-1800; Oni, Tolu/0000-0003-4499-1910; O'Garra, Anne/0000-0001-9845-6134; Xu, Zhaohui/0000-0003-0645-1737; Kon, Onn Min/0000-0003-2647-4688; Skinner, Jason/0000-0002-2408-7695; Graham, Christine/0000-0001-9329-6231	MRC; Dana Foundation; Medical Research Council, UK [U117565642]; National Institutes of Health (NIH) [R01 AR050770-01, P50 ARO54083, 1 U19 AI082715-01, U19 AIO57234-02, U01 AI082110, P01 CA084512]; Baylor Health Care System Foundation; MRC [MC_U117565642, MC_U117588499] Funding Source: UKRI; Medical Research Council [MC_U117588499, MC_U117565642] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA084512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082110, U19AI057234, U19AI082715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050770, P50AR054083] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Dana Foundation; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor Health Care System Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the patients and volunteer participants. We thank D. Kioussis (MRC National Institute for Medical Research (NIMR)) and D. Young (NIMR) for discussion and input. We thank N. Baldwin (Baylor Institute for Immunology Research (BIIR)) for advice and support on bioinformatics analysis, Q.-A. Nguyen (BIIR) and colleagues for providing technical assistance with microarray processing, and S. Caidan (NIMR), J. Wills (NIMR) and S. Phillips (BIIR) for help and advice with sample storage and transport. We thank the TB service at Imperial College Healthcare NHS Trust, B. M. Haselden and the TB service at Hillingdon Hospital, Uxbridge, UK. We also thank H. Giedon and R. Seldon for help in laboratory analyses, and Y. Hlombe for recruitment of patients and follow-up in South Africa. A. Rae (NIMR), T. Dipucchio (BIIR) and K. Palucka (BIIR) provided advice on flow cytometry. We thank G. Hayward for help depositing the microarray data. We thank J. Brock (NIMR) for help with graphics. M. P. R. B. was supported by an MRC career development fellowship and a grant from the Dana Foundation Program in Human Immunology. The research was funded by the Medical Research Council, UK, MRC Grant U117565642 and The Dana Foundation Program in Human Immunology. A.O'G., C. M. G. and F.W.McN. are funded by the Medical Research Council, UK. V. P. is supported by National Institutes of Health (NIH) R01 AR050770-01, NIH P50 ARO54083 and NIH 1 U19 AI082715-01. The work of J. B., D. C. and V. P. is supported by the Baylor Health Care System Foundation and the NIH (U19 AIO57234-02, U01 AI082110, P01 CA084512).	Allantaz F, 2007, J EXP MED, V204, P2131, DOI 10.1084/jem.20070070; Ardura MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005446; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; BECK JS, 1985, CLIN EXP IMMUNOL, V60, P49; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Cooper AM, 2000, INFECT IMMUN, V68, P6879, DOI 10.1128/IAI.68.12.6879-6882.2000; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; DYE C, 2008, GLOBAL TUBERCULOSIS, P17; Eruslanov EB, 2005, INFECT IMMUN, V73, P1744, DOI 10.1128/IAI.73.3.1744-1753.2005; EURN SY, 2010, CHEST, V137, P122; Falk A, 1969, DIAGNOSTIC STANDARDS, P68; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Kaufmann SHE, 2005, NAT MED, V11, pS33, DOI 10.1038/nm1221; Manca C, 2005, J INTERF CYTOK RES, V25, P694, DOI 10.1089/jir.2005.25.694; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Mistry R, 2007, J INFECT DIS, V195, P357, DOI 10.1086/510397; Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522; Pankla R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r127; Pascual V, 2010, ANNU REV IMMUNOL, V28, P535, DOI 10.1146/annurev-immunol-030409-101221; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; SALISBURY DM, 2006, IMMUNIZATION INFECTI, P391; Telesca Claudia, 2007, J Infect, V54, pe223, DOI 10.1016/j.jinf.2006.12.009; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614; [No title captured]	30	1261	1314	7	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2010	466	7309					973	U98		10.1038/nature09247	http://dx.doi.org/10.1038/nature09247			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640ED	20725040	Green Accepted			2022-12-01	WOS:000281030300034
J	Daneman, R; Zhou, L; Kebede, AA; Barres, BA				Daneman, Richard; Zhou, Lu; Kebede, Amanuel A.; Barres, Ben A.			Pericytes are required for blood-brain barrier integrity during embryogenesis	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; ENDOTHELIAL-CELLS; IN-VITRO; UP-REGULATION; ASTROCYTES; OCCLUDIN; RATS; CNS; OLIGODENDROCYTES; MORPHOGENESIS	Vascular endothelial cells in the central nervous system (CNS) forma barrier that restricts the movement of molecules and ions between the blood and the brain. This blood-brain barrier (BBB) is crucial to ensure proper neuronal function and protect the CNS from injury and disease(1). Transplantation studies have demonstrated that the BBB is not intrinsic to the endothelial cells, but is induced by interactions with the neural cells(2). Owing to the close spatial relationship between astrocytes and endothelial cells, it has been hypothesized that astrocytes induce this critical barrier postnatally(3), but the timing of BBB formation has been controversial(4-9). Here we demonstrate that the barrier is formed during embryogenesis as endothelial cells invade the CNS and pericytes are recruited to the nascent vessels, over a week before astrocyte generation. Analysing mice with null and hypomorphic alleles of Pdgfrb, which have defects in pericyte generation, we demonstrate that pericytes are necessary for the formation of the BBB, and that absolute pericyte coverage determines relative vascular permeability. We demonstrate that pericytes regulate functional aspects of the BBB, including the formation of tight junctions and vesicle trafficking in CNS endothelial cells. Pericytes do not induce BBB-specific gene expression in CNS endothelial cells, but inhibit the expression of molecules that increase vascular permeability and CNS immune cell infiltration. These data indicate that pericyte-endothelial cell interactions are critical to regulate the BBB during development, and disruption of these interactions may lead to BBB dysfunction and neuroinflammation during CNS injury and disease.	[Daneman, Richard; Kebede, Amanuel A.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Zhou, Lu; Barres, Ben A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Stanford University	Daneman, R (corresponding author), Univ Calif San Francisco, Dept Anat, 513 Parnassus Ave,HSW1301, San Francisco, CA 94143 USA.	Richard.daneman@ucsf.edu			NINDS [R01-NS045621]; Myelin Repair Foundation; NMSS [RG3936A7]; UCSF; AHA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045621] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Myelin Repair Foundation; NMSS(National Multiple Sclerosis Society); UCSF; AHA(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Perrino for electron microscopy preparations. Work was supported by grants from the NINDS (R01-NS045621; B.A.B), Myelin Repair Foundation (B.A.B., R.D.), NMSS (Grant-RG3936A7; B.A.B.), UCSF Fellow's Program (R.D.) and AHA (R.D.).	BAUER HC, 1993, DEV BRAIN RES, V75, P269, DOI 10.1016/0165-3806(93)90031-5; Bolz S, 1996, CELL TISSUE RES, V284, P355, DOI 10.1007/s004410050596; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; BUTT AM, 1990, J PHYSIOL-LONDON, V429, P47, DOI 10.1113/jphysiol.1990.sp018243; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cayrol R, 2008, NAT IMMUNOL, V9, P137, DOI 10.1038/ni1551; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Ek CJ, 2006, J COMP NEUROL, V496, P13, DOI 10.1002/cne.20885; Gidday JM, 2005, AM J PHYSIOL-HEART C, V289, pH558, DOI 10.1152/ajpheart.01275.2004; He ZJ, 2009, CHINESE MED J-PEKING, V122, P2346, DOI 10.3760/cma.j.issn.0366-6999.2009.19.029; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Hirase T, 1997, J CELL SCI, V110, P1603; Hori S, 2004, J NEUROCHEM, V89, P503, DOI 10.1111/j.1471-4159.2004.02343.x; Ioannidou S, 2006, P NATL ACAD SCI USA, V103, P16770, DOI 10.1073/pnas.0603501103; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Kniesel U, 1996, DEV BRAIN RES, V96, P229, DOI 10.1016/S0165-3806(96)00117-4; Korn J, 2002, J COMP NEUROL, V442, P78, DOI 10.1002/cne.1423; Lai CH, 2005, BRAIN RES REV, V50, P258, DOI 10.1016/j.brainresrev.2005.07.004; Lee SW, 2009, INT J MOL MED, V23, P279, DOI 10.3892/ijmm_00000128; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Motiejunaite R, 2008, EXP EYE RES, V86, P171, DOI 10.1016/j.exer.2007.10.013; Nag S, 2005, LAB INVEST, V85, P1189, DOI 10.1038/labinvest.3700325; SHEPRO D, 1993, FASEB J, V7, P1031, DOI 10.1096/fasebj.7.11.8370472; Shue EH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-29; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; STEWART PA, 1981, DEV BIOL, V84, P183, DOI 10.1016/0012-1606(81)90382-1; Tallquist MD, 2003, PLOS BIOL, V1, P288, DOI 10.1371/journal.pbio.0000052; Watkins TA, 2008, NEURON, V60, P555, DOI 10.1016/j.neuron.2008.09.011; Weidenfeller C, 2007, J NEUROCHEM, V101, P555, DOI 10.1111/j.1471-4159.2006.04394.x; Wosik K, 2007, J NEUROSCI, V27, P9032, DOI 10.1523/JNEUROSCI.2088-07.2007; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	33	1227	1265	7	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 25	2010	468	7323					562	U238		10.1038/nature09513	http://dx.doi.org/10.1038/nature09513			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	20944625	Green Accepted			2022-12-01	WOS:000284584200042
J	Scherber, C; Eisenhauer, N; Weisser, WW; Schmid, B; Voigt, W; Fischer, M; Schulze, ED; Roscher, C; Weigelt, A; Allan, E; Bessler, H; Bonkowski, M; Buchmann, N; Buscot, F; Clement, LW; Ebeling, A; Engels, C; Halle, S; Kertscher, I; Klein, AM; Koller, R; Konig, S; Kowalski, E; Kummer, V; Kuu, A; Lange, M; Lauterbach, D; Middelhoff, C; Migunova, VD; Milcu, A; Muller, R; Partsch, S; Petermann, JS; Renker, C; Rottstock, T; Sabais, A; Scheu, S; Schumacher, J; Temperton, VM; Tscharntke, T				Scherber, Christoph; Eisenhauer, Nico; Weisser, Wolfgang W.; Schmid, Bernhard; Voigt, Winfried; Fischer, Markus; Schulze, Ernst-Detlef; Roscher, Christiane; Weigelt, Alexandra; Allan, Eric; Bessler, Holger; Bonkowski, Michael; Buchmann, Nina; Buscot, Francois; Clement, Lars W.; Ebeling, Anne; Engels, Christof; Halle, Stefan; Kertscher, Ilona; Klein, Alexandra-Maria; Koller, Robert; Koenig, Stephan; Kowalski, Esther; Kummer, Volker; Kuu, Annely; Lange, Markus; Lauterbach, Dirk; Middelhoff, Cornelius; Migunova, Varvara D.; Milcu, Alexandru; Mueller, Ramona; Partsch, Stephan; Petermann, Jana S.; Renker, Carsten; Rottstock, Tanja; Sabais, Alexander; Scheu, Stefan; Schumacher, Jens; Temperton, Vicky M.; Tscharntke, Teja			Bottom-up effects of plant diversity on multitrophic interactions in a biodiversity experiment	NATURE			English	Article							TROPHIC GROUPS; TOP-DOWN; COMMUNITIES; ECOSYSTEMS; GRASSLANDS; SERVICES; WEB	Biodiversity is rapidly declining(1), and this may negatively affect ecosystem processes(2), including economically important ecosystem services(3). Previous studies have shown that biodiversity has positive effects on organisms and processes(4) across trophic levels(5). However, only a few studies have so far incorporated an explicit food-web perspective(6). In an eight-year biodiversity experiment, we studied an unprecedented range of above-and below-ground organisms and multitrophic interactions. A multitrophic data set originating from a single long-term experiment allows mechanistic insights that would not be gained from meta-analysis of different experiments. Here we show that plant diversity effects dampen with increasing trophic level and degree of omnivory. This was true both for abundance and species richness of organisms. Furthermore, we present comprehensive above-ground/below-ground biodiversity food webs. Both above ground and below ground, herbivores responded more strongly to changes in plant diversity than did carnivores or omnivores. Density and richness of carnivorous taxa was independent of vegetation structure. Below-ground responses to plant diversity were consistently weaker than above-ground responses. Responses to increasing plant diversity were generally positive, but were negative for biological invasion, pathogen infestation and hyperparasitism. Our results suggest that plant diversity has strong bottom-up effects on multitrophic interaction networks, with particularly strong effects on lower trophic levels. Effects on higher trophic levels are indirectly mediated through bottom-up trophic cascades.	[Scherber, Christoph; Ebeling, Anne; Tscharntke, Teja] Univ Gottingen, Dept Crop Sci, D-37077 Gottingen, Germany; [Scherber, Christoph; Weisser, Wolfgang W.; Voigt, Winfried; Roscher, Christiane; Weigelt, Alexandra; Allan, Eric; Clement, Lars W.; Ebeling, Anne; Halle, Stefan; Kertscher, Ilona; Klein, Alexandra-Maria; Kowalski, Esther; Lange, Markus; Lauterbach, Dirk; Mueller, Ramona] Univ Jena, Inst Ecol, D-07743 Jena, Germany; [Eisenhauer, Nico; Partsch, Stephan; Sabais, Alexander; Scheu, Stefan] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany; [Eisenhauer, Nico] Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; [Schmid, Bernhard; Petermann, Jana S.] Univ Zurich, Inst Environm Sci, CH-8057 Zurich, Switzerland; [Fischer, Markus] Univ Bern, CH-3013 Bern, Switzerland; [Fischer, Markus; Kummer, Volker; Rottstock, Tanja] Univ Potsdam, Inst Biochem & Biol, D-14469 Potsdam, Germany; [Schulze, Ernst-Detlef; Middelhoff, Cornelius; Schumacher, Jens; Temperton, Vicky M.] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Roscher, Christiane] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, D-06120 Halle, Germany; [Weigelt, Alexandra] Univ Leipzig, Inst Biol 1, D-04103 Leipzig, Germany; [Bessler, Holger; Engels, Christof] Humboldt Univ, Dept Plant Nutr, D-14195 Berlin, Germany; [Bonkowski, Michael; Koller, Robert] Univ Cologne, Cologne Bioctr, Dept Terr Ecol, D-50674 Cologne, Germany; [Buchmann, Nina] Swiss Fed Inst Technol, Inst Plant Anim & Agroecosyst Sci, LFW C56, CH-8092 Zurich, Switzerland; [Buscot, Francois; Koenig, Stephan] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, D-06102 Halle, Germany; [Klein, Alexandra-Maria] Leuphana Univ Lueneburg, Inst Ecol & Environm Chem, D-21335 Luneburg, Germany; [Kuu, Annely] Tallinn Univ Technol, Tartu Coll, EE-51008 Tartu, Estonia; [Migunova, Varvara D.] KI Skryabin All Russian Inst Helminthol, Moscow 117218, Russia; [Milcu, Alexandru] Imperial Coll London, Div Biol, NERC Ctr Populat Biol, Ascot SL5 7PY, Berks, England; [Petermann, Jana S.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Renker, Carsten] Mainz Museum Nat Hist, D-55116 Mainz, Germany; [Schumacher, Jens] Univ Jena, Inst Stochast, D-07743 Jena, Germany; [Temperton, Vicky M.] Forschungszentrum Julich GmbH, Phytosphere Inst ICG 3, D-52425 Julich, Germany	University of Gottingen; Friedrich Schiller University of Jena; University of Gottingen; University of Minnesota System; University of Minnesota Twin Cities; University of Zurich; University of Bern; University of Potsdam; Max Planck Society; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University; Humboldt University of Berlin; University of Cologne; Swiss Federal Institutes of Technology Domain; ETH Zurich; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leuphana University Luneburg; Tallinn University of Technology; Federal Scientific Centre VIEV; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of British Columbia; Friedrich Schiller University of Jena; Helmholtz Association; Research Center Julich	Scherber, C (corresponding author), Univ Gottingen, Dept Crop Sci, Grisebachstr 6, D-37077 Gottingen, Germany.	christoph.scherber@agr.uni-goettingen.de	Weisser, Wolfgang W/B-9718-2014; Scheu, Stefan/H-7049-2015; Kuu, Annely/AAL-4740-2020; Klein, Alexandra-Maria/J-5871-2016; Eisenhauer, Nico/I-5932-2012; Schulze, Ernst-Detlef/K-9627-2014; Buscot, Francois/A-4125-2016; Schmid, Bernhard/C-8625-2009; Buchmann, Nina/E-6095-2011; Eisenhauer, Nico/I-3191-2019; Tscharntke, Teja/N-5123-2014; Fischer, Markus/C-6411-2008; Bonkowski, Michael/C-3700-2013; Koenig, Stephan/GRX-2480-2022; Petermann, Jana/AAK-9787-2020; Migunova, Varvara/Q-3899-2018; Petermann, Jana/E-2130-2013; Allan, Eric/AAR-9566-2020; Scherber, Christoph/B-6611-2009; Milcu, Alexandru/X-6267-2018	Weisser, Wolfgang W/0000-0002-2757-8959; Klein, Alexandra-Maria/0000-0003-2139-8575; Eisenhauer, Nico/0000-0002-0371-6720; Buscot, Francois/0000-0002-2364-0006; Schmid, Bernhard/0000-0002-8430-3214; Buchmann, Nina/0000-0003-0826-2980; Eisenhauer, Nico/0000-0002-0371-6720; Fischer, Markus/0000-0002-5589-5900; Bonkowski, Michael/0000-0003-2656-1183; Petermann, Jana/0000-0002-3898-5656; Petermann, Jana/0000-0002-3898-5656; Allan, Eric/0000-0001-9641-9436; Scherber, Christoph/0000-0001-7924-8911; Temperton, Vicky/0000-0003-0543-4521; Milcu, Alexandru/0000-0002-2889-1234; Koller, Robert/0000-0001-7251-7242; Kuu, Annely/0000-0002-0335-6243	Deutsche Forschungsgemeinschaft [FOR 456]; NERC [cpb010001] Funding Source: UKRI; Natural Environment Research Council [cpb010001] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank J. M. Tylianakis, P. Batary, Y. Clough, M. J. Crawley, J. Fox, J. Frund, D. Gladbach and A. Hector for comments that improved this manuscript. The gardeners, technicians, student helpers and managers of the Jena Experiment are acknowledged for their assistance. This work was supported by the Deutsche Forschungsgemeinschaft (FOR 456).	Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Cardinale Bradley, 2009, P105; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; De Deyn GB, 2004, OIKOS, V106, P576, DOI 10.1111/j.0030-1299.2004.13265.x; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Eisenhauer N, 2010, ECOLOGY, V91, P485, DOI 10.1890/08-2338.1; Ghazoul J, 2006, J ECOL, V94, P295, DOI 10.1111/j.1365-2745.2006.01098.x; Goudard A, 2008, AM NAT, V171, P91, DOI 10.1086/523945; Grace JB, 2006, STRUCTURAL EQUATION; Haddad NM, 2009, ECOL LETT, V12, P1029, DOI 10.1111/j.1461-0248.2009.01356.x; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 1998, ECOL MONOGR, V68, P121, DOI 10.1890/0012-9615(1998)068[0121:EOPCAD]2.0.CO;2; HUNTER MD, 1992, ECOLOGY, V73, P724; Koricheva J, 2000, OECOLOGIA, V125, P271, DOI 10.1007/s004420000450; Legendre P., 1998, NUMERICAL ECOLOGY, V2nd; Mitchell CE, 2002, ECOLOGY, V83, P1713, DOI 10.1890/0012-9658(2002)083[1713:EOGPSD]2.0.CO;2; Myers N, 1996, P NATL ACAD SCI USA, V93, P2764, DOI 10.1073/pnas.93.7.2764; OGUSHI T, 2007, ECOLOGICAL COMMUNITI; Petchey OL, 2004, OIKOS, V104, P467, DOI 10.1111/j.0030-1299.2004.13257.x; PRICE PW, 1992, BIOTROPICA, V24, P273, DOI 10.2307/2388522; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; SCHMID B, 2010, BIODIVERSITY ECOSYST, P14; Srivastava DS, 2009, ECOLOGY, V90, P1073, DOI 10.1890/08-0439.1; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Wardle DA, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P155	29	598	624	31	796	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 25	2010	468	7323					553	556		10.1038/nature09492	http://dx.doi.org/10.1038/nature09492			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	20981010				2022-12-01	WOS:000284584200040
J	Sanchez, SE; Petrillo, E; Beckwith, EJ; Zhang, X; Rugnone, ML; Hernando, CE; Cuevas, JC; Herz, MAG; Depetris-Chauvin, A; Simpson, CG; Brown, JWS; Cerdan, PD; Borevitz, JO; Mas, P; Ceriani, MF; Kornblihtt, AR; Yanovsky, MJ				Sanchez, Sabrina E.; Petrillo, Ezequiel; Beckwith, Esteban J.; Zhang, Xu; Rugnone, Matias L.; Hernando, C. Esteban; Cuevas, Juan C.; Herz, Micaela A. Godoy; Depetris-Chauvin, Ana; Simpson, Craig G.; Brown, John W. S.; Cerdan, Pablo D.; Borevitz, Justin O.; Mas, Paloma; Fernanda Ceriani, M.; Kornblihtt, Alberto R.; Yanovsky, Marcelo J.			A methyl transferase links the circadian clock to the regulation of alternative splicing	NATURE			English	Article							ARABIDOPSIS-THALIANA; DROSOPHILA-MELANOGASTER; RECIPROCAL REGULATION; ARGININE METHYLATION; PHOSPHOLIPASE-C; GENE; METHYLTRANSFERASE; EXPRESSION; REQUIRES; BEHAVIOR	Circadian rhythms allow organisms to time biological processes to the most appropriate phases of the day-night cycle(1). Posttranscriptional regulation is emerging as an important component of circadian networks(2-6), but the molecular mechanisms linking the circadian clock to the control of RNA processing are largely unknown. Here we show that PROTEIN ARGININE METHYL TRANSFERASE 5 (PRMT5), which transfers methyl groups to arginine residues present in histones(7) and Sm spliceosomal proteins(8,9), links the circadian clock to the control of alternative splicing in plants. Mutations in PRMT5 impair several circadian rhythms in Arabidopsis thaliana and this phenotype is caused, at least in part, by a strong alteration in alternative splicing of the core-clock gene PSEUDO RESPONSE REGULATOR 9 (PRR9). Furthermore, genome-wide studies show that PRMT5 contributes to the regulation of many pre-messenger-RNA splicing events, probably by modulating 5'-splice-site recognition. PRMT5 expression shows daily and circadian oscillations, and this contributes to the mediation of the circadian regulation of expression and alternative splicing of a subset of genes. Circadian rhythms in locomotor activity are also disrupted in dart5-1, a mutant affected in the Drosophila melanogaster PRMT5 homologue, and this is associated with alterations in splicing of the core-clock gene period and several clock-associated genes. Our results demonstrate a key role for PRMT5 in the regulation of alternative splicing and indicate that the interplay between the circadian clock and the regulation of alternative splicing by PRMT5 constitutes a common mechanism that helps organisms to synchronize physiological processes with daily changes in environmental conditions.	[Sanchez, Sabrina E.; Rugnone, Matias L.; Hernando, C. Esteban; Yanovsky, Marcelo J.] UBA CONICET, Fac Agron, IFEVA, Buenos Aires, DF, Argentina; [Petrillo, Ezequiel; Herz, Micaela A. Godoy; Kornblihtt, Alberto R.] UBA CONICET, FCEyN, IFIBYNE, Buenos Aires, DF, Argentina; [Beckwith, Esteban J.; Depetris-Chauvin, Ana; Cerdan, Pablo D.; Fernanda Ceriani, M.; Yanovsky, Marcelo J.] IIBBA CONICET, Fdn Inst Leloir, Buenos Aires, DF, Argentina; [Zhang, Xu; Borevitz, Justin O.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Cuevas, Juan C.; Mas, Paloma] Consortium CSIC IRTA UAB, CRAG, Barcelona 08034, Spain; [Simpson, Craig G.; Brown, John W. S.] SCRI, Genet Programme, Dundee DD2 5DA, Scotland; [Brown, John W. S.] Univ Dundee, SCRI, Div Plant Sci, Dundee DD2 5DA, Scotland	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Chicago; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; University of Barcelona; James Hutton Institute; James Hutton Institute; University of Dundee	Yanovsky, MJ (corresponding author), UBA CONICET, Fac Agron, IFEVA, C1417DSE, Buenos Aires, DF, Argentina.	yanovsky@agro.uba.ar	Borevitz, Justin/B-5423-2012; Mas, Paloma/B-8215-2016	Borevitz, Justin/0000-0001-8408-3699; Mas, Paloma/0000-0002-3780-8041; Petrillo, Ezequiel/0000-0002-0025-3708; Kornblihtt, Alberto/0000-0003-4322-0831; Ceriani, Maria/0000-0001-8945-3070; Hernando, Carlos Esteban/0000-0002-7459-2083; Simpson, Craig/0000-0002-1723-1492; Cuevas, Juan C/0000-0003-0909-1247	Fundacion Antorchas; Agencia Nacional de Promocion de Ciencia y Tecnologia of Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina; University of Buenos Aires; European Union Network of Excellence on Alternative Splicing (EURASNET); Ministerio de Educacion y Ciencia; European Young Investigator Awards; EMBO; Proyecto de Investigacion Cientifica y Tecnologica [2006-1249]	Fundacion Antorchas; Agencia Nacional de Promocion de Ciencia y Tecnologia of Argentina(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires(University of Buenos Aires); European Union Network of Excellence on Alternative Splicing (EURASNET); Ministerio de Educacion y Ciencia(Spanish Government); European Young Investigator Awards; EMBO(European Molecular Biology Organization (EMBO)); Proyecto de Investigacion Cientifica y Tecnologica	We thank E. M. Farre and S. L. Harmer for seeds; J. J. Casal and S. Mora-Garcia for critical reading of the manuscript; the laboratories of A. R. K. and M.J.Y. for discussions; J. Fuller and P. Tondi for technical assistance. This work was supported by grants from the Fundacion Antorchas, the Agencia Nacional de Promocion de Ciencia y Tecnologia of Argentina, the Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina and the University of Buenos Aires to M.J.Y. and A.R.K., and from the European Union Network of Excellence on Alternative Splicing (EURASNET) to A.R.K. and J.W.S.B. M.J.Y. and A.R.K. are Howard Hughes Medical Institute international research scholars. P.M.'s laboratory is supported by a Ministerio de Educacion y Ciencia grant, the European Young Investigator Awards and the EMBO Young Investigator Awards; M.F.C.'s laboratory is supported by Proyecto de Investigacion Cientifica y Tecnologica 2006-1249.	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Anne J, 2007, DEVELOPMENT, V134, P137, DOI 10.1242/dev.02687; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Chari A, 2008, CELL, V135, P497, DOI 10.1016/j.cell.2008.09.020; Collins BH, 2004, P NATL ACAD SCI USA, V101, P1945, DOI 10.1073/pnas.0308240100; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Edwards KD, 2006, PLANT CELL, V18, P639, DOI 10.1105/tpc.105.038315; Farre EM, 2005, CURR BIOL, V15, P47, DOI 10.1016/j.cub.2004.12.067; Glaser FT, 2005, CURR BIOL, V15, P1352, DOI 10.1016/j.cub.2005.06.056; Gonsalvez GB, 2008, RNA, V14, P878, DOI 10.1261/rna.940708; Gonsalvez GB, 2006, CURR BIOL, V16, P1077, DOI 10.1016/j.cub.2006.04.037; Guo JH, 2009, CELL, V138, P1236, DOI 10.1016/j.cell.2009.06.043; Hazen SP, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r17; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; Majercak J, 2004, MOL CELL BIOL, V24, P3359, DOI 10.1128/MCB.24.8.3359-3372.2004; Matsushika A, 2002, PLANT CELL PHYSIOL, V43, P833, DOI 10.1093/pcp/pcf118; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Michael TP, 2008, PLOS BIOL, V6, P1887, DOI 10.1371/journal.pbio.0060225; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Pei YX, 2007, PLANT PHYSIOL, V144, P1913, DOI 10.1104/pp.107.099531; Perales M, 2007, PLANT CELL, V19, P2111, DOI 10.1105/tpc.107.050807; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Raczynska KD, 2010, NUCLEIC ACIDS RES, V38, P265, DOI 10.1093/nar/gkp869; Rezaval C, 2007, EUR J NEUROSCI, V25, P683, DOI 10.1111/j.1460-9568.2007.05317.x; Rosbash M, 2009, PLOS BIOL, V7, P421, DOI 10.1371/journal.pbio.1000062; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; Schmitz RJ, 2008, P NATL ACAD SCI USA, V105, P411, DOI 10.1073/pnas.0710423104; Schoning JC, 2008, NUCLEIC ACIDS RES, V36, P6977, DOI 10.1093/nar/gkn847; Schor IE, 2009, P NATL ACAD SCI USA, V106, P4325, DOI 10.1073/pnas.0810666106; Sheth N, 2006, NUCLEIC ACIDS RES, V34, P3955, DOI 10.1093/nar/gkl556; Simpson CG, 2008, PLANT J, V53, P1035, DOI 10.1111/j.1365-313X.2007.03392.x; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang X, 2007, EMBO J, V26, P1934, DOI 10.1038/sj.emboj.7601647; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zhang D, 2001, MOL CELL, V7, P319, DOI 10.1016/S1097-2765(01)00180-0; Zhang N, 2002, P NATL ACAD SCI USA, V99, P3330, DOI 10.1073/pnas.042529999; Zhang X, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r165; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	45	215	222	1	71	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 4	2010	468	7320					112	+		10.1038/nature09470	http://dx.doi.org/10.1038/nature09470			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674YF	20962777	Green Published, Green Submitted			2022-12-01	WOS:000283786900046
J	Colaprete, A; Schultz, P; Heldmann, J; Wooden, D; Shirley, M; Ennico, K; Hermalyn, B; Marshall, W; Ricco, A; Elphic, RC; Goldstein, D; Summy, D; Bart, GD; Asphaug, E; Korycansky, D; Landis, D; Sollitt, L				Colaprete, Anthony; Schultz, Peter; Heldmann, Jennifer; Wooden, Diane; Shirley, Mark; Ennico, Kimberly; Hermalyn, Brendan; Marshall, William; Ricco, Antonio; Elphic, Richard C.; Goldstein, David; Summy, Dustin; Bart, Gwendolyn D.; Asphaug, Erik; Korycansky, Don; Landis, David; Sollitt, Luke			Detection of Water in the LCROSS Ejecta Plume	SCIENCE			English	Article							LUNAR RADIOMETER OBSERVATIONS; ICE	Several remote observations have indicated that water ice may be presented in permanently shadowed craters of the Moon. The Lunar Crater Observation and Sensing Satellite (LCROSS) mission was designed to provide direct evidence (1). On 9 October 2009, a spent Centaur rocket struck the persistently shadowed region within the lunar south pole crater Cabeus, ejecting debris, dust, and vapor. This material was observed by a second "shepherding" spacecraft, which carried nine instruments, including cameras, spectrometers, and a radiometer. Near-infrared absorbance attributed to water vapor and ice and ultraviolet emissions attributable to hydroxyl radicals support the presence of water in the debris. The maximum total water vapor and water ice within the instrument field of view was 155 +/- 12 kilograms. Given the estimated total excavated mass of regolith that reached sunlight, and hence was observable, the concentration of water ice in the regolith at the LCROSS impact site is estimated to be 5.6 +/- 2.9% by mass. In addition to water, spectral bands of a number of other volatile compounds were observed, including light hydrocarbons, sulfur-bearing species, and carbon dioxide.	[Colaprete, Anthony; Heldmann, Jennifer; Wooden, Diane; Shirley, Mark; Ennico, Kimberly; Marshall, William; Ricco, Antonio; Elphic, Richard C.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Schultz, Peter; Hermalyn, Brendan] Brown Univ, Providence, RI 02912 USA; [Goldstein, David; Summy, Dustin] Univ Texas Austin, Austin, TX 78712 USA; [Bart, Gwendolyn D.] Univ Idaho, Moscow, ID 83844 USA; [Asphaug, Erik; Korycansky, Don] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Landis, David] Aurora Design & Technol, Palm Harbor, FL 34685 USA; [Sollitt, Luke] The Citadel, Charleston, SC 29409 USA; [Marshall, William] Univ Space Res Assoc, Mountain View, CA 94043 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Brown University; University of Texas System; University of Texas Austin; Idaho; University of Idaho; University of California System; University of California Santa Cruz; Universities Space Research Association (USRA)	Colaprete, A (corresponding author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.	Anthony.Colaprete-1@nasa.gov	Ricco, Antonio J/A-5273-2010; Ennico, Kimberly/L-9606-2014; Goldstein, David/AAY-8125-2020; Asphaug, Erik/AAC-9455-2020; Bart, Gwendolyn/B-1365-2009	Bart, Gwendolyn/0000-0002-4768-2972; Ricco, Antonio/0000-0002-2355-4984	LCROSS Project; NASA's Exploration Systems Mission Directorate (ESMD); NASA Science Mission Directorate (SMD); LRO	LCROSS Project; NASA's Exploration Systems Mission Directorate (ESMD); NASA Science Mission Directorate (SMD)(National Aeronautics & Space Administration (NASA)); LRO	We thank the LCROSS Project and NASA's Exploration Systems Mission Directorate (ESMD) and NASA Science Mission Directorate (SMD) for support, and are very grateful to the LRO project and the LRO instrument leads for supporting the LCROSS targeting and impact observations, and for the three referees who provided reviews that greatly improved this paper. R.C.E. was supported by an LRO Participating Scientist grant.	ARNOLD JR, 1979, J GEOPHYS RES, V84, P5659, DOI 10.1029/JB084iB10p05659; Bockelee-Morvan D, 2004, SPACE SCI S, P391; CLARK RN, 1990, J GEOPHYS RES-SOLID, V95, P12653, DOI 10.1029/JB095iB08p12653; Clark RN, 2009, SCIENCE, V326, P562, DOI 10.1126/science.1178105; COLAPRETE A, 2009, 40 LUN PLAN SCI SC L; Crider DH, 2000, J GEOPHYS RES-PLANET, V105, P26773, DOI 10.1029/2000JE001277; ELPHIC RC, 2007, GEOPHYS RES LET, V13; ENNICO K, 2009, 40 LUN PLAN SCI C LU; Feldman WC, 1998, SCIENCE, V281, P1496, DOI 10.1126/science.281.5382.1496; Gladstone GR, 2010, SCIENCE, V330, P472, DOI 10.1126/science.1186474; HANSEN JE, 1970, J ATMOS SCI, V27, P265, DOI 10.1175/1520-0469(1970)027<0265:NILSBT>2.0.CO;2; Hayne PO, 2010, SCIENCE, V330, P477, DOI 10.1126/science.1197135; Hodges R.R., 1981, LUNAR PLANETARY I SC, P451; MCCLANAHAN TP, 2009, 40 LUN PLAN SCI LUN; Mitrofanov IG, 2010, SCIENCE, V330, P483, DOI 10.1126/science.1185696; Noda H, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035692; Paige DA, 2010, SCIENCE, V330, P479, DOI 10.1126/science.1187726; Pieters CM, 2009, SCIENCE, V326, P568, DOI 10.1126/science.1178658; Press W. H., 2007, NUMERICAL RECIPES; ROUSSELOT P, 1991, ASTEORIDS COMETS MET; Schultz PH, 2007, ICARUS, V190, P295, DOI 10.1016/j.icarus.2007.06.006; Schultz PH, 2010, SCIENCE, V330, P468, DOI 10.1126/science.1187454; Spudis P. D., 1998, Solar System Research, V32, P17; SUMMY D, 2009, 40 LUN PLAN SCI C LU; Sunshine JM, 2009, SCIENCE, V326, P565, DOI 10.1126/science.1179788; TEODORO LFA, 2009, ANN M LUN EXPL AN GR; WATSON K, 1961, J GEOPHYS RES, V66, P3033, DOI 10.1029/JZ066i009p03033; Wooden DH, 2004, SPACE SCI S, P33	28	447	468	4	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					463	468		10.1126/science.1186986	http://dx.doi.org/10.1126/science.1186986			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966242				2022-12-01	WOS:000283329100028
J	Liu, B; Tahk, S; Yee, KM; Fan, GP; Shuai, K				Liu, Bin; Tahk, Samuel; Yee, Kathleen M.; Fan, Guoping; Shuai, Ke			The Ligase PIAS1 Restricts Natural Regulatory T Cell Differentiation by Epigenetic Repression	SCIENCE			English	Article							TRANSCRIPTION FACTOR FOXP3; DNA METHYLATION; STAT5 ACTIVATION; EXPRESSION; GENE; MAINTENANCE; LINEAGE; SUMO-1; DNMT3A	CD4(+)Foxp3(+) regulatory T (T(reg)) cells are important for maintaining immune tolerance. Understanding the molecular mechanism that regulates T(reg) differentiation will facilitate the development of effective therapeutic strategies against autoimmune diseases. We report here that the SUMO E3 ligase PIAS1 restricts the differentiation of natural T(reg) cells by maintaining a repressive chromatin state of the Foxp3 promoter. PIAS1 acts by binding to the Foxp3 promoter to recruit DNA methyltransferases and heterochromatin protein 1 for epigenetic modifications. Pias1 deletion caused promoter demethylation, reduced histone H3 methylation at Lys(9), and enhanced promoter accessibility. Consistently, Pias1(-/-) mice displayed an increased natural T(reg) cell population and were resistant to the development of experimental autoimmune encephalomyelitis. Our studies have identified an epigenetic mechanism that negatively regulates the differentiation of natural T(reg) cells.	[Liu, Bin; Tahk, Samuel; Shuai, Ke] Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Yee, Kathleen M.; Shuai, Ke] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Fan, Guoping] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Liu, B (corresponding author), Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, 11-934 Factor Bldg,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	bliu@ucla.edu; kshuai@mednet.ucla.edu		Fan, Guoping/0000-0001-5235-6410	NIH [R01AI063286, R01GM085797]; UCLA Jonsson Comprehensive Cancer Center; National Institutes of Health [K01 AR52717-01]; UCLA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR052717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085797] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA Jonsson Comprehensive Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank V. Chernishof and I. Garcia for technical assistance, C. Dong for helpful discussions, and the UCLA flow cytometry core facility. Supported by grants from the NIH (R01AI063286 and R01GM085797) and the UCLA Jonsson Comprehensive Cancer Center (K. S.). B. L. is supported by a Research Scientist Development Award from the National Institutes of Health (K01 AR52717-01). S.T. is supported by a UCLA Tumor Immunology Training Fellowship. K.S. and B.L. are inventors of a U.S. patent entitled "PIAS molecules that recognize and bind STAT proteins and uses thereof" (Patent No.: US 7,265,202 B1).	Burchill MA, 2003, J IMMUNOL, V171, P5853, DOI 10.4049/jimmunol.171.11.5853; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Dodge JE, 2005, J BIOL CHEM, V280, P17986, DOI 10.1074/jbc.M413246200; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fragale A, 2008, J IMMUNOL, V181, P1673, DOI 10.4049/jimmunol.181.3.1673; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Janson PCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001612; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Lal G, 2009, J IMMUNOL, V182, P259, DOI 10.4049/jimmunol.182.1.259; Ling Y, 2004, NUCLEIC ACIDS RES, V32, P598, DOI 10.1093/nar/gkh195; Liu B, 2007, CELL, V129, P903, DOI 10.1016/j.cell.2007.03.056; Liu QY, 2008, CHEM J CHINESE U, V29, P505; Lu LF, 2009, GENE DEV, V23, P1270, DOI 10.1101/gad.1791009; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Nagar M, 2008, INT IMMUNOL, V20, P1041, DOI 10.1093/intimm/dxn062; Park J, 2008, J MOL MED, V86, P1269, DOI 10.1007/s00109-008-0392-5; Riley JL, 2009, IMMUNITY, V30, P656, DOI 10.1016/j.immuni.2009.04.006; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	30	77	79	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 22	2010	330	6003					521	525		10.1126/science.1193787	http://dx.doi.org/10.1126/science.1193787			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966256	Green Accepted			2022-12-01	WOS:000283329100045
J	Su, XH; Chakravarti, D; Cho, MS; Liu, LZ; Gi, YJ; Lin, YL; Leung, ML; El-Naggar, A; Creighton, CJ; Suraokar, MB; Wistuba, I; Flores, ER				Su, Xiaohua; Chakravarti, Deepavali; Cho, Min Soon; Liu, Lingzhi; Gi, Young Jin; Lin, Yu-Li; Leung, Marco L.; El-Naggar, Adel; Creighton, Chad J.; Suraokar, Milind B.; Wistuba, Ignacio; Flores, Elsa R.			TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs	NATURE			English	Article							LI-FRAUMENI-SYNDROME; P63 EXPRESSION; P53; CANCER; P73; MUTANT; MICE; PROGRESSION; CARCINOMA; FAMILY	Aberrant expression of microRNAs (miRNAs) and the enzymes that control their processing have been reported in multiple biological processes including primary and metastatic tumours(1-6), but the mechanisms governing this are not clearly understood. Here we show that TAp63, a p53 family member, suppresses tumorigenesis and metastasis, and coordinately regulates Dicer and miR-130b to suppress metastasis. Metastatic mouse and human tumours deficient in TAp63 express Dicer at very low levels, and we found that modulation of expression of Dicer and miR-130b markedly affected the metastatic potential of cells lacking TAp63. TAp63 binds to and transactivates the Dicer promoter, demonstrating direct transcriptional regulation of Dicer by TAp63. These data provide a novel understanding of the roles of TAp63 in tumour and metastasis suppression through the coordinate transcriptional regulation of Dicer and miR-130b and may have implications for the many processes regulated by miRNAs.	[Su, Xiaohua; Chakravarti, Deepavali; Cho, Min Soon; Liu, Lingzhi; Gi, Young Jin; Lin, Yu-Li; Leung, Marco L.; Flores, Elsa R.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Chakravarti, Deepavali; Cho, Min Soon; Flores, Elsa R.] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA; [El-Naggar, Adel; Suraokar, Milind B.; Wistuba, Ignacio] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Creighton, Chad J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Flores, ER (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	elsaflores@mdanderson.org	Leung, Marco/AAH-3178-2021	Liu, Ling-Zhi/0000-0001-9234-457X; Hartl, Carla/0000-0001-9769-7462	NCI [CA16672]; American Cancer Society [RSG-07-082-01-MGO]; Susan G. Komen Foundation [BCTR600208]; Hildegardo E. and Olga M. Flores Foundation; NCI-Cancer Center [CA-16672]; Genitourinary Cancer SPORE [P50CA091846]; Lung Cancer SPORE [P50CA070907, U01DE019765]; Rita Allen Foundation; V Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA070907, P50CA091846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U01DE019765] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Hildegardo E. and Olga M. Flores Foundation; NCI-Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Genitourinary Cancer SPORE; Lung Cancer SPORE; Rita Allen Foundation; V Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank C.-g. Liu for technical assistance with miRNA analyses and A. Multani for metaphase analyses (funded by NCI CA16672); K. Y. Tsai for scientific discussions and comments on the manuscript; and D. Yu, J. Jackson and S. Rehman for reagents and advice. This work was supported by grants to E.R.F. from the American Cancer Society (RSG-07-082-01-MGO), the Susan G. Komen Foundation (BCTR600208) and the Hildegardo E. and Olga M. Flores Foundation. This work was supported in part by an NCI-Cancer Center Core Grant (CA-16672) (University of Texas M. D. Anderson Cancer Center), a Career Development Award from the Genitourinary Cancer SPORE (P50CA091846) to E.R.F., Lung Cancer SPORE (P50CA070907) to I. W. and U01DE019765 to A.E.-N. E.R.F. is a scholar of the Rita Allen Foundation and the V Foundation for Cancer Research.	Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Flores ER, 2007, CELL CYCLE, V6, P300, DOI 10.4161/cc.6.3.3793; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Keyes WM, 2006, P NATL ACAD SCI USA, V103, P8435, DOI 10.1073/pnas.0602477103; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lin YL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000680; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Maruya SI, 2004, CLIN CANCER RES, V10, P3825, DOI 10.1158/1078-0432.CCR-03-0370; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Mudhasani R, 2008, J CELL BIOL, V181, P1055, DOI 10.1083/jcb.200802105; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Park BJ, 2000, CANCER RES, V60, P3370; Park HR, 2004, TUMORI, V90, P239, DOI 10.1177/030089160409000214; Pruneri G, 2005, J PATHOL, V206, P337, DOI 10.1002/path.1787; Su XH, 2009, EMBO J, V28, P1904, DOI 10.1038/emboj.2009.151; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Urist MJ, 2002, AM J PATHOL, V161, P1199, DOI 10.1016/S0002-9440(10)64396-9; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	29	337	349	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 21	2010	467	7318					986	U168		10.1038/nature09459	http://dx.doi.org/10.1038/nature09459			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20962848	Green Accepted			2022-12-01	WOS:000283254700043
J	Rockman, MV; Skrovanek, SS; Kruglyak, L				Rockman, Matthew V.; Skrovanek, Sonja S.; Kruglyak, Leonid			Selection at Linked Sites Shapes Heritable Phenotypic Variation in C. elegans	SCIENCE			English	Article							GENE-EXPRESSION; NATURAL-SELECTION; DNA POLYMORPHISM; EVOLUTION; GENOME; RECOMBINATION; CONSEQUENCES; MUTATION; TRAITS	Mutation generates the heritable variation that genetic drift and natural selection shape. In classical quantitative genetic models, drift is a function of the effective population size and acts uniformly across traits, whereas mutation and selection act trait-specifically. We identified thousands of quantitative trait loci (QTLs) influencing transcript abundance traits in a cross of two Caenorhabditis elegans strains; although trait-specific mutation and selection explained some of the observed pattern of QTL distribution, the pattern was better explained by trait-independent variation in the intensity of selection on linked sites. Our results suggest that traits in C. elegans exhibit different levels of variation less because of their own attributes than because of differences in the effective population sizes of the genomic regions harboring their underlying loci.	[Rockman, Matthew V.] NYU, Dept Biol, New York, NY 10003 USA; [Rockman, Matthew V.] NYU, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Rockman, Matthew V.; Skrovanek, Sonja S.; Kruglyak, Leonid] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Rockman, Matthew V.; Skrovanek, Sonja S.; Kruglyak, Leonid] Princeton Univ, Dept Ecol & Evolutionary Biol, Carl Icahn Lab, Princeton, NJ 08544 USA; [Skrovanek, Sonja S.; Kruglyak, Leonid] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA	New York University; New York University; Princeton University; Princeton University; Howard Hughes Medical Institute; Princeton University	Rockman, MV (corresponding author), NYU, Dept Biol, 100 Washington Sq E, New York, NY 10003 USA.	mrockman@nyu.edu; leonid@genomics.princeton.edu			NIH National Center for Research Resources; NIH [R01 HG004321, R01 GM089972, P50 GM071508]; Jane Coffin Childs Fellowship; Ellison Foundation; James S. McDonnell Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089972, P50GM071508] Funding Source: NIH RePORTER	NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Fellowship; Ellison Foundation(Lawrence Ellison Foundation); James S. McDonnell Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Andersen, A. Chang, J. Gerke, R. Ghosh, D. Gresham, M. Hahn, A. Paaby, D. Pollard, H. Seidel, and J. Shapiro for comments on the manuscript. We thank the Caenorhabditis Genetics Center, funded by the NIH National Center for Research Resources, for strains. Our work was supported by the NIH (grants R01 HG004321 to L. K., R01 GM089972 to M. V. R., and P50 GM071508 to the Lewis-Sigler Institute), a Jane Coffin Childs Fellowship (M. V. R.), an Ellison Foundation New Scholar Award (M. V. R.), and a James S. McDonnell Foundation Centennial Fellowship (L. K.). L. K. is an investigator of the Howard Hughes Medical Institute. Microarray data have been deposited at the Gene Expression Omnibus with accession number GSE23857.	Arnold SJ, 2008, EVOLUTION, V62, P2451, DOI 10.1111/j.1558-5646.2008.00472.x; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; BARNES TM, 1995, GENETICS, V141, P159; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Cutter AD, 2003, MOL BIOL EVOL, V20, P665, DOI 10.1093/molbev/msg072; Cutter AD, 2010, GENOME RES, V20, P1103, DOI 10.1101/gr.104331.109; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Denver DR, 2009, P NATL ACAD SCI USA, V106, P16310, DOI 10.1073/pnas.0904895106; Denver DR, 2005, NAT GENET, V37, P544, DOI 10.1038/ng1554; Fay JC, 2008, HEREDITY, V100, P191, DOI 10.1038/sj.hdy.6801000; Genissel A, 2008, MOL BIOL EVOL, V25, P101, DOI 10.1093/molbev/msm247; Graustein A, 2002, GENETICS, V161, P99; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Houle D, 1998, GENETICA, V102-3, P241, DOI 10.1023/A:1017034925212; HUDSON RR, 1995, GENETICS, V141, P1605; Jovelin R, 2009, MOL BIOL EVOL, V26, P2373, DOI 10.1093/molbev/msp142; Kaiser VB, 2009, TRENDS GENET, V25, P9, DOI 10.1016/j.tig.2008.10.009; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; Lawniczak MKN, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r125; Li Y, 2006, PLOS GENET, V2, P2155, DOI 10.1371/journal.pgen.0020222; Noor MAF, 2001, GENETICS, V159, P581; Rifkin SA, 2003, NAT GENET, V33, P138, DOI 10.1038/ng1086; Rockman MV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000419; Ronald J, 2005, PLOS GENET, V1, P213, DOI 10.1371/journal.pgen.0010025; Ronald J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000678; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Tung J, 2009, MOL BIOL EVOL, V26, P2047, DOI 10.1093/molbev/msp113; Visscher PM, 2007, AM J HUM GENET, V81, P1104, DOI 10.1086/522934; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878	31	154	155	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					372	376		10.1126/science.1194208	http://dx.doi.org/10.1126/science.1194208			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947766	Green Accepted			2022-12-01	WOS:000282986700042
J	Schindel, D				Schindel, David			Biology without borders	NATURE			English	Editorial Material												schindeld@si.edu						*AUSTR NAT RES MAN, 2002, NAT CONS APPR ACC UT; Grajal A, 1999, CONSERV BIOL, V13, P6, DOI 10.1046/j.1523-1739.1999.013001006.x; *SECR CONV BIOL DI, 2008, TECHN SER SECR CONV, V38; *SECR CONV BIOL DI, 2002, APP 2 BONN GUID ACC	4	16	17	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2010	467	7317					779	781		10.1038/467779a	http://dx.doi.org/10.1038/467779a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	663PB	20944713	Bronze			2022-12-01	WOS:000282898700033
J	Xu, TD; Wen, MZ; Nagawa, S; Fu, Y; Chen, JG; Wu, MJ; Perrot-Rechenmann, C; Friml, J; Jones, AM; Yang, ZB				Xu, Tongda; Wen, Mingzhang; Nagawa, Shingo; Fu, Ying; Chen, Jin-Gui; Wu, Ming-Jing; Perrot-Rechenmann, Catherine; Friml, Jiri; Jones, Alan M.; Yang, Zhenbiao			Cell Surface- and Rho GTPase-Based Auxin Signaling Controls Cellular Interdigitation in Arabidopsis	CELL			English	Article							RESPONSIVE GENE-EXPRESSION; BOX PROTEIN TIR1; BINDING PROTEIN-1; PLANT DEVELOPMENT; PLASMA-MEMBRANE; ROP2 GTPASE; LEAF-CELLS; POLARITY; EXPANSION; GROWTH	Auxin is a multifunctional hormone essential for plant development and pattern formation. A nuclear auxin-signaling system controlling auxin-induced gene expression is well established, but cytoplasmic auxin signaling, as in its coordination of cell polarization, is unexplored. We found a cytoplasmic auxin-signaling mechanism that modulates the interdigitated growth of Arabidopsis leaf epidermal pavement cells (PCs), which develop interdigitated lobes and indentations to form a puzzle-piece shape in a two-dimensional plane. PC interdigitation is compromised in leaves deficient in either auxin biosynthesis or its export mediated by PINFORMED 1 localized at the lobe tip. Auxin coordinately activates two Rho GTPases, ROP2 and ROP6, which promote the formation of complementary lobes and indentations, respectively. Activation of these ROPs by auxin occurs within 30 s and depends on AUXIN-BINDING PROTEIN 1. These findings reveal Rho GTPase-based auxin-signaling mechanisms, which modulate the spatial coordination of cell expansion across a field of cells.	[Xu, Tongda; Wen, Mingzhang; Nagawa, Shingo; Fu, Ying; Yang, Zhenbiao] Univ Calif Riverside, Ctr Plant Cell Biol, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Chen, Jin-Gui; Wu, Ming-Jing; Jones, Alan M.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Perrot-Rechenmann, Catherine] CNRS, Inst Sci Vegetal, UPR2355, F-91198 Gif Sur Yvette, France; [Friml, Jiri] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Friml, Jiri] Univ Ghent, Dept Mol Genet, B-9052 Ghent, Belgium; [Jones, Alan M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of California System; University of California Riverside; University of North Carolina; University of North Carolina Chapel Hill; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; University of North Carolina; University of North Carolina Chapel Hill	Yang, ZB (corresponding author), Univ Calif Riverside, Ctr Plant Cell Biol, Dept Bot & Plant Sci, Riverside, CA 92521 USA.	yang@ucr.edu	Chen, Jin-Gui/AFV-6337-2022; Xu, Tongda/ABD-9589-2020; Chen, Jin-Gui/A-4773-2011; Friml, Jiri/D-9511-2012	Chen, Jin-Gui/0000-0002-1752-4201; Chen, Jin-Gui/0000-0002-1752-4201; Friml, Jiri/0000-0002-8302-7596; Xu, Tongda/0000-0003-3398-9217	U.S. National Institute of General Medical Sciences [GM081451, GM065989]; National Science Foundation [MCB-0718202]; Department of Energy [DE-FG02-05ER15671, DE-FG02-04ER15555]; Research Foundation-Flanders (Odysseus); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065989, R01GM081451, R01GM100130] Funding Source: NIH RePORTER	U.S. National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); Research Foundation-Flanders (Odysseus)(FWO); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Veronica Grieneisen, Ben Scheres, Athanasius F. M. Maree, Paulien Hogeweg, Xuemei Chen, and G. Venugopala Reddy for their stimulating discussion and critical comments on this manuscript; and to Xinping Cui for her assistance with the statistical analysis. We are grateful to Tom Guil-foyle and Yunde Zhao for their generous supply of Arabidopsis mutant lines used in this work. This work is supported by grants from the U.S. National Institute of General Medical Sciences to Z.Y. (GM081451) and to A.M.J. (GM065989), by the National Science Foundation to A.M.J. (MCB-0718202) and the Department of Energy to A.M.J. (DE-FG02-05ER15671) and to Z.Y. (DE-FG02-04ER15555) and by the Research Foundation-Flanders (Odysseus) to J.F.	Abel S, 1996, PLANT PHYSIOL, V111, P9, DOI 10.1104/pp.111.1.9; Altschuler SJ, 2008, NATURE, V454, P886, DOI 10.1038/nature07119; Badescu GO, 2006, TRENDS PLANT SCI, V11, P217, DOI 10.1016/j.tplants.2006.03.001; Baxter-Burrell A, 2002, SCIENCE, V296, P2026, DOI 10.1126/science.1071505; Braun N, 2008, PLANT CELL, V20, P2746, DOI 10.1105/tpc.108.059048; Chen JG, 2001, PLANT J, V28, P607, DOI 10.1046/j.1365-313x.2001.01152.x; Chen JG, 2001, GENE DEV, V15, P902, DOI 10.1101/gad.866201; Cheng YF, 2006, GENE DEV, V20, P1790, DOI 10.1101/gad.1415106; David KM, 2007, PLANT J, V50, P197, DOI 10.1111/j.1365-313X.2007.03038.x; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dhonukshe P, 2008, NATURE, V456, P962, DOI 10.1038/nature07409; DIEKMANN W, 1995, P NATL ACAD SCI USA, V92, P3425, DOI 10.1073/pnas.92.8.3425; Fischer U, 2006, CURR BIOL, V16, P2143, DOI 10.1016/j.cub.2006.08.091; Fu Y, 2005, CELL, V120, P687, DOI 10.1016/j.cell.2004.12.026; Fu Y, 2002, PLANT CELL, V14, P777, DOI 10.1105/tpc.001537; Fu Y, 2009, CURR BIOL, V19, P1827, DOI 10.1016/j.cub.2009.08.052; Green JBA, 2007, NAT CELL BIOL, V9, P1010, DOI 10.1038/ncb438; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Hazak O, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000282; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Hwang JU, 2005, MOL BIOL CELL, V16, P5385, DOI 10.1091/mbc.E05-05-0409; JONES AM, 1993, PLANT PHYSIOL, V101, P595, DOI 10.1104/pp.101.2.595; Jones AM, 1998, SCIENCE, V282, P1114, DOI 10.1126/science.282.5391.1114; JONES AM, 1994, ANNU REV PLANT PHYS, V45, P393, DOI 10.1146/annurev.pp.45.060194.002141; Jones MA, 2002, PLANT CELL, V14, P763, DOI 10.1105/tpc.010359; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Leblanc N, 1999, J BIOL CHEM, V274, P28314, DOI 10.1074/jbc.274.40.28314; Leyser O, 2006, CURR BIOL, V16, pR424, DOI 10.1016/j.cub.2006.05.014; Mathur J, 1997, BIOTECHNIQUES, V22, P280, DOI 10.2144/97222bm19; Mockaitis K, 2008, ANNU REV CELL DEV BI, V24, P55, DOI 10.1146/annurev.cellbio.23.090506.123214; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Parry G, 2006, CURR OPIN CELL BIOL, V18, P152, DOI 10.1016/j.ceb.2006.02.001; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Robert S, 2010, CELL, V143, P111, DOI 10.1016/j.cell.2010.09.027; Sauer M, 2006, GENE DEV, V20, P2902, DOI 10.1101/gad.390806; SENN AP, 1988, PLANT PHYSIOL, V88, P131, DOI 10.1104/pp.88.1.131; Settleman J, 2005, CELL, V120, P570, DOI 10.1016/j.cell.2005.02.025; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Shimomura S, 2006, PLANT MOL BIOL, V60, P663, DOI 10.1007/s11103-005-5471-1; Shishova M, 2004, J PLANT PHYSIOL, V161, P937, DOI 10.1016/j.jplph.2003.12.005; Steffens B, 2001, PLANT J, V27, P591, DOI 10.1046/j.1365-313X.2001.01103.x; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tao LZ, 2002, PLANT CELL, V14, P2745, DOI 10.1105/tpc.006320; Van Keymeulen A, 2006, J CELL BIOL, V174, P437, DOI 10.1083/jcb.200604113; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Wasteneys GO, 1997, J MICROSC-OXFORD, V188, P51, DOI 10.1046/j.1365-2818.1977.2390796.x; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Woo EJ, 2002, EMBO J, V21, P2877, DOI 10.1093/emboj/cdf291; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yang ZB, 2008, ANNU REV CELL DEV BI, V24, P551, DOI 10.1146/annurev.cellbio.23.090506.123233; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306	52	332	359	5	103	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 1	2010	143	1					99	110		10.1016/j.cell.2010.09.003	http://dx.doi.org/10.1016/j.cell.2010.09.003			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	656UC	20887895	Green Submitted, Bronze, Green Accepted			2022-12-01	WOS:000282362000017
J	Grandjean, P				Grandjean, Philippe			Even low-dose lead exposure is hazardous	LANCET			English	Editorial Material									[Grandjean, Philippe] Univ So Denmark, Odense, Denmark; [Grandjean, Philippe] Harvard Univ, Sch Publ Hlth, Boston, MA 02215 USA	University of Southern Denmark; Harvard University; Harvard T.H. Chan School of Public Health	Grandjean, P (corresponding author), Univ So Denmark, Odense, Denmark.	pgrandjean@health.sdu.dk	Grandjean, Philippe/I-2962-2014	Grandjean, Philippe/0000-0003-4046-9658	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Centers for Disease Control and Prevention, 2005, PREV LEAD POIS YOUNG; European Food Safety Authority, 2010, EFSA J, V8, DOI [DOI 10.2903/J.EFSA.2010.1570, 10.2903/j.efsa.2010.1570]; *JOINT FAO WHO EXP, 2000, EV CERT FOOD ADD CON; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; MARKOWITZ GE, 2002, DECEIT DENIAL DEADLY, P35; *SER FRAUD OFF, 2010, INN LTD PROS CORR SF	6	67	67	1	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 11	2010	376	9744					855	856		10.1016/S0140-6736(10)60745-3	http://dx.doi.org/10.1016/S0140-6736(10)60745-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	653DW	20833288				2022-12-01	WOS:000282069100009
J	Rothberg, MB; Sivalingam, SK; Ashraf, J; Visintainer, P; Joelson, J; Kleppel, R; Vallurupalli, N; Schweiger, MJ				Rothberg, Michael B.; Sivalingam, Senthil K.; Ashraf, Javed; Visintainer, Paul; Joelson, John; Kleppel, Reva; Vallurupalli, Neelima; Schweiger, Marc J.			Patients' and Cardiologists' Perceptions of the Benefits of Percutaneous Coronary Intervention for Stable Coronary Disease	ANNALS OF INTERNAL MEDICINE			English	Article							OPTIMAL MEDICAL THERAPY; ARTERY-DISEASE; AD-HOC; INFORMED-CONSENT; ANGIOPLASTY; SURGERY; RISKS; TRIAL; REVASCULARIZATION; PCI	Background: It is unclear whether patients understand that percutaneous coronary intervention (PCI) reduces only chronic stable angina and not myocardial infarction (MI) or associated mortality. Objective: To compare cardiologists' and patients' beliefs about PCI. Design: Survey. Setting: Academic center. Participants: 153 patients who consented to elective coronary catheterization and possible PCI, 10 interventional cardiologists, and 17 referring cardiologists. Measurements: Patients' and cardiologists' beliefs about benefits of PCI. All cardiologists reported beliefs about PCI for patients in hypothetical scenarios. Interventional cardiologists also reported beliefs for study patients who underwent PCI. Results: Of 153 patients, 68% had any angina, 42% had activity-limiting angina, 77% had a positive stress test result, and 29% had had previous MI. The 53 patients who underwent PCI were more likely than those who did not to have a positive stress test result, but angina was similar in both groups. Almost three quarters of patients thought that without PCI, they would probably have MI within 5 years, and 88% believed that PCI would reduce risk for MI. Patients were more likely than physicians to believe that PCI would prevent MI (prevalence ratio, 4.25 [95% CI, 2.31 to 7.79]) or fatal MI (prevalence ratio, 4.83 [CI, 2.23 to 10.46]). Patients were less likely than their physicians to report pre-PCI angina (prevalence ratio, 0.79 [CI, 0.67 to 0.92]). For the scenarios, 63% of cardiologists believed that the benefits of PCI were limited to symptom relief. Of cardiologists who identified no benefit of PCI in 2 scenarios, 43% indicated that they would still proceed with PCI in these cases. Limitation: The study was small and conducted at 1 center, and information about precatheterization counseling was limited. Conclusion: Cardiologists' beliefs about PCI reflect trial results, but patients' beliefs do not. Discussions with patients before PCI should better explain anticipated benefits.	[Rothberg, Michael B.] Baystate Med Ctr, Dept Med, Div Gen Med & Geriatr, Springfield, MA 01199 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA	Baystate Medical Center; Tufts University	Rothberg, MB (corresponding author), Baystate Med Ctr, Dept Med, Div Gen Med & Geriatr, 759 Chestnut St, Springfield, MA 01199 USA.	Michael.Rothberg@bhs.org		Visintainer, Paul/0000-0002-2491-1242				APPELBAUM PS, 1987, HASTINGS CENT REP, V17, P20, DOI 10.2307/3562038; Arnold SV, 2008, CIRC-CARDIOVASC QUAL, V1, P21, DOI 10.1161/CIRCOUTCOMES.108.791863; Blankenship JC, 2000, CATHETER CARDIO INTE, V49, P130, DOI 10.1002/(SICI)1522-726X(200002)49:2<130::AID-CCD3>3.3.CO;2-K; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Feldman DN, 2007, AM J CARDIOL, V99, P446, DOI 10.1016/j.amjcard.2006.09.093; Fleiss J.L., 2013, STAT METHODS RATES P; GRINES CL, 1993, NEW ENGL J MED, V328, P673, DOI 10.1056/NEJM199303113281001; Habib SB, 2008, J VASC INTERV RADIOL, V19, P177, DOI 10.1016/j.jvir.2007.10.016; Holmboe ES, 2000, J GEN INTERN MED, V15, P632, DOI 10.1046/j.1525-1497.2000.90823.x; Hueb W, 2007, CIRCULATION, V115, P1082, DOI 10.1161/CIRCULATIONAHA.106.625475; Katritsis DG, 2005, CIRCULATION, V111, P2906, DOI 10.1161/CIRCULATIONAHA.104.521864; Kee F, 1997, QUAL HEALTH CARE, V6, P131, DOI 10.1136/qshc.6.3.131; Krone RJ, 2006, CATHETER CARDIO INTE, V68, P696, DOI 10.1002/ccd.20910; Larobina ME, 2007, ANZ J SURG, V77, P530, DOI 10.1111/j.1445-2197.2007.04143.x; Le Feuvre Claude, 2003, J Interv Cardiol, V16, P195, DOI 10.1034/j.1600-0854.2003.8045.x; Lin GA, 2008, J GEN INTERN MED, V23, P1458, DOI 10.1007/s11606-008-0706-x; Lin GA, 2007, ARCH INTERN MED, V167, P1604, DOI 10.1001/archinte.167.15.1604; Lucas FL, 2008, CIRCULATION, V118, P2797, DOI 10.1161/CIRCULATIONAHA.108.789446; Morgan MW, 2000, J GEN INTERN MED, V15, P685, DOI 10.1046/j.1525-1497.2000.91139.x; Pfisterer M, 2003, JAMA-J AM MED ASSOC, V289, P1117, DOI 10.1001/jama.289.9.1117; Rahilly-Tierney CR, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-28; Ravdin PM, 1998, J CLIN ONCOL, V16, P515, DOI 10.1200/JCO.1998.16.2.515; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Siegel C, 2008, INFLAMM BOWEL DIS, V14, P1, DOI 10.1002/ibd.20283; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771; Whittle J, 2007, AM HEART J, V154, P662, DOI 10.1016/j.ahj.2007.04.065	27	134	137	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 7	2010	153	5					307	U55		10.7326/0003-4819-153-5-201009070-00005	http://dx.doi.org/10.7326/0003-4819-153-5-201009070-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	647GF	20820040				2022-12-01	WOS:000281605500004
J	Ohta, S; Bukowski-Wills, JC; Sanchez-Pulido, L; Alves, FD; Wood, L; Chen, ZA; Platani, M; Fischer, L; Hudson, DF; Ponting, CP; Fukagawa, T; Earnshaw, WC; Rappsilber, J				Ohta, Shinya; Bukowski-Wills, Jimi-Carlo; Sanchez-Pulido, Luis; Alves, Flavia de Lima; Wood, Laura; Chen, Zhuo A.; Platani, Melpi; Fischer, Lutz; Hudson, Damien F.; Ponting, Chris P.; Fukagawa, Tatsuo; Earnshaw, William C.; Rappsilber, Juri			The Protein Composition of Mitotic Chromosomes Determined Using Multiclassifier Combinatorial Proteomics	CELL			English	Article							QUANTITATIVE PROTEOMICS; CENP-A; REVEALS; COMPLEX; IDENTIFICATION	Despite many decades of study, mitotic chromosome structure and composition remain poorly characterized. Here, we have integrated quantitative proteomics with bioinformatic analysis to generate a series of independent classifiers that describe the similar to 4,000 proteins identified in isolated mitotic chromosomes. Integrating these classifiers by machine learning uncovers functional relationships between protein complexes in the context of intact chromosomes and reveals which of the similar to 560 uncharacterized proteins identified here merits further study. Indeed, of 34 GFP-tagged predicted chromosomal proteins, 30 were chromosomal, including 13 with centromere-association. Of 16 GFP-tagged predicted nonchromosomal proteins, 14 were confirmed to be nonchromosomal. An unbiased analysis of the whole chromosome proteome from genetic knockouts of kinetochore protein Ska3/Rama1 revealed that the APC/C and RanBP2/RanGAP1 complexes depend on the Ska complex for stable association with chromosomes. Our integrated analysis predicts that up to 97 new centromere-associated proteins remain to be discovered in our data set.	[Ohta, Shinya; Bukowski-Wills, Jimi-Carlo; Alves, Flavia de Lima; Wood, Laura; Chen, Zhuo A.; Platani, Melpi; Fischer, Lutz; Hudson, Damien F.; Earnshaw, William C.; Rappsilber, Juri] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland; [Bukowski-Wills, Jimi-Carlo] Univ Edinburgh, Ctr Syst Biol Edinburgh, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland; [Fukagawa, Tatsuo] Natl Inst Genet, Dept Mol Genet, Mishima, Shizuoka 4118540, Japan; [Fukagawa, Tatsuo] Grad Univ Adv Studies, Mishima, Shizuoka 4118540, Japan; [Sanchez-Pulido, Luis; Ponting, Chris P.] Univ Oxford, Dept Physiol Anat & Genet, MRC Funct Genom Unit, Oxford OX1 3QX, England	University of Edinburgh; University of Edinburgh; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; University of Oxford	Earnshaw, WC (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland.	bill.earnshaw@ed.ac.uk; juri.rappsilber@ed.ac.uk	Ponting, Chris/AAV-2621-2021; Rappsilber, Juri/ABF-3328-2020; Fukagawa, Tatsuo/AAK-3922-2021; Rappsilber, Juri/B-7265-2015; Earnshaw, William/AAY-7438-2020	Rappsilber, Juri/0000-0001-5999-1310; CHEN, ZHUO/0000-0003-0811-8348; Ohta, Shinya/0000-0003-2424-1741; Platani, Melpomeni/0000-0001-6408-4774; Sanchez Pulido, Luis/0000-0002-2300-8502; Earnshaw, William/0000-0002-7191-0621; Ponting, Chris/0000-0003-0202-7816; Fischer, Lutz/0000-0003-4978-0864; Wills, Jimi/0000-0003-1669-007X	European Community; MRC; EMBO; Wellcome Trust; BBSRC [BB/D019621/1] Funding Source: UKRI; MRC [MC_U137761446] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D019621/1] Funding Source: researchfish; Medical Research Council [MC_U137761446] Funding Source: researchfish	European Community(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EMBO(European Molecular Biology Organization (EMBO)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We dedicate this paper to Uli Laemmli on the occasion of his 70th birthday. We thank Mayumi Takahashi for assistance with preparation of the Ska3/Rama1 knockout, Frauke Melchior for anti-RanBP2 and David Tollervey, Margarete Heck, Robin Allshire, Iain Cheeseman, Kumiko Samejima, Susana Ribeiro and Jan Bergmann for critical reading of the manuscript. This work was supported by a European Community Marie Curie Excellence Grant (JR), the MRC (CPP), EMBO (LSP) and the Wellcome Trust (WCE, JR). WCE and JR are Principal and Senior Research Fellows of The Wellcome Trust, respectively.	ALTAF M, 2010, J BIOL CHEM IN PRESS; Amano M, 2009, J CELL BIOL, V186, P173, DOI 10.1083/jcb.200903100; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Andrade MA, 2000, J MOL BIOL, V298, P521, DOI 10.1006/jmbi.2000.3684; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Daum JR, 2009, CURR BIOL, V19, P1467, DOI 10.1016/j.cub.2009.07.017; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Gaitanos TN, 2009, EMBO J, V28, P1442, DOI 10.1038/emboj.2009.96; Gassmann R, 2005, CHROMOSOMA, V113, P385, DOI 10.1007/s00412-004-0326-0; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Hudson DF, 2003, DEV CELL, V5, P323, DOI 10.1016/S1534-5807(03)00199-0; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; JIANG WD, 1993, MOL CELL BIOL, V13, P4884, DOI 10.1128/MCB.13.8.4884; Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031; Kops GJPL, 2010, J CELL SCI, V123, P1623, DOI 10.1242/jcs.061549; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; LEWIS CD, 1982, CELL, V29, P171, DOI 10.1016/0092-8674(82)90101-5; Li XZ, 2009, MOL CELL, V36, P290, DOI 10.1016/j.molcel.2009.07.031; Maiato H, 2002, J CELL BIOL, V157, P749, DOI 10.1083/jcb.200201101; Marin I, 2003, J MOL EVOL, V56, P527, DOI 10.1007/s00239-002-2422-1; Morrison C, 2002, NUCLEIC ACIDS RES, V30, P5318, DOI 10.1093/nar/gkf665; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Porter IM, 2007, J CELL BIOL, V179, P187, DOI 10.1083/jcb.200704098; Raaijmakers JA, 2009, J CELL SCI, V122, P2436, DOI 10.1242/jcs.051912; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Takata H, 2007, GENES CELLS, V12, P269, DOI 10.1111/j.1365-2443.2007.01051.x; Theis M, 2009, EMBO J, V28, P1453, DOI 10.1038/emboj.2009.114; Tkaczuk KL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-73; Uchiyama S, 2005, J BIOL CHEM, V280, P16994, DOI 10.1074/jbc.M412774200; Van Hooser AA, 2005, CHROMOSOMA, V114, P377, DOI 10.1007/s00412-005-0021-9; Welburn JPI, 2009, DEV CELL, V16, P374, DOI 10.1016/j.devcel.2009.01.011; Wen H, 2010, J BIOL CHEM, V285, P9322, DOI 10.1074/jbc.C109.097667; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023	50	209	230	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2010	142	5					810	821		10.1016/j.cell.2010.07.047	http://dx.doi.org/10.1016/j.cell.2010.07.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	646FL	20813266	hybrid, Green Submitted, Green Published			2022-12-01	WOS:000281523200023
J	Altshuler, DM; Gibbs, RA; Peltonen, L; Dermitzakis, E; Schaffner, SF; Yu, FL; Bonnen, PE; de Bakker, PIW; Deloukas, P; Gabriel, SB; Gwilliam, R; Hunt, S; Inouye, M; Jia, XM; Palotie, A; Parkin, M; Whittaker, P; Chang, K; Hawes, A; Lewis, LR; Ren, YR; Wheeler, D; Muzny, DM; Barnes, C; Darvishi, K; Hurles, M; Korn, JM; Kristiansson, K; Lee, C; McCarroll, SA; Nemesh, J; Keinan, A; Montgomery, SB; Pollack, S; Price, AL; Soranzo, N; Gonzaga-Jauregui, C; Anttila, V; Brodeur, W; Daly, MJ; Leslie, S; McVean, G; Moutsianas, L; Nguyen, H; Zhang, QR; Ghori, MJR; McGinnis, R; McLaren, W; Takeuchi, F; Grossman, SR; Shlyakhter, I; Hostetter, EB; Sabeti, PC; Adebamowo, CA; Foster, MW; Gordon, DR; Licinio, J; Manca, MC; Marshall, PA; Matsuda, I; Ngare, D; Wang, VO; Reddy, D; Rotimi, CN; Royal, CD; Sharp, RR; Zeng, CQ; Brooks, LD; McEwen, JE				Altshuler, David M.; Gibbs, Richard A.; Peltonen, Leena; Dermitzakis, Emmanouil; Schaffner, Stephen F.; Yu, Fuli; Bonnen, Penelope E.; de Bakker, Paul I. W.; Deloukas, Panos; Gabriel, Stacey B.; Gwilliam, Rhian; Hunt, Sarah; Inouye, Michael; Jia, Xiaoming; Palotie, Aarno; Parkin, Melissa; Whittaker, Pamela; Chang, Kyle; Hawes, Alicia; Lewis, Lora R.; Ren, Yanru; Wheeler, David; Muzny, Donna Marie; Barnes, Chris; Darvishi, Katayoon; Hurles, Matthew; Korn, Joshua M.; Kristiansson, Kati; Lee, Charles; McCarroll, Steven A.; Nemesh, James; Keinan, Alon; Montgomery, Stephen B.; Pollack, Samuela; Price, Alkes L.; Soranzo, Nicole; Gonzaga-Jauregui, Claudia; Anttila, Verneri; Brodeur, Wendy; Daly, Mark J.; Leslie, Stephen; McVean, Gil; Moutsianas, Loukas; Nguyen, Huy; Zhang, Qingrun; Ghori, Mohammed J. R.; McGinnis, Ralph; McLaren, William; Takeuchi, Fumihiko; Grossman, Sharon R.; Shlyakhter, Ilya; Hostetter, Elizabeth B.; Sabeti, Pardis C.; Adebamowo, Clement A.; Foster, Morris W.; Gordon, Deborah R.; Licinio, Julio; Manca, Maria Cristina; Marshall, Patricia A.; Matsuda, Ichiro; Ngare, Duncan; Wang, Vivian Ota; Reddy, Deepa; Rotimi, Charles N.; Royal, Charmaine D.; Sharp, Richard R.; Zeng, Changqing; Brooks, Lisa D.; McEwen, Jean E.		Int HapMap 3 Consortium	Integrating common and rare genetic variation in diverse human populations	NATURE			English	Article							GENOME-WIDE ASSOCIATION; COPY NUMBER VARIATION; POSITIVE SELECTION; HAPLOTYPE MAP; VARIANTS; DISEASES; SIGNALS; REGIONS; SNPS	Despite great progress in identifying genetic variants that influence human disease, most inherited risk remains unexplained. A more complete understanding requires genome-wide studies that fully examine less common alleles in populations with a wide range of ancestry. To inform the design and interpretation of such studies, we genotyped 1.6 million common single nucleotide polymorphisms (SNPs) in 1,184 reference individuals from 11 global populations, and sequenced ten 100-kilobase regions in 692 of these individuals. This integrated data set of common and rare alleles, called 'HapMap 3', includes both SNPs and copy number polymorphisms (CNPs). We characterized population-specific differences among low-frequency variants, measured the improvement in imputation accuracy afforded by the larger reference panel, especially in imputing SNPs with a minor allele frequency of <= 5%, and demonstrated the feasibility of imputing newly discovered CNPs and SNPs. This expanded public resource of genome variants in global populations supports deeper interrogation of genomic variation and its role in human disease, and serves as a step towards a high-resolution map of the landscape of human genetic variation.	[Altshuler, David M.; Schaffner, Stephen F.; de Bakker, Paul I. W.; Gabriel, Stacey B.; Jia, Xiaoming; Parkin, Melissa; Korn, Joshua M.; McCarroll, Steven A.; Pollack, Samuela; Brodeur, Wendy; Nguyen, Huy; Shlyakhter, Ilya] Broad Inst, Cambridge, MA 02138 USA; [Gibbs, Richard A.; Yu, Fuli; Bonnen, Penelope E.; Chang, Kyle; Hawes, Alicia; Lewis, Lora R.; Ren, Yanru; Wheeler, David; Muzny, Donna Marie; Gonzaga-Jauregui, Claudia] Baylor Coll Med, Human Genome Sequencing Ctr, Dept Mol & Human Genet, Houston, TX 77030 USA; [Dermitzakis, Emmanouil; Montgomery, Stephen B.] Univ Geneva, Sch Med, Dept Genet Med & Dev, Fac Med, CH-1211 Geneva, Switzerland; [de Bakker, Paul I. W.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Genet, Boston, MA 02115 USA; [Deloukas, Panos; Gwilliam, Rhian; Hunt, Sarah; Inouye, Michael; Palotie, Aarno; Whittaker, Pamela; Barnes, Chris; Hurles, Matthew; Kristiansson, Kati; Soranzo, Nicole; Anttila, Verneri; Zhang, Qingrun; Ghori, Mohammed J. R.; McGinnis, Ralph; McLaren, William; Takeuchi, Fumihiko] Wellcome Trust Sanger Inst, Dept Human Genet, Cambridge CB10 1HH, England; [Palotie, Aarno; Anttila, Verneri] Univ Helsinki, Inst Mol Med Finland, FIN-00290 Helsinki, Finland; [Palotie, Aarno; Anttila, Verneri] Univ Helsinki, Dept Med Genet, FIN-00290 Helsinki, Finland; [Palotie, Aarno; Anttila, Verneri] Univ Cent Hosp, Helsinki 00290, Finland; [Darvishi, Katayoon; Lee, Charles] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Keinan, Alon] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Price, Alkes L.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Price, Alkes L.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Daly, Mark J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Simches Res Ctr, Boston, MA 02114 USA; [Leslie, Stephen; McVean, Gil; Moutsianas, Loukas] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Grossman, Sharon R.; Hostetter, Elizabeth B.; Sabeti, Pardis C.] Harvard Univ, Dept Organism & Evolutionary Biol, Ctr Syst Biol, Cambridge, MA 02215 USA; [Adebamowo, Clement A.] Univ Maryland, Sch Med, Dept Epidemiol & Preventat Med, Inst Human Virol N406, Baltimore, MD 21201 USA; [Foster, Morris W.] Univ Oklahoma, Dept Anthropol, Norman, OK 73019 USA; [Gordon, Deborah R.] Univ Calif San Francisco, Dept Anthropol Hist & Social Med, San Francisco, CA 94143 USA; [Licinio, Julio] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2603, Australia; [Manca, Maria Cristina] Inst Oncol Study & Prevent, I-50139 Florence, Italy; [Marshall, Patricia A.] Case Western Reserve Univ, Dept Bioeth, Sch Med TA200, Cleveland, OH 44106 USA; [Matsuda, Ichiro] Hlth Sci Univ Hokkaido, Tobetsu, Hokkaido 0610293, Japan; [Ngare, Duncan] Moi Univ, Dept Populat & Family Hlth, Eldoret 30100, Kenya; [Wang, Vivian Ota; Brooks, Lisa D.; McEwen, Jean E.] NHGRI, NIH, Bethesda, MD 20892 USA; [Reddy, Deepa] Univ Houston Clear Lake City, Dept Anthropol, Houston, TX 77058 USA; [Rotimi, Charles N.] NHGRI, Ctr Res Genom & Global Hlth, Bethesda, MD 20892 USA; [Royal, Charmaine D.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Sharp, Richard R.] Cleveland Clin, Dept Bioeth, Cleveland, OH 44124 USA; [Zeng, Changqing] Chinese Acad Sci, Beijing Inst Genom, Beijing 101300, Peoples R China	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Baylor College of Medicine; University of Geneva; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Wellcome Trust Sanger Institute; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Cornell University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; University of Oxford; Harvard University; University System of Maryland; University of Maryland Baltimore; University of Oklahoma System; University of Oklahoma - Norman; University of California System; University of California San Francisco; Australian National University; John Curtin School of Medical Research; Case Western Reserve University; Health Sciences University of Hokkaido; Moi University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Houston System; University of Houston; University of Houston Clear Lake; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Duke University; Cleveland Clinic Foundation; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Altshuler, DM (corresponding author), Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02138 USA.	altshuler@molbio.mgh.harvard.edu; agibbs@bcm.edu	Nguyen, Huy/GWQ-6433-2022; Daly, Mark J/B-2453-2017; Licinio, Julio/L-4244-2013; Altshuler, David M/A-4476-2009; Deloukas, Panos/B-2922-2013; Sabeti, Pardis/GQH-8610-2022; Adebamowo, Clement/C-8778-2011; Wheeler, David A/M-9740-2018; Gonzaga-Jauregui, Claudia/H-4752-2019; Dermitzakis, Emmanouil/B-7687-2013; de Bakker, Paul IW/B-8730-2009; Schaffner, Stephen F/D-1189-2011; Nguyen, Huy/AAF-9560-2019	Daly, Mark J/0000-0002-0949-8752; Licinio, Julio/0000-0001-6905-5884; Altshuler, David M/0000-0002-7250-4107; Deloukas, Panos/0000-0001-9251-070X; Adebamowo, Clement/0000-0002-6571-2880; Wheeler, David A/0000-0002-9056-6299; Gonzaga-Jauregui, Claudia/0000-0002-4667-3679; de Bakker, Paul IW/0000-0001-7735-7858; Nguyen, Huy/0000-0002-5896-9661; McLaren, William/0000-0001-6218-1116; Chang, Kyle/0000-0001-5295-9676; Montgomery, Stephen/0000-0002-5200-3903; Soranzo, Nicole/0000-0003-1095-3852; Schaffner, Stephen/0000-0001-6699-3568; Barnes, Chris/0000-0002-9459-1395; Palotie, Aarno/0000-0002-2527-5874; Keinan, Alon/0000-0002-9760-1122; Inouye, Michael/0000-0001-9413-6520; McGinnis, Ralph/0000-0003-4540-9857; Kristiansson, Kati/0000-0003-4688-107X; Jia, Xiaoming/0000-0002-5104-5431; Hunt, Sarah/0000-0002-8350-1235; Anttila, Verneri/0000-0002-0073-4675	USA National Institutes of Health; National Human Genome Research Institute; National Institute on Deafness and Other Communication Disorders; Wellcome Trust [068545/Z/02, 076113]; Louis-Jeantet Foundation; NCCR 'Frontiers in Genetics' (Swiss National Science Foundation); UK Medical Research Council [G0000934]; MRC [G0000934] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; Medical Research Council [G0000934] Funding Source: researchfish	USA National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Wellcome Trust(Wellcome TrustEuropean Commission); Louis-Jeantet Foundation; NCCR 'Frontiers in Genetics' (Swiss National Science Foundation)(Swiss National Science Foundation (SNSF)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We dedicate this work to Leena Peltonen for her vital leadership role in this study, and in memory of a valued friend and colleague. We thank E. Boerwinkle and R. Durbin for critical reading of the manuscript. We thank the USA National Institutes of Health, the National Human Genome Research Institute, the National Institute on Deafness and Other Communication Disorders and the Wellcome Trust for supporting the majority of this work. Funding was also provided by the Louis-Jeantet Foundation and the NCCR 'Frontiers in Genetics' (Swiss National Science Foundation). We thank the people from the following communities who were generous in donating their blood samples to be studied in this project: the Yoruba in Ibadan, Nigeria; the Maasai in Kinyawa, Kenya; the Luhya in Webuye, Kenya; the Han Chinese in Beijing, China; the Japanese in Tokyo, Japan; the Chinese in metropolitan Denver, Colorado; the Gujarati Indians in Houston, Texas; the Toscani in Italia; the community of African ancestry in the southwestern USA; and the community of Mexican ancestry in Los Angeles, California. We also thank the people in the Utah Centre d'Etude du Polymorphisme Humain community who allowed the samples they donated earlier to be used for the project. The authors acknowledge use of DNA from the 1958 British birth cohort collection, funded by the UK Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02. The Illumina 550K genotype data for the 1958 British birth cohort samples were made available by the Sanger Institute. For the 1958 British birth cohort Affymetrix 500K genotype data, we thank the Wellcome Trust Case Control Consortium (http://www.wtccc.org.uk), which was funded by Wellcome Trust award 076113.	Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barnes C, 2008, NAT GENET, V40, P1245, DOI 10.1038/ng.206; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Gu JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005767; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li Y., 2006, AM J HUM GENET S, V79, P2290; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Pe'er I, 2006, AM J HUM GENET, V78, P588, DOI 10.1086/502803; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Zhang JH, 2005, PLOS COMPUT BIOL, V1, P395, DOI 10.1371/journal.pcbi.0010053	27	1880	1909	3	189	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 2	2010	467	7311					52	58		10.1038/nature09298	http://dx.doi.org/10.1038/nature09298			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645MB	20811451	Green Accepted			2022-12-01	WOS:000281461200033
J	Kerr, DJ; Midgley, R				Kerr, David J.; Midgley, Rachel			Can We Treat Cancer for a Dollar a Day? Guidelines for Low-Income Countries	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kerr, David J.] Sidra Med & Res Ctr, Doha, Qatar; [Midgley, Rachel] Univ Oxford, Dept Clin Pharmacol, Oxford, England	Sidra Medical & Research Center; University of Oxford	Kerr, DJ (corresponding author), Sidra Med & Res Ctr, Doha, Qatar.			Kerr, Rachel/0000-0002-7240-3269				CanTreat Int, 2010, ANN ONCOL, V21, P680, DOI 10.1093/annonc/mdq055; Groot MT, 2006, BREAST J, V12, pS81, DOI 10.1111/j.1075-122X.2006.00206.x; Kerr F, 2006, ANN ONCOL, V17, P1730, DOI 10.1093/annonc/mdl442; Lingwood RJ, 2008, NAT REV CANCER, V8, P398, DOI 10.1038/nrc2372; Tan-Torres ET, 2003, MAKING CHOICES HLTH	5	43	44	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 26	2010	363	9					801	803		10.1056/NEJMp1002812	http://dx.doi.org/10.1056/NEJMp1002812			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	642HG	20818843				2022-12-01	WOS:000281196600001
J	Li, NX; Lee, B; Liu, RJ; Banasr, M; Dwyer, JM; Iwata, M; Li, XY; Aghajanian, G; Duman, RS				Li, Nanxin; Lee, Boyoung; Liu, Rong-Jian; Banasr, Mounira; Dwyer, Jason M.; Iwata, Masaaki; Li, Xiao-Yuan; Aghajanian, George; Duman, Ronald S.			mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists	SCIENCE			English	Article							MAJOR DEPRESSIVE DISORDER; D-ASPARTATE ANTAGONIST; KETAMINE; DISEASE	The rapid antidepressant response after ketamine administration in treatment-resistant depressed patients suggests a possible new approach for treating mood disorders compared to the weeks or months required for standard medications. However, the mechanisms underlying this action of ketamine [a glutamate N-methyl-D-aspartic acid (NMDA) receptor antagonist] have not been identified. We observed that ketamine rapidly activated the mammalian target of rapamycin (mTOR) pathway, leading to increased synaptic signaling proteins and increased number and function of new spine synapses in the prefrontal cortex of rats. Moreover, blockade of mTOR signaling completely blocked ketamine induction of synaptogenesis and behavioral responses in models of depression. Our results demonstrate that these effects of ketamine are opposite to the synaptic deficits that result from exposure to stress and could contribute to the fast antidepressant actions of ketamine.	[Duman, Ronald S.] Yale Univ, Sch Med, Dept Psychiat, Lab Mol Psychiat,Ctr Genes & Behav, New Haven, CT 06508 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06508 USA	Yale University; Yale University	Duman, RS (corresponding author), Yale Univ, Sch Med, Dept Psychiat, Lab Mol Psychiat,Ctr Genes & Behav, 34 Pk St, New Haven, CT 06508 USA.	ronald.duman@yale.edu	Lee, Boyoung/AAV-8719-2021; Li, Nanxin/D-9755-2011; Iwata, Masaaki/AAP-3732-2020	Lee, Boyoung/0000-0001-9445-510X; Iwata, Masaaki/0000-0002-6143-0181	U.S. Public Health Service [MH45481, 2P01 MH25642]; Connecticut Mental Health Center; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH045481, P01MH025642, R01MH045481, R29MH045481] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Connecticut Mental Health Center; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work is supported by U.S. Public Health Service grants MH45481 and 2P01 MH25642 and by the Connecticut Mental Health Center.	Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Drevets WC, 1998, ANNU REV MED, V49, P341, DOI 10.1146/annurev.med.49.1.341; Farber NB, 1998, PROG BRAIN RES, V116, P421, DOI 10.1016/S0079-6123(08)60453-7; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Krystal JH, 2007, SWISS MED WKLY, V137, P215; Lambe EK, 2007, NEUROSCIENCE, V145, P900, DOI 10.1016/j.neuroscience.2006.12.048; Liu RJ, 2008, P NATL ACAD SCI USA, V105, P359, DOI 10.1073/pnas.0706679105; Maeng S, 2008, BIOL PSYCHIAT, V63, P349, DOI 10.1016/j.biopsych.2007.05.028; Preskorn SH, 2008, J CLIN PSYCHOPHARM, V28, P631, DOI 10.1097/JCP.0b013e31818a6cea; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Yoshihara Y, 2009, CURR OPIN NEUROBIOL, V19, P146, DOI 10.1016/j.conb.2009.05.013; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856	14	1862	1956	6	372	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 20	2010	329	5994					959	964		10.1126/science.1190287	http://dx.doi.org/10.1126/science.1190287			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640WN	20724638	Green Accepted			2022-12-01	WOS:000281084800039
J	Lee, WL; Slutsky, AS				Lee, Warren L.; Slutsky, Arthur S.			Sepsis and Endothelial Permeability	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lee, Warren L.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; Univ Toronto, Div Respirol, Toronto, ON, Canada; Univ Toronto, Div Crit Care Med, Toronto, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto	Lee, WL (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, 30 Bond St, Toronto, ON M5B 1W8, Canada.		Slutsky, Arthur/M-3325-2019	Lee, Warren/0000-0002-1788-6587				Groger M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005391; London NR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000678; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Russell JA, 2006, NEW ENGL J MED, V355, P2267; Ye XB, 2008, J EXP MED, V205, P1303, DOI 10.1084/jem.20071393	5	334	365	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2010	363	7					689	691		10.1056/NEJMcibr1007320	http://dx.doi.org/10.1056/NEJMcibr1007320			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	636TN	20818861				2022-12-01	WOS:000280764600016
J	Ho, CY; Lopez, B; Coelho-Filho, OR; Lakdawala, NK; Cirino, AL; Jarolim, P; Kwong, R; Gonzalez, A; Colan, SD; Seidman, JG; Diez, J; Seidman, CE				Ho, Carolyn Y.; Lopez, Begona; Coelho-Filho, Otavio R.; Lakdawala, Neal K.; Cirino, Allison L.; Jarolim, Petr; Kwong, Raymond; Gonzalez, Arantxa; Colan, Steven D.; Seidman, J. G.; Diez, Javier; Seidman, Christine E.			Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIAC MAGNETIC-RESONANCE; EXTRACELLULAR-MATRIX TURNOVER; LEFT-VENTRICULAR FUNCTION; HEART-FAILURE; DILATED CARDIOMYOPATHY; DELAYED ENHANCEMENT; BIOCHEMICAL MARKERS; GENE-MUTATIONS; SERUM; ECHOCARDIOGRAPHY	BACKGROUND Myocardial fibrosis is a hallmark of hypertrophic cardiomyopathy and a proposed substrate for arrhythmias and heart failure. In animal models, profibrotic genetic pathways are activated early, before hypertrophic remodeling. Data showing early profibrotic responses to sarcomere-gene mutations in patients with hypertrophic cardiomyopathy are lacking. METHODS We used echocardiography, cardiac magnetic resonance imaging (MRI), and serum biomarkers of collagen metabolism, hemodynamic stress, and myocardial injury to evaluate subjects with hypertrophic cardiomyopathy and a confirmed genotype. RESULTS The study involved 38 subjects with pathogenic sarcomere mutations and overt hypertrophic cardiomyopathy, 39 subjects with mutations but no left ventricular hypertrophy, and 30 controls who did not have mutations. Levels of serum C-terminal propeptide of type I procollagen (PICP) were significantly higher in mutation carriers without left ventricular hypertrophy and in subjects with overt hypertrophic cardiomyopathy than in controls (31% and 69% higher, respectively; P<0.001). The ratio of PICP to C-terminal telopeptide of type I collagen was increased only in subjects with overt hypertrophic cardiomyopathy, suggesting that collagen synthesis exceeds degradation. Cardiac MRI studies showed late gadolinium enhancement, indicating myocardial fibrosis, in 71% of subjects with overt hypertrophic cardiomyopathy but in none of the mutation carriers without left ventricular hypertrophy. CONCLUSIONS Elevated levels of serum PICP indicated increased myocardial collagen synthesis in sarcomere-mutation carriers without overt disease. This profibrotic state preceded the development of left ventricular hypertrophy or fibrosis visible on MRI. (Funded by the National Institutes of Health and others.)	[Ho, Carolyn Y.; Coelho-Filho, Otavio R.; Lakdawala, Neal K.; Cirino, Allison L.; Kwong, Raymond; Seidman, J. G.; Seidman, Christine E.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Jarolim, Petr] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Colan, Steven D.] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Seidman, J. G.; Seidman, Christine E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Lopez, Begona; Gonzalez, Arantxa; Diez, Javier] Univ Navarra, Div Cardiovasc Sci, Ctr Appl Med Res, E-31080 Pamplona, Spain; [Lopez, Begona; Gonzalez, Arantxa; Diez, Javier] Univ Navarra, Univ Clin, E-31080 Pamplona, Spain; [Seidman, Christine E.] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Navarra; University of Navarra; Howard Hughes Medical Institute	Ho, CY (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	cho@partners.org	Coelho-Filho, Otavio/AAV-9557-2021; Coelho-Filho, Otavio/G-9250-2012; González, Arantxa/D-6860-2017; Kwong, Raymond Y/R-1925-2016; Díez, Javier/D-7014-2017; Colan, Steven/ABB-4580-2020	Coelho-Filho, Otavio/0000-0003-4428-5186; Coelho-Filho, Otavio/0000-0003-4428-5186; González, Arantxa/0000-0001-5986-6528; Kwong, Raymond Y/0000-0001-8212-0759; Díez, Javier/0000-0002-3414-6919; Lopez Salazar, Begona/0000-0001-8508-698X; Ho, Carolyn/0000-0002-7334-7924	National Institutes of Health; Arthur L. Lenahan Sr. Family Foundation; GlaxoSmithKline Research and Education Foundation for Cardiovascular Disease; Howard Hughes Medical Institute; Foundation for Applied Medical Research; Institute of Health Carlos III, Ministry of Science and Innovation; European Union InGenious HyperCare; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084553, K23HL078901, P20HL101408] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthur L. Lenahan Sr. Family Foundation; GlaxoSmithKline Research and Education Foundation for Cardiovascular Disease(GlaxoSmithKline); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Foundation for Applied Medical Research; Institute of Health Carlos III, Ministry of Science and Innovation(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); European Union InGenious HyperCare(European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the National Institutes of Health (to Drs. Ho, J.G. Seidman, and C.E. Seidman), the Arthur L. Lenahan Sr. Family Foundation (to Dr. Ho), the GlaxoSmithKline Research and Education Foundation for Cardiovascular Disease (to Dr. Ho), the Howard Hughes Medical Institute (to Dr. C. E. Seidman), and the Foundation for Applied Medical Research and Union Temporal de Empresas project Centro de Investigacion Medica Aplicada, the Red Tematica de Investigacion Cooperativa en Enfermedades Cardiovasculares from the Institute of Health Carlos III, Ministry of Science and Innovation, and the European Union InGenious HyperCare (all to Drs. Lopez, Gonzalez, and Diez).	Adabag AS, 2008, J AM COLL CARDIOL, V51, P1369, DOI 10.1016/j.jacc.2007.11.071; Basso C, 2000, HUM PATHOL, V31, P988, DOI 10.1053/hupa.2000.16659; Camici PG, 2007, NEW ENGL J MED, V356, P830, DOI 10.1056/NEJMra061889; Choudhury L, 2002, J AM COLL CARDIOL, V40, P2156, DOI 10.1016/S0735-1097(02)02602-5; Crilley JG, 2003, J AM COLL CARDIOL, V41, P1776, DOI 10.1016/S0735-1097(02)03009-7; Debold EP, 2007, AM J PHYSIOL-HEART C, V293, pH284, DOI 10.1152/ajpheart.00128.2007; Fassbach M, 2005, Z KARDIOL, V94, P328, DOI 10.1007/s00392-005-0214-5; GeisterferLowrance AAT, 1996, SCIENCE, V272, P731, DOI 10.1126/science.272.5262.731; Germans T, 2006, J AM COLL CARDIOL, V48, P2518, DOI 10.1016/j.jacc.2006.08.036; Gonzalez A, 2009, CARDIOVASC RES, V81, P509, DOI 10.1093/cvr/cvn235; Grothues F, 2002, AM J CARDIOL, V90, P29, DOI 10.1016/S0002-9149(02)02381-0; Ho CY, 2009, CIRC-CARDIOVASC GENE, V2, P314, DOI 10.1161/CIRCGENETICS.109.862128; Ho CY, 2002, CIRCULATION, V105, P2992, DOI 10.1161/01.CIR.0000019070.70491.6D; Kim JB, 2007, SCIENCE, V316, P1481, DOI 10.1126/science.1137325; Kim RJ, 1999, CIRCULATION, V100, P1992, DOI 10.1161/01.CIR.100.19.1992; KLAPPACHER G, 1995, AM J CARDIOL, V75, P913, DOI 10.1016/S0002-9149(99)80686-9; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lombardi R, 2003, CIRCULATION, V108, P1455, DOI 10.1161/01.CIR.0000090687.97972.10; Lombardi R, 2009, CIRCULATION, V119, P1398, DOI 10.1161/CIRCULATIONAHA.108.790501; Lopez B, 2010, CIRCULATION, V121, P1645, DOI 10.1161/CIRCULATIONAHA.109.912774; Marino P, 2002, J AM SOC ECHOCARDIOG, V15, P935, DOI 10.1067/mje.2002.121196; Maron BJ, 2004, J AM COLL CARDIOL, V44, P2125, DOI 10.1016/j.jacc.2004.08.052; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; Maron MS, 2008, CIRC-HEART FAIL, V1, P184, DOI 10.1161/CIRCHEARTFAILURE.108.768119; McKenna WJ, 1997, HEART, V77, P130, DOI 10.1136/hrt.77.2.130; Moon JC, 2005, HEART, V91, P1036, DOI 10.1136/hrt.2004.041384; Moon JCC, 2003, J AM COLL CARDIOL, V41, P1561, DOI 10.1016/S0735-1097(03)00189-X; Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF; Nagueh SF, 2001, CIRCULATION, V104, P128, DOI 10.1161/01.CIR.104.2.128; Niimura H, 2002, CIRCULATION, V105, P446, DOI 10.1161/hc0402.102990; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; Noji Y, 2004, CIRC J, V68, P355, DOI 10.1253/circj.68.355; Ommen SR, 2000, CIRCULATION, V102, P1788; Poulsen SH, 2001, CARDIOLOGY, V96, P45, DOI 10.1159/000047385; Querejeta R, 2004, CIRCULATION, V110, P1263, DOI 10.1161/01.CIR.0000140973.60992.9A; Ricciardi MJ, 2001, CIRCULATION, V103, P2780, DOI 10.1161/hc2301.092121; Richard P, 2006, J AM COLL CARDIOL, V48, pA79, DOI 10.1016/j.jacc.2006.09.014; Roldan V, 2008, AM HEART J, V156, P85, DOI 10.1016/j.ahj.2008.01.035; Rudolph A, 2009, J AM COLL CARDIOL, V53, P284, DOI 10.1016/j.jacc.2008.08.064; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Shirani J, 2000, J AM COLL CARDIOL, V35, P36, DOI 10.1016/S0735-1097(99)00492-1; Sluysmans T, 2005, J APPL PHYSIOL, V99, P445, DOI 10.1152/japplphysiol.01144.2004; Strauss DG, 2008, CIRC-ARRHYTHMIA ELEC, V1, P327, DOI 10.1161/CIRCEP.108.798660; Tardiff JC, 2005, HEART FAIL REV, V10, P237, DOI 10.1007/s10741-005-5253-5; TRIVEDI P, 1991, PEDIATR RES, V30, P276, DOI 10.1203/00006450-199109000-00016; Varnava AM, 2000, HEART, V84, P476, DOI 10.1136/heart.84.5.476; Varnava AM, 2001, AM J CARDIOL, V88, P275, DOI 10.1016/S0002-9149(01)01640-X; Wu E, 2001, LANCET, V357, P21, DOI 10.1016/S0140-6736(00)03567-4; Zannad F, 2000, CIRCULATION, V102, P2700, DOI 10.1161/01.CIR.102.22.2700	49	442	465	2	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2010	363	6					552	563		10.1056/NEJMoa1002659	http://dx.doi.org/10.1056/NEJMoa1002659			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634BB	20818890	Green Accepted, Green Published			2022-12-01	WOS:000280552700009
J	Li, XY; Gianoulis, TA; Yip, KY; Gerstein, M; Snyder, M				Li, Xiyan; Gianoulis, Tara A.; Yip, Kevin Y.; Gerstein, Mark; Snyder, Michael			Extensive In Vivo Metabolite-Protein Interactions Revealed by Large-Scale Systematic Analyses	CELL			English	Article							GLOBAL ANALYSIS; SACCHAROMYCES-CEREVISIAE; YEAST; KINASE; RECONSTRUCTION; BIOSYNTHESIS; CYTOSCAPE; MUTANTS; PATHWAY	Natural small compounds comprise most cellular molecules and bind proteins as substrates, products, cofactors, and ligands. However, a large-scale investigation of in vivo protein-small metabolite interactions has not been performed. We developed a mass spectrometry assay for the large-scale identification of in vivo protein-hydrophobic small metabolite interactions in yeast and analyzed compounds that bind ergosterol biosynthetic proteins and protein kinases. Many of these proteins bind small metabolites; a few interactions were previously known, but the vast majority are new. Importantly, many key regulatory proteins such as protein kinases bind metabolites. Ergosterol was found to bind many proteins and may function as a general regulator. It is required for the activity of Ypk1, a mammalian AKT/SGK kinase homolog. Our study defines potential key regulatory steps in lipid biosynthetic pathways and suggests that small metabolites may play a more general role as regulators of protein activity and function than previously appreciated.	[Li, Xiyan; Snyder, Michael] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Li, Xiyan; Snyder, Michael] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Gianoulis, Tara A.; Gerstein, Mark] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Yip, Kevin Y.; Gerstein, Mark; Snyder, Michael] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Gerstein, Mark] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA	Stanford University; Yale University; Yale University; Yale University; Yale University	Snyder, M (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	mpsnyder@stanford.edu	Yip, Kevin/AAT-4771-2020; Li, Xiyan/B-5495-2011	Yip, Kevin/0000-0001-5516-9944; Li, Xiyan/0000-0002-1959-2160; Snyder, Michael/0000-0003-0784-7987	NIH; NSF [DBI-1042344]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062480] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Davidov and X. Zhou for technical assistance and Drs. H. Im, M. Bruno, and L. Wu for comments on the manuscript. This work was supported by grants from the NIH (M.S. and M.G.) and in part from an NSF grant DBI-1042344 (X.L. and M.S.). The conceptual design for the project was developed by X.L. and M.S. Laboratory experiments were performed by X.L. Data analyses were performed by X.L., T.G., K.Y.Y., and M.G. The manuscript was prepared by X.L. and M.S.	Alberts B., 2002, MOL BIOL CELL; Allen J, 2003, NAT BIOTECHNOL, V21, P692, DOI 10.1038/nbt823; Babu P, 2004, J BIOL CHEM, V279, P27138, DOI 10.1074/jbc.M403071200; Beloqui A, 2009, SCIENCE, V326, P252, DOI 10.1126/science.1174094; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Carrier A, 2000, J CHROMATOGR A, V876, P97, DOI 10.1016/S0021-9673(00)00148-5; Cascante M, 2008, ESSAYS BIOCHEM, V45, P67, DOI 10.1042/BSE0450067; Caydasi AK, 2009, DEV CELL, V16, P146, DOI 10.1016/j.devcel.2008.10.013; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Horak Christine E, 2002, Funct Integr Genomics, V2, P171; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; Jacquier N, 2010, J CELL SCI, V123, P2218, DOI 10.1242/jcs.063073; KARST F, 1977, MOL GEN GENET, V154, P269, DOI 10.1007/BF00571282; Kuruvilla FG, 2002, NATURE, V416, P653, DOI 10.1038/416653a; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Maynard Jennifer A., 2009, Biotechnology Journal, V4, P1542, DOI 10.1002/biot.200900195; Morozov VN, 2003, RAPID COMMUN MASS SP, V17, P2430, DOI 10.1002/rcm.1213; Nicholson JK, 2008, J PROTEOME RES, V7, P3637, DOI 10.1021/pr8005099; PARKS LW, 1995, ANNU REV MICROBIOL, V49, P95, DOI 10.1146/annurev.mi.49.100195.000523; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Schmelzle T, 2002, MOL CELL BIOL, V22, P1329, DOI 10.1128/MCB.22.5.1329-1339.2002; Sen Gupta S, 2003, J BIOL CHEM, V278, P28831, DOI 10.1074/jbc.M303300200; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Snyder M, 2009, FEBS LETT, V583, P3895, DOI 10.1016/j.febslet.2009.11.011; Tagore R, 2008, J AM CHEM SOC, V130, P14111, DOI 10.1021/ja806463c; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Yano KI, 1997, P NATL ACAD SCI USA, V94, P1721, DOI 10.1073/pnas.94.5.1721; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	39	152	156	4	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 12	2010	143	4					639	650		10.1016/j.cell.2010.09.048	http://dx.doi.org/10.1016/j.cell.2010.09.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	679GF	21035178	Bronze, Green Accepted			2022-12-01	WOS:000284149100020
J	Feng, LA; Campbell, EB; Hsiung, YC; MacKinnon, R				Feng, Liang; Campbell, Ernest B.; Hsiung, Yichun; MacKinnon, Roderick			Structure of a Eukaryotic CLC Transporter Defines an Intermediate State in the Transport Cycle	SCIENCE			English	Article							MUSCLE CHLORIDE CHANNEL; DEPENDENT K+ CHANNEL; X-RAY-STRUCTURE; CYTOPLASMIC DOMAIN; MOLECULAR-BASIS; /H+ ANTIPORTER; OSTEOPETROSIS; SELECTIVITY; MUTATIONS; TRANSMEMBRANE	CLC proteins transport chloride (Cl-) ions across cell membranes to control the electrical potential of muscle cells, transfer electrolytes across epithelia, and control the pH and electrolyte composition of intracellular organelles. Some members of this protein family are Cl- ion channels, whereas others are secondary active transporters that exchange Cl- ions and protons (H+) with a 2: 1 stoichiometry. We have determined the structure of a eukaryotic CLC transporter at 3.5 angstrom resolution. Cytoplasmic cystathionine beta-synthase (CBS) domains are strategically positioned to regulate the ion-transport pathway, and many disease-causing mutations in human CLCs reside on the CBS-transmembrane interface. Comparison with prokaryotic CLC shows that a gating glutamate residue changes conformation and suggests a basis for 2: 1 Cl-/H+ exchange and a simple mechanistic connection between CLC channels and transporters.	[Feng, Liang; Campbell, Ernest B.; Hsiung, Yichun; MacKinnon, Roderick] Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10065 USA.	mackinn@rockefeller.edu			NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIBIB NIH HHS [P30 EB009998] Funding Source: Medline; NIGMS NIH HHS [R01 GM043949, R01 GM043949-20, R01 GM043949-21] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Accardi A, 2006, J MOL BIOL, V362, P691, DOI 10.1016/j.jmb.2006.07.081; Accardi A, 2010, BBA-BIOMEMBRANES, V1798, P1457, DOI 10.1016/j.bbamem.2010.02.022; Bennetts B, 2005, J BIOL CHEM, V280, P32452, DOI 10.1074/jbc.M502890200; Bergsdorf EY, 2009, J BIOL CHEM, V284, P11184, DOI 10.1074/jbc.M901170200; Chen TY, 2008, PHYSIOL REV, V88, P351, DOI 10.1152/physrev.00058.2006; DAVE S, CHANNELS AUSTIN, DOI DOI 10.4161/CHAN.4.4.12445; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; Duffield M, 2003, J GEN PHYSIOL, V121, P149, DOI 10.1085/jgp.20028741; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Engh AM, 2005, J GEN PHYSIOL, V125, P601, DOI 10.1085/jgp.200509258; Frattini A, 2003, J BONE MINER RES, V18, P1740, DOI 10.1359/jbmr.2003.18.10.1740; Garcia-Olivares J, 2008, J PHYSIOL-LONDON, V586, P5325, DOI 10.1113/jphysiol.2008.158097; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Hebeisen S, 2005, BIOPHYS J, V89, P1710, DOI 10.1529/biophysj.104.056093; Hebeisen S, 2004, J BIOL CHEM, V279, P13140, DOI 10.1074/jbc.M312649200; Hryciw DH, 1998, J BIOL CHEM, V273, P4304, DOI 10.1074/jbc.273.8.4304; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jayaram H, 2008, P NATL ACAD SCI USA, V105, P11194, DOI 10.1073/pnas.0804503105; Jencks W.P., 1987, CATALYSIS CHEM ENZYM; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lossin C, 2008, ADV GENET, V63, P25, DOI 10.1016/S0065-2660(08)01002-X; Maduke M, 1998, BIOCHEMISTRY-US, V37, P1315, DOI 10.1021/bi972418o; Maduke M, 2000, ANNU REV BIOPH BIOM, V29, P411, DOI 10.1146/annurev.biophys.29.1.411; Markovic S, 2007, STRUCTURE, V15, P715, DOI 10.1016/j.str.2007.04.013; Matsuda JJ, 2010, J BIOL CHEM, V285, P2569, DOI 10.1074/jbc.M109.018002; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Meyer S, 2007, NAT STRUCT MOL BIOL, V14, P60, DOI 10.1038/nsmb1188; MILLER C, 1984, P NATL ACAD SCI-BIOL, V81, P2772, DOI 10.1073/pnas.81.9.2772; Miller C, 2009, PHILOS T R SOC B, V364, P175, DOI 10.1098/rstb.2008.0138; Pangrazio A, 2010, HUM MUTAT, V31, pE1071, DOI 10.1002/humu.21167; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Picollo A, 2009, NAT STRUCT MOL BIOL, V16, P1294, DOI 10.1038/nsmb.1704; Pusch M, 2002, HUM MUTAT, V19, P423, DOI 10.1002/humu.10063; RICHARD EA, 1990, SCIENCE, V247, P1208, DOI 10.1126/science.2156338; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; SchmidtRose T, 1997, J BIOL CHEM, V272, P20515, DOI 10.1074/jbc.272.33.20515; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; Waguespack SG, 2003, J BONE MINER RES, V18, P1513, DOI 10.1359/jbmr.2003.18.8.1513; Walden M, 2007, J GEN PHYSIOL, V129, P317, DOI 10.1085/jgp.200709756; Weinert S, 2010, SCIENCE, V328, P1401, DOI 10.1126/science.1188072; ZHANG JM, 1994, J BIOL CHEM, V269, P23518; Zifarelli G, 2007, REV PHYSIOL BIOCH P, V158, P23, DOI 10.1007/112_2006_0605; Zifarelli G, 2009, EMBO J, V28, P175, DOI 10.1038/emboj.2008.284	49	195	198	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 29	2010	330	6004					635	641		10.1126/science.1195230	http://dx.doi.org/10.1126/science.1195230			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672KB	20929736	Green Accepted			2022-12-01	WOS:000283580600038
J	McCartney, M				McCartney, Margaret			Obesity Slimmed down surgery	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Colquitt JL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub3; NICE, 2006, OB GUID PREV ID ASS; Picot J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13410; 2009, DRUGS THER B, V47, P125	4	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 26	2010	341								c5499	10.1136/bmj.c5499	http://dx.doi.org/10.1136/bmj.c5499			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	674YE	20978064				2022-12-01	WOS:000283786800024
J	Mohrmann, R; de Wit, H; Verhage, M; Neher, E; Sorensen, JB				Mohrmann, Ralf; de Wit, Heidi; Verhage, Matthijs; Neher, Erwin; Sorensen, Jakob B.			Fast Vesicle Fusion in Living Cells Requires at Least Three SNARE Complexes	SCIENCE			English	Article							MEMBRANE-FUSION; SECRETORY VESICLES; EXOCYTOSIS; RELEASE; SYNAPSE; DOMAIN	Exocytosis requires formation of SNARE [soluble N-ethylmaleimide-sensitive factor attachment protein (SNAP) receptor] complexes between vesicle and target membranes. Recent assessments in reduced model systems have produced divergent estimates of the number of SNARE complexes needed for fusion. Here, we used a titration approach to answer this question in intact, cultured chromaffin cells. Simultaneous expression of wild-type SNAP-25 and a mutant unable to support exocytosis progressively altered fusion kinetics and fusion-pore opening, indicating that both proteins assemble into heteromeric fusion complexes. Expressing different wild-type: mutant ratios revealed a third-power relation for fast (synchronous) fusion and a near-linear relation for overall release. Thus, fast fusion typically observed in synapses and neurosecretory cells requires at least three functional SNARE complexes, whereas slower release might occur with fewer complexes. Heterogeneity in SNARE-complex number may explain heterogeneity in vesicular release probability.	[Mohrmann, Ralf; Neher, Erwin; Sorensen, Jakob B.] Max Planck Inst Biophys Chem, Dept Membrane Biophys, Gottingen, Germany; [Mohrmann, Ralf] Univ Saarland, Dept Physiol, D-6650 Homburg, Germany; [de Wit, Heidi; Verhage, Matthijs] Vrije Univ Amsterdam, Dept Funct Genom, Ctr Neurogenom & Cognit Res, Amsterdam, Netherlands; [de Wit, Heidi; Verhage, Matthijs] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [Sorensen, Jakob B.] Univ Copenhagen, Fac Hlth Sci, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Sorensen, Jakob B.] Univ Copenhagen, Lundbeck Fdn Ctr Biomembranes Nanomed, Copenhagen, Denmark	Max Planck Society; Saarland University; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Copenhagen; Lundbeckfonden; University of Copenhagen	Mohrmann, R (corresponding author), Max Planck Inst Biophys Chem, Dept Membrane Biophys, Gottingen, Germany.	Ralf.Mohrmann@uks.eu; jakobbs@sund.ku.dk	Neher, Erwin/A-2109-2013	verhage, matthijs/0000-0002-6085-7503; Sorensen, Jakob/0000-0001-5465-3769	Lundbeck Foundation; Lundbeck Foundation Center for Biomembranes in Nanomedicine; Danish Medical Research Council; Netherlands Organization for Scientific Research [Pionier/VICI900-01-001, ZonMW 903-42-095, VENI 916-36-043]; NeuroBsik Mouse Phenomics Consortium [BSIK03053]; European Union [HEALTH-F2-2009-242167]; Lundbeck Foundation [R28-2008-1976] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation Center for Biomembranes in Nanomedicine; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NeuroBsik Mouse Phenomics Consortium; European Union(European Commission); Lundbeck Foundation(Lundbeckfonden)	We thank I. Herfort and D. Reuter for expert technical assistance and S. Young for help with viral expression systems. This work was supported by the Lundbeck Foundation (Junior Group Leader Fellowship, J.B.S.), the Lundbeck Foundation Center for Biomembranes in Nanomedicine (J.B.S.), the Danish Medical Research Council (J.B.S.), the Netherlands Organization for Scientific Research (Pionier/VICI900-01-001 and ZonMW 903-42-095 to M.V. and VENI 916-36-043 to H.d.W.), the NeuroBsik Mouse Phenomics Consortium (BSIK03053), and the European Union Seventh Framework Programme under grant agreement no. HEALTH-F2-2009-242167 ("SynSys" project to both J.B.S. and M.V.).	Aikawa Y, 2006, MOL BIOL CELL, V17, P2113, DOI 10.1091/mbc.E06-01-0074; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; Domanska MK, 2009, J BIOL CHEM, V284, P32158, DOI 10.1074/jbc.M109.047381; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Han X, 2004, SCIENCE, V304, P289, DOI 10.1126/science.1095801; Hua YY, 2001, P NATL ACAD SCI USA, V98, P8065, DOI 10.1073/pnas.131214798; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Karatekin E, 2010, P NATL ACAD SCI USA, V107, P3517, DOI 10.1073/pnas.0914723107; Kweon DH, 2002, BIOCHEMISTRY-US, V41, P5449, DOI 10.1021/bi0256476; Liu W, 2008, BIOPHYS J, V95, P419, DOI 10.1529/biophysj.107.127886; Montecucco C, 2005, TRENDS BIOCHEM SCI, V30, P367, DOI 10.1016/j.tibs.2005.05.002; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Sorensen JB, 2009, ANNU REV CELL DEV BI, V25, P513, DOI 10.1146/annurev.cellbio.24.110707.175239; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; Sorensen JB, 2003, CELL, V114, P75, DOI 10.1016/S0092-8674(03)00477-X; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tokumaru H, 2001, CELL, V104, P421, DOI 10.1016/S0092-8674(01)00229-X; van den Bogaart G, 2010, NAT STRUCT MOL BIOL, V17, P358, DOI 10.1038/nsmb.1748; Walter AM, 2010, J CELL BIOL, V188, P401, DOI 10.1083/jcb.200907018; Wiederhold K, 2009, J BIOL CHEM, V284, P13143, DOI 10.1074/jbc.M900703200; Yersin A, 2003, P NATL ACAD SCI USA, V100, P8736, DOI 10.1073/pnas.1533137100	24	211	213	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 22	2010	330	6003					502	505		10.1126/science.1193134	http://dx.doi.org/10.1126/science.1193134			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20847232				2022-12-01	WOS:000283329100039
J	He, XA; Szewczyk, P; Karyakin, A; Evin, M; Hong, WX; Zhang, QH; Chang, G				He, Xiao; Szewczyk, Paul; Karyakin, Andrey; Evin, Mariah; Hong, Wen-Xu; Zhang, Qinghai; Chang, Geoffrey			Structure of a cation-bound multidrug and toxic compound extrusion transporter	NATURE			English	Article							ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; DIFFRACTION DATA; NMR SYSTEM; PROTEIN; DATABASE; FAMILY; MODEL; CRYSTALLOGRAPHY; SUPERFAMILY	Transporter proteins from the MATE (multidrug and toxic compound extrusion)(1) family are vital in metabolite transport in plants(2,3), directly affecting crop yields worldwide(4). MATE transporters also mediate multiple-drug resistance (MDR) in bacteria and mammals(5), modulating the efficacy of many pharmaceutical drugs used in the treatment of a variety of diseases(6-9). MATE transporters couple substrate transport to electrochemical gradients and are the only remaining class of MDR transporters whose structure has not been determined(10). Here we report the X-ray structure of the MATE transporter NorM from Vibrio cholerae determined to 3.65 angstrom, revealing an outward-facing conformation with two portals open to the outer leaflet of the membrane and a unique topology of the predicted 12 transmembrane helices distinct from any other known MDR transporter. We also report a cation-binding site in close proximity to residues previously deemed critical for transport(11). This conformation probably represents a stage of the transport cycle with high affinity for monovalent cations and low affinity for substrates.	[He, Xiao; Szewczyk, Paul; Karyakin, Andrey; Evin, Mariah; Hong, Wen-Xu; Zhang, Qinghai; Chang, Geoffrey] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Chang, G (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd,CB105, La Jolla, CA 92037 USA.	gchang@scripps.edu	Hong, Wen-Xu/H-5021-2014	Hong, Wen-Xu/0000-0003-0260-1099	National Institutes of Health [GM70480, GM73197]; Beckman Foundation; Skaggs Chemical Biology Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073197, R01GM070480] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Foundation; Skaggs Chemical Biology Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Yin for his contribution to initial clones of NorM. We also thank the Canadian Light Source (CLS), the Stanford Synchrotron Radiation Laboratory (SSRL), the Advanced Light Source (ALS) and the Advanced Photon Source (APS). This work was supported by grants from the National Institutes of Health (GM70480 to G.C., and GM73197 to Q.Z.), the Beckman Foundation and the Skaggs Chemical Biology Foundation.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Becker MSL, 2009, DIABETES, V58, P745, DOI 10.2337/db08-1028; Brown MH, 1999, MOL MICROBIOL, V31, P394, DOI 10.1046/j.1365-2958.1999.01162.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Furey W, 1997, METHOD ENZYMOL, V277, P590, DOI 10.1016/S0076-6879(97)77033-2; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Hvorup RN, 2003, EUR J BIOCHEM, V270, P799, DOI 10.1046/j.1432-1033.2003.03418.x; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kaatz GW, 2005, ANTIMICROB AGENTS CH, V49, P1857, DOI 10.1128/AAC.49.5.1857-1864.2005; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Leslie A, 1992, NEWSLETTER PROTEIN C; Li XZ, 2003, ANTIMICROB AGENTS CH, V47, P27, DOI 10.1128/AAC.47.1.27-33.2003; Magalhaes JV, 2007, NAT GENET, V39, P1156, DOI 10.1038/ng2074; McAleese F, 2005, ANTIMICROB AGENTS CH, V49, P1865, DOI 10.1128/AAC.49.5.1865-1871.2005; Morita M, 2009, P NATL ACAD SCI USA, V106, P2447, DOI 10.1073/pnas.0812512106; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Omote H, 2006, TRENDS PHARMACOL SCI, V27, P587, DOI 10.1016/j.tips.2006.09.001; Otsuka M, 2005, J BACTERIOL, V187, P1552, DOI 10.1128/JB.187.5.1552-1558.2005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SACK JS, 1988, J MOL GRAPHICS, V6, P224, DOI 10.1016/S0263-7855(98)80040-4; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tsuda M, 2009, MOL PHARMACOL, V75, P1280, DOI 10.1124/mol.109.056242; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762; Wood S., 2000, PILOT ANAL GLOBAL EC, V12; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; Zhang QH, 2007, ANGEW CHEM INT EDIT, V46, P7023, DOI 10.1002/anie.200701556; Zheleznova EE, 1999, CELL, V96, P353, DOI 10.1016/S0092-8674(00)80548-6	37	205	213	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 21	2010	467	7318					991	U139		10.1038/nature09408	http://dx.doi.org/10.1038/nature09408			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20861838	Green Accepted			2022-12-01	WOS:000283254700044
J	Kranendijk, M; Struys, EA; van Schaftingen, E; Gibson, KM; Kanhai, WA; van der Knaap, MS; Amiel, J; Buist, NR; Das, AM; de Klerk, JB; Feigenbaum, AS; Grange, DK; Hofstede, FC; Holme, E; Kirk, EP; Korman, SH; Morava, E; Morris, A; Smeitink, J; Sukhai, RN; Vallance, H; Jakobs, C; Salomons, GS				Kranendijk, Martijn; Struys, Eduard A.; van Schaftingen, Emile; Gibson, K. Michael; Kanhai, Warsha A.; van der Knaap, Marjo S.; Amiel, Jeanne; Buist, Neil R.; Das, Anibh M.; de Klerk, Johannis B.; Feigenbaum, Annette S.; Grange, Dorothy K.; Hofstede, Floris C.; Holme, Elisabeth; Kirk, Edwin P.; Korman, Stanley H.; Morava, Eva; Morris, Andrew; Smeitink, Jan; Sukhai, Ram N.; Vallance, Hilary; Jakobs, Cornelis; Salomons, Gajja S.			IDH2 Mutations in Patients with D-2-Hydroxyglutaric Aciduria	SCIENCE			English	Article									[Kranendijk, Martijn; Struys, Eduard A.; Kanhai, Warsha A.; Jakobs, Cornelis; Salomons, Gajja S.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Chem, Metab Unit, NL-1081 HV Amsterdam, Netherlands; [van Schaftingen, Emile] Catholic Univ Louvain, de Duve Inst, Lab Phys Chem, Louvain, Belgium; [Gibson, K. Michael] Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA; [van der Knaap, Marjo S.] Vrije Univ Amsterdam, Med Ctr Amsterdam, Dept Child Neurol, Amsterdam, Netherlands; [Amiel, Jeanne] Univ Paris 05, Hop Necker, Dept Genet, Paris, France; [Amiel, Jeanne] Univ Paris 05, Hop Necker, INSERM, U781, Paris, France; [Buist, Neil R.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR USA; [Buist, Neil R.] Oregon Hlth & Sci Univ, Dept Med Genet, Portland, OR USA; [Das, Anibh M.] Hannover Med Sch, Hannover, Germany; [de Klerk, Johannis B.] ErasmusMC Sophia Childrens Hosp, Dept Metab Dis, Rotterdam, Netherlands; [Feigenbaum, Annette S.] Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON, Canada; [Feigenbaum, Annette S.] Univ Toronto, Toronto, ON, Canada; [Grange, Dorothy K.] Washington Univ, Sch Med, St Louis Childrens Hosp, Dept Pediat,Div Genet & Genom Med, St Louis, MO USA; [Hofstede, Floris C.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Metab Dis, Utrecht, Netherlands; [Holme, Elisabeth] Univ Gothenburg, Sahlgrenska Univer Hosp, Dept Clin Chem & Transfus Med, Gothenburg, Sweden; [Kirk, Edwin P.] Sydney Childrens Hosp, Dept Med Genet, Sydney, NSW, Australia; [Korman, Stanley H.] Hadassah Hebrew Univ, Med Ctr, Dept Human Genet & Metab Dis, Jerusalem, Israel; [Morava, Eva] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, NL-6500 HB Nijmegen, Netherlands; [Morris, Andrew] Children Natl Hlth Serv Trust, Great Ormond St Hosp, London, England; [Smeitink, Jan] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, NL-6500 HB Nijmegen, Netherlands; [Sukhai, Ram N.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Vallance, Hilary] Univ British Columbia, BC Childrens Hosp, Dept Pathol & Lab Med, Vancouver, BC, Canada	Vrije Universiteit Amsterdam; Universite Catholique Louvain; Michigan Technological University; Vrije Universiteit Amsterdam; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Oregon Health & Science University; Oregon Health & Science University; Hannover Medical School; Erasmus University Rotterdam; Erasmus MC; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; St. Louis Children's Hospital; Washington University (WUSTL); Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; University of Gothenburg; University of Sydney; Hebrew University of Jerusalem; Hadassah University Medical Center; Radboud University Nijmegen; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; BC Childrens Hospital; University of British Columbia	Jakobs, C (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Clin Chem, Metab Unit, NL-1081 HV Amsterdam, Netherlands.	c.jakobs@vumc.nl	Van+Schaftingen, Emile/AAF-5532-2020; amiel, jeanne/AGX-1124-2022; amiel, jeanne/H-3501-2017; Morava, E./L-4529-2015; Smeitink, Jan/C-1351-2013	amiel, jeanne/0000-0001-5973-4728; Van Schaftingen, Emile/0000-0002-6199-7647; Vallance, Hilary/0000-0003-1734-1445; Kirk, Edwin/0000-0002-4662-0024				Aghili M, 2009, J NEURO-ONCOL, V91, P233, DOI 10.1007/s11060-008-9706-2; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Kranendijk M, 2010, HUM MUTAT, V31, P279, DOI 10.1002/humu.21186; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Steenweg ME, 2010, HUM MUTAT, V31, P380, DOI 10.1002/humu.21197; Struys EA, 2005, AM J HUM GENET, V76, P358, DOI 10.1086/427890; Struys EA, 2004, FEBS LETT, V557, P115, DOI 10.1016/S0014-5793(03)01459-5; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	9	145	183	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 15	2010	330	6002					336	336		10.1126/science.1192632	http://dx.doi.org/10.1126/science.1192632			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20847235				2022-12-01	WOS:000282986700031
J	Richards, M; Brayne, C				Richards, Marcus; Brayne, Carol			Alzheimer's disease What do we mean by Alzheimer's disease?	BRITISH MEDICAL JOURNAL			English	Editorial Material							DEMENTIA; DIAGNOSIS; LIFE; SERVICES; HEALTH		[Richards, Marcus] MRC Unit Lifelong Hlth & Ageing, London WC1B 5JU, England; [Brayne, Carol] Univ Cambridge, Inst Publ Hlth, Cambridge CB2 0SR, England	University of Cambridge	Richards, M (corresponding author), MRC Unit Lifelong Hlth & Ageing, London WC1B 5JU, England.	m.richards@nshd.mrc.ac.uk	Brayne, Carol/AAA-4285-2020	Brayne, Carol/0000-0001-5307-663X; Richards, Marcus/0000-0001-9191-2192	Medical Research Council [MC_U123092722, G9901400] Funding Source: Medline; MRC [G9901400, MC_U123092722] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Banerjee S, 2009, INT J GERIATR PSYCH, V24, P748, DOI 10.1002/gps.2191; BERRIOS GE, 1990, INT J GERIATR PSYCH, V5, P355, DOI 10.1002/gps.930050603; BRAYNE C, 1988, LANCET, V1, P1265; Brayne C, 2006, PLOS MED, V3, P1922, DOI 10.1371/journal.pmed.0030397; Brayne C, 2007, NAT REV NEUROSCI, V8, P233, DOI 10.1038/nrn2091; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Esiri MM, 2001, LANCET, V357, P169; HACHINSKI V, 2008, JAMA-J AM MED ASSOC, V300, P2171; Hatch SL, 2007, J GERONTOL B-PSYCHOL, V62, pS404, DOI 10.1093/geronb/62.6.S404; Iacono D, 2009, NEUROLOGY, V73, P665, DOI 10.1212/WNL.0b013e3181b01077; KATZMAN R, 1988, ANN NEUROL, V23, P138, DOI 10.1002/ana.410230206; Luengo-Fernandez R., 2010, DEMENTIA 2010; Martyn C, 2010, BMJ-BRIT MED J, V340, P1219; Matthews FE, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000180; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; National Audit Office, 2007, IMPR SERV SUPP PEOPL; Rothschild D, 1937, AM J PSYCHIAT, V93, P757, DOI 10.1176/ajp.93.4.757; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; Smith EE, 2009, STROKE, V40, P2601, DOI 10.1161/STROKEAHA.108.536839; *UK GOV DEP HLTH, 2009, LIV WELL DEM NAT DEM; Whalley LJ, 2006, LANCET NEUROL, V5, P87, DOI 10.1016/S1474-4422(05)70286-6; DSM 5 FUTURE PSYCHIA	22	33	34	1	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 12	2010	341								c4670	10.1136/bmj.c4670	http://dx.doi.org/10.1136/bmj.c4670			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	663KN	20940218				2022-12-01	WOS:000282886900022
J	Valentine, DL; Kessler, JD; Redmond, MC; Mendes, SD; Heintz, MB; Farwell, C; Hu, L; Kinnaman, FS; Yvon-Lewis, S; Du, MR; Chan, EW; Tigreros, FG; Villanueva, CJ				Valentine, David L.; Kessler, John D.; Redmond, Molly C.; Mendes, Stephanie D.; Heintz, Monica B.; Farwell, Christopher; Hu, Lei; Kinnaman, Franklin S.; Yvon-Lewis, Shari; Du, Mengran; Chan, Eric W.; Tigreros, Fenix Garcia; Villanueva, Christie J.			Propane Respiration Jump-Starts Microbial Response to a Deep Oil Spill	SCIENCE			English	Article							HYDROCARBON DEGRADATION; METHANE OXIDATION; GEN. NOV.; CARBON; PLUME; BACTERIUM; SEDIMENTS; MARGIN	The Deepwater Horizon event resulted in suspension of oil in the Gulf of Mexico water column because the leakage occurred at great depth. The distribution and fate of other abundant hydrocarbon constituents, such as natural gases, are also important in determining the impact of the leakage but are not yet well understood. From 11 to 21 June 2010, we investigated dissolved hydrocarbon gases at depth using chemical and isotopic surveys and on-site biodegradation studies. Propane and ethane were the primary drivers of microbial respiration, accounting for up to 70% of the observed oxygen depletion in fresh plumes. Propane and ethane trapped in the deep water may therefore promote rapid hydrocarbon respiration by low-diversity bacterial blooms, priming bacterial populations for degradation of other hydrocarbons in the aging plume.	[Valentine, David L.; Redmond, Molly C.; Mendes, Stephanie D.; Heintz, Monica B.; Farwell, Christopher; Kinnaman, Franklin S.; Villanueva, Christie J.] Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA; [Valentine, David L.; Redmond, Molly C.; Mendes, Stephanie D.; Heintz, Monica B.; Farwell, Christopher; Kinnaman, Franklin S.; Villanueva, Christie J.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Kessler, John D.; Hu, Lei; Yvon-Lewis, Shari; Du, Mengran; Chan, Eric W.; Tigreros, Fenix Garcia] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Texas A&M University System; Texas A&M University College Station	Valentine, DL (corresponding author), Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA.	valentine@geol.ucsb.edu	Kessler, John/U-6398-2017; Hu, Lei/AAZ-4423-2021; du, mengran/AAO-7295-2021; Yvon-Lewis, Shari/E-4108-2012; Valentine, David/E-5594-2012	Kessler, John/0000-0003-1097-6800; Yvon-Lewis, Shari/0000-0003-1378-8434; du, meng ran/0000-0001-8862-5256; Garcia-Tigreros, Fenix/0000-0001-8694-9046; Redmond, Molly/0000-0003-4227-394X; Valentine, David/0000-0001-5914-9107	National Science Foundation [OCE 1042097, OCE 0961725, OCE 1042650, OCE 0849246]; Department of Energy [DE-NT0005667]; Direct For Education and Human Resources [0929836] Funding Source: National Science Foundation; Division Of Ocean Sciences [0849246] Funding Source: National Science Foundation; Division Of Undergraduate Education [0806926] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Undergraduate Education(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))	This research was supported by the National Science Foundation through awards OCE 1042097 and OCE 0961725 to D. L. V. and OCE 1042650 and OCE 0849246 to J.D.K. and by the Department of Energy through award DE-NT0005667 to D. L. V. We thank the captain and crew of the research vessel Cape Hatteras, R. Stephens Smith, R. Amon, K. Goodman S. Bagby, G. Paradis, A. Best, L. Werra, C. Hansen, L. Sanchez, H. Hill, S. Joye, and the staff at Picarro Inc. for valuable technical assistance and discussions. Sequences are available on GenBank, accession numbers HQ222989 to HQ222996.	Brakstad OG, 2008, MICROB ECOL, V55, P540, DOI 10.1007/s00248-007-9299-x; BROOKS JM, 1975, THESIS TEXAS A M U; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Chen FH, 2004, J MARINE SYST, V45, P189, DOI 10.1016/j.jmarsys.2003.11.005; Chung WK, 2001, APPL ENVIRON MICROB, V67, P5585, DOI 10.1128/AEM.67.12.5585-5592.2001; Dasanayaka LK, 2009, J HYDRO-ENVIRON RES, V2, P243, DOI 10.1016/j.jher.2009.01.004; Department of Epidemiology I, 2010, EHES JOINT ACT PROGR, P31; DYKSTERHOUSE SE, 1995, INT J SYST BACTERIOL, V45, P116, DOI 10.1099/00207713-45-1-116; Geiselbrecht AD, 1998, APPL ENVIRON MICROB, V64, P4703; GELWICKS JT, 1994, APPL ENVIRON MICROB, V60, P467, DOI 10.1128/AEM.60.2.467-472.1994; GELWICKS JT, 1989, ORG GEOCHEM, V14, P441, DOI 10.1016/0146-6380(89)90009-0; Grant NJ, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001851; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Hedlund BP, 1999, APPL ENVIRON MICROB, V65, P251; Kinnaman FS, 2007, GEOCHIM COSMOCHIM AC, V71, P271, DOI 10.1016/j.gca.2006.09.007; Maruyama A, 2003, MICROBIAL ECOL, V46, P442, DOI 10.1007/s00248-002-3010-z; Mastalerz V, 2009, GEOCHIM COSMOCHIM AC, V73, P3849, DOI 10.1016/j.gca.2008.12.030; Mau S, 2006, MAR GEOL, V225, P129, DOI 10.1016/j.margeo.2005.09.007; Mau S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031344; Redmond MC, 2010, APPL ENVIRON MICROB, V76, P6412, DOI 10.1128/AEM.00271-10; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; Schrope M, 2010, NATURE, V465, P274, DOI 10.1038/465274a; U. S. Geological Survey, 2010, DEEPW HOR MC252 GULF; Valentine DL, 2010, NATURE, V465, P421, DOI 10.1038/465421a; Valentine DL, 2001, GEOCHIM COSMOCHIM AC, V65, P2633, DOI 10.1016/S0016-7037(01)00625-1; YAPA PD, 2008, OCEANS, V1, P109	26	320	330	8	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					208	211		10.1126/science.1196830	http://dx.doi.org/10.1126/science.1196830			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20847236				2022-12-01	WOS:000282644600038
J	DeKosky, ST; Ikonomovic, MD; Gandy, S				DeKosky, Steven T.; Ikonomovic, Milos D.; Gandy, Sam			Traumatic Brain Injury -- Football, Warfare, and Long-Term Effects.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[DeKosky, Steven T.] Univ Virginia, Sch Med, Dept Neurol, Charlottesville, VA 22908 USA; [Ikonomovic, Milos D.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Ikonomovic, Milos D.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15261 USA; [Ikonomovic, Milos D.] VA Pittsburgh Healthcare Syst, Geriatr Res Edu & Clin Ctr, Pittsburgh, PA USA; [Gandy, Sam] Mt Sinai Sch Med, Dept Neurol, New York, NY USA; [Gandy, Sam] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Gandy, Sam] Mt Sinai Sch Med, Alzheimers Dis Res Ctr, New York, NY USA; [Gandy, Sam] James J Peters VA Med Ctr, New York, NY USA	University of Virginia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	DeKosky, ST (corresponding author), Univ Virginia, Sch Med, Dept Neurol, Charlottesville, VA 22908 USA.			DeKosky, Steven/0000-0003-3743-2758	NIA NIH HHS [P01 AG010491-14, P01 AG010491] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG010491] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abrahamson EE, 2009, ANN NEUROL, V66, P407, DOI 10.1002/ana.21731; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED	5	233	236	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2010	363	14					1293	1296		10.1056/NEJMp1007051	http://dx.doi.org/10.1056/NEJMp1007051			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	655TD	20879875				2022-12-01	WOS:000282271500001
J	Charlot, M; Ahlehoff, O; Norgaard, ML; Jorgensen, CH; Sorensen, R; Abildstrom, SZ; Hansen, PR; Madsen, JK; Kober, L; Torp-Pedersen, C; Gislason, G				Charlot, Mette; Ahlehoff, Ole; Norgaard, Mette Lykke; Jorgensen, Casper H.; Sorensen, Rikke; Abildstrom, Steen Z.; Hansen, Peter Riis; Madsen, Jan Kyst; Kober, Lars; Torp-Pedersen, Christian; Gislason, Gunnar			Proton-Pump Inhibitors Are Associated With Increased Cardiovascular Risk Independent of Clopidogrel Use A Nationwide Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ANTIPLATELET THERAPY; MORTALITY; VALIDITY; ASPIRIN	Background: Controversy remains on whether the dual use of clopidogrel and proton-pump inhibitors (PPIs) affects clinical efficacy of clopidogrel. Objective: To examine the risk for adverse cardiovascular outcomes related to concomitant use of PPIs and clopidogrel compared with that of PPIs alone in adults hospitalized for myocardial infarction. Design: A nationwide cohort study based on linked administrative registry data. Setting: All hospitals in Denmark. Patients: All patients discharged after first-time myocardial infarction from 2000 to 2006. Measurements: The primary outcome was a composite of re-hospitalization for myocardial infarction or stroke or cardiovascular death. Patients were examined at several assembly time points, including 7, 14, 21, and 30 days after myocardial infarction. Follow-up was 1 year. Results: Of 56 406 included patients, 9137 (16.2%) were re-hospitalized for myocardial infarction or stroke or experienced cardiovascular death. Of the 24 702 patients (43.8%) who received clopidogrel, 6753 (27.3%) received concomitant PPIs. The hazard ratio for cardiovascular death or rehospitalization for myocardial infarction or stroke for concomitant use of a PPI and clopidogrel among the cohort assembled at day 30 after discharge was 1.29 (95% CI, 1.17 to 1.42). The corresponding ratio for use of a PPI in patients who did not receive clopidogrel was 1.29 (CI, 1.21 to 1.37). No statistically significant interaction occurred between a PPI and clopidogrel (P = 0.72). Limitations: Unmeasured and residual confounding, time-varying measurement errors of exposure, and biases from survival effects were possible. Conclusion: Proton-pump inhibitors seem to be associated with increased risk for adverse cardiovascular outcomes after discharge, regardless of clopidogrel use for myocardial infarction. Dual PPI and clopidogrel use was not associated with any additional risk for adverse cardiovascular events over that observed for patients prescribed a PPI alone.	[Charlot, Mette] Univ So Denmark, Copenhagen, Denmark; [Charlot, Mette] Copenhagen Univ Hosp Rigshosp, Copenhagen, Denmark	University of Southern Denmark; Rigshospitalet; University of Copenhagen	Charlot, M (corresponding author), Copenhagen Univ Hosp Gentofte, Dept Cardiol, Natl Inst Publ Hlth, Post 67,Niels Andersens Vej 65, DK-2900 Hellerup, Denmark.	mc@heart.dk	Hansen, Peter Riis/AAR-7659-2020; Torp-Pedersen, Christian/E-5931-2013; Gislason, Gunnar/B-7561-2009	Gislason, Gunnar/0000-0002-0548-402X; Kober, Lars/0000-0002-6635-1466; Hansen, Peter Riis/0000-0002-9056-535X; Sorensen, Rikke/0000-0001-9238-6681	Danish Medical Research Council [271-06-0572]; Danish Heart Foundation [10-04-R78-A2865-22586]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Heart Foundation	By the Danish Medical Research Council (grant 271-06-0572) and the Danish Heart Foundation (grant 10-04-R78-A2865-22586).	Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; BHATT DL, 2010, PROSPECTIVE RANDOMIZ; Dunn SP, 2008, CIRCULATION, V118, pS815; *EUR MED AG, 2010, PUBL STAT POSS INT; Gaist D, 1997, DAN MED BULL, V44, P445; Gilard M, 2006, J THROMB HAEMOST, V4, P2508, DOI 10.1111/j.1538-7836.2006.02162.x; Gilard M, 2008, J AM COLL CARDIOL, V51, P256, DOI 10.1016/j.jacc.2007.06.064; Gislason GH, 2006, CIRCULATION, V113, P2906, DOI 10.1161/CIRCULATIONAHA.106.616219; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; Ishizaki T, 1999, ALIMENT PHARM THERAP, V13, P27; JUURLINK DN, 2009, JAMA PMID, V301, P937; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; O'Donoghue ML, 2009, LANCET, V374, P989, DOI 10.1016/S0140-6736(09)61525-7; Rasmussen S, 2005, MED CARE, V43, P970, DOI 10.1097/01.mlr.0000178195.07110.d3; Rassen JA, 2009, CIRCULATION, V120, P2322, DOI 10.1161/CIRCULATIONAHA.109.873497; Ray WA, 2010, ANN INTERN MED, V152, P337, DOI 10.7326/0003-4819-152-6-201003160-00003; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Sorensen R, 2008, BRIT J CLIN PHARMACO, V66, P875, DOI 10.1111/j.1365-2125.2008.03284.x; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Tu JV, 2001, J AM COLL CARDIOL, V37, P992, DOI 10.1016/S0735-1097(01)01109-3; *US FDA, 2010, EARL COMM ONG SAF RE; Varenhorst C, 2009, EUR HEART J, V30, P1744, DOI 10.1093/eurheartj/ehp157; Yasuda H, 2009, INTERNAL MED, V48, P1725, DOI 10.2169/internalmedicine.48.2031; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Zuern CS, 2010, THROMB RES, V125, pE51, DOI 10.1016/j.thromres.2009.08.016	27	207	214	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 21	2010	153	6					378	386		10.7326/0003-4819-153-6-201009210-00005	http://dx.doi.org/10.7326/0003-4819-153-6-201009210-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	652WY	20855802				2022-12-01	WOS:000282043100004
J	Pelliccia, A; Corrado, D				Pelliccia, Antonio; Corrado, Domenico			Can electrocardiographic screening prevent sudden death in athletes? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							CONSENSUS STATEMENT; OF-CARDIOLOGY; CARDIAC DEATH; PROGRAM		[Pelliccia, Antonio] Italian Natl Olymp Comm, Inst Sports Med & Sci, I-00197 Rome, Italy; [Corrado, Domenico] Univ Padua, Sch Med, Dept Cardiac Thorac & Vasc Sci, I-35128 Padua, Italy	University of Padua	Pelliccia, A (corresponding author), Italian Natl Olymp Comm, Inst Sports Med & Sci, Largo Piero Gabrielli, 1, I-00197 Rome, Italy.	ant.pelliccia@libero.it		CORRADO, DOMENICO/0000-0003-1487-0392				Baggish AL, 2010, ANN INTERN MED, V152, P269, DOI 10.7326/0003-4819-152-5-201003020-00004; Corrado D, 2005, EUR HEART J, V26, P516, DOI 10.1093/eurheartj/ehi108; Corrado D, 2006, JAMA-J AM MED ASSOC, V296, P1593, DOI 10.1001/jama.296.13.1593; Corrado D, 2008, J AM COLL CARDIOL, V52, P1981, DOI 10.1016/j.jacc.2008.06.053; Lawless CE, 2008, MED SCI SPORT EXER, V40, P787, DOI 10.1249/MSS.0b013e318164dd18; Ljungqvist A, 2009, BRIT J SPORT MED, V43, P631, DOI 10.1136/bjsm.2009.064394; Maron BJ, 2007, CIRCULATION, V115, P1643, DOI 10.1161/CIRCULATIONAHA.107.181423; Pelliccia A, 2007, EUR HEART J, V28, P2703, DOI 10.1093/eurheartj/ehm455; Pelliccia A, 2006, EUR HEART J, V27, P2196, DOI 10.1093/eurheartj/ehl137; Wheeler MT, 2010, ANN INTERN MED, V152, P276, DOI 10.7326/0003-4819-152-5-201003020-00005	10	17	18	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 14	2010	341								c4923	10.1136/bmj.c4923	http://dx.doi.org/10.1136/bmj.c4923			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	653LK	20841394				2022-12-01	WOS:000282092600003
J	Kertesz, M; Wan, Y; Mazor, E; Rinn, JL; Nutter, RC; Chang, HY; Segal, E				Kertesz, Michael; Wan, Yue; Mazor, Elad; Rinn, John L.; Nutter, Robert C.; Chang, Howard Y.; Segal, Eran			Genome-wide measurement of RNA secondary structure in yeast	NATURE			English	Article							MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; TRANSLATION; SITE; PREDICTION; TRANSPORT; ELEMENTS	The structures of RNA molecules are often important for their function and regulation(1-6), yet there are no experimental techniques for genome-scale measurement of RNA structure. Here we describe a novel strategy termed parallel analysis of RNA structure (PARS), which is based on deep sequencing fragments of RNAs that were treated with structure-specific enzymes, thus providing simultaneous in vitro profiling of the secondary structure of thousands of RNA species at single nucleotide resolution. We apply PARS to profile the secondary structure of the messenger RNAs (mRNAs) of the budding yeast Saccharomyces cerevisiae and obtain structural profiles for over 3,000 distinct transcripts. Analysis of these profiles reveals several RNA structural properties of yeast transcripts, including the existence of more secondary structure over coding regions compared with untranslated regions, a three-nucleotide periodicity of secondary structure across coding regions and an anti-correlation between the efficiency with which an mRNA is translated and the structure over its translation start site. PARS is readily applicable to other organisms and to profiling RNA structure in diverse conditions, thus enabling studies of the dynamics of secondary structure at a genomic scale.	[Wan, Yue; Chang, Howard Y.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Program Epithelial Biol, Stanford, CA 94305 USA; [Kertesz, Michael; Mazor, Elad; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Rinn, John L.] Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; [Rinn, John L.] MIT, Cambridge, MA 02142 USA; [Nutter, Robert C.] Life Technol, Foster City, CA 94404 USA; [Segal, Eran] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Howard Hughes Medical Institute; Stanford University; Weizmann Institute of Science; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Thermo Fisher Scientific; Weizmann Institute of Science	Chang, HY (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Program Epithelial Biol, Stanford, CA 94305 USA.	howchang@stanford.edu; eran@weizmann.ac.il	Segal, Eran/AAF-4855-2019	Segal, Eran/0000-0002-6859-1164; Rinn, John/0000-0002-7231-7539	National Institutes of Health [RO1HG004361]; Agency of Science, Technology and Research of Singapore; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004361] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency of Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank D. Herschlag's group, A. Adler, A. Fire, M. Kay, the Life Technologies SOLiD team, M. Rabani, G. Sherlock and A. Weinberger for assistance and critiques. This work was supported by a National Institutes of Health grant (RO1HG004361). Y.W. is funded by the Agency of Science, Technology and Research of Singapore. H.Y.C. is an Early Career Scientist of the Howard Hughes Medical Institute. E. S. is the incumbent of the Soretta and Henry Shapiro career development chair.	Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Chartrand P, 2002, MOL CELL, V10, P1319, DOI 10.1016/S1097-2765(02)00694-9; Guo F, 2004, MOL CELL, V16, P351, DOI 10.1016/j.molcel.2004.10.003; Hofacker IL, 2002, J MOL BIOL, V319, P1059, DOI 10.1016/S0022-2836(02)00308-X; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Palazzo AF, 2007, PLOS BIOL, V5, P2862, DOI 10.1371/journal.pbio.0050322; Reineke LC, 2008, J BIOL CHEM, V283, P19011, DOI 10.1074/jbc.M803109200; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Shabalina SA, 2006, NUCLEIC ACIDS RES, V34, P2428, DOI 10.1093/nar/gkl287; Shepard KA, 2003, P NATL ACAD SCI USA, V100, P11429, DOI 10.1073/pnas.2033246100; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Tucker BJ, 2005, CURR OPIN STRUC BIOL, V15, P342, DOI 10.1016/j.sbi.2005.05.003; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Ziehler W A, 2001, Curr Protoc Nucleic Acid Chem, VChapter 6, DOI 10.1002/0471142700.nc0601s00	20	537	563	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 2	2010	467	7311					103	107		10.1038/nature09322	http://dx.doi.org/10.1038/nature09322			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645MB	20811459	Green Accepted			2022-12-01	WOS:000281461200044
J	Piao, SL; Ciais, P; Huang, Y; Shen, ZH; Peng, SS; Li, JS; Zhou, LP; Liu, HY; Ma, YC; Ding, YH; Friedlingstein, P; Liu, CZ; Tan, K; Yu, YQ; Zhang, TY; Fang, JY				Piao, Shilong; Ciais, Philippe; Huang, Yao; Shen, Zehao; Peng, Shushi; Li, Junsheng; Zhou, Liping; Liu, Hongyan; Ma, Yuecun; Ding, Yihui; Friedlingstein, Pierre; Liu, Chunzhen; Tan, Kun; Yu, Yongqiang; Zhang, Tianyi; Fang, Jingyun			The impacts of climate change on water resources and agriculture in China	NATURE			English	Review							YANGTZE-RIVER BASIN; YELLOW-RIVER; FUTURE CLIMATE; WINTER-WHEAT; ELEVATED CO2; CARBON-DIOXIDE; SPRING WHEAT; CROP YIELD; TRENDS; PRECIPITATION	China is the world's most populous country and a major emitter of greenhouse gases. Consequently, much research has focused on China's influence on climate change but somewhat less has been written about the impact of climate change on China. China experienced explosive economic growth in recent decades, but with only 7% of the world's arable land available to feed 22% of the world's population, China's economy may be vulnerable to climate change itself. We find, however, that notwithstanding the clear warming that has occurred in China in recent decades, current understanding does not allow a clear assessment of the impact of anthropogenic climate change on China's water resources and agriculture and therefore China's ability to feed its people. To reach a more definitive conclusion, future work must improve regional climate simulations-especially of precipitation-and develop a better understanding of the managed and unmanaged responses of crops to changes in climate, diseases, pests and atmospheric constituents.	[Piao, Shilong; Shen, Zehao; Peng, Shushi; Zhou, Liping; Liu, Hongyan; Ma, Yuecun; Tan, Kun; Fang, Jingyun] Peking Univ, Minist Educ, Key Lab Earth Surface Proc, Coll Urban & Environm Sci,Dept Geog,Dept Ecol, Beijing 100871, Peoples R China; [Piao, Shilong; Shen, Zehao; Peng, Shushi; Zhou, Liping; Liu, Hongyan; Ma, Yuecun; Tan, Kun; Fang, Jingyun] Peking Univ, Ctr Climate Res, Beijing 100871, Peoples R China; [Ciais, Philippe; Friedlingstein, Pierre] UMR CEA CNRS UVSQ, Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France; [Huang, Yao; Yu, Yongqiang; Zhang, Tianyi] Chinese Acad Sci, Inst Atmospher Phys, State Key Lab Atmospher Boundary Layer Phys & Atm, Beijing 100029, Peoples R China; [Li, Junsheng] Chinese Res Inst Environm Sci, Beijing 100012, Peoples R China; [Ding, Yihui] China Meteorol Adm, Natl Climate Ctr, Lab Climate Studies, Beijing 100081, Peoples R China; [Friedlingstein, Pierre] Univ Bristol, Dept Earth Sci, QUEST, Bristol BS8 1RJ, Avon, England; [Liu, Chunzhen] China Water Informat Ctr, Hydrol Bur, Beijing 100053, Peoples R China	Peking University; Peking University; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; Chinese Research Academy of Environmental Sciences; China Meteorological Administration; University of Bristol	Piao, SL (corresponding author), Peking Univ, Minist Educ, Key Lab Earth Surface Proc, Coll Urban & Environm Sci,Dept Geog,Dept Ecol, Beijing 100871, Peoples R China.	slpiao@pku.edu.cn	Huang, Yao/O-6832-2014; Shen, Zehao/GQI-1121-2022; Friedlingstein, Pierre/H-2700-2014; huang, yao/GWR-5388-2022; Peng, Shushi/J-4779-2014; LAPC, IAP/AAI-6991-2020; PENG, Shushi/AAS-2603-2020; Ciais, Philippe M/A-6840-2011; Huang, Yao/GQH-3308-2022; Zhang, Tianyi/AAJ-6909-2020; Yu, Yongqiang/C-9661-2011	Friedlingstein, Pierre/0000-0003-3309-4739; Peng, Shushi/0000-0001-5098-726X; LAPC, IAP/0000-0002-0025-3484; PENG, Shushi/0000-0001-5098-726X; Ciais, Philippe M/0000-0001-8560-4943; Huang, Yao/0000-0002-0192-1421; Zhang, Tianyi/0000-0002-9266-6082; Yu, Yongqiang/0000-0002-9345-2211	National Natural Science Foundation of China [30970511, 90711002, 30721140306, 40638039]; Chinese Academy of Sciences [KZCX2-YW-305]; National Basic Research Program of China [2004CB720207]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [FANEDD-200737]; NERC [quest010001] Funding Source: UKRI; Natural Environment Research Council [quest010001] Funding Source: researchfish	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank X. L. Yang and G. N. Liu for detailed and constructive comments. We thank J. H. Gash, M. Minnock and C. Koven for English language editing. We also thank Y. Li and Y. Kuang for providing photos of glacier retreat between 1985 and 2005 at Mt Anyemaqen, Qinghai. This study was supported by the National Natural Science Foundation of China (30970511, 90711002, 30721140306 and 40638039), the Knowledge Innovation Program of the Chinese Academy of Sciences (KZCX2-YW-305), the National Basic Research Program of China (2004CB720207) and the Foundation for the Author of National Excellent Doctoral Dissertation of PR China (FANEDD-200737).	[Anonymous], 2000, SPECIAL REPORT EMISS; Arnell NW, 2004, GLOBAL ENVIRON CHANG, V14, P31, DOI 10.1016/j.gloenvcha.2003.10.006; Baker JT, 2004, AGR FOREST METEOROL, V122, P129, DOI 10.1016/j.agrformet.2003.09.012; Bannayan M, 2005, FIELD CROP RES, V93, P237, DOI 10.1016/j.fcr.2004.10.003; Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; Becker S, 2008, INT J CLIMATOL, V28, P579, DOI 10.1002/joc.1572; Chavas DR, 2009, AGR FOREST METEOROL, V149, P1118, DOI 10.1016/j.agrformet.2009.02.001; CHEN SD, 2003, 50 YEARS PLANT PROTE; CHEN YY, 2005, CLIMATE ENV CHANGES; [初子莹 CHU ZiYing], 2005, [气候与环境研究, Climatic and environmental research], V10, P826; Ci L.-J., 1997, J DESERT RES, V17, P107; Dai A, 2004, J HYDROMETEOROL, V5, P1117, DOI 10.1175/JHM-386.1; Ding Y., 2005, CHANGES CLIMATE ENV, V1, P398; Ding YH, 2008, INT J CLIMATOL, V28, P1139, DOI 10.1002/joc.1615; Ding YH, 2007, ADV ATMOS SCI, V24, P954, DOI 10.1007/s00376-007-0954-4; Ding YJ, 2006, ANN GLACIOL-SER, V43, P97, DOI 10.3189/172756406781812005; [段建平 DUAN Jianping], 2009, [地理科学进展, Progress in Geography], V28, P231; *ED BOARD, 2007, CHIN NAT ASS REP CLI; Fu GB, 2004, CLIMATIC CHANGE, V65, P149, DOI 10.1023/B:CLIM.0000037491.95395.bb; Fuhrer J, 2003, AGR ECOSYST ENVIRON, V97, P1, DOI 10.1016/S0167-8809(03)00125-7; Gao X, 2008, METEOROL ATMOS PHYS, V100, P73, DOI 10.1007/s00703-008-0296-5; Ge QS, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041281; Gemmer M, 2008, QUATERN INT, V186, P12, DOI 10.1016/j.quaint.2007.10.001; Gong DY, 2004, THEOR APPL CLIMATOL, V77, P25, DOI 10.1007/s00704-003-0019-2; Hao XM, 2008, WATER RESOUR MANAG, V22, P1159, DOI 10.1007/s11269-007-9218-4; Hu ZZ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003651; Huang JK, 2002, SCIENCE, V295, P674, DOI 10.1126/science.1067226; Huang Y, 2007, ECOL APPL, V17, P692, DOI 10.1890/05-1792; Jiang T, 2007, GEOMORPHOLOGY, V85, P143, DOI 10.1016/j.geomorph.2006.03.015; Zhang JL, 2007, PROCEEDINGS OF THE FIRST INTERNATIONAL SYMPOSIUM ON DATA, PRIVACY, AND E-COMMERCE, P138, DOI 10.1109/ISDPE.2007.53; Kang E.S., 2000, GLACIERS THEIR ENV S, P190; Li WL, 2007, AGR WATER MANAGE, V87, P106, DOI 10.1016/j.agwat.2006.06.027; Li X, 2008, GLOBAL PLANET CHANGE, V62, P210, DOI 10.1016/j.gloplacha.2008.02.001; [李忠勤 LI Zhongqin], 2007, [冰川冻土, Journal of Glaciology and Geocryology], V29, P333; LI ZX, 2009, QUATERN INT, DOI DOI 10.1016/J.QUAINT.2009.05.010; LI ZX, 2007, HYDROL EARTH SYST SC, V4, P3395; LIN E, 2007, ADV CLIM CHANG RES, V3, P6; Lin ED, 2005, PHILOS T R SOC B, V360, P2149, DOI 10.1098/rstb.2005.1743; [刘时银 Liu Shiyin], 2006, [第四纪研究, Quaternary Sciences], V26, P762; Liu SY, 2009, J GLACIOL, V55, P353, DOI 10.3189/002214309788608778; Liu YA, 2010, GLOBAL CHANGE BIOL, V16, P2287, DOI 10.1111/j.1365-2486.2009.02077.x; Long SP, 2005, PHILOS T R SOC B, V360, P2011, DOI 10.1098/rstb.2005.1749; Longo F, 2006, ANN ONCOL, V17, P74; LU AG, 2005, CHINA J MOUNT SCI, V2, P313; Ma HL, 2007, PLANT SOIL, V294, P137, DOI 10.1007/s11104-007-9241-5; Ma ZG, 2005, CHINESE J GEOPHYS-CH, V48, P1270; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; *MIN WAT RES PEOPL, 2007, B WAT RES CHIN; *NAT BUR STAT CHIN, 2009, CHIN STAT YB 2009, P38; National Development and Reform Commission P. R. China, 2007, CHIN NAT CLIM CHANG; Piao SL, 2006, GLOBAL CHANGE BIOL, V12, P672, DOI 10.1111/j.1365-2486.2006.01123.x; Qian WH, 2004, CLIM RES, V27, P119, DOI 10.3354/cr027119; [秦年秀 Qin Nianxiu], 2005, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V14, P589; REN G, 2004, CLIMATE CHANGE YANGT; REN GY, 2007, CLIMATE CHANGE CHINA; *RUR SOC SURV ORG, 2009, NAT BUR STAT CHIN AG; Sakai H, 2006, NEW PHYTOL, V170, P321, DOI 10.1111/j.1469-8137.2006.01688.x; Seneviratne SI, 2006, NATURE, V443, P205, DOI 10.1038/nature05095; [沈永平 Shen Yongping], 2003, [冰川冻土, Journal of Glaciology and Geocryology], V25, P124; Shen YP, 2006, ADV CLIM CHANG RES, V2, P32; Shi Y., 2001, J GLACIOL GEOCRYOL, V23, P333, DOI DOI 10.3969/J.ISSN.1000-0240.2001.04.001; Shi YF, 2007, CLIMATIC CHANGE, V80, P379, DOI 10.1007/s10584-006-9121-7; Shi YF, 2000, CHINESE SCI BULL, V45, P668, DOI 10.1007/BF02886048; Solomon S, 2009, P NATL ACAD SCI USA, V106, P1704, DOI 10.1073/pnas.0812721106; State Council Information Office, 2008, CHIN POL ACT CLIM CH; Tao F, 2008, AGR FOREST METEOROL, V148, P94, DOI 10.1016/j.agrformet.2007.09.012; Tao FL, 2008, CLIM RES, V38, P83, DOI 10.3354/cr00771; Tao H, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006186; Thomas A, 2000, AGR FOREST METEOROL, V102, P71, DOI 10.1016/S0168-1923(00)00126-X; Thomas A, 2008, GLOBAL PLANET CHANGE, V60, P306, DOI 10.1016/j.gloplacha.2007.03.009; Wang FH, 2009, FIELD CROP RES, V111, P181, DOI 10.1016/j.fcr.2008.12.004; Wang GL, 2005, CLIM DYNAM, V25, P739, DOI 10.1007/s00382-005-0057-9; Wang HL, 2008, AGR FOREST METEOROL, V148, P1242, DOI 10.1016/j.agrformet.2008.03.003; Wang JX, 2009, AGR ECON-BLACKWELL, V40, P323, DOI 10.1111/j.1574-0862.2009.00379.x; Wang XP, 2004, ATMOS ENVIRON, V38, P4383, DOI 10.1016/j.atmosenv.2004.03.067; [王瑗 WANG Yuan], 2008, [水资源与水工程学报, Journal of Water Resources and Water Engineering], V19, P10; Wei K, 2009, ATMOS OCEAN SCI LETT, V2, P153, DOI 10.1080/16742834.2009.11446795; Wentz FJ, 2007, SCIENCE, V317, P233, DOI 10.1126/science.1140746; Xiao JF, 2009, EARTH INTERACT, V13, DOI 10.1175/2009EI275.1; [谢自楚 XIE Zichu], 2006, [冰川冻土, Journal of Glaciology and Geocryology], V28, P457; Xiong W, 2008, IMPACTS CLIMATE CHAN; Xiong W, 2010, AGR ECOSYST ENVIRON, V135, P58, DOI 10.1016/j.agee.2009.08.015; Xu JJ, 2008, QUATERN INT, V186, P32, DOI 10.1016/j.quaint.2007.10.014; Yang W, 2008, CHINESE SCI BULL, V53, P2547, DOI 10.1007/s11434-008-0288-3; Yang XL, 2006, FRONT ECOL ENVIRON, V4, P362, DOI 10.1890/1540-9295(2006)004[0362:ICWA]2.0.CO;2; Yao T, 2007, ARCT ANTARCT ALP RES, V39, P642, DOI 10.1657/1523-0430(07-510)[YAO]2.0.CO;2; You LZ, 2009, AGR FOREST METEOROL, V149, P1009, DOI 10.1016/j.agrformet.2008.12.004; [翟建青 Zhai Jianqing], 2009, [气候变化研究进展, Advances in Climate Change Research], V5, P220; Zhai JQ, 2010, J CLIMATE, V23, P649, DOI 10.1175/2009JCLI2968.1; Zhai P -M, 2005, ADV CLIM CHANG RES, V1, P16, DOI [10.3969/j.issn.1673-1719.2005.01.004, DOI 10.3969/J.ISSN.1673-1719.2005.01.004]; Zhai PM, 2005, J CLIMATE, V18, P1096, DOI 10.1175/JCLI-3318.1; Zhai PM, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018004; Zhang GH, 2007, T ASABE, V50, P911, DOI 10.13031/2013.23155; Zhang Q, 2009, WATER RESOUR MANAG, V23, P1157, DOI 10.1007/s11269-008-9320-2; Zhang Y, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027229; Zhou Y, 2007, CROP SCI, V47, P245, DOI 10.2135/cropsci2006.03.0175; Ziska LH, 2008, FIELD CROP RES, V108, P54, DOI 10.1016/j.fcr.2008.03.006; Zong YQ, 2000, NAT HAZARDS, V22, P165, DOI 10.1023/A:1008119805106	98	2102	2384	236	3119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2010	467	7311					43	51		10.1038/nature09364	http://dx.doi.org/10.1038/nature09364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645MB	20811450				2022-12-01	WOS:000281461200032
J	Schaller, V; Weber, C; Semmrich, C; Frey, E; Bausch, AR				Schaller, Volker; Weber, Christoph; Semmrich, Christine; Frey, Erwin; Bausch, Andreas R.			Polar patterns of driven filaments	NATURE			English	Article							SELF-ORGANIZATION; ACTIVE GELS; MOTORS; HYDRODYNAMICS; MICROTUBULES; VORTICES; DYNAMICS	The emergence of collective motion exhibited by systems ranging from flocks of animals to self-propelled microorganisms to the cytoskeleton is a ubiquitous and fascinating self-organization phenomenon(1-12). Similarities between these systems, such as the inherent polarity of the constituents, a density-dependent transition to ordered phases or the existence of very large density fluctuations(13-16), suggest universal principles underlying pattern formation. This idea is followed by theoretical models at all levels of description: micro-or mesoscopic models directly map local forces and interactions using only a few, preferably simple, interaction rules(12,17-21), and more macroscopic approaches in the hydrodynamic limit rely on the systems' generic symmetries(8,22,23). All these models characteristically have a broad parameter space with a manifold of possible patterns, most of which have not yet been experimentally verified. The complexity of interactions and the limited parameter control of existing experimental systems are major obstacles to our understanding of the underlying ordering principles(13). Here we demonstrate the emergence of collective motion in a high-density motility assay that consists of highly concentrated actin filaments propelled by immobilized molecular motors in a planar geometry. Above a critical density, the filaments self-organize to form coherently moving structures with persistent density modulations, such as clusters, swirls and interconnected bands. These polar nematic structures are long lived and can span length scales orders of magnitudes larger than their constituents. Our experimental approach, which offers control of all relevant system parameters, complemented by agent-based simulations, allows backtracking of the assembly and disassembly pathways to the underlying local interactions. We identify weak and local alignment interactions to be essential for the observed formation of patterns and their dynamics. The presented minimal polar-pattern-forming system may thus provide new insight into emerging order in the broad class of active fluids(8,23,24) and self-propelled particles(17,25)	[Schaller, Volker; Semmrich, Christine; Bausch, Andreas R.] Tech Univ Munich, Lehrstuhl Biophy E27, D-85748 Garching, Germany; [Weber, Christoph; Frey, Erwin] Univ Munich, Dept Phys, Arnold Sommerfeld Ctr Theoret Phys, D-80333 Munich, Germany; [Weber, Christoph; Frey, Erwin] Univ Munich, Dept Phys, CENS, D-80333 Munich, Germany	Technical University of Munich; University of Munich; University of Munich	Bausch, AR (corresponding author), Tech Univ Munich, Lehrstuhl Biophy E27, D-85748 Garching, Germany.	abausch@ph.tum.de	Frey, Erwin/M-2613-2017	Frey, Erwin/0000-0001-8792-3358	DFG [SFB 863]; German Excellence Initiatives via the 'Nano-Initiative Munich (NIM)'; Technische Universitat Munchen - Institute for Advanced Study; Elite Network of Bavaria	DFG(German Research Foundation (DFG)); German Excellence Initiatives via the 'Nano-Initiative Munich (NIM)'; Technische Universitat Munchen - Institute for Advanced Study; Elite Network of Bavaria	We thank A. Baskaran and C. Marchetti for discussions. Financial support from the DFG in the framework of the SFB 863 and the German Excellence Initiatives via the 'Nano-Initiative Munich (NIM)' and the Technische Universitat Munchen - Institute for Advanced Study is gratefully acknowledged. V. S. and C. W. acknowledge support from the Elite Network of Bavaria by the graduate programmes CompInt and NanoBioTechnology.	Aranson IS, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.050901; Backouche F, 2006, PHYS BIOL, V3, P264, DOI 10.1088/1478-3975/3/4/004; Baskaran A, 2009, P NATL ACAD SCI USA, V106, P15567, DOI 10.1073/pnas.0906586106; Baskaran A, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011920; Baskaran A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.268101; Chate H, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.046113; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Czirok A, 1996, PHYS REV E, V54, P1791, DOI 10.1103/PhysRevE.54.1791; Dombrowski C, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098103; Fulga F, 2009, INTEGR BIOL-UK, V1, P150, DOI 10.1039/b814985b; Ginelli F, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.184502; Grossman D, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/2/023036; Joanny JF, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/422; Julicher F, 2007, PHYS REP, V449, P3, DOI 10.1016/j.physrep.2007.02.018; Karsenti E, 2008, NAT REV MOL CELL BIO, V9, P255, DOI 10.1038/nrm2357; Kraikivski P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.258103; Kruse K, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.078101; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Mishra S, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.061916; Narayan V, 2007, SCIENCE, V317, P105, DOI 10.1126/science.1140414; Nedelec FJ, 1997, NATURE, V389, P305, DOI 10.1038/38532; Riedel IH, 2005, SCIENCE, V309, P300, DOI 10.1126/science.1110329; SHEETZ MP, 1984, J CELL BIOL, V99, P1867, DOI 10.1083/jcb.99.5.1867; Simha RA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.058101; Surrey T, 2001, SCIENCE, V292, P1167, DOI 10.1126/science.1059758; Toner J, 2005, ANN PHYS-NEW YORK, V318, P170, DOI 10.1016/j.aop.2005.04.011; van den Heuvel MGL, 2007, SCIENCE, V317, P333, DOI 10.1126/science.1139570; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226	28	545	547	6	193	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 2	2010	467	7311					73	77		10.1038/nature09312	http://dx.doi.org/10.1038/nature09312			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645MB	20811454				2022-12-01	WOS:000281461200037
J	Moynihan, R				Moynihan, Ray			Prediseases Who benefits from treating prehypertension?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Moynihan, Ray] Univ Newcastle, Newcastle, NSW 2300, Australia	University of Newcastle	Moynihan, R (corresponding author), Univ Newcastle, Newcastle, NSW 2300, Australia.	ray.moynihan@newcastle.edu.au	Moynihan, Ray/ABC-3010-2020					*AM SOC HYP, 1986, 2010 ANN SCI M EXP 2; ARMSTRONG D, 1995, SOCIOL HEALTH ILL, V17, P393, DOI 10.1111/1467-9566.ep10933329; BARKIS G, J CLIN HYPE IN PRESS; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Julius S, 2006, NEW ENGL J MED, V354, P1685, DOI 10.1056/NEJMoa060838; Meltzer JI, 2006, AM J HYPERTENS, V19, P1098, DOI 10.1016/j.amjhyper.2006.09.014; *NAT HEART LUNG BL, 7 JOINT NAT COMM PRE; *PREH CARD SYNDR I, 2010, SPONS EXH PROSP	8	12	12	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 24	2010	341								c4442	10.1136/bmj.c4442	http://dx.doi.org/10.1136/bmj.c4442			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	645IG	20736255				2022-12-01	WOS:000281445900025
J	Srikanth, CV; Wall, DM; Maldonado-Contreras, A; Shi, HN; Zhou, DG; Demma, Z; Mumy, KL; McCormick, BA				Srikanth, C. V.; Wall, Daniel M.; Maldonado-Contreras, Ana; Shi, Hai Ning; Zhou, Daoguo; Demma, Zachary; Mumy, Karen L.; McCormick, Beth A.			Salmonella Pathogenesis and Processing of Secreted Effectors by Caspase-3	SCIENCE			English	Article							EPITHELIAL-CELLS; TYPHIMURIUM; PROTEIN; INVASION; ACTIN; IDENTIFICATION; FILAMENTS; ABILITY; GROWTH; DOMAIN	The enteric pathogen Salmonella enterica serovar Typhimurium causes food poisoning resulting in gastroenteritis. The S. Typhimurium effector Salmonella invasion protein A (SipA) promotes gastroenteritis by functional motifs that trigger either mechanisms of inflammation or bacterial entry. During infection of intestinal epithelial cells, SipA was found to be responsible for the early activation of caspase-3, an enzyme that is required for SipA cleavage at a specific recognition motif that divided the protein into its two functional domains and activated SipA in a manner necessary for pathogenicity. Other caspase-3 cleavage sites identified in S. Typhimurium appeared to be restricted to secreted effector proteins, which indicates that this may be a general strategy used by this pathogen for processing of its secreted effectors.	[Srikanth, C. V.; Wall, Daniel M.; Shi, Hai Ning; Mumy, Karen L.; McCormick, Beth A.] Harvard Univ, Sch Med, Dept Pediat Gastroenterol & Nutr, Boston, MA 02129 USA; [Srikanth, C. V.; Wall, Daniel M.; Shi, Hai Ning; Mumy, Karen L.; McCormick, Beth A.] Massachusetts Gen Hosp, Boston, MA 02129 USA; [Srikanth, C. V.; Maldonado-Contreras, Ana; Demma, Zachary; Mumy, Karen L.; McCormick, Beth A.] Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA; [Wall, Daniel M.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow G12 8QQ, Lanark, Scotland; [Zhou, Daoguo] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Worcester; University of Glasgow; Purdue University System; Purdue University; Purdue University West Lafayette Campus	McCormick, BA (corresponding author), Harvard Univ, Sch Med, Dept Pediat Gastroenterol & Nutr, Boston, MA 02129 USA.	Beth.McCormick@umassmed.edu	Maldonado-Contreras, Ana/ABA-2738-2020	Maldonado-Contreras, Ana/0000-0002-5967-9623	NIH [DK56754, DK33506]; Crohn's and Colitis Foundation of America; Tenovus Scotland; Society for General Microbiology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056754, P30DK040561, P01DK033506] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Tenovus Scotland; Society for General Microbiology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The research was supported by grants from the NIH (DK56754 and DK33506) and the Crohn's and Colitis Foundation of America to B. A. M. Additional grant support was provided by Tenovus Scotland and a Society for General Microbiology travel award to D. M. W. The use of human volunteers in this study was in accordance with appropriate guidelines and was approved by the University of Massachusetts Medical School Review Board for the Protection of Human Subjects (approval no. 13006).	Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Cherayil BJ, 2000, INFECT IMMUN, V68, P5567, DOI 10.1128/IAI.68.10.5567-5574.2000; Chiu HJ, 2005, MICROBIOL-SGM, V151, P3277, DOI 10.1099/mic.0.28115-0; Deane JE, 2008, J MOL BIOL, V377, P985, DOI 10.1016/j.jmb.2008.01.072; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Kim JM, 1998, J CLIN INVEST, V102, P1815, DOI 10.1172/JCI2466; Lee CA, 2000, P NATL ACAD SCI USA, V97, P12283, DOI 10.1073/pnas.97.22.12283; LEE CA, 1992, P NATL ACAD SCI USA, V89, P1847, DOI 10.1073/pnas.89.5.1847; LEE CA, 1990, P NATL ACAD SCI USA, V87, P4304, DOI 10.1073/pnas.87.11.4304; Lilic M, 2003, SCIENCE, V301, P1918, DOI 10.1126/science.1088433; MCCORMICK BA, 1988, INFECT IMMUN, V56, P2209, DOI 10.1128/IAI.56.9.2209-2217.1988; MCCORMICK BA, 1993, J CELL BIOL, V123, P895, DOI 10.1083/jcb.123.4.895; Nhan TQ, 2006, AM J PATHOL, V169, P729, DOI 10.2353/ajpath.2006.060105; Ohlson MB, 2008, CELL HOST MICROBE, V4, P434, DOI 10.1016/j.chom.2008.08.012; Ramarao N, 2007, FEBS LETT, V581, P853, DOI 10.1016/j.febslet.2007.01.057; Van Nhieu GT, 1999, EMBO J, V18, P3249, DOI 10.1093/emboj/18.12.3249; Wall DM, 2007, CELL MICROBIOL, V9, P2299, DOI 10.1111/j.1462-5822.2007.00960.x; Wood MW, 2000, CELL MICROBIOL, V2, P293, DOI 10.1046/j.1462-5822.2000.00054.x; Zakeri Z, 2008, ADV EXP MED BIOL, V615, P1, DOI 10.1007/978-1-4020-6554-5_1; Zhang Y, 2006, MOL MICROBIOL, V62, P786, DOI 10.1111/j.1365-2958.2006.05407.x; Zhou DG, 1999, P NATL ACAD SCI USA, V96, P10176, DOI 10.1073/pnas.96.18.10176	22	76	81	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					390	393		10.1126/science.1194598	http://dx.doi.org/10.1126/science.1194598			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947770	Green Accepted			2022-12-01	WOS:000282986700046
J	Avorn, J				Avorn, Jerry			Medication Use in Older Patients Better Policy Could Encourage Better Practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Avorn, Jerry] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA; [Avorn, Jerry] Harvard Univ, Sch Med, Boston, MA USA; [Avorn, Jerry] Brigham & Womens Hosp, Dept Med, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Avorn, J (corresponding author), Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Ste 3030,1620 Tremont St, Boston, MA 02120 USA.	javorn@medsoc.harvard.edu						Avorn J., 2005, POWERFUL MED BENEFIT; Avorn J, 2003, GERIATRIC MED EVIDEN, P65; Boult C, 2010, HEALTH AFFAIR, V29, P811, DOI 10.1377/hlthaff.2010.0095; Boult C, 2009, J AM GERIATR SOC, V57, P2328, DOI 10.1111/j.1532-5415.2009.02571.x; *FUT HLTH CAR WORK, 2008, RET AG AM BUILD HLTH; *IND DRUG INF SERV, BAL DAT MED; Peterson JF, 2005, ARCH INTERN MED, V165, P802, DOI 10.1001/archinte.165.7.802; Platt R, 2009, NEW ENGL J MED, V361, P645, DOI 10.1056/NEJMp0905338; SCHONDELMEYER SW, 2010, RX PRICE WATCH REPOR; Van Spall HGC, 2007, JAMA-J AM MED ASSOC, V297, P1233, DOI 10.1001/jama.297.11.1233	10	30	31	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2010	304	14					1606	1607		10.1001/jama.2010.1495	http://dx.doi.org/10.1001/jama.2010.1495			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662OE	20940388				2022-12-01	WOS:000282816500027
J	Jones, S; Wang, TL; Shih, IM; Mao, TL; Nakayama, K; Roden, R; Glas, R; Slamon, D; Diaz, LA; Vogelstein, B; Kinzler, KW; Velculescu, VE; Papadopoulos, N				Jones, Sian; Wang, Tian-Li; Shih, Ie-Ming; Mao, Tsui-Lien; Nakayama, Kentaro; Roden, Richard; Glas, Ruth; Slamon, Dennis; Diaz, Luis A., Jr.; Vogelstein, Bert; Kinzler, Kenneth W.; Velculescu, Victor E.; Papadopoulos, Nickolas			Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma	SCIENCE			English	Article							PHOSPHATASE 2A; HUMAN BREAST; ENDOMETRIOSIS; PATHWAYS; PATTERNS; DISTINCT	Ovarian clear cell carcinoma (OCCC) is an aggressive human cancer that is generally resistant to therapy. To explore the genetic origin of OCCC, we determined the exomic sequences of eight tumors after immunoaffinity purification of cancer cells. Through comparative analyses of normal cells from the same patients, we identified four genes that were mutated in at least two tumors. PIK3CA, which encodes a subunit of phosphatidylinositol-3 kinase, and KRAS, which encodes a well-known oncoprotein, had previously been implicated in OCCC. The other two mutated genes were previously unknown to be involved in OCCC: PPP2R1A encodes a regulatory subunit of serine/threonine phosphatase 2, and ARID1A encodes adenine-thymine (AT)-rich interactive domain-containing protein 1A, which participates in chromatin remodeling. The nature and pattern of the mutations suggest that PPP2R1A functions as an oncogene and ARID1A as a tumor-suppressor gene. In a total of 42 OCCCs, 7% had mutations in PPP2R1A and 57% had mutations in ARID1A. These results suggest that aberrant chromatin remodeling contributes to the pathogenesis of OCCC.	[Jones, Sian; Diaz, Luis A., Jr.; Vogelstein, Bert; Kinzler, Kenneth W.; Velculescu, Victor E.; Papadopoulos, Nickolas] Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA; [Jones, Sian; Diaz, Luis A., Jr.; Vogelstein, Bert; Kinzler, Kenneth W.; Velculescu, Victor E.; Papadopoulos, Nickolas] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21231 USA; [Wang, Tian-Li] Johns Hopkins Med Inst, Dept Gynecol & Obstet & Oncol, Baltimore, MD 21231 USA; [Shih, Ie-Ming; Roden, Richard] Johns Hopkins Med Inst, Dept Pathol Oncol Gynecol & Obstet, Baltimore, MD 21231 USA; [Mao, Tsui-Lien] Natl Taiwan Univ, Coll Med, Dept Pathol, Taipei 100, Taiwan; [Nakayama, Kentaro] Shimane Univ, Sch Med, Dept Obstet & Gynecol, Izumo, Shimane 6938501, Japan; [Glas, Ruth; Slamon, Dennis] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol Oncol, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; National Taiwan University; Shimane University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kinzler, KW (corresponding author), Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA.	kinzlke@jhmi.edu; velculescu@jhmi.edu; npapado1@jhmi.edu	Papadopoulos, Nickolas/K-7272-2012; sdsd, shihieih/ABE-6190-2020; Jones, Sian/A-5050-2012; Velculescu, Victor/ABF-4846-2020	Velculescu, Victor/0000-0003-1195-438X; Diaz, Luis/0000-0002-7079-8914	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; American Association for Cancer Research, The Virginia; U.S. Department of Defense [OC0400600]; NIH [CA121113, CA57345, CA129080, CA103937, CA122581]; NATIONAL CANCER INSTITUTE [R37CA057345, R01CA121113, R01CA103937, R01CA129080, R01CA122581, R01CA057345] Funding Source: NIH RePORTER	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; American Association for Cancer Research, The Virginia; U.S. Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Y. He for technical advice and M. Whalen, J. Ptak, and N. Silliman for expert technical assistance. Funded by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, American Association for Cancer Research Stand Up To Cancer-Dream Team Translational Cancer Research Grant, The Virginia and D. K. Ludwig Fund for Cancer Research, U.S. Department of Defense grant OC0400600 (T.-L. W.), and NIH grants CA121113, CA57345, CA129080, CA103937 (IMS), and CA122581 (R. R.). N. P., B. V., L. D., V. V., and K. W. K. are members of the Scientific Advisory Board of Inostics, a company that is developing technologies for the molecular diagnosis of cancer. N. P., B. V., L. D., V. V., and K. W. K. also own stock in Inostics. The authors are entitled to a share of the royalties received by the university on sales of products related to genes described in this manuscript. The terms of these arrangements are being managed by the university in accordance with their conflict of interest policies. V. V., B. V., K. W. K., and Johns Hopkins University also own stock in Genzyme and Exact Sciences, which are managed under similar arrangements.	Banine F, 2005, CANCER RES, V65, P3542, DOI 10.1158/0008-5472.CAN-04-3554; Calin GA, 2000, ONCOGENE, V19, P1191, DOI 10.1038/sj.onc.1203389; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Erzen M, 2001, GYNECOL ONCOL, V83, P100, DOI 10.1006/gyno.2001.6382; Fukunaga M, 1997, HISTOPATHOLOGY, V30, P249, DOI 10.1046/j.1365-2559.1997.d01-592.x; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Huang JM, 2007, GENE CHROMOSOME CANC, V46, P745, DOI 10.1002/gcc.20459; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kuo KT, 2010, CLIN CANCER RES, V16, P1997, DOI 10.1158/1078-0432.CCR-09-2105; Kuo KT, 2009, AM J PATHOL, V174, P1597, DOI 10.2353/ajpath.2009.081000; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Marquez RT, 2005, CLIN CANCER RES, V11, P6116, DOI 10.1158/1078-0432.CCR-04-2509; Medina PP, 2008, HUM MUTAT, V29, P617, DOI 10.1002/humu.20730; Nagl NG, 2007, EMBO J, V26, P752, DOI 10.1038/sj.emboj.7601541; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Sato N, 2000, CANCER RES, V60, P7052; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Veras E, 2009, AM J SURG PATHOL, V33, P844, DOI 10.1097/PAS.0b013e31819c4271; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Weissman B, 2009, CANCER RES, V69, P8223, DOI 10.1158/0008-5472.CAN-09-2166; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009	28	873	917	0	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2010	330	6001					228	231		10.1126/science.1196333	http://dx.doi.org/10.1126/science.1196333			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20826764	Green Accepted			2022-12-01	WOS:000282644600044
J	Howard, A; Wilson, M				Howard, Andrew; Wilson, Mary			Easily Missed? Septic arthritis in children	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRANSIENT SYNOVITIS; HIP; DIFFERENTIATION; CHILDHOOD; SEQUELAE		[Howard, Andrew] Hosp Sick Children, Div Orthopaed Surg, Toronto, ON M5G 1X8, Canada; [Wilson, Mary] Marathon Family Hlth Team, Marathon, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Howard, A (corresponding author), Hosp Sick Children, Div Orthopaed Surg, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	andrew.howard@sickkids.ca		Howard, Andrew/0000-0001-7226-6471				Baskett A, 2009, PEDIATR EMERG CARE, V25, P78, DOI 10.1097/PEC.0b013e318196ea43; Caird MS, 2006, J BONE JOINT SURG AM, V88A, P1251, DOI 10.2106/JBJS.E.00216; Choi IH, 2005, CLIN ORTHOP RELAT R, P102, DOI 10.1097/01.blo.0000162412.93473.68; Forlin E, 2008, J PEDIATR ORTHOPED, V28, P524, DOI 10.1097/BPO.0b013e31817bb079; Givon U, 2004, J PEDIATR ORTHOPED, V24, P266, DOI 10.1097/01241398-200405000-00006; Goergens ED, 2005, J PAEDIATR CHILD H, V41, P59, DOI 10.1111/j.1440-1754.2005.00538.x; Gordon JE, 2002, J PEDIATR ORTHOPED, V22, P312, DOI 10.1097/00004694-200205000-00008; Kocher MS, 2004, J BONE JOINT SURG AM, V86A, P1629, DOI 10.2106/00004623-200408000-00005; Kocher MS, 1999, J BONE JOINT SURG AM, V81A, P1662, DOI 10.2106/00004623-199912000-00002; Luhmann SJ, 2004, J BONE JOINT SURG AM, V86A, P956, DOI 10.2106/00004623-200405000-00011; Nunn TR, 2007, J BONE JOINT SURG BR, V89B, P100, DOI 10.1302/0301-620X.89B1.17940; Peltola H, 2009, CLIN INFECT DIS, V48, P1201, DOI 10.1086/597582; Riise OR, 2008, PEDIATRICS, V121, pE299, DOI 10.1542/peds.2007-0291	13	3	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 7	2010	341								c4407	10.1136/bmj.c4407	http://dx.doi.org/10.1136/bmj.c4407			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	663JJ	20801999				2022-12-01	WOS:000282880500008
J	Daniels, JP; Khan, KS				Daniels, Jane P.; Khan, Khalid S.			Chronic pelvic pain in women	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PREVALENCE		[Daniels, Jane P.] Univ Birmingham, Reprod Genes & Develop & Clin Trials Unit, Birmingham B15 2TT, England; [Khan, Khalid S.] Barts & London Queen Marys Sch Med & Dent, London E1 2DD, England	University of Birmingham; University of London; Queen Mary University London	Daniels, JP (corresponding author), Univ Birmingham, Reprod Genes & Develop & Clin Trials Unit, Birmingham B15 2TT, England.	j.p.daniels@bham.ac.uk	Khan, Khalid S/AAT-8824-2020	Khan, Khalid S/0000-0001-5084-7312				ALSOM N, 2009, BJOG, V116, P1551; *AM COLL OBST GYN, 2004, ACOG PRACT B, V51; Ballard K, 2010, FERTIL STERIL, V94, P20, DOI 10.1016/j.fertnstert.2009.01.164; Cody RF, 2000, BEST PRACT RES CL OB, V14, P433, DOI 10.1053/beog.1999.0085; Daniels J, 2009, JAMA-J AM MED ASSOC, V302, P955, DOI 10.1001/jama.2009.1268; DANIELS JP, 2010, HUM REPROD UPDATE; Fall M, 2010, EUR UROL, V57, P35, DOI 10.1016/j.eururo.2009.08.020; Grace Victoria, 2006, Health Care Women Int, V27, P585, DOI 10.1080/07399330600803725; Grace VM, 2007, WOMEN HEALTH, V46, P81, DOI 10.1300/J013v46n04_05; Howard F M, 1993, Obstet Gynecol Surv, V48, P357, DOI 10.1097/00006254-199306000-00001; Howard FM, 2000, BEST PRACT RES CL OB, V14, P467, DOI 10.1053/beog.1999.0086; Kennedy S, 2005, HUM REPROD, V20, P2698, DOI 10.1093/humrep/dei135; Latthe P, 2006, BMJ-BRIT MED J, V332, P749, DOI 10.1136/bmj.38748.697465.55; Latthe P, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-177; PETERS AAW, 1991, OBSTET GYNECOL, V77, P740; *RCOG GUID AUD COM, 2006, 24 RCOG GUID AUD COM; *RCOG GUID AUT COM, 2005, 41 RCOG GUID AUD COM; Stones RW, 2002, J ROY SOC MED, V95, P531, DOI 10.1258/jrsm.95.11.531; STONES W, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000387; Wesselmann U, 2001, WORLD J UROL, V19, P180, DOI 10.1007/s003450100201; Williams RE, 2004, OBSTET GYNECOL, V103, P686, DOI 10.1097/01.AOG.0000115513.92318.b7; WONG CL, 2009, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD002120.PUB3; Zondervan KT, 2001, BRIT J GEN PRACT, V51, P541; Zondervan KT, 1999, BRIT J OBSTET GYNAEC, V106, P1149, DOI 10.1111/j.1471-0528.1999.tb08140.x	24	58	62	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 5	2010	341								c4834	10.1136/bmj.c4834	http://dx.doi.org/10.1136/bmj.c4834			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	663JB	20923840				2022-12-01	WOS:000282879000005
J	Ajikumar, PK; Xiao, WH; Tyo, KEJ; Wang, Y; Simeon, F; Leonard, E; Mucha, O; Phon, TH; Pfeifer, B; Stephanopoulos, G				Ajikumar, Parayil Kumaran; Xiao, Wen-Hai; Tyo, Keith E. J.; Wang, Yong; Simeon, Fritz; Leonard, Effendi; Mucha, Oliver; Phon, Too Heng; Pfeifer, Blaine; Stephanopoulos, Gregory			Isoprenoid Pathway Optimization for Taxol Precursor Overproduction in Escherichia coli	SCIENCE			English	Article							LYCOPENE PRODUCTION; BIOSYNTHETIC GENES; CYTOCHROME-P450; TERPENOIDS; TAXADIENE; CONSTRUCTION; OXYGENASES; CELLS; YEAST; STEP	Taxol (paclitaxel) is a potent anticancer drug first isolated from the Taxus brevifolia Pacific yew tree. Currently, cost-efficient production of Taxol and its analogs remains limited. Here, we report a multivariate-modular approach to metabolic-pathway engineering that succeeded in increasing titers of taxadiene-the first committed Taxol intermediate-approximately 1 gram per liter (similar to 15,000-fold) in an engineered Escherichia coli strain. Our approach partitioned the taxadiene metabolic pathway into two modules: a native upstream methylerythritol-phosphate (MEP) pathway forming isopentenyl pyrophosphate and a heterologous downstream terpenoid-forming pathway. Systematic multivariate search identified conditions that optimally balance the two pathway modules so as to maximize the taxadiene production with minimal accumulation of indole, which is an inhibitory compound found here. We also engineered the next step in Taxol biosynthesis, a P450-mediated 5 alpha-oxidation of taxadiene to taxadien-5 alpha-ol. More broadly, the modular pathway engineering approach helped to unlock the potential of the MEP pathway for the engineered production of terpenoid natural products.	[Wang, Yong; Pfeifer, Blaine] Tufts Univ, Dept Biol & Chem Engn, Medford, MA 02155 USA; [Ajikumar, Parayil Kumaran; Xiao, Wen-Hai; Tyo, Keith E. J.; Simeon, Fritz; Leonard, Effendi; Mucha, Oliver; Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Ajikumar, Parayil Kumaran; Phon, Too Heng; Stephanopoulos, Gregory] Singapore MIT Alliance, Chem & Pharmaceut Engn Program, Singapore 117546, Singapore	Tufts University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore-MIT Alliance for Research & Technology Centre (SMART)	Pfeifer, B (corresponding author), Tufts Univ, Dept Biol & Chem Engn, 4 Colby St, Medford, MA 02155 USA.	blaine.pfeifer@tufts.edu; gregstep@mit.edu	Tyo, Keith/H-6227-2012; Tyo, Keith/D-1817-2009	Tyo, Keith/0000-0002-2342-0687	Singapore-MIT Alliance [SMA-2]; NIH [1-R01-GM085323-01A1]; Milheim Foundation [2006-17]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085323] Funding Source: NIH RePORTER	Singapore-MIT Alliance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Milheim Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Renu for extraction, purification, and characterization of metabolite Indole; C. Santos for providing the pACYCmelA plasmid, constructive suggestions during the experiments, and preparation of the manuscript; D. Dugar, H. Zhou, and X. Huang for helping with experiments and suggestions; and K. Hiller for data analysis and comments on the manuscript. We gratefully acknowledge support by the Singapore-MIT Alliance (SMA-2) and NIH, grant 1-R01-GM085323-01A1. B.P. acknowledges the Milheim Foundation Grant for Cancer Research 2006-17. A patent application that is based on the results presented here has been filed by MIT. P. K. A. designed the experiments and performed the engineering and screening of the strains; W-H. X. performed screening of the strains, bioreactor experiments, and GC-MS analysis; F. S. carried out the quantitative PCR measurements; O.M. performed the extraction and characterization of taxadiene standard; E. L., Y.W., and B. P. supported with cloning experiments; P. K. A., K.E.J.T., T. H. P., B. P. and G. S. analyzed the data; P. K. A., K.E.J.T., and G. S. wrote the manuscript; G. S. supervised the research; and all of the authors contributed to discussion of the research and edited and commented on the manuscript.	Ajikumar PK, 2008, MOL PHARMACEUT, V5, P167, DOI 10.1021/mp700151b; Alper H, 2005, NAT BIOTECHNOL, V23, P612, DOI 10.1038/nbt1083; Chang MCY, 2006, NAT CHEM BIOL, V2, P674, DOI 10.1038/nchembio836; DeJong JM, 2006, BIOTECHNOL BIOENG, V93, P212, DOI 10.1002/bit.20694; Engels B, 2008, METAB ENG, V10, P201, DOI 10.1016/j.ymben.2008.03.001; Farmer WR, 2000, NAT BIOTECHNOL, V18, P533, DOI 10.1038/75398; Farmer WR, 2001, BIOTECHNOL PROGR, V17, P57, DOI 10.1021/bp000137t; Frense D, 2007, APPL MICROBIOL BIOT, V73, P1233, DOI 10.1007/s00253-006-0711-0; Goodman J, 2001, STORY TAXOL NATURE P; HOLTON RA, 1994, J AM CHEM SOC, V116, P1597, DOI 10.1021/ja00083a066; Holton RA., 1995, TAXOL SCI APPL, P97, DOI DOI 10.1002/CHIN.199552275; Huang QL, 2001, BIOORGAN MED CHEM, V9, P2237, DOI 10.1016/S0968-0896(01)00072-4; Jennewein S, 2005, BIOTECHNOL BIOENG, V89, P588, DOI 10.1002/bit.20390; Jennewein S, 2004, P NATL ACAD SCI USA, V101, P9149, DOI 10.1073/pnas.0403009101; Jennewein S, 2004, CHEM BIOL, V11, P379, DOI 10.1016/j.chembiol.2004.02.022; Jin YS, 2007, METAB ENG, V9, P337, DOI 10.1016/j.ymben.2007.03.003; Jones KL, 2000, METAB ENG, V2, P328, DOI 10.1006/mben.2000.0161; Kaspera Rudiger, 2006, Phytochemistry Reviews, V5, P433, DOI 10.1007/s11101-006-9006-4; Kingston DGI, 2007, PHYTOCHEMISTRY, V68, P1844, DOI 10.1016/j.phytochem.2006.11.009; Klein-Marcuschamer D, 2007, TRENDS BIOTECHNOL, V25, P417, DOI 10.1016/j.tibtech.2007.07.006; Leonard E, 2007, APPL ENVIRON MICROB, V73, P7246, DOI 10.1128/AEM.01411-07; Leonard E, 2010, P NATL ACAD SCI USA, V107, P13654, DOI 10.1073/pnas.1006138107; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Morrone D, 2010, APPL MICROBIOL BIOT, V85, P1893, DOI 10.1007/s00253-009-2219-x; Nelson DR, 1999, ARCH BIOCHEM BIOPHYS, V369, P1, DOI 10.1006/abbi.1999.1352; NICOLAOU KC, 1994, NATURE, V367, P630, DOI 10.1038/367630a0; Roberts SC, 2007, NAT CHEM BIOL, V3, P387, DOI 10.1038/nchembio.2007.8; Rontein D, 2008, J BIOL CHEM, V283, P6067, DOI 10.1074/jbc.M708950200; Schuler MA, 2003, ANNU REV PLANT BIOL, V54, P629, DOI 10.1146/annurev.arplant.54.031902.134840; Suffness M, 1995, TAXOL SCI APPL, P3; Tyo KE, 2007, TRENDS BIOTECHNOL, V25, P132, DOI 10.1016/j.tibtech.2007.01.003; Walji AM, 2007, SYNLETT, P1477, DOI 10.1055/s-2007-980382; Walker K, 2001, PHYTOCHEMISTRY, V58, P1, DOI 10.1016/S0031-9422(01)00160-1; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; WANI MC, 1971, J AM CHEM SOC, V93, P2325, DOI 10.1021/ja00738a045; Yuan LZ, 2006, METAB ENG, V8, P79, DOI 10.1016/j.ymben.2005.08.005	36	1105	1269	43	991	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 1	2010	330	6000					70	74		10.1126/science.1191652	http://dx.doi.org/10.1126/science.1191652			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20929806	Green Submitted, Green Accepted			2022-12-01	WOS:000282334500035
J	Parrinello, S; Napoli, I; Ribeiro, S; Digby, PW; Fedorova, M; Parkinson, DB; Doddrell, RDS; Nakayama, M; Adams, RH; Lloyd, AC				Parrinello, Simona; Napoli, Ilaria; Ribeiro, Sara; Digby, Patrick Wingfield; Fedorova, Marina; Parkinson, David B.; Doddrell, Robin D. S.; Nakayama, Masanori; Adams, Ralf H.; Lloyd, Alison C.			EphB Signaling Directs Peripheral Nerve Regeneration through Sox2-Dependent Schwann Cell Sorting	CELL			English	Article							NEURAL CREST MIGRATION; N-CADHERIN; AXON; SYSTEM; FIBROBLASTS; PRECURSORS; EXPRESSION; PATTERNS; ADHESION; GUIDANCE	The peripheral nervous system has astonishing regenerative capabilities in that cut nerves are able to reconnect and re-establish their function. Schwann cells are important players in this process, during which they dedifferentiate to a progenitor/stem cell and promote axonal regrowth. Here, we report that fibroblasts also play a key role. Upon nerve cut, ephrin-B/EphB2 signaling between fibroblasts and Schwann cells results in cell sorting, followed by directional collective cell migration of Schwann cells out of the nerve stumps to guide regrowing axons across the wound. Mechanistically, we find that cell-sorting downstream of EphB2 is mediated by the stemness factor Sox2 through N-cadherin relocalization to Schwann cell-cell contacts. In vivo, loss of EphB2 signaling impaired organized migration of Schwann cells, resulting in misdirected axonal regrowth. Our results identify a link between Ephs and Sox proteins, providing a mechanism by which progenitor cells can translate environmental cues to orchestrate the formation of new tissue.	[Parrinello, Simona; Napoli, Ilaria; Ribeiro, Sara; Digby, Patrick Wingfield; Fedorova, Marina; Lloyd, Alison C.] UCL, MRC Lab Mol Cell Biol, London WC1E 6BT, England; [Parrinello, Simona; Napoli, Ilaria; Ribeiro, Sara; Digby, Patrick Wingfield; Fedorova, Marina; Lloyd, Alison C.] UCL, UCL Canc Inst, London WC1E 6BT, England; [Parkinson, David B.; Doddrell, Robin D. S.] Univ Plymouth, Peninsula Coll Med & Dent, Plymouth PL6 8BU, Devon, England; [Nakayama, Masanori; Adams, Ralf H.] Univ Munster, Dept Tissue Morphogenesis, Max Planck Inst Mol Biomed, D-48149 Munster, Germany; [Nakayama, Masanori; Adams, Ralf H.] Univ Munster, Fac Med, D-48149 Munster, Germany	MRC Laboratory Molecular Biology; University of London; University College London; University of London; University College London; University of Plymouth; Max Planck Society; University of Munster; University of Munster	Lloyd, AC (corresponding author), UCL, MRC Lab Mol Cell Biol, Gower St, London WC1E 6BT, England.	alison.lloyd@ucl.ac.uk	Ribeiro, Sara/I-1615-2013; Adams, Ralf H/AAE-9274-2019	Ribeiro, Sara/0000-0002-6500-8412; Napoli, Ilaria/0000-0002-0649-1950	Cancer Research UK program; Association for International Cancer Research; Cancer Research UK [11244] Funding Source: researchfish	Cancer Research UK program(Cancer Research UK); Association for International Cancer Research; Cancer Research UK(Cancer Research UK)	S.P. is a Royal Society D.H. Research Fellow. This work was supported by a Cancer Research UK program and an Association for International Cancer Research project grant. We thank C.D. Nobes for advice and M. Raff and B. Baum for critical reading of the manuscript, M. Herlyn, J. Milbrandt, E. Battle, and D. Wilkinson for constructs and G. Parrinello, A. Mira, and J. Kriston-Vizi for statistics.	Arvanitis D, 2008, GENE DEV, V22, P416, DOI 10.1101/gad.1630408; Bundesen LQ, 2003, J NEUROSCI, V23, P7789; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen YY, 2005, J NEUROPATH EXP NEUR, V64, P613, DOI 10.1097/01.jnen.0000171650.94341.46; Cortina C, 2007, NAT GENET, V39, P1376, DOI 10.1038/ng.2007.11; Crawford AT, 2008, GLIA, V56, P1637, DOI 10.1002/glia.20716; Deschaseaux F, 2009, TRENDS MOL MED, V15, P417, DOI 10.1016/j.molmed.2009.07.002; Gilmour DT, 2002, NEURON, V34, P577, DOI 10.1016/S0896-6273(02)00683-9; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Kuriyama S, 2008, PHILOS T R SOC B, V363, P1349, DOI 10.1098/rstb.2007.2252; Lackmann M, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.115re2; Lai KO, 2004, J BIOL CHEM, V279, P13383, DOI 10.1074/jbc.M313356200; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; LETOURNEAU PC, 1991, J NEUROBIOL, V22, P707, DOI 10.1002/neu.480220706; Luria V, 2008, NEURON, V60, P1039, DOI 10.1016/j.neuron.2008.11.011; Mathon NF, 2001, SCIENCE, V291, P872, DOI 10.1126/science.1056782; Mcdonald D, 2006, NEURON GLIA BIOL, V2, P139, DOI 10.1017/S1740925X05000347; McDonald DS, 2003, J NEUROSCI METH, V122, P171, DOI 10.1016/S0165-0270(02)00319-9; MORRIS JH, 1972, Z ZELLFORSCH MIK ANA, V124, P165, DOI 10.1007/BF00335678; Morris JK, 1999, NEURON, V23, P273, DOI 10.1016/S0896-6273(00)80779-5; Navarro X, 2009, INT REV NEUROBIOL, V87, P483, DOI 10.1016/S0074-7742(09)87027-X; Nguyen QT, 2002, NAT NEUROSCI, V5, P861, DOI 10.1038/nn905; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; Parrinello S, 2008, GENE DEV, V22, P3335, DOI 10.1101/gad.490608; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Scherer SS, 2001, AXON SCHWANN CELL IN; SCHRODER JM, 1993, CLIN NEUROL NEUROSUR, V95, P78; Sorrell JM, 2009, INT REV CEL MOL BIO, V276, P161, DOI 10.1016/S1937-6448(09)76004-6; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tepass U, 2002, CURR OPIN GENET DEV, V12, P572, DOI 10.1016/S0959-437X(02)00342-8; Von Philipsborn AC, 2006, NAT PROTOC, V1, P1322, DOI 10.1038/nprot.2006.251; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; Wanner IB, 2006, GLIA, V54, P439, DOI 10.1002/glia.20390; Wanner IB, 2006, GLIA, V54, P424, DOI 10.1002/glia.20389; Zochodne DW, 2008, NEUROBIOLOGY OF PERIPHERAL NERVE REGENERATION, P1, DOI 10.1017/CBO9780511541759	38	330	341	3	48	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 1	2010	143	1					145	155		10.1016/j.cell.2010.08.039	http://dx.doi.org/10.1016/j.cell.2010.08.039			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	656UC	20869108	Bronze, Green Accepted			2022-12-01	WOS:000282362000021
J	del Zoppo, GJ; Hawkins, BT				del Zoppo, Gregory J.; Hawkins, Brian T.			Throwing Out the Thromboemboli	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PLASMINOGEN-ACTIVATOR		[del Zoppo, Gregory J.; Hawkins, Brian T.] Univ Washington, Sch Med, Div Hematol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	del Zoppo, GJ (corresponding author), Univ Washington, Sch Med, Div Hematol, Seattle, WA 98195 USA.			Hawkins, Brian/0000-0001-6719-5402				Hosomi N, 2001, STROKE, V32, P1341, DOI 10.1161/01.STR.32.6.1341; Lam CK, 2010, NATURE, V465, P478, DOI 10.1038/nature09001; LEVIN EG, 1994, AM J PATHOL, V144, P855; Rosenberg RD, 1999, NEW ENGL J MED, V340, P1555, DOI 10.1056/NEJM199905203402007; SAPPINO AP, 1993, J CLIN INVEST, V92, P679, DOI 10.1172/JCI116637	5	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2010	363	13					1282	1284		10.1056/NEJMcibr1006572	http://dx.doi.org/10.1056/NEJMcibr1006572			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	652ZA	20860513				2022-12-01	WOS:000282050000016
J	Kim, YJ; Lee, HS; Kim, ES; Bae, SS; Lim, JK; Matsumi, R; Lebedinsky, AV; Sokolova, TG; Kozhevnikova, DA; Cha, SS; Kim, SJ; Kwon, KK; Imanaka, T; Atomi, H; Bonch-Osmolovskaya, EA; Lee, JH; Kang, SG				Kim, Yun Jae; Lee, Hyun Sook; Kim, Eun Sook; Bae, Seung Seob; Lim, Jae Kyu; Matsumi, Rie; Lebedinsky, Alexander V.; Sokolova, Tatyana G.; Kozhevnikova, Darya A.; Cha, Sun-Shin; Kim, Sang-Jin; Kwon, Kae Kyoung; Imanaka, Tadayuki; Atomi, Haruyuki; Bonch-Osmolovskaya, Elizaveta A.; Lee, Jung-Hyun; Kang, Sung Gyun			Formate-driven growth coupled with H-2 production	NATURE			English	Article							SEA HYDROTHERMAL VENT; HYPERTHERMOPHILIC ARCHAEON; ESCHERICHIA-COLI; METHANOBACTERIUM-FORMICICUM; METHANOCOCCUS-MARIPALUDIS; HYDROGENLYASE SYSTEM; OPERON; HYDROGENASE-3; METABOLISM; PREDICTION	Although a common reaction in anaerobic environments, the conversion of formate and water to bicarbonate and H-2 (with a change in Gibbs free energy of Delta G degrees = + 1.3 kJ mol(-1)) has not been considered energetic enough to support growth of microorganisms. Recently, experimental evidence for growth on formate was reported for syntrophic communities of Moorella sp. strain AMP and a hydrogen-consuming Methanothermobacter species and of Desulfovibrio sp. strain G11 and Methanobrevibacter arboriphilus strain AZ(1). The basis of the sustainable growth of the formate-users is explained by H-2 consumption by the methanogens, which lowers the H-2 partial pressure, thus making the pathway exergonic(2). However, it has not been shown that a single strain can grow on formate by catalysing its conversion to bicarbonate and H-2. Here we report that several hyperthermophilic archaea belonging to the Thermococcus genus are capable of formate-oxidizing, H-2-producing growth. The actual Delta G values for the formate metabolism are calculated to range between -8 and -20 kJ mol(-1) under the physiological conditions where Thermococcus onnurineus strain NA1 are grown. Furthermore, we detected ATP synthesis in the presence of formate as a sole energy source. Gene expression profiling and disruption identified the gene cluster encoding formate hydrogen lyase, cation/proton antiporter and formate transporter, which were responsible for the growth of T. onnurineus NA1 on formate. This work shows formate-driven growth by a single microorganism with protons as the electron acceptor, and reports the biochemical basis of this ability.	[Kim, Yun Jae; Lee, Hyun Sook; Kim, Eun Sook; Bae, Seung Seob; Lim, Jae Kyu; Cha, Sun-Shin; Kim, Sang-Jin; Kwon, Kae Kyoung; Lee, Jung-Hyun; Kang, Sung Gyun] Korea Ocean Res & Dev Inst, Ansan 425600, South Korea; [Lee, Hyun Sook; Bae, Seung Seob; Lim, Jae Kyu; Cha, Sun-Shin; Kim, Sang-Jin; Kwon, Kae Kyoung; Lee, Jung-Hyun; Kang, Sung Gyun] Univ Sci & Technol, Dept Marine Biotechnol, Taejon 305333, South Korea; [Matsumi, Rie; Imanaka, Tadayuki; Atomi, Haruyuki] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan; [Lebedinsky, Alexander V.; Sokolova, Tatyana G.; Kozhevnikova, Darya A.; Bonch-Osmolovskaya, Elizaveta A.] Russian Acad Sci, Winogradsky Inst Microbiol, Moscow 117312, Russia	Korea Institute of Ocean Science & Technology (KIOST); Kyoto University; Research Center of Biotechnology RAS; Russian Academy of Sciences	Lee, JH (corresponding author), Korea Ocean Res & Dev Inst, POB 29, Ansan 425600, South Korea.	jlee@kordi.re.kr; sgkang@kordi.re.kr	Sokolova, Tatyana/AAU-3465-2021; Lebedinsky, Alexander V/E-9075-2014; Kozhevnikova, Daria/E-2536-2014	Sokolova, Tatyana/0000-0002-3879-2993; Lebedinsky, Alexander V/0000-0002-3686-7437; LIM, JAE KYU/0000-0002-9696-9830; Atomi, Haruyuki/0000-0001-9687-6426; Cha, Sun-Shin/0000-0002-0913-8706; Kozhevnikova, Daria/0000-0002-7263-3611	KORDI [PE98513]; Marine and Extreme Genome Research Center; Ministry of Land, Transport, and Maritime Affairs, Korea; RAS; Russian Foundation of Basic Research [10-04-01180]	KORDI; Marine and Extreme Genome Research Center; Ministry of Land, Transport, and Maritime Affairs, Korea(Ministry of Land, Transport and Maritime Affairs (MLTM), Republic of Korea); RAS(Russian Academy of SciencesRegione Sardegna); Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by the KORDI in-house programme (PE98513), the Marine and Extreme Genome Research Center programme and the Development of Biohydrogen Production Technology using Hyperthermophilic Archaea programme of the Ministry of Land, Transport, and Maritime Affairs, Korea, as well as by the Molecular and Cell Biology programme of RAS and the Russian Foundation of Basic Research (grant no. 10-04-01180). We thank J. Querellou and the crew of the French scientific vessel Pourquoi pas?, and A.-L. Reysenbach and the crew of the American scientific vessel Thomas G. Thompson for opportunities to obtain deep-sea samples. We thank W. B. Whitman and R. K. Thauer for comments on the manuscript, and S. G. Jeon, K.-B. Yi and J.-G. Na for discussions.	Amaratunga D, 2001, J AM STAT ASSOC, V96, P1161, DOI 10.1198/016214501753381814; Amend JP, 2001, FEMS MICROBIOL REV, V25, P175, DOI 10.1016/S0168-6445(00)00062-0; Andrews SC, 1997, MICROBIOL-SGM, V143, P3633, DOI 10.1099/00221287-143-11-3633; Bae SS, 2006, J MICROBIOL BIOTECHN, V16, P1826; Bagramyan K, 2002, FEBS LETT, V516, P172, DOI 10.1016/S0014-5793(02)02555-3; BARON SF, 1989, J BACTERIOL, V171, P3854, DOI 10.1128/jb.171.7.3854-3859.1989; BOHM R, 1990, MOL MICROBIOL, V4, P231, DOI 10.1111/j.1365-2958.1990.tb00590.x; Dolfing J, 2008, APPL ENVIRON MICROB, V74, P6126, DOI 10.1128/AEM.01428-08; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Hedderich R, 2005, J MOL MICROB BIOTECH, V10, P92, DOI 10.1159/000091557; Holden JF, 2001, FEMS MICROBIOL ECOL, V36, P51, DOI 10.1111/j.1574-6941.2001.tb00825.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jenney FE, 2008, ANN NY ACAD SCI, V1125, P252, DOI 10.1196/annals.1419.013; Lee HS, 2008, J BACTERIOL, V190, P7491, DOI 10.1128/JB.00746-08; Lupa B, 2008, APPL ENVIRON MICROB, V74, P6584, DOI 10.1128/AEM.01455-08; Matsumi R, 2007, J BACTERIOL, V189, P2683, DOI 10.1128/JB.01692-06; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Sapra R, 2000, J BACTERIOL, V182, P3423, DOI 10.1128/JB.182.12.3423-3428.2000; SAUTER M, 1992, MOL MICROBIOL, V6, P1523, DOI 10.1111/j.1365-2958.1992.tb00873.x; SCHAUER NL, 1980, J BACTERIOL, V142, P800, DOI 10.1128/JB.142.3.800-807.1980; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997; Sokolova TG, 2004, EXTREMOPHILES, V8, P317, DOI 10.1007/s00792-004-0389-0; Stams AJM, 2009, NAT REV MICROBIOL, V7, P568, DOI 10.1038/nrmicro2166; Takacs M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-88; THAUER RK, 1984, MICROBE 1984 2, P123; Wood GE, 2003, J BACTERIOL, V185, P2548, DOI 10.1128/JB.185.8.2548-2554.2003; Zivanovic Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r70	27	166	175	4	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 16	2010	467	7313					352	U137		10.1038/nature09375	http://dx.doi.org/10.1038/nature09375			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650CF	20844539				2022-12-01	WOS:000281824900044
J	Schulze, S; Koster, S; Geldmacher, U; van Scheltinga, ACT; Kuhlbrandt, W				Schulze, Sabrina; Koester, Stefan; Geldmacher, Ulrike; van Scheltinga, Anke C. Terwisscha; Kuehlbrandt, Werner			Structural basis of Na+-independent and cooperative substrate/product antiport in CaiT	NATURE			English	Article							SOLUTES GLYCINE BETAINE; CATION-PI INTERACTION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CARNITINE TRANSPORTER; PROLINE BETAINE; BINDING-SITE; MECHANISM; DETERMINANTS; SYMPORTER	Transport of solutes across biological membranes is performed by specialized secondary transport proteins in the lipid bilayer(1), and is essential for life. Here we report the structures of the sodium-independent carnitine/butyrobetaine antiporter CaiT from Proteus mirabilis (PmCaiT) at 2.3-angstrom and from Escherichia coli (EcCaiT) at 3.5-angstrom resolution. CaiT belongs to the family of betaine/carnitine/choline transporters (BCCT), which are mostly Na+ or H+ dependent, whereas EcCaiT is Na+ and H+ independent(2). The three-dimensional architecture of CaiT resembles that of the Na+-dependent transporters LeuT(3) and BetP(4), but in CaiT a methionine sulphur takes the place of the Na+ ion to coordinate the substrate in the central transport site, accounting for Na+-independent transport. Both CaiT structures show the fully open, inward-facing conformation, and thus complete the set of functional states that describe the alternating access mechanism(5). EcCaiT contains two bound butyrobetaine substrate molecules, one in the central transport site, the other in an extracellular binding pocket. In the structure of PmCaiT, a tryptophan side chain occupies the transport site, and access to the extracellular site is blocked. Binding of both substrates to CaiT reconstituted into proteoliposomes is cooperative, with Hill coefficients up to 1.7, indicating that the extracellular site is regulatory. We propose a mechanism whereby the occupied regulatory site increases the binding affinity of the transport site and initiates substrate translocation.	[Schulze, Sabrina; Koester, Stefan; Geldmacher, Ulrike; van Scheltinga, Anke C. Terwisscha; Kuehlbrandt, Werner] Max Planck Inst Biophys, Dept Biol Struct, D-60438 Frankfurt, Germany	Max Planck Society	Kuhlbrandt, W (corresponding author), Max Planck Inst Biophys, Dept Biol Struct, Max von Laue Str 3, D-60438 Frankfurt, Germany.	werner.kuehlbrandt@biophys.mpg.de		Kuhlbrandt, Werner/0000-0002-2013-4810				Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Barros T, 2009, EMBO J, V28, P298, DOI 10.1038/emboj.2008.276; CSAKY TZ, 1965, ANNU REV PHYSIOL, V27, P415, DOI 10.1146/annurev.ph.27.030165.002215; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Diallinas G, 2008, SCIENCE, V322, P1644, DOI 10.1126/science.1168107; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; FARWICK M, 1995, J BACTERIOL, V177, P4690, DOI 10.1128/jb.177.16.4690-4695.1995; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Horn C, 2006, J MOL BIOL, V357, P592, DOI 10.1016/j.jmb.2005.12.085; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jung H, 2002, J BIOL CHEM, V277, P39251, DOI 10.1074/jbc.M206319200; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Padgett CL, 2007, J NEUROSCI, V27, P886, DOI 10.1523/JNEUROSCI.4791-06.2007; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; RICARD J, 1987, EUR J BIOCHEM, V166, P255, DOI 10.1111/j.1432-1033.1987.tb13510.x; ROSSMANN MG, 1962, ACTA CRYSTALLOGR, V15, P24, DOI 10.1107/S0365110X62000067; Schiefner A, 2004, J BIOL CHEM, V279, P5588, DOI 10.1074/jbc.M309771200; Sevilla A, 2005, BIOTECHNOL PROGR, V21, P329, DOI 10.1021/bp0497583; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Tang L, 2010, NAT STRUCT MOL BIOL, V17, P492, DOI 10.1038/nsmb.1788; Terwilliger TC, 2004, ACTA CRYSTALLOGR D, V60, P2144, DOI 10.1107/S0907444904019535; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Torrice MM, 2009, P NATL ACAD SCI USA, V106, P11919, DOI 10.1073/pnas.0903260106; Vinothkumar KR, 2006, J BIOL CHEM, V281, P4795, DOI 10.1074/jbc.M508993200; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	36	98	99	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 9	2010	467	7312					233	U129		10.1038/nature09310	http://dx.doi.org/10.1038/nature09310			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647KB	20829798	Green Published, Green Submitted			2022-12-01	WOS:000281616300040
J	Rehani, M; Frush, D				Rehani, Madan; Frush, Donald			Tracking radiation exposure of patients	LANCET			English	Editorial Material							CT		[Rehani, Madan] IAEA, A-1400 Vienna, Austria; [Frush, Donald] Duke Radiol, Durham, NC USA	International Atomic Energy Agency	Rehani, M (corresponding author), IAEA, A-1400 Vienna, Austria.	m.rehani@iaea.org	Rehani, Madan/A-5198-2010	Rehani, Madan/0000-0003-3519-1516				Amis E Stephen Jr, 2007, J Am Coll Radiol, V4, P272, DOI 10.1016/j.jacr.2007.03.002; [Anonymous], ALLIANCE RAD SAFETY; [Anonymous], 2009, 160 NCRP; BERRINGTON DE, 2007, ARCH INTERN MED, V169, P2071; Birnbaum Steven, 2008, J Am Coll Radiol, V5, P714, DOI 10.1016/j.jacr.2008.02.016; FDA, 2010, FDA UNV IN RED UNN R; FDA, 2009, SAF INV CT BRAIN PER; *IAEA, IAEA SMART CARD SMAR; Neumann RD, 2010, J AM COLL RADIOL, V7, P87, DOI 10.1016/j.jacr.2009.07.012; Oikarinen H, 2009, EUR RADIOL, V19, P1161, DOI 10.1007/s00330-008-1256-7; Rehani MM, 2009, IAEA B, V50; Sodickson A, 2009, RADIOLOGY, V251, P175, DOI 10.1148/radiol.2511081296	12	36	36	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 4	2010	376	9743					754	755		10.1016/S0140-6736(10)60657-5	http://dx.doi.org/10.1016/S0140-6736(10)60657-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	650EC	20816532				2022-12-01	WOS:000281831000010
J	Kobayashi, T; Yamaguchi, T; Hamanaka, S; Kato-Itoh, M; Yamazaki, Y; Ibata, M; Sato, H; Lee, YS; Usui, J; Knisely, AS; Hirabayashi, M; Nakauchi, H				Kobayashi, Toshihiro; Yamaguchi, Tomoyuki; Hamanaka, Sanae; Kato-Itoh, Megumi; Yamazaki, Yuji; Ibata, Makoto; Sato, Hideyuki; Lee, Youn-Su; Usui, Jo-ichi; Knisely, A. S.; Hirabayashi, Masumi; Nakauchi, Hiromitsu			Generation of Rat Pancreas in Mouse by Interspecific Blastocyst Injection of Pluripotent Stem Cells	CELL			English	Article							DIFFERENTIATION; MICE; TRANSPLANTATION; CULTURE; PIGS	The complexity of organogenesis hinders in vitro generation of organs derived from a patient's pluripotent stem cells (PSCs), an ultimate goal of regenerative medicine. Mouse wild-type PSCs injected into Pdx1(-/-) (pancreatogenesis-disabled) mouse blastocysts developmentally compensated vacancy of the pancreatic "developmental niche,'' generating almost entirely PSC-derived pancreas. To examine the potential for xenogenic approaches in blastocyst complementation, we injected mouse or rat PSCs into rat or mouse blastocysts, respectively, generating interspecific chimeras and thus confirming that PSCs can contribute to xenogenic development between mouse and rat. The development of these mouse/rat chimeras was primarily influenced by host blastocyst and/or foster mother, evident by body size and species-specific organogenesis. We further injected rat wild-type PSCs into Pdx1(-/-) mouse blastocysts, generating normally functioning rat pancreas in Pdx1(-/-) mice. These data constitute proof of principle for interspecific blastocyst complementation and for generation in vivo of organs derived from donor PSCs using a xenogenic environment.	[Kobayashi, Toshihiro; Yamaguchi, Tomoyuki; Hamanaka, Sanae; Yamazaki, Yuji; Sato, Hideyuki; Lee, Youn-Su; Usui, Jo-ichi; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Therapy,Minato Ku, Tokyo 1088639, Japan; [Kobayashi, Toshihiro; Yamaguchi, Tomoyuki; Hamanaka, Sanae; Kato-Itoh, Megumi; Yamazaki, Yuji; Ibata, Makoto; Sato, Hideyuki; Lee, Youn-Su; Nakauchi, Hiromitsu] Japan Sci & Technol Agcy, ERATO, Nakauchi Stem Cell & Organ Regenerat Project, Minato Ku, Tokyo 1088639, Japan; [Kato-Itoh, Megumi; Hirabayashi, Masumi] Natl Inst Nat Sci, Natl Inst Physiol Sci, Ctr Genet Anal Behav, Okazaki, Aichi 4448585, Japan; [Hirabayashi, Masumi] Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi 4448585, Japan; [Knisely, A. S.] Kings Coll Hosp London, Inst Liver Studies, London SE5 9RS, England	University of Tokyo; Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London	Nakauchi, H (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Therapy,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	nakauchi@ims.u-tokyo.ac.jp	Hirabayashi, Masumi/C-8935-2019	Hirabayashi, Masumi/0000-0002-1059-5883; Kobayashi, Toshihiro/0000-0001-8019-0008	JST, the Ministry of Education, Culture, Sport, Science, and Technology, Japan	JST, the Ministry of Education, Culture, Sport, Science, and Technology, Japan	We thank Ryo Sumazaki for critical advice on this work, Kazuya Ise and Hirofumi Noguchi for technical advice on islet isolation and islet transplantation, and Naoki Iwamori for technical advice on embryo manipulation. This work was supported by grants from JST, the Ministry of Education, Culture, Sport, Science, and Technology, Japan. H.N. is a founder and shareholder of ReproCELL Inc.	Behringer R., 2003, MANIPULATING MOUSE E; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; DELTOUR L, 1991, DEVELOPMENT, V112, P1115; FEHILLY CB, 1984, NATURE, V307, P634, DOI 10.1038/307634a0; Fraidenraich D, 2004, SCIENCE, V306, P247, DOI 10.1126/science.1102612; Goldstein RS, 2002, DEV DYNAM, V225, P80, DOI 10.1002/dvdy.10108; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Hirabayashi M, 2010, MOL REPROD DEV, V77, P94, DOI 10.1002/mrd.21123; James D, 2006, DEV BIOL, V295, P90, DOI 10.1016/j.ydbio.2006.03.026; KAMELREID S, 1988, SCIENCE, V242, P1706, DOI 10.1126/science.2904703; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Muller SM, 2005, P NATL ACAD SCI USA, V102, P10587, DOI 10.1073/pnas.0502752102; Nagashima H, 2004, BIOL REPROD, V70, P702, DOI 10.1095/biolreprod.103.022681; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Offield MF, 1996, DEVELOPMENT, V122, P983; OGAWA S, 1971, NATURE, V233, P422, DOI 10.1038/233422a0; Oh SH, 1998, BIOL REPROD, V59, P884, DOI 10.1095/biolreprod59.4.884; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Okabe M, 2009, BLOOD, V114, P1764, DOI 10.1182/blood-2009-02-203695; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; ROSSANT J, 1980, SCIENCE, V208, P419, DOI 10.1126/science.7367871; ROSSANT J, 1982, J EMBRYOL EXP MORPH, V69, P141; Rossant J, 2007, REPROD FERT DEVELOP, V19, P111, DOI 10.1071/RD06125; Satoh M, 2007, TRANSPLANTATION, V83, P1085, DOI 10.1097/01.tp.0000260161.81775.58; Shinohara T, 2006, P NATL ACAD SCI USA, V103, P13624, DOI 10.1073/pnas.0604205103; SLACK JMW, 1995, DEVELOPMENT, V121, P1569; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; STERN MS, 1973, NATURE, V244, P472; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TARKOWSKI AK, 1962, J EMBRYOL EXP MORPH, V10, P476; Ueno H, 2009, P NATL ACAD SCI USA, V106, P175, DOI 10.1073/pnas.0810325105; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; ZEILMAKER GH, 1973, NATURE, V242, P115, DOI 10.1038/242115a0	43	364	398	2	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2010	142	5					787	799		10.1016/j.cell.2010.07.039	http://dx.doi.org/10.1016/j.cell.2010.07.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	646FL	20813264	Bronze			2022-12-01	WOS:000281523200021
J	Verdino, P; Witherden, DA; Havran, WL; Wilson, IA				Verdino, Petra; Witherden, Deborah A.; Havran, Wendy L.; Wilson, Ian A.			The Molecular Interaction of CAR and JAML Recruits the Central Cell Signal Transducer PI3K	SCIENCE			English	Article							JUNCTIONAL ADHESION MOLECULE; GROUP-B COXSACKIEVIRUSES; ADENOVIRUS RECEPTOR; T-CELLS; PROTEIN; BINDING; CD28; ACTIVATION; MIGRATION; 3-KINASE	Coxsackie and adenovirus receptor (CAR) is the primary cellular receptor for group B coxsackieviruses and most adenovirus serotypes and plays a crucial role in adenoviral gene therapy. Recent discovery of the interaction between junctional adhesion molecule-like protein (JAML) and CAR uncovered important functional roles in immunity, inflammation, and tissue homeostasis. Crystal structures of JAML ectodomain (2.2 angstroms) and its complex with CAR (2.8 angstroms) reveal an unusual immunoglobulin-domain assembly for JAML and a charged interface that confers high specificity. Biochemical and mutagenesis studies illustrate how CAR-mediated clustering of JAML recruits phosphoinositide 3-kinase (PI3K) to a JAML intracellular sequence motif as delineated for the ab T cell costimulatory receptor CD28. Thus, CAR and JAML are cell signaling receptors of the immune system with implications for asthma, cancer, and chronic nonhealing wounds.	[Verdino, Petra; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Witherden, Deborah A.; Havran, Wendy L.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu			NIH [AI42266, CA58896, AI52257, AI064811]; Austrian Science Fund; Skaggs Institute.; NATIONAL CANCER INSTITUTE [R01CA058896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052257, R01AI042266, R01AI064811, R37AI042266, R01AI036964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080301] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund(Austrian Science Fund (FWF)); Skaggs Institute.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Schiefner for help with the structure solution; S. Ferguson, H. Lindermuth, and J. Vanhasny for technical support; L. Teyton for providing cell lines; J. G. Luz, M. A. Adams-Cioaba, J. Stevens, D. A. Shore, A. L. Corper, R. L. Stanfield, and E. Ollmann Saphire for helpful discussions; and X. Dai and K. Saikatendu for assistance on synchrotron trips. We acknowledge the Advanced Light Source, Stanford Synchrotron Radiation Lightsource, and the Advanced Photon Source for use of their synchrotron facilities. This work was supported by NIH grants AI42266, CA58896 to I. A. W., and AI52257 and AI064811 to W. L. H., an Erwin-Schrodinger Fellowship of the Austrian Science Fund to P. V., and the Skaggs Institute. Atomic coordinates and structure factors for JAML and the CAR-JAML complex have been deposited in the Protein Data Bank with accession numbers 3MJ6 and 3MJ7 respectively. This is manuscript 18641-MB from The Scripps Research Institute.	Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bewley MC, 1999, SCIENCE, V286, P1579, DOI 10.1126/science.286.5444.1579; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; Carson SD, 2001, REV MED VIROL, V11, P219, DOI 10.1002/rmv.318; Davis SJ, 2003, NAT IMMUNOL, V4, P217, DOI 10.1038/ni0303-217; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Dustin ML, 2001, ANNU REV CELL DEV BI, V17, P133, DOI 10.1146/annurev.cellbio.17.1.133; Freimuth P, 2008, CURR TOP MICROBIOL, V323, P67; Guo YL, 2009, ARTERIOSCL THROM VAS, V29, P75, DOI 10.1161/ATVBAHA.108.177717; He YN, 2001, NAT STRUCT BIOL, V8, P874, DOI 10.1038/nsb1001-874; Howitt J, 2003, CURR TOP MICROBIOL, V272, P331; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jiang SK, 2007, PROTEIN SCI, V16, P539, DOI 10.1110/ps.062643507; Kanerva A, 2005, ANN MED, V37, P33, DOI 10.1080/07853890410018934; Luissint AC, 2008, J CELL BIOL, V183, P1159, DOI 10.1083/jcb.200805061; Moog-Lutz C, 2003, BLOOD, V102, P3371, DOI 10.1182/blood-2002-11-3462; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; RAAB M, 1995, P NATL ACAD SCI USA, V92, P8891, DOI 10.1073/pnas.92.19.8891; Rudd CE, 2003, NAT REV IMMUNOL, V3, P544, DOI 10.1038/nri1131; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; van Raaij MJ, 2000, STRUCTURE, V8, P1147, DOI 10.1016/S0969-2126(00)00528-1; Verma IM, 2005, ANNU REV BIOCHEM, V74, P711, DOI 10.1146/annurev.biochem.74.050304.091637; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4; WITHERDEN DA, 2010, SCIENCE, V329, pR30; Zen K, 2005, MOL BIOL CELL, V16, P2694, DOI 10.1091/mbc.E05-01-0036	25	91	100	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 3	2010	329	5996					1210	1214		10.1126/science.1187996	http://dx.doi.org/10.1126/science.1187996			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645SG	20813955	Green Accepted			2022-12-01	WOS:000281485600037
J	Beal, MF				Beal, M. Flint			Parkinson's disease: a model dilemma	NATURE			English	Editorial Material							ALPHA-SYNUCLEIN; TRANSGENIC MICE; MUTATION		[Beal, M. Flint] Weill Med Coll, Dept Neurol & Neurosci, New York, NY USA; [Beal, M. Flint] New York Presbyterian Cornell Campus, Neurol Serv, New York, NY USA	Cornell University	Beal, MF (corresponding author), Weill Med Coll, Dept Neurol & Neurosci, New York, NY USA.							Beal MF, 2001, NAT REV NEUROSCI, V2, P325, DOI 10.1038/35072550; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Li XT, 2010, J NEUROSCI, V30, P1788, DOI 10.1523/JNEUROSCI.5604-09.2010; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Lu XH, 2009, J NEUROSCI, V29, P1962, DOI 10.1523/JNEUROSCI.5351-08.2009; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Tong YR, 2009, P NATL ACAD SCI USA, V106, P14622, DOI 10.1073/pnas.0906334106	9	77	80	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2010	466	7310					S8	S10		10.1038/466S8a	http://dx.doi.org/10.1038/466S8a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20739935	Bronze			2022-12-01	WOS:000281203600060
J	Smith, K				Smith, Kerri			Treatment frontiers	NATURE			English	Editorial Material							GENOME-WIDE ASSOCIATION; PARKINSONS-DISEASE; BRAIN-STIMULATION; RISK-FACTORS; TRANSPLANTATION; NEURONS											BACKLUND EO, 1985, J NEUROSURG, V62, P169, DOI 10.3171/jns.1985.62.2.0169; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Fregni F, 2005, J NEUROL NEUROSUR PS, V76, P1614, DOI 10.1136/jnnp.2005.069849; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Lozano AM, 2008, BIOL PSYCHIAT, V64, P461, DOI 10.1016/j.biopsych.2008.05.034; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Rakovic A, 2010, HUM MOL GENET, V19, P3124, DOI 10.1093/hmg/ddq215; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105	17	8	8	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2010	466	7310					S15	S18		10.1038/466S15a	http://dx.doi.org/10.1038/466S15a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20739932	Bronze			2022-12-01	WOS:000281203600063
J	Schmidt, AC				Schmidt, Alexander C.			Response to Dengue Fever -- The Good, the Bad, and the Ugly?.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INFECTION; VACCINE		NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Schmidt, AC (corresponding author), NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA.							Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004; Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690	5	34	37	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 29	2010	363	5					484	487		10.1056/NEJMcibr1005904	http://dx.doi.org/10.1056/NEJMcibr1005904			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632GS	20818870				2022-12-01	WOS:000280411300016
J	Adeyi, O; Atun, R				Adeyi, Olusoji; Atun, Rifat			Universal access to malaria medicines: innovation in financing and delivery	LANCET			English	Editorial Material									[Adeyi, Olusoji; Atun, Rifat] Global Fund Fight AIDS TB & Malaria, CH-1214 Geneva, Switzerland; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, London, England	Imperial College London	Adeyi, O (corresponding author), Global Fund Fight AIDS TB & Malaria, Chemin Blandonnet 8, CH-1214 Geneva, Switzerland.	Olusoji.Adeyi@Theglobalfund.org	Atun, Rifat/AAH-5537-2021	Atun, Rifat/0000-0002-1531-5983				ACTwatch Group, 2009, 5 PAN AFR MAL C NAIR; AMFm Task Force of the Roll Back Malaria Partnership, 2007, AFF MED FAC MAL AMFM; [Anonymous], 2010, ECONOMIST       0107; [Anonymous], 2008, GLOB MAL ACT PLAN MA; Arrow Kenneth J., 2004, SAV LIV BUYING TIM E; Frost L, 2009, PROCESS EVALUATION P; *GLOB FUND, 2009, 5 YEAR EV GLOB FUND; Gwatkin D. R., 2005, REACHING POOR HLTH N; Laxminarayan R, 2006, HEALTH AFFAIR, V25, P325, DOI 10.1377/hlthaff.25.2.325; Laxminarayan R, 2009, HEALTH AFFAIR, V28, P949, DOI 10.1377/hlthaff.28.4.949; Lim SS, 2008, LANCET, V372, P2031, DOI 10.1016/S0140-6736(08)61869-3; President's Malaria Initiative, PRES MAL IN; Sabot OJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006857; Talisuna A, 2009, LANCET, V374, P1224, DOI 10.1016/S0140-6736(09)61767-0; The Global Fund, 2009, GLOB FUND 5 YEAR EV; The Global Fund, 2010, AFF MED FAC MAL FREQ; The World Bank, 2010, COUNT MAL OUT JUN 4; World Health Organization WHO, 2006, GUID TREATM MAL; World Health Organization (WHO, 2009, WORLD MAL REP 2009; World Health Organization (WHO), 2010, GUID TREATM MAL	20	33	33	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV-DEC	2010	376	9755					1869	1871		10.1016/S0140-6736(10)61189-0	http://dx.doi.org/10.1016/S0140-6736(10)61189-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	696KG	20940074				2022-12-01	WOS:000285439700036
J	Hu, FH; Luo, WB; Hong, M				Hu, Fanghao; Luo, Wenbin; Hong, Mei			Mechanisms of Proton Conduction and Gating in Influenza M2 Proton Channels from Solid-State NMR	SCIENCE			English	Article							A VIRUS; ION-CHANNEL; TAUTOMERIC EQUILIBRIA; TRANSMEMBRANE PEPTIDE; BINDING-SITE; ACID-BASE; H-BOND; HISTIDINE; MODEL; SPECTROSCOPY	The M2 protein of influenza viruses forms an acid-activated tetrameric proton channel. We used solid-state nuclear magnetic resonance spectroscopy to determine the structure and functional dynamics of the pH-sensing and proton-selective histidine-37 in M2 bound to a cholesterol-containing virus-envelope-mimetic membrane so as to better understand the proton conduction mechanism. In the high-pH closed state, the four histidines form an edge-face p-stacked structure, preventing the formation of a hydrogen-bonded water chain to conduct protons. In the low-pH conducting state, the imidazoliums hydrogen-bond extensively with water and undergo microsecond ring reorientations with an energy barrier greater than 59 kilojoules per mole. This barrier is consistent with the temperature dependence of proton conductivity, suggesting that histidine-37 dynamically shuttles protons into the virion. We propose a proton conduction mechanism in which ring-flip-assisted imidazole deprotonation is the rate-limiting step.	[Hu, Fanghao; Luo, Wenbin; Hong, Mei] Iowa State Univ, Dept Chem, Ames, IA 50011 USA	Iowa State University	Hong, M (corresponding author), Iowa State Univ, Dept Chem, Ames, IA 50011 USA.	mhong@iastate.edu		Hong, Mei/0000-0001-5255-5858	NSF [MCB-543473]; NIH [GM088204]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088204] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Li for discussions. This work was supported by NSF grant MCB-543473 and NIH grant GM088204.	Ash EL, 2000, P NATL ACAD SCI USA, V97, P10371, DOI 10.1073/pnas.97.19.10371; BACHOVCHIN WW, 1978, J AM CHEM SOC, V100, P8041, DOI 10.1021/ja00494a001; Brinen LS, 1996, BIOCHEMISTRY-US, V35, P5999, DOI 10.1021/bi9530200; Bureekaew S, 2009, NAT MATER, V8, P831, DOI [10.1038/NMAT2526, 10.1038/nmat2526]; Cady SD, 2010, NATURE, V463, P689, DOI 10.1038/nature08722; Cady SD, 2009, BIOCHEMISTRY-US, V48, P7356, DOI 10.1021/bi9008837; Chen HN, 2007, BIOPHYS J, V93, P3470, DOI 10.1529/biophysj.107.105742; DEREWENDA ZS, 1994, J MOL BIOL, V241, P83, DOI 10.1006/jmbi.1994.1475; Fischbach I, 2004, J PHYS CHEM B, V108, P18500, DOI 10.1021/jp046848h; Gandhi CS, 1999, J BIOL CHEM, V274, P5474, DOI 10.1074/jbc.274.9.5474; Henry B, 2002, J AM CHEM SOC, V124, P2025, DOI 10.1021/ja011638t; Hu J, 2006, P NATL ACAD SCI USA, V103, P6865, DOI 10.1073/pnas.0601944103; Khurana E, 2009, P NATL ACAD SCI USA, V106, P1069, DOI 10.1073/pnas.0811720106; Lin TI, 2001, J VIROL, V75, P3647, DOI 10.1128/JVI.75.8.3647-3656.2001; Luo WB, 2007, J PHYS CHEM B, V111, P10825, DOI 10.1021/jp073823k; Luo WB, 2010, J AM CHEM SOC, V132, P2378, DOI 10.1021/ja9096219; Luo WB, 2009, BIOCHEMISTRY-US, V48, P6361, DOI 10.1021/bi900716s; Ma CL, 2009, P NATL ACAD SCI USA, V106, P12283, DOI 10.1073/pnas.0905726106; Mauritz KA, 2004, CHEM REV, V104, P4535, DOI 10.1021/cr0207123; Mould JA, 2000, J BIOL CHEM, V275, P8592, DOI 10.1074/jbc.275.12.8592; MUNOWITZ M, 1982, J AM CHEM SOC, V104, P1192, DOI 10.1021/ja00369a007; NAGLE JF, 1978, P NATL ACAD SCI USA, V75, P298, DOI 10.1073/pnas.75.1.298; Nishimura K, 2002, BIOCHEMISTRY-US, V41, P13170, DOI 10.1021/bi0262799; Okada A, 2001, BIOCHEMISTRY-US, V40, P6053, DOI 10.1021/bi0028441; Pinto LH, 1997, P NATL ACAD SCI USA, V94, P11301, DOI 10.1073/pnas.94.21.11301; Scheiner S, 2002, J AM CHEM SOC, V124, P13257, DOI 10.1021/ja027200q; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Song XJ, 2001, MAGN RESON CHEM, V39, pS30, DOI 10.1002/mrc.956; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Tang YJ, 2002, J BIOL CHEM, V277, P39880, DOI 10.1074/jbc.M206582200; WANG C, 1995, BIOPHYS J, V69, P1363, DOI 10.1016/S0006-3495(95)80003-2; Waters ML, 2002, CURR OPIN CHEM BIOL, V6, P736, DOI 10.1016/S1367-5931(02)00359-9; Yi M, 2008, J PHYS CHEM B, V112, P7977, DOI 10.1021/jp800171m; Yi MG, 2009, P NATL ACAD SCI USA, V106, P13311, DOI 10.1073/pnas.0906553106	34	256	258	8	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					505	508		10.1126/science.1191714	http://dx.doi.org/10.1126/science.1191714			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966251	Green Accepted			2022-12-01	WOS:000283329100040
J	Rimer, JD; An, ZH; Zhu, ZN; Lee, MH; Goldfarb, DS; Wesson, JA; Ward, MD				Rimer, Jeffrey D.; An, Zhihua; Zhu, Zina; Lee, Michael H.; Goldfarb, David S.; Wesson, Jeffrey A.; Ward, Michael D.			Crystal Growth Inhibitors for the Prevention of L-Cystine Kidney Stones Through Molecular Design	SCIENCE			English	Article							ATOMIC-FORCE MICROSCOPY; CALCIUM-OXALATE MONOHYDRATE; HEXAGONAL L-CYSTINE; MALARIA PIGMENT; CRYSTALLIZATION; NUCLEATION; ADDITIVES; BINDING; MODEL; DIMETHYLESTER	Crystallization of L-cystine is a critical step in the pathogenesis of cystine kidney stones. Treatments for this disease are somewhat effective but often lead to adverse side effects. Real-time in situ atomic force microscopy (AFM) reveals that L-cystine dimethylester (L-CDME) and L-cystine methylester (L-CME) dramatically reduce the growth velocity of the six symmetry-equivalent {100} steps because of specific binding at the crystal surface, which frustrates the attachment of L-cystine molecules. L-CDME and L-CME produce L-cystine crystals with different habits that reveal distinct binding modes at the crystal surfaces. The AFM observations are mirrored by reduced crystal yield and crystal size in the presence of L-CDME and L-CME, collectively suggesting a new pathway to the prevention of L-cystine stones by rational design of crystal growth inhibitors.	[Rimer, Jeffrey D.; An, Zhihua; Zhu, Zina; Lee, Michael H.; Ward, Michael D.] NYU, Dept Chem, New York, NY 10003 USA; [Rimer, Jeffrey D.; An, Zhihua; Zhu, Zina; Lee, Michael H.; Ward, Michael D.] NYU, Inst Mol Design, New York, NY 10003 USA; [Goldfarb, David S.] New York Harbor Vet Affairs Med Ctr, Nephrol Sect, New York, NY 10010 USA; [Goldfarb, David S.] NYU, Sch Med, New York, NY 10010 USA; [Wesson, Jeffrey A.] Dept Vet Affairs Med Ctr, Div Nephrol, Milwaukee, WI 53295 USA; [Wesson, Jeffrey A.] Med Coll Wisconsin, Milwaukee, WI 53295 USA	New York University; New York University; New York University; Medical College of Wisconsin	Ward, MD (corresponding author), NYU, Dept Chem, 100 Washington Sq E, New York, NY 10003 USA.	mdw3@nyu.edu	An, Zhihua/A-6662-2009; Wesson, Jeffrey/ABA-8942-2021	Lee, Michael/0000-0002-5739-8369; Goldfarb, David/0000-0002-9215-1273	NIH [NIDDK R01-DK068551]; NYU Molecular Design Institute; Office of Rare Disease Research [1U54DK083908-01]; NSF/U.S. Department of Energy (DOE) (NSF/DOE) [CHE-0535644]; Direct For Mathematical & Physical Scien [0822838] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068551, U54DK083908] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYU Molecular Design Institute; Office of Rare Disease Research; NSF/U.S. Department of Energy (DOE) (NSF/DOE)(United States Department of Energy (DOE)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported primarily by NIH (NIDDK R01-DK068551) and the NYU Molecular Design Institute. The authors also acknowledge support from the Office of Rare Disease Research (1U54DK083908-01) and the Advanced Photon Source, ChemMatCARS Sector 15, which is principally supported by NSF/U.S. Department of Energy (DOE) (NSF/DOE; CHE-0535644). The authors thank C. Hu, M. Li, Y.-S. Chen, and G. Kowach for technical assistance and B. Kahr for helpful discussions.	Ahmed K, 2006, POSTGRAD MED J, V82, P799, DOI 10.1136/pgmj.2005.044156; Becker G, 2007, NEPHROLOGY, V12, pS4, DOI 10.1111/j.1440-1797.2006.00722.x; Buller R, 2002, CRYST GROWTH DES, V2, P553, DOI 10.1021/cg025550i; Carta R, 1996, J CHEM ENG DATA, V41, P414, DOI 10.1021/je9501853; CHANEY MO, 1974, ACTA CRYSTALLOGR B, V30, P711, DOI 10.1107/S0567740874003566; Clydesdale G, 2003, J PHYS CHEM B, V107, P4826, DOI 10.1021/jp022423o; Dahaoui S, 1999, J PHYS CHEM A, V103, P6240, DOI 10.1021/jp990641k; DAVEY RJ, 1992, J CHEM SOC FARADAY T, V88, P3461, DOI 10.1039/ft9928803461; Dolin DJ, 2005, J ENDOUROL, V19, P429, DOI 10.1089/end.2005.19.429; FOREMAN JW, 1987, METABOLISM, V36, P1185, DOI 10.1016/0026-0495(87)90246-0; Fujiki Y, 2006, ANGEW CHEM INT EDIT, V45, P4764, DOI 10.1002/anie.200601470; GIRIJA EK, 1995, J MATER SCI-MATER M, V6, P617, DOI 10.1007/BF00123439; Grohe B, 2007, J AM CHEM SOC, V129, P14946, DOI 10.1021/ja0745613; Guo SW, 2002, LANGMUIR, V18, P4284, DOI 10.1021/la011754+; HILLIER AC, 1994, SCIENCE, V263, P1261, DOI 10.1126/science.263.5151.1261; Jung T, 2004, LANGMUIR, V20, P8587, DOI 10.1021/la0488755; Kessler A, 2008, NEUROCHEM RES, V33, P737, DOI 10.1007/s11064-007-9486-7; LEVITT LS, 1975, INDIAN J PHYS, V49, P696; Liou YC, 2000, NATURE, V406, P322, DOI 10.1038/35018604; Mattoo A, 2008, SEMIN NEPHROL, V28, P181, DOI 10.1016/j.semnephrol.2008.01.011; MICHAELS AS, 1961, J PHYS CHEM-US, V65, P1730, DOI 10.1021/j100827a014; Moe OW, 2006, LANCET, V367, P333, DOI 10.1016/S0140-6736(06)68071-9; Nakagawa Y, 2000, J UROLOGY, V164, P1481, DOI 10.1016/S0022-5347(05)67011-5; Orme CA, 2001, NATURE, V411, P775, DOI 10.1038/35081034; OUGHTON BM, 1959, ACTA CRYSTALLOGR, V12, P396, DOI 10.1107/S0365110X59001177; Sheng XX, 2005, P NATL ACAD SCI USA, V102, P267, DOI 10.1073/pnas.0406835101; Sizemore JP, 2009, CRYST GROWTH DES, V9, P2637, DOI 10.1021/cg8011124; Solomonov I, 2007, J AM CHEM SOC, V129, P2615, DOI 10.1021/ja0674183; Stephenson AE, 2008, SCIENCE, V322, P724, DOI 10.1126/science.1159417; Tiller W. A., 1991, SCI CRYSTALLIZATION; Ward MD, 2001, CHEM REV, V101, P1697, DOI 10.1021/cr000020j; WEISSBUCH I, 1991, SCIENCE, V253, P637, DOI 10.1126/science.253.5020.637; Weissbuch I, 2003, CRYST GROWTH DES, V3, P125, DOI 10.1021/cg0200560; Wilmer MJ, 2007, PEDIATR RES, V62, P151, DOI 10.1203/PDR.0b013e31809fd9a7	34	155	159	6	205	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					337	341		10.1126/science.1191968	http://dx.doi.org/10.1126/science.1191968			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947757	Green Accepted			2022-12-01	WOS:000282986700032
J	Alushin, GM; Ramey, VH; Pasqualato, S; Ball, DA; Grigorieff, N; Musacchio, A; Nogales, E				Alushin, Gregory M.; Ramey, Vincent H.; Pasqualato, Sebastiano; Ball, David A.; Grigorieff, Nikolaus; Musacchio, Andrea; Nogales, Eva			The Ndc80 kinetochore complex forms oligomeric arrays along microtubules	NATURE			English	Article							CHROMOSOME BI-ORIENTATION; ELECTRON-MICROSCOPY; ATTACHMENT SITE; MOLECULAR ARCHITECTURE; OUTER KINETOCHORE; STRUCTURAL BASIS; SPINDLE POLE; RESOLUTION; HEC1; VISUALIZATION	The Ndc80 complex is a key site of regulated kinetochore-microtubule attachment (a process required for cell division), but the molecular mechanism underlying its function remains unknown. Here we present a subnanometre-resolution cryo-electron microscopy reconstruction of the human Ndc80 complex bound to microtubules, sufficient for precise docking of crystal structures of the component proteins. We find that the Ndc80 complex binds the microtubule with a tubulin monomer repeat, recognizing alpha- and beta-tubulin at both intra-and inter-tubulin dimer interfaces in a manner that is sensitive to tubulin conformation. Furthermore, Ndc80 complexes self-associate along protofilaments through interactions mediated by the amino-terminal tail of the NDC80 protein, which is the site of phospho-regulation by Aurora B kinase. The complex's mode of interaction with the microtubule and its oligomerization suggest a mechanism by which Aurora B could regulate the stability of load-bearing kinetochore-microtubule attachments.	[Ball, David A.; Nogales, Eva] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Alushin, Gregory M.; Ramey, Vincent H.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Pasqualato, Sebastiano; Musacchio, Andrea] European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy; [Grigorieff, Nikolaus] Brandeis Univ, Rosenstiel Basic Med Res Ctr, Howard Hughes Med Inst, Waltham, MA 02453 USA; [Musacchio, Andrea] Italian Inst Technol, Res Unit, I-20139 Milan, Italy; [Nogales, Eva] Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; IRCCS European Institute of Oncology (IEO); Brandeis University; Howard Hughes Medical Institute; Istituto Italiano di Tecnologia - IIT; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Nogales, E (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA.	enogales@lbl.gov	Pasqualato, Sebastiano/G-1032-2011	Pasqualato, Sebastiano/0000-0002-9038-7768; Grigorieff, Nikolaus/0000-0002-1506-909X; Alushin, Gregory/0000-0001-7250-4484; Musacchio, Andrea/0000-0003-2362-8784	National Institute of General Medical Sciences	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to K. H. Downing for supporting the work carried out by D.A.B., to C. Ciferri for his knowledge and advice about the Ndc80 complex and critical reading of the manuscript, and to P. Grob and S. Lipscomb for electron-microscopy and computer support, respectively. We also acknowledge D. Typke and B. Glaeser for advice on data collection, and C. Sindelar for discussion of data processing strategies. This work was funded by a grant from the National Institute of General Medical Sciences (E.N.). E.N. and N.G. are Howard Hughes Medical Institute Investigators.	Abr?moff MD., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Amat F, 2008, J STRUCT BIOL, V161, P260, DOI 10.1016/j.jsb.2007.07.007; Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; ARNAL I, 1995, CURR BIOL, V5, P900, DOI 10.1016/S0960-9822(95)00180-1; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Chen JZ, 2009, P NATL ACAD SCI USA, V106, P10644, DOI 10.1073/pnas.0904024106; Chen YM, 1997, MOL CELL BIOL, V17, P6049, DOI 10.1128/MCB.17.10.6049; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2003, CURR BIOL, V13, P2103, DOI 10.1016/j.cub.2003.10.056; des Georges A, 2008, NAT STRUCT MOL BIOL, V15, P1102, DOI 10.1038/nsmb.1482; Dong YM, 2007, NAT CELL BIOL, V9, P516, DOI 10.1038/ncb1576; Egelman EH, 2007, J STRUCT BIOL, V157, P83, DOI 10.1016/j.jsb.2006.05.015; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Goddard TD, 2005, STRUCTURE, V13, P473, DOI 10.1016/j.str.2005.01.006; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Guimaraes GJ, 2008, CURR BIOL, V18, P1778, DOI 10.1016/j.cub.2008.08.012; Hayashi I, 2005, MOL CELL, V19, P449, DOI 10.1016/j.molcel.2005.06.034; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; Hoenger A, 2008, METHOD CELL BIOL, V84, P425, DOI 10.1016/S0091-679X(07)84014-3; Joglekar AP, 2008, J CELL BIOL, V181, P587, DOI 10.1083/jcb.200803027; Joglekar AP, 2006, NAT CELL BIOL, V8, P581, DOI 10.1038/ncb1414; Kemmler S, 2009, EMBO J, V28, P1099, DOI 10.1038/emboj.2009.62; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu D, 2010, J CELL BIOL, V188, P809, DOI 10.1083/jcb.201001006; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; LOMBILLO VA, 1995, NATURE, V373, P161, DOI 10.1038/373161a0; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maresca TJ, 2009, J CELL BIOL, V184, P373, DOI 10.1083/jcb.200808130; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; McIntosh JR, 2008, CELL, V135, P322, DOI 10.1016/j.cell.2008.08.038; Miller SA, 2008, CURR BIOL, V18, P1785, DOI 10.1016/j.cub.2008.11.007; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mizuno N, 2007, P NATL ACAD SCI USA, V104, P20832, DOI 10.1073/pnas.0710406105; Powers AF, 2009, CELL, V136, P865, DOI 10.1016/j.cell.2008.12.045; Ramey VH, 2009, J STRUCT BIOL, V167, P97, DOI 10.1016/j.jsb.2009.05.002; Sachse C, 2007, J MOL BIOL, V371, P812, DOI 10.1016/j.jmb.2007.05.088; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Stewart A, 2004, ULTRAMICROSCOPY, V102, P67, DOI 10.1016/j.ultramic.2004.08.008; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; WADE RH, 1990, J MOL BIOL, V212, P775, DOI 10.1016/0022-2836(90)90236-F; Wan XH, 2009, CELL, V137, P672, DOI 10.1016/j.cell.2009.03.035; Wang HW, 2008, J MOL BIOL, V383, P894, DOI 10.1016/j.jmb.2008.08.077; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Wei RR, 2006, STRUCTURE, V14, P1003, DOI 10.1016/j.str.2006.04.007; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.1093/biomet/34.1-2.28; Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967; WILSON L, 1982, J MOL BIOL, V159, P125, DOI 10.1016/0022-2836(82)90035-3; Wilson-Kubalek EM, 2008, J CELL BIOL, V182, P1055, DOI 10.1083/jcb.200804170	57	213	214	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2010	467	7317					805	U68		10.1038/nature09423	http://dx.doi.org/10.1038/nature09423			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944740	Green Accepted, Green Submitted			2022-12-01	WOS:000282898700058
J	Chekeni, FB; Elliott, MR; Sandilos, JK; Walk, SF; Kinchen, JM; Lazarowski, ER; Armstrong, AJ; Penuela, S; Laird, DW; Salvesen, GS; Isakson, BE; Bayliss, DA; Ravichandran, KS				Chekeni, Faraaz B.; Elliott, Michael R.; Sandilos, Joanna K.; Walk, Scott F.; Kinchen, Jason M.; Lazarowski, Eduardo R.; Armstrong, Allison J.; Penuela, Silvia; Laird, Dale W.; Salvesen, Guy S.; Isakson, Brant E.; Bayliss, Douglas A.; Ravichandran, Kodi S.			Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis	NATURE			English	Article							ACTIVATION; CLEAVAGE; ACCUMULATION; FAMILY; CELLS	Apoptotic cells release 'find-me' signals at the earliest stages of death to recruit phagocytes(1). The nucleotides ATP and UTP represent one class of find-me signals(2), but their mechanism of release is not known. Here, we identify the plasma membrane channel pannexin 1 (PANX1) as a mediator of find-me signal/nucleotide release from apoptotic cells. Pharmacological inhibition and siRNA-mediated knockdown of PANX1 led to decreased nucleotide release and monocyte recruitment by apoptotic cells. Conversely, PANX1 overexpression enhanced nucleotide release from apoptotic cells and phagocyte recruitment. Patch-clamp recordings showed that PANX1 was basally inactive, and that induction of PANX1 currents occurred only during apoptosis. Mechanistically, PANX1 itself was a target of effector caspases (caspases 3 and 7), and a specific caspase-cleavage site within PANX1 was essential for PANX1 function during apoptosis. Expression of truncated PANX1 (at the putative caspase cleavage site) resulted in a constitutively open channel. PANX1 was also important for the 'selective' plasma membrane permeability of early apoptotic cells to specific dyes(3). Collectively, these data identify PANX1 as a plasma membrane channel mediating the regulated release of find-me signals and selective plasma membrane permeability during apoptosis, and a new mechanism of PANX1 activation by caspases.	[Chekeni, Faraaz B.; Elliott, Michael R.; Walk, Scott F.; Kinchen, Jason M.; Armstrong, Allison J.; Ravichandran, Kodi S.] Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; [Chekeni, Faraaz B.; Sandilos, Joanna K.; Bayliss, Douglas A.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Elliott, Michael R.; Walk, Scott F.; Kinchen, Jason M.; Armstrong, Allison J.; Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA; [Kinchen, Jason M.; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Isakson, Brant E.] Univ Virginia, Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Isakson, Brant E.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Lazarowski, Eduardo R.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Penuela, Silvia; Laird, Dale W.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada; [Salvesen, Guy S.] Burnham Inst Med Res, Program Apoptosis & Cell Death Res, La Jolla, CA 92037 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of North Carolina; University of North Carolina Chapel Hill; Western University (University of Western Ontario); Sanford Burnham Prebys Medical Discovery Institute	Ravichandran, KS (corresponding author), Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA.	Ravi@virgina.edu	Laird, Dale W/AAL-2407-2020; Penuela, Silvia/A-6961-2010; Kinchen, Jason/ABC-5663-2021; Laird, Dale w/E-4176-2015	Laird, Dale W/0000-0002-4568-3285; Penuela, Silvia/0000-0003-4829-5517; Elliott, Michael/0000-0002-0642-482X; Ravichandran, Kodi/0000-0001-9049-1410; Kinchen, Jason/0000-0001-8430-2265	NIGMS; NHLBI; AHA; National Institutes of Health; American Heart Association; American Cancer Society; American Asthma Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL096400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055432, T32AI007496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033583] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AHA(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Cancer Society(American Cancer Society); American Asthma Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Ravichandran laboratory for their comments and suggestions. We also thank R. E. Campbell for providing the construct for mBlueberry2. This work was supported by the Pharmacological Sciences Training Grant (F. B. C. andJ. K. S.) (NIGMS), a F30 pre-doctoral fellowship from the NHLBI (F. B. C.), a pre-doctoral fellowship from the AHA (J. K. S.), and grants from the National Institutes of Health (K. S. R.). J. M. K. is supported by grants from the American Heart Association (Scientist Development Grant) and the American Cancer Society. K. S. R. is a William Benter Senior Fellow of the American Asthma Foundation.	Ai HW, 2007, BIOCHEMISTRY-US, V46, P5904, DOI 10.1021/bi700199g; Ambrosi C, 2010, J BIOL CHEM, V285, P24420, DOI 10.1074/jbc.M110.115444; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Burnstock G, 2004, INT REV CYTOL, V240, P31, DOI 10.1016/S0074-7696(04)40002-3; Chen XD, 2009, J NEUROPHYSIOL, V101, P129, DOI 10.1152/jn.01352.2007; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Denault Jean-Bernard, 2008, V414, P191; ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; IDZIOREK T, 1995, J IMMUNOL METHODS, V185, P249, DOI 10.1016/0022-1759(95)00172-7; Johnson CE, 2008, CELL, V134, P720, DOI 10.1016/j.cell.2008.08.019; Kadl A, 2009, ARTHRITIS RHEUM-US, V60, P1362, DOI 10.1002/art.24448; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lazarowski ER, 1999, BRIT J PHARMACOL, V127, P1272, DOI 10.1038/sj.bjp.0702654; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Praetorius HA, 2009, PURINERG SIGNAL, V5, P433, DOI 10.1007/s11302-009-9146-2; Scemes E, 2009, PFLUG ARCH EUR J PHY, V457, P1207, DOI 10.1007/s00424-008-0591-5; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Sohl G, 2005, NAT REV NEUROSCI, V6, P191, DOI 10.1038/nrn1627; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Wee LJK, 2007, BIOINFORMATICS, V23, P3241, DOI 10.1093/bioinformatics/btm334	33	742	761	3	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2010	467	7317					863	U136		10.1038/nature09413	http://dx.doi.org/10.1038/nature09413			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944749	Green Accepted, Green Submitted			2022-12-01	WOS:000282898700071
J	Ruschak, AM; Religa, TL; Breuer, S; Witt, S; Kay, LE				Ruschak, Amy M.; Religa, Tomasz L.; Breuer, Sarah; Witt, Susanne; Kay, Lewis E.			The proteasome antechamber maintains substrates in an unfolded state	NATURE			English	Article							SIDE-CHAIN DYNAMICS; 20S PROTEASOME; NMR-SPECTROSCOPY; FOLDING PATHWAY; METHYL-GROUPS; BETA-SHEET; WW DOMAIN; RELAXATION; PROTEIN; MECHANISM	Eukaryotes and archaea use a protease called the proteasome that has an integral role in maintaining cellular function through the selective degradation of proteins(1-4). Proteolysis occurs in a barrelshaped 20S core particle, which in Thermoplasma acidophilum is built from four stacked homoheptameric rings of subunits, alpha and beta, arranged alpha(7)beta(7)beta(7)alpha(7) (ref. 5). These rings form three interconnected cavities, including a pair of antechambers (formed by alpha(7)beta(7)) through which substrates are passed before degradation and a catalytic chamber (beta(7)beta(7)) where the peptide-bond hydrolysis reaction occurs(4,5). Although it is clear that substrates must be unfolded to enter through narrow, gated passageways (13 angstrom in diameter) located on the alpha-rings(1,6,7), the structural and dynamical properties of substrates inside the proteasome antechamber remain unclear. Confinement in the antechamber might be expected to promote folding and thus impede proteolysis. Here we investigate the folding, stability and dynamics of three small protein substrates in the antechamber by methyl transverse-relaxation-optimized NMR spectroscopy(8). We show that these substrates interact actively with the antechamber walls and have drastically altered kinetic and equilibrium properties that maintain them in unstructured states so as to be accessible for hydrolysis.	[Ruschak, Amy M.; Religa, Tomasz L.; Kay, Lewis E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Ruschak, Amy M.; Religa, Tomasz L.; Kay, Lewis E.] Univ Toronto, Dept Biochem & Chem, Toronto, ON M5S 1A8, Canada; [Breuer, Sarah; Witt, Susanne] Max Planck Inst Biochem, Dept Biol Struct, D-82152 Martinsried, Germany	University of Toronto; University of Toronto; Max Planck Society	Kay, LE (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	kay@pound.med.utoronto.ca			European Molecular Biology Organization [ALTF 827-2006]; Canadian Institutes of Health Research (CIHR); Canada Research Chair in Biochemistry; Natural Sciences and Engineering Research Council of Canada	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Biochemistry(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The authors would like to thank J. Forman-Kay for providing laboratory space and for discussions, R. Muhandiram for NMR support, H. Lin for help designing protein purification protocols, X. Li and A. Shimmer for assistance with the plate reader, and W. Baumeister for discussions. T. L. R. acknowledges The European Molecular Biology Organization (ALTF 827-2006) and The Canadian Institutes of Health Research (CIHR) for postdoctoral fellowships. L. E. K. holds a Canada Research Chair in Biochemistry. This work was supported by grants from the CIHR and the Natural Sciences and Engineering Research Council of Canada.	Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Cheng AG, 2009, OLIGONUCLEOTIDES, V19, P203, DOI 10.1089/oli.2008.0176; Choy WY, 2003, J AM CHEM SOC, V125, P1748, DOI 10.1021/ja021179b; Clore GM, 2007, CURR OPIN STRUC BIOL, V17, P603, DOI 10.1016/j.sbi.2007.08.013; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ellis RJ, 2003, CURR BIOL, V13, pR881, DOI 10.1016/j.cub.2003.10.051; Fersht A, 1999, STRUCTURE MECH PROTE; Fitzkee NC, 2004, P NATL ACAD SCI USA, V101, P12497, DOI 10.1073/pnas.0404236101; Forster A, 2003, TRENDS CELL BIOL, V13, P550, DOI 10.1016/j.tcb.2003.09.001; Hutschenreiter S, 2004, EMBO J, V23, P2488, DOI 10.1038/sj.emboj.7600262; Jager M, 2006, P NATL ACAD SCI USA, V103, P10648, DOI 10.1073/pnas.0600511103; Jager M, 2001, J MOL BIOL, V311, P373, DOI 10.1006/jmbi.2001.4873; Jager M, 2008, BIOPOLYMERS, V90, P751, DOI 10.1002/bip.21101; Kisselev AF, 2000, J BIOL CHEM, V275, P14831, DOI 10.1074/jbc.275.20.14831; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Marques AJ, 2009, CHEM REV, V109, P1509, DOI 10.1021/cr8004857; MATSUNAGA N, 1977, J PHYS CHEM-US, V6, P1133; Mayor U, 2003, NATURE, V421, P863, DOI 10.1038/nature01428; Neudecker P, 2006, J MOL BIOL, V363, P958, DOI 10.1016/j.jmb.2006.08.047; Ruschak AM, 2010, J BIOMOL NMR, V46, P75, DOI 10.1007/s10858-009-9376-1; Sharon M, 2006, J BIOL CHEM, V281, P9569, DOI 10.1074/jbc.M511951200; Sprangers R, 2007, NAT METHODS, V4, P697, DOI 10.1038/NMETH1080; Sprangers R, 2007, NATURE, V445, P618, DOI 10.1038/nature05512; Stollar EJ, 2003, J BIOL CHEM, V278, P43699, DOI 10.1074/jbc.M308029200; Tugarinov V, 2003, J AM CHEM SOC, V125, P10420, DOI 10.1021/ja030153x; Tugarinov V, 2007, J AM CHEM SOC, V129, P1743, DOI 10.1021/ja067827z; Tugarinov V, 2006, J AM CHEM SOC, V128, P7299, DOI 10.1021/ja060817d; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Zhou HX, 2008, ARCH BIOCHEM BIOPHYS, V469, P76, DOI 10.1016/j.abb.2007.07.013; ZWICKL P, 1994, NAT STRUCT BIOL, V1, P765, DOI 10.1038/nsb1194-765	34	93	93	2	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2010	467	7317					868	U142		10.1038/nature09444	http://dx.doi.org/10.1038/nature09444			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944750				2022-12-01	WOS:000282898700072
J	Bobrow, BJ; Spaite, DW; Berg, RA; Stolz, U; Sanders, AB; Kern, KB; Vadeboncoeur, TF; Clark, LL; Gallagher, JV; Stapczynski, JS; LoVecchio, F; Mullins, TJ; Humble, WO; Ewy, GA				Bobrow, Bentley J.; Spaite, Daniel W.; Berg, Robert A.; Stolz, Uwe; Sanders, Arthur B.; Kern, Karl B.; Vadeboncoeur, Tyler F.; Clark, Lani L.; Gallagher, John V.; Stapczynski, J. Stephan; LoVecchio, Frank; Mullins, Terry J.; Humble, Will O.; Ewy, Gordon A.			Chest Compression-Only CPR by Lay Rescuers and Survival From Out-of-Hospital Cardiac Arrest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BYSTANDER CARDIOPULMONARY-RESUSCITATION; AMERICAN-HEART-ASSOCIATION; HEALTH-CARE PROFESSIONALS; BASIC LIFE-SUPPORT; VENTRICULAR-FIBRILLATION; STROKE-FOUNDATION; TASK-FORCE; STATEMENT; VENTILATION; COMMITTEE	Context Chest compression-only bystander cardiopulmonary resuscitation (CPR) may be as effective as conventional CPR with rescue breathing for out-of-hospital cardiac arrest. Objective To investigate the survival of patients with out-of-hospital cardiac arrest using compression-only CPR (COCPR) compared with conventional CPR. Design, Setting, and Patients A 5-year prospective observational cohort study of survival in patients at least 18 years old with out-of-hospital cardiac arrest between January 1, 2005, and December 31, 2009, in Arizona. The relationship between layperson bystander CPR and survival to hospital discharge was evaluated using multivariable logistic regression. Main Outcome Measure Survival to hospital discharge. Results Among 5272 adults with out-of-hospital cardiac arrest of cardiac etiology not observed by responding emergency medical personnel, 779 were excluded because bystander CPR was provided by a health care professional or the arrest occurred in a medical facility. A total of 4415 met all inclusion criteria for analysis, including 2900 who received no bystander CPR, 666 who received conventional CPR, and 849 who received COCPR. Rates of survival to hospital discharge were 5.2% (95% confidence interval [CI], 4.4%-6.0%) for the no bystander CPR group, 7.8% (95% CI, 5.8%-9.8%) for conventional CPR, and 13.3% (95% CI, 11.0%-15.6%) for COCPR. The adjusted odds ratio (AOR) for survival for conventional CPR vs no CPR was 0.99 (95% CI, 0.69-1.43), for COCPR vs no CPR, 1.59 (95% CI, 1.18-2.13), and for COCPR vs conventional CPR, 1.60 (95% CI, 1.08-2.35). From 2005 to 2009, lay rescuer CPR increased from 28.2% (95% CI, 24.6%-31.8%) to 39.9% (95% CI, 36.8%-42.9%; P<.001); the proportion of CPR that was COCPR increased from 19.6% (95% CI, 13.6%-25.7%) to 75.9% (95% CI, 71.7%-80.1%; P<.001). Overall survival increased from 3.7% (95% CI, 2.2%-5.2%) to 9.8% (95% CI, 8.0%-11.6%; P<.001). Conclusion Among patients with out-of-hospital cardiac arrest, layperson compression-only CPR was associated with increased survival compared with conventional CPR and no bystander CPR in this setting with public endorsement of chest compression-only CPR. JAMA. 2010; 304(13): 1447-1454	[Bobrow, Bentley J.; Mullins, Terry J.; Humble, Will O.] Arizona Dept Hlth Serv, 150 N 18th Ave,Ste 540, Phoenix, AZ 85007 USA; [Bobrow, Bentley J.; Spaite, Daniel W.; Stolz, Uwe] Univ Arizona, Dept Emergency Med, Arizona Emergency Med Res Ctr, Tucson, AZ USA; [Bobrow, Bentley J.; Sanders, Arthur B.; Kern, Karl B.; Clark, Lani L.; Ewy, Gordon A.] Univ Arizona, Sarver Heart Ctr, Tucson, AZ USA; [Berg, Robert A.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Vadeboncoeur, Tyler F.] Mayo Clin, Jacksonville, FL 32224 USA; [Gallagher, John V.] Phoenix Fire Dept, Phoenix, AZ USA; [Bobrow, Bentley J.; Stapczynski, J. Stephan; LoVecchio, Frank] Maricopa Cty Gen Hosp, Dept Emergency Med, Phoenix, AZ USA	Arizona Department of Health Services; University of Arizona; University of Arizona; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Mayo Clinic; Maricopa County General Hospital	Bobrow, BJ (corresponding author), Arizona Dept Hlth Serv, 150 N 18th Ave,Ste 540, Phoenix, AZ 85007 USA.	bobrowb@azdhs.gov		Spaite, Daniel/0000-0003-2601-6476	Medtronic Foundation; American Heart Association	Medtronic Foundation; American Heart Association(American Heart Association)	Drs Bobrow, Ewy, and Spaite reported that the University of Arizona has received support from the Medtronic Foundation involving community-based translation of resuscitation science. Dr Bobrow reported being a member of the American Heart Association Basic Life Support Committee and in the past having received a grant from the American Heart Association to study ultrabrief CPR video training. No other disclosures were reported.	[Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; Assar D, 2000, RESUSCITATION, V45, P7, DOI 10.1016/S0300-9572(00)00152-0; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; Becker LB, 1997, CIRCULATION, V96, P2102, DOI 10.1161/01.CIR.96.6.2102; BERG RA, 1993, CIRCULATION, V88, P1907, DOI 10.1161/01.CIR.88.4.1907; Berg RA, 1997, CIRCULATION, V96, P4364; Berg RA, 2001, CIRCULATION, V104, P2465, DOI 10.1161/hc4501.098926; Bobrow BJ, 2008, PREHOSP EMERG CARE, V12, P381, DOI 10.1080/10903120802100670; Bobrow BJ, 2008, JAMA-J AM MED ASSOC, V299, P1158, DOI 10.1001/jama.299.10.1158; Bobrow BJ, 2009, ANN EMERG MED, V54, P656, DOI 10.1016/j.annemergmed.2009.06.011; Bobrow BJ, 2009, ANN EMERG MED, V54, pe1; Coons SJ, 2009, RESUSCITATION, V80, P334, DOI 10.1016/j.resuscitation.2008.11.024; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; CUMMINS RO, 1991, CIRCULATION, V83, P1832, DOI 10.1161/01.CIR.83.5.1832; GALLAGHER EJ, 1995, JAMA-J AM MED ASSOC, V274, P1922, DOI 10.1001/jama.274.24.1922; Hallstrom A, 2000, NEW ENGL J MED, V342, P1546, DOI 10.1056/NEJM200005253422101; Heidenreich JW, 2004, RESUSCITATION, V62, P283, DOI 10.1016/j.resuscitation.2004.05.013; Iwami T, 2007, CIRCULATION, V116, P2900, DOI 10.1161/CIRCULATIONAHA.107.723411; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Kellum MJ, 2008, ANN EMERG MED, V52, P244, DOI 10.1016/j.annemergmed.2008.02.006; Kern KB, 1998, RESUSCITATION, V39, P179, DOI 10.1016/S0300-9572(98)00141-5; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; LOCKE CJ, 1995, ARCH INTERN MED, V155, P938, DOI 10.1001/archinte.155.9.938; Nagao K, 2007, LANCET, V369, P920; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Rea TD, 2010, NEW ENGL J MED, V363, P423, DOI 10.1056/NEJMoa0908993; SANDERS AB, 1985, J AM COLL CARDIOL, V6, P113, DOI 10.1016/S0735-1097(85)80261-8; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Sayre MR, 2008, CIRCULATION, V117, P2162, DOI 10.1161/CIRCULATIONAHA.107.189380; Stiell IG, 1999, ANN EMERG MED, V33, P44, DOI 10.1016/S0196-0644(99)70415-4; Svensson L, 2010, NEW ENGL J MED, V363, P434, DOI 10.1056/NEJMoa0908991; *US BUR CENS, AR QUICKFACTS; Vadeboncoeur T, 2007, RESUSCITATION, V75, P68, DOI 10.1016/j.resuscitation.2007.02.015; Vaillancourt C, 2008, CAN J EMERG MED, V10, P51, DOI 10.1017/S1481803500010010; Weisfeldt ML, 2002, JAMA-J AM MED ASSOC, V288, P3035, DOI 10.1001/jama.288.23.3035; Wik L, 2003, JAMA-J AM MED ASSOC, V289, P1389, DOI 10.1001/jama.289.11.1389; Willerson JT, 2000, CIRCULATION, V102, P1	37	328	350	1	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2010	304	13					1447	1454		10.1001/jama.2010.1392	http://dx.doi.org/10.1001/jama.2010.1392			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658SO	20924010	Bronze			2022-12-01	WOS:000282509900020
J	Snelgrove, RJ; Jackson, PL; Hardison, MT; Noerager, BD; Kinloch, A; Gaggar, A; Shastry, S; Rowe, SM; Shim, YM; Hussell, T; Blalock, JE				Snelgrove, Robert J.; Jackson, Patricia L.; Hardison, Matthew T.; Noerager, Brett D.; Kinloch, Andrew; Gaggar, Amit; Shastry, Suresh; Rowe, Steven M.; Shim, Yun M.; Hussell, Tracy; Blalock, J. Edwin			A Critical Role for LTA(4)H in Limiting Chronic Pulmonary Neutrophilic Inflammation	SCIENCE			English	Article							LEUKOTRIENE-A4 HYDROLASE; ENZYME; CHEMOATTRACTANT	Leukotriene A(4) hydrolase (LTA(4)H) is a proinflammatory enzyme that generates the inflammatory mediator leukotriene B-4 (LTB4). LTA(4)H also possesses aminopeptidase activity with unknown substrate and physiological importance; we identified the neutrophil chemoattractant proline-glycine-proline (PGP) as this physiological substrate. PGP is a biomarker for chronic obstructive pulmonary disease (COPD) and is implicated in neutrophil persistence in the lung. In acute neutrophil-driven inflammation, PGP was degraded by LTA(4)H, which facilitated the resolution of inflammation. In contrast, cigarette smoke, a major risk factor for the development of COPD, selectively inhibited LTA(4)H aminopeptidase activity, which led to the accumulation of PGP and neutrophils. These studies imply that therapeutic strategies inhibiting LTA(4)H to prevent LTB4 generation may not reduce neutrophil recruitment because of elevated levels of PGP.	[Snelgrove, Robert J.; Jackson, Patricia L.; Hardison, Matthew T.; Gaggar, Amit; Shastry, Suresh; Rowe, Steven M.; Blalock, J. Edwin] Univ Alabama Birmingham, Dept Med, Lung Hlth Ctr, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA; [Snelgrove, Robert J.; Hussell, Tracy] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Leukocyte Biol Sect, London SW7 2AZ, England; [Noerager, Brett D.] Univ Montevallo, Dept Biol Chem & Math, Montevallo, AL 35115 USA; [Kinloch, Andrew] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol, London W6 8LH, England; [Gaggar, Amit; Rowe, Steven M.; Blalock, J. Edwin] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Ctr, Birmingham, AL 35294 USA; [Gaggar, Amit] Birmingham VA Med Ctr, Birmingham, AL 35294 USA; [Rowe, Steven M.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA; [Shim, Yun M.] Univ Virginia, Dept Med, Div Pulm & Crit Care Med, Charlottesville, VA 22908 USA	University of Alabama System; University of Alabama Birmingham; Imperial College London; Imperial College London; University of Oxford; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Alabama System; University of Alabama Birmingham; University of Virginia	Snelgrove, RJ (corresponding author), Univ Alabama Birmingham, Dept Med, Lung Hlth Ctr, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA.	rjs198@imperial.ac.uk	Shim, Yun Michael/N-2049-2017; Hussell, Tracy/O-4630-2014; Kinloch, Anthony J/F-6042-2011	Shim, Yun Michael/0000-0002-3780-3371; Hussell, Tracy/0000-0001-7186-6141; Kinloch, Anthony J/0000-0002-8752-7184; Blalock, J. Edwin/0000-0001-5303-8123	Wellcome Trust [082727/Z/07/Z]; National Heart, Lung, and Blood Institute [HL07783, HL090999, HL087824, HL102371-A1, K08HL091127]; Cystic Fibrosis Foundation [GAGGAR07]; National Institute of Diabetes and Digestive and Kidney Diseases [1K23DK075788, 1R03DK084110-01]; Flight Attendant Medical Research Institute; Medical Research Council [P171/03/C1/048]; NIH [RR19231, P30CA13148, P50 AT00477, U54CA100949, P30AR050948, P30 DK079337]; MRC [G0802752, G0400795] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P30CA013148, U54CA100949] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [P50AT000477] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019231] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077783, F33HL007783, R01HL102371, R01HL087824, R01HL090999, K08HL091127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079337, R03DK084110, K23DK075788] Funding Source: NIH RePORTER; Medical Research Council [G0400795, G0802752] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Flight Attendant Medical Research Institute; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This project was supported by grants from the Wellcome Trust (082727/Z/07/Z to R.J.S.), the National Heart, Lung, and Blood Institute (HL07783, HL090999, and HL087824 to J.E.B. and HL102371-A1 to A. G.), the Cystic Fibrosis Foundation (GAGGAR07 to A. G.), the National Institute of Diabetes and Digestive and Kidney Diseases (1K23DK075788 and 1R03DK084110-01 to S. M. R.), the Flight Attendant Medical Research Institute (Young Clinical Scientist Award to Y.M.S.) and the National Heart, Lung, and Blood Institute (K08HL091127 to Y.M.S.), and the Medical Research Council (P171/03/C1/048 to T. H.). The Univ. of Alabama Birmingham (UAB) Lung Health Center Pulmonary Proteomics Laboratory is funded through the NIH (by grants RR19231, P30CA13148, P50 AT00477, U54CA100949, P30AR050948, and P30 DK079337). We thank R. Moore and L. Wilson of the UAB Targeted Metabolomics and Proteomics Laboratory for their technical assistance with mass spectrometry, D. Muccio of the UAB Chemistry Department for the use of his fast protein liquid chromatography system, G. Xia for technical assistance, and D. Saliba of the Kennedy Institute of Rheumatology, Imperial College London, for his technical assistance in the generation of murine LTA<INF>4</INF>H. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute or the NIH.	Bailie MB, 1996, J IMMUNOL, V157, P5221; BLOMSTER M, 1995, EUR J BIOCHEM, V231, P528, DOI 10.1111/j.1432-1033.1995.tb20728.x; CHEN XS, 1994, NATURE, V372, P179, DOI 10.1038/372179a0; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Crooks SW, 2000, EUR RESPIR J, V15, P274, DOI 10.1034/j.1399-3003.2000.15b09.x; Eyles JL, 2006, NAT CLIN PRACT RHEUM, V2, P500, DOI 10.1038/ncprheum0291; FITZPATRICK F, 1983, P NATL ACAD SCI-BIOL, V80, P5425, DOI 10.1073/pnas.80.17.5425; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gaggar A, 2008, J IMMUNOL, V180, P5662, DOI 10.4049/jimmunol.180.8.5662; GRIFFITHS RJ, 1995, P NATL ACAD SCI USA, V92, P517, DOI 10.1073/pnas.92.2.517; Haddox JL, 1999, INVEST OPHTH VIS SCI, V40, P2427; HAEGGSTROM JZ, 1990, BIOCHEM BIOPH RES CO, V172, P965, DOI 10.1016/0006-291X(90)91540-9; Haeggstrom JZ, 2000, AM J RESP CRIT CARE, V161, pS25, DOI 10.1164/ajrccm.161.supplement_1.ltta-6; Hardison MT, 2009, J IMMUNOL, V182, P4423, DOI 10.4049/jimmunol.0802457; MUNAFO DA, 1994, J CLIN INVEST, V93, P1042, DOI 10.1172/JCI117053; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; O'Donnell R, 2006, THORAX, V61, P448, DOI 10.1136/thx.2004.024463; O'Reilly P, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-38; ORNING L, 1994, J BIOL CHEM, V269, P11269; Orning L, 1999, ARCH BIOCHEM BIOPHYS, V368, P131, DOI 10.1006/abbi.1999.1289; ORNING L, 1992, BIOCHEMISTRY-US, V31, P4218, DOI 10.1021/bi00132a010; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; van Houwelingen AH, 2008, FASEB J, V22, P3403, DOI 10.1096/fj.07-096230; Weathington NM, 2006, NAT MED, V12, P317, DOI 10.1038/nm1361; WETTERHOLM A, 1992, BIOCHIM BIOPHYS ACTA, V1123, P275, DOI 10.1016/0005-2760(92)90007-I; WETTERHOLM A, 1992, P NATL ACAD SCI USA, V89, P9141, DOI 10.1073/pnas.89.19.9141; Whittle BJR, 2008, BRIT J PHARMACOL, V153, P983, DOI 10.1038/sj.bjp.0707645	30	182	186	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2010	330	6000					90	94		10.1126/science.1190594	http://dx.doi.org/10.1126/science.1190594			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20813919	Green Accepted			2022-12-01	WOS:000282334500042
J	Spence, D				Spence, Des			From the Frontline Vascular disease: an amateur observation	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 22	2010	341								c5196	10.1136/bmj.c5196	http://dx.doi.org/10.1136/bmj.c5196			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	655TK	20861115				2022-12-01	WOS:000282272200026
J	Heiden, MGV; Locasale, JW; Swanson, KD; Sharfi, H; Heffron, GJ; Amador-Noguez, D; Christofk, HR; Wagner, G; Rabinowitz, JD; Asara, JM; Cantley, LC				Heiden, Matthew G. Vander; Locasale, Jason W.; Swanson, Kenneth D.; Sharfi, Hadar; Heffron, Greg J.; Amador-Noguez, Daniel; Christofk, Heather R.; Wagner, Gerhard; Rabinowitz, Joshua D.; Asara, John M.; Cantley, Lewis C.			Evidence for an Alternative Glycolytic Pathway in Rapidly Proliferating Cells	SCIENCE			English	Article							PYRUVATE-KINASE M2; PHOSPHOTRANSFERASE SYSTEM; RABBIT MUSCLE; PHOSPHORYLATION; PROTEIN; METABOLISM; DEPHOSPHORYLATION; IDENTIFICATION; SINGLE; GROWTH	Proliferating cells, including cancer cells, require altered metabolism to efficiently incorporate nutrients such as glucose into biomass. The M2 isoform of pyruvate kinase (PKM2) promotes the metabolism of glucose by aerobic glycolysis and contributes to anabolic metabolism. Paradoxically, decreased pyruvate kinase enzyme activity accompanies the expression of PKM2 in rapidly dividing cancer cells and tissues. We demonstrate that phosphoenolpyruvate (PEP), the substrate for pyruvate kinase in cells, can act as a phosphate donor in mammalian cells because PEP participates in the phosphorylation of the glycolytic enzyme phosphoglycerate mutase (PGAM1) in PKM2-expressing cells. We used mass spectrometry to show that the phosphate from PEP is transferred to the catalytic histidine (His11) on human PGAM1. This reaction occurred at physiological concentrations of PEP and produced pyruvate in the absence of PKM2 activity. The presence of histidine-phosphorylated PGAM1 correlated with the expression of PKM2 in cancer cell lines and tumor tissues. Thus, decreased pyruvate kinase activity in PKM2-expressing cells allows PEP-dependent histidine phosphorylation of PGAM1 and may provide an alternate glycolytic pathway that decouples adenosine triphosphate production from PEP-mediated phosphotransfer, allowing for the high rate of glycolysis to support the anabolic metabolism observed in many proliferating cells.	[Heiden, Matthew G. Vander; Locasale, Jason W.; Swanson, Kenneth D.; Sharfi, Hadar; Christofk, Heather R.; Asara, John M.; Cantley, Lewis C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Heiden, Matthew G. Vander; Locasale, Jason W.; Swanson, Kenneth D.; Sharfi, Hadar; Christofk, Heather R.; Asara, John M.; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Heiden, Matthew G. Vander] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Heiden, Matthew G. Vander; Locasale, Jason W.; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Heffron, Greg J.; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Amador-Noguez, Daniel; Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Amador-Noguez, Daniel; Rabinowitz, Joshua D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Princeton University; Princeton University	Cantley, LC (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA.	lewis_cantley@hms.harvard.edu	Cantley, Lewis C/D-1800-2014; Rabinowitz, Joshua/GPP-4019-2022; Locasale, Jason W/ABE-6505-2020	Cantley, Lewis C/0000-0002-1298-7653; Rabinowitz, Joshua/0000-0002-1247-4727; Locasale, Jason W/0000-0002-7766-3502; Christofk, Heather/0000-0002-8662-4425	Damon Runyon Cancer Research Foundation; Burroughs Wellcome Fund; American Cancer Society; Dana-Farber/Harvard Cancer Center; NIH [1K08CA136983, 5P30CA006516-43, 5 T32 CA009361-28, R21/R33 DK070299, P01GM047467, R01 AI078063, R21 CA128620, R01-GM56302, P01CA089021, 1P01CA120964-01A]; NATIONAL CANCER INSTITUTE [P01CA120964, K08CA136983, P01CA089021, R21CA128620, T32CA009172, P30CA006516, T32CA009361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK070299, R33DK070299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203, P01GM047467] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); American Cancer Society(American Cancer Society); Dana-Farber/Harvard Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Carrecedo and P. P. Pandolfi for normal and neoplastic prostate tissue; L. Burga and G. Wulf for normal breast and breast tumor; G. Bellinger for assistance with mouse dissection; M. Sasaki for help generating constructs; V. Vyas, A. Subtelny, L. Freimark, X. Yang, L. Schmidt, and M. Balastik for technical assistance; M. Bayro and S. Hyberts for help with processing the NMR spectra; and A. Shaywitz, J. Hutti, C. Benes, D. Anastasiou, A. Couvillion, and A. Saci for helpful discussions. This work was partially supported by the Damon Runyon Cancer Research Foundation (M. V. H.), the Burroughs Wellcome Fund (M. V. H.), the American Cancer Society (J. W. L.), Dana-Farber/Harvard Cancer Center (J. M. A. and J. W. L.), and by grants from the NIH (1K08CA136983 to M. V. H., 5P30CA006516-43 to J. M. A., 5 T32 CA009361-28 to J. W. L., R21/R33 DK070299 and P01GM047467 to G. W., R01 AI078063 and R21 CA128620 to J. D. R., R01-GM56302 and P01CA089021 to L. C. C., and 1P01CA120964-01A to J. M. A. and L.C.C.).	AINSWORTH S, 1973, BIOCHEM J, V131, P223, DOI 10.1042/bj1310223; Besant PG, 2005, BBA-PROTEINS PROTEOM, V1754, P281, DOI 10.1016/j.bbapap.2005.07.026; BLATTLER WA, 1980, BIOCHEMISTRY-US, V19, P738; BURNELL JN, 1984, ARCH BIOCHEM BIOPHYS, V231, P175, DOI 10.1016/0003-9861(84)90375-8; BURNELL JN, 1986, ARCH BIOCHEM BIOPHYS, V245, P297, DOI 10.1016/0003-9861(86)90219-5; CHEUNG EC, CURR OPIN C IN PRESS; Cho J, 2008, P NATL ACAD SCI USA, V105, P5998, DOI 10.1073/pnas.0710980105; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Engel M, 2004, J BIOL CHEM, V279, P35803, DOI 10.1074/jbc.M402768200; Evans MJ, 2005, NAT BIOTECHNOL, V23, P1303, DOI 10.1038/nbt1149; FOTHERGILLGILMORE LA, 1989, ADV ENZYMOL RAMB, V62, P227; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Hohenester UM, 2010, ANAL BIOANAL CHEM, V397, P3209, DOI 10.1007/s00216-009-3372-x; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kleinnijenhuis AJ, 2007, ANAL CHEM, V79, P7450, DOI 10.1021/ac0707838; Klumpp S, 2002, EUR J BIOCHEM, V269, P1067, DOI 10.1046/j.1432-1033.2002.02755.x; Kondoh H, 2005, CANCER RES, V65, P177; LAGUNAS R, 1983, EUR J BIOCHEM, V137, P479, DOI 10.1111/j.1432-1033.1983.tb07851.x; LEE ME, 1992, BIOCHEMISTRY-US, V31, P2172, DOI 10.1021/bi00122a039; Lehninger A. L., 1993, PRINCIPLES BIOCH; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Medzihradszky KF, 1997, PROTEIN SCI, V6, P1405, DOI 10.1002/pro.5560060704; MINAKAMI S, 1965, BIOCHEM BIOPH RES CO, V18, P345, DOI 10.1016/0006-291X(65)90711-4; Olsen JV, 2007, NAT METHODS, V4, P709, DOI 10.1038/NMETH1060; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; RACKER E, 1976, J CELL PHYSIOL, V89, P697, DOI 10.1002/jcp.1040890429; SAIER MH, 1994, MOL MICROBIOL, V13, P755; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Zu XL, 2007, AMINO ACIDS, V32, P347, DOI 10.1007/s00726-007-0493-4	35	473	480	3	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2010	329	5998					1492	1499		10.1126/science.1188015	http://dx.doi.org/10.1126/science.1188015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650RK	20847263	Green Accepted, Green Submitted			2022-12-01	WOS:000281869000033
J	von Ungern-Sternberg, BS; Boda, K; Chambers, NA; Rebmann, C; Johnson, C; Sly, PD; Habre, W				von Ungern-Sternberg, Britta S.; Boda, Krisztina; Chambers, Neil A.; Rebmann, Claudia; Johnson, Chris; Sly, Peter D.; Habre, Walid			Risk assessment for respiratory complications in paediatric anaesthesia: a prospective cohort study	LANCET			English	Article							LARYNGEAL MASK AIRWAY; TRACT INFECTIONS; REFLEX BRONCHOCONSTRICTION; BRONCHIAL RESPONSIVENESS; INTRAVENOUS LIDOCAINE; TRACHEAL INTUBATION; ADVERSE EVENTS; LUNG-FUNCTION; CHILDREN; ASTHMA	Background Perioperative respiratory adverse events in children are one of the major causes of morbidity and mortality during paediatric anaesthesia. We aimed to identify associations between family history, anaesthesia management, and occurrence of perioperative respiratory adverse events. Methods We prospectively included all children who had general anaesthesia for surgical or medical interventions, elective or urgent procedures at Princess Margaret Hospital for Children, Perth, Australia, from Feb 1,2007, to Jan 31, 2008. On the day of surgery, anaesthetists in charge of paediatric patients completed an adapted version of the International Study Group for Asthma and Allergies in Childhood questionnaire. We collected data on family medical history of asthma, atopy, allergy, upper respiratory tract infection, and passive smoking. Anaesthesia management and all perioperative respiratory adverse events were recorded. Findings 9297 questionnaires were available for analysis. A positive respiratory history (nocturnal dry cough, wheezing during exercise, wheezing more than three times in the past 12 months, or a history of present or past eczema) was associated with an increased risk for bronchospasm (relative risk [RR] 8.46, 95% Cl 6.18-11.59; p<0.0001), laryngospasm (4.13, 3.37-5.08; p<0.0001), and perioperative cough, desaturation, or airway obstruction (3.05, 2.76-3.37; p<0.0001). Upper respiratory tract infection was associated with an increased risk for perioperative respiratory adverse events only when symptoms were present (RR 2.05, 95% CI 1.82-2.31; p<0.0001) or less than 2 weeks before the procedure (2.34, 2.07-2.66; p<0.0001), whereas symptoms of upper respiratory tract infection 2-4 weeks before the procedure significantly lowered the incidence of perioperative respiratory adverse events (0.66, 0.53-0.81; p<0.0001). A history of at least two family members having asthma, atopy, or smoking increased the risk for perioperative respiratory adverse events (all p<0.0001). Risk was lower with intravenous induction compared with inhalational induction (all p<0.0001), inhalational compared with intravenous maintenance of anaesthesia (all p<0.0001), airway management by a specialist paediatric anaesthetist compared with a registrar (all p<0.0001), and use of face mask compared with tracheal intubation (all p<0.0001). Interpretation Children at high risk for perioperative respiratory adverse events could be systematically identified at the preanaesthetic assessment and thus can benefit from a specifically targeted anaesthesia management.	[von Ungern-Sternberg, Britta S.; Chambers, Neil A.; Rebmann, Claudia; Johnson, Chris] Princess Margaret Hosp Children, Dept Anaesthesia, Perth, WA, Australia; [von Ungern-Sternberg, Britta S.; Sly, Peter D.] Univ Western Australia, Telethon Inst Child Hlth Res, Div Clin Sci, Perth, WA 6009, Australia; [von Ungern-Sternberg, Britta S.; Sly, Peter D.] Univ Western Australia, Ctr Child Hlth Res, Perth, WA 6009, Australia; [von Ungern-Sternberg, Britta S.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Boda, Krisztina] Univ Szeged, Dept Med Informat, Szeged, Hungary; [Habre, Walid] Univ Geneva, Geneva Childrens Hosp, Paediat Anaesthesia Unit, Geneva, Switzerland	University of Western Australia; Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Western Australia; Szeged University; University of Geneva	von Ungern-Sternberg, BS (corresponding author), Princess Margaret Hosp Children, Dept Anaesthesia, Roberts Rd, Subiaco, WA 6008, Australia.	bvonungern@uhbs.ch	von Ungern-Sternberg, Britta/S-5532-2019; von Ungern-Sternberg, Britta/CAG-9904-2022; Sly, Peter D/F-1486-2010	von Ungern-Sternberg, Britta/0000-0002-8043-8541; Sly, Peter D/0000-0001-6305-2201; Boda, Krisztina/0000-0002-9937-0460	Department of Anaesthesia, Princess Margaret Hospital for Children; Swiss Foundation for Grants in Biology and Medicine; Swiss National Science Foundation; Voluntary Academic Society Basel, Switzerland	Department of Anaesthesia, Princess Margaret Hospital for Children; Swiss Foundation for Grants in Biology and Medicine; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Voluntary Academic Society Basel, Switzerland	This study was supported by the Department of Anaesthesia, Princess Margaret Hospital for Children, a grant of the Swiss Foundation for Grants in Biology and Medicine in cooperation with the Swiss National Science Foundation, and by the Voluntary Academic Society Basel, Switzerland. We thank all staff members of the Department of Anaesthesia and the nurses in postanaesthetic care unit, Princess Margaret Hospital for Children, Perth, Australia, for their tremendous support with this study.	Adamzik M, 2007, ANESTH ANALG, V104, P168, DOI 10.1213/01.ane.0000247884.94119.d5; Arshad SH, 2005, CHEST, V127, P502, DOI 10.1378/chest.127.2.502; Backlund AB, 2006, ALLERGY, V61, P549, DOI 10.1111/j.1398-9995.2006.01027.x; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Bhananker SM, 2007, ANESTH ANALG, V105, P344, DOI 10.1213/01.ane.0000268712.00756.dd; Bjerg A, 2007, PEDIATRICS, V120, P741, DOI 10.1542/peds.2006-3742; Bordet F, 2002, PAEDIATR ANAESTH, V12, P762, DOI 10.1046/j.1460-9592.2002.00987.x; BUCKNER CK, 1985, AM REV RESPIR DIS, V132, P305; Chang HYS, 2007, ANESTH ANALG, V104, P1109, DOI 10.1213/01.ane.0000260638.57139.87; COHEN MM, 1991, ANESTH ANALG, V72, P282; Forastiere F, 1996, AM J RESP CRIT CARE, V153, P1098, DOI 10.1164/ajrccm.153.3.8630551; Groeben H, 1996, ANESTHESIOLOGY, V84, P533, DOI 10.1097/00000542-199603000-00007; Groeben H, 1999, AM J RESP CRIT CARE, V159, P530, DOI 10.1164/ajrccm.159.2.9806102; Groeben H, 2000, CHEST, V118, P509, DOI 10.1378/chest.118.2.509; Habre W, 1996, BRIT J ANAESTH, V77, P739, DOI 10.1093/bja/77.6.739; Harnett M, 2000, CAN J ANAESTH, V47, P315, DOI 10.1007/BF03020944; Homer JR, 2007, PEDIATR ANESTH, V17, P154, DOI 10.1111/j.1460-9592.2006.02059.x; Jones DT, 2006, OTOLARYNG HEAD NECK, V135, P12, DOI 10.1016/j.otohns.2006.03.011; Joos GF, 2003, EUR RESPIR J, V21, P1050, DOI 10.1183/09031936.03.00008403; Joseph-Bowen J, 2004, AM J RESP CRIT CARE, V169, P850, DOI 10.1164/rccm.200304-556OC; Lakshmipathy N, 1996, ANESTH ANALG, V82, P724, DOI 10.1097/00000539-199604000-00008; Mamie C, 2004, PEDIATR ANESTH, V14, P218, DOI 10.1111/j.1460-9592.2004.01169.x; Murat I, 2004, PAEDIATR ANAESTH, V14, P158, DOI 10.1111/j.1460-9592.2004.01167.x; Parnis SJ, 2001, PAEDIATR ANAESTH, V11, P29, DOI 10.1046/j.1460-9592.2001.00607.x; Rooke GA, 1997, ANESTHESIOLOGY, V86, P1294, DOI 10.1097/00000542-199706000-00010; Schreiner MS, 1996, ANESTHESIOLOGY, V85, P475, DOI 10.1097/00000542-199609000-00005; Schutz N, 2004, BRIT J ANAESTH, V92, P254, DOI 10.1093/bja/aeh049; Skolnick ET, 1998, ANESTHESIOLOGY, V88, P1144, DOI 10.1097/00000542-199805000-00003; Tait AR, 1998, ANESTH ANALG, V86, P706, DOI 10.1097/00000539-199804000-00006; Tait AR, 2005, ANESTH ANALG, V100, P59, DOI 10.1213/01.ANE.0000139653.53618.91; Tait AR, 2001, ANESTHESIOLOGY, V95, P299, DOI 10.1097/00000542-200108000-00008; Tay CLM, 2001, PAEDIATR ANAESTH, V11, P711, DOI 10.1046/j.1460-9592.2001.00767.x; Varughese AM, 2006, PEDIATR ANESTH, V16, P723, DOI 10.1111/j.1460-9592.2006.01856.x; Von Ungern-Stemberg BS, 2007, ANESTHESIOLOGY, V107, P714, DOI 10.1097/01.anes.0000286925.25272.b5; von Ungern-Sternberg BS, 2008, ANESTHESIOLOGY, V108, P216, DOI 10.1097/01.anes.0000299430.90352.d5	35	286	292	1	32	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 4	2010	376	9743					773	783		10.1016/S0140-6736(10)61193-2	http://dx.doi.org/10.1016/S0140-6736(10)61193-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	650EC	20816545				2022-12-01	WOS:000281831000028
J	Abbott, A				Abbott, Alison			Levodopa: the story so far	NATURE			English	Editorial Material																			0	50	55	2	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2010	466	7310					S6	S7		10.1038/466S6a	http://dx.doi.org/10.1038/466S6a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20739934	Bronze			2022-12-01	WOS:000281203600059
J	Rose, KA; Sikes, EL; Guilderson, TP; Shane, P; Hill, TM; Zahn, R; Spero, HJ				Rose, Kathryn A.; Sikes, Elisabeth L.; Guilderson, Thomas P.; Shane, Phil; Hill, Tessa M.; Zahn, Rainer; Spero, Howard J.			Upper-ocean-to-atmosphere radiocarbon offsets imply fast deglacial carbon dioxide release	NATURE			English	Article							PACIFIC-OCEAN; NORTH-ATLANTIC; NEW-ZEALAND; CO2; VENTILATION; CALIBRATION; WESTERLIES; RECORD; AGES; BEDS	Radiocarbon in the atmosphere is regulated largely by ocean circulation, which controls the sequestration of carbon dioxide (CO2) in the deep sea through atmosphere-ocean carbon exchange. During the last glaciation, lower atmospheric CO2 levels were accompanied by increased atmospheric radiocarbon concentrations that have been attributed to greater storage of CO2 in a poorly ventilated abyssal ocean(1,2). The end of the ice age was marked by a rapid increase in atmospheric CO2 concentrations(2) that coincided with reduced C-14/C-12 ratios (Delta C-14) in the atmosphere(3), suggesting the release of very 'old' (C-14-depleted) CO2 from the deep ocean to the atmosphere(3). Here we present radiocarbon records of surface and intermediate-depth waters from two sediment cores in the southwest Pacific and Southern oceans. We find a steady 170 per mil decrease in Delta C-14 that precedes and roughly equals in magnitude the decrease in the atmospheric radiocarbon signal during the early stages of the glacial-interglacial climatic transition. The atmospheric decrease in the radiocarbon signal coincides with regionally intensified upwelling and marine biological productivity(4), suggesting that CO2 released by means of deep water upwelling in the Southern Ocean lost most of its original depleted-C-14 imprint as a result of exchange and isotopic equilibration with the atmosphere. Our data imply that the deglacial C-14 depletion previously identified in the eastern tropical North Pacific(5) must have involved contributions from sources other than the previously suggested carbon release by way of a deep Southern Ocean pathway(5), and may reflect the expanded influence of the C-14-depleted North Pacific carbon reservoir across this interval. Accordingly, shallow water masses advecting north across the South Pacific in the early deglaciation had little or no residual C-14-depleted signals owing to degassing of CO2 and biological uptake in the Southern Ocean.	[Sikes, Elisabeth L.] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Rose, Kathryn A.; Hill, Tessa M.; Spero, Howard J.] Univ Calif Davis, Dept Geol, Davis, CA 95616 USA; [Guilderson, Thomas P.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Guilderson, Thomas P.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Shane, Phil] Univ Auckland, Sch Environm, Auckland 1142, New Zealand; [Zahn, Rainer] Univ Autonoma Barcelona, Inst Ciencia & Tecnol Ambientals, Dept Geol, Inst Catalana Recerca & Estudis Avancats,ICREA, Bellaterra 08193, Spain	Rutgers State University New Brunswick; University of California System; University of California Davis; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Santa Cruz; University of Auckland; Autonomous University of Barcelona; ICREA	Sikes, EL (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, 71 Dudley Rd, New Brunswick, NJ 08901 USA.	sikes@marine.rutgers.edu	Hill, Tessa Michelle/P-3401-2019	Hill, Tessa Michelle/0000-0003-4159-9104; Shane, Philip/0000-0002-7824-1184; Spero, Howard/0000-0001-5465-8607; Sikes, Elisabeth/0000-0003-2900-3283	National Science Foundation (NSF) [RR0503]; Evolving Earth Foundation; Geological Society of America; MICINN, Spain; US Department of Energy; ICREA Funding Source: Custom; Directorate For Geosciences [0823549, 0962077] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); Evolving Earth Foundation; Geological Society of America; MICINN, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); US Department of Energy(United States Department of Energy (DOE)); ICREA(ICREA); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the captain and crew of the RV Revelle, and our shipboard colleagues during the Zheng leg 3 (RR0503) cruise funded by the National Science Foundation (NSF), which collected the RR core. Core MD97-2120 was collected through the International Marine Past Global Change Study (IMAGES) program and with the technical support of the Institut Polaire Francais Paul Emile Victor (IPEV) who made the research vessel Marion Dufresne available for core retrieval. H.J.S., E.L.S. and T.P.G., and the shore analyses, were supported by NSF awards and the Evolving Earth Foundation, and the Geological Society of America provided support for K.A.R. during her MSc. R.Z. acknowledges support from the MICINN, Spain. A portion of this work was performed under the auspices of the US Department of Energy by Lawrence Livermore National Laboratory. We especially thank M. Cook for discussions, continuing input and suggestions throughout this study.	Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Bard E, 1988, PALEOCEANOGRAPHY, V3, P635, DOI 10.1029/PA003i006p00635; Bostock HC, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001047; Broecker W, 2007, EARTH PLANET SC LETT, V256, P90, DOI 10.1016/j.epsl.2007.01.015; Broecker W, 2008, EARTH PLANET SC LETT, V274, P322, DOI 10.1016/j.epsl.2008.07.035; Curry WB, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001021; Galbraith ED, 2007, NATURE, V449, P890, DOI 10.1038/nature06227; Gnanadesikan A, 2007, OCEAN SCI, V3, P43, DOI 10.5194/os-3-43-2007; Gnanadesikan A, 1999, SCIENCE, V283, P2077, DOI 10.1126/science.283.5410.2077; Hanawa K., 2001, INT GEOPHYS, VEds., P373, DOI [10.1016/S0074-6142(01)80129-7, DOI 10.1016/S0074-6142(01)80129-7]; Hughen K, 2006, QUATERNARY SCI REV, V25, P3216, DOI 10.1016/j.quascirev.2006.03.014; Keigwin LD, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001029; Key RM, 1996, RADIOCARBON, V38, P425, DOI 10.1017/S0033822200030071; Lowe DJ, 2008, QUATERNARY SCI REV, V27, P95, DOI 10.1016/j.quascirev.2007.01.013; Marchitto TM, 2007, SCIENCE, V316, P1456, DOI 10.1126/science.1138679; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Muscheler R, 2004, EARTH PLANET SC LETT, V219, P325, DOI 10.1016/S0012-821X(03)00722-2; Pahnke K, 2005, SCIENCE, V307, P1741, DOI 10.1126/science.1102163; Pahnke K, 2003, SCIENCE, V301, P948, DOI 10.1126/science.1084451; POLHOLZ RD, 2010, NATURE GEOSCI, V3, P192; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Robinson LF, 2005, SCIENCE, V310, P1469, DOI 10.1126/science.1114832; Russell JL, 2006, J CLIMATE, V19, P6382, DOI 10.1175/JCLI3984.1; Sachs JP, 2005, NATURE, V434, P1118, DOI 10.1038/nature03544; SARNTHEIN M, 2007, GEOPHYS MONOGR SER, V173, P175, DOI DOI 10.1029/173GM13; Shane P, 2006, J VOLCANOL GEOTH RES, V154, P276, DOI 10.1016/j.jvolgeores.2006.03.021; Sikes EL, 2000, NATURE, V405, P555, DOI 10.1038/35014581; Spero HJ, 2002, SCIENCE, V296, P522, DOI 10.1126/science.1069401; Toggweiler JR, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001154; Toggweiler JR, 1999, PALEOCEANOGRAPHY, V14, P571, DOI 10.1029/1999PA900033	32	58	61	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2010	466	7310					1093	1097		10.1038/nature09288	http://dx.doi.org/10.1038/nature09288			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20740012	Green Published			2022-12-01	WOS:000281203600037
J	Jong, P; McKelvie, R; Yusuf, S				Jong, Philip; McKelvie, Robert; Yusuf, Salim			Uncertainties Page Should treatment for heart failure with preserved ejection fraction differ from that for heart failure with reduced ejection fraction?	BRITISH MEDICAL JOURNAL			English	Editorial Material							SYSTOLIC FUNCTION; EUROPEAN-SOCIETY; MORTALITY; MORBIDITY; TRIAL; CANDESARTAN; CARDIOLOGY; REGISTRY; DIGOXIN		[Jong, Philip; McKelvie, Robert; Yusuf, Salim] McMaster Univ, Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada	McMaster University; Population Health Research Institute	Yusuf, S (corresponding author), McMaster Univ, Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada.	yusufs@mcmaster.ca		Yusuf, Salim/0000-0003-4776-5601				Ahmed A, 2006, CIRCULATION, V114, P397, DOI 10.1161/CIRCULATIONAHA.106.628347; Bangalore S, 2008, J AM COLL CARDIOL, V52, P1062, DOI 10.1016/j.jacc.2008.05.057; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Cleland JGF, 2006, EUR HEART J, V27, P2338, DOI 10.1093/eurheartj/ehl250; Cleland JGF, 2009, EUR J HEART FAIL, V11, P1214, DOI 10.1093/eurjhf/hfp162; Dagenais GR, 2006, LANCET, V368, P581, DOI 10.1016/S0140-6736(06)69201-5; Flather MD, 2005, EUR HEART J, V26, P215, DOI 10.1093/eurheartj/ehi118; Fonarow GC, 2007, J AM COLL CARDIOL, V50, P768, DOI 10.1016/j.jacc.2007.04.064; Hogg K, 2004, J AM COLL CARDIOL, V43, P317, DOI 10.1016/j.jacc.2003.07.046; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; National Institute Health and Clinical Excellence, 2010, CHRON HEART FAIL MAN; O'Meara E, 2004, EUR HEART J, V25, P1920, DOI 10.1016/j.ehj.2004.07.025; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Perry G, 1997, NEW ENGL J MED, V336, P525; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7	16	7	7	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 25	2010	341								c4202	10.1136/bmj.c4202	http://dx.doi.org/10.1136/bmj.c4202			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645IH	20739364				2022-12-01	WOS:000281446000015
J	Farrell, AM; Brazier, M				Farrell, Anne-Maree; Brazier, Margaret			Consent for blood transfusion	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Farrell, Anne-Maree; Brazier, Margaret] Univ Manchester, Sch Law, Inst Sci Eth & Innovat, Ctr Social Eth & Policy, Manchester M13 9PL, Lancs, England	University of Manchester	Farrell, AM (corresponding author), Univ Manchester, Sch Law, Inst Sci Eth & Innovat, Ctr Social Eth & Policy, Manchester M13 9PL, Lancs, England.	a.m.farrell@manchester.ac.uk		Farrell, Anne-Maree/0000-0001-9522-6528	Wellcome Trust [087439] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		*ADV COMM SAF BLOO, 2010, PAT CONS BLOOD TRANS; *CMO NAT BLOOD TRA, 2008, BETT BLOOD TRANSF HS; CONNON W, 2007, COMMUNICATION   0316; General Medical Council, 2008, CONS PAT DOCT MAK DE; HEWITT B, 1997, BRIT MED J, V316, P397; Killion DF, 2007, TRANSFUSION, V47, P557, DOI 10.1111/j.1537-2995.2007.01185.x; MCCLELLAND D, 2007, HDB BLOOD TRANSFUSIO; Murphy MF, 1997, TRANSFUSION MED, V7, P287, DOI 10.1046/j.1365-3148.1997.d01-41.x; Re T, 1992, ALL ER, V4, P649; *SER HAZ TRANSF, ANN REP 2008 SUMM; Williams FG, 1997, BRIT MED J, V315, P380, DOI 10.1136/bmj.315.7105.380	11	8	8	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 24	2010	341								c4336	10.1136/bmj.c4336	http://dx.doi.org/10.1136/bmj.c4336			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	645IG	20736271	Green Submitted			2022-12-01	WOS:000281445900006
J	Viles, J; Monte, D; Gawkrodger, DJ				Viles, Jennifer; Monte, Darryl; Gawkrodger, David J.			A Patient's Journey Vitiligo	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Viles, Jennifer; Monte, Darryl] Vitiligo Soc, London SE11 6SF, England; [Gawkrodger, David J.] Univ Sheffield, Royal Hallamshire Hosp, Sheffield S10 2JF, England	University of Sheffield	Viles, J (corresponding author), Vitiligo Soc, London SE11 6SF, England.	jennifer_viles@vitiligosociety.org.uk; david.gawkrodger@sth.nhs.uk	GAWKRODGER, DAVID J./AFO-6373-2022	GAWKRODGER, DAVID J./0000-0002-6863-7011					0	3	4	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 20	2010	341								c3780	10.1136/bmj.c3780	http://dx.doi.org/10.1136/bmj.c3780			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642KY	20729269				2022-12-01	WOS:000281213600014
J	Wang, BX; Yang, W; Wen, W; Sun, J; Su, B; Liu, B; Ma, DL; Lv, D; Wen, YR; Qu, T; Chen, M; Sun, MA; Shen, Y; Zhang, X				Wang, Baoxi; Yang, Wei; Wen, Wen; Sun, Jing; Su, Bin; Liu, Bo; Ma, Donglai; Lv, Dan; Wen, Yaran; Qu, Tao; Chen, Min; Sun, Miao; Shen, Yan; Zhang, Xue			gamma-Secretase Gene Mutations in Familial Acne Inversa	SCIENCE			English	Article							HIDRADENITIS-SUPPURATIVA; DISEASE		[Yang, Wei; Sun, Jing; Lv, Dan; Wen, Yaran; Sun, Miao; Shen, Yan; Zhang, Xue] Peking Union Med Coll, Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Beijing 100021, Peoples R China; [Wang, Baoxi; Su, Bin; Ma, Donglai; Qu, Tao] Peking Union Med Coll, Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100021, Peoples R China; [Wen, Wen; Zhang, Xue] China Med Univ, Shenyang, Peoples R China; [Liu, Bo; Shen, Yan] Chinese Natl Human Genome Ctr Beijing, Beijing, Peoples R China; [Chen, Min] Peking Union Med Coll, Chinese Acad Med Sci, Inst Dermatol, Nanjing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; China Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; Peking Union Medical College	Shen, Y (corresponding author), Peking Union Med Coll, Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Beijing 100021, Peoples R China.	shen.yan@imicams.ac.cn; xuezhang@pumc.edu.cn	Wen, Yaran/D-4453-2012; miao, sun/E-2834-2018	Wen, Yaran/0000-0001-6346-8653; Wang, Baoxi/0000-0002-9514-5098				Bergmans BA, 2010, LANCET NEUROL, V9, P215, DOI 10.1016/S1474-4422(09)70332-1; Gao M, 2006, J INVEST DERMATOL, V126, P1302, DOI 10.1038/sj.jid.5700272; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Prokop S, 2005, J NEUROCHEM, V94, P57, DOI 10.1111/j.1471-4159.2005.03165.x; Revuz J, 2009, J EUR ACAD DERMATOL, V23, P985, DOI 10.1111/j.1468-3083.2009.03356.x; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Shuster S, 2008, BRIT J DERMATOL, V158, P1, DOI 10.1111/j.1365-2133.2007.08282.x	7	274	308	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2010	330	6007					1065	1065		10.1126/science.1196284	http://dx.doi.org/10.1126/science.1196284			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	20929727				2022-12-01	WOS:000284374700032
J	Law, RHP; Lukoyanova, N; Voskoboinik, I; Caradoc-Davies, TT; Baran, K; Dunstone, MA; D'Angelo, ME; Orlova, EV; Coulibaly, F; Verschoor, S; Browne, KA; Ciccone, A; Kuiper, MJ; Bird, PI; Trapani, JA; Saibil, HR; Whisstock, JC				Law, Ruby H. P.; Lukoyanova, Natalya; Voskoboinik, Ilia; Caradoc-Davies, Tom T.; Baran, Katherine; Dunstone, Michelle A.; D'Angelo, Michael E.; Orlova, Elena V.; Coulibaly, Fasseli; Verschoor, Sandra; Browne, Kylie A.; Ciccone, Annette; Kuiper, Michael J.; Bird, Phillip I.; Trapani, Joseph A.; Saibil, Helen R.; Whisstock, James C.			The structural basis for membrane binding and pore formation by lymphocyte perforin	NATURE			English	Article							CHOLESTEROL-DEPENDENT CYTOLYSIN; GRANZYME-B; CRYSTAL-STRUCTURE; HUMAN-COMPLEMENT; 9TH COMPONENT; CELL-DEATH; T-CELLS; DOMAIN; CYTOTOXICITY; IDENTIFICATION	Natural killer cells and cytotoxic T lymphocytes accomplish the critically important function of killing virus-infected and neoplastic cells. They do this by releasing the pore-forming protein perforin and granzyme proteases from cytoplasmic granules into the cleft formed between the abutting killer and target cell membranes. Perforin, a 67-kilodalton multidomain protein, oligomerizes to form pores that deliver the pro-apoptopic granzymes into the cytosol of the target cell(1-6). The importance of perforin is highlighted by the fatal consequences of congenital perforin deficiency, with more than 50 different perforin mutations linked to familial haemophagocytic lymphohistiocytosis (type 2 FHL)(7). Here we elucidate the mechanism of perforin pore formation by determining the X-ray crystal structure of monomeric murine perforin, together with a cryo-electron microscopy reconstruction of the entire perforin pore. Perforin is a thin 'key-shaped' molecule, comprising an amino-terminal membrane attack complex perforin-like (MACPF)/cholesterol dependent cytolysin (CDC) domain(8,9) followed by an epidermal growth factor (EGF) domain that, together with the extreme carboxy-terminal sequence, forms a central shelf-like structure. A C-terminal C2 domain mediates initial, Ca2+-dependent membrane binding. Most unexpectedly, however, electron microscopy reveals that the orientation of the perforin MACPF domain in the pore is inside-out relative to the subunit arrangement in CDCs10,11. These data reveal remarkable flexibility in the mechanism of action of the conserved MACPF/CDC fold and provide new insights into how related immune defence molecules such as complement proteins assemble into pores.	[Voskoboinik, Ilia; Baran, Katherine; Verschoor, Sandra; Browne, Kylie A.; Ciccone, Annette; Trapani, Joseph A.] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic 3002, Australia; [Law, Ruby H. P.; Dunstone, Michelle A.; D'Angelo, Michael E.; Coulibaly, Fasseli; Bird, Phillip I.; Whisstock, James C.] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia; [Law, Ruby H. P.; Whisstock, James C.] Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Melbourne, Vic 3800, Australia; [Lukoyanova, Natalya; Orlova, Elena V.; Saibil, Helen R.] Univ London Birkbeck Coll, Inst Struct & Mol Biol, London WC1E 7HX, England; [Voskoboinik, Ilia] Univ Melbourne, Dept Genet, Parkville, Vic 3010, Australia; [Caradoc-Davies, Tom T.] Australian Synchrotron, Melbourne, Vic 3168, Australia; [Dunstone, Michelle A.] Monash Univ, Dept Microbiol, Melbourne, Vic 3800, Australia; [Kuiper, Michael J.] Victorian Partnership Adv Comp, Dept Life Sci, Carlton, Vic 3053, Australia; [Trapani, Joseph A.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia	Peter Maccallum Cancer Center; Monash University; Monash University; University of London; Birkbeck University London; University of Melbourne; Monash University; University of Melbourne	Trapani, JA (corresponding author), Peter MacCallum Canc Ctr, Canc Immunol Program, St Andrews Pl, Melbourne, Vic 3002, Australia.	joe.trapani@petermac.org; h.saibil@mail.cryst.bbk.ac.uk; james.whisstock@monash.edu	Orlova, Elena/CAF-8290-2022; Dunstone, Michelle/I-2895-2014	Dunstone, Michelle/0000-0002-6026-648X; Orlova, Elena/0000-0003-3371-415X; Bird, Phillip/0000-0002-6695-606X; Trapani, Joseph/0000-0003-0983-1532; law, ruby/0000-0001-5432-5781; Whisstock, James/0000-0003-4200-5611; D'Angelo, Michael/0000-0001-9342-0132; Coulibaly, Fasseli/0000-0003-3380-2117; Lukoyanova, Natalya/0000-0002-2051-0812; Voskoboinik, Ilia/0000-0002-6410-009X	NHMRC; ARC; UK BBSRC; Wellcome Trust; BBSRC [BB/D008573/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D008573/1] Funding Source: researchfish	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council); UK BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	J.C.W. is an Australian Research Council Federation Fellow and Honorary National Health and Medical Research Council of Australia Principal Research Fellow. I.V., F.C. and M.A.D. are NHMRC Career Development Fellows. K.B. is an NHMRC C.J. Martin overseas training fellow. J.A.T. acknowledges the support of an NHMRC Senior Principal Research Fellowship during the course of the work. The authors thank the NHMRC, the ARC, the UK BBSRC and the Wellcome Trust for grant support. We thank the Australian synchrotron beamline scientists for technical support and access to the MX-2 Microfocus Beamline; we thank D. Clare and L. Wang for electron microscopy support, and D. Houldershaw, R. Westlake and K. Mahmood for computing support. We thank D. Steer and the Monash University Proteomics Unit for technical support.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baran K, 2009, IMMUNITY, V30, P684, DOI 10.1016/j.immuni.2009.03.016; Bird CH, 2005, MOL CELL BIOL, V25, P7854, DOI 10.1128/MCB.25.17.7854-7867.2005; BRICKNER A, 1985, BIOCHEMISTRY-US, V24, P4603, DOI 10.1021/bi00338a019; Bricogne G., 2009, BUSTER VERSION 2 8 0; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Czajkowsky DM, 2004, EMBO J, V23, P3206, DOI 10.1038/sj.emboj.7600350; Dang TX, 2005, J STRUCT BIOL, V150, P100, DOI 10.1016/j.jsb.2005.02.003; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Delano W, 2002, PYMOL MOL GRAPHICS S; DOURMASHKIN RR, 1980, CLIN EXP IMMUNOL, V42, P554; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Grobler JA, 1997, NAT STRUCT BIOL, V4, P261, DOI 10.1038/nsb0497-261; Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103; Hurley JH, 2000, ANNU REV BIOPH BIOM, V29, P49, DOI 10.1146/annurev.biophys.29.1.49; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; KAWASAKI A, 1990, INT IMMUNOL, V2, P677, DOI 10.1093/intimm/2.7.677; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; LICHTENHELD MG, 1988, NATURE, V335, P448, DOI 10.1038/335448a0; LOWIN B, 1994, NATURE, V370, P650, DOI 10.1038/370650a0; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Moreno RU, 2009, BLOOD, V113, P338, DOI 10.1182/blood-2008-08-172924; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PODACK ER, 1985, P NATL ACAD SCI USA, V82, P8629, DOI 10.1073/pnas.82.24.8629; Ramachandran R, 2005, P NATL ACAD SCI USA, V102, P7139, DOI 10.1073/pnas.0500556102; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Shin OH, 2010, NAT STRUCT MOL BIOL, V17, P280, DOI 10.1038/nsmb.1758; SHINKAI Y, 1988, NATURE, V334, P525, DOI 10.1038/334525a0; Slade DJ, 2008, J MOL BIOL, V379, P331, DOI 10.1016/j.jmb.2008.03.061; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Sun JR, 1999, BIOCHEM BIOPH RES CO, V261, P251, DOI 10.1006/bbrc.1999.0989; Sutton VR, 2008, METHODS, V44, P241, DOI 10.1016/j.ymeth.2007.11.011; Thiery J, 2010, BLOOD, V115, P1582, DOI 10.1182/blood-2009-10-246116; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; TSCHOPP J, 1986, NATURE, V322, P831, DOI 10.1038/322831a0; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Voskoboinik I, 2005, J BIOL CHEM, V280, P8426, DOI 10.1074/jbc.M413303200; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; White HE, 2004, J MOL BIOL, V336, P453, DOI 10.1016/j.jmb.2003.12.015; YOUNG JDE, 1986, P NATL ACAD SCI USA, V83, P150, DOI 10.1073/pnas.83.1.150; YOUNG JDE, 1986, SCIENCE, V233, P184, DOI 10.1126/science.2425429	57	280	290	3	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 18	2010	468	7322					447	U277		10.1038/nature09518	http://dx.doi.org/10.1038/nature09518			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681KP	21037563				2022-12-01	WOS:000284313100045
J	Sabo, JL; Finlay, JC; Kennedy, T; Post, DM				Sabo, John L.; Finlay, Jacques C.; Kennedy, Theodore; Post, David M.			The Role of Discharge Variation in Scaling of Drainage Area and Food Chain Length in Rivers	SCIENCE			English	Article							ECOSYSTEM SIZE; ENERGY AVAILABILITY; WEB STRUCTURE; FRESH-WATERS; DISTURBANCE; FISH; STREAMS; HETEROGENEITY; LAKES	Food chain length (FCL) is a fundamental component of food web structure. Studies in a variety of ecosystems suggest that FCL is determined by energy supply, environmental stability, and/or ecosystem size, but the nature of the relationship between environmental stability and FCL, and the mechanism linking ecosystem size to FCL, remain unclear. Here we show that FCL increases with drainage area and decreases with hydrologic variability and intermittency across 36 North American rivers. Our analysis further suggests that hydrologic variability is the mechanism underlying the correlation between ecosystem size and FCL in rivers. Ecosystem size lengthens river food chains by integrating and attenuating discharge variation through stream networks, thereby enhancing environmental stability in larger river systems.	[Sabo, John L.] Arizona State Univ, Sch Life Sci, Fac Ecol Evolut & Environm Sci, Tempe, AZ 85287 USA; [Finlay, Jacques C.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Kennedy, Theodore] US Geol Survey, SW Biol Sci Ctr, Flagstaff, AZ 86001 USA; [Post, David M.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA	Arizona State University; Arizona State University-Tempe; University of Minnesota System; University of Minnesota Twin Cities; United States Department of the Interior; United States Geological Survey; Yale University	Sabo, JL (corresponding author), Arizona State Univ, Sch Life Sci, Fac Ecol Evolut & Environm Sci, POB 874501, Tempe, AZ 85287 USA.	John.L.Sabo@asu.edu	Post, David M/A-6987-2009; Finlay, Jacques/B-6081-2011; Sabo, John L/B-1872-2013	Post, David M/0000-0003-1434-7729; Finlay, Jacques/0000-0002-7968-7030; Kennedy, Theodore/0000-0003-3477-3629	NSF [DEB-0315990, DEB-0316679, DEB-0317137, DEB-0635088, EF-0553768]; University of California, Santa Barbara; State of California	NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California	The authors thank S. Beck, M. Bernot, M. Booth, M. Caron, O. Champoux, C. Crenshaw, D. Cunjak, D. Caissie, R. Doucett, S. J. Fisher, N. B. Grimm, R. O. Hall, T. K. Harms, B. Hungate, K. Luttermoser, W. McDowell, G. Morin, P. Mulholland, R. J. Naiman, J. Regetz, E. Rosi-Marshall, R. Sponseller, C. U. Soykan, and L. Thompson; the Minnesota Department of Natural Resources for fish samples; the STROUD New York Watersheds Project for access to study sites and metabolism data; the Los Angeles Department of Water and Power, the Coweeta Long-Term Ecological Research (LTER) project, the H. J. Andrews LTER project, Oak Ridge National Laboratory, Environment Canada, and the U.S. Forest Service for flow data. This work was supported by grants from NSF, including DEB-0315990 to J.C.F., DEB-0316679 to D.M.P., and DEB-0317137 and DEB-0635088 to J.L.S.. The work was also supported by a Sabbatical Fellowship to J.L.S. at the National Center for Ecological Analysis and Synthesis, a center funded by NSF (grant EF-0553768); the University of California, Santa Barbara; and the State of California. Any use of trade, product, or firm names is for descriptive purposes only and does not imply endorsement by the U.S. government.	Barnett TP, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006704; CLOSS GP, 1994, ECOL MONOGR, V64, P1, DOI 10.2307/2937053; Elton C., 1927, ANIMAL ECOLOGY; FISHER SG, 1982, ECOL MONOGR, V52, P93, DOI 10.2307/2937346; GROSSMAN GD, 1982, AM NAT, V120, P423, DOI 10.1086/284004; Guegan JF, 1998, NATURE, V391, P382, DOI 10.1038/34899; HAIRSTON NG, 1993, AM NAT, V142, P379, DOI 10.1086/285546; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; IPCC, 2022, CLIMATE CHANGE 2022; Jackson RB, 2001, ECOL APPL, V11, P1027, DOI 10.1890/1051-0761(2001)011[1027:WIACW]2.0.CO;2; KIDD KA, 1995, SCIENCE, V269, P240, DOI 10.1126/science.269.5221.240; Knighton D., 1998, FLUVIAL FORMS PROCES; Leopold L.B., 1953, HYDRAULIC GEOMETRY S, V252, P22; Liang S, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR007971; McHugh PA, 2010, ECOL LETT, V13, P881, DOI 10.1111/j.1461-0248.2010.01484.x; McIntyre PB, 2007, P NATL ACAD SCI USA, V104, P4461, DOI 10.1073/pnas.0608148104; Pimm S.L., 1982, FOOD WEBS; Post DM, 2007, GEOMORPHOLOGY, V89, P111, DOI 10.1016/j.geomorph.2006.07.014; Post DM, 2007, OIKOS, V116, P775, DOI 10.1111/j.2007.0030-1299.15552.x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Post DM, 2000, NATURE, V405, P1047, DOI 10.1038/35016565; Post DM, 2002, TRENDS ECOL EVOL, V17, P269, DOI 10.1016/S0169-5347(02)02455-2; Power ME, 2008, ECOL MONOGR, V78, P263, DOI 10.1890/06-0902.1; Sabo JL, 2008, ECOL MONOGR, V78, P19, DOI 10.1890/06-1340.1; Sabo JL, 2009, ANN NY ACAD SCI, V1162, P187, DOI 10.1111/j.1749-6632.2009.04445.x; Schindler DE, 1997, SCIENCE, V277, P248, DOI 10.1126/science.277.5323.248; SCHOENER TW, 1989, ECOLOGY, V70, P1559, DOI 10.2307/1938088; Takimoto G, 2008, ECOLOGY, V89, P3001, DOI 10.1890/07-1990.1; Thompson RM, 2005, OIKOS, V108, P137, DOI 10.1111/j.0030-1299.2005.11600.x; Townsend CR, 1998, ECOL LETT, V1, P200; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Walters AW, 2008, ECOLOGY, V89, P3261, DOI 10.1890/08-0273.1; Wootton JT, 1996, SCIENCE, V273, P1558, DOI 10.1126/science.273.5281.1558	33	163	169	6	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 12	2010	330	6006					965	967		10.1126/science.1196005	http://dx.doi.org/10.1126/science.1196005			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678XY	20947729				2022-12-01	WOS:000284118000043
J	McDaniel, LD; Young, E; Delaney, J; Ruhnau, F; Ritchie, KB; Paul, JH				McDaniel, Lauren D.; Young, Elizabeth; Delaney, Jennifer; Ruhnau, Fabian; Ritchie, Kim B.; Paul, John H.			High Frequency of Horizontal Gene Transfer in the Oceans	SCIENCE			English	Article							TRANSFER AGENT GENES; MARINE		[McDaniel, Lauren D.; Young, Elizabeth; Delaney, Jennifer; Paul, John H.] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Ruhnau, Fabian] Univ Duisburg Essen, Biofilm Ctr, D-47057 Duisburg, Germany; [Ritchie, Kim B.] Ctr Coral Reef Res, Mote Marine Lab, Sarasota, FL 34236 USA	State University System of Florida; University of South Florida; University of Duisburg Essen; Mote Marine Laboratory & Aquarium	McDaniel, LD (corresponding author), Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA.	mcdaniel@marine.usf.edu						Biers EJ, 2008, APPL ENVIRON MICROB, V74, P2933, DOI 10.1128/AEM.02129-07; Jiang SC, 1998, APPL ENVIRON MICROB, V64, P2780; Lang AS, 2007, TRENDS MICROBIOL, V15, P54, DOI 10.1016/j.tim.2006.12.001; Sanchez Federico, 2008, Plant Biology (Rockville), V2008, P65; Williams HG, 1997, MOL MAR BIOL BIOTECH, V6, P238; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Zhao YL, 2010, APPL ENVIRON MICROB, V76, P589, DOI 10.1128/AEM.01450-09	7	212	218	7	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 1	2010	330	6000					50	50		10.1126/science.1192243	http://dx.doi.org/10.1126/science.1192243			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	656KW	20929803				2022-12-01	WOS:000282334500029
J	Lemmers, RJLF; van der Vliet, PJ; Klooster, R; Sacconi, S; Camano, P; Dauwerse, JG; Snider, L; Straasheijm, KR; van Ommen, GJ; Padberg, GW; Miller, DG; Tapscott, SJ; Tawil, R; Frants, RR; van der Maarel, SM				Lemmers, Richard J. L. F.; van der Vliet, Patrick J.; Klooster, Rinse; Sacconi, Sabrina; Camano, Pilar; Dauwerse, Johannes G.; Snider, Lauren; Straasheijm, Kirsten R.; van Ommen, Gert Jan; Padberg, George W.; Miller, Daniel G.; Tapscott, Stephen J.; Tawil, Rabi; Frants, Rune R.; van der Maarel, Silvere M.			A Unifying Genetic Model for Facioscapulohumeral Muscular Dystrophy	SCIENCE			English	Article							DNA REARRANGEMENTS; FSHD; RNA; 4Q; D4Z4	Facioscapulohumeral muscular dystrophy (FSHD) is a common form of muscular dystrophy in adults that is foremost characterized by progressive wasting of muscles in the upper body. FSHD is associated with contraction of D4Z4 macrosatellite repeats on chromosome 4q35, but this contraction is pathogenic only in certain "permissive" chromosomal backgrounds. Here, we show that FSHD patients carry specific single-nucleotide polymorphisms in the chromosomal region distal to the last D4Z4 repeat. This FSHD-predisposing configuration creates a canonical polyadenylation signal for transcripts derived from DUX4, a double homeobox gene of unknown function that straddles the last repeat unit and the adjacent sequence. Transfection studies revealed that DUX4 transcripts are efficiently polyadenylated and are more stable when expressed from permissive chromosomes. These findings suggest that FSHD arises through a toxic gain of function attributable to the stabilized distal DUX4 transcript.	[Lemmers, Richard J. L. F.; van der Vliet, Patrick J.; Klooster, Rinse; Straasheijm, Kirsten R.; van Ommen, Gert Jan; Frants, Rune R.; van der Maarel, Silvere M.] Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZA Leiden, Netherlands; [Sacconi, Sabrina] Univ Nice, Ctr Reference Malad Neuromusculaires, F-06202 Nice, France; [Sacconi, Sabrina] Univ Nice, CNRS, UMR6543, F-06202 Nice, France; [Camano, Pilar] Hosp Donostia, BioDonostia Hlth Res Inst, Dept Neurosci, San Sebastian 20014, Spain; [Camano, Pilar] Inst Salud Carlos III, CIBERNED, Madrid 28029, Spain; [Dauwerse, Johannes G.] Leiden Univ, Med Ctr, Dept Clin Genet, NL-2333 ZA Leiden, Netherlands; [Snider, Lauren; Tapscott, Stephen J.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Padberg, George W.] Radboud Univ Nijmegen, Med Ctr Nijmegen, Dept Neurol, NL-6500 HC Nijmegen, Netherlands; [Miller, Daniel G.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Tawil, Rabi] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Instituto de Investigacion Sanitaria Biodonostia; University Hospital Donostia; CIBERNED; Instituto de Salud Carlos III; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Fred Hutchinson Cancer Center; Radboud University Nijmegen; University of Washington; University of Washington Seattle; University of Rochester	van der Maarel, SM (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZA Leiden, Netherlands.	maarel@lumc.nl	van der Maarel, Silvere/X-3631-2018; SACCONI, Sabrina/AFT-1096-2022; Camaño, Pilar/B-7733-2018; Padberg, G.W.A.M./H-8079-2014	van der Maarel, Silvere/0000-0001-8103-711X; SACCONI, Sabrina/0000-0002-0246-1455; Camaño, Pilar/0000-0002-4116-5579; Miller, Daniel/0000-0002-5700-3048; Tapscott, Stephen/0000-0002-0319-0968	Fields Center for FSHD and Neuromuscular Research; Netherlands Organization for Scientific Research [NWO 917.56.338]; Netherlands Genomics Initiative [NWO 93.51.8001]; National Institutes of Health [P01NS069539]; Muscular Dystrophy Association; Shaw Family Foundation; FSH Society; Dutch FSHD Foundation; Pacific Northwest Friends of FSH Research; Centro Investigacion Biomedica en Red para Enfermedades Neurodegenerativas (CIBERNED); Basque Government [2008111011]; Instituto Carlos III, ILUNDAIN Fundazioa; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS069539] Funding Source: NIH RePORTER	Fields Center for FSHD and Neuromuscular Research; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Shaw Family Foundation; FSH Society; Dutch FSHD Foundation; Pacific Northwest Friends of FSH Research; Centro Investigacion Biomedica en Red para Enfermedades Neurodegenerativas (CIBERNED); Basque Government(Basque Government); Instituto Carlos III, ILUNDAIN Fundazioa(Instituto de Salud Carlos III); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all patients and family members for their participation. This study was supported by the Fields Center for FSHD and Neuromuscular Research, the Netherlands Organization for Scientific Research NWO 917.56.338, a Breakthrough Project Grant by the Netherlands Genomics Initiative NWO 93.51.8001, the National Institutes of Health P01NS069539, the Muscular Dystrophy Association, the Shaw Family Foundation, a Marjorie Bronfman Fellowship grant from the FSH Society, the Dutch FSHD Foundation, the Pacific Northwest Friends of FSH Research, Centro Investigacion Biomedica en Red para Enfermedades Neurodegenerativas (CIBERNED), the Basque Government (Fellowship grant, 2008111011), and Instituto Carlos III, ILUNDAIN Fundazioa.	AHMED F, 2009, SILICO BIOL, V9, P13; Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; de Greef JC, 2009, HUM MUTAT, V30, P1449, DOI 10.1002/humu.21091; de Greef JC, 2008, MUTAT RES-FUND MOL M, V647, P94, DOI 10.1016/j.mrfmmm.2008.07.011; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Klooster R, 2009, EUR J HUM GENET, V17, P1615, DOI 10.1038/ejhg.2009.62; Lemmers RJLF, 2007, AM J HUM GENET, V81, P884, DOI 10.1086/521986; Lemmers RJLF, 2010, AM J HUM GENET, V86, P364, DOI 10.1016/j.ajhg.2010.01.035; Lemmers RJLF, 2002, NAT GENET, V32, P235, DOI 10.1038/ng999; Liu HQ, 2005, BIOINFORMATICS, V21, P671, DOI 10.1093/bioinformatics/bth437; Masny PS, 2010, EUR J HUM GENET, V18, P448, DOI 10.1038/ejhg.2009.183; Snider L, 2009, HUM MOL GENET, V18, P2414, DOI 10.1093/hmg/ddp180; Tawil R, 2006, MUSCLE NERVE, V34, P1, DOI 10.1002/mus.20522; Tupler R, 1996, J MED GENET, V33, P366, DOI 10.1136/jmg.33.5.366; van der Maarel SM, 2000, AM J HUM GENET, V66, P26, DOI 10.1086/302730; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Zeng WH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000559	22	456	475	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1650	1653		10.1126/science.1189044	http://dx.doi.org/10.1126/science.1189044			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20724583	Green Accepted, Green Published			2022-12-01	WOS:000282098100043
J	Nishikawa, S; Arimoto, I; Ikezaki, K; Sugawa, M; Ueno, H; Komori, T; Iwane, AH; Yanagida, T				Nishikawa, So; Arimoto, Ikuo; Ikezaki, Keigo; Sugawa, Mitsuhiro; Ueno, Hiroshi; Komori, Tomotaka; Iwane, Atsuko H.; Yanagida, Toshio			Switch between Large Hand-Over-Hand and Small Inchworm-like Steps in Myosin VI	CELL			English	Article							LEVER ARM; ACTIN-FILAMENTS; UNIQUE INSERT; POWER STROKE; MOTOR; MECHANISM; WALKS; DIRECTIONALITY; MICROSCOPY; SIZE	Many biological motor molecules move within cells using stepsizes predictable from their structures. Myosin VI, however, has much larger and more broadly distributed stepsizes than those predicted from its short lever arms. We explain the discrepancy by monitoring Qdots and gold nanoparticles attached to the myosin-VI motor domains using high-sensitivity nanoimaging. The large stepsizes were attributed to an extended and relatively rigid lever arm; their variability to two stepsizes, one large (72 nm) and one small (44 nm). These results suggest that there exist two tilt angles during myosin-VI stepping, which correspond to the pre- and postpowerstroke states and regulate the leading head. The large steps are consistent with the previously reported hand-over-hand mechanism, while the small steps follow an inchworm-like mechanism and increase in frequency with ADP. Switching between these two mechanisms in a strain-sensitive, ADP-dependent manner allows myosin VI to fulfill its multiple cellular tasks including vesicle transport and membrane anchoring.	[Nishikawa, So; Arimoto, Ikuo; Ikezaki, Keigo; Sugawa, Mitsuhiro; Komori, Tomotaka; Iwane, Atsuko H.; Yanagida, Toshio] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Ueno, Hiroshi] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan; [Yanagida, Toshio] Osaka Univ, Immunol Frontier Res Ctr, WPI, Osaka 5670047, Japan; [Yanagida, Toshio] RIKEN, Suita, Osaka 5650871, Japan; [Yanagida, Toshio] Natl Inst Informat & Commun Technol, Koganei, Tokyo 1848795, Japan	Osaka University; Osaka University; Osaka University; RIKEN; National Institute of Information & Communications Technology (NICT) - Japan	Yanagida, T (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	yanagida@phys1.med.osaka-u.ac.jp		Iwane, Atsuko/0000-0003-2641-2268; SUGAWA, MITSUHIRO/0000-0002-3188-1547	Ministry of Education, Science, Sports and Culture [20770121]	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study is supported by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Young Scientists (B), 20770121, 2008-2009 (to S.N.), for Scientific Research on Priority Areas, 60402997, 2007-2008 (to S.N.), by the Yuragi Project of the Japanese Ministry of Education, Culture, Sports, Science and Technology (to T.Y.). We thank member of Yanagida Lab., Noji Lab. and Kinosita Lab. for valuable discussion. We especially thank M. A. Zulliger, R. Iino, K. V. Tabata, S. Sakakihara, S. Furuike; Y. Arai, T. Mimuro-Ichinose and R. Ogawa, for technical help; P. Karagiannis for helpful discussions and comments on the manuscript.	Ali MY, 2004, BIOPHYS J, V86, P3804, DOI 10.1529/biophysj.103.037416; Altman D, 2004, CELL, V116, P737, DOI 10.1016/S0092-8674(04)00211-9; Altman D, 2007, PLOS BIOL, V5, P1712, DOI 10.1371/journal.pbio.0050210; Bahloul A, 2004, P NATL ACAD SCI USA, V101, P4787, DOI 10.1073/pnas.0306892101; Balci H, 2005, BIOPHYS J, V89, P413, DOI 10.1529/biophysj.105.060608; Bryant Z, 2007, P NATL ACAD SCI USA, V104, P772, DOI 10.1073/pnas.0610144104; Churchman LS, 2005, P NATL ACAD SCI USA, V102, P1419, DOI 10.1073/pnas.0409487102; CHURCHMAN LS, 2007, COLOCALIZATION FLUOR, P73; DE LA CRUZ EM, 2001, J BIOL CHEM, V276, P32373; Dunn AR, 2007, NAT STRUCT MOL BIOL, V14, P246, DOI 10.1038/nsmb1206; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; GOLDMAN YE, 1987, ANNU REV PHYSIOL, V49, P637, DOI 10.1146/annurev.ph.49.030187.003225; HARADA Y, 1990, J MOL BIOL, V216, P49, DOI 10.1016/S0022-2836(05)80060-9; Iwaki M, 2009, NAT CHEM BIOL, V5, P403, DOI 10.1038/nchembio.171; KINOSITA K, 1991, J CELL BIOL, V115, P67, DOI 10.1083/jcb.115.1.67; Lan GH, 2006, BIOPHYS J, V91, P4002, DOI 10.1529/biophysj.106.089888; Menetrey J, 2005, NATURE, V435, P779, DOI 10.1038/nature03592; Menetrey J, 2008, EMBO J, V27, P244, DOI 10.1038/sj.emboj.7601937; Mukherjea M, 2009, MOL CELL, V35, P305, DOI 10.1016/j.molcel.2009.07.010; Nishikawa S, 2002, BIOCHEM BIOPH RES CO, V290, P311, DOI 10.1006/bbrc.2001.6142; Okten Z, 2004, NAT STRUCT MOL BIOL, V11, P884, DOI 10.1038/nsmb815; Park H, 2006, MOL CELL, V21, P331, DOI 10.1016/j.molcel.2005.12.015; Park H, 2007, P NATL ACAD SCI USA, V104, P778, DOI 10.1073/pnas.0610066104; Phichith D, 2009, P NATL ACAD SCI USA, V106, P17320, DOI 10.1073/pnas.0909748106; Reifenberger JG, 2009, P NATL ACAD SCI USA, V106, P18255, DOI 10.1073/pnas.0900005106; Rock RS, 2005, MOL CELL, V17, P603, DOI 10.1016/j.molcel.2005.01.015; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Shiroguchi K, 2007, SCIENCE, V316, P1208, DOI 10.1126/science.1140468; Sivaramakrishnan S, 2009, J CELL BIOL, V187, P53, DOI 10.1083/jcb.200906133; Spink BJ, 2008, NAT STRUCT MOL BIOL, V15, P591, DOI 10.1038/nsmb.1429; Spudich JA, 2010, NAT REV MOL CELL BIO, V11, P128, DOI 10.1038/nrm2833; Sun YJ, 2007, MOL CELL, V28, P954, DOI 10.1016/j.molcel.2007.10.029; Sweeney HL, 2007, CURR OPIN CELL BIOL, V19, P57, DOI 10.1016/j.ceb.2006.12.005; Taniguchi Y, 2005, NAT CHEM BIOL, V1, P342, DOI 10.1038/nchembio741; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Tokunaga M, 1997, BIOCHEM BIOPH RES CO, V235, P47, DOI 10.1006/bbrc.1997.6732; Ueno H, 2010, BIOPHYS J, V98, P2014, DOI 10.1016/j.bpj.2010.01.011; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; Warshaw DM, 2005, BIOPHYS J, V88, pL30, DOI 10.1529/biophysj.105.061903; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Yildiz A, 2004, J BIOL CHEM, V279, P37223, DOI 10.1074/jbc.C400252200; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	42	51	51	0	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 17	2010	142	6					879	888		10.1016/j.cell.2010.08.033	http://dx.doi.org/10.1016/j.cell.2010.08.033			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650NA	20850010	Bronze			2022-12-01	WOS:000281855000011
J	Dobson, A; Borner, M; Sinclair, T				Dobson, Andrew; Borner, Markus; Sinclair, Tony			Road will ruin Serengeti	NATURE			English	Editorial Material							TERRESTRIAL; TANZANIA; MAMMALS		[Dobson, Andrew] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; [Borner, Markus] Frankfurt Zool Soc, Africa Programme, Arusha, Tanzania; [Sinclair, Tony] Univ British Columbia, Ctr Biodivers Res, Vancouver, BC V6T 1Z4, Canada	Princeton University; University of British Columbia	Dobson, A (corresponding author), Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA.	dobson@Princeton.edu	Durant, Sarah M/AAB-9659-2019	Durant, Sarah M/0000-0003-0724-0878; Ogutu, Joseph O/0000-0002-7379-0387; Hudson, Peter/0000-0003-0468-3403; Haydon, Daniel/0000-0002-1240-1886				Boone Randall B., 2004, African Journal of Range & Forage Science, V21, P147, DOI 10.2989/10220110409485847; Chruszcz B, 2003, CAN J ZOOL, V81, P1378, DOI 10.1139/Z03-123; Dobson A, 2008, TRENDS ECOL EVOL, V23, P177, DOI 10.1016/j.tree.2007.08.019; Gereta E., 2009, Ecohydrology and Hydrobiology, V9, P115, DOI 10.2478/v10104-009-0035-7; Harris Grant, 2009, Endangered Species Research, V7, P55, DOI 10.3354/esr00173; Holdo RM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000210; Homewood K, 2009, STUD HUM ECOL ADAPT, V5, P1, DOI 10.1007/978-0-387-87492-0; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; LEAKEY MD, 1979, NATURE, V278, P317, DOI 10.1038/278317a0; Newmark WD, 1996, AFR J ECOL, V34, P15, DOI 10.1111/j.1365-2028.1996.tb00590.x; Sinclair A.R.E., 1979, SERENGETI DYNAMICS E; Sinclair ARE., 2008, SERENGETI; SINCLAIR ARE, 1995, SERENGETI, V2; SPINAGE C A, 1992, Oryx, V26, P147; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x	15	72	72	2	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 16	2010	467	7313					272	273		10.1038/467272a	http://dx.doi.org/10.1038/467272a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	650CF	20844519				2022-12-01	WOS:000281824900018
J	Mackay, D; Haw, S; Ayres, JG; Fischbacher, C; Pell, JP				Mackay, Daniel; Haw, Sally; Ayres, Jon G.; Fischbacher, Colin; Pell, Jill P.			Smoke-free Legislation and Hospitalizations for Childhood Asthma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; CROSS-SECTIONAL SURVEY; SECONDHAND SMOKE; 2ND-HAND SMOKE; EXPOSURE; SCOTLAND; IMPLEMENTATION; CHILDREN; HEALTH	Background: Previous studies have shown that after the adoption of comprehensive smoke-free legislation, there is a reduction in respiratory symptoms among workers in bars. However, it is not known whether respiratory disease is also reduced among people who do not have occupational exposure to environmental tobacco smoke. The aim of our study was to determine whether the ban on smoking in public places in Scotland, which was initiated in March 2006, influenced the rate of hospital admissions for childhood asthma. Methods: Routine hospital administrative data were used to identify all hospital admissions for asthma in Scotland from January 2000 through October 2009 among children younger than 15 years of age. A negative binomial regression model was fitted, with adjustment for age group, sex, quintile of socioeconomic status, urban or rural residence, month, and year. Tests for interactions were also performed. Results: Before the legislation was implemented, admissions for asthma were increasing at a mean rate of 5.2% per year (95% confidence interval [CI], 3.9 to 6.6). After implementation of the legislation, there was a mean reduction in the rate of admissions of 18.2% per year relative to the rate on March 26, 2006 (95% CI, 14.7 to 21.8; P<0.001). The reduction was apparent among both preschool and school-age children. There were no significant interactions between hospital admissions for asthma and age group, sex, urban or rural residence, region, or quintile of socioeconomic status. Conclusions: In Scotland, passage of smoke-free legislation in 2006 was associated with a subsequent reduction in the rate of respiratory disease in populations other than those with occupational exposure to environmental tobacco smoke. (Funded by NHS Health Scotland.) N Engl J Med 2010;363:1139-45.	[Mackay, Daniel; Pell, Jill P.] Univ Glasgow, Sect Publ Hlth, Glasgow G12 8RZ, Lanark, Scotland; [Haw, Sally] Scottish Collaborat Publ Hlth Res Policy, Edinburgh, Midlothian, Scotland; [Ayres, Jon G.] Univ Birmingham, Inst Occupat & Environm Med, Birmingham, W Midlands, England; [Fischbacher, Colin] NHS Natl Serv, Informat Serv Div, Edinburgh, Midlothian, Scotland	University of Glasgow; University of Birmingham; NHS National Services Scotland	Pell, JP (corresponding author), Univ Glasgow, Sect Publ Hlth, Rm 305,1 Lilybank Gardens, Glasgow G12 8RZ, Lanark, Scotland.	j.pell@clinmed.gla.ac.uk		Pell, Jill/0000-0002-8898-7035; Fischbacher, Colin/0000-0003-3090-1857	NHS Health Scotland	NHS Health Scotland	Supported by a project grant from NHS Health Scotland.	Akhtar PC, 2009, TOB CONTROL, V18, P409, DOI 10.1136/tc.2009.030627; Akhtar PC, 2007, BMJ-BRIT MED J, V335, P545, DOI 10.1136/bmj.39311.550197.AE; Akhtar PC, 2010, J EPIDEMIOL COMMUN H, V64, P341, DOI 10.1136/jech.2008.084178; Anderson HR, 2007, THORAX, V62, P85, DOI 10.1136/thx.2006.066407; Ashley MJ, 1998, TOB CONTROL, V7, P61, DOI 10.1136/tc.7.1.61; Ayres JG, 2009, OCCUP ENVIRON MED, V66, P339, DOI 10.1136/oem.2008.040311; Baena-Cagnani CE, 2009, CURR OPIN ALLERGY CL, V9, P136, DOI 10.1097/ACI.0b013e3283294038; Black C, 2009, SCOTTISH SCH ADOLESC; Gergen PJ, 1998, PEDIATRICS, V101, part. no., DOI 10.1542/peds.101.2.e8; Haw SJ, 2007, BRIT MED J, V335, P549, DOI 10.1136/bmj.39315.670208.47; HERMAN PM, 2010, AM J PUBLIC HLT 0513; Meyers DG, 2009, J AM COLL CARDIOL, V54, P1902, DOI 10.1016/j.jacc.2009.10.004; Meyers DG, 2009, J AM COLL CARDIOL, V54, P1249, DOI 10.1016/j.jacc.2009.07.022; Naiman A, 2010, CAN MED ASSOC J, V182, P761, DOI 10.1503/cmaj.091130; *OFF ENV HLTH HAZ, 2005, HLTH EFF EXP ENV TOB; Pell JP, 2008, NEW ENGL J MED, V359, P482, DOI 10.1056/NEJMsa0706740; Scottish Government, 2009, SCOTL PEOPL ANN REP; Semple S, 2007, ANN OCCUP HYG, V51, P571, DOI 10.1093/annhyg/mem044; Semple S, 2007, TOB CONTROL, V16, P127, DOI 10.1136/tc.2006.018119; Vork KL, 2007, ENVIRON HEALTH PERSP, V115, P1394, DOI 10.1289/ehp.10155	20	207	215	1	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2010	363	12					1139	1145		10.1056/NEJMoa1002861	http://dx.doi.org/10.1056/NEJMoa1002861			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649TD	20843248	Green Published, Green Accepted			2022-12-01	WOS:000281795800008
J	MacLeod, N; Benfield, M; Culverhouse, P				MacLeod, Norman; Benfield, Mark; Culverhouse, Phil			Time to automate identification	NATURE			English	Editorial Material							EXPERTS		[MacLeod, Norman] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; [Benfield, Mark] Louisiana State Univ, Sch Coast & Environm, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA; [Culverhouse, Phil] Univ Plymouth, Ctr Robot Neural Syst, Plymouth PL4 8AA, Devon, England	Natural History Museum London; Louisiana State University System; Louisiana State University; University of Plymouth	MacLeod, N (corresponding author), Nat Hist Museum, Dept Palaeontol, Cromwell Rd, London SW7 5BD, England.	n.macleod@nhm.ac.uk; mbenfie@lsu.edu; pculverhouse@plymouth.ac.uk		Culverhouse, Phil/0000-0002-7586-6496				Colquhoun W. P., 1959, ERGONOMICS, V2, P367, DOI 10.1080/00140135908930451; Culverhouse PF, 2003, MAR ECOL PROG SER, V247, P17, DOI 10.3354/meps247017; Culverhouse PF, 2007, SYST ASSOC SPEC VOL, V74, P25; Gauld I.D., 2000, P303; Ginsburg RN, 1997, MAR MICROPALEONTOL, V29, P67, DOI 10.1016/S0377-8398(96)00038-2; Gobalet KW, 2001, J ARCHAEOL SCI, V28, P377, DOI 10.1006/jasc.2000.0564; Kelly MG, 2001, WATER RES, V35, P2784, DOI 10.1016/S0043-1354(00)00554-6; SIMPSON R, 1991, IEEE CONFERENCE ON NEURAL NETWORKS FOR OCEAN ENGINEERING, P223, DOI 10.1109/ICNN.1991.163354; Zachariasse W. J., 1978, UTRECHT MICROPALEONT, V17, P1	9	155	163	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 9	2010	467	7312					154	155		10.1038/467154a	http://dx.doi.org/10.1038/467154a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647KB	20829777				2022-12-01	WOS:000281616300017
J	Tehranchi, R; Woll, PS; Anderson, K; Buza-Vidas, N; Mizukami, T; Mead, AJ; Astrand-Grundstrom, I; Strombeck, B; Horvat, A; Ferry, H; Dhanda, RS; Hast, R; Ryden, T; Vyas, P; Gohring, G; Schlegelberger, B; Johansson, B; Hellstrom-Lindberg, E; List, A; Nilsson, L; Jacobsen, SEW				Tehranchi, Ramin; Woll, Petter S.; Anderson, Kristina; Buza-Vidas, Natalija; Mizukami, Takuo; Mead, Adam J.; Astrand-Grundstrom, Ingbritt; Strombeck, Bodil; Horvat, Andrea; Ferry, Helen; Dhanda, Rakesh Singh; Hast, Robert; Ryden, Tobias; Vyas, Paresh; Gohring, Gudrun; Schlegelberger, Brigitte; Johansson, Bertil; Hellstrom-Lindberg, Eva; List, Alan; Nilsson, Lars; Jacobsen, Sten Eirik W.			Persistent Malignant Stem Cells in del(5q) Myelodysplasia in Remission	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN HEMATOPOIETIC-CELLS; RECEPTOR-ALPHA CHAIN; SELF-RENEWAL; MARROW-CELLS; LENALIDOMIDE; LEUKEMIA; 5Q; DELETION; MDS; PROLIFERATION	BACKGROUND The in vivo clinical significance of malignant stem cells remains unclear. METHODS Patients who have the 5q deletion (del[5q]) myelodysplastic syndrome (interstitial deletions involving the long arm of chromosome 5) have complete clinical and cytogenetic remissions in response to lenalidomide treatment, but they often have relapse. To determine whether the persistence of rare but distinct malignant stem cells accounts for such relapses, we examined bone marrow specimens obtained from seven patients with the del(5q) myelodysplastic syndrome who became transfusion-independent while receiving lenalidomide treatment and entered cytogenetic remission. RESULTS Virtually all CD34+, CD38+ progenitor cells and stem cells that were positive for CD34 and CD90, with undetectable or low CD38 (CD38-/low), had the 5q deletion before treatment. Although lenalidomide efficiently reduced these progenitors in patients in complete remission, a larger fraction of the minor, quiescent, CD34+, CD38-/low, CD90+ del(5q) stem cells as well as functionally defined del(5q) stem cells remained distinctly resistant to lenalidomide. Over time, lenalidomide resistance developed in most of the patients in partial and complete remission, with recurrence or expansion of the del(5q) clone and clinical and cytogenetic progression. CONCLUSIONS In these patients with the del(5q) myelodysplastic syndrome, we identified rare and phenotypically distinct del(5q) myelodysplastic syndrome stem cells that were also selectively resistant to therapeutic targeting at the time of complete clinical and cytogenetic remission. (Funded by the EuroCancerStemCell Consortium and others.)	[Woll, Petter S.; Buza-Vidas, Natalija; Mizukami, Takuo; Mead, Adam J.; Ferry, Helen; Jacobsen, Sten Eirik W.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Haematopoiet Stem Cell Lab, Oxford OX3 9DS, England; [Vyas, Paresh; Jacobsen, Sten Eirik W.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Mol Haematol Unit, Oxford OX3 9DS, England; [Tehranchi, Ramin; Anderson, Kristina; Astrand-Grundstrom, Ingbritt; Dhanda, Rakesh Singh; Nilsson, Lars; Jacobsen, Sten Eirik W.] Lund Univ, Lund Stem Cell Ctr, Hematopoiet Stem Cell Lab, Lund, Sweden; [Strombeck, Bodil; Horvat, Andrea; Johansson, Bertil] Lund Univ, Skane Univ Hosp, Univ & Reg Labs, Dept Clin Genet, Lund, Sweden; [Ryden, Tobias] Lund Univ, Dept Math Stat, Lund, Sweden; [Hast, Robert] Karolinska Univ Hosp, Hematol Ctr, Stockholm, Sweden; [Hellstrom-Lindberg, Eva] Karolinska Univ Hosp Huddinge, Div Hematol, Dept Med, Stockholm, Sweden; [Gohring, Gudrun; Schlegelberger, Brigitte] Hannover Med Sch, Inst Cell & Mol Pathol, D-3000 Hannover, Germany; [List, Alan] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	University of Oxford; University of Oxford; Lund University; Lund University; Skane University Hospital; Lund University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Hannover Medical School; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Jacobsen, SEW (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Haematopoiet Stem Cell Lab, Oxford OX3 9DS, England.	sten.jacobsen@imm.ox.ac.uk	Vyas, Paresh/B-5708-2009; Mead, Adam/A-8796-2012; Jacobsen, Sten Eirik W/D-3974-2018; Mizukami, Takuo/F-9248-2016	Vyas, Paresh/0000-0003-3931-0914; Mead, Adam/0000-0001-8522-1002; Jacobsen, Sten Eirik W/0000-0002-1362-3659; Mizukami, Takuo/0000-0001-6105-6049; Woll, Petter S./0000-0002-2340-2526; LIST, ALAN/0000-0002-1647-2972	EuroCancerStemCell Consortium; Swedish Cancer Society; Swedish Research Council; Avtal om Lakerutbildning och Forskning; Region Skane; Goran Gustafsson Foundation; Hemato-Linne (Swedish Research Council); Torsten and Ragnar Soderbergs Foundation; Cluster of Excellence in the Area of Regenerative Biology and Reconstructive Therapies; Medical Research Council (MRC) United Kingdom; Swedish Research Council (Vetenskapsradet); MRC; MRC Molecular Haematology Unit; Oxford Partnership Comprehensive Biomedical Research Centre; Leukemia and Lymphoma Society; Leukaemia and Lymphoma Research Senior Bennett Fellowship; Astellas Foundation; Celgene; MRC [G84/6443, G1000729] Funding Source: UKRI; Medical Research Council [G1000729, G1000801c, G84/6443] Funding Source: researchfish	EuroCancerStemCell Consortium; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Avtal om Lakerutbildning och Forskning; Region Skane; Goran Gustafsson Foundation; Hemato-Linne (Swedish Research Council)(Swedish Research Council); Torsten and Ragnar Soderbergs Foundation; Cluster of Excellence in the Area of Regenerative Biology and Reconstructive Therapies; Medical Research Council (MRC) United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Research Council (Vetenskapsradet)(Swedish Research Council); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Molecular Haematology Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oxford Partnership Comprehensive Biomedical Research Centre; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Leukaemia and Lymphoma Research Senior Bennett Fellowship; Astellas Foundation(Astellas Pharmaceuticals); Celgene(Bristol-Myers SquibbCelgene Corporation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by grants from the EuroCancerStemCell Consortium (a sixth framework European Union integrated project), the Swedish Cancer Society, the Swedish Research Council, Avtal om Lakerutbildning och Forskning (a government public health grant), Region Skane, the Goran Gustafsson Foundation, Hemato-Linne (Swedish Research Council), the Torsten and Ragnar Soderbergs Foundation, and the Cluster of Excellence in the Area of Regenerative Biology and Reconstructive Therapies; a grant from the Medical Research Council (MRC) United Kingdom (to Dr. Jacobsen); a postdoctoral fellowship from the Swedish Research Council (Vetenskapsradet) (to Dr. Tehranchi); an MRC Disease Team Award and grants from the MRC Molecular Haematology Unit and the Oxford Partnership Comprehensive Biomedical Research Centre (to Dr. Vyas); a Career Development Program fellowship from the Leukemia and Lymphoma Society (to Dr. Woll); a Leukaemia and Lymphoma Research Senior Bennett Fellowship (to Dr. Mead); and an Astellas Foundation for Research on Metabolic Disorders fellowship (to Dr. Mizukami).; Dr. Gohring reports receiving consulting fees from Celgene; and Dr. Nilsson, honoraria and fees for the development of educational presentations from Celgene. No other potential conflict of interest relevant to this article was reported.	Abramovich C, 2005, ANN NY ACAD SCI, V1044, P109, DOI 10.1196/annals.1349.014; Ades L, 2009, BLOOD, V113, P3947, DOI 10.1182/blood-2008-08-175778; Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Akala OO, 2006, CURR OPIN GENET DEV, V16, P496, DOI 10.1016/j.gde.2006.08.011; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Eclache V, 2008, HAEMATOLOGICA, V93, P315, DOI [10.3324/haematol.11917, 10.3324/haematol.12059]; Gandhi AK, 2006, LEUKEMIA RES, V30, P849, DOI 10.1016/j.leukres.2006.01.010; Glimm H, 1999, BLOOD, V94, P2161, DOI 10.1182/blood.V94.7.2161.419k32_2161_2168; Gohring G, 2010, ANN HEMATOL, V89, P365, DOI 10.1007/s00277-009-0846-z; Hogge DE, 1996, BLOOD, V88, P3765, DOI 10.1182/blood.V88.10.3765.bloodjournal88103765; Jadersten M, 2009, HAEMATOL-HEMATOL J, V94, P1762, DOI 10.3324/haematol.2009.011528; Jin LQ, 2009, CELL STEM CELL, V5, P31, DOI 10.1016/j.stem.2009.04.018; Jordan CT, 2000, LEUKEMIA, V14, P1777, DOI 10.1038/sj.leu.2401903; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; le Viseur C, 2008, CANCER CELL, V14, P47, DOI 10.1016/j.ccr.2008.05.015; List A, 2005, NEW ENGL J MED, V352, P549, DOI 10.1056/NEJMoa041668; List A, 2006, NEW ENGL J MED, V355, P1456, DOI 10.1056/NEJMoa061292; Melchert M, 2007, INT J BIOCHEM CELL B, V39, P1489, DOI 10.1016/j.biocel.2007.01.022; Misaghian N, 2009, LEUKEMIA, V23, P25, DOI 10.1038/leu.2008.246; Nilsson L, 2000, BLOOD, V96, P2012, DOI 10.1182/blood.V96.6.2012.h8002012a_2012_2021; Nilsson L, 2002, BLOOD, V100, P259, DOI 10.1182/blood-2001-12-0188; Nilsson L, 2007, BLOOD, V110, P3005, DOI 10.1182/blood-2007-03-079368; Nimer SD, 2008, BLOOD, V111, P4841, DOI 10.1182/blood-2007-08-078139; Parseval LAM, 2008, J CLIN INVEST, V118, P248, DOI 10.1172/JCI32322; Petzer AL, 1996, P NATL ACAD SCI USA, V93, P1470, DOI 10.1073/pnas.93.4.1470; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Sato T, 2009, NAT MED, V15, P696, DOI 10.1038/nm.1973; SUTHERLAND HJ, 1990, P NATL ACAD SCI USA, V87, P3584, DOI 10.1073/pnas.87.9.3584; SUTHERLAND HJ, 1989, BLOOD, V74, P1563; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; TERSTAPPEN LWMM, 1991, BLOOD, V77, P1218; VANDENBERGHE H, 1974, NATURE, V251, P437, DOI 10.1038/251437a0; Verhelle D, 2007, CANCER RES, V67, P746, DOI 10.1158/0008-5472.CAN-06-2317; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Wei S, 2009, P NATL ACAD SCI USA, V106, P12974, DOI 10.1073/pnas.0811267106	40	186	199	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 9	2010	363	11					1025	1037		10.1056/NEJMoa0912228	http://dx.doi.org/10.1056/NEJMoa0912228			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	647HS	20825315				2022-12-01	WOS:000281609700006
J	Green, BM; Finn, KJ; Li, JJ				Green, Brian M.; Finn, Kenneth J.; Li, Joachim J.			Loss of DNA Replication Control Is a Potent Inducer of Gene Amplification	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; MULTIPLE MECHANISMS; TANDEM DUPLICATION; COPY NUMBER; REREPLICATION; RECOMBINATION; CONSEQUENCES; EVOLUTION; CANCER; DAMAGE	Eukaryotic cells use numerous mechanisms to ensure that no segment of their DNA is inappropriately re-replicated, but the importance of this stringent control on genome stability has not been tested. Here we show that re-replication in Saccharomyces cerevisiae can strongly induce the initial step of gene amplification, increasing gene copy number from one to two or more. The resulting amplicons consist of large internal chromosomal segments that are bounded by Ty repetitive elements and are intrachromosomally arrayed at their endogenous locus in direct head-to-tail orientation. These re-replication-induced gene amplifications are mediated by nonallelic homologous recombination between the repetitive elements. We suggest that re-replication may be a contributor to gene copy number changes, which are important in fields such as cancer biology, evolution, and human genetics.	[Li, Joachim J.] UCSF, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Green, Brian M.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Finn, Kenneth J.] UCSF, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Johns Hopkins University; University of California System; University of California San Francisco	Li, JJ (corresponding author), UCSF, Dept Microbiol & Immunol, San Francisco, CA 94158 USA.	joachim.li@ucsf.edu			Sandler Program in Basic Sciences; Stewart Trust; UCSF Research Evaluation and Allocation Committee; UCSF Academic Senate; UC Cancer Research Coordinating Committee; NIH [R01 GM59704]; NSF; Department of Defense [W81XWH-04-1-0409]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059704] Funding Source: NIH RePORTER	Sandler Program in Basic Sciences; Stewart Trust; UCSF Research Evaluation and Allocation Committee; UCSF Academic Senate; UC Cancer Research Coordinating Committee; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Bainton for the use of his microscope; A. Johnson for the use of his pulsed-field gel electrophoresis system and microscope; and A. Sil, D. Morgan, A. Johnson, D. Toczyski, E. Blackburn, P. O'Farrell, T. Tlsty, J. Haber, S. Elledge, and F. Winston for helpful discussions. This work was supported by grants to J. J. L. from the Sandler Program in Basic Sciences, the Stewart Trust Fund, UCSF Research Evaluation and Allocation Committee, UCSF Academic Senate, UC Cancer Research Coordinating Committee, and NIH (grant R01 GM59704). B.M.G. was supported by an NSF Predoctoral Fellowship and a Department of Defense Breast Cancer Predoctoral Fellowship (W81XWH-04-1-0409). K. J. F. was supported by an NSF Predoctoral Fellowship. Microarray data are deposited with the Gene Expression Omnibus (accession number GSE22018).	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Archambault V, 2005, MOL CELL BIOL, V25, P6707, DOI 10.1128/MCB.25.15.6707-6721.2005; Arentson E, 2002, ONCOGENE, V21, P1150, DOI 10.1038/sj.onc.1205175; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Blow JJ, 2008, NAT REV CANCER, V8, P799, DOI 10.1038/nrc2500; DORSEY MJ, 1993, CURR GENET, V23, P392, DOI 10.1007/BF00312624; Gonzalez MA, 2005, NAT REV CANCER, V5, P135, DOI 10.1038/nrc1548; Green BM, 2006, MOL BIOL CELL, V17, P2401, DOI 10.1091/mbc.E05-11-1043; Green BM, 2005, MOL BIOL CELL, V16, P421, DOI 10.1091/mbc.e04-09-0833; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; KOSHLAND D, 1985, CELL, V40, P393, DOI 10.1016/0092-8674(85)90153-9; Koszul R, 2009, CR BIOL, V332, P254, DOI 10.1016/j.crvi.2008.07.005; Liontos M, 2007, CANCER RES, V67, P10899, DOI 10.1158/0008-5472.CAN-07-2837; Lockwood WW, 2008, ONCOGENE, V27, P4615, DOI 10.1038/onc.2008.98; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; O'Neil J, 2007, J EXP MED, V204, P3059, DOI 10.1084/jem.20071637; Payen C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000175; SCHIMKE RT, 1986, P NATL ACAD SCI USA, V83, P2157, DOI 10.1073/pnas.83.7.2157; Seo J, 2005, ONCOGENE, V24, P8176, DOI 10.1038/sj.onc.1208881; STARK GR, 1989, CELL, V57, P901, DOI 10.1016/0092-8674(89)90328-0; Strout MP, 1998, P NATL ACAD SCI USA, V95, P2390, DOI 10.1073/pnas.95.5.2390; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217	26	94	94	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 20	2010	329	5994					943	946		10.1126/science.1190966	http://dx.doi.org/10.1126/science.1190966			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640WN	20724634	Green Accepted			2022-12-01	WOS:000281084800034
J	Kim, J; Zhang, CZ; Zhang, XH; Springer, TA				Kim, Jongseong; Zhang, Cheng-Zhong; Zhang, Xiaohui; Springer, Timothy A.			A mechanically stabilized receptor-ligand flex-bond important in the vasculature	NATURE			English	Article							VON-WILLEBRAND-FACTOR; IB-IX-V; LEUCINE-RICH REPEATS; FACTOR A1 DOMAIN; PLATELET-ADHESION; SINGLE-MOLECULE; CATCH BONDS; SHEAR; COMPLEX; FORCE	Haemostasis in the arteriolar circulation mediated by von Willebrand factor (VWF) binding to platelets is an example of an adhesive interaction that must withstand strong hydrodynamic forces acting on cells. VWF is a concatenated, multifunctional protein that has binding sites for platelets as well as subendothelial collagen(1,2). Binding of the A1 domain in VWF to the glycoprotein Ib alpha subunit (GPIb alpha) on the surface of platelets mediates crosslinking of platelets to one another and the formation of a platelet plug for arterioles(3,4). The importance of VWF is illustrated by its mutation in von Willebrand disease, a bleeding diathesis(1). Here, we describe a novel mechanochemical specialization of the A1-GPIb alpha bond for force-resistance. We have developed a method that enables, for the first time, repeated measurements of the binding and unbinding of a receptor and ligand in a single molecule (ReaLiSM). We demonstrate two states of the receptor-ligand bond, that is, a flex-bond. One state is seen at low force; a second state begins to engage at 10 pN with a similar to 20-fold longer lifetime and greater force resistance. The lifetimes of the two states, how force exponentiates lifetime, and the kinetics of switching between the two states are all measured. For the first time, single-molecule measurements on this system are in agreement with bulk phase measurements. The results have important implications not only for how platelets bound to VWF are able to resist force to plug arterioles, but also how increased flow activates platelet plug formation.	[Kim, Jongseong; Zhang, Cheng-Zhong; Zhang, Xiaohui; Springer, Timothy A.] Childrens Hosp, Immune Dis Inst, Boston, MA 02115 USA; [Kim, Jongseong; Zhang, Cheng-Zhong; Zhang, Xiaohui; Springer, Timothy A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School	Springer, TA (corresponding author), Childrens Hosp, Immune Dis Inst, 3 Blackfan Circle, Boston, MA 02115 USA.	springer@idi.harvard.edu	Kim, Jongseong/I-7307-2019; Kim, Jongseong/M-9940-2014; Kim, Jongseong/I-6358-2013	Kim, Jongseong/0000-0001-9595-2765; Kim, Jongseong/0000-0001-9595-2765; Zhang, Xiaohui (Frank)/0000-0002-8778-595X; Kim, Jongseong/0000-0002-9553-2258	NIH [HL-48675]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048675] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by NIH HL-48675 (TAS). The authors are indebted to S. B. Smith and C. Bustamante for help with laser tweezers construction and insightful discussion. We thank B. Coller, O. K. Dudko and C. Lu for reagents and insightful discussions, and J. Dill for software for data analysis.	Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Astrof NS, 2006, BIOCHEMISTRY-US, V45, P15020, DOI 10.1021/bi061566o; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Bustamante C, 2000, CURR OPIN STRUC BIOL, V10, P279, DOI 10.1016/S0959-440X(00)00085-3; BUSTAMANTE C, 2004, Patent No. 7133132; Celikel R, 2000, NAT STRUCT BIOL, V7, P881; Chen SQ, 1999, J CELL BIOL, V144, P185, DOI 10.1083/jcb.144.1.185; De Luca M, 2000, BLOOD, V95, P164; DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038; Dong JF, 2001, BLOOD, V97, P162, DOI 10.1182/blood.V97.1.162; Dudko OK, 2008, P NATL ACAD SCI USA, V105, P15755, DOI 10.1073/pnas.0806085105; Dumas JJ, 2004, J BIOL CHEM, V279, P23327, DOI 10.1074/jbc.M401659200; Evans E, 1999, BIOPHYS J, V76, P2439, DOI 10.1016/S0006-3495(99)77399-6; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; KIELISZEWSKI M J, 1989, Peptide Research, V2, P246; Miura S, 2000, J BIOL CHEM, V275, P7539, DOI 10.1074/jbc.275.11.7539; Nesbitt WS, 2009, NAT MED, V15, P665, DOI 10.1038/nm.1955; Phan UT, 2006, NAT IMMUNOL, V7, P883, DOI 10.1038/ni1366; Ruggeri ZM, 2007, CIRC RES, V100, P1673, DOI 10.1161/01.RES.0000267878.97021.ab; Ruggeri ZM, 2006, BLOOD, V108, P1903, DOI 10.1182/blood-2006-04-011551; Sadler JE, 2005, ANNU REV MED, V56, P173, DOI 10.1146/annurev.med.56.082103.104713; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Shen Y, 2000, BLOOD, V95, P903, DOI 10.1182/blood.V95.3.903.003k37_903_910; Shen Y, 2006, J BIOL CHEM, V281, P26419, DOI 10.1074/jbc.M604296200; Smith SB, 2003, METHOD ENZYMOL, V361, P134; Springer TA, 2009, P NATL ACAD SCI USA, V106, P91, DOI 10.1073/pnas.0810784105; Thomas W, 2006, BIOPHYS J, V90, P753, DOI 10.1529/biophysj.105.066548; Thomas WE, 2008, ANNU REV BIOPHYS, V37, P399, DOI 10.1146/annurev.biophys.37.032807.125804; Ulrichts H, 2006, J BIOL CHEM, V281, P4699, DOI 10.1074/jbc.M513314200; Yago T, 2008, J CLIN INVEST, V118, P3195, DOI 10.1172/JCI35754; Zhang XH, 2009, SCIENCE, V324, P1330, DOI 10.1126/science.1170905	31	196	203	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 19	2010	466	7309					992	U123		10.1038/nature09295	http://dx.doi.org/10.1038/nature09295			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640ED	20725043	Green Accepted			2022-12-01	WOS:000281030300038
J	Tarutani, Y; Shiba, H; Iwano, M; Kakizaki, T; Suzuki, G; Watanabe, M; Isogai, A; Takayama, S				Tarutani, Yoshiaki; Shiba, Hiroshi; Iwano, Megumi; Kakizaki, Tomohiro; Suzuki, Go; Watanabe, Masao; Isogai, Akira; Takayama, Seiji			Trans-acting small RNA determines dominance relationships in Brassica self-incompatibility	NATURE			English	Article							II S-HAPLOTYPES; GENOMIC ORGANIZATION; GENE-EXPRESSION; DNA METHYLATION; POLLEN; LOCUS; CAMPESTRIS; PARAMUTATION; ALLELES; REGION	A diploid organism has two copies of each gene, one inherited from each parent. The expression of two inherited alleles is sometimes biased by the effects known as dominant/recessive relationships, which determine the final phenotype of the organism. To explore the mechanisms underlying these relationships, we have examined the monoallelic expression of S-locus protein 11 genes (SP11), which encode the male determinants of self-incompatibility in Brassica. We previously reported that SP11 expression was monoallelic in some S heterozygotes, and that the promoter regions of recessive SP11 alleles were specifically methylated in the anther tapetum(1-3). Here we show that this methylation is controlled by trans-acting small non-coding RNA(sRNA). We identified inverted genomic sequences that were similar to the recessive SP11 promoters in the flanking regions of dominant SP11 alleles. These sequences were specifically expressed in the anther tapetum and processed into 24-nucleotide sRNA, named SP11 methylation inducer (Smi). Introduction of the Smi genomic region into the recessive S homozygotes triggered the methylation of the promoter of recessive SP11 alleles and repressed their transcription. This is an example showing sRNA encoded in the flanking region of a dominant allele acts in trans to induce transcriptional silencing of the recessive allele. Our finding may provide new insights into the widespread monoallelic gene expression systems.	[Tarutani, Yoshiaki; Shiba, Hiroshi; Iwano, Megumi; Isogai, Akira; Takayama, Seiji] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma 6300192, Japan; [Kakizaki, Tomohiro] Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan; [Suzuki, Go] Osaka Kyoiku Univ, Div Nat Sci, Osaka 5828582, Japan; [Watanabe, Masao] Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan	Nara Institute of Science & Technology; Iwate University; Osaka University of Education; Tohoku University	Takayama, S (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Ikoma 6300192, Japan.	takayama@bs.naist.jp	Watanabe, Masao/N-1465-2019; KAKIZAKI, Tomohiro/E-6304-2011; Watanabe, Masao/E-6300-2011; Isogai, Akira/O-8897-2017	Watanabe, Masao/0000-0002-9419-5149; KAKIZAKI, Tomohiro/0000-0002-3636-6616; Watanabe, Masao/0000-0002-9419-5149; Isogai, Akira/0000-0001-8095-0441	Bio-oriented Technology Research Advancement Institution (BRAIN); Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT)	Bio-oriented Technology Research Advancement Institution (BRAIN); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Q. A. Ngo and P. Kaothien-Nakayama for critical comments and discussion; K. Nakashima for helpful comments; and H. Ichikawa, T. Ohnishi, F. Yamamoto, M. Kawashima and R. Nagai for technical assistance. This work was supported by the Program for Promotion of Basic Research Activities for Innovative Biosciences (to S. T.) from the Bio-oriented Technology Research Advancement Institution (BRAIN), by Grants-in-Aid for Creative Scientific Research (to A. I., M. W. and S. T.) from the Japan Society for the Promotion of Science (JSPS), and by Grants-in-Aid for Scientific Research on Priority Area (to H. S., M. W. and S. T.) and Grants-in-Aid for the Global Center of Excellence Program to NAIST from the Ministry of Education, Culture, Sports, Science and Technology (MEXT).	Alleman M, 2006, NATURE, V442, P295, DOI 10.1038/nature04884; Bao N, 2004, DEV CELL, V7, P653, DOI 10.1016/j.devcel.2004.10.003; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Casselman AL, 2000, PLANT CELL, V12, P23, DOI 10.1105/tpc.12.1.23; Darwin CR, 1876, EFFECTS CROSS SELF F; Erhard KF, 2009, SCIENCE, V323, P1201, DOI 10.1126/science.1164508; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Guo M, 2004, PLANT CELL, V16, P1707, DOI 10.1105/tpc.022087; Hale CJ, 2007, PLOS BIOL, V5, P2156, DOI 10.1371/journal.pbio.0050275; Hatakeyama K, 1998, HEREDITY, V80, P241, DOI 10.1046/j.1365-2540.1998.00295.x; Kachroo A, 2001, SCIENCE, V293, P1824, DOI 10.1126/science.1062509; Kakizaki T, 2003, PLANT CELL PHYSIOL, V44, P70, DOI 10.1093/pcp/pcg009; Kakizaki T, 2006, GENES GENET SYST, V81, P63, DOI 10.1266/ggs.81.63; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Milani L, 2009, GENOME RES, V19, P1, DOI 10.1101/gr.083931.108; NASRALLAH JB, 1993, PLANT CELL, V5, P1325, DOI 10.2307/3869785; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; Shiba H, 2006, NAT GENET, V38, P297, DOI 10.1038/ng1734; Shiba H, 2000, BIOSCI BIOTECH BIOCH, V64, P1016, DOI 10.1271/bbb.64.1016; Shiba H, 2003, BIOSCI BIOTECH BIOCH, V67, P622, DOI 10.1271/bbb.67.622; Shiba H, 2002, PLANT CELL, V14, P491, DOI 10.1105/tpc.010378; Shiba H, 2001, PLANT PHYSIOL, V125, P2095, DOI 10.1104/pp.125.4.2095; Stam M, 2002, GENE DEV, V16, P1906, DOI 10.1101/gad.1006702; STEIN JC, 1991, P NATL ACAD SCI USA, V88, P8816, DOI 10.1073/pnas.88.19.8816; Suzuki G, 1999, GENETICS, V153, P391; Takasaki T, 2000, NATURE, V403, P913, DOI 10.1038/35002628; Takayama S, 2000, P NATL ACAD SCI USA, V97, P1920, DOI 10.1073/pnas.040556397; Takayama S, 2001, NATURE, V413, P534, DOI 10.1038/35097104; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001293	31	102	106	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 19	2010	466	7309					983	U110		10.1038/nature09308	http://dx.doi.org/10.1038/nature09308			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640ED	20725042				2022-12-01	WOS:000281030300036
J	Gonzalez-Suarez, E; Jacob, AP; Jones, J; Miller, R; Roudier-Meyer, MP; Erwert, R; Pinkas, J; Branstetter, D; Dougall, WC				Gonzalez-Suarez, Eva; Jacob, Allison P.; Jones, Jon; Miller, Robert; Roudier-Meyer, Martine P.; Erwert, Ryan; Pinkas, Jan; Branstetter, Dan; Dougall, William C.			RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis	NATURE			English	Article							HORMONE REPLACEMENT THERAPY; HUMAN BREAST-TUMORS; GLAND DEVELOPMENT; TRANSGENIC MICE; MEDROXYPROGESTERONE ACETATE; OSTEOCLAST DIFFERENTIATION; OSTEOPROTEGERIN-LIGAND; CELL FUNCTION; RECEPTOR; EXPRESSION	RANK ligand (RANKL), a TNF-related molecule, is essential for osteoclast formation, function and survival through interaction with its receptor RANK(1,2). Mammary glands of RANK-and RANKL-deficient mice develop normally during sexual maturation, but fail to form lobuloalveolar structures during pregnancy because of defective proliferation and increased apoptosis of mammary epithelium(3). It has been shown that RANKL is responsible for the major proliferative response of mouse mammary epithelium to progesterone during mammary lactational morphogenesis(4), and in mouse models, manipulated to induce activation of the RANK/RANKL pathway in the absence of strict hormonal control, inappropriate mammary proliferation is observed(5,6). However, there is no evidence so far of a functional contribution of RANKL to tumorigenesis. Here we show that RANK and RANKL are expressed within normal, pre-malignant and neoplastic mammary epithelium, and using complementary gain-of-function (mouse mammary tumour virus (MMTV)-RANK transgenic mice) and loss-of function (pharmacological inhibition of RANKL) approaches, define a direct contribution of this pathway in mammary tumorigenesis. Accelerated pre-neoplasias and increased mammary tumour formation were observed in MMTV-RANK transgenic mice after multiparity or treatment with carcinogen and hormone (progesterone). Reciprocally, selective pharmacological inhibition of RANKL attenuated mammary tumour development not only in hormone-and carcinogen-treated MMTV-RANK and wild-type mice, but also in the MMTV-neu transgenic spontaneous tumour model. The reduction in tumorigenesis upon RANKL inhibition was preceded by a reduction in pre-neoplasias as well as rapid and sustained reductions in hormone-and carcinogen-induced mammary epithelial proliferation and cyclin D1 levels. Collectively, our results indicate that RANKL inhibition is acting directly on hormone-induced mammary epithelium at early stages in tumorigenesis, and the permissive contribution of progesterone to increased mammary cancer incidence is due to RANKL-dependent proliferative changes in the mammary epithelium. The current study highlights a potential role for RANKL inhibition in the management of proliferative breast disease.	[Gonzalez-Suarez, Eva; Jacob, Allison P.; Jones, Jon; Miller, Robert; Erwert, Ryan; Dougall, William C.] Amgen Inc, Dept Hematol Oncol Res, Seattle, WA 98119 USA; [Roudier-Meyer, Martine P.; Branstetter, Dan] Amgen Inc, Dept Pathol, Seattle, WA 98119 USA; [Pinkas, Jan] Amgen Inc, Dept Hematol Oncol Res, Cambridge, MA 02139 USA	Amgen; Amgen; Amgen	Dougall, WC (corresponding author), Amgen Inc, Dept Hematol Oncol Res, Seattle, WA 98119 USA.	dougallw@amgen.com	Gonzalez-Suarez, Eva/L-6298-2014	Gonzalez-Suarez, Eva/0000-0003-0858-8171; Dougall, William/0000-0001-9487-251X				Aldaz CM, 1996, CARCINOGENESIS, V17, P2069, DOI 10.1093/carcin/17.9.2069; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Aupperlee Mark, 2005, Breast Dis, V24, P37; Beleut M, 2010, P NATL ACAD SCI USA, V107, P2989, DOI 10.1073/pnas.0915148107; Brisken C, 1998, P NATL ACAD SCI USA, V95, P5076, DOI 10.1073/pnas.95.9.5076; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Cardiff RD, 2000, ONCOGENE, V19, P968, DOI 10.1038/sj.onc.1203277; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Fernandez-Valdivia R, 2009, DEV BIOL, V328, P127, DOI 10.1016/j.ydbio.2009.01.019; Gonzalez-Suarez E, 2007, MOL CELL BIOL, V27, P1442, DOI 10.1128/MCB.01298-06; Greendale GA, 2003, J NATL CANCER I, V95, P30, DOI 10.1093/jnci/95.1.30; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hewitt SC, 2002, CANCER RES, V62, P2798; Hofseth LJ, 1999, J CLIN ENDOCR METAB, V84, P4559, DOI 10.1210/jc.84.12.4559; Holmberg L, 2008, JNCI-J NATL CANCER I, V100, P475, DOI 10.1093/jnci/djn058; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Ismail PM, 2003, STEROIDS, V68, P779, DOI 10.1016/S0039-128X(03)00133-8; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Klijn JGM, 2000, STEROIDS, V65, P825, DOI 10.1016/S0039-128X(00)00195-1; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Landis MW, 2006, CANCER CELL, V9, P13, DOI 10.1016/j.ccr.2005.12.019; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Van Poznak C, 2006, J CLIN PATHOL, V59, P56, DOI 10.1136/jcp.2005.026534; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0	28	396	408	0	43	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 4	2010	468	7320					103	+		10.1038/nature09495	http://dx.doi.org/10.1038/nature09495			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674YF	20881963				2022-12-01	WOS:000283786900044
J	Hillman, M				Hillman, Mayer			Personal View More daylight, better health: why we shouldn't be putting the clocks back this weekend	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Westminster, Policy Studies Inst, London W1R 8AL, England	University of Westminster	Hillman, M (corresponding author), Univ Westminster, Policy Studies Inst, London W1R 8AL, England.	mayer.hillman@blueyonder.co.uk						Hillman M, 2010, MAKING MOST DAYLIGHT; HILLMAN M, 1988, MAKING MOST DAYLIGHT	2	3	3	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 27	2010	341								c5964	10.1136/bmj.c5964	http://dx.doi.org/10.1136/bmj.c5964			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	674YY	20980369				2022-12-01	WOS:000283790400010
J	Ng, SF; Lin, RCY; Laybutt, DR; Barres, R; Owens, JA; Morris, MJ				Ng, Sheau-Fang; Lin, Ruby C. Y.; Laybutt, D. Ross; Barres, Romain; Owens, Julie A.; Morris, Margaret J.			Chronic high-fat diet in fathers programs beta-cell dysfunction in female rat offspring	NATURE			English	Article							LOW-BIRTH-WEIGHT; BODY-MASS INDEX; CHILDHOOD; OBESITY; UNDERNUTRITION; TRANSMISSION; ASSOCIATION; PROTEIN; PLASMA; ISLETS	The global prevalence of obesity is increasing across most ages in both sexes. This is contributing to the early emergence of type 2 diabetes and its related epidemic(1,2). Having either parent obese is an independent risk factor for childhood obesity(3). Although the detrimental impacts of diet-induced maternal obesity on adiposity and metabolism in offspring are well established(4), the extent of any contribution of obese fathers is unclear, particularly the role of non-genetic factors in the causal pathway. Here we show that paternal high-fat-diet (HFD) exposure programs beta-cell 'dysfunction' in rat F-1 female offspring. Chronic HFD consumption in Sprague-Dawley fathers induced increased body weight, adiposity, impaired glucose tolerance and insulin sensitivity. Relative to controls, their female offspring had an early onset of impaired insulin secretion and glucose tolerance that worsened with time, and normal adiposity. Paternal HFD altered the expression of 642 pancreatic islet genes in adult female offspring (P < 0.01); genes belonged to 13 functional clusters, including cation and ATP binding, cytoskeleton and intracellular transport. Broader pathway analysis of 2,492 genes differentially expressed (P < 0.05) demonstrated involvement of calcium-, MAPK- and Wnt-signalling pathways, apoptosis and the cell cycle. Hypomethylation of the Il13ra2 gene, which showed the highest fold difference in expression (1.76-fold increase), was demonstrated. This is the first report in mammals of non-genetic, intergenerational transmission of metabolic sequelae of a HFD from father to offspring.	[Ng, Sheau-Fang; Morris, Margaret J.] Univ New S Wales, Dept Pharmacol, Sch Med Sci, Sydney, NSW 2052, Australia; [Lin, Ruby C. Y.] Univ New S Wales, Ramaciotti Ctr Gene Funct Anal, Sydney, NSW 2052, Australia; [Lin, Ruby C. Y.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Laybutt, D. Ross] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Barres, Romain] Univ New S Wales, Sch Med Sci, Dept Anat, Sydney, NSW 2052, Australia; [Owens, Julie A.] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA 5005, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; Garvan Institute of Medical Research; University of New South Wales Sydney; University of Adelaide	Morris, MJ (corresponding author), Univ New S Wales, Dept Pharmacol, Sch Med Sci, Sydney, NSW 2052, Australia.	m.morris@unsw.edu.au	BARRES, Romain/N-2501-2016; Lin, Ruby CY/A-1636-2009; Morris, Margaret J/J-4285-2013; Owens, Julie A/C-9744-2009	BARRES, Romain/0000-0002-0158-519X; Lin, Ruby CY/0000-0003-4163-511X; Owens, Julie A/0000-0002-7498-1353; Morris, Margaret/0000-0003-2285-5117	National Health and Medical Research Council (NHMRC) of Australia; Ministry of Higher Education; National University of Malaysia; NHMRC	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Ministry of Higher Education(Science and Technology Development Fund (STDF)Ministry of Higher Education & Scientific Research (MHESR)); National University of Malaysia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work is supported by the National Health and Medical Research Council (NHMRC) of Australia (M.J.M.). S.F.N. is supported by Ministry of Higher Education and National University of Malaysia, R.C.Y.L. is supported by the NHMRC Peter Doherty Fellowship.	Aitken RJ, 2004, NATURE, V432, P48, DOI 10.1038/432048a; Bouchard C, 2009, AM J CLIN NUTR, V89, pS1494, DOI 10.3945/ajcn.2009.27113C; Chamson-Reig A, 2006, J ENDOCRINOL, V191, P83, DOI 10.1677/joe.1.06754; David M, 2002, ANN NY ACAD SCI, V973, P207, DOI 10.1111/j.1749-6632.2002.tb04633.x; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Du Plessis SS, 2010, NAT REV UROL, V7, P153, DOI 10.1038/nrurol.2010.6; Dunn GA, 2009, ENDOCRINOLOGY, V150, P4999, DOI 10.1210/en.2009-0500; Figueroa-Colon R, 2000, AM J CLIN NUTR, V71, P829, DOI 10.1093/ajcn/71.3.829; Fujisawa T, 2009, CANCER RES, V69, P8678, DOI 10.1158/0008-5472.CAN-09-2100; Ghanayem BI, 2010, BIOL REPROD, V82, P96, DOI 10.1095/biolreprod.109.078915; Gluckman PD, 2009, LANCET, V373, P1654, DOI 10.1016/S0140-6736(09)60234-8; Grunau C, 2000, NUCLEIC ACIDS RES, V28, P1053, DOI 10.1093/nar/28.5.1053; Guo YF, 2006, J CLIN ENDOCR METAB, V91, P4001, DOI 10.1210/jc.2006-0549; Hattersley AT, 1999, LANCET, V353, P1789, DOI 10.1016/S0140-6736(98)07546-1; Henquin JC, 2009, DIABETES OBES METAB, V11, P168, DOI 10.1111/j.1463-1326.2009.01109.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hypponen E, 2003, BMJ-BRIT MED J, V326, P19, DOI 10.1136/bmj.326.7379.19; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jimenez-Chillaron JC, 2009, DIABETES, V58, P460, DOI 10.2337/db08-0490; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kasturi SS, 2008, J ANDROL, V29, P251, DOI 10.2164/jandrol.107.003731; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Laybutt DR, 2003, J BIOL CHEM, V278, P2997, DOI 10.1074/jbc.M210581200; Laybutt DR, 2002, DIABETES, V51, P413, DOI 10.2337/diabetes.51.2.413; Le Stunff C, 2001, NAT GENET, V29, P96, DOI 10.1038/ng707; Leibel NI, 2006, J CLIN ENDOCR METAB, V91, P1275, DOI 10.1210/jc.2005-1707; Li L, 2009, AM J CLIN NUTR, V89, P551, DOI 10.3945/ajcn.2008.26759; Lindsay RS, 2000, DIABETES, V49, P445, DOI 10.2337/diabetes.49.3.445; Morris Margaret J, 2009, Expert Rev Endocrinol Metab, V4, P625, DOI 10.1586/eem.09.45; Olek A, 1996, NUCLEIC ACIDS RES, V24, P5064, DOI 10.1093/nar/24.24.5064; Pinhas-Hamiel O, 2005, J PEDIATR-US, V146, P693, DOI 10.1016/j.jpeds.2004.12.042; Power C, 2003, J EPIDEMIOL COMMUN H, V57, P969, DOI 10.1136/jech.57.12.969; Prior LJ, 2008, INT J OBESITY, V32, P1585, DOI 10.1038/ijo.2008.141; Robertson SA, 2005, CELL TISSUE RES, V322, P43, DOI 10.1007/s00441-005-1127-3; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sharpe RM, 2010, PHILOS T R SOC B, V365, P1697, DOI 10.1098/rstb.2009.0206; Sone H, 2005, DIABETOLOGIA, V48, P58, DOI 10.1007/s00125-004-1605-2; Tarquini B, 1999, PEDIATRICS, V103, P998, DOI 10.1542/peds.103.5.998; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; ZHANG XY, 1993, MOL CELL BIOL, V13, P6810, DOI 10.1128/MCB.13.11.6810	42	929	978	2	190	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 21	2010	467	7318					963	U103		10.1038/nature09491	http://dx.doi.org/10.1038/nature09491			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20962845				2022-12-01	WOS:000283254700038
J	Sima, CS; Panageas, KS; Schrag, D				Sima, Camelia S.; Panageas, Katherine S.; Schrag, Deborah			Cancer Screening Among Patients With Advanced Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; BREAST-CANCER; INCIDENCE TRENDS; PROSTATE-CANCER; MAMMOGRAPHY; OVERDIAGNOSIS; CARE; PHYSICIANS; WOMEN	Context Cancer screening has been integrated into routine primary care but does not benefit patients with limited life expectancy. Objective To evaluate the extent to which patients with advanced cancer continue to be screened for new cancers. Design, Setting, and Participants Utilization of cancer screening procedures (mammography, Papanicolaou test, prostate-specific antigen [PSA], and lower gastrointestinal [GI] endoscopy) was assessed in 87 736 fee-for-service Medicare enrollees aged 65 years or older diagnosed with advanced lung, colorectal, pancreatic, gastroesophageal, or breast cancer between 1998 and 2005, and reported to one of the Surveillance, Epidemiology, and End Results (SEER) tumor registries. Participants were followed up until death or December 31, 2007, whichever came first. A group of 87 307 Medicare enrollees without cancer were individually matched by age, sex, race, and SEER registry to patients with cancer and observed over the same period to evaluate screening rates in context. Demographic and clinical characteristics associated with screening were also investigated. Main Outcome Measure For each cancer screening test, utilization rates were defined as the percentage of patients who were screened following the diagnosis of an incurable cancer. Results Among women following advanced cancer diagnosis compared with controls, at least 1 screening mammogram was received by 8.9% (95% confidence interval [CI], 8.6%-9.1%) vs 22.0% (95% CI, 21.7%-22.5%); Papanicolaou test screening was received by 5.8% (95% CI, 5.6%-6.1%) vs 12.5% (95% CI, 12.2%-12.8%). Among men following advanced cancer diagnosis compared with controls, PSA test was received by 15.0% (95% CI, 14.7%-15.3%) vs 27.2% (95% CI, 26.8%-27.6%). For all patients following advanced diagnosis compared with controls, lower GI endoscopy was received by 1.7% (95% CI, 1.6%-1.8%) vs 4.7% (95% CI, 4.6%-4.9%). Screening was more frequent among patients with a recent history of screening (16.2% [95% CI, 15.4%-16.9%] of these patients had mammography, 14.7% [95% CI, 13.7%-15.6%] had a Papanicolaou test, 23.3% [95% CI, 22.6%-24.0%] had a PSA test, and 6.1% [95% CI, 5.2%-7.0%] had lower GI endoscopy). Conclusion A sizeable proportion of patients with advanced cancer continue to undergo cancer screening tests that do not have a meaningful likelihood of providing benefit. JAMA. 2010;304(14):1584-1591 www.jama.com	[Sima, Camelia S.; Panageas, Katherine S.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Schrag, Deborah] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute	Sima, CS (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 307 E 63rd St,2nd Floor, New York, NY 10065 USA.	simac@mskcc.org	Hug, Balthasar L./G-1568-2010		National Cancer Institute [R01 1147503]; Schrag; NATIONAL CANCER INSTITUTE [R01CA131847] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Schrag; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Obtained funding: Schrag.; This research was supported by grant R01 1147503 from the National Cancer Institute (Dr Schrag).	Amer College Physicians, 2004, ANN INTERN MED, V141, P226, DOI 10.7326/0003-4819-141-3-200408030-00015; American Cancer Society, AM CANC SOC GUID EAR; [Anonymous], 2002, AJCC CANC STAGING MA; [Anonymous], INT CLASSIFICATION D; Armstrong K, 2007, ANN INTERN MED, V146, P516, DOI 10.7326/0003-4819-146-7-200704030-00008; Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; Back AL, 2005, JAMA-J AM MED ASSOC, V293, P1374, DOI 10.1001/jama.293.11.1374; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; CREWDSON J, 2009, ATLANTIC        1119; Cronin KA, 2005, CANCER CAUSE CONTROL, V16, P701, DOI 10.1007/s10552-005-0693-8; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Elmore JG, 2005, JAMA-J AM MED ASSOC, V293, P1245, DOI 10.1001/jama.293.10.1245; Esserman L, 2009, JAMA-J AM MED ASSOC, V302, P1685, DOI 10.1001/jama.2009.1498; Etzioni R, 2002, J NATL CANCER I, V94, P981; GRADY D, NY TIMES        1103; Iglehart JK, 2009, NEW ENGL J MED, V361, P229, DOI 10.1056/NEJMp0904854; Jerant AF, 2008, ARCH INTERN MED, V168, P1317, DOI 10.1001/archinte.168.12.1317; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Keating NL, 2010, CANCER-AM CANCER SOC, V116, P998, DOI 10.1002/cncr.24761; National Cancer Institute, SEER MED MED ENR CLA; Partridge AH, 2009, NEW ENGL J MED, V361, P2499, DOI 10.1056/NEJMp0911288; Rousseau P, 2000, J CLIN ONCOL, V18, P2000, DOI 10.1200/JCO.2000.18.9.2000; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; *SEER PROGR, LOC REG DIST STAG AD; Sirovich BE, 2004, JAMA-J AM MED ASSOC, V291, P2990, DOI 10.1001/jama.291.24.2990; Swan J, 2003, CANCER, V97, P1528, DOI 10.1002/cncr.11208; Truog RD, 2009, NEW ENGL J MED, V361, P2501, DOI 10.1056/NEJMp0911447; US Preventive Services Task Force, US PREV SERV TASK FO; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Warren JL, 2002, MED CARE, V40, P3; Welch GH, 2004, SHOULD I BE TESTED C; Welch HG, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b1425; Woloshin S, 2010, JAMA-J AM MED ASSOC, V303, P164, DOI 10.1001/jama.2009.2007; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244; 2007, CPT STANDARD EDITION	35	56	57	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2010	304	14					1584	1591		10.1001/jama.2010.1449	http://dx.doi.org/10.1001/jama.2010.1449			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662OE	20940384	Bronze, Green Accepted			2022-12-01	WOS:000282816500023
J	Coste, B; Mathur, J; Schmidt, M; Earley, TJ; Ranade, S; Petrus, MJ; Dubin, AE; Patapoutian, A				Coste, Bertrand; Mathur, Jayanti; Schmidt, Manuela; Earley, Taryn J.; Ranade, Sanjeev; Petrus, Matt J.; Dubin, Adrienne E.; Patapoutian, Ardem			Piezo1 and Piezo2 Are Essential Components of Distinct Mechanically Activated Cation Channels	SCIENCE			English	Article							CURRENTS; NEURONS; PROTEIN; TRANSDUCTION	Mechanical stimuli drive many physiological processes, including touch and pain sensation, hearing, and blood pressure regulation. Mechanically activated (MA) cation channel activities have been recorded in many cells, but the responsible molecules have not been identified. We characterized a rapidly adapting MA current in a mouse neuroblastoma cell line. Expression profiling and RNA interference knockdown of candidate genes identified Piezo1 (Fam38A) to be required for MA currents in these cells. Piezo1 and related Piezo2 (Fam38B) are vertebrate multipass transmembrane proteins with homologs in invertebrates, plants, and protozoa. Overexpression of mouse Piezo1 or Piezo2 induced two kinetically distinct MA currents. Piezos are expressed in several tissues, and knockdown of Piezo2 in dorsal root ganglia neurons specifically reduced rapidly adapting MA currents. We propose that Piezos are components of MA cation channels.	[Coste, Bertrand; Schmidt, Manuela; Earley, Taryn J.; Ranade, Sanjeev; Dubin, Adrienne E.; Patapoutian, Ardem] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Mathur, Jayanti; Petrus, Matt J.; Patapoutian, Ardem] Novartis Res Fdn GNF, Genom Inst, San Diego, CA 92121 USA	Scripps Research Institute; Novartis	Patapoutian, A (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	ardem@scripps.edu		Ranade, Sanjeev/0000-0001-8601-3563; Coste, Bertrand/0000-0002-0163-2494; Schmidt, Manuela/0000-0003-1972-3519	NIH [DE016927, NS046303]; Novartis Research Foundation; American Heart Association; German Academic Exchange Service (DAAD) [D/07/41089]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046303] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Research Foundation; American Heart Association(American Heart Association); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors gratefully acknowledge H. Hu for help in cloning Piezo2, J. Walker for contributing to microarray experiments, S. Batalov for help in bioinformatics analysis, K. Spencer for help with imaging, and N. Hong and U. Muller for comments on the manuscript and helpful discussions. This work was supported by grants from NIH (DE016927 and NS046303) and the Novartis Research Foundation. B. C. is the recipient of an American Heart Association postdoctoral fellowship; M. S. is the recipient of a German Academic Exchange Service (DAAD, D/07/41089) fellowship. A provisional patent has been filed by TSRI and GNF that claims methods of screening for molecules that modulate Piezo-dependent ion channel activities. The Piezo1 and Piezo2 sequences used in the paper have been deposited in GenBank under accession numbers HQ215520 and HQ215521, respectively.	Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Besch SR, 2002, PFLUG ARCH EUR J PHY, V445, P161, DOI 10.1007/s00424-002-0903-0; Burnstock G, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-69; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Cho H, 2006, EUR J NEUROSCI, V23, P2543, DOI 10.1111/j.1460-9568.2006.04802.x; COREY DP, 1979, BIOPHYS J, V26, P499, DOI 10.1016/S0006-3495(79)85267-4; Coste B, 2007, J GEN PHYSIOL, V129, P57, DOI 10.1085/jgp.200609665; Drew LJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000515; Drew LJ, 2004, J PHYSIOL-LONDON, V556, P691, DOI 10.1113/jphysiol.2003.058693; Drew LJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-12-j0001.2002; Earley S, 2004, CIRC RES, V95, P922, DOI 10.1161/01.RES.0000147311.54833.03; GOLDSTEIN ME, 1991, J NEUROSCI RES, V30, P92, DOI 10.1002/jnr.490300111; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Hanlon MR, 2002, BIOCHEMISTRY-US, V41, P2886, DOI 10.1021/bi0119565; Hao Jizhe, 2009, V2, P51, DOI 10.1007/978-1-4020-8716-5_3; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; IWATSUKI K, 1995, COMP BIOCHEM PHYS A, V110, P167, DOI 10.1016/0300-9629(94)00125-D; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Lawson SN, 2002, EXP PHYSIOL, V87, P239, DOI 10.1113/eph8702350; LAWSON SN, 1984, J COMP NEUROL, V228, P263, DOI 10.1002/cne.902280211; Lewin GR, 2004, J NEUROBIOL, V61, P30, DOI 10.1002/neu.20078; McCarter GC, 1999, NEUROSCI LETT, V273, P179, DOI 10.1016/S0304-3940(99)00665-5; McHugh BJ, 2010, J CELL SCI, V123, P51, DOI 10.1242/jcs.056424; Monshausen GB, 2009, TRENDS CELL BIOL, V19, P228, DOI 10.1016/j.tcb.2009.02.005; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Rodat-Despoix L, 2009, PFLUG ARCH EUR J PHY, V458, P179, DOI 10.1007/s00424-008-0632-0; SANN H, 1995, CELL TISSUE RES, V282, P155, DOI 10.1007/BF00319142; Satoh K, 2006, BRAIN RES, V1108, P19, DOI 10.1016/j.brainres.2006.06.050; Schmidt M, 2009, NEURON, V64, P498, DOI 10.1016/j.neuron.2009.09.030; Sharif-Naeini R, 2009, CELL, V139, P587, DOI 10.1016/j.cell.2009.08.045; Tucker SJ, 1998, CURR OPIN NEUROBIOL, V8, P316, DOI 10.1016/S0959-4388(98)80055-X; Wetzel C, 2007, NATURE, V445, P206, DOI 10.1038/nature05394	35	1309	1373	59	451	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2010	330	6000					55	60		10.1126/science.1193270	http://dx.doi.org/10.1126/science.1193270			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20813920	Green Accepted			2022-12-01	WOS:000282334500031
J	Lansdorp-Vogelaar, I; Kuntz, KM; Knudsen, AB; Wilschut, JA; Zauber, AG; van Ballegooijen, M				Lansdorp-Vogelaar, Iris; Kuntz, Karen M.; Knudsen, Amy B.; Wilschut, Janneke A.; Zauber, Ann G.; van Ballegooijen, Marjolein			Stool DNA Testing to Screen for Colorectal Cancer in the Medicare Population A Cost-Effectiveness Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							FECAL OCCULT-BLOOD; LARGE-INTESTINE; LARGE-BOWEL; COLONOSCOPY; POLYPS; SURVEILLANCE; GUIDELINES; SOCIETY; PATIENT; UPDATE	Background: The Centers for Medicare & Medicaid Services considered whether to reimburse stool DNA testing for colorectal cancer screening among Medicare enrollees. Objective: To evaluate the conditions under which stool DNA testing could be cost-effective compared with the colorectal cancer screening tests currently reimbursed by the Centers for Medicare & Medicaid Services. Design: Comparative microsimulation modeling study using 2 independently developed models. Data Sources: Derived from literature. Target Population: A cohort of persons aged 65 years. A sensitivity analysis was also conducted, in which a cohort of persons aged 50 years was studied. Time Horizon: Lifetime. Perspective: Third-party payer. Intervention: Stool DNA test every 3 or 5 years in comparison with currently recommended colorectal cancer screening strategies. Outcome Measures: Life expectancy, lifetime costs, incremental cost-effectiveness ratios, and threshold costs. Results of Base-Case Analysis: Assuming a cost of $350 per test, strategies of stool DNA testing every 3 or 5 years yielded fewer life-years and higher costs than the currently recommended colorectal cancer screening strategies. Screening with the stool DNA test would be cost-effective at a per-test cost of $40 to $60 for stool DNA testing every 3 years, depending on the simulation model used. There were no levels of sensitivity and specificity for which stool DNA testing would be cost-effective at its current cost of $350 per test. Stool DNA testing every 3 years would be cost-effective at a cost of $350 per test if the relative adherence to stool DNA testing were at least 50% better than that with other screening tests. Results of Sensitivity Analysis: None of the results changed substantially when a cohort of persons aged 50 years was considered. Limitation: No pathways other than the traditional adenoma-carcinoma sequence were modeled. Conclusion: Stool DNA testing could be a cost-effective alternative for colorectal cancer screening if the cost of the test substantially decreased or if its availability would entice a large fraction of otherwise unscreened persons to receive screening.	[Lansdorp-Vogelaar, Iris; Wilschut, Janneke A.; van Ballegooijen, Marjolein] Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Lansdorp-Vogelaar, I (corresponding author), Erasmus MC, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	i.vogelaar@erasmusmc.nl		Wilschut, Janneke/0000-0002-4921-227X	Agency for Healthcare Research and Quality [HHSP233200700123P, HHSP233200700196P, HHSP233200700350P]; National Cancer Institute [U01-CA-088204, U01-CA-097426, U01-CA-115953]; NATIONAL CANCER INSTITUTE [U01CA097426, U01CA115953, P30CA008748, U01CA088204] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the Agency for Healthcare Research and Quality (HHSP233200700123P, HHSP233200700196P, HHSP233200700350P) and the National Cancer Institute (U01-CA-088204, U01-CA-097426, and U01-CA-115953).	Ahlquist DA, 2008, ANN INTERN MED, V149, P441, DOI 10.7326/0003-4819-149-7-200810070-00004; Allison JE, 2007, JNCI-J NATL CANCER I, V99, P1462, DOI 10.1093/jnci/djm150; ARMINSKI T. C., 1964, DIS COLON RECTUM, V7, P249, DOI 10.1007/BF02630528; Blatt LJ., 1961, DIS COLON RECTUM, V4, P277; BOMBI JA, 1988, CANCER-AM CANCER SOC, V61, P1472, DOI 10.1002/1097-0142(19880401)61:7<1472::AID-CNCR2820610734>3.0.CO;2-E; CHAPMAN I, 1963, ANN SURG, V157, P223, DOI 10.1097/00000658-196302000-00007; Chung DC, 2008, ANN INTERN MED, V149, P509, DOI 10.7326/0003-4819-149-7-200810070-00013; CLARK JC, 1985, INT J CANCER, V36, P179, DOI 10.1002/ijc.2910360209; EIDE TJ, 1986, INT J CANCER, V38, P173, DOI 10.1002/ijc.2910380205; *EX SCI CORP, 2010, EX SCI CORP ANN REP; Frazier AL, 2000, JAMA-J AM MED ASSOC, V284, P1954, DOI 10.1001/jama.284.15.1954; Gold MR., 1996, COST EFFECTIVENESS H; Imperiale TF, 2004, NEW ENGL J MED, V351, P2704, DOI 10.1056/NEJMoa033403; Itzkowitz S, 2008, AM J GASTROENTEROL, V103, P2862, DOI 10.1111/j.1572-0241.2008.02088.x; Itzkowitz SH, 2007, CLIN GASTROENTEROL H, V5, P111, DOI 10.1016/j.cgh.2006.10.006; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; JASS JR, 1992, GUT, V33, P1508, DOI 10.1136/gut.33.11.1508; JOHANNSEN LGK, 1989, SCAND J GASTROENTERO, V24, P799, DOI 10.3109/00365528909089217; KNUDSEN A, 2005, THESIS HARVARD U; Lansdorp-Vogelaar I, 2009, CANCER-AM CANCER SOC, V115, P2410, DOI 10.1002/cncr.24256; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Levin TR, 2006, ANN INTERN MED, V145, P880, DOI 10.7326/0003-4819-145-12-200612190-00004; Levin TR, 2002, GASTROENTEROLOGY, V123, P1786, DOI 10.1053/gast.2002.37064; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Loeve F, 1999, COMPUT BIOMED RES, V32, P13, DOI 10.1006/cbmr.1998.1498; Loeve F, 2000, J NATL CANCER I, V92, P557, DOI 10.1093/jnci/92.7.557; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; Mark DH, 2002, JAMA-J AM MED ASSOC, V287, P2428, DOI 10.1001/jama.287.18.2428; Morikawa T, 2005, GASTROENTEROLOGY, V129, P422, DOI 10.1053/j.gastro.2005.05.056; Morikawa T, 2007, AM J GASTROENTEROL, V102, P2259, DOI 10.1111/j.1572-0241.2007.01404.x; OBRIEN MJ, 1990, GASTROENTEROLOGY, V98, P371, DOI 10.1016/0016-5085(90)90827-N; PERRONE M, 2007, GOVT OFFICIALS WILL; Pox C, 2007, ENDOSCOPY, V39, P168, DOI 10.1055/s-2007-966182; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; RICKERT RR, 1979, CANCER-AM CANCER SOC, V43, P1847, DOI 10.1002/1097-0142(197905)43:5<1847::AID-CNCR2820430538>3.0.CO;2-L; Schroy PC, 2007, AM J MANAG CARE, V13, P393; Schroy PC, 2005, AM J PREV MED, V28, P208, DOI 10.1016/j.amepre.2004.10.008; Shapiro JA, 2008, CANCER EPIDEM BIOMAR, V17, P1623, DOI 10.1158/1055-9965.EPI-07-2838; Smith RA, 2006, CA-CANCER J CLIN, V56, P11, DOI 10.3322/canjclin.56.1.11; Song K, 2004, GASTROENTEROLOGY, V126, P1270, DOI 10.1053/j.gastro.2004.02.016; Syngal S, 2006, CANCER, V106, P277, DOI 10.1002/cncr.21558; Tagore Kuldeep S, 2003, Clin Colorectal Cancer, V3, P47, DOI 10.3816/CCC.2003.n.011; *US CENS BUR, 2010, US POP PROJ; *US PREV SERV TASK, 2008, ANN INT MED, V149; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; VANBALLEGOOIJEN M, 2008, REPORT AGENCY HEALTH; VATN MH, 1982, CANCER, V49, P819, DOI 10.1002/1097-0142(19820215)49:4<819::AID-CNCR2820490435>3.0.CO;2-D; Warren JL, 2009, ANN INTERN MED, V150, P849, DOI 10.7326/0003-4819-150-12-200906160-00008; Whitney D, 2004, J MOL DIAGN, V6, P386, DOI 10.1016/S1525-1578(10)60536-3; WILLIAMS AR, 1982, GUT, V23, P835, DOI 10.1136/gut.23.10.835; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Winawer SJ, 2006, GASTROENTEROLOGY, V130, P1872, DOI 10.1053/j.gastro.2006.03.012; Wu GHM, 2006, BMC CANCER, V6, P1, DOI 10.1186/1471-2407-6-136; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103; ZAUBER A, 2000, EFFECTIVENESS DNA ST; 2002, 59100 FED REG	57	58	58	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 21	2010	153	6					368	377		10.7326/0003-4819-153-6-201009210-00004	http://dx.doi.org/10.7326/0003-4819-153-6-201009210-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	652WY	20855801				2022-12-01	WOS:000282043100003
J	Rossman, JS; Jing, XH; Leser, GP; Lamb, RA				Rossman, Jeremy S.; Jing, Xianghong; Leser, George P.; Lamb, Robert A.			Influenza Virus M2 Protein Mediates ESCRT-Independent Membrane Scission	CELL			English	Article							ION-CHANNEL PROTEIN; A-VIRUS; CYTOPLASMIC TAIL; PROTON CHANNEL; MATRIX PROTEIN; M1 PROTEIN; PLASMA-MEMBRANES; LIPID-BILAYERS; HEMAGGLUTININ; NEURAMINIDASE	Many viruses utilize host ESCRT proteins for budding; however, influenza virus budding is thought to be ESCRT-independent. In this study we have found a role for the influenza virus M2 proton-selective ion channel protein in mediating virus budding. We observed that a highly conserved amphipathic helix located within the M2 cytoplasmic tail mediates a cholesterol-dependent alteration in membrane curvature. The 17 amino acid amphipathic helix is sufficient for budding into giant unilamellar vesicles, and mutation of this sequence inhibited budding of transfected M2 protein in vivo. We show that M2 localizes to the neck of budding virions and that mutation of the M2 amphipathic helix results in failure of the virus to undergo membrane scission and virion release. These data suggest that M2 mediates the final steps of budding for influenza viruses, bypassing the need for host ESCRT proteins.	[Rossman, Jeremy S.; Jing, Xianghong; Leser, George P.; Lamb, Robert A.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [Rossman, Jeremy S.; Lamb, Robert A.] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA	Northwestern University; Howard Hughes Medical Institute; Northwestern University	Lamb, RA (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	ralamb@northwestern.edu		Rossman, Jeremy/0000-0001-6124-4103	National Institute of Allergy and Infectious Diseases [R01 AI-20201]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020201] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Lamb laboratory for helpful discussions and critical reading of the manuscript. The electron microscopy was performed in the Northwestern University Biological Imaging Facility. This research was supported in part by a grant R01 AI-20201 from the National Institute of Allergy and Infectious Diseases. J.S.R. is an Associate and R. A. L. is an Investigator of the Howard Hughes Medical Institute.	Allain JM, 2006, EUR PHYS J E, V20, P409, DOI 10.1140/epje/i2006-10030-4; Antonny B, 2006, CURR OPIN CELL BIOL, V18, P386, DOI 10.1016/j.ceb.2006.06.003; Barman S, 2004, J VIROL, V78, P5258, DOI 10.1128/JVI.78.10.5258-5269.2004; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Bruce EA, 2010, J VIROL, V84, P5848, DOI 10.1128/JVI.00307-10; Bruce EA, 2009, VIROLOGY, V390, P268, DOI 10.1016/j.virol.2009.05.016; Bui M, 1996, J VIROL, V70, P8391, DOI 10.1128/JVI.70.12.8391-8401.1996; Carlton JG, 2009, BIOCHEM SOC T, V37, P195, DOI 10.1042/BST0370195; Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003; Chen BJ, 2008, J VIROL, V82, P10059, DOI 10.1128/JVI.01184-08; Chen BJ, 2008, VIROLOGY, V372, P221, DOI 10.1016/j.virol.2007.11.008; Chen BJ, 2007, J VIROL, V81, P7111, DOI 10.1128/JVI.00361-07; Chen BJ, 2005, J VIROL, V79, P13673, DOI 10.1128/JVI.79.21.13673-13684.2005; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; Cheung TKW, 2005, J GEN VIROL, V86, P1447, DOI 10.1099/vir.0.80727-0; DE MEYER F, 2009, P NATL ACAD SCI USA, V106, P3654; DEMPSEY CE, 1990, BIOCHIM BIOPHYS ACTA, V1031, P143, DOI 10.1016/0304-4157(90)90006-X; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Egashira M, 2002, BIOCHEMISTRY-US, V41, P4165, DOI 10.1021/bi011885+; Girard P, 2004, BIOPHYS J, V87, P419, DOI 10.1529/biophysj.104.040360; Iwatsuki-Horimoto K, 2006, J VIROL, V80, P5233, DOI 10.1128/JVI.00049-06; Jackson D, 2008, J GEN VIROL, V89, P3097, DOI 10.1099/vir.0.2008/004739-0; Jin H, 1997, EMBO J, V16, P1236, DOI 10.1093/emboj/16.6.1236; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Keller H, 2009, CHEMPHYSCHEM, V10, P2805, DOI 10.1002/cphc.200900598; Lamaziere A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000201; Lamb R.F., 2005, CONT TOPICS INFLUENZ, P65; Lee MT, 2008, P NATL ACAD SCI USA, V105, P5087, DOI 10.1073/pnas.0710625105; Leser GP, 1996, MOL BIOL CELL, V7, P155, DOI 10.1091/mbc.7.1.155; Leser GP, 2005, VIROLOGY, V342, P215, DOI 10.1016/j.virol.2005.09.049; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Liu J, 2006, P NATL ACAD SCI USA, V103, P10277, DOI 10.1073/pnas.0601045103; Ma CL, 2009, P NATL ACAD SCI USA, V106, P12283, DOI 10.1073/pnas.0905726106; McCown MF, 2006, J VIROL, V80, P8178, DOI 10.1128/JVI.00627-06; McCown MF, 2005, J VIROL, V79, P3595, DOI 10.1128/JVI.79.6.3595-3605.2005; Nguyen PA, 2008, BIOCHEMISTRY-US, V47, P9934, DOI 10.1021/bi801315m; Noton SL, 2007, J GEN VIROL, V88, P2280, DOI 10.1099/vir.0.82809-0; PATTNAIK AK, 1986, J VIROL, V60, P994, DOI 10.1128/JVI.60.3.994-1001.1986; Pinto LH, 2007, MOL BIOSYST, V3, P18, DOI 10.1039/b611613m; Pinto LH, 2006, J BIOL CHEM, V281, P8997, DOI 10.1074/jbc.R500020200; Pinto LH, 1997, P NATL ACAD SCI USA, V94, P11301, DOI 10.1073/pnas.94.21.11301; Romer W, 2010, CELL, V140, P540, DOI 10.1016/j.cell.2010.01.010; Rossman JS, 2010, J VIROL, V84, P5078, DOI 10.1128/JVI.00119-10; Russell CJ, 2001, EMBO J, V20, P4024, DOI 10.1093/emboj/20.15.4024; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Schroeder C, 2005, EUR BIOPHYS J BIOPHY, V34, P52, DOI 10.1007/s00249-004-0424-1; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Streicher P, 2009, BBA-BIOMEMBRANES, V1788, P2291, DOI 10.1016/j.bbamem.2009.07.025; Takeda M, 2003, P NATL ACAD SCI USA, V100, P14610, DOI 10.1073/pnas.2235620100; Tian CL, 2003, PROTEIN SCI, V12, P2597, DOI 10.1110/ps.03168503; TOSTESON MT, 1994, J MEMBRANE BIOL, V142, P117; VENKATACHALAPATHI, 1993, PROTEINS, V15, P349; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Yuan B, 2000, J VIROL, V74, P7250, DOI 10.1128/JVI.74.16.7250-7260.2000; ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988; Zhang J, 1996, VIROLOGY, V225, P255, DOI 10.1006/viro.1996.0599	56	359	365	2	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 17	2010	142	6					902	913		10.1016/j.cell.2010.08.029	http://dx.doi.org/10.1016/j.cell.2010.08.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650NA	20850012	Green Accepted, Bronze			2022-12-01	WOS:000281855000013
J	Boyd, K; Murray, SA				Boyd, Kirsty; Murray, Scott A.			Spotlight: Palliative Care Beyond Cancer Recognising and managing key transitions in end of life care	BRITISH MEDICAL JOURNAL			English	Article							HEART-FAILURE; PREDICTION; DISEASE; INDEX		[Boyd, Kirsty; Murray, Scott A.] Univ Edinburgh, Ctr Pop Hlth Sci, Primary Palliat Care Res Grp, Edinburgh, Scotland	University of Edinburgh	Boyd, K (corresponding author), Univ Edinburgh, Ctr Pop Hlth Sci, Primary Palliat Care Res Grp, Edinburgh, Scotland.	Kirsty.Boyd@luht.scot.nhs.uk		Boyd, Kirsty/0000-0002-5526-1078				Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Coventry PA, 2005, AGE AGEING, V34, P218, DOI 10.1093/ageing/afi054; Department of Health, 2008, END LIF CAR STRAT AD; Fortin M, 2007, BMJ-BRIT MED J, V334, P1016, DOI 10.1136/bmj.39201.463819.2C; Glare PA, 2008, J PALLIAT MED, V11, P84, DOI 10.1089/jpm.2008.9992; Larson AM, 2006, JAMA-J AM MED ASSOC, V295, P2168, DOI 10.1001/jama.295.18.2168; Lau F, 2009, J PAIN SYMPTOM MANAG, V38, P134, DOI 10.1016/j.jpainsymman.2008.05.017; Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102; Luhrs CA, 2005, J PAIN SYMPTOM MANAG, V29, P544, DOI 10.1016/j.jpainsymman.2005.02.010; Lynn J, 2001, JAMA-J AM MED ASSOC, V285, P925, DOI 10.1001/jama.285.7.925; Mitchell SL, 2009, NEW ENGL J MED, V361, P1529, DOI 10.1056/NEJMoa0902234; Munday D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2391; Murray SA, 2008, FAM PRACT, V25, P78, DOI 10.1093/fampra/cmn011; National Gold Standards Framework Centre, 2008, PROGN IND GUID PAP; NORTON SA, PROACTIVE PALLIATIVE; *ROYAL COLL PHYS, 2008, ADV CAR PLANN CONC E; *ROYAL COLL PHYS L, 2007, PALL CAR SERV M NEED; *SCOTT GOV HLTH DE, 2008, LIV DYING WELL NAT A; Selman L, 2007, HEART, V93, P963, DOI 10.1136/hrt.2006.106518; Shipman C, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1720; Stone CA, 2008, J PAIN SYMPTOM MANAG, V35, P617, DOI 10.1016/j.jpainsymman.2007.07.006	21	125	126	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 16	2010	341								c4863	10.1136/bmj.c4863	http://dx.doi.org/10.1136/bmj.c4863			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653MO	20847023				2022-12-01	WOS:000282095800011
J	Kim, HJ; Verbinnen, B; Tang, XL; Lu, LR; Cantor, H				Kim, Hye-Jung; Verbinnen, Bert; Tang, Xiaolei; Lu, Linrong; Cantor, Harvey			Inhibition of follicular T-helper cells by CD8(+) regulatory T cells is essential for self tolerance	NATURE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; AUTOIMMUNE-DISEASE; B-CELLS; SUPPRESSION; T-HELPER-2; GENERATION; EXPANSION; IL-15; IL-21; MICE	The ability to produce vigorous immune responses that spare self tissues and organs depends on the elimination of autoreactive T and B cells. However, purging of immature and mature self-reactive T and B cells is incomplete and may also require the involvement of cells programmed to suppress immune responses(1). Regulatory T cells (T-reg) belonging to the CD4(+) T-cell subset may have a role in preventing untoward inflammatory responses, but T-cell subsets programmed to inhibit the development of autoantibody formation and systemic-lupus-erythematosus-like disease have not yet been defined(2). Here we delineate a CD8(+) regulatory T-cell lineage that is essential for the maintenance of self tolerance and prevention of murine autoimmune disease. Genetic disruption of the inhibitory interaction between these CD8(+) T cells and their target Qa-1(+) follicular T-helper cells results in the development of a lethal systemic-lupus-erythematosus-like autoimmune disease. These findings define a sublineage of CD8 T cells programmed to suppress rather than activate immunity that represents an essential regulatory element of the immune response and a guarantor of self tolerance.	[Kim, Hye-Jung; Verbinnen, Bert; Tang, Xiaolei; Cantor, Harvey] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Kim, Hye-Jung; Verbinnen, Bert; Tang, Xiaolei; Cantor, Harvey] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Lu, Linrong] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Zhejiang University	Cantor, H (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, 44 Binney St, Boston, MA 02115 USA.	Harvey_Cantor@dfci.harvard.edu	Lu, Linrong/A-1429-2013	Lu, Linrong/0000-0002-0171-4115; Tang, Xiaoren/0000-0002-2402-3659	NIH [AI 037562]; Lupus Research Institute; Schecter Research Foundation; National Research Service [DFCI/NCI T32 CA070083, HSPH/NCI T32 CA009382]; Belgian American Educational Foundation; NATIONAL CANCER INSTITUTE [T32CA070083, T32CA009382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037562] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lupus Research Institute; Schecter Research Foundation; National Research Service; Belgian American Educational Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Bronson (DF/HCC Rodent Histopathology Core) for histology analysis, R. Gelman and J. Yang for help with statistical analyses, C. Daniel and T. Kreslavsky for cytometry support and critical discussions, M. Iannacone and U. von Andrian for LCMV, X. Wang for technical assistance, M. Call, D. A. Alvarez Arias, T. Kadakia and A. Angel for manuscript and figure preparation. This work was supported in part by NIH Research Grant AI 037562, the Lupus Research Institute and a gift from the Schecter Research Foundation to H.C.; National Research Service Award Fellowships (DFCI/NCI T32 CA070083) to H.-J.K. and (HSPH/NCI T32 CA009382) to X.T.; and a Belgian American Educational Foundation Fellowship to B.V.	Bubier JA, 2009, P NATL ACAD SCI USA, V106, P1518, DOI 10.1073/pnas.0807309106; Cantor H, 2004, NAT IMMUNOL, V5, P347, DOI 10.1038/ni0404-347; Cantor H, 2000, ADV IMMUNOL, V75, P209, DOI 10.1016/S0065-2776(00)75005-X; Chen WL, 2007, P NATL ACAD SCI USA, V104, P20472, DOI 10.1073/pnas.0709878104; Hao ZY, 2008, IMMUNITY, V29, P615, DOI 10.1016/j.immuni.2008.07.016; Hu D, 2004, NAT IMMUNOL, V5, P516, DOI 10.1038/ni1063; Hunziker L, 2003, NAT IMMUNOL, V4, P343, DOI 10.1038/ni911; JIANG H, 1992, SCIENCE, V256, P1213, DOI 10.1126/science.256.5060.1213; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Lu LR, 2007, IMMUNITY, V26, P593, DOI 10.1016/j.immuni.2007.03.017; Lu LR, 2008, CELL MOL IMMUNOL, V5, P401, DOI 10.1038/cmi.2008.50; Lu LR, 2008, P NATL ACAD SCI USA, V105, P19420, DOI 10.1073/pnas.0810383105; Mitchell DM, 2010, J IMMUNOL, V184, P6719, DOI 10.4049/jimmunol.0904089; Noble A, 1998, J IMMUNOL, V160, P566; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Panoutsakopoulou V, 2001, IMMUNITY, V15, P137, DOI 10.1016/S1074-7613(01)00172-8; Ray SK, 1996, P NATL ACAD SCI USA, V93, P2019, DOI 10.1073/pnas.93.5.2019; Sangster MY, 2000, J IMMUNOL, V164, P1820, DOI 10.4049/jimmunol.164.4.1820; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Yurasov S, 2007, CURR OPIN RHEUMATOL, V19, P421, DOI 10.1097/BOR.0b013e328277ef3b; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057	23	253	279	3	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 16	2010	467	7313					328	U107		10.1038/nature09370	http://dx.doi.org/10.1038/nature09370			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650CF	20844537	Green Accepted			2022-12-01	WOS:000281824900039
J	Haurwitz, RE; Jinek, M; Wiedenheft, B; Zhou, KH; Doudna, JA				Haurwitz, Rachel E.; Jinek, Martin; Wiedenheft, Blake; Zhou, Kaihong; Doudna, Jennifer A.			Sequence- and Structure-Specific RNA Processing by a CRISPR Endonuclease	SCIENCE			English	Article							IDENTIFICATION; DEFENSE; TRANSCRIPTION; RECOGNITION; SULFOLOBUS; COMPLEX	Many bacteria and archaea contain clustered regularly interspaced short palindromic repeats (CRISPRs) that confer resistance to invasive genetic elements. Central to this immune system is the production of CRISPR-derived RNAs (crRNAs) after transcription of the CRISPR locus. Here, we identify the endoribonuclease (Csy4) responsible for CRISPR transcript (pre-crRNA) processing in Pseudomonas aeruginosa. A 1.8 angstrom crystal structure of Csy4 bound to its cognate RNA reveals that Csy4 makes sequence-specific interactions in the major groove of the crRNA repeat stem-loop. Together with electrostatic contacts to the phosphate backbone, these enable Csy4 to bind selectively and cleave pre-crRNAs using phylogenetically conserved serine and histidine residues in the active site. The RNA recognition mechanism identified here explains sequence-and structure-specific processing by a large family of CRISPR-specific endoribonucleases.	[Haurwitz, Rachel E.; Jinek, Martin; Wiedenheft, Blake; Zhou, Kaihong; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Wiedenheft, Blake; Zhou, Kaihong; Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	doudna@berkeley.edu	Jinek, Martin/E-6621-2011	Jinek, Martin/0000-0002-7601-210X	U.S. NIH [5 T32 GM08295]; Human Frontier Science Program; NSF; Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008295] Funding Source: NIH RePORTER	U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); NSF(National Science Foundation (NSF)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Westphal for help with purification of Csy4 constructs; J. van der Oost for discussion; J. Doudna Cate and members of the Doudna laboratory for critical reading of the manuscript; and C. Ralston and J. Holton (Beamlines 8.2.2 and 8.3.1, Advanced Light Source, Lawrence Berkeley National Laboratory) and S. Coyle for assistance with X-ray data collection. R.E.H. is supported by the U.S. NIH training grant 5 T32 GM08295. M.J. is supported by a Human Frontier Science Program Long-Term Fellowship. B. W. is a Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation. This work was supported in part by grants from NSF and the Bill and Melinda Gates Foundation. J.A.D. is a Howard Hughes Medical Institute Investigator. Coordinates and structure factors for the Csy4-crRNA complex have been deposited in the Protein Data Bank under accession codes 2xli, 2xlj, and 2xlk. The authors have filed a related patent.	Anand K, 2008, NAT STRUCT MOL BIOL, V15, P1287, DOI 10.1038/nsmb.1513; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cai ZP, 1998, NAT STRUCT BIOL, V5, P203, DOI 10.1038/nsb0398-203; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Ebihara A, 2006, PROTEIN SCI, V15, P1494, DOI 10.1110/ps.062131106; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; HAIT DH, 2005, PLOS COMPUT BIOL, V1, pE60; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huppler A, 2002, NAT STRUCT BIOL, V9, P431, DOI 10.1038/nsb800; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Legault P, 1998, CELL, V93, P289, DOI 10.1016/S0092-8674(00)81579-2; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; Lillestol RK, 2009, MOL MICROBIOL, V72, P259, DOI 10.1111/j.1365-2958.2009.06641.x; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Tang TH, 2005, MOL MICROBIOL, V55, P469, DOI 10.1111/j.1365-2958.2004.04428.x; Tang TH, 2002, P NATL ACAD SCI USA, V99, P7536, DOI 10.1073/pnas.112047299; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Ye XM, 1996, NAT STRUCT BIOL, V3, P1026, DOI 10.1038/nsb1296-1026	23	458	558	7	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2010	329	5997					1355	1358		10.1126/science.1192272	http://dx.doi.org/10.1126/science.1192272			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647YR	20829488	Green Accepted			2022-12-01	WOS:000281657300042
J	Niles, PB; Boynton, WV; Hoffman, JH; Ming, DW; Hamara, D				Niles, Paul B.; Boynton, William V.; Hoffman, John H.; Ming, Douglas W.; Hamara, Dave			Stable Isotope Measurements of Martian Atmospheric CO2 at the Phoenix Landing Site	SCIENCE			English	Article							ALLAN HILLS 84001; SNC METEORITES; WEATHERING PRODUCTS; VOLATILE EVOLUTION; CALCIUM-CARBONATE; MARS; OXYGEN; EETA-79001; ALH84001; RATIOS	Carbon dioxide is a primary component of the martian atmosphere and reacts readily with water and silicate rocks. Thus, the stable isotopic composition of CO2 can reveal much about the history of volatiles on the planet. The Mars Phoenix spacecraft measurements of carbon isotopes [referenced to the Vienna Pee Dee belemnite (VPDB)] [delta C-13(VPDB) = -2.5 +/- 4.3 per mil (parts per thousand)] and oxygen isotopes [referenced to the Vienna standard mean ocean water (VSMOW)] (delta O-18(VSMOW) = 31.0 +/- 5.7 parts per thousand), reported here, indicate that CO2 is heavily influenced by modern volcanic degassing and equilibration with liquid water. When combined with data from the martian meteorites, a general model can be constructed that constrains the history of water, volcanism, atmospheric evolution, and weathering on Mars. This suggests that low-temperature water-rock interaction has been dominant throughout martian history, carbonate formation is active and ongoing, and recent volcanic degassing has played a substantial role in the composition of the modern atmosphere.	[Niles, Paul B.; Ming, Douglas W.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Boynton, William V.; Hamara, Dave] Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA; [Hoffman, John H.] Univ Texas Dallas, Dept Phys, Dallas, TX 75080 USA	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Arizona; University of Texas System; University of Texas Dallas	Niles, PB (corresponding author), NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA.	paul.b.niles@nasa.gov						Borg LE, 1999, SCIENCE, V286, P90, DOI 10.1126/science.286.5437.90; Boynton WV, 2009, SCIENCE, V325, P61, DOI 10.1126/science.1172768; CARR RH, 1985, NATURE, V314, P248, DOI 10.1038/314248a0; CLAYTON RN, 1988, GEOCHIM COSMOCHIM AC, V52, P925, DOI 10.1016/0016-7037(88)90363-8; Encrenaz T, 2005, ICARUS, V179, P43, DOI 10.1016/j.icarus.2005.06.022; Faure G., 1986, PRINCIPLES ISOTOPE G, Vsecond; GOODING JL, 1988, GEOCHIM COSMOCHIM AC, V52, P909, DOI 10.1016/0016-7037(88)90361-4; Hoffman JH, 2008, J AM SOC MASS SPECTR, V19, P1377, DOI 10.1016/j.jasms.2008.07.015; Holland G, 2005, GEOCHIM COSMOCHIM AC, V69, P1359, DOI 10.1016/j.gca.2004.08.023; HUNTEN DM, 1987, ICARUS, V69, P532, DOI 10.1016/0019-1035(87)90022-4; JAKOSKY BM, 1991, ICARUS, V94, P14, DOI 10.1016/0019-1035(91)90138-J; Jakosky BM, 1999, ORIGINS LIFE EVOL B, V29, P47, DOI 10.1023/A:1006586319129; Jull AJT, 2000, GEOCHIM COSMOCHIM AC, V64, P3763, DOI 10.1016/S0016-7037(00)00458-0; Jull AJT, 1998, SCIENCE, V279, P366, DOI 10.1126/science.279.5349.366; JULL AJT, 1995, METEORITICS, V30, P311, DOI 10.1111/j.1945-5100.1995.tb01129.x; Jull AJT, 1997, J GEOPHYS RES-PLANET, V102, P1663, DOI 10.1029/96JE03111; Krasnopolsky VA, 1996, ICARUS, V124, P553, DOI 10.1006/icar.1996.0230; Krasnopolsky VA, 2007, ICARUS, V192, P396, DOI 10.1016/j.icarus.2007.08.013; NIER AO, 1976, SCIENCE, V194, P68, DOI 10.1126/science.194.4260.68; Niles PB, 2005, GEOCHIM COSMOCHIM AC, V69, P2931, DOI 10.1016/j.gca.2004.12.012; Nyquist LE, 2001, SPACE SCI REV, V96, P105, DOI 10.1023/A:1011993105172; Owen T., 1977, J GEOPHYS RES, V82, P4635, DOI DOI 10.1029/JS082I028P04635; Rao MN, 1999, GEOPHYS RES LETT, V26, P3265, DOI 10.1029/1999GL005388; ROMANEK CS, 1994, NATURE, V372, P655, DOI 10.1038/372655a0; SCHREY U, 1986, ASTRON ASTROPHYS, V155, P200; Swindle TD, 2000, METEORIT PLANET SCI, V35, P107, DOI 10.1111/j.1945-5100.2000.tb01978.x; WALKER JCG, 1989, GEOPHYS RES LETT, V16, P323, DOI 10.1029/GL016i004p00323; WRIGHT IP, 1990, J GEOPHYS RES-SOLID, V95, P14789, DOI 10.1029/JB095iB09p14789; WRIGHT IP, 1988, GEOCHIM COSMOCHIM AC, V52, P917, DOI 10.1016/0016-7037(88)90362-6; WRIGHT IP, 1992, GEOCHIM COSMOCHIM AC, V56, P817, DOI 10.1016/0016-7037(92)90100-W	30	49	51	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 10	2010	329	5997					1334	1337		10.1126/science.1192863	http://dx.doi.org/10.1126/science.1192863			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647YR	20829484				2022-12-01	WOS:000281657300036
J	Gandhi, TK; Lee, TH				Gandhi, Tejal K.; Lee, Thomas H.			Patient Safety beyond the Hospital	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gandhi, Tejal K.; Lee, Thomas H.] Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA; [Gandhi, Tejal K.; Lee, Thomas H.] Partners Healthcare Syst, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Partners Healthcare System	Gandhi, TK (corresponding author), Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA.							Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; McKinsey and Company Global Institute, 2008, ACC COST US HEALTHC; National Center for Health Statistics, FASTSTATS A Z; Roy CL, 2005, ANN INTERN MED, V143, P121, DOI 10.7326/0003-4819-143-2-200507190-00011; Wachter RM, 2006, ANN INTERN MED, V145, P547, DOI 10.7326/0003-4819-145-7-200610030-00014	5	72	72	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 9	2010	363	11					1001	1003		10.1056/NEJMp1003294	http://dx.doi.org/10.1056/NEJMp1003294			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	647HS	20825311				2022-12-01	WOS:000281609700003
J	Kaveri, SV; Mouthon, L; Bayry, J				Kaveri, Srini V.; Mouthon, Luc; Bayry, Jagadeesh			Basophils and Nephritis in Lupus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ERYTHEMATOSUS		[Kaveri, Srini V.; Bayry, Jagadeesh] Univ Paris 06, INSERM, Ctr Rech Cordeliers, Paris, France; [Mouthon, Luc] Univ Paris 05, INSERM, Inst Cochin & Pole Med Interne, AP HP, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bayry, J (corresponding author), Univ Paris 06, INSERM, Ctr Rech Cordeliers, Paris, France.		Bayry, Jagadeesh/A-6589-2011	Bayry, Jagadeesh/0000-0003-0498-9808; Kaveri, Srini/0000-0002-0837-4053				Atta AM, 2010, INT ARCH ALLERGY IMM, V152, P401, DOI 10.1159/000288293; Charles N, 2010, NAT MED, V16, P701, DOI 10.1038/nm.2159; Crispin JC, 2010, TRENDS MOL MED, V16, P47, DOI 10.1016/j.molmed.2009.12.005; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297	4	25	27	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 9	2010	363	11					1080	1082		10.1056/NEJMcibr1006936	http://dx.doi.org/10.1056/NEJMcibr1006936			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	647HS	20825323				2022-12-01	WOS:000281609700015
J	Lim, WA; Pawson, T				Lim, Wendell A.; Pawson, Tony			Phosphotyrosine Signaling: Evolving a New Cellular Communication System	CELL			English	Article							PROTEIN-TYROSINE PHOSPHATASES; MONOSIGA-BREVICOLLIS; ANIMAL DEVELOPMENT; EVOLUTION; DICTYOSTELIUM; KINASE; DOMAIN; METAZOAN; GENOME; SH2		[Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Pawson, Tony] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Pawson, Tony] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Lim, WA (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	lim@cmp.ucsf.edu; pawson@lunenfeld.ca	Pawson, Tony J/E-4578-2013		Howard Hughes Medical Institute; National Institutes of health [GM55040, GM62583, GM081879, EY016546]; Packard Foundation; National Science Foundation Synthetic Biology Engineering Research Center; Canadian Institutes for Health Research [MOP-6849]; Genome Canada; Canadian Cancer Society Research Institute; NATIONAL EYE INSTITUTE [PN1EY016546, PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062583, R01GM055040, P50GM081879] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Foundation(The David & Lucile Packard Foundation); National Science Foundation Synthetic Biology Engineering Research Center; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Pincus, B. Mayer, P. Beltrao, O. Hoeller, R. Linding, G. Superti-Furga, N.King, N.Helman, L. Holt, A. Horwitz, T. Miller, G. Manning, T. Hunter, D. Morgan, J. Williams, H. Bourne, and I. Ernberg for helpful comments. This work was supported by the Howard Hughes Medical Institute (W.L.), the National Institutes of health (GM55040, GM62583, GM081879, and EY016546-W.L.), the Packard Foundation (W.L.), the National Science Foundation Synthetic Biology Engineering Research Center (W. L.), the Canadian Institutes for Health Research (T.P.-MOP-6849), Genome Canada (T.P.), and the Canadian Cancer Society Research Institute (T.P.).	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Alwayn V., 2004, OPTICAL NETWORK DESI; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Dengl S, 2009, J MOL BIOL, V389, P211, DOI 10.1016/j.jmb.2009.04.016; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Jin J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000546; Kawata T, 1997, CELL, V89, P909, DOI 10.1016/S0092-8674(00)80276-7; Kay RR, 1997, CURR BIOL, V7, pR723, DOI 10.1016/S0960-9822(06)00366-6; Kennelly PJ, 2001, CHEM REV, V101, P2291, DOI 10.1021/cr0002543; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; King N, 2004, DEV CELL, V7, P313, DOI 10.1016/j.devcel.2004.08.010; King N, 2003, SCIENCE, V301, P361, DOI 10.1126/science.1083853; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Langenick J, 2008, J CELL SCI, V121, P3524, DOI 10.1242/jcs.036798; Lee DC, 2009, TRENDS BIOCHEM SCI, V34, P351, DOI 10.1016/j.tibs.2009.03.003; Li WQ, 2009, BIOCHEMISTRY-US, V48, P5180, DOI 10.1021/bi9000672; Lim WA, 2010, NAT REV MOL CELL BIO, V11, P393, DOI 10.1038/nrm2904; Manning G, 2008, P NATL ACAD SCI USA, V105, P9674, DOI 10.1073/pnas.0801314105; Moniakis J, 2001, GENE DEV, V15, P687, DOI 10.1101/gad.871001; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; PAWSON T, 1993, PHILOS T R SOC B, V340, P279, DOI 10.1098/rstb.1993.0069; Peisajovich SG, 2010, SCIENCE, V328, P368, DOI 10.1126/science.1182376; Pincus D, 2008, P NATL ACAD SCI USA, V105, P9680, DOI 10.1073/pnas.0803161105; Rokas A, 2008, ANNU REV GENET, V42, P235, DOI 10.1146/annurev.genet.42.110807.091513; SCHIEVEN G, 1986, SCIENCE, V231, P390, DOI 10.1126/science.2417318; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Sugden C, 2010, J BIOL CHEM, V285, P22925, DOI 10.1074/jbc.M110.139733; Tan CSH, 2009, SCIENCE, V325, P1686, DOI 10.1126/science.1174301; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4	31	242	247	1	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 3	2010	142	5					661	667		10.1016/j.cell.2010.08.023	http://dx.doi.org/10.1016/j.cell.2010.08.023			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	646FL	20813250	Bronze, Green Accepted			2022-12-01	WOS:000281523200005
J	Jacquet, J; Pauly, D; Ainley, D; Holt, S; Dayton, P; Jackson, J				Jacquet, Jennifer; Pauly, Daniel; Ainley, David; Holt, Sidney; Dayton, Paul; Jackson, Jeremy			Seafood stewardship in crisis	NATURE			English	Editorial Material									[Jacquet, Jennifer; Pauly, Daniel] Univ British Columbia, Fisheries Ctr, Sea Around Us Project, Vancouver, BC V6T 1Z4, Canada; [Ainley, David] HT Harvey & Associates, Los Gatos, CA 95032 USA; [Dayton, Paul; Jackson, Jeremy] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92037 USA	University of British Columbia; University of California System; University of California San Diego; Scripps Institution of Oceanography	Jacquet, J (corresponding author), Univ British Columbia, Fisheries Ctr, Sea Around Us Project, Vancouver, BC V6T 1Z4, Canada.	j.jacquet@fisheries.ubc.ca	Pauly, Daniel Marc/AAY-2316-2021	Pauly, Daniel/0000-0003-3756-4793				Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Chuenpagdee R, 2003, FRONT ECOL ENVIRON, V1, P517; *FISH OC CAN, 2009, CAN ASS PAC HAK US C; lanelli J. N., 2009, ASSESSMENT WALLEYE P; *MAR STEW COUNC, 2010, PRINC CRIT SUST FISH	5	168	169	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 2	2010	467	7311					28	29		10.1038/467028a	http://dx.doi.org/10.1038/467028a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	645MB	20811437				2022-12-01	WOS:000281461200018
J	Makde, RD; England, JR; Yennawar, HP; Tan, S				Makde, Ravindra D.; England, Joseph R.; Yennawar, Hemant P.; Tan, Song			Structure of RCC1 chromatin factor bound to the nucleosome core particle	NATURE			English	Article							CHROMOSOME CONDENSATION RCC1; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; NUCLEAR TRANSPORT; MITOTIC SPINDLE; BETA-GAMMA; RAN; DNA; COMPLEX; BINDING	The small GTPase Ran enzyme regulates critical eukaryotic cellular functions including nuclear transport and mitosis through the creation of a RanGTP gradient around the chromosomes. This concentration gradient is created by the chromatin-bound RCC1 (regulator of chromosome condensation) protein, which recruits Ran to nucleosomes and activates Ran's nucleotide exchange activity. Although RCC1 has been shown to bind directly with the nucleosome, the molecular details of this interaction were not known. Here we determine the crystal structure of a complex of Drosophila RCC1 and the nucleosome core particle at 2.9 angstrom resolution, providing an atomic view of how a chromatin protein interacts with the histone and DNA components of the nucleosome. Our structure also suggests that the Widom 601 DNA positioning sequence present in the nucleosomes forms a 145-base-pair nucleosome core particle, not the expected canonical 147-base-pair particle.	[Makde, Ravindra D.; England, Joseph R.; Yennawar, Hemant P.; Tan, Song] Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Tan, S (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA.	sxt30@psu.edu		Makde, Ravindra D./0000-0001-7020-0065; Yennawar, Hemant P./0000-0003-2869-1109	NIGMS NIH HHS [R01 GM088236-02, R01 GM088236-01, R01 GM088236] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088236] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bao YH, 2006, J MOL BIOL, V361, P617, DOI 10.1016/j.jmb.2006.06.051; Barbera AJ, 2006, SCIENCE, V311, P856, DOI 10.1126/science.1120541; Bilbao-Cortes D, 2002, CURR BIOL, V12, P1151, DOI 10.1016/S0960-9822(02)00927-2; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Chakravarthy S, 2006, J BIOL CHEM, V281, P25522, DOI 10.1074/jbc.M602258200; Chen T, 2007, NAT CELL BIOL, V9, P596, DOI 10.1038/ncb1572; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Clapier CR, 2008, PROTEINS, V71, P1, DOI 10.1002/prot.21720; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Davis TL, 2005, BIOCHEMISTRY-US, V44, P10593, DOI 10.1021/bi050655i; DeLano W, PYMOL MOL GRAPHICS S; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Edayathumangalam RS, 2005, J MOL BIOL, V345, P103, DOI 10.1016/j.jmb.2004.10.012; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; England JR, 2010, J MOL BIOL, V398, P518, DOI 10.1016/j.jmb.2010.03.037; Gangaraju VK, 2009, MOL CELL, V35, P58, DOI 10.1016/j.molcel.2009.05.013; Hao Y, 2008, J CELL BIOL, V182, P827, DOI 10.1083/jcb.200803110; Kalab P, 2008, J CELL SCI, V121, P1577, DOI 10.1242/jcs.005959; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Koerber RT, 2009, MOL CELL, V35, P889, DOI 10.1016/j.molcel.2009.09.011; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nemergut ME, 2001, SCIENCE, V292, P1540, DOI 10.1126/science.292.5521.1540; Ong MS, 2007, J MOL BIOL, V368, P1067, DOI 10.1016/j.jmb.2007.02.062; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Partridge JR, 2009, J MOL BIOL, V391, P375, DOI 10.1016/j.jmb.2009.06.011; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; Renault L, 2001, CELL, V105, P245, DOI 10.1016/S0092-8674(01)00315-4; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Saha A, 2005, NAT STRUCT MOL BIOL, V12, P747, DOI 10.1038/nsmb973; Seewald MJ, 2002, NATURE, V415, P662, DOI 10.1038/415662a; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Suto RK, 2003, J MOL BIOL, V326, P371, DOI 10.1016/S0022-2836(02)01407-9; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; Tan S, 2005, PROTEIN EXPRES PURIF, V40, P385, DOI 10.1016/j.pep.2004.12.002; Tsunaka Y, 2005, NUCLEIC ACIDS RES, V33, P3424, DOI 10.1093/nar/gki663; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Zhang CM, 2002, EUR J CELL BIOL, V81, P623, DOI 10.1078/0171-9335-00288	50	271	273	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP	2010	467	7315					562	U81		10.1038/nature09321	http://dx.doi.org/10.1038/nature09321			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655TT	20739938	Green Accepted			2022-12-01	WOS:000282273100032
J	Young, BP; Shin, JJH; Orij, R; Chao, JT; Li, SC; Guan, XL; Khong, A; Jan, E; Wenk, MR; Prinz, WA; Smits, GJ; Loewen, CJR				Young, Barry P.; Shin, John J. H.; Orij, Rick; Chao, Jesse T.; Li, Shu Chen; Guan, Xue Li; Khong, Anthony; Jan, Eric; Wenk, Markus R.; Prinz, William A.; Smits, Gertien J.; Loewen, Christopher J. R.			Phosphatidic Acid Is a pH Biosensor That Links Membrane Biogenesis to Metabolism	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; H+-ATPASE; YEAST; PROTEIN; LOCALIZATION; HOMEOSTASIS; VACUOLAR	Recognition of lipids by proteins is important for their targeting and activation in many signaling pathways, but the mechanisms that regulate such interactions are largely unknown. Here, we found that binding of proteins to the ubiquitous signaling lipid phosphatidic acid (PA) depended on intracellular pH and the protonation state of its phosphate headgroup. In yeast, a rapid decrease in intracellular pH in response to glucose starvation regulated binding of PA to a transcription factor, Opi1, that coordinately repressed phospholipid metabolic genes. This enabled coupling of membrane biogenesis to nutrient availability.	[Young, Barry P.; Shin, John J. H.; Chao, Jesse T.; Li, Shu Chen; Loewen, Christopher J. R.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; [Orij, Rick; Smits, Gertien J.] Univ Amsterdam, Dept Mol Biol & Microbial Food Safety, NL-1018 WV Amsterdam, Netherlands; [Guan, Xue Li] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 119077, Singapore; [Guan, Xue Li; Wenk, Markus R.] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland; [Khong, Anthony; Jan, Eric] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Wenk, Markus R.] Natl Univ Singapore, Dept Biol Sci, Singapore 119077, Singapore; [Wenk, Markus R.] Univ Basel, Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Prinz, William A.] NIDDKD, Lab Cell Biochem & Biol, NIH, Bethesda, MD 20892 USA; [Loewen, Christopher J. R.] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of Amsterdam; National University of Singapore; University of Geneva; University of British Columbia; National University of Singapore; University of Basel; Swiss Tropical & Public Health Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of British Columbia	Loewen, CJR (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada.	christopher.loewen@ubc.ca	Khong, Anthony/AHD-6446-2022; Guan, Xue Li/D-2935-2014; Wenk, Markus Rene/D-1441-2014; Smits, Gertien J./I-4327-2014; Guan, Xue Li/ABA-9753-2020; Jan, Eric/O-1923-2019	Guan, Xue Li/0000-0002-5189-8178; Smits, Gertien J./0000-0002-8439-7791; Guan, Xue Li/0000-0002-5189-8178; , John/0000-0002-8905-8350; Chao, Jesse/0000-0002-6995-9581	National Sciences and Engineering Council of Canada (NSERC); Canadian Institute of Health Research (CIHR); Michael Smith Foundation for Health Research (MSFHR); Canada Foundation for Innovation; British Columbia Knowledge Development Fund; National Institute of Diabetes and Digestive and Kidney Diseases; Singapore National Research Foundation [2007-04]; Biomedical Research Council of Singapore [R-183-000-211-305]; National Medical Research Council [R-183-000-224-213]; SystemsX.ch RTD project LipidX; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060004] Funding Source: NIH RePORTER	National Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Singapore National Research Foundation(National Research Foundation, Singapore); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); SystemsX.ch RTD project LipidX; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to T. Levine for insight and critical reading of the manuscript; C. Boone for access to SGA technologies; M. Davies and L. Conibear for a preliminary inositol screen; and J. Church for discussions. This research was supported by grants from the National Sciences and Engineering Council of Canada (NSERC), the Canadian Institute of Health Research (CIHR), the Michael Smith Foundation for Health Research (MSFHR), the Canada Foundation for Innovation, and the British Columbia Knowledge Development Fund (C.J.R.L. and E.J.); the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases (W.A.P.); and the Singapore National Research Foundation under CRP Award 2007-04, the Biomedical Research Council of Singapore (R-183-000-211-305), the National Medical Research Council (R-183-000-224-213), and the SystemsX.ch RTD project LipidX (M.R.W.). J.J.H.S. is the recipient of a NSERC Alexander Graham Bell Canada Graduate Scholarship. C.J.R.L. is a CIHR New Investigator, a MSFHR Scholar, and a Tula Foundation Investigator.	BHUSHAN A, 1993, BIOPHYS J, V64, P716, DOI 10.1016/S0006-3495(93)81431-0; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Chan G, 2007, J BIOCHEM MOL TOXIC, V21, P252, DOI 10.1002/jbt.20189; Ferreira T, 2001, J BIOL CHEM, V276, P29613, DOI 10.1074/jbc.R100022200; Giaever G, 1999, NAT GENET, V21, P278, DOI 10.1038/6791; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hancock LC, 2006, GENETICS, V173, P621, DOI 10.1534/genetics.106.057489; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kooijman EE, 2008, BIOPHYS J, V94, P4320, DOI 10.1529/biophysj.107.121046; Kooijman EE, 2007, J BIOL CHEM, V282, P11356, DOI 10.1074/jbc.M609737200; Kooijman EE, 2009, BIOCHEMISTRY-US, V48, P9360, DOI 10.1021/bi9008616; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P17007, DOI 10.1021/bi0518794; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; Nakanishi H, 2004, MOL BIOL CELL, V15, P1802, DOI 10.1091/mbc.E03-11-0798; Orij R, 2009, MICROBIOL-SGM, V155, P268, DOI 10.1099/mic.0.022038-0; Porat Z, 2005, CELL MOL LIFE SCI, V62, P3106, DOI 10.1007/s00018-005-5341-7; Williams-Hart T, 2002, GENETICS, V160, P1423; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066	20	178	180	2	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 27	2010	329	5995					1085	1088		10.1126/science.1191026	http://dx.doi.org/10.1126/science.1191026			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642WZ	20798321				2022-12-01	WOS:000281253500043
J	de Jonge, R; van Esse, HP; Kombrink, A; Shinya, T; Desaki, Y; Bours, R; van der Krol, S; Shibuya, N; Joosten, MHAJ; Thomma, BPHJ				de Jonge, Ronnie; van Esse, H. Peter; Kombrink, Anja; Shinya, Tomonori; Desaki, Yoshitake; Bours, Ralph; van der Krol, Sander; Shibuya, Naoto; Joosten, Matthieu H. A. J.; Thomma, Bart P. H. J.			Conserved Fungal LysM Effector Ecp6 Prevents Chitin-Triggered Immunity in Plants	SCIENCE			English	Article							RECEPTOR-LIKE KINASE; CLADOSPORIUM-FULVUM; VIRULENCE FACTOR; BINDING; DEFENSE; TOMATO; CELLS; AVR4; RECOGNITION; ARABIDOPSIS	Multicellular organisms activate immunity upon recognition of pathogen-associated molecular patterns (PAMPs). Chitin is the major component of fungal cell walls, and chitin oligosaccharides act as PAMPs in plant and mammalian cells. Microbial pathogens deliver effector proteins to suppress PAMP-triggered host immunity and to establish infection. Here, we show that the LysM domain-containing effector protein Ecp6 of the fungal plant pathogen Cladosporium fulvum mediates virulence through perturbation of chitin-triggered host immunity. During infection, Ecp6 sequesters chitin oligosaccharides that are released from the cell walls of invading hyphae to prevent elicitation of host immunity. This may represent a common strategy of host immune suppression by fungal pathogens, because LysM effectors are widely conserved in the fungal kingdom.	[de Jonge, Ronnie; van Esse, H. Peter; Kombrink, Anja; Joosten, Matthieu H. A. J.; Thomma, Bart P. H. J.] Wageningen Univ, Phytopathol Lab, NL-6708 PB Wageningen, Netherlands; [Thomma, Bart P. H. J.] Ctr Biosyst Genom, NL-6700 AB Wageningen, Netherlands; [Shinya, Tomonori; Desaki, Yoshitake; Shibuya, Naoto] Meiji Univ, Fac Agr, Dept Life Sci, Kanagawa 2148571, Japan; [Bours, Ralph; van der Krol, Sander] Wageningen Univ, Lab Plant Physiol, NL-6708 PB Wageningen, Netherlands	Wageningen University & Research; Centre for BioSystems Genomics; Meiji University; Wageningen University & Research	Thomma, BPHJ (corresponding author), Wageningen Univ, Phytopathol Lab, Droevendaalsesteeg 1, NL-6708 PB Wageningen, Netherlands.	bart.thomma@wur.nl	van Esse, Peter/U-5304-2018; Joosten, Matthieu/AAB-5150-2022; Desaki, Yoshitake/M-7264-2015; Thomma, Bart/E-5959-2011; de Jonge, Ronnie/I-3260-2016; Thomma, Bart/ABH-6344-2020; van der Krol, Alexander/C-5720-2015; Joosten, Matthieu/AAB-5131-2022	van Esse, Peter/0000-0002-3667-060X; Desaki, Yoshitake/0000-0002-0916-9051; Thomma, Bart/0000-0003-4125-4181; de Jonge, Ronnie/0000-0001-5065-8538; Thomma, Bart/0000-0003-4125-4181; van der Krol, Alexander/0000-0001-6585-7572; Joosten, Matthieu/0000-0002-6243-4547	Research Council for Earth and Life Sciences (ALW) of the Netherlands Organization for Scientific Research (NWO); European Research Area-Network (ERA-NET) Plant Genomics; Centre for BioSystems Genomics (CBSG), Netherlands Genomics Initiative; NWO; Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN); Ministry of Education, Culture, Sports, Science and Technology, Japan	Research Council for Earth and Life Sciences (ALW) of the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Area-Network (ERA-NET) Plant Genomics; Centre for BioSystems Genomics (CBSG), Netherlands Genomics Initiative; NWO(Netherlands Organization for Scientific Research (NWO)); Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We are indebted to Yaizu Suisankagaku Industrial Co. Ltd. for the supply of chitosan oligosaccharides and to the Consortium for Functional Glycomics (CFG) for performing the glycan array analysis. This research was supported by a Vidi grant of the Research Council for Earth and Life Sciences (ALW) of the Netherlands Organization for Scientific Research (NWO), by the European Research Area-Network (ERA-NET) Plant Genomics and by the Centre for BioSystems Genomics (CBSG), which is part of the Netherlands Genomics Initiative and NWO. Part of this research was supported by the Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN) and a grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors thank P. de Wit, F. Govers, T. Bisseling, N. Talbot, and anonymous reviewers for critical evaluation of the manuscript and L. Verhage and L. Kaaij for technical assistance.	Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; BOLLER T, 1995, ANNU REV PLANT PHYS, V46, P189, DOI 10.1146/annurev.pp.46.060195.001201; Bolton MD, 2008, MOL MICROBIOL, V69, P119, DOI 10.1111/j.1365-2958.2008.06270.x; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; de Jonge R, 2009, TRENDS MICROBIOL, V17, P151, DOI 10.1016/j.tim.2009.01.002; FELIX G, 1993, PLANT J, V4, P307, DOI 10.1046/j.1365-313X.1993.04020307.x; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Iizasa E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.027540; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Lee CG, 2008, CURR OPIN IMMUNOL, V20, P684, DOI 10.1016/j.coi.2008.10.002; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Rooney HCE, 2005, SCIENCE, V308, P1783, DOI 10.1126/science.1111404; SCHLUMBAUM A, 1986, NATURE, V324, P365, DOI 10.1038/324365a0; Shabab M, 2008, PLANT CELL, V20, P1169, DOI 10.1105/tpc.107.056325; Shinya T, 2010, PLANT CELL PHYSIOL, V51, P262, DOI 10.1093/pcp/pcp185; Thomma BPHJ, 2005, MOL PLANT PATHOL, V6, P379, DOI 10.1111/J.1364-3703.2005.00292.X; van den Burg HA, 2004, J BIOL CHEM, V279, P16786, DOI 10.1074/jbc.M312594200; van den Burg HA, 2006, MOL PLANT MICROBE IN, V19, P1420, DOI 10.1094/MPMI-19-1420; van Esse HP, 2008, PLANT CELL, V20, P1948, DOI 10.1105/tpc.108.059394; van Esse HP, 2007, MOL PLANT MICROBE IN, V20, P1092, DOI 10.1094/MPMI-20-9-1092; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754	25	461	467	12	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 20	2010	329	5994					953	955		10.1126/science.1190859	http://dx.doi.org/10.1126/science.1190859			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640WN	20724636				2022-12-01	WOS:000281084800037
J	Hoffmann, M; Hilton-Taylor, C; Angulo, A; Bohm, M; Brooks, TM; Butchart, SHM; Carpenter, KE; Chanson, J; Collen, B; Cox, NA; Darwall, WRT; Dulvy, NK; Harrison, LR; Katariya, V; Pollock, CM; Quader, S; Richman, NI; Rodrigues, ASL; Tognelli, MF; Vie, JC; Aguiar, JM; Allen, DJ; Allen, GR; Amori, G; Ananjeva, NB; Andreone, F; Andrew, P; Ortiz, ALA; Baillie, JEM; Baldi, R; Bell, BD; Biju, SD; Bird, JP; Black-Decima, P; Blanc, JJ; Bolanos, F; Bolivar, W; Burfield, IJ; Burton, JA; Capper, DR; Castro, F; Catullo, G; Cavanagh, RD; Channing, A; Chao, NL; Chenery, AM; Chiozza, F; Clausnitzer, V; Collar, NJ; Collett, LC; Collette, BB; Fernandez, CFC; Craig, MT; Crosby, MJ; Cumberlidge, N; Cuttelod, A; Derocher, AE; Diesmos, AC; Donaldson, JS; Duckworth, JW; Dutson, G; Dutta, SK; Emslie, RH; Farjon, A; Fowler, S; Freyhof, J; Garshelis, DL; Gerlach, J; Gower, DJ; Grant, TD; Hammerson, GA; Harris, RB; Heaney, LR; Hedges, SB; Hero, JM; Hughes, B; Hussain, SA; Icochea, J; Inger, RF; Ishii, N; Iskandar, DT; Jenkins, RKB; Kaneko, Y; Kottelat, M; Kovacs, KM; Kuzmin, SL; La Marca, E; Lamoreux, JF; Lau, MWN; Lavilla, EO; Leus, K; Lewison, RL; Lichtenstein, G; Livingstone, SR; Lukoschek, V; Mallon, DP; McGowan, PJK; McIvor, A; Moehlman, PD; Molur, S; Alonso, AM; Musick, JA; Nowell, K; Nussbaum, RA; Olech, W; Orlov, NL; Papenfuss, TJ; Parra-Olea, G; Perrin, WF; Polidoro, BA; Pourkazemi, M; Racey, PA; Ragle, JS; Ram, M; Rathbun, G; Reynolds, RP; Rhodin, AGJ; Richards, SJ; Rodriguez, LO; Ron, SR; Rondinini, C; Rylands, AB; de Mitcheson, YS; Sanciangco, JC; Sanders, KL; Santos-Barrera, G; Schipper, J; Self-Sullivan, C; Shi, YC; Shoemaker, A; Short, FT; Sillero-Zubiri, C; Silvano, DL; Smith, KG; Smith, AT; Snoeks, J; Stattersfield, AJ; Symes, AJ; Taber, AB; Talukdar, BK; Temple, HJ; Timmins, R; Tobias, JA; Tsytsulina, K; Tweddle, D; Ubeda, C; Valenti, SV; van Dijk, PP; Veiga, LM; Veloso, A; Wege, DC; Wilkinson, M; Williamson, EA; Xie, F; Young, BE; Akcakaya, HR; Bennun, L; Blackburn, TM; Boitani, L; Dublin, HT; da Fonseca, GAB; Gascon, C; Lacher, TE; Mace, GM; Mainka, SA; McNeely, JA; Mittermeier, RA; Reid, GM; Rodriguez, JP; Rosenberg, AA; Samways, MJ; Smart, J; Stein, BA; Stuart, SN				Hoffmann, Michael; Hilton-Taylor, Craig; Angulo, Ariadne; Boehm, Monika; Brooks, Thomas M.; Butchart, Stuart H. M.; Carpenter, Kent E.; Chanson, Janice; Collen, Ben; Cox, Neil A.; Darwall, William R. T.; Dulvy, Nicholas K.; Harrison, Lucy R.; Katariya, Vineet; Pollock, Caroline M.; Quader, Suhel; Richman, Nadia I.; Rodrigues, Ana S. L.; Tognelli, Marcelo F.; Vie, Jean-Christophe; Aguiar, John M.; Allen, David J.; Allen, Gerald R.; Amori, Giovanni; Ananjeva, Natalia B.; Andreone, Franco; Andrew, Paul; Aquino Ortiz, Aida Luz; Baillie, Jonathan E. M.; Baldi, Ricardo; Bell, Ben D.; Biju, S. D.; Bird, Jeremy P.; Black-Decima, Patricia; Blanc, J. Julian; Bolanos, Federico; Bolivar-G, Wilmar; Burfield, Ian J.; Burton, James A.; Capper, David R.; Castro, Fernando; Catullo, Gianluca; Cavanagh, Rachel D.; Channing, Alan; Chao, Ning Labbish; Chenery, Anna M.; Chiozza, Federica; Clausnitzer, Viola; Collar, Nigel J.; Collett, Leah C.; Collette, Bruce B.; Fernandez, Claudia F. Cortez; Craig, Matthew T.; Crosby, Michael J.; Cumberlidge, Neil; Cuttelod, Annabelle; Derocher, Andrew E.; Diesmos, Arvin C.; Donaldson, John S.; Duckworth, J. W.; Dutson, Guy; Dutta, S. K.; Emslie, Richard H.; Farjon, Aljos; Fowler, Sarah; Freyhof, Joerg; Garshelis, David L.; Gerlach, Justin; Gower, David J.; Grant, Tandora D.; Hammerson, Geoffrey A.; Harris, Richard B.; Heaney, Lawrence R.; Hedges, S. Blair; Hero, Jean-Marc; Hughes, Baz; Hussain, Syed Ainul; Icochea M, Javier; Inger, Robert F.; Ishii, Nobuo; Iskandar, Djoko T.; Jenkins, Richard K. B.; Kaneko, Yoshio; Kottelat, Maurice; Kovacs, Kit M.; Kuzmin, Sergius L.; La Marca, Enrique; Lamoreux, John F.; Lau, Michael W. N.; Lavilla, Esteban O.; Leus, Kristin; Lewison, Rebecca L.; Lichtenstein, Gabriela; Livingstone, Suzanne R.; Lukoschek, Vimoksalehi; Mallon, David P.; McGowan, Philip J. K.; McIvor, Anna; Moehlman, Patricia D.; Molur, Sanjay; Munoz Alonso, Antonio; Musick, John A.; Nowell, Kristin; Nussbaum, Ronald A.; Olech, Wanda; Orlov, Nikolay L.; Papenfuss, Theodore J.; Parra-Olea, Gabriela; Perrin, William F.; Polidoro, Beth A.; Pourkazemi, Mohammad; Racey, Paul A.; Ragle, James S.; Ram, Mala; Rathbun, Galen; Reynolds, Robert P.; Rhodin, Anders G. J.; Richards, Stephen J.; Rodriguez, Lily O.; Ron, Santiago R.; Rondinini, Carlo; Rylands, Anthony B.; de Mitcheson, Yvonne Sadovy; Sanciangco, Jonnell C.; Sanders, Kate L.; Santos-Barrera, Georgina; Schipper, Jan; Self-Sullivan, Caryn; Shi, Yichuan; Shoemaker, Alan; Short, Frederick T.; Sillero-Zubiri, Claudio; Silvano, Debora L.; Smith, Kevin G.; Smith, Andrew T.; Snoeks, Jos; Stattersfield, Alison J.; Symes, Andrew J.; Taber, Andrew B.; Talukdar, Bibhab K.; Temple, Helen J.; Timmins, Rob; Tobias, Joseph A.; Tsytsulina, Katerina; Tweddle, Denis; Ubeda, Carmen; Valenti, Sarah V.; van Dijk, Peter Paul; Veiga, Liza M.; Veloso, Alberto; Wege, David C.; Wilkinson, Mark; Williamson, Elizabeth A.; Xie, Feng; Young, Bruce E.; Akcakaya, H. Resit; Bennun, Leon; Blackburn, Tim M.; Boitani, Luigi; Dublin, Holly T.; da Fonseca, Gustavo A. B.; Gascon, Claude; Lacher, Thomas E., Jr.; Mace, Georgina M.; Mainka, Susan A.; McNeely, Jeffery A.; Mittermeier, Russell A.; Reid, Gordon McGregor; Paul Rodriguez, Jon; Rosenberg, Andrew A.; Samways, Michael J.; Smart, Jane; Stein, Bruce A.; Stuart, Simon N.			The Impact of Conservation on the Status of the World's Vertebrates	SCIENCE			English	Article							GLOBAL BIODIVERSITY; CLIMATE-CHANGE; EXTINCTIONS; DECLINES; BENEFITS; FUTURE; INDEX	Using data for 25,780 species categorized on the International Union for Conservation of Nature Red List, we present an assessment of the status of the world's vertebrates. One-fifth of species are classified as Threatened, and we show that this figure is increasing: On average, 52 species of mammals, birds, and amphibians move one category closer to extinction each year. However, this overall pattern conceals the impact of conservation successes, and we show that the rate of deterioration would have been at least one-fifth again as much in the absence of these. Nonetheless, current conservation efforts remain insufficient to offset the main drivers of biodiversity loss in these groups: agricultural expansion, logging, overexploitation, and invasive alien species.	[Hoffmann, Michael; Stuart, Simon N.] United Nations Environm Programme World Conservat, IUCN SSC Species Survival Commiss, Cambridge CB3 0DL, England; [Cox, Neil A.; Tognelli, Marcelo F.] Conservat Int, IUCN CI Biodivers Assessment Unit, Arlington, VA 22202 USA; [Hilton-Taylor, Craig; Darwall, William R. T.; Katariya, Vineet; Pollock, Caroline M.; Allen, David J.; Collett, Leah C.; Cuttelod, Annabelle; Shi, Yichuan; Smith, Kevin G.] IUCN, Species Programme, Cambridge CB3 0DL, England; [Angulo, Ariadne] IUCN CI Biodivers Assessment Unit, Toronto, ON M5S 1X1, Canada; [Angulo, Ariadne; Carpenter, Kent E.; Chanson, Janice; Cox, Neil A.; Tognelli, Marcelo F.; Vie, Jean-Christophe; Lamoreux, John F.; Polidoro, Beth A.; Ragle, James S.; Sanciangco, Jonnell C.] IUCN, Species Programme, CH-1196 Gland, Switzerland; [Boehm, Monika; Collen, Ben; Richman, Nadia I.; Ram, Mala; Blackburn, Tim M.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Brooks, Thomas M.; Young, Bruce E.] NatureServe, Arlington, VA 22209 USA; [Brooks, Thomas M.] Univ Philippines Los Banos, World Agroforestry Ctr ICRAF, Laguna 4031, Philippines; [Brooks, Thomas M.] Univ Tasmania, Sch Geog & Environm Studies, Hobart, Tas 7001, Australia; [Butchart, Stuart H. M.; Burfield, Ian J.; Collar, Nigel J.; Crosby, Michael J.; Stattersfield, Alison J.; Symes, Andrew J.; Wege, David C.; Bennun, Leon] BirdLife Int, Cambridge CB3 0NA, England; [Carpenter, Kent E.; Polidoro, Beth A.; Sanciangco, Jonnell C.] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA; [Chanson, Janice] IUCN CI Biodivers Assessment Unit, Cheltenham, Vic 3192, Australia; [Dulvy, Nicholas K.; Harrison, Lucy R.] Simon Fraser Univ, Dept Biol Sci, IUCN Shark Specialist Grp, Burnaby, BC V5A 1S6, Canada; [Quader, Suhel] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India; [Rodrigues, Ana S. L.] CNRS, UMR5175, Ctr Ecol Fonct & Evolut, F-34293 Montpellier, France; [Tognelli, Marcelo F.] IADIZA CONICET, CCT Mendoza, RA-5500 Mendoza, Argentina; [Aguiar, John M.; Lacher, Thomas E., Jr.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Allen, Gerald R.] Western Australian Museum, Perth, WA 6986, Australia; [Amori, Giovanni] CNR, Inst Ecosyst Studies, I-00185 Rome, Italy; [Ananjeva, Natalia B.; Orlov, Nikolay L.] Russian Acad Sci, Inst Zool, St Petersburg 199034, Russia; [Andreone, Franco] Museo Reg Sci Nat, I-10123 Turin, Italy; [Andrew, Paul] Taronga Conservat Soc Australia, Taronga Zoo, Sydney, NSW 2088, Australia; [Baillie, Jonathan E. M.] Zool Soc London, London NW1 4RY, England; [Baldi, Ricardo] Ctr Nacl Pagagon CONICET, Unidad Invest Ecol Terrestre, RA-9120 Puerto Madryn, Argentina; [Baldi, Ricardo] Wildlife Conservat Soc, Patagonian & Andean Steppe Program, RA-9120 Puerto Madryn, Argentina; [Bell, Ben D.] Victoria Univ Wellington, Sch Biol Sci, Ctr Biodivers & Restorat Ecol, Wellington 6140, New Zealand; [Biju, S. D.] Univ Delhi, Sch Environm Studies, Systemat Lab, Delhi 110007, India; [Bird, Jeremy P.] Pacific Inst Sustainable Dev, Ctr Biodivers & Biosecur Studies, Manado, North Sulawesi, Indonesia; [Black-Decima, Patricia] Univ Nacl Tucuman, Fac Ciencias Nat, RA-4000 San Miguel De Tucuman, Argentina; [Black-Decima, Patricia] Univ Nacl Tucuman, Inst Miguel Lillo, RA-4000 San Miguel De Tucuman, Argentina; [Bolanos, Federico] Univ Costa Rica, Escuela Biol, San Jose 115012060, Costa Rica; [Bolivar-G, Wilmar] Univ Valle, Fac Ciencias Nat & Exactas, Dept Biol, Secc Zool, Cali, Colombia; [Burton, James A.] Earthwatch Inst, Oxford OX2 7DE, England; [Burton, James A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland; [Castro, Fernando] Univ Valle, Lab Herpetol, Cali, Colombia; [Catullo, Gianluca] WWF Italy Specis Off, I-00198 Rome, Italy; [Cavanagh, Rachel D.] British Antarctic Survey, Cambridge CB3 0ET, England; [Channing, Alan] Univ Western Cape, Biodivers & Conservat Biol Dept, ZA-7535 Bellville, South Africa; [Chao, Ning Labbish] Bioamazonia Conservat Int, Baltimore, MD 21230 USA; [Chao, Ning Labbish] Univ Fed Amazonas, Depto Ciencias Pesqueiras, BR-60700 Manaus, Amazonas, Brazil; [Chao, Ning Labbish] Natl Museum Marine Biol & Aquarium, Checheng 944, Pingtung, Taiwan; [Chiozza, Federica; Rondinini, Carlo; Boitani, Luigi] Univ Roma La Sapienza, Dept Anim & Human Biol, I-00185 Rome, Italy; [Clausnitzer, Viola] Senckenberg Museum Nat Hist Goerlitz, D-02806 Goerlitz, Germany; [Collette, Bruce B.] Smithsonian Inst, Natl Museum Nat Hist, Natl Marine Fisheries Serv Systemat Lab, Washington, DC 20013 USA; [Craig, Matthew T.] Univ Puerto Rico, Dept Marine Sci, Mayaguez, PR 00681 USA; [Cumberlidge, Neil] Univ Michigan, Dept Biol, Marquette, MI 49855 USA; [Derocher, Andrew E.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Diesmos, Arvin C.] Natl Museum Philippines, Div Zool, Herpetol Sect, Manila 1000, Philippines; [Donaldson, John S.] S African Natl Biodivers Inst, KRC, ZA-7735 Claremont, South Africa; [Dutson, Guy] Birds Australia, Carlton, Vic 3053, Australia; [Dutta, S. K.] N Orissa Univ, Mayurbhanj 757003, Orissa, India; [Emslie, Richard H.] IUCN SSC African Rhino Specialist Grp, ZA-3245 Hilton, South Africa; [Farjon, Aljos] Royal Bot Gardens, Herbarium Lib Art & Arch, Richmond TW9 3AB, Surrey, England; [Fowler, Sarah; Valenti, Sarah V.] NatureBur, Newbury RG14 5SJ, Berks, England; [Freyhof, Joerg] Leibniz Inst Freshwater Ecol & Inland Fisheries, D-12587 Berlin, Germany; [Garshelis, David L.] Minnesota Dept Nat Resources, Grand Rapids, MN 55744 USA; [Gerlach, Justin] Nat Protect Trust Seychelles, Cambridge CB1 7BX, England; [Gower, David J.; Wilkinson, Mark] Nat Hist Museum, Dept Zool, London SW7 5BD, England; [Grant, Tandora D.] San Diego Zoo Inst Conservat Res, Escondido, CA 92027 USA; [Hammerson, Geoffrey A.] NatureServe, Port Townsend, WA 98368 USA; [Harris, Richard B.] Univ Montana, Dept Ecosyst & Conservat Sci, Missoula, MT 59812 USA; [Heaney, Lawrence R.; Inger, Robert F.] Field Museum Nat Hist, Chicago, IL 60605 USA; [Hedges, S. Blair] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Hero, Jean-Marc] Griffith Univ, Sch Environm, Environm Futures Ctr, Griffith, Qld 4222, Australia; [Hughes, Baz] Wildfowl & Wetlands Trust, Slimbridge GL2 7BT, Glos, England; [Hussain, Syed Ainul] Wildlife Inst India, Dehra Dun 248001, Uttar Pradesh, India; [Ishii, Nobuo] Tokyo Womans Christian Univ, Sch Arts & Sci, Suginami Ku, Tokyo 1678585, Japan; [Iskandar, Djoko T.] Inst Teknol Bandung, Sch Life Sci & Technol, Bandung 40132, Indonesia; [Jenkins, Richard K. B.] Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Canterbury CT2 7NR, Kent, England; [Jenkins, Richard K. B.] Bangor Univ, Sch Environm & Nat Resources, Bangor LL57 2UW, Gwynedd, Wales; [Jenkins, Richard K. B.] Madagasikara Voakajy, Antananarivo 101, Madagascar; [Kaneko, Yoshio] Iwate Prefectural Univ, Takizawa, Iwate 0200193, Japan; [Kottelat, Maurice] Natl Univ Singapore, Dept Biol Sci, Raffles Museum Biodivers Res, Singapore 117546, Singapore; [Kovacs, Kit M.] Norwegian Polar Res Inst, N-9296 Tromso, Norway; [Kuzmin, Sergius L.] Russian Acad Sci, Inst Ecol & Evolut, Moscow 119071, Russia; [La Marca, Enrique] Univ Los Andes, Escuela Geog, Lab Biogeog, Merida 5101, Venezuela; [Lamoreux, John F.] IUCN Species Programme, Randolph, NH 03593 USA; [Lau, Michael W. N.] Kadoorie Farm & Bot Garden, Tai Po, Hong Kong, Peoples R China; [Lavilla, Esteban O.] Fdn Miguel Lillo CONICET, Inst Herpetol, RA-4000 San Miguel De Tucuman, Argentina; [Leus, Kristin] European Reg Off, Conservat Breeding Specialist Grp, B-2170 Merksem, Belgium; [Lewison, Rebecca L.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Lichtenstein, Gabriela] Inst Nacl Antropol & Pensamiento Latinoamer, RA-1426 Buenos Aires, DF, Argentina; [Livingstone, Suzanne R.] Univ Glasgow, Fac Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Lukoschek, Vimoksalehi] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; [Lukoschek, Vimoksalehi] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Mallon, David P.] Manchester Metropolitan Univ, Dept Biol Chem & Hlth Sci, Manchester M1 5GD, Lancs, England; [McGowan, Philip J. K.] Newcastle Univ, Biol Field Stn, World Pheasant Assoc, Newcastle Upon Tyne NE15 0HT, Tyne & Wear, England; [Moehlman, Patricia D.] Wildlife Trust Alliance, Arusha, Tanzania; [Molur, Sanjay] Zoo Outreach Org, Coimbatore 641004, Tamil Nadu, India; [Munoz Alonso, Antonio] Colegio Frontera Sur, San Cristobal Las Casas 29290, Chiapas, Mexico; [Musick, John A.] Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA; [Nowell, Kristin] CAT, Cape Neddick, ME 03902 USA; [Nussbaum, Ronald A.] Univ Michigan, Museum Zool, Div Reptiles & Amphibians, Ann Arbor, MI 48109 USA; [Olech, Wanda] Warsaw Univ Life Sci, PL-02786 Warsaw, Poland; [Papenfuss, Theodore J.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Parra-Olea, Gabriela] Univ Nacl Autonoma Mexico, Inst Biol, Dept Zool, Mexico City 04510, DF, Mexico; [Perrin, William F.] NOAA, SW Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA 92037 USA; [Pourkazemi, Mohammad] Int Sturgeon Res Inst, Rasht, Iran; [Racey, Paul A.] Univ Exeter Cornwall, Ctr Ecol & Conservat, Penryn TR10 9EZ, England; [Rathbun, Galen] Calif Acad Sci San Francisco, Dept Ornithol & Mammal, Cambria, CA 93428 USA; [Reynolds, Robert P.] Smithsonian Inst, Natl Museum Nat Hist, Patuxent Wildlife Res Ctr, USGS, Washington, DC 20013 USA; [Rhodin, Anders G. J.] Chelonian Res Fdn, Lunenburg, MA 01462 USA; [Richards, Stephen J.] S Australian Museum, Herpetol Dept, Adelaide, SA 5000, Australia; [Richards, Stephen J.] Conservat Int, Rapid Assessment Program, Atherton, Qld 4883, Australia; [Rodriguez, Lily O.] German Tech Cooperat GmbH, Lima 27, Peru; [Ron, Santiago R.] Pontificia Univ Catolica Ecuador, Escuela Biol, Museo Zool, Quito, Ecuador; [de Mitcheson, Yvonne Sadovy] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [de Mitcheson, Yvonne Sadovy] Soc Conservat Reef Fish Aggregat, San Diego, CA 92126 USA; [Sanders, Kate L.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia; [Santos-Barrera, Georgina] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Evolut Biol, Mexico City 04510, DF, Mexico; [Schipper, Jan] Univ Hawaii, Pacific Cooperat Studies Unit, Big Isl Invas Species Comm, Hilo, HI 96720 USA; [Self-Sullivan, Caryn] Sirenian Int, Fredericksburg, VA 22401 USA; [Self-Sullivan, Caryn] Georgia So Univ, Dept Biol, Statesboro, GA 30460 USA; [Shoemaker, Alan] IUCN SSC Tapir Specialist Grp, Columbia, SC 29210 USA; [Short, Frederick T.] Univ New Hampshire, Jackson Estuarine Lab, Dept Nat Resources & Environm, Durham, NH 03824 USA; [Sillero-Zubiri, Claudio] Univ Oxford, Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit, Tubney OX13 5QL, England; [Silvano, Debora L.] Univ Catolica Brasilia, Zool Lab, BR-71966700 Taguatinga, DF, Brazil; [Smith, Andrew T.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Snoeks, Jos] Royal Museum Cent Africa, B-3080 Tervuren, Belgium; [Snoeks, Jos] Katholieke Univ Leuven, Lab Anim Div & Systemat, B-3000 Louvain, Belgium; [Taber, Andrew B.] Jalan CIFOR, Ctr Int Forestry Res, Situ Gede 16115, Bogor Barat, Indonesia; [Talukdar, Bibhab K.] Aaranyak & Int Rhino Fdn, Gauhati 781028, Assam, India; [Temple, Helen J.] Biodivers Consultancy Ltd, Cambridge CB2 9LJ, England; [Tobias, Joseph A.] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; [Tsytsulina, Katerina] Natl Inst Biol Resources, Vertebrate Res Div, Inchon 404708, South Korea; [Tweddle, Denis] S African Inst Aquat Biodivers, ZA-6140 Grahamstown, South Africa; [Ubeda, Carmen] Univ Nacl Comahue, Ctr Reg Univ Bariloche, Dept Zool, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Veiga, Liza M.] Museu Paraense Emilio Goeldi, BR-66017970 Belem, Para, Brazil; [Veiga, Liza M.] Fed Univ Para, BR-66075110 Belem, Para, Brazil; [Veloso, Alberto] Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Santiago, Chile; [Williamson, Elizabeth A.] Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; [Xie, Feng] Chinese Acad Sci, Chengdu Inst Biol, Chengdu 610041, Peoples R China; [Akcakaya, H. Resit] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Dublin, Holly T.] IUCN ESARO, African Elephant Specialist Grp, IUCN SSC, Nairobi 00200, Kenya; [Dublin, Holly T.] Wildlife Conservat Soc, Bronx, NY 10460 USA; [da Fonseca, Gustavo A. B.] Global Environm Facil, Washington, DC 20433 USA; [da Fonseca, Gustavo A. B.] Univ Fed Minas Gerais, Dept Zool, BR-31270901 Belo Horizonte, MG, Brazil; [Mace, Georgina M.] Univ London Imperial Coll Sci Technol & Med, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; [Mainka, Susan A.; McNeely, Jeffery A.; Mittermeier, Russell A.; Smart, Jane] IUCN, CH-1196 Gland, Switzerland; [Reid, Gordon McGregor] N England Zool Soc, Chester Zoo, Chester CH2 1LH, Cheshire, England; [Paul Rodriguez, Jon] Inst Venezolano Invest Cient, Ctr Ecol, Caracas 1020A, Venezuela; [Samways, Michael J.] Univ Stellenbosch, Dept Conservat Ecol & Entomol, ZA-7602 Matieland, South Africa; [Stein, Bruce A.] Natl Wildlife Federat, Washington, DC 20004 USA; [Stuart, Simon N.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Stuart, Simon N.] Al Ain Wildlife Pk & Resort, Abu Dhabi, U Arab Emirates	Conservation International; Zoological Society of London; Nature Conservancy; CGIAR; World Agroforestry (ICRAF); University of the Philippines System; University of the Philippines Los Banos; University of Tasmania; BirdLife International; Old Dominion University; Simon Fraser University; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Texas A&M University System; Texas A&M University College Station; Western Australian Museum; Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio degli Ecosistemi (ISE-CNR); Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; Zoological Society of London; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Victoria University Wellington; University of Delhi; Universidad Nacional de Tucuman; Miguel Lillo Foundation; Universidad Nacional de Tucuman; Universidad Costa Rica; Universidad del Valle; University of Edinburgh; Universidad del Valle; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of the Western Cape; Universidade Federal de Amazonas; National Museum of Marine Biology & Aquarium; Sapienza University Rome; Senckenberg Gesellschaft fur Naturforschung (SGN); National Oceanic Atmospheric Admin (NOAA) - USA; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Puerto Rico; University of Puerto Rico Mayaguez; University of Michigan System; University of Michigan; University of Alberta; National Museum of the Philippines; South African National Biodiversity Institute; Royal Botanic Gardens, Kew; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Natural History Museum London; Zoological Society of San Diego; University of Montana System; University of Montana; Field Museum of Natural History (Chicago); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Griffith University; Wildlife Institute of India; Institute Technology of Bandung; University of Kent; Bangor University; Iwate Prefectural University; National University of Singapore; Norwegian Polar Institute; Russian Academy of Sciences; University of Los Andes Venezuela; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Miguel Lillo Foundation; California State University System; San Diego State University; University of Glasgow; University of California System; University of California Irvine; James Cook University; Manchester Metropolitan University; Newcastle University - UK; El Colegio de la Frontera Sur (ECOSUR); William & Mary; Virginia Institute of Marine Science; University of Michigan System; University of Michigan; Warsaw University of Life Sciences; University of California System; University of California Berkeley; Universidad Nacional Autonoma de Mexico; National Oceanic Atmospheric Admin (NOAA) - USA; University of Exeter; California Academy of Sciences; Smithsonian Institution; Smithsonian National Museum of Natural History; United States Department of the Interior; United States Geological Survey; Pontificia Universidad Catolica del Ecuador; University of Hong Kong; University of Adelaide; Universidad Nacional Autonoma de Mexico; University of Hawaii System; University Hawaii Hilo; University System of Georgia; Georgia Southern University; University System Of New Hampshire; University of New Hampshire; University of Oxford; Universidade Catolica de Brasilia; Arizona State University; Arizona State University-Tempe; Royal Museum for Central Africa; KU Leuven; CGIAR; Center for International Forestry Research (CIFOR); University of Oxford; National Institute of Biological Resources; National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity; Universidad Nacional del Comahue; Museu Paraense Emilio Goeldi; Universidade Federal do Para; Universidad de Chile; University of Stirling; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Wildlife Conservation Society; Universidade Federal de Minas Gerais; Imperial College London; Venezuelan Institute Science Research; Stellenbosch University; University of Bath	Hoffmann, M (corresponding author), United Nations Environm Programme World Conservat, IUCN SSC Species Survival Commiss, 219 Huntingdon Rd, Cambridge CB3 0DL, England.	mike.hoffmann@iucn.org	Rodrigues, Ana S.L./A-5914-2009; Ananjeva, Natalia/AAF-4308-2021; Akcakaya, H. Resit/A-7830-2008; Self-Sullivan, Caryn/H-2605-2012; Hu, Lile/E-7961-2015; ANDREONE, FRANCO/H-4942-2012; Derocher, Andrew/J-4469-2012; Olech, Wanda/AAB-5072-2022; Orlov, Nikolai/AAF-4316-2021; Veiga, Liza/C-6667-2009; Rinaldi2, Carlos/D-4479-2011; Rodriguez, Jon P/G-7224-2012; Silvano, Débora/H-4235-2012; Böhm, Michael/C-3638-2011; Diesmos, Arvin C./AGG-8542-2022; Mace, Georgina M/I-3072-2016; Harrison, Lucy/F-9494-2011; Rondinini, Carlo/E-9027-2011; Williamson, Elizabeth/N-8958-2019; Collette, Bruce B./AAA-9532-2019; Rodriguez, Jon P/A-1491-2009; Hoffmann, Michael/E-6419-2010; Lobo, Diele/I-9106-2012; Iskasndar, Djoko/AAD-2204-2021; Rodrigues, Ana/GYQ-6273-2022; Pourkazemi, Mohammad/C-9510-2017; Williamson, Elizabeth/B-9090-2011; Böhm, Monika/E-1153-2018; Blackburn, Tim M/A-7685-2011; Alonso, Luis Antonio Muñoz/V-7652-2019; Butchart, Stuart/AAJ-1852-2021; Sanders, Kate L/D-1507-2019; Wilkinson, Mark/J-2026-2014; Butchart, Stuart HM/Y-2711-2018; Ron, Santiago/J-4203-2019; Jenkins, Richard KB/A-4567-2012; Collen, Ben/F-2543-2016; Collen, Ben/D-5055-2011; Blackburn, Tim/AAC-3144-2019; Donaldson, John/F-6833-2011; Tognelli, Marcelo/L-3958-2019; Williamson, Elizabeth/E-4727-2016; Lukoschek, vimoksalehi/C-6126-2013; Dulvy, Nicholas/I-2895-2012; Cumberlidge, Neil/I-4044-2019; Stein, Bruce/S-5283-2019; Schipper, Jan/N-5266-2015	Rodrigues, Ana S.L./0000-0003-4775-0127; Akcakaya, H. Resit/0000-0002-8679-5929; Self-Sullivan, Caryn/0000-0003-0785-3682; ANDREONE, FRANCO/0000-0001-9809-5818; Derocher, Andrew/0000-0002-1104-7774; Olech, Wanda/0000-0002-6166-3954; Silvano, Débora/0000-0001-7349-5962; Mace, Georgina M/0000-0001-8965-5211; Williamson, Elizabeth/0000-0001-6848-9154; Rodriguez, Jon P/0000-0001-5019-2870; Hoffmann, Michael/0000-0003-4785-2254; Iskasndar, Djoko/0000-0002-8923-6081; Pourkazemi, Mohammad/0000-0002-0496-8049; Böhm, Monika/0000-0003-0585-0832; Alonso, Luis Antonio Muñoz/0000-0002-0225-0332; Butchart, Stuart/0000-0002-1140-4049; Sanders, Kate L/0000-0002-9581-268X; Wilkinson, Mark/0000-0002-9459-8976; Ron, Santiago/0000-0001-6300-9350; Collen, Ben/0000-0003-2564-4243; Blackburn, Tim/0000-0003-0152-2663; Donaldson, John/0000-0002-7930-1695; Tognelli, Marcelo/0000-0002-9761-4505; Williamson, Elizabeth/0000-0001-6848-9154; Lukoschek, vimoksalehi/0000-0002-0268-3808; Dulvy, Nicholas/0000-0002-4295-9725; Sanciangco, Jonnell Cueto/0000-0001-8268-3180; Molur, Sanjay/0000-0001-8230-518X; Brooks, Thomas/0000-0001-8159-3116; Samways, Michael J./0000-0003-4237-6025; CASTRO HERRERA, FERNANDO/0000-0002-7626-0103; Ragle, James/0000-0002-5829-3745; Blanc, Julian/0000-0003-4331-5339; Gerlach, Justin/0000-0002-0157-0449; Lichtenstein, Gabriela/0000-0002-1717-0941; Lavilla, Esteban Orlando/0000-0001-7024-3049; Tobias, Joseph/0000-0003-2429-6179; Ubeda, Carmen/0000-0001-8962-4001; Richman, Nadia/0000-0003-4072-1622; Rondinini, Carlo/0000-0002-6617-018X; Schipper, Jan/0000-0002-8338-7874	NERC [bas0100025, cpb010001] Funding Source: UKRI; Natural Environment Research Council [cpb010001, bas0100025] Funding Source: researchfish; Division Of Environmental Biology [0818798] Funding Source: National Science Foundation	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Akcakaya HR, 2006, GLOBAL CHANGE BIOL, V12, P2037, DOI 10.1111/j.1365-2486.2006.01253.x; Baillie JEM, 2008, CONSERV LETT, V1, P18, DOI 10.1111/j.1755-263X.2008.00009.x; Boyd C, 2008, CONSERV LETT, V1, P37, DOI 10.1111/j.1755-263X.2008.00002.x; Brook BW, 2009, BIOL LETTERS, V5, P723, DOI 10.1098/rsbl.2009.0480; Brooke MD, 2008, CONSERV BIOL, V22, P417, DOI 10.1111/j.1523-1739.2008.00905.x; Brooks TM, 2009, CONSERV BIOL, V23, P1448, DOI 10.1111/j.1523-1739.2009.01334.x; Butchart SHM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000140; Butchart SHM, 2006, ORYX, V40, P266, DOI 10.1017/S0030605306000950; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; CDB, 2002, CONTRIBUTION 6 NATL; Clucas B, 2008, BIODIVERS CONSERV, V17, P1517, DOI 10.1007/s10531-008-9361-0; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; Cooper John, 2006, Marine Ornithology, V34, P1; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; CuYlix, 2018, EUROPEAN RED LIST SA; Donald PF, 2007, SCIENCE, V317, P810, DOI 10.1126/science.1146002; Dulvy NK, 2006, CAN J FISH AQUAT SCI, V63, P1267, DOI 10.1139/F06-035; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Gascon C., 2007, P IUCNSSC AMPH CONS; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; James AN, 1999, NATURE, V401, P323, DOI 10.1038/43774; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Laurance WF, 2009, CONSERV BIOL, V23, P1427, DOI 10.1111/j.1523-1739.2009.01336.x; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Nogales M, 2004, CONSERV BIOL, V18, P310, DOI 10.1111/j.1523-1739.2004.00442.x; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Rodrigues ASL, 2006, SCIENCE, V313, P1051, DOI 10.1126/science.1131302; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Scott JM, 2010, CONSERV LETT, V3, P91, DOI 10.1111/j.1755-263X.2010.00096.x; Secretariat of the Convention on Biological Diversity, 2010, GLOB BIOD OUTL; Sitas N, 2009, ANIM CONSERV, V12, P231, DOI 10.1111/j.1469-1795.2009.00244.x; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; *TEEB, 2008, EC EC BIOD INT REP; TERBORGH J, 1988, CONSERV BIOL, V2, P402, DOI 10.1111/j.1523-1739.1988.tb00207.x; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	41	928	986	25	1013	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 10	2010	330	6010					1503	1509		10.1126/science.1194442	http://dx.doi.org/10.1126/science.1194442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692LE	20978281	Green Submitted			2022-12-01	WOS:000285153500055
J	Clarke, JA; Ksepka, DT; Salas-Gismondi, R; Altamirano, AJ; Shawkey, MD; D'Alba, L; Vinther, J; DeVries, TJ; Baby, P				Clarke, Julia A.; Ksepka, Daniel T.; Salas-Gismondi, Rodolfo; Altamirano, Ali J.; Shawkey, Matthew D.; D'Alba, Liliana; Vinther, Jakob; DeVries, Thomas J.; Baby, Patrice			Fossil Evidence for Evolution of the Shape and Color of Penguin Feathers	SCIENCE			English	Article							DIVING BIRDS	Penguin feathers are highly modified in form and function, but there have been no fossils to inform their evolution. A giant penguin with feathers was recovered from the late Eocene (similar to 36 million years ago) of Peru. The fossil reveals that key feathering features, including undifferentiated primary wing feathers and broad body contour feather shafts, evolved early in the penguin lineage. Analyses of fossilized color-imparting melanosomes reveal that their dimensions were similar to those of non-penguin avian taxa and that the feathering may have been predominantly gray and reddish-brown. In contrast, the dark black-brown color of extant penguin feathers is generated by large, ellipsoidal melanosomes previously unknown for birds. The nanostructure of penguin feathers was thus modified after earlier macrostructural modifications of feather shape linked to aquatic flight.	[Clarke, Julia A.] Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA; [Ksepka, Daniel T.] N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA; [Ksepka, Daniel T.] N Carolina Museum Nat Sci, Dept Paleontol, Raleigh, NC 27601 USA; [Salas-Gismondi, Rodolfo; Altamirano, Ali J.] Univ Nacl Mayor San Marcos, Museo Hist Nat, Dept Paleontol Vertebrados, Lima 14, Peru; [Shawkey, Matthew D.; D'Alba, Liliana] Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA; [Vinther, Jakob] Yale Univ, Dept Geol & Geophys, New Haven, CT 06511 USA; [DeVries, Thomas J.] Univ Washington, Burke Museum Nat Hist & Culture, Seattle, WA 98195 USA; [Baby, Patrice] Inst Rech Dev, Lab Mecanismes & Transferts Geol, F-31400 Toulouse, France; [Baby, Patrice] Univ Toulouse, F-31400 Toulouse, France	University of Texas System; University of Texas Austin; University of North Carolina; North Carolina State University; Universidad Nacional Mayor de San Marcos; University System of Ohio; University of Akron; Yale University; University of Washington; University of Washington Seattle; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Toulouse	Clarke, JA (corresponding author), Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA.	julia_clarke@jsg.utexas.edu	Baby, Patrice/D-2936-2009; Baby, Patrice/AAL-6640-2021; Vinther, Jakob/GZG-4679-2022; /B-4978-2011; D'Alba, Liliana/AAC-4969-2022; Ksepka, Daniel/A-2007-2009	Baby, Patrice/0000-0001-6142-5174; Baby, Patrice/0000-0001-6142-5174; /0000-0003-2218-2637; D'Alba, Liliana/0000-0002-2478-3455; Shawkey, Matthew/0000-0002-5131-8209; Vinther, Jakob/0000-0002-3584-9616; Salas-Gismondi, Rodolfo/0000-0001-9990-8841	National Science Foundation [DEB-0949897, DEB-0949899]; National Geographic Society Expeditions Council; Air Force Office of Scientific Research [FA9550-09-1-0159]	National Science Foundation(National Science Foundation (NSF)); National Geographic Society Expeditions Council(National Geographic Society); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	K. Browne helped produce the figures; W. Aguirre, P. Brinkman, and V. Schneider prepared the fossil. K. Middleton and M. Stucchi provided discussion. P. Unitt, K. Zyskowski, B. Wang, J. Tejada, J. Reyes, E. Diaz, and Z. Jiang provided professional assistance. The research was funded by the National Science Foundation (DEB-0949897 and DEB-0949899), the National Geographic Society Expeditions Council, the Air Force Office of Scientific Research (FA9550-09-1-0159), and University of Akron startup funds. MUSM 1444 is permanently deposited at the Museo de Historia Natural-UNMSM, Lima, Peru.	Arnason U, 2006, MOL PHYLOGENET EVOL, V41, P345, DOI 10.1016/j.ympev.2006.05.022; Berta A, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P861; BONSER RHC, 1995, J EXP BIOL, V198, P1029; Burtt E.H., 1986, ORNITHOL MONOGR, V38, P1; Clarke JA, 2007, P NATL ACAD SCI USA, V104, P11545, DOI 10.1073/pnas.0611099104; Dawson C, 1999, J THEOR BIOL, V199, P291, DOI 10.1006/jtbi.1999.0959; Denny M., 1993, AIR WATER; Fordyce R.E., 1990, P419; Jadwiszczak P, 2009, POL POLAR RES, V30, P3; Ksepka DT, 2010, B AM MUS NAT HIST, P1; Lovvorn JR, 2001, J EXP BIOL, V204, P1547; McGraw KJ, 2007, PIGM CELL RES, V20, P301, DOI 10.1111/j.1600-0749.2007.00386.x; McGraw KJ., 2006, BIRD COLORATION, P243; Rowland HM, 2009, PHILOS T R SOC B, V364, P519, DOI 10.1098/rstb.2008.0261; Slack KE, 2006, MOL BIOL EVOL, V23, P1144, DOI 10.1093/molbev/msj124; Stone-house Bernard, 1975, BIOL PENGUINS; STONEHOUSE B., 1967, ADVAN ECOL RESADVANCES IN ECOLOGICAL RESEARCH, V4, P131, DOI 10.1016/S0065-2504(08)60321-9; Tickell WLN, 2003, WATERBIRDS, V26, P1, DOI 10.1675/1524-4695(2003)026[0001:WP]2.0.CO;2; Vinther J, 2008, BIOL LETTERS, V4, P522, DOI 10.1098/rsbl.2008.0302; Voitkevich A.A.E., 1966, FEATHERS PLUMAGE BIR; WILSON RP, 1992, AM NAT, V140, P179, DOI 10.1086/285409	21	129	133	8	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 12	2010	330	6006					954	957		10.1126/science.1193604	http://dx.doi.org/10.1126/science.1193604			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678XY	20929737				2022-12-01	WOS:000284118000040
J	Karl, T; Harley, P; Emmons, L; Thornton, B; Guenther, A; Basu, C; Turnipseed, A; Jardine, K				Karl, T.; Harley, P.; Emmons, L.; Thornton, B.; Guenther, A.; Basu, C.; Turnipseed, A.; Jardine, K.			Efficient Atmospheric Cleansing of Oxidized Organic Trace Gases by Vegetation	SCIENCE			English	Article							DRY DEPOSITION; AEROSOLS; MODEL	The biosphere is the major source and sink of nonmethane volatile organic compounds (VOCs) in the atmosphere. Gas-phase chemical reactions initiate the removal of these compounds from the atmosphere, which ultimately proceeds via deposition at the surface or direct oxidation to carbon monoxide or carbon dioxide. We performed ecosystem-scale flux measurements that show that the removal of oxygenated VOC via dry deposition is substantially larger than is currently assumed for deciduous ecosystems. Laboratory experiments indicate efficient enzymatic conversion and potential up-regulation of various stress-related genes, leading to enhanced uptake rates as a response to ozone and methyl vinyl ketone exposure or mechanical wounding. A revised scheme for the uptake of oxygenated VOCs, incorporated into a global chemistry-transport model, predicts appreciable regional changes in annual dry deposition fluxes.	[Karl, T.; Harley, P.; Emmons, L.; Guenther, A.; Turnipseed, A.] Natl Ctr Atmospher Res, Boulder, CO 80301 USA; [Thornton, B.; Basu, C.] Univ No Colorado, Sch Biol Sci, Greeley, CO 80639 USA; [Jardine, K.] Univ Arizona, Tucson, AZ 85738 USA	National Center Atmospheric Research (NCAR) - USA; University of Northern Colorado; University of Arizona	Karl, T (corresponding author), Natl Ctr Atmospher Res, Boulder, CO 80301 USA.	tomkarl@ucar.edu	Jardine, Kolby J./N-2802-2013; Karl, Thomas/D-1891-2009; Emmons, Louisa K/R-8922-2016; Guenther, Alex B/B-1617-2008; Harley, Peter/E-1856-2014	Jardine, Kolby J./0000-0001-8491-9310; Karl, Thomas/0000-0003-2869-9426; Emmons, Louisa K/0000-0003-2325-6212; Guenther, Alex B/0000-0001-6283-8288; Harley, Peter/0000-0002-2647-1973; Basu, Chhandak/0000-0003-0520-0100	National Science Foundation	National Science Foundation(National Science Foundation (NSF))	The National Center for Atmospheric Research is operated by the University Corporation for Atmospheric Research under sponsorship from the National Science Foundation.	Atkinson R, 2003, CHEM REV, V103, P4605, DOI 10.1021/cr0206420; COLLINS W, 2004, CLIMATIC CHANGE, V52, P453; Emmons LK, 2010, GEOSCI MODEL DEV, V3, P43, DOI 10.5194/gmd-3-43-2010; Fall R, 2003, CHEM REV, V103, P4941, DOI 10.1021/cr0206521; Goldstein AH, 2007, ENVIRON SCI TECHNOL, V41, P1514, DOI 10.1021/es072476p; Guenther A, 2006, ATMOS CHEM PHYS, V6, P3181, DOI 10.5194/acp-6-3181-2006; Hallquist M, 2009, ATMOS CHEM PHYS, V9, P5155, DOI 10.5194/acp-9-5155-2009; Jimenez JL, 2009, SCIENCE, V326, P1525, DOI 10.1126/science.1180353; Kirch HH, 2004, TRENDS PLANT SCI, V9, P371, DOI 10.1016/j.tplants.2004.06.004; Lelieveld J, 2008, NATURE, V452, P737, DOI 10.1038/nature06870; Paulot F, 2009, SCIENCE, V325, P730, DOI 10.1126/science.1172910; Paulson C.A., 1970, J APPL METEOROL CLIM, V9, P857, DOI [10.1175/1520-0450(1970)0092.0.co;2, DOI 10.1175/1520-0450(1970)009<0857:TMROWS>2.0.CO;2, 10.1175/1520-0450(1970)0092.0.CO;2, DOI 10.1175/1520-0450(1970)009%3C0857:TMROWS%3E2.0.CO;2]; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; WESELY ML, 1989, ATMOS ENVIRON, V23, P1293, DOI 10.1016/0004-6981(89)90153-4; Zhang LM, 2002, ATMOS ENVIRON, V36, P537, DOI 10.1016/S1352-2310(01)00447-2	15	157	159	4	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 5	2010	330	6005					816	819		10.1126/science.1192534	http://dx.doi.org/10.1126/science.1192534			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675SY	20966216	Green Submitted			2022-12-01	WOS:000283855700041
J	Lopez-Garcia, C; Klein, AM; Simons, BD; Winton, DJ				Lopez-Garcia, Carlos; Klein, Allon M.; Simons, Benjamin D.; Winton, Douglas J.			Intestinal Stem Cell Replacement Follows a Pattern of Neutral Drift	SCIENCE			English	Article							MOUSE SMALL-INTESTINE; SOMATIC MUTATION; CRYPT; ORGANIZATION; COLON; CLONALITY; KINETICS; CYCLES	With the capacity for rapid self-renewal and regeneration, the intestinal epithelium is stereotypical of stem cell-supported tissues. Yet the pattern of stem cell turnover remains in question. Applying analytical methods from population dynamics and statistical physics to an inducible genetic labeling system, we showed that clone size distributions conform to a distinctive scaling behavior at short times. This result demonstrates that intestinal stem cells form an equipotent population in which the loss of a stem cell is compensated by the multiplication of a neighbor, leading to neutral drift dynamics in which clones expand and contract at random until they either take over the crypt or they are lost. Combined with long-term clonal fate data, we show that the rate of stem cell replacement is comparable to the cell division rate, implying that neutral drift and symmetrical cell divisions are central to stem cell homeostasis.	[Klein, Allon M.; Simons, Benjamin D.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Lopez-Garcia, Carlos; Winton, Douglas J.] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Klein, Allon M.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Harvard University; Harvard Medical School	Simons, BD (corresponding author), Univ Cambridge, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England.	bds10@cam.ac.uk; doug.winton@cancer.org.uk	Simons, Benjamin/AAY-8920-2020	Simons, Benjamin/0000-0002-3875-7071; Lopez-Garcia, Carlos/0000-0001-9848-8216	Cancer Research UK; Cambridge Research Institute (CRI); CRI Biological Resource Unit and Histopathology Core; Seneca Foundation; Engineering and Physical Sciences Research Council [EP/F043325/1, EP/F032773/1]; EPSRC [EP/F032773/1, EP/F043325/1] Funding Source: UKRI; MRC [G0800784] Funding Source: UKRI; Medical Research Council [G0800784, G0800784B] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cambridge Research Institute (CRI); CRI Biological Resource Unit and Histopathology Core; Seneca Foundation(Fundacion Seneca); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank H. Zecchini and R. Kemp at Cancer Research UK, Cambridge Research Institute (CRI), and the CRI Biological Resource Unit and Histopathology Core. This work was supported by Cancer Research UK (D.J.W.), Seneca Foundation (Region de Murcia, Spain) (C.L.-G.), the Engineering and Physical Sciences Research Council fellowship EP/F043325/1 (A. M. K.), and the Engineering and Physical Sciences Research Council Programme grant EP/F032773/1 (B. D. S.). A patent application on drug and toxicity testing has been submitted.	ALDEWACHI HS, 1979, VIRCHOWS ARCH B, V31, P37, DOI 10.1007/BF02889921; ALDEWACHI HS, 1975, VIRCHOWS ARCH B, V18, P225; Barker N, 2008, COLD SH Q B, V73, P351, DOI 10.1101/sqb.2008.72.003; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BJERKNES M, 1985, BIOPHYS J, V48, P85, DOI 10.1016/S0006-3495(85)83762-0; Booth C, 2000, J CLIN INVEST, V105, P1493, DOI 10.1172/JCI10229; GRIFFITHS DFR, 1988, NATURE, V333, P461, DOI 10.1038/333461a0; Klein AM, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021910; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; LOEFFLER M, 1993, J THEOR BIOL, V160, P471, DOI 10.1006/jtbi.1993.1031; Loeffler M, 1997, J THEOR BIOL, V186, P41, DOI 10.1006/jtbi.1996.0340; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; PARK HS, 1995, AM J PATHOL, V147, P1416; Potten CS, 2002, J CELL SCI, V115, P2381; POTTEN CS, 1986, INT J RADIAT BIOL, V49, P257, DOI 10.1080/09553008514552541; Quyn AJ, 2010, CELL STEM CELL, V6, P175, DOI 10.1016/j.stem.2009.12.007; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; WILLIAMS ED, 1992, AM J PATHOL, V141, P773; WINTON DJ, 1990, P ROY SOC B-BIOL SCI, V241, P13, DOI 10.1098/rspb.1990.0059; WINTON DJ, 1988, NATURE, V333, P463, DOI 10.1038/333463a0; WRIGHT NA, 1982, CELL TISSUE KINET, V15, P595, DOI 10.1111/j.1365-2184.1982.tb01066.x	23	441	447	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 5	2010	330	6005					822	825		10.1126/science.1196236	http://dx.doi.org/10.1126/science.1196236			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675SY	20929733				2022-12-01	WOS:000283855700043
J	Rouget, C; Papin, C; Boureux, A; Meunier, AC; Franco, B; Robine, N; Lai, EC; Pelisson, A; Simonelig, M				Rouget, Christel; Papin, Catherine; Boureux, Anthony; Meunier, Anne-Cecile; Franco, Benedicte; Robine, Nicolas; Lai, Eric C.; Pelisson, Alain; Simonelig, Martine			Maternal mRNA deadenylation and decay by the piRNA pathway in the early Drosophila embryo	NATURE			English	Article							TRANSLATIONAL REGULATION; AXIS SPECIFICATION; BINDING-PROTEIN; GERMLINE; LOCALIZATION; NANOS; PIWI; MELANOGASTER; ACTIVATION; MUTATIONS	Piwi-associated RNAs (piRNAs), a specific class of 24- to 30-nucleotide-long RNAs produced by the Piwi-type of Argonaute proteins, have a specific germline function in repressing transposable elements. This repression is thought to involve heterochromatin formation and transcriptional and post-transcriptional silencing(1-6). The piRNA pathway has other essential functions in germline stem cell maintenance(7) and in maintaining germline DNA integrity(8-10). Here we uncover an unexpected function of the piRNA pathway in the decay of maternal messenger RNAs and in translational repression in the early embryo. A subset of maternal mRNAs is degraded in the embryo at the maternal-to-zygotic transition. In Drosophila, maternal mRNA degradation depends on the RNA-binding protein Smaug and the deadenylase CCR4(11-13), as well as the zygotic expression of a microRNA cluster(14). Using mRNA encoding the embryonic posterior morphogen Nanos (Nos) as a paradigm to study maternal mRNA decay, we found that CCR4-mediated deadenylation of nos depends on components of the piRNA pathway including piRNAs complementary to a specific region in the nos 3' untranslated region. Reduced deadenylation when piRNA-induced regulation is impaired correlates with nos mRNA stabilization and translational derepression in the embryo, resulting in head development defects. Aubergine, one of the Argonaute proteins in the piRNA pathway, is present in a complex with Smaug, CCR4, nos mRNA and piRNAs that target the nos 3' untranslated region, in the bulk of the embryo. We propose that piRNAs and their associated proteins act together with Smaug to recruit the CCR4 deadenylation complex to specific mRNAs, thus promoting their decay. Because the piRNAs involved in this regulation are produced from transposable elements, this identifies a direct developmental function for transposable elements in the regulation of gene expression.	[Rouget, Christel; Papin, Catherine; Meunier, Anne-Cecile; Franco, Benedicte; Simonelig, Martine] CNRS, UPR1142, Inst Human Genet, mRNA Regulat & Dev, F-34396 Montpellier 5, France; [Boureux, Anthony] Univ Montpellier 2, CNRS, UMR5237, CRBM, F-34293 Montpellier, France; [Robine, Nicolas; Lai, Eric C.] Sloan Kettering Inst, Dept Dev Biol, Rockefeller Res Labs 1017, New York, NY 10065 USA; [Pelisson, Alain] CNRS, UPR1142, Inst Human Genet, RNA Silencing & Control Transposit, F-34396 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Memorial Sloan Kettering Cancer Center; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Simonelig, M (corresponding author), CNRS, UPR1142, Inst Human Genet, mRNA Regulat & Dev, 141 Rue Cardonille, F-34396 Montpellier 5, France.	Martine.Simonelig@igh.cnrs.fr	Lai, Eric/AAO-1143-2021; Lai, Eric C/A-3412-2008	Lai, Eric/0000-0002-8432-5851; Simonelig, Martine/0000-0002-3731-6979; Robine, Nicolas/0000-0001-5698-8183	Centre National de la Recherche Scientifique [UPR1142]; Agence Nationale de la Recherche (ANR Blanche) [ANR-06-BLAN-0343]; Fondation pour la Recherche Medicale (FRM); Association pour la Recherche sur le Cancer (ARC); National Institutes of Health (NIH) [R01-GM083300]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083300] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR Blanche)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to A. Nakamura, M. Siomi, H. Siomi, C. Smibert, H. Lin, P. Macdonald, T. Schupbach, W. Theurkauf, R. Wharton and P. Zamore, for their gifts of antibodies or Drosophila stocks. We thank M. Benkirane for the gift of 29-O-methyl anti-miR129. This work was supported by the Centre National de la Recherche Scientifique UPR1142, the Agence Nationale de la Recherche (ANR Blanche ANR-06-BLAN-0343), the Fondation pour la Recherche Medicale (FRM, Equipe FRM 2007) and the Association pour la Recherche sur le Cancer (ARC Libre 2009) to M.S. and by the National Institutes of Health (NIH R01-GM083300) to E.C.L. C.R., A.C.M. and B.F. held salaries from ANR Blanche.	Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Benoit B, 1999, NUCLEIC ACIDS RES, V27, P3771, DOI 10.1093/nar/27.19.3771; Benoit B, 2005, DEV CELL, V9, P511, DOI 10.1016/j.devcel.2005.09.002; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Bushati N, 2008, CURR BIOL, V18, P501, DOI 10.1016/j.cub.2008.02.081; Chen Y, 2007, CURR BIOL, V17, P637, DOI 10.1016/j.cub.2007.02.027; Chou TB, 1996, GENETICS, V144, P1673; Chung WJ, 2008, CURR BIOL, V18, P795, DOI 10.1016/j.cub.2008.05.006; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Dahanukar A, 1996, GENE DEV, V10, P2610, DOI 10.1101/gad.10.20.2610; Dahanukar A, 1999, MOL CELL, V4, P209, DOI 10.1016/S1097-2765(00)80368-8; GAVIS ER, 1994, NATURE, V369, P315, DOI 10.1038/369315a0; GILLESPIE DE, 1995, GENE DEV, V9, P2495, DOI 10.1101/gad.9.20.2495; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Harris AN, 2001, DEVELOPMENT, V128, P2823; Juge F, 2002, EMBO J, V21, P6603, DOI 10.1093/emboj/cdf633; Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; LEHMANN R, 1991, DEVELOPMENT, V112, P679; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Lim AK, 2009, J CELL BIOL, V186, P333, DOI 10.1083/jcb.200904063; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; Pelisson A, 2007, J VIROL, V81, P1951, DOI 10.1128/JVI.01980-06; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; SCHUPBACH T, 1991, GENETICS, V129, P1119; Semotok JL, 2005, CURR BIOL, V15, P284, DOI 10.1016/j.cub.2005.01.048; Tadros W, 2007, DEV CELL, V12, P143, DOI 10.1016/j.devcel.2006.10.005; Temme C, 2004, EMBO J, V23, P2862, DOI 10.1038/sj.emboj.7600273; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; WANG C, 1994, DEV DYNAM, V199, P103, DOI 10.1002/aja.1001990204; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263; Zaessinger S, 2006, DEVELOPMENT, V133, P4573, DOI 10.1242/dev.02649	40	312	327	3	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 28	2010	467	7319					1128	U144		10.1038/nature09465	http://dx.doi.org/10.1038/nature09465			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671XW	20953170	Green Accepted			2022-12-01	WOS:000283548600052
J	West, XZ; Malinin, NL; Merkulova, AA; Tischenko, M; Kerr, BA; Borden, EC; Podrez, EA; Salomon, RG; Byzova, TV				West, Xiaoxia Z.; Malinin, Nikolay L.; Merkulova, Alona A.; Tischenko, Mira; Kerr, Bethany A.; Borden, Ernest C.; Podrez, Eugene A.; Salomon, Robert G.; Byzova, Tatiana V.			Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands	NATURE			English	Article							TOLL-LIKE RECEPTOR-2; MACULAR DEGENERATION; CHRONIC INFLAMMATION; PATTERN-RECOGNITION; INNATE IMMUNITY; SYSTEM; CANCER; CELLS; CD36	Reciprocity of inflammation, oxidative stress and neovascularization is emerging as an important mechanism underlying numerous processes from tissue healing and remodelling to cancer progression(1,2). Whereas the mechanism of hypoxia-driven angiogenesis is well understood(3,4), the link between inflammation-induced oxidation and de novo blood vessel growth remains obscure. Here we show that the end products of lipid oxidation, omega-(2-carboxyethyl) pyrrole (CEP) and other related pyrroles(5), are generated during inflammation and wound healing and accumulate at high levels in ageing tissues in mice and in highly vascularized tumours in both murine and human melanoma. The molecular patterns of carboxyalkylpyrroles are recognized by Toll-like receptor 2 (TLR2), but not TLR4 or scavenger receptors on endothelial cells, leading to an angiogenic response that is independent of vascular endothelial growth factor. CEP promoted angiogenesis in hindlimb ischaemia and wound healing models through MyD88-dependent TLR2 signalling. Neutralization of endogenous carboxyalkylpyrroles impaired wound healing and tissue revascularization and diminished tumour angiogenesis. Both TLR2 and MyD88 are required for CEP-induced stimulation of Rac1 and endothelial migration. Taken together, these findings establish a new function of TLR2 as a sensor of oxidation-associated molecular patterns, providing a key link connecting inflammation, oxidative stress, innate immunity and angiogenesis.	[West, Xiaoxia Z.; Malinin, Nikolay L.; Merkulova, Alona A.; Tischenko, Mira; Kerr, Bethany A.; Podrez, Eugene A.; Byzova, Tatiana V.] Cleveland Clin Fdn, Dept Mol Cardiol, JJ Jacobs Ctr Thrombosis & Vasc Biol, Cleveland, OH 44195 USA; [West, Xiaoxia Z.; Salomon, Robert G.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Borden, Ernest C.; Byzova, Tatiana V.] Cleveland Clin Fdn, Taussig Canc Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Byzova, TV (corresponding author), Cleveland Clin Fdn, Dept Mol Cardiol, JJ Jacobs Ctr Thrombosis & Vasc Biol, NB50,9500 Euclid Ave, Cleveland, OH 44195 USA.	byzovat@ccf.org	Salomon, Robert G/C-3463-2008; Kerr, Bethany/D-1644-2012; Malinin, Nikolay/Z-5308-2019; Malinin, Nikolay/J-4271-2012	Kerr, Bethany/0000-0002-2995-7549; Malinin, Nikolay/0000-0002-2654-1783; Salomon, Robert/0000-0001-9456-3557; Byzova, Tatiana/0000-0002-2615-875X	NIH [HL073311, HL071625, CA126847, HL077213, GM021249]; American Heart Association [10SDG4300062]; NATIONAL CANCER INSTITUTE [R01CA126847] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071625, P01HL073311, R01HL077213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021249] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Hong for the help with synthesis of CEP and CPP adducts, Y. Cui for expressing and purifying anti-CEP monoclonal antibodies, and J. Crabb for providing anti-CEP monoclonal antibody hybridoma cells. This work was supported by NIH grants HL073311, HL071625, CA126847 to T.V.B., HL077213 to E.A.P. and GM021249 to R.G.S. and an American Heart Association grant (10SDG4300062) to N.L.M.	Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Ebrahem Q, 2006, P NATL ACAD SCI USA, V103, P13480, DOI 10.1073/pnas.0601552103; Feng WY, 2008, J CELL BIOL, V183, P1145, DOI 10.1083/jcb.200802179; Fraisl P, 2009, DEV CELL, V16, P167, DOI 10.1016/j.devcel.2009.01.003; Grote K, 2010, BLOOD, V115, P2543, DOI 10.1182/blood-2009-05-224402; Gu XR, 2003, J BIOL CHEM, V278, P42027, DOI 10.1074/jbc.M305460200; Jackson JR, 1997, FASEB J, V11, P457, DOI 10.1096/fasebj.11.6.9194526; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kim HS, 2007, IMMUNITY, V27, P321, DOI 10.1016/j.immuni.2007.06.010; Mahabeleshwar Ganapati H., 2006, V129, P197; Manley PW, 2002, J MED CHEM, V45, P5687, DOI 10.1021/jm020899q; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Mullick AE, 2005, J CLIN INVEST, V115, P3149, DOI 10.1172/JCI25482; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Podrez EA, 2007, NAT MED, V13, P1086, DOI 10.1038/nm1626; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Tan WF, 2008, FASEB J, V22, P1829, DOI 10.1096/fj.07-096438; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005	32	328	337	1	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 21	2010	467	7318					972	U150		10.1038/nature09421	http://dx.doi.org/10.1038/nature09421			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20927103	Green Accepted			2022-12-01	WOS:000283254700040
J	Minassian, C; D'Aiuto, F; Hingorani, AD; Smeeth, L				Minassian, Caroline; D'Aiuto, Francesco; Hingorani, Aroon D.; Smeeth, Liam			Invasive Dental Treatment and Risk for Vascular Events A Self-Controlled Case Series	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; PERIODONTAL THERAPY; ACUTE INFECTION; ATHEROSCLEROSIS; INFLAMMATION; ASSOCIATIONS; MARKERS; UPDATE	Background: Treatment of periodontal disease may reduce cardiovascular risk in the longer term, but studies have suggested a link among dental procedures, acute inflammation, and endothelial dysfunction. However, whether such acute inflammatory effects translate into a short-lived increased risk for vascular events is not known. Objective: To investigate whether invasive dental treatment transiently increases the risk for vascular events. Design: Self-controlled case series. Setting: Data came from the U.S. Medicaid claims database. Patients: All persons exposed to invasive dental treatment with a primary hospital discharge diagnosis of ischemic stroke (n = 650) or myocardial infarction (n = 525) from 2002 to 2006. Measurements: The incidence of ischemic stroke and myocardial infarction in periods immediately after invasive dental treatment was compared with the incidence in all other observed time periods. Incidence ratios and 95% CIs were calculated. Results: The rate of vascular events significantly increased in the first 4 weeks after invasive dental treatment (incidence ratio, 1.50 [95% CI, 1.09 to 2.06]) and gradually returned to the baseline rate within 6 months. The positive association remained after exclusion of persons with diabetes, hypertension, or coronary artery disease or persons with prescriptions for antiplatelet or salicylate drugs before treatment. Limitations: Power to examine the effects of invasive dental treatment on stroke and myocardial infarction separately was limited because of the low frequency of invasive dental procedures. Lack of information about use of over-the-counter drugs limited the ability to assess confounding by possible withholding of antiplatelet or salicylate drugs before invasive dental treatment or by the use of nonsteroidal anti-inflammatory drugs after treatment. Conclusion: Invasive dental treatment may be associated with a transient increase in the risk for vascular events. However, the absolute risks are minimal, and the long-term benefits on vascular health will probably outweigh the short-lived adverse effects.	[Smeeth, Liam] UCL, London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Eastman Dent Inst, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine; University College London	Smeeth, L (corresponding author), UCL, London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Eastman Dent Inst, Keppel St, London WC1E 7HT, England.	liam.smeeth@lshtm.ac.uk	Smeeth, Liam/X-5862-2018	Smeeth, Liam/0000-0002-9168-6022; Hingorani, Aroon/0000-0001-8365-0081; Minassian, Caroline/0000-0001-9406-1928	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	Primary Funding Source: Wellcome Trust.	*AM DENT ASS, 2007, CURR DENT TERM 2007; D'Aiuto F, 2005, INFLAMM RES, V54, P412, DOI 10.1007/s00011-005-1375-4; D'Aiuto F, 2007, J CLIN PERIODONTOL, V34, P124, DOI 10.1111/j.1600-051X.2006.01037.x; D'Aiuto F, 2006, AM HEART J, V151, P977, DOI 10.1016/j.ahj.2005.06.018; Dietrich T, 2008, CIRCULATION, V117, P1668, DOI 10.1161/CIRCULATIONAHA.107.711507; Douglas IJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000154; El-Sharrawy Eman A, 2006, Anesth Prog, V53, P78, DOI 10.2344/0003-3006(2006)53[78:AOCPIA]2.0.CO;2; Farrington CP, 2010, J R STAT SOC C-APPL, V59, P457; FARRINGTON CP, 1995, BIOMETRICS, V51, P228, DOI 10.2307/2533328; FARRINGTON CP, 2006, J ROYAL STAT SOC C, V55, P1; FARRINGTON P, 1995, LANCET, V345, P567, DOI 10.1016/S0140-6736(95)90471-9; Gibson JE, 2009, AM J EPIDEMIOL, V169, P761, DOI 10.1093/aje/kwn364; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Higashi Y, 2009, ATHEROSCLEROSIS, V206, P604, DOI 10.1016/j.atherosclerosis.2009.03.037; Hingorani AD, 2000, CIRCULATION, V102, P994, DOI 10.1161/01.CIR.102.9.994; Hocine M, 2005, STAT MED, V24, P4035, DOI 10.1002/sim.2413; Hubbard R, 2003, AM J EPIDEMIOL, V158, P77, DOI 10.1093/aje/kwg114; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lockhart PB, 2008, CIRCULATION, V117, P3118, DOI 10.1161/CIRCULATIONAHA.107.758524; Loos BG, 2000, J PERIODONTOL, V71, P1528, DOI 10.1902/jop.2000.71.10.1528; MAMODE N, 1995, BMJ-BRIT MED J, V310, P1215, DOI 10.1136/bmj.310.6989.1215; Meier CR, 1998, LANCET, V351, P1467, DOI 10.1016/S0140-6736(97)11084-4; Noack B, 2001, J PERIODONTOL, V72, P1221, DOI 10.1902/jop.2000.72.9.1221; Olsen I, 2008, TRANSFUS APHER SCI, V39, P173, DOI 10.1016/j.transci.2008.06.008; Persson GR, 2008, J CLIN PERIODONTOL, V35, P362, DOI 10.1111/j.1600-051X.2008.01281.x; Scannapieco Frank A, 2003, Ann Periodontol, V8, P38, DOI 10.1902/annals.2003.8.1.38; Slade GD, 2003, ARCH INTERN MED, V163, P1172, DOI 10.1001/archinte.163.10.1172; Slade GD, 2000, J DENT RES, V79, P49, DOI 10.1177/00220345000790010701; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Smeeth L, 2006, LANCET, V367, P1075, DOI 10.1016/S0140-6736(06)68474-2; Strom BL, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P1; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Whitaker HJ, 2009, STAT METHODS MED RES, V18, P7, DOI 10.1177/0962280208092342	36	63	67	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 19	2010	153	8					499	506		10.7326/0003-4819-153-8-201010190-00006	http://dx.doi.org/10.7326/0003-4819-153-8-201010190-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	665SA	20956706				2022-12-01	WOS:000283054600002
J	Lamont, T; Cousins, D; Hillson, R; Bischler, A; Terblanche, M				Lamont, Tara; Cousins, David; Hillson, Rowan; Bischler, Anna; Terblanche, Martinette			Safety Alerts Safer administration of insulin: summary of a safety report from the National Patient Safety Agency	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lamont, Tara; Cousins, David; Bischler, Anna; Terblanche, Martinette] Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England; [Hillson, Rowan] Hillingdon Hosp, London UB8 3NN, England	Brunel University; Imperial College London	Lamont, T (corresponding author), Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England.	tara.lamont@npsa.nhs.uk						Belknap S., 2001, INT J QUAL HEALTH C, V13, P339; Cox AR., 2009, BR J DIABETES VASC D, V9, P84, DOI 10.1177/1474651409103902; Derr RL., 2007, DIABETES SPECTRUM, V20, P177, DOI [DOI 10.2337/diaspect.20.3.177, https://doi.org/10.2337/diaspect.20.3.177]; Fowler D., 2010, SAFE EFFECTIVE USE I; *NHS DIAB, 2010, FIND 2009 NAT DIAB I; PAGE MD, 1992, DIABETIC MED, V9, P938, DOI 10.1111/j.1464-5491.1992.tb01735.x; Rushmer R, 2008, DIABETIC MED, V25, P960, DOI 10.1111/j.1464-5491.2008.02470.x; United States Pharmacopeia, 2010, MEDMARX 5 ANN DAT RE	8	27	27	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 13	2010	341								c5269	10.1136/bmj.c5269	http://dx.doi.org/10.1136/bmj.c5269			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	668FB	20943723				2022-12-01	WOS:000283252900017
J	Bodenheimer, T; West, D				Bodenheimer, Thomas; West, David			Low-Cost Lessons from Grand Junction, Colorado	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bodenheimer, Thomas] Univ Calif San Francisco, Sch Med, Dept Family & Community Med, Ctr Excellence Primary Care, San Francisco, CA 94143 USA; [West, David] St Marys Hosp, Grand Junction, CO USA	University of California System; University of California San Francisco	Bodenheimer, T (corresponding author), Univ Calif San Francisco, Sch Med, Dept Family & Community Med, Ctr Excellence Primary Care, San Francisco, CA 94143 USA.							Berenson RA, 2010, NEW ENGL J MED, V363, P101, DOI 10.1056/NEJMp1005588; Gawande A., 2009, NEW YORKER; Medicare Payment Advisory Committee, 2009, REP C MEAS REG VAR S; Nichols L., 2009, GRAND JUNCTION COLOR; WEST D, 2009, MESA COUNTY COLORADO	5	8	8	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2010	363	15					1391	1393		10.1056/NEJMp1008450	http://dx.doi.org/10.1056/NEJMp1008450			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	659NV	20925540				2022-12-01	WOS:000282575100002
J	Galazka, JM; Tian, CG; Beeson, WT; Martinez, B; Glass, NL; Cate, JHD				Galazka, Jonathan M.; Tian, Chaoguang; Beeson, William T.; Martinez, Bruno; Glass, N. Louise; Cate, Jamie H. D.			Cellodextrin Transport in Yeast for Improved Biofuel Production	SCIENCE			English	Article							FUEL ETHANOL-PRODUCTION; SIMULTANEOUS SACCHARIFICATION; FERMENTATION; DEGRADATION; HYDROLYSIS; MECHANISMS; BIOMASS	Fungal degradation of plant biomass may provide insights for improving cellulosic biofuel production. We show that the model cellulolytic fungus Neurospora crassa relies on a high-affinity cellodextrin transport system for rapid growth on cellulose. Reconstitution of the N. crassa cellodextrin transport system in Saccharomyces cerevisiae promotes efficient growth of this yeast on cellodextrins. In simultaneous saccharification and fermentation experiments, the engineered yeast strains more rapidly convert cellulose to ethanol when compared with yeast lacking this system.	[Galazka, Jonathan M.; Cate, Jamie H. D.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Tian, Chaoguang; Glass, N. Louise] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Tian, Chaoguang] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin Airport Econ Area, Tianjin 300308, Peoples R China; [Beeson, William T.; Cate, Jamie H. D.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Martinez, Bruno; Cate, Jamie H. D.] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Cate, JHD (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	jcate@lbl.gov	Galazka, Jonathan Galazka/K-4847-2012; Glass, N. Louise/ABA-7303-2021	Galazka, Jonathan Galazka/0000-0002-4153-0249; 	Energy Biosciences Institute	Energy Biosciences Institute	We thank J. Doudna, M. Marletta, J. Taylor, T. Bruns, and C. Phillips for helpful discussions and comments on the manuscript; M. Toews for help with growth assays; S. Bauer and A. Ibanez for help with analytical methods; and C. Anderson for help with confocal microscopy. This work was supported by funding from the Energy Biosciences Institute to J. H. D. C. and N.L.G. The Regents of the University of California, the authors, and British Petroleum Technology Ventures (through the Energy Biosciences Institute) have submitted a patent for the use of cellodextrin transporters in fermenting organisms for the use of plant biomass.	Bai FW, 2008, BIOTECHNOL ADV, V26, P89, DOI 10.1016/j.biotechadv.2007.09.002; Basso LC, 2008, FEMS YEAST RES, V8, P1155, DOI 10.1111/j.1567-1364.2008.00428.x; BHAT KM, 1987, APPL ENVIRON MICROB, V53, P2175, DOI 10.1128/AEM.53.9.2175-2182.1987; Chauve M, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-3; Doran-Peterson J, 2009, METHODS MOL BIOL, V581, P263, DOI 10.1007/978-1-60761-214-8_17; Drissen RET, 2009, BIOCATAL BIOTRANSFOR, V27, P27, DOI 10.1080/10242420802564358; FREER SN, 1991, APPL ENVIRON MICROB, V57, P655, DOI 10.1128/AEM.57.3.655-659.1991; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Martin F, 2010, NATURE, V464, P1033, DOI 10.1038/nature08867; Noguchi Y, 2009, APPL MICROBIOL BIOT, V85, P141, DOI 10.1007/s00253-009-2236-9; Reifenberger E, 1997, EUR J BIOCHEM, V245, P324, DOI 10.1111/j.1432-1033.1997.00324.x; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Skinner KA, 2004, J IND MICROBIOL BIOT, V31, P401, DOI 10.1007/s10295-004-0159-0; Stephanopoulos G, 2007, SCIENCE, V315, P801, DOI 10.1126/science.1139612; Sun Y, 2002, BIORESOURCE TECHNOL, V83, P1, DOI 10.1016/S0960-8524(01)00212-7; Tian CG, 2009, P NATL ACAD SCI USA, V106, P22157, DOI 10.1073/pnas.0906810106; USDA, 2006, EC FEASIBILITY ETHAN; Voutilainen SP, 2008, BIOTECHNOL BIOENG, V101, P515, DOI 10.1002/bit.21940; Wymelenberg AV, 2010, APPL ENVIRON MICROB, V76, P3599, DOI 10.1128/AEM.00058-10; XIN Z, 1993, ENZYME MICROB TECH, V15, P62, DOI 10.1016/0141-0229(93)90117-K	21	231	246	3	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2010	330	6000					84	86		10.1126/science.1192838	http://dx.doi.org/10.1126/science.1192838			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20829451				2022-12-01	WOS:000282334500039
J	Snippert, HJ; van der Flier, LG; Sato, T; van Es, JH; van den Born, M; Kroon-Veenboer, C; Barker, N; Klein, AM; van Rheenen, J; Simons, BD; Clevers, H				Snippert, Hugo J.; van der Flier, Laurens G.; Sato, Toshiro; van Es, Johan H.; van den Born, Maaike; Kroon-Veenboer, Carla; Barker, Nick; Klein, Allon M.; van Rheenen, Jacco; Simons, Benjamin D.; Clevers, Hans			Intestinal Crypt Homeostasis Results from Neutral Competition between Symmetrically Dividing Lgr5 Stem Cells	CELL			English	Article							MOUSE SMALL-INTESTINE; SELF-RENEWAL; HAIR FOLLICLE; BETA-CATENIN; IN-VITRO; DIFFERENTIATION; DIVISION; MARKER; GENE; IDENTIFICATION	Intestinal stem cells, characterized by high Lgr5 expression, reside between Paneth cells at the small intestinal crypt base and divide every day. We have carried out fate mapping of individual stem cells by generating a multicolor Cre-reporter. As a population, Lgr5(hi) stem cells persist life-long, yet crypts drift toward clonality within a period of 1-6 months. We have collected short- and long-term clonal tracing data of individual Lgr5(hi) cells. These reveal that most Lgr5(hi) cell divisions occur symmetrically and do not support a model in which two daughter cells resulting from an Lgr5(hi) cell division adopt divergent fates (i.e., one Lgr5(hi) cell and one transit-amplifying [TA] cell per division). The cellular dynamics are consistent with a model in which the resident stem cells double their numbers each day and stochastically adopt stem or TA fates. Quantitative analysis shows that stem cell turnover follows a pattern of neutral drift dynamics.	[Snippert, Hugo J.; van der Flier, Laurens G.; Sato, Toshiro; van Es, Johan H.; van den Born, Maaike; Kroon-Veenboer, Carla; Barker, Nick; van Rheenen, Jacco; Clevers, Hans] KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Snippert, Hugo J.; van der Flier, Laurens G.; Sato, Toshiro; van Es, Johan H.; van den Born, Maaike; Kroon-Veenboer, Carla; Barker, Nick; van Rheenen, Jacco; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Klein, Allon M.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Klein, Allon M.; Simons, Benjamin D.] Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Harvard University; Harvard Medical School; University of Cambridge	Clevers, H (corresponding author), KNAW, Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	clevers@hubrecht.eu	Barker, Nick/AAE-9833-2021; van+Es, Johan/ABD-5411-2021; Barker, Nick/AAS-2774-2020; Simons, Benjamin/AAY-8920-2020; Barker, Nick/A-5535-2011; Sato, Toshiro/J-3522-2014; van Rheenen, Jacco/G-3655-2014	Barker, Nick/0000-0003-3566-4475; Simons, Benjamin/0000-0002-3875-7071; Sato, Toshiro/0000-0001-8353-8137; 	Engineering and Physical Sciences Research Council [EP/F032773/1, EP/F043325/1] Funding Source: researchfish; EPSRC [EP/F043325/1, EP/F032773/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; BenNaim E, 1996, PHYS REV E, V53, P3078, DOI 10.1103/PhysRevE.53.3078; BRAMSON M, 1980, Z WAHRSCHEINLICHKEIT, V53, P183, DOI 10.1007/BF01013315; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; CHENG H, 1974, AM J ANAT, V141, P461, DOI 10.1002/aja.1001410403; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Cowan CR, 2004, ANNU REV CELL DEV BI, V20, P427, DOI 10.1146/annurev.cellbio.19.111301.113823; Deng W, 1997, DEV BIOL, V189, P79, DOI 10.1006/dbio.1997.8669; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; GRIFFITHS DFR, 1988, NATURE, V333, P461, DOI 10.1038/333461a0; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Ireland H, 2005, DEV DYNAM, V233, P1332, DOI 10.1002/dvdy.20446; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; Krapivsky PL, 1997, PHYS REV E, V56, P3788, DOI 10.1103/PhysRevE.56.3788; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; LOPEZGARCIA C, 2010, SCIENCE IN PRESS; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; POTTEN CS, 1974, CELL TISSUE KINET, V7, P271, DOI 10.1111/j.1365-2184.1974.tb00907.x; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Quyn AJ, 2010, CELL STEM CELL, V6, P175, DOI 10.1016/j.stem.2009.12.007; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Snippert HJ, 2009, GASTROENTEROLOGY, V136, P2187, DOI 10.1053/j.gastro.2009.03.002; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; WINTON DJ, 1990, P ROY SOC B-BIOL SCI, V241, P13, DOI 10.1098/rspb.1990.0059; WINTON DJ, 1988, NATURE, V333, P463, DOI 10.1038/333463a0; WU FY, 1982, REV MOD PHYS, V54, P235, DOI 10.1103/RevModPhys.54.235; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	40	1267	1290	8	139	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 1	2010	143	1					134	144		10.1016/j.cell.2010.09.016	http://dx.doi.org/10.1016/j.cell.2010.09.016			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	656UC	20887898	Bronze			2022-12-01	WOS:000282362000020
J	Wang, YJ; Deng, XX; Mancarella, S; Hendron, E; Eguchi, S; Soboloff, J; Tang, XAD; Gill, DL				Wang, Youjun; Deng, Xiaoxiang; Mancarella, Salvatore; Hendron, Eunan; Eguchi, Satoru; Soboloff, Jonathan; Tang, Xiang D.; Gill, Donald L.			The Calcium Store Sensor, STIM1, Reciprocally Controls Orai and Ca(V)1.2 Channels	SCIENCE			English	Article							TRPC CHANNELS; CA2+ ENTRY; I-CRAC; ACTIVATION; DOMAINS; CELLS	Calcium signals, pivotal in controlling cell function, can be generated by calcium entry channels activated by plasma membrane depolarization or depletion of internal calcium stores. We reveal a regulatory link between these two channel subtypes mediated by the ubiquitous calcium-sensing STIM proteins. STIM1 activation by store depletion or mutational modification strongly suppresses voltage-operated calcium (Ca(V)1.2) channels while activating store-operated Orai channels. Both actions are mediated by the short STIM-Orai activating region (SOAR) of STIM1. STIM1 interacts with Ca(V)1.2 channels and localizes within discrete endoplasmic reticulum/plasma membrane junctions containing both Ca(V)1.2 and Orai1 channels. Hence, STIM1 interacts with and reciprocally controls two major calcium channels hitherto thought to operate independently. Such coordinated control of the widely expressed Ca(V)1.2 and Orai channels has major implications for Ca2+ signal generation in excitable and nonexcitable cells.	[Wang, Youjun; Deng, Xiaoxiang; Mancarella, Salvatore; Hendron, Eunan; Soboloff, Jonathan; Gill, Donald L.] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; [Wang, Youjun; Deng, Xiaoxiang; Mancarella, Salvatore; Hendron, Eunan; Soboloff, Jonathan; Gill, Donald L.] Temple Univ, Sch Med, Cardiovasc Res Ctr, Philadelphia, PA 19140 USA; [Eguchi, Satoru] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19140 USA; [Tang, Xiang D.] Nankai Univ, Sch Med, Dept Pharmacol, Tianjin 300071, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Nankai University	Gill, DL (corresponding author), Temple Univ, Sch Med, Dept Biochem, 3400 N Broad St, Philadelphia, PA 19140 USA.	dgill@temple.edu	Soboloff, Jonathan/I-6995-2012; Wang, Youjun/H-4016-2013	Soboloff, Jonathan/0000-0001-5192-1297; Wang, Youjun/0000-0003-0961-1716; Deng, Xiaoxiang/0000-0002-7051-9057	NIH [HL55426, AI058173]; Novartis Institutes for Biomedical Research; American Heart Association; NSFC [30871011]; Tianjin S&T Support Project [08ZCKFSH04500]; "973" program [2010CB945001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058173] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Institutes for Biomedical Research; American Heart Association(American Heart Association); NSFC(National Natural Science Foundation of China (NSFC)); Tianjin S&T Support Project; "973" program(National Basic Research Program of China); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Rabbit smooth muscle alpha<INF>1C</INF>, beta<INF>2a</INF>, and alpha<INF>2</INF>-delta<INF>1</INF> DNA were gifts from M. Davis, University of Missouri School of Medicine. This work was supported by NIH grants HL55426 and AI058173 (D. L. G.), a Novartis Institutes for Biomedical Research fellowship (Y.W.), the American Heart Association (J.S.), NSFC 30871011, Tianjin S&T Support Project 08ZCKFSH04500, and "973" program 2010CB945001 (X.P.T.).	Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Berna-Erro A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000522; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; DeHaven WI, 2009, J PHYSIOL-LONDON, V587, P2275, DOI 10.1113/jphysiol.2009.170431; Deng XX, 2009, J BIOL CHEM, V284, P22501, DOI 10.1074/jbc.R109.018655; Grabner M, 1998, P NATL ACAD SCI USA, V95, P1903, DOI 10.1073/pnas.95.4.1903; Hewavitharana T, 2008, J BIOL CHEM, V283, P26252, DOI 10.1074/jbc.M802239200; Hofer AM, 1998, J CELL BIOL, V140, P325, DOI 10.1083/jcb.140.2.325; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Matza D, 2009, IMMUNOL REV, V231, P257, DOI 10.1111/j.1600-065X.2009.00805.x; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Shistik E, 1998, J BIOL CHEM, V273, P17901, DOI 10.1074/jbc.273.28.17901; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Suzuki Y, 2010, MOL IMMUNOL, V47, P640, DOI 10.1016/j.molimm.2009.10.013; Wang YJ, 2008, CLIN EXP PHARMACOL P, V35, P1127, DOI 10.1111/j.1440-1681.2008.05018.x; Wang YJ, 2009, P NATL ACAD SCI USA, V106, P7391, DOI 10.1073/pnas.0900293106; Yuan JP, 2009, CHANNELS, V3, P221, DOI 10.4161/chan.3.4.9198; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhou YD, 2009, J BIOL CHEM, V284, P19164, DOI 10.1074/jbc.C109.010900	27	262	263	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2010	330	6000					105	109		10.1126/science.1191086	http://dx.doi.org/10.1126/science.1191086			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20929813	Green Accepted			2022-12-01	WOS:000282334500046
J	Yu, HJ; Liao, QH; Yuan, YA; Zhou, L; Xiang, NJ; Huai, Y; Guo, XH; Zheng, YD; van Doorn, HR; Farrar, J; Gao, ZC; Feng, ZJ; Wang, Y; Yang, WZ				Yu, Hongjie; Liao, Qiaohong; Yuan, Yuan; Zhou, Lei; Xiang, Nijuan; Huai, Yang; Guo, Xiuhua; Zheng, Yingdong; van Doorn, H. Rogier; Farrar, Jeremy; Gao, Zhancheng; Feng, Zijian; Wang, Yu; Yang, Weizhong			Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NEURAMINIDASE INHIBITOR OSELTAMIVIR; HOSPITALIZED-PATIENTS; RESPIRATORY-FAILURE; INFECTION; THERAPY; A(H1N1); PREVENTION; EFFICACY; SAFETY	Objective To describe the clinical features and effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A(H1N1) virus infection. Design Opportunistic retrospective review of medical charts of patients with confirmed 2009 H1N1 identified through the national surveillance system in China from May to July 2009. Setting Under coordination of the Ministry of Health, local health departments were asked to collect medical records of confirmed patients and send them to the Chinese Centre for Disease Control and Prevention on a voluntary basis as part of the public health response. Population 1291 patients with confirmed 2009 H1N1 infection and available data for chart review. Main outcome measures Demographic characteristics, comorbidities, symptoms and signs, laboratory tests, findings on chest radiography, antiviral treatment, duration of fever, and duration of viral RNA shedding. Results The median age of 1291 patients was 20 years (interquartile range 12-26); 701 (54%) were male. The most common symptoms were fever (820, 64%), cough (864, 67%), sore throat (425, 33%), sputum (239, 19%), and rhinorrhoea (228, 18%). Of 920 patients who underwent chest radiography, 110 (12%) had abnormal findings consistent with pneumonia. Some 983 (76%) patients were treated with oseltamivir from a median of the third day of symptoms (2-4). No patients required admission to the intensive care unit or mechanical ventilation. 2009 H1N1 was shed from one day before onset of symptoms to up to eight days after onset in most (91%) patients, with a median of 5 (3-6) days of shedding after onset. Treatment with oseltamivir significantly protected against subsequent development of radiographically confirmed pneumonia (odds ratio 0.12, 95% confidence interval 0.08 to 0.18), and treatment started within two days of symptom onset reduced the duration of fever and viral RNA shedding. Conclusions Chinese patients with 2009 H1N1 infection predominantly presented with features of uncomplicated, self limiting acute respiratory illness. 2009 H1N1 might be shed longer than seasonal influenza virus. Treatment with oseltamivir was associated with a significantly reduced development of radiographically confirmed pneumonia and a shorter duration of fever and viral RNA shedding. Though these patients benefited from treatment, the findings should be interpreted with caution as the study was retrospective and not all patients underwent chest radiography.	[Yu, Hongjie; Yang, Weizhong] Chinese Ctr Dis Control & Prevent, Beijing 102206, Peoples R China	Chinese Center for Disease Control & Prevention	Yang, WZ (corresponding author), Chinese Ctr Dis Control & Prevent, 155 Changbai Rd, Beijing 102206, Peoples R China.	yuhj@chinacdc.cn; yangwz@chinacdc.cn	Yu, Hongjie/GZK-5351-2022; van Doorn, H Rogier/H-3080-2019; Farrar, Jeremy J./HGA-7610-2022	van Doorn, H Rogier/0000-0002-9807-1821; Zhou, Lei/0000-0002-6640-0774; Farrar, Jeremy/0000-0002-2700-623X	US National Institutes of Health [U19 AI51915]; China-US Collaborative Program on Emerging and Re-emerging Infectious Diseases; South East Asia Infectious Disease Clinical Research Network; Wellcome Trust; Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051915] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China-US Collaborative Program on Emerging and Re-emerging Infectious Diseases; South East Asia Infectious Disease Clinical Research Network; Wellcome Trust(Wellcome TrustEuropean Commission); Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from US National Institutes of Health (Comprehensive International Program for Research on AIDS grant U19 AI51915), the China-US Collaborative Program on Emerging and Re-emerging Infectious Diseases, South East Asia Infectious Disease Clinical Research Network, and Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam. None of the funders had any role in the study design and the collection, analysis, and interpretation of data, or in the writing of the article and the decision to submit it for publication. The researchers confirm their independence from funders and sponsors. All authors had full access to all data included in the study and are jointly responsible for the integrity of the data and accuracy of data analyses.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; [Anonymous], 2009, GAZ BOSNIA HERZEGOVI, V43; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; *CDCP, 2009, UPD INT REC US ANT M; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1071; Davies A, 2009, JAMA-J AM MED ASSOC, V302, P1888, DOI 10.1001/jama.2009.1535; De Serres G, 2010, EMERG INFECT DIS, V16, P783, DOI 10.3201/eid1605.091894; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Fiore Anthony E., 2008, Morbidity and Mortality Weekly Report, V57, P1; FRANK AL, 1981, J INFECT DIS, V144, P433, DOI 10.1093/infdis/144.5.433; HALL CB, 1975, PEDIATRICS, V55, P673; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hanshaoworakul W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006051; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; KLIMOV AI, 1995, J INFECT DIS, V172, P1352, DOI 10.1093/infdis/172.5.1352; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Lee N, 2008, CLIN INFECT DIS, V46, P1323, DOI 10.1086/533477; Lee N, 2007, ANTIVIR THER, V12, P501; Leekha S, 2007, INFECT CONT HOSP EP, V28, P1071, DOI 10.1086/520101; Li IW, 2010, CHEST, V137, P759, DOI 10.1378/chest.09-3072; Ling LM, 2010, CLIN INFECT DIS, V50, P963, DOI 10.1086/651083; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; *MIN HLTH CHIN, 2009, DISCH CRIT HUM INF P; *MIN HLTH CHIN, 2009, CLIN MAN HUM INF PAN; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Nicholson K G, 1992, Semin Respir Infect, V7, P26; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Nicoll A, 2010, EUROSURVEILLANCE, V15; Ong AK, 2007, J INFECT DIS, V196, P181, DOI 10.1086/518939; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Rello J, 2009, CRIT CARE, V13, DOI 10.1186/cc8044; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Uyeki Tim, 2009, N Engl J Med, V361, pe110, DOI 10.1056/NEJMopv0910738; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; WHO, 2009, CDC PROT REALT RTPCR; WHO, CLIN MAN HUM INF PAN; Witkop CT, 2010, AM J PREV MED, V38, P121, DOI 10.1016/j.amepre.2009.10.005; World Health Organization, 2010, PAND H1N1 2009 UPD 1; 2009, N ENGL J MED, V260, P2605	43	75	80	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 28	2010	341								c4779	10.1136/bmj.c4779	http://dx.doi.org/10.1136/bmj.c4779			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	659MF	20876641	Green Published, hybrid			2022-12-01	WOS:000282569900004
J	Litvak, E; Pronovost, PJ				Litvak, Eugene; Pronovost, Peter J.			Rethinking Rapid Response Teams	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Litvak, Eugene] Inst Healthcare Optimizat, Newton, MA 02459 USA; [Litvak, Eugene] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Litvak, E (corresponding author), Inst Healthcare Optimizat, 7 Wells Ave, Newton, MA 02459 USA.	elitvak@ihoptimize.org						Baker DR, 2009, CRIT CARE MED, V37, P2882, DOI 10.1097/CCM.0b013e3181b01caf; Berwick DM, 2006, JAMA-J AM MED ASSOC, V295, P324, DOI 10.1001/jama.295.3.324; BUTTERFIELD S, 2007, ACP HOSP         DEC; DeVita MA, 2006, CRIT CARE MED, V34, P2463, DOI 10.1097/01.CCM.0000235743.38172.6E; Gross D., 2008, FUNDAMENTALS QUEUING; Litvak E., 2009, MANAGING PATIENT FLO; Litvak E, 2005, JT COMM J QUAL PATIE, V31, P330, DOI 10.1016/S1553-7250(05)31044-0; Organisation for Economic Co-operation and Development, OECD HLTH DAT 2010 S; Ranji SR, 2007, J HOSP MED, V2, P422, DOI 10.1002/jhm.238; Sakai T, 2009, J ANESTH, V23, P403, DOI 10.1007/s00540-009-0778-8	10	58	73	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2010	304	12					1375	1376		10.1001/jama.2010.1385	http://dx.doi.org/10.1001/jama.2010.1385			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	652LK	20858881				2022-12-01	WOS:000282007900021
J	Sasai, M; Linehan, MM; Iwasaki, A				Sasai, Miwa; Linehan, Melissa M.; Iwasaki, Akiko			Bifurcation of Toll-Like Receptor 9 Signaling by Adaptor Protein 3	SCIENCE			English	Article							INTERFERON-ALPHA PRODUCTION; I INTERFERON; DENDRITIC CELLS; AP-3 ADAPTER; INDUCTION; ACTIVATION; TLR9; TOLL-LIKE-RECEPTOR-9; LOCALIZATION; TRAF3	Endosomal Toll-like receptors (TLRs) 7 and 9 recognize viral pathogens and induce signals leading to the activation of nuclear factor kappa B (NF-kappa B)-dependent proinflammatory cytokines and interferon regulatory factor 7 (IRF7)-dependent type I interferons (IFNs). Recognition of viral nucleic acids by TLR9 requires its cleavage in the endolysosomal compartment. Here, we show that TLR9 signals leading to the activation of type I IFN, but not proinflammatory cytokine genes, require TLR9 trafficking from endosomes to a specialized lysosome-related organelle. Furthermore, we identify adapter protein-3 as the protein complex responsible for the trafficking of TLR9 to this subcellular compartment. Our results reveal an intracellular mechanism for bifurcation of TLR9 signals by selective receptor trafficking within the endosomal system.	[Sasai, Miwa; Linehan, Melissa M.; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Yale University	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	akiko.iwasaki@yale.edu	Iwasaki, Akiko/Z-1591-2019	Iwasaki, Akiko/0000-0002-7824-9856; Sasai, Miwa/0000-0001-6440-3958	NIH [AI054359, AI081884, AI064705]; Uehara Memorial Foundation; Gilead Sciences; Burroughs Wellcome Investigators in Pathogenesis of Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054359, R01AI064705, R01AI081884] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); Gilead Sciences(Gilead Sciences); Burroughs Wellcome Investigators in Pathogenesis of Infectious Disease(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Medzhitov for critical reading of the manuscript and W. Mothes for helpful discussion. This work is supported by NIH grants to A. I. (AI054359, AI081884, and AI064705). M. S. is a Japan Society for the Promotion of Science fellow and a recipient of Uehara Memorial Foundation fellowship. A. I. acknowledges support by Gilead Sciences. A. I. is a recipient of the Burroughs Wellcome Investigators in Pathogenesis of Infectious Disease.	Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; DE MATTEIS MA, 2004, NAT CELL BIOL, V6, P487; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Gotoh K, 2010, J EXP MED, V207, P721, DOI 10.1084/jem.20091776; Guiducci C, 2006, J EXP MED, V203, P1999, DOI 10.1084/jem.20060401; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Ikonomov OC, 2006, AM J PHYSIOL-CELL PH, V291, pC393, DOI 10.1152/ajpcell.00019.2006; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Shinohara ML, 2006, NAT IMMUNOL, V7, P498, DOI 10.1038/ni1327; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Watarai H, 2008, P NATL ACAD SCI USA, V105, P2993, DOI 10.1073/pnas.0710351105	29	257	260	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2010	329	5998					1530	1534		10.1126/science.1187029	http://dx.doi.org/10.1126/science.1187029			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650RK	20847273	Green Accepted			2022-12-01	WOS:000281869000044
J	Aguirre, A; Rubio, ME; Gallo, V				Aguirre, Adan; Rubio, Maria E.; Gallo, Vittorio			Notch and EGFR pathway interaction regulates neural stem cell number and self-renewal	NATURE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; GROWTH-FACTOR RECEPTOR; SUBVENTRICULAR ZONE; PROGENITOR CELLS; IN-VIVO; INTRACELLULAR DOMAIN; MAMMALIAN BRAIN; PROLIFERATION; NICHE; VISUALIZATION	Specialized cellular microenvironments, or 'niches', modulate stem cell properties, including cell number, self-renewal and fate decisions(1,2). In the adult brain, niches that maintain a source of neural stem cells (NSCs) and neural progenitor cells (NPCs) are the subventricular zone (SVZ) of the lateral ventricle and the dentate gyrus of the hippocampus(3-5). The size of the NSC population of the SVZ at any time is the result of several ongoing processes, including self-renewal, cell differentiation, and cell death. Maintaining the balance between NSCs and NPCs in the SVZ niche is critical to supply the brain with specific neural populations, both under normal conditions or after injury. A fundamental question relevant to both normal development and to cell-based repair strategies in the central nervous system is how the balance of different NSC and NPC populations is maintained in the niche. EGFR (epidermal growth factor receptor) and Notch signalling pathways have fundamental roles during development of multicellular organisms(6). In Drosophila and in Caenorhabditis elegans these pathways may have either cooperative or antagonistic functions(7-9). In the SVZ, Notch regulates NSC identity and self-renewal, whereas EGFR specifically affects NPC proliferation and migration(10-13). This suggests that interplay of these two pathways may maintain the balance between NSC and NPC numbers. Here we show that functional cell-cell interaction between NPCs and NSCs through EGFR and Notch signalling has a crucial role in maintaining the balance between these cell populations in the SVZ. Enhanced EGFR signalling in vivo results in the expansion of the NPC pool, and reduces NSC number and self-renewal. This occurs through a non-cell-autonomous mechanism involving EGFR-mediated regulation of Notch signalling. Our findings define a novel interaction between EGFR and Notch pathways in the adult SVZ, and thus provide a mechanism for NSC and NPC pool maintenance.	[Aguirre, Adan; Gallo, Vittorio] Childrens Natl Med Ctr, Neurosci Res Ctr, Washington, DC 20010 USA; [Rubio, Maria E.] Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA 15261 USA	Children's National Health System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gallo, V (corresponding author), Childrens Natl Med Ctr, Neurosci Res Ctr, Washington, DC 20010 USA.	vgallo@cnmcresearch.org			NIH [R01NS045702, R01NS056427, K99NS057944, ROO NS057944-03, R01DC006881]; NIH IDDRC [P30HD40677]; NSF [DBI-0420580]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD040677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045702, K99NS057944, R00NS057944, R01NS056427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006881] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH IDDRC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank N. Ratner for the Cnp-hEGFR mice. We are thankful to T. Hawley for technical advice in all FACS sorting experiments. We are grateful to J. Corbin and T. Haydar for critically reading this manuscript, and to all our colleagues at the Center for Neuroscience Research for discussion and support. We are thankful to N. Gaiano for discussion, for providing reagents and for his continuous advice on this project. We thank G. Corfas, A. Israel, C. L. Cepko, R. Kopan, R. Grosschedl, N. Gaiano and R. Kageyama for the gift of CBF-1, Hes1-GFP, Hes1-dsRED, Notch constructs, Dll-GFP, CBFRE-EGFP and Hes5-GFP, respectively. This work was supported by NIH R01NS045702 and R01NS056427 (V. G.), K99NS057944 (A. A.), ROO NS057944-03 (A. A.) and by NIH IDDRC P30HD40677 (V. G.). Electron microscopy was performed at the University of Connecticut, Department of Physiology and Neurobiology, with funding from NIH R01DC006881 to M.E.R., and from NSF DBI-0420580 for funds to purchase the Tecnai 12 Biotwin electron microscope.	Aguirre A, 2005, J NEUROSCI, V25, P11092, DOI 10.1523/JNEUROSCI.2981-05.2005; Aguirre A, 2004, J NEUROSCI, V24, P10530, DOI 10.1523/JNEUROSCI.3572-04.2004; Aguirre A, 2007, NEURON GLIA BIOL, V3, P209, DOI 10.1017/S1740925X08000082; Aguirre A, 2007, NAT NEUROSCI, V10, P990, DOI 10.1038/nn1938; Alexson TO, 2006, DEV NEUROSCI-BASEL, V28, P34, DOI 10.1159/000090751; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Chapman G, 2006, J CELL BIOL, V175, P535, DOI 10.1083/jcb.200602009; Colak D, 2008, J NEUROSCI, V28, P434, DOI 10.1523/JNEUROSCI.4374-07.2008; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Galceran J, 2004, GENE DEV, V18, P2718, DOI 10.1101/gad.1249504; Hasson P, 2005, NAT GENET, V37, P101, DOI 10.1038/ng1486; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Jablonska B, 2007, J CELL BIOL, V179, P1231, DOI 10.1083/jcb.200702031; Kohyama J, 2005, DEV BIOL, V286, P311, DOI 10.1016/j.ydbio.2005.08.003; Kolev V, 2005, FEBS LETT, V579, P5798, DOI 10.1016/j.febslet.2005.09.042; Kumar JP, 2001, DEVELOPMENT, V128, P2689; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Lillien L, 2000, DEVELOPMENT, V127, P4993; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Ling BC, 2005, CANCER CELL, V7, P65, DOI 10.1016/j.ccr.2004.10.016; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; Mercier F, 2002, J COMP NEUROL, V451, P170, DOI 10.1002/cne.10342; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Morshead CM, 1998, DEVELOPMENT, V125, P2251; Ohtsuka T, 2006, MOL CELL NEUROSCI, V31, P109, DOI 10.1016/j.mcn.2005.09.006; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Steiner B, 2006, GLIA, V54, P805, DOI 10.1002/glia.20407; Sundaram MV, 2005, GENE DEV, V19, P1825, DOI 10.1101/gad.1330605; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Wehner T, 2003, J NEUROSCI, V23, P5004; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639	38	330	350	1	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 16	2010	467	7313					323	U101		10.1038/nature09347	http://dx.doi.org/10.1038/nature09347			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650CF	20844536	Green Accepted			2022-12-01	WOS:000281824900038
J	Liao, L; Lin, YC; Bao, MQ; Cheng, R; Bai, JW; Liu, YA; Qu, YQ; Wang, KL; Huang, Y; Duan, XF				Liao, Lei; Lin, Yung-Chen; Bao, Mingqiang; Cheng, Rui; Bai, Jingwei; Liu, Yuan; Qu, Yongquan; Wang, Kang L.; Huang, Yu; Duan, Xiangfeng			High-speed graphene transistors with a self-aligned nanowire gate	NATURE			English	Article							EPITAXIAL GRAPHENE; DIELECTRICS; MOBILITY; PHASE	Graphene has attracted considerable interest as a potential new electronic material(1-11). With its high carrier mobility, graphene is of particular interest for ultrahigh-speed radio-frequency electronics(12-18). However, conventional device fabrication processes cannot readily be applied to produce high-speed graphene transistors because they often introduce significant defects into the monolayer of carbon lattices and severely degrade the device performance(19-21). Here we report an approach to the fabrication of high-speed graphene transistors with a self-aligned nanowire gate to prevent such degradation. A Co(2)Si-Al(2)O(3) core-shell nanowire is used as the gate, with the source and drain electrodes defined through a self-alignment process and the channel length defined by the nanowire diameter. The physical assembly of the nanowire gate preserves the high carrier mobility in graphene, and the self-alignment process ensures that the edges of the source, drain and gate electrodes are automatically and precisely positioned so that no overlapping or significant gaps exist between these electrodes, thus minimizing access resistance. It therefore allows for transistor performance not previously possible. Graphene transistors with a channel length as low as 140 nm have been fabricated with the highest scaled on-current (3.32 mA mu m(-1)) and transconductance (1.27 mS mu m(-1)) reported so far. Significantly, on-chip microwave measurements demonstrate that the self-aligned devices have a high intrinsic cut-off (transit) frequency of f(T) = 100-300 GHz, with the extrinsic f(T) (in the range of a few gigahertz) largely limited by parasitic pad capacitance. The reported intrinsic f(T) of the graphene transistors is comparable to that of the very best high-electron-mobility transistors with similar gate lengths(10).	[Liao, Lei; Qu, Yongquan; Duan, Xiangfeng] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Lin, Yung-Chen; Cheng, Rui; Bai, Jingwei; Liu, Yuan; Huang, Yu] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA; [Bao, Mingqiang; Wang, Kang L.] Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90095 USA; [Wang, Kang L.; Huang, Yu] Univ Calif Los Angeles, Calif Nanosyst Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Duan, XF (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	xduan@chem.ucla.edu	Qu, Yongquan/A-7203-2011; Duan, Xiangfeng/AAQ-9674-2020; Bai, Jingwei/G-4245-2012; liao, lei/O-4052-2014; Lin, Yung-Chen/G-7333-2012; Liu, Yuan/G-4834-2016; Huang, Yu/AAZ-9747-2020; Duan, Xiangfeng/E-7522-2011	Duan, Xiangfeng/0000-0002-4321-6288; Liu, Yuan/0000-0002-0024-9290; Huang, Yu/0000-0003-1793-0741; Duan, Xiangfeng/0000-0002-4321-6288; Qu, Yongquan/0000-0002-6202-1929	NSF [0956171]; NIH [1DP2OD004342-01]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004342] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Jooyaie and S. Martin for discussions. We also acknowledge the Electron Imaging Center for Nanomachines at UCLA for TEM technical support and the Nanoelectronics Research Facility at UCLA for device fabrication technical support. X.D. acknowledges financial support by the NSF CAREER award 0956171 and the NIH Director's New Innovator Award Program, part of the NIH Roadmap for Medical Research, through grant number 1DP2OD004342-01.	[Anonymous], 2007, PHYS SEMICONDUCTOR D; Avouris P, 2007, NAT NANOTECHNOL, V2, P605, DOI 10.1038/nnano.2007.300; Berger C, 2006, SCIENCE, V312, P1191, DOI 10.1126/science.1125925; Bolotin KI, 2008, SOLID STATE COMMUN, V146, P351, DOI 10.1016/j.ssc.2008.02.024; Bunch JS, 2005, NANO LETT, V5, P287, DOI 10.1021/nl048111+; Farmer DB, 2009, NANO LETT, V9, P4474, DOI 10.1021/nl902788u; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Jeon DY, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.091601; Kim DH, 2008, IEEE ELECTR DEVICE L, V29, P830, DOI 10.1109/LED.2008.2000794; Lee BK, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2928228; Lemme MC, 2007, IEEE ELECTR DEVICE L, V28, P282, DOI 10.1109/LED.2007.891668; Liao L, 2010, ADV MATER, V22, P1941, DOI 10.1002/adma.200904415; Liao L, 2010, NANO LETT, V10, P1917, DOI 10.1021/nl100840z; Liao L, 2010, P NATL ACAD SCI USA, V107, P6711, DOI 10.1073/pnas.0914117107; Lin YM, 2010, SCIENCE, V327, P662, DOI 10.1126/science.1184289; Lin YM, 2010, IEEE ELECTR DEVICE L, V31, P68, DOI 10.1109/LED.2009.2034876; Lin YM, 2009, NANO LETT, V9, P422, DOI 10.1021/nl803316h; MERIC I, 2008, P EL DEV M 2008, DOI DOI 10.1109/IEDM.2008.4796738; Meric I, 2008, NAT NANOTECHNOL, V3, P654, DOI 10.1038/nnano.2008.268; Miao F, 2007, SCIENCE, V317, P1530, DOI 10.1126/science.1144359; Moon JS, 2009, IEEE ELECTR DEVICE L, V30, P650, DOI 10.1109/LED.2009.2020699; Murali R, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3147183; Ni ZH, 2008, ACS NANO, V2, P1033, DOI 10.1021/nn800031m; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Schwierz F, 2010, NAT NANOTECHNOL, V5, P487, DOI [10.1038/NNANO.2010.89, 10.1038/nnano.2010.89]; Seo K, 2009, ACS NANO, V3, P1145, DOI 10.1021/nn900191g; Wang XR, 2008, J AM CHEM SOC, V130, P8152, DOI 10.1021/ja8023059; Xuan Y, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2828338; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	30	1032	1080	16	778	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 16	2010	467	7313					305	308		10.1038/nature09405	http://dx.doi.org/10.1038/nature09405			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650CF	20811365	Green Accepted			2022-12-01	WOS:000281824900034
J	Baratz, KH; Tosakulwong, N; Ryu, E; Brown, WL; Branham, K; Chen, W; Tran, KD; Schmid-Kubista, KE; Heckenlively, JR; Swaroop, A; Abecasis, G; Bailey, KR; Edwards, AO				Baratz, Keith H.; Tosakulwong, Nirubol; Ryu, Euijung; Brown, William L.; Branham, Kari; Chen, Wei; Tran, Khoa D.; Schmid-Kubista, Katharina E.; Heckenlively, John R.; Swaroop, Anand; Abecasis, Goncalo; Bailey, Kent R.; Edwards, Albert O.			E2-2 Protein and Fuchs's Corneal Dystrophy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SNOWFLAKE VITREORETINAL DEGENERATION; TYROSINE-PHOSPHATASE-GAMMA; ENDOTHELIAL DYSTROPHY; MACULAR DEGENERATION; TRANSCRIPTION FACTOR; MISSENSE MUTATIONS; IN-SITU; LINKAGE; FAMILY; EXPRESSION	BACKGROUND Fuchs's corneal dystrophy (FCD) is a leading cause of corneal transplantation and affects 5% of persons in the United States who are over the age of 40 years. Clinically visible deposits called guttae develop under the corneal endothelium in patients with FCD. A loss of endothelial cells and deposition of an abnormal extracellular matrix are observed microscopically. In advanced disease, the cornea swells and becomes cloudy because the remaining endothelial cells are not sufficient to keep the cornea dehydrated and clear. Although rare genetic variation that contributes to both early-onset and typical late-onset forms of FCD has been identified, to our knowledge, no common variants have been reported. METHODS We performed a genomewide association study and replicated the most significant observations in a second, independent group of subjects. RESULTS Alleles in the transcription factor 4 gene (TCF4), encoding a member of the E-protein family (E2-2), were associated with typical FCD (P = 2.3x10(-26)). The association increased the odds of having FCD by a factor of 30 for persons with two copies of the disease variants (homozygotes) and discriminated between case subjects and control subjects with about 76% accuracy. At least two regions of the TCF4 locus were associated independently with FCD. Alleles in the gene encoding protein tyrosine phosphatase receptor type G (PTPRG) were associated with FCD (P = 4.0x10(-7)), but the association did not reach genomewide significance. CONCLUSIONS Genetic variation in TCF4 contributes to the development of FCD. (Funded by the National Eye Institute and others.)	[Tran, Khoa D.; Edwards, Albert O.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Baratz, Keith H.; Brown, William L.; Schmid-Kubista, Katharina E.] Mayo Clin, Dept Ophthalmol, Rochester, MN USA; [Tosakulwong, Nirubol; Ryu, Euijung; Bailey, Kent R.] Mayo Clin, Dept Biomed Stat & Informat, Rochester, MN USA; [Branham, Kari; Heckenlively, John R.] Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Chen, Wei; Abecasis, Goncalo] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Swaroop, Anand] NEI, Bethesda, MD 20892 USA	University of Oregon; Mayo Clinic; Mayo Clinic; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Edwards, AO (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	edwardsa@uoregon.edu	Brown, William/GXN-2777-2022; Abecasis, Goncalo R/B-7840-2010; Chen, Wei/AAX-5994-2020; Branham, Kari/AAA-8336-2022	Chen, Wei/0000-0001-7196-8703; Branham, Kari/0000-0002-2492-254X; Swaroop, Anand/0000-0002-1975-1141; Abecasis, Goncalo/0000-0003-1509-1825	National Institutes of Health [EY014467, EY016862, HHSN268200782096C]; Foundation Fighting Blindness; American Health Assistance Foundation; Research to Prevent Blindness; Max Kade Foundation; NATIONAL EYE INSTITUTE [R01EY016862, R01EY014467, ZIAEY000475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); American Health Assistance Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Max Kade Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by grants from the National Institutes of Health (EY014467, EY016862, and HHSN268200782096C), the Foundation Fighting Blindness, the American Health Assistance Foundation, Research to Prevent Blindness, and the Max Kade Foundation.	Afshari NA, 2009, INVEST OPHTH VIS SCI, V50, P1093, DOI 10.1167/iovs.08-1839; Amiel J, 2007, AM J HUM GENET, V80, P988, DOI 10.1086/515582; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beltran PJ, 2003, FRONT BIOSCI, V8, pD87, DOI 10.2741/941; Biswas S, 2001, HUM MOL GENET, V10, P2415, DOI 10.1093/hmg/10.21.2415; Bouyain S, 2010, P NATL ACAD SCI USA, V107, P2443, DOI 10.1073/pnas.0911235107; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Engler C, 2010, AM J OPHTHALMOL, V149, P194, DOI 10.1016/j.ajo.2009.09.009; EPHRUSSI A, 1985, SCIENCE, V227, P134, DOI 10.1126/science.3917574; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; Flora A, 2007, P NATL ACAD SCI USA, V104, P15382, DOI 10.1073/pnas.0707456104; Hecker LA, 2010, HUM MOL GENET, V19, P209, DOI 10.1093/hmg/ddp472; Hejtmancik JF, 2008, AM J HUM GENET, V82, P174, DOI 10.1016/j.ajhg.2007.08.002; HOGAN MJ, 1974, AM J OPHTHALMOL, V78, P363, DOI 10.1016/0002-9394(74)90224-4; Joyce NC, 1996, INVEST OPHTH VIS SCI, V37, P1566; Jurkunas UV, 2008, INVEST OPHTH VIS SCI, V49, P2956, DOI 10.1167/iovs.07-1529; Kolligs FT, 2002, CANCER CELL, V1, P145, DOI 10.1016/S1535-6108(02)00035-1; KRACHMER JH, 1978, ARCH OPHTHALMOL-CHIC, V96, P2036, DOI 10.1001/archopht.1978.03910060424004; LAING RA, 1984, OPHTHALMOLOGY, V91, P1129; Lee MM, 2003, OPHTHALMOLOGY, V110, P2418, DOI 10.1016/S0161-6420(03)00828-5; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Liu SL, 2004, ONCOGENE, V23, P1256, DOI 10.1038/sj.onc.1207235; Liu YQ, 2008, DEVELOPMENT, V135, P579, DOI 10.1242/dev.007047; LORENZETTI DW, 1967, AM J OPHTHALMOL, V64, P1155, DOI 10.1016/0002-9394(67)93073-5; McGowan SL, 2007, MOL VIS, V13, P1984; Moshirfar M, 2005, J CATARACT REFR SURG, V31, P2281, DOI 10.1016/j.jcrs.2004.05.061; MURRE C, 1994, BBA-GENE STRUCT EXPR, V1218, P129, DOI 10.1016/0167-4781(94)90001-9; Ratcliffe CF, 2000, NAT NEUROSCI, V3, P437, DOI 10.1038/74805; Riazuddin SA, 2010, AM J HUM GENET, V86, P45, DOI 10.1016/j.ajhg.2009.12.001; Riazuddin SA, 2009, INVEST OPHTH VIS SCI, V50, P5667, DOI 10.1167/iovs.09-3764; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Skerjanc IS, 1996, J BIOL CHEM, V271, P3555, DOI 10.1074/jbc.271.7.3555; Sobrado VR, 2009, J CELL SCI, V122, P1014, DOI 10.1242/jcs.028241; Sundin OH, 2006, INVEST OPHTH VIS SCI, V47, P140, DOI 10.1167/iovs.05-0578; Sundin OH, 2006, INVEST OPHTH VIS SCI, V47, P3919, DOI 10.1167/iovs.05-1619; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; van Niekerk CC, 1999, CANCER LETT, V137, P61, DOI 10.1016/S0304-3835(98)00344-9; Vithana EN, 2008, HUM MOL GENET, V17, P656, DOI 10.1093/hmg/ddm337; Wang Z, 2007, OPHTHALMOLOGY, V114, P1453, DOI 10.1016/j.ophtha.2006.10.049; Zhang Cheng, 2006, Trans Am Ophthalmol Soc, V104, P85	42	191	200	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 9	2010	363	11					1016	1024		10.1056/NEJMoa1007064	http://dx.doi.org/10.1056/NEJMoa1007064			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	647HS	20825314				2022-12-01	WOS:000281609700005
J	Liu, HL; Juo, ZS; Shim, AHR; Focia, PJ; Chen, XY; Garcia, KC; He, XL				Liu, Heli; Juo, Z. Sean; Shim, Ann Hye-Ryong; Focia, Pamela J.; Chen, Xiaoyan; Garcia, K. Christopher; He, Xiaolin			Structural Basis of Semaphorin-Plexin Recognition and Viral Mimicry from Sema7A and A39R Complexes with PlexinC1	CELL			English	Article							HIGH-LEVEL EXPRESSION; CRYSTAL-STRUCTURE; MOLECULAR-BIOLOGY; BIVALENT BINDING; KIT RECEPTOR; DIMERIZATION; INTEGRINS; FAMILY; DOMAIN; 7A	Repulsive signaling by Semaphorins and Plexins is crucial for the development and homeostasis of the nervous, immune, and cardiovascular systems. Sema7A acts as both an immune and a neural Semaphorin through PlexinC1, and A39R is a Sema7A mimic secreted by smallpox virus. We report the structures of Sema7A and A39R complexed with the Semaphorin-binding module of PlexinC1. Both structures show two PlexinC1 molecules symmetrically bridged by Semaphorin dimers, in which the Semaphorin and PlexinC1 beta propellers interact in an edge-on, orthogonal orientation. Both binding interfaces are dominated by the insertion of the Semaphorin's 4c-4d loop into a deep groove in blade 3 of the PlexinC1 propeller. A39R appears to achieve Sema7A mimicry by preserving key Plexin-binding determinants seen in the mammalian Sema7A complex that have evolved to achieve higher affinity binding to the host-derived PlexinC1. The complex structures support a conserved Semaphorin-Plexin recognition mode and suggest that Plexins are activated by dimerization.	[Liu, Heli; Shim, Ann Hye-Ryong; Focia, Pamela J.; Chen, Xiaoyan; He, Xiaolin] Northwestern Univ, Feinberg Sch Med, Dept Biol Chem & Mol Pharmacol, Chicago, IL 60611 USA; [Juo, Z. Sean; Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Juo, Z. Sean; Garcia, K. Christopher] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Juo, Z. Sean; Garcia, K. Christopher] Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA	Northwestern University; Feinberg School of Medicine; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	He, XL (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Biol Chem & Mol Pharmacol, Searle 8-417,303 E Chicago Ave, Chicago, IL 60611 USA.	x-he@northwestern.edu			NIH [1R01GM07805, NIH-R01-AI51321]; R.H. Lurie Comprehensive Cancer Center of Northwestern University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098259, R01GM078055] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); R.H. Lurie Comprehensive Cancer Center of Northwestern University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at the LS-CAT beamlines at APS and the staffs of ALS and SSRL for the support in X-ray data collection. We also thank L. Colf, and N. Goriatcheva for help with the expression of A39R. X.H. is supported by the NIH grant 1R01GM07805, and K.C.G. is an Investigator of the Howard Hughes Medical Institute and is supported by NIH-R01-AI51321. The Structural Biology Facility is supported by the R.H. Lurie Comprehensive Cancer Center of Northwestern University.	Antipenko A, 2003, NEURON, V39, P589, DOI 10.1016/S0896-6273(03)00502-6; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bork P, 1999, TRENDS BIOCHEM SCI, V24, P261, DOI 10.1016/S0968-0004(99)01416-4; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; Dukkipati A, 2008, PROTEIN EXPRES PURIF, V62, P160, DOI 10.1016/j.pep.2008.08.004; Gewurz BE, 2001, CURR OPIN IMMUNOL, V13, P442, DOI 10.1016/S0952-7915(00)00239-9; Goodman CS, 1999, CELL, V97, P551, DOI 10.1016/S0092-8674(00)80766-7; He HW, 2009, P NATL ACAD SCI USA, V106, P15610, DOI 10.1073/pnas.0906923106; He XL, 2006, J MOL BIOL, V361, P698, DOI 10.1016/j.jmb.2006.06.060; He Zhigang, 2002, Sci STKE, V2002, pre1, DOI 10.1126/stke.2002.119.re1; Holmes S, 2002, SCAND J IMMUNOL, V56, P270, DOI 10.1046/j.1365-3083.2002.01129.x; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; KOLLER KJ, 1992, CIRCULATION, V86, P1081, DOI 10.1161/01.CIR.86.4.1081; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Koppel AM, 1997, NEURON, V19, P531, DOI 10.1016/S0896-6273(00)80369-4; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Lemmon MA, 1997, J BIOL CHEM, V272, P6311, DOI 10.1074/jbc.272.10.6311; LEV S, 1992, J BIOL CHEM, V267, P15970; Love CA, 2003, NAT STRUCT BIOL, V10, P843, DOI 10.1038/nsb977; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Scott GA, 2009, J INVEST DERMATOL, V129, P954, DOI 10.1038/jid.2008.329; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; Suzuki K, 2008, NAT IMMUNOL, V9, P17, DOI 10.1038/ni1553; Suzuki K, 2007, NATURE, V446, P680, DOI 10.1038/nature05652; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tong Y, 2007, J BIOL CHEM, V282, P37215, DOI 10.1074/jbc.M703800200; Tong YF, 2009, J BIOL CHEM, V284, P35962, DOI 10.1074/jbc.M109.056275; Uniewicz KA, 2008, FRONT BIOSCI-LANDMRK, V13, P4339, DOI 10.2741/3008; Waimey KE, 2006, NEUROSCIENTIST, V12, P398, DOI 10.1177/1073858406292631; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Xu XM, 1998, J BIOL CHEM, V273, P22428, DOI 10.1074/jbc.273.35.22428; Yamada A, 1999, J IMMUNOL, V162, P4094	46	100	109	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2010	142	5					749	761		10.1016/j.cell.2010.07.040	http://dx.doi.org/10.1016/j.cell.2010.07.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	646FL	20727575	Bronze, Green Accepted			2022-12-01	WOS:000281523200018
J	Suganuma, T; Mushegian, A; Swanson, SK; Abmayr, SM; Florens, L; Washburn, MP; Workman, JL				Suganuma, Tamaki; Mushegian, Arcady; Swanson, Selene K.; Abmayr, Susan M.; Florens, Laurence; Washburn, Michael P.; Workman, Jerry L.			The ATAC Acetyltransferase Complex Coordinates MAP Kinases to Regulate JNK Target Genes	CELL			English	Article							ACTIVATED PROTEIN-KINASE; C-JUN PROMOTER; MOLYBDOPTERIN SYNTHASE; DNA INTERACTIONS; STRESS; TRANSCRIPTION; OSMOSTRESS; HOG1; EXPRESSION; MISSHAPEN	In response to extracellular cues, signal transduction activates downstream transcription factors like c-Jun to induce expression of target genes. We demonstrate that the ATAC (Ada two A containing) histone acetyltransferase (HAT) complex serves as a transcriptional cofactor for c-Jun at the Jun N-terminal kinase (JNK) target genes Jra and chick-adee. ATAC subunits are required for c-Jun occupancy of these genes and for H4K16 acetylation at the Jra enhancer, promoter, and transcribed sequences. Under conditions of osmotic stress, ATAC colocalizes with c-Jun, recruits the upstream kinases Misshapen, MKK4, and JNK, and suppresses further activation of JNK. Relocalization of these MAPKs and suppression of JNK activation by ATAC are dependent on the CG10238 subunit of ATAC. Thus, ATAC governs the transcriptional response to MAP kinase signaling by serving as both a coactivator of transcription and as a suppressor of upstream signaling.	[Suganuma, Tamaki; Mushegian, Arcady; Swanson, Selene K.; Abmayr, Susan M.; Florens, Laurence; Washburn, Michael P.; Workman, Jerry L.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Mushegian, Arcady] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66160 USA; [Swanson, Selene K.; Abmayr, Susan M.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Workman, JL (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	jlw@stowers.org	Mushegian, Arcady/ABF-5387-2021	Mushegian, Arcady/0000-0002-6809-9225; Florens, Laurence/0000-0002-9310-6650; Washburn, Michael/0000-0001-7568-2585	Stowers Institute for Medical Research; Workman Lab; Zeitlinger Lab; Conaway Lab; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047867] Funding Source: NIH RePORTER	Stowers Institute for Medical Research; Workman Lab; Zeitlinger Lab; Conaway Lab; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Workman Lab members, Bjoern Gaertner in the Zeitlinger Lab, and Hidehisa Takahashi in the Conaway Lab for advice and support during this project. This research was supported by the Stowers Institute for Medical Research.	Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; Alexaki VI, 2008, PIGM CELL MELANOMA R, V21, P429, DOI 10.1111/j.1755-148X.2008.00466.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Butterfield L, 1997, J BIOL CHEM, V272, P10110; Ciurciu A, 2006, MOL CELL BIOL, V26, P9413, DOI 10.1128/MCB.01401-06; Das M, 2007, P NATL ACAD SCI USA, V104, P15759, DOI 10.1073/pnas.0707782104; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; de Nadal E, 2002, EMBO REP, V3, P735, DOI 10.1093/embo-reports/kvf158; de Nadal E, 2010, EMBO J, V29, P4, DOI 10.1038/emboj.2009.346; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; Dioum EM, 2009, CELL, V139, P462, DOI 10.1016/j.cell.2009.10.007; Edmunds JW, 2004, J CELL SCI, V117, P3715, DOI 10.1242/jcs.01346; Fan Y, 2010, CELL DEATH DIFFER, V17, P912, DOI 10.1038/cdd.2009.182; Fukuyama K, 2000, J BIOL CHEM, V275, P21247, DOI 10.1074/jbc.M001488200; Guelman S, 2006, MOL CELL BIOL, V26, P871, DOI 10.1128/MCB.26.3.871-882.2006; Ham J, 2000, BIOCHEM PHARMACOL, V60, P1015, DOI 10.1016/S0006-2952(00)00372-5; Hu SH, 2009, CELL, V139, P610, DOI 10.1016/j.cell.2009.08.037; Iyer LM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r60; Jasper H, 2001, DEV CELL, V1, P579, DOI 10.1016/S1534-5807(01)00045-4; Kayali AG, 2000, DIABETES, V49, P1783, DOI 10.2337/diabetes.49.11.1783; Kimura A, 2005, J BIOCHEM, V138, P647, DOI 10.1093/jb/mvi184; Kusch T, 2003, MOL CELL BIOL, V23, P3305, DOI 10.1128/MCB.23.9.3305-3319.2003; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lawrence MC, 2009, P NATL ACAD SCI USA, V106, P22181, DOI 10.1073/pnas.0912596106; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Leimkuhler S, 2003, J BIOL CHEM, V278, P26127, DOI 10.1074/jbc.M303092200; Mas G, 2009, EMBO J, V28, P326, DOI 10.1038/emboj.2008.299; Morrison DK, 2000, J CELL BIOL, V150, pF57, DOI 10.1083/jcb.150.2.F57; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Proft M, 2006, MOL CELL, V23, P241, DOI 10.1016/j.molcel.2006.05.031; ROZEK D, 1993, MOL CELL BIOL, V13, P5490, DOI 10.1128/MCB.13.9.5490; ROZEK D, 1995, J CELL BIOCHEM, V57, P479, DOI 10.1002/jcb.240570313; Rudolph MJ, 2001, NAT STRUCT BIOL, V8, P42; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Schwarz G, 2006, ANNU REV PLANT BIOL, V57, P623, DOI 10.1146/annurev.arplant.57.032905.105437; Su YC, 1998, GENE DEV, V12, P2371, DOI 10.1101/gad.12.15.2371; Suganuma T, 2008, NAT STRUCT MOL BIOL, V15, P364, DOI 10.1038/nsmb.1397; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Thomson S, 1999, SEMIN CELL DEV BIOL, V10, P205, DOI 10.1006/scdb.1999.0302; Treisman JE, 1997, GENE, V186, P119, DOI 10.1016/S0378-1119(96)00694-4; Wang YL, 2008, J BIOL CHEM, V283, P33808, DOI 10.1074/jbc.M806936200; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Yang SH, 2003, GENE, V320, P3, DOI 10.1016/S0378-1119(03)00816-3; Zapater M, 2007, MOL CELL BIOL, V27, P3900, DOI 10.1128/MCB.00089-07; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	48	48	49	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2010	142	5					726	736		10.1016/j.cell.2010.07.045	http://dx.doi.org/10.1016/j.cell.2010.07.045			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	646FL	20813260	Bronze			2022-12-01	WOS:000281523200016
J	Lee, HH; Molla, MN; Cantor, CR; Collins, JJ				Lee, Henry H.; Molla, Michael N.; Cantor, Charles R.; Collins, James J.			Bacterial charity work leads to population-wide resistance	NATURE			English	Article							ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; INDUCED MUTAGENESIS; EVOLUTION; INDOLE; DEATH; ADAPTATION; EXPRESSION; MUTATIONS; STRAINS	Bacteria show remarkable adaptability in the face of antibiotic therapeutics. Resistance alleles in drug target-specific sites and general stress responses have been identified in individual end-point isolates(1-7). Less is known, however, about the population dynamics during the development of antibiotic-resistant strains. Here we follow a continuous culture of Escherichia coli facing increasing levels of antibiotic and show that the vast majority of isolates are less resistant than the population as a whole. We find that the few highly resistant mutants improve the survival of the population's less resistant constituents, in part by producing indole, a signalling molecule generated by actively growing, unstressed cells(8). We show, through transcriptional profiling, that indole serves to turn on drug efflux pumps and oxidative-stress protective mechanisms. The indole production comes at a fitness cost to the highly resistant isolates, and whole-genome sequencing reveals that this bacterial altruism is made possible by drug-resistance mutations unrelated to indole production. This work establishes a population-based resistance mechanism constituting a form of kin selection(9) whereby a small number of resistant mutants can, at some cost to themselves, provide protection to other, more vulnerable, cells, enhancing the survival capacity of the overall population in stressful environments.	[Lee, Henry H.; Molla, Michael N.; Collins, James J.] Howard Hughes Med Inst, Ctr BioDynam, Boston, MA 02115 USA; [Lee, Henry H.; Molla, Michael N.; Cantor, Charles R.; Collins, James J.] Boston Univ, Dept Biomed Engn, Ctr Adv Biotechnol, Boston, MA 02215 USA; [Collins, James J.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02215 USA	Howard Hughes Medical Institute; Boston University; Harvard University	Collins, JJ (corresponding author), Howard Hughes Med Inst, Ctr BioDynam, Boston, MA 02115 USA.	jcollins@bu.edu	Lee, Henry/GVS-2114-2022	Lee, Henry/0000-0002-0577-2275	National Institutes of Health [DP1OD003644]; National Science Foundation [DMS-0602204]; Howard Hughes Medical Institute; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003644] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Chaparian and Q. Beg for help with bioreactor instrumentation. We also thank A. Herbert and C. Ordija for use of the Covaris sonicator for preparing sequencing libraries. This work was supported by the National Institutes of Health through the NIH Director's Pioneer Award Program, grant number DP1OD003644; the National Science Foundation through RTG grant number DMS-0602204; and the Howard Hughes Medical Institute.	Albert TJ, 2005, NAT METHODS, V2, P951, DOI 10.1038/NMETH805; Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Friedman L, 2006, ANTIMICROB AGENTS CH, V50, P2137, DOI 10.1128/AAC.00039-06; GOODER H, 1954, BIOCHEM J, V57, P369, DOI 10.1042/bj0570369; Herring CD, 2006, NAT GENET, V38, P1406, DOI 10.1038/ng1906; Hirakawa H, 2005, MOL MICROBIOL, V55, P1113, DOI 10.1111/j.1365-2958.2004.04449.x; Kobayashi A, 2006, J BACTERIOL, V188, P5693, DOI 10.1128/JB.00217-06; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Lee JT, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-42; Livermore DM, 2003, CLIN INFECT DIS, V36, pS11, DOI 10.1086/344654; Long F, 2008, ANTIMICROB AGENTS CH, V52, P3052, DOI 10.1128/AAC.00475-08; Miller JH, 1996, ANNU REV MICROBIOL, V50, P625, DOI 10.1146/annurev.micro.50.1.625; MILLER PF, 1994, ANTIMICROB AGENTS CH, V38, P1773, DOI 10.1128/AAC.38.8.1773; Mouneimne H, 1999, ANTIMICROB AGENTS CH, V43, P62, DOI 10.1128/AAC.43.1.62; Smith BT, 1998, GENETICS, V148, P1599; Smith PA, 2007, NAT CHEM BIOL, V3, P549, DOI 10.1038/nchembio.2007.27; Steiling K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005043; Talloen W, 2007, BIOINFORMATICS, V23, P2897, DOI 10.1093/bioinformatics/btm478; Travisano M, 1996, GENETICS, V143, P15; Tucker NP, 2010, TRENDS MICROBIOL, V18, P149, DOI 10.1016/j.tim.2009.12.009; Wang H, 2001, ANTIMICROB AGENTS CH, V45, P1515, DOI 10.1128/AAC.45.5.1515-1521.2001; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; Woodford N, 2007, CLIN MICROBIOL INFEC, V13, P5, DOI 10.1111/j.1469-0691.2006.01492.x	30	398	418	7	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 2	2010	467	7311					82	U113		10.1038/nature09354	http://dx.doi.org/10.1038/nature09354			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645MB	20811456	Green Accepted			2022-12-01	WOS:000281461200039
J	Burke, MK; Dunham, JP; Shahrestani, P; Thornton, KR; Rose, MR; Long, AD				Burke, Molly K.; Dunham, Joseph P.; Shahrestani, Parvin; Thornton, Kevin R.; Rose, Michael R.; Long, Anthony D.			Genome-wide analysis of a long-term evolution experiment with Drosophila	NATURE			English	Article							SELECTION; ADAPTATION; GENETICS; LOCUS	Experimental evolution systems allow the genomic study of adaptation, and so far this has been done primarily in asexual systems with small genomes, such as bacteria and yeast(1-3). Here we present whole-genome resequencing data from Drosophila melanogaster populations that have experienced over 600 generations of laboratory selection for accelerated development. Flies in these selected populations develop from egg to adult similar to 20% faster than flies of ancestral control populations, and have evolved a number of other correlated phenotypes. On the basis of 688,520 intermediate-frequency, high-quality single nucleotide polymorphisms, we identify several dozen genomic regions that show strong allele frequency differentiation between a pooled sample of five replicate populations selected for accelerated development and pooled controls. On the basis of resequencing data from a single replicate population with accelerated development, as well as single nucleotide polymorphism data from individual flies from each replicate population, we infer little allele frequency differentiation between replicate populations within a selection treatment. Signatures of selection are qualitatively different than what has been observed in asexual species; in our sexual populations, adaptation is not associated with 'classic' sweeps whereby newly arising, unconditionally advantageous mutations become fixed. More parsimonious explanations include 'incomplete' sweep models, in which mutations have not had enough time to fix, and 'soft' sweep models, in which selection acts on pre-existing, common genetic variants. We conclude that, at least for life history characters such as development time, unconditionally advantageous alleles rarely arise, are associated with small net fitness gains or cannot fix because selection coefficients change over time.	[Burke, Molly K.; Shahrestani, Parvin; Thornton, Kevin R.; Rose, Michael R.; Long, Anthony D.] Univ Calif Irvine, Irvine, CA 92697 USA; [Dunham, Joseph P.] Univ So Calif, Los Angeles, CA 90098 USA	University of California System; University of California Irvine; University of Southern California	Burke, MK (corresponding author), Univ Calif Irvine, 321 Steinhaus Hall, Irvine, CA 92697 USA.	burkem@uci.edu; tdlong@uci.edu		Burke, Molly/0000-0002-4280-0247; Long, Tony/0000-0002-5007-8514; Rose, Michael/0000-0002-7766-0731; Thornton, Kevin/0000-0003-0743-4445	UCI; NSF [DEB-0614429, DGE-0638751]	UCI; NSF(National Science Foundation (NSF))	We thank K. Aeling and D. Heck at the UCI DNA and Protein Microarray Facility for help with preparation and sequencing of the ACO<INF>1</INF> library. The pooled ACO and CO libraries were sequenced at the University of Oregon High-Throughput Sequencing Facility, with advice from D. Turnbull. We are grateful to S. Nuzdhin, T. Turner and J. J. Emerson for providing suggestions during the conception of the project, and to O. Tenaillon and F. Barreto for comments on previous versions of the manuscript. We also thank A. K. Chippindale for discussion of the phenotype data. This work was supported by a UCI Faculty Research and Training Grant to M.R.R. and NSF DEB-0614429 to A.D.L. M.K.B. is supported by an NSF Graduate Fellowship in STEM K-12 Education (DGE-0638751).	Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bloom JS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-221; Chevin LM, 2008, GENETICS, V180, P1645, DOI 10.1534/genetics.108.093351; Chippindale Adam K., 2004, P413, DOI 10.1142/9789812567222_0034; Chippindale AK, 1997, EVOLUTION, V51, P1536, DOI [10.2307/2411206, 10.1111/j.1558-5646.1997.tb01477.x]; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Feder JL, 2003, P NATL ACAD SCI USA, V100, P10314, DOI 10.1073/pnas.1730757100; Garland T., 2009, EXPT EVOLUTION CONCE; Hegreness M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-201; Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947; Herring CD, 2006, NAT GENET, V38, P1406, DOI 10.1038/ng1906; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Innan H, 2004, P NATL ACAD SCI USA, V101, P10667, DOI 10.1073/pnas.0401720101; KAPLAN NL, 1989, GENETICS, V123, P887; Papadopoulos D, 1999, P NATL ACAD SCI USA, V96, P3807, DOI 10.1073/pnas.96.7.3807; Pelz HJ, 2005, GENETICS, V170, P1839, DOI 10.1534/genetics.104.040360; Przeworski M, 2005, EVOLUTION, V59, P2312, DOI 10.1554/05-273.1; Rose MR, 2004, METHUSELAH FLIES CAS; Teotonio H, 2000, NATURE, V408, P463, DOI 10.1038/35044070; Teotonio H, 2009, NAT GENET, V41, P251, DOI 10.1038/ng.289	22	297	299	6	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP	2010	467	7315					587	U111		10.1038/nature09352	http://dx.doi.org/10.1038/nature09352			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655TT	20844486				2022-12-01	WOS:000282273100038
J	de Bono, JS; Ashworth, A				de Bono, J. S.; Ashworth, Alan			Translating cancer research into targeted therapeutics	NATURE			English	Article							CIRCULATING TUMOR-CELLS; RESISTANT PROSTATE-CANCER; PROGRESSION-FREE SURVIVAL; CLINICAL-TRIAL; ABIRATERONE ACETATE; PHASE-I; DRUG; GENE; IMATINIB; INHIBITION	The emphasis in cancer drug development has shifted from cytotoxic, non-specific chemotherapies to molecularly targeted, rationally designed drugs promising greater efficacy and less side effects. Nevertheless, despite some successes drug development remains painfully slow. Here, we highlight the issues involved and suggest ways in which this process can be improved and expedited. We envision an increasing shift to integrated cancer research and biomarker-driven adaptive and hypothesis testing clinical trials. The goal is the development of specific cancer medicines to treat the individual patient, with treatment selection being driven by a detailed understanding of the genetics and biology of the patient and their cancer.	[de Bono, J. S.] Inst Canc Res, Sutton SM2 5NG, Surrey, England; [de Bono, J. S.] Royal Marsden NHS Fdn Trust, Sutton SM2 5PT, Surrey, England; [Ashworth, Alan] Inst Canc Res, Breakthrough Breast Canc Ctr, London SW3 6JB, England	University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	de Bono, JS (corresponding author), Inst Canc Res, Cotswold Rd, Sutton SM2 5NG, Surrey, England.	johann.de-bono@icr.ac.uk; alan.ashworth@icr.ac.uk		de Bono, Johann S/0000-0002-2034-595X	Breast Cancer Now [BREAST CANCER NOW RESEARCH CENTRE] Funding Source: Medline	Breast Cancer Now		Ashworth A, 2008, J CLIN ONCOL, V26, P3785, DOI 10.1200/JCO.2008.16.0812; Attard G, 2008, J CLIN PATHOL, V61, P891, DOI 10.1136/jcp.2008.056341; Attard G, 2008, J CLIN ONCOL, V26, P4563, DOI 10.1200/JCO.2007.15.9749; Attard G, 2009, CANCER CELL, V16, P458, DOI 10.1016/j.ccr.2009.11.006; Attard G, 2009, NAT REV UROL, V6, P473, DOI 10.1038/nrurol.2009.130; Attard G, 2009, J CLIN ONCOL, V27, P3742, DOI 10.1200/JCO.2008.20.0642; Attard G, 2009, CANCER RES, V69, P2912, DOI 10.1158/0008-5472.CAN-08-3667; Becher OJ, 2006, CANCER RES, V66, P3355, DOI 10.1158/0008-5472.CAN-05-3827; Betensky RA, 2002, J CLIN ONCOL, V20, P2495, DOI 10.1200/JCO.2002.06.140; BOLLAG G, 2010, NATURE          0907, DOI DOI 10.1038/NATURE09454; Budd GT, 2006, CLIN CANCER RES, V12, P6403, DOI 10.1158/1078-0432.CCR-05-1769; Buyse M, 2000, BIOSTATISTICS, V1, P49, DOI DOI 10.1093/BIOSTATISTICS/1.1.49; Buyse M, 2007, J CLIN ONCOL, V25, P5218, DOI 10.1200/JCO.2007.11.8836; Carden CP, 2009, CLIN PHARMACOL THER, V85, P131, DOI 10.1038/clpt.2008.223; Carden CP, 2010, DRUG DISCOV TODAY, V15, P88, DOI 10.1016/j.drudis.2009.11.006; Collins I, 2006, NAT CHEM BIOL, V2, P689, DOI 10.1038/nchembio840; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; de Bono JS, 2007, CLIN CANCER RES, V13, P3611, DOI 10.1158/1078-0432.CCR-07-0268; de Bono JS, 2003, BREAST CANCER RES, V5, P154, DOI 10.1186/bcr597; De Giorgi U, 2009, J CLIN ONCOL, V27, P3303, DOI 10.1200/JCO.2008.19.4423; DiMasi JA, 2007, J CLIN ONCOL, V25, P209, DOI 10.1200/JCO.2006.09.0803; Dowsett M, 2007, JNCI-J NATL CANCER I, V99, P167, DOI 10.1093/jnci/djk020; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Goodsaid F, 2007, AAPS J, V9, pE105, DOI 10.1208/aapsj0901010; Grantab R, 2006, CANCER RES, V66, P1033, DOI 10.1158/0008-5472.CAN-05-3077; Greystoke A, 2008, ANN ONCOL, V19, P990, DOI 10.1093/annonc/mdn014; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hennessy BT, 2009, CLIN CANCER RES, V15, P417, DOI 10.1158/1078-0432.CCR-08-2620; INGLE JN, 1981, NEW ENGL J MED, V304, P16, DOI 10.1056/NEJM198101013040104; Iorns E, 2007, NAT REV DRUG DISCOV, V6, P556, DOI 10.1038/nrd2355; Jordan VC, 2003, J NATL CANCER I, V95, P338, DOI 10.1093/jnci/95.5.338; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kreeger PK, 2010, CARCINOGENESIS, V31, P2, DOI 10.1093/carcin/bgp261; Kwak EL, 2009, J CLIN ONCOL, V27; Lord CJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-38; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Mandrekar SJ, 2009, J CLIN ONCOL, V27, P4027, DOI 10.1200/JCO.2009.22.3701; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Olmos D, 2009, ANN ONCOL, V20, P27, DOI 10.1093/annonc/mdn544; Propper DJ, 2003, J CLIN ONCOL, V21, P203, DOI 10.1200/JCO.2003.02.008; Reid AHM, 2010, BRIT J CANCER, V102, P678, DOI 10.1038/sj.bjc.6605554; Reid AHM, 2010, J CLIN ONCOL, V28, P1489, DOI 10.1200/JCO.2009.24.6819; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Sarker D, 2009, CLIN CANCER RES, V15, P4799, DOI 10.1158/1078-0432.CCR-08-0125; Sausville EA, 2006, CANCER RES, V66, P3351, DOI 10.1158/0008-5472.CAN-05-3627; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Sobrero A, 2009, J CLIN ONCOL, V27, P5868, DOI 10.1200/JCO.2009.22.4162; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Taube SE, 2009, JNCI-J NATL CANCER I, V101, P1453, DOI 10.1093/jnci/djp334; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; van Oosterom AT, 2001, LANCET, V358, P1421, DOI 10.1016/S0140-6736(01)06535-7; Verweij J, 2004, LANCET, V364, P1127, DOI 10.1016/S0140-6736(04)17098-0; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Workman P, 2008, CURR OPIN PHARMACOL, V8, P359, DOI 10.1016/j.coph.2008.07.007; Workman P, 2006, JNCI-J NATL CANCER I, V98, P580, DOI 10.1093/jnci/djj162; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004	70	242	246	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP	2010	467	7315					543	549		10.1038/nature09339	http://dx.doi.org/10.1038/nature09339			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655TT	20882008				2022-12-01	WOS:000282273100029
J	Moster, D; Wilcox, AJ; Vollset, SE; Markestad, T; Lie, RT				Moster, Dag; Wilcox, Allen J.; Vollset, Stein Emil; Markestad, Trond; Lie, Rolv Terje			Cerebral Palsy Among Term and Postterm Births	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GESTATIONAL-AGE; EPIDEMIOLOGIC RESEARCH; PERINATAL FACTORS; PRETERM BIRTH; ANTECEDENTS; OUTCOMES; CHILDREN; COMPLICATIONS; PREVALENCE; INFANTS	Context Although preterm delivery is a well-established risk factor for cerebral palsy (CP), preterm deliveries contribute only a minority of affected infants. There is little information on the relation of CP risk to gestational age in the term range, where most CP occurs. Objective To determine whether timing of birth in the term and postterm period is associated with risk of CP. Design, Setting, and Participants Population-based follow-up study using the Medical Birth Registry of Norway to identify 1 682 441 singleton children born in the years 1967-2001 with a gestational age of 37 through 44 weeks and no congenital anomalies. The cohort was followed up through 2005 by linkage to other national registries. Main Outcome Measures Absolute and relative risk of CP for children surviving to at least 4 years of age. Results Of the cohort of term and postterm children, 1938 were registered with CP in the National Insurance Scheme. Infants born at 40 weeks had the lowest risk of CP, with a prevalence of 0.99/1000 (95% confidence interval [CI], 0.90-1.08). Risk for CP was higher with earlier or later delivery, with a prevalence at 37 weeks of 1.91/1000 (95% CI, 1.58-2.25) and a relative risk (RR) of 1.9 (95% CI, 1.6-2.4), a prevalence at 38 weeks of 1.25/1000 (95% CI, 1.07-1.42) and an RR of 1.3 (95% CI, 1.1-1.6), a prevalence at 42 weeks of 1.36/1000 (95% CI, 1.19-1.53) and an RR of 1.4 (95% CI, 1.2-1.6), and a prevalence after 42 weeks of 1.44 (95% CI, 1.15-1.72) and an RR of 1.4 (95% CI, 1.1-1.8). These associations were even stronger in a subset with gestational age based on ultrasound measurements: at 37 weeks the prevalence was 1.17/1000 (95% CI, 0.30-2.04) and the relative risk was 3.7 (95% CI, 1.5-9.1). At 42 weeks the prevalence was 0.85/1000 (95% CI, 0.33-1.38) and the relative risk was 2.4 (95% CI, 1.1-5.3). Adjustment for infant sex, maternal age, and various socioeconomic measures had little effect. Conclusion Compared with delivery at 40 weeks' gestation, delivery at 37 or 38 weeks or at 42 weeks or later was associated with an increased risk of CP. JAMA. 2010; 304(9): 976-982 www.jama.com	[Moster, Dag; Vollset, Stein Emil; Lie, Rolv Terje] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, N-5020 Bergen, Norway; [Markestad, Trond] Univ Bergen, Dept Clin Med, Sect Pediat, N-5020 Bergen, Norway; [Moster, Dag; Markestad, Trond] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway; [Wilcox, Allen J.] NIEHS, Epidemiol Branch, NIH, Durham, NC USA; [Vollset, Stein Emil; Lie, Rolv Terje] Norwegian Inst Publ Hlth, Med Birth Registry Norway, Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Norwegian Institute of Public Health (NIPH)	Moster, D (corresponding author), Univ Bergen, Dept Publ Hlth & Primary Hlth Care, POB 7804, N-5020 Bergen, Norway.	Dag.Moster@smis.uib.no	Wilcox, Allen J/C-7723-2019	Wilcox, Allen J/0000-0002-3376-1311	National Institutes of Health, National Institute of Environmental Health Sciences; Unger-Vetlesen Charitable Fund; US-Norway Fulbright Foundation; Norwegian Society of Pediatricians; University of Bergen; Research Council of Norway; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES044003] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Unger-Vetlesen Charitable Fund; US-Norway Fulbright Foundation; Norwegian Society of Pediatricians; University of Bergen; Research Council of Norway(Research Council of Norway); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences; the Unger-Vetlesen Charitable Fund; The US-Norway Fulbright Foundation; the Norwegian Society of Pediatricians; the University of Bergen; and the Research Council of Norway.	Allen MC, 2008, CURR OPIN NEUROL, V21, P123, DOI 10.1097/WCO.0b013e3282f88bb4; Backe Bjorn, 1997, Tidsskrift for den Norske Laegeforening, V117, P2314; Blair E, 2009, FETAL NEONATAL NEURO, V4th, P867; Chaudhari BP, 2008, CLIN GENET, V74, P493, DOI 10.1111/j.1399-0004.2008.01124.x; Gulmezoglu AM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004945; Hack M, 2008, CLIN OBSTET GYNECOL, V51, P763, DOI 10.1097/GRF.0b013e3181870922; Himpens E, 2008, DEV MED CHILD NEUROL, V50, P334, DOI 10.1111/j.1469-8749.2008.02047.x; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Jones K.L, 2006, SMITHS RECOGNIZABLE, V6th, P13; Kamel RM, 2010, ARCH GYNECOL OBSTET, V281, P975, DOI 10.1007/s00404-010-1365-9; Krageloh-Mann I, 2009, BRAIN DEV-JPN, V31, P537, DOI 10.1016/j.braindev.2009.03.009; Lynch CD, 2007, PAEDIATR PERINAT EP, V21, P86, DOI 10.1111/j.1365-3016.2007.00865.x; MANNINO F, 1988, J REPROD MED, V33, P271; Mesterman R, 2010, J CHILD NEUROL, V25, P36, DOI 10.1177/0883073809336677; Montenegro MA, 2005, J CHILD NEUROL, V20, P675, DOI 10.1177/08830738050200080801; Moster D, 2001, J PEDIATR-US, V138, P798, DOI 10.1067/mpd.2001.114694; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; Msall ME, 2006, CLIN PERINATOL, V33, P269, DOI 10.1016/j.clp.2006.03.012; Nelson KB, 2008, CLIN OBSTET GYNECOL, V51, P749, DOI 10.1097/GRF.0b013e318187087c; Nelson KB, 2009, DEV MED CHILD NEUROL, V51, P765, DOI 10.1111/j.1469-8749.2009.03489.x; NELSON KB, 1985, AM J DIS CHILD, V139, P1031, DOI 10.1001/archpedi.1985.02140120077032; NELSON KB, 1986, NEW ENGL J MED, V315, P81, DOI 10.1056/NEJM198607103150202; *NORW MIN LAB, 2010, SURV NORW SOC INS SC; Pakula AT, 2009, PHYS MED REH CLIN N, V20, P427, DOI 10.1016/j.pmr.2009.06.001; Paneth N, 2008, CLIN OBSTET GYNECOL, V51, P742, DOI 10.1097/GRF.0b013e318187081a; Perlman JM, 2006, CLIN PERINATOL, V33, P335, DOI 10.1016/j.clp.2006.03.004; Rankin J, 2010, DEV MED CHILD NEUROL, V52, P345, DOI 10.1111/j.1469-8749.2009.03415.x; Robertson CMT, 2009, PEDIATR NEUROL, V40, P189, DOI 10.1016/j.pediatrneurol.2008.09.017; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V49, P8, DOI 10.1111/j.1469-8749.2007.tb12610.x; Shea KM, 1998, EPIDEMIOLOGY, V9, P199, DOI 10.1097/00001648-199803000-00017; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; *STAT NORW, THIS IS STAT NORW I; The Norwegian Labour and Welfare Administration, MEMB NAT INS SCHEM; Thorngren-Jerneck K, 2006, OBSTET GYNECOL, V108, P1499, DOI 10.1097/01.AOG.0000247174.27979.6b; TORFS CP, 1990, J PEDIATR-US, V116, P615, DOI 10.1016/S0022-3476(05)81615-4; Walstab J, 2002, AUST NZ J OBSTET GYN, V42, P138, DOI 10.1111/j.0004-8666.2002.00138.x; Weijerman ME, 2008, J PEDIATR-US, V152, P15, DOI 10.1016/j.jpeds.2007.09.045; World Health Organization, INT CLASS DIS ICD; Yang S, 2010, AM J EPIDEMIOL, V171, P399, DOI 10.1093/aje/kwp413	39	78	79	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 1	2010	304	9					976	982		10.1001/jama.2010.1271	http://dx.doi.org/10.1001/jama.2010.1271			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645AD	20810375	Green Accepted			2022-12-01	WOS:000281422400023
J	Larkin, J; Gore, M				Larkin, James; Gore, Martin			Is advanced renal cell carcinoma becoming a chronic disease?	LANCET			English	Editorial Material							INTERFERON-ALPHA; DOUBLE-BLIND; SUNITINIB; RESISTANCE		[Larkin, James; Gore, Martin] Royal Marsden Hosp, Dept Med, Renal Canc Unit, London SW3 6JJ, England	Royal Marsden NHS Foundation Trust	Larkin, J (corresponding author), Royal Marsden Hosp, Dept Med, Renal Canc Unit, London SW3 6JJ, England.	james.larkin@rmh.nhs.uk		Larkin, James/0000-0001-5569-9523				Ainsworth NL, 2009, EXPERT REV ANTICANC, V9, P1793, DOI 10.1586/ERA.09.144; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Feldman DR, 2009, J CLIN ONCOL, V27, P1432, DOI 10.1200/JCO.2008.19.0108; Furge KA, 2010, LANCET ONCOL, V11, P571, DOI 10.1016/S1470-2045(09)70380-8; Huang D, 2010, CANCER RES, V70, P1053, DOI 10.1158/0008-5472.CAN-09-3722; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Ravaud A, 2010, ANN ONCOL, V21, DOI 10.1093/annonc/mdp548; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Rini BI, 2008, J CLIN ONCOL, V26, P5422, DOI 10.1200/JCO.2008.16.9847; Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764	13	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 21	2010	376	9741					574	575		10.1016/S0140-6736(10)60816-1	http://dx.doi.org/10.1016/S0140-6736(10)60816-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	643PB	20728740				2022-12-01	WOS:000281309100008
J	Colgrove, J; Abiola, S; Mello, MM				Colgrove, James; Abiola, Sara; Mello, Michelle M.			HPV Vaccination Mandates - Lawmaking amid Political and Scientific Controversy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PUBLIC-HEALTH; ADOLESCENTS; COVERAGE		[Abiola, Sara; Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Colgrove, James] Columbia Univ, Dept Sociomed Sci, Mailman Sch Publ Hlth, New York, NY USA	Harvard University; Harvard T.H. Chan School of Public Health; Columbia University	Mello, MM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	mmello@hsph.harvard.edu			Robert Wood Johnson Foundation; Greenwall Foundation	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Greenwall Foundation	Supported by the Robert Wood Johnson Foundation and the Greenwall Foundation's Faculty Scholars in Bioethics Program.	*ASS IMM MAN, POS STAT SCH CHILD C; Briss PA, 2000, AM J PREV MED, V18, P97, DOI 10.1016/S0749-3797(99)00118-X; *CDCP, 2007, SCH ENTR IMM ASS REP; Charo RA, 2007, NEW ENGL J MED, V356, P1905, DOI 10.1056/NEJMp078054; Childress JF, 2002, J LAW MED ETHICS, V30, P170, DOI 10.1111/j.1748-720X.2002.tb00384.x; COLGROVE J, 2008, PENN CTR GUIDE BIOET, P647; Colgrove J, 2006, STATE IMMUNITY POLIT; Freed GL, 2008, AM J PREV MED, V35, P145, DOI 10.1016/j.amepre.2008.03.033; Gibbs N., 2006, TIME            0621; Giffin R, 2004, HEALTH AFFAIR, V23, P98, DOI 10.1377/hlthaff.23.5.98; Hinman AR, 2000, AM J PREV MED, V18, P92; Lo B, 2006, BMJ-BRIT MED J, V332, P1106, DOI 10.1136/bmj.332.7550.1106; National Conference of State Legislatures, HPV VACC; Olshen E, 2007, J ADOLESCENT HEALTH, V40, P405, DOI 10.1016/j.jadohealth.2006.12.013; OROURKE M, 2007, CANC SLUTS DOES HPV; Salmon DA, 2005, AM J PUBLIC HEALTH, V95, P778, DOI 10.2105/AJPH.2004.046193; Wynia MK, 2007, AM J BIOETHICS, V7, P2, DOI 10.1080/15265160701795809	17	72	72	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 19	2010	363	8					785	791		10.1056/NEJMsr1003547	http://dx.doi.org/10.1056/NEJMsr1003547			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	639TE	20818883				2022-12-01	WOS:000280996600016
J	Manuel, DG; Rosella, LC; Stukel, TA				Manuel, Douglas G.; Rosella, Laura C.; Stukel, Therese A.			Importance of accurately identifying disease in studies using electronic health records	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PREVALENCE; QUALITY; CARE; MISCLASSIFICATION; VALIDITY; ONTARIO		[Manuel, Douglas G.] Ottawa Hosp Res Inst, Ottawa, ON K1Y 4E9, Canada; [Manuel, Douglas G.] Stats Canada, Ottawa, ON, Canada; [Manuel, Douglas G.] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada; [Manuel, Douglas G.] Univ Ottawa, Dept Epidemiol, Ottawa, ON, Canada; [Manuel, Douglas G.] Univ Ottawa, Dept Community Med, Ottawa, ON, Canada; [Manuel, Douglas G.; Rosella, Laura C.; Stukel, Therese A.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Manuel, Douglas G.; Rosella, Laura C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Rosella, Laura C.; Stukel, Therese A.] Ontario Agcy Hlth Protect & Promot, Toronto, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; Statistics Canada; University of Ottawa; University of Ottawa; University of Ottawa; University of Toronto; University of Toronto	Manuel, DG (corresponding author), Ottawa Hosp Res Inst, 1053 Carling Ave, Ottawa, ON K1Y 4E9, Canada.	dmanuel@ohri.ca		Stukel, Therese/0000-0002-2951-1360; armstrong, benedict/0000-0003-4407-0409				Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Couris CM, 2009, J CLIN EPIDEMIOL, V62, P660, DOI 10.1016/j.jclinepi.2008.07.013; Habbema J.D., 2002, EVIDENCE BASE CLIN D, P117; Health Council of Canada, 2007, WHY HLTH CAR REN MAT; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hurtado M, 2001, ENVISIONING NATL HLT; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Joshy G, 2006, DIABETES TECHNOL THE, V8, P587, DOI 10.1089/dia.2006.8.587; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Kelsey J., 1996, METHODS OBSERVATIONA; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Lix L., 2006, DEFINING VALIDATING; Lix LM, 2008, J CLIN EPIDEMIOL, V61, P1250, DOI 10.1016/j.jclinepi.2008.02.002; Mower WR, 1999, ANN EMERG MED, V33, P85, DOI 10.1016/S0196-0644(99)70422-1; Mullooly JP, 1996, AM J EPIDEMIOL, V144, P782; National Centre for Classification in Health, 2010, INT STAT CLASS DIS R; Newton J., 2002, DIS REGISTERS ENGLAN; *ONT MIN HLTH LONG, 2008, DIAB STRAT BACKGR; Powell AE, 2003, QUAL SAF HEALTH CARE, V12, P122, DOI 10.1136/qhc.12.2.122; ROGAN WJ, 1978, AM J EPIDEMIOL, V107, P71, DOI 10.1093/oxfordjournals.aje.a112510; Schulz EB, 1998, J AM MED INFORM ASSN, V5, P337, DOI 10.1136/jamia.1998.0050337; Sturmer T, 2002, EPIDEMIOLOGY, V13, P507, DOI 10.1097/01.EDE.0000023361.94572.7C; Tu JV, 2008, CAN MED ASSOC J, V179, P909, DOI 10.1503/cmaj.080749; van Walraven C, 2010, J CLIN EPIDEMIOL, V63, P1000, DOI 10.1016/j.jclinepi.2010.01.023; WHITE E, 1986, AM J EPIDEMIOL, V124, P816, DOI 10.1093/oxfordjournals.aje.a114458; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Woodward G, 2006, CAN MED ASSOC J, V174, P327, DOI 10.1503/cmaj.1031433	27	71	71	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 19	2010	341								c4226	10.1136/bmj.c4226	http://dx.doi.org/10.1136/bmj.c4226			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642KW	20724404				2022-12-01	WOS:000281213400009
J	Pen, I; Uller, T; Feldmeyer, B; Harts, A; While, GM; Wapstra, E				Pen, Ido; Uller, Tobias; Feldmeyer, Barbara; Harts, Anna; While, Geoffrey M.; Wapstra, Erik			Climate-driven population divergence in sex-determining systems	NATURE			English	Article							ADAPTIVE SIGNIFICANCE; OFFSPRING SEX; EVOLUTION; RATIO; SIZE	Sex determination is a fundamental biological process, yet its mechanisms are remarkably diverse(1,2). In vertebrates, sex can be determined by inherited genetic factors or by the temperature experienced during embryonic development(2,3). However, the evolutionary causes of this diversity remain unknown. Here we show that live-bearing lizards at different climatic extremes of the species' distribution differ in their sex-determining mechanisms, with temperature-dependent sex determination in lowlands and genotypic sex determination in highlands. A theoretical model parameterized with field data accurately predicts this divergence in sex-determining systems and the consequence thereof for variation in cohort sex ratios among years. Furthermore, we show that divergent natural selection on sex determination across altitudes is caused by climatic effects on lizard life history and variation in the magnitude of between-year temperature fluctuations. Our results establish an adaptive explanation for intra-specific divergence in sex-determining systems driven by phenotypic plasticity and ecological selection, thereby providing a unifying framework for integrating the developmental, ecological and evolutionary basis for variation in vertebrate sex determination.	[Pen, Ido; Feldmeyer, Barbara; Harts, Anna] Univ Groningen, Theoret Biol Grp, NL-9750 AA Haren, Netherlands; [Uller, Tobias] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; [While, Geoffrey M.; Wapstra, Erik] Univ Tasmania, Sch Zool, Hobart, Tas 7001, Australia	University of Groningen; University of Oxford; University of Tasmania	Pen, I (corresponding author), Univ Groningen, Theoret Biol Grp, POB 14, NL-9750 AA Haren, Netherlands.	i.r.pen@rug.nl	Feldmeyer, Barbara/E-5067-2015; While, Geoffrey M/O-6306-2017; Feldmeyer, Barbara/F-9652-2013; Wapstra, Erik/J-7482-2014	Feldmeyer, Barbara/0000-0002-0413-7245; While, Geoffrey M/0000-0001-8122-9322; Wapstra, Erik/0000-0002-2050-8026	Australian Research Council [DP0877948]; Hermon Slade Foundation; Wenner-Gren Foundations	Australian Research Council(Australian Research Council); Hermon Slade Foundation; Wenner-Gren Foundations	Funding was provided by the Australian Research Council to E.W., T.U. and I.P. (DP0877948), by the Hermon Slade Foundation to E.W., T.U. and I.P., and by the Wenner-Gren Foundations to T.U.	Adolph SC, 1996, OIKOS, V77, P267, DOI 10.2307/3546065; [Anonymous], 2004, TEMPERATURE DEPENDEN; Atkins N., 2007, THESIS U TASMANIA; Bull J.J., 1983, EVOLUTION SEX DETERM; BULMER MG, 1982, EVOLUTION, V36, P13, DOI 10.1111/j.1558-5646.1982.tb05005.x; Cadby CD, 2010, INTEGR ZOOL, V5, P164, DOI 10.1111/j.1749-4877.2010.00201.x; CHARNOV EL, 1977, NATURE, V266, P828, DOI 10.1038/266828a0; CONOVER DO, 1987, NATURE, V326, P496, DOI 10.1038/326496a0; CONOVER DO, 1984, AM NAT, V123, P297, DOI 10.1086/284205; Crews D, 2009, SEMIN CELL DEV BIOL, V20, P251, DOI 10.1016/j.semcdb.2009.02.004; Janzen FJ, 2006, J EVOLUTION BIOL, V19, P1775, DOI 10.1111/j.1420-9101.2006.01138.x; Leimar O, 2006, AM NAT, V167, P367, DOI 10.1086/499566; Melville J, 2000, BIOL J LINN SOC, V70, P667; Neaves L, 2006, J EXP ZOOL PART A, V305A, P74, DOI 10.1002/jez.a.249; Olsson M, 2002, EVOLUTION, V56, P1538; Ospina-Alvarez N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002837; Quinn AE, 2007, SCIENCE, V316, P411, DOI 10.1126/science.1135925; Radder R., 2009, CURR BIOL, V19, P1; Uller T, 2007, TRENDS ECOL EVOL, V22, P292, DOI 10.1016/j.tree.2007.03.008; Uller T, 2009, SEMIN CELL DEV BIOL, V20, P304, DOI 10.1016/j.semcdb.2008.11.013; Van Dooren TJM, 2003, EVOLUTION, V57, P2667, DOI 10.1554/03-280; Wapstra E, 2004, P ROY SOC B-BIOL SCI, V271, pS230, DOI 10.1098/rsbl.2003.0152; Wapstra E, 2001, COPEIA, P646, DOI 10.1643/0045-8511(2001)001[0646:GVIAAS]2.0.CO;2; Wapstra E, 2001, J HERPETOL, V35, P194, DOI 10.2307/1566108; Wapstra E, 2009, J ANIM ECOL, V78, P84, DOI 10.1111/j.1365-2656.2008.01470.x; Warner DA, 2008, NATURE, V451, P566, DOI 10.1038/nature06519; Warner DA, 2009, EVOL ECOL, V23, P281, DOI 10.1007/s10682-007-9222-4; West-Eberhard Mary Jane, 2003, pi	28	120	122	1	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 18	2010	468	7322					436	U262		10.1038/nature09512	http://dx.doi.org/10.1038/nature09512			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681KP	20981009				2022-12-01	WOS:000284313100042
J	Becks, L; Agrawal, AF				Becks, Lutz; Agrawal, Aneil F.			Higher rates of sex evolve in spatially heterogeneous environments	NATURE			English	Article							DELETERIOUS MUTATIONS; RECOMBINATION; SELECTION; EVOLUTION; ADVANTAGE; INCREASES	The evolution and maintenance of sexual reproduction has puzzled biologists for decades(1,2). Although this field is rich in hypotheses(3-5), experimental evidence is scarce. Some important experiments have demonstrated differences in evolutionary rates between sexual and asexual populations(6-8); other experiments have documented evolutionary changes in phenomena related to genetic mixing, such as recombination(9,10) and selfing(11). However, direct experiments of the evolution of sex within populations are extremely rare (but see ref. 12). Here we use the rotifer, Brachionus calyciflorus, which is capable of both sexual and asexual reproduction, to test recent theory(13-15) predicting that there is more opportunity for sex to evolve in spatially heterogeneous environments. Replicated experimental populations of rotifers were maintained in homogeneous environments, composed of either high-or low-quality food habitats, or in heterogeneous environments that consisted of a mix of the two habitats. For populations maintained in either type of homogeneous environment, the rate of sex evolves rapidly towards zero. In contrast, higher rates of sex evolve in populations experiencing spatially heterogeneous environments. The data indicate that the higher level of sex observed under heterogeneity is not due to sex being less costly or selection against sex being less efficient; rather sex is sufficiently advantageous in heterogeneous environments to overwhelm its inherent costs(2). Counter to some alternative theories(16,17) for the evolution of sex, there is no evidence that genetic drift plays any part in the evolution of sex in these populations.	[Becks, Lutz; Agrawal, Aneil F.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3B2, Canada; [Becks, Lutz] Univ Cologne, Ctr Biol Sci, Inst Zool, Dept Gen Ecol, D-50931 Cologne, Germany	University of Toronto; University of Cologne	Becks, L (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3B2, Canada.	lutz.becks@utoronto.ca	Becks, Lutz/I-8256-2012		Volkswagen Foundation [I/83 517]; Natural Sciences and Engineering Research Council (Canada)	Volkswagen Foundation(Volkswagen); Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank C. Kearns and N. G. Hairston Jr for providing the sediment with resting eggs from which the Brachionus cultures were established. This research was funded by the Volkswagen Foundation to L.B. (I/83 517) and the Natural Sciences and Engineering Research Council (Canada) to A.F.A.	Agrawal AF, 2006, CURR BIOL, V16, pR696, DOI 10.1016/j.cub.2006.07.063; Agrawal AF, 2009, AM NAT, V174, pS54, DOI 10.1086/599082; Agrawal AF, 2009, EVOLUTION, V63, P2131, DOI 10.1111/j.1558-5646.2009.00695.x; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Bell G., 1982, MASTERPIECE NATURE E; Colegrave N, 2002, NATURE, V420, P664, DOI 10.1038/nature01191; Feldman MW, 1996, ANNU REV GENET, V30, P261, DOI 10.1146/annurev.genet.30.1.261; FELSENSTEIN J, 1976, ANNU REV GENET, V10, P253, DOI 10.1146/annurev.ge.10.120176.001345; FELSENSTEIN J, 1976, GENETICS, V83, P845; Fussmann GF, 2000, SCIENCE, V290, P1358, DOI 10.1126/science.290.5495.1358; Gilbert JJ, 2003, LIMNOL OCEANOGR, V48, P1297, DOI 10.4319/lo.2003.48.3.1297; Goddard MR, 2005, NATURE, V434, P636, DOI 10.1038/nature03405; Hadany L, 2007, GENETICS, V176, P1713, DOI 10.1534/genetics.107.074203; HEDRICK PW, 1986, ANNU REV ECOL SYST, V17, P535; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Keightley PD, 2006, NATURE, V443, P89, DOI 10.1038/nature05049; KONDRASHOV AS, 1984, GENET RES, V44, P199, DOI 10.1017/S0016672300026392; KONDRASHOV AS, 1993, J HERED, V84, P372, DOI 10.1093/oxfordjournals.jhered.a111358; KOROL AB, 1994, HEREDITY, V72, P64, DOI 10.1038/hdy.1994.7; Lenormand T, 2000, GENETICS, V156, P423; Maynard-Smith J., 1978, MODELS ECOLOGY; Morran LT, 2009, NATURE, V462, P350, DOI 10.1038/nature08496; Otto SP, 2009, AM NAT, V174, pS1, DOI 10.1086/599084; Otto SP, 2004, SCIENCE, V304, P1018, DOI 10.1126/science.1094072; Otto SP, 2001, EVOLUTION, V55, P1921, DOI 10.1111/j.0014-3820.2001.tb01310.x; Peters AD, 2007, J EVOLUTION BIOL, V20, P1206, DOI 10.1111/j.1420-9101.2006.01283.x; Poon A, 2004, GENETICS, V166, P19, DOI 10.1534/genetics.166.1.19; Pylkov KV, 1998, GENET RES, V71, P247, DOI 10.1017/S0016672398003243; Roze D, 2010, GENETICS, V184, P1095, DOI 10.1534/genetics.109.108258; Team R.D.C., 2009, R LANGUAGE ENV STAT; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi; WOLF HG, 1987, GENETICA, V72, P151, DOI 10.1007/BF00123174	32	100	101	3	308	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 4	2010	468	7320					89	+		10.1038/nature09449	http://dx.doi.org/10.1038/nature09449			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674YF	20944628				2022-12-01	WOS:000283786900041
J	Ou, GS; Stuurman, N; D'Ambrosio, M; Vale, RD				Ou, Guangshuo; Stuurman, Nico; D'Ambrosio, Michael; Vale, Ronald D.			Polarized Myosin Produces Unequal-Size Daughters During Asymmetric Cell Division	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; STEM-CELLS; CYTOKINESIS; NEUROBLAST; MECHANISMS; MIGRATION; DYNAMICS	Asymmetric positioning of the mitotic spindle before cytokinesis can produce different-sized daughter cells that have distinct fates. Here, we found an asymmetric division in the Caenorhabditis elegans Q neuroblast lineage that began with a centered spindle but generated different-sized daughters, the smaller (anterior) of which underwent apoptosis. During this division, more myosin II accumulated anteriorly, suggesting that asymmetric contractile forces might produce different-sized daughters. Indeed, partial inactivation of anterior myosin by chromophore-assisted laser inactivation created a more symmetric division and allowed the survival and differentiation of the anterior daughter. Thus, the balance of myosin activity on the two sides of a dividing cell can govern the size and fate of the daughters.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ou, GS (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	gou@ibp.ac.cn; vale@cmp.ucsf.edu	Stuurman, Nico/AAV-4894-2021	Stuurman, Nico/0000-0002-6179-8613	Damon Runyon Cancer Research Foundation; NIH; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038499] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Cai, D. Sherwood, J. Ziel, P. Zhang, I. Cheeseman, C. Kenyon, G. Garriga, and Caenorhabditis Genetics Center for reagents, equipments and strains, and thank C. Locke and W. Li for myosin quantifications. This work was supported by the Damon Runyon Cancer Research Foundation (G.O.) and the NIH and Howard Hughes Medical Institute (R.D.V.).	Cabernard C, 2010, NATURE, V467, P91, DOI 10.1038/nature09334; Cai Y, 2003, CELL, V112, P51, DOI 10.1016/S0092-8674(02)01170-4; Cordes S, 2006, DEVELOPMENT, V133, P2747, DOI 10.1242/dev.02447; Diefenbach TJ, 2002, J CELL BIOL, V158, P1207, DOI 10.1083/jcb.200202028; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Hickson GRX, 2006, CURR BIOL, V16, P359, DOI 10.1016/j.cub.2005.12.043; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Jacobson K, 2008, TRENDS CELL BIOL, V18, P443, DOI 10.1016/j.tcb.2008.07.001; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; Monier B, 2010, NAT CELL BIOL, V12, P60, DOI 10.1038/ncb2005; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; Ou GS, 2009, J CELL BIOL, V185, P77, DOI 10.1083/jcb.200812077; Schneider SQ, 2003, ANNU REV GENET, V37, P221, DOI 10.1146/annurev.genet.37.110801.142443; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Vale RD, 2009, J CELL BIOL, V186, P727, DOI 10.1083/jcb.200902083; Wang FS, 1996, SCIENCE, V273, P660, DOI 10.1126/science.273.5275.660; Zipkin ID, 1997, CELL, V90, P883, DOI 10.1016/S0092-8674(00)80353-0	20	119	122	2	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 29	2010	330	6004					677	680		10.1126/science.1196112	http://dx.doi.org/10.1126/science.1196112			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672KB	20929735	Green Accepted			2022-12-01	WOS:000283580600050
J	De Roock, W; Jonker, DJ; Di Nicolantonio, F; Sartore-Bianchi, A; Tu, DS; Siena, S; Lamba, S; Arena, S; Frattini, M; Piessevaux, H; Van Cutsem, E; O'Callaghan, CJ; Khambata-Ford, S; Zalcberg, JR; Simes, J; Karapetis, CS; Bardelli, A; Tejpar, S				De Roock, Wendy; Jonker, Derek J.; Di Nicolantonio, Federica; Sartore-Bianchi, Andrea; Tu, Dongsheng; Siena, Salvatore; Lamba, Simona; Arena, Sabrina; Frattini, Milo; Piessevaux, Hubert; Van Cutsem, Eric; O'Callaghan, Chris J.; Khambata-Ford, Shirin; Zalcberg, John R.; Simes, John; Karapetis, Christos S.; Bardelli, Alberto; Tejpar, Sabine			Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GROWTH; OXALIPLATIN; IRINOTECAN; CARCINOMA; EFFICACY	Context Patients with metastatic colorectal cancer who have KRAS codon 12- or KRAS codon 13-mutated tumors are presently excluded from treatment with the anti-epidermal growth factor receptor monoclonal antibody cetuximab. Objective To test the hypothesis that KRAS codon 13 mutations are associated with a better outcome after treatment with cetuximab than observed with other KRAS mutations. Design, Setting, and Patients We studied the association between KRAS mutation status (p.G13D vs other KRAS mutations) and response and survival in a pooled data set of 579 patients with chemotherapy-refractory colorectal cancer treated with cetuximab between 2001 and 2008. Patients were included in the CO. 17, BOND, MABEL, EMR202600, EVEREST, BABEL, or SALVAGE clinical trials or received off-study treatment. Univariate and multivariate analyses, adjusting for possible prognostic factors and data set, were performed. The effect of the different mutations was studied in vitro by constructing isogenic cell lines with wild-type KRAS, p.G12V, or p.G13D mutant alleles and treating them with cetuximab. Main Outcome Measures The main efficacy end point was overall survival. Secondary efficacy end points were response rate and progression-free survival. Results In comparison with patients with other KRAS-mutated tumors, patients with p.G13D-mutated tumors (n=32) treated with cetuximab had longer overall survival (median, 7.6 [95% confidence interval {CI}, 5.7-20.5] months vs 5.7 [95% CI, 4.9-6.8] months; adjusted hazard ratio [HR], 0.50; 95% CI, 0.31-0.81; P=.005) and longer progression-free survival (median, 4.0 [95% CI, 1.9-6.2] months vs 1.9 [95% CI, 1.8-2.8] months; adjusted HR, 0.51; 95% CI, 0.32-0.81; P=.004). There was a significant interaction between KRAS mutation status (p.G13D vs other KRAS mutations) and overall survival benefit with cetuximab treatment (adjusted HR, 0.30; 95% CI, 0.14-0.67; P=.003). In vitro and mouse model analysis showed that although p.G12V-mutated colorectal cells were insensitive to cetuximab, p.G13D-mutated cells were sensitive, as were KRAS wild-type cells. Conclusions In this analysis, use of cetuximab was associated with longer overall and progression-free survival among patients with chemotherapy-refractory colorectal cancer with p.G13D-mutated tumors than with other KRAS-mutated tumors. Evaluation of cetuximab therapy in these tumors in prospective randomized trials may be warranted. JAMA. 2010; 304(16): 1812-1820	[Van Cutsem, Eric; Tejpar, Sabine] Univ Hosp Gasthuisberg, Digest Oncol Unit, B-3000 Louvain, Belgium; [Di Nicolantonio, Federica; Lamba, Simona; Arena, Sabrina; Bardelli, Alberto] Univ Turin, Sch Med, Inst Canc Res & Treatment, Mol Genet Lab, I-10060 Turin, Italy; [De Roock, Wendy; Tejpar, Sabine] Katholieke Univ Leuven, Ctr Human Genet, Leuven, Belgium; [Jonker, Derek J.] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Di Nicolantonio, Federica; Bardelli, Alberto] Italian Fdn Canc Res, Inst Mol Oncol, Milan, Italy; [Sartore-Bianchi, Andrea; Siena, Salvatore] Osped Niguarda Ca Granda, Falck Div Med Oncol, Milan, Italy; [Tu, Dongsheng; O'Callaghan, Chris J.] Natl Canc Inst Canada, Clin Trials Grp, Kingston, ON, Canada; [Frattini, Milo] Inst Pathol, Lab Mol Diagnost, Locarno, Switzerland; [Piessevaux, Hubert] Clin Univ St Luc, B-1200 Brussels, Belgium; [Khambata-Ford, Shirin] Bristol Myers Squibb Res & Dev, Princeton, NJ USA; [Zalcberg, John R.] Univ Melbourne, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Zalcberg, John R.] Australasian Gastrointestinal Trials Grp, Melbourne, Vic, Australia; [Simes, John] Univ Sydney, Natl Hlth & Med Res Council, Clin Trials Ctr, Sydney, NSW 2006, Australia; [Karapetis, Christos S.] Flinders Med Ctr, Adelaide, SA, Australia; [Karapetis, Christos S.] Flinders Univ S Australia, Adelaide, SA, Australia	KU Leuven; University Hospital Leuven; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Turin; KU Leuven; University of Ottawa; Ottawa Hospital Research Institute; IFOM - FIRC Institute of Molecular Oncology; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; Queens University - Canada; Canadian Cancer Trials Group; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Bristol-Myers Squibb; Peter Maccallum Cancer Center; University of Melbourne; University of Sydney; Flinders Medical Centre; Flinders University South Australia	Tejpar, S (corresponding author), Univ Hosp Gasthuisberg, Digest Oncol Unit, Herestr 49, B-3000 Louvain, Belgium.	a.bardelli@unito.it; sabine.tejpar@uzleuven.be	Sartore-Bianchi, Andrea/AAB-9848-2019; Vickers, Michael M/E-4095-2010; Arena, Sabrina/H-4985-2012; Piessevaux, Hubert/N-9558-2019; Van+Cutsem, Eric/ABE-1762-2021; Di Nicolantonio, Federica/A-2503-2011; Simes, Robert John/P-1497-2014; SIENA, SALVATORE/AAC-5806-2019; BARDELLI, Alberto/J-9721-2018	Sartore-Bianchi, Andrea/0000-0003-0780-0409; Arena, Sabrina/0000-0002-1318-2494; Piessevaux, Hubert/0000-0003-1193-0601; Di Nicolantonio, Federica/0000-0001-9618-2010; SIENA, SALVATORE/0000-0002-2681-2846; Lamba, Simona Elena/0000-0003-3207-1594; Zalcberg, John/0000-0002-6624-0782; BARDELLI, Alberto/0000-0003-1647-5070; Karapetis, Christos/0000-0003-1741-996X	Merck Serono; Amgen; Bristol-Myers Squibb; Horizon Discovery; Institute for the Promotion of Innovation Through Science and Technology in Flanders (IWT-Vlaanderen); Siena are supported by Associazione Italiana Ricerca Cancro and Oncologia Ca'Granda Onlus Fondazione; Belgian Federation Against Cancer; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Merck Serono(Merck & Company); Amgen(Amgen); Bristol-Myers Squibb(Bristol-Myers Squibb); Horizon Discovery; Institute for the Promotion of Innovation Through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Siena are supported by Associazione Italiana Ricerca Cancro and Oncologia Ca'Granda Onlus Fondazione(Fondazione AIRC per la ricerca sul cancro); Belgian Federation Against Cancer; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	Dr Siena reports serving as a member of advisory boards for Merck Serono, Amgen, AstraZeneca, and Celgene. Dr Van Cutsem reports receiving research funding from Merck Serono and Amgen. Dr Khambata-Ford reports owning equity in and is an employee of Bristol-Myers Squibb. Dr Zalcberg reports receiving travel and research support from Merck Serono and research support from Bristol-Myers Squibb. Dr Simes reports that his institution has received research grants from Bristol-Myers Squibb. Dr Karapetis reports serving as a member of an advisory board for Merck Serono. Dr Bardelli reports that he owns stock in and has received consultancy fees from Horizon Discovery. Dr Tejpar reports receiving research grants from Merck Serono. No other disclosures were reported.; Dr De Roock is supported by a PhD grant from the Institute for the Promotion of Innovation Through Science and Technology in Flanders (IWT-Vlaanderen). Drs Sartore-Bianchi and Siena are supported by Associazione Italiana Ricerca Cancro and Oncologia Ca'Granda Onlus Fondazione. Drs Van Cutsem and Tejpar are senior clinical investigators for the Fund for Scientific Research, Flanders and received research grants from the Belgian Federation Against Cancer.	Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; [Anonymous], 2008, CHMPEWP185042006 EMA; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; De Roock W, 2008, ANN ONCOL, V19, P508, DOI 10.1093/annonc/mdm496; Di Nicolantonio F, 2008, P NATL ACAD SCI USA, V105, P20864, DOI 10.1073/pnas.0808757105; European Medicines Agency, 2007, QUEST ANSW MARK AUTH; Frattini M, 2007, BRIT J CANCER, V97, P1139, DOI 10.1038/sj.bjc.6604009; Guerrero S, 2000, CANCER RES, V60, P6750; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Lee CN, 2010, J CLIN ONCOL, V28, pE111, DOI 10.1200/JCO.2009.24.0747; Lenz HJ, 2006, J CLIN ONCOL, V24, P4914, DOI 10.1200/JCO.2006.06.7595; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Pessino A, 2008, ANN ONCOL, V19, P711, DOI 10.1093/annonc/mdm516; Tejpar S, 2007, J CLIN ONCOL, V25; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; US Food and Drug Administration, CET ERB PAN VECT; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Wellcome Trust Sanger Institute, CAT SOM MUT CANC; Wilke H, 2006, J CLIN ONCOL, V24, p158S	23	570	590	0	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 27	2010	304	16					1812	1820		10.1001/jama.2010.1535	http://dx.doi.org/10.1001/jama.2010.1535			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671JZ	20978259	Bronze			2022-12-01	WOS:000283501300022
J	Karunatilaka, KS; Solem, A; Pyle, AM; Rueda, D				Karunatilaka, Krishanthi S.; Solem, Amanda; Pyle, Anna Marie; Rueda, David			Single-molecule analysis of Mss116-mediated group II intron folding	NATURE			English	Article							DEAD-BOX PROTEIN; CHAPERONE ACTIVITY; ATP HYDROLYSIS; SPECTROSCOPY; REQUIRES; RIBOZYME; FRET	DEAD-box helicases are conserved enzymes involved in nearly all aspects of RNA metabolism, but their mechanisms of action remain unclear. Here, we investigated the mechanism of the DEAD-box protein Mss116 on its natural substrate, the group II intron ai5 gamma. Group II introns are structurally complex catalytic RNAs considered evolutionarily related to the eukaryotic spliceosome, and an interesting paradigm for large RNA folding. We used single-molecule fluorescence to monitor the effect of Mss116 on folding dynamics of a minimal active construct, ai5 gamma-D135. The data show that Mss116 stimulates dynamic sampling between states along the folding pathway, an effect previously observed only with high Mg2+ concentrations. Furthermore, the data indicate that Mss116 promotes folding through discrete ATP-independent and ATP-dependent steps. We propose that Mss116 stimulates group II intron folding through a multi-step process that involves electrostatic stabilization of early intermediates and ATP hydrolysis during the final stages of native state assembly.	[Karunatilaka, Krishanthi S.; Solem, Amanda; Rueda, David] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA; [Pyle, Anna Marie] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Pyle, Anna Marie] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Pyle, Anna Marie] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Wayne State University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Rueda, D (corresponding author), Wayne State Univ, Dept Chem, 5101 Cass Ave, Detroit, MI 48202 USA.	anna.pyle@yale.edu; david.rueda@wayne.edu	Solem, Amanda/A-3553-2010; Solem, Amanda/M-5959-2013; Rueda, David S./F-9065-2014	Solem, Amanda/0000-0002-2056-9419; Rueda, David S./0000-0003-4657-6323	National Institutes of Health [R01GM085116, R01GM050313]; National Science Foundation [MCB-0747285]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050313, R01GM085116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. K. Sigel and O. Fedorova for many helpful and stimulating discussions and for commenting on the manuscript, and A. Feig, K. Musier-Forsyth and R. Lamichhane for protein gifts. This work was supported by the National Institutes of Health (R01GM085116 to D.R., R01GM050313 to A.M.P.) and the National Science Foundation (MCB-0747285 to D.R.). A.M.P. is an HHMI investigator.	Bifano AL, 2010, J MOL BIOL, V398, P429, DOI 10.1016/j.jmb.2010.03.025; Christian TD, 2009, P NATL ACAD SCI USA, V106, P21109, DOI 10.1073/pnas.0908640106; Clodi E, 1999, EMBO J, V18, P3776, DOI 10.1093/emboj/18.13.3776; Del Campo M, 2007, MOL CELL, V28, P159, DOI 10.1016/j.molcel.2007.07.028; Diges CM, 2001, EMBO J, V20, P5503, DOI 10.1093/emboj/20.19.5503; Fedorova O, 2007, J MOL BIOL, V366, P1099, DOI 10.1016/j.jmb.2006.12.003; Fedorova O, 2010, J MOL BIOL, V397, P799, DOI 10.1016/j.jmb.2010.02.001; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Halls C, 2007, J MOL BIOL, V365, P835, DOI 10.1016/j.jmb.2006.09.083; Hopkins JF, 2009, NUCLEIC ACIDS RES, V37, P6205, DOI 10.1093/nar/gkp646; Huang HR, 2005, P NATL ACAD SCI USA, V102, P163, DOI 10.1073/pnas.0407896101; KOCH JL, 1992, MOL CELL BIOL, V12, P1950, DOI 10.1128/MCB.12.5.1950; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; Lamichhane R, 2010, P NATL ACAD SCI USA, V107, P4105, DOI 10.1073/pnas.0907072107; Lehmann K, 2003, CRIT REV BIOCHEM MOL, V38, P249, DOI 10.1080/713609236; Levin JG, 2005, PROG NUCLEIC ACID RE, V80, P217, DOI 10.1016/S0079-6603(05)80006-6; Linder P, 2000, CURR BIOL, V10, pR887, DOI 10.1016/S0960-9822(00)00857-5; Liu F, 2008, P NATL ACAD SCI USA, V105, P20209, DOI 10.1073/pnas.0811115106; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; MICHELS WJ, 1995, BIOCHEMISTRY-US, V34, P2965, DOI 10.1021/bi00009a028; Noah JW, 2003, BIOCHEMISTRY-US, V42, P12466, DOI 10.1021/bi035339n; Pyle AM, 2006, COLD SPRING HARB MON, V43, P469; Qin PZ, 1998, CURR OPIN STRUC BIOL, V8, P301, DOI 10.1016/S0959-440X(98)80062-6; Qin PZF, 1997, BIOCHEMISTRY-US, V36, P4718, DOI 10.1021/bi962665c; SHUMAN S, 1980, J BIOL CHEM, V255, P5396; Solem A, 2006, MOL CELL, V24, P611, DOI 10.1016/j.molcel.2006.10.032; Steiner M, 2008, P NATL ACAD SCI USA, V105, P13853, DOI 10.1073/pnas.0804034105; Steiner M, 2009, ANGEW CHEM INT EDIT, V48, P9739, DOI 10.1002/anie.200903809; Su LJ, 2005, NUCLEIC ACIDS RES, V33, P6674, DOI 10.1093/nar/gki973; Toor N, 2001, RNA, V7, P1142, DOI 10.1017/S1355838201010251; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Waldsich C, 2007, NAT STRUCT MOL BIOL, V14, P37, DOI 10.1038/nsmb1181; ZHANG A, 1995, RNA, V1, P783; Zhao R, 2009, METHODS, V49, P112, DOI 10.1016/j.ymeth.2009.04.017; ZINGLER N, 2010, NUCL ACIDS IN PRESS	35	61	62	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 21	2010	467	7318					935	U75		10.1038/nature09422	http://dx.doi.org/10.1038/nature09422			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20944626	Green Accepted			2022-12-01	WOS:000283254700031
J	Noppe, IC				Noppe, Illene C.			Sounds of My Father	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												noppei@uwgb.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2010	304	14					1535	1536		10.1001/jama.2010.1404	http://dx.doi.org/10.1001/jama.2010.1404			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662OE	20940374				2022-12-01	WOS:000282816500001
J	Smets, T; Bilsen, J; Cohen, J; Rurup, ML; Mortier, F; Deliens, L				Smets, Tinne; Bilsen, Johan; Cohen, Joachim; Rurup, Mette L.; Mortier, Freddy; Deliens, Luc			Reporting of euthanasia in medical practice in Flanders, Belgium: cross sectional analysis of reported and unreported cases	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OF-LIFE DECISIONS; PHYSICIAN-ASSISTED SUICIDE; NETHERLANDS; DEATH; LAW; NOTIFICATION	Objectives To estimate the rate of reporting of euthanasia cases to the Federal Control and Evaluation Committee and to compare the characteristics of reported and unreported cases of euthanasia. Design Cross sectional analysis. Setting Flanders, Belgium. Participants A stratified at random sample was drawn of people who died between 1 June 2007 and 30 November 2007. The certifying physician of each death was sent a questionnaire on end of life decision making in the death concerned. Main outcome measures The rate of euthanasia cases reported to the Federal Control and Evaluation Committee; physicians' reasons for not reporting cases of euthanasia; the relation between reporting and non-reporting and the characteristics of the physician and patient; the time by which life was shortened according to the physician; the labelling of the end of life decision by the physician involved; and differences in characteristics of due care between reported and unreported euthanasia cases. Results The survey response rate was 58.4% (3623/6202 eligible cases). The estimated total number of cases of euthanasia in Flanders in 2007 was 1040 (95% CI 970 to 1109), thus the incidence of euthanasia was estimated as 1.9% of all deaths (95% CI 1.6% to 2.3%). Approximately half (549/1040 (52.8%, 95% CI 43.9% to 60.5%)) of all estimated cases of euthanasia were reported to the Federal Control and Evaluation Committee. Physicians who perceived their case as euthanasia reported it in 93.1% (67/72) of cases. Cases of euthanasia were reported less often when the time by which life was shortened was less than one week compared with when the perceived life shortening was greater (37.3% v 74.1%; P<0.001). Unreported cases were generally dealt with less carefully than reported cases: a written request for euthanasia was more often absent (87.7% v 17.6% verbal request only; P<0.001), other physicians and caregivers specialised in palliative care were consulted less often (54.6% v 97.5%; 33.0% v 63.9%; P<0.001 for both), the life ending act was more often performed with opioids or sedatives (92.1% v 4.4%; P<0.001), and the drugs were more often administered by a nurse (41.3% v 0.0%; P<0.001). Conclusions One out of two euthanasia cases is reported to the Federal Control and Evaluation Committee. Most non-reporting physicians do not perceive their act as euthanasia. Countries debating legalisation of euthanasia should simultaneously consider developing a policy facilitating the due care and reporting obligations of physicians.	[Smets, Tinne; Bilsen, Johan; Cohen, Joachim; Deliens, Luc] Vrije Univ Brussel, Fac Med & Pharm, End Life Care Res Grp, B-1090 Brussels, Belgium; [Rurup, Mette L.; Deliens, Luc] Vrije Univ Amsterdam Med Ctr, Expertise Ctr Palliat Care, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Mortier, Freddy] Univ Ghent, Bioeth Inst Ghent, B-9000 Ghent, Belgium	Vrije Universiteit Brussel; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Ghent University	Smets, T (corresponding author), Vrije Univ Brussel, Fac Med & Pharm, End Life Care Res Grp, Laarbeeklaan 103, B-1090 Brussels, Belgium.	tinne.smets@vub.ac.be	Smets, Tinne/G-3988-2012; Cohen, Joachim/B-6803-2008	Cohen, Joachim/0000-0002-7224-9476; Mortier, Freddy/0000-0002-5390-3508; Smets, Tinne/0000-0003-1439-316X; Deliens, Luc/0000-0002-8158-2422	Institute for the Promotion of Innovation by Science and Technology in Flanders (Instituut voor de aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen) [050158]	Institute for the Promotion of Innovation by Science and Technology in Flanders (Instituut voor de aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This study is part of the Monitoring Quality of End of Life Care (MELC) study, a collaboration between the Vrije Universiteit Brussel, Ghent University, Antwerp University, the Scientific Institute of Public Health, all in Belgium, and VU University Medical Center Amsterdam, The Netherlands. This study is supported by a grant from the Institute for the Promotion of Innovation by Science and Technology in Flanders (Instituut voor de aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen; SBO IWT nr. 050158). The funders had no role in study design; in the collection, analysis and interpretation of the data; in the writing of the manuscript; or in the decision to submit for publication.	ADAMS M, 2001, REGULATING PHYS NEGO, P29; Bilsen J, 2009, NEW ENGL J MED, V361, P1119, DOI 10.1056/NEJMc0904292; Chambaere Kenneth, 2010, J Pain Symptom Manage, V39, pe5, DOI 10.1016/j.jpainsymman.2009.10.001; Chambaere K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-299; Deliens L, 2003, LANCET, V362, P1239, DOI 10.1016/S0140-6736(03)14520-5; Deliens L, 2000, LANCET, V356, P1806, DOI 10.1016/S0140-6736(00)03233-5; DILLMAN T, 1978, MAIL TELEPHONE SURVE; Distelmans W, 2006, PSYCHO-ONCOLOGY, V15, pS226; Distelmans W, 2008, PSYCHO-ONCOL, V17, pS222; Douglas C, 2008, BIOETHICS, V22, P388, DOI 10.1111/j.1467-8519.2008.00661.x; George RJD, 2005, BMJ-BRIT MED J, V331, P684, DOI 10.1136/bmj.331.7518.684; Keown J, 2006, J MED ETHICS, V32, P29, DOI 10.1136/jme.2004.011148; Magnusson RS, 2004, J MED ETHICS, V30, P441, DOI 10.1136/jme.2003.005090; Materstvedt LJ, 2003, PALLIATIVE MED, V17, P97, DOI 10.1191/0269216303pm673oa; Meier DE, 1998, NEW ENGL J MED, V338, P1193, DOI 10.1056/NEJM199804233381706; Mortier F, 2000, BIOETHICS, V14, P254, DOI 10.1111/1467-8519.00195; New York State Task Force on Life and the Law, 1994, DEATH IS SOUGHT ASS; Onwuteaka-Philipsen BD, 2000, SOC SCI MED, V51, P429, DOI 10.1016/S0277-9536(99)00476-1; Pollard BJ, 2001, PALLIATIVE MED, V15, P61, DOI 10.1191/026921601668201749; Rurup ML, 2008, MED CARE, V46, P1198, DOI 10.1097/MLR.0b013e31817d69e8; Smets T, 2010, MED CARE, V48, P187, DOI 10.1097/MLR.0b013e3181bd4dde; Smets T, 2009, HEALTH POLICY, V90, P181, DOI 10.1016/j.healthpol.2008.10.003; Sprung CL, 2008, CRIT CARE MED, V36, P8, DOI 10.1097/01.CCM.0000295304.99946.58; Teno Joan M, 2005, J Palliat Med, V8 Suppl 1, pS42; Van den Block L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-79; van der Heide A, 2004, LANCET, V364, P24, DOI 10.1016/S0140-6736(04)17628-9; van der Heide A, 2003, LANCET, V362, P345, DOI 10.1016/S0140-6736(03)14019-6; van der Heide A, 2007, NEW ENGL J MED, V356, P1957, DOI 10.1056/NEJMsa071143; Van Wesemael Y, 2009, HEALTH SERV RES, V44, P2180, DOI 10.1111/j.1475-6773.2009.01042.x; vanderWal G, 1996, NEW ENGL J MED, V335, P1706; Weide MCJV, 2005, ARCH INTERN MED, V165, P1698, DOI 10.1001/archinte.165.15.1698; Weide MCJVD, 2004, HEALTH POLICY, V69, P365, DOI 10.1016/j.healthpol.2004.04.010; Weyers H, 2006, SOCIOL HEALTH ILL, V28, P802, DOI 10.1111/j.1467-9566.2006.00543.x	33	46	46	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 5	2010	341								c5174	10.1136/bmj.c5174	http://dx.doi.org/10.1136/bmj.c5174			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	663JB	20923842	Green Published, hybrid			2022-12-01	WOS:000282879000004
J	Knox, SM; Lombaert, IMA; Reed, X; Vitale-Cross, L; Gutkind, JS; Hoffman, MP				Knox, S. M.; Lombaert, I. M. A.; Reed, X.; Vitale-Cross, L.; Gutkind, J. S.; Hoffman, M. P.			Parasympathetic Innervation Maintains Epithelial Progenitor Cells During Salivary Organogenesis	SCIENCE			English	Article							GLAND BRANCHING MORPHOGENESIS; SUBMANDIBULAR-GLAND; STEM-CELLS; CONDITIONAL EXPRESSION; K-RAS; DIFFERENTIATION; MECHANISMS; NERVES; LIVER; SKIN	The maintenance of a progenitor cell population as a reservoir of undifferentiated cells is required for organ development and regeneration. However, the mechanisms by which epithelial progenitor cells are maintained during organogenesis are poorly understood. We report that removal of the parasympathetic ganglion in mouse explant organ culture decreased the number and morphogenesis of keratin 5-positive epithelial progenitor cells. These effects were rescued with an acetylcholine analog. We demonstrate that acetylcholine signaling, via the muscarinic M1 receptor and epidermal growth factor receptor, increased epithelial morphogenesis and proliferation of the keratin 5-positive progenitor cells. Parasympathetic innervation maintained the epithelial progenitor cell population in an undifferentiated state, which was required for organogenesis. This mechanism for epithelial progenitor cell maintenance may be targeted for organ repair or regeneration.	[Knox, S. M.; Lombaert, I. M. A.; Reed, X.; Hoffman, M. P.] Natl Inst Dent & Craniofacial Res, Matrix & Morphogenesis Unit, Lab Cell & Dev Biol, NIH, Bethesda, MD 20892 USA; [Vitale-Cross, L.; Gutkind, J. S.] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Hoffman, MP (corresponding author), Natl Inst Dent & Craniofacial Res, Matrix & Morphogenesis Unit, Lab Cell & Dev Biol, NIH, 30 Convent Dr, Bethesda, MD 20892 USA.	mhoffman@mail.nih.gov	Gutkind, J. Silvio/J-1201-2016; Knox, Sarah Monica/GNW-5445-2022; Kim, Ji-Youn/A-5779-2017; Gutkind, J. Silvio/A-1053-2009	Gutkind, J. Silvio/0000-0002-5150-4482; VItale-Cross, Lynn/0000-0001-7850-547X	National Institute of Dental and Craniofacial Research, NIH; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000722, ZIADE000551] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors would like to thank V. N. Patel, I. T. Rebustini, L. M. Angerer, K. G. Ten-Hagen, K. M. Yamada, and S. Powers for discussions and critical reading of this manuscript. The study was supported by the Intramural Research Program of the National Institute of Dental and Craniofacial Research, NIH.	Avril-Delplanque A, 2005, STEM CELLS, V23, P992, DOI 10.1634/stemcells.2004-0197; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; COUGHLIN MD, 1975, DEV BIOL, V43, P123, DOI 10.1016/0012-1606(75)90136-0; Hai B, 2010, STEM CELLS DEV, V19, P1793, DOI 10.1089/scd.2009.0499; Hogan BLM, 1999, CELL, V96, P225, DOI 10.1016/S0092-8674(00)80562-0; Hudson DL, 2001, J HISTOCHEM CYTOCHEM, V49, P271, DOI 10.1177/002215540104900214; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lu PF, 2008, SCIENCE, V322, P1506, DOI 10.1126/science.1162783; Macias E, 2008, CANCER RES, V68, P162, DOI 10.1158/0008-5472.CAN-07-2461; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Okubo T, 2009, STEM CELLS, V27, P442, DOI 10.1634/stemcells.2008-0611; Patel VN, 2006, DIFFERENTIATION, V74, P349, DOI 10.1111/j.1432-0436.2006.00088.x; Pavlov I. P., 1906, SCIENCE, V24, P613, DOI DOI 10.1126/SCIENCE.24.620.613; Peters B, 2001, MOL BIOL CELL, V12, P1775, DOI 10.1091/mbc.12.6.1775; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Proctor GB, 2007, AUTON NEUROSCI-BASIC, V133, P3, DOI 10.1016/j.autneu.2006.10.006; Raimondi AR, 2006, AM J PATHOL, V168, P1654, DOI 10.2353/ajpath.2006.050847; Rebustini IT, 2009, DEV CELL, V17, P482, DOI 10.1016/j.devcel.2009.07.016; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Schafer MKH, 1998, NEUROSCIENCE, V84, P361, DOI 10.1016/S0306-4522(97)80196-0; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; Steinberg Z, 2005, DEVELOPMENT, V132, P1223, DOI 10.1242/dev.01690; Vitale-Cross L, 2004, CANCER RES, V64, P8804, DOI 10.1158/0008-5472.CAN-04-2623	24	223	226	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1645	1647		10.1126/science.1192046	http://dx.doi.org/10.1126/science.1192046			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20929848	Green Accepted			2022-12-01	WOS:000282098100041
J	Rubtsov, YP; Niec, RE; Josefowicz, S; Li, L; Darce, J; Mathis, D; Benoist, C; Rudensky, AY				Rubtsov, Yuri P.; Niec, Rachel E.; Josefowicz, Steven; Li, Li; Darce, Jaime; Mathis, Diane; Benoist, Christophe; Rudensky, Alexander Y.			Stability of the Regulatory T Cell Lineage in Vivo	SCIENCE			English	Article							TRANSCRIPTION FACTOR FOXP3; DIFFERENTIATION; SELF; AUTOIMMUNITY; HOMEOSTASIS; GENERATION; INDUCTION; ORIGIN	Tissue maintenance and homeostasis can be achieved through the replacement of dying cells by differentiating precursors or self-renewal of terminally differentiated cells or relies heavily on cellular longevity in poorly regenerating tissues. Regulatory T cells (T(reg) cells) represent an actively dividing cell population with critical function in suppression of lethal immune-mediated inflammation. The plasticity of T(reg) cells has been actively debated because it could factor importantly in protective immunity or autoimmunity. By using inducible labeling and tracking of T(reg) cell fate in vivo, or transfers of highly purified T(reg) cells, we have demonstrated notable stability of this cell population under physiologic and inflammatory conditions. Our results suggest that self-renewal of mature T(reg) cells serves as a major mechanism of maintenance of the T(reg) cell lineage in adult mice.	[Rubtsov, Yuri P.; Niec, Rachel E.; Josefowicz, Steven; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Rubtsov, Yuri P.; Niec, Rachel E.; Josefowicz, Steven; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Li, Li; Darce, Jaime; Mathis, Diane; Benoist, Christophe] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Harvard Medical School	Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA.	rudenska@mskcc.org	Li, Li/C-8478-2011; Rubtsov, Yury P/A-8227-2014; Josefowicz, Steven Z/B-8716-2011	Rubtsov, Yury P/0000-0001-9175-3013; Niec, Rachel/0000-0002-8525-3693; josefowicz, steven/0000-0001-7453-779X	NIH [GM07739, AI51530]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034206, R01AI051530, R37AI051530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Forbush, T. Chu, L. Karpik, A. Bravo, J. Herlihy, P. Zarin, G. Gerard, A. Ortiz-Lopes, and K. Hattori for assistance with mouse colony management; F. Costantini for R26Y mice; V. Kuchroo for Foxp3-IRES-GFP mice; P. Chambon for Cre-ERT2 plasmid; E. Pamer, C. Shi, and E. Leiner for L. monocytogenes and assistance with experiments; and P. Fink and K. Simmons for cells from Rag2pGFP mice and helpful discussion. R.E.N. was supported by NIH Medical Scientist Training Program grant GM07739. A.Y.R. is an investigator with the Howard Hughes Medical Institute, and this work was also supported by grant AI51530 from the NIH to C. B. and D.M.	Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Bayer AL, 2007, J IMMUNOL, V178, P4062, DOI 10.4049/jimmunol.178.7.4062; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Hori S, 2003, ADV IMMUNOL, V81, P331, DOI 10.1016/S0065-2776(03)81008-8; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Malek TR, 2008, J CLIN IMMUNOL, V28, P635, DOI 10.1007/s10875-008-9235-y; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zhou XY, 2009, CURR OPIN IMMUNOL, V21, P281, DOI 10.1016/j.coi.2009.05.007	27	496	509	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1667	1671		10.1126/science.1191996	http://dx.doi.org/10.1126/science.1191996			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20929851	Green Accepted			2022-12-01	WOS:000282098100048
J	Yang, JY; Reth, M				Yang, Jianying; Reth, Michael			Oligomeric organization of the B-cell antigen receptor on resting cells	NATURE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; IG-ALPHA/IG-BETA; LIVING CELLS; PROTEIN INTERACTIONS; ACTIVATION; VISUALIZATION; INITIATION; ITAM; BCR	B lymphocytes are activated by many different antigens to produce specific antibodies protecting higher organisms from infection. To detect its cognate antigen, each B cell contains up to 120,000 B-cell antigen receptor (BCR) complexes on its cell surface. How these abundant receptors stay silent on resting B cells and how they can be activated by a molecularly diverse set of ligands is poorly understood(1). Here we show, with the use of a quantitative bifluorescence complementation assay (BiFC)(2,3), that the BCR has an intrinsic ability to form oligomers on the surface of living cells. A BCR mutant that fails to form oligomers is more active and cannot be expressed stably on the B-cell surface, whereas BiFC-stabilized BCR oligomers are less active and more strongly expressed on the surface. We propose that oligomers are the autoinhibited form of the BCR and that it is the shift from closed BCR oligomers to clustered monomers that drives B-cell activation in a way that is independent of the structural input from the antigen.	[Yang, Jianying; Reth, Michael] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, Dept Mol Immunol, Fac Biol, D-79108 Freiburg, Germany; [Yang, Jianying; Reth, Michael] Max Planck Inst Immunobiol, D-79108 Freiburg, Germany	University of Freiburg; Max Planck Society	Reth, M (corresponding author), Univ Freiburg, Ctr Biol Signalling Studies BIOSS, Dept Mol Immunol, Fac Biol, Stubeweg 51, D-79108 Freiburg, Germany.	michael.reth@bioss.uni-freiburg.de		YANG, JIANYING/0000-0001-8197-5413	Excellence Initiative of the German Federal and State Governments [EXC 294]; Deutsche Forschungsgemeinschaft [SFB746]; FRISYS	Excellence Initiative of the German Federal and State Governments; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); FRISYS	We thank L. Leclercq, P. Nielsen, H. Jumaa and W. Schamel for critical reading of this manuscript. This study was supported by the Excellence Initiative of the German Federal and State Governments (EXC 294), by the Deutsche Forschungsgemeinschaft through SFB746 and by the FRISYS programme.	Chiorazzi N, 2003, ANNU REV IMMUNOL, V21, P841, DOI 10.1146/annurev.immunol.21.120601.141018; Engels N, 2008, ADV IMMUNOL, V97, P251, DOI 10.1016/S0065-2776(08)00005-9; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Harwood NE, 2008, IMMUNITY, V28, P609, DOI 10.1016/j.immuni.2008.04.007; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Kawauchi K, 2002, INT J HEMATOL, V75, P508, DOI 10.1007/BF02982115; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kim JH, 2005, J IMMUNOL, V175, P147, DOI 10.4049/jimmunol.175.1.147; Kim YM, 2006, P NATL ACAD SCI USA, V103, P3327, DOI 10.1073/pnas.0511315103; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Lankester AC, 1996, LEUKEMIA LYMPHOMA, V24, P27, DOI 10.3109/10428199609045711; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Meixlsperger S, 2007, IMMUNITY, V26, P323, DOI 10.1016/j.immuni.2007.01.012; Minguet S, 2007, IMMUNITY, V26, P43, DOI 10.1016/j.immuni.2006.10.019; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; Payelle-Brogard B, 2002, BRIT J HAEMATOL, V118, P976, DOI 10.1046/j.1365-2141.2002.03759.x; Peng SL, 2009, AUTOIMMUN REV, V8, P179, DOI 10.1016/j.autrev.2008.07.040; Pugh-Bernard AE, 2006, CURR OPIN RHEUMATOL, V18, P451, DOI 10.1097/01.bor.0000240353.99808.5f; Reth M, 2001, TRENDS IMMUNOL, V22, P356, DOI 10.1016/S1471-4906(01)01964-0; Rolli V, 2002, MOL CELL, V10, P1057, DOI 10.1016/S1097-2765(02)00739-6; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Schrum Adam G, 2007, Sci STKE, V2007, ppl2, DOI 10.1126/stke.3892007pl2; Semichon M, 1997, LEUKEMIA, V11, P1921, DOI 10.1038/sj.leu.2400832; Siegers GM, 2006, INT IMMUNOL, V18, P1385, DOI 10.1093/intimm/dxl072; Storch B, 2007, EUR J IMMUNOL, V37, P252, DOI 10.1002/eji.200636667; Tolar P, 2005, NAT IMMUNOL, V6, P1168, DOI 10.1038/ni1262; Tolar P, 2008, IMMUNOL REV, V221, P64, DOI 10.1111/j.1600-065X.2008.00583.x; Treanor B, 2010, IMMUNITY, V32, P187, DOI 10.1016/j.immuni.2009.12.005; VENKITARAMAN AR, 1991, NATURE, V352, P777, DOI 10.1038/352777a0	31	125	127	0	29	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2010	467	7314					465	U117		10.1038/nature09357	http://dx.doi.org/10.1038/nature09357			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KO	20818374				2022-12-01	WOS:000282090200044
J	Spies, S; Schipper, K; Nollet, F; Abma, TA				Spies, Stefan; Schipper, Karen; Nollet, Frans; Abma, Tineke A.			A Patient's Journey Duchenne muscular dystrophy	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Spies, Stefan; Schipper, Karen] Reinaerde, NL-3502 GJ Utrecht, Netherlands; [Schipper, Karen; Abma, Tineke A.] Vrije Univ Amsterdam Med Ctr, EMGO Inst, Dept Med Humanities, NL-1007 MB Amsterdam, Netherlands; [Nollet, Frans] Univ Amsterdam, Acad Med Ctr, Dept Rehabil, NL-1100 DD Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam	Schipper, K (corresponding author), Reinaerde, Post Box 3364, NL-3502 GJ Utrecht, Netherlands.	k.schipper@vumc.nl; f.nollet@amc.nl	Abma, Tineke/AER-4580-2022	Abma, Tineke/0000-0002-8902-322X					0	5	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 7	2010	341								c4364	10.1136/bmj.c4364	http://dx.doi.org/10.1136/bmj.c4364			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	649ZI	20823012				2022-12-01	WOS:000281814900008
J	Malzahn, E; Ciprianidis, S; Kaldi, K; Schafmeier, T; Brunner, M				Malzahn, Erik; Ciprianidis, Stilianos; Kaldi, Krisztina; Schafmeier, Tobias; Brunner, Michael			Photoadaptation in Neurospora by Competitive Interaction of Activating and Inhibitory LOV Domains	CELL			English	Article							BLUE-LIGHT PHOTORECEPTOR; CIRCADIAN GENE-EXPRESSION; CLOCK GENE; TRANSCRIPTION FACTOR; BINDING DOMAINS; WHITE COLLAR-1; PROTEIN; TRANSFORMATION; ORGANIZATION; ARABIDOPSIS	Light responses and photoadaptation of Neurospora depend on the photosensory light-oxygen-voltage (LOV) domains of the circadian transcription factor White Collar Complex (WCC) and its negative regulator VIVID (VVD). We found that light triggers LOV-mediated dimerization of the WCC. The activated WCC induces expression of VVD, which then disrupts and inactivates the WCC homodimers by the competitive formation of WCC-VVD heterodimers, leading to photoadaptation. During the day, expression levels of VVD correlate with light intensity, allowing photoadaptation over several orders of magnitude. At night, previously synthesized VVD serves as a molecular memory of the brightness of the preceding day and suppresses responses to light cues of lower intensity. We show that VVD is essential to discriminate between day and night, even in naturally ambiguous photoperiods with moonlight.	[Malzahn, Erik; Ciprianidis, Stilianos; Schafmeier, Tobias; Brunner, Michael] Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany; [Kaldi, Krisztina] Semmelweis Univ, Dept Physiol, H-1444 Budapest, Hungary	Ruprecht Karls University Heidelberg; Semmelweis University	Brunner, M (corresponding author), Heidelberg Univ, Biochem Ctr, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	michael.brunner@bzh.uni-heidelberg.de	Káldi, Krisztina/X-4080-2019	Kaldi, Krisztina/0000-0002-5724-0182; Brunner, Michael/0000-0001-9798-3047	DFG [BR 1375-3-1, SFB 638]; FCI [GP1188]; Hungarian OTKA [K 68960]; ETT [477-05]	DFG(German Research Foundation (DFG)); FCI(Fonds der Chemischen Industrie); Hungarian OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); ETT	We thank Johanna Scholz and Krisztina Makara for excellent technical assistance. We are grateful to Cornelia Ulbrich for her experienced help with setting up the yeast two-hybrid system. This work was supported by the DFG grant BR 1375-3-1 to M.B. and T.S., SFB 638 and the FCI to M.B., GP1188 to E.M. and by an EMBO-HHMI startup grant by the Hungarian OTKA (K 68960) and ETT (477-05) to K.K., M.B. is a member of CellNetworks and S.C. is a member of HBIGS.	Bachleitner W, 2007, P NATL ACAD SCI USA, V104, P3538, DOI 10.1073/pnas.0606870104; Belden WJ, 2007, GENE DEV, V21, P1494, DOI 10.1101/gad.1551707; Brunner M, 2006, GENE DEV, V20, P1061, DOI 10.1101/gad.1410406; Cho HY, 2007, PLANT PHYSIOL, V143, P517, DOI 10.1104/pp.106.089839; Christie JM, 2002, PLANT J, V32, P205, DOI 10.1046/j.1365-313X.2002.01415.x; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Corchnoy SB, 2003, J BIOL CHEM, V278, P724, DOI 10.1074/jbc.M209119200; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Doyle S, 2007, COLD SPRING HARB SYM, V72, P499, DOI 10.1101/sqb.2007.72.003; Elvin M, 2005, GENE DEV, V19, P2593, DOI 10.1101/gad.349305; Foster Russell G, 2007, Methods Mol Biol, V362, P3; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; He QY, 2005, GENE DEV, V19, P2888, DOI 10.1101/gad.1369605; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Helfrich-Forster C, 2002, ZOOLOGY, V105, P297, DOI 10.1078/0944-2006-00074; Herzberg C, 2007, PROTEOMICS, V7, P4032, DOI 10.1002/pmic.200700491; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; James P, 1996, GENETICS, V144, P1425; Kaiserli E, 2009, PLANT CELL, V21, P3226, DOI 10.1105/tpc.109.067876; Kaldi K, 2006, EMBO REP, V7, P199, DOI 10.1038/sj.embor.7400595; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; Krauss U, 2009, J BACTERIOL, V191, P7234, DOI 10.1128/JB.00923-09; Liu Y, 2003, J BIOL RHYTHM, V18, P195, DOI 10.1177/0748730403018003002; Loros JJ, 2007, COLD SPRING HARB SYM, V72, P201, DOI 10.1101/sqb.2007.72.067; McClung CR, 2008, CURR OPIN PLANT BIOL, V11, P514, DOI 10.1016/j.pbi.2008.06.010; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Merrow M, 2007, COLD SPRING HARB SYM, V72, P279, DOI 10.1101/sqb.2007.72.032; Merrow M, 1999, NATURE, V399, P584, DOI 10.1038/21190; Nayak SK, 2007, CELL MOL LIFE SCI, V64, P144, DOI 10.1007/s00018-006-5581-1; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Schafmeier T, 2006, GENE DEV, V20, P297, DOI 10.1101/gad.360906; Schafmeier T, 2005, CELL, V122, P235, DOI 10.1016/j.cell.2005.05.032; Schafmeier T, 2008, GENE DEV, V22, P3397, DOI 10.1101/gad.507408; Schwerdtfeger C, 2003, EMBO J, V22, P4846, DOI 10.1093/emboj/cdg451; Schwerdtfeger C, 2001, MOL MICROBIOL, V39, P1080, DOI 10.1046/j.1365-2958.2001.02306.x; Siepka SM, 2007, COLD SPRING HARB SYM, V72, P251, DOI 10.1101/sqb.2007.72.052; SMITH KM, 2010, CELL IN PRESS, DOI DOI 10.1128/EC.00154-10; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Tan Y, 2004, J BIOL RHYTHM, V19, P135, DOI 10.1177/0748730404263015; Vitalini MW, 2006, J BIOL RHYTHM, V21, P432, DOI 10.1177/0748730406294396; Woelfle MA, 2006, J BIOL RHYTHM, V21, P419, DOI 10.1177/0748730406294418; Zoltowski BD, 2008, BIOCHEMISTRY-US, V47, P7012, DOI 10.1021/bi8007017; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128; Zoltowski BD, 2009, NAT CHEM BIOL, V5, P827, DOI 10.1038/nchembio.210	47	115	120	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2010	142	5					762	772		10.1016/j.cell.2010.08.010	http://dx.doi.org/10.1016/j.cell.2010.08.010			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	646FL	20813262	Bronze			2022-12-01	WOS:000281523200019
J	McKenna, NJ; O'Malley, BW				McKenna, Neil J.; O'Malley, Bert W.			SnapShot: Nuclear Receptors I	CELL			English	Editorial Material							UNION-OF-PHARMACOLOGY; SUPERFAMILY		[McKenna, Neil J.; O'Malley, Bert W.] Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine	McKenna, NJ (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.			McKenna, Neil/0000-0001-6689-0104	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434] Funding Source: NIH RePORTER; NIDDK NIH HHS [U19-DK62434] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Auwerx J, 1999, CELL, V97, P161; Flamant F, 2006, PHARMACOL REV, V58, P705, DOI 10.1124/pr.58.4.3; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; Moore DD, 2006, PHARMACOL REV, V58, P742, DOI 10.1124/pr.58.4.6; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Scarpin Katherine M, 2009, Nucl Recept Signal, V7, pe009, DOI 10.1621/nrs.07009; Sonoda J, 2008, FEBS LETT, V582, P2, DOI 10.1016/j.febslet.2007.11.016; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Zhou Changcheng, 2009, Nucl Recept Signal, V7, pe001, DOI 10.1621/nrs.07001	10	12	12	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 3	2010	142	5							882.e1	10.1016/j.cell.2010.08.026	http://dx.doi.org/10.1016/j.cell.2010.08.026			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	646FL	20813267	Bronze			2022-12-01	WOS:000281523200024
J	Fisher, DE; James, WD				Fisher, David E.; James, William D.			Indoor Tanning - Science, Behavior, and Policy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MELANOMA		[Fisher, David E.] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Fisher, David E.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Fisher, David E.] Harvard Univ, Sch Med, Boston, MA USA; [James, William D.] Univ Penn, Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Pennsylvania	Fisher, DE (corresponding author), Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA.		Fisher, David/AAH-2878-2019		NIAMS NIH HHS [R01 AR043369] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; Eller MS, 1996, P NATL ACAD SCI USA, V93, P1087, DOI 10.1073/pnas.93.3.1087; Lazovich D, 2010, CANCER EPIDEM BIOMAR, V19, P1557, DOI 10.1158/1055-9965.EPI-09-1249; Mosher CE, 2010, ARCH DERMATOL, V146, P412, DOI 10.1001/archdermatol.2009.385; Purdue MP, 2008, J INVEST DERMATOL, V128, P2905, DOI 10.1038/jid.2008.159	5	71	72	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 2	2010	363	10					901	903		10.1056/NEJMp1005999	http://dx.doi.org/10.1056/NEJMp1005999			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	645GW	20818900	Green Accepted			2022-12-01	WOS:000281441500003
J	Logan, GD; Crump, MJC				Logan, Gordon D.; Crump, Matthew J. C.			Cognitive Illusions of Authorship Reveal Hierarchical Error Detection in Skilled Typists	SCIENCE			English	Article							NEURAL SYSTEM; HANDS	The ability to detect errors is an essential component of cognitive control. Studies of error detection in humans typically use simple tasks and propose single-process theories of detection. We examined error detection by skilled typists and found illusions of authorship that provide evidence for two error-detection processes. We corrected errors that typists made and inserted errors in correct responses. When asked to report errors, typists took credit for corrected errors and accepted blame for inserted errors, claiming authorship for the appearance of the screen. However, their typing rate showed no evidence of these illusions, slowing down after corrected errors but not after inserted errors. This dissociation suggests two error-detection processes: one sensitive to the appearance of the screen and the other sensitive to keystrokes.	[Logan, Gordon D.; Crump, Matthew J. C.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37203 USA	Vanderbilt University	Logan, GD (corresponding author), Vanderbilt Univ, Dept Psychol, Nashville, TN 37203 USA.	gordon.logan@vanderbilt.edu	Crump, Matthew/A-9103-2011	Crump, Matthew/0000-0002-5612-0090; Logan, Gordon/0000-0002-8301-7726	NSF [BCS 0646588, BCS 0957074]	NSF(National Science Foundation (NSF))	We thank J. D. Schall for comments on the manuscript. This research was supported by grants BCS 0646588 and BCS 0957074 from the NSF.	Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Botvinick MM, 2008, TRENDS COGN SCI, V12, P201, DOI 10.1016/j.tics.2008.02.009; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Cooper R, 2000, COGN NEUROPSYCHOL, V17, P297, DOI 10.1080/026432900380427; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gordon AM, 1995, EXP BRAIN RES, V107, P281; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI [10.1037//0033-295X.109.4.679, 10.1037/0033-295X.109.4.679]; Knoblich G, 2004, J EXP PSYCHOL HUMAN, V30, P657, DOI 10.1037/0096-1523.30.4.657; Lashley K. S., 1951, CEREBRAL MECH BEHAV, P112, DOI DOI 10.1093/RFS/HHQ153; Liu X, 2010, MEM COGNITION, V38, P474, DOI 10.3758/MC.38.4.474; Logan GD, 2009, PSYCHOL SCI, V20, P1296, DOI 10.1111/j.1467-9280.2009.02442.x; LONG J, 1976, ERGONOMICS, V19, P93, DOI 10.1080/00140137608931517; NIELSEN TI, 1963, SCAND J PSYCHOL, V4, P225, DOI 10.1111/j.1467-9450.1963.tb01326.x; NORMAN DA, 1981, PSYCHOL REV, V88, P1, DOI 10.1037/0033-295X.88.1.1; RABBITT P, 1978, ERGONOMICS, V21, P945, DOI 10.1080/00140137808931800; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; RUMELHART DE, 1982, COGNITIVE SCI, V6, P1; SALTHOUSE TA, 1986, PSYCHOL BULL, V99, P303, DOI 10.1037/0033-2909.99.3.303; SHAFFER LH, 1976, PSYCHOL REV, V83, P375, DOI 10.1037/0033-295X.83.5.375; Wegner DM, 2002, BRADFORD BOOKS, P1; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI 10.1037/0033-295x.111.4.931	22	96	96	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 29	2010	330	6004					683	686		10.1126/science.1190483	http://dx.doi.org/10.1126/science.1190483			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	672KB	21030660				2022-12-01	WOS:000283580600052
J	Chen, YH; Hu, L; Punta, M; Bruni, R; Hillerich, B; Kloss, B; Rost, B; Love, J; Siegelbaum, SA; Hendrickson, WA				Chen, Yu-hang; Hu, Lei; Punta, Marco; Bruni, Renato; Hillerich, Brandan; Kloss, Brian; Rost, Burkhard; Love, James; Siegelbaum, Steven A.; Hendrickson, Wayne A.			Homologue structure of the SLAC1 anion channel for closing stomata in leaves	NATURE			English	Article							ABSCISIC-ACID; CHLORIDE CHANNEL; GUARD-CELL; PLASMA-MEMBRANE; SULFITE EFFLUX; PROTEIN; SELECTIVITY; MODEL; GENE; CONSERVATION	The plant SLAC1 anion channel controls turgor pressure in the aperture-defining guard cells of plant stomata, thereby regulating the exchange of water vapour and photosynthetic gases in response to environmental signals such as drought or high levels of carbon dioxide. Here we determine the crystal structure of a bacterial homologue (Haemophilus influenzae) of SLAC1 at 1.20 angstrom resolution, and use structure-inspired mutagenesis to analyse the conductance properties of SLAC1 channels. SLAC1 is a symmetrical trimer composed from quasi-symmetrical subunits, each having ten transmembrane helices arranged from helical hairpin pairs to form a central five-helix transmembrane pore that is gated by an extremely conserved phenylalanine residue. Conformational features indicate a mechanism for control of gating by kinase activation, and electrostatic features of the pore coupled with electrophysiological characteristics indicate that selectivity among different anions is largely a function of the energetic cost of ion dehydration.	[Chen, Yu-hang; Rost, Burkhard; Hendrickson, Wayne A.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Chen, Yu-hang; Punta, Marco; Bruni, Renato; Hillerich, Brandan; Kloss, Brian; Rost, Burkhard; Love, James; Hendrickson, Wayne A.] New York Struct Biol Ctr, NYCOMPS, New York, NY 10027 USA; [Hu, Lei; Siegelbaum, Steven A.] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Punta, Marco; Rost, Burkhard] Tech Univ Munich, Dept Comp Sci, D-85748 Munich, Germany; [Punta, Marco; Rost, Burkhard] Tech Univ Munich, Inst Adv Study, D-85748 Munich, Germany; [Siegelbaum, Steven A.] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Siegelbaum, Steven A.; Hendrickson, Wayne A.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Hendrickson, Wayne A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Columbia University; Columbia University; Technical University of Munich; Technical University of Munich; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University	Hendrickson, WA (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.	wayne@convex.hhmi.columbia.edu	Rost, Burkhard/A-1908-2016; Punta, Marco/ABH-4698-2020; Hu, Lei/B-1455-2009	Rost, Burkhard/0000-0003-0179-8424; Punta, Marco/0000-0002-0050-0676; Kloss, Brian/0000-0003-0130-8739; Bruni, Renato/0000-0002-2312-0254	New York Consortium on Membrane Protein Structure (NYCOMPS) from the NIGMS Protein Structure Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034102, U54GM075026, U54GM095315] Funding Source: NIH RePORTER	New York Consortium on Membrane Protein Structure (NYCOMPS) from the NIGMS Protein Structure Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Mancia, L. Shapiro and M. Zhou for discussions; P. Rodriguez and A. Morrison for help with cloning and expression; J. Cheung, M. Collins, C. Min, S. Ye and Z. Zhang for advice in protein chemistry and crystallography; J. Schwanof and R. Abramowitz for help with synchrotron experiments; J. Riley for help with Xenopus oocyte injections; and M. Su for advice on the PSI-BLAST analysis of SLAC relatives. This project was supported in part by an award to the New York Consortium on Membrane Protein Structure (NYCOMPS) from the NIGMS Protein Structure Initiative. Beamline X4A at the National Synchrotron Light Source (NSLS), a DOE facility at Brookhaven National Laboratory, is supported by the New York Structural Biology Center.	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FATT P, 1958, J PHYSIOL-LONDON, V142, P516, DOI 10.1113/jphysiol.1958.sp006034; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Geiger D, 2009, P NATL ACAD SCI USA, V106, P21425, DOI 10.1073/pnas.0912021106; Grobler J, 1995, YEAST, V11, P1485, DOI 10.1002/yea.320111503; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Kendrick BS, 2001, ANAL BIOCHEM, V299, P136, DOI 10.1006/abio.2001.5411; Kouyama T, 2010, J MOL BIOL, V396, P564, DOI 10.1016/j.jmb.2009.11.061; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lechenne B, 2007, MICROBIOL-SGM, V153, P905, DOI 10.1099/mic.0.2006/003335-0; Lee SC, 2009, P NATL ACAD SCI USA, V106, P21419, DOI 10.1073/pnas.0910601106; LEUNG J, 1994, SCIENCE, V264, P1448, DOI 10.1126/science.7910981; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; MEYER K, 1994, SCIENCE, V264, P1452, DOI 10.1126/science.8197457; Meyer S, 2010, PLANT J, V63, P1054, DOI 10.1111/j.1365-313X.2010.04302.x; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Negi J, 2008, NATURE, V452, P483, DOI 10.1038/nature06720; Nishimura N, 2010, PLANT J, V61, P290, DOI 10.1111/j.1365-313X.2009.04054.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Park H, 2000, YEAST, V16, P881, DOI 10.1002/1097-0061(200007)16:10<881::AID-YEA576>3.3.CO;2-V; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Picollo A, 2009, NAT STRUCT MOL BIOL, V16, P1294, DOI 10.1038/nsmb.1704; Punta Marco, 2009, Journal of Structural and Functional Genomics, V10, P255, DOI 10.1007/s10969-009-9071-1; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Saji S, 2008, PLANT CELL PHYSIOL, V49, P2, DOI 10.1093/pcp/pcm174; Sasaki T, 2010, PLANT CELL PHYSIOL, V51, P354, DOI 10.1093/pcp/pcq016; SCHMIDT C, 1994, PLANT PHYSIOL, V106, P383, DOI 10.1104/pp.106.1.383; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; SCHROEDER JI, 1992, P NATL ACAD SCI USA, V89, P5025, DOI 10.1073/pnas.89.11.5025; SCHROEDER JI, 1989, NATURE, V338, P427, DOI 10.1038/338427a0; Sirichandra C, 2009, J EXP BOT, V60, P1439, DOI 10.1093/jxb/ern340; TAYLOR DE, 1994, J BACTERIOL, V176, P2740, DOI 10.1128/JB.176.9.2740-2742.1994; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vahisalu T, 2008, NATURE, V452, P487, DOI 10.1038/nature06608; Vahisalu T, 2010, PLANT J, V62, P442, DOI 10.1111/j.1365-313X.2010.04159.x; WALTER EG, 1991, GENE, V101, P1, DOI 10.1016/0378-1119(91)90217-Y; WRIGHT EM, 1977, PHYSIOL REV, V57, P109, DOI 10.1152/physrev.1977.57.1.109; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yin P, 2009, NAT STRUCT MOL BIOL, V16, P1230, DOI 10.1038/nsmb.1730	57	92	98	6	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 28	2010	467	7319					1074	U157		10.1038/nature09487	http://dx.doi.org/10.1038/nature09487			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671XW	20981093	Green Accepted			2022-12-01	WOS:000283548600040
J	Shin, J; Bossenz, M; Chung, Y; Ma, H; Byron, M; Taniguchi-Ishigaki, N; Zhu, XC; Jiao, BW; Hall, LL; Green, MR; Jones, SN; Hermans-Borgmeyer, I; Lawrence, JB; Bach, I				Shin, JongDae; Bossenz, Michael; Chung, Young; Ma, Hong; Byron, Meg; Taniguchi-Ishigaki, Naoko; Zhu, Xiaochun; Jiao, Baowei; Hall, Lisa L.; Green, Michael R.; Jones, Stephen N.; Hermans-Borgmeyer, Irm; Lawrence, Jeanne B.; Bach, Ingolf			Maternal Rnf12/RLIM is required for imprinted X-chromosome inactivation in mice	NATURE			English	Article							HOMEODOMAIN TRANSCRIPTION FACTORS; EMBRYONIC STEM-CELLS; DOSAGE COMPENSATION; LIM COFACTORS; EXPRESSION; GENE; LINES; RLIM; DIFFERENTIATION; DISRUPTION	Two forms of X-chromosome inactivation (XCI) ensure the selective silencing of female sex chromosomes during mouse embryogenesis. Imprinted XCI begins with the detection of Xist RNA expression on the paternal X chromosome (Xp) at about the four-cell stage of embryonic development. In the embryonic tissues of the inner cell mass, a random form of XCI occurs in blastocysts that inactivates either Xp or the maternal X chromosome (Xm)(1,2). Both forms of XCI require the non-coding Xist RNA that coats the inactive X chromosome from which it is expressed. Xist has crucial functions in the silencing of X-linked genes, including Rnf12 (refs 3, 4) encoding the ubiquitin ligase RLIM (RING finger LIM-domain-interacting protein). Here we show, by targeting a conditional knockout of Rnf12 to oocytes where RLIM accumulates to high levels, that the maternal transmission of the mutant X chromosome (Delta m) leads to lethality in female embryos as a result of defective imprinted XCI. We provide evidence that in Delta m female embryos the initial formation of Xist clouds and Xp silencing are inhibited. In contrast, embryonic stem cells lacking RLIM are able to form Xist clouds and silence at least some X-linked genes during random XCI. These results assign crucial functions to the maternal deposit of Rnf12/RLIM for the initiation of imprinted XCI.	[Shin, JongDae; Ma, Hong; Taniguchi-Ishigaki, Naoko; Zhu, Xiaochun; Jiao, Baowei; Green, Michael R.; Bach, Ingolf] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Green, Michael R.; Bach, Ingolf] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Zhu, Xiaochun; Green, Michael R.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Byron, Meg; Hall, Lisa L.; Jones, Stephen N.; Lawrence, Jeanne B.] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01605 USA; [Bossenz, Michael; Hermans-Borgmeyer, Irm] Univ Hamburg, Ctr Mol Neurobiol, D-20246 Hamburg, Germany; [Chung, Young] Stem Cell & Regenerat Med Int Inc, Marlborough, MA 01752 USA; [Chung, Young] CHA Univ, Sch Med, Seoul 135081, South Korea	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Hamburg; Pochon Cha University	Bach, I (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	ingolf.bach@umassmed.edu	Chung, Young Gie/AAC-8149-2020	JIAO, BAOWEI/0000-0001-8559-9160; Lawrence, Jeanne/0000-0001-6572-3128	National Institutes of Health (National Cancer Institute) [R01CA131158]; National Institute of Diabetes and Digestive and Kidney Diseases [5 P30 DK32520, GM053234]; NATIONAL CANCER INSTITUTE [R01CA131158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033977, R01GM053234] Funding Source: NIH RePORTER	National Institutes of Health (National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank V. Boyartchuk, T. Fazzio, E. Heard, P. Kaufman, O. Rando, D. Riethmacher and J. Sharp for advice and/or reagents, D. Kim for help in ES cell analysis, and J. Zhu for statistics. I.B. is a member of the University of Massachusetts DERC (DK32520). This work was supported by National Institutes of Health grants R01CA131158 (National Cancer Institute) and 5 P30 DK32520 (National Institute of Diabetes and Digestive and Kidney Diseases) to I.B., and GM053234 to J.B.L.	Bach I, 1999, NAT GENET, V22, P394, DOI 10.1038/11970; BARLOW PW, 1972, J EMBRYOL EXP MORPH, V27, P447; BECK F, 1995, DEV DYNAM, V204, P219, DOI 10.1002/aja.1002040302; Behringer R., 2003, MANIPULATING MOUSE E; Chung Y, 2006, NATURE, V439, P216, DOI 10.1038/nature04277; Chung Y, 2008, CELL STEM CELL, V2, P113, DOI 10.1016/j.stem.2007.12.013; Chung Y, 2006, METHOD ENZYMOL, V418, P135, DOI 10.1016/S0076-6879(06)18009-X; Clemson CM, 2006, P NATL ACAD SCI USA, V103, P7688, DOI 10.1073/pnas.0601069103; FEINBERG RF, 1989, LAB INVEST, V61, P20; Gungor C, 2007, P NATL ACAD SCI USA, V104, P15000, DOI 10.1073/pnas.0703738104; Guidi CJ, 2001, MOL CELL BIOL, V21, P3598, DOI 10.1128/MCB.21.10.3598-3603.2001; Hall LL, 2002, P NATL ACAD SCI USA, V99, P8677, DOI 10.1073/pnas.132468999; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; Johnsen SA, 2009, CANCER RES, V69, P128, DOI 10.1158/0008-5472.CAN-08-1630; Jonkers I, 2009, CELL, V139, P999, DOI 10.1016/j.cell.2009.10.034; Kalantry S, 2009, NATURE, V460, P647, DOI 10.1038/nature08161; Lee JT, 2000, CELL, V103, P17, DOI 10.1016/S0092-8674(00)00101-X; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Marks H, 2009, GENOME RES, V19, P1361, DOI 10.1101/gr.092643.109; Novik EI, 2006, TISSUE ENG, V12, P1515, DOI 10.1089/ten.2006.12.1515; NUSSLEINVOLHARD C, 1987, SCIENCE, V238, P1675, DOI 10.1126/science.3686007; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; OSHIMA RG, 1983, DEV BIOL, V99, P447, DOI 10.1016/0012-1606(83)90294-4; Ostendorff HP, 2000, GENOMICS, V69, P120, DOI 10.1006/geno.2000.6311; Ostendorff HP, 2006, DEV DYNAM, V235, P786, DOI 10.1002/dvdy.20669; Ostendorff HP, 2002, NATURE, V416, P99, DOI 10.1038/416099a; Panning B, 2004, METHOD ENZYMOL, V376, P419; Patrat C, 2009, P NATL ACAD SCI USA, V106, P5198, DOI 10.1073/pnas.0810683106; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stavropoulos N, 2001, P NATL ACAD SCI USA, V98, P10232, DOI 10.1073/pnas.171243598; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Tursun B, 2005, GENE DEV, V19, P2307, DOI 10.1101/gad.1340605; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007	37	120	122	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 21	2010	467	7318					977	U157		10.1038/nature09457	http://dx.doi.org/10.1038/nature09457			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20962847	Green Accepted			2022-12-01	WOS:000283254700041
J	Arie, S				Arie, Sophie			International Health Hungry for profit	BRITISH MEDICAL JOURNAL			English	Editorial Material												ariesophie@yahoo.co.uk						Defourny Isabelle, 2007, MANAGEMENT MODERATE; Diop EHI, 2003, AM J CLIN NUTR, V78, P302, DOI 10.1093/ajcn/78.2.302; PRUDHON C, 21 SCN; World Health Organization, 2007, JOINT STAT COMM BAS	4	4	4	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 6	2010	341								c5221	10.1136/bmj.c5221	http://dx.doi.org/10.1136/bmj.c5221			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	663JE	20926480				2022-12-01	WOS:000282879400005
J	Rosenthal, MS				Rosenthal, Marjorie S.			Anticipatory Guidance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												marjorie.rosenthal@yale.edu							0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2010	304	13					1421	1422		10.1001/jama.2010.1388	http://dx.doi.org/10.1001/jama.2010.1388			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658SO	20924000				2022-12-01	WOS:000282509900001
J	Stein, CM; Ray, WA				Stein, C. Michael; Ray, Wayne A.			The Ethics of Placebo in Studies with Fracture End Points in Osteoporosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LOW BONE-DENSITY; POSTMENOPAUSAL WOMEN; CLINICAL-TRIALS; PREVENT FRACTURES; DEVELOPING-COUNTRIES; ZOLEDRONIC ACID; UNETHICAL USE; ISSUES; RECOMMENDATIONS; DESIGN		[Stein, C. Michael] Vanderbilt Univ, Sch Med, Dept Med, Div Clin Pharmacol & Rheumatol, Nashville, TN 37212 USA; [Ray, Wayne A.] Vanderbilt Univ, Sch Med, Dept Prevent Med, Div Pharmacoepidemiol, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University	Stein, CM (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Clin Pharmacol & Rheumatol, Nashville, TN 37212 USA.							Al-Khatib SM, 2001, SCIENCE, V292, P2013, DOI 10.1126/science.1057783; Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Boers M, 2002, NETH J MED, V60, P310; Brody BA, 2003, J BONE MINER RES, V18, P1105, DOI 10.1359/jbmr.2003.18.6.1105; Cranney A, 2002, ENDOCR REV, V23, P570, DOI 10.1210/er.2001-9002; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Cummings SR, 2008, NEW ENGL J MED, V359, P697, DOI 10.1056/NEJMoa0800743; Cummings SR, 2010, NEW ENGL J MED, V362, P686, DOI 10.1056/NEJMoa0808692; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Delmas PD, 2002, OSTEOPOROSIS INT, V13, P1, DOI 10.1007/s198-002-8331-3; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; European Medicines Agency Committee for Medicinal Products for Human Use, GUID EV MED PROD TRE; Fink HA, 2003, OSTEOPOROSIS INT, V14, P69, DOI 10.1007/s00198-002-1314-y; *FOOD DRUG ADM, 2002, CTR DRUG EV RES ART; Greenspan SL, 2007, ANN INTERN MED, V146, P326, DOI 10.7326/0003-4819-146-5-200703060-00005; Khosla S, 2009, NEW ENGL J MED, V361, P818, DOI 10.1056/NEJMe0905480; Lurie P, 1997, NEW ENGL J MED, V337, P853, DOI 10.1056/NEJM199709183371212; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; MacLean C, 2008, ANN INTERN MED, V148, P197, DOI 10.7326/0003-4819-148-3-200802050-00198; Michels KB, 2003, BIOETHICS, V17, P188, DOI 10.1111/1467-8519.00332; National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, BELM REP ETH PRINC G; Pace C, 2003, CRIT CARE MED, V31, pS121, DOI 10.1097/01.CCM.0000054907.33928.48; Qaseem A, 2008, ANN INTERN MED, V149, P404, DOI 10.7326/0003-4819-149-6-200809160-00007; Reginster JY, 2008, ARTHRITIS RHEUM-US, V58, P1687, DOI 10.1002/art.23461; Reginster JY, 2006, OSTEOPOROSIS INT, V17, P1, DOI 10.1007/s00198-005-1984-3; ROTHMAN KJ, 1994, NEW ENGL J MED, V331, P394, DOI 10.1056/NEJM199408113310611; Shapiro HT, 2001, NEW ENGL J MED, V345, P139, DOI 10.1056/NEJM200107123450212; Shea B, 2004, COCHRANE DB SYST REV, V1; Silverman SL, 2008, J BONE MINER RES, V23, P159, DOI 10.1359/JBMR.070905; Stein CM, 1999, LANCET, V353, P400, DOI 10.1016/S0140-6736(98)01373-7; Stevenson M, 2005, HEALTH TECHNOL ASSES, V9, P1; Tang BMP, 2007, LANCET, V370, P657, DOI 10.1016/S0140-6736(07)61342-7; Tanne JH, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1618; Temple R, 2000, ANN INTERN MED, V133, P455, DOI 10.7326/0003-4819-133-6-200009190-00014; WMA, WMA DECL HELS ETH PR	35	16	16	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2010	363	14					1367	1370		10.1056/NEJMsb1006120	http://dx.doi.org/10.1056/NEJMsb1006120			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	655TD	20879888				2022-12-01	WOS:000282271500015
J	Rutz, C; Bluff, LA; Reed, N; Troscianko, J; Newton, J; Inger, R; Kacelnik, A; Bearhop, S				Rutz, Christian; Bluff, Lucas A.; Reed, Nicola; Troscianko, Jolyon; Newton, Jason; Inger, Richard; Kacelnik, Alex; Bearhop, Stuart			The Ecological Significance of Tool Use in New Caledonian Crows	SCIENCE			English	Article							STABLE-ISOTOPES; CORVUS-MONEDULOIDES; WILD CHIMPANZEES; NITROGEN; WOOD	Tool use is so rare in the animal kingdom that its evolutionary origins cannot be traced with comparative analyses. Valuable insights can be gained from investigating the ecological context and adaptive significance of tool use under contemporary conditions, but obtaining robust observational data is challenging. We assayed individual-level tool-use dependence in wild New Caledonian crows by analyzing stable isotope profiles of the birds' feathers, blood, and putative food sources. Bayesian diet-mixing models revealed that a substantial amount of the crows' protein and lipid intake comes from prey obtained with stick tools-wood-boring beetle larvae. Our calculations provide estimates of larva-intake rates and show that just a few larvae can satisfy a crow's daily energy requirements, highlighting the substantial rewards available to competent tool users.	[Rutz, Christian; Bluff, Lucas A.; Kacelnik, Alex] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Reed, Nicola; Inger, Richard; Bearhop, Stuart] Univ Exeter, Sch Biosci, Ctr Ecol & Conservat, Penryn TR10 9EZ, Cornwall, England; [Troscianko, Jolyon] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Newton, Jason] Scottish Univ Environm Res Ctr, NERC, Life Sci Mass Spectrometry Facil, E Kilbride G75 0QF, Lanark, Scotland	University of Oxford; University of Exeter; University of Birmingham; Scottish Universities Research & Reactor Center; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Rutz, C (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	christian.rutz@zoo.ox.ac.uk	Inger, Richard/D-3445-2009; Bearhop, Stuart/G-3105-2012; Newton, Jason/A-9536-2009	Inger, Richard/0000-0003-1660-3706; Bearhop, Stuart/0000-0002-5864-0129; Newton, Jason/0000-0001-7594-3693; Rutz, Christian/0000-0001-5187-7417; Troscianko, Jolyon/0000-0001-9071-2594	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/C517392/1, BB/G023913/1]; Cogito Foundation [R-120/07]; NERC [NE/F021690/1]; Province Sud (New Caledonia); Rhodes Scholarship; University of Oxford; Linacre College, Oxford; Evolution and Ecology Research Centre, University of New South Wales, Sydney; Biotechnology and Biological Sciences Research Council [BB/C517392/1, BB/G023913/1] Funding Source: researchfish; Natural Environment Research Council [lsmsf010002, NE/F021690/1] Funding Source: researchfish; BBSRC [BB/G023913/1] Funding Source: UKRI; NERC [lsmsf010002] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cogito Foundation; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Province Sud (New Caledonia); Rhodes Scholarship; University of Oxford; Linacre College, Oxford; Evolution and Ecology Research Centre, University of New South Wales, Sydney; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank N. Barre, S. Blancher, and J. Paimbou-Ayouma for logistical support in New Caledonia. Fieldwork was carried out with permissions from the Centre de Recherches sur la Biologie des Populations d'Oiseaux (France) and the Province Sud (New Caledonia), and was in accordance with the University of Oxford's procedures for local ethical review. We are grateful to M. Collett, I. Owens, B. Sheldon, and three referees for comments on the manuscript. The Edward Grey Institute of Field Ornithology (Oxford) kindly allowed us to dry blood samples in one of their ovens. Supported by the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/C517392/1 to A. K.; BB/G023913/1 to C. R.), the Cogito Foundation (R-120/07 to A. K.), NERC (NE/F021690/1 to S. B.), the Province Sud (New Caledonia; to C. R.), a Rhodes Scholarship (to L. A. B.), the University of Oxford (grant to C. R.), and a Junior Research Fellowship at Linacre College, Oxford (to C. R.). C. R. is a BBSRC David Phillips Fellow and currently holds a Visiting Fellowship at the Evolution and Ecology Research Centre, University of New South Wales, Sydney.	Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Bluff LA, 2007, COMP COGN BEHAV REV, V2, P1; Bluff LA, 2010, P ROY SOC B-BIOL SCI, V277, P1377, DOI 10.1098/rspb.2009.1953; Boesch C., 2000, CHIMPANZEES TAI FORE; GOODALL J, 1964, NATURE, V201, P1264, DOI 10.1038/2011264a0; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; Hunt G.R., 2006, ACTA ZOOL SINICA, V52, P622; Hunt GR, 2002, EMU, V102, P283, DOI 10.1071/MU01037; Hunt GR, 2000, EMU, V100, P109, DOI 10.1071/MU9852; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Kenward B, 2005, NATURE, V433, P121, DOI 10.1038/433121a; Mann J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003868; NISHIDA T, 1982, J HUM EVOL, V11, P73, DOI 10.1016/S0047-2484(82)80033-X; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Pearson SF, 2003, OECOLOGIA, V135, P516, DOI 10.1007/s00442-003-1221-8; Rutz C, 2007, SCIENCE, V318, P765, DOI 10.1126/science.1146788; SMITH AC, 1981, EUPHORBIACEAE FLORA, V2; Tebbich S, 2002, ECOL LETT, V5, P656, DOI 10.1046/j.1461-0248.2002.00370.x; Yamakoshi G, 1998, AM J PHYS ANTHROPOL, V106, P283, DOI 10.1002/(SICI)1096-8644(199807)106:3<283::AID-AJPA2>3.0.CO;2-O	19	60	63	4	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 17	2010	329	5998					1523	1526		10.1126/science.1192053	http://dx.doi.org/10.1126/science.1192053			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650RK	20847272				2022-12-01	WOS:000281869000042
J	Michele, TM; Pinheiro, S; Iyasu, S				Michele, Theresa M.; Pinheiro, Simone; Iyasu, Solomon			The Safety of Tiotropium -- The FDA's Conclusions.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Michele, Theresa M.] US FDA, Ctr Drug Evaluat & Res, Off New Drugs, Div Pulm Allergy & Rheumatol Prod, Silver Spring, MD USA; [Pinheiro, Simone; Iyasu, Solomon] US FDA, Ctr Drug Evaluat & Res, Off Surveillance & Epidemiol, Div Epidemiol, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Michele, TM (corresponding author), US FDA, Ctr Drug Evaluat & Res, Off New Drugs, Div Pulm Allergy & Rheumatol Prod, Silver Spring, MD USA.							Food and Drug Administration, 2009, EARL COMM ONG SAF RE; Singh S, 2009, JAMA-J AM MED ASSOC, V301, P1227; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; World Health Organization, WORLD HLTH REP 2008	4	80	84	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2010	363	12					1097	1099		10.1056/NEJMp1008502	http://dx.doi.org/10.1056/NEJMp1008502			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649TD	20843240				2022-12-01	WOS:000281795800001
J	Ramin, B; MacPherson, P				Ramin, Brodie; MacPherson, Paul			Easily Missed? Human brucellosis	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ramin, Brodie] Univ Ottawa, Ottawa Hosp, Ottawa, ON K1H 8L6, Canada; [MacPherson, Paul] Univ Ottawa, Ottawa Hlth Res Inst, Ottawa Hosp, Div Infect Dis, Ottawa, ON K1H 8L6, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute	Ramin, B (corresponding author), Univ Ottawa, Ottawa Hosp, Ottawa, ON K1H 8L6, Canada.	bramin@ottawahospital.on.ca						Andriopoulos P, 2007, INT J INFECT DIS, V11, P52, DOI 10.1016/j.ijid.2005.10.011; Ariza J, 2007, PLOS MED, V4, P1872, DOI 10.1371/journal.pmed.0040317; BUZGAN T, INT J INFEC IN PRESS; Centers for Disease Control and Prevention, 2007, BRUC; Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4; Memish ZA, 2004, J TRAVEL MED, V11, P49, DOI 10.2310/7060.2004.13551; Nicoletti P, 2002, VET MICROBIOL, V90, P5, DOI 10.1016/S0378-1135(02)00209-2; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Pappas G, 2005, NEW ENGL J MED, V352, P2325, DOI 10.1056/NEJMra050570; Vassalos CM, 2009, REV MED MICROBIOL, V20, P63, DOI 10.1097/MRM.0b013e3283344b5a	10	9	14	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 10	2010	341								c4545	10.1136/bmj.c4545	http://dx.doi.org/10.1136/bmj.c4545			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649ZL	20833741				2022-12-01	WOS:000281815200007
J	Howard, A; Wilson, M				Howard, Andrew; Wilson, Mary			Easily Missed? Septic arthritis in children	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRANSIENT SYNOVITIS; HIP; DIFFERENTIATION; CHILDHOOD		[Howard, Andrew] Hosp Sick Children, Div Orthopaed Surg, Toronto, ON M5G 1X8, Canada; [Wilson, Mary] Marathon Family Hlth Team, Marathon, ON P0T 2E0, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Howard, A (corresponding author), Hosp Sick Children, Div Orthopaed Surg, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	andrew.howard@sickkids.ca		Howard, Andrew/0000-0001-7226-6471				Baskett A, 2009, PEDIATR EMERG CARE, V25, P78, DOI 10.1097/PEC.0b013e318196ea43; Caird MS, 2006, J BONE JOINT SURG AM, V88A, P1251, DOI 10.2106/JBJS.E.00216; Choi IH, 2005, CLIN ORTHOP RELAT R, P102, DOI 10.1097/01.blo.0000162412.93473.68; Forlin E, 2008, J PEDIATR ORTHOPED, V28, P524, DOI 10.1097/BPO.0b013e31817bb079; Givon U, 2004, J PEDIATR ORTHOPED, V24, P266, DOI 10.1097/01241398-200405000-00006; Goergens ED, 2005, J PAEDIATR CHILD H, V41, P59, DOI 10.1111/j.1440-1754.2005.00538.x; Gordon JE, 2002, J PEDIATR ORTHOPED, V22, P312, DOI 10.1097/00004694-200205000-00008; Kocher MS, 2004, J BONE JOINT SURG AM, V86A, P1629, DOI 10.2106/00004623-200408000-00005; Kocher MS, 1999, J BONE JOINT SURG AM, V81A, P1662, DOI 10.2106/00004623-199912000-00002; Luhmann SJ, 2004, J BONE JOINT SURG AM, V86A, P956, DOI 10.2106/00004623-200405000-00011; Nunn TR, 2007, J BONE JOINT SURG BR, V89B, P100, DOI 10.1302/0301-620X.89B1.17940; Peltola H, 2009, CLIN INFECT DIS, V48, P1201, DOI 10.1086/597582; Riise OR, 2008, PEDIATRICS, V121, pE299, DOI 10.1542/peds.2007-0291	13	3	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 27	2010	341								c4407	10.1136/bmj.c4407Easily	http://dx.doi.org/10.1136/bmj.c4407Easily			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645IJ	20801999				2022-12-01	WOS:000281446300016
J	Ginhoux, F; Greter, M; Leboeuf, M; Nandi, S; See, P; Gokhan, S; Mehler, MF; Conway, SJ; Ng, LG; Stanley, ER; Samokhvalov, IM; Merad, M				Ginhoux, Florent; Greter, Melanie; Leboeuf, Marylene; Nandi, Sayan; See, Peter; Gokhan, Solen; Mehler, Mark F.; Conway, Simon J.; Ng, Lai Guan; Stanley, E. Richard; Samokhvalov, Igor M.; Merad, Miriam			Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages	SCIENCE			English	Article							MOUSE BRAIN; YOLK-SAC; CELLS; RECEPTOR; ORIGIN; MICE; HEMATOPOIESIS; FRACTALKINE; PHAGOCYTES; MONOCYTES	Microglia are the resident macrophages of the central nervous system and are associated with the pathogenesis of many neurodegenerative and brain inflammatory diseases; however, the origin of adult microglia remains controversial. We show that postnatal hematopoietic progenitors do not significantly contribute to microglia homeostasis in the adult brain. In contrast to many macrophage populations, we show that microglia develop in mice that lack colony stimulating factor-1 (CSF-1) but are absent in CSF-1 receptor-deficient mice. In vivo lineage tracing studies established that adult microglia derive from primitive myeloid progenitors that arise before embryonic day 8. These results identify microglia as an ontogenically distinct population in the mononuclear phagocyte system and have implications for the use of embryonically derived microglial progenitors for the treatment of various brain disorders.	[Ginhoux, Florent; Greter, Melanie; Leboeuf, Marylene; Merad, Miriam] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; [Ginhoux, Florent; Greter, Melanie; Leboeuf, Marylene; Merad, Miriam] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA; [Ginhoux, Florent; See, Peter; Ng, Lai Guan] BIOPOLIS, Singapore Immunol Network SIgN, Singapore 138648, Singapore; [Nandi, Sayan; Stanley, E. Richard] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Gokhan, Solen; Mehler, Mark F.] Albert Einstein Coll Med, Inst Brain Disorders & Neural Regenerat, Rose F Kennedy Ctr Res Intellectual & Dev Disabil, Bronx, NY 10461 USA; [Gokhan, Solen; Mehler, Mark F.] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA; [Mehler, Mark F.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Mehler, Mark F.] Albert Einstein Coll Med, Dept Psychiat, Bronx, NY 10461 USA; [Mehler, Mark F.] Albert Einstein Coll Med, Dept Behav Sci, Bronx, NY 10461 USA; [Conway, Simon J.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Samokhvalov, Igor M.] RIKEN Kobe, CDB, Lab Stem Cell Biol, Kobe, Hyogo 6500047, Japan	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Indiana University System; Indiana University Bloomington; RIKEN	Ginhoux, F (corresponding author), Mt Sinai Sch Med, Dept Gene & Cell Med, 1425 Madison Ave, New York, NY 10029 USA.	Florent_ginhoux@immunol.a-star.edu.sg; Miriam.Merad@mssm.edu	Ng, Lai Guan/E-5673-2011; Ng, Lai Guan/N-6980-2019; Stanley, Evan R/J-9154-2013	Ng, Lai Guan/0000-0003-1905-3586; Ng, Lai Guan/0000-0003-1905-3586; Stanley, Evan R/0000-0002-2910-2065; See, Peter/0000-0003-4428-7763; Greter, Melanie/0000-0002-7220-5369	NIH [CA112100, HL086899, AI080884, CA32551, CA26504, MH66290, NS38902]; RIKEN; National Science Foundation of Switzerland; NATIONAL CANCER INSTITUTE [R37CA026504, R01CA026504, R01CA032551, R01CA112100] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086899, R01HL060714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038902] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RIKEN; National Science Foundation of Switzerland(Swiss National Science Foundation (SNSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Nishikawa, H. Snoeck, and P. S. Frenette for intellectual input in the study; the RIKEN CDB Laboratory for Animal Resources and Genetic Engineering for providing the Runx1-MER-Cre-MER mice; G. Hoeffel, X. H. Zong, R. Basu and H. Ketchum for technical assistance; and L. Robinson for critical review and editing of the manuscript. This work was supported by NIH grants CA112100, HL086899, and AI080884 to M. M.; CA32551 and CA26504 to E. R. S.; and MH66290 and NS38902 to M. M. I. M. S. is supported by a grant from RIKEN Strategic Programs for Research and Development (President's Fund). M. G. is supported by the National Science Foundation of Switzerland. Runx1-MER-Cre-MER mice have CDB accession. no. CDB0524K (www.cdb.riken.jp/arg/mutant%20mice%20list.html).	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; BLEVINS G, 1995, J NEUROSCI RES, V40, P535, DOI 10.1002/jnr.490400412; Bogunovic M, 2006, J EXP MED, V203, P2627, DOI 10.1084/jem.20060667; Chan WY, 2007, BRAIN RES REV, V53, P344, DOI 10.1016/j.brainresrev.2006.11.002; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Cuadros MA, 1998, PROG NEUROBIOL, V56, P173, DOI 10.1016/S0301-0082(98)00035-5; Garceau V, 2010, J LEUKOCYTE BIOL, V87, P753, DOI 10.1189/jlb.0909624; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Koushik SV, 2001, FASEB J, V15, P1209, DOI 10.1096/fj.00-0696fje; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; LEONG SK, 1992, GLIA, V6, P39, DOI 10.1002/glia.440060106; Lichanska AM, 2000, EXP HEMATOL, V28, P601, DOI 10.1016/S0301-472X(00)00157-0; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; LING EA, 1979, J ANAT, V128, P847; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Ovchinnikov DA, 2008, J LEUKOCYTE BIOL, V83, P430, DOI 10.1189/jlb.0807585; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; SOROKIN SP, 1992, ANAT REC, V232, P527, DOI 10.1002/ar.1092320410; Vallieres L, 2003, J NEUROSCI, V23, P5197; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822	31	2930	3002	16	240	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 5	2010	330	6005					841	845		10.1126/science.1194637	http://dx.doi.org/10.1126/science.1194637			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675SY	20966214	Green Accepted			2022-12-01	WOS:000283855700049
J	Gilbert, LA; Hemann, MT				Gilbert, Luke A.; Hemann, Michael T.			DNA Damage-Mediated Induction of a Chemoresistant Niche	CELL			English	Article							BONE-MARROW; HEPATOCELLULAR-CARCINOMA; SIGNALING PATHWAY; BREAST-CANCER; IN-VIVO; CELLS; SENESCENCE; INTERLEUKIN-6; SURVIVAL; CHEMOTHERAPY	While numerous cell-intrinsic processes are known to play decisive roles in chemotherapeutic response, relatively little is known about the impact of the tumor microenvironment on therapeutic outcome. Here, we use a well-established mouse model of Burkitt's lymphoma to show that paracrine factors in the tumor microenvironment modulate lymphoma cell survival following the administration of genotoxic chemotherapy. Specifically, IL-6 and Timp-1 are released in the thymus in response to DNA damage, creating a "chemo-resistant niche'' that promotes the survival of a minimal residual tumor burden and serves as a reservoir for eventual tumor relapse. Notably, IL-6 is released acutely from thymic endothelial cells in a p38-dependent manner following genotoxic stress, and this acute secretory response precedes the gradual induction of senescence in tumor-associated stromal cells. Thus, conventional chemotherapies can induce tumor regression while simultaneously eliciting stress responses that protect subsets of tumor cells in select anatomical locations from drug action.	[Gilbert, Luke A.; Hemann, Michael T.] MIT, Koch Inst Integrat Canc Res MIT, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Hemann, MT (corresponding author), MIT, Koch Inst Integrat Canc Res MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	hemann@mit.edu	Gilbert, Luke/AAC-5300-2019	Gilbert, Luke/0000-0001-5854-0825	NIH [RO1 CA128803]; Ludwig Center for Molecular Oncology at MIT; MIT; NATIONAL CANCER INSTITUTE [R01CA128803] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Center for Molecular Oncology at MIT; MIT; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Holly Criscione and Tyler Miller for their experimental assistance. We thank Corbin Meacham for assistance with the cell migration assay. We would also like to acknowledge Eliza Vasile in the Koch Institute Microscopy Core Facility and Glen Paradis in the Koch Institute Flow Cytometry Core Facility for advice and services. Roderick Bronson provided expert pathology analysis, and Justin Pritchard performed bioinformatic analysis of cytokine arrays. We are grateful to Corbin Meacham, David Feldser, and Ross Dickins for critically reading the manuscript and the entire Hemann lab for helpful discussions. M.T.H. is a Rita Allen Fellow and the Latham Family Career Development Assistant Professor of Biology and is supported by NIH RO1 CA128803 and Ludwig Center for Molecular Oncology at MIT. L.A.G. is supported by the MIT Herman Eisen fellowship.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Burgess DJ, 2008, P NATL ACAD SCI USA, V105, P9053, DOI 10.1073/pnas.0803513105; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Corradini P, 1999, LEUKEMIA, V13, P1691, DOI 10.1038/sj.leu.2401559; DELREZ M, 1978, EXPERIENTIA, V34, P1221, DOI 10.1007/BF01922970; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Eckstein N, 2009, CANCER RES, V69, P2996, DOI 10.1158/0008-5472.CAN-08-3153; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Gu L, 2005, BIOORGAN MED CHEM, V13, P4269, DOI 10.1016/j.bmc.2005.04.022; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Holen KD, 2001, LANCET ONCOL, V2, P290, DOI 10.1016/S1470-2045(00)00324-7; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Igntiadis M, 2008, EUR J CANCER, V44, P2726, DOI 10.1016/j.ejca.2008.09.033; Jourdan M, 2000, CELL DEATH DIFFER, V7, P1244, DOI 10.1038/sj.cdd.4400758; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Lambert E, 2003, BIOCHEM J, V372, P767, DOI 10.1042/BJ20030187; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Morrison AJ, 2005, CELL CYCLE, V4, P568; MULLERHERMELINK HK, 1987, AM J PATHOL, V129, P242; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Rebouissou S, 2009, NATURE, V457, P200, DOI 10.1038/nature07475; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Salgado R, 2003, INT J CANCER, V103, P642, DOI 10.1002/ijc.10833; SEYMOUR JF, 1995, J CLIN ONCOL, V13, P575, DOI 10.1200/JCO.1995.13.3.575; Sfikakis PP, 2005, EUR J CLIN INVEST, V35, P380, DOI 10.1111/j.1365-2362.2005.01499.x; Sharpless NE, 2006, NAT REV DRUG DISCOV, V5, P741, DOI 10.1038/nrd2110; Trikha M, 2003, CLIN CANCER RES, V9, P4653; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Williams RT, 2007, GENE DEV, V21, P2283, DOI 10.1101/gad.1588607; Wong VWS, 2009, INT J CANCER, V124, P2766, DOI 10.1002/ijc.24281; Xenidis N, 2009, J CLIN ONCOL, V27, P2177, DOI 10.1200/JCO.2008.18.0497; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529	39	317	330	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 29	2010	143	3					355	366		10.1016/j.cell.2010.09.043	http://dx.doi.org/10.1016/j.cell.2010.09.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672RF	21029859	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000283603900010
J	Hemberger, M; Pedersen, R				Hemberger, Myriam; Pedersen, Roger			Epigenome Disruptors	SCIENCE			English	Editorial Material							PLURIPOTENT STEM-CELLS; DNA METHYLATION; PROMOTER; GENOME; LINES		[Hemberger, Myriam] Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB22 3AT, England; [Pedersen, Roger] Univ Cambridge, Anne McLaren Lab Regenerat Med, Cambridge CB2 0SZ, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge	Hemberger, M (corresponding author), Babraham Inst, Lab Dev Genet & Imprinting, Babraham Res Campus, Cambridge CB22 3AT, England.	myriam.hemberger@bbsrc.ac.uk		Hemberger, Myriam/0000-0003-3332-6958	Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C230] Funding Source: Medline; Medical Research Council [G0600275] Funding Source: Medline; BBSRC [BBS/E/B/0000C230] Funding Source: UKRI; MRC [G0600275] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Allegrucci C, 2007, HUM MOL GENET, V16, P1253, DOI 10.1093/hmg/ddm074; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Dean W, 1998, DEVELOPMENT, V125, P2273; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Hesson LB, 2010, CURR OPIN GENET DEV, V20, P290, DOI 10.1016/j.gde.2010.02.005; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Yamanaka S, 2010, CELL STEM CELL, V7, P1, DOI 10.1016/j.stem.2010.06.009; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	16	9	10	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 29	2010	330	6004					598	599		10.1126/science.1199006	http://dx.doi.org/10.1126/science.1199006			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672KB	21030637				2022-12-01	WOS:000283580600025
J	Baker, M				Baker, Monya			The search for association	NATURE			English	Editorial Material							GENOME-WIDE ASSOCIATION; COMMON; VARIANTS											Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Burkhardt R, 2008, ARTERIOSCL THROM VAS, V28, P2078, DOI 10.1161/ATVBAHA.108.172288; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Pang AW, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r52; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661	10	22	22	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 28	2010	467	7319					1135	U150		10.1038/4671135a	http://dx.doi.org/10.1038/4671135a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671XW	20981103	Bronze			2022-12-01	WOS:000283548600053
J	Inoue, K; Kohda, T; Sugimoto, M; Sado, T; Ogonuki, N; Matoba, S; Shiura, H; Ikeda, R; Mochida, K; Fujii, T; Sawai, K; Otte, AP; Tian, XC; Yang, XZ; Ishino, F; Abe, K; Ogura, A				Inoue, Kimiko; Kohda, Takashi; Sugimoto, Michihiko; Sado, Takashi; Ogonuki, Narumi; Matoba, Shogo; Shiura, Hirosuke; Ikeda, Rieko; Mochida, Keiji; Fujii, Takashi; Sawai, Ken; Otte, Arie P.; Tian, X. Cindy; Yang, Xiangzhong; Ishino, Fumitoshi; Abe, Kuniya; Ogura, Atsuo			Impeding Xist Expression from the Active X Chromosome Improves Mouse Somatic Cell Nuclear Transfer	SCIENCE			English	Article							INACTIVATION; CLONING; MICE	Cloning mammals by means of somatic cell nuclear transfer (SCNT) is highly inefficient because of erroneous reprogramming of the donor genome. Reprogramming errors appear to arise randomly, but the nature of nonrandom, SCNT-specific errors remains elusive. We found that Xist, a noncoding RNA that inactivates one of the two X chromosomes in females, was ectopically expressed from the active X (Xa) chromosome in cloned mouse embryos of both sexes. Deletion of Xist on Xa showed normal global gene expression and resulted in about an eight-to ninefold increase in cloning efficiency. We also identified an Xist-independent mechanism that specifically down-regulated a subset of X-linked genes through somatic-type repressive histone blocks. Thus, we have identified nonrandom reprogramming errors in mouse cloning that can be altered to improve the efficiency of SCNT methods.	[Inoue, Kimiko; Sugimoto, Michihiko; Ogonuki, Narumi; Matoba, Shogo; Shiura, Hirosuke; Ikeda, Rieko; Mochida, Keiji; Abe, Kuniya; Ogura, Atsuo] RIKEN, BioResource Ctr, Tsukuba, Ibaraki 3050024, Japan; [Inoue, Kimiko; Abe, Kuniya; Ogura, Atsuo] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Kohda, Takashi; Ishino, Fumitoshi] Tokyo Med & Dent Univ, Med Res Inst, Tokyo 1138510, Japan; [Sado, Takashi] Kyushu Univ, Med Inst Bioregulat, Fukuoka 8128582, Japan; [Fujii, Takashi; Sawai, Ken] Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan; [Otte, Arie P.] Univ Amsterdam, Swammerdam Inst Life Sci, NL-1018 TV Amsterdam, Netherlands; [Tian, X. Cindy; Yang, Xiangzhong] Univ Connecticut, Ctr Regenerat Biol, Storrs, CT 06269 USA; [Tian, X. Cindy; Yang, Xiangzhong] Univ Connecticut, Dept Anim Sci, Storrs, CT 06269 USA; [Ogura, Atsuo] Univ Tokyo, Fac ofMedicine, Ctr Dis Biol & Integrat Med, Tokyo 1130033, Japan	RIKEN; University of Tsukuba; Tokyo Medical & Dental University (TMDU); Kyushu University; Iwate University; University of Amsterdam; University of Connecticut; University of Connecticut; University of Tokyo	Ogura, A (corresponding author), RIKEN, BioResource Ctr, Tsukuba, Ibaraki 3050024, Japan.	ogura@rtc.riken.go.jp	Sado, Takashi/AAI-1689-2019; Ogura, Atsuo/J-3916-2014; MATOBA, Shogo/D-9995-2016; Kohda, Takashi/C-2879-2014	Ogura, Atsuo/0000-0003-0447-1988; MATOBA, Shogo/0000-0003-0474-232X; Sado, Takashi/0000-0002-1232-0250; Shiura, Hirosuke/0000-0003-2553-6971; Kohda, Takashi/0000-0002-6856-5601	Ministry of Education, Culture, Sports, Science and Technology; NOVARTIS Foundation (Japan) for the Promotion of Science; Grants-in-Aid for Scientific Research [19061001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NOVARTIS Foundation (Japan) for the Promotion of Science(Novartis); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The mice in which Xist had been knocked out (RBRC 01260) were provided by the RIKEN BioResource Center. This research was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology and NOVARTIS Foundation (Japan) for the Promotion of Science. The H3K9me2 antibody used for chromatin immunoprecipitation on chip was a kind gift from H. Kimura. We thank M. Tachibana, Y. Shinkai, H. Koseki, T. H. Endo, and S. L. Marjani for their invaluable suggestions. The microarray data have been deposited in the Gene Expression Omnibus and given the series accession number GSE23181.	Bao SQ, 2005, EMBO REP, V6, P748, DOI 10.1038/sj.embor.7400461; Fulka J, 2004, NAT BIOTECHNOL, V22, P25, DOI 10.1038/nbt0104-25; Huynh KD, 2005, NAT REV GENET, V6, P410, DOI 10.1038/nrg1604; Inoue K, 2002, SCIENCE, V295, P297, DOI 10.1126/science.295.5553.297; Inoue K, 2006, J CELL SCI, V119, P1985, DOI 10.1242/jcs.02913; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; McDonald LE, 1998, GENOMICS, V54, P379, DOI 10.1006/geno.1998.5570; Meissner A, 2006, DEV DYNAM, V235, P2460, DOI 10.1002/dvdy.20915; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Nolen LD, 2005, DEV BIOL, V279, P525, DOI 10.1016/j.ydbio.2005.01.016; Ogonuki N, 2002, NAT GENET, V30, P253, DOI 10.1038/ng841; Sado T, 2005, DEV CELL, V9, P159, DOI 10.1016/j.devcel.2005.05.015; SALIDO EC, 1992, NAT GENET, V2, P196, DOI 10.1038/ng1192-196; Sung LY, 2006, NAT GENET, V38, P1323, DOI 10.1038/ng1895; Tanaka S, 2001, BIOL REPROD, V65, P1813, DOI 10.1095/biolreprod65.6.1813; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Xue F, 2002, NAT GENET, V31, P216, DOI 10.1038/ng900; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973	18	177	195	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					496	499		10.1126/science.1194174	http://dx.doi.org/10.1126/science.1194174			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20847234				2022-12-01	WOS:000283329100037
J	Lobo, MK; Covington, HE; Chaudhury, D; Friedman, AK; Sun, HS; Damez-Werno, D; Dietz, DM; Zaman, S; Koo, JW; Kennedy, PJ; Mouzon, E; Mogri, M; Neve, RL; Deisseroth, K; Han, MH; Nestler, EJ				Lobo, Mary Kay; Covington, Herbert E., III; Chaudhury, Dipesh; Friedman, Allyson K.; Sun, HaoSheng; Damez-Werno, Diane; Dietz, David M.; Zaman, Samir; Koo, Ja Wook; Kennedy, Pamela J.; Mouzon, Ezekiell; Mogri, Murtaza; Neve, Rachael L.; Deisseroth, Karl; Han, Ming-Hu; Nestler, Eric J.			Cell Type-Specific Loss of BDNF Signaling Mimics Optogenetic Control of Cocaine Reward	SCIENCE			English	Article							CONDITIONED-PLACE PREFERENCE; MESOLIMBIC DOPAMINE SYSTEM; NUCLEUS-ACCUMBENS; IN-VIVO; BASAL GANGLIA; NEUROTROPHIC FACTOR; DELTA-FOSB; KINASE-B; RECEPTOR; NEURONS	The nucleus accumbens is a key mediator of cocaine reward, but the distinct roles of the two subpopulations of nucleus accumbens projection neurons, those expressing dopamine D1 versus D2 receptors, are poorly understood. We show that deletion of TrkB, the brain-derived neurotrophic factor (BDNF) receptor, selectively from D1+ or D2+ neurons oppositely affects cocaine reward. Because loss of TrkB in D2+ neurons increases their neuronal excitability, we next used optogenetic tools to control selectively the firing rate of D1+ and D2+ nucleus accumbens neurons and studied consequent effects on cocaine reward. Activation of D2+ neurons, mimicking the loss of TrkB, suppresses cocaine reward, with opposite effects induced by activation of D1+ neurons. These results provide insight into the molecular control of D1+ and D2+ neuronal activity as well as the circuit-level contribution of these cell types to cocaine reward.	[Lobo, Mary Kay; Covington, Herbert E., III; Sun, HaoSheng; Damez-Werno, Diane; Dietz, David M.; Zaman, Samir; Koo, Ja Wook; Kennedy, Pamela J.; Mouzon, Ezekiell; Han, Ming-Hu; Nestler, Eric J.] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA; [Mogri, Murtaza; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Icahn School of Medicine at Mount Sinai; Stanford University; Massachusetts Institute of Technology (MIT)	Nestler, EJ (corresponding author), Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA.	eric.nestler@mssm.edu	Dietz, David/J-9458-2015; Han, Ming-Hu/G-8836-2012; Lobo, Mary Kay/K-7734-2015; Dietz, David/AAW-4574-2021	Dietz, David/0000-0002-6927-9236; Lobo, Mary Kay/0000-0002-9419-2079; Dietz, David/0000-0002-6927-9236; Sun, Haosheng/0000-0003-3919-559X	National Institute on Drug Abuse; MSSM [NIDA T32 DA007135-26A2]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA008227, R01DA007359, T32DA007135, R01DA014133] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); MSSM; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank N. Heintz and P. Greengard (Rockefeller University) and C. R. Gerfen (NIH/NIMH) for providing us with D1-Cre, D2-Cre, D1-GFP, and D2-GFP mice. We thank M. S. Levine and X. W. Yang (UCLA) for providing us with D1-GFP and D2-GFP mice. We thank L. Parada (UTSouthwestern) for providing us with the flTrkB mice. We thank V. Lessman (Otto-von-Guericke-Universitat) for providing us with the TrkB (full length)-GFP construct. This work was supported by grants from the National Institute on Drug Abuse, and M. K. L. is supported by the Drug Abuse Research Training Program at MSSM (NIDA T32 DA007135-26A2).	Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Ambroggi F, 2009, NAT NEUROSCI, V12, P247, DOI 10.1038/nn.2282; Bahi A, 2008, PSYCHOPHARMACOLOGY, V199, P169, DOI 10.1007/s00213-008-1164-1; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; CAO JL, 2010, P NATL ACAD IN PRESS; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Carlezon WA, 2009, NEUROPHARMACOLOGY, V56, P122, DOI 10.1016/j.neuropharm.2008.06.075; Cornish JL, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-15-j0006.2000; Crooks KR, 2010, NEUROPHARMACOLOGY, V58, P1067, DOI 10.1016/j.neuropharm.2010.01.014; Durieux PF, 2009, NAT NEUROSCI, V12, P393, DOI 10.1038/nn.2286; Freeman AY, 2003, NEUROSCIENCE, V117, P147, DOI 10.1016/S0306-4522(02)00802-3; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.ne.15.030192.001441; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Graham DL, 2007, NAT NEUROSCI, V10, P1029, DOI 10.1038/nn1929; Graham DL, 2009, BIOL PSYCHIAT, V65, P696, DOI 10.1016/j.biopsych.2008.09.032; Grimm JW, 2003, J NEUROSCI, V23, P742; Heusner CL, 2005, J NEUROSCI, V25, P6651, DOI 10.1523/JNEUROSCI.1474-05.2005; Horger BA, 1999, J NEUROSCI, V19, P4110; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Koya E, 2009, NAT NEUROSCI, V12, P1069, DOI 10.1038/nn.2364; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Lu L, 2006, TRENDS NEUROSCI, V29, P695, DOI 10.1016/j.tins.2006.10.005; Luikart BW, 2003, NEUROSCIENCE, V117, P847, DOI 10.1016/S0306-4522(02)00719-4; Mikkelsen JD, 2005, EUR J PHARMACOL, V519, P223, DOI 10.1016/j.ejphar.2005.06.049; Paul S, 2003, NAT NEUROSCI, V6, P34, DOI 10.1038/nn989; Peoples L L, 2007, ScientificWorldJournal, V7, P22; Renthal W, 2008, J NEUROSCI, V28, P7344, DOI 10.1523/JNEUROSCI.1043-08.2008; Robinson TE, 2008, PHILOS T R SOC B, V363, P3137, DOI 10.1098/rstb.2008.0093; Self DW, 2010, RECEPT SER, P479, DOI 10.1007/978-1-60327-333-6_17; Valjent E, 2000, J NEUROSCI, V20, P8701; Valjent E, 2009, TRENDS NEUROSCI, V32, P538, DOI 10.1016/j.tins.2009.06.005; Vassoler FM, 2008, J NEUROSCI, V28, P8735, DOI 10.1523/JNEUROSCI.5277-07.2008; Zhang JH, 2006, J NEUROSCI, V26, P13287, DOI 10.1523/JNEUROSCI.3795-06.2006	40	571	583	3	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					385	390		10.1126/science.1188472	http://dx.doi.org/10.1126/science.1188472			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947769	Green Accepted			2022-12-01	WOS:000282986700045
J	McDonald, B; Pittman, K; Menezes, GB; Hirota, SA; Slaba, I; Waterhouse, CCM; Beck, PL; Muruve, DA; Kubes, P				McDonald, Braedon; Pittman, Keir; Menezes, Gustavo B.; Hirota, Simon A.; Slaba, Ingrid; Waterhouse, Christopher C. M.; Beck, Paul L.; Muruve, Daniel A.; Kubes, Paul			Intravascular Danger Signals Guide Neutrophils to Sites of Sterile Inflammation	SCIENCE			English	Article							TOLL-LIKE RECEPTORS; DYING CELLS; NLRP3 INFLAMMASOME; NALP3 INFLAMMASOME; IMMUNE-SYSTEM; INJURY; IDENTIFICATION; HEPATOTOXICITY; RELEASE; HMGB1	Neutrophils are recruited from the blood to sites of sterile inflammation, where they contribute to wound healing but may also cause tissue damage. By using spinning disk confocal intravital microscopy, we examined the kinetics and molecular mechanisms of neutrophil recruitment to sites of focal hepatic necrosis in vivo. Adenosine triphosphate released from necrotic cells activated the Nlrp3 inflammasome to generate an inflammatory microenvironment that alerted circulating neutrophils to adhere within liver sinusoids. Subsequently, generation of an intravascular chemokine gradient directed neutrophil migration through healthy tissue toward foci of damage. Lastly, formyl-peptide signals released from necrotic cells guided neutrophils through nonperfused sinusoids into the injury. Thus, dynamic in vivo imaging revealed a multistep hierarchy of directional cues that guide neutrophil localization to sites of sterile inflammation.	[McDonald, Braedon; Pittman, Keir; Menezes, Gustavo B.; Slaba, Ingrid; Waterhouse, Christopher C. M.; Muruve, Daniel A.; Kubes, Paul] Univ Calgary, Immunol Res Grp, Calgary, AB T2N 4N1, Canada; [Hirota, Simon A.; Beck, Paul L.] Univ Calgary, Snyder Inst Infect Immun & Inflammat, Gastrointestinal Res Grp, Calgary, AB T2N 4N1, Canada; [Waterhouse, Christopher C. M.] Univ Calgary, Dept Pediat, Div Pediat Gastroenterol, Calgary, AB T2N 4N1, Canada; [Beck, Paul L.; Muruve, Daniel A.] Univ Calgary, Dept Med, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary	Kubes, P (corresponding author), Univ Calgary, Immunol Res Grp, Calgary, AB T2N 4N1, Canada.	pkubes@ucalgary.ca	Menezes, Gustavo B/B-3350-2013		Canadian Institutes of Health Research; Alberta Innovates (Health Solutions)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates (Health Solutions)	We thank C. Badick for excellent technical support. This study was supported by grants from the Canadian Institutes of Health Research and Alberta Innovates (Health Solutions).	Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Hyman MC, 2009, J CLIN INVEST, V119, P1136, DOI 10.1172/JCI36433; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kono H, 2010, J IMMUNOL, V184, P4470, DOI 10.4049/jimmunol.0902485; Lee WY, 2010, NAT IMMUNOL, V11, P295, DOI 10.1038/ni.1855; Liu ZX, 2006, HEPATOLOGY, V43, P1220, DOI 10.1002/hep.21175; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	23	833	853	6	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					362	366		10.1126/science.1195491	http://dx.doi.org/10.1126/science.1195491			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947763				2022-12-01	WOS:000282986700039
J	Stefl, R; Oberstrass, FC; Hood, JL; Jourdan, M; Zimmermann, M; Skrisovska, L; Maris, C; Peng, L; Hofr, C; Emeson, RB; Allain, FHT				Stefl, Richard; Oberstrass, Florian C.; Hood, Jennifer L.; Jourdan, Muriel; Zimmermann, Michal; Skrisovska, Lenka; Maris, Christophe; Peng, Li; Hofr, Ctirad; Emeson, Ronald B.; Allain, Frederic H-T			The Solution Structure of the ADAR2 dsRBM-RNA Complex Reveals a Sequence-Specific Readout of the Minor Groove	CELL			English	Article							DOUBLE-STRANDED-RNA; TORSION ANGLE DYNAMICS; DSRNA-BINDING DOMAIN; ADENOSINE DEAMINASES; RIBONUCLEASE-III; EDITING ENZYME; PROTEIN-KINASE; GLUR-B; NMR; RECOGNITION	Sequence-dependent recognition of dsDNA-binding proteins is well understood, yet sequence-specific recognition of dsRNA by proteins remains largely unknown, despite their importance in RNA maturation pathways. Adenosine deaminases that act on RNA (ADARs) recode genomic information by the site-selective deamination of adenosine. Here, we report the solution structure of the ADAR2 double-stranded RNA-binding motifs (dsRBMs) bound to a stem-loop pre-mRNA encoding the R/G editing site of GluR-2. The structure provides a molecular basis for how dsRBMs recognize the shape, and also more surprisingly, the sequence of the dsRNA. The unexpected direct readout of the RNA primary sequence by dsRBMs is achieved via the minor groove of the dsRNA and this recognition is critical for both editing and binding affinity at the R/G site of GluR-2. More generally, our findings suggest a solution to the sequence-specific paradox faced by many dsRBM-containing proteins that are involved in post-transcriptional regulation of gene expression.	[Stefl, Richard; Oberstrass, Florian C.; Jourdan, Muriel; Skrisovska, Lenka; Maris, Christophe; Allain, Frederic H-T] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Peng, Li; Emeson, Ronald B.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Hood, Jennifer L.] Vanderbilt Univ, Grad Program Neurosci, Nashville, TN 37232 USA; [Stefl, Richard] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, CZ-62500 Brno, Czech Republic; [Zimmermann, Michal; Hofr, Ctirad] Masaryk Univ, Fac Sci, Inst Expt Biol, Dept Funct Genom & Prote, CZ-62500 Brno, Czech Republic	Swiss Federal Institutes of Technology Domain; ETH Zurich; Vanderbilt University; Vanderbilt University; Masaryk University Brno; Masaryk University Brno	Allain, FHT (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	allain@mol.biol.ethz.ch	Hofr, Ctirad/E-3322-2012; Stefl, Richard/D-7010-2012	Emeson, Ronald/0000-0002-4585-1648; Stefl, Richard/0000-0003-0558-5952	Swiss National Science Foundation [3100A0-118118]; SNF-NCCR; National Institutes of Health [R01 NS33323]; Ministry of Education of the Czech Republic [MSM0021622413, Ingo LA08008]; GACR [204/08/1212, 305/10/1490]; GAAV [IAA401630903]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033323] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SNF-NCCR; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); GACR(Grant Agency of the Czech Republic); GAAV(Grant Agency of the Czech Republic); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Swiss National Science Foundation (Nr. 3100A0-118118) and the SNF-NCCR structural biology to F. H. T. A and the National Institutes of Health (R01 NS33323) to R. B. E. R. S. is supported by the Ministry of Education of the Czech Republic (MSM0021622413, Ingo LA08008), GACR (204/08/1212, 305/10/1490), GAAV (IAA401630903), HHMI/EMBO start-up grant, and HFSP Career Development Award. M.Z. and C. H. are supported by GACR (204/08/H054) and by the Ministry of Education of the Czech Republic (MSM0021622415). M.Z. is in receipt of a Brno City Scholarship for Talented Ph.D.Students. The coordinates of the structures of GluR-2 LSL RNA, ADAR2 dsRBM1 bound to GluR-2 USL RNA, ADAR2 dsRBM2 bound to GluR-2 LSL RNA and ADAR2 dsRBM12 bound to GluR-2 have been deposited in the Protein Data Bank with accession codes 2l2j, 2I3c, 2l2k, and 2I3j, respectively.	Aruscavage PJ, 2000, RNA, V6, P257, DOI 10.1017/S1355838200991921; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Blaszczyk J, 2004, STRUCTURE, V12, P457, DOI 10.1016/j.str.2004.02.004; Case D. A., 2002, AMBER 7; Chilibeck KA, 2006, J BIOL CHEM, V281, P16530, DOI 10.1074/jbc.M511831200; Cho DSC, 2003, J BIOL CHEM, V278, P17093, DOI 10.1074/jbc.M213127200; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Gallo A, 2003, EMBO J, V22, P3421, DOI 10.1093/emboj/cdg327; Gan JH, 2006, CELL, V124, P355, DOI 10.1016/j.cell.2005.11.034; Gan J, 2008, MOL MICROBIOL, V67, P143, DOI 10.1111/j.1365-2958.2007.06032.x; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HEALE BS, 2009, EMBO J; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Katoh T, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1120; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kuzmic P, 2006, MOL CELL ENDOCRINOL, V248, P172, DOI 10.1016/j.mce.2005.10.012; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LEGAULT P, 1994, J AM CHEM SOC, V116, P8390, DOI 10.1021/ja00097a066; Lehmann KA, 2000, BIOCHEMISTRY-US, V39, P12875, DOI 10.1021/bi001383g; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Liu Y, 2000, P NATL ACAD SCI USA, V97, P12541, DOI 10.1073/pnas.97.23.12541; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Macbeth MR, 2004, RNA, V10, P1563, DOI 10.1261/rna.7920904; MCMILLAN NAJ, 1995, J BIOL CHEM, V270, P2601, DOI 10.1074/jbc.270.6.2601; Melcher T, 1996, NATURE, V379, P460, DOI 10.1038/379460a0; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Oberstrass FC, 2006, NAT STRUCT MOL BIOL, V13, P160, DOI 10.1038/nsmb1038; Ohman M, 2000, RNA, V6, P687, DOI 10.1017/S1355838200000200; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; Parks Malcolm R, 2004, J Transl Med, V2, P28, DOI 10.1186/1479-5876-2-28; Ramos A, 2000, EMBO J, V19, P997, DOI 10.1093/emboj/19.5.997; Riedmann EM, 2008, RNA, V14, P1110, DOI 10.1261/rna.923308; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Sansam CL, 2003, P NATL ACAD SCI USA, V100, P14018, DOI 10.1073/pnas.2336131100; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Steffensen M, 2002, INSUR MATH ECON, V31, P71, DOI 10.1016/S0167-6687(02)00127-0; Stefl R, 2006, STRUCTURE, V14, P345, DOI 10.1016/j.str.2005.11.013; Stefl R, 2005, RNA, V11, P592, DOI 10.1261/rna.7276805; Stefl R, 2005, EMBO REP, V6, P33, DOI 10.1038/sj.embor.7400325; Tian B, 2004, NAT REV MOL CELL BIO, V5, P1013, DOI 10.1038/nrm1528; Tonkin LA, 2003, SCIENCE, V302, P1725, DOI 10.1126/science.1091340; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Tsui V, 2000, J BIOMOL NMR, V16, P9, DOI 10.1023/A:1008302430561; Valente L, 2005, PROG NUCLEIC ACID RE, V79, P299, DOI 10.1016/S0079-6603(04)79006-6; Valente L, 2007, J BIOL CHEM, V282, P16054, DOI 10.1074/jbc.M611392200; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Wu HH, 2004, P NATL ACAD SCI USA, V101, P8307, DOI 10.1073/pnas.0402627101; Xu M, 2006, MOL BIOL CELL, V17, P3211, DOI 10.1091/mbc.E06-02-0162; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	63	166	172	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					225	237		10.1016/j.cell.2010.09.026	http://dx.doi.org/10.1016/j.cell.2010.09.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946981	Green Accepted, Bronze			2022-12-01	WOS:000283052200012
J	Zhang, MJ; Su, YQ; Sugiura, K; Xia, GL; Eppig, JJ				Zhang, Meijia; Su, You-Qiang; Sugiura, Koji; Xia, Guoliang; Eppig, John J.			Granulosa Cell Ligand NPPC and Its Receptor NPR2 Maintain Meiotic Arrest in Mouse Oocytes	SCIENCE			English	Article							NATRIURETIC-PEPTIDE; CUMULUS CELLS; CYCLIC-GMP; MATURATION; GPR3; FOLLICLES; VITRO; OVARY; BMP15	Granulosa cells of mammalian Graafian follicles maintain oocytes in meiotic arrest, which prevents their precocious maturation. We show that mouse mural granulosa cells, which line the follicle wall, express natriuretic peptide precursor type C (Nppc) messenger RNA (mRNA), whereas cumulus cells surrounding oocytes express mRNA of the NPPC receptor NPR2, a guanylyl cyclase. NPPC increased cGMP levels in cumulus cells and oocytes and inhibited meiotic resumption in vitro. Meiotic arrest was not sustained in most Graafian follicles of Nppc or Npr2 mutant mice, and meiosis resumed precociously. Oocyte-derived paracrine factors promoted cumulus cell expression of Npr2 mRNA. Therefore, the granulosa cell ligand NPPC and its receptor NPR2 in cumulus cells prevent precocious meiotic maturation, which is critical for maturation and ovulation synchrony and for normal female fertility.	[Zhang, Meijia; Xia, Guoliang] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Zhang, Meijia; Su, You-Qiang; Sugiura, Koji; Eppig, John J.] Jackson Lab, 600 Main St, Bar Harbor 04609, ME USA	China Agricultural University; Jackson Laboratory	Eppig, JJ (corresponding author), Jackson Lab, 600 Main St, Bar Harbor 04609, ME USA.	glxia@cau.edu.cn; john.eppig@jax.org	Su, You-Qiang/C-6160-2019; Sugiura, Koji/AAE-2966-2019	Su, You-Qiang/0000-0003-3537-6246; Sugiura, Koji/0000-0001-8945-3353; Xia, Guoliang/0000-0003-3674-0142	Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD23839, HD21970]; National Basic Research Program of China [2007CB947401, 2006CB504003]; State Key Laboratory for Agrobiotechnology of China [2009SKLAB07-5]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD023839] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD021970, U01HD021970] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Basic Research Program of China(National Basic Research Program of China); State Key Laboratory for Agrobiotechnology of China; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank G. Cox, T. Gridley, and M. A. Handel for comments in preparation of the manuscript and L. Jaffe for helpful discussions. J.J.E., K. S., and Y.-Q.S. were supported by grants HD23839 and HD21970 from Eunice Kennedy Shriver National Institute of Child Health and Human Development. M.Z. and G. X. received support from National Basic Research Program of China (grants 2007CB947401 and 2006CB504003) and grant 2009SKLAB07-5 from State Key Laboratory for Agrobiotechnology of China. We also thank M. Mazuk, Baylor College of Medicine, for providing GDF9 and BMP15 and M. O'Brien and K. Wigglesworth for technical assistance.	Diaz FJ, 2007, J CELL SCI, V120, P1330, DOI 10.1242/jcs.000968; EDWARDS RG, 1965, NATURE, V208, P349, DOI 10.1038/208349a0; Hinckley M, 2005, DEV BIOL, V287, P249, DOI 10.1016/j.ydbio.2005.08.019; Jankowski M, 1997, BIOL REPROD, V56, P59, DOI 10.1095/biolreprod56.1.59; Ledent C, 2005, P NATL ACAD SCI USA, V102, P8922, DOI 10.1073/pnas.0503840102; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; Norris RP, 2009, DEVELOPMENT, V136, P1869, DOI 10.1242/dev.035238; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; Pincus G, 1935, J EXP MED, V62, P665, DOI 10.1084/jem.62.5.665; Richard FJ, 2001, BIOL REPROD, V65, P1444, DOI 10.1095/biolreprod65.5.1444; Su YQ, 2008, DEVELOPMENT, V135, P111, DOI 10.1242/dev.009068; Sugiura K, 2007, DEVELOPMENT, V134, P2593, DOI 10.1242/dev.006882; TORNELL J, 1990, ENDOCRINOLOGY, V126, P1504, DOI 10.1210/endo-126-3-1504; Tsuji T, 2008, BIOCHEM BIOPH RES CO, V376, P186, DOI 10.1016/j.bbrc.2008.08.139; Vaccari S, 2009, BIOL REPROD, V81, P595, DOI 10.1095/biolreprod.109.077768	15	349	391	3	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					366	369		10.1126/science.1193573	http://dx.doi.org/10.1126/science.1193573			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947764	Green Accepted			2022-12-01	WOS:000282986700040
J	Allen, HL; Estrada, K; Lettre, G; Berndt, SI; Weedon, MN; Rivadeneira, F; Willer, CJ; Jackson, AU; Vedantam, S; Raychaudhuri, S; Ferreira, T; Wood, AR; Weyant, RJ; Segre, AV; Speliotes, EK; Wheeler, E; Soranzo, N; Park, JH; Yang, J; Gudbjartsson, D; Heard-Costa, NL; Randall, JC; Qi, L; Smith, AV; Magi, R; Pastinen, T; Liang, L; Heid, IM; Luan, J; Thorleifsson, G; Winkler, TW; Goddard, ME; Lo, KS; Palmer, C; Workalemahu, T; Aulchenko, YS; Johansson, A; Zillikens, MC; Feitosa, MF; Esko, T; Johnson, T; Ketkar, S; Kraft, P; Mangino, M; Prokopenko, I; Absher, D; Albrecht, E; Ernst, F; Glazer, NL; Hayward, C; Hottenga, JJ; Jacobs, KB; Knowles, JW; Kutalik, Z; Monda, KL; Polasek, O; Preuss, M; Rayner, NW; Robertson, NR; Steinthorsdottir, V; Tyrer, JP; Voight, BF; Wiklund, F; Xu, JF; Zhao, JH; Nyholt, DR; Pellikka, N; Perola, M; Perry, JRB; Surakka, I; Tammesoo, ML; Altmaier, EL; Amin, N; Aspelund, T; Bhangale, T; Boucher, G; Chasman, DI; Chen, C; Coin, L; Cooper, MN; Dixon, AL; Gibson, Q; Grundberg, E; Hao, K; Junttila, MJ; Kaplan, LM; Kettunen, J; Konig, IR; Kwan, T; Lawrence, RW; Levinson, DF; Lorentzon, M; McKnight, B; Morris, AP; Muller, M; Ngwa, JS; Purcell, S; Rafelt, S; Salem, RM; Salvi, E; Sanna, S; Shi, JX; Sovio, U; Thompson, JR; Turchin, MC; Vandenput, L; Verlaan, DJ; Vitart, V; White, CC; Ziegler, A; Almgren, P; Balmforth, AJ; Campbell, H; Citterio, L; De Grandi, A; Dominiczak, A; Duan, J; Elliott, P; Elosua, R; Eriksson, JG; Freimer, NB; Geus, EJC; Glorioso, N; Haiqing, S; Hartikainen, AL; Havulinna, AS; Hicks, AA; Hui, JN; Igl, W; Illig, T; Jula, A; Kajantie, E; Kilpelaeinen, TO; Koiranen, M; Kolcic, I; Koskinen, S; Kovacs, P; Laitinen, J; Liu, JJ; Lokki, ML; Marusic, A; Maschio, A; Meitinger, T; Mulas, A; Pare, G; Parker, AN; Peden, JF; Petersmann, A; Pichler, I; Pietilainen, KH; Pouta, A; Riddertrale, M; Rotter, JI; Sambrook, JG; Sanders, AR; Schmidt, CO; Sinisalo, J; Smit, JH; Stringham, HM; Walters, GB; Widen, E; Wild, SH; Willemsen, G; Zagato, L; Zgaga, L; Zitting, P; Alavere, H; Farrall, M; McArdle, WL; Nelis, M; Peters, MJ; Ripatti, S; Meurs, JBJ; Aben, KK; Ardlie, KG; Beckmann, JS; Beilby, JP; Bergman, RN; Bergmann, S; Collins, FS; Cusi, D; den Heijer, M; Eiriksdottir, G; Gejman, PV; Hall, AS; Hamsten, A; Huikuri, HV; Iribarren, C; Kahonen, M; Kaprio, J; Kathiresan, S; Kiemeney, L; Kocher, T; Launer, LJ; Lehtimaki, T; Melander, O; Mosley, TH; Musk, AW; Nieminen, MS; O'Donnell, CJ; Ohlsson, C; Oostra, B; Palmer, LJ; Raitakari, O; Ridker, PM; Rioux, JD; Rissanen, A; Rivolta, C; Schunkert, H; Shuldiner, AR; Siscovick, DS; Stumvoll, M; Tonjes, A; Tuomilehto, J; van Ommen, GJ; Viikari, J; Heath, AC; Martin, NG; Montgomery, GW; Province, MA; Kayser, M; Arnold, AM; Atwood, LD; Boerwinkle, E; Chanock, SJ; Deloukas, P; Gieger, C; Gronberg, H; Hall, P; Hattersley, AT; Hengstenberg, C; Hoffman, W; Lathrop, GM; Salomaa, V; Schreiber, S; Uda, M; Waterworth, D; Wright, AF; Assimes, TL; Barroso, I; Hofman, A; Mohlke, KL; Boomsma, DI; Caulfield, MJ; Cupples, LA; Erdmann, J; Fox, CS; Gudnason, V; Gyllensten, U; Harris, TB; Hayes, RB; Jarvelin, MR; Mooser, V; Munroe, PB; Ouwehand, WH; Penninx, BW; Pramstaller, PP; Quertermous, T; Rudan, I; Samani, NJ; Spector, TD; Volzke, H; Watkins, H; Wilson, JF; Groop, LC; Haritunians, T; Hu, FB; Kaplan, RC; Metspalu, A; North, KE; Schlessinger, D; Wareham, NJ; Hunter, DJ; O'Connell, JR; Strachan, DP; Schadt, HE; Thorsteinsdottir, U; Peltonen, L; Uitterlinden, AG; Visscher, PM; Chatterjee, N; Loos, RJF; Boehnke, M; McCarthy, MI; Ingelsson, E; Lindgren, CM; Abecasis, GR; Stefansson, K; Frayling, TM; Hirschhorn, JN				Allen, Hana Lango; Estrada, Karol; Lettre, Guillaume; Berndt, Sonja I.; Weedon, Michael N.; Rivadeneira, Fernando; Willer, Cristen J.; Jackson, Anne U.; Vedantam, Sailaja; Raychaudhuri, Soumya; Ferreira, Teresa; Wood, Andrew R.; Weyant, Robert J.; Segre, Ayellet V.; Speliotes, Elizabeth K.; Wheeler, Eleanor; Soranzo, Nicole; Park, Ju-Hyun; Yang, Jian; Gudbjartsson, Daniel; Heard-Costa, Nancy L.; Randall, Joshua C.; Qi, Lu; Smith, Albert Vernon; Maegi, Reedik; Pastinen, Tomi; Liang, Liming; Heid, Iris M.; Luan, Jian'an; Thorleifsson, Gudmar; Winkler, Thomas W.; Goddard, Michael E.; Lo, Ken Sin; Palmer, Cameron; Workalemahu, Tsegaselassie; Aulchenko, Yurii S.; Johansson, Asa; Zillikens, M. Carola; Feitosa, Mary F.; Esko, Tonu; Johnson, Toby; Ketkar, Shamika; Kraft, Peter; Mangino, Massimo; Prokopenko, Inga; Absher, Devin; Albrecht, Eva; Ernst, Florian; Glazer, Nicole L.; Hayward, Caroline; Hottenga, Jouke-Jan; Jacobs, Kevin B.; Knowles, Joshua W.; Kutalik, Zoltan; Monda, Keri L.; Polasek, Ozren; Preuss, Michael; Rayner, Nigel W.; Robertson, Neil R.; Steinthorsdottir, Valgerdur; Tyrer, Jonathan P.; Voight, Benjamin F.; Wiklund, Fredrik; Xu, Jianfeng; Zhao, Jing Hua; Nyholt, Dale R.; Pellikka, Niina; Perola, Markus; Perry, John R. B.; Surakka, Ida; Tammesoo, Mari-Liis; Altmaier, Elizabeth L.; Amin, Najaf; Aspelund, Thor; Bhangale, Tushar; Boucher, Gabrielle; Chasman, Daniel I.; Chen, Constance; Coin, Lachlan; Cooper, Matthew N.; Dixon, Anna L.; Gibson, Quince; Grundberg, Elin; Hao, Ke; Junttila, M. Juhani; Kaplan, Lee M.; Kettunen, Johannes; Koenig, Inke R.; Kwan, Tony; Lawrence, Robert W.; Levinson, Douglas F.; Lorentzon, Mattias; McKnight, Barbara; Morris, Andrew P.; Mueller, Martina; Ngwa, Julius Suh; Purcell, Shaun; Rafelt, Suzanne; Salem, Rany M.; Salvi, Erika; Sanna, Serena; Shi, Jianxin; Sovio, Ulla; Thompson, John R.; Turchin, Michael C.; Vandenput, Liesbeth; Verlaan, Dominique J.; Vitart, Veronique; White, Charles C.; Ziegler, Andreas; Almgren, Peter; Balmforth, Anthony J.; Campbell, Harry; Citterio, Lorena; De Grandi, Alessandro; Dominiczak, Anna; Duan, Jubao; Elliott, Paul; Elosua, Roberto; Eriksson, Johan G.; Freimer, Nelson B.; Geus, Eco J. C.; Glorioso, Nicola; Haiqing, Shen; Hartikainen, Anna-Liisa; Havulinna, Aki S.; Hicks, Andrew A.; Hui, Jennie; Igl, Wilmar; Illig, Thomas; Jula, Antti; Kajantie, Eero; Kilpelaeinen, Tuomas O.; Koiranen, Markku; Kolcic, Ivana; Koskinen, Seppo; Kovacs, Peter; Laitinen, Jaana; Liu, Jianjun; Lokki, Marja-Liisa; Marusic, Ana; Maschio, Andrea; Meitinger, Thomas; Mulas, Antonella; Pare, Guillaume; Parker, Alex N.; Peden, John F.; Petersmann, Astrid; Pichler, Irene; Pietilainen, Kirsi H.; Pouta, Anneli; Riddertrale, Martin; Rotter, Jerome I.; Sambrook, Jennifer G.; Sanders, Alan R.; Schmidt, Carsten Oliver; Sinisalo, Juha; Smit, Jan H.; Stringham, Heather M.; Walters, G. Bragi; Widen, Elisabeth; Wild, Sarah H.; Willemsen, Gonneke; Zagato, Laura; Zgaga, Lina; Zitting, Paavo; Alavere, Helene; Farrall, Martin; McArdle, Wendy L.; Nelis, Mari; Peters, Marjolein J.; Ripatti, Samuli; vVan Meurs, Joyce B. J.; Aben, Katja K.; Ardlie, Kristin G.; Beckmann, Jacques S.; Beilby, John P.; Bergman, Richard N.; Bergmann, Sven; Collins, Francis S.; Cusi, Daniele; den Heijer, Martin; Eiriksdottir, Gudny; Gejman, Pablo V.; Hall, Alistair S.; Hamsten, Anders; Huikuri, Heikki V.; Iribarren, Carlos; Kahonen, Mika; Kaprio, Jaakko; Kathiresan, Sekar; Kiemeney, Lambertus; Kocher, Thomas; Launer, Lenore J.; Lehtimaki, Terho; Melander, Olle; Mosley, Tom H., Jr.; Musk, Arthur W.; Nieminen, Markku S.; O'Donnell, Christopher J.; Ohlsson, Claes; Oostra, Ben; Palmer, Lyle J.; Raitakari, Olli; Ridker, Paul M.; Rioux, John D.; Rissanen, Aila; Rivolta, Carlo; Schunkert, Heribert; Shuldiner, Alan R.; Siscovick, David S.; Stumvoll, Michael; Toenjes, Anke; Tuomilehto, Jaakko; van Ommen, Gert-Jan; Viikari, Jorma; Heath, Andrew C.; Martin, Nicholas G.; Montgomery, Grant W.; Province, Michael A.; Kayser, Manfred; Arnold, Alice M.; Atwood, Larry D.; Boerwinkle, Eric; Chanock, Stephen J.; Deloukas, Panos; Gieger, Christian; Gronberg, Henrik; Hall, Per; Hattersley, Andrew T.; Hengstenberg, Christian; Hoffman, Wolfgang; Lathrop, G. Mark; Salomaa, Veikko; Schreiber, Stefan; Uda, Manuela; Waterworth, Dawn; Wright, Alan F.; Assimes, Themistocles L.; Barroso, Ines; Hofman, Albert; Mohlke, Karen L.; Boomsma, Dorret I.; Caulfield, Mark J.; Cupples, L. Adrienne; Erdmann, Jeanette; Fox, Caroline S.; Gudnason, Vilmundur; Gyllensten, Ulf; Harris, Tamara B.; Hayes, Richard B.; Jarvelin, Marjo-Ritta; Mooser, Vincent; Munroe, Patricia B.; Ouwehand, Willem H.; Penninx, Brenda W.; Pramstaller, Peter P.; Quertermous, Thomas; Rudan, Igor; Samani, Nilesh J.; Spector, Timothy D.; Voelzke, Henry; Watkins, Hugh; Wilson, James F.; Groop, Leif C.; Haritunians, Talin; Hu, Frank B.; Kaplan, Robert C.; Metspalu, Andres; North, Kari E.; Schlessinger, David; Wareham, Nicholas J.; Hunter, David J.; O'Connell, Jeffrey R.; Strachan, David P.; Schadt, H. -Erich; Thorsteinsdottir, Unnur; Peltonen, Leena; Uitterlinden, Andre G.; Visscher, Peter M.; Chatterjee, Nilanjan; Loos, Ruth J. F.; Boehnke, Michael; McCarthy, Mark I.; Ingelsson, Erik; Lindgren, Cecilia M.; Abecasis, Goncalo R.; Stefansson, Kari; Frayling, Timothy M.; Hirschhorn, Joel N.		Procardis Consortium	Hundreds of variants clustered in genomic loci and biological pathways affect human height	NATURE			English	Article							WIDE ASSOCIATION; COMMON VARIANTS; HERITABILITY; ADULT	Most common human traits and diseases have a polygenic pattern of inheritance: DNA sequence variants at many genetic loci influence the phenotype. Genome-wide association (GWA) studies have identified more than 600 variants associated with human traits(1), but these typically explain small fractions of phenotypic variation, raising questions about the use of further studies. Here, using 183,727 individuals, we show that hundreds of genetic variants, in at least 180 loci, influence adult height, a highly heritable and classic polygenic trait(2,3). The large number of loci reveals patterns with important implications for genetic studies of common human diseases and traits. First, the 180 loci are not random, but instead are enriched for genes that are connected in biological pathways (P = 0.016) and that underlie skeletal growth defects (P<0.001). Second, the likely causal gene is often located near the most strongly associated variant: in 13 of 21 loci containing a known skeletal growth gene, that gene was closest to the associated variant. Third, at least 19 loci have multiple independently associated variants, suggesting that allelic heterogeneity is a frequent feature of polygenic traits, that comprehensive explorations of already-discovered loci should discover additional variants and that an appreciable fraction of associated loci may have been identified. Fourth, associated variants are enriched for likely functional effects on genes, being over-represented among variants that alter amino-acid structure of proteins and expression levels of nearby genes. Our data explain approximately 10% of the phenotypic variation in height, and we estimate that unidentified common variants of similar effect sizes would increase this figure to approximately 16% of phenotypic variation (approximately 20% of heritable variation). Although additional approaches are needed to dissect the genetic architecture of polygenic human traits fully, our findings indicate that GWA studies can identify large numbers of loci that implicate biologically relevant genes and pathways.	[Allen, Hana Lango; Weedon, Michael N.; Wood, Andrew R.; Perry, John R. B.; Hattersley, Andrew T.; Frayling, Timothy M.] Univ Exeter, Peninsula Coll Med & Dent, Exeter EX1 2LU, Devon, England; [Estrada, Karol; Rivadeneira, Fernando; Aulchenko, Yurii S.; Amin, Najaf; vVan Meurs, Joyce B. J.; Hofman, Albert; Uitterlinden, Andre G.] Erasmus Sch Ctr, Dept Epidemiol, NL-3015 GE Rotterdam, Netherlands; [Estrada, Karol; Rivadeneira, Fernando; Zillikens, M. Carola; Peters, Marjolein J.; vVan Meurs, Joyce B. J.; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, NL-3015 GE Rotterdam, Netherlands; [Estrada, Karol; Rivadeneira, Fernando; Aulchenko, Yurii S.; Peters, Marjolein J.; vVan Meurs, Joyce B. J.; Hofman, Albert; Uitterlinden, Andre G.] NCHA, NGI, NL-42300 RC Leiden, Netherlands; [Lettre, Guillaume; Lo, Ken Sin; Boucher, Gabrielle; Rioux, John D.] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Lettre, Guillaume; Rioux, John D.] Univ Montreal, Dept Med, Montreal, PQ H3T 1J4, Canada; [Berndt, Sonja I.; Park, Ju-Hyun; Shi, Jianxin; Chatterjee, Nilanjan] Natl Canc Inst, Natl Inst Hlth, Divis Canc Epidemiol & Genet, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Willer, Cristen J.; Jackson, Anne U.; Weyant, Robert J.; Stringham, Heather M.; Boehnke, Michael; Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Vedantam, Sailaja; Palmer, Cameron; Altmaier, Elizabeth L.; Salem, Rany M.; Turchin, Michael C.] Childrens Hosp, Div Genet & Endocrinol, Boston, MA 02115 USA; [Vedantam, Sailaja; Palmer, Cameron; Altmaier, Elizabeth L.; Salem, Rany M.; Turchin, Michael C.] Childrens Hosp, Program Gen, Boston, MA 02115 USA; [Vedantam, Sailaja; Palmer, Cameron; Altmaier, Elizabeth L.; Salem, Rany M.; Turchin, Michael C.] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Raychaudhuri, Soumya; Segre, Ayellet V.; Voight, Benjamin F.; Ardlie, Kristin G.; Kathiresan, Sekar] MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Raychaudhuri, Soumya; Segre, Ayellet V.; Voight, Benjamin F.; Ardlie, Kristin G.; Kathiresan, Sekar] Broad Inst Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Raychaudhuri, Soumya] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Ferreira, Teresa; Randall, Joshua C.; Maegi, Reedik; Prokopenko, Inga; Rayner, Nigel W.; Robertson, Neil R.; Morris, Andrew P.; Peden, John F.; Farrall, Martin; Watkins, Hugh; McCarthy, Mark I.; Lindgren, Cecilia M.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Segre, Ayellet V.; Voight, Benjamin F.; Purcell, Shaun; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Segre, Ayellet V.; Voight, Benjamin F.] Massachusetts Gen Hosp, Dept Biol Mol, Boston, MA 02114 USA; [Speliotes, Elizabeth K.; Kaplan, Lee M.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Wheeler, Eleanor; Soranzo, Nicole; Grundberg, Elin; Chanock, Stephen J.; Deloukas, Panos; Barroso, Ines; Ouwehand, Willem H.; Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Soranzo, Nicole; Mangino, Massimo; Spector, Timothy D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Yang, Jian; Visscher, Peter M.] Queensland Inst Med Res, Queensland Stat Genet Lab, Queensland 4006, Australia; [Gudbjartsson, Daniel; Thorleifsson, Gudmar; Steinthorsdottir, Valgerdur; Walters, G. Bragi; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Heard-Costa, Nancy L.; Atwood, Larry D.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Qi, Lu; Workalemahu, Tsegaselassie; Hu, Frank B.; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Qi, Lu; Pietilainen, Kirsi H.; Kaprio, Jaakko; Hu, Frank B.; Hunter, David J.] Harvard Univ, Sch Med, Dept Nutr, Boston, MA 02115 USA; [Qi, Lu; Hu, Frank B.; Hunter, David J.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Smith, Albert Vernon; Aspelund, Thor; Eiriksdottir, Gudny; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Smith, Albert Vernon; Aspelund, Thor; Gudnason, Vilmundur] Univ Iceland, IS-101 Reykjavik, Iceland; [Pastinen, Tomi; Grundberg, Elin; Kwan, Tony; Verlaan, Dominique J.] McGill Univ, Montreal, PQ H3A 1A4, Canada; [Pastinen, Tomi; Grundberg, Elin; Kwan, Tony; Verlaan, Dominique J.] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Pastinen, Tomi; Grundberg, Elin; Kwan, Tony; Verlaan, Dominique J.] McGill Univ, Ctr Hlth, Dept Human Genet, Montreal, PQ H3G 1A4, Canada; [Liang, Liming] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Cambridge, MA 02138 USA; [Liang, Liming] Harvard Univ, Sch Publ Hlth, Dept Biostat, Cambridge, MA 02138 USA; [Heid, Iris M.; Winkler, Thomas W.] Univ Regensburg, Med Ctr, Dept Epidemiol & Prevent Med, D-93053 Regensburg, Germany; [Heid, Iris M.; Albrecht, Eva; Mueller, Martina; Illig, Thomas; Gieger, Christian; Schadt, H. -Erich] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol, D-85764 Neuherberg, Germany; [Luan, Jian'an; Zhao, Jing Hua; Kilpelaeinen, Tuomas O.; Wareham, Nicholas J.; Loos, Ruth J. F.] Addenbrookes Hosp, Inst Met Sci, MRC Epidemiol Unit, Cambridge CB2 0QQ, England; [Goddard, Michael E.] Univ Melbourne, Fac Land & Environm, Parkville, Vic 3010, Australia; [Goddard, Michael E.] Dept Primary Ind, Bundoora, Vic 3086, Australia; [Johansson, Asa; Igl, Wilmar; Gyllensten, Ulf] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden; [Johansson, Asa] Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Fac Med, N-7489 Trondheim, Norway; [Feitosa, Mary F.; Ketkar, Shamika; Province, Michael A.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Esko, Tonu; Tammesoo, Mari-Liis; Alavere, Helene; Nelis, Mari] Univ Tartu, Estonian Genome Ctr, EE-50410 Tartu, Estonia; [Esko, Tonu; Nelis, Mari; Metspalu, Andres] Estonian Bioctr, EE-51010 Tartu, Estonia; [Esko, Tonu; Nelis, Mari; Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Johnson, Toby; Kutalik, Zoltan; Beckmann, Jacques S.; Bergmann, Sven; Rivolta, Carlo] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland; [Johnson, Toby; Kutalik, Zoltan; Bergmann, Sven] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Johnson, Toby] Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London EC1M 6BQ, England; [Johnson, Toby; Caulfield, Mark J.; Munroe, Patricia B.] Univ London, William Harvey Res Inst, Barts & London Genome Ctr, Barts & London Sch Med & Dent, London EC1M6BQ, England; [Kraft, Peter; Hu, Frank B.; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Prokopenko, Inga; Rayner, Nigel W.; Robertson, Neil R.; Lindgren, Cecilia M.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Absher, Devin] Hudson Alpha Inst Biotechnol, Huntsville, AL 35806 USA; [Ernst, Florian] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Gen, D-17487 Greifswald, Germany; [Glazer, Nicole L.; Wiklund, Fredrik] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Glazer, Nicole L.; Wiklund, Fredrik] Univ Washington, Dept Med, Seattle, WA 98101 USA; [Hayward, Caroline; Xu, Jianfeng; Vitart, Veronique; Wright, Alan F.; Rudan, Igor] Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Hottenga, Jouke-Jan; Geus, Eco J. C.; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, NL-1081 BT Amsterdam, Netherlands; [Jacobs, Kevin B.] NCI Frederick, SAIC Frederick Inc, Frederick, MD 21702 USA; [Knowles, Joshua W.; Assimes, Themistocles L.; Quertermous, Thomas] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Monda, Keri L.; North, Kari E.] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27514 USA; [Polasek, Ozren; Kolcic, Ivana; Zgaga, Lina] Univ Zagreb, Andrija Stampar Sch Publ Hlth, Sch Med, Zagreb 10000, Croatia; [Polasek, Ozren] Gen Info Ltd, Zagreb 10000, Croatia; [Preuss, Michael; Koenig, Inke R.] Univ Lubeck, Inst Med Biometrie & Stat, D-23562 Lubeck, Germany; [Tyrer, Jonathan P.] Univ Cambridge, Dept Oncol, Cambridge CB1 8RN, England; [Gronberg, Henrik; Hall, Per; Ingelsson, Erik] Karolinska Inst, Dept Med Epidemiol & Biostatist, S-17177 Stockholm, Sweden; [Shuldiner, Alan R.] Wake Forest Univ, Ctr Human Genome, Winston Salem, NC 27157 USA; [Nyholt, Dale R.] Queensland Inst Med Res, Neurogenet Lab, Queensland 4006, Australia; [Pellikka, Niina; Perola, Markus; Surakka, Ida; Kettunen, Johannes; Widen, Elisabeth; Ripatti, Samuli; Kaprio, Jaakko] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki 00014, Finland; [Pellikka, Niina; Perola, Markus; Surakka, Ida; Kettunen, Johannes; Ripatti, Samuli; Peltonen, Leena] Natl Inst Hlth & Welfare, Dept Chron Dis Prevent, Unit Publ Hlth Gen, FIN-00014 Helsinki, Finland; [Bhangale, Tushar] Univ Washington, Dept Gen Sci, Seattle, WA 98195 USA; [Chasman, Daniel I.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; [Chasman, Daniel I.; Kaplan, Lee M.; Ridker, Paul M.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Chen, Constance] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Coin, Lachlan; Sovio, Ulla; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Fac Med, Dept Epidemiol & Biostat, London W2 1PG, England; [Cooper, Matthew N.; Lawrence, Robert W.; Hui, Jennie; Palmer, Lyle J.] Univ Western Australia, Ctr Genet Epidemiol & Biostatist, Crawley, WA 6009, Australia; [Dixon, Anna L.] Univ Bath, Bath BA1 1RL, Avon, England; [Dixon, Anna L.] Royal Natl Hosp Rheumat Dis, Bath BA1 1RL, Avon, England; [Gibson, Quince; Haiqing, Shen; Shuldiner, Alan R.; O'Connell, Jeffrey R.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Hao, Ke] Rosetta Inpharmat Wholly Owned Subsidiary Merck&C, Dept Genet, Seattle, WA 98109 USA; [Junttila, M. Juhani; Huikuri, Heikki V.] Univ Oulu, Dept Internal Med, Oulu 90014, Finland; [Kaplan, Lee M.] Massachusetts Gen Hosp, MGH Weight Ctr, Boston, MA 02114 USA; [Levinson, Douglas F.] Stanford Univ, Sch ofMedicine, Stanford, CA 93405 USA; [Lorentzon, Mattias; Vandenput, Liesbeth; Ohlsson, Claes] Univ Gothenburg, Inst Med, Dept Internal Med, Sahlgrenska Acad, S-41345 Gothenburg, Sweden; [McKnight, Barbara; Arnold, Alice M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Mueller, Martina] Univ Munich, Dept Med 1, Univ Hosp Grosshadern, D-81377 Munich, Germany; [Mueller, Martina; Schadt, H. -Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Chair Epidemiol, D-81377 Munich, Germany; [Ngwa, Julius Suh; White, Charles C.; Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Purcell, Shaun; Schreiber, Stefan; Peltonen, Leena] Broad Inst Harvard, Cambridge, MA 02142 USA; [Purcell, Shaun; Peltonen, Leena] MIT, Cambridge, MA 02142 USA; [Purcell, Shaun] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Rafelt, Suzanne; Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Salvi, Erika; Cusi, Daniele] Univ Milan, Dept Med Surg & Dent, I-20139 Milan, Italy; [Salvi, Erika] KOS Genet Srl, I-20123 Milan, Italy; [Sanna, Serena; Maschio, Andrea; Mulas, Antonella; Uda, Manuela] Ist Neurogenet & Neurofarmacol CNR, I-09042 Cagliari, Italy; [Thompson, John R.; Samani, Nilesh J.] Glenfield Hosp, Leicester NIHR Biomed Res Unit Cardiovasc Dis, Leicester LE3 9QP, Leics, England; [Thompson, John R.] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [Ziegler, Andreas] Univ Lubeck, Inst Med Biometrie & Stat, D-23562 Lubeck, Germany; [Almgren, Peter; Groop, Leif C.] Lund Univ, Ctr Diabet, Dept Clin Sci, S-20502 Malmo, Sweden; [Balmforth, Anthony J.; Hall, Alistair S.] Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, Leeds Inst Genet Hlth & Therapeut, Leeds LS2 9JT, W Yorkshire, England; [Campbell, Harry; Wild, Sarah H.; Wilson, James F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; [Citterio, Lorena; Zagato, Laura] Univ Vita Salute San Raffaele, Div Nephrol & Dialysis, I-20132 Milan, Italy; [De Grandi, Alessandro; Dominiczak, Anna; Hicks, Andrew A.; Pichler, Irene; Pramstaller, Peter P.] European Acad Bozen Bolzano EURAC, Inst Med Genet, I-39100 Bolzano, Italy; [De Grandi, Alessandro; Dominiczak, Anna; Hicks, Andrew A.; Pichler, Irene; Pramstaller, Peter P.] Univ Lubeck, Affiliated Inst, Lubeck, Germany; [Strachan, David P.] Univ Glasgow, British Heart Fdn Glasgow Cardiovascular Res Ct, Glasgow G12 8TA, Lanark, Scotland; [Duan, Jubao; Sanders, Alan R.; Gejman, Pablo V.] Northshore Univ Healthsyst, Evanston, IL 60201 USA; [Elosua, Roberto; Eriksson, Johan G.] Inst Municipal Invest Medica & CIBER Epidemiol &, Barcelona, Spain; Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki 00014, Finland; [Eriksson, Johan G.; Kajantie, Eero] Natl Inst Hlth & Welf, Helsinki 00271, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki 00280, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki 00250, Finland; [Eriksson, Johan G.] Vasa Cent Hosp, Vaasa 65130, Finland; [Freimer, Nelson B.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA; [Glorioso, Nicola] Univ Sassari, Hypertens & Cardiovasc Prevent Ctr, I-07100 Sassari, Italy; [Hartikainen, Anna-Liisa; Pouta, Anneli] Univ Oulu, Dept Clin Sci Obstet & Gynecol, Oulu 90014, Finland; [Havulinna, Aki S.; Koskinen, Seppo; Salomaa, Veikko] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Chron Dis Epidemiol & Prevent Unit, Helsinki 00014, Finland; [Hui, Jennie; Beilby, John P.] QEII Med Ctr, PathW Lab Western Australia, Dept Mol Genet, Nedlands, WA 6009, Australia; [Hui, Jennie; Beilby, John P.; Musk, Arthur W.; Palmer, Lyle J.] Sir Charles Gairdner Hosp, Busselton Populat Med Res Fdn Inc, Nedlands, WA, Australia; [Jula, Antti] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Populat Studies Unit, Turku 20720, Finland; [Koiranen, Markku; Jarvelin, Marjo-Ritta] Univ Oulu, Inst Hlth Sci, Oulu 90014, Finland; [Kovacs, Peter] Univ Leipzig, Interdisciplinary Ctr Clin Res, D-04103 Leipzig, Germany; [Laitinen, Jaana] Finnish Inst Occupat Hlth, Oulu 90220, Finland; [Liu, Jianjun] Genome Inst Singapore, Singapore 138672, Singapore; [Lokki, Marja-Liisa] Univ Helsinki, Haartman Inst, Transplantat Lab, Helsinki 00014, Finland; [Marusic, Ana; Rudan, Igor] Univ Split, Sch Med, Croatian Ctr Global Hlth, Split 21000, Croatia; [Meitinger, Thomas] Klinikum Rechts Isar Techn Univ Mu nchen, Inst Human Genet, D-81675 Munich, Germany; [Meitinger, Thomas] Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Human Genet, D-85764 Neuherberg, Germany; [Pare, Guillaume] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada; [Parker, Alex N.] Amgen Inc, Cambridge, MA 02139 USA; [Peden, John F.; Farrall, Martin; Watkins, Hugh; Procardis Consortium] Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England; [Petersmann, Astrid] Ernst Moritz Arndt Univ Greifswald, Inst Klin Chem, D-17475 Greifswald, Germany; [Petersmann, Astrid] Ernst Moritz Arndt Univ Greifswald, Lab Med, D-17475 Greifswald, Germany; [Pietilainen, Kirsi H.; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Helsinki 00014, Finland; [Pietilainen, Kirsi H.; Rissanen, Aila] Univ Helsinki, Cent Hosp, Dept Psychiat, Obes Res unit, Helsinki, Finland; [Pouta, Anneli; Jarvelin, Marjo-Ritta] Natl Inst Hlth & Welf, Oulu 90101, Finland; [Riddertrale, Martin; Melander, Olle] Lund Univ, Dept Clin Sci, S-20502 Maimo, Sweden; [Sambrook, Jennifer G.; Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge CB2 OPT, England; [Sambrook, Jennifer G.; Ouwehand, Willem H.] Cambridge Ctr, Cambridge CB2 0PT, England; [Schmidt, Carsten Oliver; Hoffman, Wolfgang; Voelzke, Henry] Inst Community Med, D-17489 Greifswald, Germany; [Sinisalo, Juha; Nieminen, Markku S.] Univ Helsinki, Cent Hosp, Cardiovasc Lab, Div Cardiol, Helsinki 00029, Finland; [Smit, Jan H.; Penninx, Brenda W.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiatry EMGO Inst, NL-1081 BT Amsterdam, Netherlands; [Zitting, Paavo] Lapland Cent Hosp, Dept Physiat, Rovaniemi 96101, Finland; [Farrall, Martin] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [McArdle, Wendy L.] Univ Bristol, Dept Social Med, ALSPAC, Bristol BS8 2BN, Avon, England; [Aben, Katja K.; Kiemeney, Lambertus] Comprehens Canc Ctr E, NL-6501 BG Nijmegen, Netherlands; [Beckmann, Jacques S.] CHU Vaudois, Univ Hosp, Serv Med Genet, CH-1011 Lausanne, Switzerland; [Beilby, John P.] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia; [Bergman, Richard N.] Univ So Calif, Keck Sch Med, Dept Phys & Biophys, Los Angeles, CA 90033 USA; [Collins, Francis S.] Natl Human Genome Res Inst, Natl Inst Hlth, Bethesda, MD 20892 USA; [den Heijer, Martin] Radboud Univ Nijmegen, Med Ctr, Dept Endocrinol, NL-6500 HB Nijmegen, Netherlands; [Hamsten, Anders] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Atherosclerosis Res Unit, S-17176 Solna, Sweden; [Iribarren, Carlos] Kaiser Permanente No Calif, Div Res, Oakland, CA 94612 USA; [Iribarren, Carlos] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94107 USA; [Kahonen, Mika] Univ Tampere, Dept Clin Physiol, Tampere 33520, Finland; [Kahonen, Mika] Tampere Univ Hosp, Tampere 33520, Finland; [Kaprio, Jaakko] Natl Inst Hlth & Welf, Dept Mental Hlth & Substance Abuse Serv, Unit Child & Adolescent Mental Hlth, Helsinki 00271, Finland; [Kathiresan, Sekar; McCarthy, Mark I.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Kathiresan, Sekar; McCarthy, Mark I.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Kathiresan, Sekar; O'Donnell, Christopher J.] Boston Univ, Framingham, MA 01702 USA; [Kathiresan, Sekar; O'Donnell, Christopher J.] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; [Kathiresan, Sekar] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Kiemeney, Lambertus] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostatist & HTA, NL-6500 HB Nijmegen, Netherlands; [Kiemeney, Lambertus] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6500 HB Nijmegen, Netherlands; [Kocher, Thomas] Zentrum Zahn Mund & Kieferheilkunde, D-17489 Greifswald, Germany; [Launer, Lenore J.; Harris, Tamara B.] Natl Inst Hlth, NIA, Lab Epidemiol Demog, Bethesda, MD 20892 USA; [Lehtimaki, Terho] Univ Tampere, Dept Clin Chem, Tampere 33520, Finland; [Lehtimaki, Terho] Tampere Univ Hosp, Dept Clin Chem, Tampere 33520, Finland; [Mosley, Tom H., Jr.] Univ Mississippi, Div Geriatr, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Musk, Arthur W.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [O'Donnell, Christopher J.] Natl Inst Hlth, Nat Lung & Blood Inst, Framingham, MA 01702 USA; [Oostra, Ben] Erasmus MC, Dept Clin Genet, NL-3015 GE Rotterdam, Netherlands; [Raitakari, Olli] Turku Univ, Res Ctr Appl & Prevent Cardiovasc Med, Turku 20520, Finland; [Raitakari, Olli] Turku Univ Hosp, Dept Clin Physiol, Turku 20520, Finland; [Schunkert, Heribert; Erdmann, Jeanette] Univ Lubeck, Med Klin 2, D-23562 Lubeck, Germany; [Shuldiner, Alan R.] Baltimore Vet Adm Med Ctr, Geriatr Res & Educ Clin Ctr, Baltimore, MD 21201 USA; [Siscovick, David S.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Siscovick, David S.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Siscovick, David S.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Stumvoll, Michael; Toenjes, Anke] Univ Leipzig, Dept Med, D-04103 Leipzig, Germany; [Stumvoll, Michael] Univ Leipzig, LIFE Study Ctr, Leipzig, Germany; [Toenjes, Anke] Univ Leipzig, Coordinat Ctr Clin Trials, D-04103 Leipzig, Germany; [Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki 00271, Finland; [Tuomilehto, Jaakko] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki 00014, Finland; [Tuomilehto, Jaakko] S Ostrobothnia Cent Hosp, Seinajoki 60220, Finland; [van Ommen, Gert-Jan] Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZC Leiden, Netherlands; [van Ommen, Gert-Jan] Leiden Univ, Med Ctr, Ctr Med Syst Biol, NL-2333 ZC Leiden, Netherlands; [Viikari, Jorma] Univ Turku, Dept Med, Turku 20520, Finland; [Viikari, Jorma] Turku Univ Hosp, Turku 20520, Finland; [Heath, Andrew C.] Washington Univ, Sch Med, Dept Psychiat & Midwest, Res Inst Alcoholism, St Louis, MO 63108 USA; [Martin, Nicholas G.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Montgomery, Grant W.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Province, Michael A.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Kayser, Manfred] Erasmus MC, Dept Forens Mol Biol, NL-3015 GE Rotterdam, Netherlands; [Arnold, Alice M.] Collaborat Hlth Studies Coordinating Ctr, Seattle, WA 98115 USA; [Boerwinkle, Eric] Univ Texas Houston, Hlth Sci Ctr, Ctr Human Genet, Houston, TX 77030 USA; [Boerwinkle, Eric] Univ Texas Houston, Hlth Sci Ctr, Inst Mol Med, Houston, TX 77030 USA; [Boerwinkle, Eric] Univ Texas Houston, Hlth Sci Ctr, Div Epidemiol, Houston, TX 77030 USA; [Hengstenberg, Christian] Univ Regensburg, Klin & Poliklin Innere Med 2, D-93053 Regensburg, Germany; [Hengstenberg, Christian] Univ Regensburg, Med Ctr, Innere Med 2, D-93053 Regensburg, Germany; [Lathrop, G. Mark] Ctr Natl Genotypage, F-91057 Paris, France; [Schreiber, Stefan] Univ Kiel, Univ Hosp Schleswig Holstein, Clin Mol Biol, D-24105 Kiel, Germany; [Schreiber, Stefan] Dept Internal Med 1, D-24105 Kiel, Germany; [Waterworth, Dawn; Mooser, Vincent] GlaxoSmithKline, Div Genet, King Of Prussia, PA 19406 USA; [Barroso, Ines] Addenbrookes Hosp, Metab Res Labs, Inst Metab Sci, Cambridge CB2 OQQ, England; [Fox, Caroline S.] NHLBI, Div Intramural Res, Framingham, MA 01702 USA; [Hayes, Richard B.] NYU, Med Ctr, New York, NY 10016 USA; [Jarvelin, Marjo-Ritta] Univ Oulu, Bioctr Oulu, Oulu 90014, Finland; [Penninx, Brenda W.] Leiden Univ, Med Ctr, Dept Psychiat, NL-2300 RC Leiden, Netherlands; [Penninx, Brenda W.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9713 GZ Groningen, Netherlands; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, Bolzano, Italy; [Kaplan, Robert C.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; [North, Kari E.] Univ N Carolina, Sch Publ Hlth, Carolina Ctr Genome Sci, Chapel Hill, NC 27514 USA; [Schlessinger, David] NIA, Genet Lab, Baltimore, MD 21224 USA; [Strachan, David P.] St Georges Univ London, Div Community Hlth Sci, London SW17 0RE, England; [Schadt, H. -Erich] Klinikum Grosshadern, D-81377 Munich, Germany; [Eriksson, Johan G.] Pacific Biosci, Menlo Pk, CA 94025 USA; Sage Bionetworks, Seattle, WA 98109 USA; [Thorsteinsdottir, Unnur] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Peltonen, Leena] Univ Helsinki, Dept Med Genet, Helsinki 00014, Finland; [McCarthy, Mark I.] Churchill Hosp, NIHR Oxford Biomed Res Ctr, Oxford OX3 7LJ, England; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	University of Exeter; University of Plymouth; Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; Universite de Montreal; Universite de Montreal; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Michigan System; University of Michigan; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Oxford; Wellcome Centre for Human Genetics; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Wellcome Trust Sanger Institute; University of London; King's College London; QIMR Berghofer Medical Research Institute; Boston University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Icelandic Heart Association; University of Iceland; McGill University; McGill University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Regensburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Melbourne; Uppsala University; Norwegian University of Science & Technology (NTNU); Washington University (WUSTL); University of Tartu; Estonian Biocentre; University of Tartu; University of Lausanne; Swiss Institute of Bioinformatics; University of London; Queen Mary University London; University of London; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Oxford; Ernst Moritz Arndt Universitat Greifswald; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Edinburgh; Vrije Universiteit Amsterdam; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Stanford University; University of North Carolina; University of North Carolina Chapel Hill; University of Zagreb; University of Zagreb, School of Dental Medicine; University of Lubeck; University of Cambridge; Karolinska Institutet; Wake Forest University; QIMR Berghofer Medical Research Institute; University of Helsinki; Finland National Institute for Health & Welfare; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Imperial College London; University of Western Australia; University of Bath; Royal National Hospital for Rheumatic Diseases (RNHRD); University System of Maryland; University of Maryland Baltimore; Merck & Company; University of Oulu; Harvard University; Massachusetts General Hospital; Stanford University; University of Gothenburg; University of Washington; University of Washington Seattle; University of Munich; University of Munich; Boston University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Milan; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Leicester; University of Lubeck; Lund University; University of Leeds; University of Edinburgh; Vita-Salute San Raffaele University; European Academy of Bozen-Bolzano; University of Lubeck; University of Glasgow; NorthShore University Health System; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Vaasa Central Hospital; University of California System; University of California Los Angeles; University of Sassari; University of Oulu; Finland National Institute for Health & Welfare; University of Western Australia; University of Western Australia; Finland National Institute for Health & Welfare; University of Oulu; Leipzig University; Finnish Institute of Occupational Health; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Helsinki; University of Split; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; McMaster University; Amgen; University of Oxford; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; Lund University; University of Cambridge; University of Helsinki; Helsinki University Central Hospital; Vrije Universiteit Amsterdam; University of Oxford; Wellcome Centre for Human Genetics; University of Bristol; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Western Australia; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Radboud University Nijmegen; Karolinska Institutet; Karolinska University Hospital; Kaiser Permanente; University of California System; University of California San Francisco; Tampere University; Tampere University; Tampere University Hospital; Finland National Institute for Health & Welfare; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Harvard Medical School; Radboud University Nijmegen; Radboud University Nijmegen; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Tampere University; Tampere University; Tampere University Hospital; University of Mississippi; University of Mississippi Medical Center; University of Western Australia; National Institutes of Health (NIH) - USA; Erasmus University Rotterdam; Erasmus MC; University of Turku; University of Turku; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; Geriatric Research Education & Clinical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Leipzig University; Leipzig University; Leipzig University; Finland National Institute for Health & Welfare; University of Helsinki; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Turku; University of Turku; Washington University (WUSTL); QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; Washington University (WUSTL); Erasmus University Rotterdam; Erasmus MC; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Regensburg; University of Regensburg; CEA; University of Kiel; Schleswig Holstein University Hospital; GlaxoSmithKline; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); New York University; University of Oulu; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; Krankenhaus Bozen; Yeshiva University; Albert Einstein College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); St Georges University London; University of Munich; University of Iceland; University of Helsinki; University of Oxford; Harvard University; Harvard Medical School	Allen, HL (corresponding author), Univ Exeter, Peninsula Coll Med & Dent, Exeter EX1 2LU, Devon, England.		Stefansson, Kari/AAE-7187-2019; Prokopenko, Inga/AAU-9895-2020; Mägi, Reedik/AAJ-9679-2021; Salvi, Erika/C-1033-2015; Assimes, Themistocles Leonard/D-9696-2015; Ridderstråle, Martin/F-7678-2012; Rudan, Igor/I-1467-2012; Liu, Jianjun/AAK-4989-2020; Abecasis, Goncalo R/B-7840-2010; Aben, Katja KH/G-9686-2016; Stumvoll, Michael/ABE-1121-2021; Müller-Nurasyid, Martina/I-8735-2018; Walters, G. Bragi/L-4215-2013; Polasek, Ozren/B-6002-2011; mangino, massimo/F-5134-2011; de Geus, Eco J.C./M-9318-2015; Hayward, Caroline/M-8818-2016; Salvi, Erika/AAA-1415-2019; Erdmann, Jeanette/P-7513-2014; Palmer, Lyle John/K-3196-2014; Rivadeneira, Fernando/O-5385-2015; Hicks, Andrew Anthony/E-9518-2017; Nyholt, Dale Robert/J-3174-2017; Uda, Manuela/AAC-2645-2019; Hall, Alistair/K-1953-2019; Segre, Ayellet V/E-9800-2010; Montgomery, Grant W/B-7148-2008; Pare, Guillaume/T-9631-2018; Beckmann, Jacques Simon/A-9772-2008; sanna, serena/H-3009-2019; Palmer, Lyle John/N-1948-2019; Mulas, Antonella/B-4231-2015; Sovio, Ulla/H-8532-2019; Hengstenberg, Christian/U-5485-2019; Kolcic, Ivana/E-2713-2017; Johansson, Åsa/G-5270-2011; Zagato, Laura/AAC-7739-2022; Allen, Hana Lango/G-9026-2012; Ohlsson, Claes/AGP-3544-2022; Colaus, PsyColaus/K-6607-2013; Zgaga, Lina/Q-9415-2018; Loos, Ruth/GON-5877-2022; Voight, Benjamin/F-1775-2011; Havulinna, Aki/AAM-4769-2021; Amin, Najaf N/D-1859-2012; Maschio, Andrea/AAX-8185-2020; Loos, Ruth J F/Q-2862-2016; Yang, Jian/A-5852-2010; Aspelund, Thor/F-4826-2011; Vandenput, Liesbeth/AAI-4100-2021; Prokopenko, Inga/H-3241-2014; Gudnason, Vilmundur/K-6885-2015; Erdmann, Jeanette/A-4417-2009; Ripatti, Samuli/H-9446-2014; Rioux, John D/A-9599-2015; Lorentzon, Mattias/W-7878-2019; König, Inke R/A-4544-2009; Hui, Jennie/A-9543-2013; Coin, Lachlan JM/A-9001-2014; Wilson, James F/A-5704-2009; Aulchenko, Yurii/M-8270-2013; Rotter, Jerome/AAY-6598-2021; Aspelund, Thor/C-5983-2008; Aspelund, Thor/K-7022-2019; Johansson, Åsa/AAG-6799-2021; Campbell, Harry/E-2959-2010; Kiemeney, Lambertus A./D-3357-2009; Marusic, Ana/E-7683-2013; Schmidt, Carsten Oliver/AAH-2778-2019; Pramstaller, Peter P/C-2357-2008; Gudnason, Vilmundur/AAE-7126-2019; Berndt, Sonja I/J-8423-2016; Citterio, Lorena/AAC-1589-2019; Smith, Albert Vernon/K-5150-2015; Kaprio, Jaakko/A-1820-2008; Kilpeläinen, Tuomas/F-8569-2012; Deloukas, Panos/B-2922-2013; Boomsma, Dorret I/AAX-4470-2020; Wood, Andrew R/AAB-3807-2019; Lehtimäki, Terho/AAD-1094-2022; Raitakari, Olli/AAQ-7389-2021; Visscher, Peter/ABB-6151-2020; Meitinger, Thomas/O-1318-2015; Nelis, Mari/ABG-7775-2020; Spector, Tim D/F-6533-2012; Cooper, Matthew N/J-4420-2014; Vandenput, Liesbeth/AAP-3655-2020; Kaplan, Robert/A-2526-2011; Penninx, Brenda WJH/S-7627-2017; Feitosa, Mary F/K-8044-2012; Coin, Lachlan/O-4976-2019; Dominiczak, Anna F/P-9390-2017; den Heijer, Martin/J-8036-2015; Ziegler, Andreas/G-4246-2012; McCarthy, Mark/M-3763-2015	Salvi, Erika/0000-0002-2724-2291; Assimes, Themistocles Leonard/0000-0003-2349-0009; Rudan, Igor/0000-0001-6993-6884; Liu, Jianjun/0000-0002-3255-3019; Aben, Katja KH/0000-0002-0214-2147; Stumvoll, Michael/0000-0001-6225-8240; Müller-Nurasyid, Martina/0000-0003-3793-5910; Walters, G. Bragi/0000-0002-5415-6487; Polasek, Ozren/0000-0002-5765-1862; mangino, massimo/0000-0002-2167-7470; de Geus, Eco J.C./0000-0001-6022-2666; Hayward, Caroline/0000-0002-9405-9550; Salvi, Erika/0000-0002-2724-2291; Erdmann, Jeanette/0000-0002-4486-6231; Palmer, Lyle John/0000-0002-1628-3055; Rivadeneira, Fernando/0000-0001-9435-9441; Hicks, Andrew Anthony/0000-0001-6320-0411; Nyholt, Dale Robert/0000-0001-7159-3040; Uda, Manuela/0000-0002-4890-6456; Montgomery, Grant W/0000-0002-4140-8139; Pare, Guillaume/0000-0002-6795-4760; Beckmann, Jacques Simon/0000-0002-9741-1900; sanna, serena/0000-0002-3768-1749; Palmer, Lyle John/0000-0002-1628-3055; Sovio, Ulla/0000-0002-0799-1105; Kolcic, Ivana/0000-0001-7918-6052; Johansson, Åsa/0000-0002-2915-4498; Allen, Hana Lango/0000-0002-7803-8688; Ohlsson, Claes/0000-0002-9633-2805; Zgaga, Lina/0000-0003-4089-9703; Loos, Ruth J F/0000-0002-8532-5087; Yang, Jian/0000-0003-2001-2474; Vandenput, Liesbeth/0000-0002-1712-6131; Prokopenko, Inga/0000-0003-1624-7457; Gudnason, Vilmundur/0000-0001-5696-0084; Ripatti, Samuli/0000-0002-0504-1202; Rioux, John D/0000-0001-7560-8326; Lorentzon, Mattias/0000-0003-0749-1431; König, Inke R/0000-0003-0504-6465; Hui, Jennie/0000-0002-1653-2496; Coin, Lachlan JM/0000-0002-4300-455X; Wilson, James F/0000-0001-5751-9178; Aulchenko, Yurii/0000-0002-7899-1575; Aspelund, Thor/0000-0002-7998-5433; Aspelund, Thor/0000-0002-7998-5433; Johansson, Åsa/0000-0002-2915-4498; Campbell, Harry/0000-0002-6169-6262; Kiemeney, Lambertus A./0000-0002-2368-1326; Marusic, Ana/0000-0001-6272-0917; Schmidt, Carsten Oliver/0000-0001-5266-9396; Gudnason, Vilmundur/0000-0001-5696-0084; Citterio, Lorena/0000-0001-6455-2291; Smith, Albert Vernon/0000-0003-1942-5845; Kaprio, Jaakko/0000-0002-3716-2455; Kilpeläinen, Tuomas/0000-0002-8349-3028; Deloukas, Panos/0000-0001-9251-070X; Wood, Andrew R/0000-0003-1726-948X; Lehtimäki, Terho/0000-0002-2555-4427; Visscher, Peter/0000-0002-2143-8760; Nelis, Mari/0000-0001-9748-1020; Cooper, Matthew N/0000-0003-1139-3682; Penninx, Brenda WJH/0000-0001-7779-9672; Feitosa, Mary F/0000-0002-0933-2410; Coin, Lachlan/0000-0002-4300-455X; Dominiczak, Anna F/0000-0003-4913-3608; Munroe, Patricia/0000-0002-4176-2947; Goddard, Michael/0000-0001-9917-7946; Beilby, John/0000-0002-4915-2254; Barroso, Ines/0000-0001-5800-4520; Wheeler, Eleanor/0000-0002-8616-6444; Bergmann, Sven/0000-0002-6785-9034; Pichler, Irene/0000-0001-8251-0757; Raychaudhuri, Soumya/0000-0002-1901-8265; Quertermous, Thomas/0000-0002-7645-9067; Weedon, Michael/0000-0002-6174-6135; Sinisalo, Juha/0000-0002-0169-5137; Van Duijn, Cornelia/0000-0002-2374-9204; Pramstaller, Peter P/0000-0002-9831-8302; Ouwehand, Willem/0000-0002-7744-1790; Pietilainen, Kirsi/0000-0002-8522-1288; den Heijer, Martin/0000-0003-3620-5617; Weyant, Robert/0000-0002-5252-9120; Willemsen, Gonneke/0000-0003-3755-0236; Martin, Nicholas/0000-0003-4069-8020; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Lindgren, Cecilia/0000-0002-4903-9374; Elliott, Paul/0000-0002-7511-5684; Caulfield, Mark/0000-0001-9295-3594; Surakka, Ida/0000-0002-6669-5541; Ziegler, Andreas/0000-0002-8386-5397; Gieger, Christian/0000-0001-6986-9554; Randall, Joshua/0000-0003-1540-203X; van Meurs, Joyce/0000-0001-6245-2123; Kovacs, Peter/0000-0002-0290-5423; Amin, Najaf/0000-0002-8944-1771; Johnson, Toby/0000-0002-5998-3270; McCarthy, Mark/0000-0002-4393-0510; maschio, andrea/0000-0002-4238-9144; Hall, Alistair/0000-0003-0306-7887; Willer, Cristen/0000-0001-5645-4966; Bergman, Richard/0000-0003-1539-4471; Salem, Rany/0000-0001-8816-6862; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Esko, Tonu/0000-0003-1982-6569; Shuldiner, Alan/0000-0001-9921-4305; Magi, Reedik/0000-0002-2964-6011; Meitinger, Thomas/0000-0002-8838-8403; Preuss, Michael/0000-0001-5266-8465; Cupples, L. Adrienne/0000-0003-0273-7965; Melander, Olle/0000-0002-2581-484X; Hayes, Richard/0000-0002-0918-661X; Gudbjartsson, Daniel/0000-0002-5222-9857; Rivolta, Carlo/0000-0002-0733-9950; Zagato, Laura/0000-0002-0441-2120; Peters, Marjolein/0000-0003-3167-9063; Heard-Costa, Nancy/0000-0001-9730-0306; Watkins, Hugh/0000-0002-5287-9016; Workalemahu, Tsegaselassie/0000-0003-4571-9740; Glazer, Nicole/0000-0002-6397-609X; Kahonen, Mika/0000-0002-4510-7341; Eriksson, Johan/0000-0002-2516-2060; Abecasis, Goncalo/0000-0003-1509-1825; Mulas, Antonella/0000-0002-6856-1483; Turchin, Michael/0000-0003-3569-1529; Soranzo, Nicole/0000-0003-1095-3852; Frayling, Timothy/0000-0001-8362-2603; Hattersley, Andrew/0000-0001-5620-473X	Academy of Finland [104781, 117797, 120315, 121584, 126925, 129269, 129494, 129680, 213506]; Affymetrix for genotyping services [N02-HL-6-4278]; Agency for Science, Technology and Research of Singapore; ALF/LUA Gothenburg; Althingi (the Icelandic Parliament); Amgen; AstraZeneca AB; Australian National Health and Medical Research Council [241944, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 496688, 552485, 613672]; Australian Research Council [DP0770096]; Biocentrum Helsinki; Boston Obesity Nutrition Research Center [DK46200]; British Diabetes Association; British Heart Foundation [PG/02/128]; British Heart Foundation Centre for Research Excellence, Oxford; CamStrad; Cancer Research UK; Centre for Neurogenomics and Cognitive Research; Chief Scientist Office of the Scottish Government [CZB/4/279]; Council of Health of the Academy of Finland; German Network of Diabetes; Diabetes UK; Donald W. Reynolds Foundation; Emil and Vera Cornell Foundation; Erasmus MC; Estonian Government [SF0180142s08]; European Commission [201413, ECOGENE:205419, BBMRI:212111, OPENGENE:245536, ENGAGE:HEALTH-F4-2007-201413, EURODIA:LSHG-CT-2004-518153, EU/WLRT-2001-01254, HEALTH-F2-2008-ENGAGE, HEALTH-F4-2007-201550, LSH-2006-037593, LSHG-CT-2006-018947, LSHG-CT-2006-01947, Procardis:LSHM-CT-2007-037273, POLYGENE:LSHC-CT-2005, QLG1-CT-2000-01643, QLG2-CT-2002-01254]; Eve Appeal; Finnish Ministry of Education; Finnish Diabetes Research Foundation; Finnish Diabetes Research Society; Finnish Foundation for Cardiovascular Research; Finnish Medical Society; Finska Lakaresallskapet; Folkhalsan Research Foundation; Fondation LeDucq; Foundation for Life and Health in Finland; Foundation for Strategic Research; GEN-AU; Genetic Association Information Network; German Bundesministerium fuer Forschung und Technology [01 AK 803 A-H, 01 IG 07015 G]; German Federal Ministry of Education and Research [01GS0831]; German Ministry for Health, Welfare and Sports; German Ministry of Cultural Affairs; German Ministry of Education, Culture and Science; German National Genome Research Net [01GS0823, 01ZZ0103, 01ZZ0403, 01ZZ9603, 03ZIK012]; German Research Council [KFO-152]; GlaxoSmithKline; Goteborg Medical Society; Gyllenberg Foundation; Helmholtz Center Munich; Juvenile Diabetes Research Foundation International [U01 DK062418]; Karolinska Institute; Knut and Alice Wallenberg Foundation; Lundberg Foundation; March of Dimes [6-FY-09-507]; MC Health; Medical Research Council UK [G0000649, G0000934, G0500539, G0600331, G0601261, G9521010D]; Microarray Core Facility of the Interdisciplinary Centre for Clinical Research [B27]; Mid-Atlantic Nutrition and Obesity Research Center of Maryland [P30 DK072488]; Ministry of Health and Department of Educational Assistance (South Tyrol, Italy); Ministry of Science, Education and Sport of the Republic of Croatia [216-1080315-0302]; Montreal Heart Institute Foundation; Narpes Health Care Foundation; National Cancer Institute; National Institute for Health Research Cambridge Biomedical Research Centre; National Institute for Health Research Oxford Biomedical Research Centre; National Institute for Health Research Comprehensive Biomedical Research Centre; National Institutes of Health [263-MA-410953, AA014041, AA07535, AA10248, AA13320, AA13321, AA13326, CA047988, CA49449, CA50385, CA65725, CA67262, CA87969, DA12854, DK062370, DK063491, DK072193, DK079466, DK080145, DK58845, HG002651, HG005214, HG005581, HL043851, HL084729, HL69757, HL71981, K08-AR055688]; ADA; Netherlands Genomics Initiative/Netherlands Consortium for Healthy Aging [050-060-810]; Netherlands Organisation for Scientific Research [175.010.2005.011, 911-03-012]; Netherlands Organization for the Health Research and Development [10-000-1002]; Netherlands Scientific Organization [904-61-090, 904-61-193, 480-04-004, 400-05-717, SPI 56-464-1419]; NIA; Nordic Center of Excellence in Disease Genetics; Novo Nordisk Foundation; Ollqvist Foundation; Paavo Nurmi Foundation; Perklen Foundation; Petrus and Augusta Hedlunds Foundation; Queensland Institute of Medical Research; Radboud University Nijmegen Medical Centre; Research Institute for Diseases in the Elderly [014-93-015]; Royal Swedish Academy of Science; Sahlgrenska Center for Cardiovascular and Metabolic Research [A305:188]; Siemens Healthcare, Erlangen, Germany; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation; Social Insurance Institution of Finland; Social Ministry of the Federal State of Mecklenburg-West Pomerania; South Tyrolean Sparkasse Foundation; Stockholm County Council; Support for Science Funding programme; Susan G. Komen Breast Cancer Foundation; Swedish Cancer Society; Swedish Cultural Foundation in Finland; Swedish Foundation for Strategic Research; Swedish Heart-Lung Foundation; Swedish Medical Research Council; Swedish National Cancer Institute; Swedish Research Council; Swedish Society of Medicine; Swiss National Science Foundation; Torsten and Ragnar Soderberg's Foundation; Vandervell Foundation; Vastra Gotaland Foundation; Wellcome Trust [072960, 075491, 079557, 079895, 083270, 068545/Z/02, 076113/B/04/Z, 076113/C/04/Z, 077016/Z/05/Z, 081682/Z/06/Z, 084183/Z/07/Z, 085301/Z/08/Z, 086596/Z/08/Z, 091746/Z/10/Z]; Wellcome Trust; Western Australian Genetic Epidemiology Resource; Western Australian DNA Bank;  [560183];  [K2007-66X-20270-01-3];  [8691];  [33CSCO-122661]; Medical Research Council [G0600331, G9521010, MC_qA137934, MC_U106179471, MC_U106188470, G0000934, G0601261, MC_U127561128, G0701863] Funding Source: researchfish; Chief Scientist Office [CZB/4/710] Funding Source: researchfish; MRC [G0701863, G0601261, MC_U127561128, G0000934, MC_qA137934, G0600331, G9521010, MC_U106188470] Funding Source: UKRI; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055016, N01HC055018, N01HC085081, N01HC055021, N01HC045133, N01HC055019, N01HC085086, N01HC085084, N01HC055015, N01HC015103, N01HC085083, N01HC085085, N01HC055022, N01HC035129, N01HC085080, N01HC075150, N01HC025195, N01HC055020, N01HC085079, N01HC085082, N01HC055222] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA065725, R01CA050385, R01CA104021, U01CA049449, P01CA087969, U01CA067262, R01CA049449, R01CA067262, R01CA047988, U01CA098233] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005, M01RR000425, U54RR020278] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, R01HL087641, K99HL094535, R01HL117078, R01HL088119, R01HL059367, R01HL087652, R01HL086694, R42HL055018, ZIAHL006094, R01HL087679, U19HL069757, ZIAHL006002, U01HL084729, R01HL087700, U01HL069757, R01HL087647, R01HL064278, R01HL087676, U01HL084756, U01HL072515, R41HL055018, R01HL043851, R01HL071981] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG005214, T32HG000040, N01HG065403, U01HG004399, ZIAHG000024, Z01HG000024, R01HG002651, RC2HG005581, U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR055688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073490, R01DK072193, R01DK058845, R01DK089256, R01DK091718, U01DK062418, P30DK072488, F32DK079466, U01DK062370, P30DK046200, R01DK075681, R01DK062370, R56DK062370, K23DK080145, R01DK075787, R01DK068336, P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059586, R01MH067257, R01MH061675, R01MH059571, R01MH081800, RL1MH083268, R01MH063706, R01MH059566, R01MH060870, R01MH060879, R01MH059565, U01MH079470, U01MH079469, R01MH059587, R01MH059588, R01MH084698, R01MH059160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG007380, N01AG012100, Z01AG000675, ZIAAG006000, ZIAAG000675, ZIAAG007380, R01AG031890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013321, K05AA017688, R01AA014041, R01AA007535, R01AA013320, R01AA013326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012854, R56DA012854] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Affymetrix for genotyping services; Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR)); ALF/LUA Gothenburg; Althingi (the Icelandic Parliament); Amgen(Amgen); AstraZeneca AB(AstraZeneca); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Biocentrum Helsinki; Boston Obesity Nutrition Research Center; British Diabetes Association(Diabetes UK); British Heart Foundation(British Heart Foundation); British Heart Foundation Centre for Research Excellence, Oxford; CamStrad; Cancer Research UK(Cancer Research UK); Centre for Neurogenomics and Cognitive Research; Chief Scientist Office of the Scottish Government; Council of Health of the Academy of Finland(Academy of Finland); German Network of Diabetes; Diabetes UK(Diabetes UK); Donald W. Reynolds Foundation; Emil and Vera Cornell Foundation; Erasmus MC; Estonian Government; European Commission(European CommissionEuropean Commission Joint Research Centre); Eve Appeal; Finnish Ministry of Education; Finnish Diabetes Research Foundation; Finnish Diabetes Research Society; Finnish Foundation for Cardiovascular Research; Finnish Medical Society; Finska Lakaresallskapet; Folkhalsan Research Foundation; Fondation LeDucq(Leducq Foundation); Foundation for Life and Health in Finland; Foundation for Strategic Research; GEN-AU; Genetic Association Information Network; German Bundesministerium fuer Forschung und Technology; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Ministry for Health, Welfare and Sports; German Ministry of Cultural Affairs; German Ministry of Education, Culture and Science; German National Genome Research Net; German Research Council(German Research Foundation (DFG)); GlaxoSmithKline(GlaxoSmithKline); Goteborg Medical Society; Gyllenberg Foundation; Helmholtz Center Munich(Helmholtz Association); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Karolinska Institute(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Lundberg Foundation(European Commission); March of Dimes(March of Dimes); MC Health; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Microarray Core Facility of the Interdisciplinary Centre for Clinical Research; Mid-Atlantic Nutrition and Obesity Research Center of Maryland; Ministry of Health and Department of Educational Assistance (South Tyrol, Italy); Ministry of Science, Education and Sport of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); Montreal Heart Institute Foundation; Narpes Health Care Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research Comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ADA(American Diabetes Association); Netherlands Genomics Initiative/Netherlands Consortium for Healthy Aging; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for the Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Scientific Organization; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Nordic Center of Excellence in Disease Genetics; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Ollqvist Foundation; Paavo Nurmi Foundation; Perklen Foundation; Petrus and Augusta Hedlunds Foundation; Queensland Institute of Medical Research; Radboud University Nijmegen Medical Centre; Research Institute for Diseases in the Elderly; Royal Swedish Academy of Science; Sahlgrenska Center for Cardiovascular and Metabolic Research; Siemens Healthcare, Erlangen, Germany(Siemens AG); Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Social Insurance Institution of Finland; Social Ministry of the Federal State of Mecklenburg-West Pomerania; South Tyrolean Sparkasse Foundation; Stockholm County Council(Stockholm County Council); Support for Science Funding programme; Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Swedish Cancer Society(Swedish Cancer Society); Swedish Cultural Foundation in Finland; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish National Cancer Institute; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society of Medicine; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Torsten and Ragnar Soderberg's Foundation; Vandervell Foundation; Vastra Gotaland Foundation; Wellcome Trust(Wellcome Trust); Wellcome Trust(Wellcome Trust); Western Australian Genetic Epidemiology Resource; Western Australian DNA Bank; ; ; ; ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Several participating studies are members of the CHARGE and ENGAGE consortia. We acknowledge funding from the following organizations: the Academy of Finland (104781, 117797, 120315, 121584, 126925, 129269, 129494, 129680, 213506); Affymetrix for genotyping services (N02-HL-6-4278); Agency for Science, Technology and Research of Singapore; ALF/LUA Gothenburg; Althingi (the Icelandic Parliament); Amgen; AstraZeneca AB; Australian National Health and Medical Research Council (241944, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 496688, 552485, 613672); Australian Research Council (DP0770096); Biocentrum Helsinki; Boston Obesity Nutrition Research Center (DK46200); British Diabetes Association; British Heart Foundation (PG/02/128); British Heart Foundation Centre for Research Excellence, Oxford; CamStrad; Cancer Research UK; Centre for Neurogenomics and Cognitive Research; Chief Scientist Office of the Scottish Government (CZB/4/279); Council of Health of the Academy of Finland; DIAB Core project of the German Network of Diabetes; Diabetes UK; Donald W.; Reynolds Foundation; Emil and Vera Cornell Foundation; Erasmus MC; Estonian Government (SF0180142s08); European Commission (201413, ECOGENE:205419, BBMRI:212111, OPENGENE:245536, ENGAGE:HEALTH-F4-2007-201413, EURODIA:LSHG-CT-2004-518153, EU/WLRT-2001-01254, HEALTH-F2-2008-ENGAGE, HEALTH-F4-2007-201550, LSH-2006-037593, LSHG-CT-2006-018947, LSHG-CT-2006-01947, Procardis:LSHM-CT-2007-037273, POLYGENE:LSHC-CT-2005, QLG1-CT-2000-01643, QLG2-CT-2002-01254, DG XII, Marie Curie Intra-European Fellowship); Eve Appeal; Finnish Ministry of Education; Finnish Diabetes Research Foundation; Finnish Diabetes Research Society; Finnish Foundation for Cardiovascular Research; Finnish Medical Society; Finska Lakaresallskapet; Folkhalsan Research Foundation; Fondation LeDucq; Foundation for Life and Health in Finland; Foundation for Strategic Research; GEN-AU-Programme 'GOLD'; Genetic Association Information Network; German Bundesministerium fuer Forschung und Technology (01 AK 803 A-H, 01 IG 07015 G); German Federal Ministry of Education and Research (01GS0831); German Ministry for Health, Welfare and Sports; German Ministry of Cultural Affairs; German Ministry of Education, Culture and Science; German National Genome Research Net (01GS0823, 01ZZ0103, 01ZZ0403, 01ZZ9603, 03ZIK012); German Research Council (KFO-152); GlaxoSmithKline; Goteborg Medical Society; Gyllenberg Foundation; Helmholtz Center Munich; Juvenile Diabetes Research Foundation International (U01 DK062418); Karolinska Institute; Knut and Alice Wallenberg Foundation; Lundberg Foundation; March of Dimes (6-FY-09-507); MC Health; Medical Research Council UK (G0000649, G0000934, G0500539, G0600331, G0601261, G9521010D, PrevMetSyn); Microarray Core Facility of the Interdisciplinary Centre for Clinical Research (B27); Mid-Atlantic Nutrition and Obesity Research Center of Maryland (P30 DK072488); Ministry of Health and Department of Educational Assistance (South Tyrol, Italy); Ministry of Science, Education and Sport of the Republic of Croatia (216-1080315-0302); Montreal Heart Institute Foundation; Narpes Health Care Foundation; National Cancer Institute; National Institute for Health Research Cambridge Biomedical Research Centre; National Institute for Health Research Oxford Biomedical Research Centre; National Institute for Health Research Comprehensive Biomedical Research Centre; National Institutes of Health (263-MA-410953, AA014041, AA07535, AA10248, AA13320, AA13321, AA13326, CA047988, CA49449, CA50385, CA65725, CA67262, CA87969, A12854, DK062370, DK063491, DK072193, DK079466, DK080145, DK58845, HG002651, HG005214, HG005581, HL043851, HL084729, HL69757, HL71981, K08-AR055688, K23-DK080145, K99-HL094535, M01-RR00425, MH084698, N01-AG12100, N01-AG12109, N01-HC15103, N01-HC25195, N01-HC35129, N01-HC45133, N01-HC55015, N01-HC55016, N01-HC55018N01-HC55022, N01-HC55222, N01-HC75150, N01-HC85079-N01-HC85086, N01-HG65403, R01-AG031890, R01 CA104021, R01-DK068336, R01-DK073490, R01-DK075681, R01-DK075787, R01-HL086694, R01-HL087641, R01-HL087647, R01-HL087652, R01-HL087676, R01-HL087679, R01-HL087700, R01-HL088119, R01-HL59367, R01-MH059160, R01-MH59565, R01-MH59566, R01-MH59571, R01-MH59586, R01-MH59587, R01-MH59588, R01-MH60870, R01-MH60879, R01-MH61675, R01-MH63706, R01-MH67257, R01-MH79469, R01-MH81800, RL1-MH083268, T32-HG00040, U01-CA098233, U01-GM074518, U01-HG004399, U01-HG004402, U01-HL080295, U01-HL084756, U01-HL72515, U01-MH79469, U01-MH79470, U54-RR020278, UL1-RR025005, Z01-AG00675, Z01-AG007380, Z01-HG000024; contract HHSN268200625226C; ADA Mentor-Based Postdoctoral Fellowship; Pew S; holarship for the Biomedical Sciences); Netherlands Genomics Initiative/Netherlands Consortium for Healthy Aging (050-060-810); Netherlands Organisation for Scientific Research (investment number 175.010.2005.011, 911-03-012); Netherlands Organization for the Health Research and Development (10-000-1002); Netherlands Scientific Organization (904-61-090, 904-61-193, 480-04-004, 400-05-717, Center for Medical Systems Biology (NOW Genomics), SPI 56-464-1419); NIA Intramural Research Program; Nordic Center of Excellence in Disease Genetics; Novo Nordisk Foundation; Ollqvist Foundation; Paavo Nurmi Foundation; Perklen Foundation; Petrus and Augusta Hedlunds Foundation; Queensland Institute of Medical Research; Radboud University Nijmegen Medical Centre; Research Institute for Diseases in the Elderly (014-93-015); Royal Swedish Academy of Science; Sahlgrenska Center for Cardiovascular and Metabolic Research (A305:188); Siemens Healthcare, Erlangen, Germany; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation; Social Insurance Institution of Finland; Social Ministry of the Federal State of Mecklenburg-West Pomerania; South Tyrolean Sparkasse Foundation; Stockholm County Council (560183); Support for Science Funding programme; Susan G. Komen Breast Cancer Foundation; Swedish Cancer Society; Swedish Cultural Foundation in Finland; Swedish Foundation for Strategic Research; Swedish Heart-Lung Foundation; Swedish Medical Research Council (K2007-66X-20270-01-3, 8691); Swedish National Cancer Institute; Swedish Research Council; Swedish Society of Medicine; Swiss National Science Foundation (33CSCO-122661); Torsten and Ragnar Soderberg's Foundation; Vandervell Foundation; Vastra Gotaland Foundation; Wellcome Trust (072960, 075491, 079557, 079895, 083270, 068545/Z/02, 076113/B/04/Z, 076113/C/04/Z, 076113/C/04/Z, 077016/Z/05/Z, 081682/Z/06/Z, 084183/Z/07/Z, 085301/Z/08/Z, 086596/Z/ 08/Z, 091746/Z/10/Z; Wellcome Trust Research Career Development Fellowship); Western Australian Genetic Epidemiology Resource and the Western Australian DNA Bank (both National Health and Medical Research Council of Australia Enabling Facilities). A detailed list of acknowledgements by study is given in the Supplementary Information.	Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Estrada K, 2009, HUM MOL GENET, V18, P3516, DOI 10.1093/hmg/ddp296; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Galton F, 1885, J R ANTHR I, V5, P329; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Johansson A, 2009, HUM MOL GENET, V18, P373, DOI 10.1093/hmg/ddn350; Kofoed EM, 2003, NEW ENGL J MED, V349, P1139, DOI 10.1056/NEJMoa022926; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Soranzo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000445; Superti-Furga A, 2007, AM J MED GENET A, V143A, P1, DOI 10.1002/ajmg.a.31483; Visscher PM, 2006, PLOS GENET, V2, P316, DOI 10.1371/journal.pgen.0020041; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; Weinstein M, 1998, DEVELOPMENT, V125, P3615; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	28	1393	1422	6	277	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2010	467	7317					832	838		10.1038/nature09410	http://dx.doi.org/10.1038/nature09410			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20881960	Green Accepted, Green Submitted			2022-12-01	WOS:000282898700065
J	Wagner, CR; Kuervers, L; Baillie, DL; Yanowitz, JL				Wagner, Cynthia R.; Kuervers, Lynnette; Baillie, David L.; Yanowitz, Judith L.			xnd-1 regulates the global recombination landscape in Caenorhabditis elegans	NATURE			English	Article							DOUBLE-STRAND BREAKS; MEIOTIC RECOMBINATION; C-ELEGANS; DNA; COMPLEX; PRDM9; CROSSOVERS; GERMLINE; HOTSPOTS; REVEALS	Meiotic crossover (CO) recombination establishes physical linkages between homologous chromosomes that are required for their proper segregation into developing gametes, and promotes genetic diversity by shuffling genetic material between parental chromosomes. COs require the formation of double strand breaks (DSBs) to create the substrate for strand exchange. DSBs occur in small intervals called hotspots(1-3) and significant variation in hotspot usage exists between and among individuals(4). This variation is thought to reflect differences in sequence identity and chromatin structure, DNA topology and/or chromosome domain organization(1,5-9). Chromosomes show different frequencies of nondisjunction (NDJ)(10), reflecting inherent differences in meiotic crossover control, yet the underlying basis of these differences remains elusive. Here we show that a novel chromatin factor, X non-disjunction factor 1 (xnd-1), is responsible for the global distribution of COs in C. elegans. xnd-1 is also required for formation of double-strand breaks (DSBs) on the X, but surprisingly XND-1 protein is autosomally enriched. We show that xnd-1 functions independently of genes required for X chromosome-specific gene silencing, revealing a novel pathway that distinguishes the X from autosomes in the germ line, and further show that xnd-1 exerts its effects on COs, at least in part, by modulating levels of H2A lysine 5 acetylation.	[Wagner, Cynthia R.; Yanowitz, Judith L.] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA; [Kuervers, Lynnette; Baillie, David L.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Yanowitz, Judith L.] Magee Womens Res Inst, Pittsburgh, PA 15213 USA; [Yanowitz, Judith L.] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA	Carnegie Institution for Science; Simon Fraser University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yanowitz, JL (corresponding author), Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA.	yanowitzjl@mwri.magee.edu	Yanowitz, Judith L/AGJ-8504-2022	Yanowitz, Judith L/0000-0001-6886-8787	Carnegie Institution of Washington, NIH [K01AG031296]; MWRI; NSERC; NATIONAL INSTITUTE ON AGING [K01AG031296] Funding Source: NIH RePORTER	Carnegie Institution of Washington, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MWRI; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Bembenek, A. Bortvin, G. Deshpande, M. Halpern, V. Jantsch, A. MacQueen and D. Mets for comments on the manuscript; the Koshland lab and Baltimore Area Worm Club for discussions; M. Siddiqi for microscopy support. We are indebted to the Caenorhabditis Genetics Center and the C. elegans Knockout Consortium for worm stocks and Y. Kohara for cDNAs. This work was supported by the Carnegie Institution of Washington, NIH K01AG031296, and MWRI start-up funds to J.L.Y.D.L.B. was supported by a Canada Research Chair and a grant from NSERC.	BARNES TM, 1995, GENETICS, V141, P159; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; BRENNER S, 1974, GENETICS, V77, P71; Buard J, 2009, EMBO J, V28, P2616, DOI 10.1038/emboj.2009.207; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Ceol CJ, 2004, DEV CELL, V6, P563, DOI 10.1016/S1534-5807(04)00065-6; CHAN A, 2006, PROTOCOL 21 ANTIBODY; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Fong YY, 2002, SCIENCE, V296, P2235, DOI 10.1126/science.1070790; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Hassold T, 2007, HUM MOL GENET, V16, pR203, DOI 10.1093/hmg/ddm243; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; HODGKIN J, 1979, GENETICS, V91, P67; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kelly WG, 1997, GENETICS, V146, P227; Kelly WG, 2002, DEVELOPMENT, V129, P479; Lim JGY, 2008, GENETICS, V180, P715, DOI 10.1534/genetics.108.090142; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Mets DG, 2009, CELL, V139, P73, DOI 10.1016/j.cell.2009.07.035; Mieczkowski PA, 2007, P NATL ACAD SCI USA, V104, P3955, DOI 10.1073/pnas.0700412104; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Petty EL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000699; Phillips CM, 2005, CELL, V123, P1051, DOI 10.1016/j.cell.2005.09.035; Robine N, 2007, MOL CELL BIOL, V27, P1868, DOI 10.1128/MCB.02063-06; Rockman MV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000419; Smolikov S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000088; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tsai CJ, 2008, GENE DEV, V22, P194, DOI 10.1101/gad.1618508; ZETKA MC, 1995, GENETICS, V141, P1339	36	56	57	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2010	467	7317					839	U103		10.1038/nature09429	http://dx.doi.org/10.1038/nature09429			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944745	Green Submitted, Green Accepted			2022-12-01	WOS:000282898700066
J	Gibiansky, ML; Conrad, JC; Jin, F; Gordon, VD; Motto, DA; Mathewson, MA; Stopka, WG; Zelasko, DC; Shrout, JD; Wong, GCL				Gibiansky, Maxsim L.; Conrad, Jacinta C.; Jin, Fan; Gordon, Vernita D.; Motto, Dominick A.; Mathewson, Margie A.; Stopka, Wiktor G.; Zelasko, Daria C.; Shrout, Joshua D.; Wong, Gerard C. L.			Bacteria Use Type IV Pili to Walk Upright and Detach from Surfaces	SCIENCE			English	Article							BIOFILM FORMATION; MOTILITY	Bacterial biofilms are structured multicellular communities involved in a broad range of infections. Knowing how free-swimming bacteria adapt their motility mechanisms near surfaces is crucial for understanding the transition between planktonic and biofilm phenotypes. By translating microscopy movies into searchable databases of bacterial behavior, we identified fundamental type IV pili-driven mechanisms for Pseudomonas aeruginosa surface motility involved in distinct foraging strategies. Bacteria stood upright and "walked" with trajectories optimized for two-dimensional surface exploration. Vertical orientation facilitated surface detachment and could influence biofilm morphology.	[Gibiansky, Maxsim L.; Jin, Fan; Gordon, Vernita D.; Wong, Gerard C. L.] Univ Calif Los Angeles, Dept Bioengn, Calif Nano Syst Inst, Los Angeles, CA 90024 USA; [Conrad, Jacinta C.] Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77204 USA; [Mathewson, Margie A.; Stopka, Wiktor G.; Zelasko, Daria C.; Wong, Gerard C. L.] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [Motto, Dominick A.; Shrout, Joshua D.] Univ Notre Dame, Dept Civil Engn & Geol Sci, Notre Dame, IN 46556 USA	University of California System; University of California Los Angeles; University of Houston System; University of Houston; University of Illinois System; University of Illinois Urbana-Champaign; University of Notre Dame	Wong, GCL (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Calif Nano Syst Inst, Los Angeles, CA 90024 USA.	gclwong@seas.ucla.edu	Conrad, Jacinta/D-6432-2013; Shrout, Joshua D/C-4743-2012	Conrad, Jacinta/0000-0001-6084-4772; Shrout, Joshua D/0000-0001-9509-2187; fan, jin/0000-0003-2313-0388; Gordon, Vernita/0000-0002-5989-9378				Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; Sun H, 2000, CURR BIOL, V10, P1143, DOI 10.1016/S0960-9822(00)00705-3; Tolker-Nielsen T, 2000, J BACTERIOL, V182, P6482, DOI 10.1128/JB.182.22.6482-6489.2000	7	138	143	9	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					197	U50		10.1126/science.1194238	http://dx.doi.org/10.1126/science.1194238			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20929769	Green Published			2022-12-01	WOS:000282644600033
J	Kotov, NA				Kotov, Nicholas A.			Inorganic Nanoparticles as Protein Mimics	SCIENCE			English	Editorial Material							SEMICONDUCTOR NANOPARTICLES; QUANTUM DOTS; SIZE; DNA		Univ Michigan, Dept Biomed Engn, Dept Chem Engn, Dept Mat Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Kotov, NA (corresponding author), Univ Michigan, Dept Biomed Engn, Dept Chem Engn, Dept Mat Sci, Ann Arbor, MI 48109 USA.	kotov@umich.edu	Nanozymes, Nanozymes/D-8197-2019; Kotov, Nicholas/AAZ-4204-2021	Kotov, Nicholas/0000-0002-6864-5804				AGRANOVSKY AA, 1995, P NATL ACAD SCI USA, V92, P2470, DOI 10.1073/pnas.92.7.2470; Aubin-Tam ME, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034001; Bayraktar H, 2006, CHEM COMMUN, P1390, DOI 10.1039/b516096k; Bharali DJ, 2005, P NATL ACAD SCI USA, V102, P11539, DOI 10.1073/pnas.0504926102; Cai YR, 2007, J MATER CHEM, V17, P3780, DOI 10.1039/b705129h; CHEMSEDDINE A, 1993, BER BUNSEN PHYS CHEM, V97, P636, DOI 10.1002/bbpc.19930970417; Du C, 2005, SCIENCE, V307, P1450, DOI 10.1126/science.1105675; Errington J, 2001, NAT REV MOL CELL BIO, V2, P538, DOI 10.1038/35080005; Ishii D, 2003, NATURE, V423, P628, DOI 10.1038/nature01663; Kirchner C, 2005, NANO LETT, V5, P331, DOI 10.1021/nl047996m; Klein J, 2007, P NATL ACAD SCI USA, V104, P2029, DOI 10.1073/pnas.0611610104; Li XQ, 2008, CATAL LETT, V124, P413, DOI 10.1007/s10562-008-9494-5; Mahtab R, 2000, J AM CHEM SOC, V122, P14, DOI 10.1021/ja9907156; Manea F, 2004, ANGEW CHEM INT EDIT, V43, P6165, DOI 10.1002/anie.200460649; Mohanan JL, 2005, SCIENCE, V307, P397, DOI 10.1126/science.1106525; Seleverstov O, 2006, NANO LETT, V6, P2826, DOI 10.1021/nl0619711; Sinyagin AY, 2006, J PHYS CHEM B, V110, P7500, DOI 10.1021/jp057105e; Sleytr UB, 1999, ANGEW CHEM INT EDIT, V38, P1035, DOI 10.1002/(SICI)1521-3773(19990419)38:8<1034::AID-ANIE1034>3.0.CO;2-#; Srivastava S, 2010, SCIENCE, V327, P1355, DOI 10.1126/science.1177218; Tang ZY, 2006, SCIENCE, V314, P274, DOI 10.1126/science.1128045; Tang ZY, 2002, SCIENCE, V297, P237, DOI 10.1126/science.1072086	21	261	265	5	228	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2010	330	6001					188	189		10.1126/science.1190094	http://dx.doi.org/10.1126/science.1190094			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20929766				2022-12-01	WOS:000282644600030
J	Moellering, ER; Muthan, B; Benning, C				Moellering, Eric R.; Muthan, Bagyalakshmi; Benning, Christoph			Freezing Tolerance in Plants Requires Lipid Remodeling at the Outer Chloroplast Membrane	SCIENCE			English	Article							COLD RESPONSE PATHWAY; ARABIDOPSIS-THALIANA; GALACTOLIPID GALACTOSYLTRANSFERASE; BETA-GLUCOSIDASE; PLASMA-MEMBRANE; ACCLIMATION; MECHANISMS; BIOSYNTHESIS; ENVELOPES; SYSTEMS	Plants show complex adaptations to freezing that prevent cell damage caused by cellular dehydration. Lipid remodeling of cell membranes during dehydration is one critical mechanism countering loss of membrane integrity and cell death. SENSITIVE TO FREEZING 2 (SFR2), a gene essential for freezing tolerance in Arabidopsis, encodes a galactolipid remodeling enzyme of the outer chloroplast envelope membrane. SFR2 processively transfers galactosyl residues from the abundant monogalactolipid to different galactolipid acceptors, forming oligogalactolipids and diacylglycerol, which is further converted to triacylglycerol. The combined activity of SFR2 and triacylglycerol-biosynthetic enzymes leads to the removal of monogalactolipids from the envelope membrane, changing the ratio of bilayer-to non-bilayer-forming membrane lipids. This SFR2-based mechanism compensates for changes in organelle volume and stabilizes membranes during freezing.	[Moellering, Eric R.; Muthan, Bagyalakshmi; Benning, Christoph] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Moellering, Eric R.] Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Benning, C (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	benning@msu.edu	Benning, Christoph/Y-2528-2019	Benning, Christoph/0000-0001-8585-3667	U.S. Department of Energy [DE-FG02-98ER20305]; Michigan Agricultural Experiment Station	U.S. Department of Energy(United States Department of Energy (DOE)); Michigan Agricultural Experiment Station	We thank S. Marshall and T. Durret for help with proton-NMR and mass spectrometry analyses, respectively, and the laboratory of M. Thomashow for use of equipment and advice on the plant freezing experiments conducted in this work. This work was supported in parts by a grant from the U.S. Department of Energy (DE-FG02-98ER20305) and Michigan Agricultural Experiment Station.	Benning C, 2005, J BIOL CHEM, V280, P2397, DOI 10.1074/jbc.R400032200; BROWSE J, 1989, PLANT PHYSIOL, V90, P522, DOI 10.1104/pp.90.2.522; Cook D, 2004, P NATL ACAD SCI USA, V101, P15243, DOI 10.1073/pnas.0406069101; Dormann P, 1999, SCIENCE, V284, P2181, DOI 10.1126/science.284.5423.2181; DORNE AJ, 1982, FEBS LETT, V145, P30, DOI 10.1016/0014-5793(82)81200-3; Du ZY, 2010, PLANT PHYSIOL, V152, P1585, DOI 10.1104/pp.109.147066; Fourrier N, 2008, PLANT J, V55, P734, DOI 10.1111/j.1365-313X.2008.03549.x; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; HEEMSKERK JW, 1983, BIOCHIM BIOPHYS ACTA, V754, P181, DOI 10.1016/0005-2760(83)90160-1; HEINZ E, 1996, ADV LIPID METHODOLOG, P211; Hill AD, 2008, BIOPOLYMERS, V89, P1021, DOI 10.1002/bip.21052; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Kelly AA, 2003, PLANT CELL, V15, P2694, DOI 10.1105/tpc.016675; Li W, 2008, J BIOL CHEM, V283, P461, DOI 10.1074/jbc.M706692200; Marques AR, 2003, BIOCHEM J, V370, P793, DOI 10.1042/BJ20021249; McKown R, 1996, J EXP BOT, V47, P1919, DOI 10.1093/jxb/47.12.1919; Perugino G, 2004, TRENDS BIOTECHNOL, V22, P31, DOI 10.1016/j.tibtech.2003.10.008; Siegel DP, 1997, BIOPHYS J, V73, P3089, DOI 10.1016/S0006-3495(97)78336-X; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; STEPONKUS PL, 1984, ANNU REV PLANT PHYS, V35, P543, DOI 10.1146/annurev.pp.35.060184.002551; Steponkus PL, 1998, P NATL ACAD SCI USA, V95, P14570, DOI 10.1073/pnas.95.24.14570; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Thorlby G, 2004, PLANT CELL, V16, P2192, DOI 10.1105/tpc.104.024018; Uemura M, 2003, PLANT PHYSIOL, V131, P1800, DOI 10.1104/pp.102.013227; UEMURA M, 1995, PLANT PHYSIOL, V109, P15, DOI 10.1104/pp.109.1.15; VANBESOUW A, 1978, BIOCHIM BIOPHYS ACTA, V529, P44, DOI 10.1016/0005-2760(78)90102-9; WIESLANDER A, 1986, BIOCHEMISTRY-US, V25, P7511, DOI 10.1021/bi00371a038; Wolfe J, 1999, CRYOBIOLOGY, V39, P103, DOI 10.1006/cryo.1999.2195	28	318	331	7	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					226	228		10.1126/science.1191803	http://dx.doi.org/10.1126/science.1191803			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20798281				2022-12-01	WOS:000282644600043
J	Dierolf, M; Menzel, A; Thibault, P; Schneider, P; Kewish, CM; Wepf, R; Bunk, O; Pfeiffer, F				Dierolf, Martin; Menzel, Andreas; Thibault, Pierre; Schneider, Philipp; Kewish, Cameron M.; Wepf, Roger; Bunk, Oliver; Pfeiffer, Franz			Ptychographic X-ray computed tomography at the nanoscale	NATURE			English	Article							DIFFRACTION MICROSCOPY; PHASE RETRIEVAL	X-ray tomography is an invaluable tool in biomedical imaging. It can deliver the three-dimensional internal structure of entire organisms as well as that of single cells, and even gives access to quantitative information, crucially important both for medical applications and for basic research(1-4). Most frequently such information is based on X-ray attenuation. Phase contrast is sometimes used for improved visibility but remains significantly harder to quantify(5,6). Here we describe an X-ray computed tomography technique that generates quantitative high-contrast three-dimensional electron density maps from phase contrast information without reverting to assumptions of a weak phase object or negligible absorption. This method uses a ptychographic coherent imaging approach to record tomographic data sets, exploiting both the high penetration power of hard X-rays and the high sensitivity of lensless imaging(7-9). As an example, we present images of a bone sample in which structures on the 100 nm length scale such as the osteocyte lacunae and the interconnective canalicular network are clearly resolved. The recovered electron density map provides a contrast high enough to estimate nanoscale bone density variations of less than one per cent. We expect this high-resolution tomography technique to provide invaluable information for both the life and materials sciences.	[Dierolf, Martin; Thibault, Pierre; Pfeiffer, Franz] Tech Univ Munich, Dept Phys E17, D-85748 Garching, Germany; [Menzel, Andreas; Kewish, Cameron M.; Bunk, Oliver] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Schneider, Philipp] ETH, Inst Biomech, CH-8093 Zurich, Switzerland; [Wepf, Roger] EMEZ, CH-8093 Zurich, Switzerland	Technical University of Munich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Thibault, P (corresponding author), Tech Univ Munich, Dept Phys E17, D-85748 Garching, Germany.	pierre.thibault@tum.de	Bunk, Oliver/B-7602-2013; Schneider, Philipp/AAP-6133-2021; Thibault, Pierre/B-2656-2010; Dierolf, Martin J/B-9816-2008; Menzel, Andreas/C-4388-2012; Kewish, Cameron/H-5103-2011	Bunk, Oliver/0000-0001-6563-4053; Schneider, Philipp/0000-0001-7499-3576; Thibault, Pierre/0000-0003-1278-8846; Dierolf, Martin J/0000-0001-5150-2949; Menzel, Andreas/0000-0002-0489-609X; Kewish, Cameron/0000-0001-6242-7059; Wepf, Roger/0000-0003-2203-3674	DFG Cluster of Excellence "Munich-Centre for Advanced Photonics"	DFG Cluster of Excellence "Munich-Centre for Advanced Photonics"(German Research Foundation (DFG))	We acknowledge technical support by X. Donath, FIB preparation of the specimen by P. Gasser and M. Meier and the assistance of W. Gutscher during the experiments. P. T., M. D. and F. P. acknowledge support through the DFG Cluster of Excellence "Munich-Centre for Advanced Photonics''.	Chapman HN, 2006, J OPT SOC AM A, V23, P1179, DOI 10.1364/JOSAA.23.001179; Chu YS, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2857476; Cloetens P, 1996, J PHYS D APPL PHYS, V29, P133, DOI 10.1088/0022-3727/29/1/023; DAVIS TJ, 1995, NATURE, V373, P595, DOI 10.1038/373595a0; Dierolf M, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/035017; Faulkner HML, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.023903; Ghiglia D.C., 1998, 2 DIMENSIONAL PHASE; Giewekemeyer K, 2010, P NATL ACAD SCI USA, V107, P529, DOI 10.1073/pnas.0905846107; Guizar-Sicairos M, 2008, OPT EXPRESS, V16, P7264, DOI 10.1364/OE.16.007264; HADDAD WS, 1994, SCIENCE, V266, P1213, DOI 10.1126/science.266.5188.1213; Howells MR, 2009, J ELECTRON SPECTROSC, V170, P4, DOI 10.1016/j.elspec.2008.10.008; Hubbell J.H., 2004, NISTIR, DOI 10.18434/T4D01F; Kamioka H, 2009, MICROSC MICROANAL, V15, P377, DOI 10.1017/S1431927609990420; Kraft P, 2009, J SYNCHROTRON RADIAT, V16, P368, DOI 10.1107/S0909049509009911; Momose A, 1996, NAT MED, V2, P473, DOI 10.1038/nm0496-473; MORRISON GR, 1983, OPTIK, V64, P1; Nishino Y, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.018101; Nugent KA, 1996, PHYS REV LETT, V77, P2961, DOI 10.1103/PhysRevLett.77.2961; Nugent KA, 2010, ADV PHYS, V59, P1, DOI 10.1080/00018730903270926; Parkinson DY, 2008, J STRUCT BIOL, V162, P380, DOI 10.1016/j.jsb.2008.02.003; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; Rodenburg JM, 2008, ADV IMAG ELECT PHYS, V150, P87, DOI 10.1016/S1076-5670(07)00003-1; Rodenburg JM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.034801; Schneider P, 2010, BONE, V47, P848, DOI 10.1016/j.bone.2010.07.026; Schropp A, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3332591; Thibault P, 2008, SCIENCE, V321, P379, DOI 10.1126/science.1158573; Thibault P, 2009, ULTRAMICROSCOPY, V109, P338, DOI 10.1016/j.ultramic.2008.12.011; Vine DJ, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.063823; Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0; Yin GC, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2211300	30	590	619	9	264	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2010	467	7314					436	U82		10.1038/nature09419	http://dx.doi.org/10.1038/nature09419			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KO	20864997				2022-12-01	WOS:000282090200037
J	Moffatt, MF; Gut, IG; Demenais, F; Strachan, DP; Bouzigon, E; Heath, S; von Mutius, E; Farrall, M; Lathrop, M; Cookson, WOCM; Kumar, A; Burney, P; Jarvis, D; Wjst, M; Kogevinas, M; Jogi, R; Janson, C; Franklin, KA; Omenaas, E; Leynaert, B; Pin, I; Heinrich, J; Probst-Hensch, NM; Anto, JM; Sunyer, J; Maldonado, JA; Martinez-Moratalla, J; Urrutia, I; Payo, F; Kauffmann, F; Dizier, MH; Siroux, V; Boznanski, A; Braun-Fahrlander, C; Genuneit, J; Glas, J; Horak, E; Kabesch, M; Pillai, SG; Helms, PJ; Carlsen, K; Carlsen, KH; Gerritsen, J; Silverman, M; Sly, P; Tsanakas, J; Von Berg, A; Whyte, M; Blumenthal, M; Imboden, M; Rochat, T; Thun, GA; Gerbase, MW; Curjuric, I; Gaspoz, JM; Liu, LJS; Wouters, IM; Sigsgaard, T; Heederik, D; Basinas, I; Schlunssen, V; Omland, O; Cullinan, P; Vermeulen, R; Henderson, J; Granell, R; McArdle, WL; Smith, GD; James, AL; Hui, J; Palmer, LJ; Beilby, J; Musk, AW; Laprise, C; Hudson, TJ; Lemire, M; Daley, D; Becker, A; Chan-Yeung, M; Sandford, A; Kozyrskyj, AL; Pare, P; Ferguson, A; Dimich-Ward, H; Watson, WT; Freidin, MB; Bragina, EI; Deev, IA; Deeva, EV; Kobyakova, OS; Puzyrev, VP; Ogorodova, LM; Khusnutdinova, EK; Karunas, AS; Fedorova, YY; Hall, IP; Sayers, I; Tobin, MD; Wan, YI; Heaney, LG; Al-Momani, BAH; Mansur, AH; Manney, S; Thomson, NC; Chaudhuri, R; Brightling, CE; Bafadhel, M; Singapuri, A; Niven, R; Simpson, A; Holloway, JW; Howarth, PH; Polonikov, AV; Ivanov, VP; Solodilova, MA; Melen, E; Pershagen, G; Bergstrom, A; Kull, I; Nyberg, F; Wickman, M; Soderhall, C; Kere, J; Postma, DS; Kerkhof, M; Brunekreef, B; Smit, HA; de Jongste, JC; Wijga, A; Aalberse, RC; Hoekstra, MO; Koppelman, GH; Binia, A; Chung, KF; Bhavsar, P; Chow, F; Macedo, P; Menzies-Gow, A; van Stiphout, N; Bush, A; Lee, YA; Esparza-Gordillo, J; Nickel, R; Wahn, U; Lau, S; Marenholz, I; Haahtela, T; von Hertzen, L; Jousilahti, P; Laatikainen, T; Makela, MJ; Vartiainen, E; Laitinen, T; Balding, DJ; Peden, JF; Corda, E; Lechner, D; Besse, C; Zelenika, D; Boland, A; Bacq, D; Demonchy, S; Blanche, H; Kamatani, Y; von Mutius, E; Farrall, M; Lathrop, M; Cookson, WOCM				Moffatt, Miriam F.; Gut, Ivo G.; Demenais, Florence; Strachan, David P.; Bouzigon, Emmanuelle; Heath, Simon; von Mutius, Erika; Farrall, Martin; Lathrop, Mark; Cookson, William O. C. M.; Kumar, Ashish; Burney, Peter; Jarvis, Debbie; Wjst, Matthias; Kogevinas, Manolis; Jogi, Rain; Janson, Christer; Franklin, Karl A.; Omenaas, Ernst; Leynaert, Benedicte; Pin, Isabelle; Heinrich, Joachim; Probst-Hensch, Nicole M.; Anto, Josep M.; Sunyer, Jordi; Maldonado, Jose-Antonio; Martinez-Moratalla, Jesus; Urrutia, Isabel; Payo, Felix; Kauffmann, Francine; Dizier, Marie-Helene; Siroux, Valerie; Boznanski, Andrzej; Braun-Fahrlaender, Charlotte; Genuneit, Jon; Glas, Juergen; Horak, Elisabeth; Kabesch, Michael; Pillai, Sreekumar G.; Helms, Peter J.; Carlsen, Karin; Carlsen, Kai-Hakon; Gerritsen, Jorrit; Silverman, Michael; Sly, Peter; Tsanakas, John; Von Berg, Andrea; Whyte, Moira; Blumenthal, Malcolm; Imboden, Medea; Rochat, Thierry; Thun, Gian Andri; Gerbase, Margaret W.; Curjuric, Ivan; Gaspoz, Jean-Michel; Liu, Lee-Jane S.; Wouters, Inge M.; Sigsgaard, Torben; Heederik, Dick; Basinas, Ioannis; Schlunssen, Vivi; Omland, Oyvind; Cullinan, Paul; Vermeulen, Roel; Henderson, John; Granell, Raquel; McArdle, Wendy L.; Smith, George Davey; James, Alan L.; Hui, Jennie; Palmer, Lyle J.; Beilby, John; Musk, A. William; Laprise, Catherine; Hudson, Thomas J.; Lemire, Mathieu; Daley, Denise; Becker, Allan; Chan-Yeung, Moira; Sandford, Andrew; Kozyrskyj, Anita L.; Pare, Peter; Ferguson, Alexander; Dimich-Ward, Helen; Watson, Wade T.; Freidin, Maxim B.; Bragina, Elena Iu.; Deev, Ivan A.; Deeva, Eugenia V.; Kobyakova, Olga S.; Puzyrev, Valery P.; Ogorodova, Ludmila M.; Khusnutdinova, Elza K.; Karunas, Alexandra S.; Fedorova, Yuliya Y.; Hall, Ian P.; Sayers, Ian; Tobin, Martin D.; Wan, Yize I.; Heaney, Liam G.; Al-Momani, Basima A. H.; Mansur, Adel H.; Manney, Sarah; Thomson, Neil C.; Chaudhuri, Rekha; Brightling, Christopher E.; Bafadhel, Mona; Singapuri, Amisha; Niven, Robert; Simpson, Angela; Holloway, John W.; Howarth, Peter H.; Polonikov, Alexey V.; Ivanov, Vladimir P.; Solodilova, Maria A.; Melen, Erik; Pershagen, Goeran; Bergstroem, Anna; Kull, Inger; Nyberg, Fredrik; Wickman, Magnus; Soderhall, Cilla; Kere, Juha; Postma, Dirkje S.; Kerkhof, Marjan; Brunekreef, Bert; Smit, Henriette A.; de Jongste, Johan C.; Wijga, Alet; Aalberse, R. C.; Hoekstra, Maarten O.; Koppelman, Gerard H.; Binia, Aristea; Chung, Kian Fan; Bhavsar, Pankaj; Chow, Florence; Macedo, Patricia; Menzies-Gow, Andrew; van Stiphout, Nicole; Bush, Andrew; Lee, Young-Ae; Esparza-Gordillo, Jorge; Nickel, Renate; Wahn, Ulrich; Lau, Susanne; Marenholz, Ingo; Haahtela, Tari; von Hertzen, Leena; Jousilahti, Pekka; Laatikainen, Tiina; Makela, Mika J.; Vartiainen, Erkki; Laitinen, Tarja; Balding, David J.; Peden, John F.; Corda, Eve; Lechner, Doris; Besse, Celine; Zelenika, Diana; Boland, Anne; Bacq, Delphine; Demonchy, Stephanie; Blanche, Helene; Kamatani, Yoichiro; von Mutius, Erika; Farrall, Martin; Lathrop, Mark; Cookson, William O. C. M.		GABRIEL Consortium	A Large-Scale, Consortium-Based Genomewide Association Study of Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SUSCEPTIBILITY GENE; POSITIONAL CLONING; IN-VIVO; VARIANTS; DISEASE; EXPRESSION; CYTOKINE; RECEPTOR; ALLERGY; TRAITS	BACKGROUND Susceptibility to asthma is influenced by genes and environment; implicated genes may indicate pathways for therapeutic intervention. Genetic risk factors may be useful in identifying subtypes of asthma and determining whether intermediate phenotypes, such as elevation of the total serum IgE level, are causally linked to disease. METHODS We carried out a genomewide association study by genotyping 10,365 persons with physician-diagnosed asthma and 16,110 unaffected persons, all of whom were matched for ancestry. We used random-effects pooled analysis to test for association in the overall study population and in subgroups of subjects with childhood-onset asthma (defined as asthma developing before 16 years of age), later-onset asthma, severe asthma, and occupational asthma. RESULTS We observed associations of genomewide significance between asthma and the following single-nucleotide polymorphisms: rs3771166 on chromosome 2, implicating IL1RL1/IL18R1 (P = 3x10(-9)); rs9273349 on chromosome 6, implicating HLA-DQ (P = 7x10(-14)); rs1342326 on chromosome 9, flanking IL33 (P = 9x10(-10)); rs744910 on chromosome 15 in SMAD3 (P = 4x10(-9)); and rs2284033 on chromosome 22 in IL2RB (P = 1.1x10(-8)). Association with the ORMDL3/GSDMB locus on chromosome 17q21 was specific to childhood-onset disease (rs2305480, P = 6x10(-23)). Only HLA-DR showed a significant genomewide association with the total serum IgE concentration, and loci strongly associated with IgE levels were not associated with asthma. CONCLUSIONS Asthma is genetically heterogeneous. A few common alleles are associated with disease risk at all ages. Implicated genes suggest a role for communication of epithelial damage to the adaptive immune system and activation of airway inflammation. Variants at the ORMDL3/GSDMB locus are associated only with childhood-onset disease. Elevation of total serum IgE levels has a minor role in the development of asthma.	[Moffatt, Miriam F.; Cookson, William O. C. M.; Burney, Peter; Jarvis, Debbie; Cullinan, Paul; Binia, Aristea; Chung, Kian Fan; Bhavsar, Pankaj; Macedo, Patricia; Menzies-Gow, Andrew; Bush, Andrew; Cookson, William O. C. M.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England; [Farrall, Martin; Peden, John F.; Farrall, Martin] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [von Mutius, Erika; von Mutius, Erika] Univ Munich, Asthma & Allergy Dept, Univ Childrens Hosp, Munich, Germany; [Demenais, Florence; Bouzigon, Emmanuelle; Dizier, Marie-Helene] Univ Paris 07, Inst Univ Hematol, Paris, France; [Demenais, Florence; Bouzigon, Emmanuelle; Lathrop, Mark; Dizier, Marie-Helene; Corda, Eve; Blanche, Helene; Kamatani, Yoichiro; Lathrop, Mark] Fdn Jean Dausset CEPH, Paris, France; [Demenais, Florence; Bouzigon, Emmanuelle; Dizier, Marie-Helene; Corda, Eve] Fdn Jean Dausset, CEPH, INSERM, U946, Paris, France; [Gut, Ivo G.; Heath, Simon; Lathrop, Mark; Lechner, Doris; Besse, Celine; Zelenika, Diana; Boland, Anne; Bacq, Delphine; Demonchy, Stephanie; Lathrop, Mark] Commissariat Energie Atom, Inst Genom, Ctr Natl Genotypage, Evry, France; [Cookson, William O. C. M.; van Stiphout, Nicole; Bush, Andrew] Royal Brompton & Harefield NHS Fdn Trust, London, England; [Strachan, David P.] Univ London, Div Community Hlth Sci, London, England; [Burney, Peter; Jarvis, Debbie] Imperial Coll, NHLI, Respiratory Epidemiol & Publ Hlth, London, England; [Wjst, Matthias] Helmholtz Zentrum, Inst Lung Biol & Dis, Munich, Germany; [Wjst, Matthias] German Res Ctr Environm Hlth GmbH, Neuherberg, Germany; [Kogevinas, Manolis; Anto, Josep M.; Sunyer, Jordi] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Kogevinas, Manolis; Anto, Josep M.; Sunyer, Jordi] Municipal Inst Med Res IMIM Hosp Mar, Barcelona, Spain; [Kogevinas, Manolis; Anto, Josep M.; Sunyer, Jordi] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Kogevinas, Manolis] Natl Sch Publ Hlth, Athens, Greece; [Jogi, Rain] Tartu Univ Hosp, Lung Clin, Tartu, Estonia; [Janson, Christer] Uppsala Univ, Resp Med & Allergol, Uppsala, Sweden; [Franklin, Karl A.] Umea Univ, Dept Surg, S-90187 Umea, Sweden; [Omenaas, Ernst] Univ Bergen, Inst Med, N-5020 Bergen, Norway; [Omenaas, Ernst] Haukeland Hosp, Ctr Clin Res, Bergen, Norway; [Leynaert, Benedicte] Inserm, Unite 700, Paris, France; [Leynaert, Benedicte] Univ Paris Diderot, Paris, France; [Pin, Isabelle] Ctr Hosp Univ, Grenoble, France; [Pin, Isabelle; Siroux, Valerie] Inserm, Unite 823, Grenoble, France; [Pin, Isabelle; Siroux, Valerie] Univ Joseph Fourier, F-38041 Grenoble, France; [Heinrich, Joachim] Helmholtz Zentrum Munich, Inst Epidemiol, Munich, Germany; [Probst-Hensch, Nicole M.; Braun-Fahrlaender, Charlotte; Imboden, Medea; Thun, Gian Andri; Curjuric, Ivan; Liu, Lee-Jane S.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Probst-Hensch, Nicole M.; Braun-Fahrlaender, Charlotte; Imboden, Medea; Thun, Gian Andri; Curjuric, Ivan; Liu, Lee-Jane S.] Univ Basel, CH-4003 Basel, Switzerland; [Probst-Hensch, Nicole M.; Imboden, Medea; Thun, Gian Andri; Curjuric, Ivan] Univ Zurich, UPF, Dept Ciencies Expt Salut, CH-8006 Zurich, Switzerland; [Maldonado, Jose-Antonio] Hosp Juan Ramon Jimenez, Serv Neumol, Huelva, Spain; [Maldonado, Jose-Antonio; Martinez-Moratalla, Jesus] Hosp Gen Univ Albacete, Serv Neumol, Albacete, Spain; [Urrutia, Isabel] Galdakao Hosp, Pneumol Serv, Galdakao, Bizkaia, Spain; [Payo, Felix] Hosp Gen Asturias, Serv Neumol, Oviedo, Asturias, Spain; [Kauffmann, Francine] Inserm, Unite 780, Villejuif, France; [Kauffmann, Francine] Univ Paris Sud, IFR69, Villejuif, France; [Boznanski, Andrzej] Wroclaw Med Univ, Dep Paediat Allergol & Cardiol 1, Wroclaw, Poland; [Genuneit, Jon] Ulm Univ, Inst Epidemiol, Ulm, Germany; [Glas, Juergen] Univ Munich, Dept Prevent Dentistry & Periodontol, Munich, Germany; [Glas, Juergen] Rhein Westfal TH Aachen, Dept Human Genet, Aachen, Germany; [Horak, Elisabeth] Innsbruck Med Univ, Dept Pediat Pediat Pulmonol, Innsbruck, Austria; [Kabesch, Michael] Hannover Med Sch, Clin Paediat Pneumol & Neonatol, Ctr Paediat Adolescent Med, Hannover, Germany; [Pillai, Sreekumar G.] GlaxoSmithKline R&D, Genet, Res Triangle Pk, NC USA; [Helms, Peter J.] Univ Aberdeen, Royal Aberdeen Childrens Hosp, Aberdeen, Scotland; [Carlsen, Karin; Carlsen, Kai-Hakon] Oslo Univ Hosp, Dept Paediat, N-0316 Oslo, Norway; [Carlsen, Karin; Carlsen, Kai-Hakon] Univ Oslo, Fac Med, Oslo, Norway; [Gerritsen, Jorrit] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Groningen, Netherlands; [Silverman, Michael] Univ Leicester, Div Child Hlth, Leicester, Leics, England; [Sly, Peter] Univ Western Australia, Ctr Child Hlth Res, Perth, WA, Australia; [Tsanakas, John] Aristotle Univ Thessaloniki, Pediat Pulmonol, Thessaloniki, Greece; [Whyte, Moira] Univ Sheffield, Acad Unit Resp Med, Sheffield S10 2TN, S Yorkshire, England; [Blumenthal, Malcolm] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Rochat, Thierry; Gerbase, Margaret W.] Univ Hosp Geneva, Div Pulm Med, Geneva, Switzerland; [Gaspoz, Jean-Michel] Univ Hosp Geneva, Div Commun Med & Primary Care, Geneva, Switzerland; [Wouters, Inge M.; Heederik, Dick; Basinas, Ioannis; Vermeulen, Roel; Brunekreef, Bert] Univ Utrecht, IRAS, NL-3508 TC Utrecht, Netherlands; [Sigsgaard, Torben; Basinas, Ioannis; Schlunssen, Vivi; Omland, Oyvind] Univ Aarhus, Sch Publ Hlth, Dept Environm & Occupat Med, DK-8000 Aarhus, Denmark; [Omland, Oyvind] Aarhus Univ Hosp, Aalborg Hosp, Dept Occupat Hlth, DK-9000 Aalborg, Denmark; [Henderson, John] Univ Bristol, Dept Community Based Med, Bristol BS8 1TH, Avon, England; [Granell, Raquel; McArdle, Wendy L.; Smith, George Davey] Univ Bristol, Dept Med, Bristol BS8 1TH, Avon, England; [Smith, George Davey] Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol CAiTE, Bristol BS8 1TH, Avon, England; [James, Alan L.] Sir Charles Gairdner Hosp, West Australian Sleep Disorders Res Inst, Dept Pulm Physiol, Nedlands, WA, Australia; [James, Alan L.] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia; [Hui, Jennie] PathWest Lab Med, Mol Genet, Nedlands, WA, Australia; [Palmer, Lyle J.] Univ Western Australia, Ctr Genet Epidemiol & Biostat, Nedlands, WA 6009, Australia; [Beilby, John] PathWest Lab Med, Biochem, Nedlands, WA, Australia; [Musk, A. William] Sir Charles Gairdner Hosp, Dept Resp Med, Nedlands, WA, Australia; [Musk, A. William] Univ Western Australia, Sch Populat Hlth, Nedlands, WA 6009, Australia; [Laprise, Catherine] Univ Montreal, Chicoutimi Univ Hosp, Commun Genom Med Ctr, Chicoutimi, PQ, Canada; [Laprise, Catherine] Univ Quebec Chicoutimi, Chicoutimi, PQ, Canada; [Hudson, Thomas J.; Lemire, Mathieu] Ontario Inst Canc Res, Toronto, ON, Canada; [Daley, Denise; Sandford, Andrew; Pare, Peter] Univ British Columbia, James Hogg iCAPTURE Ctr, Vancouver, BC V5Z 1M9, Canada; [Becker, Allan; Kozyrskyj, Anita L.; Watson, Wade T.] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada; [Chan-Yeung, Moira; Dimich-Ward, Helen] Univ British Columbia, Occupat & Environm Lung Dis Unit, Vancouver, BC V5Z 1M9, Canada; [Kozyrskyj, Anita L.] Univ Alberta, Univ Alberta & Sch Publ Hlth, Fac Med & Dent, Dept Pediat, Edmonton, AB T6G 2M7, Canada; [Kozyrskyj, Anita L.] Univ Manitoba, Fac Med, Dept Commun Hlth Sci, Winnipeg, MB R3T 2N2, Canada; [Ferguson, Alexander] Univ British Columbia, Dept Pediat, Div Allergy, Vancouver, BC V5Z 1M9, Canada; [Freidin, Maxim B.; Bragina, Elena Iu.; Puzyrev, Valery P.] Russian Acad Med Sci, Res Inst Med Genet Siberian Branch, Populat Genet Lab, Tomsk 634050, Russia; [Deev, Ivan A.; Deeva, Eugenia V.; Ogorodova, Ludmila M.] Siberian State Med Univ, Dept Fac Paediat, Tomsk 634050, Russia; [Kobyakova, Olga S.] Siberian State Med Univ, Gen Doctor Practice Dept, Tomsk 634050, Russia; [Khusnutdinova, Elza K.; Karunas, Alexandra S.; Fedorova, Yuliya Y.] Russian Acad Sci, UFA Sci Ctr, Inst Biochem & Genet, Ufa 450054, Russia; [Hall, Ian P.; Sayers, Ian; Wan, Yize I.] Queens Med Ctr, Nottingham Resp Biomed Res Unit, Div Therapeut & Mol Med, Nottingham, England; [Tobin, Martin D.] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [Heaney, Liam G.] Queens Univ Belfast, Ctr Infect & Immun, Belfast BT7 1NN, Antrim, North Ireland; [Al-Momani, Basima A. H.] Queens Univ Belfast, Sch Pharm, Belfast BT7 1NN, Antrim, North Ireland; [Mansur, Adel H.; Manney, Sarah] Univ Birmingham, Birmingham B15 2TT, W Midlands, England; [Mansur, Adel H.; Manney, Sarah] Birmingham Heartlands Hosp, Resp Med, Birmingham B15 2TT, W Midlands, England; [Thomson, Neil C.; Chaudhuri, Rekha] Univ Glasgow, Div Immunol Infect & Inflammat, Resp Med Sect, Glasgow G12 8QQ, Lanark, Scotland; [Brightling, Christopher E.; Bafadhel, Mona; Singapuri, Amisha] Univ Leicester, Glenfield Hosp, Inst Lung Hlth, Leicester LE1 7RH, Leics, England; [Niven, Robert; Simpson, Angela] Univ Manchester, Manchester Acad Hlth Sci Ctr, NIHR Translat Res Fac Resp Med, Manchester, Lancs, England; [Holloway, John W.; Howarth, Peter H.] Univ Southampton, Sch Med, Div Human Genet, Southampton SO9 5NH, Hants, England; [Holloway, John W.; Howarth, Peter H.] Univ Southampton, Sch Med, Div Infect, Southampton SO9 5NH, Hants, England; [Howarth, Peter H.] Univ Southampton, Sch Med, Southampton NIHR Resp Biomed Res Unit, Southampton SO9 5NH, Hants, England; [Polonikov, Alexey V.; Ivanov, Vladimir P.; Solodilova, Maria A.] Kursk State Med Univ, Dept Biol Med Genet & Ecol, Kursk 305041, Russia; [Melen, Erik; Pershagen, Goeran; Bergstroem, Anna; Kull, Inger; Nyberg, Fredrik; Wickman, Magnus] Karolinska Inst, Inst Environ Med, Stockholm, Sweden; [Melen, Erik] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Stockholm, Sweden; [Nyberg, Fredrik] AstraZeneca R&D, Molndal, Sweden; [Wickman, Magnus] Sachs Childrens Hosp, Stockholm, Sweden; [Soderhall, Cilla; Kere, Juha] Karolinska Inst, Dept Biosci & Nutrit, S-10401 Stockholm, Sweden; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonology, NL-9700 AB Groningen, Netherlands; [Kerkhof, Marjan] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiology, NL-9700 AB Groningen, Netherlands; [Brunekreef, Bert; Smit, Henriette A.] Uni Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [de Jongste, Johan C.] Sophia Childrens Univ Hosp, Erasmus Univ Med Ctr, Dept Pediat, Rotterdam, Netherlands; [Wijga, Alet] Natl Inst Publ Hlth & Environm, Ctr Prevent & Hlth Serv Res, Bilthoven, Netherlands; [Aalberse, R. C.] Sanquin Res, Dept Immunopathol, Amsterdam, Netherlands; [Hoekstra, Maarten O.] Radboud Univ Nijmegen Med Ctr, Dept Gen Paediat, Nijmegen, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat Pulmonol & Pediat Allergol, NL-9700 AB Groningen, Netherlands; Royal Brompton & Harefield NHS Fdn Trust, Dept Paediat Resp Med, London, England; [Lee, Young-Ae; Esparza-Gordillo, Jorge; Nickel, Renate; Wahn, Ulrich; Lau, Susanne; Marenholz, Ingo] Charite Univ Med Berlin, Pediat Pneumol & Immunol, Berlin, Germany; [Lee, Young-Ae; Esparza-Gordillo, Jorge; Marenholz, Ingo] Max Delbruck Centrum MDC Mol Med, Berlin, Germany; [Haahtela, Tari; von Hertzen, Leena; Makela, Mika J.] Helsinki Univ Cent Hosp, Skin & Allergy Hosp, Helsinki, Finland; [Jousilahti, Pekka; Laatikainen, Tiina; Vartiainen, Erkki] Natl Inst Hlth & Welfare, Helsinki, Finland; [Laitinen, Tarja] Helsinki Univ Cent Hosp, Dept Pulm Med, Helsinki, Finland; [Balding, David J.] Imperial Coll, Dept Epidemiol & Publ Hlth, London, England; Univ Munich, Univ Childrens Hosp, Asthma & Allergy Dept, D-80337 Munich, Germany	Imperial College London; University of Oxford; Wellcome Centre for Human Genetics; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; UDICE-French Research Universities; Universite Paris Cite; Foundation Jean Dausset-CEPH; Foundation Jean Dausset-CEPH; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Royal Brompton & Harefield NHS Foundation Trust; University of London; Imperial College London; Helmholtz Association; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; National & Kapodistrian University of Athens; Uppsala University; Umea University; University of Bergen; University of Bergen; Haukeland University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Zurich; Hospital Juan Ramon Jimenez; Galdakao Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Wroclaw Medical University; Ulm University; University of Munich; RWTH Aachen University; Medical University of Innsbruck; Hannover Medical School; GlaxoSmithKline; University of Aberdeen; University of Oslo; University of Oslo; University of Groningen; University of Leicester; University of Western Australia; Aristotle University of Thessaloniki; University of Sheffield; University of Minnesota System; University of Minnesota Twin Cities; University of Geneva; University of Geneva; Utrecht University; Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University; University of Bristol; University of Bristol; University of Bristol; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; Universite de Montreal; University of Quebec; University of Quebec Chicoutimi; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of British Columbia; University of Manitoba; University of British Columbia; University of Alberta; University of Manitoba; University of British Columbia; Russian Academy of Medical Sciences; Russian Academy of Sciences; Tomsk National Research Medical Center; Research Institute of Medical Genetics - Tomsk; Siberian State Medical University; Siberian State Medical University; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; University of Nottingham; University of Leicester; Queens University Belfast; Queens University Belfast; University of Birmingham; Heart of England NHS Foundation Trust; University of Birmingham; University of Glasgow; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Manchester; University of Southampton; University of Southampton; University of Southampton; Kursk State Medical University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; AstraZeneca; Karolinska Institutet; University of Groningen; University of Groningen; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Netherlands National Institute for Public Health & the Environment; Radboud University Nijmegen; University of Groningen; Royal Brompton & Harefield NHS Foundation Trust; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; Imperial College London; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich	Cookson, WOCM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Royal Brompton Campus,Guy Scadding Bldg,Dovehouse, London SW3 6LY, England.	w.cookson@imperial.ac.uk	Heath, Simon C/J-4138-2012; Karunas, Alexandra S/E-6421-2014; Sigsgaard, Torben/AAC-1292-2020; Holloway, John W/B-5424-2009; Fedorova, Yuliya/P-8808-2017; Kabesch, Michael/AAB-5701-2020; Demenais, Florence/G-3298-2013; Laatikainen, Tiina/ABD-6622-2021; Genuneit, Jon/I-9323-2012; Granell, Raquel/AAY-4846-2020; Palmer, Lyle John/N-1948-2019; Dizier, Marie-Hélène/K-8463-2018; Kere, Juha/A-9179-2008; Bafadhel, Mona/ABB-1170-2021; Solodilova, Maria/GSJ-2104-2022; Bragina, Elena/A-8049-2014; Vermeulen, Roel/F-8037-2011; Kere, Juha/AAX-9117-2021; Söderhäll, Cilla/E-3940-2012; Anto, J M/H-2676-2014; Freydin, Maxim/A-5603-2011; Koppelman, Gerard/AAG-9187-2020; Leynaert, Benedicte/N-5251-2018; Bragina, Elena/AAF-7983-2019; Kogevinas, Manolis/C-3918-2017; Khusnutdinova, Elza Kamilevna/A-4810-2013; Sly, Peter D/F-1486-2010; Puzyrev, Valery P/S-3144-2016; Chung, Kian Fan/B-1872-2012; Pare, Peter D/C-7425-2011; Gut, Ivo/ABF-3188-2020; Davey Smith, George/A-7407-2013; Balding, David/G-9898-2011; Sunyer, Jordi/G-6909-2014; Palmer, Lyle John/K-3196-2014; Kobyakova, Olga/M-5287-2014; Kabesch, Michael/GZM-1583-2022; Hui, Jennie/A-9543-2013; Puzyrev, Valery P/A-7925-2014; Freidin, Maxim B/A-8222-2014; PIN, Isabelle/N-3020-2013; Bouzigon, Emmanuelle/L-2766-2017; Heinrich, Joachim/N-1720-2013; Granell, Raquel/AAB-5256-2022; Polonikov, Alexey/R-7537-2016	Heath, Simon C/0000-0002-9550-0897; Karunas, Alexandra S/0000-0002-2570-0789; Sigsgaard, Torben/0000-0002-2043-7571; Holloway, John W/0000-0001-9998-0464; Demenais, Florence/0000-0001-8361-0936; Laatikainen, Tiina/0000-0002-6614-4782; Genuneit, Jon/0000-0001-5764-1528; Palmer, Lyle John/0000-0002-1628-3055; Dizier, Marie-Hélène/0000-0001-8460-7667; Kere, Juha/0000-0003-1974-0271; Solodilova, Maria/0000-0003-4607-4913; Bragina, Elena/0000-0002-1103-3073; Vermeulen, Roel/0000-0003-4082-8163; Kere, Juha/0000-0003-1974-0271; Söderhäll, Cilla/0000-0002-8397-3080; Anto, J M/0000-0002-4736-8529; Freydin, Maxim/0000-0002-1439-6259; Kogevinas, Manolis/0000-0002-9605-0461; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Sly, Peter D/0000-0001-6305-2201; Puzyrev, Valery P/0000-0002-2113-4556; Chung, Kian Fan/0000-0001-7101-1426; Davey Smith, George/0000-0002-1407-8314; Balding, David/0000-0002-1480-6115; Sunyer, Jordi/0000-0002-2602-4110; Palmer, Lyle John/0000-0002-1628-3055; Kobyakova, Olga/0000-0003-0098-1403; Hui, Jennie/0000-0002-1653-2496; Freidin, Maxim B/0000-0002-1439-6259; Bouzigon, Emmanuelle/0000-0001-5756-4286; Heinrich, Joachim/0000-0002-9620-1629; Granell, Raquel/0000-0002-4890-4012; Polonikov, Alexey/0000-0001-6280-247X; Makela, Mika/0000-0002-2933-3111; Beilby, John/0000-0002-4915-2254; Fedorova, Yuliya/0000-0002-9344-828X; Wouters, Inge M./0000-0001-7834-9390; Simpson, Angela/0000-0003-2733-6666; Burney, Peter/0000-0001-8635-5678; Sayers, Ian/0000-0001-5601-5410; Franklin, Karl/0000-0002-5306-1697; Schlunssen, Vivi/0000-0003-4915-1734; Jarvis, Deborah/0000-0002-1753-3896; Leynaert, Benedicte/0000-0001-5045-2492; Kumar, Ashish/0000-0002-7075-5930; Nyberg, Fredrik/0000-0003-0892-5668; Pershagen, Goran/0000-0002-9701-1130; Kull, Inger/0000-0001-6096-3771; Heederik, Dick/0000-0002-4550-1437; von Mutius, Erika/0000-0002-8893-4515; Bafadhel, Mona/0000-0002-9993-2478; Niven, Robert/0000-0003-2249-960X; Binia, Aristea/0000-0002-8327-049X; Basinas, Ioannis/0000-0001-7708-3017; Koppelman, Gerard/0000-0001-8567-3252	European Commission [018996]; French Ministry of Research; Wellcome Trust [WT084703MA]; Asthma UK; MRC [G0501942, G0000934, MC_qA137934, G0401540, G0902125, G0800649] Funding Source: UKRI; Medical Research Council [G0800649, MC_qA137934, G0501942, G0401540, G0902125, G0801056B, G9815508, G0000934] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007048] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Asthma UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by a contract from the European Commission (018996) and grants from the French Ministry of Research, the Wellcome Trust (WT084703MA), and Asthma UK.	Allen M, 2003, NAT GENET, V35, P258, DOI 10.1038/ng1256; Anthoni M, 2007, INT J BIOL SCI, V3, P477; Balaci L, 2007, AM J HUM GENET, V80, P1103, DOI 10.1086/518259; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bouzigon E, 2008, NEW ENGL J MED, V359, P1985, DOI 10.1056/NEJMoa0806604; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; DUFFY DL, 1990, AM REV RESPIR DIS, V142, P1351, DOI 10.1164/ajrccm/142.6_Pt_1.1351; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Fukao T, 2000, J IMMUNOL, V164, P64, DOI 10.4049/jimmunol.164.1.64; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Konstantinidis AK, 2007, EUR RESPIR J, V30, P40, DOI 10.1183/09031936.00025706; Koppelman GH, 2009, AM J RESP CRIT CARE, V180, P929, DOI 10.1164/rccm.200810-1621OC; Laitinen T, 2004, SCIENCE, V304, P300, DOI 10.1126/science.1090010; Letourneau S, 2009, J ALLERGY CLIN IMMUN, V123, P758, DOI 10.1016/j.jaci.2009.02.011; MARSH DG, 1981, NEW ENGL J MED, V305, P1551, DOI 10.1056/NEJM198112243052603; MARSH DG, 1992, P 11 INT HIST WORKSH, P765; Moffatt MF, 1997, HUM MOL GENET, V6, P551, DOI 10.1093/hmg/6.4.551; Moffatt MF, 2001, EUR J HUM GENET, V9, P341, DOI 10.1038/sj.ejhg.5200636; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; *NAT ASTHM CAMP, 1998, ASTHM AG; Nicolae D, 2005, AM J HUM GENET, V76, P349, DOI 10.1086/427763; Nixon GF, 2009, BRIT J PHARMACOL, V158, P982, DOI 10.1111/j.1476-5381.2009.00281.x; Nouri-Aria Kayhan T., 2008, Inflammation & Allergy Drug Targets, V7, P237, DOI 10.2174/187152808786848405; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sheehan NA, 2008, PLOS MED, V5, P1205, DOI 10.1371/journal.pmed.0050177; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Smith DH, 1997, AM J RESP CRIT CARE, V156, P787, DOI 10.1164/ajrccm.156.3.9611072; Taylor JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007651; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Vercelli D, 2008, J ALLERGY CLIN IMMUN, V122, P267, DOI 10.1016/j.jaci.2008.06.008; Verlaan DJ, 2009, AM J HUM GENET, V85, P377, DOI 10.1016/j.ajhg.2009.08.007; Walley AJ, 2001, NAT GENET, V29, P175, DOI 10.1038/ng728; Weidinger S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000166; Weinmayr G, 2007, AM J RESP CRIT CARE, V176, P565, DOI 10.1164/rccm.200607-994OC; White JH, 2008, HUM MOL GENET, V17, P1890, DOI 10.1093/hmg/ddn087; Zhang YM, 2003, NAT GENET, V34, P181, DOI 10.1038/ng1166	47	1398	1440	1	204	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2010	363	13					1211	1221		10.1056/NEJMoa0906312	http://dx.doi.org/10.1056/NEJMoa0906312			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	652ZA	20860503	Green Accepted, Green Published			2022-12-01	WOS:000282050000005
J	Rodondi, N; den Elzen, WPJ; Bauer, DC; Cappola, AR; Razvi, S; Walsh, JP; Asvold, BO; Iervasi, G; Imaizumi, M; Collet, TH; Bremner, A; Maisonneuve, P; Sgarbi, JA; Khaw, KT; Vanderpump, MPJ; Newman, AB; Cornuz, J; Franklyn, JA; Westendorp, RGJ; Vittinghoff, E; Gussekloo, J				Rodondi, Nicolas; den Elzen, Wendy P. J.; Bauer, Douglas C.; Cappola, Anne R.; Razvi, Salman; Walsh, John P.; Asvold, Bjorn O.; Iervasi, Giorgio; Imaizumi, Misa; Collet, Tinh-Hai; Bremner, Alexandra; Maisonneuve, Patrick; Sgarbi, Jose A.; Khaw, Kay-Tee; Vanderpump, Mark P. J.; Newman, Anne B.; Cornuz, Jacques; Franklyn, Jayne A.; Westendorp, Rudi G. J.; Vittinghoff, Eric; Gussekloo, Jacobijn		Thyroid Studies Collaboration	Subclinical Hypothyroidism and the Risk of Coronary Heart Disease and Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							INDIVIDUAL PATIENT DATA; 20-YEAR FOLLOW-UP; THYROID-DYSFUNCTION; CARDIOVASCULAR RISK; ALL-CAUSE; METAANALYSIS; ASSOCIATION; THYROXINE; FAILURE; EVENTS	Context Data regarding the association between subclinical hypothyroidism and cardiovascular disease outcomes are conflicting among large prospective cohort studies. This might reflect differences in participants' age, sex, thyroid-stimulating hormone (TSH) levels, or preexisting cardiovascular disease. Objective To assess the risks of coronary heart disease (CHD) and total mortality for adults with subclinical hypothyroidism. Data Sources and Study Selection The databases of MEDLINE and EMBASE (1950 to May 31, 2010) were searched without language restrictions for prospective cohort studies with baseline thyroid function and subsequent CHD events, CHD mortality, and total mortality. The reference lists of retrieved articles also were searched. Data Extraction Individual data on 55 287 participants with 542 494 person-years of follow-up between 1972 and 2007 were supplied from 11 prospective cohorts in the United States, Europe, Australia, Brazil, and Japan. The risk of CHD events was examined in 25 977 participants from 7 cohorts with available data. Euthyroidism was defined as a TSH level of 0.50 to 4.49 mIU/L. Subclinical hypothyroidism was defined as a TSH level of 4.5 to 19.9 mIU/L with normal thyroxine concentrations. Results Among 55 287 adults, 3450 had subclinical hypothyroidism (6.2%) and 51 837 had euthyroidism. During follow-up, 9664 participants died (2168 of CHD), and 4470 participants had CHD events (among 7 studies). The risk of CHD events and CHD mortality increased with higher TSH concentrations. In age-and sex-adjusted analyses, the hazard ratio (HR) for CHD events was 1.00 (95% confidence interval [CI], 0.86-1.18) for a TSH level of 4.5 to 6.9 mIU/L (20.3 vs 20.3/1000 person-years for participants with euthyroidism), 1.17 (95% CI, 0.96-1.43) for a TSH level of 7.0 to 9.9 mIU/L (23.8/1000 person-years), and 1.89 (95% CI, 1.28-2.80) for a TSH level of 10 to 19.9 mIU/L (n=70 events/235; 38.4/1000 person-years; P<.001 for trend). The corresponding HRs for CHD mortality were 1.09 (95% CI, 0.91-1.30; 5.3 vs 4.9/1000 person-years for participants with euthyroidism), 1.42 (95% CI, 1.03-1.95; 6.9/1000 person-years), and 1.58 (95% CI, 1.10-2.27, n=28 deaths/333; 7.7/1000 person-years; P=.005 for trend). Total mortality was not increased among participants with subclinical hypothyroidism. Results were similar after further adjustment for traditional cardiovascular risk factors. Risks did not significantly differ by age, sex, or preexisting cardiovascular disease. Conclusions Subclinical hypothyroidism is associated with an increased risk of CHD events and CHD mortality in those with higher TSH levels, particularly in those with a TSH concentration of 10 mIU/L or greater. JAMA. 2010; 304(12): 1365-1374	[Rodondi, Nicolas; Collet, Tinh-Hai; Cornuz, Jacques] Univ Lausanne, Dept Ambulatory Care & Community Med, CH-1011 Lausanne, Switzerland; [den Elzen, Wendy P. J.; Gussekloo, Jacobijn] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands; [Westendorp, Rudi G. J.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Bauer, Douglas C.; Vittinghoff, Eric] Univ Calif San Francisco, Dept Med Epidemiol & Biostat, San Francisco, CA 94143 USA; [Bauer, Douglas C.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Cappola, Anne R.] Univ Penn, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; [Razvi, Salman] Gateshead Hlth Fdn NHS Trust, Dept Endocrinol, Gateshead, England; [Walsh, John P.] Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Nedlands, WA, Australia; [Walsh, John P.] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia; [Bremner, Alexandra] Univ Western Australia, Sch Populat Hlth, Crawley, WA, Australia; [Asvold, Bjorn O.] Norwegian Univ Sci & Technol, Dept Publ Hlth, N-7034 Trondheim, Norway; [Iervasi, Giorgio] CNR, Inst Clin Physiol, I-56100 Pisa, Italy; [Imaizumi, Misa] Radiat Effects Res Fdn, Dept Clin Studies, Nagasaki, Japan; [Maisonneuve, Patrick] European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy; [Sgarbi, Jose A.] Univ Fed Sao Paulo, Dept Med, Div Endocrinol, Sao Paulo, Brazil; [Sgarbi, Jose A.] Fac Med Marilia, Div Endocrinol, Marilia, Brazil; [Khaw, Kay-Tee] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Vanderpump, Mark P. J.] Royal Free Hosp, Dept Endocrinol, London NW3 2QG, England; [Newman, Anne B.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Franklyn, Jayne A.] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Westendorp, Rudi G. J.] Netherlands Consortium Healthy Ageing, Leiden, Netherlands	University of Lausanne; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Pennsylvania; University of Western Australia; University of Western Australia; University of Western Australia; Norwegian University of Science & Technology (NTNU); Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Radiation Effects Research Foundation - Japan; IRCCS European Institute of Oncology (IEO); Universidade Federal de Sao Paulo (UNIFESP); Faculdade de Medicina de Marilia; University of Cambridge; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Birmingham	Rodondi, N (corresponding author), Univ Lausanne, Dept Ambulatory Care & Community Med, Bugnon 44, CH-1011 Lausanne, Switzerland.	Nicolas.Rodondi@hospvd.ch	Razvi, Salman/H-6118-2019; Newman, Anne B./C-6408-2013; Maisonneuve, Patrick/U-9789-2018; Khaw, Kay-Tee/AAZ-3209-2021; Collet, Tinh-Hai/I-4462-2019; Gussekloo, Jacobijn/ABE-3879-2021	Razvi, Salman/0000-0002-9047-1556; Newman, Anne B./0000-0002-0106-1150; Maisonneuve, Patrick/0000-0002-5309-4704; Collet, Tinh-Hai/0000-0002-3243-1222; Gussekloo, Jacobijn/0000-0001-7186-8278; Bremner, Alexandra/0000-0002-4068-4860; Rodondi, Nicolas/0000-0001-9083-6896; Walsh, John/0000-0002-1766-2612; den Elzen, Wendy/0000-0002-6774-4077; Sgarbi, Jose/0000-0001-7187-984X	National Heart, Lung, and Blood Institute [N01-HC-80007, N01-HC-85079, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, U01 HL080295, R01 HL-075366]; National Institute of Neurological Disorders and Stroke; National Institute on Aging [R01 AG-15928, R01 AG-20098, AG027058, AG-032317, N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106, AG-023629]; University of Pittsburgh Claude. D. Pepper Older Americans Independence Center [P30-AG-024827]; American Heart Association; Dutch Ministry of Health, Welfare, and Sports; UK Department of Health; Wallac Oy (Turku, Finland); Radiation Effects Research Foundation, Hiroshima and Nagasaki, Japan; Japanese Ministry of Health, Labor and Welfare; US Department of Energy; National Academy of Sciences; Radiation Effects Research Foundation [A-10-08]; UK Medical Research Council; UK Cancer Research; Sao Paulo State Research Foundation (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [6/59737-9]; Netherlands Organization for Scientific Research [NGI/NWO911-03-016]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC045133, N01HC085079, N01HC085083, N01HC075150, N01HC085080, N01HC085084, N01HC085085, N01HC085081, N01HC085082, N01HC055222, N01HC035129, N01HC085086, N01HC015103] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075366, U01HL080295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG062103, N01AG062101, R01AG032317, N01AG062106, R01AG015928, R56AG023629, P30AG024827, R01AG027058, R01AG020098, R01AG023629] Funding Source: NIH RePORTER; Medical Research Council [G0401527] Funding Source: researchfish	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Pittsburgh Claude. D. Pepper Older Americans Independence Center; American Heart Association(American Heart Association); Dutch Ministry of Health, Welfare, and Sports; UK Department of Health; Wallac Oy (Turku, Finland); Radiation Effects Research Foundation, Hiroshima and Nagasaki, Japan; Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); US Department of Energy(United States Department of Energy (DOE)); National Academy of Sciences; Radiation Effects Research Foundation; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Cancer Research; Sao Paulo State Research Foundation (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Cardiovascular Health Study and the research reported in this article were supported by contract numbers N01-HC-80007, N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, grant number U01 HL080295 from the National Heart, Lung, and Blood Institute, with additional funding from the National Institute of Neurological Disorders and Stroke. Additional support was provided through grants R01 AG-15928, R01 AG-20098, AG027058, and AG-032317 from the National Institute on Aging, grant R01 HL-075366 from the National Heart, Lung, and Blood Institute, and grant P30-AG-024827 from the University of Pittsburgh Claude. D. Pepper Older Americans Independence Center. A full list of principal investigators and institutions of the Cardiovascular Health Study can be found at http://www.chs-nhlbi.org/pi.htm. The thyroid measurements in the Cardiovascular Health Study were supported by an American Heart Association Grant-in-Aid (to Linda Fried). The Health, Aging, and Body Composition Study is supported by National Institute on Aging contract numbers N01-AG-6-2101, N01-AG-6-2103, and N01-AG-6-2106, and in part by the Intramural Research Program of the National Institutes of Health. The National Institute on Aging funded the Health Aging, and Body Composition study. The Leiden 85-plus Study was partly funded by the Dutch Ministry of Health, Welfare, and Sports. The Whickham Survey was supported by the UK Department of Health. The HUNT Study was a collaborative effort of the Faculty of Medicine, Norwegian University of Science and Technology, the Norwegian Institute of Public Health, and the Nord-Trondelag County Council. The thyroid testing in the HUNT Study was financially supported by Wallac Oy (Turku, Finland). The Nagasaki Adult Health Study was supported by the Radiation Effects Research Foundation, Hiroshima and Nagasaki, Japan, a private, nonprofit foundation funded by the Japanese Ministry of Health, Labor and Welfare and the US Department of Energy, the latter in part through the National Academy of Sciences. This publication was supported by research protocol A-10-08 from the Radiation Effects Research Foundation. The EPIC-Norfolk study was supported by research grants from the UK Medical Research Council and the UK Cancer Research. The Brazilian Thyroid Study was supported by an unrestricted grant from the Sao Paulo State Research Foundation (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo grant 6/59737-9 to Rui Maciel). Dr Newman is supported by grant AG-023629 from the the National Institute on Aging. Dr Westendorp is supported by grant NGI/NWO911-03-016 from the Netherlands Organization for Scientific Research. Role of the Sponsor: The majority of the sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript. The National Institute on Aging funded the Health, Aging, and Body Composition study and reviewed the manuscript and approved its publication. The Radiation Effects Research Foundation funded the Nagasaki Adult Health Study and reviewed the manuscript and approved its publication.	Asvold BO, 2008, ARCH INTERN MED, V168, P855, DOI 10.1001/archinte.168.8.855; Biondi B, 2008, ENDOCR REV, V29, P76, DOI 10.1210/er.2006-0043; Boekholdt SM, 2010, CLIN ENDOCRINOL, V72, P404, DOI 10.1111/j.1365-2265.2009.03640.x; Cappola AR, 2007, J CLIN ENDOCR METAB, V92, P3404, DOI 10.1210/jc.2007-1575; Cappola AR, 2006, JAMA-J AM MED ASSOC, V295, P1033, DOI 10.1001/jama.295.9.1033; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cooper DS, 2004, JAMA-J AM MED ASSOC, V292, P2651, DOI 10.1001/jama.292.21.2651; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EGGER M, 2001, SYSTEMATIC REV HLTH; Fatourechi V, 2003, MAYO CLIN PROC, V78, P554, DOI 10.4065/78.5.554; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Gharib H, 2005, J CLIN ENDOCR METAB, V90, P581, DOI 10.1210/jc.2004-1231; Gussekloo J, 2004, JAMA-J AM MED ASSOC, V292, P2591, DOI 10.1001/jama.292.21.2591; Hak AE, 2000, ANN INTERN MED, V132, P270, DOI 10.7326/0003-4819-132-4-200002150-00004; Heinze G, 2001, BIOMETRICS, V57, P114, DOI 10.1111/j.0006-341X.2001.00114.x; Helfand M, 2004, ANN INTERN MED, V140, P128, DOI 10.7326/0003-4819-140-2-200401200-00015; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Iervasi G, 2007, ARCH INTERN MED, V167, P1526, DOI 10.1001/archinte.167.14.1526; Imaizumi M, 2004, J CLIN ENDOCR METAB, V89, P3365, DOI 10.1210/jc.2003-031089; Klein I, 2001, NEW ENGL J MED, V344, P501, DOI 10.1056/NEJM200102153440707; Klein I, 2007, CIRCULATION, V116, P1725, DOI 10.1161/CIRCULATIONAHA.106.678326; Ladenson PW, 2008, ANN INTERN MED, V148, P880, DOI 10.7326/0003-4819-148-11-200806030-00011; Monzani F, 2004, J CLIN ENDOCR METAB, V89, P2099, DOI 10.1210/jc.2003-031669; NICOLOFF JT, 1990, J CLIN ENDOCR METAB, V71, P553, DOI 10.1210/jcem-71-3-553; Ochs N, 2008, ANN INTERN MED, V148, P832, DOI 10.7326/0003-4819-148-11-200806030-00225; Parle JV, 2001, LANCET, V358, P861, DOI 10.1016/S0140-6736(01)06067-6; Razvi S, 2008, J CLIN ENDOCR METAB, V93, P2998, DOI 10.1210/jc.2008-0167; Razvi S, 2007, J CLIN ENDOCR METAB, V92, P1715, DOI 10.1210/jc.2006-1869; Razvi S, 2010, J CLIN ENDOCR METAB, V95, P1734, DOI 10.1210/jc.2009-1749; Riley RD, 2007, J CLIN EPIDEMIOL, V60, P431, DOI 10.1016/j.jclinepi.2006.09.009; Rodondi N, 2005, ARCH INTERN MED, V165, P2460, DOI 10.1001/archinte.165.21.2460; Rodondi N, 2008, J AM COLL CARDIOL, V52, P1152, DOI 10.1016/j.jacc.2008.07.009; SAWIN CT, 1994, NEW ENGL J MED, V331, P1249, DOI 10.1056/NEJM199411103311901; Sgarbi JA, 2010, EUR J ENDOCRINOL, V162, P569, DOI 10.1530/EJE-09-0845; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; STEWART LA, 1995, STAT MED, V14, P2057, DOI 10.1002/sim.4780141902; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; Vanderpump MPJ, 1996, THYROID, V6, P155; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; Volzke H, 2007, J CLIN ENDOCR METAB, V92, P2421, DOI 10.1210/jc.2007-0179; Walsh JP, 2005, ARCH INTERN MED, V165, P2467, DOI 10.1001/archinte.165.21.2467	45	724	773	2	75	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2010	304	12					1365	1374		10.1001/jama.2010.1361	http://dx.doi.org/10.1001/jama.2010.1361			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	652LK	20858880	Green Accepted, Green Published			2022-12-01	WOS:000282007900020
J	Dyrbye, LN; Massie, FS; Eacker, A; Harper, W; Power, D; Durning, SJ; Thomas, MR; Moutier, C; Satele, D; Sloan, J; Shanafelt, TD				Dyrbye, Liselotte N.; Massie, F. Stanford, Jr.; Eacker, Anne; Harper, William; Power, David; Durning, Steven J.; Thomas, Matthew R.; Moutier, Christine; Satele, Daniel; Sloan, Jeff; Shanafelt, Tait D.			Relationship Between Burnout and Professional Conduct and Attitudes Among US Medical Students	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SCHOOL; CARE; PERCEPTIONS; DISTRESS; MULTICENTER; INSTRUMENTS; DEPRESSION; EXPOSURE; EMPATHY	Context The relationship between professionalism and distress among medical students is unknown. Objective To determine the relationship between measures of professionalism and burnout among US medical students. Design, Setting, and Participants Cross-sectional survey of all medical students attending 7 US medical schools (overall response rate, 2682/4400 [61%]) in the spring of 2009. The survey included the Maslach Burnout Inventory (MBI), the PRIME-MD depression screening instrument, and the SF-8 quality of life (QOL) assessment tool, as well as items exploring students' personal engagement in unprofessional conduct, understanding of appropriate relationships with industry, and attitudes regarding physicians' responsibility to society. Main Outcome Measures Frequency of self-reported cheating/dishonest behaviors, understanding of appropriate relationships with industry as defined by American Medical Association policy, attitudes about physicians' responsibility to society, and the relationship of these dimensions of professionalism to burnout, symptoms of depression, and QOL. Results Of the students who responded to all the MBI items, 1354 of 2566 (52.8%) had burnout. Cheating/dishonest academic behaviors were rare (endorsed by < 10%) in comparison to unprofessional conduct related to patient care (endorsed by up to 43%). Only 14% (362/2531) of students had opinions on relationships with industry consistent with guidelines for 6 scenarios. Students with burnout were more likely to report engaging in 1 or more unprofessional behaviors than those without burnout (35.0% vs 21.9%; odds ratio [OR], 1.89; 95% confidence interval [CI], 1.59-2.24). Students with burnout were also less likely to report holding altruistic views regarding physicians' responsibility to society. For example, students with burnout were less likely to want to provide care for the medically underserved than those without burnout (79.3% vs 85.0%; OR, 0.68; 95% CI, 0.55-0.83). After multivariable analysis adjusting for personal and professional characteristics, burnout was the only aspect of distress independently associated with reporting 1 or more unprofessional behaviors (OR, 1.76; 95% CI, 1.45-2.13) or holding at least 1 less altruistic view regarding physicians' responsibility to society (OR, 1.65; 95% CI, 1.35-2.01). Conclusion Burnout was associated with self-reported unprofessional conduct and less altruistic professional values among medical students at 7 US schools. JAMA. 2010;304(11):1173-1180 www.jama.com	[Dyrbye, Liselotte N.; Thomas, Matthew R.; Shanafelt, Tait D.] Mayo Clin, Coll Med, Rochester, MN USA; [Satele, Daniel; Sloan, Jeff] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Massie, F. Stanford, Jr.] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; [Eacker, Anne] Univ Washington, Sch Med, Seattle, WA USA; [Harper, William] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Power, David] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Durning, Steven J.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Moutier, Christine] Univ Calif San Diego, San Diego, CA 92103 USA	Mayo Clinic; Mayo Clinic; University of Alabama System; University of Alabama Birmingham; University of Washington; University of Washington Seattle; University of Chicago; University of Minnesota System; University of Minnesota Twin Cities; Uniformed Services University of the Health Sciences - USA; University of California System; University of California San Diego	Dyrbye, LN (corresponding author), 200 1st St SW, Rochester, MN 55905 USA.	dyrbye.liselotte@mayo.edu			Mayo Clinic; Mayo Clinic Department of Medicine; Division of Primary Care; Mayo Medical School Office of Educational Research	Mayo Clinic; Mayo Clinic Department of Medicine; Division of Primary Care; Mayo Medical School Office of Educational Research	This work was supported by a Professionalism Award from the Mayo Clinic; from the Mayo Clinic Department of Medicine, Division of Primary Care intramural funds; the Mayo Clinic Department of Medicine Program on Physician Well-being; and the Mayo Medical School Office of Educational Research.	*AM MED ASS, COD MED ETH OP 8 061; American Medical Association, 2001, DECL PROF RESP MED S; ANDERSON RE, 1994, ACAD MED, V69, P323, DOI 10.1097/00001888-199405000-00002; *ASS AM MED COLL, 1996, GRAD QUEST 1995 1996; *ASS AM MED COLL, 2002, ENR GRAD MD PHD DAT; Cooke M, 2006, NEW ENGL J MED, V355, P1339, DOI 10.1056/NEJMra055445; Crandall SJS, 2007, ADV HEALTH SCI EDUC, V12, P71, DOI 10.1007/s10459-005-2297-1; Crandall Sonia J. S., 1993, JAMA (Journal of the American Medical Association), V269, P2519, DOI 10.1001/jama.269.19.2519; Dans PE, 1996, ACAD MED, V71, pS70, DOI 10.1097/00001888-199601000-00046; Dyrbye LN, 2008, ANN INTERN MED, V149, P334, DOI 10.7326/0003-4819-149-5-200809020-00008; Dyrbye LN, 2010, ACAD MED, V85, P94, DOI 10.1097/ACM.0b013e3181c46aad; Dyrbye LN, 2006, ACAD MED, V81, P354, DOI 10.1097/00001888-200604000-00009; Dyrbye LN, 2006, ACAD MED, V81, P374, DOI 10.1097/00001888-200604000-00010; FEUDTNER C, 1994, ACAD MED, V69, P670, DOI 10.1097/00001888-199408000-00017; FirthCozens J, 1997, SOC SCI MED, V44, P1017, DOI 10.1016/S0277-9536(96)00227-4; Grande D, 2009, ARCH INTERN MED, V169, P887, DOI 10.1001/archinternmed.2009.64; Kellerman SE, 2001, AM J PREV MED, V20, P61, DOI 10.1016/S0749-3797(00)00258-0; Lo B, 2010, NEW ENGL J MED, V362, P669, DOI 10.1056/NEJMp1000213; Maslach C., 1996, MASLACH BURNOUT INVE; MORIN K, 2003, AM MED ASS ETHICAL G; Norman Geoffrey R, 2004, Expert Rev Pharmacoecon Outcomes Res, V4, P581, DOI 10.1586/14737167.4.5.581; Papadakis MA, 2005, NEW ENGL J MED, V353, P2673, DOI 10.1056/NEJMsa052596; Schaufeli WB, 2001, PSYCHOL HEALTH, V16, P565, DOI 10.1080/08870440108405527; Shanafelt TD, 2009, ANN SURG, V250, P463, DOI 10.1097/SLA.0b013e3181ac4dfd; Shanafelt TD, 2005, J GEN INTERN MED, V20, P559, DOI 10.1007/s11606-005-0102-8; Shanafelt TD, 2002, ANN INTERN MED, V136, P358, DOI 10.7326/0003-4819-136-5-200203050-00008; SIERLES F, 1980, J MED EDUC, V55, P124; Sierles FS, 2005, JAMA-J AM MED ASSOC, V294, P1034, DOI 10.1001/jama.294.9.1034; SIMPSON DE, 1989, ACAD MED, V64, P221, DOI 10.1097/00001888-198904000-00013; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Thomas MR, 2007, J GEN INTERN MED, V22, P177, DOI 10.1007/s11606-006-0039-6; Thomas NK, 2004, JAMA-J AM MED ASSOC, V292, P2880, DOI 10.1001/jama.292.23.2880; Turner-Bowker DM, 2003, QUAL LIFE RES, V12, P1003, DOI 10.1023/A:1026179517081; Veloski JJ, 2005, ACAD MED, V80, P366, DOI 10.1097/00001888-200504000-00014; Ware J.E., 2001, CORE INTERPRET SINGL; West CP, 2009, JAMA-J AM MED ASSOC, V302, P1294, DOI 10.1001/jama.2009.1389; WEST CP, 2007, BMC MED ED, V7; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x	39	499	514	2	108	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2010	304	11					1173	1180		10.1001/jama.2010.1318	http://dx.doi.org/10.1001/jama.2010.1318			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	649LF	20841530				2022-12-01	WOS:000281770600009
J	Park, JS; Karnas, E; Ohkubo, K; Chen, P; Kadish, KM; Fukuzumi, S; Bielawski, CW; Hudnall, TW; Lynch, VM; Sessler, JL				Park, Jung Su; Karnas, Elizabeth; Ohkubo, Kei; Chen, Ping; Kadish, Karl M.; Fukuzumi, Shunichi; Bielawski, Christopher W.; Hudnall, Todd W.; Lynch, Vincent M.; Sessler, Jonathan L.			Ion-Mediated Electron Transfer in a Supramolecular Donor-Acceptor Ensemble	SCIENCE			English	Article							PHOTOSYSTEM-II; ANION-BINDING; RECEPTOR	Ion binding often mediates electron transfer in biological systems as a cofactor strategy, either as a promoter or as an inhibitor. However, it has rarely, if ever, been exploited for that purpose in synthetic host-guest assemblies. We report here that strong binding of specific anions (chloride, bromide, and methylsulfate but not tetrafluoroborate or hexafluorophosphate) to a tetrathiafulvalene calix[4]pyrrole (TTF-C4P) donor enforces a host conformation that favors electron transfer to a bisimidazolium quinone (BIQ(2+)) guest acceptor. In contrast, the addition of a tetraethylammonium cation, which binds more effectively than the BIQ(2+) guest in the TTF-C4P cavity, leads to back electron transfer, restoring the initial oxidation states of the donor and acceptor pair. The products of these processes were characterized via spectroscopy and x-ray crystallography.	[Chen, Ping; Kadish, Karl M.] Univ Houston, Dept Chem, Houston, TX 77204 USA; [Park, Jung Su; Karnas, Elizabeth; Bielawski, Christopher W.; Hudnall, Todd W.; Lynch, Vincent M.; Sessler, Jonathan L.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Ohkubo, Kei; Fukuzumi, Shunichi] Osaka Univ, Grad Sch Engn, Dept Mat & Life Sci, Suita, Osaka 5650871, Japan; [Fukuzumi, Shunichi] Ewha Womans Univ, Dept Bioinspired Sci, Seoul 120750, South Korea; [Sessler, Jonathan L.] Yonsei Univ, Dept Chem, Seoul 120749, South Korea	University of Houston System; University of Houston; University of Texas System; University of Texas Austin; Osaka University; Ewha Womans University; Yonsei University	Kadish, KM (corresponding author), Univ Houston, Dept Chem, Univ Pk, Houston, TX 77204 USA.		Ohkubo, Kei/L-5002-2019; Sessler, Jonathan/AAY-7091-2021; Fukuzumi, Shunichi/E-4728-2010; Hudnall, Todd W/K-8354-2014; Ohkubo, Kei/E-5127-2012	Ohkubo, Kei/0000-0001-8328-9249; Ohkubo, Kei/0000-0001-8328-9249; Hudnall, Todd/0000-0002-9260-2986	Ministry of Education, Culture, Sports, Science and Technology, Japan; NSF [CHE 0749571, 0741973]; R.A. Welch Foundation [F-1018, E-680, F-1621]; Korean World Class University [R32-20080-000-10217-0, R31-2008-000-10010-0];  [20108010]; Direct For Mathematical & Physical Scien [0741973] Funding Source: National Science Foundation; Grants-in-Aid for Scientific Research [20108001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NSF(National Science Foundation (NSF)); R.A. Welch Foundation(The Welch Foundation); Korean World Class University; ; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid (no. 20108010 to S.F.) and a Global Centers of Excellence program from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to S.F.); NSF (grants CHE 0749571 to J.L.S. and 0741973 for the x-ray diffractometer); and the R.A. Welch Foundation (grants F-1018, E-680, and F-1621 to J.LS., K.M.K., and C.W.B., respectively). Support to J.L.S. and S.F. under the Korean World Class University program is also acknowledged (grants R32-20080-000-10217-0 and R31-2008-000-10010-0, respectively). Crystallographic data have been deposited with the Cambridge Crystallographic Data Centre under reference numbers CCDC-775796 to 775804.	Battistuzzi G, 1996, EUR J BIOCHEM, V241, P208, DOI 10.1111/j.1432-1033.1996.0208t.x; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Fukuzumi S, 2009, PROG INORG CHEM, V56, P49, DOI 10.1002/9780470440124.ch2; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; Nielsen K. A., 2006, ANGEW CHEM, V118, P7002; Nielsen KA, 2006, J AM CHEM SOC, V128, P2444, DOI 10.1021/ja057367u; Nielsen KA, 2004, J AM CHEM SOC, V126, P16296, DOI 10.1021/ja044664a; Rosokha SV, 2007, J AM CHEM SOC, V129, P828, DOI 10.1021/ja064166x; Sessler JL, 2006, J AM CHEM SOC, V128, P12281, DOI 10.1021/ja064012h; Tennyson AG, 2010, CHEM-EUR J, V16, P304, DOI 10.1002/chem.200901883; Utschig LM, 2004, ACCOUNTS CHEM RES, V37, P439, DOI 10.1021/ar020197v; Yocum CF, 2008, COORDIN CHEM REV, V252, P296, DOI 10.1016/j.ccr.2007.08.010; Zhao X, 2005, BIOCHEMISTRY-US, V44, P6559, DOI 10.1021/bi047465c	14	151	151	3	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 10	2010	329	5997					1324	1327		10.1126/science.1192044	http://dx.doi.org/10.1126/science.1192044			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647YR	20829481				2022-12-01	WOS:000281657300033
J	Bonham, VL; Dover, GJ; Brody, LC				Bonham, Vence L.; Dover, George J.; Brody, Lawrence C.			Screening Student Athletes for Sickle Cell Trait - A Social and Clinical Experiment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bonham, Vence L.] NHGRI, Social & Behav Res Branch, Bethesda, MD 20892 USA; [Brody, Lawrence C.] NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; [Dover, George J.] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Johns Hopkins University	Bonham, VL (corresponding author), NHGRI, Social & Behav Res Branch, Bethesda, MD 20892 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200324] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		*NAT COLL ATHL ASS, 2010, M NAT COLL ATHL ASS; RUTKOW IM, 1974, AM J PUBLIC HEALTH, V64, P217, DOI 10.2105/AJPH.64.3.217; VANCAMP SP, 1995, MED SCI SPORT EXER, V27, P641; WHITTEN CF, 1973, NEW ENGL J MED, V288, P318, DOI 10.1056/NEJM197302082880612; WILSON B, 2009, NCAA MAY FORCE SCH T	5	62	63	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 9	2010	363	11					997	999		10.1056/NEJMp1007639	http://dx.doi.org/10.1056/NEJMp1007639			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	647HS	20825310				2022-12-01	WOS:000281609700001
J	Jain, D; Hebden, AK; Nakamura, TM; Miller, KM; Cooper, JP				Jain, Devanshi; Hebden, Anna K.; Nakamura, Toru M.; Miller, Kyle M.; Cooper, Julia Promisel			HAATI survivors replace canonical telomeres with blocks of generic heterochromatin	NATURE			English	Article							FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; DROSOPHILA TELOMERES; EPIGENETIC CONTROL; BINDING-PROTEIN; DOMAIN PROTEIN; 2 MODES; RECOMBINATION; MAINTENANCE; CENTROMERE	The notion that telomeres are essential for chromosome linearity stems from the existence of two chief dangers: inappropriate DNA damage response (DDR) reactions that mistake natural chromosome ends for double-strand DNA breaks (DSBs), and the progressive loss of DNA from chromosomal termini due to the end replication problem. Telomeres avert the former peril by binding sequence-specific end-protection factors that control the access of DDR activities(1,2). The latter threat is tackled by recruiting telomerase, a reverse transcriptase that uses an integral RNA subunit to template the addition of telomere repeats to chromosome ends(3). Here we describe an alternative mode of linear chromosome maintenance in which canonical telomeres are superseded by blocks of heterochromatin. We show that in the absence of telomerase, Schizosaccharomyces pombe cells can survive telomere sequence loss by continually amplifying and rearranging heterochromatic sequences. Because the heterochromatin assembly machinery is required for this survival mode, we have termed it 'HAATI' (heterochromatin amplification-mediated and telomerase-independent). HAATI uses the canonical end-protection protein Pot1 (ref. 4) and its interacting partner Ccq1 (ref. 5) to preserve chromosome linearity. The data suggest a model in which Ccq1 is recruited by the amplified heterochromatin and provides an anchor for Pot1, which accomplishes its end-protection function in the absence of its cognate DNA-binding sequence. HAATI resembles the chromosome end-maintenance strategy found in Drosophila melanogaster, which lacks specific telomere sequences but nonetheless assembles terminal heterochromatin structures that recruit end-protection factors. These findings reveal a previously unrecognized mode by which cancer cells might escape the requirement for telomerase activation, and offer a tool for studying genomes that sustain unusually high levels of heterochromatinization.	[Jain, Devanshi; Cooper, Julia Promisel] Canc Res UK, London Res Inst, London WC2A 3PX, England; [Hebden, Anna K.] Univ London Imperial Coll Sci Technol & Med, Ovarian Canc Act Grp, London W12 0NN, England; [Nakamura, Toru M.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Miller, Kyle M.] Gurdon Inst, Cambridge CB2 1QN, England	Cancer Research UK; Imperial College London; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cooper, JP (corresponding author), Canc Res UK, London Res Inst, 44 Lincolns Inn Fields, London WC2A 3PX, England.	julie.cooper@cancer.org.uk	Nakamura, Toru M/B-2055-2008	Nakamura, Toru M/0000-0001-5752-0814; cooper, julia promisel/0000-0003-2171-2587; Miller, Kyle/0000-0002-4544-0013	Cancer Research UK	Cancer Research UK(Cancer Research UK)	We thank T. Cech for discussions and gratefully acknowledge that initial work by T.M.N. on reintroducing Trt1 to circular strains was performed in the Cech laboratory. We thank our current and former laboratory members for discussions and advice. This work was supported by Cancer Research UK.	Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Cenci G, 2005, CHROMOSOMA, V114, P135, DOI 10.1007/s00412-005-0005-9; Cenci G, 2003, NAT CELL BIOL, V5, P82, DOI 10.1038/ncb902; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Ekwall K, 1996, J CELL SCI, V109, P2637; Ferreira MG, 2004, GENE DEV, V18, P2249, DOI 10.1101/gad.315804; Ferreira MG, 2001, MOL CELL, V7, P55, DOI 10.1016/S1097-2765(01)00154-X; Gao GJ, 2010, EMBO J, V29, P819, DOI 10.1038/emboj.2009.394; Haering CH, 2000, P NATL ACAD SCI USA, V97, P6367, DOI 10.1073/pnas.130187397; Ishii K, 2008, SCIENCE, V321, P1088, DOI 10.1126/science.1158699; Kanoh J, 2005, CURR BIOL, V15, P1808, DOI 10.1016/j.cub.2005.09.041; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Maringele L, 2004, GENE DEV, V18, P2663, DOI 10.1101/gad.316504; Mason JM, 2008, BIOESSAYS, V30, P25, DOI 10.1002/bies.20688; McEachern MJ, 2006, ANNU REV BIOCHEM, V75, P111, DOI 10.1146/annurev.biochem.74.082803.133234; Miller KM, 2006, NATURE, V440, P824, DOI 10.1038/nature04638; Miyoshi T, 2008, SCIENCE, V320, P1341, DOI 10.1126/science.1154819; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakamura KI, 2008, EMBO J, V27, P3036, DOI 10.1038/emboj.2008.215; Nakamura TM, 1998, SCIENCE, V282, P493, DOI 10.1126/science.282.5388.493; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pardue ML, 2003, ANNU REV GENET, V37, P485, DOI 10.1146/annurev.genet.38.072902.093115; Pitt CW, 2010, NUCLEIC ACIDS RES, V38, P6968, DOI 10.1093/nar/gkq580; Rog O, 2008, CURR OPIN GENET DEV, V18, P212, DOI 10.1016/j.gde.2008.01.011; Sugawara N. F., 1988, THESIS HARVARD U; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; Teng SC, 1999, MOL CELL BIOL, V19, P8083; TODA T, 1984, CURR GENET, V8, P93, DOI 10.1007/BF00420224; Tomita K, 2003, MOL CELL BIOL, V23, P5186, DOI 10.1128/MCB.23.15.5186-5197.2003; Tomita K, 2007, CELL, V130, P113, DOI 10.1016/j.cell.2007.05.024; Tomita K, 2008, GENE DEV, V22, P3461, DOI 10.1101/gad.498608; Wang X, 2008, MOL CELL, V31, P463, DOI 10.1016/j.molcel.2008.05.028	37	65	65	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2010	467	7312					223	U118		10.1038/nature09374	http://dx.doi.org/10.1038/nature09374			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647KB	20829796				2022-12-01	WOS:000281616300038
J	Lestas, I; Vinnicombe, G; Paulsson, J				Lestas, Ioannis; Vinnicombe, Glenn; Paulsson, Johan			Fundamental limits on the suppression of molecular fluctuations	NATURE			English	Article							PLASMID REPLICATION; FEEDBACK-CONTROL; GENE-EXPRESSION; POISSON-TYPE; SINGLE-CELL; NOISE; PERFORMANCE; INFORMATION; LIMITATIONS; ROBUSTNESS	Negative feedback is common in biological processes and can increase a system's stability to internal and external perturbations. But at the molecular level, control loops always involve signalling steps with finite rates for random births and deaths of individual molecules. Here we show, by developing mathematical tools that merge control and information theory with physical chemistry, that seemingly mild constraints on these rates place severe limits on the ability to suppress molecular fluctuations. Specifically, the minimum standard deviation in abundances decreases with the quartic root of the number of signalling events, making it extremely expensive to increase accuracy. Our results are formulated in terms of experimental observables, and existing data show that cells use brute force when noise suppression is essential; for example, regulatory genes are transcribed tens of thousands of times per cell cycle. The theory challenges conventional beliefs about biochemical accuracy and presents an approach to the rigorous analysis of poorly characterized biological systems.	[Lestas, Ioannis; Vinnicombe, Glenn] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England; [Paulsson, Johan] Harvard Univ, Dept Syst Biol, Boston, MA 02115 USA	University of Cambridge; Harvard University	Vinnicombe, G (corresponding author), Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England.	gv@eng.cam.ac.uk; johan_paulsson@hms.harvard.edu			BBSRC [BB/C008073/1]; National Science Foundation [DMS-074876-0, 0720056]; National Institutes of Health [GM081563-02, GM068763-06]; Biotechnology and Biological Sciences Research Council [BB/C008073/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081563, P50GM068763] Funding Source: NIH RePORTER; Division Of Mathematical Sciences [0748760] Funding Source: National Science Foundation	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This research was supported by the BBSRC under grant BB/C008073/1, by the National Science Foundation grants DMS-074876-0 and CAREER 0720056, and by grants GM081563-02 and GM068763-06 from the National Institutes of Health.	Barkai N, 2007, MOL CELL, V28, P755, DOI 10.1016/j.molcel.2007.11.013; Bialek W, 2005, P NATL ACAD SCI USA, V102, P10040, DOI 10.1073/pnas.0504321102; Bialek W, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.258101; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Cover T. M., 2006, ELEMENTS INFORM THEO, V2nd; Das N, 2005, P NATL ACAD SCI USA, V102, P2856, DOI 10.1073/pnas.0409790102; DAVIS MHA, 1980, IEEE T INFORM THEORY, V26, P710, DOI 10.1109/TIT.1980.1056262; Doan T, 2006, SCIENCE, V313, P530, DOI 10.1126/science.1126612; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; El-Samad H, 2005, P NATL ACAD SCI USA, V102, P2736, DOI 10.1073/pnas.0403510102; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Gorbunov A. K., 1973, Problems of Information Transmission, V9, P184; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; KABANOV YM, 1978, THEOR PROBAB APPL+, V23, P143, DOI 10.1137/1123013; Keizer J., 1987, STAT THERMODYNAMICS; Korobkova EA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.058105; Martins NC, 2008, IEEE T AUTOMAT CONTR, V53, P1604, DOI 10.1109/TAC.2008.929361; Martins NC, 2007, IEEE T AUTOMAT CONTR, V52, P56, DOI 10.1109/TAC.2006.887898; MAXWELL JC, 1867, P ROY SOC, V16, P270; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2001, Q REV BIOPHYS, V34, P1, DOI 10.1017/S0033583501003663; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; SAVAGEAU MA, 1971, NATURE, V229, P542, DOI 10.1038/229542a0; SHANNON E, 1948, BELL SYST TECH J, V379, P623; Singh A, 2009, BIOPHYS J, V96, P4013, DOI 10.1016/j.bpj.2009.02.064; Tkacik G, 2008, P NATL ACAD SCI USA, V105, P12265, DOI 10.1073/pnas.0806077105; TOMIZAWA J, 1986, CELL, V47, P89, DOI 10.1016/0092-8674(86)90369-7; Walczak AM, 2009, P NATL ACAD SCI USA, V106, P6529, DOI 10.1073/pnas.0811999106; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649	32	285	287	2	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 9	2010	467	7312					174	178		10.1038/nature09333	http://dx.doi.org/10.1038/nature09333			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647KB	20829788	Green Accepted			2022-12-01	WOS:000281616300027
J	Beasley, R; Perrin, K; Weatherall, M; Wijesinghe, M				Beasley, Richard; Perrin, Kyle; Weatherall, Mark; Wijesinghe, Meme			Call for withdrawal of LABA single-therapy inhaler in asthma	LANCET			English	Editorial Material							ACTING BETA-AGONISTS; CORTICOSTEROIDS; SALMETEROL; MORTALITY; RISK; METAANALYSIS; FORMOTEROL		[Beasley, Richard; Perrin, Kyle; Wijesinghe, Meme] Med Res Inst New Zealand, Wellington 6242, New Zealand; [Beasley, Richard; Perrin, Kyle; Weatherall, Mark] Capital & Coast Dist Hlth Board, Wellington, New Zealand; [Weatherall, Mark] Univ Otago Wellington, Wellington, New Zealand	Medical Research Institute Of New Zealand; University of Otago	Beasley, R (corresponding author), Med Res Inst New Zealand, Wellington 6242, New Zealand.	richard.beasley@mrinz.ac.nz	Weatherall, Mark/Y-6824-2019; Beasley, Richard/AAH-3908-2019	Weatherall, Mark/0000-0002-0051-9107; Beasley, Richard/0000-0003-0337-406X				Bateman E, 2008, ANN INTERN MED, V149, P33, DOI 10.7326/0003-4819-149-1-200807010-00229; Chowdhury BA, 2010, NEW ENGL J MED, V362, P1169, DOI 10.1056/NEJMp1002074; Kramer JM, 2009, NEW ENGL J MED, V360, P1592, DOI 10.1056/NEJMp0810561; Nelson H, 2010, J ALLERGY CLIN IMMUN, V125, P390, DOI 10.1016/j.jaci.2009.11.036; O'Driscoll BR, 2008, THORAX, V63, DOI 10.1136/thx.2008.102947; Stempel DA, 2005, RESP MED, V99, P1263, DOI 10.1016/j.rmed.2005.03.002; Stoloff SW, 2004, J ALLERGY CLIN IMMUN, V113, P245, DOI 10.1016/j.jaci.2003.10.011; Suissa S, 2000, NEW ENGL J MED, V343, P332, DOI 10.1056/NEJM200008033430504; Taylor DR, 2008, NEW ZEAL MED J, V121, P106; Weatherall M, 2010, THORAX, V65, P39, DOI 10.1136/thx.2009.116608; Wijesinghe M, 2008, POSTGRAD MED J, V84, P467, DOI 10.1136/pgmj.2007.067165; Wijesinghe M, 2009, EUR RESPIR J, V34, P803, DOI 10.1183/09031936.00159708	12	34	34	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 4	2010	376	9743					750	751		10.1016/S0140-6736(10)61158-0	http://dx.doi.org/10.1016/S0140-6736(10)61158-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	650EC	20816529				2022-12-01	WOS:000281831000007
J	Tomer, R; Denes, AS; Tessmar-Raible, K; Arendt, D				Tomer, Raju; Denes, Alexandru S.; Tessmar-Raible, Kristin; Arendt, Detlev			Profiling by Image Registration Reveals Common Origin of Annelid Mushroom Bodies and Vertebrate Pallium	CELL			English	Article							IN-SITU HYBRIDIZATION; PLATYNEREIS-DUMERILII; CELL-TYPES; EVOLUTION; BRAIN; TELENCEPHALON; EXPRESSION; FATE; WNT; FOREBRAIN	The evolution of the highest-order human brain center, the "pallium'' or "cortex,'' remains enigmatic. To elucidate its origins, we set out to identify related brain parts in phylogenetically distant animals, to then unravel common aspects in cellular composition and molecular architecture. Here, we compare vertebrate pallium development to that of the mushroom bodies, sensory-associative brain centers, in an annelid. Using a newly developed protocol for cellular profiling by image registration (PrImR), we obtain a high-resolution gene expression map for the developing annelid brain. Comparison to the vertebrate pallium reveals that the annelid mushroom bodies develop from similar molecular coordinates within a conserved overall molecular brain topology and that their development involves conserved patterning mechanisms and produces conserved neuron types that existed already in the protostome- deuterostome ancestors. These data indicate deep homology of pallium and mushroom bodies and date back the origin of higher brain centers to prebilaterian times.	[Tomer, Raju; Denes, Alexandru S.; Tessmar-Raible, Kristin; Arendt, Detlev] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Tomer, R (corresponding author), European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany.	tomer@embl.de; arendt@embl.de	Tomer, Raju/F-2335-2010; Tessmar-Raible, Kristin/F-9642-2011	Tessmar-Raible, Kristin/0000-0002-8038-1741	Marie Curie RTN ZOONET [MRTN-CT-2004-005624]; DFG Collaborative Research Network [SFB-488]; Louis Jeantet Foundation	Marie Curie RTN ZOONET(European Commission); DFG Collaborative Research Network(German Research Foundation (DFG)); Louis Jeantet Foundation	We thank F. Christodoulou for providing larvae stained with mir-9, 9*, H. Snyman for expert technical assistance, and the Arendt lab for support. The electron micrograph in Figure 5 was taken with C. Nielsen during a practical course. R.T. and K.T.-R. were supported by fellowships of the Marie Curie RTN ZOONET (MRTN-CT-2004-005624), R.T. by DFG Collaborative Research Network SFB-488, and A.D. by a Louis Jeantet Foundation fellowship. R.T. conceived and developed PrImR, designed and performed the experiments, analyzed and interpreted the data, and wrote the paper. A.S.D. contributed clones of vglut and gad. K.T.-R. contributed clones of brn124 and emx. D.A. proposed to study annelid mushroom bodies, provided ideas, interpreted the data, and wrote the paper.	Arendt D, 2005, THEOR BIOSCI, V124, P185, DOI 10.1016/j.thbio.2005.08.002; Arendt D, 2002, DEVELOPMENT, V129, P1143; Arendt D, 2008, NAT REV GENET, V9, P868, DOI 10.1038/nrg2416; Backman M, 2005, DEV BIOL, V279, P155, DOI 10.1016/j.ydbio.2004.12.010; Bani-Yaghoub M, 2006, DEV BIOL, V295, P52, DOI 10.1016/j.ydbio.2006.03.007; Caubit X, 1999, DEV DYNAM, V214, P66, DOI 10.1002/(SICI)1097-0177(199901)214:1<66::AID-DVDY7>3.0.CO;2-7; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Danesin C, 2009, DEV CELL, V16, P576, DOI 10.1016/j.devcel.2009.03.007; Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Ekonomou A, 2005, PLOS BIOL, V3, P1111, DOI 10.1371/journal.pbio.0030186; EVANS SM, 1966, NATURE, V211, P945, DOI 10.1038/211945a0; Farris SA, 2005, ARTHROPOD STRUCT DEV, V34, P211, DOI 10.1016/j.asd.2005.01.008; Farris SM, 2008, BRAIN BEHAV EVOLUT, V72, P106, DOI 10.1159/000151471; Fischer A, 2004, BIOESSAYS, V26, P314, DOI 10.1002/bies.10409; Forster E, 2006, NAT REV NEUROSCI, V7, P259, DOI 10.1038/nrn1882; Garel S, 1999, DEVELOPMENT, V126, P5285; Hebert JM, 2008, NAT REV NEUROSCI, V9, P678, DOI 10.1038/nrn2463; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Houart C, 2002, NEURON, V35, P255, DOI 10.1016/S0896-6273(02)00751-1; Inoue T, 2000, DEV BIOL, V219, P373, DOI 10.1006/dbio.2000.9616; Jekely G, 2007, BIOTECHNIQUES, V42, P751, DOI 10.2144/000112462; Kandel ER., 2000, PRINCIPLES NEURAL SC, P67; Keeble TR, 2006, J NEUROSCI, V26, P5840, DOI 10.1523/JNEUROSCI.1175-06.2006; Kimura J, 2005, J NEUROSCI, V25, P5097, DOI 10.1523/JNEUROSCI.0239-05.2005; Liu X, 2009, CELL, V139, P623, DOI 10.1016/j.cell.2009.08.044; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132; Miura H, 1997, MECH DEVELOP, V65, P99, DOI 10.1016/S0925-4773(97)00062-2; MULLER WA, 1973, Z ZELLFORSCH MIK ANA, V139, P487, DOI 10.1007/BF02028390; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Nieuwenhuys R, 2002, BRAIN RES BULL, V57, P257, DOI 10.1016/S0361-9230(01)00668-2; Noveen A, 2000, DEVELOPMENT, V127, P3475; Raible F, 2005, SCIENCE, V310, P1325, DOI 10.1126/science.1119089; Schneider SQ, 2007, DEV CELL, V13, P73, DOI 10.1016/j.devcel.2007.05.002; Shimamura K, 1995, DEVELOPMENT, V121, P3923; Stigloher C, 2006, DEVELOPMENT, V133, P2925, DOI 10.1242/dev.02450; Strausfeld NJ, 2006, P ROY SOC B-BIOL SCI, V273, P1857, DOI 10.1098/rspb.2006.3536; Strausfeld NJ, 2009, J COMP NEUROL, V513, P265, DOI 10.1002/cne.21948; STRAUSFELD NJ, 1993, J COMP NEUROL, V328, P43, DOI 10.1002/cne.903280104; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Swanson LW, 2000, BRAIN RES, V886, P113, DOI 10.1016/S0006-8993(00)02905-X; Taglialatela P, 2004, DEVELOPMENT, V131, P4239, DOI 10.1242/dev.01299; Tessmar-Raible K, 2005, BIOTECHNIQUES, V39, P460, DOI 10.2144/000112023; Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041; Tole S, 2000, DEV BIOL, V217, P254, DOI 10.1006/dbio.1999.9509; Tuoc TC, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-23; Urbach R, 2003, DEVELOPMENT, V130, P3621, DOI 10.1242/dev.00533; Viola P, 1997, INT J COMPUT VISION, V24, P137, DOI 10.1023/A:1007958904918; Wang B, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-5; Woodger J. H., 1945, ESSAYS GROWTH FORM P, P95; Yun K, 2001, DEVELOPMENT, V128, P193	53	204	205	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2010	142	5					800	809		10.1016/j.cell.2010.07.043	http://dx.doi.org/10.1016/j.cell.2010.07.043			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	646FL	20813265	Bronze			2022-12-01	WOS:000281523200022
J	Mouquet, H; Scheid, JF; Zoller, MJ; Krogsgaard, M; Ott, RG; Shukair, S; Artyomov, MN; Pietzsch, J; Connors, M; Pereyra, F; Walker, BD; Ho, DD; Wilson, PC; Seaman, MS; Eisen, HN; Chakraborty, AK; Hope, TJ; Ravetch, JV; Wardemann, H; Nussenzweig, MC				Mouquet, Hugo; Scheid, Johannes F.; Zoller, Markus J.; Krogsgaard, Michelle; Ott, Rene G.; Shukair, Shetha; Artyomov, Maxim N.; Pietzsch, John; Connors, Mark; Pereyra, Florencia; Walker, Bruce D.; Ho, David D.; Wilson, Patrick C.; Seaman, Michael S.; Eisen, Herman N.; Chakraborty, Arup K.; Hope, Thomas J.; Ravetch, Jeffrey V.; Wardemann, Hedda; Nussenzweig, Michel C.			Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; MEMORY B-CELLS; NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEIN; TYPE-1; AUTOREACTIVITY; INDIVIDUALS; MODULATION; GENERATION	During immune responses, antibodies are selected for their ability to bind to foreign antigens with high affinity, in part by their ability to undergo homotypic bivalent binding. However, this type of binding is not always possible. For example, the small number of gp140 glycoprotein spikes displayed on the surface of the human immunodeficiency virus (HIV) disfavours homotypic bivalent antibody binding(1-3). Here we show that during the human antibody response to HIV, somatic mutations that increase antibody affinity also increase breadth and neutralizing potency. Surprisingly, the responding naive and memory B cells produce polyreactive antibodies, which are capable of bivalent heteroligation between one high-affinity anti-HIV-gp140 combining site and a second low-affinity site on another molecular structure on HIV. Although cross-reactivity to self-antigens or polyreactivity is strongly selected against during B-cell development(4), it is a common serologic feature of certain infections in humans, including HIV, Epstein-Barr virus and hepatitis C virus. Seventy-five per cent of the 134 monoclonal anti-HIV-gp140 antibodies cloned from six patients(5) with high titres of neutralizing antibodies are polyreactive. Despite the low affinity of the polyreactive combining site, heteroligation demonstrably increases the apparent affinity of polyreactive antibodies to HIV.	[Mouquet, Hugo; Scheid, Johannes F.; Pietzsch, John; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Scheid, Johannes F.] Charite, D-10117 Berlin, Germany; [Zoller, Markus J.; Wardemann, Hedda] Max Planck Inst Infect Biol, D-10117 Berlin, Germany; [Krogsgaard, Michelle] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Krogsgaard, Michelle] NYU, Sch Med, Inst Canc, New York, NY 10016 USA; [Ott, Rene G.; Ravetch, Jeffrey V.] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA; [Shukair, Shetha; Hope, Thomas J.] Northwestern Univ, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Artyomov, Maxim N.; Eisen, Herman N.; Chakraborty, Arup K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Artyomov, Maxim N.; Eisen, Herman N.; Chakraborty, Arup K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Artyomov, Maxim N.; Eisen, Herman N.; Chakraborty, Arup K.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Artyomov, Maxim N.; Eisen, Herman N.; Chakraborty, Arup K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Artyomov, Maxim N.; Eisen, Herman N.; Chakraborty, Arup K.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Pietzsch, John] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Connors, Mark] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Connors, Mark] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Pereyra, Florencia; Walker, Bruce D.] MIT, Massachusetts Gen Hosp, Ragon Inst, Boston, MA 02114 USA; [Pereyra, Florencia; Walker, Bruce D.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Ho, David D.] Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA; [Wilson, Patrick C.] Univ Chicago, Dept Med, Rheumatol Sect, Chicago, IL 60637 USA; [Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; New York University; New York University; Rockefeller University; Northwestern University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Free University of Berlin; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard Medical School; University of Chicago; Harvard University; Beth Israel Deaconess Medical Center; Howard Hughes Medical Institute; Rockefeller University	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	nussenzweig@rockefeller.edu	Ravetch, Jeffrey/Z-1596-2019; Mouquet, Hugo/M-2750-2014; Nussenzweig, Michel/AAE-7292-2019	Ravetch, Jeffrey/0000-0003-2024-9041; Mouquet, Hugo/0000-0002-4230-610X; Wardemann, Hedda/0000-0003-3921-5933	Rockefeller University; National Institutes of Health [NIH 1 PO1 AI081677, R01 AI047770]; International AIDS Vaccine Initiative; Bill and Melinda Gates Foundation; German Research Foundation [GRK1121]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047770, ZIAAI001090, P01AI081677, ZIAAI000855] Funding Source: NIH RePORTER	Rockefeller University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. R. Mascola and R. T. Wyatt for discussion and supplying gp140 and gp120 proteins. This research was supported by the Rockefeller University, the National Institutes of Health (NIH 1 PO1 AI081677), the International AIDS Vaccine Initiative and the Bill and Melinda Gates Foundation. T.J.H. was supported by the National Institutes of Health (R01 AI047770). M.J.Z. and H.W. were supported by the German Research Foundation (GRK1121). B.D.W. and M.C.N. are Howard Hughes Medical Institute investigators.	Aguilera I, 2001, IMMUNOLOGY, V102, P273, DOI 10.1046/j.1365-2567.2001.01159.x; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; Cheskis B, 1996, BIOCHEMISTRY-US, V35, P3309, DOI 10.1021/bi952283r; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; ICHIYOSHI Y, 1994, J EXP MED, V180, P885, DOI 10.1084/jem.180.3.885; Jay JI, 2009, ADV FUNCT MATER, V19, P2969, DOI 10.1002/adfm.200900757; Karlsson GB, 1996, J VIROL, V70, P6136, DOI 10.1128/JVI.70.9.6136-6142.1996; Klein JS, 2009, P NATL ACAD SCI USA, V106, P7385, DOI 10.1073/pnas.0811427106; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Mascola JR, 2007, NATURE, V449, P29, DOI 10.1038/449029a; Meffre E, 2004, J EXP MED, V199, P145, DOI 10.1084/jem.20031550; MICHAELIDES MC, 1974, J EXP MED, V140, P687, DOI 10.1084/jem.140.3.687; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Shen XY, 2010, P NATL ACAD SCI USA, V107, P5972, DOI 10.1073/pnas.0912381107; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Tsuiji M, 2006, J EXP MED, V203, P393, DOI 10.1084/jem.20052033; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817; ZINKERNAGEL RM, 1990, NATURE, V345, P68, DOI 10.1038/345068a0; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307	31	317	332	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP	2010	467	7315					591	U117		10.1038/nature09385	http://dx.doi.org/10.1038/nature09385			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655TT	20882016	Green Accepted			2022-12-01	WOS:000282273100039
J	Baum, M				Baum, Michael			Homoeopathy waives the rules	LANCET			English	Editorial Material									Royal Free & Univ Coll Med Sch, Ctr Clin Sci & Technol, Clin Trials Grp, London N19 5LW, England	University of London; University College London	Baum, M (corresponding author), Royal Free & Univ Coll Med Sch, Ctr Clin Sci & Technol, Clin Trials Grp, London N19 5LW, England.	michael@mbaum.freeserve.co.uk						Department of Health, 2010, GOV RESP SCI TECHN C; Kmietowicz Z, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1091; Vaidya JS, 2010, LANCET, V376, P91, DOI 10.1016/S0140-6736(10)60837-9; DISCUSSIONS DEP HLTH	4	2	2	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 21	2010	376	9741					577	577		10.1016/S0140-6736(10)61227-5	http://dx.doi.org/10.1016/S0140-6736(10)61227-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	643PB	20728742				2022-12-01	WOS:000281309100010
J	Schramek, D; Leibbrandt, A; Sigl, V; Kenner, L; Pospisilik, JA; Lee, HJ; Hanada, R; Joshi, PA; Aliprantis, A; Glimcher, L; Pasparakis, M; Khokha, R; Ormandy, CJ; Widschwendter, M; Schett, G; Penninger, JM				Schramek, Daniel; Leibbrandt, Andreas; Sigl, Verena; Kenner, Lukas; Pospisilik, John A.; Lee, Heather J.; Hanada, Reiko; Joshi, Purna A.; Aliprantis, Antonios; Glimcher, Laurie; Pasparakis, Manolis; Khokha, Rama; Ormandy, Christopher J.; Widschwendter, Martin; Schett, Georg; Penninger, Josef M.			Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer	NATURE			English	Article							HORMONE-REPLACEMENT THERAPY; ESTROGEN-PLUS-PROGESTIN; STEM-CELL; POSTMENOPAUSAL WOMEN; EPITHELIAL-CELLS; MEDROXYPROGESTERONE ACETATE; OSTEOPROTEGERIN-LIGAND; RECEPTOR ACTIVATOR; GLAND DEVELOPMENT; BONE METASTASIS	Breast cancer is one of the most common cancers in humans and will on average affect up to one in eight women in their lifetime in the United States and Europe(1). The Women's Health Initiative and the Million Women Study have shown that hormone replacement therapy is associated with an increased risk of incident and fatal breast cancer(2,3). In particular, synthetic progesterone derivatives (progestins) such as medroxyprogesterone acetate (MPA), used in millions of women for hormone replacement therapy and contraceptives, markedly increase the risk of developing breast cancer. Here we show that the in vivo administration of MPA triggers massive induction of the key osteoclast differentiation factor RANKL (receptor activator of NF-kappa B ligand) in mammary-gland epithelial cells. Genetic inactivation of the RANKL receptor RANK in mammary-gland epithelial cells prevents MPA-induced epithelial proliferation, impairs expansion of the CD49f(hi) stem-cell-enriched population, and sensitizes these cells to DNA-damage-induced cell death. Deletion of RANK from the mammary epithelium results in a markedly decreased incidence and delayed onset of MPA-driven mammary cancer. These data show that the RANKL/RANK system controls the incidence and onset of progestin-driven breast cancer.	[Schramek, Daniel; Leibbrandt, Andreas; Sigl, Verena; Pospisilik, John A.; Hanada, Reiko; Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria; [Kenner, Lukas] Med Univ Vienna, A-1090 Vienna, Austria; [Lee, Heather J.; Ormandy, Christopher J.] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Joshi, Purna A.; Khokha, Rama] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Aliprantis, Antonios; Glimcher, Laurie] Harvard Univ, Sch Med, Dept Med, Sch Publ Hlth,Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Aliprantis, Antonios; Glimcher, Laurie] MGH MIT, Ragon Inst, Boston, MA 02115 USA; [Pasparakis, Manolis] Univ Cologne, Ctr Mol Med CMMC, Inst Genet, D-50674 Cologne, Germany; [Pasparakis, Manolis] Univ Cologne, Cologne Excellence Cluster CECAD, D-50674 Cologne, Germany; [Widschwendter, Martin] UCL, Dept Gynaecol Oncol, London WC1E 6AU, England; [Schett, Georg] Univ Erlangen Nurnberg, Dept Internal Med 3, D-91054 Erlangen, Germany	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Medical University of Vienna; Garvan Institute of Medical Research; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Cologne; University of Cologne; University of London; University College London; University of Erlangen Nuremberg	Penninger, JM (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria.	josef.penninger@imba.oeaw.ac.at	Penninger, Josef M/I-6860-2013; Lee, Heather/M-2670-2019; Lee, Heather/B-5302-2012; Ormandy, Chris/G-4165-2014; Pasparakis, Manolis/N-4350-2019; Pasparakis, Manolis/H-9292-2017; Schramek, Daniel/AAL-1470-2020; Schramek, Daniel/J-5792-2014	Penninger, Josef M/0000-0002-8194-3777; Lee, Heather/0000-0002-6482-0337; Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966; Schramek, Daniel/0000-0001-9977-2104; Widschwendter, Martin/0000-0002-7778-8380; Kenner, Lukas/0000-0003-2184-1338; Ormandy, Christopher/0000-0002-2504-7919; Joshi, Purna/0000-0002-1628-9940	Burroughs Wellcome Fund; National Institutes of Health (NIH) [HD055601]; German Research Council (Deutsche Forschungsgemeinschaft (DFG)) [FOR643, SFB641, SPP1468]; Interdisciplinary Center for Clinical Sciences Erlangen; European Union (EU); National Health and Medical Research Council of Australia; Australian Cancer Research Fund; Cancer Institute New South Wales; EU InflaCare network; University College London (UCL) Hospital/UCL Comprehensive Biomedical Research Centre [152]; Department of Health National Institute for Health Research Biomedical Research Centres; Institute of Molecular Biotechnology; Austrian Ministry of Sciences; Austrian Academy of Sciences; GEN-AU (AustroMouse); European Research Council; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055601] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Council (Deutsche Forschungsgemeinschaft (DFG))(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Sciences Erlangen; European Union (EU)(CGIAREuropean Commission); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Fund; Cancer Institute New South Wales; EU InflaCare network; University College London (UCL) Hospital/UCL Comprehensive Biomedical Research Centre; Department of Health National Institute for Health Research Biomedical Research Centres(National Institute for Health Research (NIHR)); Institute of Molecular Biotechnology; Austrian Ministry of Sciences; Austrian Academy of Sciences; GEN-AU (AustroMouse); European Research Council(European Research Council (ERC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank all members of our laboratories for helpful discussions; G. Forni for providing NeuT transgenic mice. A.O.A. is a recipient of a Career Award for Medical Scientists from the Burroughs Wellcome Fund. L.G. is supported by National Institutes of Health (NIH) grant HD055601. G.S's work is supported by the German Research Council (Deutsche Forschungsgemeinschaft (DFG): FOR643, SFB641 and SPP1468), by the Interdisciplinary Center for Clinical Sciences Erlangen and by the focus programme SPP1468 (Immunobone) of the DFG and the Masterswitch project of the European Union (EU). C.J.O. is supported by the National Health and Medical Research Council of Australia, the Australian Cancer Research Fund and the Cancer Institute New South Wales. D.S. is supported by the EU InflaCare network. M.W. is supported by a grant from the University College London (UCL) Hospital/UCL Comprehensive Biomedical Research Centre project no. 152, and part of this work was undertaken at UCL Hospital/UCL, which received a proportion of its funding from the Department of Health National Institute for Health Research Biomedical Research Centres funding scheme. J.M.P. is supported by grants from Institute of Molecular Biotechnology, the Austrian Ministry of Sciences, the Austrian Academy of Sciences, GEN-AU (AustroMouse), an EU Marie Curie Excellence Grant, and a European Research Council Advanced Grant. Special thanks go to Limin Zhang, who provided a first idea for this manuscript and died much too early of breast cancer.	Aldaz CM, 1996, CARCINOGENESIS, V17, P2069, DOI 10.1093/carcin/17.9.2069; Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Beleut M, 2010, P NATL ACAD SCI USA, V107, P2989, DOI 10.1073/pnas.0915148107; Boggio K, 1998, J EXP MED, V188, P589, DOI 10.1084/jem.188.3.589; Cao YX, 2007, P NATL ACAD SCI USA, V104, P15852, DOI 10.1073/pnas.0706728104; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; ELMAHGOUB S, 1972, ACTA OBSTET GYN SCAN, V51, P251, DOI 10.3109/00016347209156855; Ewan KB, 2002, CANCER RES, V62, P5627; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; Gareus R, 2007, NAT CELL BIOL, V9, P461, DOI 10.1038/ncb1560; Hanada R, 2009, NATURE, V462, P505, DOI 10.1038/nature08596; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hofseth LJ, 1999, J CLIN ENDOCR METAB, V84, P4559, DOI 10.1210/jc.84.12.4559; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Kim NS, 2006, MOL CELL BIOL, V26, P1002, DOI 10.1128/MCB.26.3.1002-1013.2006; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee J, 2006, BLOOD, V107, P2686, DOI 10.1182/blood-2005-07-2798; McTiernan A, 2005, JNCI-J NATL CANCER I, V97, P1366, DOI 10.1093/jnci/dji279; Morony S, 2001, CANCER RES, V61, P4432; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Pike MC, 1997, J NATL CANCER I, V89, P1110, DOI 10.1093/jnci/89.15.1110; Robinson GW, 1997, DEVELOPMENT, V124, P2701; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Srivastava S, 2003, J BIOL CHEM, V278, P46171, DOI 10.1074/jbc.M308545200; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Wright A, 2007, DEV CELL, V13, P705, DOI 10.1016/j.devcel.2007.09.007	41	413	437	0	55	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 4	2010	468	7320					98	+		10.1038/nature09387	http://dx.doi.org/10.1038/nature09387			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674YF	20881962	Green Accepted			2022-12-01	WOS:000283786900043
J	Baker, M				Baker, M.			Genomics The tough new variants	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 28	2010	467	7319					1136	1136		10.1038/4671136a	http://dx.doi.org/10.1038/4671136a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671XW	20981104	Bronze			2022-12-01	WOS:000283548600058
J	Campbell, PJ; Yachida, S; Mudie, LJ; Stephens, PJ; Pleasance, ED; Stebbings, LA; Morsberger, LA; Latimer, C; McLaren, S; Lin, ML; McBride, DJ; Varela, I; Nik-Zainal, SA; Leroy, C; Jia, MM; Menzies, A; Butler, AP; Teague, JW; Griffin, CA; Burton, J; Swerdlow, H; Quail, MA; Stratton, MR; Iacobuzio-Donahue, C; Futreal, PA				Campbell, Peter J.; Yachida, Shinichi; Mudie, Laura J.; Stephens, Philip J.; Pleasance, Erin D.; Stebbings, Lucy A.; Morsberger, Laura A.; Latimer, Calli; McLaren, Stuart; Lin, Meng-Lay; McBride, David J.; Varela, Ignacio; Nik-Zainal, Serena A.; Leroy, Catherine; Jia, Mingming; Menzies, Andrew; Butler, Adam P.; Teague, Jon W.; Griffin, Constance A.; Burton, John; Swerdlow, Harold; Quail, Michael A.; Stratton, Michael R.; Iacobuzio-Donahue, Christine; Futreal, P. Andrew			The patterns and dynamics of genomic instability in metastatic pancreatic cancer	NATURE			English	Article							COPY NUMBER ANALYSIS; HUMAN BREAST-CANCER; GENETIC-HETEROGENEITY; EVOLUTION; TUMORS; REARRANGEMENTS; RESOLUTION; MUTATIONS; LEUKEMIA; CELLS	Pancreatic cancer is an aggressive malignancy with a five-year mortality of 97-98%, usually due to widespread metastatic disease. Previous studies indicate that this disease has a complex genomic landscape, with frequent copy number changes and point mutations(1-5), but genomic rearrangements have not been characterized in detail. Despite the clinical importance of metastasis, there remain fundamental questions about the clonal structures of metastatic tumours(6,7), including phylogenetic relationships among metastases, the scale of ongoing parallel evolution in metastatic and primary sites(7), and how the tumour disseminates. Here we harness advances in DNA sequencing(8-12) to annotate genomic rearrangements in 13 patients with pancreatic cancer and explore clonal relationships among metastases. We find that pancreatic cancer acquires rearrangements indicative of telomere dysfunction and abnormal cell-cycle control, namely dysregulated G1-to-S-phase transition with intact G2-M checkpoint. These initiate amplification of cancer genes and occur predominantly in early cancer development rather than the later stages of the disease. Genomic instability frequently persists after cancer dissemination, resulting in ongoing, parallel and even convergent evolution among different metastases. We find evidence that there is genetic heterogeneity among metastasis-initiating cells, that seeding metastasis may require driver mutations beyond those required for primary tumours, and that phylogenetic trees across metastases show organ-specific branches. These data attest to the richness of genetic variation in cancer, brought about by the tandem forces of genomic instability and evolutionary selection.	[Campbell, Peter J.; Mudie, Laura J.; Stephens, Philip J.; Pleasance, Erin D.; Stebbings, Lucy A.; Latimer, Calli; McLaren, Stuart; Lin, Meng-Lay; McBride, David J.; Varela, Ignacio; Nik-Zainal, Serena A.; Leroy, Catherine; Jia, Mingming; Menzies, Andrew; Butler, Adam P.; Teague, Jon W.; Burton, John; Swerdlow, Harold; Quail, Michael A.; Stratton, Michael R.; Futreal, P. Andrew] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England; [Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge CB2 2XY, England; [Yachida, Shinichi; Morsberger, Laura A.; Griffin, Constance A.; Iacobuzio-Donahue, Christine] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21287 USA; [Yachida, Shinichi; Morsberger, Laura A.; Griffin, Constance A.; Iacobuzio-Donahue, Christine] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21287 USA; [Stratton, Michael R.] Inst Canc Res, Sutton SM2 5NG, Surrey, England	Wellcome Trust Sanger Institute; University of Cambridge; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University of London; Institute of Cancer Research - UK	Futreal, PA (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England.	ciacobu@jhmi.edu; paf@sanger.ac.uk	Varela, Ignacio/G-1699-2016; Varela, Ignacio/AAA-7680-2021; Iacobuzio-Donahue, Christine/ABF-1295-2020; Quail, michael/ABE-6131-2020; Nik-Zainal, Serena/ABD-4437-2020	Varela, Ignacio/0000-0002-0969-506X; Varela, Ignacio/0000-0002-0969-506X; Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Swerdlow, Harold/0000-0002-9510-160X; Nik-Zainal, Serena/0000-0001-5054-1727	Wellcome Trust [077012/Z/05/Z, WT088340MA]; Uehara memorial foundation; Skip Viragh Foundation; Michael Rolphe Foundation; National Institutes of Health [CA106610, CA140599]; The International Human Frontier Science Program Organization; NATIONAL CANCER INSTITUTE [R01CA140599, K08CA106610] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Uehara memorial foundation(Uehara Memorial Foundation); Skip Viragh Foundation; Michael Rolphe Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The International Human Frontier Science Program Organization(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Wellcome Trust (grant reference 077012/Z/05/Z). P.J.C. is funded through a Wellcome Trust Senior Clinical Research Fellowship (grant reference WT088340MA). S.Y. has support from the Uehara memorial foundation. We would also like to acknowledge the financial support of the Skip Viragh Foundation and the Michael Rolphe Foundation for the autopsy programme, and funding from the National Institutes of Health (grants CA106610 and CA140599). I.V. is supported by a fellowship from The International Human Frontier Science Program Organization. We would like to thank U. McDermott for discussions and a critical reading of the manuscript.	Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Bignell GR, 2007, GENOME RES, V17, P1296, DOI 10.1101/gr.6522707; Blow JJ, 2008, NAT REV CANCER, V8, P799, DOI 10.1038/nrc2500; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Embuscado EE, 2005, CANCER BIOL THER, V4, P548, DOI 10.4161/cbt.4.5.1663; Flohr T, 2008, LEUKEMIA, V22, P771, DOI 10.1038/leu.2008.5; Fu BJ, 2008, CANCER BIOL THER, V7, P1593, DOI 10.4161/cbt.7.10.6565; Gisselsson D, 2001, P NATL ACAD SCI USA, V98, P12683, DOI 10.1073/pnas.211357798; Harada T, 2008, ONCOGENE, V27, P1951, DOI 10.1038/sj.onc.1210832; Hashimoto Y, 2008, J GASTROINTEST SURG, V12, P17, DOI 10.1007/s11605-007-0383-9; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kimmelman AC, 2008, P NATL ACAD SCI USA, V105, P19372, DOI 10.1073/pnas.0809966105; Klein CA, 2002, LANCET, V360, P683, DOI 10.1016/S0140-6736(02)09838-0; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Kuukasjarvi T, 1997, CANCER RES, V57, P1597; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; MCLINTOCK B, 1941, GENETICS, V26, P234; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645	30	970	1003	4	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 28	2010	467	7319					1109	1113		10.1038/nature09460	http://dx.doi.org/10.1038/nature09460			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671XW	20981101	Green Accepted			2022-12-01	WOS:000283548600048
J	Nogi, T; Yasui, N; Mihara, E; Matsunaga, Y; Noda, M; Yamashita, N; Toyofuku, T; Uchiyama, S; Goshima, Y; Kumanogoh, A; Takagi, J				Nogi, Terukazu; Yasui, Norihisa; Mihara, Emiko; Matsunaga, Yukiko; Noda, Masanori; Yamashita, Naoya; Toyofuku, Toshihiko; Uchiyama, Susumu; Goshima, Yoshio; Kumanogoh, Atsushi; Takagi, Junichi			Structural basis for semaphorin signalling through the plexin receptor	NATURE			English	Article							CRYSTAL-STRUCTURE; PROTEIN; BINDING; LIGAND; RESOLUTION; COMPLEX; DOMAIN; MET	Semaphorins and their receptor plexins constitute a pleiotropic cell-signalling system that is used in a wide variety of biological processes, and both protein families have been implicated in numerous human diseases(1-4). The binding of soluble or membrane-anchored semaphorins to the membrane-distal region of the plexin ecto-domain activates plexin's intrinsic GTPase-activating protein (GAP) at the cytoplasmic region, ultimately modulating cellular adhesion behaviour(5). However, the structural mechanism underlying the receptor activation remains largely unknown. Here we report the crystal structures of the semaphorin 6A (Sema6A) receptor-binding fragment and the plexin A2 (PlxnA2) ligand-binding fragment in both their pre-signalling (that is, before binding) and signalling (after complex formation) states. Before binding, the Sema6A ectodomain was in the expected 'face-to-face' homodimer arrangement, similar to that adopted by Sema3A and Sema4D, whereas PlxnA2 was in an unexpected 'head-on' homodimer arrangement. In contrast, the structure of the Sema6A-PlxnA2 signalling complex revealed a 2:2 heterotetramer in which the two PlxnA2 monomers dissociated from one another and docked onto the top face of the Sema6A homodimer using the same interface as the head-on homodimer, indicating that plexins undergo 'partner exchange'. Cell-based activity measurements using mutant ligands/receptors confirmed that the Sema6A face-to-face dimer arrangement is physiologically relevant and is maintained throughout signalling events. Thus, homodimer-to-heterodimer transitions of cell-surface plexin that result in a specific orientation of its molecular axis relative to the membrane may constitute the structural mechanism by which the ligand-binding 'signal' is transmitted to the cytoplasmic region, inducing GAP domain rearrangements and activation.	[Nogi, Terukazu; Yasui, Norihisa; Mihara, Emiko; Matsunaga, Yukiko; Takagi, Junichi] Osaka Univ, Inst Prot Res, Lab Prot Synth & Express, Suita, Osaka 5650871, Japan; [Noda, Masanori; Uchiyama, Susumu] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka 5650871, Japan; [Yamashita, Naoya; Goshima, Yoshio] Yokohama City Univ, Grad Sch Med, Dept Mol Pharmacol & Neurobiol, Yokohama, Kanagawa 2360004, Japan; [Toyofuku, Toshihiko; Kumanogoh, Atsushi] Osaka Univ, Microbial Dis Res Inst, Immunol Frontier Res Ctr, Dept Immunopathol, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Yokohama City University; Osaka University	Takagi, J (corresponding author), Osaka Univ, Inst Prot Res, Lab Prot Synth & Express, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	takagi@protein.osaka-u.ac.jp	UCHIYAMA, Susumu/F-9590-2017; Yasui, Norihisa/V-8252-2019; Nogi, Terukazu/GPF-7203-2022	UCHIYAMA, Susumu/0000-0002-5181-179X; Yasui, Norihisa/0000-0001-7117-3070; Nogi, Terukazu/0000-0001-8663-3519; Matsunaga, Yukiko/0000-0002-1392-5681	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We would like to thank Y. Yamada, N. Matsugaki and N. Igarashi of Photon Factory and Y. Kawano and N. Shimizu of SPring-8 BL-41XU for their help with the X-ray data collection; A. Rowe for discussions on the sedimentation equilibrium data analysis; C. Wu for performing the Sema6A-AP binding assay; K. Tamura-Kawakami and M. Nampo for their technical support; and M. Nakano for preparation of the manuscript. This work was supported in part by a 'Target Proteins Research Program (TPRP)' grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Antipenko A, 2003, NEURON, V39, P589, DOI 10.1016/S0896-6273(03)00502-6; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Chaudhry C, 2009, EMBO J, V28, P1518, DOI 10.1038/emboj.2009.86; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goshima Y, 1997, J NEUROBIOL, V33, P316, DOI 10.1002/(SICI)1097-4695(199709)33:3<316::AID-NEU9>3.0.CO;2-4; He HW, 2009, P NATL ACAD SCI USA, V106, P15610, DOI 10.1073/pnas.0906923106; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Le Du MH, 2001, J BIOL CHEM, V276, P9158, DOI 10.1074/jbc.M009250200; Leahy DJ, 2000, PROTEIN EXPRES PURIF, V20, P500, DOI 10.1006/prep.2000.1331; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Liu HL, 2010, CELL, V142, P749, DOI 10.1016/j.cell.2010.07.040; Love CA, 2003, NAT STRUCT BIOL, V10, P843, DOI 10.1038/nsb977; Luo BH, 2006, CURR OPIN CELL BIOL, V18, P579, DOI 10.1016/j.ceb.2006.08.005; Merte J, 2010, J NEUROSCI, V30, P5767, DOI 10.1523/JNEUROSCI.5061-09.2010; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Niemann HH, 2007, CELL, V130, P235, DOI 10.1016/j.cell.2007.05.037; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pasterkamp RJ, 2005, TRENDS CELL BIOL, V15, P61, DOI 10.1016/j.tcb.2004.12.005; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Renaud J, 2008, NAT NEUROSCI, V11, P440, DOI 10.1038/nn2064; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; STANLEY P, 1989, MOL CELL BIOL, V9, P377, DOI 10.1128/MCB.9.2.377; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; Suzuki K, 2008, NAT IMMUNOL, V9, P17, DOI 10.1038/ni1553; Tabata S, 2010, J PROTEOMICS, V73, P1777, DOI 10.1016/j.jprot.2010.05.012; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Tamagnone L, 2004, EMBO REP, V5, P356, DOI 10.1038/sj.embor.7400114; Tong Y, 2007, J BIOL CHEM, V282, P37215, DOI 10.1074/jbc.M703800200; Tong YF, 2009, J BIOL CHEM, V284, P35962, DOI 10.1074/jbc.M109.056275; Toyofuku T, 2008, DEV BIOL, V321, P251, DOI 10.1016/j.ydbio.2008.06.028; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Xu XM, 2000, J NEUROSCI, V20, P2638; Zhou YP, 2008, TRENDS BIOCHEM SCI, V33, P161, DOI 10.1016/j.tibs.2008.01.006	42	117	129	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 28	2010	467	7319					1123	U138		10.1038/nature09473	http://dx.doi.org/10.1038/nature09473			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671XW	20881961				2022-12-01	WOS:000283548600051
J	Doak, DF; Morris, WF				Doak, Daniel F.; Morris, William F.			Demographic compensation and tipping points in climate-induced range shifts	NATURE			English	Article							EXTINCTION; RESPONSES; IMPACTS; PLANTS	To persist, species are expected to shift their geographical ranges polewards or to higher elevations as the Earth's climate warms(1-4). However, although many species' ranges have shifted in historical times, many others have not, or have shifted only at the high-latitude or high-elevation limits, leading to range expansions rather than contractions(5-11). Given these idiosyncratic responses to climate warming, and their varied implications for species' vulnerability to climate change, a critical task is to understand why some species have not shifted their ranges, particularly at the equatorial or low-elevation limits, and whether such resilience will last as warming continues. Here we show that compensatory changes in demographic rates are buffering southern populations of two North American tundra plants against the negative effects of a warming climate, slowing their northward range shifts, but that this buffering is unlikely to continue indefinitely. Southern populations of both species showed lower survival and recruitment but higher growth of individual plants, possibly owing to longer, warmer growing seasons. Because of these and other compensatory changes, the population growth rates of southern populations are not at present lower than those of northern ones. However, continued warming may yet prove detrimental, as most demographic rates that improved in moderately warmer years declined in the warmest years, with the potential to drive future population declines. Our results emphasize the need for long-term, range-wide measurement of all population processes to detect demographic compensation and to identify nonlinear responses that may lead to sudden range shifts as climatic tipping points are exceeded.	[Doak, Daniel F.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Morris, William F.] Duke Univ, Dept Biol, Durham, NC 27708 USA	University of Wyoming; Duke University	Doak, DF (corresponding author), Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.	ddoak@uwyo.edu			NSF [DEB-9806818, DEB-0087096, DEB-0716433]	NSF(National Science Foundation (NSF))	This work was supported by NSF grants DEB-9806818, DEB-0087096 and DEB-0716433. We thank the many field and laboratory assistants who have helped over the years, and J. Estes, N. Haddad, A. Rose and W. Thuiller.	Arft AM, 1999, ECOL MONOGR, V69, P491, DOI 10.1890/0012-9615(1999)069[0491:ROTPTE]2.0.CO;2; Chapin FS, 1996, ECOLOGY, V77, P822, DOI 10.2307/2265504; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; HARTE J, 1995, SCIENCE, V267, P876, DOI 10.1126/science.267.5199.876; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Mysterud A, 2001, NATURE, V410, P1096, DOI 10.1038/35074099; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Purves DW, 2009, P R SOC B, V276, P1477, DOI 10.1098/rspb.2008.1241; Rosenzweig C, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P79; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas CD, 2006, TRENDS ECOL EVOL, V21, P415, DOI 10.1016/j.tree.2006.05.012; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; TULJAPURKAR S, 1990, POPULATION DYNAMICS, P91; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000	23	308	310	2	272	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 21	2010	467	7318					959	962		10.1038/nature09439	http://dx.doi.org/10.1038/nature09439			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20962844				2022-12-01	WOS:000283254700037
J	Frankel, A; Vecchio, P				Frankel, Adam; Vecchio, Phillip			Personal View Commonly used, easily confused: let's eliminate hyper and hypo	BRITISH MEDICAL JOURNAL			English	Editorial Material							DOCTOR-PATIENT COMMUNICATION		[Frankel, Adam; Vecchio, Phillip] Princess Alexandra Hosp, Medicat Safety Team, Woolloongabba, Qld 4102, Australia		Frankel, A (corresponding author), Princess Alexandra Hosp, Medicat Safety Team, Woolloongabba, Qld 4102, Australia.	a.frankel@uq.edu.au; phillip_vecchio@health.qld.gov.au	Frankel, Adam J/A-5001-2013	Frankel, Adam J/0000-0002-5198-7664				Kountz DS, 2009, POSTGRAD MED, V121, P171, DOI 10.3810/pgm.2009.09.2065; ONG LML, 1995, SOC SCI MED, V40, P903, DOI 10.1016/0277-9536(94)00155-M; Reason J., 1990, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Roughead Elizabeth E, 2009, Aust New Zealand Health Policy, V6, P18, DOI 10.1186/1743-8462-6-18; Schroeder R E, 1999, J Health Adm Educ, V17, P175; SIMPSON M, 1991, BRIT MED J, V303, P1385, DOI 10.1136/bmj.303.6814.1385; Valentin A, 2006, INTENS CARE MED, V32, P1591, DOI 10.1007/s00134-006-0290-7	7	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 20	2010	341								c5867	10.1136/bmj.c5867	http://dx.doi.org/10.1136/bmj.c5867			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	671ZL	20961983				2022-12-01	WOS:000283552700002
J	Golomb, BA; Erickson, LC; Koperski, S; Sack, D; Enkin, M; Howick, J				Golomb, Beatrice A.; Erickson, Laura C.; Koperski, Sabrina; Sack, Deanna; Enkin, Murray; Howick, Jeremy			What's in Placebos: Who Knows? Analysis of Randomized, Controlled Trials	ANNALS OF INTERNAL MEDICINE			English	Article							LACTOSE-INTOLERANCE; HEART-DISEASE; OLIVE OIL; COUGH	Background: No regulations govern placebo composition. The composition of placebos can influence trial outcomes and merits reporting. Purpose: To assess how often investigators specify the composition of placebos in randomized, placebo-controlled trials. Data Sources: 4 English-language general and internal medicine journals with high impact factors. Study Selection: 3 reviewers screened titles and abstracts of the journals to identify randomized, placebo-controlled trials published from January 2008 to December 2009. Data Extraction: Reviewers independently abstracted data from the introduction and methods sections of identified articles, recording treatment type (pill, injection, or other) and whether placebo composition was stated. Discrepancies were resolved by consensus. Data Synthesis: Most studies did not disclose the composition of the study placebo. Disclosure was less common for pills than for injections and other treatments (8.2% vs. 26.7%; P = 0.002). Limitation: Journals with high impact factors may not be representative. Conclusion: Placebos were seldom described in randomized, controlled trials of pills or capsules. Because the nature of the placebo can influence trial outcomes, placebo formulation should be disclosed in reports of placebo-controlled trials.	Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; McMaster Univ, Hamilton, ON, Canada; Univ Oxford, Ctr Evidence Based Med, Oxford, England	University of California System; University of California San Diego; McMaster University; University of Oxford	Golomb, BA (corresponding author), Univ Calif San Diego, Sch Med, 9500 Gilman Dr 0995, La Jolla, CA 92093 USA.	bgolomb@ucsd.edu	Koperski, Sabrina/E-8112-2011; Howick, Jeremy/ADP-7644-2022	Howick, Jeremy/0000-0003-0280-7206; Koperski, Sabrina/0000-0003-0001-6478	University of California Foundation [3929]; Medical Research Council/Economic and Social Research Council [G0800055]; MRC [G0800055] Funding Source: UKRI; Medical Research Council [G0800055] Funding Source: researchfish	University of California Foundation; Medical Research Council/Economic and Social Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	By University of California Foundation Fund 3929-Medical Reasoning. The manuscript was revised while Dr. Howick was a recipient of a Medical Research Council/Economic and Social Research Council Interdisciplinary Postdoctoral Fellowship (G0800055).	ACHESON J, 1972, ATHEROSCLEROSIS, V15, P177, DOI 10.1016/0021-9150(72)90067-6; Covas M. -I., 2008, Inflammopharmacology, V16, P216, DOI 10.1007/s10787-008-8019-6; Cullinen Kathleen, 2006, Med Health R I, V89, P113; DEAN AG, 2009, OPENEPI OPEN SOURCE, V2010; Eccles R, 2006, RESP PHYSIOL NEUROBI, V152, P340, DOI 10.1016/j.resp.2005.10.004; Fito M, 2005, ATHEROSCLEROSIS, V181, P149, DOI 10.1016/j.atherosclerosis.2004.12.036; Golomb B, 2002, JAMA-J AM MED ASSOC, V287, P2502; GOLOMB BA, 1995, NATURE, V375, P530, DOI 10.1038/375530a0; Golomb BA, 2009, AM J BIOETHICS, V9, P34, DOI 10.1080/15265160903244242; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Kaptchuk TJ, 2006, BMJ-BRIT MED J, V332, P391, DOI 10.1136/bmj.38726.603310.55; LOPRINZI CL, 1990, JNCI-J NATL CANCER I, V82, P1127, DOI 10.1093/jnci/82.13.1127; MCCANN IL, 1984, J PERS SOC PSYCHOL, V46, P1142, DOI 10.1037/0022-3514.46.5.1142; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Osterlund P, 2004, CLIN GASTROENTEROL H, V2, P696, DOI 10.1016/S1542-3565(04)00293-9; Paul IM, 2007, ARCH PEDIAT ADOL MED, V161, P1140, DOI 10.1001/archpedi.161.12.1140; Research Committee of the Scottish Society of Physicians, 1971, BMJ-BRIT MED J, V4, P775; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Streitberger K, 1998, LANCET, V352, P364, DOI 10.1016/S0140-6736(97)10471-8; Wedlake L, 2008, EUR J CANCER, V44, P2212, DOI 10.1016/j.ejca.2008.07.018	21	43	44	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 19	2010	153	8					532	535		10.7326/0003-4819-153-8-201010190-00010	http://dx.doi.org/10.7326/0003-4819-153-8-201010190-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	665SA	20956710				2022-12-01	WOS:000283054600006
J	Vila-Perello, M; Muir, TW				Vila-Perello, Miquel; Muir, Tom W.			Biological Applications of Protein Splicing	CELL			English	Article							SITE-SPECIFIC INCORPORATION; SIGNALING PROTEIN; CYCLIC-PEPTIDES; REAL-TIME; SEMISYNTHESIS; LIGATION; RECOGNITION; SELECTIVITY; CHEMISTRY; REVEALS	Protein splicing is a naturally occurring process in which a protein editor, called an intein, performs a molecular disappearing act by cutting itself out of a host protein in a traceless manner. In the two decades since its discovery, protein splicing has been harnessed for the development of several protein-engineering methods. Collectively, these technologies help bridge the fields of chemistry and biology, allowing hitherto impossible manipulations of protein covalent structure. These tools and their application are the subject of this Primer.	[Vila-Perello, Miquel; Muir, Tom W.] Rockefeller Univ, Lab Synthet Prot Chem, New York, NY 10021 USA	Rockefeller University	Muir, TW (corresponding author), Rockefeller Univ, Lab Synthet Prot Chem, 1230 York Ave, New York, NY 10021 USA.	muirt@rockefeller.edu	Muir, Tom/AHD-0860-2022	Muir, Tom/0000-0001-9635-0344	NATIONAL CANCER INSTITUTE [RC2CA148354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055843, R01GM086868] Funding Source: NIH RePORTER; NCI NIH HHS [RC2 CA148354] Funding Source: Medline; NIGMS NIH HHS [R01 GM086868, R01 GM055843] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnold U, 2002, J AM CHEM SOC, V124, P8522, DOI 10.1021/ja026114n; Bertozzi CR, 2001, SCIENCE, V291, P2357, DOI 10.1126/science.1059820; Brunsveld L, 2006, ANGEW CHEM INT EDIT, V45, P6622, DOI 10.1002/anie.200600855; Buskas T, 2006, GLYCOBIOLOGY, V16, p113R, DOI 10.1093/glycob/cwj125; Ceccarini G, 2009, CELL METAB, V10, P148, DOI 10.1016/j.cmet.2009.07.001; Chacko BM, 2004, MOL CELL, V15, P813, DOI 10.1016/j.molcel.2004.07.016; Chatterjee C, 2010, J BIOL CHEM, V285, P11045, DOI 10.1074/jbc.R109.080291; Chatterjee C, 2010, NAT CHEM BIOL, V6, P267, DOI [10.1038/NCHEMBIO.315, 10.1038/nchembio.315]; Chen JJ, 2010, NAT CHEM BIOL, V6, P270, DOI [10.1038/NCHEMBIO.316, 10.1038/nchembio.316]; Cheriyan M, 2009, ADV DRUG DELIVER REV, V61, P899, DOI 10.1016/j.addr.2009.04.021; Erlanson DA, 1996, CHEM BIOL, V3, P981, DOI 10.1016/S1074-5521(96)90165-9; Evans TC, 1998, PROTEIN SCI, V7, P2256, DOI 10.1002/pro.5560071103; Frutos S, 2010, NAT CHEM BIOL, V6, P527, DOI [10.1038/NCHEMBIO.371, 10.1038/nchembio.371]; Giriat I, 2003, J AM CHEM SOC, V125, P7180, DOI 10.1021/ja034736i; Hackenberger CPR, 2008, ANGEW CHEM INT EDIT, V47, P10030, DOI 10.1002/anie.200801313; Hahn ME, 2004, ANGEW CHEM INT EDIT, V43, P5800, DOI 10.1002/anie.200461141; Hahn ME, 2007, CHEMBIOCHEM, V8, P2100, DOI 10.1002/cbic.200700404; Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1; Hofmann RM, 2001, BIOORG MED CHEM LETT, V11, P3091, DOI 10.1016/S0960-894X(01)00650-3; Kanno A, 2007, ANGEW CHEM INT EDIT, V46, P7595, DOI 10.1002/anie.200700538; Kent SBH, 2009, CHEM SOC REV, V38, P338, DOI 10.1039/b700141j; Kritzer JA, 2009, NAT CHEM BIOL, V5, P655, DOI 10.1038/nchembio.193; Kumar KSA, 2009, ANGEW CHEM INT EDIT, V48, P8090, DOI 10.1002/anie.200902936; Lepenies B, 2010, CURR OPIN CHEM BIOL, V14, P404, DOI 10.1016/j.cbpa.2010.02.016; Li J, 2008, HUM GENE THER, V19, P958, DOI 10.1089/hum.2008.009; Li X, 2009, ANGEW CHEM INT EDIT, V48, P9184, DOI 10.1002/anie.200904472; Lin MZ, 2008, PHYSIOLOGY, V23, P131, DOI 10.1152/physiol.00007.2008; Lockless SW, 2009, P NATL ACAD SCI USA, V106, P10999, DOI 10.1073/pnas.0902964106; Lu W, 2001, MOL CELL, V8, P759, DOI 10.1016/S1097-2765(01)00369-0; Lu XQ, 2010, J AM CHEM SOC, V132, P1748, DOI 10.1021/ja9088549; Maag D, 2005, MOL CELL, V17, P265, DOI 10.1016/j.molcel.2004.11.051; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; Mootz HD, 2009, CHEMBIOCHEM, V10, P2579, DOI 10.1002/cbic.200900370; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Muralidharan V, 2006, NAT METHODS, V3, P429, DOI 10.1038/NMETH886; Noren CJ, 2000, ANGEW CHEM INT EDIT, V39, P450; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Ozawa T, 2003, NAT BIOTECHNOL, V21, P287, DOI 10.1038/nbt791; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Pickin KA, 2008, J AM CHEM SOC, V130, P5667, DOI 10.1021/ja711244h; Piontek C, 2009, ANGEW CHEM INT EDIT, V48, P1941, DOI 10.1002/anie.200804735; Schwarzer D, 2005, CURR OPIN CHEM BIOL, V9, P561, DOI 10.1016/j.cbpa.2005.09.018; Scott CP, 1999, P NATL ACAD SCI USA, V96, P13638, DOI 10.1073/pnas.96.24.13638; Valiyaveetil FI, 2006, SCIENCE, V314, P1004, DOI 10.1126/science.1133415; Valiyaveetil FI, 2006, J AM CHEM SOC, V128, P11591, DOI 10.1021/ja0631955; Vila-Perello M, 2007, J AM CHEM SOC, V129, P8068, DOI 10.1021/ja072013j; Vitali F, 2006, EMBO J, V25, P150, DOI 10.1038/sj.emboj.7600911; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Wang L, 2006, ANNU REV BIOPH BIOM, V35, P225, DOI 10.1146/annurev.biophys.35.101105.121507; Wu JW, 2001, MOL CELL, V8, P1277, DOI 10.1016/S1097-2765(01)00421-X; Wu YW, 2010, NAT CHEM BIOL, V6, P534, DOI [10.1038/NCHEMBIO.386, 10.1038/nchembio.386]; Xie N, 2009, BIOCONJUGATE CHEM, V20, P360, DOI 10.1021/bc800467a; Yuen CM, 2006, J AM CHEM SOC, V128, P8939, DOI 10.1021/ja062980e; Zeidler MP, 2004, NAT BIOTECHNOL, V22, P871, DOI 10.1038/nbt979; Zuger S, 2005, NAT BIOTECHNOL, V23, P736, DOI 10.1038/nbt1097	56	126	141	0	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					191	200		10.1016/j.cell.2010.09.031	http://dx.doi.org/10.1016/j.cell.2010.09.031			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946979	Green Accepted, Bronze			2022-12-01	WOS:000283052200009
J	Jensen, RB; Carreira, A; Kowalczykowski, SC				Jensen, Ryan B.; Carreira, Aura; Kowalczykowski, Stephen C.			Purified human BRCA2 stimulates RAD51-mediated recombination	NATURE			English	Article							REPLICATION PROTEIN-A; DNA STRAND EXCHANGE; HUMAN RAD51 PROTEIN; SUSCEPTIBILITY GENE BRCA2; HOMOLOGY-DIRECTED REPAIR; RADIATION HYPERSENSITIVITY; NUCLEOPROTEIN FILAMENTS; BINDING SELECTIVITY; COMPLEX-FORMATION; RECA PROTEIN	Mutation of the breast cancer susceptibility gene, BRCA2, leads to breast and ovarian cancers. Mechanistic insight into the functions of human BRCA2 has been limited by the difficulty of isolating this large protein (3,418 amino acids). Here we report the purification of full-length BRCA2 and show that it both binds RAD51 and potentiates recombinational DNA repair by promoting assembly of RAD51 onto single-stranded DNA (ssDNA). BRCA2 acts by targeting RAD51 to ssDNA over double-stranded DNA, enabling RAD51 to displace replication protein-A (RPA) from ssDNA and stabilizing RAD51-ssDNA filaments by blocking ATP hydrolysis. BRCA2 does not anneal ssDNA complexed with RPA, implying it does not directly function in repair processes that involve ssDNA annealing. Our findings show that BRCA2 is a key mediator of homologous recombination, and they provide a molecular basis for understanding how this DNA repair process is disrupted by BRCA2 mutations, which lead to chromosomal instability and cancer.	[Jensen, Ryan B.; Carreira, Aura; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Jensen, Ryan B.; Carreira, Aura; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA.	sckowalczykowski@ucdavis.edu		Carreira, Aura/0000-0001-5489-4343	NIH [NIH GM 62653]; DOD [BC085223]; American Cancer Society [PF-05-225-01-GMC]; Ministerio de Educacion y Ciencia (Spain); American Cancer Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062653, R37GM062653] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); American Cancer Society(American Cancer Society); Ministerio de Educacion y Ciencia (Spain)(Spanish Government); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Shin for BRCA2 cDNA clones; M. Zdzienicka for VC8 cells; A. Mazin for RAD52; A. Nimonkar for DMC1; W. Heyer and Kowalczykowski laboratory for comments. Supported by grants from NIH (NIH GM 62653) and DOD-Breast Cancer Research Program (BC085223) to S.C.K., American Cancer Society Postdoctoral Fellowship to R.B.J. (PF-05-225-01-GMC), and Postdoctoral Fellowship from Ministerio de Educacion y Ciencia (Spain) to A.C.; R.B.J. acknowledges financial support from C. Hornung, who funded this work through the American Cancer Society and who passed away last year.	Baumann P, 1999, J MOL BIOL, V291, P363, DOI 10.1006/jmbi.1999.2954; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; Bianco P. R., 1998, FRONT BIOSCI, V3, pD570; Bignell G, 1997, HUM MOL GENET, V6, P53, DOI 10.1093/hmg/6.1.53; Carreira A, 2009, CELL CYCLE, V8, P3445, DOI 10.4161/cc.8.21.9748; Carreira A, 2009, CELL, V136, P1032, DOI 10.1016/j.cell.2009.02.019; Chen CF, 1999, J BIOL CHEM, V274, P32931, DOI 10.1074/jbc.274.46.32931; Chen PL, 1998, P NATL ACAD SCI USA, V95, P5287, DOI 10.1073/pnas.95.9.5287; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; Esashi F, 2007, NAT STRUCT MOL BIOL, V14, P468, DOI 10.1038/nsmb1245; Godthelp BC, 2002, ONCOGENE, V21, P5002, DOI 10.1038/sj.onc.1205656; Hartley CL, 2008, MOL MICROBIOL, V68, P1237, DOI 10.1111/j.1365-2958.2008.06230.x; Hilario J, 2009, P NATL ACAD SCI USA, V106, P361, DOI 10.1073/pnas.0811965106; Kantake N, 2002, P NATL ACAD SCI USA, V99, P15327, DOI 10.1073/pnas.252633399; LEBOWITZ JH, 1985, THESIS J HOPKINS U; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lio YC, 2003, J BIOL CHEM, V278, P2469, DOI 10.1074/jbc.M211038200; LIU J, NATURE STRU IN PRESS; Lomonosov M, 2003, GENE DEV, V17, P3017, DOI 10.1101/gad.279003; Marmorstein LY, 1998, P NATL ACAD SCI USA, V95, P13869, DOI 10.1073/pnas.95.23.13869; Mazloum N, 2007, BIOCHEMISTRY-US, V46, P7163, DOI 10.1021/bi700399m; McIlwraith MJ, 2000, J MOL BIOL, V304, P151, DOI 10.1006/jmbi.2000.4180; Mine J, 2007, NUCLEIC ACIDS RES, V35, P7171, DOI 10.1093/nar/gkm752; Mirshad JK, 2003, BIOCHEMISTRY-US, V42, P5945, DOI 10.1021/bi027233i; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Petalcorin MIR, 2006, J MOL BIOL, V361, P231, DOI 10.1016/j.jmb.2006.06.020; Phelan CM, 1996, NAT GENET, V13, P120, DOI 10.1038/ng0596-120; Saeki H, 2006, P NATL ACAD SCI USA, V103, P8768, DOI 10.1073/pnas.0600298103; San Filippo J, 2006, J BIOL CHEM, V281, P11649, DOI 10.1074/jbc.M601249200; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; SHINOHARA A, 1993, NAT GENET, V4, P239, DOI 10.1038/ng0793-239; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Sigurdsson S, 2001, J BIOL CHEM, V276, P8798, DOI 10.1074/jbc.M010011200; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Thorslund T, 2007, EMBO J, V26, P2915, DOI 10.1038/sj.emboj.7601739; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; van der Heijden T, 2007, NUCLEIC ACIDS RES, V35, P5646, DOI 10.1093/nar/gkm629; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; Wong JMS, 2003, ONCOGENE, V22, P28, DOI 10.1038/sj.onc.1206071; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; YOSHIMURA Y, 1993, NUCLEIC ACIDS RES, V21, P1665, DOI 10.1093/nar/21.7.1665; Yu VPCC, 2000, GENE DEV, V14, P1400; Yuan SSF, 1999, CANCER RES, V59, P3547; Zaitseva EM, 1999, J BIOL CHEM, V274, P2907, DOI 10.1074/jbc.274.5.2907	53	444	455	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 7	2010	467	7316					678	U62		10.1038/nature09399	http://dx.doi.org/10.1038/nature09399			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659NE	20729832	Green Accepted, Green Submitted			2022-12-01	WOS:000282572500031
J	Choate, KA; Lu, Y; Zhou, J; Choi, M; Elias, PM; Farhi, A; Nelson-Williams, C; Crumrine, D; Williams, ML; Nopper, AJ; Bree, A; Milstone, LM; Lifton, RP				Choate, Keith A.; Lu, Yin; Zhou, Jing; Choi, Murim; Elias, Peter M.; Farhi, Anita; Nelson-Williams, Carol; Crumrine, Debra; Williams, Mary L.; Nopper, Amy J.; Bree, Alanna; Milstone, Leonard M.; Lifton, Richard P.			Mitotic Recombination in Patients with Ichthyosis Causes Reversion of Dominant Mutations in KRT10	SCIENCE			English	Article							EPIDERMOLYSIS-BULLOSA SIMPLEX; REVERTANT MOSAICISM; STEM-CELLS; INTERMEDIATE FILAMENTS; HUMAN EPIDERMIS; KERATIN-10; RNA; RETINOBLASTOMA; ERYTHRODERMA; MECHANISM	Somatic loss of wild-type alleles can produce disease traits such as neoplasia. Conversely, somatic loss of disease-causing mutations can revert phenotypes; however, these events are infrequently observed. Here we show that ichthyosis with confetti, a severe, sporadic skin disease in humans, is associated with thousands of revertant clones of normal skin that arise from loss of heterozygosity on chromosome 17q via mitotic recombination. This allowed us to map and identify disease-causing mutations in the gene encoding keratin 10 (KRT10); all result in frameshifts into the same alternative reading frame, producing an arginine-rich C-terminal peptide that redirects keratin 10 from the cytokeratin filament network to the nucleolus. The high frequency of somatic reversion in ichthyosis with confetti suggests that revertant stem cell clones are under strong positive selection and/or that the rate of mitotic recombination is elevated in individuals with this disorder.	[Choate, Keith A.; Lu, Yin; Choi, Murim; Farhi, Anita; Nelson-Williams, Carol; Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06510 USA; [Choate, Keith A.; Zhou, Jing; Milstone, Leonard M.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Elias, Peter M.; Crumrine, Debra; Williams, Mary L.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94122 USA; [Nopper, Amy J.] Childrens Mercy Hosp & Clin, Kansas City, MO 64108 USA; [Bree, Alanna] Texas Childrens Hosp, Houston, TX 77030 USA	Howard Hughes Medical Institute; Yale University; Yale University; University of California System; University of California San Francisco; Children's Mercy Hospital; Baylor College of Medicine	Lifton, RP (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06510 USA.	richard.lifton@yale.edu	Choi, Murim/AAP-9120-2021		NIAMS; Foundation for Ichthyosis and Related Skin Types; National Center for Research Resources; Yale Clinical and Translational Science Award; Yale Center for Human Genetics and Genomics; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR056305, T32AR007016] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Foundation for Ichthyosis and Related Skin Types; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Yale Clinical and Translational Science Award; Yale Center for Human Genetics and Genomics; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the patients studied and their families for their invaluable contributions to this study. We thank L. Boyden and S. Baserga for helpful discussions; N. DeSilva, S. Mane, and the Yale Center for Genome Analysis for assistance in development of critical methodologies; and M. Ceneri for the identification of a previously unreported IWC kindred. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, and the Yale Skin Diseases Research Center provided cell culture support for this work. K. A. C. is supported by a K08 award from NIAMS and a fellowship from the Foundation for Ichthyosis and Related Skin Types. Supported in part by a National Center for Research Resources High-End Instrumentation Grant, the Yale Clinical and Translational Science Award, and the Yale Center for Human Genetics and Genomics. R. P. L. is an investigator of the Howard Hughes Medical Institute.	Almaani N, 2010, J INVEST DERMATOL, V130, P1937, DOI 10.1038/jid.2010.64; BRUSASCO A, 1994, DERMATOLOGY, V188, P40, DOI 10.1159/000247084; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; CAMENZIND M, 1984, ANN DERMATOL VENER, V111, P675; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; Chen JL, 2006, J CELL SCI, V119, P5067, DOI 10.1242/jcs.03298; Darling TN, 1999, J CLIN INVEST, V103, P1371, DOI 10.1172/JCI4338; Davis BR, 2009, IMMUNOL RES, V44, P127, DOI 10.1007/s12026-008-8091-4; Draper DE, 1999, J MOL BIOL, V293, P255, DOI 10.1006/jmbi.1999.2991; ELLIS NA, 1995, AM J HUM GENET, V57, P1019; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Ghazizadeh S, 2005, J INVEST DERMATOL, V124, P367, DOI 10.1111/j.0022-202X.2004.23599.x; Hirschhorn R, 2003, J MED GENET, V40, P721, DOI 10.1136/jmg.40.10.721; Jensen UB, 1999, DEVELOPMENT, V126, P2409; Jonkman MF, 1997, CELL, V88, P543, DOI 10.1016/S0092-8674(00)81894-2; Kalb R, 2006, GENOME DYN, V1, P218, DOI 10.1159/000092510; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kocer SS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-359; MARGHESCU S, 1984, HAUTARZT, V35, P522; O'Keefe C, 2010, BLOOD, V115, P2731, DOI 10.1182/blood-2009-10-201848; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Pasmooij AMG, 2005, AM J HUM GENET, V77, P727, DOI 10.1086/497344; Pasmooij AMG, 2007, J CLIN INVEST, V117, P1240, DOI 10.1172/JCI30465; ROTHNAGEL JA, 1992, SCIENCE, V257, P1128, DOI 10.1126/science.257.5073.1128; Schuilenga-Hut PHL, 2002, J INVEST DERMATOL, V118, P626, DOI 10.1046/j.1523-1747.2002.01715.x; Shen J, 2006, GENE THER, V13, P225, DOI 10.1038/sj.gt.3302641; Smith FJD, 2004, J INVEST DERMATOL, V122, P73, DOI 10.1046/j.0022-202X.2003.22129.x; STEINERT PM, 1991, J STRUCT BIOL, V107, P175, DOI 10.1016/1047-8477(91)90020-W; STEINERT PM, 1990, J BIOL CHEM, V265, P8766; Sugaya M, 2008, J PEPT SCI, V14, P924, DOI 10.1002/psc.1027; Wang G, 1996, SCIENCE, V271, P802, DOI 10.1126/science.271.5250.802; ZHOU XM, 1988, J BIOL CHEM, V263, P15584	32	126	129	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 1	2010	330	6000					94	97		10.1126/science.1192280	http://dx.doi.org/10.1126/science.1192280			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20798280	Green Accepted			2022-12-01	WOS:000282334500043
J	Broberg, CA; Zhang, LL; Gonzalez, H; Laskowski-Arce, MA; Orth, K				Broberg, Christopher A.; Zhang, Lingling; Gonzalez, Herman; Laskowski-Arce, Michelle A.; Orth, Kim			A Vibrio Effector Protein Is an Inositol Phosphatase and Disrupts Host Cell Membrane Integrity	SCIENCE			English	Article							PARAHAEMOLYTICUS; AUTOPHAGY; BINDING; DOMAINS; GENOME	The marine bacterium Vibrio parahaemolyticus causes gastroenteritis in humans and encodes the type III effector protein VPA0450, which contributes to host cell death caused by autophagy, cell rounding, and cell lysis. We found that VPA0450 is an inositol polyphosphate 5-phosphatase that hydrolyzed the D5 phosphate from the plasma membrane phospholipid phosphatidylinositol 4,5-bisphosphate. VPA0450 disrupted cytoskeletal binding sites on the inner surface of membranes of human cells and caused plasma membrane blebbing, which compromised membrane integrity and probably contributed to cell death by facilitating lysis. Thus, bacterial pathogens can disrupt adaptor protein-binding sites required for proper membrane and cytoskeleton dynamics by altering the homeostasis of membrane-bound inositol-signaling molecules.	[Broberg, Christopher A.; Zhang, Lingling; Gonzalez, Herman; Laskowski-Arce, Michelle A.; Orth, Kim] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Orth, K (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	kim.orth@utsouthwestern.edu	Zhang, Lingling/A-1100-2015; Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620; Broberg, Christopher/0000-0002-9497-5866	NIH [R01-AI056404, R01-AI087808]; Welch Foundation [I-1561]; National Institute of General Medical Sciences [5T32GM008203]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087808, R01AI056404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008203] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Alto, H. Yin, J. Hurley, F. Robinson, J. Albanesi, B. Barylko, K. Luby-Phelps, Chris Smith, T. Iida, T. Honda, L. McCarter, and the Orth lab for insightful discussions, critical reading, and generous supply of reagents. K.O., L.Z., H. G., M. L.-A., and C. A. B. are supported by grants from NIH-Allergy and Infectious Disease (R01-AI056404 and R01-AI087808) and the Welch Foundation (I-1561). C. A. B is supported by National Institute of General Medical Sciences training grant 5T32GM008203 in cellular and molecular biology. K.O. is a Burroughs Wellcome Investigator in Pathogenesis of Infectious Disease and a W. W. Caruth Jr. Biomedical Scholar.	Broberg CA, 2010, CURR OPIN MICROBIOL, V13, P34, DOI 10.1016/j.mib.2009.12.004; Burdette DL, 2008, P NATL ACAD SCI USA, V105, P12497, DOI 10.1073/pnas.0802773105; Burdette DL, 2009, MOL MICROBIOL, V73, P639, DOI 10.1111/j.1365-2958.2009.06798.x; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Hurley JH, 2000, ANNU REV BIOPH BIOM, V29, P49, DOI 10.1146/annurev.biophys.29.1.49; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Mallo GV, 2008, J CELL BIOL, V182, P741, DOI 10.1083/jcb.200804131; Ono T, 2006, INFECT IMMUN, V74, P1032, DOI 10.1128/IAI.74.2.1032-1042.2006; Park KS, 2004, INFECT IMMUN, V72, P6659, DOI 10.1128/IAI.72.11.6659-6665.2004; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Reith ME, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-427; Taylor Gregory S, 2004, Methods Mol Biol, V284, P217; Tsujishita Y, 2001, CELL, V105, P379, DOI 10.1016/S0092-8674(01)00326-9; Whisstock JC, 2002, IUBMB LIFE, V53, P15, DOI 10.1080/15216540210814; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382	20	78	86	3	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1660	1662		10.1126/science.1192850	http://dx.doi.org/10.1126/science.1192850			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20724587				2022-12-01	WOS:000282098100046
J	Yamada, K; Hirotsu, T; Matsuki, M; Butcher, RA; Tomioka, M; Ishihara, T; Clardy, J; Kunitomo, H; Iino, Y				Yamada, Koji; Hirotsu, Takaaki; Matsuki, Masahiro; Butcher, Rebecca A.; Tomioka, Masahiro; Ishihara, Takeshi; Clardy, Jon; Kunitomo, Hirofumi; Iino, Yuichi			Olfactory Plasticity Is Regulated by Pheromonal Signaling in Caenorhabditis elegans	SCIENCE			English	Article							DAUER PHEROMONE; C-ELEGANS; ADAPTATION; NEURONS; MEDIATE; EVOLUTION; ACTS	Population density-dependent dispersal is a well-characterized strategy of animal behavior in which dispersal rate increases when population density is higher. Caenorhabditis elegans shows positive chemotaxis to a set of odorants, but the chemotaxis switches from attraction to dispersal after prolonged exposure to the odorants. We show here that this plasticity of olfactory behavior is dependent on population density and that this regulation is mediated by pheromonal signaling. We show that a peptide, suppressor of NEP-2 (SNET-1), negatively regulates olfactory plasticity and that its expression is down-regulated by the pheromone. NEP-2, a homolog of the extracellular peptidase neprilysin, antagonizes SNET-1, and this function is essential for olfactory plasticity. These results suggest that population density information is transmitted through the external pheromone and endogenous peptide signaling to modulate chemotactic behavior.	[Yamada, Koji; Hirotsu, Takaaki; Matsuki, Masahiro; Tomioka, Masahiro; Kunitomo, Hirofumi; Iino, Yuichi] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan; [Hirotsu, Takaaki; Ishihara, Takeshi] Kyushu Univ, Grad Sch Sci, Dept Biol, Fukuoka 8128581, Japan; [Butcher, Rebecca A.; Clardy, Jon] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	University of Tokyo; Kyushu University; Harvard University; Harvard Medical School	Iino, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan.	iino@biochem.s.u-tokyo.ac.jp	TOMIOKA, MASAHIRO/G-4890-2014; KUNITOMO, HIROFUMI/G-4963-2014; IINO, YUICHI/G-4962-2014; Hirotsu, Takaaki/G-9358-2013	TOMIOKA, MASAHIRO/0000-0002-7537-714X; KUNITOMO, HIROFUMI/0000-0001-7312-7051; Hirotsu, Takaaki/0000-0003-3936-8382	NIH [CA24487, GM087533]; NATIONAL CANCER INSTITUTE [R01CA024487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM087533, R00GM087533] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge J. Ragains for synthesis of the dauer pheromone ascarosides. Y.I. and T. I. were supported by a Grant-in-aid for Scientific Research, J. C. by NIH grant CA24487, and R. A. B. by an NIH K99 Pathway to Independence Award (GM087533). We thank S. Mitani and P. Sengupta for srbc-64 and srbc-66 strains.	BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Butcher RA, 2008, P NATL ACAD SCI USA, V105, P14288, DOI 10.1073/pnas.0806676105; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Butcher RA, 2009, P NATL ACAD SCI USA, V106, P1875, DOI 10.1073/pnas.0810338106; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; DEVAULT A, 1988, FEBS LETT, V231, P54, DOI 10.1016/0014-5793(88)80701-4; Hirotsu T, 2005, GENES CELLS, V10, P517, DOI 10.1111/j.1365-2443.2005.00856.x; Hu Patrick J, 2007, WormBook, P1; Iwata N, 2005, PHARMACOL THERAPEUT, V108, P129, DOI 10.1016/j.pharmthera.2005.03.010; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Kim K, 2009, SCIENCE, V326, P994, DOI 10.1126/science.1176331; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Nuttley WM, 2002, P NATL ACAD SCI USA, V99, P12449, DOI 10.1073/pnas.192101699; Peckol EL, 2001, P NATL ACAD SCI USA, V98, P11032, DOI 10.1073/pnas.191352498; Poethke HJ, 2002, P ROY SOC B-BIOL SCI, V269, P637, DOI 10.1098/rspb.2001.1936; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; TAUSSIG R, 1984, P NATL ACAD SCI-BIOL, V81, P4988, DOI 10.1073/pnas.81.15.4988; Travis JMJ, 1999, P ROY SOC B-BIOL SCI, V266, P1837, DOI 10.1098/rspb.1999.0854; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Yamada K, 2009, GENETICS, V181, P1347, DOI 10.1534/genetics.108.099002; Zahn TR, 2004, TRAFFIC, V5, P544, DOI 10.1111/j.1600-0854.2004.00195.x	23	64	69	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2010	329	5999					1647	1650		10.1126/science.1192020	http://dx.doi.org/10.1126/science.1192020			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20929849	Green Accepted			2022-12-01	WOS:000282098100042
J	Lopez-Mosqueda, J; Maas, NL; Jonsson, ZO; DeFazio-Eli, LG; Wohlschlegel, J; Toczyski, DP				Lopez-Mosqueda, Jaime; Maas, Nancy L.; Jonsson, Zophonias O.; DeFazio-Eli, Lisa G.; Wohlschlegel, James; Toczyski, David P.			Damage-induced phosphorylation of Sld3 is important to block late origin firing	NATURE			English	Article							PROTEIN IDENTIFICATION TECHNOLOGY; S-PHASE CHECKPOINT; DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; SHOTGUN PROTEOMICS; BUDDING YEAST; MEC1 KINASE; COMPLEX; INITIATION; CDC7-DBF4	Origins of replication are activated throughout the S phase of the cell cycle such that some origins fire early and others fire late to ensure that each chromosome is completely replicated in a timely fashion. However, in response to DNA damage or replication fork stalling, eukaryotic cells block activation of unfired origins. Human cells derived from patients with ataxia telangiectasia are deficient in this process due to the lack of a functional ataxia telangiectasia mutated (ATM) kinase and elicit radioresistant DNA synthesis(1-3) after gamma-irradiation(2). This effect is conserved in budding yeast, as yeast cells lacking the related kinase Mec1 (ATM and Rad3-related (ATR in humans)) also fail to inhibit DNA synthesis in the presence of DNA damage(4). This intra-S-phase checkpoint actively regulates DNA synthesis by inhibiting the firing of late replicating origins, and this inhibition requires both Mec1 and the downstream checkpoint kinase Rad53 (Chk2 in humans)(5,6). However, the Rad53 substrate(s) whose phosphorylation is required to mediate this function has remained unknown. Here we show that the replication initiation protein Sld3 is phosphorylated by Rad53, and that this phosphorylation, along with phosphorylation of the Cdc7 kinase regulatory subunit Dbf4, blocks late origin firing in Saccharomyces cerevisiae. Upon exposure to DNA-damaging agents, cells expressing non-phosphorylatable alleles of SLD3 and DBF4 (SLD3-m25 and dbf4-m25, respectively) proceed through the S phase faster than wild-type cells by inappropriately firing late origins of replication. SLD3-m25 dbf4-m25 cells grow poorly in the presence of the replication inhibitor hydroxyurea and accumulate multiple Rad52 foci. Moreover, SLD3-m25 dbf4-m25 cells are delayed in recovering from transient blocks to replication and subsequently arrest at the DNA damage checkpoint. These data indicate that the intra-S-phase checkpoint functions to block late origin firing in adverse conditions to prevent genomic instability and maximize cell survival.	[Lopez-Mosqueda, Jaime; Maas, Nancy L.; DeFazio-Eli, Lisa G.; Toczyski, David P.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Jonsson, Zophonias O.; Wohlschlegel, James] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA	University of California System; University of California San Francisco; University of California System; University of California Los Angeles	Toczyski, DP (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	toczyski@cc.ucsf.edu	Jónsson, Zophonías Oddur/AAO-1354-2020; Jónsson, Zophonías/E-1960-2015	Jónsson, Zophonías Oddur/0000-0001-5798-9647; Eli, Lisa/0000-0003-3896-0966	Ford Foundation; National Institutes of Health [GM059691]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089778, R01GM059691] Funding Source: NIH RePORTER	Ford Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank members of the Toczyski, Morgan, Li and O'Farrell laboratories for discussions. We also thank D. Morgan, G. Narlikar and J. Li for intellectual contributions, J. Benanti and M. Downey for critical reading of this manuscript, and S. Makovets and M. Hoang for assistance with two-dimensional DNA gels. We thank H. Araki for strains, R. Sclafani for plasmids and J. Diffley for communicating results before publication. We are especially grateful to N. Lopez for help with GFP foci and colony quantification. Funding was provided by a Ford Foundation Pre-Doctoral Diversity Fellowship and a National Institutes of Health grant GM059691.	Alabert C, 2009, EMBO J, V28, P1131, DOI 10.1038/emboj.2009.75; Barlow JH, 2009, EMBO J, V28, P1121, DOI 10.1038/emboj.2009.43; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Dohrmann PR, 1999, GENETICS, V151, P965; Donaldson AD, 1998, GENE DEV, V12, P491, DOI 10.1101/gad.12.4.491; Duncker BP, 2002, P NATL ACAD SCI USA, V99, P16087, DOI 10.1073/pnas.252093999; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Florens L, 2006, METHODS, V40, P303, DOI 10.1016/j.ymeth.2006.07.028; Francis LI, 2009, GENE DEV, V23, P643, DOI 10.1101/gad.1759609; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; Gabrielse C, 2006, GENETICS, V173, P541, DOI 10.1534/genetics.106.057521; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; LARNER JM, 1994, MOL CELL BIOL, V14, P1901, DOI 10.1128/MCB.14.3.1901; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Paciotti V, 2001, MOL CELL BIOL, V21, P3913, DOI 10.1128/MCB.21.12.3913-3925.2001; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Pike BL, 2004, J BIOL CHEM, V279, P39636, DOI 10.1074/jbc.M405080200; Sanchez-Pulido L, 2010, CURR BIOL, V20, pR509, DOI 10.1016/j.cub.2010.05.021; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tam ATY, 2008, BIOCHEMISTRY-US, V47, P3912, DOI 10.1021/bi800027t; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Wohlschlegel James A., 2009, V497, P33, DOI 10.1007/978-1-59745-566-4_3; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; YOUNG BR, 1989, HUM GENET, V82, P113, DOI 10.1007/BF00284040; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zhao XL, 2002, P NATL ACAD SCI USA, V99, P3746, DOI 10.1073/pnas.062502299	39	139	141	0	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2010	467	7314					479	U133		10.1038/nature09377	http://dx.doi.org/10.1038/nature09377			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KO	20865002	Green Accepted, Green Submitted			2022-12-01	WOS:000282090200047
J	Elliott, MR; Zheng, SQ; Park, D; Woodson, RI; Reardon, MA; Juncadella, IJ; Kinchen, JM; Zhang, J; Lysiak, JJ; Ravichandran, KS				Elliott, Michael R.; Zheng, Shuqiu; Park, Daeho; Woodson, Robin I.; Reardon, Michael A.; Juncadella, Ignacio J.; Kinchen, Jason M.; Zhang, Jun; Lysiak, Jeffrey J.; Ravichandran, Kodi S.			Unexpected requirement for ELMO1 in clearance of apoptotic germ cells in vivo	NATURE			English	Article							CRKII/DOCK180/RAC PATHWAY; SCAVENGER RECEPTOR; SERTOLI-CELLS; PH DOMAIN; PHAGOCYTOSIS; ELEGANS; CORPSE; ISCHEMIA/REPERFUSION; ACTIVATION; ENGULFMENT	Apoptosis and the subsequent clearance of dying cells occurs throughout development and adult life in many tissues. Failure to promptly clear apoptotic cells has been linked to many diseases(1-3). ELMO1 is an evolutionarily conserved cytoplasmic engulfment protein that functions downstream of the phosphatidylserine receptor BAI1, and, along with DOCK1 and the GTPase RAC1, promotes internalization of the dying cells(4-7). Here we report the generation of ELMO1-deficient mice, which we found to be unexpectedly viable and grossly normal. However, they had a striking testicular pathology, with disrupted seminiferous epithelium, multinucleated giant cells, uncleared apoptotic germ cells and decreased sperm output. Subsequent in vitro and in vivo analyses revealed a crucial role for ELMO1 in the phagocytic clearance of apoptotic germ cells by Sertoli cells lining the seminiferous epithelium. The engulfment receptor BAI1 and RAC1 (upstream and downstream of ELMO1, respectively) were also important for Sertoli-cell-mediated engulfment. Collectively, these findings uncover a selective requirement for ELMO1 in Sertoli-cell-mediated removal of apoptotic germ cells and make a compelling case for a relationship between engulfment and tissue homeostasis in vivo.	[Elliott, Michael R.; Park, Daeho; Juncadella, Ignacio J.; Ravichandran, Kodi S.] Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; [Elliott, Michael R.; Park, Daeho; Juncadella, Ignacio J.; Kinchen, Jason M.; Lysiak, Jeffrey J.; Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA; [Zheng, Shuqiu; Woodson, Robin I.; Reardon, Michael A.; Zhang, Jun; Lysiak, Jeffrey J.] Univ Virginia, Dept Urol, Charlottesville, VA 22908 USA; [Kinchen, Jason M.; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Ravichandran, KS (corresponding author), Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA.	jl6n@virginia.edu; ravi@virginia.edu	Reardon, Michael/ABF-8880-2021; Kinchen, Jason/ABC-5663-2021	Zhang, Jun/0000-0002-3339-0346; Elliott, Michael/0000-0002-0642-482X; Ravichandran, Kodi/0000-0001-9049-1410; Kinchen, Jason/0000-0001-8430-2265	National Institutes of Health; American Cancer Society; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD057242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064709] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Turner, K. Tung and members of the Ravichandran and Lysiak groups for suggestions. We also thank L. Haney, A. C. Tosello-Trampont, J. Kim and S. Clugston for technical assistance. This work was supported by funding from the National Institutes of Health (to K.S.R. and J.J.L.) and the American Cancer Society (to M.R.E.). K.S.R. is a Bill Benter fellow of the American Asthma Foundation.	A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; Akakura S, 2004, EXP CELL RES, V292, P403, DOI 10.1016/j.yexcr.2003.09.011; Bailey RW, 2002, BIOL REPROD, V66, P1042, DOI 10.1095/biolreprod66.4.1042; Braun RE, 1998, NAT GENET, V18, P202, DOI 10.1038/ng0398-202; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Chen YM, 2009, REPRODUCTION, V138, P655, DOI 10.1530/REP-09-0101; Cool J, 2009, SEMIN REPROD MED, V27, P5, DOI 10.1055/s-0028-1108005; DeBakker CD, 2004, CURR BIOL, V14, P2208, DOI 10.1016/j.cub.2004.12.029; Gillot I, 2005, J CELL SCI, V118, P3027, DOI 10.1242/jcs.02430; Gregory Christopher D., 2009, P271, DOI 10.1007/978-1-4020-9293-0_9; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Henson PM, 2005, NAT IMMUNOL, V6, P1179, DOI 10.1038/ni1205-1179; Holdcraft RW, 2004, DEVELOPMENT, V131, P459, DOI 10.1242/dev.00957; HOLSTEIN AF, 1986, ANDROLOGIA, V18, P5; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Loveland KL, 2005, ANN NY ACAD SCI, V1061, P173, DOI 10.1196/annals.1336.018; Lu MJ, 2004, NAT STRUCT MOL BIOL, V11, P756, DOI 10.1038/nsmb800; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lysiak JJ, 2007, CELL TISSUE RES, V328, P411, DOI 10.1007/s00441-006-0341-y; Lysiak JJ, 2000, BIOL REPROD, V63, P1465, DOI 10.1095/biolreprod63.5.1465; Lysiak JJ, 2001, BIOL REPROD, V65, P718, DOI 10.1095/biolreprod65.3.718; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; ROTTER V, 1993, P NATL ACAD SCI USA, V90, P9075, DOI 10.1073/pnas.90.19.9075; Shiratsuchi A, 1999, J BIOL CHEM, V274, P5901, DOI 10.1074/jbc.274.9.5901; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Wu YC, 2001, DEV CELL, V1, P491, DOI 10.1016/S1534-5807(01)00056-9; Xiong W, 2008, REPRODUCTION, V135, P77, DOI 10.1530/REP-07-0287; Zhou Z, 2004, CURR TOP DEV BIOL, V63, P91, DOI 10.1016/S0070-2153(04)63004-3; Zhou Z, 2001, DEV CELL, V1, P477, DOI 10.1016/S1534-5807(01)00058-2	37	110	110	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2010	467	7313					333	U114		10.1038/nature09356	http://dx.doi.org/10.1038/nature09356			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650CF	20844538	Green Accepted			2022-12-01	WOS:000281824900040
J	Lencucha, R				Lencucha, Raphael			Philip Morris versus Uruguay: health governance challenged	LANCET			English	Editorial Material									Univ Lethbridge, Fac Hlth Sci, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge	Lencucha, R (corresponding author), Univ Lethbridge, Fac Hlth Sci, Lethbridge, AB T1K 3M4, Canada.	raphael.lencucha@uleth.ca						[Anonymous], 2010, LANCET, V375, P1580; [Anonymous], 1988, SWITZERLAND URUGUAY; Chapman S, 2003, TOB CONTROL, V12, P13; Koivusalo M, 2009, GLOBALIZATION HLTH P, P105, DOI DOI 10.1001/JAMA.2009.1694; LALIVE, 2009, WHY PLAIN PACK IS VI; Lee K, 2009, LANCET, V373, P416, DOI 10.1016/S0140-6736(08)61776-6; PETERSON LE, 2010, INVESTMENT ARBI 0302; Roemer R, 2005, AM J PUBLIC HEALTH, V95, P936, DOI 10.2105/AJPH.2003.025908; United Nations Conference on Trade and Development, 2007, INT PROP PROV INT IN; Wakefield MA, 2008, TOB CONTROL, V17, P416, DOI 10.1136/tc.2008.026732; Woo Alyssa, 2002, VANDERBILT J TRANSNA, V35, P1731; *WORLD TRAD ORG, 1986, WTO LEG TEXTS GEN AG	12	21	21	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 11	2010	376	9744					852	853		10.1016/S0140-6736(10)61256-1	http://dx.doi.org/10.1016/S0140-6736(10)61256-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	653DW	20833287				2022-12-01	WOS:000282069100007
J	Chen, M; Schliep, M; Willows, RD; Cai, ZL; Neilan, BA; Scheer, H				Chen, Min; Schliep, Martin; Willows, Robert D.; Cai, Zheng-Li; Neilan, Brett A.; Scheer, Hugo			A Red-Shifted Chlorophyll	SCIENCE			English	Article								Chlorophylls are essential for light-harvesting and energy transduction in photosynthesis. Four chemically distinct varieties have been known for the past 60 years. Here we report isolation of a fifth, which we designate chlorophyll f. Its in vitro absorption (706 nanometers) and fluorescence (722 nanometers) maxima are red-shifted compared to all other chlorophylls from oxygenic phototrophs. On the basis of the optical, mass, and nuclear magnetic resonance spectra, we propose that chlorophyll f is [2-formyl]-chlorophyll a (C55H70O6N4Mg). This finding suggests that oxygenic photosynthesis can be extended further into the infrared region and may open associated bioenergy applications.	[Chen, Min; Schliep, Martin; Scheer, Hugo] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Willows, Robert D.] Macquarie Univ, Dept Chem & Biomol Sci, N Ryde, NSW 2109, Australia; [Cai, Zheng-Li] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia; [Neilan, Brett A.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Scheer, Hugo] Univ Munich, Dept Biol 1, D-80638 Munich, Germany	University of Sydney; Macquarie University; University of Sydney; University of New South Wales Sydney; University of Munich	Chen, M (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	min.chen@sydney.edu.au	Neilan, Brett A/I-5767-2012; Willows, Robert/C-1537-2010	Neilan, Brett A/0000-0001-6113-772X; Willows, Robert/0000-0002-0731-2950; Chen, Min/0000-0001-8070-3248	Macquarie University; ARC; National Health and Medical Research Council (NHMRC)	Macquarie University; ARC(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	M.C. and B.A.N. hold Australian Research Council (ARC) fellowships and associated financial support. M.C. thanks K. Donohoe (University of Sydney) for assistance with polymerase chain reactions. M. C. and M. S. thank B. Crossett (University of Sydney) for mass spectral analysis. M.C. and H.S. thank A. Kwan and J. Mackay (University of Sydney) for NMR spectral analysis and A. W. D. Larkum (University of Sydney) for valuable discussions and continued support. R.D.W. acknowledges support from Macquarie University Strategic Infrastructure Scheme and Research and Development Scheme grants and the ARC and National Health and Medical Research Council (NHMRC) fluorescent applications for biotechnology in life sciences network for use of the Leica confocal imaging system. R.D.W. and M.C. thank D. Birch (Macquarie University) for help with the Olympus confocal imaging. Z.-L.C. thanks J. Reimers (University of Sydney) for supercomputer access. The 16S rRNA sequence has been deposited in GenBank under accession number 1370306.	Allen M.B., 1966, CHLOROPHYLLS, P511; Bjorn L, 2009, PHOTOSYNTH RES, V99, P85, DOI 10.1007/s11120-008-9395-x; Falk J. E., 1975, PORPHYRNS MET, P399; Holt A.S., 1966, CHLOROPHYLLS, P111; Kuhl Michael, 2007, V11, P101; Manning WM, 1943, J BIOL CHEM, V151, P1; MEEKS JC, 1974, ALGAL PHYSL BIOCH, V10, P161; Miyashita H, 1996, NATURE, V383, P402, DOI 10.1038/383402a0; Nieuwenburg P, 2003, PHOTOCHEM PHOTOBIOL, V77, P628, DOI 10.1562/0031-8655(2003)077<0628:EOTPPO>2.0.CO;2; Reid RP, 2000, NATURE, V406, P989, DOI 10.1038/35023158; Scheer Hugo, 2006, V25, P1; Strain H.H., 1951, MANUAL PHYCOLOGY, P243; Tanaka A, 1998, P NATL ACAD SCI USA, V95, P12719, DOI 10.1073/pnas.95.21.12719	13	332	344	7	178	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2010	329	5997					1318	1319		10.1126/science.1191127	http://dx.doi.org/10.1126/science.1191127			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647YR	20724585				2022-12-01	WOS:000281657300031
J	Fung, TT; van Dam, RM; Hankinson, SE; Stampfer, M; Willett, WC; Hu, FB				Fung, Teresa T.; van Dam, Rob M.; Hankinson, Susan E.; Stampfer, Meir; Willett, Walter C.; Hu, Frank B.			Low-Carbohydrate Diets and All-Cause and Cause-Specific Mortality Two Cohort Studies	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; HIGH-PROTEIN-DIET; RISK-FACTORS; WEIGHT-LOSS; MEAT CONSUMPTION; LUNG-CANCER; COLORECTAL-CANCER; FAT; METAANALYSIS; SCORE	Background: Data on the long-term association between low-carbohydrate diets and mortality are sparse. Objective: To examine the association of low-carbohydrate diets with mortality during 26 years of follow-up in women and 20 years in men. Design: Prospective cohort study of women and men who were followed from 1980 (women) or 1986 (men) until 2006. Low-carbohydrate diets, either animal-based (emphasizing animal sources of fat and protein) or vegetable-based (emphasizing vegetable sources of fat and protein), were computed from several validated food-frequency questionnaires assessed during follow-up. Setting: Nurses' Health Study and Health Professionals' Follow-up Study. Participants: 85 168 women (aged 34 to 59 years at baseline) and 44 548 men (aged 40 to 75 years at baseline) without heart disease, cancer, or diabetes. Measurements: Investigators documented 12 555 deaths (2458 cardiovascular-related and 5780 cancer-related) in women and 8678 deaths (2746 cardiovascular-related and 2960 cancer-related) in men. Results: The overall low-carbohydrate score was associated with a modest increase in overall mortality in a pooled analysis (hazard ratio [HR] comparing extreme deciles, 1.12 [95% CI, 1.01 to 1.24]; P for trend = 0.136). The animal low-carbohydrate score was associated with higher all-cause mortality (pooled HR comparing extreme deciles, 1.23 [CI, 1.11 to 1.37]; P for trend = 0.051), cardiovascular mortality (corresponding HR, 1.14 [CI, 1.01 to 1.29]; P for trend = 0.029), and cancer mortality (corresponding HR, 1.28 [CI, 1.02 to 1.60]; P for trend = 0.089). In contrast, a higher vegetable low-carbohydrate score was associated with lower all-cause mortality (HR, 0.80 [CI, 0.75 to 0.85]; P for trend <= 0.001) and cardiovascular mortality (HR, 0.77 [CI, 0.68 to 0.87]; P for trend < 0.001). Limitations: Diet and lifestyle characteristics were assessed with some degree of error. Sensitivity analyses indicated that results were probably not substantively affected by residual confounding or an unmeasured confounder. Participants were not a representative sample of the U. S. population. Conclusion: A low-carbohydrate diet based on animal sources was associated with higher all-cause mortality in both men and women, whereas a vegetable-based low-carbohydrate diet was associated with lower all-cause and cardiovascular disease mortality rates.	[Fung, Teresa T.] Harvard Univ, Sch Publ Hlth, Simmons Coll, Dept Nutr, Boston, MA 02115 USA; Natl Univ Singapore, Singapore 117548, Singapore	Harvard University; Harvard T.H. Chan School of Public Health; Simmons University; National University of Singapore	Fung, TT (corresponding author), Harvard Univ, Sch Publ Hlth, Simmons Coll, Dept Nutr, 300 Fenway, Boston, MA 02115 USA.	teresa.fung@simmons.edu	van Dam, Rob M/F-9674-2010	van Dam, Rob M/0000-0002-7354-8734	National Institutes of Health [CA87969, HL60712, CA95589]; NATIONAL CANCER INSTITUTE [P01CA087969, R01CA095589] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Grant Support: By the National Institutes of Health (grants CA87969, HL60712, and CA95589).	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Benetou V, 2008, CANCER EPIDEM BIOMAR, V17, P387, DOI 10.1158/1055-9965.EPI-07-2665; Chao A, 2005, JAMA-J AM MED ASSOC, V293, P172, DOI 10.1001/jama.293.2.172; CHAUNCEY KB, 2003, LOW CARB DIETING DUM; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Cross AJ, 2007, PLOS MED, V4, P1973, DOI 10.1371/journal.pmed.0040325; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; De Stefani E, 2008, LUNG CANCER, V61, P283, DOI 10.1016/j.lungcan.2008.01.004; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; Halton TL, 2008, AM J CLIN NUTR, V87, P339, DOI 10.1093/ajcn/87.2.339; Halton TL, 2006, NEW ENGL J MED, V355, P1991, DOI 10.1056/NEJMoa055317; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 2002, JAMA-J AM MED ASSOC, V288, P2569, DOI 10.1001/jama.288.20.2569; Jenkins DJA, 2009, ARCH INTERN MED, V169, P1046, DOI 10.1001/archinternmed.2009.115; Kelemen LE, 2005, AM J EPIDEMIOL, V161, P239, DOI 10.1093/aje/kwi038; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; Lagiou P, 2007, J INTERN MED, V261, P366, DOI 10.1111/j.1365-2796.2007.01774.x; Lam TK, 2009, CANCER RES, V69, P932, DOI 10.1158/0008-5472.CAN-08-3162; Larsson SC, 2006, INT J CANCER, V119, P2657, DOI 10.1002/ijc.22170; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; McMillan-Price J, 2006, ARCH INTERN MED, V166, P1466, DOI 10.1001/archinte.166.14.1466; Muzio F, 2007, AM J CLIN NUTR, V86, P946, DOI 10.1093/ajcn/86.4.946; Nordmann AJ, 2006, ARCH INTERN MED, V166, P285, DOI 10.1001/archinte.166.3.285; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Rubin D.B., 1987, MULTIPLE IMPUTATION, P1; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Sandhu MS, 2001, CANCER EPIDEM BIOMAR, V10, P439; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Smith-Warner SA, 2002, CANCER EPIDEM BIOMAR, V11, P987; Spiegelman D, 1997, AM J CLIN NUTR, V65, P1179; Trichopoulou A, 2007, EUR J CLIN NUTR, V61, P575, DOI 10.1038/sj.ejcn.1602557; Willett W., 2013, NUTR EPIDEMIOLOGY, V3rd	35	222	225	1	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 7	2010	153	5					289	+		10.7326/0003-4819-153-5-201009070-00003	http://dx.doi.org/10.7326/0003-4819-153-5-201009070-00003			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	647GF	20820038	Green Accepted			2022-12-01	WOS:000281605500002
J	Chao, MP; Alizadeh, AA; Tang, C; Myklebust, JH; Varghese, B; Gill, S; Jan, M; Cha, AC; Chan, CK; Tan, BT; Park, CY; Zhao, FF; Kohrt, HE; Malumbres, R; Briones, J; Gascoyne, RD; Lossos, IS; Levy, R; Weissman, IL; Majeti, R				Chao, Mark P.; Alizadeh, Ash A.; Tang, Chad; Myklebust, June H.; Varghese, Bindu; Gill, Saar; Jan, Max; Cha, Adriel C.; Chan, Charles K.; Tan, Brent T.; Park, Christopher Y.; Zhao, Feifei; Kohrt, Holbrook E.; Malumbres, Raquel; Briones, Javier; Gascoyne, Randy D.; Lossos, Izidore S.; Levy, Ronald; Weissman, Irving L.; Majeti, Ravindra			Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma	CELL			English	Article							B-CELL LYMPHOMA; CHRONIC LYMPHOCYTIC-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; MONOCLONAL-ANTIBODY; ANTITUMOR-ACTIVITY; DRUG-COMBINATION; CD20 EXPRESSION; CD47; THERAPY; MECHANISMS	Monoclonal antibodies are standard therapeutics for several cancers including the anti-CD20 antibody rituximab for B cell non-Hodgkin lymphoma (NHL). Rituximab and other antibodies are not curative and must be combined with cytotoxic chemotherapy for clinical benefit. Here we report the eradication of human NHL solely with a monoclonal antibody therapy combining rituximab with a blocking anti-CD47 antibody. We identified increased expression of CD47 on human NHL cells and determined that higher CD47 expression independently predicted adverse clinical outcomes in multiple NHL subtypes. Blocking anti-CD47 antibodies preferentially enabled phagocytosis of NHL cells and synergized with rituximab. Treatment of human NHL-engrafted mice with anti-CD47 antibody reduced lymphoma burden and improved survival, while combination treatment with rituximab led to elimination of lymphoma and cure. These antibodies synergized through a mechanism combining Fc receptor (FcR)-dependent and FcR-independent stimulation of phagocytosis that might be applicable to many other cancers.	[Chao, Mark P.; Alizadeh, Ash A.; Tang, Chad; Jan, Max; Cha, Adriel C.; Chan, Charles K.; Park, Christopher Y.; Zhao, Feifei; Weissman, Irving L.; Majeti, Ravindra] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford Canc Ctr, Palo Alto, CA 94304 USA; [Chao, Mark P.; Alizadeh, Ash A.; Tang, Chad; Jan, Max; Cha, Adriel C.; Chan, Charles K.; Park, Christopher Y.; Zhao, Feifei; Weissman, Irving L.; Majeti, Ravindra] Stanford Univ, Ludwig Ctr Stanford, Palo Alto, CA 94304 USA; [Alizadeh, Ash A.; Kohrt, Holbrook E.; Majeti, Ravindra] Stanford Univ, Dept Internal Med, Div Hematol, Palo Alto, CA 94304 USA; [Alizadeh, Ash A.; Myklebust, June H.; Varghese, Bindu; Kohrt, Holbrook E.; Levy, Ronald] Stanford Univ, Div Oncol, Palo Alto, CA 94304 USA; [Tan, Brent T.; Park, Christopher Y.; Weissman, Irving L.] Stanford Univ, Dept Pathol, Palo Alto, CA 94304 USA; [Gill, Saar] Stanford Univ, Div Blood & Bone Marrow Transplantat, Palo Alto, CA 94304 USA; [Malumbres, Raquel; Lossos, Izidore S.] Univ Miami, Miller Sch Med, Div Hematol Oncol, Dept Med, Miami, FL 33136 USA; [Briones, Javier] Autonomous Univ Barcelona, Hosp Santa Creu & St Pau, Dept Hematol, E-08193 Barcelona, Spain; [Gascoyne, Randy D.] British Columbia Canc Agcy, Dept Pathol, Vancouver, BC V5Z 1L3, Canada; [Myklebust, June H.] Univ Oslo, Inst Canc Res, Dept Immunol, Oslo Univ Hosp,Ctr Canc Biomed, N-0310 Oslo, Norway	Stanford Cancer Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; University of Miami; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; British Columbia Cancer Agency; University of Oslo	Chao, MP (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford Canc Ctr, Palo Alto, CA 94304 USA.	mpchao@stanford.edu	Myklebust, June Helen/ABH-6494-2020; Malumbres, Raquel/N-3745-2014; Alizadeh, Ash A/C-5594-2009	Myklebust, June Helen/0000-0003-0394-9986; Malumbres, Raquel/0000-0003-0767-9442; Alizadeh, Ash A/0000-0002-5153-5625; Levy, Ronald/0000-0003-2061-0650; Majeti, Ravindra/0000-0002-5814-0984; Tan, Brent/0000-0001-7375-6878; Briones Meijide, Javier/0000-0003-2750-3735	HHMI; Stanford Cancer Biology Program; NIH [HL007970, CA122105, P01CA139490]; Fundacion Caja Madrid; AACR; Burroughs Wellcome Fund; Smith Family Fund; NATIONAL CANCER INSTITUTE [R01CA122105, T32CA009302, P01CA139490] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007970, R01HL058770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290, P30AI073961] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); Stanford Cancer Biology Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacion Caja Madrid; AACR; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Smith Family Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge Dr. Christopher Contag for providing luciferase constructs, Dr. Robert Negrin for assistance, Dr. Yaso Natkunam for immunohistochemistry, Libuse Jerabek and Theresa Storm for lab management, and Adriane Mosely for animal husbandry. We also acknowledge the patients and surgeons including Drs. Wapnir, Chang, Cheng, Janisiewicz, Koltai, Liebowitz, and Messner for providing research specimens. M.P.C. is supported by the HHMI and the Stanford Cancer Biology Program, A.A.A. by an NIH T32 Ruth L. Kirschstein National Research Service Award (HL007970), R. Malumbres by a fellowship from Fundacion Caja Madrid, I.S.L. by NIH grant CA122105, and R. Majeti by a grant from the AACR. R. Majeti holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund. I.L.W., M.P.C., A.A.A., and R. Majeti have filed U.S. Patent Application Serial No. 12/321,215 entitled "Methods For Manipulating Phagocytosis Mediated by CD47.'' This research is supported by NIH grant P01CA139490 to I.L.W. and funding from the Smith Family Fund.	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Cartron G, 2004, BLOOD, V104, P2635, DOI 10.1182/blood-2004-03-1110; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Cheson BD, 2008, NEW ENGL J MED, V359, P613, DOI 10.1056/NEJMra0708875; Chou TC, 2008, LEUKEMIA LYMPHOMA, V49, P2059, DOI 10.1080/10428190802353591; Daniel D, 2007, BLOOD, V110, P4037, DOI 10.1182/blood-2007-02-076075; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Foran JM, 2001, BRIT J HAEMATOL, V114, P881, DOI 10.1046/j.1365-2141.2001.03019.x; Glennie MJ, 2007, MOL IMMUNOL, V44, P3823, DOI 10.1016/j.molimm.2007.06.151; Hiraga J, 2009, BLOOD, V113, P4885, DOI 10.1182/blood-2008-08-175208; Jaiswal S, 2010, TRENDS IMMUNOL, V31, P212, DOI 10.1016/j.it.2010.04.001; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Kennedy AD, 2004, J IMMUNOL, V172, P3280, DOI 10.4049/jimmunol.172.5.3280; Kikuchi Y, 2005, LEUKEMIA RES, V29, P445, DOI 10.1016/j.leukres.2004.09.005; Kikuchi Y, 2004, BIOCHEM BIOPH RES CO, V315, P912, DOI 10.1016/j.bbrc.2004.01.128; Kim MJ, 2008, TUMOR BIOL, V29, P28, DOI 10.1159/000132568; Leonard JP, 2007, ANN ONCOL, V18, P1216, DOI 10.1093/annonc/mdm114; Leonard JP, 2008, CANCER-AM CANCER SOC, V113, P2714, DOI 10.1002/cncr.23890; Leonard JP, 2005, J CLIN ONCOL, V23, P5044, DOI 10.1200/JCO.2005.13.821; Maddipatla S, 2007, CLIN CANCER RES, V13, P4556, DOI 10.1158/1078-0432.CCR-07-0680; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Mateo V, 1999, NAT MED, V5, P1277, DOI 10.1038/15233; Milush JM, 2009, BLOOD, V114, P4823, DOI 10.1182/blood-2009-04-216374; Nimmerjahn F, 2007, CURR OPIN IMMUNOL, V19, P239, DOI 10.1016/j.coi.2007.01.005; Oscier DG, 2002, BLOOD, V100, P1177, DOI 10.1182/blood.V100.4.1177.h81602001177_1177_1184; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Rosenwald A, 2003, CANCER CELL, V3, P185, DOI 10.1016/S1535-6108(03)00028-X; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Smith MR, 2003, ONCOGENE, V22, P7359, DOI 10.1038/sj.onc.1206939; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Tallarida RJ, 2006, J PHARMACOL EXP THER, V319, P1, DOI 10.1124/jpet.106.104117; Taylor RP, 2008, CURR OPIN IMMUNOL, V20, P444, DOI 10.1016/j.coi.2008.05.011; Uno S, 2007, ONCOL REP, V17, P1189	37	702	780	1	104	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 3	2010	142	5					699	713		10.1016/j.cell.2010.07.044	http://dx.doi.org/10.1016/j.cell.2010.07.044			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	646FL	20813259	Green Accepted, Bronze			2022-12-01	WOS:000281523200014
J	Grunwald, D; Singer, RH				Grunwald, David; Singer, Robert H.			In vivo imaging of labelled endogenous beta-actin mRNA during nucleocytoplasmic transport	NATURE			English	Article							NUCLEAR-PORE COMPLEX; CRYOELECTRON TOMOGRAPHY; AMPHIBIAN OOCYTES; SINGLE-MOLECULE; MYOSIN-V; EXPORT; TRANSLOCATION; ARCHITECTURE; ENVELOPE; PROTEIN	Export of messenger RNA occurs via nuclear pores, which are large nanomachines with diameters of roughly 120 nm that are the only link between the nucleus and cytoplasm(1). Hence, mRNA export occurs over distances smaller than the optical resolution of conventional light microscopes. There is extensive knowledge on the physical structure and composition of the nuclear pore complex(2-7), but transport selectivity and the dynamics of mRNA export at nuclear pores remain unknown(8). Here we developed a super-registration approach using fluorescence microscopy that can overcome the current limitations of co-localization by means of measuring intermolecular distances of chromatically different fluorescent molecules with nanometre precision. With this method we achieve 20-ms time-precision and at least 26-nm spatial precision, enabling the capture of highly transient interactions in living cells. Using this approach we were able to spatially resolve the kinetics of mRNA transport in mammalian cells and present a three-step model consisting of docking (80 ms), transport (5-20 ms) and release (80 ms), totalling 180 +/- 10 ms. Notably, the translocation through the channel was not the rate-limiting step, mRNAs can move bi-directionally in the pore complex and not all pores are equally active.	[Grunwald, David; Singer, Robert H.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Grunwald, David; Singer, Robert H.] Gruss Lipper Biophoton Ctr, Bronx, NY 10461 USA; [Grunwald, David] Delft Univ Technol, Dept BioNanoSci, Kavli Inst NanoSci, NL-2628 CJ Delft, Netherlands	Yeshiva University; Albert Einstein College of Medicine; Delft University of Technology	Singer, RH (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	Robert.Singer@einstein.yu.edu		Grunwald, David/0000-0001-9067-804X	DFG [3388/1]; NIH [EB2060, GM86217]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084364, R01GM086217] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Dange, K. Czaplinski, T. Lionnet and X. Meng for help with cell lines and cloning; A. Gennerich, H. Y. Park and D. Entenberg for help on data analysis and programming; S. M. Shenoy for development of alignment software for detector pre-registration and his additional support; D. Larson, I. Lepper and U. Kubitscheck for providing fitting routines; and A. Wells for FISH and TIRF data, proof reading and discussion. Lentiviral vector was a gift from G. Mostoslavsky and R. C. Mulligan. Supported by DFG 3388/1 to D.G. Supported by NIH EB2060 and GM86217 to R.H.S. The authors express their appreciation to E. Gruss Lipper for her gift founding the Gruss Lipper Biophotonics Center that provided the equipment used in this research.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Bachi A, 2000, RNA, V6, P136, DOI 10.1017/S1355838200991994; Bastos R, 1995, INT REV CYTOL, V162B, P257; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Carmody SR, 2009, J CELL SCI, V122, P1933, DOI 10.1242/jcs.041236; Chakraborty P, 2006, METHODS, V39, P363, DOI 10.1016/j.ymeth.2006.07.002; Clemen AEM, 2005, BIOPHYS J, V88, P4402, DOI 10.1529/biophysj.104.053504; Cordes VC, 1997, J CELL BIOL, V136, P515, DOI 10.1083/jcb.136.3.515; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Dange T, 2008, J CELL BIOL, V183, P77, DOI 10.1083/jcb.200806173; FRANKE WW, 1970, J ULTRA MOL STRUCT R, V30, P317, DOI 10.1016/S0022-5320(70)80065-X; FRANKE WW, 1970, J ULTRA MOL STRUCT R, V30, P288, DOI 10.1016/S0022-5320(70)80064-8; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; HALLBERG E, 1993, J CELL BIOL, V122, P513, DOI 10.1083/jcb.122.3.513; Kiseleva E, 1998, J CELL SCI, V111, P223; Kopito RB, 2007, P NATL ACAD SCI USA, V104, P12743, DOI 10.1073/pnas.0702690104; Kubitscheck U, 2005, J CELL BIOL, V168, P233, DOI 10.1083/jcb.200411005; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Mor A, 2010, NAT CELL BIOL, V12, P543, DOI 10.1038/ncb2056; Nachury MV, 1999, P NATL ACAD SCI USA, V96, P9622, DOI 10.1073/pnas.96.17.9622; Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; STOCKLEY PG, 1995, NUCLEIC ACIDS RES, V23, P2512, DOI 10.1093/nar/23.13.2512; Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3; Sun C, 2008, P NATL ACAD SCI USA, V105, P8613, DOI 10.1073/pnas.0710867105; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	31	226	229	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP	2010	467	7315					604	U128		10.1038/nature09438	http://dx.doi.org/10.1038/nature09438			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655TT	20844488	Green Accepted			2022-12-01	WOS:000282273100042
J	Reddy, VS; Natchiar, SK; Stewart, PL; Nemerow, GR				Reddy, Vijay S.; Natchiar, S. Kundhavai; Stewart, Phoebe L.; Nemerow, Glen R.			Crystal Structure of Human Adenovirus at 3.5 angstrom Resolution	SCIENCE			English	Article							CRYOELECTRON MICROSCOPY STRUCTURE; PROTEIN; VECTOR; INFECTIVITY; REVEALS; PENTON; TRIALS	Rational development of adenovirus vectors for therapeutic gene transfer is hampered by the lack of accurate structural information. Here, we report the x-ray structure at 3.5 angstrom resolution of the 150-megadalton adenovirus capsid containing nearly 1 million amino acids. We describe interactions between the major capsid protein (hexon) and several accessory molecules that stabilize the capsid. The virus structure also reveals an altered association between the penton base and the trimeric fiber protein, perhaps reflecting an early event in cell entry. The high-resolution structure provides a substantial advance toward understanding the assembly and cell entry mechanisms of a large double-stranded DNA virus and provides new opportunities for improving adenovirus-mediated gene transfer.	[Reddy, Vijay S.; Natchiar, S. Kundhavai; Nemerow, Glen R.] Scripps Res Inst, La Jolla, CA 92037 USA; [Stewart, Phoebe L.] Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA	Scripps Research Institute; Vanderbilt University	Reddy, VS (corresponding author), Scripps Res Inst, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gnemerow@scripps.edu; reddyv@scripps.edu			National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Science [Y1-GM-1104]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; NIH [R01 AI070771, HL054352, EY011431, AI042929]; NATIONAL EYE INSTITUTE [R01EY011431] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI042929, R01AI042929, R01AI070771] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors express their deep gratitude to J. E. Johnson for advice and guidance during all phases of the structure determination and for reading the manuscript; T.-M. Mullen and L. Gritton for the outstanding technical support for vector production; S. Venkataraman for help with the early crystallization setups of HAdV; I. Mathews of the Stanford Synchrotron Radiation Lightsource for initial help with the data collection; W. Minor and I. Minor for generously providing the larger version of the SCALEPACK program; E. Ollmann-Saphire and J. G. Smith for comments on the manuscript; T. McCarthy for preparation of this paper; and R. Fischetti, N. Sanishvili, and other members at General Medicine and Cancer Institutes Collaborative Access Team (GM/CA CAT) for discussions and technical support. GM/CA CAT has been funded in whole or in part with federal funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Science (Y1-GM-1104). The use of the Advance Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science (contract no. DE-AC02-06CH11357). The coordinates of Ad35F crystal structure have been deposited in the Protein Data Bank (PDB) with the identification code 1VSZ. This work was supported by NIH grants R01 AI070771 to V. S. R., HL054352 and EY011431 to G.R.N., and AI042929 to P.L.S. This is manuscript no. 20538 from the Scripps Research Institute. G.R.N. holds a patent titled "Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use" (patent no. 7,232,899).	Butt AL, 2006, CORNEA, V25, P199, DOI 10.1097/01.ico.0000170693.13326.fb; Campos SK, 2007, CURR GENE THER, V7, P189, DOI 10.2174/156652307780859062; Edelstein ML, 2004, J GENE MED, V6, P597, DOI 10.1002/jgm.619; Fabry CMS, 2005, EMBO J, V24, P1645, DOI 10.1038/sj.emboj.7600653; Fuschiotti P, 2006, J MOL BIOL, V356, P510, DOI 10.1016/j.jmb.2005.11.048; Gordon YJ, 1996, INVEST OPHTH VIS SCI, V37, P2774; Henry TD, 2007, J AM COLL CARDIOL, V50, P1038, DOI 10.1016/j.jacc.2007.06.010; HILLEMAN MR, 1954, P SOC EXP BIOL MED, V85, P183, DOI 10.3181/00379727-85-20825; Hoffman R, 2006, NETW COMPUT, V17, P18; Lenaerts L, 2008, REV MED VIROL, V18, P357, DOI 10.1002/rmv.589; Metzgar D, 2007, J INFECT DIS, V196, P1465, DOI 10.1086/522970; Reddy VS, 2010, VIROLOGY, V402, P209, DOI 10.1016/j.virol.2010.03.028; Saban SD, 2005, J MOL BIOL, V349, P526, DOI 10.1016/j.jmb.2005.04.034; Saban SD, 2006, J VIROL, V80, P12049, DOI 10.1128/JVI.01652-06; Shayakhmetov DM, 2000, J VIROL, V74, P10274, DOI 10.1128/JVI.74.22.10274-10286.2000; Silvestry M, 2009, J VIROL, V83, P7375, DOI 10.1128/JVI.00331-09; STEWART PL, 1993, EMBO J, V12, P2589, DOI 10.1002/j.1460-2075.1993.tb05919.x; van Raaij MJ, 1999, NATURE, V401, P935, DOI 10.1038/44880; VANOOSTRUM J, 1985, J VIROL, V56, P439, DOI 10.1128/JVI.56.2.439-448.1985; von Seggern DJ, 1999, J VIROL, V73, P1601, DOI 10.1128/JVI.73.2.1601-1608.1999; Wiethoff CM, 2005, J VIROL, V79, P1992, DOI 10.1128/JVI.79.4.1992-2000.2005; Zubieta C, 2005, MOL CELL, V17, P121, DOI 10.1016/j.molcel.2004.11.041	22	173	176	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 27	2010	329	5995					1071	1075		10.1126/science.1187292	http://dx.doi.org/10.1126/science.1187292			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642WZ	20798318	Green Accepted			2022-12-01	WOS:000281253500039
J	Rao, P; Hayden, MS; Long, MX; Scott, ML; West, AP; Zhang, DK; Oeckinghaus, A; Lynch, C; Hoffmann, A; Baltimore, D; Ghosh, S				Rao, Ping; Hayden, Mathew S.; Long, Meixiao; Scott, Martin L.; West, A. Philip; Zhang, Dekai; Oeckinghaus, Andrea; Lynch, Candace; Hoffmann, Alexander; Baltimore, David; Ghosh, Sankar			I kappa B beta acts to inhibit and activate gene expression during the inflammatory response	NATURE			English	Article							TUMOR NECROSIS FACTOR; C-REL; RHEUMATOID-ARTHRITIS; DEFICIENT MICE; DNA-BINDING; ALPHA; PHOSPHORYLATION; BIOSYNTHESIS; SIMILARITIES; SEQUENCES	The activation of pro-inflammatory gene programs by nuclear factor-kappa B (NF-kappa B) is primarily regulated through cytoplasmic sequestration of NF-kappa B by the inhibitor of kappa B (I kappa B) family of proteins(1). I kappa B beta, a major isoform of I kappa B, can sequester NF-kappa B in the cytoplasm(2), although its biological role remains unclear. Although cells lacking IkBb have been reported(3,4), in vivo studies have been limited and suggested redundancy between I kappa B alpha and I kappa B beta(5). Like I kappa B alpha, I kappa B beta is also inducibly degraded; however, upon stimulation by lipopolysaccharide (LPS), it is degraded slowly and re-synthesized as a hypophosphorylated form that can be detected in the nucleus(6-11). The crystal structure of I kappa B beta bound to p65 suggested this complex might bind DNA(12). In vitro, hypophosphorylated I kappa B beta can bind DNA with p65 and c-Rel, and the DNA-bound NF-kappa B:I kappa B beta complexes are resistant to I kappa B alpha, suggesting hypophosphorylated, nuclear I kappa B beta may prolong the expression of certain genes(9-11). Here we report that in vivo I kappa B beta serves both to inhibit and facilitate the inflammatory response. I kappa B beta degradation releases NF-kappa B dimers which upregulate proinflammatory target genes such as tumour necrosis factor-alpha (TNF-alpha). Surprisingly, absence of I kappa B beta results in a dramatic reduction of TNF-alpha in response to LPS even though activation of NF-kappa B is normal. The inhibition of TNF-alpha messenger RNA (mRNA) expression correlates with the absence of nuclear, hypophosphorylated-I kappa B beta bound to p65:c-Rel heterodimers at a specific kappa B site on the TNF-alpha promoter. Therefore I kappa B beta acts through p65:c-Rel dimers to maintain prolonged expression of TNF-alpha. As a result, I kappa B beta(-/-) mice are resistant to LPS-induced septic shock and collagen-induced arthritis. Blocking I kappa B beta might be a promising new strategy for selectively inhibiting the chronic phase of TNF-alpha production during the inflammatory response.	[Rao, Ping; Hayden, Mathew S.; Long, Meixiao; West, A. Philip; Zhang, Dekai; Oeckinghaus, Andrea; Ghosh, Sankar] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Rao, Ping; Hayden, Mathew S.; Long, Meixiao; West, A. Philip; Zhang, Dekai; Oeckinghaus, Andrea; Ghosh, Sankar] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Hayden, Mathew S.; Long, Meixiao; Oeckinghaus, Andrea; Ghosh, Sankar] Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA; [Scott, Martin L.; Baltimore, David] CALTECH, Dept Biol, Pasadena, CA 91125 USA; [Lynch, Candace; Hoffmann, Alexander] Univ Calif San Diego, Signaling Syst Lab, Dept Chem & Biochem, La Jolla, CA 92093 USA	Yale University; Yale University; Columbia University; California Institute of Technology; University of California System; University of California San Diego	Ghosh, S (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	sg2715@columbia.edu	Hayden, Matthew/C-1263-2008; Oeckinghaus, Andrea/AAW-9933-2020; West, A. Phillip/A-7867-2009; West, A. Phillip/W-8171-2019	West, A. Phillip/0000-0003-2884-6895; Hayden, Matthew/0000-0003-1670-6430	National Institutes of Health [R37-AI03343]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083453, R37AI033443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071573] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Lin at the Yale W. M. Keck Biostatistics Resource for analysis of microarray data. S. G. was supported by grants from the National Institutes of Health (R37-AI03343).	BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Cheng JD, 1998, J EXP MED, V188, P1055, DOI 10.1084/jem.188.6.1055; Chu ZL, 1996, MOL CELL BIOL, V16, P5974; ERNST MK, 1995, MOL CELL BIOL, V15, P872; EVANS GF, 1989, CIRC SHOCK, V29, P279; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Goudeau B, 2003, P NATL ACAD SCI USA, V100, P15800, DOI 10.1073/pnas.2535880100; HAN J, 1990, J EXP MED, V171, P465, DOI 10.1084/jem.171.2.465; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hertlein E, 2005, MOL CELL BIOL, V25, P4956, DOI 10.1128/MCB.25.12.4956-4968.2005; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054; KERR LD, 1991, GENE DEV, V5, P1464, DOI 10.1101/gad.5.8.1464; Klement JF, 1996, MOL CELL BIOL, V16, P2341; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Kuprash DV, 1999, J IMMUNOL, V162, P4045; Malek S, 2003, J BIOL CHEM, V278, P23094, DOI 10.1074/jbc.M301022200; Malek S, 2001, J BIOL CHEM, V276, P45225, DOI 10.1074/jbc.M105865200; Memet S, 1999, J IMMUNOL, V163, P5994; Miagkov AV, 1998, P NATL ACAD SCI USA, V95, P13859, DOI 10.1073/pnas.95.23.13859; Phillips RJ, 1997, MOL CELL BIOL, V17, P4390, DOI 10.1128/MCB.17.8.4390; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Sanjabi S, 2000, P NATL ACAD SCI USA, V97, P12705, DOI 10.1073/pnas.230436397; Suyang H, 1996, MOL CELL BIOL, V16, P5444; Tergaonkar V, 2005, NAT CELL BIOL, V7, P921, DOI 10.1038/ncb1296; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; Tran K, 1997, MOL CELL BIOL, V17, P5386, DOI 10.1128/MCB.17.9.5386; Weil R, 1997, J BIOL CHEM, V272, P9942	30	139	143	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2010	466	7310					1115	U132		10.1038/nature09283	http://dx.doi.org/10.1038/nature09283			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20740013	Green Accepted			2022-12-01	WOS:000281203600042
J	Zhao, MS; Running, SW				Zhao, Maosheng; Running, Steven W.			Drought-Induced Reduction in Global Terrestrial Net Primary Production from 2000 Through 2009	SCIENCE			English	Article							FORESTS GREEN-UP; CARBON; ECOSYSTEMS; HEAT; RESPIRATION; VARIABILITY; FEEDBACK; SINKS	Terrestrial net primary production (NPP) quantifies the amount of atmospheric carbon fixed by plants and accumulated as biomass. Previous studies have shown that climate constraints were relaxing with increasing temperature and solar radiation, allowing an upward trend in NPP from 1982 through 1999. The past decade (2000 to 2009) has been the warmest since instrumental measurements began, which could imply continued increases in NPP; however, our estimates suggest a reduction in the global NPP of 0.55 petagrams of carbon. Large-scale droughts have reduced regional NPP, and a drying trend in the Southern Hemisphere has decreased NPP in that area, counteracting the increased NPP over the Northern Hemisphere. A continued decline in NPP would not only weaken the terrestrial carbon sink, but it would also intensify future competition between food demand and proposed biofuel production.	[Zhao, Maosheng; Running, Steven W.] Univ Montana, Numer Terradynam Simulat Grp, Dept Ecosyst & Conservat Sci, Missoula, MT 59812 USA	University of Montana System; University of Montana	Zhao, MS (corresponding author), Univ Montana, Numer Terradynam Simulat Grp, Dept Ecosyst & Conservat Sci, Missoula, MT 59812 USA.	zhao@ntsg.umt.edu	Zhao, Maosheng/G-5706-2010		NASA [NNX08AG87A]	NASA(National Aeronautics & Space Administration (NASA))	We thank the reviewers and L. Jones, C. Cleveland, and Q. Mu for helpful comments. This work would not have been possible without continuous financial support from the NASA Earth Observing System MODIS project (grant NNX08AG87A). Moreover, we gratefully acknowledge all MODIS land product science team members for their efforts in generating high-quality data sets. NCEP_Reanalysis 2 data were provided by the NOAA/OAR/Earth System Research Laboratory Physical Sciences Division, Boulder, Colorado, USA, from their Web site at www.esrl.noaa.gov/psd/.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Angert A, 2005, P NATL ACAD SCI USA, V102, P10823, DOI 10.1073/pnas.0501647102; Baldocchi D, 2008, AUST J BOT, V56, P1, DOI 10.1071/BT07151; Canadell Josep G., 2007, P1; Chen JM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025919; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Dai A, 2004, J HYDROMETEOROL, V5, P1117, DOI 10.1175/JHM-386.1; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Fung IY, 2005, P NATL ACAD SCI USA, V102, P11201, DOI 10.1073/pnas.0504949102; Funk C, 2008, P NATL ACAD SCI USA, V105, P11081, DOI 10.1073/pnas.0708196105; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Huete AR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025583; Janssens IA, 2010, NAT GEOSCI, V3, P315, DOI [10.1038/NGEO844, 10.1038/ngeo844]; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI 10.1175/Bams-83-11-1631; KEELING CD, 2001, SIO REFERENCE SERIES, V21; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; MASARIE KA, 1995, J GEOPHYS RES-ATMOS, V100, P11593, DOI 10.1029/95JD00859; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Mildrexler DJ, 2009, REMOTE SENS ENVIRON, V113, P2103, DOI 10.1016/j.rse.2009.05.016; Monteith J L, 1965, Symp Soc Exp Biol, V19, P205; Myneni RB, 2002, REMOTE SENS ENVIRON, V83, P214, DOI 10.1016/S0034-4257(02)00074-3; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Palmer W. C., 1965, 45 US DEP COMM; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Running SW, 2004, BIOSCIENCE, V54, P547, DOI 10.1641/0006-3568(2004)054[0547:ACSMOG]2.0.CO;2; Saleska SR, 2007, SCIENCE, V318, P612, DOI 10.1126/science.1146663; Samanta A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042154; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; van der Werf GR, 2006, ATMOS CHEM PHYS, V6, P3423, DOI 10.5194/acp-6-3423-2006; van der Werf GR, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003122; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Zhao MS, 2005, REMOTE SENS ENVIRON, V95, P164, DOI 10.1016/j.rse.2004.12.011	36	1711	1862	77	1220	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 20	2010	329	5994					940	943		10.1126/science.1192666	http://dx.doi.org/10.1126/science.1192666			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640WN	20724633				2022-12-01	WOS:000281084800033
J	Nakada, S; Tai, I; Panier, S; Al-Hakim, A; Iemura, S; Juang, YC; O'Donnell, L; Kumakubo, A; Munro, M; Sicheri, F; Gingras, AC; Natsume, T; Suda, T; Durocher, D				Nakada, Shinichiro; Tai, Ikue; Panier, Stephanie; Al-Hakim, Abdallah; Iemura, Shun-ichiro; Juang, Yu-Chi; O'Donnell, Lara; Kumakubo, Ayako; Munro, Meagan; Sicheri, Frank; Gingras, Anne-Claude; Natsume, Tohru; Suda, Toshio; Durocher, Daniel			Non-canonical inhibition of DNA damage-dependent ubiquitination by OTUB1	NATURE			English	Article							DOUBLE-STRAND BREAKS; STATISTICAL-MODEL; STRUCTURAL BASIS; MAMMALIAN-CELLS; REPAIR PROTEINS; BINDING; COMPLEX; ENZYME; CHAINS; SPECIFICITY	DNA double-strand breaks (DSBs) pose a potent threat to genome integrity. These lesions also contribute to the efficacy of radiotherapy and many cancer chemotherapeutics. DSBs elicit a signalling cascade that modifies the chromatin surrounding the break, first by ATM-dependent phosphorylation and then by RNF8-, RNF168- and BRCA1-dependent regulatory ubiquitination. Here we report that OTUB1, a deubiquitinating enzyme, is an inhibitor of DSB-induced chromatin ubiquitination. Surprisingly, we found that OTUB1 suppresses RNF168-dependent poly-ubiquitination independently of its catalytic activity. OTUB1 does so by binding to and inhibiting UBC13 (also known as UBE2N), the cognate E2 enzyme for RNF168. This unusual mode of regulation is unlikely to be limited to UBC13 because analysis of OTUB1-associated proteins revealed that OTUB1 binds to E2s of the UBE2D and UBE2E subfamilies. Finally, OTUB1 depletion mitigates the DSB repair defect associated with defective ATM signalling, indicating that pharmacological targeting of the OTUB1-UBC13 interaction might enhance the DNA damage response.	[Panier, Stephanie; Al-Hakim, Abdallah; Juang, Yu-Chi; O'Donnell, Lara; Munro, Meagan; Sicheri, Frank; Gingras, Anne-Claude; Durocher, Daniel] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Nakada, Shinichiro; Tai, Ikue] Keio Univ, Sch Med, Ctr Integrated Med Res, Shinjuku Ku, Tokyo 1608582, Japan; [Nakada, Shinichiro; Tai, Ikue; Kumakubo, Ayako; Suda, Toshio] Keio Univ, Sch Med, Dept Cell Differentiat, Sakaguchi Lab Dev Biol,Shinjuku Ku, Tokyo 1608582, Japan; [Panier, Stephanie; Sicheri, Frank; Gingras, Anne-Claude; Durocher, Daniel] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Iemura, Shun-ichiro; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Biol Syst Control Team, Koto Ku, Tokyo 1350064, Japan	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Keio University; Keio University; University of Toronto; National Institute of Advanced Industrial Science & Technology (AIST)	Durocher, D (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	snakada@z3.keio.jp; durocher@lunenfeld.ca	OsakaU/AAY-3661-2020; Suda, Toshio/H-6761-2013; Gingras, Anne-Claude/E-9982-2010; Gingras, Anne-Claude/ABA-8341-2020; Durocher, Daniel/A-7733-2010; Sicheri, Frank/F-8856-2013; Panier, Stephanie/GVT-6365-2022; Natsume, Tohru/M-7627-2018	Suda, Toshio/0000-0001-7540-1771; Gingras, Anne-Claude/0000-0002-6090-4437; Gingras, Anne-Claude/0000-0002-6090-4437; Durocher, Daniel/0000-0003-3863-8635; Natsume, Tohru/0000-0002-1510-2582; Nakada, Shinichiro/0000-0001-9297-1565	Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan; MEXT [21870033]; Takeda Science Foundation; Mitsubishi Pharma Research Foundation; Daiwa Anglo-Japanese Foundation; New Energy and Industrial Technology Development Organization (NEDO); Boehringer Ingelheim Fonds; Canadian Institutes of Health Research [MOP10703115, MOP84314]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Pharma Research Foundation; Daiwa Anglo-Japanese Foundation(Daiwa Anglo-Japanese Foundation); New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We are grateful to T. Ikura, S. Olivarius, R. Sakasai, A. Shibata, T. Oikawa, J. Unno, Y. Katuski, I. Imoto, S. Koyasu, R. Greenberg and the Core Instrumentation Facility, Keio University School of Medicine for technical support and reagents. We also thank R. Szilard and S. Angers for reading the manuscript. Work in the Nakada group in the Suda laboratory is supported by the Promotion of Environmental Improvement for Independence of Young Researchers, 'Kanrinmaru Project' from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan, Grant-in-Aid for Young Scientists (Startup 2009, 21870033) from MEXT, Takeda Science Foundation, Mitsubishi Pharma Research Foundation and the Daiwa Anglo-Japanese Foundation. I. T. is supported by MEXT's Distinctive University Education Support Program 'Good Practice'. Work in the Natsume laboratory is supported by the New Energy and Industrial Technology Development Organization (NEDO). S. P. holds a studentship from the Boehringer Ingelheim Fonds. D. D. is the Thomas Kierans Chair in Mechanisms of Cancer Development and a Canada Research Chair (Tier 2) in Proteomics, Bioinformatics and Functional genomics. Work in the Durocher and Gingras laboratories is supported by grants MOP10703115 (DD) and MOP84314 (ACG) from the Canadian Institutes of Health Research.	Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; Beucher A, 2009, EMBO J, V28, P3413, DOI 10.1038/emboj.2009.276; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kittler R, 2005, NAT METHODS, V2, P779, DOI 10.1038/nmeth1005-779; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Petroski MD, 2007, J BIOL CHEM, V282, P29936, DOI 10.1074/jbc.M703911200; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Quesada V, 2004, BIOCHEM BIOPH RES CO, V314, P54, DOI 10.1016/j.bbrc.2003.12.050; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stewart GS, 2007, P NATL ACAD SCI USA, V104, P16910, DOI 10.1073/pnas.0708408104; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Tran H, 2008, GENE DEV, V22, P528, DOI 10.1101/gad.463208; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang T, 2009, J MOL BIOL, V386, P1011, DOI 10.1016/j.jmb.2008.12.085; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wu JX, 2009, MOL CELL BIOL, V29, P849, DOI 10.1128/MCB.01302-08	38	262	273	4	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2010	466	7309					941	U59		10.1038/nature09297	http://dx.doi.org/10.1038/nature09297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	640ED	20725033				2022-12-01	WOS:000281030300027
J	Hall, W; Chikritzhs, T				Hall, Wayne; Chikritzhs, Tanya			The Australian alcopops tax revisited	LANCET			English	Editorial Material							ALCOHOL PROGRAM; HEALTH; DRINKING; TAXATION; MODEL		[Hall, Wayne] Univ Queensland, UQ Ctr Clin Res, Herston, Qld 4029, Australia; [Chikritzhs, Tanya] Curtin Univ Technol, Natl Drug Res Inst, Perth, WA, Australia	University of Queensland; Curtin University	Hall, W (corresponding author), Univ Queensland, UQ Ctr Clin Res, Herston, Qld 4029, Australia.	w.hall@sph.uq.edu.au	Hall, Wayne D/A-3283-2008	Hall, Wayne D/0000-0003-1984-0096; Chikritzhs, Tanya/0000-0001-8871-3205				Australian Bureau of Statistics, 2010, APP CONS ALC AUSTR 2; Australian Bureau of Statistics, 2010, AUSTR WIN GRAP IND 2; Babor T., 2010, ALCOHOL NO ORDINARY; Chikritzhs T, 2005, ADDICTION, V100, P1625, DOI 10.1111/j.1360-0443.2005.01234.x; Chikritzhs TN, 2009, MED J AUSTRALIA, V190, P294, DOI 10.5694/j.1326-5377.2009.tb02415.x; Doran CM, 2008, LANCET, V372, P701, DOI 10.1016/S0140-6736(08)61287-8; Gray D, 1999, AUST NZ J PUBL HEAL, V23, P651, DOI 10.1111/j.1467-842X.1999.tb01554.x; Gruenewald PJ, 2010, J STUD ALCOHOL DRUGS, V71, P237, DOI 10.15288/jsad.2010.71.237; Hawks D V, 1990, Drug Alcohol Rev, V9, P91, DOI 10.1080/09595239000185121; Laslett A.-M., 2010, RANGE MAGNITUDE ALCO; Purshouse RC, 2010, LANCET, V375, P1355, DOI 10.1016/S0140-6736(10)60058-X; Stockwell T, 2001, Int J Drug Policy, V12, P139, DOI 10.1016/S0955-3959(01)00079-2; Stockwell T, 2001, DRUG ALCOHOL REV, V20, P167, DOI 10.1080/09595230124886; Vandenberg B, 2008, DRUG ALCOHOL REV, V27, P579, DOI 10.1080/09595230802491600; Victorian Alcohol and Drug Association, 2010, ALC TAX; Wagenaar AC, 2009, AM J PUBLIC HEALTH, V99, P1464, DOI 10.2105/AJPH.2007.131326	16	15	15	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2011	377	9772					1136	1137		10.1016/S0140-6736(10)61420-1	http://dx.doi.org/10.1016/S0140-6736(10)61420-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	750IH	20833425				2022-12-01	WOS:000289539300010
J	Pavelka, N; Rancati, G; Zhu, J; Bradford, WD; Saraf, A; Florens, L; Sanderson, BW; Hattem, GL; Li, R				Pavelka, Norman; Rancati, Giulia; Zhu, Jin; Bradford, William D.; Saraf, Anita; Florens, Laurence; Sanderson, Brian W.; Hattem, Gaye L.; Li, Rong			Aneuploidy confers quantitative proteome changes and phenotypic variation in budding yeast	NATURE			English	Article							IDENTIFICATION TECHNOLOGY; SACCHAROMYCES-CEREVISIAE; CELLS; EVOLUTION; PEPTIDES	Aneuploidy, referring here to genome contents characterized by abnormal numbers of chromosomes, has been associated with developmental defects, cancer and adaptive evolution in experimental organisms(1-9). However, it remains unresolved how aneuploidy impacts gene expression and whether aneuploidy could directly bring about phenotypic variation and improved fitness over that of euploid counterparts. Here we show, using quantitative mass spectrometry-based proteomics and phenotypic profiling, that levels of protein expression in aneuploid yeast strains largely scale with chromosome copy numbers, following the same trend as that observed for the transcriptome, and that aneuploidy confers diverse phenotypes. We designed a novel scheme to generate, through random meiotic segregation, 38 stable and fully isogenic aneuploid yeast strains with distinct karyotypes and genome contents between 1N and 3N without involving any genetic selection. Through quantitative growth assays under various conditions or in the presence of a panel of chemotherapeutic or antifungal drugs, we found that some aneuploid strains grew significantly better than euploid control strains under conditions suboptimal for the latter. These results provide strong evidence that aneuploidy directly affects gene expression at both the transcriptome and proteome levels and can generate significant phenotypic variation that could bring about fitness gains under diverse conditions. Our findings suggest that the fitness ranking between euploid and aneuploid cells is dependent on context and karyotype, providing the basis for the notion that aneuploidy can directly underlie phenotypic evolution and cellular adaptation.	[Pavelka, Norman; Rancati, Giulia; Zhu, Jin; Bradford, William D.; Saraf, Anita; Florens, Laurence; Sanderson, Brian W.; Hattem, Gaye L.; Li, Rong] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Li, Rong] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Li, R (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	rli@stowers.org	Pavelka, Norman/G-4577-2018	Pavelka, Norman/0000-0003-4542-9970; Hattem, Gaye/0000-0002-2411-3056; Florens, Laurence/0000-0002-9310-6650; Rancati, Giulia/0000-0003-0835-0139	NIH [RO1GM059964]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059964] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. W. Seidel for assistance with microarray data analysis, B. Fleharty and A. Peak for technical assistance with microarray hybridization, A. Perera and K. Walton for assistance in genome resequencing, W. McDowell for technical assistance with qPCR, J. Haug for technical support with flow cytometry experiments, G. Chen for technical suggestions, and A. Paulson for assistance with the submission of microarray and sequencing data to public repositories. This work was performed to fulfil, in part, requirements for J. Zhu's PhD thesis research as a student registered with the Open University. This work was supported by NIH grant RO1GM059964 to R.L.	de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Florens Laurence, 2006, V328, P159; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gresham D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000303; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; MACK M, 1988, MOL GEN GENET, V211, P260, DOI 10.1007/BF00330602; PARRY EM, 1970, GENET RES, V16, P333, DOI 10.1017/S0016672300002597; Pavelka N, 2010, CURR OPIN CELL BIOL, V22, P809, DOI 10.1016/j.ceb.2010.06.003; Polakova S, 2009, P NATL ACAD SCI USA, V106, P2688, DOI 10.1073/pnas.0809793106; Rancati G, 2008, CELL, V135, P879, DOI 10.1016/j.cell.2008.09.039; Selmecki A, 2008, MOL MICROBIOL, V68, P624, DOI 10.1111/j.1365-2958.2008.06176.x; Selmecki A, 2006, SCIENCE, V313, P367, DOI 10.1126/science.1128242; Selmecki AM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000705; Springer M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.19; STCHARLES J, 2010, GENETICS        0810, DOI DOI 10.1534/GENETICS.110.121533; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999	25	386	389	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	2010	468	7321					321	325		10.1038/nature09529	http://dx.doi.org/10.1038/nature09529			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678DG	20962780	Green Accepted			2022-12-01	WOS:000284051000054
J	Burden, AD; Boon, MH; Leman, J; Wilson, H; Richmond, R; Ormerod, AD				Burden, A. D.; Boon, M. Hilton; Leman, J.; Wilson, H.; Richmond, R.; Ormerod, A. D.		Guideline Dev Grp	Diagnosis and management of psoriasis and psoriatic arthritis in adults: summary of SIGN guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material							MYOCARDIAL-INFARCTION; EPIDEMIOLOGY; DISEASES; RISK		[Boon, M. Hilton] Scottish Intercollegiate Guidelines Network, Glasgow, Lanark, Scotland; [Burden, A. D.] Univ Glasgow, Western Infirm, Alan Lyell Ctr Dermatol, Glasgow G11 6NT, Lanark, Scotland; [Leman, J.] Western Infirm & Associated Hosp, Glasgow G11 6NT, Lanark, Scotland; [Wilson, H.] Stobhill Hosp, Glasgow G21 3UW, Lanark, Scotland; [Richmond, R.] Borders Gen Hosp, Melrose TD6 9BS, Roxburghshire, Scotland; [Ormerod, A. D.] Univ Aberdeen, Dept Appl Med, Aberdeen AB9 1FX, Scotland; [Ormerod, A. D.] Aberdeen Royal Infirm, Aberdeen AB25 2ZN, Scotland	University of Glasgow; University of Aberdeen; University of Aberdeen	Boon, MH (corresponding author), Scottish Intercollegiate Guidelines Network, Glasgow, Lanark, Scotland.	michele.hiltonboon@nhs.net	Boon, Michele Hilton/AAB-8745-2021; Ozakinci, Gozde/B-7897-2012	Boon, Michele Hilton/0000-0002-2240-7923; Ozakinci, Gozde/0000-0001-5869-3274	Janssen-Cilag; Merck; Serono; Schering-Plough; Abbott; Pfizer; Wyeth	Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); Serono; Schering-Plough(Merck & CompanySchering Plough Corporation); Abbott(Abbott Laboratories); Pfizer(Pfizer); Wyeth(Wyeth)	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no funding from any organisation for the submitted work; ADB has been paid for consultancy and delivering lectures for Abbott, Pfizer, MSD, Janssen-Cilag, Leo, and Basilea and does consultancy for Merck and Novartis; MHB is employed by SIGN; JL was paid to attend one Abbott Advisory Board meeting and to deliver postgraduate education by Leo, has received meeting expenses from Pfizer, and has undertaken trials funded by Janssen-Cilag, Merck, Serono, Schering-Plough, Abbott, and Pfizer; HW has been paid to provide expert testimony to the Psoriatic Arthritis Advisory Panel and to develop and deliver a Wyeth educational presentation, and has received expenses from Abbott to attend one conference; HW's institution will receive payment for participating in a study of the validity of the PEST questionnaire; RR received travel costs and a conference registration fee from Wyeth; ADO was paid to attend one Abbott advisory board meeting, one Schering-Plough advisory board meeting, and to deliver lectures for Wyeth and Abbott, and received expenses to attend one conference from Wyeth and one conference from Janssen-Cilag; ADO's institution has received grants to conduct clinical trials of biologics for Abbott, Wyeth, Schering-Plough, and Janssen-Cilag; no other relationships or activities that could appear to have influenced the submitted work.	Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Ibrahim GH, 2009, CLIN EXP RHEUMATOL, V27, P469; Kaye JA, 2008, BRIT J DERMATOL, V159, P895, DOI 10.1111/j.1365-2133.2008.08707.x; Kimball AB, 2005, AM J CLIN DERMATOL, V6, P383, DOI 10.2165/00128071-200506060-00005; Neimann AL, 2006, J AM ACAD DERMATOL, V55, P829, DOI 10.1016/j.jaad.2006.08.040; Rapp SR, 1999, J AM ACAD DERMATOL, V41, P401, DOI 10.1016/S0190-9622(99)70112-X; Reich K, 2009, BRIT J DERMATOL, V160, P1040, DOI 10.1111/j.1365-2133.2008.09023.x; SIGN, 2010, 121 SIGN	8	32	34	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 29	2010	341								c5623	10.1136/bmj.c5623	http://dx.doi.org/10.1136/bmj.c5623			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	674ZN	21036815	Green Submitted			2022-12-01	WOS:000283792500001
J	Halfmann, R; Lindquist, S				Halfmann, Randal; Lindquist, Susan			Epigenetics in the Extreme: Prions and the Inheritance of Environmentally Acquired Traits	SCIENCE			English	Editorial Material							YEAST; EVOLUTION; FORM	Prions are an unusual form of epigenetics: Their stable inheritance and complex phenotypes come about through protein folding rather than nucleic acid-associated changes. With intimate ties to protein homeostasis and a remarkable sensitivity to stress, prions are a robust mechanism that links environmental extremes with the acquisition and inheritance of new traits.	[Halfmann, Randal; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Halfmann, Randal; Lindquist, Susan] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lindquist, Susan] Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu		Halfmann, Randal/0000-0002-6592-1471	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Brown JCS, 2009, GENE DEV, V23, P2320, DOI 10.1101/gad.1839109; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Derdowski A, 2010, SCIENCE, V330, P680, DOI 10.1126/science.1197785; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Eigen M, 1996, BIOPHYS CHEM, V63, pA1, DOI 10.1016/S0301-4622(96)02250-8; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; Fleming AB, 2001, EMBO J, V20, P5219, DOI 10.1093/emboj/20.18.5219; Halfmann R, 2010, TRENDS CELL BIOL, V20, P125, DOI 10.1016/j.tcb.2009.12.003; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Koonin EV, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-42; Lancaster AK, 2010, GENETICS, V184, P393, DOI 10.1534/genetics.109.110213; Masel J, 2009, TRENDS GENET, V25, P395, DOI 10.1016/j.tig.2009.07.005; Namy O, 2008, NAT CELL BIOL, V10, P1069, DOI 10.1038/ncb1766; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Rogoza T, 2010, P NATL ACAD SCI USA, V107, P10573, DOI 10.1073/pnas.1005949107; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Saupe SJ, 2007, PRION, V1, P110, DOI 10.4161/pri.1.2.4666; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shkundina IS, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1519, DOI 10.1134/S0006297907130081; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; Uversky VN, 2009, FRONT BIOSCI-LANDMRK, V14, P5188, DOI 10.2741/3594; Weissman DB, 2009, THEOR POPUL BIOL, V75, P286, DOI 10.1016/j.tpb.2009.02.006; West-Eberhard Mary Jane, 2003, pi	31	162	165	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 29	2010	330	6004					629	632		10.1126/science.1191081	http://dx.doi.org/10.1126/science.1191081			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672KB	21030648				2022-12-01	WOS:000283580600036
J	Law, MJ; Lower, KM; Voon, HPJ; Hughes, JR; Garrick, D; Viprakasit, V; Mitson, M; De Gobbi, M; Marra, M; Morris, A; Abbott, A; Wilder, SP; Taylor, S; Santos, GM; Cross, J; Ayyub, H; Jones, S; Ragoussis, J; Rhodes, D; Dunham, I; Higgs, DR; Gibbons, RJ				Law, Martin J.; Lower, Karen M.; Voon, Hsiao P. J.; Hughes, Jim R.; Garrick, David; Viprakasit, Vip; Mitson, Matthew; De Gobbi, Marco; Marra, Marco; Morris, Andrew; Abbott, Aaron; Wilder, Steven P.; Taylor, Stephen; Santos, Guilherme M.; Cross, Joe; Ayyub, Helena; Jones, Steven; Ragoussis, Jiannis; Rhodes, Daniela; Dunham, Ian; Higgs, Douglas R.; Gibbons, Richard J.			ATR-X Syndrome Protein Targets Tandem Repeats and Influences Allele-Specific Expression in a Size-Dependent Manner	CELL			English	Article							LINKED MENTAL-RETARDATION; CHROMATIN IMMUNOPRECIPITATION; HISTONE CHAPERONE; MUTATIONS; LOCALIZATION; DAXX; HETEROCHROMATIN; QUADRUPLEXES; BINDING; GENES	ATRX is an X-linked gene of the SWI/SNF family, mutations in which cause syndromal mental retardation and downregulation of a-globin expression. Here we show that ATRX binds to tandem repeat (TR) sequences in both telomeres and euchromatin. Genes associated with these TRs can be dysregulated when ATRX is mutated, and the change in expression is determined by the size of the TR, producing skewed allelic expression. This reveals the characteristics of the affected genes, explains the variable phenotypes seen with identical ATRX mutations, and illustrates a new mechanism underlying variable penetrance. Many of the TRs are G rich and predicted to form non-B DNA structures (including G-quadruplex) in vivo. We show that ATRX binds G-quadruplex structures in vitro, suggesting a mechanism by which ATRX may play a role in various nuclear processes and how this is perturbed when ATRX is mutated.	[Law, Martin J.; Lower, Karen M.; Voon, Hsiao P. J.; Hughes, Jim R.; Garrick, David; Mitson, Matthew; De Gobbi, Marco; Cross, Joe; Ayyub, Helena; Higgs, Douglas R.; Gibbons, Richard J.] John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Mol Haematol Unit, Oxford OX3 9DS, England; [Taylor, Stephen] John Radcliffe Hosp, Weatherall Inst Mol Med, Computat Biol Res Grp, Oxford OX3 9DS, England; [Viprakasit, Vip] Mahidol Univ, Siriaj Hosp, Fac Med, Dept Paediat, Bangkok 10700, Thailand; [Morris, Andrew; Abbott, Aaron; Ragoussis, Jiannis] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Wilder, Steven P.; Dunham, Ian] European Bioinformat Inst, Cambridge CB10 1SD, England; [Santos, Guilherme M.; Rhodes, Daniela] MRC, Struct Studies Div, Mol Biol Lab, Cambridge CB2 0QH, England; [Marra, Marco; Jones, Steven] Univ British Columbia, BCCA Genome Sci Ctr, Vancouver, BC V6T 1Z4, Canada	University of Oxford; University of Oxford; Mahidol University; University of Oxford; Wellcome Centre for Human Genetics; European Molecular Biology Laboratory (EMBL); MRC Laboratory Molecular Biology; University of British Columbia	Gibbons, RJ (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Mol Haematol Unit, Oxford OX3 9DS, England.	richard.gibbons@imm.ox.ac.uk	GARRICK, David/O-5734-2019; De Gobbi, Marco/E-8136-2013; Garrick, David/F-1728-2017; Voon, Hsiao/G-9264-2014; Ragoussis, Ioannis/AAD-9790-2022; Marra, Marco A/B-5987-2008; Jones, Steven J/C-3621-2009; Gibbons, Richard/E-6937-2011	GARRICK, David/0000-0001-7422-7986; Garrick, David/0000-0001-7422-7986; Voon, Hsiao/0000-0002-7179-6611; Marra, Marco A/0000-0001-7146-7175; Jones, Steven J/0000-0003-3394-2208; Higgs, Douglas/0000-0003-3579-8705; Dunham, Ian/0000-0003-2525-5598; Cross, Joe Wilson/0000-0003-4814-7098; Lower, Karen/0000-0003-2196-5234; Wilder, Steven/0000-0001-8049-2559; Gibbons, Richard/0000-0002-7680-9311; De Gobbi, Marco/0000-0003-4261-7642; Ragoussis, Ioannis/0000-0002-8515-0934; Santos, Guilherme/0000-0003-1489-2161	Medical Research Council; National Institute of Health Biomedical Research Centre; Thailand Research Fund (TRF); BIOTEC, Thailand; Oxford University; Medical Research Council [G1000801b, MC_U105184333, MC_U137961147, G1000801j] Funding Source: researchfish; MRC [MC_U105184333, MC_U137961147] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Biomedical Research Centre; Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); BIOTEC, Thailand; Oxford University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the members of the families studied for their participation; S. Butler and J. Sloane-Stanley for tissue culture; C. Wippo, J. Huddleston, and L. Marcelline for genotyping; P. Vathesatogkit and R. Totong for SNP validation; A. Goriely for assistance with pyrosequencing; C. Bachrati for gel-shift probes; and W. Wood for critical reading of the manuscript. In addition to others, the work was supported by the Medical Research Council and the National Institute of Health Biomedical Research Centre Programme. V.V. is supported by Thailand Research Fund (TRF) and BIOTEC, Thailand. K.M.L. was supported by an Oxford Nuffield Medical Fellowship, Oxford University.	Argentaro A, 2007, P NATL ACAD SCI USA, V104, P11939, DOI 10.1073/pnas.0704057104; Bachrati CZ, 2006, METHOD ENZYMOL, V409, P86, DOI 10.1016/S0076-6879(05)09005-1; Bacolla A, 2009, MOL CARCINOGEN, V48, P273, DOI 10.1002/mc.20507; Berube NG, 2000, HUM MOL GENET, V9, P539, DOI 10.1093/hmg/9.4.539; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; De Gobbi M, 2007, BLOOD, V110, P4503, DOI 10.1182/blood-2007-06-097964; DIGNAM JD, 1990, METHOD ENZYMOL, V182, P194; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; FIBACH E, 1991, INT J CELL CLONING, V9, P57, DOI 10.1002/stem.5530090108; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Gibbons RJ, 2008, HUM MUTAT, V29, P796, DOI 10.1002/humu.20734; GIBBONS RJ, 1991, J MED GENET, V28, P729, DOI 10.1136/jmg.28.11.729; GIBBONS RJ, 1992, AM J HUM GENET, V51, P1136; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; Gibbons RJ, 2000, NAT GENET, V24, P368, DOI 10.1038/74191; GIRALDO R, 1994, P NATL ACAD SCI USA, V91, P7658, DOI 10.1073/pnas.91.16.7658; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Higgs DR, 1998, SEMIN HEMATOL, V35, P93; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kernohan KD, 2010, DEV CELL, V18, P191, DOI 10.1016/j.devcel.2009.12.017; Kourmouli N, 2005, BIOCHEM BIOPH RES CO, V337, P901, DOI 10.1016/j.bbrc.2005.09.132; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; McDowell TL, 1999, P NATL ACAD SCI USA, V96, P13983, DOI 10.1073/pnas.96.24.13983; Paramasivan S, 2007, METHODS, V43, P324, DOI 10.1016/j.ymeth.2007.02.009; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Schneiderman JI, 2009, P NATL ACAD SCI USA, V106, P14472, DOI 10.1073/pnas.0905816106; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WILKIE AOM, 1990, AM J HUM GENET, V46, P1127; Wong LH, 2010, GENOME RES, V20, P351, DOI 10.1101/gr.101477.109; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100	37	286	297	3	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 29	2010	143	3					367	378		10.1016/j.cell.2010.09.023	http://dx.doi.org/10.1016/j.cell.2010.09.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672RF	21029860	Bronze			2022-12-01	WOS:000283603900011
J	Tian, D; Sun, S; Lee, JT				Tian, Di; Sun, Sha; Lee, Jeannie T.			The Long Noncoding RNA, Jpx, Is a Molecular Switch for X Chromosome Inactivation	CELL			English	Article							IMPRINTED XIST EXPRESSION; EMBRYONIC STEM-CELLS; EARLY MOUSE EMBRYOS; DOSAGE COMPENSATION; TSIX TRANSCRIPTION; ANTISENSE TRANSCRIPTION; CHROMATIN-STRUCTURE; GENE; METHYLATION; REPEAT	Once protein-coding, the X-inactivation center (Xic) is now dominated by large noncoding RNAs (ncRNA). X chromosome inactivation (XCI) equalizes gene expression between mammalian males and females by inactivating one X in female cells. XCI requires Xist, an ncRNA that coats the X and recruits Polycomb proteins. How Xist is controlled remains unclear but likely involves negative and positive regulators. For the active X, the antisense Tsix RNA is an established Xist repressor. For the inactive X, here, we identify Xic-encoded Jpx as an Xist activator. Jpx is developmentally regulated and accumulates during XCI. Deleting Jpx blocks XCI and is female lethal. Posttranscriptional Jpx knockdown recapitulates the knockout, and supplying Jpx in trans rescues lethality. Thus, Jpx is trans-acting and functions as ncRNA. Furthermore, Delta Jpx is rescued by truncating Tsix, indicating an antagonistic relationship between the ncRNAs. We conclude that Xist is controlled by two RNA-based switches: Tsix for Xa and Jpx for Xi.	[Tian, Di; Sun, Sha; Lee, Jeannie T.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Tian, Di; Sun, Sha; Lee, Jeannie T.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02115 USA; [Tian, Di; Sun, Sha; Lee, Jeannie T.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Tian, Di; Lee, Jeannie T.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Lee, JT (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA.	lee@molbio.mgh.harvard.edu			NIH [K08-HD053824, RO1-GM58839];  [T32-CA009216]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD053824] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058839] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Jeon for providing Xist riboprobes, and A. Chess, D. Lessing, B. Payer, and S. Pinter for critical reading of the manuscript and all members of the laboratory for their helpful input throughout this project. This work was funded by NIH grants K08-HD053824 to D.T., RO1-GM58839 to J.T.L., and a Pathology training grant T32-CA009216. J.T.L. is also an Investigator of the Howard Hughes Medical Institute.	Ahn Janice Y, 2010, BMC Dev Biol, V10, P90, DOI 10.1186/1471-213X-10-90; ARIEL M, 1995, NAT GENET, V9, P312, DOI 10.1038/ng0395-312; Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1991, NATURE, V349, P82, DOI 10.1038/349082a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; CATTANACH BM, 1967, GENETICS, V57, P331; Chow JC, 2003, GENOMICS, V82, P309, DOI 10.1016/S0888-7543(03)00170-8; Chureau C, 2002, GENOME RES, V12, P894, DOI 10.1101/gr.152902; Clemson CM, 2006, P NATL ACAD SCI USA, V103, P7688, DOI 10.1073/pnas.0601069103; Davidow LS, 2007, CHROMOSOME RES, V15, P137, DOI 10.1007/s10577-007-1121-6; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; Hoki Y, 2009, DEVELOPMENT, V136, P139, DOI 10.1242/dev.026427; Hore TA, 2007, CHROMOSOME RES, V15, P147, DOI 10.1007/s10577-007-1119-0; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Johnston CM, 2002, GENOMICS, V80, P236, DOI 10.1006/geno.2002.6819; Jonkers I, 2009, CELL, V139, P999, DOI 10.1016/j.cell.2009.10.034; Koerner MV, 2009, DEVELOPMENT, V136, P1771, DOI 10.1242/dev.030403; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; Lee JT, 2000, CELL, V103, P17, DOI 10.1016/S0092-8674(00)00101-X; Lee JT, 2005, SCIENCE, V309, P768, DOI 10.1126/science.1113673; Lee JT, 1999, P NATL ACAD SCI USA, V96, P3836, DOI 10.1073/pnas.96.7.3836; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lucchesi JC, 2005, ANNU REV GENET, V39, P615, DOI 10.1146/annurev.genet.39.073003.094210; Luikenhuis S, 2001, MOL CELL BIOL, V21, P8512, DOI 10.1128/MCB.21.24.8512-8520.2001; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; MONK M, 1979, NATURE, V281, P311, DOI 10.1038/281311a0; Monkhorst K, 2008, CELL, V132, P410, DOI 10.1016/j.cell.2007.12.036; Morey C, 2004, EMBO J, V23, P594, DOI 10.1038/sj.emboj.7600071; Namekawa SH, 2010, MOL CELL BIOL, V30, P3187, DOI 10.1128/MCB.00227-10; Navarro P, 2005, GENE DEV, V19, P1474, DOI 10.1101/gad.341105; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Nicodemi M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108104; NORRIS DP, 1994, CELL, V77, P41, DOI 10.1016/0092-8674(94)90233-X; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Ogawa Y, 2008, SCIENCE, V320, P1336, DOI 10.1126/science.1157676; Ohhata T, 2006, CYTOGENET GENOME RES, V113, P345, DOI 10.1159/000090851; Ohhata T, 2008, DEVELOPMENT, V135, P227, DOI 10.1242/dev.008490; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Sado T, 2005, DEV CELL, V9, P159, DOI 10.1016/j.devcel.2005.05.015; Sado T, 2001, DEVELOPMENT, V128, P1275; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Shevchenko AI, 2007, CHROMOSOME RES, V15, P127, DOI 10.1007/s10577-006-1115-9; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Simmler MC, 1996, HUM MOL GENET, V5, P1713, DOI 10.1093/hmg/5.11.1713; Starmer J, 2009, DEVELOPMENT, V136, P1, DOI 10.1242/dev.025908; Stavropoulos N, 2001, P NATL ACAD SCI USA, V98, P10232, DOI 10.1073/pnas.171243598; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Tsai CL, 2008, DEV BIOL, V319, P416, DOI 10.1016/j.ydbio.2008.04.010; Vigneau S, 2006, P NATL ACAD SCI USA, V103, P7390, DOI 10.1073/pnas.0602381103; Wan LB, 2008, ADV GENET, V61, P207, DOI 10.1016/S0065-2660(07)00007-7; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Wutz A, 2007, CURR OPIN GENET DEV, V17, P387, DOI 10.1016/j.gde.2007.08.001; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; Yang Y, 2003, NAT BIOTECHNOL, V21, P447, DOI 10.1038/nbt803; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; ZUCCOTTI M, 1995, NAT GENET, V9, P316, DOI 10.1038/ng0395-316	63	363	399	2	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 29	2010	143	3					390	403		10.1016/j.cell.2010.09.049	http://dx.doi.org/10.1016/j.cell.2010.09.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672RF	21029862	Bronze, Green Accepted			2022-12-01	WOS:000283603900013
J	Baker, M				Baker, M.			Genomics Seeing more SNPs	NATURE			English	Editorial Material																			0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 28	2010	467	7319					1138	1138		10.1038/4671138a	http://dx.doi.org/10.1038/4671138a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671XW	20981105	Bronze			2022-12-01	WOS:000283548600059
J	Rappaport, SM; Smith, MT				Rappaport, Stephen M.; Smith, Martyn T.			Environment and Disease Risks	SCIENCE			English	Editorial Material							GENOME; DAMAGE		[Rappaport, Stephen M.; Smith, Martyn T.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Rappaport, SM (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	srappaport@berkeley.edu			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004705, U54ES016115] Funding Source: NIH RePORTER; NIEHS NIH HHS [U54 ES016115, P42 ES004705, P42ES04705, U54ES016115] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Collins FS, 2003, SCIENCE, V300, P286, DOI 10.1126/science.1084564; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Dunn WB, 2008, INT J EPIDEMIOL, V37, P23, DOI 10.1093/ije/dym281; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Haltdorsson TL, 2009, ENVIRON RES, V109, P22, DOI 10.1016/j.envres.2008.08.011; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Liebler DC, 2008, CHEM RES TOXICOL, V21, P117, DOI 10.1021/tx700235t; McHale CM, 2010, MUTAT RES-REV MUTAT, V705, P172, DOI 10.1016/j.mrrev.2010.04.001; Mounicou S, 2009, CHEM SOC REV, V38, P1119, DOI 10.1039/b713633c; Patel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010746; Rubino FM, 2009, MASS SPECTROM REV, V28, P725, DOI 10.1002/mas.20207; Vineis P, 2004, INT J EPIDEMIOL, V33, P945, DOI 10.1093/ije/dyh277; Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456; Willett WC, 2002, SCIENCE, V296, P695, DOI 10.1126/science.1071055	15	477	506	14	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					460	461		10.1126/science.1192603	http://dx.doi.org/10.1126/science.1192603			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966241	Green Accepted			2022-12-01	WOS:000283329100026
J	Long, F; Su, CC; Zimmermann, MT; Boyken, SE; Rajashankar, KR; Jernigan, RL; Yu, EW				Long, Feng; Su, Chih-Chia; Zimmermann, Michael T.; Boyken, Scott E.; Rajashankar, Kanagalaghatta R.; Jernigan, Robert L.; Yu, Edward W.			Crystal structures of the CusA efflux pump suggest methionine-mediated metal transport	NATURE			English	Article							MEMBRANE-FUSION PROTEIN; MULTIDRUG EFFLUX; RECOGNITION; SYSTEM; CU(I); CRYSTALLOGRAPHY; RESISTANCE; SOFTWARE; DYNAMICS; COMPLEX	Gram-negative bacteria, such as Escherichia coli, frequently use tripartite efflux complexes in the resistance-nodulation-cell division (RND) family to expel various toxic compounds from the cell(1,2). The efflux system CusCBA is responsible for extruding biocidal Cu(I) and Ag(I) ions(3,4). No previous structural information was available for the heavy-metal efflux (HME) subfamily of the RND efflux pumps. Here we describe the crystal structures of the inner-membrane transporter CusA in the absence and presence of bound Cu(I) or Ag(I). These CusA structures provide new structural information about the HME subfamily of RND efflux pumps. The structures suggest that the metal-binding sites, formed by a three-methionine cluster, are located within the cleft region of the periplasmic domain. This cleft is closed in the apo-CusA form but open in the CusA-Cu(I) and CusA-Ag(I) structures, which directly suggests a plausible pathway for ion export. Binding of Cu(I) and Ag(I) triggers significant conformational changes in both the periplasmic and transmembrane domains. The crystal structure indicates that CusA has, in addition to the three-methionine metal-binding site, four methionine pairs-three located in the transmembrane region and one in the periplasmic domain. Genetic analysis and transport assays suggest that CusA is capable of actively picking up metal ions from the cytosol, using these methionine pairs or clusters to bind and export metal ions. These structures suggest a stepwise shuttle mechanism for transport between these sites.	[Long, Feng; Yu, Edward W.] Iowa State Univ, Mol Cellular & Dev Biol Interdept Grad Program, Ames, IA 50011 USA; [Su, Chih-Chia; Yu, Edward W.] Iowa State Univ, Dept Chem, Ames, IA 50011 USA; [Zimmermann, Michael T.; Boyken, Scott E.; Jernigan, Robert L.; Yu, Edward W.] Iowa State Univ, Bioinformat & Computat Biol Interdept Grad Progra, Ames, IA 50011 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Dept Chem & Chem Biol, Argonne Natl Lab, Argonne, IL 60439 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, NE CAT, Argonne Natl Lab, Argonne, IL 60439 USA; [Jernigan, Robert L.; Yu, Edward W.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Yu, Edward W.] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA	Iowa State University; Iowa State University; Iowa State University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Iowa State University; Iowa State University	Yu, EW (corresponding author), Iowa State Univ, Mol Cellular & Dev Biol Interdept Grad Program, Ames, IA 50011 USA.	ewyu@iastate.edu	Long, Feng/F-5475-2011; Jernigan, Robert L/A-5421-2012	Long, Feng/0000-0001-6313-8558; Jernigan, Robert L/0000-0003-0996-8360; Zimmermann, Michael/0000-0001-7073-0525; Boyken, Scott/0000-0002-5378-0632	National Institutes of Health (NIH), National Center for Research Resources [RR-15301]; US Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NIH [GM074027, GM086431, GM081680, GM072014]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086431, R01GM072014, R01GM081680, R01GM074027] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. D. Routh for critical reading of the manuscript. This work is based on research conducted at the Northeastern Collaborative Access Team beamlines of the Advanced Photon Source, supported by National Institutes of Health (NIH) award RR-15301 from the National Center for Research Resources. Use of the Advanced Photon Source is supported by the US Department of Energy, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357. This work was supported by NIH grants GM074027 (to E.W.Y.), GM086431 (to E.W.Y.), GM081680 (to R.L.J.) and GM072014 (to R.L.J.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aires JR, 2005, J BACTERIOL, V187, P1923, DOI 10.1128/JB.187.6.1923-1929.2005; Akama H, 2004, J BIOL CHEM, V279, P52816, DOI 10.1074/jbc.C400445200; Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; Arnesano F, 2001, BIOCHEMISTRY-US, V40, P1528, DOI 10.1021/bi0014711; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banci L, 2006, NAT CHEM BIOL, V2, P367, DOI 10.1038/nchembio797; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; Franke S, 2001, MICROBIOL-SGM, V147, P965, DOI 10.1099/00221287-147-4-965; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Goldberg M, 1999, J BIOL CHEM, V274, P26065, DOI 10.1074/jbc.274.37.26065; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; Jiang JF, 2005, INORG CHEM, V44, P9787, DOI 10.1021/ic051180m; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Loftin IR, 2007, PROTEIN SCI, V16, P2287, DOI 10.1110/ps.073021307; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OTWINOWSKI Z, 1991, CCP4 P, V80; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sennhauser G, 2007, PLOS BIOL, V5, P106, DOI 10.1371/journal.pbio.0050007; Sennhauser G, 2009, J MOL BIOL, V389, P134, DOI 10.1016/j.jmb.2009.04.001; Su CC, 2006, J BACTERIOL, V188, P7290, DOI 10.1128/JB.00684-06; Su CC, 2009, J MOL BIOL, V393, P342, DOI 10.1016/j.jmb.2009.08.029; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Xue Y, 2008, NAT CHEM BIOL, V4, P107, DOI 10.1038/nchembio.2007.57; Zhou H, 2001, J BIOL CHEM, V276, P20529, DOI 10.1074/jbc.M102004200	44	174	177	1	70	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2010	467	7314					484	U140		10.1038/nature09395	http://dx.doi.org/10.1038/nature09395			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KO	20865003	Green Accepted			2022-12-01	WOS:000282090200048
J	Delamothe, T; Knapton, M; Richardson, E				Delamothe, Tony; Knapton, Mike; Richardson, Eve			We're all going to die. Deal with it	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Delamothe, Tony] BMJ, London WC1H 9JR, England; [Knapton, Mike] British Heart Fdn, London NW1 7AW, England; [Richardson, Eve] Natl Council Palliat Care, London N7 9AS, England	University of London; University College London	Delamothe, T (corresponding author), BMJ, London WC1H 9JR, England.	tdelamothe@bmj.com			British Heart Foundation	British Heart Foundation(British Heart Foundation)	We are pleased to acknowledge the financial support of the British Heart Foundation in producing this Spotlight. The articles were commissioned and peer reviewed according to the BMJ's usual process. We benefited from discussions with Jane Maher, Scott Murray, Ruth Sack, and Teresa Tate.	Barclay S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4862; Bell D, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3231; Boyd K, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4863; Ellershaw J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4861; General Medical Council, 2010, TREATM CAR END LIF G; Grant L, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4859; Seymour JE, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4860	7	6	6	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 16	2010	341								c5028	10.1136/bmj.c5028	http://dx.doi.org/10.1136/bmj.c5028			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653MO	20847024				2022-12-01	WOS:000282095800015
J	Moreno-Risueno, MA; Van Norman, JM; Moreno, A; Zhang, JY; Ahnert, SE; Benfey, PN				Moreno-Risueno, Miguel A.; Van Norman, Jaimie M.; Moreno, Antonio; Zhang, Jingyuan; Ahnert, Sebastian E.; Benfey, Philip N.			Oscillating Gene Expression Determines Competence for Periodic Arabidopsis Root Branching	SCIENCE			English	Article							PATTERN DETECTION; AUXIN TRANSPORT; INITIATION; MODEL	Plants and animals produce modular developmental units in a periodic fashion. In plants, lateral roots form as repeating units along the root primary axis; however, the developmental mechanism regulating this process is unknown. We found that cyclic expression pulses of a reporter gene mark the position of future lateral roots by establishing prebranch sites and that prebranch site production and root bending are periodic. Microarray and promoter-luciferase studies revealed two sets of genes oscillating in opposite phases at the root tip. Genetic studies show that some oscillating transcriptional regulators are required for periodicity in one or both developmental processes. This molecular mechanism has characteristics that resemble molecular clock-driven activities in animal species.	[Moreno-Risueno, Miguel A.; Van Norman, Jaimie M.; Zhang, Jingyuan; Benfey, Philip N.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Moreno-Risueno, Miguel A.; Van Norman, Jaimie M.; Zhang, Jingyuan; Benfey, Philip N.] Duke Univ, Inst Genome Sci, Durham, NC 27708 USA; [Moreno-Risueno, Miguel A.; Van Norman, Jaimie M.; Zhang, Jingyuan; Benfey, Philip N.] Duke Univ, Policy Ctr Syst Biol, Durham, NC 27708 USA; [Moreno, Antonio] CSIC, Inst Acust, Dept Acust Ambiental, E-28006 Madrid, Spain; [Ahnert, Sebastian E.] Univ Cambridge, Cavendish Lab, Condensed Matter Theory Grp, Cambridge CB3 0HE, England	Duke University; Duke University; Duke University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acustica (IA); University of Cambridge	Benfey, PN (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	philip.benfey@duke.edu	MORENO-RISUENO, MIGUEL ANGEL/J-8832-2016	MORENO-RISUENO, MIGUEL ANGEL/0000-0002-9794-1450	Defense Advanced Research Projects Agency (DARPA) [HR0011-05-1-0057, HR0011-09-1-0055]; NIH [R01-GM043778]; Ministry of Science and Innovation (MICINN), government of Spain; Leverhulme Trust, UK; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043778] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Innovation (MICINN), government of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Leverhulme Trust, UK(Leverhulme Trust); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Tsukagoshi for cloning the promoter regions of ARF7, SHP1, and ATAF1. This work was supported by grants to P.N.B. from Defense Advanced Research Projects Agency (DARPA, grants HR0011-05-1-0057 and HR0011-09-1-0055) and the NIH (R01-GM043778); a fellowship from the Ministry of Science and Innovation (MICINN), government of Spain, to M.A.M.-R.; a National Research Service Award fellowship from the NIH to J.M.V.N.; and support from the Leverhulme Trust, UK, to S.E.A. We thank W. Busch, J. Petricka, I. Rubio-Somoza, and R. Sozzani for critical reading of the manuscript. The authors would like to thank O. Pourquie for many useful discussions. The authors have declared that no competing interests exist. The National Center for Biotechnology Information Gene Expression Omnibus accession numbers for new microarrays data discussed in this manuscript are GSE21611.	Ahnert SE, 2006, BIOINFORMATICS, V22, P1471, DOI 10.1093/bioinformatics/btl121; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; De Smet I, 2008, SCIENCE, V322, P594, DOI 10.1126/science.1160158; De Smet I, 2007, DEVELOPMENT, V134, P681, DOI 10.1242/dev.02753; De Smet I, 2010, P NATL ACAD SCI USA, V107, P2705, DOI 10.1073/pnas.0915001107; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Dequeant ML, 2006, SCIENCE, V314, P1595, DOI 10.1126/science.1133141; Dequeant ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002856; Dinneny JR, 2005, BIOESSAYS, V27, P42, DOI 10.1002/bies.20165; Ditengou FA, 2008, P NATL ACAD SCI USA, V105, P18818, DOI 10.1073/pnas.0807814105; Dubrovsky JG, 2006, ANN BOT-LONDON, V97, P903, DOI 10.1093/aob/mcj604; Dubrovsky JG, 2008, P NATL ACAD SCI USA, V105, P8790, DOI 10.1073/pnas.0712307105; Dunlap JC, 2007, COLD SPRING HARB SYM, V72, P57, DOI 10.1101/sqb.2007.72.072; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Fukaki H, 2007, INT REV CYTOL, V256, P111, DOI 10.1016/S0074-7696(07)56004-3; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Himanen K, 2004, P NATL ACAD SCI USA, V101, P5146, DOI 10.1073/pnas.0308702101; Jonsson H, 2006, P NATL ACAD SCI USA, V103, P1633, DOI 10.1073/pnas.0509839103; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Laskowski M, 2008, PLOS BIOL, V6, P2721, DOI 10.1371/journal.pbio.0060307; Lu PL, 2007, PLANT MOL BIOL, V63, P289, DOI 10.1007/s11103-006-9089-8; Lucas M, 2008, J EXP BOT, V59, P55, DOI 10.1093/jxb/erm171; Lucas M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003673; Malamy JE, 1997, DEVELOPMENT, V124, P33; Malamy JE, 2001, PLANT PHYSIOL, V127, P899, DOI 10.1104/pp.010406; McGregor Alistair P., 2009, Communicative & Integrative Biology, V2, P174; McSteen P, 2005, ANNU REV PLANT BIOL, V56, P353, DOI 10.1146/annurev.arplant.56.032604.144122; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; Peret B, 2009, TRENDS PLANT SCI, V14, P399, DOI 10.1016/j.tplants.2009.05.002; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Schroter C, 2008, DEV DYNAM, V237, P545, DOI 10.1002/dvdy.21458; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vanneste S, 2005, PLANT CELL, V17, P3035, DOI 10.1105/tpc.105.035493; Yant L, 2009, CURR OPIN PLANT BIOL, V12, P580, DOI 10.1016/j.pbi.2009.07.006	34	399	406	2	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2010	329	5997					1306	1311		10.1126/science.1191937	http://dx.doi.org/10.1126/science.1191937			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647YR	20829477	Green Accepted			2022-12-01	WOS:000281657300028
J	Ortega, F; Escaso, F; Sanz, JL				Ortega, Francisco; Escaso, Fernando; Sanz, Jose L.			A bizarre, humped Carcharodontosauria (Theropoda) from the Lower Cretaceous of Spain	NATURE			English	Article							DINOSAUR; FEATHER; PHYLOGENY; EVOLUTION	Carcharodontosaurs were the largest predatory dinosaurs, and their early evolutionary history seems to be more intricate than was previously thought. Until recently, carcharodontosaurs were restricted to a group of large theropods inhabiting the Late Cretaceous Gondwanan land masses(1,2), but in the last few years Laurasian evidence(3-5) has been causing a reevaluation of their initial diversification(6). Here we describe an almost complete and exquisitely preserved skeleton of a medium-sized (roughly six metres long) theropod from the Lower Cretaceous series (Barremian stage) Konservat-Lagerstatte of Las Hoyas(7) in Cuenca, Spain. Cladistic analysis supports the idea that the new taxon Concavenator corcovatus is a primitive member of Carcharodontosauria(6), exhibiting two unusual features: elongation of the neurapophyses of two presacral vertebrae forming a pointed, hump-like structure and a series of small bumps on the ulna. We think that these bumps are homologous to quill knobs present on some modern birds; the knobs are related to the insertion area of follicular ligaments that anchor the roots of the flight feathers (remiges) to the arm. We propose that Concavenator has integumentary follicular structures inserted on the ulna, as in modern birds. Because scales do not have follicles, we consider the structures anchored to the Concavenator arms to be non-scale skin appendages homologous to the feathers of modern birds. If this is true, then the phylogenetic bracket for the presence of non-scale skin structures homologous to feathers in theropod dinosaurs would be extended to the Neotetanurae, enlarging the scope for explaining the origin of feathers in theropods.	[Ortega, Francisco; Escaso, Fernando] Univ Nacl Educ Distancia, Fac Ciencias, Dept Fis Matemat & Fluidos, Grp Biol, E-28040 Madrid, Spain; [Escaso, Fernando; Sanz, Jose L.] Univ Autonoma Madrid, Fac Ciencias, Dept Biol, Unidad Paleontol, E-28049 Madrid, Spain	Universidad Nacional de Educacion a Distancia (UNED); Autonomous University of Madrid	Ortega, F (corresponding author), Univ Nacl Educ Distancia, Fac Ciencias, Dept Fis Matemat & Fluidos, Grp Biol, Paseo Senda del Rey 9, E-28040 Madrid, Spain.	fortega@ccia.uned.es	Ortega, Francisco/B-5760-2009; Ortega, Francisco/K-3255-2015; Escaso, Fernando/H-9782-2015; Sanz, Jose Luis/O-1421-2019	Ortega, Francisco/0000-0002-7431-354X; Ortega, Francisco/0000-0002-7431-354X; Escaso, Fernando/0000-0001-7642-1555; Sanz, Jose Luis/0000-0002-5214-5725	Museo de las Ciencias de Castilla-La Mancha; Spanish Ministerio de Ciencia e Innovacion [CGL2005-05614]	Museo de las Ciencias de Castilla-La Mancha; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	We thank S. Prieto for information about the location of the specimen; C. Diaz-Romeral, R. de la Fuente, M. Garcia Oliva and N. Santamaria for participating in the field; P. Garcia, M. Llandres, P. Moyano and J. Saiz for specimen preparation; L. Chiappe (Natural History Museum of LA County) for comments on the manuscript; E. Feeman and Plan de Promocion de la Investigacion en la Universidad Nacional de Educacion a Distancia for manuscript revision; R. Martin for the flesh reconstruction of Concavenator in Fig. 2; and S. Torralba for photography. We acknowledge the Museo de las Ciencias de Castilla-La Mancha for support and funding. Part of this research was financed by project CGL2005-05614 of the Spanish Ministerio de Ciencia e Innovacion.	Alibardi L, 2008, PROG HISTOCHEM CYTO, V43, P1, DOI 10.1016/j.proghi.2008.01.001; Bailey JB, 1997, J PALEONTOL, V71, P1124, DOI 10.1017/S0022336000036076; Benson RBJ, 2010, NATURWISSENSCHAFTEN, V97, P71, DOI 10.1007/s00114-009-0614-x; Brown B, 1913, B AM MUS NAT HIST, V32, P395; Brusatte SL, 2008, J SYST PALAEONTOL, V6, P155, DOI 10.1017/S1477201907002404; Brusatte SL, 2009, NATURWISSENSCHAFTEN, V96, P1051, DOI 10.1007/s00114-009-0565-2; Brusatte Stephen L., 2008, Monograph of the Palaeontographical Society, P1; Carrano MT, 2008, J SYST PALAEONTOL, V6, P183, DOI 10.1017/S1477201907002246; Chuong CM, 2003, J EXP ZOOL PART B, V298B, P42, DOI 10.1002/jez.b.00025; Chuong CM, 2000, CURR OPIN GENET DEV, V10, P449, DOI 10.1016/S0959-437X(00)00111-8; Coria RA, 2006, GEODIVERSITAS, V28, P71; CORIA RA, 1995, NATURE, V377, P224, DOI 10.1038/377224a0; Currie Philip J., 2000, Geodiversitas, V22, P207; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P71; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P111; MADSEN JH, 1976, B UTAH GEOLOGICAL MI, V109, P1; Mayr G, 2002, NATURWISSENSCHAFTEN, V89, P361, DOI 10.1007/s00114-002-0339-6; Norman D.B., 1986, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V56, P281; Novas FE, 2005, NATURWISSENSCHAFTEN, V92, P226, DOI 10.1007/s00114-005-0623-3; Olshevsky G., 1991, SAN DIEGO CALIFORNIA, P1; Paul Gregory S., 2007, P69; Sanz JL, 2001, PALAEOBIOLOGY, VII, P356; Sawyer RH, 2003, J EXP ZOOL PART B, V298B, P57, DOI 10.1002/jez.b.26; Sereno PC, 2008, ACTA PALAEONTOL POL, V53, P15, DOI 10.4202/app.2008.0102; Sereno PC, 1998, SCIENCE, V282, P1298, DOI 10.1126/science.282.5392.1298; STOVALL JW, 1950, AM MIDL NAT, V43, P696, DOI 10.2307/2421859; Stromer E, 1915, ABHANDLUNGEN KONIGLI, V28, P1; Taquet P., 1976, GEOLOGIE PALEONTOLOG; Turner AH, 2007, SCIENCE, V317, P1721, DOI 10.1126/science.1145076; Zheng XT, 2009, NATURE, V458, P333, DOI 10.1038/nature07856	30	83	89	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2010	467	7312					203	206		10.1038/nature09181	http://dx.doi.org/10.1038/nature09181			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647KB	20829793				2022-12-01	WOS:000281616300033
J	van Gils, EJM; Veenhoven, RH; Hak, E; Rodenburg, GD; Keijzers, WCM; Bogaert, D; Trzcinski, K; Bruin, JP; van Alphen, L; van der Ende, A; Sanders, EAM				van Gils, Elske J. M.; Veenhoven, Reinier H.; Hak, Eelko; Rodenburg, Gerwin D.; Keijzers, Wendy C. M.; Bogaert, Debby; Trzcinski, Krzysztof; Bruin, Jacob P.; van Alphen, Loek; van der Ende, Arie; Sanders, Elisabeth A. M.			Pneumococcal Conjugate Vaccination and Nasopharyngeal Acquisition of Pneumococcal Serotype 19A Strains	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE OTITIS-MEDIA; STREPTOCOCCUS-PNEUMONIAE SEROTYPES; INVASIVE DISEASE; ANTIMICROBIAL RESISTANCE; POPULATION SNAPSHOT; TEMPORAL TRENDS; UNITED-STATES; CHILDREN; CARRIAGE; EMERGENCE	Context The rapid increase in multiresistant serotype 19A as a cause of invasive and respiratory pneumococcal disease has been associated in time with the widespread implementation of 7-valent pneumococcal conjugate vaccination (PCV-7) in several countries. Because spontaneous fluctuations in time and antibiotic selective pressure may have induced this serotype 19A increase, controlled studies are needed to assess the role of PCV-7. Objective To examine the association of PCV-7 vaccination and nasopharyngeal acquisition of serotype 19A pneumococci, their clonal distribution, and antibiotic susceptibility. Design, Setting, and Patients Post hoc per-protocol completer's analysis as part of a randomized controlled trial of nasopharyngeal Streptococcus pneumoniae carriage enrolling 1003 healthy newborns with follow-up to the age of 24 months in the Netherlands, which has low antibiotic resistance rates. The study was conducted before widespread PCV-7 implementation in infants, between July 7, 2005, and February 14, 2008. Nasopharyngeal swabs were obtained at the age of 6 weeks and at 6, 12, 18, and 24 months. Intervention Infants were randomly assigned to receive 2 doses of PCV-7 at 2 and 4 months; 2 + 1 doses of PCV-7 at 2, 4, and 11 months; or no dosage (unvaccinated control group). Main Outcome Measure Cumulative proportion of children with nasopharyngeal acquisition of a new serotype 19A strain from 6 through 24 months of age. Results Nine hundred forty-eight children completed the study. Fifty-four nasopharyngeal serotype 19A carriage isolates from 318 in the 2-dose group, 66 isolates from 327 in the 2 + 1-dose group, and 33 isolates from 303 in the unvaccinated were collected from 6 weeks through 24 months. The cumulative proportion who tested positive for new nasopharyngeal serotype 19A acquisition from 6 through 24 months of age was significantly higher in those having received the 2 + 1-dose PCV-7 schedule (16.2%; 95% confidence interval [CI], 12.6%-20.6%) vs those who were unvaccinated (9.2%; 95% CI, 6.5%-13.0%; relative risk [RR], 1.75; 95% CI, 1.14-2.70) but not after a 2-dose schedule (13.2%; 95% CI, 9.9%-17.4%; RR, 1.43; 95% CI, 0.91-2.25). There were 28 different sequence types identified, including 6 new types. The proportion of children with new 19A acquisition who had used antibiotics in the last 6 months (18.7%) did not differ among groups. Five isolates were penicillin-intermediate susceptible and another 3 were nonsusceptible to erythromycin and azithromycin, all in the vaccine groups. Conclusion A 2 + 1-dose PCV-7 schedule was associated with an increase in serotype 19A nasopharyngeal acquisition compared with unvaccinated controls.	[van Gils, Elske J. M.; Hak, Eelko; Rodenburg, Gerwin D.; Bogaert, Debby; Trzcinski, Krzysztof; Sanders, Elisabeth A. M.] Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Dept Pediat Immunol & Infect Dis, NL-3508 AB Utrecht, Netherlands; [van Gils, Elske J. M.; Veenhoven, Reinier H.; Rodenburg, Gerwin D.] Univ Groningen, Univ Med Ctr Groningen, Spaarne Hosp Hoofddorp, Dept Pediat, Groningen, Netherlands; [Hak, Eelko] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Pharm Pharmacoepidemiol & PharmacoEcon, Groningen, Netherlands; [Hak, Eelko] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Bruin, Jacob P.] Reg Lab Publ Hlth, Haarlem, Netherlands; [van Alphen, Loek] Netherlands Vaccine Inst, Bilthoven, Netherlands; [Keijzers, Wendy C. M.; van der Ende, Arie] Netherlands Reference Lab Bacterial Meningitis, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Spaarne Hospital; University of Groningen; University of Groningen; University of Groningen	Sanders, EAM (corresponding author), Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Dept Pediat Immunol & Infect Dis, KB 03-023-3,POB 85090, NL-3508 AB Utrecht, Netherlands.	l.sanders@umcutrecht.nl	Trzcinski, Krzysztof/I-8840-2019; van der Ende, Arie/A-4346-2012	Trzcinski, Krzysztof/0000-0002-5433-8846; Bogaert, Debby/0000-0003-2651-7000; van der Ende, Arie/0000-0003-1298-3086	GlaxoSmithKline; Wyeth/Pfizer; Baxter; Novartis; Dutch Ministry of Health; Wellcome Trust	GlaxoSmithKline(GlaxoSmithKline); Wyeth/Pfizer(WyethPfizer); Baxter; Novartis(Novartis); Dutch Ministry of Health; Wellcome Trust(Wellcome TrustEuropean Commission)	Dr Veenhoven reported receiving grant support from GlaxoSmithKline and Wyeth/Pfizer for vaccine studies and consulting fees for GlaxoSmithKline. Dr Sanders reported receiving unrestricted grants from Wyeth/Pfizer and Baxter for research, consulting fees for Wyeth/Pfizer and GlaxoSmithKline, lecturing fees from Wyeth/Pfizer, and grant support from Wyeth/Pfizer and GlaxoSmithKline for vaccine studies. Dr Van der Ende reports receiving unrestricted grants from Wyeth/Pfizer and Novartis. For all other authors no potential conflicts were reported.; This work was supported by the Dutch Ministry of Health.; We thank the participating children and their families for their time and effort. We also thank the members of the research team for their invaluable dedicated work and support. We thank all cooperating organizations for their support. We acknowledge the use of the pneumococcal MLST database, which is located at Imperial College London and is funded by Wellcome Trust.	Aguiar SI, 2008, CLIN MICROBIOL INFEC, V14, P835, DOI 10.1111/j.1469-0691.2008.02031.x; Aguiar SI, 2010, J CLIN MICROBIOL, V48, P101, DOI 10.1128/JCM.00665-09; [Anonymous], 2008, M100S18 CLIN LAB STA; Ardanuy C, 2009, J ANTIMICROB CHEMOTH, V64, P507, DOI 10.1093/jac/dkp210; Beall B, 2006, J CLIN MICROBIOL, V44, P999, DOI 10.1128/JCM.44.3.999-1017.2006; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Choi EH, 2008, EMERG INFECT DIS, V14, P275, DOI 10.3201/eid1402.070807; Dagan R, 2009, J INFECT DIS, V199, P776, DOI 10.1086/597044; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fenoll A, 2009, J CLIN MICROBIOL, V47, P1012, DOI 10.1128/JCM.01454-08; FILIUS PMG, 2008, NETHMAP 2008 CONSUMP; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Harboe ZB, 2010, CLIN INFECT DIS, V50, P329, DOI 10.1086/649872; Harboe ZB, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000081; Huang SS, 2009, PEDIATRICS, V124, pE1, DOI 10.1542/peds.2008-3099; JACOBS MR, 1992, DIAGN MICR INFEC DIS, V15, P473, DOI 10.1016/0732-8893(92)90093-9; Kaplan SL, 2010, PEDIATRICS, V125, P429, DOI 10.1542/peds.2008-1702; Linares J, 2010, CLIN MICROBIOL INFEC, V16, P402, DOI 10.1111/j.1469-0691.2010.03182.x; Lipsitch M, 2007, J INFECT DIS, V196, P1221, DOI 10.1086/521831; Mahjoub-Messai F, 2008, ARCH PEDIATRIE, V15, P1713, DOI 10.1016/j.arcped.2008.09.003; Mahjoub-Messai F, 2009, J CLIN MICROBIOL, V47, P837, DOI 10.1128/JCM.01547-08; McNeil JC, 2009, PEDIATR INFECT DIS J, V28, P766, DOI 10.1097/INF.0b013e3181a24557; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI 10.1097/00006454-200302000-00009; Pai R, 2005, J INFECT DIS, V192, P1988, DOI 10.1086/498043; Pelton SI, 2007, PEDIATR INFECT DIS J, V26, P468, DOI 10.1097/INF.0b013e31803df9ca; Pichichero ME, 2007, JAMA-J AM MED ASSOC, V298, P1772, DOI 10.1001/jama.298.15.1772; Reingold A., 2008, Morbidity and Mortality Weekly Report, V57, P144; Robinson DA, 2001, J INFECT DIS, V183, P1501, DOI 10.1086/320194; Shouval DS, 2006, PEDIATR INFECT DIS J, V25, P602, DOI 10.1097/01.inf.0000220231.79968.f6; Singleton RJ, 2007, JAMA-J AM MED ASSOC, V297, P1784, DOI 10.1001/jama.297.16.1784; Techasaensiri C, 2010, PEDIATR INFECT DIS J, V29, P294, DOI 10.1097/INF.0b013e3181c2a229; van Gils EJM, 2009, JAMA-J AM MED ASSOC, V302, P159, DOI 10.1001/jama.2009.975; VANOOSTEN M, 2006, EUROSURVEILLANCE, V11; Veenhoven RH, 2004, CLIN INFECT DIS, V39, P911, DOI 10.1086/422651; Weinberger DM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000476	38	53	53	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2010	304	10					1099	1106		10.1001/jama.2010.1290	http://dx.doi.org/10.1001/jama.2010.1290			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646RM	20823436	Green Published			2022-12-01	WOS:000281559800020
J	Rabe, KF; Decramer, M; Siafakas, N				Rabe, Klaus F.; Decramer, Marc; Siafakas, Nikolaos			The Year of the Lung	LANCET			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE		[Rabe, Klaus F.] Leiden Univ, Med Ctr, Dept Pulmonol, NL-2333 ZA Leiden, Netherlands; [Decramer, Marc] Univ Hosp Gasthuisberg, Dept Pulmonol, Ghent, Belgium; [Siafakas, Nikolaos] Univ Gen Hosp, Dept Pulmonol, Iraklion, Greece	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; KU Leuven; University Hospital Leuven; University Hospital of Heraklion	Rabe, KF (corresponding author), Leiden Univ, Med Ctr, Dept Pulmonol, NL-2333 ZA Leiden, Netherlands.	k.f.rabe@lumc.nl	Rabe, Klaus F./AAW-6296-2021; Siafakas, Nikolas/AAI-3324-2020	Rabe, Klaus F./0000-0002-7020-1401; 				Beaglehole R, 2003, LANCET, V362, P903, DOI 10.1016/S0140-6736(03)14335-8; Bousquet J., 2007, GLOBAL SURVEILLANCE; *CDCP, 2004, MMWR-MORBID MORTAL W, V58, P29; *GLOB ALL CHRON RE, STOP GLOB EP CHRON D; MacNee W, 2007, EUR RESPIR J, V29, P223, DOI 10.1183/09031936.00159006; *NAT HEART LUNG BL, PARTN GLOB HLTH; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Pawankar R, 2009, ASIAN PAC J ALLERGY, V27, P237; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; World Health Organization, CHRON RESP DIS; 2010, YEAR LUNG	11	5	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 4	2010	376	9743					753	754		10.1016/S0140-6736(10)61347-5	http://dx.doi.org/10.1016/S0140-6736(10)61347-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	650EC	20816531				2022-12-01	WOS:000281831000009
J	Allmann, S; Baldwin, IT				Allmann, Silke; Baldwin, Ian T.			Insects Betray Themselves in Nature to Predators by Rapid Isomerization of Green Leaf Volatiles	SCIENCE			English	Article							OLFACTORY RECEPTOR NEURONS; PLANT VOLATILES; EMISSIONS; MAIZE; PARASITOIDS; ATTRACTION; SUFFICIENT; HERBIVORES; PATHOGENS; ACID	Plants emit green leaf volatiles (GLVs) in response to herbivore damage, thereby attracting predators of the herbivores as part of an indirect defense. The GLV component of this indirect defense was thought to be a general wound signal lacking herbivore-specific information. We found that Manduca sexta-infested Nicotiana attenuata attract the generalist hemipteran predator Geocoris spp. as the result of an herbivore-induced decrease in the (Z)/(E) ratio of released GLVs, and that these changes in the volatile bouquet triple the foraging efficiency of predators in nature. These (E)-isomers are produced from plant-derived (Z)-isomers but are converted by a heat-labile constituent of herbivore oral secretions. Hence, attacking herbivores initiate the release of an indirect defense a full day before the attacked plants manufacture their own defensive compounds.	[Allmann, Silke; Baldwin, Ian T.] Max Planck Inst Chem Ecol, Dept Mol Ecol, DE-07745 Jena, Germany; [Allmann, Silke] Swammerdam Inst Life Sci, Dept Plant Physiol, NL-1098 XH Amsterdam, Netherlands	Max Planck Society; University of Amsterdam	Baldwin, IT (corresponding author), Max Planck Inst Chem Ecol, Dept Mol Ecol, Hans Knoll Str 8, DE-07745 Jena, Germany.	baldwin@ice.mpg.de	Allmann, Silke/Q-6522-2017; Baldwin, Ian T/K-1809-2013	Allmann, Silke/0000-0001-6300-3741; Baldwin, Ian/0000-0001-5371-2974	Max Planck Society	Max Planck Society(Max Planck Society)	Supported by the Max Planck Society. We thank M. Kant, R. Schuurink, E. Gaquerel, G. Bonaventure, and three anonymous reviewers for comments on the manuscript; S. Meldau for providing ir-sipk x ir-wipk seeds; D. Kessler and C. Diezel for help with the field experiments and enzyme assays; M. Kallenbach and A. Weinhold for analytical help; and Brigham Young University for the use of their Lytle Ranch Preserve field station.	Alborn HT, 1997, SCIENCE, V276, P945, DOI 10.1126/science.276.5314.945; Allison JD, 2009, NEW PHYTOL, V184, P768, DOI 10.1111/j.1469-8137.2009.03046.x; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; D'Auria JC, 2007, PLANT J, V49, P194, DOI 10.1111/j.1365-313X.2006.02946.x; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; Dicke M, 2009, PLANT CELL ENVIRON, V32, P654, DOI 10.1111/j.1365-3040.2008.01913.x; Gouinguene SP, 2002, PLANT PHYSIOL, V129, P1296, DOI 10.1104/pp.001941; Halitschke R, 2001, PLANT PHYSIOL, V125, P711, DOI 10.1104/pp.125.2.711; Halitschke R, 2008, ECOL LETT, V11, P24, DOI 10.1111/j.1461-0248.2007.01123.x; Hansson BS, 1999, PHYSIOL ENTOMOL, V24, P121, DOI 10.1046/j.1365-3032.1999.00121.x; Hoballah ME, 2005, J CHEM ECOL, V31, P2003, DOI 10.1007/s10886-005-6074-7; Kant MR, 2004, PLANT PHYSIOL, V135, P483, DOI 10.1104/pp.103.038315; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; KLUN JA, 1973, SCIENCE, V181, P661, DOI 10.1126/science.181.4100.661; Mithofer A, 2005, PLANT PHYSIOL, V137, P1160, DOI 10.1104/pp.104.054460; MUELLER MJ, 1994, ANAL BIOCHEM, V218, P425, DOI 10.1006/abio.1994.1202; Noordermeer MA, 1999, FEBS LETT, V443, P201, DOI 10.1016/S0014-5793(98)01706-2; Prost I, 2005, PLANT PHYSIOL, V139, P1902, DOI 10.1104/pp.105.066274; Rostas M, 2006, J CHEM ECOL, V32, P1897, DOI 10.1007/s10886-006-9147-3; Shiojiri K, 2006, P NATL ACAD SCI USA, V103, P16672, DOI 10.1073/pnas.0607780103; Shiojiri K, 2006, J CHEM ECOL, V32, P969, DOI 10.1007/s10886-006-9047-6; Stensmyr MC, 2001, J COMP PHYSIOL A, V187, P509; Takabayashi J, 1996, TRENDS PLANT SCI, V1, P109, DOI 10.1016/S1360-1385(96)90004-7; Takamura H, 1996, BBA-LIPID LIPID MET, V1303, P83, DOI 10.1016/0005-2760(96)00076-8; Turlings TCJ, 1998, PLANTA, V207, P146, DOI 10.1007/s004250050466; von Dahl CC, 2006, PLANT J, V46, P948, DOI 10.1111/j.1365-313X.2006.02760.x; Wu JQ, 2009, PLANT CELL ENVIRON, V32, P1161, DOI 10.1111/j.1365-3040.2009.01943.x	28	171	183	4	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 27	2010	329	5995					1075	1078		10.1126/science.1191634	http://dx.doi.org/10.1126/science.1191634			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642WZ	20798319				2022-12-01	WOS:000281253500040
J	Williams, R				Williams, Ruth			Slowing the decline	NATURE			English	Editorial Material							EARLY PARKINSON-DISEASE; COENZYME Q(10); DOUBLE-BLIND; CLINICAL-TRIAL; DELAYED-START; RASAGILINE											Beal MF, 1998, BRAIN RES, V783, P109, DOI 10.1016/S0006-8993(97)01192-X; Fahn S, 2006, J NEURAL TRANSM-SUPP, P419; Kieburtz K, 2007, NEUROLOGY, V68, P20; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; Marks WJ, 2008, LANCET NEUROL, V7, P400, DOI 10.1016/S1474-4422(08)70065-6; Moon Y, 2005, J NEUROCHEM, V93, P1199, DOI 10.1111/j.1471-4159.2005.03112.x; Nutt JG, 2003, NEUROLOGY, V60, P69, DOI 10.1212/WNL.60.1.69; Olanow CW, 2009, NEW ENGL J MED, V361, P1268, DOI 10.1056/NEJMoa0809335; Ravina B, 2006, NEUROLOGY, V66, P664; SCHAPIRA A, 2009, PARKINSONISM RELA S2, V15; Shults CW, 2002, ARCH NEUROL-CHICAGO, V59, P1541, DOI 10.1001/archneur.59.10.1541; Siderowf A, 2004, ARCH NEUROL-CHICAGO, V61, P561; WARD CD, 1994, J NEUROL NEUROSUR PS, V57, P217, DOI 10.1136/jnnp.57.2.217	13	4	4	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2010	466	7310					S13	S14		10.1038/466S13a	http://dx.doi.org/10.1038/466S13a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20739931	Bronze			2022-12-01	WOS:000281203600062
J	Pryke, SR; Rollins, LA; Griffith, SC				Pryke, Sarah R.; Rollins, Lee A.; Griffith, Simon C.			Females Use Multiple Mating and Genetically Loaded Sperm Competition to Target Compatible Genes	SCIENCE			English	Article							EXTRA-PAIR PATERNITY; SOCIALLY MONOGAMOUS PASSERINES; MATE CHOICE; SELECTION; BIRDS; INFIDELITY; EVOLUTION; INCOMPATIBILITY; FERTILIZATIONS; ALLOCATION	Individuals in socially monogamous species may participate in copulations outside of the pair bond, resulting in extra-pair offspring. Although males benefit from such extra-pair behavior if they produce more offspring, the adaptive function of infidelity to females remains elusive. Here we show that female participation in extra-pair copulations, combined with a genetically loaded process of sperm competition, enables female finches to target genes that are optimally compatible with their own to ensure fertility and optimize offspring viability. Such female behavior, along with the postcopulatory processes demonstrated here, may provide an adaptive function of female infidelity in socially monogamous animals.	[Pryke, Sarah R.; Rollins, Lee A.; Griffith, Simon C.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia	Macquarie University	Griffith, SC (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	simon.griffith@mq.edu.au	Griffith, Simon/AAH-3706-2021; Griffith, Simon/A-1996-2010; Pryke, Sarah/G-7484-2011; Rollins, Lee/G-3688-2011	Griffith, Simon/0000-0001-7612-4999; Griffith, Simon/0000-0001-7612-4999; Rollins, Lee/0000-0002-3279-7005	Australian Research Council [DP0770889, DP0881019]; L'Oreal; Save the Gouldian Fund	Australian Research Council(Australian Research Council); L'Oreal(L'Oreal Group); Save the Gouldian Fund	We thank T. Birkhead, R. Brooks, R. Calsbeek, S. Immler, S. Ulfstrand, D. Westneat, and M. Whiting for comments on the manuscript. This work was supported by Discovery Grants DP0770889 (S.R.P.) and DP0881019 (S.C.G.) from the Australian Research Council, a L'Oreal for Women in Science Fellowship (S.R.P.), and the Save the Gouldian Fund. The Animal Care and Ethics Committee of Macquarie University approved this research.	Akcay E, 2007, EVOL ECOL RES, V9, P855; Albrecht T, 2006, AM NAT, V167, P739, DOI 10.1086/502633; Arnqvist G, 2005, AM NAT, V165, pS26, DOI 10.1086/429350; Ball MA, 2003, J THEOR BIOL, V224, P27, DOI 10.1016/S0022-5193(03)00118-8; Birkhead T.R., 1988, Advances in the Study of Behavior, V18, P35; BIRKHEAD TR, 1988, NATURE, V334, P60, DOI 10.1038/334060a0; Cockburn A, 2009, BEHAV ECOL, V20, P501, DOI 10.1093/beheco/arp024; COLEGRAVE N, 1995, P ROY SOC B-BIOL SCI, V259, P223, DOI 10.1098/rspb.1995.0033; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Griffith SC, 2007, AM NAT, V169, P274, DOI 10.1086/510601; Griffith SC, 2009, J AVIAN BIOL, V40, P97, DOI 10.1111/j.1600-048X.2009.04562.x; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Merila J, 2001, NATURE, V412, P76, DOI 10.1038/35083580; Merila J, 2003, ANN ZOOL FENN, V40, P269; Olsson M, 1996, NATURE, V383, P585, DOI 10.1038/383585a0; Petrie M, 1998, TRENDS ECOL EVOL, V13, P52, DOI 10.1016/S0169-5347(97)01232-9; Pizzari T, 2003, NATURE, V426, P70, DOI 10.1038/nature02004; Pryke SR, 2007, J EVOLUTION BIOL, V20, P1512, DOI 10.1111/j.1420-9101.2007.01332.x; Pryke SR, 2010, EVOLUTION, V64, P1301, DOI 10.1111/j.1558-5646.2009.00897.x; Pryke SR, 2009, SCIENCE, V323, P1605, DOI 10.1126/science.1168928; Pryke SR, 2009, EVOLUTION, V63, P793, DOI 10.1111/j.1558-5646.2008.00584.x; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; Sheldon BC, 1998, P ROY SOC B-BIOL SCI, V265, P1737, DOI 10.1098/rspb.1998.0496; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Veen T, 2001, NATURE, V411, P45, DOI 10.1038/35075000; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439	27	61	62	0	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 20	2010	329	5994					964	967		10.1126/science.1192407	http://dx.doi.org/10.1126/science.1192407			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640WN	20724639				2022-12-01	WOS:000281084800040
J	Bonfanti, P; Claudinot, S; Amici, AW; Farley, A; Blackburn, CC; Barrandon, Y				Bonfanti, Paola; Claudinot, Stephanie; Amici, Alessandro W.; Farley, Alison; Blackburn, C. Clare; Barrandon, Yann			Microenvironmental reprogramming of thymic epithelial cells to skin multipotent stem cells	NATURE			English	Article							HAIR-FOLLICLES; PROGENITOR CELLS; CLONAL ANALYSIS; TOLERANCE; IDENTIFICATION; ORGANOGENESIS; REGENERATION; KERATINOCYTE; GENERATION; AIRE	The thymus develops from the third pharyngeal pouch of the anterior gut and provides the necessary environment for thymopoiesis (the process by which thymocytes differentiate into mature T lymphocytes) and the establishment and maintenance of self-tolerance(1-3). It contains thymic epithelial cells (TECs) that form a complex three-dimensional network organized in cortical and medullary compartments, the organization of which is notably different from simple or stratified epithelia(4). TECs have an essential role in the generation of self-tolerant thymocytes through expression of the autoimmune regulator Aire(5,6), but the mechanisms involved in the specification and maintenance of TECs remain unclear(7-9). Despite the different embryological origins of thymus and skin (endodermal and ectodermal, respectively), some cells of the thymic medulla express stratified-epithelium markers(10-12), interpreted as promiscuous gene expression. Here we show that the thymus of the rat contains a population of clonogenic TECs that can be extensively cultured while conserving the capacity to integrate in a thymic epithelial network and to express major histocompatibility complex class II (MHC II) molecules and Aire. These cells can irreversibly adopt the fate of hair follicle multipotent stem cells when exposed to an inductive skin microenvironment; this change in fate is correlated with robust changes in gene expression. Hence, microenvironmental cues are sufficient here to re-direct epithelial cell fate, allowing crossing of primitive germ layer boundaries and an increase in potency(13).	[Bonfanti, Paola; Claudinot, Stephanie; Amici, Alessandro W.; Barrandon, Yann] Ecole Polytech Fed Lausanne, Sch Life Sci, Lab Stem Cell Dynam, CH-1015 Lausanne, Switzerland; [Bonfanti, Paola; Claudinot, Stephanie; Amici, Alessandro W.; Barrandon, Yann] CHU Vaudois, Univ Lausanne Hosp, Dept Expt Surg, CH-1011 Lausanne, Switzerland; [Farley, Alison; Blackburn, C. Clare] Univ Edinburgh, Sch Biol Sci, MRC, Ctr Regenerat Med,Inst Stem Cell Res, Edinburgh EH16 4SB, Midlothian, Scotland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Edinburgh	Barrandon, Y (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Lab Stem Cell Dynam, CH-1015 Lausanne, Switzerland.	Yann.Barrandon@epfl.ch	Blackburn, Clare/B-2847-2009; Blackburn, Clare/AAM-7954-2020; Amici, Alessandro W/AGL-7640-2022	Blackburn, Clare/0000-0002-6326-640X; Blackburn, Clare/0000-0002-6326-640X; FARLEY, ALISON/0000-0002-9609-8983; Bonfanti, Paola/0000-0001-9655-3766	Swiss National Science Foundation [3100A0-104160]; Juvenile Diabetes Research Foundation; EPFL; CHUV; Leukaemia Research Fund; European Union (EU); Heiwa Nakajima Foundation; Medical Research Council [G0700711B] Funding Source: researchfish	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); EPFL; CHUV; Leukaemia Research Fund; European Union (EU)(CGIAREuropean Commission); Heiwa Nakajima Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to M. Nicolas and A. Smith for discussions and support, M. Okabe for supplying EGFP rats, J. Roberts, M. Garcia and R. Teisanu for help with cell sorting, J. C. Sarria and T. Laroche for confocal imaging, and K. Harsman, O. Hagenbuchle and S. Pradervand from the DAFL for microarray analyses. Y.B was supported in this work by the Swiss National Science Foundation (grant 3100A0-104160), the Juvenile Diabetes Research Foundation, the EPFL and the CHUV. C. B. was supported by a Leukaemia Research Fund grant. The European Union (EU) supported Y.B. and C. B. through the sixth (EuroStemCell) and seventh (EuroSyStem, OptiStem) framework programmes. A. W. A. was supported by a fellowship from the Heiwa Nakajima Foundation.	Abramson J, 2010, CELL, V140, P123, DOI 10.1016/j.cell.2009.12.030; ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; Anderson G, 2007, NAT REV IMMUNOL, V7, P954, DOI 10.1038/nri2187; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; BARRANDON Y, 1985, P NATL ACAD SCI USA, V82, P5390, DOI 10.1073/pnas.82.16.5390; Bennett AR, 2002, IMMUNITY, V16, P803, DOI 10.1016/S1074-7613(02)00321-7; Blackburn CC, 2002, TRENDS IMMUNOL, V23, P391, DOI 10.1016/S1471-4906(02)02265-2; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Boehm T, 2008, CURR OPIN IMMUNOL, V20, P178, DOI 10.1016/j.coi.2008.03.001; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; Depreter MGL, 2008, P NATL ACAD SCI USA, V105, P961, DOI 10.1073/pnas.0711170105; Gill J, 2002, NAT IMMUNOL, V3, P635, DOI 10.1038/ni812; Hale LP, 2004, J IMMUNOL, V172, P617, DOI 10.4049/jimmunol.172.1.617; Hamazaki Y, 2007, NAT IMMUNOL, V8, P304, DOI 10.1038/ni1438; HEID HW, 1988, DIFFERENTIATION, V37, P137, DOI 10.1111/j.1432-0436.1988.tb00805.x; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hollander G, 2006, IMMUNOL REV, V209, P28, DOI 10.1111/j.0105-2896.2006.00357.x; Ito T, 2001, J AM SOC NEPHROL, V12, P2625, DOI 10.1681/ASN.V12122625; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; LASTER AJ, 1986, DIFFERENTIATION, V31, P67, DOI 10.1111/j.1432-0436.1986.tb00385.x; Manley NR, 2003, CURR OPIN IMMUNOL, V15, P225, DOI 10.1016/S0952-7915(03)00006-2; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; MOSCONA A, 1961, EXP CELL RES, V22, P455, DOI 10.1016/0014-4827(61)90122-7; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; Ronfard V, 2000, TRANSPLANTATION, V70, P1588, DOI 10.1097/00007890-200012150-00009; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Sheridan JM, 2009, GENESIS, V47, P346, DOI 10.1002/dvg.20505; Smith A, 2006, NATURE, V441, P1060, DOI 10.1038/nature04954; Smyth G.K., 2004, STAT APPL GENET MOL, V3, pArticl, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; SUN TT, 1984, CELL IMMUNOL, V83, P1, DOI 10.1016/0008-8749(84)90219-3; van Ewijk W, 1999, SEMIN IMMUNOL, V11, P57, DOI 10.1006/smim.1998.0158	33	105	106	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 19	2010	466	7309					978	U105		10.1038/nature09269	http://dx.doi.org/10.1038/nature09269			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640ED	20725041				2022-12-01	WOS:000281030300035
J	Cornwallis, CK; West, SA; Davis, KE; Griffin, AS				Cornwallis, Charlie K.; West, Stuart A.; Davis, Katie E.; Griffin, Ashleigh S.			Promiscuity and the evolutionary transition to complex societies	NATURE			English	Article							KIN SELECTION; BIRDS; PATERNITY; CONSTRAINTS; MONOGAMY; BEHAVIOR; HELPERS; MODELS; SPITE	Theory predicts that the evolution of cooperative behaviour is favoured by low levels of promiscuity leading to high within-group relatedness(1-5). However, in vertebrates, cooperation often occurs between non-relatives and promiscuity rates are among the highest recorded. Here we resolve this apparent inconsistency with a phylogenetic analysis of 267 bird species, demonstrating that cooperative breeding is associated with low promiscuity; that in cooperative species, helping is more common when promiscuity is low; and that intermediate levels of promiscuity favour kin discrimination. Overall, these results suggest that promiscuity is a unifying feature across taxa in explaining transitions to and from cooperative societies.	[Cornwallis, Charlie K.; Griffin, Ashleigh S.] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; [West, Stuart A.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Davis, Katie E.] Nat Hist Museum, Dept Entomol, London SW7 5BD, England	University of Oxford; University of Oxford; Natural History Museum London	Griffin, AS (corresponding author), Univ Oxford, Dept Zool, Edward Grey Inst, S Parks Rd, Oxford OX1 3PS, England.	ashleigh.griffin@zoo.ox.ac.uk	West, Stuart A/M-3608-2014; Griffin, Ashleigh/C-6244-2014; Cornwallis, Charlie/A-6276-2012	West, Stuart A/0000-0003-2152-3153; Griffin, Ashleigh/0000-0001-7674-9825; 	ERC; Royal Society	ERC(European Research Council (ERC)European Commission); Royal Society(Royal Society of London)	We thank J. Hadfield for statistical advice, K. Boomsma, S. Nakagawa and B. Sheldon for comments and discussion, M. Nelson-Flower and P. Brennan for access to unpublished data, and the ERC and Royal Society for funding. The compilation of our data set was made possible by access to the collections of the Alexander Library.	Arnold KE, 1999, BEHAV ECOL, V10, P465, DOI 10.1093/beheco/10.5.465; Arnold KE, 1998, P ROY SOC B-BIOL SCI, V265, P739, DOI 10.1098/rspb.1998.0355; Bennett P.M., 2002, EVOL ECOL; Boomsma JJ, 2007, CURR BIOL, V17, pR673, DOI 10.1016/j.cub.2007.06.033; Boomsma JJ, 2009, PHILOS T R SOC B, V364, P3191, DOI 10.1098/rstb.2009.0101; Boomsma JJ, 1996, PHILOS T R SOC B, V351, P947, DOI 10.1098/rstb.1996.0087; CHARNOV EL, 1978, J THEOR BIOL, V75, P451, DOI 10.1016/0022-5193(78)90356-9; CHARNOV EL, 1981, ANIM BEHAV, V29, P631, DOI 10.1016/S0003-3472(81)80130-3; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Cockburn A, 1998, ANNU REV ECOL SYST, V29, P141, DOI 10.1146/annurev.ecolsys.29.1.141; Cockburn A, 2006, P ROY SOC B-BIOL SCI, V273, P1375, DOI 10.1098/rspb.2005.3458; Cornwallis CK, 2009, J EVOLUTION BIOL, V22, P2445, DOI 10.1111/j.1420-9101.2009.01853.x; DAVIES NB, 1992, DUNNOCK BEHAV SOCIAL, P117; de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x; Gardner A, 2004, P ROY SOC B-BIOL SCI, V271, P1529, DOI 10.1098/rspb.2004.2756; Geweke J., 1992, BAYESIAN STAT, V4, P169, DOI DOI 10.21034/SR.148; Goloboff P, 2008, CLADISTICS, V24, P91; Griffin AS, 2003, SCIENCE, V302, P634, DOI 10.1126/science.1089402; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Hadfield JD, 2010, J EVOLUTION BIOL, V23, P494, DOI 10.1111/j.1420-9101.2009.01915.x; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hamilton W.D., 1972, Annual Rev Ecol Syst, V3, P193, DOI 10.1146/annurev.es.03.110172.001205; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hatchwell BJ, 2009, PHILOS T R SOC B, V364, P3217, DOI 10.1098/rstb.2009.0109; Hatchwell BJ, 2000, ANIM BEHAV, V59, P1079, DOI 10.1006/anbe.2000.1394; HEIDELBERGER P, 1983, OPER RES, V31, P1109, DOI 10.1287/opre.31.6.1109; Hughes WOH, 2008, SCIENCE, V320, P1213, DOI 10.1126/science.1156108; KOMDEUR J, 1992, NATURE, V358, P493, DOI 10.1038/358493a0; KREBS JR, 1993, BEHAV ECOLOGY EVOLUT, P291; MULDER RA, 1994, P ROY SOC B-BIOL SCI, V255, P223, DOI 10.1098/rspb.1994.0032; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Queller DC, 1998, BIOSCIENCE, V48, P165, DOI 10.2307/1313262; Queller DC, 2000, PHILOS T R SOC B, V355, P1647, DOI 10.1098/rstb.2000.0727; Raftery A., 1992, STAT SCI, V7, P493, DOI DOI 10.1214/SS/1177011143; Raudenbush S. W., 1994, HDB RES SYNTHESIS, P301, DOI DOI 10.1111/ACPS.12078; SMITH JM, 1995, MAJOR TRANSITIONS EV, P6; Spottiswoode C, 2004, BEHAV ECOL, V15, P41, DOI 10.1093/beheco/arg100; West SA, 2010, SCIENCE, V327, P1341, DOI 10.1126/science.1178332; Wilson E.O., 1975, P1; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	42	244	247	2	347	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 19	2010	466	7309					969	U91		10.1038/nature09335	http://dx.doi.org/10.1038/nature09335			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640ED	20725039				2022-12-01	WOS:000281030300033
J	Filippakopoulos, P; Qi, J; Picaud, S; Shen, Y; Smith, WB; Fedorov, O; Morse, EM; Keates, T; Hickman, TT; Felletar, I; Philpott, M; Munro, S; McKeown, MR; Wang, YC; Christie, AL; West, N; Cameron, MJ; Schwartz, B; Heightman, TD; La Thangue, N; French, CA; Wiest, O; Kung, AL; Knapp, S; Bradner, JE				Filippakopoulos, Panagis; Qi, Jun; Picaud, Sarah; Shen, Yao; Smith, William B.; Fedorov, Oleg; Morse, Elizabeth M.; Keates, Tracey; Hickman, Tyler T.; Felletar, Ildiko; Philpott, Martin; Munro, Shonagh; McKeown, Michael R.; Wang, Yuchuan; Christie, Amanda L.; West, Nathan; Cameron, Michael J.; Schwartz, Brian; Heightman, Tom D.; La Thangue, Nicholas; French, Christopher A.; Wiest, Olaf; Kung, Andrew L.; Knapp, Stefan; Bradner, James E.			Selective inhibition of BET bromodomains	NATURE			English	Article							ABL TYROSINE KINASE; PROTEIN BRD4; P-TEFB; AGGRESSIVE CARCINOMA; MITOTIC CHROMOSOMES; SIGNAL-TRANSDUCTION; STRUCTURAL BASIS; CHEMICAL PROBES; IN-VIVO; LEUKEMIA	Epigenetic proteins are intently pursued targets in ligand discovery. So far, successful efforts have been limited to chromatin modifying enzymes, or so-called epigenetic 'writers' and 'erasers'. Potent inhibitors of histone binding modules have not yet been described. Here we report a cell-permeable small molecule (JQ1) that binds competitively to acetyl-lysine recognition motifs, or bromodomains. High potency and specificity towards a subset of human bromodomains is explained by co-crystal structures with bromodomain and extra-terminal (BET) family member BRD4, revealing excellent shape complementarity with the acetyl-lysine binding cavity. Recurrent translocation of BRD4 is observed in a genetically-defined, incurable subtype of human squamous carcinoma. Competitive binding by JQ1 displaces the BRD4 fusion oncoprotein from chromatin, prompting squamous differentiation and specific antiproliferative effects in BRD4-dependent cell lines and patient-derived xenograft models. These data establish proof-of-concept for targeting protein-protein interactions of epigenetic 'readers', and provide a versatile chemical scaffold for the development of chemical probes more broadly throughout the bromodomain family.	[Filippakopoulos, Panagis; Picaud, Sarah; Fedorov, Oleg; Keates, Tracey; Felletar, Ildiko; Philpott, Martin; Heightman, Tom D.; Knapp, Stefan] Univ Oxford, Struct Genom Consortium, Dept Clin Med, Oxford OX3 7DQ, England; [Qi, Jun; Smith, William B.; Morse, Elizabeth M.; McKeown, Michael R.; West, Nathan; Bradner, James E.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Shen, Yao; Wiest, Olaf] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Shen, Yao; Wiest, Olaf] Univ Notre Dame, Walther Canc Res Ctr, Notre Dame, IN 46556 USA; [Hickman, Tyler T.; Cameron, Michael J.; Schwartz, Brian; French, Christopher A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Munro, Shonagh; La Thangue, Nicholas; Knapp, Stefan] Univ Oxford, Dept Clin Pharmacol, Oxford OX3 7DQ, England; [McKeown, Michael R.; Bradner, James E.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Wang, Yuchuan] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Imaging, Boston, MA 02115 USA; [Christie, Amanda L.; Kung, Andrew L.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Lurie Family Imaging Ctr, Boston, MA 02115 USA; [Kung, Andrew L.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Kung, Andrew L.] Childrens Hosp, Boston, MA 02115 USA	University of Oxford; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Notre Dame; University of Notre Dame; Walther Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Oxford; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital	Knapp, S (corresponding author), Univ Oxford, Struct Genom Consortium, Dept Clin Med, Old Rd Campus,Roosevelt Dr, Oxford OX3 7DQ, England.	stefan.knapp@sgc.ox.ac.uk; james_bradner@dfci.harvard.edu	Kung, Andrew L/AEU-0826-2022; Kung, Andrew/AAL-2384-2020; Knapp, Stefan/AAG-2347-2019; Fedorov, Oleg Y./B-6412-2014	Kung, Andrew L/0000-0002-9091-488X; Knapp, Stefan/0000-0001-5995-6494; Fedorov, Oleg Y./0000-0001-9004-1815; Wang, Yuchuan/0000-0001-5111-6562; Hickman, Tyler/0000-0003-2623-3251; Filippakopoulos, Panagis/0000-0002-1515-1317; Luoma, Elizabeth/0000-0001-9371-5715; Schwartz, Brian/0000-0002-4659-9800; Philpott, Martin/0000-0003-3632-0084	Canadian Institutes for Health Research [1097737]; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; University of Notre Dame; NIGMS [T32-075762]; DF/HCC; National Institutes of Health; Burroughs Wellcome Fund; Leukemia & Lymphoma Society; MRC [G0500905, G9400953] Funding Source: UKRI; Medical Research Council [G0500905, G9400953] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [K08CA128972] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); University of Notre Dame; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DF/HCC; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to U. Oppermann, S. Muller, S. Sallan, C. Lathan, P. Rahl, R. Young, K. Lee and K. Shaw for discussions and sharing unpublished information; K. Agu, S. Johnston and L. Li for analytical chemistry support; J. Daley for flow cytometry support; T. Bowman, T. Caron, C. Marvin and S. Rodig for immunohistochemistry; and A. Bass for sharing cell lines. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. This research was supported by a Graduate Fellowship from the Chemistry-Biochemistry-Biology Interface Program at the University of Notre Dame, NIGMS T32-075762 (to Y.S.), the DF/HCC (to C. A. F. and J. E. B.), the National Institutes of Health, the Burroughs Wellcome Fund, and the Leukemia & Lymphoma Society (to J.E.B.).	Abbate EA, 2006, MOL CELL, V24, P877, DOI 10.1016/j.molcel.2006.11.002; Adachi K, 2006, WPO Patent, Patent No. [WO2006129623A1, 2006129623, PCT/JP2006/310709 (WO/2006/129623)]; [Anonymous], 2009, [No title captured], Patent No. [2009084693, WO2009084693]; Buchdunger E, 1996, CANCER RES, V56, P100; BUCHDUNGER E, 1995, P NATL ACAD SCI USA, V92, P2558, DOI 10.1073/pnas.92.7.2558; Bullock AN, 2005, J MED CHEM, V48, P7604, DOI 10.1021/jm0504858; Cole PA, 2008, NAT CHEM BIOL, V4, P590, DOI 10.1038/nchembio.111; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Dey A, 2009, MOL BIOL CELL, V20, P4899, DOI 10.1091/mbc.E09-05-0380; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; French CA, 2008, ONCOGENE, V27, P2237, DOI 10.1038/sj.onc.1210852; French CA, 2003, CANCER RES, V63, P304; French CA, 2001, AM J PATHOL, V159, P1987, DOI 10.1016/S0002-9440(10)63049-0; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Haack H, 2009, AM J SURG PATHOL, V33, P984, DOI 10.1097/PAS.0b013e318198d666; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; le Coutre P, 1999, J NATL CANCER I, V91, P163, DOI 10.1093/jnci/91.2.163; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; MARUSHIGE K, 1976, P NATL ACAD SCI USA, V73, P3937, DOI 10.1073/pnas.73.11.3937; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Oprea TI, 2009, NAT CHEM BIOL, V5, P441, DOI 10.1038/nchembio0709-441; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Phelps MA, 2009, BLOOD, V113, P2637, DOI 10.1182/blood-2008-07-168583; Ptashne M, 2009, CURR BIOL, V19, pR234, DOI 10.1016/j.cub.2009.02.015; Quinn AM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp899; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; SUEOKA H, 1998, THIENOTRIAZOLODIAZEP, P1; Toretsky JA, 2003, AM J CLIN ONCOL-CANC, V26, P300, DOI 10.1097/00000421-200306000-00019; Vollmuth F, 2009, J BIOL CHEM, V284, P36547, DOI 10.1074/jbc.M109.033712; VONVOIGTLANDER PF, 1985, DRUG DEVELOP RES, V6, P1, DOI 10.1002/ddr.430060102; Yang XJ, 2005, ONCOGENE, V24, P1653, DOI 10.1038/sj.onc.1208173; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; You JX, 2006, J VIROL, V80, P8909, DOI 10.1128/JVI.00502-06; You JX, 2009, MOL CELL BIOL, V29, P5094, DOI 10.1128/MCB.00299-09; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9	43	2669	2902	21	553	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					1067	1073		10.1038/nature09504	http://dx.doi.org/10.1038/nature09504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	697XT	20871596	Green Accepted			2022-12-01	WOS:000285553800051
J	Del Bene, F; Wyart, C; Robles, E; Tran, A; Looger, L; Scott, EK; Isacoff, EY; Baier, H				Del Bene, Filippo; Wyart, Claire; Robles, Estuardo; Tran, Amanda; Looger, Loren; Scott, Ethan K.; Isacoff, Ehud Y.; Baier, Herwig			Filtering of Visual Information in the Tectum by an Identified Neural Circuit	SCIENCE			English	Article							ZEBRAFISH OPTIC TECTUM; SUPERIOR COLLICULUS; LARVAL ZEBRAFISH; IN-VIVO; ENHANCER; CELLS	The optic tectum of zebrafish is involved in behavioral responses that require the detection of small objects. The superficial layers of the tectal neuropil receive input from retinal axons, while its deeper layers convey the processed information to premotor areas. Imaging with a genetically encoded calcium indicator revealed that the deep layers, as well as the dendrites of single tectal neurons, are preferentially activated by small visual stimuli. This spatial filtering relies on GABAergic interneurons (using the neurotransmitter gamma-aminobutyric acid) that are located in the superficial input layer and respond only to large visual stimuli. Photo-ablation of these cells with KillerRed, or silencing of their synaptic transmission, eliminates the size tuning of deeper layers and impairs the capture of prey.	[Wyart, Claire; Isacoff, Ehud Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Wyart, Claire; Isacoff, Ehud Y.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Del Bene, Filippo; Robles, Estuardo; Tran, Amanda; Scott, Ethan K.; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Looger, Loren] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Isacoff, Ehud Y.] Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Isacoff, Ehud Y.] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco; Howard Hughes Medical Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Isacoff, EY (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	ehud@calmail.berkeley.edu; herwig.baier@ucsf.edu	Wyart, Claire/H-3783-2016; del bene, filippo/D-1245-2010; isacoff, ehud/AAP-1459-2020; Wyart, Claire/AAB-4603-2020	Wyart, Claire/0000-0002-1668-4975; del bene, filippo/0000-0001-8551-2846; Wyart, Claire/0000-0002-1668-4975; Isacoff, Ehud Y./0000-0003-4775-9359; Tran, Amanda/0000-0002-8393-6124; Robles, Estuardo/0000-0002-1202-2050; Scott, Ethan/0000-0003-3150-9216	Human Frontier Science Program long-term postdoctoral fellowship; Marie Curie Outgoing International Fellowship [UMR5020]; CNRS [UMR5020]; NSF; NIH Nanomedicine Development Center for the Optical Control of Biological Function [PN2 EY018241]; NSF/FIBR [0623527]; Sandler Opportunity Award; Byers Basic Science Award; NIHR [R01 EY012406, R01 NS053358]; NATIONAL EYE INSTITUTE [R01EY012406, PN2EY018241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053358, R01NS050833] Funding Source: NIH RePORTER	Human Frontier Science Program long-term postdoctoral fellowship(Human Frontier Science Program); Marie Curie Outgoing International Fellowship(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); NSF(National Science Foundation (NSF)); NIH Nanomedicine Development Center for the Optical Control of Biological Function(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF/FIBR(National Science Foundation (NSF)); Sandler Opportunity Award; Byers Basic Science Award; NIHR(National Institute for Health Research (NIHR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank W. Staub for care of animals, T. Muller for the gad67 probe, K. Kawakami for Tol2 and TeTxLC-CFP reagents, L. Garner for advice on the visual setup, and J. Nakai for the GCaMP1.6 vector. F. D. B. and C. W. were supported, respectively, by a Human Frontier Science Program long-term postdoctoral fellowship and a Marie Curie Outgoing International Fellowship (with CNRS UMR5020 "Neurosciences Sensorielles, Comportement Cognition," Lyon, France). E. R. was supported by an NSF postdoctoral fellowship. This work was funded by the NIH Nanomedicine Development Center for the Optical Control of Biological Function (PN2 EY018241, E.Y.I. and H. B.), NSF/FIBR 0623527 (E.Y.I.), a Sandler Opportunity Award (H. B.), the Byers Basic Science Award (H. B.), and NIH grants R01 EY012406 and R01 NS053358 (H.B.).	Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Baier H, 2009, CURR OPIN NEUROBIOL, V19, P553, DOI 10.1016/j.conb.2009.08.001; Bollmann JH, 2009, NEURON, V61, P895, DOI 10.1016/j.neuron.2009.01.018; Bulina ME, 2006, NAT BIOTECHNOL, V24, P95, DOI 10.1038/nbt1175; DRAGER UC, 1975, NATURE, V253, P203, DOI 10.1038/253203a0; Gahtan E, 2005, J NEUROSCI, V25, P9294, DOI 10.1523/JNEUROSCI.2678-05.2005; Isa T, 2002, CURR OPIN NEUROBIOL, V12, P668, DOI 10.1016/S0959-4388(02)00387-2; MEEK J, 1978, J COMP NEUROL, V182, P89, DOI 10.1002/cne.901820107; Meyer MP, 2006, J NEUROSCI, V26, P3604, DOI 10.1523/JNEUROSCI.0223-06.2006; Nevin LM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-126; Nevin LM, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-36; Niell CM, 2005, NEURON, V45, P941, DOI 10.1016/j.neuron.2005.01.047; Ohkura M, 2005, ANAL CHEM, V77, P5861, DOI 10.1021/ac0506837; Portugues R, 2009, CURR OPIN NEUROBIOL, V19, P644, DOI 10.1016/j.conb.2009.10.007; Ramdya P, 2008, NAT NEUROSCI, V11, P1083, DOI 10.1038/nn.2166; Ramdya P, 2006, J NEUROSCI METH, V157, P230, DOI 10.1016/j.jneumeth.2006.04.021; Roeser T, 2003, J NEUROSCI, V23, P3726; SAJOVIC P, 1982, NEUROSCIENCE, V7, P2407, DOI 10.1016/0306-4522(82)90204-4; Sato T, 2007, J NEUROSCI, V27, P5271, DOI 10.1523/JNEUROSCI.0883-07.2007; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Scott Jared M., 2009, Journal of the Botanical Research Institute of Texas, V3, P13; Smear MC, 2007, NEURON, V53, P65, DOI 10.1016/j.neuron.2006.12.013; Sumbre G, 2008, NATURE, V456, P102, DOI 10.1038/nature07351; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; VANEGAS H, 1974, J COMP NEUROL, V154, P43, DOI 10.1002/cne.901540104; Vanegas H, 1984, COMP NEUROLOGY OPTIC; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861; Zerucha T, 2000, J NEUROSCI, V20, P709, DOI 10.1523/JNEUROSCI.20-02-00709.2000	28	172	174	4	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 29	2010	330	6004					669	673		10.1126/science.1192949	http://dx.doi.org/10.1126/science.1192949			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672KB	21030657	Green Accepted			2022-12-01	WOS:000283580600048
J	Gladstone, GR; Hurley, DM; Retherford, KD; Feldman, PD; Pryor, WR; Chaufray, JY; Versteeg, M; Greathouse, TK; Steffl, AJ; Throop, H; Parker, JW; Kaufmann, DE; Egan, AF; Davis, MW; Slater, DC; Mukherjee, J; Miles, PF; Hendrix, AR; Colaprete, A; Stern, SA				Gladstone, G. Randall; Hurley, Dana M.; Retherford, Kurt D.; Feldman, Paul D.; Pryor, Wayne R.; Chaufray, Jean-Yves; Versteeg, Maarten; Greathouse, Thomas K.; Steffl, Andrew J.; Throop, Henry; Parker, Joel Wm.; Kaufmann, David E.; Egan, Anthony F.; Davis, Michael W.; Slater, David C.; Mukherjee, Joey; Miles, Paul F.; Hendrix, Amanda R.; Colaprete, Anthony; Stern, S. Alan			LRO-LAMP Observations of the LCROSS Impact Plume	SCIENCE			English	Article							MOLECULAR-HYDROGEN; BAND SYSTEM; LUNAR; MISSION; TABLE	On 9 October 2009, the Lunar Crater Observation and Sensing Satellite (LCROSS) sent a kinetic impactor to strike Cabeus crater, on a mission to search for water ice and other volatiles expected to be trapped in lunar polar soils. The Lyman Alpha Mapping Project (LAMP) ultraviolet spectrograph onboard the Lunar Reconnaissance Orbiter (LRO) observed the plume generated by the LCROSS impact as far-ultraviolet emissions from the fluorescence of sunlight by molecular hydrogen and carbon monoxide, plus resonantly scattered sunlight from atomic mercury, with contributions from calcium and magnesium. The observed light curve is well simulated by the expansion of a vapor cloud at a temperature of similar to 1000 kelvin, containing similar to 570 kilograms (kg) of carbon monoxide, similar to 140 kg of molecular hydrogen, similar to 160 kg of calcium, similar to 120 kg of mercury, and similar to 40 kg of magnesium.	[Gladstone, G. Randall; Retherford, Kurt D.; Chaufray, Jean-Yves; Versteeg, Maarten; Greathouse, Thomas K.; Davis, Michael W.; Slater, David C.; Mukherjee, Joey; Miles, Paul F.] SW Res Inst, San Antonio, TX 78238 USA; [Hurley, Dana M.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Feldman, Paul D.] Johns Hopkins Univ, Baltimore, MD 21218 USA; [Pryor, Wayne R.] Cent Arizona Coll, Coolidge, AZ 85228 USA; [Steffl, Andrew J.; Throop, Henry; Parker, Joel Wm.; Kaufmann, David E.; Egan, Anthony F.; Stern, S. Alan] SW Res Inst, Boulder, CO 80302 USA; [Hendrix, Amanda R.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Colaprete, Anthony] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	Southwest Research Institute; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Johns Hopkins University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Gladstone, GR (corresponding author), SW Res Inst, San Antonio, TX 78238 USA.	rgladstone@swri.edu	Davis, Michael/AAK-3433-2021; Hurley, Dana/F-4488-2015	Davis, Michael/0000-0003-4338-1635; Hurley, Dana/0000-0003-1052-1494; Parker, Joel/0000-0002-3672-0603	NASA; NASA Lunar Science Institute [NNA09DB31A]	NASA(National Aeronautics & Space Administration (NASA)); NASA Lunar Science Institute	We thank the LRO project and other LRO instrument leads for supporting the LCROSS support observations. In particular we thank C. Tooley, D. Everett, M. Houghton, A. Bartels, R. Saylor, R. Vondrak, G. Chin, J. Keller, T. Johnson, and C. Baker for making it happen. We also thank D. Goldstein and D. Summy for useful simulations and predictions, R. Killen and D. Boice for helpful discussions, and the referees for excellent comments. The LAMP is funded by NASA, whose financial support we gratefully acknowledge. One of us (D.M.H.) also acknowledges support from NASA Lunar Science Institute grant NNA09DB31A.	ABGRALL H, 1993, ASTRON ASTROPHYS SUP, V101, P323; ABGRALL H, 1993, ASTRON ASTROPHYS SUP, V101, P273; Abgrall H, 1997, ASTROPHYS J, V481, P557, DOI 10.1086/304017; ANDERS E, 1977, PHILOS T R SOC A, V285, P23, DOI 10.1098/rsta.1977.0040; ARNOLD JR, 1979, J GEOPHYS RES, V84, P5659, DOI 10.1029/JB084iB10p05659; Blanford G., 1985, LUNAR BASES SPACE AC, P603; Chin G, 2007, SPACE SCI REV, V129, P391, DOI 10.1007/s11214-007-9153-y; Colaprete A, 2010, SCIENCE, V330, P463, DOI 10.1126/science.1186986; Crider DH, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002030; CRIDER DH, 2000, J GEOPHYS RES, V26, P773; Curdt W, 2001, ASTRON ASTROPHYS, V375, P591, DOI 10.1051/0004-6361:20010364; Gladstone GR, 2010, SPACE SCI REV, V150, P161, DOI 10.1007/s11214-009-9578-6; Goldstein DB, 2009, AIP CONF PROC, V1084, P1061; Hodges R.R., 1981, LUNAR PLANETARY I SC, P451; HUEBNER WF, 1992, ASTROPHYS SPACE SCI, V195, P1, DOI 10.1007/BF00644558; Korycansky DG, 2009, METEORIT PLANET SCI, V44, P603, DOI 10.1111/j.1945-5100.2009.tb00755.x; McClintock WE, 2009, SCIENCE, V324, P610, DOI 10.1126/science.1172525; Paige DA, 2010, SCIENCE, V330, P479, DOI 10.1126/science.1187726; PILLINGER CT, 1979, REP PROG PHYS, V42, P897, DOI 10.1088/0034-4885/42/5/003; Reed GW, 1999, METEORIT PLANET SCI, V34, P809, DOI 10.1111/j.1945-5100.1999.tb01394.x; Tozzi GP, 1998, ASTRON ASTROPHYS, V330, P753; WATSON K, 1961, J GEOPHYS RES, V66, P3033, DOI 10.1029/JZ066i009p03033	22	102	104	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 22	2010	330	6003					472	476		10.1126/science.1186474	http://dx.doi.org/10.1126/science.1186474			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966244				2022-12-01	WOS:000283329100030
J	Gong, ZF; Liu, JQ; Guo, C; Zhou, YQ; Teng, Y; Liu, L				Gong, Zhefeng; Liu, Jiangqu; Guo, Chao; Zhou, Yanqiong; Teng, Yan; Liu, Li			Two Pairs of Neurons in the Central Brain Control Drosophila Innate Light Preference	SCIENCE			English	Article							SENSORY NEURONS; MELANOGASTER; BEHAVIOR; ULTRASTRUCTURE; EXPRESSION; DISTINCT; CIRCUIT; MEDIATE; SWITCH; CLOCK	Appropriate preferences for light or dark conditions can be crucial for an animal's survival. Innate light preferences are not static in some animals, including the fruit fly Drosophila melanogaster, which prefers darkness in the feeding larval stage but prefers light in adulthood. To elucidate the neural circuit underlying light preference, we examined the neurons involved in larval phototactic behavior by regulating neuronal functions. Modulating activity of two pairs of isomorphic neurons in the central brain switched the larval light preference between photophobic and photophilic. These neurons were found to be immediately downstream of pdf-expressing lateral neurons, which are innervated by larval photoreceptors. Our results revealed a neural mechanism that could enable the adjustment of animals' response strategies to environmental stimuli according to biological needs.	[Gong, Zhefeng; Liu, Jiangqu; Guo, Chao; Zhou, Yanqiong; Liu, Li] Chinese Acad Sci, State Key Lab Brain & Cognit Sci, Inst Biophys, Beijing 100101, Peoples R China; [Liu, Jiangqu; Guo, Chao; Zhou, Yanqiong] Chinese Acad Sci, Grad Univ, Beijing 100039, Peoples R China; [Teng, Yan] Chinese Acad Sci, Inst Biophys, Prot Sci Core Facil Ctr, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Gong, ZF (corresponding author), Chinese Acad Sci, State Key Lab Brain & Cognit Sci, Inst Biophys, Beijing 100101, Peoples R China.	zfgong@moon.ibp.ac.cn; liuli@sun5.ibp.ac.cn			National Natural Sciences Foundation of China [30770682, 30621004, 30625022]; '973 Program' [2005CB522804, 2009CB918702]; Chinese Academy of Sciences [KSCX2-YW-R-247]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); '973 Program'(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank K. Rao for antibody to Pdf; J. Blau, K. Scott, M. Rosbach, T. Lee, C. Feng, Y. Zhong, W. Yi, Y. Jan, and R. Jiao for fly stocks and constructs; and C. Wang and X. Hao for facility setup. We thank the DGRC (Kyoto) and the Bloomington fly stock center for the fly stocks, and Developmental Studies Hybridoma Bank for antibodies. We also thank H. Gong for technical assistance, and J. Fleming and R. Wolf for valuable comments. This work was supported by the National Natural Sciences Foundation of China [grant 30770682 (Z.G.) and grants 30621004 and 30625022 (L.L.)], the '973 Program' [grants 2005CB522804 and 2009CB918702 (L.L.)], and the Knowledge Innovation Program of the Chinese Academy of Sciences [grant KSCX2-YW-R-247 (L.L.)].	Ben-Shahar Y, 2003, J EXP BIOL, V206, P2507, DOI 10.1242/jeb.00442; Busto M, 1999, J NEUROSCI, V19, P3337; Crawley Jacqueline N., 2007, WHATS WRONG MY MOUSE, V2nd; DIRCKSEN H, 1987, CELL TISSUE RES, V250, P377; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; GROSSFIELD J, 1971, P NATL ACAD SCI USA, V68, P2669, DOI 10.1073/pnas.68.11.2669; Hassan J, 2005, J COMP NEUROL, V481, P266, DOI 10.1002/cne.20383; Helfrich-Forster C, 2002, J NEUROSCI, V22, P9255; Li WZ, 2009, CELL TISSUE RES, V336, P509, DOI 10.1007/s00441-009-0781-2; Malpel S, 2002, DEVELOPMENT, V129, P1443; MANNING M, 1981, BEHAV GENET, V11, P557, DOI 10.1007/BF01065790; Mazzoni EO, 2005, NEURON, V45, P293, DOI 10.1016/j.neuron.2004.12.038; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; SAWIN FP, 1994, J INSECT BEHAV, V7, P553, DOI 10.1007/BF02025449; SawinMcCormack EP, 1995, J NEUROGENET, V10, P119, DOI 10.3109/01677069509083459; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Sprecher SG, 2008, NATURE, V454, P533, DOI 10.1038/nature07062; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Yang CH, 2009, NEURON, V61, P519, DOI 10.1016/j.neuron.2008.12.021	25	62	67	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 22	2010	330	6003					499	502		10.1126/science.1195993	http://dx.doi.org/10.1126/science.1195993			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966250				2022-12-01	WOS:000283329100038
J	Lawniczak, MKN; Emrich, SJ; Holloway, AK; Regier, AP; Olson, M; White, B; Redmond, S; Fulton, L; Appelbaum, E; Godfrey, J; Farmer, C; Chinwalla, A; Yang, SP; Minx, P; Nelson, J; Kyung, K; Walenz, BP; Garcia-Hernandez, E; Aguiar, M; Viswanathan, LD; Rogers, YH; Strausberg, RL; Saski, CA; Lawson, D; Collins, FH; Kafatos, FC; Christophides, GK; Clifton, SW; Kirkness, EF; Besansky, NJ				Lawniczak, M. K. N.; Emrich, S. J.; Holloway, A. K.; Regier, A. P.; Olson, M.; White, B.; Redmond, S.; Fulton, L.; Appelbaum, E.; Godfrey, J.; Farmer, C.; Chinwalla, A.; Yang, S. -P.; Minx, P.; Nelson, J.; Kyung, K.; Walenz, B. P.; Garcia-Hernandez, E.; Aguiar, M.; Viswanathan, L. D.; Rogers, Y. -H.; Strausberg, R. L.; Saski, C. A.; Lawson, D.; Collins, F. H.; Kafatos, F. C.; Christophides, G. K.; Clifton, S. W.; Kirkness, E. F.; Besansky, N. J.			Widespread Divergence Between Incipient Anopheles gambiae Species Revealed by Whole Genome Sequences	SCIENCE			English	Article							MOLECULAR-FORMS; ECOLOGICAL SPECIATION; GENE FLOW; ISLANDS; SEGREGATION; CULICIDAE; SELECTION; DIPTERA; S.S.	The Afrotropical mosquito Anopheles gambiae sensu stricto, a major vector of malaria, is currently undergoing speciation into the M and S molecular forms. These forms have diverged in larval ecology and reproductive behavior through unknown genetic mechanisms, despite considerable levels of hybridization. Previous genome-wide scans using gene-based microarrays uncovered divergence between M and S that was largely confined to gene-poor pericentromeric regions, prompting a speciation-with-ongoing-gene-flow model that implicated only about 3% of the genome near centromeres in the speciation process. Here, based on the complete M and S genome sequences, we report widespread and heterogeneous genomic divergence inconsistent with appreciable levels of interform gene flow, suggesting a more advanced speciation process and greater challenges to identify genes critical to initiating that process.	[White, B.; Collins, F. H.; Besansky, N. J.] Univ Notre Dame, Eck Inst Global Hlth, Dept Biol Sci, Notre Dame, IN 46556 USA; [Lawniczak, M. K. N.; Redmond, S.; Kafatos, F. C.; Christophides, G. K.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London SW7 2AZ, England; [Emrich, S. J.; Regier, A. P.; Olson, M.] Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA; [Holloway, A. K.] J David Gladstone Inst, San Francisco, CA 94158 USA; [Fulton, L.; Appelbaum, E.; Godfrey, J.; Farmer, C.; Chinwalla, A.; Yang, S. -P.; Minx, P.; Nelson, J.; Kyung, K.; Clifton, S. W.] Washington Univ, Genome Ctr, St Louis, MO 63108 USA; [Walenz, B. P.; Garcia-Hernandez, E.; Aguiar, M.; Viswanathan, L. D.; Rogers, Y. -H.; Strausberg, R. L.; Kirkness, E. F.] J Craig Venter Inst, Rockville, MD 20850 USA; [Saski, C. A.] Clemson Univ, Clemson Univ Genom Inst, Clemson, SC 29634 USA; [Lawson, D.] European Bioinformat Inst EMBL EBI, Cambridge CB10 1SD, England	University of Notre Dame; Imperial College London; University of Notre Dame; University of California System; University of California San Francisco; The J David Gladstone Institutes; Washington University (WUSTL); J. Craig Venter Institute; Clemson University; European Molecular Biology Laboratory (EMBL)	Besansky, NJ (corresponding author), Univ Notre Dame, Eck Inst Global Hlth, Dept Biol Sci, Notre Dame, IN 46556 USA.	nbesansk@nd.edu	Holloway, Alisha/H-9574-2013	Holloway, Alisha/0000-0001-9810-389X; Chinwalla, Asif/0000-0001-7831-3996; Lawson, Daniel/0000-0001-7765-983X; Christophides, George/0000-0002-3323-1687; Lawniczak, Mara/0000-0002-3006-2080; redmond, seth/0000-0003-2653-760X	National Human Genome Research Institute [U54-HG00379, U54-HG03068]; NIH [RO1 AI63508, AI076584]; Biotechnology and Biological Sciences Research Council [BB/E002641/1]; BBSRC [BB/E002641/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C519670/1] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003068, R01HG000379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076584, R01AI063508] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank W. M. Gelbart, an early advocate of this project, and J. L. Feder, P. Nosil, and M. W. Hahn for critical review. P. Howell of MR4 provided mosquitoes. Funding for genome sequencing of M (U54-HG00379) and S (U54-HG03068) was provided by the National Human Genome Research Institute. N.J.B. was supported by NIH (RO1 AI63508 and AI076584). M.K.N.L. was supported by Biotechnology and Biological Sciences Research Council research grant BB/E002641/1 to G.K.C. Sequence data are deposited with GenBank (accessions ABKP00000000 and ABKQ00000000).	Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Caputo B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-182; Carneiro M, 2009, GENETICS, V181, P593, DOI 10.1534/genetics.108.096826; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Diabate A, 2006, J MED ENTOMOL, V43, P480, DOI 10.1603/0022-2585(2006)43[480:MSOTMM]2.0.CO;2; Diabate A, 2007, J MED ENTOMOL, V44, P60, DOI 10.1603/0022-2585(2007)44[60:ETEOPI]2.0.CO;2; Diabate A, 2009, P ROY SOC B-BIOL SCI, V276, P4215, DOI 10.1098/rspb.2009.1167; Du W, 2005, INSECT MOL BIOL, V14, P179, DOI 10.1111/j.1365-2583.2005.00544.x; Feder JL, 2010, EVOLUTION, V64, P1729, DOI [10.1111/j.1558-5646.2009.00943.x, 10.1111/j.1558-5646.2010.00943.x]; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Lehmann T, 2008, INFECT GENET EVOL, V8, P737, DOI 10.1016/j.meegid.2008.06.003; Li YF, 2008, EVOLUTION, V62, P2984, DOI 10.1111/j.1558-5646.2008.00486.x; Mehren JE, 2007, CURR BIOL, V17, pR240, DOI 10.1016/j.cub.2007.02.014; Neafsey DE, 2010, SCIENCE, V330, P514, DOI 10.1126/science.1193036; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Oliveira E, 2008, J MED ENTOMOL, V45, P1057, DOI 10.1603/0022-2585(2008)45[1057:HLOHBM]2.0.CO;2; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Tripet F, 2001, MOL ECOL, V10, P1725, DOI 10.1046/j.0962-1083.2001.01301.x; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; White BJ, 2010, MOL ECOL, V19, P925, DOI 10.1111/j.1365-294X.2010.04531.x	24	206	208	2	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					512	514		10.1126/science.1195755	http://dx.doi.org/10.1126/science.1195755			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966253	Green Accepted			2022-12-01	WOS:000283329100042
J	Guichard, A; McGillivray, SM; Cruz-Moreno, B; van Sorge, NM; Nizet, V; Bier, E				Guichard, Annabel; McGillivray, Shauna M.; Cruz-Moreno, Beatriz; van Sorge, Nina M.; Nizet, Victor; Bier, Ethan			Anthrax toxins cooperatively inhibit endocytic recycling by the Rab11/Sec15 exocyst	NATURE			English	Article							LETHAL FACTOR; EDEMA FACTOR; WING VEIN; SEC15; RAB11; MORPHOGENESIS; PATHOGENESIS; COMPONENTS; ENDOSOMES; EFFECTOR	Bacillus anthracis is the causative agent of anthrax in humans and other mammals(1,2). In lethal systemic anthrax, proliferating bacilli secrete large quantities of the toxins lethal factor (LF) and oedema factor (EF), leading to widespread vascular leakage and shock. Whereas host targets of LF (mitogen-activated protein-kinase kinases) and EF (cAMP-dependent processes)(3) have been implicated in the initial phase of anthrax(1,2), less is understood about toxin action during the final stage of infection. Here we use Drosophila melanogaster to identify the Rab11/Sec15 exocyst, which acts at the last step of endocytic recycling, as a novel target of both EF and LF. EF reduces levels of apically localized Rab11 and indirectly blocks vesicle formation by its binding partner and effector Sec15 (Sec15-GFP), whereas LF acts more directly to reduce Sec15-GFP vesicles. Convergent effects of EF and LF on Rab11/Sec15 inhibit expression of and signalling by the Notch ligand Delta and reduce DE-cadherin levels at adherens junctions. In human endothelial cells, the two toxins act in a conserved fashion to block formation of Sec15 vesicles, inhibit Notch signalling, and reduce cadherin expression at adherens junctions. This coordinated disruption of the Rab11/Sec15 exocyst by anthrax toxins may contribute to toxin-dependent barrier disruption and vascular dysfunction during B. anthracis infection.	[Guichard, Annabel; Cruz-Moreno, Beatriz; Bier, Ethan] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [McGillivray, Shauna M.; van Sorge, Nina M.; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [McGillivray, Shauna M.] Texas Christian Univ, Dept Biol, Ft Worth, TX 76129 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Texas Christian University; University of California System; University of California San Diego	Bier, E (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ebier@ucsd.edu	McGillivray, Shauna/AAN-3074-2021; Nizet, Victor/AAF-3190-2019; van Sorge, Nina/E-3290-2017	McGillivray, Shauna/0000-0002-8863-1522; van Sorge, Nina/0000-0002-2695-5863; Nizet, Victor/0000-0003-3847-0422	National Institutes of Health (NIH) [AI070654, NS29870, AI077780]; IRACDA NIH [GM068524]; Hartwell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI070654, R01AI077780, R01AI070654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS029870, R01NS029870] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IRACDA NIH; Hartwell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Kurciyan for help in analysing the effects of expressing wild-type and dominant-negative forms of Rab in Drosophila, A. Cooper and members of the E.B. and V.N. laboratories and H. Bellen for comments on the manuscript and suggestions. We thank S. Leppla for providing purified preparations of LF, EF and PA, S. Stibitz for B. anthracis mutants, and the following investigators for providing antibodies: R. Cohen (anti-Rab11), A. Parks (anti-Dl), K. Irvine (anti-Serrate) and J. Collier (anti-LF). Support for these studies was provided by National Institutes of Health (NIH) R01 grants AI070654 and NS29870 (E. B.), AI077780 (V. N.), an IRACDA NIH postdoctoral fellowship GM068524 (S.M.M.) and a Biomedical Research Fellowship from The Hartwell Foundation (S.M.M.).	Balzac F, 2005, J CELL SCI, V118, P4765, DOI 10.1242/jcs.02584; Cook O, 2004, DEVELOPMENT, V131, P2113, DOI 10.1242/dev.01100; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Firoved AM, 2005, AM J PATHOL, V167, P1309, DOI 10.1016/S0002-9440(10)61218-7; Fortini ME, 2009, CURR OPIN GENET DEV, V19, P323, DOI 10.1016/j.gde.2009.04.005; Gozes Y, 2006, INFECT IMMUN, V74, P1266, DOI 10.1128/IAI.74.2.1266-1272.2006; Guichard A, 2006, P NATL ACAD SCI USA, V103, P3244, DOI 10.1073/pnas.0510748103; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Jafar-Nejad H, 2005, DEV CELL, V9, P351, DOI 10.1016/j.devcel.2005.06.010; Janes BK, 2006, INFECT IMMUN, V74, P1949, DOI 10.1128/IAI.74.3.1949-1953.2006; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Kuo SR, 2008, MICROB PATHOGENESIS, V44, P467, DOI 10.1016/j.micpath.2007.12.001; Lacy DB, 2002, CURR TOP MICROBIOL, V271, P61; Langevin J, 2005, DEV CELL, V9, P365, DOI 10.1016/j.devcel.2005.07.013; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Lunde K, 2003, DEVELOPMENT, V130, P235, DOI 10.1242/dev.00207; Moayeri M, 2004, CURR OPIN MICROBIOL, V7, P19, DOI 10.1016/j.mib.2003.12.001; Mourez M, 2005, REV PHYSIOL BIOCH P, V152, P135, DOI 10.1007/s10254-004-0028-2; ONEILL JW, 1994, BIOTECHNIQUES, V17, P870; PEZARD C, 1991, INFECT IMMUN, V59, P3472, DOI 10.1128/IAI.59.10.3472-3477.1991; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; SALMINEN A, 1989, J CELL BIOL, V109, P1023, DOI 10.1083/jcb.109.3.1023; Silvis MR, 2009, MOL BIOL CELL, V20, P2337, DOI 10.1091/mbc.E08-01-0084; Tessier J, 2007, INFECT IMMUN, V75, P1895, DOI 10.1128/IAI.01632-06; Tournier JN, 2007, CELL MICROBIOL, V9, P555, DOI 10.1111/j.1462-5822.2006.00866.x; van Sorge NM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002964; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Wu H, 2008, TRENDS CELL BIOL, V18, P397, DOI 10.1016/j.tcb.2008.06.007; Wu SY, 2005, NAT STRUCT MOL BIOL, V12, P879, DOI 10.1038/nsmb987; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761; Zhang XM, 2004, J BIOL CHEM, V279, P43027, DOI 10.1074/jbc.M402264200	33	77	78	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2010	467	7317					854	U123		10.1038/nature09446	http://dx.doi.org/10.1038/nature09446			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944747	Green Accepted			2022-12-01	WOS:000282898700069
J	Virtanen, A; Joutsensaari, J; Koop, T; Kannosto, J; Yli-Pirila, P; Leskinen, J; Makela, JM; Holopainen, JK; Poschl, U; Kulmala, M; Worsnop, DR; Laaksonen, A				Virtanen, Annele; Joutsensaari, Jorma; Koop, Thomas; Kannosto, Jonna; Yli-Pirila, Pasi; Leskinen, Jani; Makela, Jyrki M.; Holopainen, Jarmo K.; Poeschl, Ulrich; Kulmala, Markku; Worsnop, Douglas R.; Laaksonen, Ari			An amorphous solid state of biogenic secondary organic aerosol particles	NATURE			English	Article							ATMOSPHERIC PARTICLES; OLEIC-ACID; MODEL; OXIDATION; CLIMATE; CHEMISTRY; DIFFUSION; EMISSIONS; PRODUCTS; FORESTS	Secondary organic aerosol (SOA) particles are formed in the atmosphere from condensable oxidation products of anthropogenic and biogenic volatile organic compounds (VOCs)(1-7). On a global scale, biogenic VOCs account for about 90% of VOC emissions(1,8) and of SOA formation (90 billion kilograms of carbon per year)(1-4). SOA particles can scatter radiation and act as cloud condensation or ice nuclei, and thereby influence the Earth's radiation balance and climate(1,2,5,9,10). They consist of a myriad of different compounds with varying physicochemical properties, and little information is available on the phase state of SOA particles. Gas-particle partitioning models usually assume that SOA particles are liquid(1,5,11), but here we present experimental evidence that they can be solid under ambient conditions. We investigated biogenic SOA particles formed from oxidation products of VOCs in plant chamber experiments and in boreal forests within a few hours after atmospheric nucleation events. On the basis of observed particle bouncing in an aerosol impactor and of electron microscopy we conclude that biogenic SOA particles can adopt an amorphous solid-most probably glassy-state. This amorphous solid state should provoke a rethinking of SOA processes because it may influence the partitioning of semi-volatile compounds, reduce the rate of heterogeneous chemical reactions, affect the particles' ability to accommodate water and act as cloud condensation or ice nuclei, and change the atmospheric lifetime of the particles(12-15). Thus, the results of this study challenge traditional views of the kinetics and thermodynamics of SOA formation and transformation in the atmosphere and their implications for air quality and climate.	[Virtanen, Annele; Kannosto, Jonna; Makela, Jyrki M.] Tampere Univ Technol, Dept Phys, FIN-33101 Tampere, Finland; [Joutsensaari, Jorma; Worsnop, Douglas R.; Laaksonen, Ari] Univ Eastern Finland, Dept Math & Phys, Kuopio 70211, Finland; [Koop, Thomas] Univ Bielefeld, Dept Chem, D-33615 Bielefeld, Germany; [Yli-Pirila, Pasi; Leskinen, Jani; Holopainen, Jarmo K.] Univ Eastern Finland, Dept Environm Sci, Kuopio 70211, Finland; [Poeschl, Ulrich] Max Planck Inst Chem, Biogeochem Dept, D-55128 Mainz, Germany; [Kulmala, Markku; Worsnop, Douglas R.] Univ Helsinki, Dept Phys, Helsinki 00014, Finland; [Kulmala, Markku] Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden; [Worsnop, Douglas R.] Aerodyne Res Inc, Billerica, MA 01821 USA; [Worsnop, Douglas R.; Laaksonen, Ari] Finnish Meteorol Inst, FIN-00101 Helsinki, Finland	Tampere University; University of Eastern Finland; University of Bielefeld; University of Eastern Finland; Max Planck Society; University of Helsinki; Stockholm University; Aerodyne Research; Finnish Meteorological Institute	Virtanen, A (corresponding author), Tampere Univ Technol, Dept Phys, POB 692, FIN-33101 Tampere, Finland.	annele.virtanen@tut.fi; thomas.koop@uni-bielefeld.de	Virtanen, Annele/E-7699-2010; Pöschl, Ulrich/A-6263-2010; Laaksonen, Ari/B-5094-2011; Kulmala, Markku T/I-7671-2016; Mäkelä, Jyrki/G-4223-2014; Koop, Thomas/B-7861-2008; Worsnop, Douglas R/D-2817-2009; Holopainen, Jarmo K./B-1656-2008	Virtanen, Annele/0000-0002-2917-5344; Pöschl, Ulrich/0000-0003-1412-3557; Laaksonen, Ari/0000-0002-1657-2383; Kulmala, Markku T/0000-0003-3464-7825; Koop, Thomas/0000-0002-7571-3684; Worsnop, Douglas R/0000-0002-8928-8017; Holopainen, Jarmo K./0000-0001-5026-3245; Makela, Jyrki Mikael/0000-0002-6757-3589	Academy of Finland [110763, 111543, 131019, 218115]; Maj and Tor Nessling foundation	Academy of Finland(Academy of Finland); Maj and Tor Nessling foundation	We acknowledge support by the Academy of Finland (decision numbers 110763, 111543, 131019, 218115 and Centre of Excellence Programme) and the Maj and Tor Nessling foundation. We also acknowledge J. Keskinen and A. Arffman for fruitful discussions concerning impactor performance, H. Kuuluvainen for his help in bounce factor measurements, K. Rissa for SEM imaging, L. Hao, P. Tiitta, A. Kortelainen and P. Miettinen for aerosol mass spectrometer analyses and their help during experiments, J. Jokiniemi, U. Tapper and J. Lyyranen (VTT Technical Research Centre of Finland) for the development of SEM sample collection and image analysis methods, A. Diekmann for the differential scanning calorimeter measurements and T. Wagner for providing polystyrene samples.	Bahreini R, 2005, ENVIRON SCI TECHNOL, V39, P5674, DOI 10.1021/es048061a; Claeys M, 2004, SCIENCE, V303, P1173, DOI 10.1126/science.1092805; DAHNEKE B, 1971, J COLLOID INTERF SCI, V37, P342, DOI 10.1016/0021-9797(71)90302-X; Ehn M, 2007, ATMOS CHEM PHYS, V7, P211, DOI 10.5194/acp-7-211-2007; Fuzzi S, 2006, ATMOS CHEM PHYS, V6, P2017, DOI 10.5194/acp-6-2017-2006; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Hallquist M, 2009, ATMOS CHEM PHYS, V9, P5155, DOI 10.5194/acp-9-5155-2009; HAMERI K, 2000, REP SER AEROSOL SCI, V47, P47; Hari P, 2005, BOREAL ENVIRON RES, V10, P315; *IPCC, 2007, CLIM CHANG 2007 PHYS, P161; Jimenez JL, 2009, SCIENCE, V326, P1525, DOI 10.1126/science.1180353; Joutsensaari J, 2005, ATMOS CHEM PHYS, V5, P1489, DOI 10.5194/acp-5-1489-2005; Kalberer M, 2004, SCIENCE, V303, P1659, DOI 10.1126/science.1092185; Kanakidou M, 2005, ATMOS CHEM PHYS, V5, P1053, DOI 10.5194/acp-5-1053-2005; Kavouras IG, 1998, NATURE, V395, P683, DOI 10.1038/27179; Laaksonen A, 2008, ATMOS CHEM PHYS, V8, P2657, DOI 10.5194/acp-8-2657-2008; Marcolli C, 2004, J PHYS CHEM A, V108, P2216, DOI 10.1021/jp0360801; Maria SF, 2004, SCIENCE, V306, P1921, DOI 10.1126/science.1103491; Mentel TF, 2009, ATMOS CHEM PHYS, V9, P4387, DOI 10.5194/acp-9-4387-2009; Mikhailov E, 2009, ATMOS CHEM PHYS, V9, P9491, DOI 10.5194/acp-9-9491-2009; Murray BJ, 2008, ATMOS CHEM PHYS, V8, P5423, DOI 10.5194/acp-8-5423-2008; PANKOW JF, 1994, ATMOS ENVIRON, V28, P189, DOI 10.1016/1352-2310(94)90094-9; PANKOW JF, 1987, ATMOS ENVIRON, V21, P2275, DOI 10.1016/0004-6981(87)90363-5; PARKER R, 1995, CARBOHYD RES, V273, P147, DOI 10.1016/0008-6215(95)00120-I; Shiraiwa M, 2010, ATMOS CHEM PHYS, V10, P3673, DOI 10.5194/acp-10-3673-2010; STEIN SW, 1994, ATMOS ENVIRON, V28, P1739, DOI 10.1016/1352-2310(94)90136-8; Tunved P, 2006, SCIENCE, V312, P261, DOI 10.1126/science.1123052; Zahardis J, 2007, ATMOS CHEM PHYS, V7, P1237, DOI 10.5194/acp-7-1237-2007; Zobrist B, 2008, ATMOS CHEM PHYS, V8, P5221, DOI 10.5194/acp-8-5221-2008	29	550	554	12	555	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2010	467	7317					824	827		10.1038/nature09455	http://dx.doi.org/10.1038/nature09455			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20944744				2022-12-01	WOS:000282898700063
J	Duncan, AW; Taylor, MH; Hickey, RD; Newell, AEH; Lenzi, ML; Olson, SB; Finegold, MJ; Grompe, M				Duncan, Andrew W.; Taylor, Matthew H.; Hickey, Raymond D.; Newell, Amy E. Hanlon; Lenzi, Michelle L.; Olson, Susan B.; Finegold, Milton J.; Grompe, Markus			The ploidy conveyor of mature hepatocytes as a source of genetic variation	NATURE			English	Article							TYROSINEMIA TYPE-I; MURINE MODEL; CELL-FUSION; MOUSE MODEL; STEM-CELLS; LIVER; MICE; VIVO; FUMARYLACETOACETATE; POLYPLOIDIZATION	Mononucleated and binucleated polyploid hepatocytes (4n, 8n, 16n and higher) are found in all mammalian species, but the functional significance of this conserved phenomenon remains unknown(1-4). Polyploidization occurs through failed cytokinesis, begins at weaning in rodents and increases with age(2,5-7). Previously, we demonstrated that the opposite event, ploidy reversal, also occurs in polyploid hepatocytes generated by artificial cell fusion(8-10). This raised the possibility that somatic 'reductive mitoses' can also happen in normal hepatocytes. Here we show that multipolar mitotic spindles form frequently in mouse polyploid hepatocytes and can result in one-step ploidy reversal to generate offspring with halved chromosome content. Proliferating hepatocytes produce a highly diverse population of daughter cells with multiple numerical chromosome imbalances as well as uniparental origins. Our findings support a dynamic model of hepatocyte polyploidization, ploidy reversal and aneuploidy, a phenomenon that we term the 'ploidy conveyor'. We propose that this mechanism evolved to generate genetic diversity and permits adaptation of hepatocytes to xenobiotic or nutritional injury.	[Duncan, Andrew W.; Hickey, Raymond D.; Grompe, Markus] Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, Oregon Stem Cell Ctr, Portland, OR 97239 USA; [Taylor, Matthew H.] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97239 USA; [Hickey, Raymond D.; Newell, Amy E. Hanlon; Lenzi, Michelle L.; Olson, Susan B.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Finegold, Milton J.] Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Baylor College of Medicine	Duncan, AW (corresponding author), Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, Oregon Stem Cell Ctr, Portland, OR 97239 USA.	duncanan@ohsu.edu		Grompe, Markus/0000-0002-6616-4345; Duncan, Andrew/0000-0003-4962-4191	Advanced Light Microscopy Core at OHSU [S10-RR023432]; Morphology Core of the Texas Medical Center [DK56338]; National Institute of Health [R01DK067636, F32DK076232]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK076232, P30DK056338, R01DK067636] Funding Source: NIH RePORTER	Advanced Light Microscopy Core at OHSU; Morphology Core of the Texas Medical Center; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank P. Canaday (Flow Cytometry Resource at OHSU) for cell sorting; A. Snyder and S. Kaech Petrie (Advanced Light Microscopy Core at OHSU, Core grant S10-RR023432) for microscopy assistance; and the Morphology Core of the Texas Medical Center (DK56338) for histology support. We also thank L. Smith and M. Thayer for discussions. This work was supported by grants from the National Institute of Health to M.G. (R01DK067636) and A.W.D. (F32DK076232).	BARBASON H, 1974, CELL TISSUE KINET, V7, P319, DOI 10.1111/j.1365-2184.1974.tb00414.x; BAYANI J, 2004, CURR PROTOC CELL BIO, DOI DOI 10.1002/0471143030.CB2204S2322; Celton-Morizur S, 2009, J CLIN INVEST, V119, P1880, DOI 10.1172/JCI38677; DARLINGTON GJ, 1987, IN VITRO CELL DEV B, V23, P349; Duncan AW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000385; FAKTOR VM, 1975, TSITOLOGIYA+, V17, P909; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; GROMPE M, 1993, GENE DEV, V7, P2298, DOI 10.1101/gad.7.12a.2298; Guidotti JE, 2003, J BIOL CHEM, V278, P19095, DOI 10.1074/jbc.M300982200; Jorquera R, 1997, BIOCHEM BIOPH RES CO, V232, P42, DOI 10.1006/bbrc.1997.6220; Ko MA, 2005, NAT GENET, V37, P883, DOI 10.1038/ng1605; KUDRYAVTSEV BN, 1993, VIRCHOWS ARCH B, V64, P387, DOI 10.1007/BF02915139; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Manning K, 1999, P NATL ACAD SCI USA, V96, P11928, DOI 10.1073/pnas.96.21.11928; Margall-Ducos G, 2007, J CELL SCI, V120, P3633, DOI 10.1242/jcs.016907; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Overturf K, 1997, HUM GENE THER, V8, P513, DOI 10.1089/hum.1997.8.5-513; Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Rancati G, 2008, CELL, V135, P879, DOI 10.1016/j.cell.2008.09.039; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Willenbring H, 2004, NAT MED, V10, P744, DOI 10.1038/nm1062; Yannoutsos N, 1996, GENES CELLS, V1, P409, DOI 10.1046/j.1365-2443.1996.d01-244.x; YIM APC, 1982, BRIT J EXP PATHOL, V63, P458	26	333	342	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 7	2010	467	7316					707	U93		10.1038/nature09414	http://dx.doi.org/10.1038/nature09414			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659NE	20861837	Green Accepted			2022-12-01	WOS:000282572500038
J	Heazell, AE				Heazell, Alexander E.			Personal View Towards an end to stillbirths	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Manchester, Manchester M13 9PL, Lancs, England	University of Manchester	Heazell, AE (corresponding author), Univ Manchester, Manchester M13 9PL, Lancs, England.	alexander.heazell@manchester.ac.uk		Heazell, Alexander/0000-0002-4303-7845	National Institute for Health Research [CL-2009-06-002] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Ahman E, 2007, NEONATAL PERINATAL M; [Anonymous], 2009, STUD STILLB CLAIMS; *CONF ENQ STILLB D, 1998, 5 ANN REP CONF ENQ S; *CONF ENQ STILLB D, 2001, 8 ANN REP CONF ENQ S; Confidential Enquiry into Maternal and Child Health, 2009, PER MORT 2007 ENGL W; Guildea ZES, 2001, ARCH DIS CHILD, V84, P307, DOI 10.1136/adc.84.4.307; Haws RA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S5; Henley A, 2008, SEMIN FETAL NEONAT M, V13, P325, DOI 10.1016/j.siny.2008.03.003; *NAT I HLTH RES, 2008, TRANSF HLTH RES 1 2; Scott J, 2009, SAVING BABIES LIVES	10	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 6	2010	341								c5070	10.1136/bmj.c5070	http://dx.doi.org/10.1136/bmj.c5070			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	663JE	20926491				2022-12-01	WOS:000282879400015
J	Kosik, KS				Kosik, Kenneth S.			MicroRNAs and Cellular Phenotypy	CELL			English	Article							NEURAL DEVELOPMENT; STEM-CELLS; MESSENGER-RNAS; EVOLUTION; GENE; BIOLOGY; GENOME; PLURIPOTENCY; CANALIZATION; DEGRADATION		Univ Calif Santa Barbara, Neurosci Res Inst, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Kosik, KS (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	kenneth.kosik@lifesci.ucsb.edu						Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; [Anonymous], 2005, PLAUSIBILITY LIFE; Banerjee S, 2009, NEURON, V64, P871, DOI 10.1016/j.neuron.2009.11.023; Caviness VS, 2003, CEREB CORTEX, V13, P592, DOI 10.1093/cercor/13.6.592; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Chi AS, 2009, SCIENCE, V323, P220, DOI 10.1126/science.1166261; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; Johnston RJ, 2005, P NATL ACAD SCI USA, V102, P12449, DOI 10.1073/pnas.0505530102; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Kosik KS, 2009, NAT REV NEUROSCI, V10, P754, DOI 10.1038/nrn2713; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Martinez NJ, 2008, GENE DEV, V22, P2535, DOI 10.1101/gad.1678608; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Parter M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000206; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Prochnik SE, 2007, DEV GENES EVOL, V217, P73, DOI 10.1007/s00427-006-0116-1; Puzio-Kuter AM, 2009, NAT BIOTECHNOL, V27, P914, DOI 10.1038/nbt1009-914; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Rouhana L, 2010, DEV BIOL, V341, P429, DOI 10.1016/j.ydbio.2010.02.037; Sakarya O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000506; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Tsang JS, 2010, MOL CELL, V38, P140, DOI 10.1016/j.molcel.2010.03.007; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wu CI, 2009, GENOME RES, V19, P734, DOI 10.1101/gr.084640.108; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Xu JZ, 2008, RNA, V14, P1276, DOI 10.1261/rna.997708; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	48	95	104	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 1	2010	143	1					21	26		10.1016/j.cell.2010.09.008	http://dx.doi.org/10.1016/j.cell.2010.09.008			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	656UC	20887887	Bronze			2022-12-01	WOS:000282362000008
J	Johnson, WE; Onorato, DP; Roelke, ME; Land, ED; Cunningham, M; Belden, RC; McBride, R; Jansen, D; Lotz, M; Shindle, D; Howard, J; Wildt, DE; Penfold, LM; Hostetler, JA; Oli, MK; O'Brien, SJ				Johnson, Warren E.; Onorato, David P.; Roelke, Melody E.; Land, E. Darrell; Cunningham, Mark; Belden, Robert C.; McBride, Roy; Jansen, Deborah; Lotz, Mark; Shindle, David; Howard, JoGayle; Wildt, David E.; Penfold, Linda M.; Hostetler, Jeffrey A.; Oli, Madan K.; O'Brien, Stephen J.			Genetic Restoration of the Florida Panther	SCIENCE			English	Article							CONSERVATION; PUMAS	The rediscovery of remnant Florida panthers (Puma concolor coryi) in southern Florida swamplands prompted a program to protect and stabilize the population. In 1995, conservation managers translocated eight female pumas (P. c. stanleyana) from Texas to increase depleted genetic diversity, improve population numbers, and reverse indications of inbreeding depression. We have assessed the demographic, population-genetic, and biomedical consequences of this restoration experiment and show that panther numbers increased threefold, genetic heterozygosity doubled, survival and fitness measures improved, and inbreeding correlates declined significantly. Although these results are encouraging, continued habitat loss, persistent inbreeding, infectious agents, and possible habitat saturation pose new dilemmas. This intensive management program illustrates the challenges of maintaining populations of large predators worldwide.	[Johnson, Warren E.; O'Brien, Stephen J.] NCI, Lab Genom Divers, Frederick, MD 21702 USA; [Onorato, David P.; Land, E. Darrell; Cunningham, Mark; Lotz, Mark; Shindle, David] Florida Fish & Wildlife Conservat Commiss, Naples, FL 34114 USA; [Roelke, Melody E.] NCI, SAIC Frederick, Lab Genom Divers, Frederick, MD 21702 USA; [Belden, Robert C.] US Fish & Wildlife Serv, Vero Beach, FL 32960 USA; [McBride, Roy] Livestock Protect Co, Alpine, TX 79832 USA; [Jansen, Deborah] Big Cypress Natl Preserve, Ochopee, FL 34141 USA; [Howard, JoGayle; Wildt, David E.] Smithsonian Conservat Biol Inst, Front Royal, VA 22630 USA; [Penfold, Linda M.] White Oak Conservat Ctr, Yulee, FL 32046 USA; [Hostetler, Jeffrey A.; Oli, Madan K.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Florida Fish & Wildlife Conservation Commission; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; United States Department of the Interior; US Fish & Wildlife Service; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; State University System of Florida; University of Florida	Johnson, WE (corresponding author), NCI, Lab Genom Divers, Frederick, MD 21702 USA.	warjohns@mail.nih.gov; Dave.Onorato@MyFWC.com; stephenobrien@nih.gov	Johnson, Warren/D-4149-2016; Onorato, Dave/AAD-2563-2021; OBRIEN, STEPHEN/ABD-1346-2020; Hostetler, Jeffrey A./A-3345-2011	Johnson, Warren/0000-0002-5954-186X; Onorato, Dave/0000-0002-4716-6847; Hostetler, Jeffrey A./0000-0003-3669-1758; OBRIEN, STEPHEN/0000-0001-7857-0757	Florida Fish and Wildlife Conservation Commission (FWC); Everglades National Park (EVER); BCNP; U.S. Fish and Wildlife Service; National Cancer Institute, National Institutes of Health (NIH) [N01-CO-12400]; NIH, National Cancer Institute, Center for Cancer Research; Florida Panther Research and Management Trust; NATIONAL CANCER INSTITUTE [ZIABC005367] Funding Source: NIH RePORTER	Florida Fish and Wildlife Conservation Commission (FWC); Everglades National Park (EVER); BCNP; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); National Cancer Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Florida Panther Research and Management Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We dedicate this study to the memory of Ulysses Seal and Ernst Mayr, important heroes in the conservation struggle of the Florida panther. Funded by the Florida Fish and Wildlife Conservation Commission (FWC) via purchases of Florida panther license plates. Other major funding for the field work was provided by Everglades National Park (EVER), the BCNP, and federal funds from the U.S. Fish and Wildlife Service (especially in the early years) as well as from the National Cancer Institute, National Institutes of Health (NIH), under contract number N01-CO-12400. This research was supported in part by the Intramural Research Program of NIH, National Cancer Institute, Center for Cancer Research, and the Florida Panther Research and Management Trust Fund. All panther captures, sampling, and radio collaring were authorized by U. S. Fish and Wildlife Service Endangered Species Permits TE01553-3 (FWC) and TE146761-1 (BCNP). We thank many individuals for their help in this project, who are named in SOM reference S25.	BARONE MA, 1994, J MAMMAL, V75, P150, DOI 10.2307/1382247; Culver M, 2008, ANIM CONSERV, V11, P104, DOI 10.1111/j.1469-1795.2007.00154.x; Culver M, 2000, J HERED, V91, P186, DOI 10.1093/jhered/91.3.186; Cunningham MW, 2008, J WILDLIFE DIS, V44, P537, DOI 10.7589/0090-3558-44.3.537; Cunningham MW, 1999, J WILDLIFE DIS, V35, P519, DOI 10.7589/0090-3558-35.3.519; Currier M.J.P, 1983, MAMMALIAN SPECIES, V200, P1, DOI [10.2307/3503951, DOI 10.2307/3503951]; FOSTER ML, 1995, WILDLIFE SOC B, V23, P95; Frankham R, 1998, NATURE, V392, P441, DOI 10.1038/33022; Hedrick PW, 2010, CONSERV GENET, V11, P615, DOI 10.1007/s10592-009-9999-5; Hedrick PW, 2000, ANNU REV ECOL SYST, V31, P139, DOI 10.1146/annurev.ecolsys.31.1.139; Janis MW, 2002, J WILDLIFE MANAGE, V66, P839, DOI 10.2307/3803148; Kautz R, 2006, BIOL CONSERV, V130, P118, DOI 10.1016/j.biocon.2005.12.007; Lacy RC, 1997, J MAMMAL, V78, P320, DOI 10.2307/1382885; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; McBride RT, 2008, SOUTHEAST NAT, V7, P381, DOI 10.1656/1528-7092-7.3.381; O'Brien SJ., 2003, TEARS CHEETAH OTHER; OBRIEN SJ, 1990, NATL GEOGR RES, V6, P485; OBRIEN SJ, 1991, SCIENCE, V251, P1187, DOI 10.1126/science.251.4998.1187; Roelke ME, 2006, J WILDLIFE DIS, V42, P234, DOI 10.7589/0090-3558-42.2.234; ROELKE ME, 1993, J WILDLIFE DIS, V29, P36, DOI 10.7589/0090-3558-29.1.36; ROELKE ME, 1993, CURR BIOL, V3, P340, DOI 10.1016/0960-9822(93)90197-V; Seal US., 1994, PLAN GENETIC RESTORA	22	334	340	4	477	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2010	329	5999					1641	1645		10.1126/science.1192891	http://dx.doi.org/10.1126/science.1192891			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20929847	Green Accepted			2022-12-01	WOS:000282098100040
J	Asher, G; Reinke, H; Altmeyer, M; Gutierrez-Arcelus, M; Hottiger, MO; Schibler, U				Asher, Gad; Reinke, Hans; Altmeyer, Matthias; Gutierrez-Arcelus, Maria; Hottiger, Michael O.; Schibler, Ueli			Poly(ADP-Ribose) Polymerase 1 Participates in the Phase Entrainment of Circadian Clocks to Feeding	CELL			English	Article							GENE-EXPRESSION; DNA-BINDING; TRANSCRIPTION; FEEDBACK; PROTEIN; PARP-1; LIVER	Circadian clocks in peripheral organs are tightly coupled to cellular metabolism and are readily entrained by feeding-fasting cycles. However, the molecular mechanisms involved are largely unknown. Here we show that in liver the activity of PARP-1, an NAD(+)-dependent ADP-ribosyltransferase, oscillates in a daily manner and is regulated by feeding. We provide biochemical evidence that PARP-1 binds and poly(ADP-ribosyl)ates CLOCK at the beginning of the light phase. The loss of PARP-1 enhances the binding of CLOCK-BMAL1 to DNA and leads to a phase-shift of the interaction of CLOCK-BMAL1 with PER and CRY repressor proteins. As a consequence, CLOCK-BMAL1-dependent gene expression is altered in PARP-1-deficient mice, in particular in response to changes in feeding times. Our results show that Parp-1 knockout mice exhibit impaired food entrainment of peripheral circadian clocks and support a role for PARP-1 in connecting feeding with the mammalian timing system.	[Asher, Gad; Gutierrez-Arcelus, Maria; Schibler, Ueli] Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland; [Reinke, Hans] Heinrich Heine Univ IUF, Inst Mol Prevent Med, Sch Med, Heinrich Heine Univ,Inst Clin Chem & Lab Diagnost, D-40225 Dusseldorf, Germany; [Altmeyer, Matthias; Hottiger, Michael O.] Univ Zurich, Inst Vet Biochem & Mol Biol, CH-8057 Zurich, Switzerland; [Altmeyer, Matthias] Univ Zurich, Mol Life Sci Program, Life Sci Zurich Grad Sch, CH-8057 Zurich, Switzerland	University of Geneva; Heinrich Heine University Dusseldorf; University of Zurich; University of Zurich	Asher, G (corresponding author), Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland.	gad.asher@unige.ch; ueli.schibler@unige.ch	ASHER, GAD/K-1333-2012; Altmeyer, Matthias/AAE-8186-2019; Hottiger, Michael O./J-7747-2013	Altmeyer, Matthias/0000-0003-3780-1170; Hottiger, Michael O./0000-0002-7323-2270; Asher, Gad/0000-0001-9403-7856	Swiss National Foundation [SNF 31-113565, SNF 31-128656/1]; European Research Council [ERC2009-AdG 20090506]; State of Geneva; Louis Jeantet Foundation of Medicine	Swiss National Foundation(Swiss National Science Foundation (SNSF)); European Research Council(European Research Council (ERC)European Commission); State of Geneva; Louis Jeantet Foundation of Medicine	The work performed in the laboratory of U.S. was supported by the Swiss National Foundation (SNF 31-113565, SNF 31-128656/1, and the NCCR program grant Frontiers in Genetics), the European Research Council (ERC2009-AdG 20090506), the State of Geneva, the Louis Jeantet Foundation of Medicine, and the 6<SUP>th</SUP> European Framework Project EUCLOCK. The work conducted in the laboratory of M.O.H. was supported by the Swiss National Foundation (SNF 31-122421) and the Kanton of Zurich. G. A. received long-term fellowships from EMBO and the Human Frontier Science Program.	Altmeyer M, 2009, AGING-US, V1, P458, DOI 10.18632/aging.100052; Altmeyer M, 2009, NUCLEIC ACIDS RES, V37, P3723, DOI 10.1093/nar/gkp229; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Davidovic L, 2001, EXP CELL RES, V268, P7, DOI 10.1006/excr.2001.5263; Dodd AN, 2007, SCIENCE, V318, P1789, DOI 10.1126/science.1146757; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Hassa PO, 2005, J BIOL CHEM, V280, P40450, DOI 10.1074/jbc.M507553200; Kauppinen TM, 2006, P NATL ACAD SCI USA, V103, P7136, DOI 10.1073/pnas.0508606103; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; LE MINH N, 2001, EMBO J, V20, P7128; MAZEN A, 1989, NUCLEIC ACIDS RES, V17, P4689, DOI 10.1093/nar/17.12.4689; Mohammad DH, 2009, DNA REPAIR, V8, P1009, DOI 10.1016/j.dnarep.2009.04.004; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Panda S, 2002, DEV CELL, V3, P51, DOI 10.1016/S1534-5807(02)00200-9; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Reinke H, 2008, GENE DEV, V22, P331, DOI 10.1101/gad.453808; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Zaniolo K, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-96	37	250	263	3	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2010	142	6					943	953		10.1016/j.cell.2010.08.016	http://dx.doi.org/10.1016/j.cell.2010.08.016			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650NA	20832105	Bronze			2022-12-01	WOS:000281855000016
J	Lu, LF; Boldin, MP; Chaudhry, A; Lin, LL; Taganov, KD; Hanada, T; Yoshimura, A; Baltimore, D; Rudensky, AY				Lu, Li-Fan; Boldin, Mark P.; Chaudhry, Ashutosh; Lin, Ling-Li; Taganov, Konstantin D.; Hanada, Toshikatsu; Yoshimura, Akihiko; Baltimore, David; Rudensky, Alexander Y.			Function of miR-146a in Controlling Treg Cell-Mediated Regulation of Th1 Responses	CELL			English	Article							TRANSCRIPTION FACTOR FOXP3; T-REG-CELLS; IFN-GAMMA; SIGNALING PATHWAYS; IMMUNE-RESPONSES; TARGET GENES; CD4(+); DIFFERENTIATION; CYTOKINE; SOCS1	Foxp3(+) regulatory T (Treg) cells maintain immune homeostasis by limiting different types of inflammatory responses. Here, we report that miR-146a, one of the miRNAs prevalently expressed in Treg cells, is critical for their suppressor function. The deficiency of miR-146a in Treg cells resulted in a breakdown of immunological tolerance manifested in fatal IFN gamma-dependent immune-mediated lesions in a variety of organs. This was likely due to augmented expression and activation of signal transducer and activator transcription 1 (Stat1), a direct target of miR-146a. Likewise, heightened Stat1 activation in Treg cells subjected to a selective ablation of SOCS1, a key negative regulator of Stat1 phosphorylation downstream of the IFN gamma receptor, was associated with analogous Th1-mediated pathology. Our results suggest that specific aspects of Treg suppressor function are controlled by a single miRNA and that an optimal range of Stat1 activation is important for Treg-mediated control of Th1 responses and associated autoimmunity.	[Lu, Li-Fan; Chaudhry, Ashutosh; Lin, Ling-Li; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Lu, Li-Fan; Chaudhry, Ashutosh; Lin, Ling-Li; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Boldin, Mark P.; Taganov, Konstantin D.; Baltimore, David] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Hanada, Toshikatsu; Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjyuku Ku, Tokyo 1608582, Japan; [Hanada, Toshikatsu; Yoshimura, Akihiko] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Baltimore, David] Regulus Therapeut, San Diego, CA 92121 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; California Institute of Technology; Keio University; Japan Science & Technology Agency (JST); Isis Pharmaceuticals Inc	Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA.	rudenska@mskcc.org	Yoshimura, Akihiko/K-5515-2013	Chaudhry, Ashutosh/0000-0003-3379-5236; Boldin, Mark/0000-0003-4593-0669; Lu, Li-Fan/0000-0002-9727-0036	NIH; Ministry of Education, Culture, Sports, Science; Technology of Japan; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034206] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Technology of Japan; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Ramos for the help in key experiments, Y. Liang, P. Zarin, A. Bravo, and J. Herlihy for superb technical assistance, and all members of our laboratory for discussions. This work was supported by grants from the NIH (A. Y. R. and D. B.) and from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (A. Y.). L.-F. L. is a Leukemia and Lymphoma Society Fellow. A. C. is a Cancer Research Institute Fellow. A. Y. R. is a Howard Hughes Medical Institute investigator. D. B. is the director and M. P. B. and K. D. T. are employees of Regulus Therapeutics Inc., a company devoted to commercializing therapies directed at microRNAs.	Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Barbi J, 2007, BLOOD, V110, P2215, DOI 10.1182/blood-2007-03-081307; Beima KM, 2006, J BIOL CHEM, V281, P11992, DOI 10.1074/jbc.M513613200; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Cameron JE, 2008, J VIROL, V82, P1946, DOI 10.1128/JVI.02136-07; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Curtale G, 2010, BLOOD, V115, P265, DOI 10.1182/blood-2009-06-225987; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Horino J, 2008, INT IMMUNOL, V20, P753, DOI 10.1093/intimm/dxn033; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Huang B, 2009, EMBO REP, V10, P180, DOI 10.1038/embor.2008.224; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kohlhaas S, 2009, J IMMUNOL, V182, P2578, DOI 10.4049/jimmunol.0803162; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Lord GM, 2005, BLOOD, V106, P3432, DOI 10.1182/blood-2005-04-1393; Lu LF, 2009, GENE DEV, V23, P1270, DOI 10.1101/gad.1791009; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Maitra U, 2009, J IMMUNOL, V182, P5763, DOI 10.4049/jimmunol.0900124; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; Nakajima C, 2002, EUR J IMMUNOL, V32, P1792, DOI 10.1002/1521-4141(200206)32:6<1792::AID-IMMU1792>3.0.CO;2-0; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Siebler J, 2003, HEPATOLOGY, V38, P1573, DOI 10.1016/j.hep.2003.09.020; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tanaka K, 2008, J IMMUNOL, V180, P3746, DOI 10.4049/jimmunol.180.6.3746; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Zhan YF, 2009, IMMUNOL CELL BIOL, V87, P473, DOI 10.1038/icb.2009.23; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	56	695	760	5	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2010	142	6					914	929		10.1016/j.cell.2010.08.012	http://dx.doi.org/10.1016/j.cell.2010.08.012			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650NA	20850013	Green Accepted, Bronze			2022-12-01	WOS:000281855000014
J	Rai, K; Sarkar, S; Broadbent, TJ; Voas, M; Grossmann, KF; Nadauld, LD; Dehghanizadeh, S; Hagos, FT; Li, YM; Toth, RK; Chidester, S; Bahr, TM; Johnson, WE; Sklow, B; Burt, R; Cairns, BR; Jones, DA				Rai, Kunal; Sarkar, Sharmistha; Broadbent, Talmage J.; Voas, Matthew; Grossmann, Kenneth F.; Nadauld, Lincoln D.; Dehghanizadeh, Somaye; Hagos, Fanuel T.; Li, Yumei; Toth, Rachel K.; Chidester, Stephanie; Bahr, Timothy M.; Johnson, W. Evan; Sklow, Brad; Burt, Randall; Cairns, Bradley R.; Jones, David A.			DNA Demethylase Activity Maintains Intestinal Cells in an Undifferentiated State Following Loss of APC	CELL			English	Article							ADENOMATOUS POLYPOSIS-COLI; RETINOIC ACID; COLORECTAL-CANCER; ALDEHYDE DEHYDROGENASE; REGULATES EXPRESSION; GENE-EXPRESSION; BETA-CATENIN; ZEBRAFISH; HYPOMETHYLATION; MICE	Although genome-wide hypomethylation is a hallmark of many cancers, roles for active DNA demethylation during tumorigenesis are unknown. Here, loss of the APC tumor suppressor gene causes upregulation of a DNA demethylase system and the concomitant hypomethylation of key intestinal cell fating genes. Notably, this hypomethylation maintained zebrafish intestinal cells in an undifferentiated state that was released upon knockdown of demethylase components. Mechanistically, the demethylase genes are directly activated by Pou5f1 and Cebp beta and are indirectly repressed by retinoic acid, which antagonizes Pou5f1 and Cebp beta. Apc mutants lack retinoic acid as a result of the transcriptional repression of retinol dehydrogenase l1 via a complex that includes Lef1, Groucho2, Ctbp1, Lsd1, and Corest. Our findings imply a model wherein APC controls intestinal cell fating through a switch in DNA methylation dynamics. Wild-type APC and retinoic acid downregulate demethylase components, thereby promoting DNA methylation of key genes and helping progenitors commit to differentiation.	[Rai, Kunal; Sarkar, Sharmistha; Broadbent, Talmage J.; Voas, Matthew; Grossmann, Kenneth F.; Nadauld, Lincoln D.; Dehghanizadeh, Somaye; Hagos, Fanuel T.; Li, Yumei; Toth, Rachel K.; Chidester, Stephanie; Johnson, W. Evan; Sklow, Brad; Burt, Randall; Cairns, Bradley R.; Jones, David A.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Rai, Kunal; Grossmann, Kenneth F.; Cairns, Bradley R.] Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; [Rai, Kunal; Sarkar, Sharmistha; Broadbent, Talmage J.; Voas, Matthew; Grossmann, Kenneth F.; Dehghanizadeh, Somaye; Hagos, Fanuel T.; Toth, Rachel K.; Cairns, Bradley R.; Jones, David A.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Jones, David A.] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Burt, Randall] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [Li, Yumei; Johnson, W. Evan; Sklow, Brad] Univ Utah, Dept Surg, Salt Lake City, UT 84112 USA; [Bahr, Timothy M.] Brigham Young Univ, Dept Stat, Provo, UT 84602 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Brigham Young University	Cairns, BR (corresponding author), Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.	brad.cairns@hci.utah.edu; david.jones@hci.utah.edu		Johnson, W. Evan/0000-0002-6247-6595; Chidester, Stephanie/0000-0003-4163-3480; Rai, Kunal/0000-0003-2321-6894	National Cancer Institute [CA073992, CA96934]; National Institute of Child Health and Development [HD058506]; Howard Hughes Medical Institute; Huntsman Cancer Foundation; Cancer Center [CA042014]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058506] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA116468, P01CA073992, P30CA042014] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Huntsman Cancer Foundation; Cancer Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Smitha James and Adam Karpf for liquid chromatography-mass spectrometry assay, Kornelia Edes, Chad Zavala, Jennifer Swift, Abby Evans, and Erek Winett for technical help, and Richard Dorsky for reagents. This work is supported by grants from the National Cancer Institute (CA073992 and CA96934) awarded to D. A. J., the National Institute of Child Health and Development (HD058506 to B. R. C. and D. A. J), the Howard Hughes Medical Institute (to B. R. C), and the Huntsman Cancer Foundation. The work was also supported by access to technical cores supported by a Cancer Center Support Grant (CA042014).	Begemann G, 2001, DEVELOPMENT, V128, P3081; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Blanc V, 2007, CANCER RES, V67, P8565, DOI 10.1158/0008-5472.CAN-07-1593; Dobbs-McAuliffe B, 2004, MECH DEVELOP, V121, P339, DOI 10.1016/j.mod.2004.02.008; Duester G, 2000, EUR J BIOCHEM, V267, P4315, DOI 10.1046/j.1432-1327.2000.01497.x; Duester G, 2003, CHEM-BIOL INTERACT, V143, P201, DOI 10.1016/S0009-2797(02)00204-1; Eads CA, 2002, CANCER RES, V62, P1296; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Eisinger AL, 2007, J BIOL CHEM, V282, P29394, DOI 10.1074/jbc.M609768200; Eisinger AL, 2006, J BIOL CHEM, V281, P20474, DOI 10.1074/jbc.M602859200; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; GOELZ SE, 1985, SCIENCE, V228, P187, DOI 10.1126/science.2579435; Guimond J, 2002, BBA-GENE STRUCT EXPR, V1579, P81, DOI 10.1016/S0167-4781(02)00510-9; HOLLIDAY R, 1985, CANCER SURV, V4, P557; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; Jette C, 2004, J BIOL CHEM, V279, P34397, DOI 10.1074/jbc.M314021200; LAIRD PW, 1995, CELL, V81, P197, DOI 10.1016/0092-8674(95)90329-1; Millar CB, 2002, SCIENCE, V297, P403, DOI 10.1126/science.1073354; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Mudumana SP, 2004, DEV DYNAM, V230, P165, DOI 10.1002/dvdy.20032; Nadauld LD, 2005, J BIOL CHEM, V280, P30490, DOI 10.1074/jbc.M504973200; Nadauld LD, 2004, J BIOL CHEM, V279, P51581, DOI 10.1074/jbc.M408830200; Nadauld LD, 2006, J BIOL CHEM, V281, P37828, DOI 10.1074/jbc.M602119200; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Parvin MS, 2008, DEV DYNAM, V237, P1373, DOI 10.1002/dvdy.21539; Phelps RA, 2009, CELL CYCLE, V8, P2549, DOI 10.4161/cc.8.16.9278; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; RUSSO JE, 1988, BIOCHEM PHARMACOL, V37, P1639, DOI 10.1016/0006-2952(88)90030-5; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sparks AB, 1998, CANCER RES, V58, P1130; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990	37	75	77	1	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 17	2010	142	6					930	942		10.1016/j.cell.2010.08.030	http://dx.doi.org/10.1016/j.cell.2010.08.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650NA	20850014	Green Accepted, Bronze			2022-12-01	WOS:000281855000015
J	Jiao, XF; Xiang, S; Oh, C; Martin, CE; Tong, LA; Kiledjian, M				Jiao, Xinfu; Xiang, Song; Oh, ChanSeok; Martin, Charles E.; Tong, Liang; Kiledjian, Megerditch			Identification of a quality-control mechanism for mRNA 5 '-end capping	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; DECAPPING ENZYME; CAP METHYLTRANSFERASE; POLYMERASE-II; YEAST-CELLS; PROTEIN; COMPLEX; DEADENYLATION; TRANSLATION; EXPRESSION	The 7-methylguanosine cap structure at the 5' end of eukaryotic messenger RNAs is a critical determinant of their stability and translational efficiency(1-3). It is generally believed that 5'-end capping is a constitutive process that occurs during mRNA maturation and lacks the need for a quality-control mechanism to ensure its fidelity. We recently reported that the yeast Rai1 protein has pyrophosphohydrolase activity towards mRNAs lacking a 5'-end cap(4). Here we show that, in vitro as well as in yeast cells, Rai1 possesses a novel decapping endonuclease activity that can also remove the entire cap structure dinucleotide from an mRNA. This activity is targeted preferentially towards mRNAs with unmethylated caps in contrast to the canonical decapping enzyme, Dcp2, which targets mRNAs with a methylated cap. Capped but unmethylated mRNAs generated in yeast cells with a defect in the methyltransferase gene are more stable in a rai1-gene-disrupted background. Moreover, rai1 Delta yeast cells with wild-type capping enzymes show significant accumulation of mRNAs with 5'-end capping defects under nutritional stress conditions of glucose starvation or amino acid starvation. These findings provide evidence that 5'-end capping is not a constitutive process that necessarily always proceeds to completion and demonstrates that Rai1 has an essential role in clearing mRNAs with aberrant 5'-end caps. We propose that Rai1 is involved in an as yet uncharacterized quality control process that ensures mRNA 5'-end integrity by an aberrant-cap-mediated mRNA decay mechanism.	[Jiao, Xinfu; Oh, ChanSeok; Martin, Charles E.; Kiledjian, Megerditch] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; [Xiang, Song; Tong, Liang] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Rutgers State University New Brunswick; Columbia University	Kiledjian, M (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA.	kiledjian@biology.rutgers.edu	Xiang, Song/AAF-6422-2019	Xiang, Song/0000-0001-9314-4684; Tong, Liang/0000-0002-0563-6468	National Institutes of Health (NIH) [GM077175, GM67005]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090059, R01GM067005, R01GM077175] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Schwer for the abd1-5 yeast strain and A. Shatkin for discussions. This research was supported by grants from the National Institutes of Health (NIH) to L.T. (GM077175) and M.K. (GM67005).	Cowling VH, 2007, MOL CELL BIOL, V27, P2059, DOI 10.1128/MCB.01828-06; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Dunckley T, 1999, EMBO J, V18, P5411, DOI 10.1093/emboj/18.19.5411; Fischer PM, 2009, CELL CYCLE, V8, P2535, DOI 10.4161/cc.8.16.9301; Furuichi Y, 2000, ADV VIRUS RES, V55, P135, DOI 10.1016/S0065-3527(00)55003-9; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Goodfellow IG, 2008, INT J BIOCHEM CELL B, V40, P2675, DOI 10.1016/j.biocel.2007.10.023; He F, 2001, MOL CELL BIOL, V21, P1515, DOI 10.1128/MCB.21.5.1515-1530.2001; HERRICK D, 1990, MOL CELL BIOL, V10, P2269, DOI 10.1128/MCB.10.5.2269; Hilgers V, 2006, RNA, V12, P1835, DOI 10.1261/rna.241006; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; Jiao XF, 2009, J NEUROSCI, V29, P12419, DOI 10.1523/JNEUROSCI.5954-08.2009; Jimeno-Gonzalez S, 2010, MOL CELL, V37, P580, DOI 10.1016/j.molcel.2010.01.019; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; Li Y, 2010, WIRES RNA, V1, P253, DOI 10.1002/wrna.15; Liu HD, 2005, MOL CELL BIOL, V25, P9764, DOI 10.1128/MCB.25.22.9764-9772.2005; Liu HD, 2002, EMBO J, V21, P4699, DOI 10.1093/emboj/cdf448; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; Mannan MAU, 2009, ANAL BIOCHEM, V389, P77, DOI 10.1016/j.ab.2009.03.014; Merrick WC, 2004, GENE, V332, P1, DOI 10.1016/j.gene.2004.02.051; Meyer S, 2004, CRIT REV BIOCHEM MOL, V39, P197, DOI 10.1080/10409230490513991; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Otsuka Y, 2009, MOL CELL BIOL, V29, P2155, DOI 10.1128/MCB.01325-08; Piccirillo C, 2003, RNA, V9, P1138, DOI 10.1261/rna.5690503; Schwer B, 2000, GENETICS, V155, P1561; SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8; Shuman S, 2002, NAT REV MOL CELL BIO, V3, P619, DOI 10.1038/nrm880; SHUMAN S, 1995, PROG NUCLEIC ACID RE, V50, P101, DOI 10.1016/S0079-6603(08)60812-0; Wang ZR, 2002, P NATL ACAD SCI USA, V99, P12663, DOI 10.1073/pnas.192445599; Wang ZR, 1999, MOL CELL BIOL, V19, P4552; Wang ZR, 2001, CELL, V107, P751, DOI 10.1016/S0092-8674(01)00592-X; Wen YX, 2000, GENE DEV, V14, P2944, DOI 10.1101/gad.848200; Xiang S, 2009, NATURE, V458, P784, DOI 10.1038/nature07731; Yue ZY, 1997, P NATL ACAD SCI USA, V94, P12898, DOI 10.1073/pnas.94.24.12898; Zhang S, 1999, METHODS, V17, P46, DOI 10.1006/meth.1998.0706	35	119	120	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP	2010	467	7315					608	U137		10.1038/nature09338	http://dx.doi.org/10.1038/nature09338			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655TT	20802481	Green Accepted			2022-12-01	WOS:000282273100043
J	Lowe, AR; Siegel, JJ; Kalab, P; Siu, M; Weis, K; Liphardt, JT				Lowe, Alan R.; Siegel, Jake J.; Kalab, Petr; Siu, Merek; Weis, Karsten; Liphardt, Jan T.			Selectivity mechanism of the nuclear pore complex characterized by single cargo tracking	NATURE			English	Article							PHENYLALANINE-GLYCINE NUCLEOPORINS; PROTEIN IMPORT; TRANSLOCATION; TRANSPORT; MOLECULE; DIFFUSION; HYDROGEL; BETA	The nuclear pore complex (NPC) mediates all exchange between the cytoplasm and the nucleus. Small molecules can passively diffuse through the NPC, whereas larger cargos require transport receptors to translocate(1). How the NPC facilitates the translocation of transport receptor/cargo complexes remains unclear. To investigate this process, we tracked single protein-functionalized quantum dot cargos as they moved through human NPCs. Here we show that import proceeds by successive substeps comprising cargo capture, filtering and translocation, and release into the nucleus. Most quantum dots are rejected at one of these steps and return to the cytoplasm, including very large cargos that abort at a size-selective barrier. Cargo movement in the central channel is subdiffusive and cargos that can bind more transport receptors diffuse more freely. Without Ran GTPase, a critical regulator of transport directionality(1), cargos still explore the entire NPC, but have a markedly reduced probability of exit into the nucleus, suggesting that NPC entry and exit steps are not equivalent and that the pore is functionally asymmetric to importing cargos. The overall selectivity of the NPC seems to arise from the cumulative action of multiple reversible substeps and a final irreversible exit step.	[Lowe, Alan R.; Siegel, Jake J.; Weis, Karsten; Liphardt, Jan T.] Univ Calif Berkeley, QB3, Berkeley, CA 94720 USA; [Lowe, Alan R.; Liphardt, Jan T.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Lowe, Alan R.; Liphardt, Jan T.] Univ Calif Berkeley, Bay Area Phys Sci Oncol Ctr, Berkeley, CA 94720 USA; [Siegel, Jake J.; Siu, Merek; Liphardt, Jan T.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Kalab, Petr; Weis, Karsten] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Lowe, Alan R.; Liphardt, Jan T.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Weis, K (corresponding author), Univ Calif Berkeley, QB3, Berkeley, CA 94720 USA.	kweis@berkeley.edu	Liphardt, Jan/A-5906-2012; Kalab, Petr/B-2478-2009; Weis, Karsten/F-5719-2011	Weis, Karsten/0000-0001-7224-925X; Liphardt, Jan/0000-0003-2835-5025; Lowe, Alan/0000-0002-0558-3597	NIH [GM058065, GM77856]; NCI [U54CA143836]; NATIONAL CANCER INSTITUTE [U54CA143836, ZIABC011084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084716, R01GM077856, R01GM058065] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Agarwal for help with initial experiments; H. Aaron, A. Fischer and B. Cohen for use of facilities and discussions; the Bustamante, Chu and Krantz laboratories for use of equipment; and C. Bustamante, M. Welch and D. Grunwald for discussions and comments on the manuscript. This work was partially funded by the NIH (GM058065 to K.W. and GM77856 to J.T.L.) and the NCI (U54CA143836 to J.T.L.).	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Arhel N, 2006, NAT METHODS, V3, P817, DOI 10.1038/nmeth928; Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170; Bickel T, 2002, BIOPHYS J, V83, P3079, DOI 10.1016/S0006-3495(02)75312-5; BUKRINSKY MI, 1992, P NATL ACAD SCI USA, V89, P6580, DOI 10.1073/pnas.89.14.6580; Dange T, 2008, J CELL BIOL, V183, P77, DOI 10.1083/jcb.200806173; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Huber J, 2002, J CELL BIOL, V156, P467, DOI 10.1083/jcb.200108114; Kubitscheck U, 2005, J CELL BIOL, V168, P233, DOI 10.1083/jcb.200411005; Lacoste TD, 2000, P NATL ACAD SCI USA, V97, P9461, DOI 10.1073/pnas.170286097; Lim RYH, 2007, J STRUCT BIOL, V159, P277, DOI 10.1016/j.jsb.2007.01.018; Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980; Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103; Mitrousis G, 2008, J BIOL CHEM, V283, P7877, DOI 10.1074/jbc.M709093200; MOORE MS, 1993, NATURE, V365, P661, DOI 10.1038/365661a0; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x; Peters R, 2009, BIOESSAYS, V31, P466, DOI 10.1002/bies.200800159; Pyhtila B, 2003, J BIOL CHEM, V278, P42699, DOI 10.1074/jbc.M307135200; Rabe B, 2003, P NATL ACAD SCI USA, V100, P9849, DOI 10.1073/pnas.1730940100; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Weis K, 2007, CELL, V130, P405, DOI 10.1016/j.cell.2007.07.029; Yang WD, 2004, P NATL ACAD SCI USA, V101, P12887, DOI 10.1073/pnas.0403675101	28	123	125	0	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP	2010	467	7315					600	U126		10.1038/nature09285	http://dx.doi.org/10.1038/nature09285			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655TT	20811366	Green Accepted			2022-12-01	WOS:000282273100041
J	Rabone, J; Yue, YF; Chong, SY; Stylianou, KC; Bacsa, J; Bradshaw, D; Darling, GR; Berry, NG; Khimyak, YZ; Ganin, AY; Wiper, P; Claridge, JB; Rosseinsky, MJ				Rabone, J.; Yue, Y. -F.; Chong, S. Y.; Stylianou, K. C.; Bacsa, J.; Bradshaw, D.; Darling, G. R.; Berry, N. G.; Khimyak, Y. Z.; Ganin, A. Y.; Wiper, P.; Claridge, J. B.; Rosseinsky, M. J.			An Adaptable Peptide-Based Porous Material	SCIENCE			English	Article							METAL-ORGANIC FRAMEWORKS; ADSORPTION; COMPLEXES	Porous materials find widespread application in storage, separation, and catalytic technologies. We report a crystalline porous solid with adaptable porosity, in which a simple dipeptide linker is arranged in a regular array by coordination to metal centers. Experiments reinforced by molecular dynamics simulations showed that low-energy torsions and displacements of the peptides enabled the available pore volume to evolve smoothly from zero as the guest loading increased. The observed cooperative feedback in sorption isotherms resembled the response of proteins undergoing conformational selection, suggesting an energy landscape similar to that required for protein folding. The flexible peptide linker was shown to play the pivotal role in changing the pore conformation.	[Rabone, J.; Yue, Y. -F.; Chong, S. Y.; Stylianou, K. C.; Bacsa, J.; Bradshaw, D.; Darling, G. R.; Berry, N. G.; Khimyak, Y. Z.; Ganin, A. Y.; Wiper, P.; Claridge, J. B.; Rosseinsky, M. J.] Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England	University of Liverpool	Rosseinsky, MJ (corresponding author), Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England.	m.j.rosseinsky@liverpool.ac.uk	Berry, Neil G/B-7960-2009; Bradshaw, Darren/D-6174-2013; Khimyak, Yaroslav/A-4624-2012; Stylianou, Kyriakos/G-7117-2012; Chong, Samantha Y/B-4031-2009; Yue, Yanfeng/F-9332-2011; BACSA, JOHN/L-8501-2016; Claridge, John B/I-7395-2012	Berry, Neil G/0000-0003-1928-0738; Khimyak, Yaroslav/0000-0003-0424-4128; Chong, Samantha Y/0000-0002-3095-875X; Claridge, John B/0000-0003-4849-6714; Darling, George/0000-0001-9329-9993; Stylianou, Kyriakos/0000-0003-1670-0020; Wiper, Paul/0000-0003-1350-2299; Ganin, Alexey/0000-0002-3754-5819	UK Engineering and Physical Sciences Research Council [EP/F027443]; Engineering and Physical Sciences Research Council [EP/F027443/1] Funding Source: researchfish; EPSRC [EP/F027443/1] Funding Source: UKRI	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank the UK Engineering and Physical Sciences Research Council for funding under grant EP/F027443.	ALLISON SA, 1969, J CHEM SOC A, P1717, DOI 10.1039/j19690001717; Anedda R, 2008, CHEM MATER, V20, P2908, DOI 10.1021/cm8001805; Asakura T, 2005, PROTEIN SCI, V14, P2654, DOI 10.1110/ps.051525505; Atwood JL, 2002, SCIENCE, V296, P2367, DOI 10.1126/science.1072252; Bell JA, 1999, PROTEIN SCI, V8, P2033, DOI 10.1110/ps.8.10.2033; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Choi HJ, 2008, J AM CHEM SOC, V130, P7848, DOI 10.1021/ja8024092; Comotti A, 2009, CHEM COMMUN, P284, DOI 10.1039/b820200a; DAVIS ME, 1991, IND ENG CHEM RES, V30, P1675, DOI 10.1021/ie00056a001; Dubbeldam D, 2007, MOL SIMULAT, V33, P305, DOI 10.1080/08927020601156418; Duren T, 2009, CHEM SOC REV, V38, P1237, DOI 10.1039/b803498m; Gorbitz CH, 2008, J PEPT SCI, V14, P210, DOI 10.1002/psc.985; Gorbitz CH, 2007, CHEM-EUR J, V13, P1022, DOI 10.1002/chem.200601427; Hill A, 1910, J PHYSIOL-LONDON, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Horike S, 2009, NAT CHEM, V1, P695, DOI [10.1038/nchem.444, 10.1038/NCHEM.444]; Kitaura R, 2003, ANGEW CHEM INT EDIT, V42, P428, DOI 10.1002/anie.200390130; Lee HY, 2008, CRYST GROWTH DES, V8, P296, DOI 10.1021/cg700724h; Mantion A, 2008, J AM CHEM SOC, V130, P2517, DOI 10.1021/ja0762588; MIZUKAMI H, 1977, P SOC EXP BIOL MED, V154, P304, DOI 10.3181/00379727-154-39659; Ohgo K, 2006, BIOMACROMOLECULES, V7, P1210, DOI 10.1021/bm0600522; Okay O, 2000, PROG POLYM SCI, V25, P711, DOI 10.1016/S0079-6700(00)00015-0; OLSON DH, 1981, J PHYS CHEM-US, V85, P2238, DOI 10.1021/j150615a020; Peterca M, 2006, J AM CHEM SOC, V128, P6713, DOI 10.1021/ja0611902; Salles F, 2008, ANGEW CHEM INT EDIT, V47, P8487, DOI 10.1002/anie.200803067; Serre C, 2007, SCIENCE, V315, P1828, DOI 10.1126/science.1137975; Sing K. S. W., 1995, POROSITY CARBONS, P49; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Soldatov DV, 2006, J CHEM CRYSTALLOGR, V36, P747, DOI 10.1007/s10870-006-9133-1; Soldatov DV, 2004, ANGEW CHEM INT EDIT, V43, P6308, DOI 10.1002/anie.200460952; Takayama T, 1996, B CHEM SOC JPN, V69, P1579, DOI 10.1246/bcsj.69.1579; Tiliakos M, 2005, INORG CHEM COMMUN, V8, P1085, DOI 10.1016/j.inoche.2005.09.008; Tranchemontagne DJ, 2009, CHEM SOC REV, V38, P1257, DOI 10.1039/b817735j; Ueda E, 2004, B CHEM SOC JPN, V77, P981, DOI 10.1246/bcsj.77.981; Winston EB, 2008, PHYS CHEM CHEM PHYS, V10, P5188, DOI 10.1039/b808104b	34	286	292	20	392	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 27	2010	329	5995					1053	1057		10.1126/science.1190672	http://dx.doi.org/10.1126/science.1190672			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642WZ	20798314				2022-12-01	WOS:000281253500034
J	Hamilton, W; Watson, J; Round, A				Hamilton, William; Watson, Jessica; Round, Alison			Rational Testing Investigating fatigue in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GENERAL-PRACTICE; FAMILY-PHYSICIANS; COMMON SYMPTOMS; CONSULTATION; PREVALENCE; TIREDNESS; DIAGNOSES; PROGNOSIS; PATIENT		[Hamilton, William] Mt Pleasant Hlth Ctr, Exeter EX4 7BW, Devon, England; [Hamilton, William] Peninsula Coll Med & Dent, Exeter EX2 4SG, Devon, England; [Watson, Jessica] Univ Bristol, Dept Community Based Med, Acad Unit Primary Hlth Care, Bristol BS8 2AA, Avon, England; [Round, Alison] Castle Pl Practice, Tiverton, ON EX16 6NP, Canada	University of Exeter; University of Plymouth; University of Bristol	Hamilton, W (corresponding author), Mt Pleasant Hlth Ctr, Exeter EX4 7BW, Devon, England.	w.t.hamilton@btopenworld.com	Hamilton, Willie/G-8612-2014	Hamilton, William/0000-0003-1611-1373; Watson, Jessica/0000-0002-8177-6438	National Institute for Health Research [ACF-2008-25-003] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		CATHEBRAS PJ, 1992, J GEN INTERN MED, V7, P276, DOI 10.1007/BF02598083; Coeliac Disease, 2009, COEL DIS REC ASS COE; Cullen W, 2002, IRISH J MED SCI, V171, P10, DOI 10.1007/BF03168931; DAVID A, 1990, BMJ-BRIT MED J, V301, P1199, DOI 10.1136/bmj.301.6762.1199; Gallagher AM, 2004, J ROY SOC MED, V97, P571, DOI 10.1258/jrsm.97.12.571; Gialamas Angela, 2003, Aust Fam Physician, V32, P663; Godwin M, 1999, CAN FAM PHYSICIAN, V45, P373; Hamilton WT, 2005, FAM PRACT, V22, P383, DOI 10.1093/fampra/cmi021; Harrison M, 2008, AUST FAM PHYSICIAN, V37, P908; Hin H, 1999, BMJ-BRIT MED J, V318, P164, DOI 10.1136/bmj.318.7177.164; Kenter EGH, 2003, FAM PRACT, V20, P434, DOI 10.1093/fampra/cmg418; Koch H, 2009, BRIT J GEN PRACT, V59, P243, DOI 10.3399/bjgp09X420310; Kroenke K, 1998, FAM PRACT, V15, P398, DOI 10.1093/fampra/15.5.398; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Melbye H, 2004, BRIT J GEN PRACT, V54, P653; *NAT I HLTH CLIN E, 2007, CHRON FAT SYNDR MY E; *NHS CLIN KNOWL SU, TIR FAT AD MAN; Okkes IM, 2002, J FAM PRACTICE, V51, P31; RIDSDALE L, 1993, BMJ-BRIT MED J, V307, P103, DOI 10.1136/bmj.307.6896.103; RIDSDALE L, 1994, BRIT J GEN PRACT, V44, P413; Stolper E, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-17; Summerton N, 2003, BRIT J GEN PRACT, V53, P50; Verdon F, 2003, BRIT MED J, V326, P1124, DOI 10.1136/bmj.326.7399.1124; WESSELY S, 1995, LANCET, V345, P1333, DOI 10.1016/S0140-6736(95)92537-6; White PD, 1998, BRIT J PSYCHIAT, V173, P475, DOI 10.1192/bjp.173.6.475	25	15	15	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 24	2010	341								c4259	10.1136/bmj.c4259	http://dx.doi.org/10.1136/bmj.c4259			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	645IG	20736254				2022-12-01	WOS:000281445900012
J	Musunuru, K; Pirruccello, JP; Do, R; Peloso, GM; Guiducci, C; Sougnez, C; Garimella, KV; Fisher, S; Abreu, J; Barry, AJ; Fennell, T; Banks, E; Ambrogio, L; Cibulskis, K; Kernytsky, A; Gonzalez, E; Rudzicz, N; Engert, JC; DePristo, MA; Daly, MJ; Cohen, JC; Hobbs, HH; Altshuler, D; Schonfeld, G; Gabriel, SB; Yue, P; Kathiresan, S				Musunuru, Kiran; Pirruccello, James P.; Do, Ron; Peloso, Gina M.; Guiducci, Candace; Sougnez, Carrie; Garimella, Kiran V.; Fisher, Sheila; Abreu, Justin; Barry, Andrew J.; Fennell, Tim; Banks, Eric; Ambrogio, Lauren; Cibulskis, Kristian; Kernytsky, Andrew; Gonzalez, Elena; Rudzicz, Nicholas; Engert, James C.; DePristo, Mark A.; Daly, Mark J.; Cohen, Jonathan C.; Hobbs, Helen H.; Altshuler, David; Schonfeld, Gustav; Gabriel, Stacey B.; Yue, Pin; Kathiresan, Sekar			Exome Sequencing, ANGPTL3 Mutations, and Familial Combined Hypolipidemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOW-DENSITY-LIPOPROTEIN; APO-B GENE; APOLIPOPROTEIN-B; FATTY LIVER; CAUCASIAN FAMILIES; HYPOBETALIPOPROTEINEMIA; METABOLISM; LIPASE; INHIBITION; CAPTURE	We sequenced all protein-coding regions of the genome (the "exome") in two family members with combined hypolipidemia, marked by extremely low plasma levels of low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides. These two participants were compound heterozygotes for two distinct nonsense mutations in ANGPTL3 (encoding the angiopoietin-like 3 protein). ANGPTL3 has been reported to inhibit lipoprotein lipase and endothelial lipase, thereby increasing plasma triglyceride and HDL cholesterol levels in rodents. Our finding of ANGPTL3 mutations highlights a role for the gene in LDL cholesterol metabolism in humans and shows the usefulness of exome sequencing for identification of novel genetic causes of inherited disorders.	[Musunuru, Kiran; Pirruccello, James P.; Do, Ron; Daly, Mark J.; Altshuler, David; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Musunuru, Kiran; Pirruccello, James P.; Do, Ron; Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Altshuler, David] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Musunuru, Kiran; Daly, Mark J.; Altshuler, David; Kathiresan, Sekar] Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; [Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; [Peloso, Gina M.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Musunuru, Kiran; Pirruccello, James P.; Do, Ron; Guiducci, Candace; Sougnez, Carrie; Garimella, Kiran V.; Fisher, Sheila; Abreu, Justin; Barry, Andrew J.; Fennell, Tim; Banks, Eric; Ambrogio, Lauren; Cibulskis, Kristian; Kernytsky, Andrew; Gonzalez, Elena; DePristo, Mark A.; Daly, Mark J.; Altshuler, David; Gabriel, Stacey B.; Kathiresan, Sekar] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Musunuru, Kiran; Pirruccello, James P.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Do, Ron; Rudzicz, Nicholas; Engert, James C.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Peloso, Gina M.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Cohen, Jonathan C.; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Cohen, Jonathan C.; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Schonfeld, Gustav; Yue, Pin] Washington Univ, Sch Med, St Louis, MO USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Boston University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Johns Hopkins University; McGill University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Washington University (WUSTL)	Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, 185 Cambridge St,CPZN 5-252, Boston, MA 02114 USA.	skathiresan@partners.org	Daly, Mark J/B-2453-2017; Cibulskis, Kristian/AAC-7380-2019; Altshuler, David M/A-4476-2009	Daly, Mark J/0000-0002-0949-8752; Altshuler, David M/0000-0002-7250-4107; Gonzalez, Elena/0000-0003-4380-663X; Cibulskis, Kristian/0000-0003-1343-1582; Pirruccello, James/0000-0001-6088-4037; Engert, James/0000-0001-8411-4790; Garimella, Kiran/0000-0002-6212-5736	National Human Genome Research Institute of the National Institutes of Health (NIH) [U54 HG003067]; National Heart, Lung, and Blood Institute (NHLBI) of the NIH [RC1 HL099793, RC1 HL099634, RC2 HL101864, K99 HL098364, R01 HL082896]; Donovan Family Foundation; Sarnoff Cardiovascular Research Foundation; Canadian Institutes of Health Research; National Human Genome Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL099793, RC1HL099634, R01HL082896, K99HL098364, RC2HL101864, RL1HL092550] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	National Human Genome Research Institute of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute (NHLBI) of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Donovan Family Foundation; Sarnoff Cardiovascular Research Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Supported by grants from the National Human Genome Research Institute of the National Institutes of Health (NIH) (Medical Sequencing Program grant U54 HG003067, to the Broad Institute for exome sequencing), the National Heart, Lung, and Blood Institute (NHLBI) of the NIH (RC1 HL099793, RC1 HL099634, and RC2 HL101864, to Dr. Kathiresan; K99 HL098364, to Dr. Musunuru; and R01 HL082896, to Drs. Cohen and Hobbs for analysis of ANGPTL3 in the Dallas Heart Study), the Donovan Family Foundation (to Dr. Kathiresan), the Sarnoff Cardiovascular Research Foundation (a research fellowship, to Mr. Pirruccello), and the Canadian Institutes of Health Research (a Canada Graduate Doctoral Scholarship, to Mr. Do).; Funded by the National Human Genome Research Institute and others	Ando Y, 2003, J LIPID RES, V44, P1216, DOI 10.1194/jlr.M300031-JLR200; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Elias N, 2000, ARTERIOSCL THROM VAS, V20, P1309, DOI 10.1161/01.ATV.20.5.1309; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hooper AJ, 2005, CRIT REV CL LAB SCI, V42, P515, DOI 10.1080/10408360500295113; Jin WJ, 2007, CELL METAB, V6, P129, DOI 10.1016/j.cmet.2007.07.009; Koishi R, 2002, NAT GENET, V30, P151, DOI 10.1038/ng814; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Lee EC, 2009, J BIOL CHEM, V284, P13735, DOI 10.1074/jbc.M807899200; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Pulai JI, 1998, AM J MED GENET, V76, P79, DOI 10.1002/(SICI)1096-8628(19980226)76:1<79::AID-AJMG15>3.3.CO;2-E; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Schonfeld G, 2005, CELL MOL LIFE SCI, V62, P1372, DOI 10.1007/s00018-005-4473-0; Schonfeld G, 2003, J LIPID RES, V44, P470, DOI 10.1194/jlr.M200342-JLR200; Sherva R, 2007, J LIPID RES, V48, P2632, DOI 10.1194/jlr.M700078-JLR200; Shimamura M, 2007, ARTERIOSCL THROM VAS, V27, P366, DOI 10.1161/01.ATV.0000252827.51626.89; Shimizugawa T, 2002, J BIOL CHEM, V277, P33742, DOI 10.1074/jbc.M203215200; Tarugi P, 1996, GASTROENTEROLOGY, V111, P1125, DOI 10.1016/S0016-5085(96)70082-3; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Yuan B, 2000, AM J HUM GENET, V66, P1699, DOI 10.1086/302904; Yue P, 2005, METABOLISM, V54, P682, DOI 10.1016/j.metabol.2004.12.013	22	461	497	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 2	2010	363	23					2220	2227		10.1056/NEJMoa1002926	http://dx.doi.org/10.1056/NEJMoa1002926			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	688EP	20942659	Green Accepted			2022-12-01	WOS:000284832900009
J	Armulik, A; Genove, G; Mae, M; Nisancioglu, MH; Wallgard, E; Niaudet, C; He, LQ; Norlin, J; Lindblom, P; Strittmatter, K; Johansson, BR; Betsholtz, C				Armulik, Annika; Genove, Guillem; Mae, Maarja; Nisancioglu, Maya H.; Wallgard, Elisabet; Niaudet, Colin; He, Liqun; Norlin, Jenny; Lindblom, Per; Strittmatter, Karin; Johansson, Bengt R.; Betsholtz, Christer			Pericytes regulate the blood-brain barrier	NATURE			English	Article							ENDOTHELIAL-CELLS; UP-REGULATION; MUTANT MICE; EXPRESSION; INDUCTION; LEADS; ABNORMALITIES; TRANSCRIPTS; ASTROCYTES; ACTIVATION	The blood-brain barrier (BBB) consists of specific physical barriers, enzymes and transporters, which together maintain the necessary extracellular environment of the central nervous system (CNS)(1). The main physical barrier is found in the CNS endothelial cell, and depends on continuous complexes of tight junctions combined with reduced vesicular transport(2). Other possible constituents of the BBB include extracellular matrix, astrocytes and pericytes(3), but the relative contribution of these different components to the BBB remains largely unknown(1,3). Here we demonstrate a direct role of pericytes at the BBB in vivo. Using a set of adult viable pericyte-deficient mouse mutants we show that pericyte deficiency increases the permeability of the BBB to water and a range of low-molecular-mass and high-molecular-mass tracers. The increased permeability occurs by endothelial transcytosis, a process that is rapidly arrested by the drug imatinib. Furthermore, we show that pericytes function at the BBB in at least two ways: by regulating BBB-specific gene expression patterns in endothelial cells, and by inducing polarization of astrocyte end-feet surrounding CNS blood vessels. Our results indicate a novel and critical role for pericytes in the integration of endothelial and astrocyte functions at the neurovascular unit, and in the regulation of the BBB.	[Armulik, Annika; Genove, Guillem; Mae, Maarja; Nisancioglu, Maya H.; Wallgard, Elisabet; Niaudet, Colin; He, Liqun; Norlin, Jenny; Strittmatter, Karin; Betsholtz, Christer] Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, SE-17177 Stockholm, Sweden; [Lindblom, Per] AstraZeneca AB, Clin Dev, SE-43183 Molndal, Sweden; [Johansson, Bengt R.] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Electron Microscopy Unit, SE-40530 Gothenburg, Sweden	Karolinska Institutet; AstraZeneca; University of Gothenburg	Betsholtz, C (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, Scheelesvag 2, SE-17177 Stockholm, Sweden.	annika.armulik@ki.se; christer.betsholtz@ki.se	Andaloussi Mäe, Maarja/AAA-9215-2022; Genove, Guillem/F-1158-2011	He, Liqun/0000-0003-2127-7597; Genove, Guillem/0000-0002-8558-3107; Keller, Annika/0000-0003-1466-3633	Leducq Foundation; Swedish Governmental Agency for Innovation Systems (Vinnova); EU; Swedish Cancer Society and Research Council; Knut and Alice Wallenberg, Inga-Britt and Arne Lundberg, and Torsten and Ragnar Soderberg Foundations	Leducq Foundation(Leducq Foundation); Swedish Governmental Agency for Innovation Systems (Vinnova)(Vinnova); EU(European Commission); Swedish Cancer Society and Research Council; Knut and Alice Wallenberg, Inga-Britt and Arne Lundberg, and Torsten and Ragnar Soderberg Foundations(Knut & Alice Wallenberg Foundation)	We thank U. Eriksson and members of the Betsholtz laboratory for discussion, P. Soriano, L. Sorokin and R. Hallman for reagents, and S. Kamph and the Scheele animal house for technical assistance. This work was supported by the Leducq Foundation, the Swedish Governmental Agency for Innovation Systems (Vinnova), the EU Fp6 Program Lymphangiogenomics, the Swedish Cancer Society and Research Council, the Knut and Alice Wallenberg, Inga-Britt and Arne Lundberg, and Torsten and Ragnar Soderberg Foundations.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Bender A, 2008, NEUROBIOL AGING, V29, P1404, DOI 10.1016/j.neurobiolaging.2007.03.001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernacki J, 2008, PHARMACOL REP, V60, P600; Bjarnegard M, 2004, DEVELOPMENT, V131, P1847, DOI 10.1242/dev.01080; Bondjers C, 2006, FASEB J, V20, P1703, DOI 10.1096/fj.05-4944fje; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Enge M, 2002, EMBO J, V21, P4307, DOI 10.1093/emboj/cdf418; Hayashi Y, 1997, GLIA, V19, P13, DOI 10.1002/(SICI)1098-1136(199701)19:1<13::AID-GLIA2>3.3.CO;2-E; He L, 2008, J AM SOC NEPHROL, V19, P260, DOI 10.1681/ASN.2007050588; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Hori S, 2004, J NEUROCHEM, V89, P503, DOI 10.1111/j.1471-4159.2004.02343.x; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; KARNOVASKY MORRIS J., 1967, J CELL BIOL, V35, P213, DOI 10.1083/jcb.35.1.213; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; MOOS T, 1993, NEUROPATH APPL NEURO, V19, P120, DOI 10.1111/j.1365-2990.1993.tb00416.x; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; REESE TS, 1967, J CELL BIOL, V34, P207, DOI 10.1083/jcb.34.1.207; Sobue K, 1999, NEUROSCI RES, V35, P155, DOI 10.1016/S0168-0102(99)00079-6; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Tidhar A, 2001, DEV DYNAM, V220, P60, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1089>3.0.CO;2-X; Wallgard E, 2008, ARTERIOSCL THROM VAS, V28, P1469, DOI 10.1161/ATVBAHA.108.165738; Wolburg H, 2009, NEUROSCIENTIST, V15, P180, DOI 10.1177/1073858408329509; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	33	1618	1668	7	242	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 25	2010	468	7323					557	U231		10.1038/nature09522	http://dx.doi.org/10.1038/nature09522			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684WA	20944627				2022-12-01	WOS:000284584200041
J	Ellwood, MJ; Wille, M; Maher, W				Ellwood, Michael J.; Wille, Martin; Maher, William			Glacial Silicic Acid Concentrations in the Southern Ocean	SCIENCE			English	Article							CIRCUMPOLAR DEEP-WATER; DIATOMS; CIRCULATION; FRACTIONATION; NUTRIENTS	Reconstruction of nutrient concentrations in the deep Southern Ocean has produced conflicting results. The cadmium/calcium (Cd/Ca) data set suggests little change in nutrient concentrations during the last glacial period, whereas the carbon isotope data set suggests that nutrient concentrations were higher. We determined the silicon isotope composition of sponge spicules from the Atlantic and Pacific sectors of the Southern Ocean and found higher silicic acid concentrations in the Pacific sector during the last glacial period. We propose that this increase results from changes in the stoichiometric uptake of silicic acid relative to nitrate and phosphate by diatoms, thus facilitating a redistribution of nutrients across the Pacific and Southern Oceans. Our results are consistent with the global Cd/Ca data set and support the silicic acid leakage hypothesis.	[Ellwood, Michael J.; Wille, Martin] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Maher, William] Univ Canberra, Fac Sci Appl, Inst Appl Ecol, Canberra, ACT 2601, Australia	Australian National University; University of Canberra	Ellwood, MJ (corresponding author), Australian Natl Univ, Res Sch Earth Sci, GPO Box 4, Canberra, ACT 0200, Australia.	michael.ellwood@anu.edu.au	Wille, Martin/AAU-7512-2020; Wille, Martin/A-1973-2009; Ellwood, Michael/G-7390-2011	Maher, William A./0000-0001-7564-3383; Ellwood, Michael/0000-0003-4288-8530; Wille, Martin/0000-0003-1083-4730	Australian Research Council [DP0770820, DP0771519]	Australian Research Council(Australian Research Council)	We acknowledge the Antarctic Research Facility at Florida State University for E33-22 core samples and the Ocean Drilling Program for ODP177 site 1089 core samples. This research was supported with funds from the Australian Research Council (grants DP0770820 and DP0771519). This manuscript benefited from the thoughtful comments of two anonymous reviewers.	Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Barker S, 2009, NATURE, V457, P1097, DOI 10.1038/nature07770; BOYLE EA, 1992, ANNU REV EARTH PL SC, V20, P245, DOI 10.1146/annurev.ea.20.050192.001333; Brzezinski MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014349; Chase Z, 2003, DEEP-SEA RES PT II, V50, P799, DOI 10.1016/S0967-0645(02)00595-7; De La Rocha CL, 1998, NATURE, V395, P680, DOI 10.1038/27174; De La Rocha CL, 1997, GEOCHIM COSMOCHIM AC, V61, P5051, DOI 10.1016/S0016-7037(97)00300-1; Ellwood MJ, 2006, EARTH PLANET SC LETT, V243, P749, DOI 10.1016/j.epsl.2006.01.016; Froelich PN, 1992, PALEOCEANOGRAPHY, V7, P739, DOI 10.1029/92PA02090; Georg RB, 2009, EARTH PLANET SC LETT, V283, P67, DOI 10.1016/j.epsl.2009.03.041; Hendry KR, 2010, EARTH PLANET SC LETT, V292, P290, DOI 10.1016/j.epsl.2010.02.005; Hodell DA, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000367; HODELL DA, 2002, P OC DRILL PROGR SCI, V177; LEA DW, 1995, PALEOCEANOGRAPHY, V10, P733, DOI 10.1029/95PA01546; Matsumoto K, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001442; McCave IN, 2008, QUATERNARY SCI REV, V27, P1886, DOI 10.1016/j.quascirev.2008.07.010; MORTLOCK RA, 1991, NATURE, V351, P220, DOI 10.1038/351220a0; Moy AD, 2006, J QUATERNARY SCI, V21, P763, DOI 10.1002/jqs.1067; Ninnemann US, 2002, EARTH PLANET SC LETT, V201, P383, DOI 10.1016/S0012-821X(02)00708-2; Ninnemann US, 1997, PALEOCEANOGRAPHY, V12, P560, DOI 10.1029/97PA01032; Pichevin LE, 2009, NATURE, V459, P1114, DOI 10.1038/nature08101; Piotrowski AM, 2004, EARTH PLANET SC LETT, V225, P205, DOI 10.1016/j.epsl.2004.06.002; Rosenthal Y, 1997, PALEOCEANOGRAPHY, V12, P787, DOI 10.1029/97PA02508; Sarmiento JL, 2004, NATURE, V427, P56, DOI 10.1038/nature02127; SARMIENTO JL, 2007, GLOBAL BIOGEOCHEM CY, V21; Sigman DM, 2010, NATURE, V466, P47, DOI 10.1038/nature09149; Skinner LC, 2010, SCIENCE, V328, P1147, DOI 10.1126/science.1183627; Takeda S, 1998, NATURE, V393, P774, DOI 10.1038/31674; Wille M, 2010, EARTH PLANET SC LETT, V292, P281, DOI 10.1016/j.epsl.2010.01.036	29	32	33	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2010	330	6007					1088	1091		10.1126/science.1194614	http://dx.doi.org/10.1126/science.1194614			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	20966217				2022-12-01	WOS:000284374700039
J	Bartke, T; Vermeulen, M; Xhemalce, B; Robson, SC; Mann, M; Kouzarides, T				Bartke, Till; Vermeulen, Michiel; Xhemalce, Blerta; Robson, Samuel C.; Mann, Matthias; Kouzarides, Tony			Nucleosome-Interacting Proteins Regulated by DNA and Histone Methylation	CELL			English	Article							CHROMATIN MODIFICATIONS; HETEROCHROMATIN; TRANSCRIPTION; BINDING; H3; ACETYLATION; RECOGNITION; COMPLEX; KDM2A; HP1	Modifications on histones or on DNA recruit proteins that regulate chromatin function. Here, we use nucleosomes methylated on DNA and on histone H3 in an affinity assay, in conjunction with a SILAC-based proteomic analysis, to identify "crosstalk'' between these two distinct classes of modification. Our analysis reveals proteins whose binding to nucleosomes is regulated by methylation of CpGs, H3K4, H3K9, and H3K27 or a combination thereof. We identify the origin recognition complex (ORC), including LRWD1 as a subunit, to be a methylation-sensitive nucleosome interactor that is recruited cooperatively by DNA and histone methylation. Other interactors, such as the lysine demethylase Fbxl11/KDM2A, recognize nucleosomes methylated on histones, but their recruitment is disrupted by DNA methylation. These data establish SILAC nucleosome affinity purifications (SNAP) as a tool for studying the dynamics between different chromatin modifications and provide a modification binding "profile'' for proteins regulated by DNA and histone methylation.	[Bartke, Till; Xhemalce, Blerta; Robson, Samuel C.; Kouzarides, Tony] Gurdon Inst, Cambridge CB2 1QN, England; [Bartke, Till; Xhemalce, Blerta; Robson, Samuel C.; Kouzarides, Tony] Dept Pathol, Cambridge CB2 1QN, England; [Vermeulen, Michiel; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany	Max Planck Society	Kouzarides, T (corresponding author), Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	t.kouzarides@gurdon.cam.ac.uk	Vermeulen, Michiel/C-8883-2013; Mann, Matthias/A-3454-2013	Vermeulen, Michiel/0000-0003-0836-6894; Mann, Matthias/0000-0003-1292-4799; Kouzarides, Tony/0000-0002-8918-4162; Xhemalce, Blerta/0000-0002-0517-9607	EMBO; HFSP; Dutch Cancer Society; European Union; Cancer Research UK	EMBO(European Molecular Biology Organization (EMBO)); HFSP(Human Frontier Science Program); Dutch Cancer Society(KWF Kankerbestrijding); European Union(European Commission); Cancer Research UK(Cancer Research UK)	We would like to thank Kevin Ford, Timothy Richmond, Bruce Stillman, Jonathan Widom, and Yi Zhang for providing materials; Helder Ferreira and Tom Owen-Hughes for advice on native chemical ligations; and Peter Tessarz and Emmanuelle Vire for experimental help. This work was supported by postdoctoral fellowships to T.B. from EMBO and HFSP and by a fellowship to M.V. from the Dutch Cancer Society. The M.M. laboratory is supported by the Max-Planck Society for the Advancement of Science and HEROIC, a grant from the European Union under the 6<SUP>th</SUP> Research Framework Programme. The T.K. lab is funded by grants from Cancer Research UK and the European Union (Epitron, HEROIC, and SMARTER). T. K. is a director of Abcam Ltd.	Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Frescas D, 2008, CELL CYCLE, V7, P3539, DOI 10.4161/cc.7.22.7062; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Hashimoto H, 2009, EPIGENETICS-US, V4, P8, DOI 10.4161/epi.4.1.7370; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; Kleine-Kohlbrecher D, 2010, MOL CELL, V38, P165, DOI 10.1016/j.molcel.2010.03.002; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Nguyen DP, 2009, J AM CHEM SOC, V131, P14194, DOI 10.1021/ja906603s; Vicent GP, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000567; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; Prasanth SG, 2004, EMBO J, V23, P2651, DOI 10.1038/sj.emboj.7600255; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sasai N, 2009, INT J DEV BIOL, V53, P323, DOI 10.1387/ijdb.082652ns; Shogren-Knaak MA, 2003, J BIOL CHEM, V278, P15744, DOI 10.1074/jbc.M301445200; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Tanaka Y, 2010, EMBO J, V29, P1510, DOI 10.1038/emboj.2010.56; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Tolbert TJ, 2002, ANGEW CHEM INT EDIT, V41, P2171, DOI 10.1002/1521-3773(20020617)41:12<2171::AID-ANIE2171>3.0.CO;2-Q; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; van der Laan MJ, 2003, J STAT PLAN INFER, V117, P275, DOI 10.1016/S0378-3758(02)00388-9; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Xhemalce B, 2010, GENE DEV, V24, P647, DOI 10.1101/gad.1881710; Zhao Q, 2007, J BIOL CHEM, V282, P647, DOI 10.1074/jbc.M604029200	34	421	435	0	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 29	2010	143	3					470	484		10.1016/j.cell.2010.10.012	http://dx.doi.org/10.1016/j.cell.2010.10.012			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672RF	21029866	Green Accepted, Bronze			2022-12-01	WOS:000283603900019
J	Yachida, S; Jones, S; Bozic, I; Antal, T; Leary, R; Fu, BJ; Kamiyama, M; Hruban, RH; Eshleman, JR; Nowak, MA; Velculescu, VE; Kinzler, KW; Vogelstein, B; Iacobuzio-Donahue, CA				Yachida, Shinichi; Jones, Sian; Bozic, Ivana; Antal, Tibor; Leary, Rebecca; Fu, Baojin; Kamiyama, Mihoko; Hruban, Ralph H.; Eshleman, James R.; Nowak, Martin A.; Velculescu, Victor E.; Kinzler, Kenneth W.; Vogelstein, Bert; Iacobuzio-Donahue, Christine A.			Distant metastasis occurs late during the genetic evolution of pancreatic cancer	NATURE			English	Article							CARCINOMA; GENOME; TUMORS; MODEL	Metastasis, the dissemination and growth of neoplastic cells in an organ distinct from that in which they originated(1,2), is the most common cause of death in cancer patients. This is particularly true for pancreatic cancers, where most patients are diagnosed with metastatic disease and few show a sustained response to chemotherapy or radiation therapy(3). Whether the dismal prognosis of patients with pancreatic cancer compared to patients with other types of cancer is a result of late diagnosis or early dissemination of disease to distant organs is not known. Here we rely on data generated by sequencing the genomes of seven pancreatic cancer metastases to evaluate the clonal relationships among primary and metastatic cancers. We find that clonal populations that give rise to distant metastases are represented within the primary carcinoma, but these clones are genetically evolved from the original parental, non-metastatic clone. Thus, genetic heterogeneity of metastases reflects that within the primary carcinoma. A quantitative analysis of the timing of the genetic evolution of pancreatic cancer was performed, indicating at least a decade between the occurrence of the initiating mutation and the birth of the parental, non-metastatic founder cell. At least five more years are required for the acquisition of metastatic ability and patients die an average of two years thereafter. These data provide novel insights into the genetic features underlying pancreatic cancer progression and define a broad time window of opportunity for early detection to prevent deaths from metastatic disease.	[Yachida, Shinichi; Fu, Baojin; Kamiyama, Mihoko; Hruban, Ralph H.; Eshleman, James R.; Iacobuzio-Donahue, Christine A.] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Pathol, Baltimore, MD 21231 USA; [Jones, Sian; Leary, Rebecca; Velculescu, Victor E.; Kinzler, Kenneth W.; Vogelstein, Bert] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA; [Jones, Sian; Leary, Rebecca; Velculescu, Victor E.; Kinzler, Kenneth W.; Vogelstein, Bert] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21231 USA; [Bozic, Ivana; Antal, Tibor; Nowak, Martin A.] Harvard Univ, Dept Organism & Evolutionary Biol, Dept Math, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Antal, Tibor] Univ Edinburgh, Sch Math, Edinburgh EH9 3JZ, Midlothian, Scotland; [Hruban, Ralph H.; Iacobuzio-Donahue, Christine A.] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Oncol, Baltimore, MD 21231 USA; [Iacobuzio-Donahue, Christine A.] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Surg, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Harvard University; University of Edinburgh; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Iacobuzio-Donahue, CA (corresponding author), Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Pathol, Baltimore, MD 21231 USA.	ciacobu@jhmi.edu	Gotoh, Osamu/B-4704-2012; Jones, Sian/A-5050-2012; Nowak, Martin A/A-6977-2008; Velculescu, Victor/ABF-4846-2020; Iacobuzio-Donahue, Christine/ABF-1295-2020; Antal, Tibor/A-4512-2008; Bozic, Ivana/C-5003-2008	Velculescu, Victor/0000-0003-1195-438X; Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Bozic, Ivana/0000-0003-2761-825X	National Institutes of Health [CA106610, CA62924, CA43460, CA57345, CA121113, GM078986]; Bill and Melinda Gates Foundation [37874]; Uehara Memorial Foundation; AACR-Barletta Foundation; John Templeton Foundation; Sol Goldman Pancreatic Cancer Research Center; Michael Rolfe Pancreatic Cancer Foundation; George Rubis Endowment for Pancreatic Cancer Research; Joseph C. Monastra Foundation for Pancreatic Cancer Research; Alfredo Scatena Memorial Fund; Virginia and the D. K. Ludwig Fund for Cancer Research; The Joint Programin Mathematical Biology and J. Epstein; NATIONAL CANCER INSTITUTE [R01CA043460, P50CA062924, R01CA121113, R37CA057345, K08CA106610, R01CA057345, R01CA140599, R37CA043460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078986] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); AACR-Barletta Foundation; John Templeton Foundation; Sol Goldman Pancreatic Cancer Research Center; Michael Rolfe Pancreatic Cancer Foundation; George Rubis Endowment for Pancreatic Cancer Research; Joseph C. Monastra Foundation for Pancreatic Cancer Research; Alfredo Scatena Memorial Fund; Virginia and the D. K. Ludwig Fund for Cancer Research; The Joint Programin Mathematical Biology and J. Epstein; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants CA106610 (C.A.I.-D.), CA62924 (C.A.I.-D., M.A.N.), CA43460 (B. V.), CA57345 (K. W. K. and V. E. V.), CA121113 (V. E. V. and K. W. K.), GM078986 (M.A.N.), the Bill and Melinda Gates Foundation Grand Challenges Grant 37874, the Uehara Memorial Foundation (S.Y.), the AACR-Barletta Foundation (C.A.I.-D.), the John Templeton Foundation, Pilot Funding from the Sol Goldman Pancreatic Cancer Research Center, the Michael Rolfe Pancreatic Cancer Foundation, the George Rubis Endowment for Pancreatic Cancer Research, the Joseph C. Monastra Foundation for Pancreatic Cancer Research, the Alfredo Scatena Memorial Fund, the Virginia and the D. K. Ludwig Fund for Cancer Research, The Joint Programin Mathematical Biology and J. Epstein. We would like to acknowledge T. C. Cornish, C. Henderson,	AMIKURA K, 1995, INT J PANCREATOL, V17, P139; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Embuscado EE, 2005, CANCER BIOL THER, V4, P548, DOI 10.4161/cbt.4.5.1663; Fidler IJ, 2002, SEMIN CANCER BIOL, V12, P89, DOI 10.1006/scbi.2001.0416; Fu BJ, 2007, CANCER BIOL THER, V6, P1546, DOI 10.4161/cbt.6.10.4708; Hisa T, 2008, WORLD J GASTROENTERO, V14, P1958, DOI 10.3748/wjg.14.1958; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Naumov GN, 2006, JNCI-J NATL CANCER I, V98, P316, DOI 10.1093/jnci/djj068; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Rew DA, 2000, EUR J SURG ONCOL, V26, P405, DOI 10.1053/ejso.1999.0907; SASAKI K, 1988, CANCER, V62, P989, DOI 10.1002/1097-0142(19880901)62:5<989::AID-CNCR2820620525>3.0.CO;2-U; Sidransky D, 2002, NAT REV CANCER, V2, P210, DOI 10.1038/nrc755; Stathis A, 2010, NAT REV CLIN ONCOL, V7, P163, DOI 10.1038/nrclinonc.2009.236; Steel G.G., 1977, GROWTH KINETICS TUMO; Terada T, 1998, ARCH PATHOL LAB MED, V122, P42; Yachida S, 2009, ARCH PATHOL LAB MED, V133, P413, DOI 10.1043/1543-2165-133.3.413	21	1759	1844	4	254	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 28	2010	467	7319					1114	U126		10.1038/nature09515	http://dx.doi.org/10.1038/nature09515			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671XW	20981102	Green Accepted			2022-12-01	WOS:000283548600049
J	Snow, RW; Okiro, EA; Gething, PW; Atun, R; Hay, SI				Snow, Robert W.; Okiro, Emelda A.; Gething, Peter W.; Atun, Rifat; Hay, Simon I.			Equity and adequacy of international donor assistance for global malaria control:an analysis of populations at risk and external funding commitments	LANCET			English	Article							ELIMINATION		KEMRI Univ Oxford Wellcome Trust Collaborat, Ctr Geog Med, Malaria Publ Hlth & Epidemiol Grp, Nairobi, Kenya; Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford, England; Imperial Coll, Imperial Coll Business Sch, London, England; Global Fund To Fight AIDS TB & Malaria, Strategy Performance & Evaluat Cluster, Geneva, Switzerland	University of Oxford; Imperial College London	Snow, RW (corresponding author), KEMRI Univ Oxford Wellcome Trust Collaborat, Ctr Geog Med, Malaria Publ Hlth & Epidemiol Grp, Nairobi, Kenya.		Gething, Peter/ABD-2110-2020; Atun, Rifat/AAH-5537-2021; Snow, Robert William/AFR-1436-2022; Hay, Simon I/F-8967-2015; Gething, Peter/GQR-1884-2022	Snow, Robert William/0000-0003-3725-6088; Hay, Simon I/0000-0002-0611-7272; Gething, Peter/0000-0001-6759-5449; Atun, Rifat/0000-0002-1531-5983; Okiro, Emelda/0000-0001-9543-8360	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	Wellcome Trust	Baird JK, 2007, TRENDS PARASITOL, V23, P533, DOI 10.1016/j.pt.2007.08.011; BALK DL, ADV PARASIT, V62, P119; *BBC, 2010, DAV 2010 W ACC IND C; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; *DON ASS COMM OECD, DAC LIST ODA REC US; Eisele TP, 2010, INT J EPIDEMIOL, V39, P88, DOI 10.1093/ije/dyq026; Feachem RGA, 2009, SHRINKING MALARIA MA, P187; GUERRA CA, 2009, PLOS NEGLECT TROP D, V4, pE744; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; International Monetary Fund, DEBT REL HEAV IND PO; Kiszewski A, 2007, B WORLD HEALTH ORGAN, V85, P623, DOI 10.2471/BLT.06.039529; Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882; Organization for Economic Cooperation and Development, CRED REP SYST; Presidents Malaria Initiative, 2009, PMI COUNTR PROF; *ROLL BACK MAL, MON EV REF GROUP; Roll Back Malaria, 2008, GLOB MAL ACT PLAN MA; Snow RW, 2008, PLOS MED, V5, P1068, DOI 10.1371/journal.pmed.0050142; Snow RW, 2010, LANCET, V376, P137, DOI 10.1016/S0140-6736(10)60577-6; Teklehaimanot HD, 2009, AM J TROP MED HYG, V80, P133, DOI 10.4269/ajtmh.2009.80.133; The World Bank, WORLDW GOV IND; *UN POP DIV, 2003, HUM DEV REP 2003 MIL; United Nat ions Populat ion Division, 2008, WORLD URB PROSP 2007; Vassall A, 2022, BMJ, V378, DOI [10.1136/bmj.o2320, DOI 10.1136/BMJ.O2320]; *WHO, WORLD MAL REP 2009; World Bank, BOOST PROGR MAL CONT; Yukich JO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-258	27	43	43	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 23	2010	376	9750					1409	1416		10.1016/S0140-6736(10)61340-2	http://dx.doi.org/10.1016/S0140-6736(10)61340-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672ZO	20889199	Green Submitted, Green Published			2022-12-01	WOS:000283627500039
J	Wright, CF; Brice, P; Stewart, A; Burton, H				Wright, Caroline F.; Brice, Philippa; Stewart, Alison; Burton, Hilary			Realising the benefits of genetics for health	LANCET			English	Editorial Material							CONGENITAL-ANOMALIES; GENOME; CHALLENGES; BLOOD		[Wright, Caroline F.; Brice, Philippa; Stewart, Alison; Burton, Hilary] PHG Fdn, Strangeways Res Lab, Cambridge CB1 8RN, England		Wright, CF (corresponding author), PHG Fdn, Strangeways Res Lab, Cambridge CB1 8RN, England.	caroline.wright@phgfoundation.org	Wright, Caroline/N-5355-2015	Wright, Caroline/0000-0003-2958-5076				ALBERG C, 2010, BR J MIDWIFERY, V18, P220; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Burton H, 2010, HEART, V96, P474, DOI 10.1136/hrt.2009.189159; Burton H, 2010, J PUBLIC HEALTH-UK, V32, P259, DOI 10.1093/pubmed/fdp110; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; Hadfield SG, 2007, BMJ-BRIT MED J, V335, P683, DOI 10.1136/bmj.39353.483160.BE; Janssens ACJW, 2008, HUM MOL GENET, V17, pR166, DOI 10.1093/hmg/ddn250; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Pollitt RJ, 2009, J INHERIT METAB DIS, V32, P395, DOI 10.1007/s10545-009-9962-0; Sagoo GS, 2009, GENET MED, V11, P139, DOI 10.1097/GIM.0b013e318194ee8f; Srinivasan BS, 2010, REPROD BIOMED ONLINE, V21, P537, DOI 10.1016/j.rbmo.2010.05.012; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; *UK DEP HLTH, 2010, STAT PUBL HLTH ANN R; Wright CF, 2009, HUM REPROD UPDATE, V15, P139, DOI 10.1093/humupd/dmn047	15	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 23	2010	376	9750					1370	1371		10.1016/S0140-6736(10)61310-4	http://dx.doi.org/10.1016/S0140-6736(10)61310-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672ZO	20971348				2022-12-01	WOS:000283627500008
J	Mitrofanov, IG; Sanin, AB; Boynton, WV; Chin, G; Garvin, JB; Golovin, D; Evans, LG; Harshman, K; Kozyrev, AS; Litvak, ML; Malakhov, A; Mazarico, E; McClanahan, T; Milikh, G; Mokrousov, M; Nandikotkur, G; Neumann, GA; Nuzhdin, I; Sagdeev, R; Shevchenko, V; Shvetsov, V; Smith, DE; Starr, R; Tretyakov, VI; Trombka, J; Usikov, D; Varenikov, A; Vostrukhin, A; Zuber, MT				Mitrofanov, I. G.; Sanin, A. B.; Boynton, W. V.; Chin, G.; Garvin, J. B.; Golovin, D.; Evans, L. G.; Harshman, K.; Kozyrev, A. S.; Litvak, M. L.; Malakhov, A.; Mazarico, E.; McClanahan, T.; Milikh, G.; Mokrousov, M.; Nandikotkur, G.; Neumann, G. A.; Nuzhdin, I.; Sagdeev, R.; Shevchenko, V.; Shvetsov, V.; Smith, D. E.; Starr, R.; Tretyakov, V. I.; Trombka, J.; Usikov, D.; Varenikov, A.; Vostrukhin, A.; Zuber, M. T.			Hydrogen Mapping of the Lunar South Pole Using the LRO Neutron Detector Experiment LEND	SCIENCE			English	Article							NEAR-SURFACE; ICE; PROSPECTOR; MERCURY; WATER; MOON; MARS	Hydrogen has been inferred to occur in enhanced concentrations within permanently shadowed regions and, hence, the coldest areas of the lunar poles. The Lunar Crater Observation and Sensing Satellite (LCROSS) mission was designed to detect hydrogen-bearing volatiles directly. Neutron flux measurements of the Moon's south polar region from the Lunar Exploration Neutron Detector (LEND) on the Lunar Reconnaissance Orbiter (LRO) spacecraft were used to select the optimal impact site for LCROSS. LEND data show several regions where the epithermal neutron flux from the surface is suppressed, which is indicative of enhanced hydrogen content. These regions are not spatially coincident with permanently shadowed regions of the Moon. The LCROSS impact site inside the Cabeus crater demonstrates the highest hydrogen concentration in the lunar south polar region, corresponding to an estimated content of 0.5 to 4.0% water ice by weight, depending on the thickness of any overlying dry regolith layer. The distribution of hydrogen across the region is consistent with buried water ice from cometary impacts, hydrogen implantation from the solar wind, and/or other as yet unknown sources.	[Mitrofanov, I. G.; Sanin, A. B.; Golovin, D.; Kozyrev, A. S.; Litvak, M. L.; Malakhov, A.; Mokrousov, M.; Nuzhdin, I.; Tretyakov, V. I.; Varenikov, A.; Vostrukhin, A.] Russian Acad Sci, Inst Space Res, Moscow 117997, Russia; [Boynton, W. V.; Harshman, K.] Univ Arizona, Tucson, AZ USA; [Chin, G.; Garvin, J. B.; Mazarico, E.; McClanahan, T.; Neumann, G. A.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Evans, L. G.] Comp Sci Corp, Greenbelt, MD USA; [Milikh, G.; Nandikotkur, G.; Sagdeev, R.; Usikov, D.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Starr, R.] Catholic Univ, Washington, DC USA; [Shevchenko, V.] Moscow MV Lomonosov State Univ, Sternberg Astron Inst, Moscow, Russia; [Shvetsov, V.] Joint Inst Nucl Res, Dubna, Russia; [Smith, D. E.; Zuber, M. T.] MIT, Cambridge, MA 02139 USA; [Trombka, J.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA	Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; University of Arizona; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland College Park; Catholic University of America; Lomonosov Moscow State University; Joint Institute for Nuclear Research - Russia; Massachusetts Institute of Technology (MIT); University System of Maryland; University of Maryland College Park	Mitrofanov, IG (corresponding author), Russian Acad Sci, Inst Space Res, Moscow 117997, Russia.	imitrofa@space.ru	Sanin, Anton/T-9393-2017; Litvak, Maxim/C-6453-2017; Chin, Gordon/E-1520-2012; Evans, Larry/F-7462-2012; Neumann, Gregory A/I-5591-2013; Malakhov, Alexey Vladimirovich/F-7953-2017; Mazarico, Erwan/N-6034-2014; McClanahan, Timothy/C-8164-2012; Golovin, Dmitry/F-8588-2017	Neumann, Gregory A/0000-0003-0644-9944; Malakhov, Alexey Vladimirovich/0000-0003-4292-7077; Mazarico, Erwan/0000-0003-3456-427X; Garvin, James/0000-0003-1606-5645; Mitrofanov, Igor/0000-0001-7204-2101	NASA Exploration System Mission Directorate; Russian Federal Space Agency	NASA Exploration System Mission Directorate; Russian Federal Space Agency	The LRO Mission is supported by the NASA Exploration System Mission Directorate, and the LEND investigation is supported by the Russian Federal Space Agency. We acknowledge the LRO Project team at NASA's Goddard Space Flight Center for their outstanding support of the LEND investigation.	Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; Chin G, 2007, SPACE SCI REV, V129, P391, DOI 10.1007/s11214-007-9153-y; Colaprete A, 2010, SCIENCE, V330, P463, DOI 10.1126/science.1186986; Crider DH, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002030; Crider DH, 2003, ADV SPACE RES, V31, P2293, DOI 10.1016/S0273-1177(03)00530-1; Elphic RC, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029954; Feldman WC, 1999, NUCL INSTRUM METH A, V422, P562, DOI 10.1016/S0168-9002(98)00934-6; Feldman WC, 1998, SCIENCE, V281, P1496, DOI 10.1126/science.281.5382.1496; Lawrence DJ, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002637; Lawrence DJ, 2010, ASTROBIOLOGY, V10, P183, DOI 10.1089/ast.2009.0401; McKay D.S., 1991, LUNAR SOURCEBOOK, P285, DOI DOI 10.1006/ICAR.1999.6165; Mitrofanov I, 2002, SCIENCE, V297, P78, DOI 10.1126/science.1073616; Mitrofanov IG, 2008, ASTROBIOLOGY, V8, P793, DOI 10.1089/ast.2007.0158; Mitrofanov IG, 2010, SPACE SCI REV, V150, P183, DOI 10.1007/s11214-009-9608-4; Paige DA, 2010, SCIENCE, V330, P479, DOI 10.1126/science.1187726; SALVAIL JR, 1994, ICARUS, V111, P441, DOI 10.1006/icar.1994.1155; Spudis P. D., 1998, Solar System Research, V32, P17; Vasavada AR, 1999, ICARUS, V141, P179, DOI 10.1006/icar.1999.6175; Vondrak R, 2010, SPACE SCI REV, V150, P7, DOI 10.1007/s11214-010-9631-5; Zuber MT, 2010, SPACE SCI REV, V150, P63, DOI 10.1007/s11214-009-9511-z	20	196	208	3	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					483	486		10.1126/science.1185696	http://dx.doi.org/10.1126/science.1185696			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966247				2022-12-01	WOS:000283329100033
J	Tingen, C; Rodriguez, S; Campo-Engelstein, L; Woodruff, TK				Tingen, C.; Rodriguez, S.; Campo-Engelstein, L.; Woodruff, T. K.			Politics and Parthenotes	SCIENCE			English	Editorial Material							PARTHENOGENETIC ACTIVATION; STEM-CELLS; FERTILITY; CHILDREN; OOCYTES; CANCER		[Tingen, C.; Rodriguez, S.; Campo-Engelstein, L.; Woodruff, T. K.] Northwestern Univ, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Rodriguez, S.; Campo-Engelstein, L.] Northwestern Univ, Ctr Bioeth Sci & Soc, Chicago, IL 60611 USA	Northwestern University; Northwestern University	Woodruff, TK (corresponding author), Northwestern Univ, Dept Obstet & Gynecol, Chicago, IL 60611 USA.	tkw@northwestern.edu		Woodruff, Teresa/0000-0002-1197-3399; Tingen, Candace/0000-0003-3503-019X				Aziz D, 2004, J PEDIATR SURG, V39, P750, DOI 10.1016/j.jpedsurg.2004.01.034; Barksdale EM, 2009, CURR OPIN PEDIATR, V21, P344, DOI 10.1097/MOP.0b013e32832b41ee; Chen VW, 2003, CANCER, V97, P2631, DOI 10.1002/cncr.11345; Cibelli JB, 2002, SCIENCE, V295, P819, DOI 10.1126/science.1065637; Jeruss JS, 2009, NEW ENGL J MED, V360, P902, DOI 10.1056/NEJMra0801454; Kim K, 2007, SCIENCE, V315, P482, DOI 10.1126/science.1133542; Lampert KP, 2008, SEX DEV, V2, P290, DOI 10.1159/000195678; Lehrman S, 2010, SCI AM, V303, P18, DOI 10.1038/scientificamerican0910-18; Marshall VS, 1998, BIOL REPROD, V59, P1491, DOI 10.1095/biolreprod59.6.1491; Mitalipov SM, 2001, BIOL REPROD, V65, P253, DOI 10.1095/biolreprod65.1.253; *NIH, 1994, REP; NOONAN J, 1996, INTERVENTION REFLECT; Revazova ES, 2007, CLONING STEM CELLS, V9, P432, DOI 10.1089/clo.2007.0033; Talmor-Cohen A, 2002, MOL CELL ENDOCRINOL, V187, P145, DOI 10.1016/S0303-7207(01)00691-8; Woodruff TK, 2010, NAT REV CLIN ONCOL, V7, P466, DOI 10.1038/nrclinonc.2010.81	15	11	13	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					453	453		10.1126/science.1196881	http://dx.doi.org/10.1126/science.1196881			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966235				2022-12-01	WOS:000283329100020
J	Hassan, F; Kamruzzaman, M; Mekalanos, JJ; Faruque, SM				Hassan, Faizule; Kamruzzaman, M.; Mekalanos, John J.; Faruque, Shah M.			Satellite phage TLC phi enables toxigenic conversion by CTX phage through dif site alteration	NATURE			English	Article							VIBRIO-CHOLERAE O139; FILAMENTOUS PHAGE; INTEGRATION; GENOME; TOXIN; FORM; RECOMBINASES; REPLICATION; GENES; XERD	Bacterial chromosomes often carry integrated genetic elements (for example plasmids, transposons, prophages and islands) whose precise function and contribution to the evolutionary fitness of the host bacterium are unknown. The CTX phi prophage, which encodes cholera toxin in Vibrio cholerae(1), is known to be adjacent to a chromosomally integrated element of unknown function termed the toxin-linked cryptic (TLC)(2). Here we report the characterization of a TLC-related element that corresponds to the genome of a satellite filamentous phage (TLC-Kn phi 1), which uses the morphogenesis genes of another filamentous phage (fs2 phi) to form infectious TLC-Kn phi 1 phage particles. The TLC-Kn phi 1 phage genome carries a sequence similar to the dif recombination sequence, which functions in chromosome dimer resolution using XerC and XerD recombinases(3). The dif sequence is also exploited by lysogenic filamentous phages (for example CTX phi) for chromosomal integration of their genomes. Bacterial cells defective in the dimer resolution often show an aberrant filamentous cell morphology(3,4). We found that acquisition and chromosomal integration of the TLC-Kn phi 1 genome restored a perfect dif site and normal morphology to V. cholerae wild-type and mutant strains with dif(-) filamentation phenotypes. Furthermore, lysogeny of a dif(-) non-toxigenic V. cholerae with TLC-Kn phi 1 promoted its subsequent toxigenic conversion through integration of CTX phi into the restored dif site. These results reveal a remarkable level of cooperative interactions between multiple filamentous phages in the emergence of the bacterial pathogen that causes cholera.	[Hassan, Faizule; Kamruzzaman, M.; Faruque, Shah M.] Int Ctr Diarrhoeal Dis Res, Mol Genet Lab, Dhaka 1212, Bangladesh; [Mekalanos, John J.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	International Centre for Diarrhoeal Disease Research (ICDDR); Harvard University; Harvard Medical School	Faruque, SM (corresponding author), Int Ctr Diarrhoeal Dis Res, Mol Genet Lab, Dhaka 1212, Bangladesh.	faruque@icddrb.org	Kamruzzaman, Muhammad/S-2756-2019	Faruque, Shah/0000-0002-7006-622X; Kamruzzaman, Muhammad/0000-0003-2005-9846	National Institutes of Health under Harvard Medical School and the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B) [RO1-GM068851, RO1-AI070963]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068851] Funding Source: NIH RePORTER	National Institutes of Health under Harvard Medical School and the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. M. Zaved Waise and S. M. Nashir Udden for technical assistance. This research was funded in part by the National Institutes of Health (grants RO1-GM068851 and RO1-AI070963) under different sub-agreements between the Harvard Medical School and the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B). The ICDDR,B is supported by countries and agencies that share its concern for the health problems of developing countries.	BLAKELY G, 1993, CELL, V75, P351, DOI 10.1016/0092-8674(93)80076-Q; Cameron DE, 2008, P NATL ACAD SCI USA, V105, P8736, DOI 10.1073/pnas.0803281105; Das B, 2010, P NATL ACAD SCI USA, V107, P4377, DOI 10.1073/pnas.0910212107; Davis BM, 2000, P NATL ACAD SCI USA, V97, P8572, DOI 10.1073/pnas.140109997; Davis BM, 2002, EMBO J, V21, P4240, DOI 10.1093/emboj/cdf427; Ehara M, 1997, FEMS MICROBIOL LETT, V154, P293, DOI 10.1016/S0378-1097(97)00345-5; Faruque SA, 2002, INFECT IMMUN, V70, P163, DOI 10.1128/IAI.70.1.163-170.2002; Faruque SM, 2003, P NATL ACAD SCI USA, V100, P1280, DOI 10.1073/pnas.0237385100; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Faruque SM, 2001, INFECT IMMUN, V69, P6084, DOI 10.1128/IAI.69.10.6084-6090.2001; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Huber KE, 2002, NATURE, V417, P656, DOI 10.1038/nature00782; Iida T, 2002, J BACTERIOL, V184, P4933, DOI 10.1128/JB.184.17.4933-4935.2002; Ikema M, 1998, MICROBIOL-SGM, V144, P1901, DOI 10.1099/00221287-144-7-1901; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kimsey HH, 2004, J BIOL CHEM, V279, P2640, DOI 10.1074/jbc.M311109200; McLeod SM, 2004, MOL MICROBIOL, V54, P935, DOI 10.1111/j.1365-2958.2004.04309.x; Rubin EJ, 1998, MOL MICROBIOL, V28, P1247, DOI 10.1046/j.1365-2958.1998.00889.x; Val ME, 2005, MOL CELL, V19, P559, DOI 10.1016/j.molcel.2005.07.002; Waldor MK, 1997, MOL MICROBIOL, V24, P917, DOI 10.1046/j.1365-2958.1997.3911758.x; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910	21	71	76	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 21	2010	467	7318					982	985		10.1038/nature09469	http://dx.doi.org/10.1038/nature09469			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20944629	Bronze, Green Accepted			2022-12-01	WOS:000283254700042
J	Ashton-Beaucage, D; Udell, CM; Lavoie, H; Baril, C; Lefrancois, M; Chagnon, P; Gendron, P; Caron-Lizotte, O; Bonneil, E; Thibault, P; Therrien, M				Ashton-Beaucage, Dariel; Udell, Christian M.; Lavoie, Hugo; Baril, Caroline; Lefrancois, Martin; Chagnon, Pierre; Gendron, Patrick; Caron-Lizotte, Olivier; Bonneil, Eric; Thibault, Pierre; Therrien, Marc			The Exon Junction Complex Controls the Splicing of mapk and Other Long Intron-Containing Transcripts in Drosophila	CELL			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; OSKAR MESSENGER-RNA; HUMAN RNPS1; MAMMALIAN-CELLS; MAGO NASHI; RAS; KINASE; GENE; COACTIVATOR; MUTATIONS	Signaling pathways are controlled by a vast array of posttranslational mechanisms. By contrast, little is known regarding the mechanisms that regulate the expression of their core components. We conducted an RNAi screen in Drosophila for factors modulating RAS/MAPK signaling and identified the Exon Junction Complex (EJC) as a key element of this pathway. The EJC binds the exon-exon junctions of mRNAs and thus far, has been linked exclusively to post-splicing events. Here, we report that the EJC is required for proper splicing of mapk transcripts by a mechanism that apparently controls exon definition. Moreover, whole transcriptome and RT-PCR analyses of EJC-depleted cells revealed that the splicing of long intron-containing genes, which includes mapk, is sensitive to EJC activity. These results identify a role for the EJC in the splicing of a subset of transcripts and suggest that RAS/MAPK signaling depends on the regulation of MAPK levels by the EJC.	[Ashton-Beaucage, Dariel; Udell, Christian M.; Lavoie, Hugo; Baril, Caroline; Lefrancois, Martin; Chagnon, Pierre; Gendron, Patrick; Caron-Lizotte, Olivier; Bonneil, Eric; Thibault, Pierre; Therrien, Marc] Univ Montreal, Inst Res Immunol & Canc, Lab Intracellular Signaling, Montreal, PQ H3C 3J7, Canada; [Therrien, Marc] Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ H3C 3J7, Canada; [Thibault, Pierre] Univ Montreal, Dept Chim, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Therrien, M (corresponding author), Univ Montreal, Inst Res Immunol & Canc, Lab Intracellular Signaling, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	marc.therrien@umontreal.ca		Ashton-Beaucage, Dariel/0000-0001-6987-5487; Gendron, Patrick/0000-0001-9829-2600; Thibault, Pierre/0000-0001-5993-0331; Lavoie, Hugo/0000-0003-0560-2409	Canadian Cancer Society; Canadian Institutes for Health Research	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	We are grateful to R. Boswell, E. Perkins, N. Perrimon, and D. St-Johnston, as well as the Bloomington and VDRC stock centers for fly stocks and cell lines. We thank Christian Charbonneau and Monica Nelea for assistance with microscopy; and Philippe Roux, Pierre Zindy, and Katherine Borden for their help with the polysome fractionation experiments. We also extend our gratitude to the IRIC HTS platform for use of the automated fluorescence microscope; to Michael Kubal (ABI) for help with analysis of the RNA-Seq data; and to Raphaelle Lambert for assistance with RT-qPCR and sequencing. D. A. B. is a recipient of Frederick Banting and Charles Best Canada Doctoral Scholarship. HL is a recipient of a Cancer Research Society postdoctoral fellowship. P. T. is recipient of a Tier I Canada Research Chair in Proteomics and Bioanalytical Spectrometry. M. T. is recipient of a Tier II Canada Research Chair in Intracellular Signaling. This work was supported by the Canadian Cancer Society and by the Canadian Institutes for Health Research.	BAKER NE, 1989, NATURE, V340, P150, DOI 10.1038/340150a0; Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; Berghella L, 1996, GENETICS, V144, P117; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Blencowe BJ, 1998, GENE DEV, V12, P996, DOI 10.1101/gad.12.7.996; BOSWELL RE, 1991, DEVELOPMENT, V113, P373; Budagyan B, 2004, 2004 IEEE COMPUTATIONAL SYSTEMS BIOINFORMATICS CONFERENCE, PROCEEDINGS, P515; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cheng CH, 2006, MOL CELL BIOL, V26, P362, DOI 10.1128/MCB.26.1.362-370.2006; Cheng CH, 2006, GENE DEV, V20, P1715, DOI 10.1101/gad.1430906; Degot S, 2004, J BIOL CHEM, V279, P33702, DOI 10.1074/jbc.M402754200; Diem MD, 2007, NAT STRUCT MOL BIOL, V14, P1173, DOI 10.1038/nsmb1321; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Douziech M, 2003, EMBO J, V22, P5068, DOI 10.1093/emboj/cdg506; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Eldridge AG, 1999, P NATL ACAD SCI USA, V96, P6125, DOI 10.1073/pnas.96.11.6125; FORTINI ME, 1992, NATURE, V355, P559, DOI 10.1038/355559a0; Fox-Walsh KL, 2005, P NATL ACAD SCI USA, V102, P16176, DOI 10.1073/pnas.0508489102; Gatfield D, 2003, EMBO J, V22, P3960, DOI 10.1093/emboj/cdg371; Gatfield D, 2002, J CELL BIOL, V159, P579, DOI 10.1083/jcb.200207128; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Gehring NH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000120; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Herold N, 2009, MOL CELL BIOL, V29, P281, DOI 10.1128/MCB.01415-08; House AE, 2008, J BIOL CHEM, V283, P1217, DOI 10.1074/jbc.R700031200; Hurlbut GD, 2007, CURR OPIN CELL BIOL, V19, P166, DOI 10.1016/j.ceb.2007.02.012; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Karim FD, 1996, GENETICS, V143, P315; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2001, EMBO REP, V2, P1119, DOI 10.1093/embo-reports/kve245; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lee MH, 2007, PLOS GENET, V3, P2540, DOI 10.1371/journal.pgen.0030233; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Longman D, 2007, GENE DEV, V21, P1075, DOI 10.1101/gad.417707; Lykke-Andersen J, 2001, SCIENCE, V293, P1836, DOI 10.1126/science.1062786; Macchi P, 2003, J NEUROSCI, V23, P5778; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; Mayeda A, 1999, EMBO J, V18, P4560, DOI 10.1093/emboj/18.16.4560; McCracken S, 2003, J BIOL CHEM, V278, P44153, DOI 10.1074/jbc.M306856200; McCracken S, 2002, MOL CELL BIOL, V22, P148, DOI 10.1128/MCB.22.1.148-160.2002; McGuire AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r50; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; MELNICK MB, 1993, DEVELOPMENT, V118, P127; Merz C, 2007, RNA, V13, P116, DOI 10.1261/rna.336807; Mohr SE, 2001, GENE DEV, V15, P2886; MOUNT SM, 1992, NUCLEIC ACIDS RES, V20, P4255, DOI 10.1093/nar/20.16.4255; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Nykamp K, 2008, RNA, V14, P1378, DOI 10.1261/rna.1066008; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; PERKINS LA, 1992, CELL, V70, P225, DOI 10.1016/0092-8674(92)90098-W; Perkins LA, 1996, DEV BIOL, V180, P63, DOI 10.1006/dbio.1996.0285; ROY M, 2008, GENOMES RNA, V14, P1; Sakashita E, 2004, MOL CELL BIOL, V24, P1174, DOI 10.1128/MCB.24.3.1174-1187.2004; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Sterner DA, 1996, P NATL ACAD SCI USA, V93, P15081, DOI 10.1073/pnas.93.26.15081; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; Therrien M, 2000, GENETICS, V156, P1231; Trembley JH, 2005, MOL CELL BIOL, V25, P1446, DOI 10.1128/MCB.25.4.1446-1457.2005; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; van Eeden FJM, 2001, J CELL BIOL, V154, P511, DOI 10.1083/jcb.200105056; WASSARMAN DA, 1995, CURR OPIN GENET DEV, V5, P44, DOI 10.1016/S0959-437X(95)90052-7; WEN J, 2010, EMBO J; Wiegand HL, 2003, P NATL ACAD SCI USA, V100, P11327, DOI 10.1073/pnas.1934877100; XU T, 1993, DEVELOPMENT, V117, P1223; Yu Y, 2008, CELL, V135, P1224, DOI 10.1016/j.cell.2008.10.046; Zebisch A, 2007, CURR MED CHEM, V14, P601, DOI 10.2174/092986707780059670	72	92	96	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					251	262		10.1016/j.cell.2010.09.014	http://dx.doi.org/10.1016/j.cell.2010.09.014			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946983	Bronze			2022-12-01	WOS:000283052200014
J	Hawkes, N				Hawkes, Nigel			Climate Change Giving it 10%	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						VIDEO BRIGHTON HOVE	1	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 6	2010	341								c5448	10.1136/bmj.c5448	http://dx.doi.org/10.1136/bmj.c5448			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	663JE	20926481				2022-12-01	WOS:000282879400004
J	Orom, UA; Derrien, T; Beringer, M; Gumireddy, K; Gardini, A; Bussotti, G; Lai, F; Zytnicki, M; Notredame, C; Huang, QH; Guigo, R; Shiekhattar, R				Orom, Ulf Andersson; Derrien, Thomas; Beringer, Malte; Gumireddy, Kiranmai; Gardini, Alessandro; Bussotti, Giovanni; Lai, Fan; Zytnicki, Matthias; Notredame, Cedric; Huang, Qihong; Guigo, Roderic; Shiekhattar, Ramin			Long Noncoding RNAs with Enhancer-like Function in Human Cells	CELL			English	Article							TRANSCRIPTION; GENE; REVEALS; IDENTIFICATION; MECHANISMS; EXPRESSION; POSITION; ELEMENT; GENOME; REGION	While the long noncoding RNAs (ncRNAs) constitute a large portion of the mammalian transcriptome, their biological functions has remained elusive. A few long ncRNAs that have been studied in any detail silence gene expression in processes such as X-inactivation and imprinting. We used a GENCODE annotation of the human genome to characterize over a thousand long ncRNAs that are expressed in multiple cell lines. Unexpectedly, we found an enhancer-like function for a set of these long ncRNAs in human cell lines. Depletion of a number of ncRNAs led to decreased expression of their neighboring protein-coding genes, including the master regulator of hematopoiesis, SCL (also called TAL1), Snai1 and Snai2. Using heterologous transcription assays we demonstrated a requirement for the ncRNAs in activation of gene expression. These results reveal an unanticipated role for a class of long ncRNAs in activation of critical regulators of development and differentiation.	[Orom, Ulf Andersson; Beringer, Malte; Gumireddy, Kiranmai; Gardini, Alessandro; Lai, Fan; Huang, Qihong; Shiekhattar, Ramin] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Derrien, Thomas; Bussotti, Giovanni; Zytnicki, Matthias; Notredame, Cedric; Guigo, Roderic; Shiekhattar, Ramin] UPF, Ctr Genom Regulat CRG, Barcelona, Spain; [Shiekhattar, Ramin] ICREA, Barcelona, Spain	The Wistar Institute; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Shiekhattar, R (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	shiekhattar@wistar.org	Derrien, Thomas/ABD-6197-2020; Jha, Rajneesh/L-5606-2017; Beringer, Malte/N-3766-2015; lai, fan/A-9732-2011; Guigo, Roderic/D-1303-2010; Beringer, Malte/AAC-5734-2020; Lai, Fan/ABD-2862-2021; Orom, Ulf A/G-1327-2010; Ørom, Ulf A/F-6727-2010; Bussotti, Giovanni/C-3082-2019; notredame, cedric/G-3868-2010	Beringer, Malte/0000-0003-1958-9786; Guigo, Roderic/0000-0002-5738-4477; Derrien, Thomas/0000-0002-8211-5789; Bussotti, Giovanni/0000-0002-4078-7413; notredame, cedric/0000-0003-1461-0988; Lai, Fan/0000-0002-0568-2616; Orom, Ulf/0000-0002-0643-0592	Danish Research Council; HFSPO; American Italian Cancer Foundation; Spanish ministry, GENCODE [U54 HG004555-01]; NIH [GM 079091]; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079091] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Danish Research Council(Det Frie Forskningsrad (DFF)); HFSPO(Human Frontier Science Program); American Italian Cancer Foundation; Spanish ministry, GENCODE(Spanish Government); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ICREA(ICREA)	Thanks to the HAVANA team for use of their genome annotation. We also thank the CRG Genomic Facility and the Functional Genomics Core Facility at Wistar and UPenn for expertise in microarray analysis. We thank Dr. Ken Zaret for helpful discussions. U.A.O. is supported by a grant from the Danish Research Council; M.B. is supported by an HFSPO fellowship; A.G. was supported by a fellowship from the American Italian Cancer Foundation; R.G. was supported through Spanish ministry, GENCODE U54 HG004555-01, and NIH; and R.S. was supported by a grant from NIH, GM 079091.	BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; BANERJI J, 1983, CELL, V33, P729, DOI 10.1016/0092-8674(83)90015-6; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berezikov E, 2005, HUM MOL GENET, V14, pR183, DOI 10.1093/hmg/ddi271; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blanco Enrique, 2007, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0403s18; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; De Craene B, 2005, CANCER RES, V65, P6237, DOI 10.1158/0008-5472.CAN-04-3545; Denoeud F, 2007, GENOME RES, V17, P746, DOI 10.1101/gr.5660607; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Euskirchen GM, 2007, GENOME RES, V17, P898, DOI 10.1101/gr.5583007; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GILLIES SD, 1983, CELL, V33, P717, DOI 10.1016/0092-8674(83)90014-4; Gumireddy K, 2009, NAT CELL BIOL, V11, P1297, DOI 10.1038/ncb1974; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; IMPERIALE MJ, 1984, MOL CELL BIOL, V4, P875, DOI 10.1128/MCB.4.5.875; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; KHALIL AM, 2009, P NATL ACAD SCI US; KHOURY G, 1983, CELL, V33, P313, DOI 10.1016/0092-8674(83)90410-5; KIM TK, 2010, NATURE; Kong SM, 1997, MOL CELL BIOL, V17, P3955, DOI 10.1128/MCB.17.7.3955; Lanz RB, 1999, CELL, V97, P17, DOI 10.1016/S0092-8674(00)80711-4; Lecuyer E, 2004, EXP HEMATOL, V32, P11, DOI 10.1016/j.exphem.2003.10.010; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lunter G, 2006, PLOS COMPUT BIOL, V2, P2, DOI 10.1371/journal.pcbi.0020005; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Parra G, 2000, GENOME RES, V10, P511, DOI 10.1101/gr.10.4.511; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shamovsky I, 2006, NATURE, V440, P556, DOI 10.1038/nature04518; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yang PK, 2007, CELL, V128, P777, DOI 10.1016/j.cell.2007.01.032	47	1395	1461	3	196	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2010	143	1					46	58		10.1016/j.cell.2010.09.001	http://dx.doi.org/10.1016/j.cell.2010.09.001			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	656UC	20887892	Green Accepted, Green Submitted, Green Published, Bronze			2022-12-01	WOS:000282362000013
J	Torres, EM; Dephoure, N; Panneerselvam, A; Tucker, CM; Whittaker, CA; Gygi, SP; Dunham, MJ; Amon, A				Torres, Eduardo M.; Dephoure, Noah; Panneerselvam, Amudha; Tucker, Cheryl M.; Whittaker, Charles A.; Gygi, Steven P.; Dunham, Maitreya J.; Amon, Angelika			Identification of Aneuploidy-Tolerating Mutations	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; CHROMOSOMAL INSTABILITY; YEAST; DEGRADATION; PROTEASOME; CELLS; DEUBIQUITINATION; DEPLETION; CODE	Aneuploidy causes a proliferative disadvantage in all normal cells analyzed to date, yet this condition is associated with a disease characterized by unabated proliferative potential, cancer. The mechanisms that allow cancer cells to tolerate the adverse effects of aneuploidy are not known. To probe this question, we identified aneuploid yeast strains with improved proliferative abilities. Their molecular characterization revealed strain-specific genetic alterations as well as mutations shared between different aneuploid strains. Among the latter, a loss-of-function mutation in the gene encoding the deubiquitinating enzyme Ubp6 improves growth rates in four different aneuploid yeast strains by attenuating the changes in intracellular protein composition caused by aneuploidy. Our results demonstrate the existence of aneuploidy-tolerating mutations that improve the fitness of multiple different aneuploidies and highlight the importance of ubiquitin-proteasomal degradation in suppressing the adverse effects of aneuploidy.	[Torres, Eduardo M.; Panneerselvam, Amudha; Whittaker, Charles A.; Amon, Angelika] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Torres, Eduardo M.; Amon, Angelika] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Dephoure, Noah; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Tucker, Cheryl M.] Princeton Univ, Lewis Sigler Inst, Princeton, NJ 08540 USA; [Dunham, Maitreya J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Princeton University; University of Washington; University of Washington Seattle	Amon, A (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	angelika@mit.edu	Dephoure, Noah/N-7818-2014	Dephoure, Noah/0000-0001-5802-2657; Whittaker, Charles/0000-0002-2400-0094; Amon, Angelika/0000-0001-9837-0314; Dunham, Maitreya/0000-0001-9944-2666	National Institutes of Health [GM56800, P50 GM071508]; Charles King Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508, R29GM056800, R01GM056800] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles King Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Daniel Finley, Philip Hieter, and Juergen Dohmen for reagents and to Daniel Finley, John Hanna, Frank Solomon, and members of the Amon lab for suggestions and their critical reading of this manuscript. This work was supported by National Institutes of Health grant GM56800 and a Charles King Trust postdoctoral Fellowship to ET. M.J.D. and C.M.T. were supported in part by National Institutes of Health grant P50 GM071508. A.A. is also an Investigator of the Howard Hughes Medical Institute.	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Anders KR, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-36; Ben-Aroya S, 2008, MOL CELL, V30, P248, DOI 10.1016/j.molcel.2008.02.021; Chernova TA, 2003, J BIOL CHEM, V278, P52102, DOI 10.1074/jbc.M310283200; DAVIES J, 1964, P NATL ACAD SCI USA, V51, P883, DOI 10.1073/pnas.51.5.883; DAVIES J, 1968, J BIOL CHEM, V243, P3312; Dettman JR, 2007, NATURE, V447, P585, DOI 10.1038/nature05856; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gresham D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000303; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; KATZ W, 1990, MOL CELL BIOL, V10, P5286, DOI 10.1128/MCB.10.10.5286; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; MEEKSWAGNER D, 1986, CELL, V44, P43, DOI 10.1016/0092-8674(86)90483-6; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Williams BR, 2009, CANCER RES, V69, P5289, DOI 10.1158/0008-5472.CAN-09-0944; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Zeyl C, 2006, FEMS YEAST RES, V6, P685, DOI 10.1111/j.1567-1364.2006.00061.x	29	267	269	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2010	143	1					71	83		10.1016/j.cell.2010.08.038	http://dx.doi.org/10.1016/j.cell.2010.08.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	656UC	20850176	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000282362000015
J	Choa, R; Sharp, R; Mahtani, KR				Choa, Robert; Sharp, Robert; Mahtani, Kamal R.			10-Minute Consultation Hallux valgus	BRITISH MEDICAL JOURNAL			English	Editorial Material							ORTHOSES		[Mahtani, Kamal R.] Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England; [Choa, Robert; Sharp, Robert] Nuffield Orthopaed Ctr, Dept Foot & Ankle Surg, Oxford OX3 7LD, England	University of Oxford; Nuffield Orthopaedic Centre	Mahtani, KR (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England.	kamal.mahtani@dphpc.ox.ac.uk			National Institute for Health Research [ACF-2008-13-014] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Coughlin MJ, 2007, FOOT ANKLE INT, V28, P759, DOI 10.3113/FAI.2007.0759; Coughlin MJ, 1996, J BONE JOINT SURG AM, V78A, P932, DOI 10.2106/00004623-199606000-00018; COUGHLIN MJ, 2006, SURG FOOT ANKLE, P230; Landsman A, 2009, J AM PODIAT MED ASSN, V99, P206, DOI 10.7547/0980206; Nguyen USDT, 2010, OSTEOARTHR CARTILAGE, V18, P41, DOI 10.1016/j.joca.2009.07.008; SIMFOOK L, 1958, J BONE JOINT SURG AM, V40, P1058, DOI 10.2106/00004623-195840050-00007; Torkki M, 2003, ACTA ORTHOP SCAND, V74, P209, DOI 10.1080/00016470310013987	7	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 27	2010	341								c5130	10.1136/bmj.c5130	http://dx.doi.org/10.1136/bmj.c5130			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	659LV	20876149				2022-12-01	WOS:000282568900002
J	Bhatt, DL; Eagle, KA; Ohman, EM; Hirsch, AT; Goto, S; Mahoney, EM; Wilson, PWF; Alberts, MJ; D'Agostino, R; Liau, CS; Mas, JL; Rother, J; Smith, SC; Salette, G; Contant, CF; Massaro, JM; Steg, PG				Bhatt, Deepak L.; Eagle, Kim A.; Ohman, E. Magnus; Hirsch, Alan T.; Goto, Shinya; Mahoney, Elizabeth M.; Wilson, Peter W. F.; Alberts, Mark J.; D'Agostino, Ralph; Liau, Chiau-Suong; Mas, Jean-Louis; Roether, Joachim; Smith, Sidney C., Jr.; Salette, Genevieve; Contant, Charles F.; Massaro, Joseph M.; Steg, Ph. Gabriel		REACH Registry Investigators	Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE CORONARY SYNDROME; DISEASE; ROSIGLITAZONE; CLOPIDOGREL; PREVENTION; REDUCTION; CANGRELOR; MORTALITY; OUTCOMES; ASPIRIN	Context Clinicians and trialists have difficulty with identifying which patients are highest risk for cardiovascular events. Prior ischemic events, polyvascular disease, and diabetes mellitus have all been identified as predictors of ischemic events, but their comparative contributions to future risk remain unclear. Objective To categorize the risk of cardiovascular events in stable outpatients with various initial manifestations of atherothrombosis using simple clinical descriptors. Design, Setting, and Patients Outpatients with coronary artery disease, cerebrovascular disease, or peripheral arterial disease or with multiple risk factors for atherothrombosis were enrolled in the global Reduction of Atherothrombosis for Continued Health (REACH) Registry and were followed up for as long as 4 years. Patients from 3647 centers in 29 countries were enrolled between 2003 and 2004 and followed up until 2008. Final database lock was in April 2009. Main Outcome Measures Rates of cardiovascular death, myocardial infarction, and stroke. Results A total of 45 227 patients with baseline data were included in this 4-year analysis. During the follow-up period, a total of 5481 patients experienced at least 1 event, including 2315 with cardiovascular death, 1228 with myocardial infarction, 1898 with stroke, and 40 with both a myocardial infarction and stroke on the same day. Among patients with atherothrombosis, those with a prior history of ischemic events at baseline (n=21 890) had the highest rate of subsequent ischemic events (18.3%; 95% confidence interval [CI], 17.4%-19.1%); patients with stable coronary, cerebrovascular, or peripheral artery disease (n=15 264) had a lower risk (12.2%; 95% CI, 11.4%-12.9%); and patients without established atherothrombosis but with risk factors only (n=8073) had the lowest risk (9.1%; 95% CI, 8.3%-9.9%) (P<.001 for all comparisons). In addition, in multivariable modeling, the presence of diabetes (hazard ratio [HR], 1.44; 95% CI, 1.36-1.53; P<.001), an ischemic event in the previous year (HR, 1.71; 95% CI, 1.57-1.85; P<.001), and polyvascular disease (HR, 1.99; 95% CI, 1.78-2.24; P<.001) each were associated with a significantly higher risk of the primary end point. Conclusion Clinical descriptors can assist clinicians in identifying high-risk patients within the broad range of risk for outpatients with atherothrombosis. JAMA. 2010; 304(12): 1350-1357	[Bhatt, Deepak L.] VA Boston Healthcare Syst, Boston, MA 02132 USA; [Alberts, Mark J.] Northwestern Univ, Sch Med, Chicago, IL USA; [Bhatt, Deepak L.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Bhatt, Deepak L.] Harvard Univ, Sch Med, Boston, MA USA; [D'Agostino, Ralph] Boston Univ, Boston, MA 02215 USA; [Eagle, Kim A.] Univ Michigan, Ann Arbor, MI 48109 USA; [Goto, Shinya] Tokai Univ, Sch Med, Isehara, Kanagawa 25911, Japan; [Hirsch, Alan T.] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA; [Liau, Chiau-Suong] Taiwan Univ Hosp, Taipei, Taiwan; [Liau, Chiau-Suong] Coll Med, Taipei, Taiwan; [Mas, Jean-Louis] Ctr Raymond Garcin, Paris, France; [Ohman, E. Magnus] Duke Univ, Med Ctr, Durham, NC USA; [Roether, Joachim] Asklepios Klin Altona, Dept Neurol, Hamburg, Germany; [Smith, Sidney C., Jr.] Univ N Carolina, Chapel Hill, NC USA; [Steg, Ph. Gabriel] Hop Bichat Claude Bernard, F-75877 Paris 18, France; [Wilson, Peter W. F.] Emory Univ, Sch Med, Atlanta, GA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Northwestern University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston University; University of Michigan System; University of Michigan; Tokai University; University of Minnesota System; University of Minnesota Twin Cities; National Taiwan University; Duke University; Asklepios Klinik Altona; University of North Carolina; University of North Carolina Chapel Hill; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Emory University	Bhatt, DL (corresponding author), VA Boston Healthcare Syst, 1400 VFW Pkwy, Boston, MA 02132 USA.	dlbhattmd@post.harvard.edu	Statsenko, Mikhail E./N-7573-2015; Wilson, Peter W.F./J-2455-2016; STEG, Philippe Gabriel/Z-1567-2019; Goto, Shinya/AAU-6045-2020	Statsenko, Mikhail E./0000-0002-3306-0312; Goto, Shinya/0000-0002-6821-1504; Massaro, Joseph/0000-0002-2682-4812; STEG, Philippe Gabriel/0000-0001-6896-2941	AstraZeneca; Bristol-Myers Squibb; Eisai; Ethicon; Heartscape; Sanofi-Aventis; Medicines Company; Blue Cross Blue Shield of Michigan; National Institutes of Health (NIH); Mardigian Foundation; GORE; Hewlett Foundation; CV Therapeutics; Daiichi Sankyo; Datascope; Eli Lilly; Marquet; Schering-Plough; Abbott Vascular; Ono; Otsuka; Sankyo; Daiichi; Takeda; Asteras; Kowa; AGA Medical; Boehringer Ingelheim; EKR; Servier; Waksman Foundation (Tokyo, Japan)	AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb); Eisai(Eisai Co Ltd); Ethicon; Heartscape; Sanofi-Aventis(Sanofi-Aventis); Medicines Company; Blue Cross Blue Shield of Michigan; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mardigian Foundation; GORE; Hewlett Foundation; CV Therapeutics; Daiichi Sankyo(Daiichi Sankyo Company Limited); Datascope; Eli Lilly(Eli Lilly); Marquet; Schering-Plough(Merck & CompanySchering Plough Corporation); Abbott Vascular(Abbott Laboratories); Ono; Otsuka(Otsuka Pharmaceutical); Sankyo; Daiichi(Daiichi Sankyo Company Limited); Takeda(Takeda Pharmaceutical Company Ltd); Asteras; Kowa; AGA Medical; Boehringer Ingelheim(Boehringer Ingelheim); EKR; Servier(Servier); Waksman Foundation (Tokyo, Japan)	Dr Bhatt reported having received institutional research support from AstraZeneca, Bristol-Myers Squibb, Eisai, Ethicon, Heartscape, Sanofi-Aventis, and The Medicines Company. Dr Eagle reported having received grant/research support from Bristol-Myers Squibb, Blue Cross Blue Shield of Michigan, the National Institutes of Health (NIH), Sanofi-Aventis, the Mardigian Foundation Varbedian Fund, GORE, and the Hewlett Foundation and being a consultant for the NIH National Heart, Lung, and Blood Institute, Sanofi-Aventis, and the Robert Wood Johnson Foundation. Dr Ohman reported receiving research grants from Bristol-Myers Squibb, CV Therapeutics, Daiichi Sankyo, Datascope, Eli Lilly, Marquet, Sanofi-Aventis, Schering-Plough, and The Medicines Company and providing consulting or other services for Abiomed, AstraZeneca, CV Therapeutics, Datascope, Gilead Sciences, Liposcience, Marquet, Northpoint Domain, Pozen, Response Biomedical, Sanofi-Aventis, The Medicines Company, and WebMD (theheart.org). Dr Hirsch reported having received research grants from Bristol-Myers Squibb, Sanofi-Aventis, and Abbott Vascular and served as a consultant to Roche, Cytokinetics, ev3, and Talecris. Dr Goto reported having received research grants from Pfizer, Sanofi-Aventis, Ono, Eisai, Otsuka, Sankyo, Daiichi, Takeda, Asteras, Kowa, and AstraZeneca and honoraria from Sanofi-Aventis, Eisai, Otsuka, Daiichi-Sankyo, and Schering-Plough. Dr Mahoney reported having received grant support from Sanofi-Aventis, Bristol-Myers Squibb, Daiichi-Sankyo, and Eli Lilly and honoraria from Sanofi-Aventis and Bristol-Myers Squibb. Dr Wilson reported having received research grants from Sanofi-Aventis. Dr Alberts reported having received research support from AGA Medical, AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, EKR, Sanofi-Aventis, and Schering-Plough; having participated in speakers' bureaus for Bristol-Myers Squibb, Boehringer Ingelheim, DiaDexus, Genentech, MedScape, and Sanofi-Aventis; having received honoraria from Bristol-Myers Squibb, Boehringer Ingelheim, DiaDexus, Genentech, MedScape, and Sanofi-Aventis; and having acted as a consultant or advisory board member for Bristol-Myers Squibb, Boehringer Ingelheim, EKR, Genentech, Merck, Pfizer, and Sanofi-Aventis. Dr D'Agostino reported having received honoraria from Sanofi-Aventis. Dr Liau reported no disclosures. Dr Mas reported having received research grants, honoraria, and consulting fees from Sanofi-Aventis, Bristol-Myers Squibb, and Servier and honoraria and consulting fees from Boehringer Ingelheim. Dr Rother reported having participated in speakers' bureaus for Boehringer-Ingelheim, Bristol-Myers Squibb, Sanofi-Aventis, and Lundbeck and having acted as a consultant or advisory board member for Bayer, Boehringer-Ingelheim, Bristol-Myers Squibb, Sanofi-Aventis, and Lundbeck. Dr Smith Jr reported no disclosures. Dr Salette reported being an employee of Sanofi-Aventis. Dr Contant reported no disclosures. Dr Massaro reported having received honoraria from Sanofi-Aventis. Dr Steg reported having received research grants (to his institution) from Servier; participating in consultancy or advisory boards for Astellas, AstraZeneca, Bayer, Boehringer-Ingelheim, BMS, Daiichi-Sankyo-Lilly, GlaxoSmithKline, Medtronic, Otsuka, Pfizer, Roche, Sanofi-Aventis, Servier, and The Medicines Company; and being a stockholder in Aterovax.; The REACH Registry is sponsored by Sanofi-Aventis, Bristol-Myers Squibb, and the Waksman Foundation (Tokyo, Japan). The REACH Registry is endorsed by the World Heart Federation.	Alberts MJ, 2009, EUR HEART J, V30, P2318, DOI 10.1093/eurheartj/ehp355; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V303, P2188, DOI 10.1001/jama.2010.743; Bhatt DL, 2009, NEW ENGL J MED, V361, P2330, DOI 10.1056/NEJMoa0908629; Bhatt DL, 2009, EUR HEART J, V30, P1195, DOI 10.1093/eurheartj/ehp099; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Brilakis ES, 2009, CIRCULATION, V120, P560, DOI 10.1161/CIRCULATIONAHA.109.877092; CHANG IM, 1982, J CHRON DIS, V35, P669, DOI 10.1016/0021-9681(82)90019-4; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Fonarow GC, 2005, JAMA-J AM MED ASSOC, V293, P572, DOI 10.1001/jama.293.5.572; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Harrington RA, 2009, NEW ENGL J MED, V361, P2318, DOI 10.1056/NEJMoa0908628; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; Krempf M, 2010, AM J CARDIOL, V105, P667, DOI 10.1016/j.amjcard.2009.10.048; Mahoney EM, 2008, CIRC-CARDIOVASC QUAL, V1, P38, DOI 10.1161/CIRCOUTCOMES.108.775247; Mehta C, 2009, CIRCULATION, V119, P597, DOI 10.1161/CIRCULATIONAHA.108.809707; Muller-Riemenschneider F, 2010, ARCH INTERN MED, V170, P719, DOI 10.1001/archinternmed.2010.66; Ohman EM, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.11.004; Sacco RL, 2008, NEW ENGL J MED, V359, P1238, DOI 10.1056/NEJMoa0805002; Singh S, 2007, JAMA-J AM MED ASSOC, V298, P1189, DOI 10.1001/jama.298.10.1189; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197; Topol EJ, 2010, LANCET, V376, P517, DOI 10.1016/S0140-6736(10)60935-X	23	539	591	0	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2010	304	12					1350	1357		10.1001/jama.2010.1322	http://dx.doi.org/10.1001/jama.2010.1322			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	652LK	20805624	Bronze			2022-12-01	WOS:000282007900018
J	Akella, JS; Wloga, D; Kim, J; Starostina, NG; Lyons-Abbott, S; Morrissette, NS; Dougan, ST; Kipreos, ET; Gaertig, J				Akella, Jyothi S.; Wloga, Dorota; Kim, Jihyun; Starostina, Natalia G.; Lyons-Abbott, Sally; Morrissette, Naomi S.; Dougan, Scott T.; Kipreos, Edward T.; Gaertig, Jacek			MEC-17 is an alpha-tubulin acetyltransferase	NATURE			English	Article							TOUCH RECEPTOR NEURONS; TETRAHYMENA-THERMOPHILA; CAENORHABDITIS-ELEGANS; C-ELEGANS; ACETYLATION; MICROTUBULE; CILIA; TRANSPORT; DOMAIN; IDENTIFICATION	In most eukaryotic cells, subsets of microtubules are adapted for specific functions by post-translational modifications (PTMs) of tubulin subunits. Acetylation of the epsilon-amino group of K40 on alpha-tubulin is a conserved PTM on the luminal side of microtubules(1) that was discovered in the flagella of Chlamydomonas reinhardtii(2,3). Studies on the significance of microtubule acetylation have been limited by the undefined status of the alpha-tubulin acetyltransferase. Here we show that MEC-17, a protein related to the Gcn5 histone acetyltransferases(4) and required for the function of touch receptor neurons in Caenorhabditis elegans(5,6), acts as a K40-specific acetyltransferase for alpha-tubulin. In vitro, MEC-17 exclusively acetylates K40 of alpha-tubulin. Disruption of the Tetrahymena MEC-17 gene phenocopies the K40R alpha-tubulin mutation and makes microtubules more labile. Depletion of MEC-17 in zebrafish produces phenotypes consistent with neuromuscular defects. In C. elegans, MEC-17 and its paralogue W06B11.1 are redundantly required for acetylation of MEC-12 alpha-tubulin, and contribute to the function of touch receptor neurons partly via MEC-12 acetylation and partly via another function, possibly by acetylating another protein. In summary, we identify MEC-17 as an enzyme that acetylates the K40 residue of alpha-tubulin, the only PTM known to occur on the luminal surface of microtubules.	[Akella, Jyothi S.; Wloga, Dorota; Kim, Jihyun; Starostina, Natalia G.; Dougan, Scott T.; Kipreos, Edward T.; Gaertig, Jacek] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Lyons-Abbott, Sally; Morrissette, Naomi S.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	University System of Georgia; University of Georgia; University of California System; University of California Irvine	Gaertig, J (corresponding author), Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA.	jgaertig@cb.uga.edu	Gaertig, Jacek/F-1553-2010; Dougan, Scott/B-8416-2008; Włoga, Dorota/R-4078-2016	Dougan, Scott/0000-0003-0214-4772; Włoga, Dorota/0000-0003-3314-7773; Akella, Jyothi Shilpa/0000-0003-4839-4910	National Science Foundation [MBC-033965]; American Cancer Society [RSG DDC-112979]; National Institutes of Health [R01GM074212, R01AI067981, R01GM089912]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089912, R01GM074212] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds from the National Science Foundation (MBC-033965 to J.G.), American Cancer Society (RSG DDC-112979 to S.T.D.), and National Institutes of Health (R01GM074212 to E. T. K., R01AI067981 to N.S.M., R01GM089912 to J.G.). S.T.D. is a Georgia Cancer Coalition Distinguished Investigator. We are grateful to M. Chalfie for the mec-12(e1607) mutant, J. Frankel for 12G10 mAb (available from the Developmental Studies Hybridoma Bank), M. Gorovsky for SG anti-tubulin antibodies, D. Allis for anti-hv1 antibodies, B. Feldman for mismatch morpholinos, and S. T. Dougan laboratory members for advice and assistance with zebrafish experiments.	Barlow SB, 2002, J CELL SCI, V115, P3469; Bounoutas A, 2009, CURR BIOL, V19, P1362, DOI 10.1016/j.cub.2009.06.036; BRENNER S, 1974, GENETICS, V77, P71; CassidyHanley D, 1997, GENETICS, V146, P135; CHALFIE M, 1989, SCIENCE, V243, P1027, DOI 10.1126/science.2646709; Chen CC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000561; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Fox MA, 2007, J COMP NEUROL, V503, P280, DOI 10.1002/cne.21381; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Fukushige T, 1999, J CELL SCI, V112, P395; GAERTIG J, 1995, J CELL BIOL, V129, P1301, DOI 10.1083/jcb.129.5.1301; Gaertig J, 1999, NAT BIOTECHNOL, V17, P462, DOI 10.1038/8638; Hai B, 1997, P NATL ACAD SCI USA, V94, P1310, DOI 10.1073/pnas.94.4.1310; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Jerka-Dziadosz M, 2001, PROTIST, V152, P53, DOI 10.1078/1434-4610-00043; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; KOZMINSKI KG, 1993, CELL MOTIL CYTOSKEL, V25, P158, DOI 10.1002/cm.970250205; Kuninger D, 2007, J BIOTECHNOL, V131, P253, DOI 10.1016/j.jbiotec.2007.07.498; LEDIZET M, 1987, P NATL ACAD SCI USA, V84, P5720, DOI 10.1073/pnas.84.16.5720; LEDIZET M, 1991, METHOD ENZYMOL, V196, P264; LHERNAULT SW, 1983, J CELL BIOL, V97, P258, DOI 10.1083/jcb.97.1.258; MARUTA H, 1986, J CELL BIOL, V103, P571, DOI 10.1083/jcb.103.2.571; Miller DM, 1995, METHOD CELL BIOL, V48, P365; Mochizuki K, 2008, GENE, V425, P79, DOI 10.1016/j.gene.2008.08.007; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Ohkawa N, 2008, GENES CELLS, V13, P1171, DOI 10.1111/j.1365-2443.2008.01235.x; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Shen Q, 2009, EXP CELL RES, V315, P1653, DOI 10.1016/j.yexcr.2009.03.007; Solinger JA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000820; Steczkiewicz K, 2006, CELL CYCLE, V5, P2927, DOI 10.4161/cc.5.24.3572; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; WILSON SW, 1991, DEVELOPMENT, V112, P723; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Wloga D, 2008, EUKARYOT CELL, V7, P1362, DOI 10.1128/EC.00084-08; Wloga D, 2006, MOL BIOL CELL, V17, P2799, DOI 10.1091/mbc.E05-05-0450; Wloga D, 2009, DEV CELL, V16, P867, DOI 10.1016/j.devcel.2009.04.008; Yakovich AJ, 2006, EXP PARASITOL, V114, P289, DOI 10.1016/j.exppara.2006.04.008; Zhang Y, 2002, NATURE, V418, P331, DOI 10.1038/nature00891	44	319	335	3	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2010	467	7312					218	U111		10.1038/nature09324	http://dx.doi.org/10.1038/nature09324			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647KB	20829795	Green Accepted			2022-12-01	WOS:000281616300037
J	Bilguvar, K; Ozturk, AK; Louvi, A; Kwan, KY; Choi, M; Tatli, B; Yalnizoglu, D; Tuysuz, B; Caglayan, AO; Gokben, S; Kaymakcalan, H; Barak, T; Bakircioglu, M; Yasuno, K; Ho, W; Sanders, S; Zhu, Y; Yilmaz, S; Dincer, A; Johnson, MH; Bronen, RA; Kocer, N; Per, H; Mane, S; Pamir, MN; Yalcinkaya, C; Kumandas, S; Topcu, M; Ozmen, M; Sestan, N; Lifton, RP; State, MW; Gunel, M				Bilguvar, Kaya; Ozturk, Ali Kemal; Louvi, Angeliki; Kwan, Kenneth Y.; Choi, Murim; Tatli, Burak; Yalnizoglu, Dilek; Tuysuz, Beyhan; Caglayan, Ahmet Okay; Gokben, Sarenur; Kaymakcalan, Hande; Barak, Tanyeri; Bakircioglu, Mehmet; Yasuno, Katsuhito; Ho, Winson; Sanders, Stephan; Zhu, Ying; Yilmaz, Sanem; Dincer, Alp; Johnson, Michele H.; Bronen, Richard A.; Kocer, Naci; Per, Hueseyin; Mane, Shrikant; Pamir, Mehmet Necmettin; Yalcinkaya, Cengiz; Kumandas, Sefer; Topcu, Meral; Ozmen, Meral; Sestan, Nenad; Lifton, Richard P.; State, Matthew W.; Gunel, Murat			Whole-exome sequencing identifies recessive WDR62 mutations in severe brain malformations	NATURE			English	Article							HUMAN CEREBRAL-CORTEX; GENETIC MALFORMATIONS; CLASSIFICATION; SLITRK1; CAPTURE	The development of the human cerebral cortex is an orchestrated process involving the generation of neural progenitors in the periventricular germinal zones, cell proliferation characterized by symmetric and asymmetric mitoses, followed by migration of post-mitotic neurons to their final destinations in six highly ordered, functionally specialized layers(1,2). An understanding of the molecular mechanisms guiding these intricate processes is in its infancy, substantially driven by the discovery of rare mutations that cause malformations of cortical development(3-6). Mapping of disease loci in putative Mendelian forms of malformations of cortical development has been hindered by marked locus heterogeneity, small kindred sizes and diagnostic classifications that may not reflect molecular pathogenesis. Here we demonstrate the use of whole-exome sequencing to overcome these obstacles by identifying recessive mutations in WD repeat domain 62 (WDR62) as the cause of a wide spectrum of severe cerebral cortical malformations including microcephaly, pachygyria with cortical thickening as well as hypoplasia of the corpus callosum. Some patients with mutations in WDR62 had evidence of additional abnormalities including lissencephaly, schizencephaly, polymicrogyria and, in one instance, cerebellar hypoplasia, all traits traditionally regarded as distinct entities. In mice and humans, WDR62 transcripts and protein are enriched in neural progenitors within the ventricular and subventricular zones. Expression of WDR62 in the neocortex is transient, spanning the period of embryonic neurogenesis. Unlike other known microcephaly genes, WDR62 does not apparently associate with centrosomes and is predominantly nuclear in localization. These findings unify previously disparate aspects of cerebral cortical development and highlight the use of whole-exome sequencing to identify disease loci in settings in which traditional methods have proved challenging.	[Bilguvar, Kaya; Ozturk, Ali Kemal; Louvi, Angeliki; Choi, Murim; Barak, Tanyeri; Bakircioglu, Mehmet; Yasuno, Katsuhito; Ho, Winson; Sanders, Stephan; Mane, Shrikant; Lifton, Richard P.; State, Matthew W.; Gunel, Murat] Yale Univ, Sch Med, Dept Genet, Ctr Human Genet & Genom, New Haven, CT 06510 USA; [Bilguvar, Kaya; Ozturk, Ali Kemal; Louvi, Angeliki; Choi, Murim; Barak, Tanyeri; Bakircioglu, Mehmet; Yasuno, Katsuhito; Ho, Winson; Sanders, Stephan; Mane, Shrikant; Lifton, Richard P.; State, Matthew W.; Gunel, Murat] Yale Univ, Sch Med, Program Neurogenet, New Haven, CT 06510 USA; [Bilguvar, Kaya; Ozturk, Ali Kemal; Louvi, Angeliki; Barak, Tanyeri; Bakircioglu, Mehmet; Yasuno, Katsuhito; Ho, Winson; Johnson, Michele H.; Bronen, Richard A.; Gunel, Murat] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06510 USA; [Bilguvar, Kaya; Ozturk, Ali Kemal; Louvi, Angeliki; Kwan, Kenneth Y.; Barak, Tanyeri; Bakircioglu, Mehmet; Yasuno, Katsuhito; Ho, Winson; Zhu, Ying; Sestan, Nenad; Gunel, Murat] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Kwan, Kenneth Y.; Zhu, Ying; Sestan, Nenad] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Tatli, Burak; Ozmen, Meral] Istanbul Univ, Istanbul Fac Med, Dept Pediat, Div Neurol, TR-34093 Istanbul, Turkey; [Yalnizoglu, Dilek; Topcu, Meral] Hacettepe Univ, Sch Med, Dept Pediat, Div Neurol, TR-06100 Ankara, Turkey; [Tuysuz, Beyhan] Istanbul Univ, Cerrahpasa Fac Med, Dept Pediat, Div Genet, TR-34098 Istanbul, Turkey; [Caglayan, Ahmet Okay] Kayseri Educ & Res Hosp, Dept Med Genet, TR-38010 Kayseri, Turkey; [Gokben, Sarenur; Yilmaz, Sanem] Ege Univ, Fac Med, Dept Pediat, Div Neurol, TR-35100 Izmir, Turkey; [Kaymakcalan, Hande] Bahcesehir Univ, Fac Arts & Sci, TR-34353 Istanbul, Turkey; [Sanders, Stephan; State, Matthew W.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA; [Sanders, Stephan; State, Matthew W.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA; [Dincer, Alp] Acibadem Univ, Sch Med, Dept Radiol, TR-34742 Istanbul, Turkey; [Johnson, Michele H.; Bronen, Richard A.] Yale Univ, Sch Med, Dept Radiol, New Haven, CT 06510 USA; [Johnson, Michele H.] Yale Univ, Sch Med, Dept Otolaryngol, New Haven, CT 06510 USA; [Kocer, Naci] Istanbul Univ, Cerrahpasa Fac Med, Dept Radiol, TR-34098 Istanbul, Turkey; [Per, Hueseyin; Kumandas, Sefer] Erciyes Univ, Sch Med, Dept Pediat, Div Neurol, TR-38039 Kayseri, Turkey; [Mane, Shrikant] Yale Univ, Sch Med, Yale Ctr Genome Anal, New Haven, CT 06510 USA; [Pamir, Mehmet Necmettin] Acibadem Univ, Sch Med, Dept Neurosurg, TR-34742 Istanbul, Turkey; [Yalcinkaya, Cengiz] Istanbul Univ, Cerrahpasa Fac Med, Dept Neurol, Div Child Neurol, TR-34098 Istanbul, Turkey; [Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Istanbul University; Hacettepe University; Istanbul University; Istanbul University - Cerrahpasa; Kayseri Training & Research Hospital; Ege University; Bahcesehir University; Yale University; Yale University; Acibadem University; Yale University; Yale University; Istanbul University; Istanbul University - Cerrahpasa; Erciyes University; Yale University; Acibadem University; Istanbul University; Istanbul University - Cerrahpasa; Howard Hughes Medical Institute; Yale University	Lifton, RP (corresponding author), Yale Univ, Sch Med, Dept Genet, Ctr Human Genet & Genom, New Haven, CT 06510 USA.	richard.lifton@yale.edu; matthew.state@yale.edu; murat.gunel@yale.edu	Caglayan, Ahmet O/D-1066-2012; Kaymakcalan, Hande/AFP-2191-2022; State, Matthew/W-2256-2019; Yasuno, Katsuhito/E-1960-2012; Kwan, Kenneth Y/F-8489-2011; Zhu, Ying/T-2268-2019; Tüysüz, Beyhan/AAN-4858-2020; Kocer, Naci/AAH-7923-2021; Choi, Murim/AAP-9120-2021; Yalcinkaya, Cengiz/B-6288-2012; Sanders, Stephan/S-8645-2019; Kwan, Kenneth/AAI-2841-2021; Kaymakcalan, Hande/AAO-4208-2021; Dincer, Alp/D-3658-2015	Caglayan, Ahmet O/0000-0002-2332-322X; Yasuno, Katsuhito/0000-0002-3606-532X; Kwan, Kenneth Y/0000-0003-4711-071X; Kocer, Naci/0000-0003-0884-6492; Yalcinkaya, Cengiz/0000-0002-3443-8524; Kwan, Kenneth/0000-0003-4711-071X; Kaymakcalan, Hande/0000-0001-7736-7634; Dincer, Alp/0000-0001-9158-8353; Tuysuz, Beyhan/0000-0002-9620-5021; Sanders, Stephan/0000-0001-9112-5148; Zhu, Ying/0000-0002-6594-3734; Pamir, M Necmettin/0000-0002-5958-8625; Barak, Tanyeri/0000-0002-8522-1552; State, Matthew/0000-0003-1624-8302	Yale Program on Neurogenetics; Yale Center for Human Genetics and Genomics; National Institutes of Health [RC2 NS070477, UL1 RR024139NIH, UO1MH081896]; National Institutes of Health Neuroscience Microarray Consortium [U24 NS051869-02S1]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR002413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH081896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS070477, U24NS051869] Funding Source: NIH RePORTER	Yale Program on Neurogenetics; Yale Center for Human Genetics and Genomics; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Neuroscience Microarray Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are indebted to the patients and families who have contributed to this study. We thank J. Noonan for expert advice and C. Camputaro for her help with three-dimensional reconstruction of the magnetic resonance images. This study was supported by the Yale Program on Neurogenetics, the Yale Center for Human Genetics and Genomics, and National Institutes of Health grants RC2 NS070477 (to M.G.), UL1 RR024139NIH (Yale Clinical and Translational Science Award) and UO1MH081896 (to N.S.). SNP genotyping was supported in part by a National Institutes of Health Neuroscience Microarray Consortium award U24 NS051869-02S1 (to S.M.). R.P.L. is an investigator of the Howard Hughes Medical Institute.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Barkovich AJ, 2005, NEUROLOGY, V65, P1873, DOI 10.1212/01.wnl.0000183747.05269.2d; Barkovich AJ, 2001, NEUROLOGY, V57, P2168, DOI 10.1212/WNL.57.12.2168; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Guerrini R, 2005, EPILEPSIA, V46, P32, DOI 10.1111/j.0013-9580.2005.461010.x; Guerrini R, 2001, AM J MED GENET, V106, P160, DOI 10.1002/ajmg.1569; Guerrini R, 2008, TRENDS NEUROSCI, V31, P154, DOI 10.1016/j.tins.2007.12.004; Hartl D, 2008, PROTEOMICS, V8, P1257, DOI 10.1002/pmic.200700724; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017; Kwan KY, 2008, P NATL ACAD SCI USA, V105, P16021, DOI 10.1073/pnas.0806791105; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Roberts E, 1999, EUR J HUM GENET, V7, P815, DOI 10.1038/sj.ejhg.5200385; Stillman AA, 2009, J COMP NEUROL, V513, P21, DOI 10.1002/cne.21919; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; Wasserman T, 2010, MOL BIOL CELL, V21, P117, DOI 10.1091/mbc.E09-06-0512	25	354	378	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2010	467	7312					207	U93		10.1038/nature09327	http://dx.doi.org/10.1038/nature09327			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647KB	20729831	Green Submitted, Green Accepted, Green Published			2022-12-01	WOS:000281616300034
J	Vincent, JL; Singer, M				Vincent, Jean-Louis; Singer, Mervyn			Critical Care 3 Critical care: advances and future perspectives	LANCET			English	Article							ACTIVATED PROTEIN-C; INTENSIVE INSULIN THERAPY; SURVIVING SEPSIS CAMPAIGN; QUALITY-OF-LIFE; ILL PATIENTS; INTRAVENOUS IMMUNOGLOBULIN; HEMODYNAMIC OPTIMIZATION; ECONOMIC OUTCOMES; DIGESTIVE-TRACT; SEPTIC SHOCK	Intensive care offers a standard of monitoring, intervention, and organ support that cannot be readily delivered in a general ward. Its expansion in the past few decades, including the creation of emergency and outreach teams, emphasises that intensive care has an increasingly prominent role within the hospital. Although outcomes are clearly improving, intensive care remains a nascent specialty in which we are still learning how to harness a powerful ability to manipulate physiology, biochemistry, and immunology to achieve best outcomes for the patient. The results of many multicentre studies have not lent support to, or have even confounded, expectations, drawing attention to several issues related to patient heterogeneity, trial design, and elucidation of underlying pathophysiological processes. However, these results have generated constructive introspection and reappraisal of treatments and management strategies that have benefited the patient. In addition to the medical, financial, and logistical challenges in the future, exciting opportunities will arise as new developments in diagnostic tests, therapeutic interventions, and technology are used to exploit an increasing awareness of how critical illness should be managed.	[Vincent, Jean-Louis] Univ Libre Bruxelles, Erasme Hosp, Dept Intens Care, Brussels, Belgium; [Singer, Mervyn] UCL, Dept Med, Bloomsbury Inst Intens Care Med, London, England	Universite Libre de Bruxelles; University of London; University College London	Vincent, JL (corresponding author), Erasme Univ Hosp, Dept Intens Care, Route Lennik 808, B-1070 Brussels, Belgium.	jlvincen@ulb.ac.be	Singer, Mervyn/Q-6142-2019; Singer, Mervyn/J-4425-2012	Singer, Mervyn/0000-0002-1042-6350; Singer, Mervyn/0000-0002-1042-6350; Vincent, Jean-Louis/0000-0001-6011-6951	Eisai; Eli Lilly; Artisan; Astellas; UK Department of Health's National Institute for Health Research Comprehensive Biomedical Research Centre	Eisai(Eisai Co Ltd); Eli Lilly(Eli Lilly); Artisan; Astellas(Astellas Pharmaceuticals); UK Department of Health's National Institute for Health Research Comprehensive Biomedical Research Centre	J-LV has served as a paid consultant for Eli Lilly, Eisai, and GlaxoSmithKline; participated in clinical trials sponsored by Eisai, Eli Lilly, Artisan, and Astellas; and been an invited speaker at conferences supported by Eli Lilly, Esai, and GlaxoSmithKline. MS has served as a consultant to, and has been an invited speaker at conferences supported by, Eli Lilly and Deltas Medical. Additionally, Deltex Medical provides a yearly unrestricted donation to MS's research fund at University College London.; University College London Hospital/University College London receives support from the UK Department of Health's National Institute for Health Research Comprehensive Biomedical Research Centre funding scheme.	Abraham E, 2005, NEW ENGL J MED, V353, P1332, DOI 10.1056/NEJMoa050935; *AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801; Angus DC, 2004, CRIT CARE MED, V32, P2199, DOI 10.1097/01.CCM.0000145228.62451.F6; Angus DC, 2000, JAMA-J AM MED ASSOC, V284, P2762, DOI 10.1001/jama.284.21.2762; Armstrong L, 1999, AM J RESP CRIT CARE, V160, P1910, DOI 10.1164/ajrccm.160.6.9811084; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Breslow MJ, 2004, CRIT CARE MED, V32, P31, DOI 10.1097/01.CCM.0000104204.61296.41; Brienza N, 2009, CRIT CARE MED, V37, P2079, DOI 10.1097/CCM.0b013e3181a00a43; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Cheung AM, 2006, AM J RESP CRIT CARE, V174, P538, DOI 10.1164/rccm.200505-693OC; Cuthbertson BH, 2010, CRIT CARE, V14, DOI 10.1186/cc8848; de Backer D, 2006, CRIT CARE MED, V34, P1918, DOI 10.1097/01.CCM.0000220498.48773.3C; de Jonge E, 2003, LANCET, V362, P1011, DOI 10.1016/S0140-6736(03)14409-1; de Smet AMGA, 2009, NEW ENGL J MED, V360, P20, DOI 10.1056/NEJMoa0800394; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Dhainaut JF, 2004, J THROMB HAEMOST, V2, P1924, DOI 10.1111/j.1538-7836.2004.00955.x; Eichacker PQ, 2007, INTENS CARE MED, V33, P396, DOI 10.1007/s00134-007-0556-8; Eichacker PQ, 2006, NEW ENGL J MED, V355, P1640, DOI 10.1056/NEJMp068197; ESCARCE JJ, 1990, JAMA-J AM MED ASSOC, V264, P2389, DOI 10.1001/jama.264.18.2389; Esteban A, 2004, NEW ENGL J MED, V350, P2452, DOI 10.1056/NEJMoa032736; Ferrer R, 2008, JAMA-J AM MED ASSOC, V299, P2294, DOI 10.1001/jama.299.19.2294; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Flabouris Arthas, 2008, Crit Care Resusc, V10, P97; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Gomersall CD, 2000, CRIT CARE MED, V28, P607, DOI 10.1097/00003246-200003000-00001; Griffiths RD, 2007, CURR OPIN CRIT CARE, V13, P508, DOI 10.1097/MCC.0b013e3282efae05; Gupta A, 2009, J AM SOC NEPHROL, V20, P267, DOI 10.1681/ASN.2008030294; GUTIERREZ G, 1992, LANCET, V339, P195, DOI 10.1016/0140-6736(92)90002-K; HAYES MA, 1994, NEW ENGL J MED, V330, P1717, DOI 10.1056/NEJM199406163302404; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Herzig SJ, 2009, JAMA-J AM MED ASSOC, V301, P2120, DOI 10.1001/jama.2009.722; Hillman Ken, 2002, Curr Opin Crit Care, V8, P594, DOI 10.1097/00075198-200212000-00019; Jackson JC, 2009, CRIT CARE CLIN, V25, P615, DOI 10.1016/j.ccc.2009.04.005; Joyce DE, 2004, CRIT CARE MED, V32, pS280, DOI 10.1097/01.CCM.0000128037.72072.22; Joyce DE, 2001, J BIOL CHEM, V276, P11199, DOI 10.1074/jbc.C100017200; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Kreyrnann KG, 2007, CRIT CARE MED, V35, P2677, DOI 10.1097/01.CCM.0000295263.12774.97; Laupland KB, 2007, CRIT CARE MED, V35, P2686, DOI 10.1097/01.CCM.0000295312.13466.1C; Lopez A, 2004, CRIT CARE MED, V32, P21, DOI 10.1097/01.CCM.0000105581.01815.C6; Mackenzie AF, 2005, INTENS CARE MED, V31, P1624, DOI 10.1007/s00134-005-2829-4; MacLaren R, 2008, CRIT CARE MED, V36, P3184, DOI 10.1097/CCM.0b013e31818f2269; Marshall JC, 2008, J LEUKOCYTE BIOL, V83, P471, DOI 10.1189/jlb.0607380; Marshall JC, 2009, CRIT CARE MED, V37, P2290, DOI 10.1097/CCM.0b013e3181a02afc; Martin G, 2009, CRIT CARE, V13, DOI 10.1186/cc7936; Matzo M, 2009, BIOSECUR BIOTERROR, V7, P199, DOI 10.1089/bsp.2009.0017; Moran JL, 2008, CRIT CARE MED, V36, P46, DOI 10.1097/01.CCM.0000295313.08084.58; Nadel S, 2007, LANCET, V369, P836, DOI 10.1016/S0140-6736(07)60411-5; Nobre V, 2008, AM J RESP CRIT CARE, V177, P498, DOI 10.1164/rccm.200708-1238OC; Ospina-Tascon GA, 2008, CRIT CARE MED, V36, P1311, DOI 10.1097/CCM.0b013e318168ea3e; Papadimos Thomas J, 2008, Patient Saf Surg, V2, P3, DOI 10.1186/1754-9493-2-3; Poeze M, 2005, CRIT CARE, V9, pR771, DOI 10.1186/cc3902; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Pontes-Arruda A, 2008, JPEN-PARENTER ENTER, V32, P596, DOI 10.1177/0148607108324203; Pronovost P, 2006, CRIT CARE MED, V34, P1988, DOI 10.1097/01.CCM.0000226412.12612.B6; Pronovost PJ, 1999, JAMA-J AM MED ASSOC, V281, P1310, DOI 10.1001/jama.281.14.1310; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; Protti A, 2006, CRIT CARE, V10, DOI 10.1186/cc5014; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rubinson L, 2008, CHEST, V133, p18S, DOI 10.1378/chest.07-2690; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Shulman R, 2005, CRIT CARE, V9, pR516, DOI 10.1186/cc3793; Singer M, 2004, LANCET, V364, P545, DOI 10.1016/S0140-6736(04)16815-3; Singer M, 2007, LANCET, V370, P636, DOI 10.1016/S0140-6736(07)61317-8; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Takala J, 1999, NEW ENGL J MED, V341, P785, DOI 10.1056/NEJM199909093411102; Tan T, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b822; Turgeon AF, 2007, ANN INTERN MED, V146, P193, DOI 10.7326/0003-4819-146-3-200702060-00009; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; *VET AFF TOT PAR N, 1991, NEW ENGL J MED, V325, P525, DOI DOI 10.1056/NEJM199108223250801; Vincent JL, 2006, PLOS MED, V3, P1488, DOI 10.1371/journal.pmed.0030346; Vincent JL, 2010, CRIT CARE MED, V38, P283, DOI 10.1097/CCM.0b013e3181b785a2; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Vincent JL, 2005, CRIT CARE MED, V33, P2266, DOI 10.1097/01.CCM.0000181729.46010.83; Vincent JL, 2005, CRIT CARE MED, V33, P1225, DOI 10.1097/01.CCM.0000165962.16682.46; Wagner F, 2009, CRIT CARE, V13, DOI 10.1186/cc7700; Zambon M, 2008, CHEST, V133, P1120, DOI 10.1378/chest.07-2134	79	50	54	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 16	2010	376	9749					1354	1361		10.1016/S0140-6736(10)60575-2	http://dx.doi.org/10.1016/S0140-6736(10)60575-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671RX	20934211				2022-12-01	WOS:000283528600039
J	Buhr, ED; Yoo, SH; Takahashi, JS				Buhr, Ethan D.; Yoo, Seung-Hee; Takahashi, Joseph S.			Temperature as a Universal Resetting Cue for Mammalian Circadian Oscillators	SCIENCE			English	Article							HEAT-SHOCK FACTOR-1; SUPRACHIASMATIC NUCLEUS; GENE-EXPRESSION; INDIVIDUAL FIBROBLASTS; REVEALS PERSISTENT; PERIPHERAL-TISSUES; BODY-TEMPERATURE; DNA-BINDING; CLOCK GENE; ENTRAINMENT	Environmental temperature cycles are a universal entraining cue for all circadian systems at the organismal level with the exception of homeothermic vertebrates. We report here that resistance to temperature entrainment is a property of the suprachiasmatic nucleus (SCN) network and is not a cell-autonomous property of mammalian clocks. This differential sensitivity to temperature allows the SCN to drive circadian rhythms in body temperature, which can then act as a universal cue for the entrainment of cell-autonomous oscillators throughout the body. Pharmacological experiments show that network interactions in the SCN are required for temperature resistance and that the heat shock pathway is integral to temperature resetting and temperature compensation in mammalian cells. These results suggest that the evolutionarily ancient temperature resetting response can be used in homeothermic animals to enhance internal circadian synchronization.	[Buhr, Ethan D.; Yoo, Seung-Hee; Takahashi, Joseph S.] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Buhr, Ethan D.; Yoo, Seung-Hee; Takahashi, Joseph S.] Northwestern Univ, Ctr Funct Genom, Evanston, IL 60208 USA; [Yoo, Seung-Hee; Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	Northwestern University; Northwestern University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Takahashi, JS (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	joseph.takahashi@utsouthwestern.edu	Takahashi, Joseph S/E-8482-2012	Takahashi, Joseph S/0000-0003-0384-8878; Buhr, Ethan/0000-0002-9250-6644	NIH [P50 MH074924, T32 AG 20418]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020418] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Takahashi laboratory for helpful discussions; S. Panda and J. B. Hogenesch for providing the U-2 OS cells; S. A. Kay for providing PG 99-465; and R. I. Morimoto for providing HSP70 antibody. We especially thank V. Kumar and K. Shimomura for suggestions and discussion on the manuscript. This work was supported by NIH P50 MH074924 to J. S. T. and T32 AG 20418 to E. D. B. J. S. T. is an Investigator and S.H.Y. was an Associate in the Howard Hughes Medical Institute. J. S. T. has a paid consulting relationship with, and owns stock in, ReSet Therapeutics, Inc., a biotechnology company that works on circadian rhythms and metabolism.	Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Ahn SG, 2003, GENE DEV, V17, P516, DOI 10.1101/gad.1044503; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; CHOI HS, 1991, J BIOL CHEM, V266, P11858; CROSTHWAITE SK, 1995, CELL, V81, P1003, DOI 10.1016/S0092-8674(05)80005-4; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; de la Iglesia HO, 2004, CURR BIOL, V14, P796, DOI 10.1016/j.cub.2004.04.034; Diernfellner ACR, 2005, GENE DEV, V19, P1968, DOI 10.1101/gad.345905; Glaser FT, 2005, CURR BIOL, V15, P1352, DOI 10.1016/j.cub.2005.06.056; Grad W, 2007, MOL CELL ENDOCRINOL, V275, P2, DOI 10.1016/j.mce.2007.05.018; Herzog ED, 2003, J NEUROPHYSIOL, V90, P763, DOI 10.1152/jn.00129.2003; HOFFMANN K, 1969, OECOLOGIA, V3, P184, DOI 10.1007/BF00416981; HONMA S, 1988, PHYSIOL BEHAV, V44, P247, DOI 10.1016/0031-9384(88)90146-1; Honma S, 2008, J BIOL RHYTHM, V23, P91, DOI 10.1177/0748730407311124; Kabrita CS, 2008, BRAIN RES, V1195, P20, DOI 10.1016/j.brainres.2007.12.020; Kaushik R, 2007, PLOS BIOL, V5, P1257, DOI 10.1371/journal.pbio.0050146; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Lahiri K, 2005, PLOS BIOL, V3, P2005, DOI 10.1371/journal.pbio.0030351; Liu Y, 1998, SCIENCE, V281, P825, DOI 10.1126/science.281.5378.825; Liu Y, 1997, CELL, V89, P477, DOI 10.1016/S0092-8674(00)80228-7; Low KH, 2008, NEURON, V60, P1054, DOI 10.1016/j.neuron.2008.10.048; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Majercak J, 1999, NEURON, V24, P219, DOI 10.1016/S0896-6273(00)80834-X; MOSSER DD, 1990, P NATL ACAD SCI USA, V87, P3748, DOI 10.1073/pnas.87.10.3748; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Pennartz CMA, 2002, NATURE, V416, P286, DOI 10.1038/nature728; PITTENDRIGH CS, 1960, COLD SPRING HARB SYM, V25, P159, DOI 10.1101/SQB.1960.025.01.015; Prolo LM, 2005, J NEUROSCI, V25, P404, DOI 10.1523/JNEUROSCI.4133-04.2005; Reinke H, 2008, GENE DEV, V22, P331, DOI 10.1101/gad.453808; Rensing L, 2002, CHRONOBIOL INT, V19, P807, DOI 10.1081/CBI-120014569; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Sehadova H, 2009, NEURON, V64, P251, DOI 10.1016/j.neuron.2009.08.026; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Stratmann M, 2006, J BIOL RHYTHM, V21, P494, DOI 10.1177/0748730406293889; Tataroglu O, 2006, J BIOL RHYTHM, V21, P185, DOI 10.1177/0748730406287529; Wadekar SA, 2004, MOL ENDOCRINOL, V18, P500, DOI 10.1210/me.2003-0215; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yokota S, 2000, CANCER RES, V60, P2942; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshida T, 2009, P NATL ACAD SCI USA, V106, P1648, DOI 10.1073/pnas.0806741106	48	543	554	14	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	2010	330	6002					379	385		10.1126/science.1195262	http://dx.doi.org/10.1126/science.1195262			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947768	Green Accepted			2022-12-01	WOS:000282986700044
J	Luo, SJ; Kleemann, GA; Ashraf, JM; Shaw, WM; Murphy, CT				Luo, Shijing; Kleemann, Gunnar A.; Ashraf, Jasmine M.; Shaw, Wendy M.; Murphy, Coleen T.			TGF-beta and Insulin Signaling Regulate Reproductive Aging via Oocyte and Germline Quality Maintenance	CELL			English	Article							AGE-RELATED-CHANGES; CAENORHABDITIS-ELEGANS; LIFE-SPAN; GENE-EXPRESSION; STEM-CELLS; SPERM; NONDISJUNCTION; ABNORMALITIES; TEMPERATURE; DROSOPHILA	Reproductive cessation is perhaps the earliest aging phenotype that humans experience. Similarly, reproduction of Caenorhabditis elegans ceases in midadulthood. Although somatic aging has been studied in both worms and humans, mechanisms regulating reproductive aging are not yet understood. Here, we show that TGF-beta Sma/Mab and Insulin/IGF-1 signaling regulate C. elegans reproductive aging by modulating multiple aspects of the reproductive process, including embryo integrity, oocyte fertilizability, chromosome segregation fidelity, DNA damage resistance, and oocyte and germline morphology. TGF-beta activity regulates reproductive span and germline/oocyte quality noncell-autonomously and is temporally and transcriptionally separable from its regulation of growth. Chromosome segregation, cell cycle, and DNA damage response genes are upregulated in TGF-beta mutant oocytes, decline in aged mammalian oocytes, and are critical for oocyte quality maintenance. Our data suggest that C. elegans and humans share many aspects of reproductive aging, including the correlation between reproductive aging and declining oocyte quality and mechanisms determining oocyte quality.	[Luo, Shijing; Kleemann, Gunnar A.; Ashraf, Jasmine M.; Shaw, Wendy M.; Murphy, Coleen T.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Luo, Shijing; Kleemann, Gunnar A.; Ashraf, Jasmine M.; Shaw, Wendy M.; Murphy, Coleen T.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University	Murphy, CT (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	ctmurphy@princeton.edu		Murphy, Coleen/0000-0002-8257-984X	NIH [1DP2OD004402-01, P50 GM071508]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004402] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Cathy Savage-Dunn (CUNY) for CS122 and pCS227; David Sherwood (Duke University) for NK640; Barth Grant (Rutgers) for RT130 and alpha-RME-2 antibody; members of the Murphy Laboratory and Z. Gitai for comments on the manuscript; and March of Dimes Basil O'Connor Starting Scholar, NIH New Innovator (1DP2OD004402-01), and NIH (P50 GM071508) awards for funding.	Andux S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000295; Angelo G, 2009, SCIENCE, V326, P954, DOI 10.1126/science.1178343; Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; Blondin P, 1997, J ANDROL, V18, P454; Cant MA, 2008, P NATL ACAD SCI USA, V105, P5332, DOI 10.1073/pnas.0711911105; Carlson ME, 2009, AGING CELL, V8, P676, DOI 10.1111/j.1474-9726.2009.00517.x; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Flatt T, 2008, P NATL ACAD SCI USA, V105, P6368, DOI 10.1073/pnas.0709128105; Garigan D, 2002, GENETICS, V161, P1101; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Ghazi A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000639; Goud P, 1999, FERTIL STERIL, V72, P245, DOI 10.1016/S0015-0282(99)00231-9; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Greenstein David, 2005, WormBook, P1, DOI 10.1895/wormbook.1.53.1; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hagedorn EJ, 2009, DEV CELL, V17, P187, DOI 10.1016/j.devcel.2009.06.006; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; HARTGE P, 1979, GENETICS, V91, P67; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes SE, 2007, PLOS GENET, V3, P254, DOI 10.1371/journal.pgen.0030025; Jud M, 2007, DEV GENES EVOL, V217, P221, DOI 10.1007/s00427-006-0130-3; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Liang J, 2003, DEVELOPMENT, V130, P6453, DOI 10.1242/dev.00863; Liang J, 2007, DEV BIOL, V305, P714, DOI 10.1016/j.ydbio.2007.02.038; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Luo SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000789; Magli MC, 2007, FERTIL STERIL, V87, P534, DOI 10.1016/j.fertnstert.2006.07.1512; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Mehlmann LM, 2005, REPRODUCTION, V130, P791, DOI 10.1530/rep.1.00793; Miller Michael A., 2006, V351, P193; Murphy CT, 2007, P NATL ACAD SCI USA, V104, P19046, DOI 10.1073/pnas.0709613104; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nimmo RA, 2009, CHROMOSOMA, V118, P405, DOI 10.1007/s00412-009-0210-z; Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382; ROSE AM, 1979, GENETICS, V92, P409; Rubio C, 2003, HUM REPROD, V18, P182, DOI 10.1093/humrep/deg015; Saito TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000735; Savage-Dunn C, 2000, DEV BIOL, V223, P70, DOI 10.1006/dbio.2000.9713; Savage-Dunn Cathy, 2005, WormBook, P1; Shaw WM, 2007, CURR BIOL, V17, P1635, DOI 10.1016/j.cub.2007.08.058; Steuerwald NM, 2007, REPROD BIOMED ONLINE, V14, P700, DOI 10.1016/S1472-6483(10)60671-2; Stolk L, 2009, NAT GENET, V41, P645, DOI 10.1038/ng.387; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Tang L, 2010, MOL BIOL CELL, V21, P885, DOI 10.1091/mbc.E09-09-0811; TOKUNAGA C, 1970, GENETICS, V65, P75; Trombly DJ, 2009, SEMIN REPROD MED, V27, P14, DOI 10.1055/s-0028-1108006; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Velde ERT, 2002, HUM REPROD UPDATE, V8, P141, DOI 10.1093/humupd/8.2.141; Wang JJ, 2002, DEVELOPMENT, V129, P4989; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Yamashita YM, 2005, J CELL SCI, V118, P665, DOI 10.1242/jcs.01680; Zhao R, 2008, AGING CELL, V7, P344, DOI 10.1111/j.1474-9726.2008.00379.x	57	154	160	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					299	312		10.1016/j.cell.2010.09.013	http://dx.doi.org/10.1016/j.cell.2010.09.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946987	Green Accepted, Bronze			2022-12-01	WOS:000283052200018
J	Murakami, K; Yasunaga, T; Noguchi, TQP; Gomibuchi, Y; Ngo, KX; Uyeda, TQP; Wakabayashi, T				Murakami, Kenji; Yasunaga, Takuo; Noguchi, Taro Q. P.; Gomibuchi, Yuki; Ngo, Kien X.; Uyeda, Taro Q. P.; Wakabayashi, Takeyuki			Structural Basis for Actin Assembly, Activation of ATP Hydrolysis, and Delayed Phosphate Release	CELL			English	Article							ATOMIC MODEL; F-ACTIN; ELECTRON-MICROGRAPHS; INORGANIC-PHOSPHATE; CRYSTAL-STRUCTURE; POLYMERIZATION; FILAMENT; ADP; VISUALIZATION; TROPOMYOSIN	Assembled actin filaments support cellular signaling, intracellular trafficking, and cytokinesis. ATP hydrolysis triggered by actin assembly provides the structural cues for filament turnover in vivo. Here, we present the cryo-electron microscopic (cryo-EM) structure of filamentous actin (F-actin) in the presence of phosphate, with the visualization of some alpha-helical backbones and large side chains. A complete atomic model based on the EM map identified intermolecular interactions mediated by bound magnesium and phosphate ions. Comparison of the F-actin model with G-actin monomer crystal structures reveals a critical role for bending of the conserved proline-rich loop in triggering phosphate release following ATP hydrolysis. Crystal structures of G-actin show that mutations in this loop trap the catalytic site in two intermediate states of the ATPase cycle. The combined structural information allows us to propose a detailed molecular mechanism for the biochemical events, including actin polymerization and ATPase activation, critical for actin filament dynamics.	[Murakami, Kenji; Gomibuchi, Yuki; Wakabayashi, Takeyuki] Teikyo Univ, Sch Sci & Engn, Dept Biosci, Utsunomiya, Tochigi 3208551, Japan; [Wakabayashi, Takeyuki] Teikyo Univ, Fac Med Technol, Dept Judo Therapy, Utsunomiya, Tochigi 3208551, Japan; [Yasunaga, Takuo] Kyushu Inst Technol, Fac Comp Sci & Syst Engn, Dept Biosci & Bioinformat, Fukuoka 820850, Japan; [Noguchi, Taro Q. P.; Ngo, Kien X.; Uyeda, Taro Q. P.] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki 3058562, Japan; [Wakabayashi, Takeyuki] Univ Tokyo, Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	Teikyo University; Teikyo University; Kyushu Institute of Technology; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Wakabayashi, T (corresponding author), Teikyo Univ, Sch Sci & Engn, Dept Biosci, Toyosatodai 1-1, Utsunomiya, Tochigi 3208551, Japan.	wakabayashi@nasu.bio.teikyo-u.ac.jp	NGO, Kien Xuan/GLU-7155-2022; Yasunaga, Takuo/C-8316-2009	Yasunaga, Takuo/0000-0002-2494-9603; NGO, Kien Xuan/0000-0002-9710-5452	Ministry of Education, Science, Technology, and Sports of Japan; SENTAN,	Ministry of Education, Science, Technology, and Sports of Japan; SENTAN,(Japan Science & Technology Agency (JST))	We thank Dr. Murray Stewart (MRC Lab. Mol. Biol., Cambridge) for discussions and advice on crystallography; Dr. Ralph Davis and Dr. Karl-Magnus Larsson (Stanford University) for critical reading of the manuscript; Dr. Akihiro Narita for his contribution to this work at the early stages; Dr. Soichi Wakatsuki and colleagues at Photon Factory, KEK for data collection at the synchrotron site; Dr. Koji Yonekura for the program to calculate a figure of merit; Dr. Hideo Higuchi for fluorometry; and Yuji Tuji, Akito Tominaga, Ryuta Mikawa, and Harumi Kiuchi for assistance with crystallography and/or biochemical experiments. This work was supported by grants from Human Frontier Science Program and Grant-in-Aid for Scientific Research on Priority Areas (Bio-supramolecule) from the Ministry of Education, Science, Technology, and Sports of Japan to T.W. and a grant from SENTAN, JST to T.Q.P.U.	Baek K, 2008, P NATL ACAD SCI USA, V105, P11748, DOI 10.1073/pnas.0805852105; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belmont LD, 1999, P NATL ACAD SCI USA, V96, P29, DOI 10.1073/pnas.96.1.29; Blanchoin L, 2002, BIOCHEMISTRY-US, V41, P597, DOI 10.1021/bi011214b; CARLIER MF, 1986, J BIOL CHEM, V261, P778; CARLIER MF, 1986, BIOCHEMISTRY-US, V25, P7789, DOI 10.1021/bi00372a001; DANCKER P, 1990, BIOCHIM BIOPHYS ACTA, V1035, P197, DOI 10.1016/0304-4165(90)90116-E; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fujiwara I, 2007, P NATL ACAD SCI USA, V104, P8827, DOI 10.1073/pnas.0702510104; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.3.CO;2-I; Heintz D, 1996, BIOCHEMISTRY-US, V35, P12686, DOI 10.1021/bi961159k; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KHAITLINA SY, 1993, EUR J BIOCHEM, V218, P911, DOI 10.1111/j.1432-1033.1993.tb18447.x; Klenchin VA, 2003, NAT STRUCT BIOL, V10, P1058, DOI 10.1038/nsb1006; Klenchin VA, 2006, J MOL BIOL, V362, P140, DOI 10.1016/j.jmb.2006.07.001; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LAKI K, 1962, ARCH BIOCHEM BIOPHYS, V98, P323, DOI 10.1016/0003-9861(62)90190-X; Liu X, 2006, P NATL ACAD SCI USA, V103, P13694, DOI 10.1073/pnas.0606321103; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; Matsuura Y, 2000, J MOL BIOL, V296, P579, DOI 10.1006/jmbi.1999.3467; Narita A, 2007, J MOL BIOL, V365, P480, DOI 10.1016/j.jmb.2006.06.056; Noda K, 2006, J PLASMA PHYS, V72, P1037, DOI 10.1017/S0022377806005174; Noguchi TQP, 2007, J BIOL CHEM, V282, P27721, DOI 10.1074/jbc.M703165200; Nolen BJ, 2007, MOL CELL, V26, P449, DOI 10.1016/j.molcel.2007.04.017; NONOMURA Y, 1975, J BIOCHEM, V78, P1101, DOI 10.1093/oxfordjournals.jbchem.a130988; Nyman T, 2002, J MOL BIOL, V317, P577, DOI 10.1006/jmbi.2002.5436; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RICKARD JE, 1986, J MOL BIOL, V191, P273, DOI 10.1016/0022-2836(86)90264-0; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Rould MA, 2006, J BIOL CHEM, V281, P31909, DOI 10.1074/jbc.M601973200; Saeki K, 1996, BIOCHEMISTRY-US, V35, P14465, DOI 10.1021/bi961292c; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100; Wriggers W, 1999, PROTEINS, V35, P262, DOI 10.1002/(SICI)1097-0134(19990501)35:2<262::AID-PROT11>3.0.CO;2-N; Yasunaga T, 1996, J STRUCT BIOL, V116, P155, DOI 10.1006/jsbi.1996.0025; Yasunaga T, 2008, J ELECTRON MICROSC, V57, P101, DOI 10.1093/jmicro/dfn006; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830	43	108	109	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					275	287		10.1016/j.cell.2010.09.034	http://dx.doi.org/10.1016/j.cell.2010.09.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946985	Bronze			2022-12-01	WOS:000283052200016
J	Burre, J; Sharma, M; Tsetsenis, T; Buchman, V; Etherton, MR; Sudhof, TC				Burre, Jacqueline; Sharma, Manu; Tsetsenis, Theodoros; Buchman, Vladimir; Etherton, Mark R.; Suedhof, Thomas C.			alpha-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro	SCIENCE			English	Article							MEMBRANE-FUSION; GAMMA-SYNUCLEIN; CSP-ALPHA; NEURODEGENERATION; DEGENERATION; MICE	Presynaptic nerve terminals release neurotransmitters repeatedly, often at high frequency, and in relative isolation from neuronal cell bodies. Repeated release requires cycles of soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE)-complex assembly and disassembly, with continuous generation of reactive SNARE-protein intermediates. Although many forms of neurodegeneration initiate presynaptically, only few pathogenic mechanisms are known, and the functions of presynaptic proteins linked to neurodegeneration, such as a-synuclein, remain unclear. Here, we show that maintenance of continuous presynaptic SNARE-complex assembly required a nonclassical chaperone activity mediated by synucleins. Specifically, a-synuclein directly bound to the SNARE-protein synaptobrevin-2/vesicle-associated membrane protein 2 (VAMP2) and promoted SNARE-complex assembly. Moreover, triple-knockout mice lacking synucleins developed age-dependent neurological impairments, exhibited decreased SNARE-complex assembly, and died prematurely. Thus, synucleins may function to sustain normal SNARE-complex assembly in a presynaptic terminal during aging.	[Burre, Jacqueline; Sharma, Manu; Tsetsenis, Theodoros; Etherton, Mark R.; Suedhof, Thomas C.] Stanford Univ, Dept Mol & Cellular Physiol, Palo Alto, CA 94304 USA; [Burre, Jacqueline; Sharma, Manu; Tsetsenis, Theodoros; Etherton, Mark R.; Suedhof, Thomas C.] Stanford Univ, Howard Hughes Med Inst, Palo Alto, CA 94304 USA; [Buchman, Vladimir] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales	Stanford University; Howard Hughes Medical Institute; Stanford University; Cardiff University	Sudhof, TC (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, 1050 Arastradero Rd, Palo Alto, CA 94304 USA.	tcs1@stanford.edu	Buchman, Vladimir L/A-4814-2010	Buchman, Vladimir L/0000-0002-7631-8352; Tsetsenis, Theodoros/0000-0002-4642-6539	Human Frontiers Program [LT00527/2006-L, LT000135/2009-L]; Deutsche Akademie der Naturforscher Leopoldina [BMBF-LPD 9901/8-161]	Human Frontiers Program; Deutsche Akademie der Naturforscher Leopoldina	We thank S. Chandra for advice. This work was supported by postdoctoral fellowships from the Human Frontiers Program (LT00527/2006-L to M. S. and LT000135/2009-L to T. T.) and the Deutsche Akademie der Naturforscher Leopoldina (BMBF-LPD 9901/8-161 to J.B.).	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Ahmad M, 2007, FASEB J, V21, P3419, DOI 10.1096/fj.07-8379rev; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Garcia-Junco-Clemente P, 2010, J NEUROSCI, V30, P7377, DOI 10.1523/JNEUROSCI.0924-10.2010; Gray BC, 2009, NEUROBIOL DIS, V35, P63, DOI 10.1016/j.nbd.2009.04.001; Gupta A, 2008, ANN NEUROL, V64, pS3, DOI 10.1002/ana.21573; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Kahle PJ, 2001, AM J PATHOL, V159, P2215, DOI 10.1016/S0002-9440(10)63072-6; Kramer ML, 2007, J NEUROSCI, V27, P1405, DOI 10.1523/JNEUROSCI.4564-06.2007; Liu CW, 2005, J BIOL CHEM, V280, P22670, DOI 10.1074/jbc.M501508200; Liu SM, 2004, EMBO J, V23, P4506, DOI 10.1038/sj.emboj.7600451; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Ninkina N, 2003, MOL CELL BIOL, V23, P8233, DOI 10.1128/MCB.23.22.8233-8245.2003; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Takeda A, 1998, AM J PATHOL, V152, P367; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451	25	1113	1134	3	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2010	329	5999					1663	1667		10.1126/science.1195227	http://dx.doi.org/10.1126/science.1195227			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20798282	Green Accepted			2022-12-01	WOS:000282098100047
J	Winter, SE; Thiennimitr, P; Winter, MG; Butler, BP; Huseby, DL; Crawford, RW; Russell, JM; Bevins, CL; Adams, LG; Tsolis, RM; Roth, JR; Baumler, AJ				Winter, Sebastian E.; Thiennimitr, Parameth; Winter, Maria G.; Butler, Brian P.; Huseby, Douglas L.; Crawford, Robert W.; Russell, Joseph M.; Bevins, Charles L.; Adams, L. Garry; Tsolis, Renee M.; Roth, John R.; Baeumler, Andreas J.			Gut inflammation provides a respiratory electron acceptor for Salmonella	NATURE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; INTESTINAL MICROBIOTA; SEROTYPE TYPHIMURIUM; VIRULENCE FACTORS; HYDROGEN-SULFIDE; HOST; METHANETHIOL; DISRUPTS; DISEASE; MUCOSA	Salmonella enterica serotype Typhimurium (S. Typhimurium) causes acute gut inflammation by using its virulence factors to invade the intestinal epithelium and survive in mucosal macrophages. The inflammatory response enhances the transmission success of S. Typhimurium by promoting its outgrowth in the gut lumen through unknown mechanisms. Here we show that reactive oxygen species generated during inflammation react with endogenous, luminal sulphur compounds (thiosulphate) to form a new respiratory electron acceptor, tetrathionate. The genes conferring the ability to use tetrathionate as an electron acceptor produce a growth advantage for S. Typhimurium over the competing microbiota in the lumen of the inflamed gut. We conclude that S. Typhimurium virulence factors induce host-driven production of a new electron acceptor that allows the pathogen to use respiration to compete with fermenting gut microbes. Thus the ability to trigger intestinal inflammation is crucial for the biology of this diarrhoeal pathogen.	[Winter, Sebastian E.; Thiennimitr, Parameth; Winter, Maria G.; Butler, Brian P.; Crawford, Robert W.; Russell, Joseph M.; Bevins, Charles L.; Tsolis, Renee M.; Baeumler, Andreas J.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Thiennimitr, Parameth] Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai 50000, Thailand; [Huseby, Douglas L.; Roth, John R.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Adams, L. Garry] Texas A&M Univ, Dept Vet Pathobiol, Coll Vet Med, College Stn, TX 77843 USA	University of California System; University of California Davis; Chiang Mai University; University of California System; University of California Davis; Texas A&M University System; Texas A&M University College Station	Baumler, AJ (corresponding author), Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA.	ajbaumler@ucdavis.edu	Thiennimitr, Parameth/AAH-1761-2019; Baumler, Andreas J/H-2301-2011; Butler, Brian/AAF-4821-2019; Bevins, Charles L/P-4438-2015; Winter, Sebastian E/A-4118-2009	Baumler, Andreas J/0000-0001-9152-7809; Butler, Brian/0000-0002-8554-2997; Bevins, Charles L/0000-0003-2725-2622; Winter, Sebastian E/0000-0003-1532-9178; Thiennimitr, Parameth/0000-0002-6339-8744; Huseby, Douglas/0000-0001-9974-578X; Tsolis, Renee/0000-0001-9131-6657	Public Health Service [AI040124, AI044170, AI073120, AI076246, AI088122]; Department of Microbiology, Chiang Mai University, Thailand; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI040124, R21AI088122, R21AI073120, R01AI040124, R01AI076246, R01AI044170, R37AI032738] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Department of Microbiology, Chiang Mai University, Thailand; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank H. Chu for providing real-time PCR primers, V. Tolstikov for performing the liquid chromatography-mass spectrometry analysis, M. Xavier for assistance with histopathology and V. Gerriets for technical assistance. Work in A.J.B.'s laboratory is supported by Public Health Service grants AI040124, AI044170, AI073120, AI076246 and AI088122. P. T. was supported by a stipend from the Department of Microbiology, Chiang Mai University, Thailand.	Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Furne J, 2001, BIOCHEM PHARMACOL, V62, P255, DOI 10.1016/S0006-2952(01)00657-8; HARRIS JC, 1972, ANN INTERN MED, V76, P697, DOI 10.7326/0003-4819-76-5-697; Hensel M, 1999, MOL MICROBIOL, V32, P275, DOI 10.1046/j.1365-2958.1999.01345.x; Hensel M, 1999, MOL MICROBIOL, V31, P489, DOI 10.1046/j.1365-2958.1999.01190.x; Hinsley AP, 2002, MICROBIOL-SGM, V148, P3631, DOI 10.1099/00221287-148-11-3631; Lawley TD, 2008, INFECT IMMUN, V76, P403, DOI 10.1128/IAI.01189-07; Levitt MD, 1999, J CLIN INVEST, V104, P1107, DOI 10.1172/JCI7712; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Muller L, 1923, CR SOC BIOL, V89, P434; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Reinders CI, 2007, SCAND J GASTROENTERO, V42, P1151, DOI 10.1080/00365520701320505; Santos RL, 2009, TRENDS MICROBIOL, V17, P498, DOI 10.1016/j.tim.2009.08.008; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Thomson NR, 2006, PLOS GENET, V2, P2039, DOI 10.1371/journal.pgen.0020206; Tsolis RM, 1999, INFECT IMMUN, V67, P4879, DOI 10.1128/IAI.67.9.4879-4885.1999; Zhang SP, 2002, INFECT IMMUN, V70, P3843, DOI 10.1128/IAI.70.7.3843-3855.2002	19	790	805	8	142	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2010	467	7314					426	429		10.1038/nature09415	http://dx.doi.org/10.1038/nature09415			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KO	20864996	Green Submitted, Green Accepted			2022-12-01	WOS:000282090200035
J	Waage, J; Banerji, R; Campbell, O; Chirwa, E; Collender, G; Dieltiens, V; Dorward, A; Godfrey-Faussett, P; Hanvoravongchai, P; Kingdon, G; Little, A; Mills, A; Mulholland, K; Mwinga, A; North, A; Patcharanarumol, W; Poulton, C; Tangcharoensathien, V; Unterhalter, E				Waage, Jeff; Banerji, Rukmini; Campbell, Oona; Chirwa, Ephraim; Collender, Guy; Dieltiens, Veerle; Dorward, Andrew; Godfrey-Faussett, Peter; Hanvoravongchai, Piya; Kingdon, Geeta; Little, Angela; Mills, Anne; Mulholland, Kim; Mwinga, Alwyn; North, Amy; Patcharanarumol, Walaiporn; Poulton, Colin; Tangcharoensathien, Viroj; Unterhalter, Elaine			The Millennium Development Goals: a cross-sectoral analysis and principles for goal setting after 2015	LANCET			English	Review							HEALTH-CARE; CHILD-MORTALITY; POVERTY; GENDER; EQUITY; INEQUALITIES; PROGRESS; AFRICA; POLICY		[Waage, Jeff; Collender, Guy] London Int Dev Ctr, London WC1H 0PD, England; [Banerji, Rukmini] Pratham ASER Ctr, New Delhi, India; [Campbell, Oona; Godfrey-Faussett, Peter; Hanvoravongchai, Piya; Mills, Anne; Mulholland, Kim] London Sch Hyg & Trop Med, London WC1, England; [Hanvoravongchai, Piya] London Sch Hyg & Trop Med, Bangkok, Thailand; [Chirwa, Ephraim] Univ Malawi, Zomba, Malawi; [Dieltiens, Veerle] Univ Witwatersrand, Johannesburg, South Africa; [Dorward, Andrew; Poulton, Colin] Univ London, Sch Oriental & African Studies, London, England; [Kingdon, Geeta; Little, Angela; North, Amy; Unterhalter, Elaine] Univ London, Inst Educ, London WC1N 1AZ, England; [Mwinga, Alwyn] Ctr Dis Control & Prevent, Global AIDS Program, Lusaka, Zambia; [Patcharanarumol, Walaiporn; Tangcharoensathien, Viroj] Int Hlth Policy Program, Nonthaburi, Thailand	University of London; London School of Hygiene & Tropical Medicine; University of Malawi; University of Witwatersrand; University of London; University of London School Oriental & African Studies (SOAS); University of London; University College London; UCL Institute of Education	Waage, J (corresponding author), London Int Dev Ctr, 36 Gordon Sq, London WC1H 0PD, England.	jeff.waage@lidc.bloomsbury.ac.uk	North, Amy/AAS-7619-2021; Kingdon, Geeta/AAQ-2321-2021; Hanvoravongchai, Piya/A-1569-2012	Hanvoravongchai, Piya/0000-0003-4256-1271; Mills, Anne/0000-0001-9863-9950; North, Amy/0000-0003-0546-2397; Kingdon, Geeta/0000-0002-1583-5540; Unterhalter, Elaine/0000-0002-2302-6583; Campbell, Oona/0000-0002-9311-0115	Economic and Social Research Council [RES-167-25-0260]; Economic and Social Research Council [ES/E021859/1] Funding Source: researchfish; ESRC [ES/E021859/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	EU has received a grant from the Economic and Social Research Council (award number RES-167-25-0260).	ADDISON T, 2008, CHRONIC POVERTY REPO; Anand S, 2000, WORLD DEV, V28, P2029, DOI 10.1016/S0305-750X(00)00071-1; [Anonymous], 2010, GLOBAL INEQUALITIES; Barton Carol., 2005, GENDER DEV, V13, P25, DOI DOI 10.1080/13552070512331332274; Bhana D, 2009, EDUC REV, V61, P49, DOI 10.1080/00131910802684771; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bose C., 2009, GLOBAL GENDER RES TR; BOURGUIGNON F, 2009, 2015 BRUSS JUN; Brundtland, 1987, A42427 UN; CABRERA L, 2005, POLITICAL THEORY GLO; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Castello LD, 2010, ENVIRON SCI POLICY, V13, P154, DOI 10.1016/j.envsci.2009.12.001; *CENTR STAT OFF MA, 2009, ZAMB DEM HLTH SURV 2; CHEN S, 2007, ABSOLUTE POVERTY MEA; *COMM MACR HLTH, 2002, INV HLTH EC DEV; *COMM MACR HLTH, 2002, 5 WHO COMM MACR HLTH; CONWAY GR, 1985, AGR ADMIN EXT, V20, P31, DOI 10.1016/0309-586X(85)90064-0; Corbett EL, 2009, INT J TUBERC LUNG D, V13, P1231; *CSO CENTR BOARD H, 2003, ZAMB DEM HLTH SURV 2; *DAW, 2009, EXP GROUP M IMP IMPL; *DFID, 2006, CHIN COUNTR ASS PLAN; DFID, 2009, EL WORLD POV BUILD O; *DHS, 2003, ER 2002 FIN REP; Dieltiens V, 2009, PERSPECT EDUC, V27, P365; Dorward A, 2009, DEV POLICY REV, V27, P131, DOI 10.1111/j.1467-7679.2009.00439.x; Easterly W, 2009, WORLD DEV, V37, P26, DOI 10.1016/j.worlddev.2008.02.009; FISCHER AM, 2009, 2015 PROM PROP POL M; FLEISCH B, 2007, PRIMARY ED CRISIS S; FLEURBAEY M, 2008, GDP IS THERE PROGR M; Fraser N., 1997, JUSTICE INTERRUPTUS; FUKUDAPARR S, 2008, 48 UN DEV PROGR INT; Glewwe P, 2002, J ECON LIT, V40, P436, DOI 10.1257/002205102320161258; GORE C, 2009, 2015 PROM PROP POL M; Gore C, 2010, IDS BULL-I DEV STUD, V41, P70, DOI 10.1111/j.1759-5436.2010.00106.x; *GOV MAL, 2008, MAL MILL DEV GOALS R; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grubb M, 2010, CLIM POLICY, V10, P127, DOI 10.3763/cpol.2010.ED83; *GRZ, 2008, ZAMB MILL DEV GOALS; GWATICIN DR, 2000, CURRENT STATE KNOWLE; Gwatkin D. R., 2005, REACHING POOR HLTH N; Habermas J., 1984, THEORY COMMUNICATIVE, V1; Held D., 2005, POLITICAL PHILOS COS, P10; HILLS J, 2010, ANATOMY EC INEQUALIT; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Houweling TAJ, 2007, B WORLD HEALTH ORGAN, V85, P745, DOI 10.2471/BLT.06.038588; Hulme D., 2007, MAKING MILLENNIUM DE; HULME D, 2009, 2015 PROM PROP POL M; Jahan Rounaq., 1995, ELUSIVE AGENDA MAINS; Jewkes R, 2002, SOC SCI MED, V55, P1603, DOI 10.1016/S0277-9536(01)00294-5; Joint United Nations Programme on HIV/AIDS (UNAIDS) Zambia National HIV/AIDS/STI/TB Council, 2009, ZAMB HIV PREV RESP M; Jones N, 2010, IDS BULL-I DEV STUD, V41, P113, DOI 10.1111/j.1759-5436.2010.00112.x; KABEER N, 2008, POVERTY FOCUS, V13, P3; Kai M., 2006, 11 5 YEAR PLAN TARGE; KAKURU DM, 2008, GENDER EQUALITY HIV; KINGDON G, 2010, WPS201014 CSAE U OXF; Kingdon GG, 2006, J DEV STUD, V42, P1199, DOI 10.1080/00220380600884167; Knights F, 2010, EARLY MUSIC, V38, P1, DOI 10.1093/em/caq003; Langford M, 2010, IDS BULL-I DEV STUD, V41, P83, DOI 10.1111/j.1759-5436.2010.00108.x; Limwattananon S, 2007, B WORLD HEALTH ORGAN, V85, P600, DOI 10.2471/BLT.06.033720; Limwattananon S, 2010, B WORLD HEALTH ORGAN, V88, P420, DOI 10.2471/BLT.09.068791; Macdonald M., 2003, GENDER EQUALITY MAIN; Malawi Government, 2011, MAL GROWTH DEV STRAT; Manning, 2009, USING INDICATORS ENC; McCowan, 2009, RETHINKING CITIZENSH; *MHRD, 2006, ANN REP 2005 2006; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY, DOI DOI 10.1196/ANNALS.1439.003; *MIN HLTH ZAMB, 2005, NAT HLTH STRAT PLAN; *MIN HLTH ZAMB, 2000, NAT HLTH STRAT PLAN; MINUJIN A, 2004, SOCIOECONOMIC INEQUA; MOLETSANE R, 2010, ENG EMP ED EQ E4 C D; MOOROSI P, 2006, THESIS U KWAZULUNATA; Morrell R., 2009, GENDER EQUALITY S AF; Moser C., 2005, GENDER DEV, V13, P11, DOI [10.1080/13552070512331332283, DOI 10.1080/13552070512331332283]; Mulholland EK, 2008, B WORLD HEALTH ORGAN, V86, P399, DOI 10.2471/BLT.07.044545; *NAC, 2008, COMPR HIV AIDS PREV; *OECD, 2008, EFF AID BETT HLTH; OECD, 1996, SHAP 21 CENT CONTR D; Office of the National Economic and Social Development Board, 2004, THAIL MILL DEV GOALS; Phillips Ann, 2007, MULTICULTURALISM CUL; Pogge Thomas, 2008, GLOBAL JUSTICE SEMIN; Prakongsai P, 2009, J INT DEV, V21, P291, DOI 10.1002/jid.1553; PRIDMORE P, 2007, CREATE PATHWAYS ACCE, V2; Prins G., 2010, HARTWELL PAPER NEW D; Reetika Khera, 2006, Economic and Political Weekly, V41, P4742; Rohde J, 2008, LANCET, V372, P950, DOI 10.1016/S0140-6736(08)61405-1; ROLLESTON C, 2009, HUMAN CAPITAL POVERT; Ruger JP, 2008, GEORGETOWN LAW J, V96, P423; Rutherford ME, 2009, B WORLD HEALTH ORGAN, V87, P216, DOI 10.2471/BLT.08.052175; Sachs J., 2005, END POVERTY WE CAN M; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Schaefer I., 2013, WORLD BANK; Schech S, 2010, SOC POLIT, V17, P111, DOI 10.1093/sp/jxp025; Sen A., 2010, IDEA JUSTICE, DOI [10.2307/j.ctvjnrv7n, DOI 10.2307/J.CTVJNRV7N]; Sen Amartya, 1999, DEV FREEDOM; SETS A, 1992, INEQUALITY REEXAMINE; SHETTY S, 2009, 2015 BRUSS JUN; Shiva Kumar AK., 2003, READINGS HUMAN DEV; Skard T, 2009, FORUM DEV STUD, V36, P155, DOI 10.1080/08039410.2009.9666429; Snow RW, 2010, LANCET, V376, P137, DOI 10.1016/S0140-6736(10)60577-6; Stiglitz J, MEASUREMENT EC PERFO; Sumner A., 2009, BROKER, V14, P8; Sumner A, 2010, IDS BULL-I DEV STUD, V41, P1, DOI 10.1111/j.1759-5436.2010.00097.x; TANGCHAROENSATH.V, 2009, BUILDING DECENT SOC; Tangcharoensathien V, 2005, SOC POLICY DEV CONTE, P257; *TASKF INN INT FIN, 2009, 1 WHO TASKF INN INT; Tiwari M., 2009, 2015 INT DEV POLICY; Tottrup C, 2009, TROP MED INT HEALTH, V14, P653, DOI 10.1111/j.1365-3156.2009.02275.x; UN, 2008, MILL DEV GOALS REP 2; *UN MDG GAP TASK F, 2009, STRENGTH GLOB PARTN; *UN STAT DIV, OFF LIST MDG IND 200; *UNDG, 2005, MAK MDGS MATT COUNTR; UNDP, 2003, HUMAN DEV REPORT 200; *UNDP, MDG PLUS CAS STUD TH; UNESCO, 2010, ED ALL GLOB MON REP; *UNESCO, 2008, ED ALL GLOB MON REP; United Nation, 2001, ROAD MAP IMPL UN MIL; United Nations, 2010, MILL DEV GOALS REP 2; United Nations Development Programme (UNDP), 2007, HUMAN DEV REPORT 200; United Nations General Assembly Resolution, 2000, A55L2 UN; UNTERHALTER E, 2000, CHALLENGING DEMOCRAC; UNTERHALTER E, 2009, 1 GEND ED GLOB POV R; Unterhalter E, 2009, STUD PHILOS EDUC, V28, P415, DOI 10.1007/s11217-009-9125-7; *USAID DEL PROJ, 2009, ZAMB NAT LONG TERM F; Vandemoortele J, 2009, DEV POLICY REV, V27, P355, DOI 10.1111/j.1467-7679.2009.00451.x; Vapattanawong P, 2007, LANCET, V369, P850, DOI 10.1016/S0140-6736(07)60413-9; Victora CG, 2006, B WORLD HEALTH ORGAN, V84, P792, DOI 10.2471/BLT.06.030502; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; Wilkinson R., 2009, SPIRIT LEVEL; World Bank, 1993, INV HLTH WORLD DEV R; World Health Organization, 2007, EV BUS STRENGTH HLTH; 2009, ASER ANN STATUS ED R; COUNTDOWN 2015 TRACK	132	196	202	0	50	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 18	2010	376	9745					991	1023		10.1016/S0140-6736(10)61196-8	http://dx.doi.org/10.1016/S0140-6736(10)61196-8			33	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	655JZ	20833426	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000282247600031
J	Ludermir, AB; Lewis, G; Valongueiro, SA; de Araujo, TVB; Araya, R				Ludermir, Ana Bernarda; Lewis, Glyn; Valongueiro, Sandra Alves; Barreto de Araujo, Thalia Velho; Araya, Ricardo			Violence against women by their intimate partner during pregnancy and postnatal depression: a prospective cohort study	LANCET			English	Article							DOMESTIC VIOLENCE; HEALTH; MISCLASSIFICATION; PREVALENCE; MOTHERS; SCALE; ABUSE; CARE	Background Partner violence against women is common during pregnancy and might have an adverse effect on the mental health of women after delivery. We aimed to investigate the association of postnatal depression with psychological, physical, and sexual violence against women by their intimate partners during pregnancy. Methods In a prospective cohort study undertaken in Recife, northeastern Brazil, between July, 2005, and December, 2006, we enrolled pregnant women (aged 18-49 years) in their third trimester of pregnancy who were attending primary health-care clinics. The women were interviewed during pregnancy and after delivery. The form of partner violence in pregnancy was assessed with a validated questionnaire, and the Edinburgh postnatal depression scale was used to measure postnatal depression. Associations were estimated with odds ratios (ORs), adjusted for confounding factors contributing to the association between postnatal depression and intimate partner violence. Findings 1133 pregnant women were eligible for inclusion in the study, of whom 1045 had complete data for all variables and were included in the analysis. 270 women (25.8%, 95% CI 23.2-28.6) had postnatal depression. The most common form of partner violence was psychological (294 [28.1%, 25.4-31.0]). Frequency of psychological violence during pregnancy was positively associated with occurrence of postnatal depression, and although this association was attenuated after adjustment, women reporting the highest frequency of psychological violence were more likely to have postnatal depression even after adjustment (adjusted OR 2-29, 95% CI 1-15-4.57). Women who reported physical or sexual violence in pregnancy were more likely to develop postnatal depression (OR 3.28, 2.29-4.70), but this association was substantially reduced after adjustment for psychological violence and confounding factors. Interpretation Psychological violence during pregnancy by an intimate partner is strongly associated with postnatal depression, independently of physical or sexual violence. This finding has important policy implications since most social policies focus on prevention and treatment of physical violence.	[Ludermir, Ana Bernarda; Valongueiro, Sandra Alves; Barreto de Araujo, Thalia Velho] Univ Fed Pernambuco, Hosp Clin, Programa Posgrad Integrado Saude Colet, Recife, PE, Brazil; [Lewis, Glyn; Araya, Ricardo] Univ Bristol, Acad Unit Psychiat, Bristol, Avon, England	Universidade Federal de Pernambuco; University of Bristol	Ludermir, AB (corresponding author), Ave Conselheiro Rosa & Silva 377-1601, BR-52020220 Recife, PE, Brazil.	abl@ufpe.br	Araya, Ricardo/S-3144-2019; Lewis, Glyn/E-9944-2012; Ludermir, Ana B/A-9026-2009	Araya, Ricardo/0000-0002-0420-5148; Lewis, Glyn/0000-0001-5205-8245; 	Departamento de Ciencia e Tecnologia da Secretaria de Ciencia, Tecnologia, e Insumos Estrategicos (DECIT); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil [403060/2004-4, 473545/2004-7]	Departamento de Ciencia e Tecnologia da Secretaria de Ciencia, Tecnologia, e Insumos Estrategicos (DECIT); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We are greatly indebted to the women of Recife who participated in the study, and without whom this research would not have been possible. This study was funded by the Departamento de Ciencia e Tecnologia da Secretaria de Ciencia, Tecnologia, e Insumos Estrategicos (DECIT), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil (grant numbers 403060/2004-4 and 473545/2004-7).	Alvarado R, 1992, REV PSIQUIATR, V3, P1168; Bacchus L, 2004, EUR J OBSTET GYN R B, V113, P6, DOI 10.1016/S0301-2115(03)00326-9; BROWN GW, 1995, PSYCHOL MED, V25, P7, DOI 10.1017/S003329170002804X; CANTILINO A, 2003, NEUROBIOLOGIA, V66, P75; COUTO MT, 2006, CIENC SAUDE COLETIVA, V11, pS1323; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Doubova SV, 2007, REV SAUDE PUBL, V41, P582, DOI 10.1590/S0034-89102007000400012; Ellsberg M, 1999, AM PSYCHOL, V54, P30, DOI 10.1037/0003-066X.54.1.30; Ellsberg M., 1997, CANDIES HELL DOMESTI; Figueira Patrícia, 2009, Rev. Saúde Pública, V43, P79, DOI 10.1590/S0034-89102009000800012; *FUND I BRAS GEOGR, 1991, CENS DEM PERN; Garcia-Moreno C, 2002, LANCET, V359, P1509, DOI 10.1016/S0140-6736(02)08417-9; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; Habermas Jurgen, 1990, DISCURSO FILOSOFICO; HARDING TW, 1980, PSYCHOL MED, V10, P231, DOI 10.1017/S0033291700043993; Heise L., 2002, WORLD REPORT VIOLENC; Heise Lori L., 1994, WORLD BANK DISCUSSIO; Leung WC, 2002, INT J GYNECOL OBSTET, V79, P159, DOI 10.1016/S0020-7292(02)00236-9; Ludermir AB, 2010, PSYCHOL MED, V40, P1467, DOI 10.1017/S003329170999184X; Ludermir AB, 2005, SOC PSYCH PSYCH EPID, V40, P36, DOI 10.1007/s00127-005-0840-2; Ludermir AB, 2003, SOC PSYCH PSYCH EPID, V38, P485, DOI 10.1007/s00127-003-0658-8; Ludermir AB, 2008, SOC SCI MED, V66, P1008, DOI 10.1016/j.socscimed.2007.10.021; Lutz KF, 2005, WESTERN J NURS RES, V27, P802, DOI 10.1177/0193945905278078; MARI JD, 1986, J CHRON DIS, V39, P371; Matthey S, 2006, ARCH WOMEN MENT HLTH, V9, P309, DOI 10.1007/s00737-006-0152-x; Moraes CL, 2002, INT J GYNECOL OBSTET, V79, P269, DOI 10.1016/S0020-7292(02)00250-3; Parker B, 1999, RES NURS HEALTH, V22, P59; Patel V, 2002, AM J PSYCHIAT, V159, P43, DOI 10.1176/appi.ajp.159.1.43; Pinheiro RT, 2006, ACTA PSYCHIAT SCAND, V113, P230, DOI 10.1111/j.1600-0447.2005.00708.x; Pollock JI, 2006, J AFFECT DISORDERS, V92, P267, DOI 10.1016/j.jad.2006.02.020; *PREF CID REC, 2006, REC SAUD INCL SOC QU; Ramsay J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005043.pub2; Rojas G, 2007, LANCET, V370, P1629, DOI 10.1016/S0140-6736(07)61685-7; SANTOS MF, 2000, ESCALAS AVALIACAO CL; Schraiber LB, 2009, CAD SAUDE PUBLICA, V25, pS205, DOI 10.1590/S0102-311X2009001400003; Sharma SP, 2007, LANCET ONCOL, V8, P105, DOI 10.1016/S1470-2045(07)70024-4; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Tiwari A, 2005, BJOG-INT J OBSTET GY, V112, P1249, DOI 10.1111/j.1471-0528.2005.00709.x; VENTURI Gustavo, 2004, MULHER BRASILEIRA NO; Watts C, 2002, LANCET, V359, P1232, DOI 10.1016/S0140-6736(02)08221-1; World Health Organization, 1994, US GUID SELF REP QUE; Yost NR, 2005, OBSTET GYNECOL, V106, P61, DOI 10.1097/01.AOG.0000164468.06070.2a	43	202	215	1	47	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 11	2010	376	9744					903	910		10.1016/S0140-6736(10)60887-2	http://dx.doi.org/10.1016/S0140-6736(10)60887-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	653DW	20822809				2022-12-01	WOS:000282069100031
J	Belongia, EA; Irving, SA; Waring, SC; Coleman, LA; Meece, JK; Vandermause, M; Lindstrom, S; Kempf, D; Shay, DK				Belongia, Edward A.; Irving, Stephanie A.; Waring, Stephen C.; Coleman, Laura A.; Meece, Jennifer K.; Vandermause, Mary; Lindstrom, Stephen; Kempf, Debra; Shay, David K.			Clinical Characteristics and 30-Day Outcomes for Influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) Infections	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CRITICALLY-ILL PATIENTS; NASOPHARYNGEAL ASPIRATE; A(H1N1) INFECTION; NASAL SWAB; OSELTAMIVIR; AUSTRALIA; VIRUS	Context The clinical characteristics of pandemic 2009 influenza A(H1N1) infections have not been compared directly with illnesses caused by other influenza A strains. Objective To compare clinical features and outcomes for 2009 H1N1, seasonal H1N1, and H3N2 influenza in a population-based cohort. Design, Setting, and Participants Active surveillance with 30-day follow-up for influenza cases among children and adults living in a 14-zip code area in Wisconsin. Patients with subjective fever, chills, or cough of fewer than 8 days' duration were screened for eligibility during an outpatient or inpatient encounter. Consenting patients were interviewed and tested for influenza A during the 2007-2008 and 2008-2009 influenza seasons and from May to November 2009; 6874 patients (70%-86% of eligible patients) agreed to participate. Medical records were reviewed to assess outcomes. Main Outcome Measures Hospital admission, radiographically confirmed pneumonia, and clinical characteristics of influenza A by strain. Results We identified 545 2009 H1N1, 221 seasonal H1N1, and 632 H3N2 infections. The median ages of infected participants were 10, 11, and 25 years, respectively (P<.001). Hospital admission occurred within 30 days for 6 of 395 children with 2009 H1N1 (1.5%; 95% confidence interval [CI], 0.6%-3.1%), 5 of 135 with seasonal H1N1 (3.7%; 95% CI, 1.4%-8.0%), and 8 of 255 with H3N2 (3.1%; 95% CI, 1.5%-5.9%). Among adults, hospital admission occurred in 6 of 150 with 2009 H1N1 (4.0%; 95% CI, 1.6%-8.1%), 2 of 86 with seasonal H1N1 (2.3%; 95% CI, 0.3%-8.1%), and 17 of 377 with H3N2 (4.5%; 95% CI, 2.7%-7.0%). Pneumonia occurred in 10 children with 2009 H1N1 (2.5%; 95% CI, 1.3%-4.5%), 2 with seasonal H1N1 (1.5%; 95% CI, 0.2%-5.2%), and 5 with H3N2 (2.0%; 95% CI, 0.7%-4.3%). Among adults, pneumonia occurred in 6 with 2009 H1N1 (4.0%; 95% CI, 1.6%-8.1%), 2 with seasonal H1N1 (2.3%; 95% CI, 0.3%-8.1%), and 4 with H3N2 (1.1%; 95% CI, 0.3%-2.7%). Conclusions In this population, individuals with 2009 H1N1 infection were younger than those with H3N2. The risk of most serious complications was not elevated in adults or children with 2009 H1N1 compared with recent seasonal strains. JAMA. 2010; 304(10): 1091-1098	[Belongia, Edward A.] Marshfield Clin Res Fdn, Epidemiol Res Ctr ML2, Marshfield, WI 54449 USA; [Lindstrom, Stephen; Shay, David K.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Belongia, EA (corresponding author), Marshfield Clin Res Fdn, Epidemiol Res Ctr ML2, 1000 N Oak Ave, Marshfield, WI 54449 USA.	belongia.edward@marshfieldclinic.org	Waring, Stephen/AAR-6870-2021	Waring, Stephen/0000-0002-9674-0083; Belongia, Edward/0000-0001-7478-0415; Irving, Stephanie/0000-0001-7437-6797; Shay, David/0000-0001-9619-4820	CDC [1 U01 CI000192-01]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000192] Funding Source: NIH RePORTER	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding for this research was provided by a cooperative agreement with the CDC (grant 1 U01 CI000192-01).	Abramson Joseph H, 2004, Epidemiol Perspect Innov, V1, P6, DOI 10.1186/1742-5573-1-6; Baker MG, 2009, EUROSURVEILLANCE, V14, P6; Belongia E., 2008, Morbidity and Mortality Weekly Report, V57, P393; Belongia EA, 2009, J INFECT DIS, V199, P159, DOI 10.1086/595861; Bishop JF, 2009, NEW ENGL J MED, V361, P2591, DOI 10.1056/NEJMp0910445; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P941; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Denholm JT, 2010, MED J AUSTRALIA, V192, P84, DOI 10.5694/j.1326-5377.2010.tb03424.x; DeStefano F, 1996, J CLIN EPIDEMIOL, V49, P643, DOI 10.1016/0895-4356(96)00008-X; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Greenlee Robert T, 2003, Clin Med Res, V1, P273; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Heikkinen T, 2002, J CLIN MICROBIOL, V40, P4337, DOI 10.1128/JCM.40.11.4337-4339.2002; Heikkinen T, 2001, BMJ-BRIT MED J, V322, P138, DOI 10.1136/bmj.322.7279.138; Irving SA, 2009, VACCINE, V27, P6546, DOI 10.1016/j.vaccine.2009.08.050; Jackson ML, 2008, LANCET, V372, P398, DOI 10.1016/S0140-6736(08)61160-5; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kelly HA, 2009, MED J AUSTRALIA, V191, P146, DOI 10.5694/j.1326-5377.2009.tb02723.x; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Libster R, 2010, NEW ENGL J MED, V362, P45, DOI 10.1056/NEJMoa0907673; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Sato M, 2005, PEDIATR INFECT DIS J, V24, P931, DOI 10.1097/01.inf.0000180976.81055.ce; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; WHO, 2009, CDC PROT REALT RTPCR	27	123	132	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2010	304	10					1091	1098		10.1001/jama.2010.1277	http://dx.doi.org/10.1001/jama.2010.1277			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646RM	20823435	Bronze			2022-12-01	WOS:000281559800019
J	Cohen, D				Cohen, Deborah			Drug Regulation Rosiglitazone: what went wrong?	BRITISH MEDICAL JOURNAL			English	Editorial Material												dcohen@bmj.com						*AM DIAB ASS, FDA REV DAT 2 NEW DI; CALABRESI M, 1916, TIME            0816; Department of Health and Human Services, 2010, ADV COMM M NDA 21071; Douglas IJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000154; *EUR MED AG, 2001, EPAR AV; *EUR MED AG, AV PROC STEPS TAK SC; Gale EAM, 2001, LANCET, V357, P1870, DOI 10.1016/S0140-6736(00)04960-6; Harris G., 2010, NY TIMES        0713; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Krentz AJ, 2000, BMJ-BRIT MED J, V321, P252, DOI 10.1136/bmj.321.7256.252; *MHRA DEAR DOCT CE, 2010, CURR ADV INF US ROS; MULLARD A, 2010, SCRIP           0730; MULLARD A, 2010, SCRIP           0106; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Nissen SE, 2010, EUR HEART J, V31, P773, DOI 10.1093/eurheartj/ehq016; THEPH, 1999, AV CPMP KNOCKB OV SB; US Senate Committee on Finance, 2010, STAFF REP GLAXOSMITH; 2006, SCIRPP          0922; 2007, SCRIPP          0214; 2010, GLAXOSMITHKLINE 0323; 1999, THEPHARMLETTER  0429; 1998, SCRIPP          0515; 2010, THEPHARMLETTER  0825; 1998, SCRIPP          1202; 2007, SCRIP           0801	25	73	75	0	12	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 6	2010	341								c4848	10.1136/bmj.c4848	http://dx.doi.org/10.1136/bmj.c4848			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	649ZH	20819889				2022-12-01	WOS:000281814700012
J	Das, G; Baglioni, P; Okosieme, O				Das, Gautam; Baglioni, Piero; Okosieme, Onyebuchi			Easily Missed? Primary HIV infection	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIAGNOSIS		[Das, Gautam; Baglioni, Piero; Okosieme, Onyebuchi] Prince Charles Hosp, Merthyr Tydfil CF47 9DT, M Glam, Wales		Das, G (corresponding author), Prince Charles Hosp, Merthyr Tydfil CF47 9DT, M Glam, Wales.	drgdas@gmail.com						British Association for Sexual Health and HIV, 2010, BASHH STAT HIV WIND; British HIV Association British Association of Sexual Health and HIV and British Infection Society, UK NAT GUID HIV TEST; Daar ES, 2001, ANN INTERN MED, V134, P25, DOI 10.7326/0003-4819-134-1-200101020-00010; Health Protection Agency, 2009, HIV UK 2009 REP 2009; Kassutto S, 2004, CLIN INFECT DIS, V38, P1452, DOI 10.1086/420745; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Koblin B, 2004, LANCET, V364, P41, DOI 10.1016/S0140-6736(04)16588-4; Macdonald N, 2007, SEX TRANSM INFECT, V84, P8, DOI 10.1136/sti.2007.027946; Newton PJ, 2002, BRIT MED J, V325, P1225, DOI 10.1136/bmj.325.7374.1225; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Sudarshi D, 2007, SEX TRANSM INFECT, V84, P14, DOI 10.1136/sti.2007.026963; Weintrob AC, 2003, ARCH INTERN MED, V163, P2097, DOI 10.1001/archinte.163.17.2097	12	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2010	341								c4583	10.1136/bmj.c4583	http://dx.doi.org/10.1136/bmj.c4583			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	649ZH	20819875	Green Accepted			2022-12-01	WOS:000281814700009
J	Freemantle, N				Freemantle, Nick			Commentary: What can we learn from the continuing regulatory focus on the thiazolidinediones?	BRITISH MEDICAL JOURNAL			English	Editorial Material							MYOCARDIAL-INFARCTION; ROSIGLITAZONE		[Freemantle, Nick] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Freemantle, N (corresponding author), Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England.	N.Freemantle@bham.ac.uk		Freemantle, Nick/0000-0001-5807-5740				[Anonymous], 2008, GUID IND DIAB MELL E; Fisher R. A., 1966, DESIGN EXPT; Freemantle N, 2008, BMJ-BRIT MED J, V336, P627, DOI 10.1136/bmj.39491.493252.80; HIGGINS JPT, COCHRANE HDB; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; TEMPLE R, 1980, NEW ENGL J MED, V303; Van de Werf F, 1999, LANCET, V354, P716, DOI 10.1016/S0140-6736(99)07403-6	9	7	7	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 6	2010	341								c4812	10.1136/bmj.c4812	http://dx.doi.org/10.1136/bmj.c4812			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	649ZH	20819888				2022-12-01	WOS:000281814700002
J	Cheng, G; Cox, J; Wang, PH; Krishnan, MN; Dai, JF; Qian, F; Anderson, JF; Fikrig, E				Cheng, Gong; Cox, Jonathan; Wang, Penghua; Krishnan, Manoj N.; Dai, Jianfeng; Qian, Feng; Anderson, John F.; Fikrig, Erol			A C-Type Lectin Collaborates with a CD45 Phosphatase Homolog to Facilitate West Nile Virus Infection of Mosquitoes	CELL			English	Article							MANNOSE-BINDING LECTIN; PROTEIN-TYROSINE PHOSPHATASES; DENGUE-VIRUS; DC-SIGN; DENDRITIC CELL; COMPLEMENT; RECEPTOR; IDENTIFICATION; EPIDEMIOLOGY; ACTIVATION	West Nile virus (WNV) is the most common arthropod-borne flavivirus in the United States; however, the vector ligand(s) that participate in infection are not known. We now show that an Aedes aegypti C-type lectin, mosGCTL-1, is induced by WNV, interacts with WNV in a calcium-dependent manner, and facilitates infection in vivo and in vitro. A mosquito homolog of human CD45 in A. aegypti, designated mosPTP-1, recruits mosGCTL-1 to enable viral attachment to cells and to enhance viral entry. In vivo experiments show that mosGCTL-1 and mosPTP-1 function as part of the same pathway and are critical for WNV infection of mosquitoes. A similar phenomenon was also observed in Culex quinquefasciatus, a natural vector of WNV, further demonstrating that these genes participate in WNV infection. During the mosquito blood-feeding process, WNV infection was blocked in vivo with mosGCTL-1 antibodies. A molecular understanding of flaviviral-arthropod interactions may lead to strategies to control viral dissemination in nature.	[Cheng, Gong; Cox, Jonathan; Wang, Penghua; Krishnan, Manoj N.; Dai, Jianfeng; Fikrig, Erol] Yale Univ, Sch Med, Infect Dis Sect, Dept Internal Med, New Haven, CT 06520 USA; [Qian, Feng] Yale Univ, Sch Med, Rheumatol Sect, Dept Internal Med, New Haven, CT 06520 USA; [Anderson, John F.] Connecticut Agr Expt Stn, Dept Entomol, New Haven, CT 06504 USA; [Fikrig, Erol] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Yale University; Connecticut Agricultural Experiment Station; Howard Hughes Medical Institute	Fikrig, E (corresponding author), Yale Univ, Sch Med, Infect Dis Sect, Dept Internal Med, 333 Cedar St, New Haven, CT 06520 USA.	erol.fikrig@yale.edu	wang, Penghua/AAL-4011-2020; Dai, Jianfeng/ACP-1114-2022; Qian, Feng/F-8186-2010		National Institutes of Health [AI 50031, AI 070343]; Northeast Biodefense Center [U54-AI057158-Lipkin]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041440, U54AI057158, U01AI070343, R01AI032947, N01AI050031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeast Biodefense Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI 50031 and AI 070343. We thank Yue Zhang, Lei Liu, Lili Zhang, and Sukanya Narasimhan for help with the biochemical studies, Debbie Beck for technical assistance, and Michel Ledizet for providing the purified WNV E protein and the flaviviral E protein antibodies. G.C. is a James Hudson Brown-Alexander Brown Coxe Postdoctoral Fellow at the Yale School of Medicine. P.W. is supported by a Career Development Award from Northeast Biodefense Center (U54-AI057158-Lipkin). E.F. is an investigator with the Howard Hughes Medical Institute. G.C. and E.F. designed the experiments and wrote the manuscript; G.C. performed the majority of the experiments and analyzed data; J.C. assisted the mosquito techniques; J.F.A. provided the A. aegypti and C. quinque-fasciatus mosquitoes and helped with the mosquito feeding; J.D. and F.Q. assisted in FACS and confocal microscopy; and P.W., M.N.K. and J.D. provided suggestions for the project. All authors reviewed, critiqued, and provided comments on the text.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; [Anonymous], FLAVIVIRUSES; Arnold JN, 2006, IMMUNOL LETT, V106, P103, DOI 10.1016/j.imlet.2006.05.007; Bai FW, 2007, J VIROL, V81, P2047, DOI 10.1128/JVI.01840-06; Baldwin TA, 2001, J IMMUNOL, V167, P3829, DOI 10.4049/jimmunol.167.7.3829; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Brackney DE, 2008, AM J TROP MED HYG, V79, P267, DOI 10.4269/ajtmh.2008.79.267; Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Cheng G, 2009, J INTERF CYTOK RES, V29, P461, DOI 10.1089/jir.2008.0078; Chong WP, 2005, HEPATOLOGY, V42, P1037, DOI 10.1002/hep.20891; Coleman Judy, 2007, J Vis Exp, P228, DOI 10.3791/228; Dauphin G, 2007, VACCINE, V25, P5563, DOI 10.1016/j.vaccine.2006.12.005; Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006; EZEKOWITZ RAB, 1989, J EXP MED, V169, P185, DOI 10.1084/jem.169.1.185; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326; Han YS, 1999, DEV COMP IMMUNOL, V23, P553, DOI 10.1016/S0145-305X(99)00047-6; Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005; Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a; Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505; Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101; Klimstra WB, 2003, J VIROL, V77, P12022, DOI 10.1128/JVI.77.22.12022-12032.2003; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06; Leis AA, 2002, NEW ENGL J MED, V347, P1279, DOI 10.1056/NEJM2002c021587; Lin CC, 2007, VIRUS RES, V124, P176, DOI 10.1016/j.virusres.2006.11.002; Lindsey NP, 2009, PEDIATRICS, V123, pE1084, DOI 10.1542/peds.2008-3278; Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Neth O, 2002, J IMMUNOL, V169, P4430, DOI 10.4049/jimmunol.169.8.4430; NIR Y, 1968, AM J EPIDEMIOL, V87, P496, DOI 10.1093/oxfordjournals.aje.a120839; Pal U, 2004, CELL, V119, P457, DOI 10.1016/j.cell.2004.10.027; PIZZI M, 1950, Hum Biol, V22, P151; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Reisen W, 2007, PEST MANAG SCI, V63, P641, DOI 10.1002/ps.1325; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Saifuddin M, 2000, J GEN VIROL, V81, P949, DOI 10.1099/0022-1317-81-4-949; Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967; Soilleux EJ, 2002, J LEUKOCYTE BIOL, V71, P445; Tanji T, 2006, BIOCHEM J, V396, P127, DOI 10.1042/BJ20051921; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; THOMAS ML, 1989, ANNU REV IMMUNOL, V7, P339, DOI 10.1146/annurev.iy.07.040189.002011; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; Turell MJ, 2000, AM J TROP MED HYG, V62, P413, DOI 10.4269/ajtmh.2000.62.413; van der Meulen KM, 2005, ARCH VIROL, V150, P637, DOI 10.1007/s00705-004-0463-z; Vanlandingham DL, 2007, AM J TROP MED HYG, V77, P925, DOI 10.4269/ajtmh.2007.77.925; Wilson R, 1999, J IMMUNOL, V162, P1590; Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	53	125	128	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2010	142	5					714	725		10.1016/j.cell.2010.07.038	http://dx.doi.org/10.1016/j.cell.2010.07.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	646FL	20797779	Green Accepted, Bronze			2022-12-01	WOS:000281523200015
J	Tuli, K				Tuli, Karunesh			Personal View The Commonwealth games and "Delhi belly": what India can learn from LA	BRITISH MEDICAL JOURNAL			English	Editorial Material												karuneshtuli@hotmail.com							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 1	2010	341								c4507	10.1136/bmj.c4507	http://dx.doi.org/10.1136/bmj.c4507			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	647JT	20810484				2022-12-01	WOS:000281615500001
J	Olivier, N; Luengo-Oroz, MA; Duloquin, L; Faure, E; Savy, T; Veilleux, I; Solinas, X; Debarre, D; Bourgine, P; Santos, A; Peyrieras, N; Beaurepaire, E				Olivier, Nicolas; Luengo-Oroz, Miguel A.; Duloquin, Louise; Faure, Emmanuel; Savy, Thierry; Veilleux, Israel; Solinas, Xavier; Debarre, Delphine; Bourgine, Paul; Santos, Andres; Peyrieras, Nadine; Beaurepaire, Emmanuel			Cell Lineage Reconstruction of Early Zebrafish Embryos Using Label-Free Nonlinear Microscopy	SCIENCE			English	Article							3RD-HARMONIC GENERATION MICROSCOPY; 2ND-HARMONIC GENERATION; DEVELOPMENTAL BIOLOGY; HARMONIC-GENERATION; ZYGOTIC TRANSITION; ORIGIN; EMBRYOGENESIS; FLUORESCENCE	Quantifying cell behaviors in animal early embryogenesis remains a challenging issue requiring in toto imaging and automated image analysis. We designed a framework for imaging and reconstructing unstained whole zebrafish embryos for their first 10 cell division cycles and report measurements along the cell lineage with micrometer spatial resolution and minute temporal accuracy. Point-scanning multiphoton excitation optimized to preferentially probe the innermost regions of the embryo provided intrinsic signals highlighting all mitotic spindles and cell boundaries. Automated image analysis revealed the phenomenology of cell proliferation. Blastomeres continuously drift out of synchrony. After the 32-cell stage, the cell cycle lengthens according to cell radial position, leading to apparent division waves. Progressive amplification of this process is the rule, contrasting with classical descriptions of abrupt changes in the system dynamics.	[Duloquin, Louise; Peyrieras, Nadine] CNRS, Inst Neurobiol Alfred Fessard, Gif Sur Yvette, France; [Olivier, Nicolas; Veilleux, Israel; Solinas, Xavier; Debarre, Delphine; Beaurepaire, Emmanuel] Ecole Polytech, CNRS, INSERM, Lab Opt & Biosci, F-91128 Palaiseau, France; [Luengo-Oroz, Miguel A.; Santos, Andres] Univ Politecn Madrid, Madrid, Spain; [Luengo-Oroz, Miguel A.; Santos, Andres] CIBER, Biomed Res Ctr, BBN, Madrid, Spain; [Faure, Emmanuel; Savy, Thierry; Bourgine, Paul] Ecole Polytech, CNRS, Ctr Rech Epistemol Appl, F-75230 Paris, France; [Bourgine, Paul] Reseau Natl Syst Complexes, Paris, France; [Peyrieras, Nadine] Inst Syst Complexes Paris Ile de France, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Polytechnique de Paris; Universidad Politecnica de Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Peyrieras, N (corresponding author), CNRS, Inst Neurobiol Alfred Fessard, Gif Sur Yvette, France.	nadine.peyrieras@inaf.cnrs-gif.fr; emmanuel.beaurepaire@polytechnique.edu	Olivier, Nicolas/AAM-4414-2021; Santos, Andres/C-4012-2009; Luengo-Oroz, Miguel A/C-2245-2011; Beaurepaire, Emmanuel/C-6343-2014	Santos, Andres/0000-0001-7423-9135; Luengo-Oroz, Miguel A/0000-0002-8694-2001; Beaurepaire, Emmanuel/0000-0002-2082-8214; Olivier, Nicolas/0000-0001-9042-5456; Faure, Emmanuel/0000-0003-2787-0885; Peyrieras, Nadine/0000-0002-4905-6414; Debarre, Delphine/0000-0002-0513-6172; savy, thierry/0000-0001-5970-3817	Direction Generale de l'Armament; Agence Nationale de la Recherche,; FP6 New Emerging Science and Technology program; Association pour le Recherche Contre le Cancer; Egide Picasso France-Spain; Fondation Louis D.; Institut de France	Direction Generale de l'Armament; Agence Nationale de la Recherche,(French National Research Agency (ANR)); FP6 New Emerging Science and Technology program; Association pour le Recherche Contre le Cancer; Egide Picasso France-Spain; Fondation Louis D.; Institut de France	We thank G. Lutfalla for pAct26H2B/mcherry, pAct26mcherry-F DNA constructs, and transgenic fish lines. We thank P. Herbomel, C. Little, J.-L. Martin, H. Myllykallio, and J.-L. Rubio for critical reading of the manuscript. This work was supported by Direction Generale de l'Armament, Agence Nationale de la Recherche, FP6 New Emerging Science and Technology program, Association pour le Recherche Contre le Cancer, Egide Picasso France-Spain, and Fondation Louis D., Institut de France. Patent application PCT/FR2010/050173 describes the combination of conformal acquisition and beam conditioning in scanning microscopy of 3D objects.	Abrams EW, 2009, CURR OPIN GENET DEV, V19, P396, DOI 10.1016/j.gde.2009.06.002; Barad Y, 1997, APPL PHYS LETT, V70, P922, DOI 10.1063/1.118442; Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3; Debarre D, 2005, OPT LETT, V30, P2134, DOI 10.1364/OL.30.002134; Debarre D, 2004, OPT LETT, V29, P2881, DOI 10.1364/OL.29.002881; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; KANE DA, 1992, NATURE, V360, P735, DOI 10.1038/360735a0; KANE DA, 1993, DEVELOPMENT, V119, P447; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; KIMMEL CB, 1990, DEVELOPMENT, V108, P581; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kwan AC, 2008, P NATL ACAD SCI USA, V105, P11370, DOI 10.1073/pnas.0805199105; Levraud JP, 2007, J IMMUNOL, V178, P4385, DOI 10.4049/jimmunol.178.7.4385; Lu XM, 2009, DEVELOPMENT, V136, P2101, DOI 10.1242/dev.034421; Mathavan S, 2005, PLOS GENET, V1, P260, DOI 10.1371/journal.pgen.0010029; McMahon A, 2008, SCIENCE, V322, P1546, DOI 10.1126/science.1167094; Muzzey D, 2009, ANNU REV CELL DEV BI, V25, P301, DOI 10.1146/annurev.cellbio.042308.113408; Oates AC, 2009, NAT REV GENET, V10, P517, DOI 10.1038/nrg2548; Oron D, 2004, J STRUCT BIOL, V147, P3, DOI 10.1016/S1047-8477(03)00125-4; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; Sun CK, 2004, J STRUCT BIOL, V147, P19, DOI 10.1016/j.jsb.2003.10.017; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; TRINKAUS JP, 1993, J EXP ZOOL, V265, P258, DOI 10.1002/jez.1402650308; Vachier C, 2005, J MATH IMAGING VIS, V22, P251, DOI 10.1007/s10851-005-4893-3; Yabe T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000518; Zimmer C, 2006, IEEE SIGNAL PROC MAG, V23, P54, DOI 10.1109/MSP.2006.1628878; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100	27	258	264	5	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 20	2010	329	5994					967	971		10.1126/science.1189428	http://dx.doi.org/10.1126/science.1189428			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640WN	20724640	Green Submitted			2022-12-01	WOS:000281084800041
J	Lentine, KL; Schnitzler, MA; Xiao, HL; Saab, G; Salvalaggio, PR; Axelrod, D; Davis, CL; Abbott, KC; Brennan, DC				Lentine, Krista L.; Schnitzler, Mark A.; Xiao, Huiling; Saab, Georges; Salvalaggio, Paolo R.; Axelrod, David; Davis, Connie L.; Abbott, Kevin C.; Brennan, Daniel C.			Racial Variation in Medical Outcomes among Living Kidney Donors	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STAGE RENAL-DISEASE; HYPERTENSION PREVALENCE; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; TRANSPLANTATION; RATES; AWARENESS; RISK; DISPARITIES; INSURANCE	BACKGROUND Data regarding health outcomes among living kidney donors are lacking, especially among nonwhite persons. METHODS We linked identifiers from the Organ Procurement and Transplantation Network (OPTN) with administrative data of a private U. S. health insurer and performed a retrospective study of 4650 persons who had been living kidney donors from October 1987 through July 2007 and who had post-donation nephrectomy benefits with this insurer at some point from 2000 through 2007. We ascertained post-nephrectomy medical diagnoses and conditions requiring medical treatment from billing claims. Cox regression analyses with left and right censoring to account for observed periods of insurance benefits were used to estimate absolute prevalence and prevalence ratios for diagnoses after nephrectomy. We then compared prevalence patterns with those in the 2005-2006 National Health and Nutrition Examination Survey (NHANES) for the general population. RESULTS Among the donors, 76.3% were white, 13.1% black, 8.2% Hispanic, and 2.4% another race or ethnic group. The median time from donation to the end of insurance benefits was 7.7 years. After kidney donation, black donors, as compared with white donors, had an increased risk of hypertension (adjusted hazard ratio, 1.52; 95% confidence interval [CI], 1.23 to 1.88), diabetes mellitus requiring drug therapy (adjusted hazard ratio, 2.31; 95% CI, 1.33 to 3.98), and chronic kidney disease (adjusted hazard ratio, 2.32; 95% CI, 1.48 to 3.62); findings were similar for Hispanic donors. The absolute prevalence of diabetes among all donors did not exceed that in the general population, but the prevalence of hypertension exceeded NHANES estimates in some subgroups. End-stage renal disease was identified in less than 1% of donors but was more common among black donors than among white donors. CONCLUSIONS As in the general U. S. population, racial disparities in medical conditions occur among living kidney donors. Increased attention to health outcomes among demographically diverse kidney donors is needed.	[Lentine, Krista L.] St Louis Univ, Ctr Outcomes Res, Salus Ctr, Sch Med, St Louis, MO 63104 USA; [Lentine, Krista L.] St Louis Univ, Sch Med, Div Nephrol, St Louis, MO 63104 USA; [Saab, Georges; Brennan, Daniel C.] Washington Univ, Div Nephrol, Sch Med, St Louis, MO 63130 USA; [Salvalaggio, Paolo R.; Davis, Connie L.] Univ Washington, Kidney & Pancreas Transplant Program, Seattle, WA 98195 USA; [Axelrod, David] Dartmouth Hitchcock Med Ctr, Dept Surg, Hanover, NH USA; [Abbott, Kevin C.] Walter Reed Army Med Ctr, Serv Nephrol, Washington, DC 20307 USA	Saint Louis University; Saint Louis University; Washington University (WUSTL); University of Washington; University of Washington Seattle; Dartmouth College; United States Department of Defense; United States Army; Walter Reed National Military Medical Center	Lentine, KL (corresponding author), St Louis Univ, Ctr Outcomes Res, Salus Ctr, Sch Med, 4th Fl,3545 Lafayette Ave, St Louis, MO 63104 USA.	lentinek@slu.edu	Lentine, Krista/AAQ-6549-2020	Lentine, Krista/0000-0002-9423-4849; Abbott, Kevin/0000-0003-2111-7112; Axelrod, David/0000-0001-5684-0613	National Institute of Diabetes and Digestive and Kidney Diseases [K08DK073036, P30DK079333]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK073036, P30DK079333, K24DK002886] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported in part by grants (K08DK073036 and P30DK079333) from the National Institute of Diabetes and Digestive and Kidney Diseases.	Agency for Healthcare Research and Quality, CREAT VAL IND SOC ST; Boudville N, 2006, ANN INTERN MED, V145, P185, DOI 10.7326/0003-4819-145-3-200608010-00006; BRANCATI FL, 1992, JAMA-J AM MED ASSOC, V268, P3079, DOI 10.1001/jama.268.21.3079; Brown RS, 2009, AM J TRANSPLANT, V9, P31, DOI 10.1111/j.1600-6143.2008.02433.x; Carter JS, 1996, ANN INTERN MED, V125, P221, DOI 10.7326/0003-4819-125-3-199608010-00011; Centers for Disease Control and Prevention National Center for Health Statistics, NAT HLTH NUTR EX SUR; Cherikh WS, 2008, AM J TRANSPLANT, V8, P335; COWIE CC, 1989, NEW ENGL J MED, V321, P1074, DOI 10.1056/NEJM198910193211603; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Delmonico FL, 2005, TRANSPLANTATION, V79, pS53; Garg AX, 2008, TRANSPLANTATION, V86, P399, DOI 10.1097/TP.0b013e31817ba9e3; Gibney EM, 2007, TRANSPLANTATION, V84, P647, DOI 10.1097/01.tp.0000277288.78771.c2; Gore JL, 2009, AM J TRANSPLANT, V9, P1124, DOI 10.1111/j.1600-6143.2009.02620.x; Graham W, 2008, LIVING DONOR FOLLOW; HAFFNER SM, 1990, HYPERTENSION, V16, P225, DOI 10.1161/01.HYP.16.3.225; Hebert P L, 1999, Am J Med Qual, V14, P270, DOI 10.1177/106286069901400607; Herring AA, 2008, INT J HEALTH SERV, V38, P641, DOI 10.2190/HS.38.4.d; Horvat LD, 2009, KIDNEY INT, V75, P1088, DOI 10.1038/ki.2009.20; Ibrahim HN, 2009, NEW ENGL J MED, V360, P459, DOI 10.1056/NEJMoa0804883; Kasiske BL, 2003, AM J TRANSPLANT, V3, P178, DOI 10.1034/j.1600-6143.2003.00010.x; Lentine KL, 2009, CLIN J AM SOC NEPHRO, V4, P1213, DOI 10.2215/CJN.00670109; Mandelbrot DA, 2009, TRANSPLANTATION, V88, P855, DOI 10.1097/TP.0b013e3181b6dfb9; MITCHELL BD, 1990, AM J EPIDEMIOL, V131, P423, DOI 10.1093/oxfordjournals.aje.a115517; National Institute of Diabetes and Digestive and Kidney Diseases, 2008, US REN DAT SYST USRD; Nogueira JM, 2009, TRANSPLANTATION, V88, P1371, DOI 10.1097/TP.0b013e3181c1e156; Ommen ES, 2010, AM J TRANSPLANT, V10, P747, DOI 10.1111/j.1600-6143.2009.02994.x; Ommen ES, 2006, CLIN J AM SOC NEPHRO, V1, P885, DOI 10.2215/CJN.00840306; *ORG PROC TRANSPL, AB OPTN DAT; Organ Procurement and Transplantation Network, ORG PROC TRANSPL NET; PAPPAS G, 1990, AM J PUBLIC HEALTH, V80, P1431, DOI 10.2105/AJPH.80.12.1431; RAMIREZ E A, 1991, Ethnicity and Disease, V1, P188; Reeves-Daniel A, 2009, CLIN TRANSPLANT, V23, P39, DOI 10.1111/j.1399-0012.2008.00898.x; Segev DL, 2010, JAMA-J AM MED ASSOC, V303, P959, DOI 10.1001/jama.2010.237; Stevens LA, 2005, J AM SOC NEPHROL, V16, P2439, DOI 10.1681/ASN.2005020192; STORSLEY LJ, 2010, TRANSPLANTATION 0618; TERASAKI PI, 1995, NEW ENGL J MED, V333, P333, DOI 10.1056/NEJM199508103330601; Textor SC, 2004, TRANSPLANTATION, V78, P276, DOI 10.1097/01.TP.0000128168.97735.B3; Wainright JL, 2009, AM J TRANSPLANT, V9, P310; Young CJ, 2000, NEW ENGL J MED, V343, P1545, DOI 10.1056/NEJM200011233432107	39	203	204	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 19	2010	363	8					724	732		10.1056/NEJMoa1000950	http://dx.doi.org/10.1056/NEJMoa1000950			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639TE	20818874	Green Published, Green Accepted			2022-12-01	WOS:000280996600006
J	Guo, Z; Kozlov, S; Lavin, MF; Person, MD; Paull, TT				Guo, Zhi; Kozlov, Sergei; Lavin, Martin F.; Person, Maria D.; Paull, Tanya T.			ATM Activation by Oxidative Stress	SCIENCE			English	Article							TELANGIECTASIA GENE-PRODUCT; ATAXIA-TELANGIECTASIA; DNA-DAMAGE; DEFICIENT MICE; PROTEIN; PHOSPHORYLATION; PURIFICATION; CELLS; ANTIOXIDANTS; MANGANESE	The ataxia-telangiectasia mutated (ATM) protein kinase is activated by DNA double-strand breaks (DSBs) through the Mre11-Rad50-Nbs1 (MRN) DNA repair complex and orchestrates signaling cascades that initiate the DNA damage response. Cells lacking ATM are also hypersensitive to insults other than DSBs, particularly oxidative stress. We show that oxidation of ATM directly induces ATM activation in the absence of DNA DSBs and the MRN complex. The oxidized form of ATM is a disulfide-cross-linked dimer, and mutation of a critical cysteine residue involved in disulfide bond formation specifically blocked activation through the oxidation pathway. Identification of this pathway explains observations of ATM activation under conditions of oxidative stress and shows that ATM is an important sensor of reactive oxygen species in human cells.	[Guo, Zhi; Paull, Tanya T.] Univ Texas Austin, Dept Mol Genet & Microbiol, Howard Hughes Med Inst, Austin, TX 78712 USA; [Guo, Zhi; Paull, Tanya T.] Univ Texas Austin, ICMB, Austin, TX 78712 USA; [Kozlov, Sergei; Lavin, Martin F.] Univ Queensland, Queensland Inst Med Res, Radiat Biol & Oncol Lab, Brisbane, Qld 4006, Australia; [Kozlov, Sergei; Lavin, Martin F.] Univ Queensland, Sch Med, Brisbane, Qld 4006, Australia; [Person, Maria D.] Univ Texas Austin, Coll Pharm, ICMB Analyt Instrumentat Facil Core, Austin, TX 78712 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland; University of Texas System; University of Texas Austin	Paull, TT (corresponding author), Univ Texas Austin, Dept Mol Genet & Microbiol, Howard Hughes Med Inst, Austin, TX 78712 USA.	tpaull@mail.utexas.edu	Lavin, Martin F/F-5961-2014; Guo, Zhi/A-4589-2013; Kozlov, Sergei/M-2067-2014; Kozlov, Sergei/T-9779-2019	Lavin, Martin F/0000-0002-5940-4769; Kozlov, Sergei/0000-0001-6183-7339; Paull, Tanya/0000-0002-2991-651X	NIH [CA132813]; NHMRC [569591]; NIEHS [007784]; NATIONAL CANCER INSTITUTE [R01CA132813] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to members of the Paull laboratory as well as to M. Weitzman for cell lines; to D. Johnson, G. Georgiou, J. Huibregtse, and K. Dalby for discussion; and to C. Walker for communication of data in press. This work was supported by NIH grant CA132813 (Paull laboratory), NHMRC 569591 (Lavin laboratory), and NIEHS 007784 (ICMB mass spectrometry core facility).	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Barzilai A, 2002, DNA REPAIR, V1, P3, DOI 10.1016/S1568-7864(01)00007-6; Bencokova Z, 2009, MOL CELL BIOL, V29, P526, DOI 10.1128/MCB.01301-08; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chan DW, 2000, J BIOL CHEM, V275, P7803, DOI 10.1074/jbc.275.11.7803; CHESSA L, 1992, AM J MED GENET, V42, P741, DOI 10.1002/ajmg.1320420524; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Gilad S, 1998, AM J HUM GENET, V62, P551, DOI 10.1086/301755; HaMai D, 2004, NEUROCHEM INT, V44, P223, DOI 10.1016/S0197-0186(03)00152-9; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Kim DY, 2007, J NEUROCHEM, V101, P1316, DOI 10.1111/j.1471-4159.2007.04483.x; Kobayashi M, 2006, GENES CELLS, V11, P779, DOI 10.1111/j.1365-2443.2006.00976.x; KOSOWER NS, 1995, METHOD ENZYMOL, V251, P123, DOI 10.1016/0076-6879(95)51116-4; Kurz EU, 2004, J BIOL CHEM, V279, P53272, DOI 10.1074/jbc.M406879200; Lee JH, 2006, METHOD ENZYMOL, V408, P529, DOI 10.1016/S0076-6879(06)08033-5; Lee SM, 2005, J SHELLFISH RES, V24, P99; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Reliene R, 2008, FOOD CHEM TOXICOL, V46, P1371, DOI 10.1016/j.fct.2007.08.028; Reliene R, 2007, J NUTR, V137, p229S, DOI 10.1093/jn/137.1.229S; Sasaki M, 2008, FREE RADICAL RES, V42, P625, DOI 10.1080/10715760802244768; Shackelford RE, 2001, J BIOL CHEM, V276, P21951, DOI 10.1074/jbc.M011303200; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Smith GCM, 1999, P NATL ACAD SCI USA, V96, P11134, DOI 10.1073/pnas.96.20.11134; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; Toyoshima M, 1998, AM J MED GENET, V75, P141, DOI 10.1002/(SICI)1096-8628(19980113)75:2<141::AID-AJMG4>3.0.CO;2-W; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; VOS O, 1976, INT J RADIAT BIOL, V29, P513, DOI 10.1080/09553007614550611; Watters D, 1999, J BIOL CHEM, V274, P34277, DOI 10.1074/jbc.274.48.34277	31	767	785	2	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					517	521		10.1126/science.1192912	http://dx.doi.org/10.1126/science.1192912			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966255	Green Submitted			2022-12-01	WOS:000283329100044
J	O'Donnell, MR; Jarand, J; Loveday, M; Padayatchi, N; Zelnick, J; Werner, L; Naidoo, K; Master, I; Osburn, G; Kvasnovsky, C; Shean, K; Pai, M; Van der Walt, M; Horsburgh, CR; Dheda, K				O'Donnell, Max R.; Jarand, Julie; Loveday, Marian; Padayatchi, Nesri; Zelnick, Jennifer; Werner, Lise; Naidoo, Kasavan; Master, Iqbal; Osburn, Garth; Kvasnovsky, Charlotte; Shean, Karen; Pai, Madhukar; Van der Walt, Martie; Horsburgh, Charles R.; Dheda, Keertan			High Incidence of Hospital Admissions With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Among South African Health Care Workers	ANNALS OF INTERNAL MEDICINE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; NOSOCOMIAL TRANSMISSION; RISK; HIV; INFECTION; TB	Background: Nosocomial transmission has been described in extensively drug-resistant tuberculosis (XDR-TB) and HIV co-infected patients in South Africa. However, little is known about the rates of drug-resistant tuberculosis among health care workers in countries with high tuberculosis and HIV burden. Objective: To estimate rates of multidrug-resistant tuberculosis (MDR-TB) and XDR-TB hospitalizations among health care workers in KwaZulu-Natal, South Africa. Design: Retrospective study of patients with drug-resistant tuberculosis who were admitted from 2003 to 2008 for the initiation of drug-resistant tuberculosis therapy. Setting: A public tuberculosis referral hospital in KwaZulu-Natal, South Africa. Participants: 231 health care workers and 4151 non-health care workers admitted for initiation of MDR-TB or XDR-TB treatment. Measurements: Hospital admission rates and hospital admission incidence rate ratios. Results: Estimated incidence of MDR-TB hospitalization was 64.8 per 100 000 health care workers versus 11.9 per 100 000 non-health care workers (incidence rate ratio, 5.46 [95% CI, 4.75 to 6.28]). Estimated incidence of XDR-TB hospitalizations was 7.2 per 100 000 health care workers versus 1.1 per 100 000 non-health care workers (incidence rate ratio, 6.69 [CI, 4.38 to 10.20]). A higher percentage of health care workers than non-health care workers with MDR-TB or XDR-TB were women (78% vs. 47%; P < 0.001), and health care workers were less likely to report previous tuberculosis treatment (41% vs. 92%; P < 0.001). HIV infection did not differ between health care workers and nonhealth care workers (55% vs. 57%); however, among HIV-infected patients, a higher percentage of health care workers were receiving antiretroviral medications (63% vs. 47%; P < 0.001). Limitation: The study had an observational retrospective design, is subject to referral bias, and had no information on type of health care work or duration of occupational exposure to tuberculosis. Conclusion: Health care workers in this HIV-endemic area were substantially more likely to be hospitalized with either MDR-TB or XDR-TB than were non-health care workers. The increased risk may be explained by occupational exposure, underlining the urgent need for tuberculosis infection-control programs.	Boston Univ, Sch Med, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Boston, MA USA; Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa, Durban, South Africa; Univ Calgary, Calgary, AB, Canada; MRC, Cape Town, South Africa; Salem State Coll, Sch Social Work, Salem, MA 01970 USA; King George V Mem Hosp, Sydenham, South Africa; Emory Univ, Sch Med, Atlanta, GA USA; Rollins Sch Publ Hlth, Atlanta, GA USA; UCL, London, England; McGill Univ, Montreal, PQ, Canada	Boston University; Boston University; University of Kwazulu Natal; University of Calgary; Massachusetts System of Public Higher Education; Salem State University; Emory University; Emory University; Rollins School Public Health; University of London; University College London; McGill University	O'Donnell, MR (corresponding author), Albert Einstein Coll Med, Div Pulm Med, 1301 Morris Pk Ave, Bronx, NY 10461 USA.	max.odonnell@einstein.yu.edu	Mitchell, Ellen/H-5475-2013; Loveday, Marian/M-8016-2013; Pai, Madhukar/AAX-9901-2021; padayatchi, nesri/Q-2780-2019; van der Walt, Martie/CAH-0101-2022; PAL, MRINAL/ABG-9676-2020	Loveday, Marian/0000-0001-9205-9314; Pai, Madhukar/0000-0003-3667-4536; padayatchi, nesri/0000-0003-2543-9071; van der Walt, Martie/0000-0001-9987-3167; PAL, MRINAL/0000-0002-1032-272X; Naidoo, Kogieleum/0000-0002-8874-6661; Horsburgh, C./0000-0001-6838-7895	National Institutes of Health, National Institutes of Allergy and Infectious Diseases [T32 AI52074]; American Thoracic Society; Centre for AIDS Programme of Research; National Institutes of Health; U.S. Department of Health and Human Services the Centre for AIDS Programme of Research [A1069469]; Fogarty International Center, National Institutes of Health [D43TW00231]; Canadian Institutes of Health Research; FOGARTY INTERNATIONAL CENTER [D43TW000231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069469, T32AI052074] Funding Source: NIH RePORTER	National Institutes of Health, National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Thoracic Society; Centre for AIDS Programme of Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Health and Human Services the Centre for AIDS Programme of Research; Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr. O'Donnell was supported by the National Institutes of Health (T32 AI52074; National Institutes of Allergy and Infectious Diseases) and an American Thoracic Society Career Development Award. In addition, Drs. O'Donnell and Padayatchi were supported by the Centre for AIDS Programme of Research. The National Institutes of Health and the U.S. Department of Health and Human Services funds the Centre for AIDS Programme of Research (A1069469). Dr. Padayatchi was also supported by Columbia University-Southern African Fogarty AIDS International Training and Research Programme funded by the Fogarty International Center, National Institutes of Health (D43TW00231). Dr. Pai is supported by a New Investigator Award from the Canadian Institutes of Health Research. These funding sources played no role in the study design or data analysis.	Askew GL, 1997, PEDIATRICS, V100, P19, DOI 10.1542/peds.100.1.19; Basu S, 2008, EPIDEMIOL INFECT, V136, P1585, DOI 10.1017/S0950268808000964; Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5; BUTHELEZI S, 2008, 2 GLOB XDR TB TASK F; *CDCP, 2006, MMWR-MORBID MORTAL W, V55, P1176; CLEVELAND JL, 1995, INFECT CONT HOSP EP, V16, P7; Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8; Dimitrova B, 2005, INT J TUBERC LUNG D, V9, P43; DOOLEY SW, 1992, JAMA-J AM MED ASSOC, V267, P2632, DOI 10.1001/jama.267.19.2632; Galgalo T, 2008, INT J TUBERC LUNG D, V12, P949; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; GANDHI NR, 2006, JAMA-J AM MED ASSOC, V296, P2927; GANDHI NR, 2008, J CLIN EPIDEMIOL, V61, P344; *HLTH SYST TRUST, 2007, S AFR HLTH REV; James P, 2009, INT J TUBERC LUNG D, V13, P795; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Karim QA, 2002, INT J EPIDEMIOL, V31, P37, DOI 10.1093/ije/31.1.37; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Naidoo S, 2006, INT J TUBERC LUNG D, V10, P676; O'Donnell MR, 2009, INT J TUBERC LUNG D, V13, P855; PEARSON ML, 1992, ANN INTERN MED, V117, P191, DOI 10.7326/0003-4819-117-3-191; Raviglione MC, 2007, NEW ENGL J MED, V356, P656, DOI 10.1056/NEJMp068273; REISNER BS, 1995, DIAGN MICR INFEC DIS, V22, P325, DOI 10.1016/0732-8893(95)00147-7; Rusch-Gerdes S, 2006, J CLIN MICROBIOL, V44, P688, DOI 10.1128/JCM.44.3.688-692.2006; Sotgiu G, 2008, INT J TUBERC LUNG D, V12, P606; *STAT S AFR, 2007, S AFR COMM SURV; *STAT S AFR, 2001, S AFR NAT POP CENS; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; World Health Organization, 2009, WHO POL TB INF CONTR; World Health Organization, 2008, GLOB TUB CONTR SURV; Zelnick J, 2005, J PUBLIC HEALTH POL, V26, P163, DOI 10.1057/palgrave.jphp.3200021	33	146	151	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 19	2010	153	8					516	522		10.7326/0003-4819-153-8-201010190-00008	http://dx.doi.org/10.7326/0003-4819-153-8-201010190-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	665SA	20956708	Green Accepted			2022-12-01	WOS:000283054600004
J	Rodriguez-Trigo, G; Zock, JP; Pozo-Rodriguez, F; Gomez, FP; Monyarch, G; Bouso, L; Coll, MD; Verea, H; Anto, JM; Fuster, C; Barbera, JA				Rodriguez-Trigo, Gema; Zock, Jan-Paul; Pozo-Rodriguez, Francisco; Gomez, Federico P.; Monyarch, Gemma; Bouso, Laura; Dolors Coll, M.; Verea, Hector; Anto, Josep M.; Fuster, Carme; Albert Barbera, Joan		SEPAR Soc Espanola Neumologia Ciru	Health Changes in Fishermen 2 Years After Clean-up of the Prestige Oil Spill	ANNALS OF INTERNAL MEDICINE			English	Article							EXHALED BREATH CONDENSATE; CHROMOSOMAL-ABERRATIONS; OXIDATIVE STRESS; TANKER BRAER; INCREASED 8-ISOPROSTANE; ASTHMATIC-CHILDREN; REFERENCE VALUES; CANCER-RISK; EXPOSURE; BIOMARKERS	Background: In 2002, the oil tanker Prestige spilled more than 67 000 tons of bunker oil, heavily contaminating the coast of northwestern Spain. Objective: To assess respiratory effects and chromosomal damage in clean-up workers of the oil spill 2 years after the exposure. Design: Cross-sectional study. Setting: Fishermen cooperatives in coastal villages. Participants: Local fishermen who were highly exposed (n = 501) or not exposed (n = 177) to oil 2 years after the spill. Measurements: Respiratory symptoms; forced spirometry; methacholine challenge; markers of oxidative stress (8-isoprostane), airway inflammation (interleukins, tumor necrosis factor-alpha, and interferon-gamma), and growth factor activity in exhaled breath condensate; and chromosomal lesions and structural alterations in circulating lymphocytes. Results: Compared with nonexposed participants, persons exposed to oil were at increased risk for lower respiratory tract symptoms (risk difference, 8.0 [95% CI, 1.1 to 14.8]). Lung function did not significantly differ between the groups. Among nonsmoking participants, exposed individuals had higher exhaled 8-isoprostane levels than nonexposed individuals (geometric mean ratio, 2.5 [CI, 1.7 to 3.7]), and exposed individuals with lower respiratory tract symptoms had higher 8-isoprostane levels than those of exposed individuals without symptoms. Exposed nonsmoking participants also had higher levels of exhaled vascular endothelial growth factor (risk difference, 44.8 [CI, 27.9 to 61.6]) and basic fibroblast growth factor (risk difference, 16.0 [CI, 3.5 to 28.6]). A higher proportion of exposed participants had structural chromosomal alterations (risk difference, 27.4 [CI, 10.0 to 44.8]), predominantly unbalanced alterations. The risk for elevated levels of exhaled 8-isoprostane, vascular endothelial growth factor, and basic fibroblast growth factor and structural chromosomal alterations seemed to increase with intensity of exposure to clean-up work. Limitations: The clinical significance of exhaled biomarkers and chromosomal findings are uncertain. The association between oil exposure and the observed changes may not be causal. The findings may not apply to spills involving other types of oil or to different populations of oil spill workers. Conclusion: Participation in clean-up of a major oil spill was associated with persistent respiratory symptoms, elevated markers of airway injury in breath condensate, and chromosomal damage.	Complexo Hosp Univ A Coruna, La Coruna, Spain; Hosp Clin San Carlos, Madrid, Spain; Univ Hosp 12 Octubre, Madrid, Spain; Autonomous Univ Barcelona, Ctr Res Environm Epidemiol CREAL, Hosp Clin Inst Invest Biomed August Pi & Sunyer I, IMIM Hosp Mar,CIBERESP,Municipal Inst Med Res, Barcelona, Spain; Pompeu Fabra Univ, Barcelona, Spain; Ctr Invest Biomed Red Enfermedades Resp CIBERES, Bunyola, Mallorca, Spain	Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Hospital Clinico San Carlos; Hospital Universitario 12 de Octubre; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Barbera, JA (corresponding author), Hosp Clin Barcelona, Serv Pneumol, Villarroel 170, E-08036 Barcelona, Spain.	jbarbera@clinic.ub.es	Zock, Jan-Paul/P-5034-2018; Burgos, Felip/J-3055-2014; Burgos, Felip/E-5734-2015; Anto, J M/H-2676-2014	Zock, Jan-Paul/0000-0002-2941-6259; Burgos, Felip/0000-0002-4938-4581; Burgos, Felip/0000-0002-4938-4581; Anto, J M/0000-0002-4736-8529; Barbera, Joan Albert/0000-0003-1469-4990; Serrano-Mollar, Anna/0000-0002-4990-8162	Complexo Hospitalario Universitario A Coruna; Instituto de Salud Carlos III/European Regional Development Fund [PI03/1685, PI05/0548, BAE 06/90018, 01-3058]; SEPAR; Centro de Investigacion en Red de Enfermedades Respiratorias	Complexo Hospitalario Universitario A Coruna; Instituto de Salud Carlos III/European Regional Development Fund(Instituto de Salud Carlos IIIEuropean Commission); SEPAR; Centro de Investigacion en Red de Enfermedades Respiratorias	The authors thank the participating fishermen, the staff of their cooperatives, and the efforts made by A. Devesa; the SEPAR-Prestige data collection team (Y. Torralba, A. Souto, M. Rodriguez-Valcarcel, and L. Vazquez-Rey) for their outstanding work; the staff of Complexo Hospitalario Universitario A Coruna (S. Lamela, E. Rodriguez, M. Garea, and M. Saleta) for their support; D. Macfarlane for assistance with data management and reviewing the manuscript; A. Espinosa for her contribution to the statistical analyses; A. Serrano-Mollar and G. Gay for analysis of EBC; A. Lopez-Rodriguez and C. Rodriguez-Escudero, formerly of Servizo Galego de Saude, for their valuable collaboration; and J.L. Alvarez-Sala and J. Ancochea, past presidents of SEPAR, for their initiative and continuous support.; By Instituto de Salud Carlos III/European Regional Development Fund (grants PI03/1685 and PI05/0548), SEPAR, and Centro de Investigacion en Red de Enfermedades Respiratorias. The Instituto de Salud Carlos III/European Regional Development Fund also provided grants to Dr. Rodriguez-Trigo (grant BAE 06/90018) and Dr. Zock (grant Miguel Servet 01-3058).	*AG TOX SUBST DIS, 1995, TOX PROF FUEL OILS A; [Anonymous], 2009, OIL TANK SPILL STAT; Antczak Adam, 2002, Int J Occup Med Environ Health, V15, P317; Au WW, 2007, INT J HYG ENVIR HEAL, V210, P239, DOI 10.1016/j.ijheh.2006.11.001; Barreto M, 2009, CHEST, V135, P66, DOI 10.1378/chest.08-0722; Beinert T, 1999, Eur J Med Res, V4, P328; Biernacki WA, 2003, THORAX, V58, P294, DOI 10.1136/thorax.58.4.294; Bonassi S, 2008, CARCINOGENESIS, V29, P1178, DOI 10.1093/carcin/bgn075; CAMPBELL D, 1993, BRIT MED J, V307, P1251, DOI 10.1136/bmj.307.6914.1251; CAMPBELL D, 1994, BRIT MED J, V309, P773, DOI 10.1136/bmj.309.6957.773; Celik M, 2007, MUTAT RES-GEN TOX EN, V627, P158, DOI 10.1016/j.mrgentox.2006.11.003; Cole J, 1997, ENVIRON MOL MUTAGEN, V30, P97; Fedorov IA, 2005, THORAX, V60, P389, DOI 10.1136/thx.2004.030262; Forni A, 1996, ENVIRON HEALTH PERSP, V104, P1309, DOI 10.2307/3433181; Frohling S, 2008, NEW ENGL J MED, V359, P722, DOI 10.1056/NEJMra0803109; Hagmar L, 2004, CANCER RES, V64, P2258, DOI 10.1158/0008-5472.CAN-03-3360; Holeckova B, 2004, ANN AGR ENV MED, V11, P175; Horvath I, 2005, EUR RESPIR J, V26, P523, DOI 10.1183/09031936.05.00029705; Idali F, 2006, EUR RESPIR J, V27, P451, DOI 10.1183/09031936.06.00067105; *INT AG RES CANC, 1998, IARC MON OV EV CA S7, V1; Jang An-Soo, 2007, Korean Journal of Internal Medicine, V22, P8; Koutsokera A, 2008, CURR MED CHEM, V15, P620; Laffon B, 2006, FOOD CHEM TOXICOL, V44, P1714, DOI 10.1016/j.fct.2006.05.010; Leung TF, 2005, INT ARCH ALLERGY IMM, V137, P66, DOI 10.1159/000085106; LITTLEFIELD LG, 1986, MUTAT RES, V170, P145, DOI 10.1016/0165-1218(86)90028-5; Lyons RA, 1999, J EPIDEMIOL COMMUN H, V53, P306, DOI 10.1136/jech.53.5.306; McHale Cliona M, 2008, J Natl Cancer Inst Monogr, P74, DOI 10.1093/jncimonographs/lgn010; Meo SA, 2008, MAR POLLUT BULL, V56, P88, DOI 10.1016/j.marpolbul.2007.09.039; Montuschi P, 1999, AM J RESP CRIT CARE, V160, P216, DOI 10.1164/ajrccm.160.1.9809140; Montuschi P, 2000, AM J RESP CRIT CARE, V162, P1175, DOI 10.1164/ajrccm.162.3.2001063; Norppa H, 2006, MUTAT RES-FUND MOL M, V600, P37, DOI 10.1016/j.mrfmmm.2006.05.030; Norppa H, 2004, TOXICOL LETT, V149, P309, DOI 10.1016/j.toxlet.2003.12.042; Pelclova D, 2008, IND HEALTH, V46, P484, DOI 10.2486/indhealth.46.484; Perez-Cadahia B, 2008, MUTAT RES-GEN TOX EN, V653, P117, DOI 10.1016/j.mrgentox.2008.04.002; Perez-Cadahia B, 2007, ENVIRON INT, V33, P176, DOI 10.1016/j.envint.2006.09.006; Podechard N, 2008, TOXICOL LETT, V177, P130, DOI 10.1016/j.toxlet.2008.01.006; ROCA J, 1986, B EUR PHYSIOPATH RES, V22, P217; Rodriguez-Trigo G, 2007, ARCH BRONCONEUMOL, V43, P628; Roma-Torres J, 2006, MUTAT RES-GEN TOX EN, V604, P19, DOI 10.1016/j.mrgentox.2005.12.005; Rossner P, 2005, ENVIRON HEALTH PERSP, V113, P517, DOI 10.1289/ehp.6925; Shaffer LG, 2009, HUMAN GENETICS, DOI DOI 10.1007/S00439-009-0726-6; SPRENT J, 1994, SCIENCE, V265, P1395, DOI 10.1126/science.8073282; Tompa A, 2005, INT J HYG ENVIR HEAL, V208, P509, DOI 10.1016/j.ijheh.2005.01.029; Zhang LP, 2002, CRIT REV TOXICOL, V32, P1, DOI 10.1080/20024091064165; Zock JP, 2007, AM J RESP CRIT CARE, V176, P610, DOI 10.1164/rccm.200701-016OC	45	54	55	0	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 19	2010	153	8					489	498		10.7326/0003-4819-153-8-201010190-00279	http://dx.doi.org/10.7326/0003-4819-153-8-201010190-00279			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	665SA	20733177				2022-12-01	WOS:000283054600001
J	Garattini, S; Bertele, V				Garattini, Silvio; Bertele, Vittorio			Personal View Rosiglitazone and the need for a new drug safety agency	BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK		[Garattini, Silvio] Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy; [Bertele, Vittorio] Mario Negri Inst Pharmacol Res, Drug Regulatory Policies Lab, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Garattini, S (corresponding author), Mario Negri Inst Pharmacol Res, Via Eritrea 62, I-20157 Milan, Italy.	silvio.garattini@marionegri.it	Garattini, Silvio/AAA-6390-2020; Bertele, Vittorio/AAA-6461-2020	Garattini, Silvio/0000-0003-0647-9297; Bertele, Vittorio/0000-0002-0032-7033				Cohen D, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5291; Green J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4444; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; James WPT, 2010, NEW ENGL J MED, V363, P905, DOI 10.1056/NEJMoa1003114; Juni P, 2004, LANCET, V364, P2021, DOI 10.1016/S0140-6736(04)17514-4; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761	6	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 6	2010	341								c5506	10.1136/bmj.c5506	http://dx.doi.org/10.1136/bmj.c5506			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	663JE	20926483				2022-12-01	WOS:000282879400010
J	Korley, FK; Pham, JC; Kirsch, TD				Korley, Frederick Kofi; Pham, Julius Cuong; Kirsch, Thomas Dean			Use of Advanced Radiology During Visits to US Emergency Departments for Injury-Related Conditions, 1998-2007	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CERVICAL-SPINE INJURY; COMPUTED-TOMOGRAPHY; TRAUMA PATIENTS; RADIATION-EXPOSURE; BLUNT TRAUMA; HEAD TRAUMA; CT; RADIOGRAPHY; CRITERIA; RULE	Context Excessive use of medical imaging increases health care costs and exposure to ionizing radiation (a potential carcinogen) without yielding significant benefits to all patients. Objective To determine whether there has been a change in the prevalence of emergency department visits for injury-related conditions for which computed tomography (CT) or magnetic resonance imaging (MRI) was obtained and whether there has been a change in the diagnosis of life-threatening conditions and patient disposition. Design, Setting, and Participants Retrospective cross-sectional analysis of emergency department visits using data from the National Hospital Ambulatory Medical Care Survey (1998-2007). Sampled visits were weighted to produce estimates for the United States. Main Outcomes Measures Proportion of visits for injury-related conditions during which a CT or MRI was obtained, a life-threatening condition was diagnosed (eg, cervical spine fracture, skull fracture, intracranial bleeding, liver and spleen laceration), and which resulted in hospital and intensive care unit admission. Results The prevalence of CT or MRI use during emergency department visits for injury-related conditions increased from 6% (95% confidence interval [CI], 5%-7%) (257 of 5237 visits) in 1998 to 15% (95% CI, 14%-17%) (981 of 6567 visits) in 2007 (P<.001 for trend). There was a small increase in the prevalence of life-threatening conditions (1.7% [95% CI, 1.2%-2.2%; 59 of 5237 visits] in 1998 and 2.0% [95% CI, 1.6%-2.5%; 142 of 6567 visits] in 2007; P=.04 for trend). There was no change in prevalence of visits during which patients were either admitted to the hospital (5.9% [95% CI, 4.9%-6.9%] in 1998 and 5.5% [95% CI, 4.7%-6.5%] in 2007; P=.50 for trend) or to an intensive care unit (0.62% [95% CI, 0.40%-1.00%] in 1998 and 0.80% [95% CI, 0.53%-1.21%] in 2007; P=.14 for trend). Visits during which CT or MRI was obtained lasted 126 minutes (95% CI, 123-131 minutes) longer than those for which CT or MRI was not obtained. Conclusion From 1998 to 2007, the prevalence of CT or MRI use during emergency department visits for injury-related conditions increased significantly, without an equal increase in the prevalence of life-threatening conditions. JAMA. 2010; 304(13): 1465-1471	[Korley, Frederick Kofi; Pham, Julius Cuong; Kirsch, Thomas Dean] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD USA; [Pham, Julius Cuong] Johns Hopkins Univ, Sch Med, Dept Anesthesia & Crit Care Med, Baltimore, MD USA; [Kirsch, Thomas Dean] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Korley, FK (corresponding author), 5801 Smith Ave,Davis Bldg,Ste 3220, Baltimore, MD 21209 USA.	fkorley1@jhmi.edu			National Center Research Resources, National Institutes of Health (NIH) [5KL2RR025006]; NIH Roadmap for Medical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025006] Funding Source: NIH RePORTER	National Center Research Resources, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Dr Korley is supported by the Robert E. Meyerhoff Professorship at the Johns Hopkins University School of Medicine, and by grant 5KL2RR025006 from the National Center Research Resources, a component of the National Institutes of Health (NIH), and the NIH Roadmap for Medical Research.	[Anonymous], 2014, INT CLASS DIS 9 REV; Atzema C, 2004, ANN EMERG MED, V44, P47, DOI 10.1016/j.annemergmed.2004.02.032; Baker LC, 2008, HEALTH AFFAIR, V27, P1467, DOI 10.1377/hlthaff.27.6.1467; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Boland GWL, 2009, EUR RADIOL, V19, P9, DOI 10.1007/s00330-008-1159-7; Boone John M, 2008, J Am Coll Radiol, V5, P132, DOI 10.1016/j.jacr.2007.07.008; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Broder J, 2007, EMERG RADIOL, V14, P227, DOI 10.1007/s10140-007-0618-9; Broder J, 2006, EMERG RADIOL, V13, P25, DOI 10.1007/s10140-006-0493-9; Charlson ME, 2005, J GEN INTERN MED, V20, P497, DOI 10.1111/j.1525-1497.2005.0085.x; Deunk J, 2009, J TRAUMA, V66, P1108, DOI 10.1097/TA.0b013e31817e55c3; Doria AS, 2006, RADIOLOGY, V241, P83, DOI 10.1148/radiol.2411050913; Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; Griffen MM, 2003, J TRAUMA, V55, P222, DOI 10.1097/01.TA.0000083332.93868.E2; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Holmes JF, 2005, J TRAUMA, V58, P902, DOI 10.1097/01.TA.0000162138.36519.2A; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lee CI, 2004, RADIOLOGY, V231, P393, DOI 10.1148/radiol.2312030767; MADDEN C, 1995, ACAD EMERG MED, V2, P248, DOI 10.1111/j.1553-2712.1995.tb03217.x; Markel TA, 2009, J TRAUMA, V67, P23, DOI 10.1097/TA.0b013e318184ba9a; McCaig L F, 1994, Vital Health Stat 1, P1; Mitchell AM, 2007, J THROMB HAEMOST, V5, P50, DOI 10.1111/j.1538-7836.2006.02251.x; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; National Academies/National Research Council, 2006, HLTH RISKS EXP LOW L; Pham JC, 2009, ACAD EMERG MED, V16, P949, DOI 10.1111/j.1553-2712.2009.00515.x; Pines JM, 2009, MED CARE, V47, P782, DOI 10.1097/MLR.0b013e31819748e9; PITTS SR, 2008, NATL HLTH STAT REPOR, V7, P1; Prologo JD, 2004, AM J ROENTGENOL, V183, P1093, DOI 10.2214/ajr.183.4.1831093; Salim A, 2006, ARCH SURG-CHICAGO, V141, P468, DOI 10.1001/archsurg.141.5.468; Schneider D, 1979, VITAL HLTH STAT, V2, pi; Self ML, 2003, AM J SURG, V186, P609, DOI 10.1016/j.amjsurg.2003.08.003; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841; Tien HC, 2007, J TRAUMA, V62, P151, DOI 10.1097/TA.0b013e31802d9700; U.S. Government Accountability Office, MEDICARE B	36	253	257	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2010	304	13					1465	1471		10.1001/jama.2010.1408	http://dx.doi.org/10.1001/jama.2010.1408			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658SO	20924012	Bronze			2022-12-01	WOS:000282509900022
J	Keevil, SF; Krestin, GP				Keevil, Stephen F.; Krestin, Gabriel P.			EMF directive still poses a risk to MRI research in Europe	LANCET			English	Editorial Material							EXPOSURE; WORKERS; FUTURE		[Keevil, Stephen F.] Guys & St Thomas NHS Fdn Trust, Dept Med Phys, London SE1 7EH, England; [Keevil, Stephen F.] Kings Coll London, Div Imaging Sci, London WC2R 2LS, England; [Krestin, Gabriel P.] Erasmus MC, Univ Med Ctr, Dept Radiol, Rotterdam, Netherlands	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Erasmus University Rotterdam; Erasmus MC	Keevil, SF (corresponding author), Guys & St Thomas NHS Fdn Trust, Dept Med Phys, London SE1 7EH, England.	stephen.keevil@kcl.ac.uk						Ahlbom A, 1998, HEALTH PHYS, V74, P494; Capstick M, 2008, INVESTIGATION OCCUPA; Crozier S, 2007, J MAGN RESON IMAGING, V26, P1261, DOI 10.1002/jmri.21160; Crozier S, 2007, J MAGN RESON IMAGING, V26, P1236, DOI 10.1002/jmri.21162; *EUR PARL, 2008, OFFICIAL J EUR UNI L, V114; *EUR PARL, 2004, OFFICIAL J EUR UNI L, V159; Hill DLG, 2005, ACAD RADIOL, V12, P1135, DOI 10.1016/j.acra.2005.05.023; International Electrotechnical Commission, 2010, MEDICAL ELECT EQUIPM, V3rd; Keevil SF, 2005, BRIT J RADIOL, V78, P973, DOI 10.1259/bjr/21943393	9	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 2	2010	376	9747					1124	+		10.1016/S0140-6736(10)61387-6	http://dx.doi.org/10.1016/S0140-6736(10)61387-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	663UN	20822810				2022-12-01	WOS:000282915700007
J	Liu, WM; Li, YY; Learn, GH; Rudicell, RS; Robertson, JD; Keele, BF; Ndjango, JBN; Sanz, CM; Morgan, DB; Locatelli, S; Gonder, MK; Kranzusch, PJ; Walsh, PD; Delaporte, E; Mpoudi-Ngole, E; Georgiev, AV; Muller, MN; Shaw, GM; Peeters, M; Sharp, PM; Rayner, JC; Hahn, BH				Liu, Weimin; Li, Yingying; Learn, Gerald H.; Rudicell, Rebecca S.; Robertson, Joel D.; Keele, Brandon F.; Ndjango, Jean-Bosco N.; Sanz, Crickette M.; Morgan, David B.; Locatelli, Sabrina; Gonder, Mary K.; Kranzusch, Philip J.; Walsh, Peter D.; Delaporte, Eric; Mpoudi-Ngole, Eitel; Georgiev, Alexander V.; Muller, Martin N.; Shaw, George M.; Peeters, Martine; Sharp, Paul M.; Rayner, Julian C.; Hahn, Beatrice H.			Origin of the human malaria parasite Plasmodium falciparum in gorillas	NATURE			English	Article							INFECTION; HIV-1; DIVERSIFICATION; EVOLUTIONARY; PHYLOGENIES; RESERVOIRS; MULTIPLE; ACID; GENE; APES	Plasmodium falciparum is the most prevalent and lethal of the malaria parasites infecting humans, yet the origin and evolutionary history of this important pathogen remain controversial. Here we develop a single-genome amplification strategy to identify and characterize Plasmodium spp. DNA sequences in faecal samples from wild-living apes. Among nearly 3,000 specimens collected from field sites throughout central Africa, we found Plasmodium infection in chimpanzees (Pan troglodytes) and western gorillas (Gorilla gorilla), but not in eastern gorillas (Gorilla beringei) or bonobos (Pan paniscus). Ape plasmodial infections were highly prevalent, widely distributed and almost always made up of mixed parasite species. Analysis of more than 1,100 mitochondrial, apicoplast and nuclear gene sequences from chimpanzees and gorillas revealed that 99% grouped within one of six host-specific lineages representing distinct Plasmodium species within the subgenus Laverania. One of these from western gorillas comprised parasites that were nearly identical to P. falciparum. In phylogenetic analyses of full-length mitochondrial sequences, human P. falciparum formed a monophyletic lineage within the gorilla parasite radiation. These findings indicate that P. falciparum is of gorilla origin and not of chimpanzee, bonobo or ancient human origin.	[Liu, Weimin; Li, Yingying; Learn, Gerald H.; Robertson, Joel D.; Keele, Brandon F.; Shaw, George M.; Rayner, Julian C.; Hahn, Beatrice H.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Rudicell, Rebecca S.; Shaw, George M.; Hahn, Beatrice H.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Ndjango, Jean-Bosco N.] Univ Kisangani, Dept Ecol & Management Plant & Anim Resources, Fac Sci, Kisangani, DEM REP CONGO; [Sanz, Crickette M.] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA; [Sanz, Crickette M.; Morgan, David B.] Wildlife Conservat Soc, Congo Program, Brazzaville, Rep Congo; [Morgan, David B.] Lester E Fisher Ctr Study & Conservat Apes, Chicago, IL 60614 USA; [Locatelli, Sabrina; Gonder, Mary K.] SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA; [Kranzusch, Philip J.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Walsh, Peter D.] VaccinApe, Bethesda, MD USA; [Delaporte, Eric; Peeters, Martine] Univ Montpellier I, F-34394 Montpellier, France; [Delaporte, Eric; Peeters, Martine] Inst Rech Dev, F-34394 Montpellier, France; [Mpoudi-Ngole, Eitel] Ctr Rech Med, Inst Rech Med & Etud Plantes Med Prevent Sida Cam, Yaounde, Cameroon; [Georgiev, Alexander V.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Muller, Martin N.] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA; [Sharp, Paul M.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [Sharp, Paul M.] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh EH9 3JT, Midlothian, Scotland; [Rayner, Julian C.] Wellcome Trust Sanger Inst, Sanger Inst, Malaria Programme, Cambridge CB10 1SA, England	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Washington University (WUSTL); State University of New York (SUNY) System; State University of New York (SUNY) Albany; Harvard University; Harvard Medical School; Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Harvard University; University of New Mexico; University of Edinburgh; University of Edinburgh; Wellcome Trust Sanger Institute	Hahn, BH (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	bhahn@uab.edu	Sharp, Paul/Y-3787-2019; Learn, Gerald H/B-6934-2011; Locatelli, Sabrina/I-5777-2019; Sharp, Paul M/F-5783-2010; Learn, Jerry/E-3356-2012; Delaporte, Eric/J-5397-2018; Sharp, Paul M/GPX-1497-2022; Georgiev, Alexander/C-5061-2015	Learn, Gerald H/0000-0003-0434-7733; Locatelli, Sabrina/0000-0002-1133-0561; Sharp, Paul M/0000-0001-9771-543X; Delaporte, Eric/0000-0002-1822-9853; Sharp, Paul M/0000-0001-9771-543X; Hahn, Beatrice/0000-0002-9400-9887; Rayner, Julian/0000-0002-9835-1014; Georgiev, Alexander/0000-0001-5622-3826	National Institutes of Health [R01 AI50529, R01 AI58715, U19 AI 067854, R03 AI074778, T32 GM008111, T32 AI007245, P30 AI 27767]; BillAMP;Melinda Gates Foundation [37874]; National Science Foundation [0755823]; Agence Nationale de Recherche sur le Sida [12152/12182]; US Fish and Wildlife Service; Arthur L. Greene Fund; Wallace Global Fund; Bristol Myers Freedom to Discover Program; Wellcome Trust; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767, R37AI050529, R03AI074778, R01AI058715, T32AI007245, F32AI007767, U19AI067854, R01AI050529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BillAMP;Melinda Gates Foundation(CGIAR); National Science Foundation(National Science Foundation (NSF)); Agence Nationale de Recherche sur le Sida(ANRSFrench National Research Agency (ANR)); US Fish and Wildlife Service(US Fish & Wildlife Service); Arthur L. Greene Fund; Wallace Global Fund; Bristol Myers Freedom to Discover Program; Wellcome Trust(Wellcome TrustEuropean Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Neel, S. Loul, A. Mebanga, B. Yangda and F. Liegeois for field work in Cameroon; the Cameroonian Ministries of Health, Forestry and Wildlife, and Research for permission to collect samples in Cameroon; the Water and Forest Ministry for permission to collect samples in the Central African Republic; the Ministries of Science and Technology and Forest Economy for permission to collect samples in the Republic of the Congo; the Ministry of Scientific Research and Technology and the Department of Ecology and Management of Plant and Animal Resources of the University of Kisangani for permission to collect samples in the Democratic Republic of the Congo; M. Ndunda, S. Coxe, A. Lokasola, A. Todd and the staff of the World Wildlife Fund in the Central African Republic for logistical support; R. Carter for helpful discussions; M. Salazar, Y. Chen and B. Cochran for technical assistance; and J. White for artwork and manuscript preparation. This work was supported by grants from the National Institutes of Health (R01 AI50529, R01 AI58715, U19 AI 067854, R03 AI074778, T32 GM008111, T32 AI007245, P30 AI 27767), the Bill&Melinda Gates Foundation(37874), the National Science Foundation (0755823), the Agence Nationale de Recherche sur le Sida (12152/12182), the Great Ape Conservation Fund of the US Fish and Wildlife Service, the Arthur L. Greene Fund, the Wallace Global Fund, the Bristol Myers Freedom to Discover Program and the Wellcome Trust. R. S. R. was supported by a Howard Hughes Medical Institute Med-into-Grad Fellowship.	BRAY RS, 1958, AM J TROP MED HYG, V7, P20, DOI 10.4269/ajtmh.1958.7.20; Brown WM, 2004, BIOCHEMISTRY-US, V43, P6219, DOI 10.1021/bi049892w; Carter R, 2002, CLIN MICROBIOL REV, V15, P564, DOI 10.1128/CMR.15.4.564-594.2002; Coluzzi M, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P277; Duval L, 2010, P NATL ACAD SCI USA, V107, P10561, DOI 10.1073/pnas.1005435107; Duval L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005520; ESCALANTE AA, 1995, MOL BIOL EVOL, V12, P616; ESCALANTE AA, 1994, P NATL ACAD SCI USA, V91, P11373, DOI 10.1073/pnas.91.24.11373; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Jeffares DC, 2007, NAT GENET, V39, P120, DOI 10.1038/ng1931; Kappe SHI, 2010, SCIENCE, V328, P862, DOI 10.1126/science.1184785; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Keele BF, 2009, J EXP MED, V206, P1117, DOI 10.1084/jem.20082831; Krief S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000765; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Li Y., 2010, P 17 C RETR OPP INF; Liu WM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000097; Martin MJ, 2005, P NATL ACAD SCI USA, V102, P12819, DOI 10.1073/pnas.0503819102; Neel C, 2010, J VIROL, V84, P1464, DOI 10.1128/JVI.02129-09; Nwakanma DC, 2009, J INFECT DIS, V199, P1567, DOI 10.1086/598856; Ollomo B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000446; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Prugnolle F, 2010, P NATL ACAD SCI USA, V107, P1458, DOI 10.1073/pnas.0914440107; Rich SM, 1998, P NATL ACAD SCI USA, V95, P4425, DOI 10.1073/pnas.95.8.4425; Rich SM, 2009, P NATL ACAD SCI USA, V106, P14902, DOI 10.1073/pnas.0907740106; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; SIMMONDS P, 1990, J VIROL, V64, P864, DOI 10.1128/JVI.64.2.864-872.1990; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Su XZ, 2003, MICROBES INFECT, V5, P891, DOI 10.1016/S1286-4579(03)00173-4; Talman AM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-140; VAN HEUVERSWYN F, 2007, VIROLOGY, V368, P155	37	366	370	1	186	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2010	467	7314					420	+		10.1038/nature09442	http://dx.doi.org/10.1038/nature09442			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KO	20864995	Green Accepted			2022-12-01	WOS:000282090200034
J	Zhang, FL; Saha, S; Shabalina, SA; Kashina, A				Zhang, Fangliang; Saha, Sougata; Shabalina, Svetlana A.; Kashina, Anna			Differential Arginylation of Actin Isoforms Is Regulated by Coding Sequence-Dependent Degradation	SCIENCE			English	Article							N-END RULE; RNA-PROTEIN TRANSFERASE; CELLS; IDENTIFICATION; TRANSLATION; RIBOSOME; PATHWAY	The mammalian cytoskeletal proteins beta- and gamma-actin are highly homologous, but only beta-actin is amino-terminally arginylated in vivo, which regulates its function. We examined the metabolic fate of exogenously expressed arginylated and nonarginylated actin isoforms. Arginylated gamma-actin, unlike beta-, was highly unstable and was selectively ubiquitinated and degraded in vivo. This instability was regulated by the differences in the nucleotide coding sequence between the two actin isoforms, which conferred different translation rates. gamma-actin was translated more slowly than beta-actin, and this slower processing resulted in the exposure of a normally hidden lysine residue for ubiquitination, leading to the preferential degradation of gamma-actin upon arginylation. This degradation mechanism, coupled to nucleotide coding sequence, may regulate protein arginylation in vivo.	[Zhang, Fangliang; Saha, Sougata; Kashina, Anna] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Shabalina, Svetlana A.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA	University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Kashina, A (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA.	akashina@vet.upenn.edu	Shabalina, Svetlana/N-8939-2013	Shabalina, Svetlana/0000-0003-2272-7473	NIH [5R01HL084419]; W. W. Smith Charitable Trust; Philip Morris Research Management Group; NIH, National Center for Biotechnology Information; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084419] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. W. Smith Charitable Trust; Philip Morris Research Management Group; NIH, National Center for Biotechnology Information(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank R. Dominguez for help with actin structure analysis and the preparation of fig. S15; D. Volgin for helpful suggestions on quantitative polymerase chain reaction; S. Fuchs, Y. Goldman, and J. M. Murray for helpful discussions; and S. Kurosaka for critical reading of the manuscript. This work was supported by NIH grant 5R01HL084419 and W. W. Smith Charitable Trust and Philip Morris Research Management Group awards to A. K. and by the Intramural Research Program of NIH, National Center for Biotechnology Information, to S.A.S.	BALZI E, 1990, J BIOL CHEM, V265, P7464; Condeelis J, 2005, BIOL CELL, V97, P97; ELIAS S, 1990, J BIOL CHEM, V265, P15511; FERBER S, 1987, NATURE, V326, P808, DOI 10.1038/326808a0; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; GONDA DK, 1989, J BIOL CHEM, V264, P16700; GROLLMAN AP, 1967, J BIOL CHEM, V242, P3226; Hofer D, 1997, J CELL SCI, V110, P765; Karakozova M, 2006, SCIENCE, V313, P192, DOI 10.1126/science.1129344; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Kwon YT, 1999, MOL CELL BIOL, V19, P182; LOPO AC, 1989, BIOCHEM J, V258, P553, DOI 10.1042/bj2580553; OTEY CA, 1986, J CELL BIOL, V102, P1726, DOI 10.1083/jcb.102.5.1726; OTEY CA, 1987, J CELL BIOCHEM, V34, P113, DOI 10.1002/jcb.240340205; Rai R, 2005, P NATL ACAD SCI USA, V102, P10123, DOI 10.1073/pnas.0504500102; REDMAN KL, 1984, METHOD ENZYMOL, V106, P179; RUBENSTEIN PA, 1983, J BIOL CHEM, V258, P3961; VAN DEN ENT F, 2001, NATURE, V413, P39; VANDEKERCKHOVE J, 1978, ARCH INT PHYSIOL BIO, V86, P891; VARSHAVSKY A, 1992, CELL, V69, P725, DOI 10.1016/0092-8674(92)90285-K; Wong CCL, 2007, PLOS BIOL, V5, P2231, DOI 10.1371/journal.pbio.0050258	22	139	141	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2010	329	5998					1534	1537		10.1126/science.1191701	http://dx.doi.org/10.1126/science.1191701			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650RK	20847274	Green Accepted			2022-12-01	WOS:000281869000045
J	Hurst, JR; Vestbo, J; Anzueto, A; Locantore, N; Mullerova, H; Tal-Singer, R; Miller, B; Lomas, DA; Agusti, A; MacNee, W; Calverley, P; Rennard, S; Wouters, EFM; Wedzicha, JA				Hurst, John R.; Vestbo, Jorgen; Anzueto, Antonio; Locantore, Nicholas; Muellerova, Hana; Tal-Singer, Ruth; Miller, Bruce; Lomas, David A.; Agusti, Alvar; MacNee, William; Calverley, Peter; Rennard, Stephen; Wouters, Emiel F. M.; Wedzicha, Jadwiga A.		Evaluation COPD Longitudinally	Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COPD EXACERBATIONS; INFLAMMATORY MARKERS; SYMPTOMS; POPULATION; DIAGNOSIS; COHORT	Background: Although we know that exacerbations are key events in chronic obstructive pulmonary disease (COPD), our understanding of their frequency, determinants, and effects is incomplete. In a large observational cohort, we tested the hypothesis that there is a frequent-exacerbation phenotype of COPD that is independent of disease severity. Methods: We analyzed the frequency and associations of exacerbation in 2138 patients enrolled in the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) study. Exacerbations were defined as events that led a care provider to prescribe antibiotics or corticosteroids (or both) or that led to hospitalization (severe exacerbations). Exacerbation frequency was observed over a period of 3 years. Results: Exacerbations became more frequent (and more severe) as the severity of COPD increased; exacerbation rates in the first year of follow-up were 0.85 per person for patients with stage 2 COPD (with stage defined in accordance with Global Initiative for Chronic Obstructive Lung Disease [GOLD] stages), 1.34 for patients with stage 3, and 2.00 for patients with stage 4. Overall, 22% of patients with stage 2 disease, 33% with stage 3, and 47% with stage 4 had frequent exacerbations (two or more in the first year of follow-up). The single best predictor of exacerbations, across all GOLD stages, was a history of exacerbations. The frequent-exacerbation phenotype appeared to be relatively stable over a period of 3 years and could be predicted on the basis of the patient's recall of previous treated events. In addition to its association with more severe disease and prior exacerbations, the phenotype was independently associated with a history of gastroesophageal reflux or heartburn, poorer quality of life, and elevated white-cell count. Conclusions: Although exacerbations become more frequent and more severe as COPD progresses, the rate at which they occur appears to reflect an independent susceptibility phenotype. This has implications for the targeting of exacerbation-prevention strategies across the spectrum of disease severity. (Funded by GlaxoSmithKline; ClinicalTrials.gov number, NCT00292552.) N Engl J Med 2010;363:1128-38.	[Hurst, John R.; Wedzicha, Jadwiga A.] UCL Med Sch, Acad Unit Resp Med, London, England; [Vestbo, Jorgen] Hvidovre Univ Hosp, Copenhagen, Denmark; [Vestbo, Jorgen] Univ Copenhagen, Copenhagen, Denmark; [Vestbo, Jorgen] Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Translat Med, Resp Res Grp, Manchester, Lancs, England; [Lomas, David A.] Univ Cambridge, Dept Med, Cambridge Inst Med Res, Cambridge CB2 2QQ, England; [Calverley, Peter] Univ Liverpool, Sch Clin Sci, Dept Resp Med, Liverpool L69 3BX, Merseyside, England; [Anzueto, Antonio] Univ Texas Hlth Sci Ctr San Antonio, Pulm Sect, San Antonio, TX 78229 USA; [Locantore, Nicholas] GlaxoSmithKline Inc, Res Triangle Pk, NC USA; [Muellerova, Hana] GlaxoSmithKline Inc, London, England; [Tal-Singer, Ruth; Miller, Bruce] GlaxoSmithKline Inc, King Of Prussia, PA USA; [Agusti, Alvar] Hosp Clin Barcelona, Inst Torax, CIBER Enfermedades Resp, Barcelona, Spain; [Agusti, Alvar] Fdn Caubet Cimera, Barcelona, Spain; [MacNee, William] Univ Edinburgh, ELEGI Colt Res Labs, Queens Med Res Inst, MRC Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Rennard, Stephen] Nebraska Med Ctr, Dept Pulm & Crit Care Med, Omaha, NE USA; [Wouters, Emiel F. M.] Maastricht Univ Med Ctr, Dept Resp Med, Maastricht, Netherlands	University of London; University College London; University of Copenhagen; University of Copenhagen; University of Manchester; University of Cambridge; University of Liverpool; University of Texas System; University of Texas Health San Antonio; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; Atencio Primaria de Menorca; University of Edinburgh; University of Nebraska System; University of Nebraska Medical Center; Maastricht University; Maastricht University Medical Centre (MUMC)	Vestbo, J (corresponding author), Univ Copenhagen, Hvidovre Hosp, Dept Cardiol & Resp Med 253, Kettegaard Alle 30, DK-2650 Hvidovre, Denmark.	jorgen.vestbo@manchester.ac.uk	Coxson, Harvey O/A-9861-2017; Vestbo, Jorgen/Y-2912-2019; Wouters, Emiel/ABD-6200-2021; Garcia-Navarro, Alvar Agusti/F-4474-2015; Tal-Singer, Ruth/AAQ-2925-2021	Coxson, Harvey O/0000-0001-5750-9711; Garcia-Navarro, Alvar Agusti/0000-0003-3271-3788; Tal-Singer, Ruth/0000-0002-5275-8062; Vestbo, Jorgen/0000-0001-6355-6362; Hurst, John/0000-0002-7246-6040; Mullerova, Hana/0000-0002-0949-0101; MacNee, William/0000-0002-3692-1448	GlaxoSmithKline; Boehringer Ingelheim; Nycomed; Novartis; AstraZeneca; Chiesi; Talecris; Pfizer; Dey Pharma; Bayer Schering Pharma; Schering-Plough; Almirall; Roche; Esteve; SMB; Biomarck; Centocor; Mpex; Nabi; Otsuka; Able Associates; Adelphi Research; APT Pharma; Britnall; Aradign; CommonHealth; Consult Complete; COPD Forum; Data Monitor; Decision Resource; Defined Health; Dey; Dunn Group; Easton Associates; Equinox; Gerson; Infomed; KOL Connection; M. Pankove; MedaCorp; MDRx Financial; Oriel Therapeutics; Pennside; PharmaVentures; Pharmaxis; PriceWaterhouse; Propagate; Pulmatrix; Reckner Associates; Recruiting Resources; Schlesinger Medical; Scimed; Sudler and Hennessey; TargeGen; Theravance; UBC; Uptake Medical; VantagePoint Management; Respifor; MRC [G0500306, G0800570] Funding Source: UKRI; Medical Research Council [G0500306, G0800570, G9900991B] Funding Source: researchfish	GlaxoSmithKline(GlaxoSmithKline); Boehringer Ingelheim(Boehringer Ingelheim); Nycomed; Novartis(Novartis); AstraZeneca(AstraZeneca); Chiesi(Chiesi Pharmaceuticals Inc); Talecris; Pfizer(Pfizer); Dey Pharma; Bayer Schering Pharma(Bayer AG); Schering-Plough(Merck & CompanySchering Plough Corporation); Almirall(Almirall); Roche(Roche Holding); Esteve; SMB; Biomarck; Centocor; Mpex; Nabi; Otsuka(Otsuka Pharmaceutical); Able Associates; Adelphi Research; APT Pharma; Britnall; Aradign; CommonHealth; Consult Complete; COPD Forum; Data Monitor; Decision Resource; Defined Health; Dey; Dunn Group; Easton Associates; Equinox; Gerson; Infomed; KOL Connection; M. Pankove; MedaCorp; MDRx Financial; Oriel Therapeutics; Pennside; PharmaVentures; Pharmaxis; PriceWaterhouse; Propagate; Pulmatrix; Reckner Associates; Recruiting Resources; Schlesinger Medical; Scimed; Sudler and Hennessey; TargeGen; Theravance; UBC; Uptake Medical; VantagePoint Management; Respifor; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by grants from GlaxoSmithKline (to Drs. Vestbo, Hurst, Anzueto, Lomas, Agusti, MacNee, Calverley, Rennard, Wouters, and Wedzicha).; Dr. Vestbo reports receiving consulting fees from GlaxoSmithKline, Boehringer Ingelheim, Nycomed, Novartis, and AstraZeneca, receiving speaking fees from GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Nycomed, and Talecris, and serving as chairman of the GOLD Scientific Committee; Dr. Hurst, receiving consulting fees from AstraZeneca, speaking fees from AstraZeneca, Chiesi, and Pfizer, and travel support from GlaxoSmithKline and AstraZeneca; Dr. Anzueto, consulting fees, speaking fees, and grants from GlaxoSmithKline and consulting fees and speaking fees from Dey Pharma, Pfizer, Boehringer Ingelheim, Bayer Schering Pharma, and Schering-Plough; Dr. Agusti, consulting fees from Almirall, AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Novartis, Nycomed, and Roche, speaking fees from Almirall, AstraZeneca, Boehringer Ingelheim, Chiesi, Esteve, GlaxoSmithKline, Novartis, and Nycomed, grants from Almirall, GlaxoSmithKline, and Nycomed, and travel support from Almirall, AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Novartis, and Nycomed; Dr. MacNee, consulting fees from Boehringer Ingelheim, SMB, GlaxoSmithKline, Pfizer, and AstraZeneca and speaking fees from GlaxoSmithKline and AstraZeneca; Dr. Calverley, receiving consulting fees from GlaxoSmithKline, AstraZeneca, Nycomed, and Boehringer Ingelheim, speaking fees from GlaxoSmithKline and Nycomed, and travel support from Boehringer Ingelheim and providing expert testimony for Forest and Nycomed; Dr. Rennard, receiving grants from AstraZeneca, Biomarck, Centocor, Mpex, Nabi, Novartis, and Otsuka, consulting or speaking fees from Able Associates, Adelphi Research, APT Pharma and Britnall, Aradign, AstraZeneca, Boehringer Ingelheim, Chiesi, CommonHealth, Consult Complete, COPD Forum, Data Monitor, Decision Resource, Defined Health, Dey, Dunn Group, Easton Associates, Equinox, Gerson, GlaxoSmithKline, Infomed, KOL Connection, M. Pankove, MedaCorp, MDRx Financial, Mpex, Oriel Therapeutics, Otsuka, Pennside, PharmaVentures, Pharmaxis, PriceWaterhouse, Propagate, Pulmatrix, Reckner Associates, Recruiting Resources, Roche, Schlesinger Medical, Scimed, Sudler and Hennessey, TargeGen, Theravance, UBC, Uptake Medical, and VantagePoint Management; Dr. Wouters, consulting fees from GlaxoSmithKline and Nycomed, speaking fees from GlaxoSmithKline, Nycomed, and AstraZeneca, and grants from GlaxoSmithKline and AstraZeneca; and Dr. Wedzicha, speaking fees from GlaxoSmithKline, AstraZeneca, Novartis, Bayer, Boehringer Ingelheim, Chiesi, and Respifor, grants from GlaxoSmithKline, AstraZeneca, Chiesi, and Novartis, and travel reimbursements from Boehringer Ingelheim. Drs. Mullerova, Locantore, Miller, and Tal-Singer are employees of GlaxoSmithKline and report owning stocks and shares of GlaxoSmithKline.	Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Bhowmik A, 2000, THORAX, V55, P114, DOI 10.1136/thorax.55.2.114; Burgel PR, 2009, CHEST, V135, P975, DOI 10.1378/chest.08-2062; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Cella D, 2002, CANCER-AM CANCER SOC, V94, P528, DOI 10.1002/cncr.10245; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; COMSTOCK GW, 1979, AM REV RESPIR DIS, V119, P45; Donaldson GC, 2008, THORAX, V63, P753; Donaldson GC, 2006, THORAX, V61, P164, DOI 10.1136/thx.2005.041806; Donaldson GC, 2005, AM J RESP CRIT CARE, V171, P446, DOI 10.1164/rccm.200408-1054OC; Foreman MG, 2007, EUR RESPIR J, V30, P1124, DOI 10.1183/09031936.00009307; Global Initiative for Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; HAN MK, 2010, AM J RESP CRIT  0602; Kanner RE, 2001, AM J RESP CRIT CARE, V164, P358, DOI 10.1164/ajrccm.164.3.2010017; Langsetmo L, 2008, AM J RESP CRIT CARE, V177, P396, DOI 10.1164/rccm.200708-1290OC; Meguro M, 2007, CHEST, V132, P456, DOI 10.1378/chest.06-0702; Miravitlles M, 2000, RESPIRATION, V67, P495, DOI 10.1159/000067462; Radloff L, 1977, J APPL PSYCHOL MEASU, V3, P385, DOI DOI 10.1177/014662167700100306; Rascon-Aguilar IE, 2006, CHEST, V130, P1096, DOI 10.1378/chest.130.4.1096; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Shahab L, 2006, THORAX, V61, P1043, DOI 10.1136/thx.2006.064410; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Sullivan SD, 2000, CHEST, V117, P5; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Vestbo J, 2008, EUR RESPIR J, V31, P869, DOI 10.1183/09031936.00111707; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8	27	1841	1933	4	149	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2010	363	12					1128	1138		10.1056/NEJMoa0909883	http://dx.doi.org/10.1056/NEJMoa0909883			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649TD	20843247	Green Published, Green Submitted			2022-12-01	WOS:000281795800007
J	Roffi, M				Roffi, Marco			Is there a role for revascularisation in asymptomatic carotid stenosis? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							ARTERY STENOSIS; ENDARTERECTOMY; STROKE; TRIAL; RISK; ANGIOPLASTY; GUIDELINES; MANAGEMENT		[Roffi, Marco] Univ Hosp Geneva, Div Cardiol, Intervent Cardiol Unit, CH-1211 Geneva, Switzerland	University of Geneva	Roffi, M (corresponding author), Univ Hosp Geneva, Div Cardiol, Intervent Cardiol Unit, Rue Micheli-du-Crest 24, CH-1211 Geneva, Switzerland.	Marco.Roffi@hcuge.ch	Spence, J. David/K-6396-2013	Spence, J. David/0000-0001-7478-1098				Aichner FT, 2009, EUR J NEUROL, V16, P902, DOI 10.1111/j.1468-1331.2009.02614.x; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Chaturvedi S, 2005, NEUROLOGY, V65, P794, DOI 10.1212/01.wnl.0000176036.07558.82; Eckstein HH, 2008, LANCET NEUROL, V7, P893, DOI 10.1016/S1474-4422(08)70196-0; Halliday A, 2004, LANCET, V363, P1491; Hobson RW, 2008, J VASC SURG, V48, P480, DOI 10.1016/j.jvs.2008.05.036; Inzitari D, 2000, NEW ENGL J MED, V342, P1693, DOI 10.1056/NEJM200006083422302; Kakkos SK, 2009, J VASC SURG, V49, P902, DOI 10.1016/j.jvs.2008.10.059; Liapis CD, 2009, EUR J VASC ENDOVASC, V37, pS1, DOI 10.1016/j.ejvs.2008.11.006; Markus HS, 2010, LANCET NEUROL, V9, P663, DOI 10.1016/S1474-4422(10)70120-4; Mas JL, 2008, LANCET NEUROL, V7, P885, DOI 10.1016/S1474-4422(08)70195-9; Nicolaides AN, 2005, EUR J VASC ENDOVASC, V30, P275, DOI 10.1016/j.ejvs.2005.04.031; Sabeti S, 2007, STROKE, V38, P2887, DOI 10.1161/STROKEAHA.107.488387; 2008, CEREBROVASC DIS, V25, P457	14	6	7	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 15	2010	341								c4898	10.1136/bmj.c4898	http://dx.doi.org/10.1136/bmj.c4898			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653LV	20843932				2022-12-01	WOS:000282093800008
J	Witherden, DA; Verdino, P; Rieder, SE; Garijo, O; Mills, RE; Teyton, L; Fischer, WH; Wilson, IA; Havran, WL				Witherden, Deborah A.; Verdino, Petra; Rieder, Stephanie E.; Garijo, Olivia; Mills, Robyn E.; Teyton, Luc; Fischer, Wolfgang H.; Wilson, Ian A.; Havran, Wendy L.			The Junctional Adhesion Molecule JAML Is a Costimulatory Receptor for Epithelial gamma delta T Cell Activation	SCIENCE			English	Article							ADENOVIRUS RECEPTOR; SKIN; CAR; COXSACKIE; RECOGNITION; HOMEOSTASIS; PROTEIN	gamma delta T cells present in epithelial tissues provide a crucial first line of defense against environmental insults, including infection, trauma, and malignancy, yet the molecular events surrounding their activation remain poorly defined. Here we identify an epithelial gamma delta T cell-specific costimulatory molecule, junctional adhesion molecule-like protein (JAML). Binding of JAML to its ligand Coxsackie and adenovirus receptor (CAR) provides costimulation leading to cellular proliferation and cytokine and growth factor production. Inhibition of JAML costimulation leads to diminished gamma delta T cell activation and delayed wound closure akin to that seen in the absence of gamma delta T cells. Our results identify JAML as a crucial component of epithelial gamma delta T cell biology and have broader implications for CAR and JAML in tissue homeostasis and repair.	[Witherden, Deborah A.; Rieder, Stephanie E.; Garijo, Olivia; Mills, Robyn E.; Teyton, Luc; Havran, Wendy L.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Verdino, Petra; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Fischer, Wolfgang H.] Salk Inst Biol Studies, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Salk Institute	Havran, WL (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	havran@scripps.edu			NIH [AI52257, AI064811, AI42266, CA58896, NS057096]; Austrian Science Fund; Leukemia and Lymphoma Society; Vincent J. Coates Foundation; NATIONAL CANCER INSTITUTE [R01CA058896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042266, R01AI036964, R01AI042266, R01AI052257, R01AI064811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057096] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund(Austrian Science Fund (FWF)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Vincent J. Coates Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Park and W. Low for MS analysis; G. Nemerow for Fiber 5 and Fiber 11 reagents; J. Kaye for the DPK cell line; and M. Haynes, M. Svoboda, J. Barcas, K. Sendaydiego, D. Yeh, and B. Atteberry for technical assistance. J. Lewis provided advice on culture of short-term DETC lines. M. Kronenberg, R. Boismenu, J. Jameson, K. Mowen, T. Meehan, and K. Komori provided advice and critical reading of the manuscript. This work was supported by NIH grants to W. L. H. (AI52257, AI064811) and I. A. W. (AI42266, CA58896), as well as an Erwin-Schroedinger Fellowship of the Austrian Science Fund (P. V.) and the Leukemia and Lymphoma Society (S. E. R.). MS instrumentation was acquired with an NSF shared equipment grant. The MS Laboratory at the Salk Institute is supported by the Vincent J. Coates Foundation and NIH Blueprint NS057096. This is manuscript number 17711-IMM from The Scripps Research Institute.	Bazzoni G, 2003, CURR OPIN CELL BIOL, V15, P525, DOI 10.1016/S0955-0674(03)00104-2; Bergelson JM, 1998, J VIROL, V72, P415, DOI 10.1128/JVI.72.1.415-419.1998; Coyne CB, 2005, ADV DRUG DELIVER REV, V57, P869, DOI 10.1016/j.addr.2005.01.007; Croft M, 1997, CRIT REV IMMUNOL, V17, P89, DOI 10.1615/CritRevImmunol.v17.i1.40; Davis MM, 2003, ANNU REV BIOCHEM, V72, P717, DOI 10.1146/annurev.biochem.72.121801.161625; Ebnet K, 2004, J CELL SCI, V117, P19, DOI 10.1242/jcs.00930; Frauwirth KA, 2002, J CLIN INVEST, V109, P295, DOI 10.1172/JCI200214941; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Havran WL, 2010, J IMMUNOL, V184, P5423, DOI 10.4049/jimmunol.0902733; HAVRAN WL, 1991, SCIENCE, V252, P1430, DOI 10.1126/science.1828619; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Howitt J, 2003, CURR TOP MICROBIOL, V272, P331; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jameson J, 2007, IMMUNOL REV, V215, P114, DOI 10.1111/j.1600-065X.2006.00483.x; Kirby I, 2001, J VIROL, V75, P7210, DOI 10.1128/JVI.75.15.7210-7214.2001; Luissint AC, 2008, J CELL BIOL, V183, P1159, DOI 10.1083/jcb.200805061; Moog-Lutz C, 2003, BLOOD, V102, P3371, DOI 10.1182/blood-2002-11-3462; Rudd CE, 2003, NAT REV IMMUNOL, V3, P544, DOI 10.1038/nri1131; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; Sharp LL, 2005, NAT IMMUNOL, V6, P73, DOI 10.1038/ni1152; Strid J, 2009, SEMIN IMMUNOL, V21, P110, DOI 10.1016/j.smim.2009.03.002; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Verdino P, 2010, SCIENCE, V329, P1210, DOI 10.1126/science.1187996; Whang MI, 2009, J IMMUNOL, V182, P4557, DOI 10.4049/jimmunol.0802439; Zen K, 2005, MOL BIOL CELL, V16, P2694, DOI 10.1091/mbc.E05-01-0036	25	148	160	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 3	2010	329	5996					1205	1210		10.1126/science.1192698	http://dx.doi.org/10.1126/science.1192698			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645SG	20813954	Green Accepted			2022-12-01	WOS:000281485600036
J	Ma, RCW; Tam, CHT; Wang, Y; Luk, AO; Hu, C; Yang, XL; Lam, V; Chan, AWH; Ho, JSK; Chow, CC; Tong, PCY; Jia, WP; Ng, MCY; So, WY; Chan, JCN				Ma, Ronald C. W.; Tam, Claudia H. T.; Wang, Ying; Luk, Andrea O.; Hu, Cheng; Yang, Xilin; Lam, Vincent; Chan, Alfred W. H.; Ho, Janice S. K.; Chow, Chun-Chung; Tong, Peter C. Y.; Jia, Weiping; Ng, Maggie C. Y.; So, Wing-Yee; Chan, Juliana C. N.			Genetic Variants of the Protein Kinase C-beta 1 Gene and Development of End-Stage Renal Disease in Patients With Type 2 Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							KONG CHINESE PATIENTS; GROWTH-FACTOR-BETA; C-BETA; OXIDATIVE STRESS; KIDNEY-DISEASE; RISK SCORE; NEPHROPATHY; EXPRESSION; LOCI; ASSOCIATION	Context Protein kinase C-beta (PKC-beta) is a cell-signaling intermediate implicated in development of diabetic complications. Objective To examine the risk association of PKC-beta 1 gene (PRKCB1) polymorphisms and end-stage renal disease (ESRD) in an 8-year prospective cohort of Chinese patients with type 2 diabetes. Design, Setting, and Participants We genotyped 18 common tag single-nucleotide polymorphisms (SNPs) that span the PRKCB1 gene (r(2)=0.80) in 1172 Chinese patients (recruited 1995-1998) without renal disease at baseline. A validation cohort included an additional 1049 patients with early-onset diabetes who were free of renal disease at baseline and were recruited after 1998. Main Outcome Measures Associations of PRKCB1 polymorphisms under additive, dominant, and recessive genetic models with new onset of ESRD (defined as estimated glomerular filtration rate <15 mL/min/1.73 m(2) or dialysis or renal-related death) were assessed by Cox proportional hazard regression, adjusted for all conventional risk factors including use of medications. Results After a mean (SD) of 7.9 (1.9) years, 90 patients (7.7%) progressed to ESRD. Four common SNPs were associated with ESRD (P<.05). The closely linked T allele at rs3760106 and G allele rs2575390 (r(2)=0.98) showed the strongest association with ESRD (hazard ratio [HR], 2.25; 95% confidence interval [Cl], 1.31-3.87; P=.003, and HR, 2.26; 95% Cl, 1.31-3.88; P=.003, respectively). Four common variants predicted ESRD in separate models. The HR for ESRD increased with increasing number of risk alleles (P<.001) in the joint effect analysis. The adjusted risk for ESRD was 6.04 (95% Cl, 2.00-18.31) for patients with 4 risk alleles compared with patients with 0 or 1 risk allele. Incidence was 4.4 per 1000 person-years (95% Cl, 0.5-8.2) among individuals with 0 or 1 risk allele compared with 20.0 per 1000 person-years (95% Cl, 8.8-31.1) in those carrying 4 risk alleles (6.9% of the cohort). These results were validated in a separate prospective cohort of young-onset diabetic patients. Of 1049 patients in the validation cohort, 151 (14.3%) developed chronic kidney disease (CKD) during follow-up, and there were significant associations between both the T allele of rs3760106 and the G allele of rs2575390 and development of CKD (HR, 1.68; 95% Cl, 1.10-2.57; P=.02, and HR, 1.62; 95% Cl, 1.07-2.47; P=.02, respectively). Conclusion Genetic variants in the PRKCB1 gene were independently associated with development of ESRD in Chinese patients with type 2 diabetes. JAMA. 2010;304(8):881-889	[Ma, Ronald C. W.; Tam, Claudia H. T.; Wang, Ying; Luk, Andrea O.; Yang, Xilin; Lam, Vincent; Chan, Alfred W. H.; Ho, Janice S. K.; Chow, Chun-Chung; Tong, Peter C. Y.; Ng, Maggie C. Y.; So, Wing-Yee; Chan, Juliana C. N.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Ma, Ronald C. W.; Chan, Juliana C. N.] Chinese Univ Hong Kong, Prince Wales Hosp, Hong Kong Inst Diabet & Obes, Shatin, Hong Kong, Peoples R China; [Chan, Juliana C. N.] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Hu, Cheng; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6,Shanghai Diabet Inst, Shanghai Key Lab Diabet Mellitus, Dept Endocrinol & Metab,Shanghai Clin Ctr Diabet, Shanghai 200030, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Shanghai Jiao Tong University	Ma, RCW (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.	rcwma@cuhk.edu.hk	Hu, Cheng/C-3346-2008; Jia, Weiping/B-7483-2012; Luk, Andrea/B-5766-2016; Ma, Ronald/C-2788-2009; Chan, Juliana/B-7918-2016; Chan, Anthony/N-6719-2016	Hu, Cheng/0000-0003-4314-2386; Ma, Ronald/0000-0002-1227-803X; Chan, Juliana/0000-0003-1325-1194; Chan, Anthony/0000-0002-1771-163X	AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi-Sankyo; GlaxoSmithKline; Lilly; Merck Serono; Merck Sharp Dohme; Novo Nordisk; Pfizer; Roche; Sanofi-Aventis; Chinese University of Hong Kong; Hong Kong Government Research Grant Committee; Innovation and Technology Fund [ITS/088/08]; Department of Medicine and Therapeutics, Chinese University of Hong Kong	AstraZeneca(AstraZeneca); Bayer(Bayer AG); Bristol-Myers Squibb(Bristol-Myers Squibb); Daiichi-Sankyo(Daiichi Sankyo Company Limited); GlaxoSmithKline(GlaxoSmithKline); Lilly(Eli Lilly); Merck Serono(Merck & Company); Merck Sharp Dohme(Merck & Company); Novo Nordisk(Novo Nordisk); Pfizer(Pfizer); Roche(Roche Holding); Sanofi-Aventis(Sanofi-Aventis); Chinese University of Hong Kong(Chinese University of Hong Kong); Hong Kong Government Research Grant Committee; Innovation and Technology Fund; Department of Medicine and Therapeutics, Chinese University of Hong Kong(Chinese University of Hong Kong)	Dr Ma reported receiving speakers' honoraria from Sanofi-Aventis and serving as a member of an advisory board for Pfizer, the proceeds of which go to the Chinese University of Hong Kong to support ongoing research. Dr J. Chan reported receiving research funding or speakers' honoraria from AstraZeneca, Bayer, Bristol-Myers Squibb, Daiichi-Sankyo, GlaxoSmithKline, Lilly, Merck Serono, Merck Sharp & Dohme, Novo Nordisk, Pfizer, Roche, and Sanofi-Aventis; serving as a member of advisory boards, and/or speaker forums, and/or steering committees of international projects sponsored by AstraZeneca, Bayer, Lilly, and Merck Sharp & Dohme; with her group and on behalf of the Chinese University of Hong Kong, holding patents to use genetic markers to predict risk of diabetes and diabetic kidney disease in Chinese populations; and in a technology transfer project, establishing a university-affiliated diabetes center (Qualigenics) to deliver a multidisciplinary chronic care program in the community (all related revenues and proceeds go to the Chinese University of Hong Kong to support ongoing research and development in diabetes). None of the coauthors reported currently holding or having filed patents relating to the information contained in the article, namely, the use of the genetic variants of the protein kinase C-beta 1 gene (rs3760106, rs7404928, and rs4787733) for the prediction of diabetic kidney disease. The authors reported that they will not be pursuing any patent application relating to this information, in China or in the United States, until this information has appeared in JAMA.; The study was supported by the Hong Kong Foundation for Research and Development in Diabetes established under the auspices of the Chinese University of Hong Kong, the Hong Kong Government Research Grant Committee, the Innovation and Technology Fund (ITS/088/08), and the Research Fund of the Department of Medicine and Therapeutics, Chinese University of Hong Kong.	Araki SI, 2006, DIABETES CARE, V29, P864, DOI 10.2337/diacare.29.04.06.dc05-1723; Araki SI, 2003, J AM SOC NEPHROL, V14, P2015, DOI 10.1097/01.ASN.0000077347.27669.5C; Asaba K, 2005, KIDNEY INT, V67, P1890, DOI 10.1111/j.1523-1755.2005.00287.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chambers JC, 2010, NAT GENET, V42, P149, DOI 10.1038/ng.516; Chan JC, 2009, DIABETES CARE, V32, P977, DOI 10.2337/dc08-1908; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Etoh T, 2003, DIABETOLOGIA, V46, P1428, DOI 10.1007/s00125-003-1205-6; Ferretti V, 2007, NUCLEIC ACIDS RES, V35, pD122, DOI 10.1093/nar/gkl879; Fioretto P, 2008, DIABETOLOGIA, V51, P1347, DOI 10.1007/s00125-008-1051-7; Fioretto P, 1996, DIABETOLOGIA, V39, P1569, DOI 10.1007/s001250050616; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Freedman BI, 2007, CLIN J AM SOC NEPHRO, V2, P1306, DOI 10.2215/CJN.02560607; Gao L, 2009, CARDIOVASC RES, V82, P9, DOI 10.1093/cvr/cvp031; Gilbert RE, 2007, DIABETES CARE, V30, P995, DOI 10.2337/dc06-2079; Gorin Y, 2005, J BIOL CHEM, V280, P39616, DOI 10.1074/jbc.M502412200; HE Z, 2004, DIABETES CARDIOVASCU, P37; Hu C, 2010, DIABETOLOGIA, V53, P290, DOI 10.1007/s00125-009-1594-2; Ishii H, 1996, SCIENCE, V272, P728, DOI 10.1126/science.272.5262.728; Karter AJ, 2002, JAMA-J AM MED ASSOC, V287, P2519, DOI 10.1001/jama.287.19.2519; Kelly DJ, 2009, NEPHROL DIAL TRANSPL, V24, P1782, DOI 10.1093/ndt/gfn729; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Koya D, 2000, FASEB J, V14, P439, DOI 10.1096/fasebj.14.3.439; Koya D, 1997, J CLIN INVEST, V100, P115, DOI 10.1172/JCI119503; Kramer HJ, 2003, JAMA-J AM MED ASSOC, V289, P3273, DOI 10.1001/jama.289.24.3273; Langham RG, 2008, DIABETOLOGIA, V51, P668, DOI 10.1007/s00125-008-0927-x; Luk AOY, 2008, DIABETES CARE, V31, P2357, DOI 10.2337/dc08-0971; MA RC, 2004, KIDNEY HYPERTENSION; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; MACLSAAC RJ, 2004, DIABETES CARE, V27, P195; Morrish NJ, 2001, DIABETOLOGIA, V44, pS14, DOI 10.1007/PL00002934; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Noh H, 2007, KIDNEY INT, V72, pS49, DOI 10.1038/sj.ki.5002386; Ohshiro Y, 2006, DIABETES, V55, P3112, DOI 10.2337/db06-0895; Parving HH, 2008, J AM SOC NEPHROL, V19, P771, DOI 10.1681/ASN.2007050582; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Ritz E, 1999, AM J KIDNEY DIS, V34, P795, DOI 10.1016/S0272-6386(99)70035-1; Robertson G, 2006, NUCLEIC ACIDS RES, V34, pD68, DOI 10.1093/nar/gkj075; Rothman KJ, 2005, AM J PUBLIC HEALTH, V95, pS144, DOI 10.2105/AJPH.2004.059204; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P16837, DOI 10.1073/pnas.0407387101; Sarafidis PA, 2006, AM J NEPHROL, V26, P232, DOI 10.1159/000093632; Sheetz MJ, 2002, JAMA-J AM MED ASSOC, V288, P2579, DOI 10.1001/jama.288.20.2579; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Soldatos G, 2008, DIABETES RES CLIN PR, V82, pS75, DOI 10.1016/j.diabres.2008.09.042; Song XY, 2009, DIABETOLOGIA, V52, P1543, DOI 10.1007/s00125-009-1400-1; Toyoda M, 2004, KIDNEY INT, V66, P1107, DOI 10.1111/j.1523-1755.2004.00798.x; Tuttle KR, 2008, DIABETES RES CLIN PR, V82, pS70, DOI 10.1016/j.diabres.2008.09.041; Tuttle KR, 2005, DIABETES CARE, V28, P2686, DOI 10.2337/diacare.28.11.2686; TUTTLE KR, 2007, J AM SOC NEPHROL, V18, pA48; Wu AYT, 2005, DIABETOLOGIA, V48, P17, DOI 10.1007/s00125-004-1599-9; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yang XL, 2007, DIABETOLOGIA, V50, P1348, DOI 10.1007/s00125-007-0639-7; Yang XL, 2006, DIABETOLOGIA, V49, P2299, DOI 10.1007/s00125-006-0376-3; Yang XL, 2008, ARCH INTERN MED, V168, P451, DOI 10.1001/archinte.168.5.451; Yang X, 2007, DIABETES CARE, V30, P65, DOI 10.2337/dc06-1273; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1	60	48	57	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2010	304	8					881	889		10.1001/jama.2010.1191	http://dx.doi.org/10.1001/jama.2010.1191			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644OY	20736472	Bronze			2022-12-01	WOS:000281389900026
J	Visintin, C; Mugglestone, MA; Almerie, MQ; Nherera, LM; James, D; Walkinshaw, S				Visintin, Cristina; Mugglestone, Moira A.; Almerie, Muhammad Q.; Nherera, Leo M.; James, David; Walkinshaw, Stephen		Guideline Dev Grp	Guidelines Management of hypertensive disorders during pregnancy: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Visintin, Cristina; Mugglestone, Moira A.; Nherera, Leo M.; James, David] Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England; [Almerie, Muhammad Q.] Diana Princess Wales Hosp, N Yorkshire & E Coast Fdn Sch, Grimsby DN33 2BA, Lincs, England; [Walkinshaw, Stephen] Liverpool Womens Hosp, Liverpool L8 7SS, Merseyside, England	University of Liverpool	Mugglestone, MA (corresponding author), Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England.	mmugglestone@ncc-wch.org.uk	Nherera, Leo/P-1567-2018; Nherera, Leo/L-1978-2019	Nherera, Leo/0000-0003-1758-9504; Nherera, Leo/0000-0003-1758-9504				Lyons G, 2008, INT J OBSTET ANESTH, V17, P103, DOI 10.1016/j.ijoa.2008.01.006; National Collaborating Centre for Ws Children's H. National Institute for Health and Clinical Excellence: Guidance, 2008, ANT CAR ROUT CAR HLT; National Institute for Health and Clinical Excellence, 2007, INTR CAR MAN DEL CAR; National Institute for Health and Clinical Excellence, 2006, POSTN CAR ROUT POSTN; National Institute for Health and Clinical Excellence, 2006, HYP MAN HYP AD PRIM; National Institute for Health and Clinical Excellence: Guidance, 2010, HYP PREGN MAN HYP DI; Royal College of Obstetricians and Gynaecologists, 2006, MAN SEV PREECL ECL; Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089	8	117	131	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 25	2010	341								c2207	10.1136/bmj.c2207	http://dx.doi.org/10.1136/bmj.c2207			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	645IH	20739360				2022-12-01	WOS:000281446000009
J	Deahl, M				Deahl, Martin			Service personnel move to NHS mental health inpatient care	LANCET			English	Editorial Material									S Staffordshire & Shropshire NHS Fdn Trust, Stafford ST16 3AG, England		Deahl, M (corresponding author), S Staffordshire & Shropshire NHS Fdn Trust, Stafford ST16 3AG, England.	martindeahl@doctors.org.uk						*CAR QUAL COMM, 2009, MENT HLTH SERV AC IN; Crisp AH, 2000, BRIT J PSYCHIAT, V177, P4, DOI 10.1192/bjp.177.1.4; Iversen A, 2005, BRIT J PSYCHIAT, V186, P480, DOI 10.1192/bjp.186.6.480; *MENT HLTH FDN, 2010, MIL MENT HLTH; *NAT ARCH, DEF NEWS INP ME 1118; *NHS CONF, 2009, DEAL DOWNT GREAT EV; PALMER C, 2010, 2010 MOD PATIENT SAT	7	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 20	2010	376	9754					1717	1719		10.1016/S0140-6736(10)61190-7	http://dx.doi.org/10.1016/S0140-6736(10)61190-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	690EI	20850177				2022-12-01	WOS:000284984900007
J	Chia, NY; Chan, YS; Feng, B; Lu, XY; Orlov, YL; Moreau, D; Kumar, P; Yang, L; Jiang, JM; Lau, MS; Huss, M; Soh, BS; Kraus, P; Li, P; Lufkin, T; Lim, B; Clarke, ND; Bard, F; Ng, HH				Chia, Na-Yu; Chan, Yun-Shen; Feng, Bo; Lu, Xinyi; Orlov, Yuriy L.; Moreau, Dimitri; Kumar, Pankaj; Yang, Lin; Jiang, Jianming; Lau, Mei-Sheng; Huss, Mikael; Soh, Boon-Seng; Kraus, Petra; Li, Pin; Lufkin, Thomas; Lim, Bing; Clarke, Neil D.; Bard, Frederic; Ng, Huck-Hui			A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity	NATURE			English	Article							DEFINED FACTORS; MOUSE EMBRYOS; SELF-RENEWAL; LINES; ESTABLISHMENT; TRANSCRIPTION; EXPRESSION; REGULATOR; PROTEINS; COMPLEX	The derivation of human ES cells (hESCs) from human blastocysts represents one of the milestones in stem cell biology(1). The full potential of hESCs in research and clinical applications requires a detailed understanding of the genetic network that governs the unique properties of hESCs. Here, we report a genome-wide RNA interference screen to identify genes which regulate self-renewal and pluripotency properties in hESCs. Interestingly, functionally distinct complexes involved in transcriptional regulation and chromatin remodelling are among the factors identified in the screen. To understand the roles of these potential regulators of hESCs, we studied transcription factor PRDM14 to gain new insights into its functional roles in the regulation of pluripotency. We showed that PRDM14 regulates directly the expression of key pluripotency gene POU5F1 through its proximal enhancer. Genome-wide location profiling experiments revealed that PRDM14 colocalized extensively with other key transcription factors such as OCT4, NANOG and SOX2, indicating that PRDM14 is integrated into the core transcriptional regulatory network. More importantly, in a gain-of-function assay, we showed that PRDM14 is able to enhance the efficiency of reprogramming of human fibroblasts in conjunction with OCT4, SOX2 and KLF4. Altogether, our study uncovers a wealth of novel hESC regulators wherein PRDM14 exemplifies a key transcription factor required for the maintenance of hESC identity and the reacquisition of pluripotency in human somatic cells.	[Chia, Na-Yu; Chan, Yun-Shen; Feng, Bo; Lu, Xinyi; Yang, Lin; Jiang, Jianming; Lau, Mei-Sheng; Ng, Huck-Hui] Genome Inst Singapore, Gene Regulat Lab, Singapore 138672, Singapore; [Chia, Na-Yu; Ng, Huck-Hui] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Chan, Yun-Shen; Ng, Huck-Hui] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore; [Lu, Xinyi; Ng, Huck-Hui] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Orlov, Yuriy L.; Huss, Mikael; Clarke, Neil D.] Genome Inst Singapore, Computat & Syst Biol Grp, Singapore 138672, Singapore; [Moreau, Dimitri; Kumar, Pankaj; Bard, Frederic] Inst Mol & Cell Biol, Singapore 138673, Singapore; [Lim, Bing] Harvard Univ, Sch Med, Ctr Life Sci, Boston, MA 02115 USA; [Clarke, Neil D.; Bard, Frederic; Ng, Huck-Hui] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Harvard University; Harvard Medical School; National University of Singapore	Ng, HH (corresponding author), Genome Inst Singapore, Gene Regulat Lab, 60 Biopolis St, Singapore 138672, Singapore.	fbard@imcb.a-star.edu.sg; nghh@gis.a-star.edu.sg	Feng, Bo/D-7831-2014; BARD, Frederic/G-9914-2011; Clarke, Neil/D-9613-2014; jiang, jianming/B-3421-2012; Kraus, Petra/I-5849-2014; Lufkin, Thomas/B-5352-2011; Moreau, Dimitri/E-5092-2012; Lufkin, Thomas/AAG-7476-2019; Chan, Yun-Shen/GWC-4616-2022; Orlov, Yuriy L/F-1520-2013; Ng, Huck Hui/A-1135-2009	Feng, Bo/0000-0002-4018-3257; BARD, Frederic/0000-0002-3783-4805; jiang, jianming/0000-0003-3251-2716; Kraus, Petra/0000-0002-6716-5550; Lufkin, Thomas/0000-0002-7902-4771; Moreau, Dimitri/0000-0002-9282-3324; Lufkin, Thomas/0000-0002-7902-4771; Orlov, Yuriy L/0000-0003-0587-1609; LU, Xinyi/0000-0002-3885-3960; Huss, Mikael/0000-0003-0839-2451; CHIA, NA YU/0000-0003-1092-4699	Biomedical Research Council (BMRC); Agency for Science, Technology and Research (A*STAR); Singapore Stem Cell Consortium	Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Singapore Stem Cell Consortium	We are grateful to the Biomedical Research Council (BMRC), Agency for Science, Technology and Research (A*STAR) and Singapore Stem Cell Consortium for funding. We are grateful to K. Kuay, L.-P. Yaw, C.-K. Tong and C.-W. Chang for technical assistance. We acknowledge V. Cacheux-Rataboul for karyotype analysis and the GTB group for sequencing. We are grateful to A. Surani, P. Tesar and R. Mckay for gift of EpiSCs and Q. Yu for plasmids. We thank A. Colman, A. Hutchins and T. Huber for comments on the manuscript.	Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Casamassimi A, 2007, BIOCHIMIE, V89, P1439, DOI 10.1016/j.biochi.2007.08.002; Chamovitz DA, 2009, EMBO REP, V10, P352, DOI 10.1038/embor.2009.33; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Nordhoff V, 2001, MAMM GENOME, V12, P309, DOI 10.1007/s003350010279; Park IH, 2008, NATURE, V451, P141, DOI 10.1038/natureO6534; Pera MF, 2004, DEVELOPMENT, V131, P5515, DOI 10.1242/dev.01451; Rino J, 2009, TRENDS CELL BIOL, V19, P375, DOI 10.1016/j.tcb.2009.05.004; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Sharov AA, 2009, DNA RES, V16, P261, DOI 10.1093/dnares/dsp014; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsuneyoshi N, 2008, BIOCHEM BIOPH RES CO, V367, P899, DOI 10.1016/j.bbrc.2007.12.189; Van Hoof D, 2006, MOL CELL PROTEOMICS, V5, P1261, DOI 10.1074/mcp.M500405-MCP200; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yu JY, 2008, GENE DEV, V22, P1987, DOI 10.1101/gad.1689808	30	346	374	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 11	2010	468	7321					316	U207		10.1038/nature09531	http://dx.doi.org/10.1038/nature09531			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678DG	20953172				2022-12-01	WOS:000284051000053
J	Woodcock, J; Sharfstein, JM; Hamburg, M				Woodcock, Janet; Sharfstein, Joshua M.; Hamburg, Margaret			Regulatory Action on Rosiglitazone by the US Food and Drug Administration	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Woodcock, Janet] Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Sharfstein, Joshua M.; Hamburg, Margaret] US FDA, Dept Hlth & Human Serv, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Woodcock, J (corresponding author), Ctr Drug Evaluat & Res, Silver Spring, MD USA.							[Anonymous], GUID IND DIAB MELL E; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Nissen SE, 2007, NEW ENGL J MED, V357, P100; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; United States Food and Drug Administration (FDA), FDA DRUG SAF COMM ON	6	114	116	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 14	2010	363	16					1489	1491		10.1056/NEJMp1010788	http://dx.doi.org/10.1056/NEJMp1010788			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	663KP	20942663				2022-12-01	WOS:000282887100001
J	Bennett-Guerrero, E; Zhao, Y; O'Brien, SM; Ferguson, TB; Peterson, ED; Gammie, JS; Song, HK				Bennett-Guerrero, Elliott; Zhao, Yue; O'Brien, Sean M.; Ferguson, T. B., Jr.; Peterson, Eric D.; Gammie, James S.; Song, Howard K.			Variation in Use of Blood Transfusion in Coronary Artery Bypass Graft Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-THORACIC-SURGEONS; LONG-TERM SURVIVAL; CARDIAC-SURGERY; CELL TRANSFUSION; CABG SURGERY; CONSERVATION; VARIABILITY; MORTALITY; SOCIETY; OPERATIONS	Context Perioperative blood transfusions are costly and have safety concerns. As a result, there have been multiple initiatives to reduce transfusion use. However, the degree to which perioperative transfusion rates vary among hospitals is unknown. Objective To assess hospital-level variation in use of allogeneic red blood cell (RBC), fresh-frozen plasma, and platelet transfusions in patients undergoing coronary artery bypass graft (CABG) surgery. Design, Setting, and Patients An observational cohort of 102 470 patients undergoing primary isolated CABG surgery with cardiopulmonary bypass during calendar year 2008 at 798 sites in the United States, contributing data to the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Main Outcome Measures Perioperative (intraoperative and postoperative) transfusion of RBCs, fresh-frozen plasma, and platelets. Results At hospitals performing at least 100 on-pump CABG operations (82 446 cases at 408 sites), the rates of blood transfusion ranged from 7.8% to 92.8% for RBCs, 0% to 97.5% for fresh-frozen plasma, and 0.4% to 90.4% for platelets. Multivariable analysis including data from all 798 sites (102 470 cases) revealed that after adjustment for patient-level risk factors, hospital transfusion rates varied by geographic location (P=.007), academic status (P=.03), and hospital volume (P<.001). However, these 3 hospital characteristics combined only explained 11.1% of the variation in hospital risk-adjusted RBC usage. Case mix explained 20.1% of the variation between hospitals in RBC usage. Conclusion Wide variability occurred in the rates of transfusion of RBCs and other blood products, independent of case mix, among patients undergoing CABG surgery with cardiopulmonary bypass in US hospitals in an adult cardiac surgical database. JAMA. 2010;304(14):1568-1575 www.jama.com	[Bennett-Guerrero, Elliott] Duke Univ, Med Ctr, Duke Clin Res Inst, Div Perioperat Clin Res, Durham, NC 27710 USA; [Zhao, Yue; O'Brien, Sean M.] Duke Univ, Med Ctr, Duke Clin Res Inst, Div Biostat, Durham, NC 27710 USA; [Peterson, Eric D.] Duke Univ, Med Ctr, Duke Clin Res Inst, Div Cardiol, Durham, NC 27710 USA; [Ferguson, T. B., Jr.] E Carolina Heart Inst, Dept Cardiovasc Sci, Greenville, NC USA; [Gammie, James S.] Univ Maryland, Med Ctr, Div Cardiac Surg, Baltimore, MD 21201 USA; [Song, Howard K.] Oregon Hlth & Sci Univ, Div Cardiothorac Surg, Portland, OR 97201 USA	Duke University; Duke University; Duke University; University of North Carolina; East Carolina University; University System of Maryland; University of Maryland Baltimore; Oregon Health & Science University	Bennett-Guerrero, E (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, Div Perioperat Clin Res, POB 3094, Durham, NC 27710 USA.	elliott.bennettguerrero@duke.edu	Peterson, Eric David/ABF-5033-2021; O'Brien, Sean/H-6268-2013		National Institutes of Health [R01 HL101382-01]; Society of Thoracic Surgeons (STS) through the National Adult Cardiac Surgery Database and the Duke Clinical Research Institute (DCRI)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Society of Thoracic Surgeons (STS) through the National Adult Cardiac Surgery Database and the Duke Clinical Research Institute (DCRI)	Dr Bennett-Guerrero is principal investigator (grant R01 HL101382-01 from the National Institutes of Health) for a multicenter study assessing the impact of blood transfusion on peripheral and cerebral oxygenation and the microcirculation. He is also a named inventor on a patent application related to methods of washing red blood cells. No other authors have any disclosures.; This study was supported by the Society of Thoracic Surgeons (STS) through the National Adult Cardiac Surgery Database and the Duke Clinical Research Institute (DCRI).; This study was sponsored by the STS. Specifically, the DCRI has a contract with the STS to be their National Cardiac Data Warehouse and Analysis Center. In this role, the DCRI independently harvests data from each participating STS center, creates a national analysis database, and performs statistical analyses. The proposal for this study was submitted to and approved of by the STS National Database Publications Committee. After approval, the manuscript was reviewed by the coauthors and a final version was approved by the publications committee. The STS was involved in the design and conduct of the study; in the collection, management, analysis, and interpretation of the data; and in the review and approval of the manuscript.	Covin R, 2003, ARCH PATHOL LAB MED, V127, P415; DeAnda A, 2006, AM J MED QUAL, V21, P230, DOI 10.1177/1062860606289784; Edwards FH, 1998, J INVASIVE CARDIOL, V10, P485; Engoren MC, 2002, ANN THORAC SURG, V74, P1180, DOI 10.1016/S0003-4975(02)03766-9; Ferguson TB, 2002, JAMA-J AM MED ASSOC, V287, P2221, DOI 10.1001/jama.287.17.2221; Ferguson TB, 2003, JAMA-J AM MED ASSOC, V290, P49, DOI 10.1001/jama.290.1.49; Ferguson TB, 2000, ANN THORAC SURG, V69, P680, DOI 10.1016/S0003-4975(99)01538-6; Ferraris VA, 2007, ANN THORAC SURG, V83, P27, DOI 10.1016/j.athoracsur.2007.02.099; GOODNOUGH LT, 1991, JAMA-J AM MED ASSOC, V265, P86, DOI 10.1001/jama.265.1.86; Helm RE, 1998, ANN THORAC SURG, V65, P125, DOI 10.1016/S0003-4975(97)01004-7; JACOBS JP, 2008, 46 ANN M SOC THOR SU; Koch CG, 2006, CRIT CARE MED, V34, P1608, DOI 10.1097/01.CCM.0000217920.48559.D8; Koch CG, 2006, ANN THORAC SURG, V81, P1650, DOI 10.1016/j.athoracsur.2005.12.037; Koch CG, 2008, NEW ENGL J MED, V358, P1229, DOI 10.1056/NEJMoa070403; Kuduvalli M, 2005, EUR J CARDIO-THORAC, V27, P592, DOI 10.1016/j.ejcts.2005.01.030; Maddux FW, 2009, AM J MED QUAL, V24, P403, DOI 10.1177/1062860609339384; Murphy GJ, 2007, CIRCULATION, V116, P2544, DOI 10.1161/CIRCULATIONAHA.107.698977; Peterson ED, 2004, JAMA-J AM MED ASSOC, V291, P195, DOI 10.1001/jama.291.2.195; Rosengart TK, 1997, J AM COLL SURGEONS, V184, P618; Scott BH, 2008, ANN CARD ANAESTH, V11, P15, DOI 10.4103/0971-9784.38444; Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053; Shander A, 2007, BEST PRAC RES-CL ANA, V21, P271, DOI 10.1016/j.bpa.2007.01.002; Shander A, 2010, TRANSFUSION, V50, P753, DOI 10.1111/j.1537-2995.2009.02518.x; Shibata K, 2002, ANN THORAC SURG, V73, P739, DOI 10.1016/S0003-4975(01)03392-6; Snyder-Ramos SA, 2008, TRANSFUSION, V48, P1284, DOI 10.1111/j.1537-2995.2008.01666.x; Spiegelhalter DJ, 2005, STAT MED, V24, P1185, DOI 10.1002/sim.1970; Stover EP, 1998, ANESTHESIOLOGY, V88, P327, DOI 10.1097/00000542-199802000-00009; Surgenor SD, 2006, CIRCULATION, V114, pI43, DOI 10.1161/CIRCULATIONAHA.105.001271; US Department of Health and Human Services, 2007, 2007 NATIONWIDE BLOO; Van der Linden P, 2001, CAN J ANAESTH, V48, P894, DOI 10.1007/BF03017357; Welke KF, 2004, ANN THORAC SURG, V77, P1137, DOI 10.1016/j.athoracsur.2003.07.030	31	337	347	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 13	2010	304	14					1568	1575		10.1001/jama.2010.1406	http://dx.doi.org/10.1001/jama.2010.1406			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	662OE	20940382	Bronze			2022-12-01	WOS:000282816500021
J	Gray, CM; Loubser, S; Kriel, C; Mercer, M; Brookes, H				Gray, Clive M.; Loubser, Shayne; Kriel, Carina; Mercer, Monica; Brookes, Heather			Immunology for Clinicians: A "Trojan Horse" Approach	SCIENCE			English	Editorial Material									[Gray, Clive M.; Loubser, Shayne; Kriel, Carina; Mercer, Monica] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Johannesburg, South Africa; [Brookes, Heather] Univ Johannesburg, Johannesburg, South Africa	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Johannesburg	Gray, CM (corresponding author), Natl Inst Communicable Dis, Natl Hlth Lab Serv, Johannesburg, South Africa.	cgray@nicd.ac.za		Gray, Clive/0000-0002-9293-901X				Abdool Karim S. S., 2010, HIV AIDS S AFRICA; Davis C., TEACHING MAT USING C; Debard N, 2005, NAT REV IMMUNOL, V5, P736, DOI 10.1038/nri1687; Kreber C., 2001, TEACH HIGH EDUC, V6, P217, DOI [10.1080/13562510120045203, DOI 10.1080/13562510120045203]; Maguire L., 2009, J SCHOLARSHIP LEARN, V9, P93; UNAIDS, 2009, 2009 AIDS EP UPD	6	3	3	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1613	1614		10.1126/science.1186963	http://dx.doi.org/10.1126/science.1186963			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	653NK	20929838				2022-12-01	WOS:000282098100030
J	Zegerman, P; Diffley, JFX				Zegerman, Philip; Diffley, John F. X.			Checkpoint-dependent inhibition of DNA replication initiation by Sld3 and Dbf4 phosphorylation	NATURE			English	Article							S-PHASE CHECKPOINT; BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; PROGRESSION; FORKS; ORIGINS; ACTIVATION; KINASES; PATHWAY; STRESS	The initiation of eukaryotic DNA replication is regulated by three protein kinase classes: cyclin-dependent kinases (CDK), Dbf4-dependent kinase (DDK) and the DNA damage checkpoint kinases(1). CDK phosphorylation of two key initiation factors, Sld2 and Sld3, promotes essential interactions with Dpb11 (refs 2-4), whereas DDK acts by phosphorylating subunits of the Mcm2-7 helicase(5). CDK has an additional role in replication by preventing the re-loading of Mcm2-7 during the S, G2 and M phases(6), thus preventing origin re-firing and re-replication. During the G1 phase, both CDK and DDK are downregulated, which allows origin licensing and prevents premature replication initiation(3). Origin firing is also inhibited during the S phase when DNA damage or replication fork stalling activates the checkpoint kinases(7-10). Here we show that, analogous to the situation in the G1 phase, the Saccharomyces cerevisiae checkpoint kinase Rad53 inhibits both CDK- and DDK-dependent pathways, which acts redundantly to block further origin firing. Rad53 acts on DDK directly by phosphorylating Dbf4, whereas the CDK pathway is blocked by Rad53-mediated phosphorylation of the downstream CDK substrate, Sld3. This allows CDK to remain active during the S phase in the presence of DNA damage, which is crucial to prevent re-loading of Mcm2-7 onto origins that have already fired(6). Our results explain how checkpoints regulate origin firing and demonstrate that the slowing of S phase by the 'intra-S checkpoint' is primarily due to the inhibition of origin firing.	[Zegerman, Philip; Diffley, John F. X.] Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Cancer Research UK	Diffley, JFX (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.	John.Diffley@cancer.org.uk		Zegerman, Philip/0000-0002-5707-1083; Diffley, John/0000-0001-5184-7680	Cancer Research UK	Cancer Research UK(Cancer Research UK)	We are grateful to K. Bousset, M. Godinho Ferreira, D. Quintana and C. Santocanale for early contributions to this project. We thank J. Gannon and T. Hunt for providing recombinant cyclin A/Cdk2, N. O'Reilly and the Peptide Synthesis Facility at the London Research Institute for the peptide arrays, and D. Toczyski for sharing information before publication. Work was supported by Cancer Research UK.	Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; Hardy CFJ, 1997, P NATL ACAD SCI USA, V94, P3151, DOI 10.1073/pnas.94.7.3151; Heffernan TP, 2007, J BIOL CHEM, V282, P9458, DOI 10.1074/jbc.M611292200; Jares P, 2000, EMBO REP, V1, P319, DOI 10.1093/embo-reports/kvd076; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kanemaki M, 2006, EMBO J, V25, P1753, DOI 10.1038/sj.emboj.7601063; Kim Y, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-18; Kumagai A, 2010, CELL, V140, P349, DOI 10.1016/j.cell.2009.12.049; Larner JM, 1999, NUCLEIC ACIDS RES, V27, P803, DOI 10.1093/nar/27.3.803; Liu PJ, 2006, J BIOL CHEM, V281, P30631, DOI 10.1074/jbc.M602982200; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Masumoto H, 2002, NATURE, V415, P651, DOI 10.1038/nature713; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Sanchez-Pulido L, 2010, CURR BIOL, V20, pR509, DOI 10.1016/j.cub.2010.05.021; Sansam CL, 2010, GENE DEV, V24, P183, DOI 10.1101/gad.1860310; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Santocanale C, 1999, GENE DEV, V13, P2360, DOI 10.1101/gad.13.18.2360; Segurado M, 2008, GENE DEV, V22, P1816, DOI 10.1101/gad.477208; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	30	202	205	0	15	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2010	467	7314					474	478		10.1038/nature09373	http://dx.doi.org/10.1038/nature09373			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KO	20835227	Green Accepted			2022-12-01	WOS:000282090200046
J	Rottmann, M; McNamara, C; Yeung, BKS; Lee, MCS; Zou, B; Russell, B; Seitz, P; Plouffe, DM; Dharia, NV; Tan, J; Cohen, SB; Spencer, KR; Gonzalez-Paez, GE; Lakshminarayana, SB; Goh, A; Suwanarusk, R; Jegla, T; Schmitt, EK; Beck, HP; Brun, R; Nosten, F; Renia, L; Dartois, V; Keller, TH; Fidock, DA; Winzeler, EA; Diagana, TT				Rottmann, Matthias; McNamara, Case; Yeung, Bryan K. S.; Lee, Marcus C. S.; Zou, Bin; Russell, Bruce; Seitz, Patrick; Plouffe, David M.; Dharia, Neekesh V.; Tan, Jocelyn; Cohen, Steven B.; Spencer, Kathryn R.; Gonzalez-Paez, Gonzalo E.; Lakshminarayana, Suresh B.; Goh, Anne; Suwanarusk, Rossarin; Jegla, Timothy; Schmitt, Esther K.; Beck, Hans-Peter; Brun, Reto; Nosten, Francois; Renia, Laurent; Dartois, Veronique; Keller, Thomas H.; Fidock, David A.; Winzeler, Elizabeth A.; Diagana, Thierry T.			Spiroindolones, a Potent Compound Class for the Treatment of Malaria	SCIENCE			English	Article							PARASITE PLASMODIUM-FALCIPARUM; CALCIUM-PUMP; DRUG-RESISTANCE; SARCOPLASMIC-RETICULUM; ARTEMISININ; VIVAX; IDENTIFICATION; ANTIMALARIALS; ERADICATION; CHLOROQUINE	Recent reports of increased tolerance to artemisinin derivatives-the most recently adopted class of antimalarials-have prompted a need for new treatments. The spirotetrahydro-beta-carbolines, or spiroindolones, are potent drugs that kill the blood stages of Plasmodium falciparum and Plasmodium vivax clinical isolates at low nanomolar concentration. Spiroindolones rapidly inhibit protein synthesis in P. falciparum, an effect that is ablated in parasites bearing nonsynonymous mutations in the gene encoding the P-type cation-transporter ATPase4 (PfATP4). The optimized spiroindolone NITD609 shows pharmacokinetic properties compatible with once-daily oral dosing and has single-dose efficacy in a rodent malaria model.	[McNamara, Case; Plouffe, David M.; Cohen, Steven B.; Winzeler, Elizabeth A.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Rottmann, Matthias; Seitz, Patrick; Beck, Hans-Peter; Brun, Reto] Swiss Trop & Publ Hlth Inst, CH-4002 Basel, Switzerland; [Rottmann, Matthias; Seitz, Patrick; Beck, Hans-Peter; Brun, Reto] Univ Basel, CH-4003 Basel, Switzerland; [Yeung, Bryan K. S.; Zou, Bin; Tan, Jocelyn; Lakshminarayana, Suresh B.; Goh, Anne; Dartois, Veronique; Keller, Thomas H.; Diagana, Thierry T.] Novartis Inst Trop Dis, Singapore 138670, Singapore; [Lee, Marcus C. S.; Fidock, David A.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Russell, Bruce; Suwanarusk, Rossarin; Renia, Laurent] ASTAR, Singapore Immunol Network, Lab Malaria Immunobiol, Biopolis 138648, Singapore; [Russell, Bruce] Natl Univ Singapore, Dept Microbiol, Singapore 117597, Singapore; [Dharia, Neekesh V.; Spencer, Kathryn R.; Gonzalez-Paez, Gonzalo E.; Winzeler, Elizabeth A.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Jegla, Timothy] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Jegla, Timothy] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Schmitt, Esther K.] Novartis Pharma AG, Nat Prod Unit, CH-4002 Basel, Switzerland; [Nosten, Francois] Shoklo Malaria Res Unit, Mae Sot 63110, Tak, Thailand; [Nosten, Francois] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Nosten, Francois] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX3 7LJ, England; [Fidock, David A.] Columbia Univ, Med Ctr, Dept Med, Div Infect Dis, New York, NY 10032 USA	Novartis; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Novartis; Columbia University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; Scripps Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Novartis; Mahidol University; Mahidol University; University of Oxford; Columbia University	Winzeler, EA (corresponding author), Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA.	winzeler@scripps.edu; thierry.diagana@novartis.com	Renia, Laurent/E-2117-2011; Dharia, Neekesh/AAC-1245-2020; Nosten, Francois/AAC-5509-2019; Suwanarusk, Rossarin/E-2115-2013; Russell, Bruce/A-9240-2011; Winzeler, Elizabeth/AAP-6752-2020	Renia, Laurent/0000-0003-0349-1557; Dharia, Neekesh/0000-0001-5048-067X; Nosten, Francois/0000-0002-7951-0745; Suwanarusk, Rossarin/0000-0002-7310-245X; Russell, Bruce/0000-0003-2333-4348; Winzeler, Elizabeth/0000-0002-4049-2113; Fidock, David/0000-0001-6753-8938; Rottmann, Matthias/0000-0002-2207-7899; Keller, Thomas/0000-0002-7553-6235; Lee, Marcus/0000-0002-4973-0915; Gonzalez-Paez, Gonzalo/0000-0003-4708-5753; Jegla, Timothy/0000-0001-8616-2390; Yeung, Bryan KS/0000-0002-8866-1764; Beck, Hans-Peter/0000-0001-8326-4834	Fidock laboratory, Medicines for Malaria Venture [MMV08/0015]; Wellcome Trust of Great Britain, Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University; Singapore Immunology Network, A*STAR; Wellcome Trust [WT078285]; Genomics Institute of the Novartis Research Foundation; Swiss Tropical Institute; W. M. Keck Foundation; NIH [R01AI059472]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059472] Funding Source: NIH RePORTER	Fidock laboratory, Medicines for Malaria Venture; Wellcome Trust of Great Britain, Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University(Wellcome Trust); Singapore Immunology Network, A*STAR(Agency for Science Technology & Research (A*STAR)); Wellcome Trust(Wellcome Trust); Genomics Institute of the Novartis Research Foundation; Swiss Tropical Institute; W. M. Keck Foundation(W.M. Keck Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Matter, M. Tanner, and P. Herrling for their foresight and support in establishing a malaria drug discovery program in the context of a public-private partnership. We thank T. A. Smith (SwissTPH) for the statistical analysis of the stage and rate of action studies. We thank S. Rao (Novartis Institute for Tropical Diseases) and M. Traebert (Novartis-preclinical safety), respectively, for the cytotoxicity and hERG inhibition data. We also thank M. Weaver (Novartis-preclinical safety) for the interpretation of the preclinical toxicology data. The team acknowledges P. Schultz, who had the vision to see the potential of the drug resistance experiments in the exploratory phase. In addition, we are grateful to T. Eastman for providing guidance to establish the in vitro drug-selection protocol and for providing the cloned Dd2 parasites. Finally, the scientific expertise provided by S. E. R. Bopp and S. K. Sharma and their helpful discussions throughout this project are greatly appreciated. Funding for the PfATP4 transfectants was provided to the Fidock laboratory in part by the Medicines for Malaria Venture (MMV08/0015; PI D. Fidock). The Shoklo Malaria Research Unit is sponsored by the Wellcome Trust of Great Britain, as part of the Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University. Laurent Renia's laboratory is supported by a core grant from the Singapore Immunology Network, A*STAR. This work was supported by a grant from the Medicines for Malaria Venture and a translational research grant (WT078285) from the Wellcome Trust to the Novartis Institute for Tropical Diseases, the Genomics Institute of the Novartis Research Foundation and the Swiss Tropical Institute, and by grants to E. A. W. from the W. M. Keck Foundation and the NIH (R01AI059472). NITD609 is described in the Novartis patent application WO2009/132921. All requests for spiroindolones or related compounds are subject to a Material Transfer Agreement. T. H. K. and E. A. W. own shares in Novartis (Switzerland).	AMES BN, 1973, P NATL ACAD SCI USA, V70, P782, DOI 10.1073/pnas.70.3.782; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; Dharia NV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r21; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Dyer M, 1996, MOL BIOCHEM PARASIT, V78, P1, DOI 10.1016/S0166-6851(96)02593-5; Eastman RT, 2009, NAT REV MICROBIOL, V7, P864, DOI 10.1038/nrmicro2239; Fidock DA, 2004, NAT REV DRUG DISCOV, V3, P509, DOI 10.1038/nrd1416; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Guiguemde WA, 2010, NATURE, V465, P311, DOI 10.1038/nature09099; Guthmann JP, 2008, TROP MED INT HEALTH, V13, P91, DOI 10.1111/j.1365-3156.2007.01978.x; Hayton K, 2008, CURR GENET, V54, P223, DOI 10.1007/s00294-008-0214-x; Jeffares DC, 2007, NAT GENET, V39, P120, DOI 10.1038/ng1931; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; Krishna S, 2001, J BIOL CHEM, V276, P10782, DOI 10.1074/jbc.M010554200; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Lee MCS, 2008, MOL MICROBIOL, V68, P1535, DOI 10.1111/j.1365-2958.2008.06250.x; Moncoq K, 2007, J BIOL CHEM, V282, P9748, DOI 10.1074/jbc.M611653200; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Nzila A, 2010, J ANTIMICROB CHEMOTH, V65, P390, DOI 10.1093/jac/dkp449; Olliaro P, 2009, CLIN PHARMACOL THER, V85, P584, DOI 10.1038/clpt.2009.51; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; Rathod PK, 1997, P NATL ACAD SCI USA, V94, P9389, DOI 10.1073/pnas.94.17.9389; Russell BM, 2003, ANTIMICROB AGENTS CH, V47, P170, DOI 10.1128/AAC.47.1.170-173.2003; Sharrock WW, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-94; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Traebert Martin, 2005, Expert Opin Drug Saf, V4, P421, DOI 10.1517/14740338.4.3.421; TROTTEIN F, 1995, GENE, V158, P133, DOI 10.1016/0378-1119(95)00158-3; Vennerstrom JL, 2004, NATURE, V430, P900, DOI 10.1038/nature02779; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; Wells TNC, 2009, NAT REV DRUG DISCOV, V8, P879, DOI 10.1038/nrd2972; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; White NJ, 2007, LANCET INFECT DIS, V7, P549, DOI 10.1016/S1473-3099(07)70187-1; WHITE NJ, 1992, J ANTIMICROB CHEMOTH, V30, P571, DOI 10.1093/jac/30.5.571; *WHO, WORLD MAL REP 2009; Winzeler EA, 2008, NATURE, V455, P751, DOI 10.1038/nature07361; Yatime L, 2009, BBA-BIOENERGETICS, V1787, P207, DOI 10.1016/j.bbabio.2008.12.019	41	890	896	4	432	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2010	329	5996					1175	1180		10.1126/science.1193225	http://dx.doi.org/10.1126/science.1193225			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645SG	20813948	Green Accepted			2022-12-01	WOS:000281485600027
J	Schnabel, J				Schnabel, Jim			Secrets of the shaking palsy	NATURE			English	Editorial Material							NEURONAL CELL-DEATH; PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; LEWY BODIES; TRANSMISSION; PROPAGATION; PATHOLOGY; BRAIN											Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Sulzer D, 2010, MOVEMENT DISORD, V25, pS27, DOI 10.1002/mds.22639; Taylor TN, 2009, J NEUROSCI, V29, P8103, DOI 10.1523/JNEUROSCI.1495-09.2009	14	12	13	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2010	466	7310					S2	S5		10.1038/466S2b	http://dx.doi.org/10.1038/466S2b			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20739933				2022-12-01	WOS:000281203600058
J	Al-Mohammad, A; Mant, J; Laramee, P; Swain, S				Al-Mohammad, Abdallah; Mant, Jonathan; Laramee, Philippe; Swain, Sharon		Chronic Heart Failure Guideline De	Guidelines Diagnosis and management of adults with chronic heart failure: summary of updated NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Al-Mohammad, Abdallah] Sheffield Teaching Hosp NHS Fdn Trust, S Yorkshire Cardiothorac Ctr, Sheffield S5 7AU, S Yorkshire, England; [Mant, Jonathan] Univ Cambridge, Gen Practice & Primary Care Res Unit, Cambridge CB2 0SR, England; [Laramee, Philippe; Swain, Sharon] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England	University of Sheffield; University of Cambridge; Royal College of Physicians	Al-Mohammad, A (corresponding author), Sheffield Teaching Hosp NHS Fdn Trust, S Yorkshire Cardiothorac Ctr, Sheffield S5 7AU, S Yorkshire, England.	a.al.mohammad.87@googlemail.com	Dawda, Paresh/I-6947-2015; Al-Mohammad, Abdallah/I-5663-2019	Dawda, Paresh/0000-0003-2727-8320; Al-Mohammad, Abdallah/0000-0001-6517-8692; Mant, Jonathan/0000-0002-9531-0268; Foley, Paul/0000-0002-4856-832X				Cowie MR, 1999, EUR HEART J, V20, P421, DOI 10.1053/euhj.1998.1280; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Mehta PA, 2009, HEART, V95, P1851, DOI 10.1136/hrt.2008.156034; *NAT I CLIN EXC, 2003, CHRON HEART FAIL MAN; *NAT I HLTH CLIN E, 2007, HEART FAIL CARD RES; National Institute for Health and Clinical Excellence, 2006, ARRH IMPL CARD DEF I; National Institute Health and Clinical Excellence, 2010, CHRON HEART FAIL MAN; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; PETERSEN S, 2002, CORONARY HEART DIS S	9	31	31	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 25	2010	341								c4130	10.1136/bmj.c4130	http://dx.doi.org/10.1136/bmj.c4130			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	645IH	20739363				2022-12-01	WOS:000281446000003
J	Kodera, N; Yamamoto, D; Ishikawa, R; Ando, T				Kodera, Noriyuki; Yamamoto, Daisuke; Ishikawa, Ryoki; Ando, Toshio			Video imaging of walking myosin V by high-speed atomic force microscopy	NATURE			English	Article							HAND-OVER-HAND; PROCESSIVE MYOSIN; MECHANISM; ADP; COORDINATION; MOVEMENT; DYNAMICS; KINETICS; BINDING; STROKE	The dynamic behaviour of myosin V molecules translocating along actin filaments has been mainly studied by optical microscopy. The processive hand-over-hand movement coupled with hydrolysis of adenosine triphosphate was thereby demonstrated. However, the protein molecules themselves are invisible in the observations and have therefore been visualized by electron microscopy in the stationary states. The concomitant assessment of structure and dynamics has been unfeasible, a situation prevailing throughout biological research. Here we directly visualize myosin V molecules walking along actin tracks, using high-speed atomic force microscopy. The high-resolution movies not only provide corroborative 'visual evidence' for previously speculated or demonstrated molecular behaviours, including lever-arm swing, but also reveal more detailed behaviours of the molecules, leading to a comprehensive understanding of the motor mechanism. Our direct and dynamic high-resolution visualization is a powerful new approach to studying the structure and dynamics of biomolecules in action.	[Kodera, Noriyuki; Yamamoto, Daisuke; Ando, Toshio] Kanazawa Univ, Dept Phys, Kanazawa, Ishikawa 9201192, Japan; [Kodera, Noriyuki; Yamamoto, Daisuke; Ando, Toshio] JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Ishikawa, Ryoki] Gunma Univ, Grad Sch Med, Dept Mol & Cellular Pharmacol, Maebashi, Gunma 3718511, Japan	Kanazawa University; Japan Science & Technology Agency (JST); Gunma University	Ando, T (corresponding author), Kanazawa Univ, Dept Phys, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	tando@kenroku.kanazawa-u.ac.jp	Kodera, Noriyuki/E-6569-2015; Kodera, Noriyuki/AAJ-1797-2020; ANDO, Toshio/E-7054-2015	Kodera, Noriyuki/0000-0003-4880-8423; Kodera, Noriyuki/0000-0003-4880-8423; ANDO, Toshio/0000-0001-8819-154X	JST; JSPS; MEXT-Japan	JST(Japan Science & Technology Agency (JST)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT-Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank T. Uchihashi and H. Yamashita for technical assistance and discussion, and J. Sellers for critical reading of the draft and for comments. This work was supported by CREST/JST, Special Coordination Funds for Promoting Science and Technology (Effective Promotion of Joint Research with Industry, Academia, and Government) from JST, a Grant-in-Aid for Basic Research (S) from JSPS, and Knowledge Cluster/MEXT-Japan.	Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; Ando T, 2008, PROG SURF SCI, V83, P337, DOI 10.1016/j.progsurf.2008.09.001; Baker JE, 2004, P NATL ACAD SCI USA, V101, P5542, DOI 10.1073/pnas.0307247101; Burgess S, 2002, J CELL BIOL, V159, P983, DOI 10.1083/jcb.200208172; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Forgacs E, 2008, J BIOL CHEM, V283, P766, DOI 10.1074/jbc.M704313200; Forkey JN, 2003, NATURE, V422, P399, DOI 10.1038/nature01529; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Hansma PK, 2006, SCIENCE, V314, P601, DOI 10.1126/science.1133497; Hua W, 2002, SCIENCE, V295, P844, DOI 10.1126/science.1063089; HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356; Joo C, 2008, ANNU REV BIOCHEM, V77, P51, DOI 10.1146/annurev.biochem.77.070606.101543; Kitazawa M, 2003, JPN J APPL PHYS 1, V42, P4844, DOI 10.1143/JJAP.42.4844; Kodera N, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2336113; Koide H, 2006, BIOCHEMISTRY-US, V45, P11598, DOI 10.1021/bi0613877; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Oguchi Y, 2008, P NATL ACAD SCI USA, V105, P7714, DOI 10.1073/pnas.0800564105; Okada T, 2007, BIOCHEM BIOPH RES CO, V354, P379, DOI 10.1016/j.bbrc.2006.12.200; Oke OA, 2010, P NATL ACAD SCI USA, V107, P2509, DOI 10.1073/pnas.0906907107; Purcell TJ, 2005, P NATL ACAD SCI USA, V102, P13873, DOI 10.1073/pnas.0506441102; Rosenfeld SS, 2004, J BIOL CHEM, V279, P40100, DOI 10.1074/jbc.M402583200; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; Sakamoto T, 2008, NATURE, V455, P128, DOI 10.1038/nature07188; Sellers J. R., 2008, MYOS SUP MOL MOT, P289; Sellers JR, 2010, NAT STRUCT MOL BIOL, V17, P590, DOI 10.1038/nsmb.1820; Shibata M, 2010, NAT NANOTECHNOL, V5, P208, DOI [10.1038/NNANO.2010.7, 10.1038/nnano.2010.7]; Syed S, 2006, EMBO J, V25, P1795, DOI 10.1038/sj.emboj.7601060; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Viani MB, 2000, NAT STRUCT BIOL, V7, P644, DOI 10.1038/77936; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; Yamamoto D, 2010, METHOD ENZYMOL, V475, P541, DOI 10.1016/S0076-6879(10)75020-5; Yamamoto D, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384009; Yamashita H, 2009, J STRUCT BIOL, V167, P153, DOI 10.1016/j.jsb.2009.04.011; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	35	558	569	7	249	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 4	2010	468	7320					72	+		10.1038/nature09450	http://dx.doi.org/10.1038/nature09450			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674YF	20935627	Green Submitted			2022-12-01	WOS:000283786900037
J	Cheong, C; Matos, I; Choi, JH; Dandamudi, DB; Shrestha, E; Longhi, MP; Jeffrey, KL; Anthony, RM; Kluger, C; Nchinda, G; Koh, H; Rodriguez, A; Idoyaga, J; Pack, M; Velinzon, K; Park, CG; Steinman, RM				Cheong, Cheolho; Matos, Ines; Choi, Jae-Hoon; Dandamudi, Durga Bhavani; Shrestha, Elina; Longhi, M. Paula; Jeffrey, Kate L.; Anthony, Robert M.; Kluger, Courtney; Nchinda, Godwin; Koh, Hyein; Rodriguez, Anthony; Idoyaga, Juliana; Pack, Maggi; Velinzon, Klara; Park, Chae Gyu; Steinman, Ralph M.			Microbial Stimulation Fully Differentiates Monocytes to DC-SIGN/CD209(+) Dendritic Cells for Immune T Cell Areas	CELL			English	Article							DC-SIGN; LYMPH-NODES; CROSS-PRESENTATION; MELANOMA PATIENTS; IN-VIVO; RECEPTOR; ANTIGEN; IDENTIFICATION; TOLERANCE; RESPONSES	Dendritic cells (DCs), critical antigen-presenting cells for immune control, normally derive from bone marrow precursors distinct from monocytes. It is not yet established if the large reservoir of monocytes can develop into cells with critical features of DCs in vivo. We now show that fully differentiated monocyte-derived DCs (Mo-DCs) develop in mice and DC-SIGN/CD209a marks the cells. Mo-DCs are recruited from blood monocytes into lymph nodes by lipopolysaccharide and live or dead gram-negative bacteria. Mobilization requires TLR4 and its CD14 coreceptor and Trif. When tested for antigen-presenting function, Mo-DCs are as active as classical DCs, including cross-presentation of proteins and live gram-negative bacteria on MHC I in vivo. Fully differentiated Mo-DCs acquire DC morphology and localize to T cell areas via L-selectin and CCR7. Thus the blood monocyte reservoir becomes the dominant presenting cell in response to select microbes, yielding DC-SIGN(+) cells with critical functions of DCs.	[Cheong, Cheolho; Matos, Ines; Choi, Jae-Hoon; Dandamudi, Durga Bhavani; Shrestha, Elina; Longhi, M. Paula; Kluger, Courtney; Nchinda, Godwin; Koh, Hyein; Rodriguez, Anthony; Idoyaga, Juliana; Pack, Maggi; Park, Chae Gyu; Steinman, Ralph M.] Rockefeller Univ, Cellular Physiol & Immunol Lab, New York, NY 10065 USA; [Cheong, Cheolho; Matos, Ines; Choi, Jae-Hoon; Dandamudi, Durga Bhavani; Shrestha, Elina; Longhi, M. Paula; Kluger, Courtney; Nchinda, Godwin; Koh, Hyein; Rodriguez, Anthony; Idoyaga, Juliana; Pack, Maggi; Park, Chae Gyu; Steinman, Ralph M.] Rockefeller Univ, Chris Browne Ctr Immunol & Immune Dis, New York, NY 10065 USA; [Jeffrey, Kate L.] Rockefeller Univ, Lab Lymphocyte Signaling, New York, NY 10065 USA; [Anthony, Robert M.] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA; [Velinzon, Klara] Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Immunol, New York, NY 10065 USA	Rockefeller University; Rockefeller University; Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Cheong, C (corresponding author), Rockefeller Univ, Cellular Physiol & Immunol Lab, 1230 York Ave, New York, NY 10065 USA.	ccheong@rockefeller.edu; parkc@rockefeller.edu; steinma@rockefeller.edu	Markofski, Melissa M/Q-6372-2016; Steinman, Ralph/F-7729-2012	Markofski, Melissa M/0000-0003-0214-4246; Jeffrey, Kate/0000-0001-5746-0153; Longhi, Paula/0000-0003-1854-4594; Park, Chae Gyu/0000-0003-1906-1308	NIGMS [GM62116]; NIH [AI40045, AI40874]; Bill and Melinda Gates Foundation; New York Community Trust; Fundacao para a Ciencia e Tecnologia [SFRH/BD/41073/2007]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040045, R56AI040045, R01AI040874, R37AI040045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); New York Community Trust; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Steinman lab for valuable discussion, J. Adams for graphics, A.J. North and S.A. Galdeen for DIC imaging at the bioimaging resource center, S. Mazel and C. Bare for flow cytometry at the resource center of Rockefeller University, Y. Oh and I. Jang for CSP preparation, J.D. Schauer for mAb purification, J. Gonzalez for ELISA assays (Rockefeller University Center for Clinical and Translational Science, UL1RR024143 from National Center for Research Resource). We thank the Consortium for Functional Glycomics supported by NIGMS (GM62116) for DC-SIGN/CD209a<SUP>-/-</SUP> mice. We were supported by grants from the NIH (AI40045 and AI40874), the Bill and Melinda Gates Foundation (R.M.S.), New York Community Trust's Francis Florio funds for blood diseases (C.C.), and a Fundacao para a Ciencia e Tecnologia PhD scholarship (I.M. SFRH/BD/41073/2007).	Agger R, 2000, SCAND J IMMUNOL, V52, P138; Cheong C, 2010, J IMMUNOL METHODS, V360, P66, DOI 10.1016/j.jim.2010.06.006; Choi JH, 2009, J EXP MED, V206, P497, DOI 10.1084/jem.20082129; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; de Vries IJM, 2003, CANCER RES, V63, P12; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; DEVILLIERS WJS, 1994, J EXP MED, V180, P705, DOI 10.1084/jem.180.2.705; Dhodapkar MV, 1999, J CLIN INVEST, V104, P173, DOI 10.1172/JCI6909; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; Granelli-Piperno A, 2005, J IMMUNOL, V175, P4265, DOI 10.4049/jimmunol.175.7.4265; Halary F, 2002, IMMUNITY, V17, P653, DOI 10.1016/S1074-7613(02)00447-8; HEARD JM, 1987, CELL, V51, P663, DOI 10.1016/0092-8674(87)90135-8; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Hohl TM, 2009, CELL HOST MICROBE, V6, P470, DOI 10.1016/j.chom.2009.10.007; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; JOHNSON WD, 1977, J EXP MED, V146, P1613, DOI 10.1084/jem.146.5.1613; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Luckashenak N, 2008, IMMUNITY, V28, P521, DOI 10.1016/j.immuni.2008.02.018; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Moron VG, 2003, J IMMUNOL, V171, P2242, DOI 10.4049/jimmunol.171.5.2242; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; ONAI N, 2007, J EXP MED, V193, P233; Park CG, 2001, INT IMMUNOL, V13, P1283, DOI 10.1093/intimm/13.10.1283; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Schreurs MWJ, 1999, EUR J IMMUNOL, V29, P2835, DOI 10.1002/(SICI)1521-4141(199909)29:09<2835::AID-IMMU2835>3.0.CO;2-Q; Schuler-Thurner B, 2000, J IMMUNOL, V165, P3492, DOI 10.4049/jimmunol.165.6.3492; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Siddiqui KRR, 2010, IMMUNITY, V32, P557, DOI 10.1016/j.immuni.2010.03.017; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; STEINMAN RM, 1978, P NATL ACAD SCI USA, V75, P5132, DOI 10.1073/pnas.75.10.5132; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tacken PJ, 2005, BLOOD, V106, P1278, DOI 10.1182/blood-2005-01-0318; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Vremec D, 1997, J IMMUNOL, V159, P565; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577	63	435	440	3	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 29	2010	143	3					416	429		10.1016/j.cell.2010.09.039	http://dx.doi.org/10.1016/j.cell.2010.09.039			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672RF	21029863	Green Accepted, Bronze, Green Submitted			2022-12-01	WOS:000283603900015
J	Lane, N; Martin, W				Lane, Nick; Martin, William			The energetics of genome complexity	NATURE			English	Article							MITOCHONDRIAL GENE-EXPRESSION; EUKARYOTIC GENOMES; EVOLUTION; BACTERIA; ORIGIN; CELL; OXYGEN; DNA; COMPARTMENTALIZATION; CHROMOSOMES	All complex life is composed of eukaryotic (nucleated) cells. The eukaryotic cell arose from prokaryotes just once in four billion years, and otherwise prokaryotes show no tendency to evolve greater complexity. Why not? Prokaryotic genome size is constrained by bioenergetics. The endosymbiosis that gave rise to mitochondria restructured the distribution of DNA in relation to bioenergetic membranes, permitting a remarkable 200,000-fold expansion in the number of genes expressed. This vast leap in genomic capacity was strictly dependent on mitochondrial power, and prerequisite to eukaryote complexity: the key innovation en route to multicellular life.	[Lane, Nick] UCL, Dept Genet Evolut & Environm, London W1E 6BT, England; [Martin, William] Univ Dusseldorf, Inst Bot 3, D-40225 Dusseldorf, Germany	University of London; University College London; Heinrich Heine University Dusseldorf	Lane, N (corresponding author), UCL, Dept Genet Evolut & Environm, Gower St, London W1E 6BT, England.	nick.lane@ucl.ac.uk	Martin, William/C-5680-2008; Martin, William F./O-5446-2015	Martin, William F./0000-0003-1478-6449; Lane, Nick/0000-0002-5433-3973	UCL; German Research Foundation; European Research Council (Networkorigins)	UCL; German Research Foundation(German Research Foundation (DFG)); European Research Council (Networkorigins)(European Research Council (ERC))	We are indebted to A. Hidalgo, D. Braben, F. Harold, J. Ellis, H. Schulz-Vogt, J. Allen, G. Shields and L. Sweetlove for many discussions and comments on the manuscript, M. Farmer, H. Schulz-Vogt and R. Allen for microscopic images. N.L. is very grateful to the UCL Provost's Venture Research Fellowship, W. M. to the German Research Foundation and the European Research Council (Networkorigins) for funding.	ALLEN JF, 1993, J THEOR BIOL, V165, P609, DOI 10.1006/jtbi.1993.1210; Allen JF, 2003, PHILOS T R SOC B, V358, P19, DOI 10.1098/rstb.2002.1191; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Bai YD, 2000, MOL CELL BIOL, V20, P805, DOI 10.1128/MCB.20.3.805-815.2000; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bidle KD, 2004, NAT REV MICROBIOL, V2, P643, DOI 10.1038/nrmicro956; Brighouse A, 2010, CELL MOL LIFE SCI, V67, P3449, DOI 10.1007/s00018-010-0436-1; Brocchieri L, 2005, NUCLEIC ACIDS RES, V33, P3390, DOI 10.1093/nar/gki615; Cavalier-Smith T, 2009, INT J BIOCHEM CELL B, V41, P307, DOI 10.1016/j.biocel.2008.10.002; Chomyn A, 2001, J BIOENERG BIOMEMBR, V33, P251, DOI 10.1023/A:1010791204961; Cox CJ, 2008, P NATL ACAD SCI USA, V105, P20356, DOI 10.1073/pnas.0810647105; DANIELS EW, 1968, Z ZELLFORSCH MIK ANA, V91, P159, DOI 10.1007/BF00364307; Davidov Y, 2009, BIOESSAYS, V31, P748, DOI 10.1002/bies.200900018; de Duve C, 2007, NAT REV GENET, V8, P395, DOI 10.1038/nrg2071; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; FENCHEL T, 1983, MICROBIAL ECOL, V9, P99, DOI 10.1007/BF02015125; Forterre P, 2010, P NATL ACAD SCI USA, V107, P12739, DOI 10.1073/pnas.1007720107; Fritz-Laylin LK, 2010, CELL, V140, P631, DOI 10.1016/j.cell.2010.01.032; Gray MW, 2004, ANNU REV GENET, V38, P477, DOI 10.1146/annurev.genet.37.110801.142526; Harold F. M., 1986, VITAL FORCE STUDY BI; Johnston DT, 2009, P NATL ACAD SCI USA, V106, P16925, DOI 10.1073/pnas.0909248106; Koonin EV, 2009, NUCLEIC ACIDS RES, V37, P1011, DOI 10.1093/nar/gkp089; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Kunin V, 2003, GENOME RES, V13, P1589, DOI 10.1101/gr.1092603; Kuo CH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001050; Kurland CG, 2006, SCIENCE, V312, P1011, DOI 10.1126/science.1121674; Lane CE, 2008, TRENDS ECOL EVOL, V23, P268, DOI 10.1016/j.tree.2008.02.004; Lane N., 2005, POWER SEX SUICIDE MI; Lane N., 2009, LIFE ASCENDING 10 GR; Lindsay MR, 2001, ARCH MICROBIOL, V175, P413, DOI 10.1007/s002030100280; Lonhienne TGA, 2010, P NATL ACAD SCI USA, V107, P12883, DOI 10.1073/pnas.1001085107; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Makarieva AM, 2005, P ROY SOC B-BIOL SCI, V272, P2219, DOI 10.1098/rspb.2005.3225; MARGULIS L, 1976, NATURE, V264, P620, DOI 10.1038/264620a0; Martin W, 2006, NATURE, V440, P41, DOI 10.1038/nature04531; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; Maynard Smith J., 1995, MAJOR TRANSITIONS EV; Mendell JE, 2008, P NATL ACAD SCI USA, V105, P6730, DOI 10.1073/pnas.0707522105; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; Nilsson M, 1997, BIOTECHNOL BIOENG, V54, P461, DOI 10.1002/(SICI)1097-0290(19970605)54:5<461::AID-BIT6>3.0.CO;2-C; Parfrey LW, 2008, MOL BIOL EVOL, V25, P787, DOI 10.1093/molbev/msn032; Peterson KJ, 2009, BIOESSAYS, V31, P736, DOI 10.1002/bies.200900033; Pinevich AV, 1997, ENDOCYTOBIOSIS CELL, V12, P9; Piruat JI, 2005, J BIOL CHEM, V280, P42676, DOI 10.1074/jbc.M507044200; Pisani D, 2007, MOL BIOL EVOL, V24, P1752, DOI 10.1093/molbev/msm095; Rivera MC, 2004, NATURE, V431, P152, DOI 10.1038/nature02848; Robinson NP, 2007, P NATL ACAD SCI USA, V104, P5806, DOI 10.1073/pnas.0700206104; Rocher C, 2008, J BIOENERG BIOMEMBR, V40, P59, DOI 10.1007/s10863-008-9130-5; Rokas A, 2008, ANNU REV GENET, V42, P235, DOI 10.1146/annurev.genet.42.110807.091513; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Schulz HN, 2002, APPL ENVIRON MICROB, V68, P5746, DOI 10.1128/AEM.68.11.5746-5749.2002; Schulz HN, 2001, ANNU REV MICROBIOL, V55, P105, DOI 10.1146/annurev.micro.55.1.105; SHAY JW, 1990, J BIOL CHEM, V265, P14802; Shimizu M, 2010, P NATL ACAD SCI USA, V107, P10760, DOI 10.1073/pnas.0911692107; Simon DM, 2008, NUCLEIC ACIDS RES, V36, P7219, DOI 10.1093/nar/gkn867; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Tielens AGM, 2002, TRENDS BIOCHEM SCI, V27, P564, DOI 10.1016/S0968-0004(02)02193-X; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945; Van Der Giezen M, 2009, J EUKARYOT MICROBIOL, V56, P221, DOI 10.1111/j.1550-7408.2009.00407.x; Vats P, 2009, CELL MOL LIFE SCI, V66, P3353, DOI 10.1007/s00018-009-0092-5; Vellai T, 1998, J MOL EVOL, V46, P499, DOI 10.1007/PL00006331; Vellai T, 1999, P ROY SOC B-BIOL SCI, V266, P1571, DOI 10.1098/rspb.1999.0817; von Dohlen CD, 2001, NATURE, V412, P433, DOI 10.1038/35086563; Wagner A, 2005, MOL BIOL EVOL, V22, P1365, DOI 10.1093/molbev/msi126; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; WEIBEL ER, 1969, J CELL BIOL, V42, P68, DOI 10.1083/jcb.42.1.68; WILLIAMS RS, 1986, J BIOL CHEM, V261, P376; WILLIAMS RS, 1986, J BIOL CHEM, V261, P2390; WUJEK DE, 1979, T AM MICROSC SOC, V98, P143, DOI 10.2307/3225953; Yang S, 2005, P NATL ACAD SCI USA, V102, P373, DOI 10.1073/pnas.0408810102; Yutin N, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-9; [No title captured]	74	691	708	13	284	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 21	2010	467	7318					929	934		10.1038/nature09486	http://dx.doi.org/10.1038/nature09486			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20962839				2022-12-01	WOS:000283254700030
J	Shaw, DE; Maragakis, P; Lindorff-Larsen, K; Piana, S; Dror, RO; Eastwood, MP; Bank, JA; Jumper, JM; Salmon, JK; Shan, YB; Wriggers, W				Shaw, David E.; Maragakis, Paul; Lindorff-Larsen, Kresten; Piana, Stefano; Dror, Ron O.; Eastwood, Michael P.; Bank, Joseph A.; Jumper, John M.; Salmon, John K.; Shan, Yibing; Wriggers, Willy			Atomic-Level Characterization of the Structural Dynamics of Proteins	SCIENCE			English	Article							PANCREATIC TRYPSIN-INHIBITOR; DISULFIDE BOND ISOMERIZATION; FOLDING TRANSITION-STATES; BETA-HAIRPIN FORMATION; PHI-VALUE ANALYSIS; WW DOMAIN; RELAXATION DISPERSION; FORCE-FIELD; SPEED LIMIT; SIMULATIONS	Molecular dynamics (MD) simulations are widely used to study protein motions at an atomic level of detail, but they have been limited to time scales shorter than those of many biologically critical conformational changes. We examined two fundamental processes in protein dynamics-protein folding and conformational change within the folded state-by means of extremely long all-atom MD simulations conducted on a special-purpose machine. Equilibrium simulations of a WW protein domain captured multiple folding and unfolding events that consistently follow a well-defined folding pathway; separate simulations of the protein's constituent substructures shed light on possible determinants of this pathway. A 1-millisecond simulation of the folded protein BPTI reveals a small number of structurally distinct conformational states whose reversible interconversion is slower than local relaxations within those states by a factor of more than 1000.	[Shaw, David E.; Maragakis, Paul; Lindorff-Larsen, Kresten; Piana, Stefano; Dror, Ron O.; Eastwood, Michael P.; Bank, Joseph A.; Jumper, John M.; Salmon, John K.; Shan, Yibing; Wriggers, Willy] DE Shaw Res, New York, NY 10036 USA; [Shaw, David E.] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA	D. E. Shaw Research; Columbia University	Shaw, DE (corresponding author), DE Shaw Res, 120 W 45th St, New York, NY 10036 USA.	David.Shaw@DEShawResearch.com	Lindorff-Larsen, Kresten/K-6469-2014	Lindorff-Larsen, Kresten/0000-0002-4750-6039; Wriggers, Willy/0000-0001-5326-3152; Dror, Ron/0000-0002-6418-2793				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Best RB, 2005, P NATL ACAD SCI USA, V102, P6732, DOI 10.1073/pnas.0408098102; Chakrapani S, 2005, P NATL ACAD SCI USA, V102, P87, DOI 10.1073/pnas.0406777102; Chung HS, 2009, P NATL ACAD SCI USA, V106, P11837, DOI 10.1073/pnas.0901178106; Cota E, 2000, J MOL BIOL, V302, P713, DOI 10.1006/jmbi.2000.4053; Deechongkit S, 2004, NATURE, V430, P101, DOI 10.1038/nature02611; Ensign DL, 2009, BIOPHYS J, V96, pL53, DOI 10.1016/j.bpj.2009.01.024; Fersht AR, 2004, P NATL ACAD SCI USA, V101, P7976, DOI 10.1073/pnas.0402684101; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Freddolino PL, 2008, BIOPHYS J, V94, pL75, DOI 10.1529/biophysj.108.131565; Freddolino PL, 2009, BIOPHYS J, V96, P3772, DOI 10.1016/j.bpj.2009.02.033; Gardino AK, 2009, CELL, V139, P1109, DOI 10.1016/j.cell.2009.11.022; Geierhaas CD, 2008, PROTEIN ENG DES SEL, V21, P215, DOI 10.1093/protein/gzm092; Gianni S, 2003, P NATL ACAD SCI USA, V100, P13286, DOI 10.1073/pnas.1835776100; Grey MJ, 2003, J AM CHEM SOC, V125, P14324, DOI 10.1021/ja0367389; Jager M, 2006, P NATL ACAD SCI USA, V103, P10648, DOI 10.1073/pnas.0600511103; Jager M, 2009, PROTEIN SCI, V18, P1806, DOI 10.1002/pro.172; Jager M, 2001, J MOL BIOL, V311, P373, DOI 10.1006/jmbi.2001.4873; Juraszek J, 2010, BIOPHYS J, V98, P646, DOI 10.1016/j.bpj.2009.10.039; KARPLUS M, 1994, PROTEIN SCI, V3, P650; Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Kubelka J, 2006, J MOL BIOL, V359, P546, DOI 10.1016/j.jmb.2006.03.034; Lei HX, 2007, CURR OPIN STRUC BIOL, V17, P187, DOI 10.1016/j.sbi.2007.03.003; LEVITT M, 1975, NATURE, V253, P694, DOI 10.1038/253694a0; Lindorff-Larsen K, 2005, NATURE, V433, P128, DOI 10.1038/nature03199; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Liu F, 2008, P NATL ACAD SCI USA, V105, P2369, DOI 10.1073/pnas.0711908105; Liu F, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3262489; MATOUSCHEK A, 1989, NATURE, V340, P122, DOI 10.1038/340122a0; McCallister EL, 2000, NAT STRUCT BIOL, V7, P669, DOI 10.1038/77971; MCCAMMON JA, 1977, NATURE, V267, P585, DOI 10.1038/267585a0; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Noe F, 2009, P NATL ACAD SCI USA, V106, P19011, DOI 10.1073/pnas.0905466106; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Nymeyer H, 2000, P NATL ACAD SCI USA, V97, P634, DOI 10.1073/pnas.97.2.634; OTTING G, 1993, BIOCHEMISTRY-US, V32, P3571, DOI 10.1021/bi00065a008; OTTING G, 1991, SCIENCE, V254, P974, DOI 10.1126/science.1948083; Persson E, 2008, J AM CHEM SOC, V130, P1774, DOI 10.1021/ja0775873; Petrovich M, 2006, J MOL BIOL, V360, P865, DOI 10.1016/j.jmb.2006.05.050; Settanni G, 2005, P NATL ACAD SCI USA, V102, P628, DOI 10.1073/pnas.0406754102; Shaw D. E, 2009, P ACM IEEE C SUP SC0; Snow CD, 2002, NATURE, V420, P102, DOI 10.1038/nature01160; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; WAGNER G, 1987, J MOL BIOL, V196, P227, DOI 10.1016/0022-2836(87)90524-9; WLODAWER A, 1984, J MOL BIOL, V180, P301, DOI 10.1016/S0022-2836(84)80006-6; WUTHRICH K, 1975, FEBS LETT, V50, P265, DOI 10.1016/0014-5793(75)80504-7; Zhou YQ, 1999, J MOL BIOL, V285, P1371, DOI 10.1006/jmbi.1998.2374	48	1272	1281	12	506	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 15	2010	330	6002					341	346		10.1126/science.1187409	http://dx.doi.org/10.1126/science.1187409			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947758				2022-12-01	WOS:000282986700033
J	Vossel, KA; Zhang, K; Brodbeck, J; Daub, AC; Sharma, P; Finkbeiner, S; Cui, BX; Mucke, L				Vossel, Keith A.; Zhang, Kai; Brodbeck, Jens; Daub, Aaron C.; Sharma, Punita; Finkbeiner, Steven; Cui, Bianxiao; Mucke, Lennart			Tau Reduction Prevents A beta-Induced Defects in Axonal Transport	SCIENCE			English	Article							ALZHEIMERS-DISEASE; AMYLOID-BETA; HIPPOCAMPAL-NEURONS; MOUSE MODEL; OVEREXPRESSION; TRAFFICKING; MECHANISM	Amyloid-beta (A beta) peptides, derived from the amyloid precursor protein, and the microtubule-associated protein tau are key pathogenic factors in Alzheimer's disease (AD). How exactly they impair cognitive functions is unknown. We assessed the effects of A beta and tau on axonal transport of mitochondria and the neurotrophin receptor TrkA, cargoes that are critical for neuronal function and survival and whose distributions are altered in AD. A beta oligomers rapidly inhibited axonal transport of these cargoes in wild-type neurons. Lowering tau levels prevented these defects without affecting baseline axonal transport. Thus, A beta requires tau to impair axonal transport, and tau reduction protects against A beta-induced axonal transport defects.	[Vossel, Keith A.; Brodbeck, Jens; Daub, Aaron C.; Sharma, Punita; Finkbeiner, Steven; Mucke, Lennart] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Vossel, Keith A.; Finkbeiner, Steven; Mucke, Lennart] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Zhang, Kai; Cui, Bianxiao] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Stanford University	Vossel, KA (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	kvossel@gladstone.ucsf.edu; lmucke@gladstone.ucsf.edu	Zhang, Kai/G-6437-2010; Brodbeck, Jens/AAB-9275-2020; Zhang, Kai/ABD-1498-2021	Zhang, Kai/0000-0002-6687-4558; Zhang, Kai/0000-0002-6687-4558	NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS057906, R01NS041787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011385, R37AG011385] Funding Source: NIH RePORTER; NCRR NIH HHS [C06 RR018928] Funding Source: Medline; NIA NIH HHS [AG011385, R01 AG011385, R37 AG011385, R01 AG011385-07] Funding Source: Medline; NINDS NIH HHS [R00 NS057906-05, K99 NS057906, NS057906, NS041787, R00 NS057906, R01 NS041787, R01 NS041787-09] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Dawson HN, 2010, NEUROSCIENCE, V169, P516, DOI 10.1016/j.neuroscience.2010.04.037; Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Hiruma H, 2003, J NEUROSCI, V23, P8967; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Pigino G, 2009, P NATL ACAD SCI USA, V106, P5907, DOI 10.1073/pnas.0901229106; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rui YF, 2006, J NEUROSCI, V26, P10480, DOI 10.1523/JNEUROSCI.3231-06.2006; Schindowski K, 2008, GENES BRAIN BEHAV, V7, P43, DOI 10.1111/j.1601-183X.2007.00378.x; Yuan A, 2008, J NEUROSCI, V28, P1682, DOI 10.1523/JNEUROSCI.5242-07.2008	12	373	386	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					198	U52		10.1126/science.1194653	http://dx.doi.org/10.1126/science.1194653			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20829454	Green Accepted			2022-12-01	WOS:000282644600034
J	Matute, DR; Butler, IA; Turissini, DA; Coyne, JA				Matute, Daniel R.; Butler, Ian A.; Turissini, David A.; Coyne, Jerry A.			A Test of the Snowball Theory for the Rate of Evolution of Hybrid Incompatibilities	SCIENCE			English	Article							DROSOPHILA; INVIABILITY; GENETICS; MELANOGASTER; SPECIATION; STERILITY	Hybrids between species are often sterile or inviable because the long-diverged genomes of their parents cause developmental problems when they come together in a single individual. According to the Dobzhansky-Muller (DM) model, the number of genes involved in these "intrinsic postzygotic incompatibilities" should increase faster than linearly with the divergence time between species. This straightforward prediction of the DM model has remained contentious owing to a lack of explicit tests. Examining two pairs of Drosophila species, we show that the number of genes involved in postzygotic isolation increases at least as fast as the square of the number of substitutions (an index of divergence time) between species. This observation verifies a key prediction of the DM model.	[Matute, Daniel R.; Butler, Ian A.; Turissini, David A.; Coyne, Jerry A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Matute, DR (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.	dmatute@uchicago.edu		Butler, Ian/0000-0002-1386-2430	NIH [R01GM058260]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058260] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. C. Presgraves, T. D. Price, R. Unckless, D. Kennedy, M. A. Sprigge, and M. Przeworski for discussions and reading of the manuscript; P. Andolfatto, T. Hu, and K. Thornton for sharing data; and A. Harris and J. Gladstone for technical help. Funded by NIH grant R01GM058260 (J.A.C.).	Bolnick DI, 2005, EVOLUTION, V59, P1754, DOI 10.1111/j.0014-3820.2005.tb01824.x; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Burnham KP., 2002, MODEL SELECTION MULT, V2; Coyne J.A., 2004, SPECIATION; Coyne JA, 1998, GENETICS, V150, P1091; Dobzhansky T, 1937, GENETICS ORIGIN SPEC; Gourbiere S, 2010, EVOLUTION, V64, P1, DOI 10.1111/j.1558-5646.2009.00844.x; Johnson Norman A., 2006, P374; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; Matute DR, 2009, CELL, V139, P1180, DOI 10.1016/j.cell.2009.10.033; Moyle LC, 2008, GENETICS, V179, P1437, DOI 10.1534/genetics.107.083618; Moyle LC, 2009, TRENDS ECOL EVOL, V24, P591, DOI 10.1016/j.tree.2009.05.010; Muller H., 1942, BIOL S, V6, P71; ORR HA, 1995, GENETICS, V139, P1805; Orr HA, 2001, EVOLUTION, V55, P1085; Phadnis N, 2009, SCIENCE, V323, P376, DOI 10.1126/science.1163934; Presgraves DC, 2007, CURR BIOL, V17, pR125, DOI 10.1016/j.cub.2006.12.030; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Presgraves DC, 2003, GENETICS, V163, P955; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Tang SW, 2009, SCIENCE, V323, P779, DOI 10.1126/science.1169123	21	131	132	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 17	2010	329	5998					1518	1521		10.1126/science.1193440	http://dx.doi.org/10.1126/science.1193440			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650RK	20847270				2022-12-01	WOS:000281869000040
J	Nathanson, E; Nunn, P; Uplekar, M; Floyd, K; Jaramillo, E; Lonnroth, K; Weil, D; Raviglione, M				Nathanson, Eva; Nunn, Paul; Uplekar, Mukund; Floyd, Katherine; Jaramillo, Ernesto; Loennroth, Knut; Weil, Diana; Raviglione, Mario			MDR Tuberculosis - Critical Steps for Prevention and Control	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MULTIDRUG-RESISTANT TUBERCULOSIS; COMMUNITY-BASED TREATMENT; XDR-TB; RUSSIAN-FEDERATION; TREATMENT OUTCOMES; HEALTH; CARE; SYSTEMS; PRACTITIONERS; EXPERIENCE		[Nathanson, Eva; Nunn, Paul; Uplekar, Mukund; Floyd, Katherine; Jaramillo, Ernesto; Loennroth, Knut; Weil, Diana; Raviglione, Mario] WHO, Stop TB Dept, CH-1211 Geneva, Switzerland	World Health Organization	Jaramillo, E (corresponding author), WHO, Stop TB Dept, CH-1211 Geneva, Switzerland.	jaramilloe@who.int	alzahrani, saud hamed/C-2014-2012; Lönnroth, Knut/L-2339-2014; Lonnroth, Knut/H-5470-2017	Lönnroth, Knut/0000-0001-5054-8240; Lonnroth, Knut/0000-0001-6944-0256; RAVIGLIONE, Mario/0000-0002-9331-2067	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Supported by a grant from the Bill and Melinda Gates Foundation.	Basu S, 2009, P NATL ACAD SCI USA, V106, P7672, DOI 10.1073/pnas.0812472106; Birx D, 2009, AM J CLIN PATHOL, V131, P849, DOI 10.1309/AJCPGH89QDSWFONS; Blomberg B, 2003, DRUGS, V63, P535, DOI 10.2165/00003495-200363060-00002; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Cars O, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1438; Caudron JM, 2008, TROP MED INT HEALTH, V13, P1062, DOI 10.1111/j.1365-3156.2008.02106.x; Cheng MH, 2009, LANCET, V373, P1328, DOI 10.1016/S0140-6736(09)60757-1; Cox HS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001126; Dye C, 2009, NAT REV MICROBIOL, V7, P81, DOI 10.1038/nrmicro2048; FAUCI AS, 2009, OPINION FIGHTING TB; Floyd K, 2006, B WORLD HEALTH ORGAN, V84, P43, DOI 10.2471/BLT.04.018705; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Garrett L, 2009, LANCET, V374, P1294, DOI 10.1016/S0140-6736(09)61503-8; Gelmanova IY, 2007, B WORLD HEALTH ORGAN, V85, P703, DOI 10.2471/BLT.06.038331; HANSON C, 2006, TB COMPREHENSIVE INT, P1097; Heller T, 2010, INT J TUBERC LUNG D, V14, P420; Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4; International Labour Organization, 2008, SOC HLTH PROT ILO ST; Irawati SR, 2007, INT J TUBERC LUNG D, V11, P33; KOBAIDZE K, 2009, INTERDISCIP PERSPECT, P513; Lonnroth K, 2006, B WORLD HEALTH ORGAN, V84, P876; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Lonnroth K, 2007, HEALTH POLICY PLANN, V22, P156, DOI 10.1093/heapol/czm007; Loveday M, 2008, INT J TUBERC LUNG D, V12, P1042; Malla P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008313; Marais BJ, 2006, J CLIN MICROBIOL, V44, P3539, DOI 10.1128/JCM.01291-06; Naidoo S, 2006, INT J TUBERC LUNG D, V10, P676; Newton PN, 2006, LANCET INFECT DIS, V6, P602, DOI 10.1016/S1473-3099(06)70581-3; Nodieva A, 2010, INT J TUBERC LUNG D, V14, P427; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Pantoja A, 2009, INT J TUBERC LUNG D, V13, P698; Paramasivan CN, 2010, INT J TUBERC LUNG D, V14, P59; Raviglione MC, 2007, NEW ENGL J MED, V356, P656, DOI 10.1056/NEJMp068273; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; Reichman LB, 2009, LANCET, V373, P28, DOI 10.1016/S0140-6736(08)61952-2; Shin S, 2004, SOC SCI MED, V59, P1529, DOI 10.1016/j.socscimed.2004.01.027; Singh JA, 2007, PLOS MED, V4, P19, DOI 10.1371/journal.pmed.0040050; Skodric-Trifunovic V, 2009, INT J TUBERC LUNG D, V13, P640; Sotgiu G, 2009, EUR RESPIR J, V33, P871, DOI 10.1183/09031936.00168008; *STOP TB, PARTN GLOB PLAN STOP; *TB ALL, 2007, PATHW PAT CHART DYN; Tupasi TE, 2006, PLOS MED, V3, P1587, DOI 10.1371/journal.pmed.0030352; Uplekar M, 2001, LANCET, V358, P912, DOI 10.1016/S0140-6736(01)06076-7; Uplekar M, 1998, INT J TUBERC LUNG D, V2, P324; Uplekar M, 2008, INT J TUBERC LUNG D, V12, P986; VANDEUN A, 2010, AM J RESP CRIT  0504; WHO, 2015, PREQ PROGR; WHO, 2009, WHOHTMTB2009411; WHO, 2011, NEW WHO REP ANT DRUG; *WHO, GLOB TUB CONTR PAT C; WHO, 2006, WORLD HLTH REPORT 20; World Health Organization, 2009, WHO POL TB INF CONTR; World Health Organization, 2005, SOC HLTH INS SUST HL; World Health Organization, 2008, MOL LIN PROB ASS RAP; World Health Organization, 2010, GUIDELINES TREATMENT, V4th; World Health Organization, 2006, ENG ALL HLTH CAR PRO; World Health Organization, 2001, MACROECONOMICS HLTH; World Health Organization (WHO), 2010, GUID PROGR MAN DRUG; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5	59	137	139	1	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 9	2010	363	11					1050	1058		10.1056/NEJMra0908076	http://dx.doi.org/10.1056/NEJMra0908076			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	647HS	20825317	Bronze			2022-12-01	WOS:000281609700008
J	Park, SY; Cromie, MJ; Lee, EJ; Groisman, EA				Park, Sun-Yang; Cromie, Michael J.; Lee, Eun-Jin; Groisman, Eduardo A.			A Bacterial mRNA Leader that Employs Different Mechanisms to Sense Disparate Intracellular Signals	CELL			English	Article							ESCHERICHIA-COLI K-12; SALMONELLA-ENTERICA; GENE-EXPRESSION; TRANSCRIPTION ATTENUATION; OSMOTIC-STRESS; MG2+; RIBOSWITCH; TRANSPORT; VIRULENCE; MGTA	Bacterial mRNAs often contain leader sequences that respond to specific metabolites or ions by altering expression of the associated downstream protein-coding sequences. Here we report that the leader RNA of the Mg2+ transporter gene mgtA of Salmonella enterica, which was previously known to function as a Mg2+-sensing riboswitch, harbors an 18 codon proline-rich open reading frame-termed mgtL-that permits intracellular proline to regulate mgtA expression. Interfering with mgtL translation by genetic, pharmacological, or environmental means was observed to increase the mRNA levels from the mgtA coding region. Substitution of the mgtL proline codons by other codons abolished the response to proline and to hyperosmotic stress but not to Mg2+. Our findings show that mRNA leader sequences can consist of complex regulatory elements that utilize different mechanisms to sense separate signals and mediate an appropriate cellular response.	[Cromie, Michael J.; Lee, Eun-Jin; Groisman, Eduardo A.] Washington Univ, Howard Hughes Med Inst, Sch Med, St Louis, MO 63110 USA; [Park, Sun-Yang; Cromie, Michael J.; Lee, Eun-Jin; Groisman, Eduardo A.] Washington Univ, Dept Mol Microbiol, Sch Med, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL)	Groisman, EA (corresponding author), Yale Univ, Sch Med, Sect Microbial Pathogenesis, Howard Hughes Med Inst,Boyer Ctr Mol Med, 295 Congress Ave, New Haven, CT 06536 USA.	eduardo.groisman@yale.edu			NIH [AI49561]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049561] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Laszlo Csonka, Kerry Hollands, Robert Landick, and Charles Yanofsky for comments on the manuscript; Henry Huang for the plasmid harboring supF; and John Roth for strains. This work was supported, in part, by grant AI49561 from the NIH to E.A.G., who is an Investigator of the Howard Hughes Medical Institute.	Bader MW, 2005, CELL, V122, P461, DOI 10.1016/j.cell.2005.05.030; Barchiesi J, 2008, J BACTERIOL, V190, P4951, DOI 10.1128/JB.00195-08; BlancPotard AB, 1997, EMBO J, V16, P5376, DOI 10.1093/emboj/16.17.5376; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; CAYLEY S, 1992, J BACTERIOL, V174, P1586, DOI 10.1128/jb.174.5.1586-1595.1992; CHEN JW, 1991, J BACTERIOL, V173, P2328, DOI 10.1128/JB.173.7.2328-2340.1991; Choi E, 2009, J BACTERIOL, V191, P7174, DOI 10.1128/JB.00958-09; Cromie MJ, 2010, J BACTERIOL, V192, P604, DOI 10.1128/JB.01239-09; Cromie MJ, 2006, CELL, V125, P71, DOI 10.1016/j.cell.2006.01.043; Csonka L.N., 2007, ECOSALESCHERICHIA CO; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eguchi Y, 2004, J BACTERIOL, V186, P3006, DOI 10.1128/JB.186.10.3006-3014.2004; Froschauer EM, 2004, FEMS MICROBIOL LETT, V237, P49, DOI 10.1016/j.femsle.2004.06.013; Grundy FJ, 2006, CRIT REV BIOCHEM MOL, V41, P329, DOI 10.1080/10409230600914294; Hammarlof DL, 2008, MOL MICROBIOL, V70, P1194, DOI 10.1111/j.1365-2958.2008.06472.x; Henkin TM, 2008, GENE DEV, V22, P3383, DOI 10.1101/gad.1747308; Henkin TM, 2002, BIOESSAYS, V24, P700, DOI 10.1002/bies.10125; LANDICK R, 1996, ESCHERICHIA COLI SAL; LANDICK R, 1987, ESCHERICHIA COLI SAL; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Lejona S, 2003, J BACTERIOL, V185, P6287, DOI 10.1128/JB.185.21.6287-6294.2003; Loh E, 2009, CELL, V139, P770, DOI 10.1016/j.cell.2009.08.046; MAGUIRE ME, 1992, J BIOENERG BIOMEMBR, V24, P319; Maguire ME, 2006, FRONT BIOSCI-LANDMRK, V11, P3149, DOI 10.2741/2039; Merino E, 2005, TRENDS GENET, V21, P260, DOI 10.1016/j.tig.2005.03.002; O'Connor K, 2009, P NATL ACAD SCI USA, V106, P17522, DOI 10.1073/pnas.0906160106; Perez-Arellano I, 2005, FEBS LETT, V579, P6903, DOI 10.1016/j.febslet.2005.11.037; Prost LR, 2007, MOL CELL, V26, P165, DOI 10.1016/j.molcel.2007.03.008; Schiller D, 2000, J BACTERIOL, V182, P6247, DOI 10.1128/JB.182.21.6247-6249.2000; Shin D, 2006, SCIENCE, V314, P1607, DOI 10.1126/science.1134930; SNAVELY MD, 1991, J BIOL CHEM, V266, P815; Soncini FC, 1996, J BACTERIOL, V178, P5092, DOI 10.1128/jb.178.17.5092-5099.1996; Spinelli SV, 2008, FEMS MICROBIOL LETT, V280, P226, DOI 10.1111/j.1574-6968.2008.01065.x; Sudarsan N, 2006, SCIENCE, V314, P300, DOI 10.1126/science.1130716; Turnbough CL, 2008, MICROBIOL MOL BIOL R, V72, P266, DOI 10.1128/MMBR.00001-08; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Wortham BW, 2007, ADV EXP MED BIOL, V603, P106; YANOFSKY C, 1994, J BACTERIOL, V176, P6245, DOI 10.1128/jb.176.20.6245-6254.1994	40	66	68	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2010	142	5					737	748		10.1016/j.cell.2010.07.046	http://dx.doi.org/10.1016/j.cell.2010.07.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	646FL	20813261	Bronze, Green Accepted			2022-12-01	WOS:000281523200017
J	Elden, AC; Kim, HJ; Hart, MP; Chen-Plotkin, AS; Johnson, BS; Fang, XD; Armakola, M; Geser, F; Greene, R; Lu, MM; Padmanabhan, A; Clay-Falcone, D; McCluskey, L; Elman, L; Juhr, D; Gruber, PJ; Rub, U; Auburger, G; Trojanowski, JQ; Lee, VMY; Van Deerlin, VM; Bonini, NM; Gitler, AD				Elden, Andrew C.; Kim, Hyung-Jun; Hart, Michael P.; Chen-Plotkin, Alice S.; Johnson, Brian S.; Fang, Xiaodong; Armakola, Maria; Geser, Felix; Greene, Robert; Lu, Min Min; Padmanabhan, Arun; Clay-Falcone, Dana; McCluskey, Leo; Elman, Lauren; Juhr, Denise; Gruber, Peter J.; Rueb, Udo; Auburger, Georg; Trojanowski, John Q.; Lee, Virginia M. -Y.; Van Deerlin, Vivianna M.; Bonini, Nancy M.; Gitler, Aaron D.			Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS	NATURE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SPINOCEREBELLAR ATAXIA; ALPHA-SYNUCLEIN; SACCHAROMYCES-CEREVISIAE; TRINUCLEOTIDE REPEAT; STRESS GRANULES; P-BODIES; TDP-43; TOXICITY; AGGREGATION	The causes of amyotrophic lateral sclerosis (ALS), a devastating human neurodegenerative disease, are poorly understood, although the protein TDP-43 has been suggested to have a critical role in disease pathogenesis. Here we show that ataxin 2 (ATXN2), a polyglutamine (polyQ) protein mutated in spinocerebellar ataxia type 2, is a potent modifier of TDP-43 toxicity in animal and cellular models. ATXN2 and TDP-43 associate in a complex that depends on RNA. In spinal cord neurons of ALS patients, ATXN2 is abnormally localized; likewise, TDP-43 shows mislocalization in spinocerebellar ataxia type 2. To assess the involvement of ATXN2 in ALS, we analysed the length of the polyQ repeat in the ATXN2 gene in 915 ALS patients. We found that intermediate-length polyQ expansions (27-33 glutamines) in ATXN2 were significantly associated with ALS. These data establish ATXN2 as a relatively common ALS susceptibility gene. Furthermore, these findings indicate that the TDP-43-ATXN2 interaction may be a promising target for therapeutic intervention in ALS and other TDP-43 proteinopathies.	[Elden, Andrew C.; Hart, Michael P.; Johnson, Brian S.; Fang, Xiaodong; Armakola, Maria; Lu, Min Min; Padmanabhan, Arun; Gitler, Aaron D.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Kim, Hyung-Jun; Bonini, Nancy M.] Univ Penn, Howard Hughes Med Inst, Dept Biol, Philadelphia, PA 19104 USA; [Chen-Plotkin, Alice S.; Geser, Felix; Greene, Robert; Clay-Falcone, Dana; Trojanowski, John Q.; Lee, Virginia M. -Y.; Van Deerlin, Vivianna M.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Chen-Plotkin, Alice S.; Geser, Felix; Greene, Robert; Clay-Falcone, Dana; Trojanowski, John Q.; Lee, Virginia M. -Y.; Van Deerlin, Vivianna M.] Univ Penn, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; [Chen-Plotkin, Alice S.; McCluskey, Leo; Elman, Lauren] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Juhr, Denise; Gruber, Peter J.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Rueb, Udo] Goethe Univ Frankfurt, Inst Clin Neuroanat, D-60590 Frankfurt, Germany; [Auburger, Georg] Goethe Univ Frankfurt, Dept Neurol, D-60528 Frankfurt, Germany	University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Goethe University Frankfurt; Goethe University Frankfurt	Gitler, AD (corresponding author), Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	nbonini@sas.upenn.edu; gitler@mail.med.upenn.edu	Sander-Effron, Samuel/AAX-2231-2020; Resource Center, NINDS Human Genetics/AGF-2474-2022	Johnson, Brian/0000-0003-3711-5920; Gitler, Aaron/0000-0001-8603-1526; Hart, Michael/0000-0001-8865-3062	University of Pennsylvania Institute on Aging; NIH [1DP2OD004417-01, 1R01NS065317-01, P01 AG-09215, AG-10124, AG-17586, K08 AG-033101-01]; Pew Charitable Trusts; Burroughs Wellcome Fund; Howard Hughes Medical Institute; Deutsche Heredo-Ataxie Gesellschaft (DHAG); Autosomal Dominant Cerebellar Ataxia (ADCA) Vereniging Nederland; Spinocerebellar Ataxias (EuroSCA); Deutsche Forschungsgemeinschaft (DFG) [AU96/11-1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009215, K08AG033101, P01AG017586, P30AG010124] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004417] Funding Source: NIH RePORTER	University of Pennsylvania Institute on Aging; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Trusts; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Deutsche Heredo-Ataxie Gesellschaft (DHAG); Autosomal Dominant Cerebellar Ataxia (ADCA) Vereniging Nederland; Spinocerebellar Ataxias (EuroSCA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by a Pilot grant from the University of Pennsylvania Institute on Aging (A.D.G.), an NIH Director's New Innovator Award 1DP2OD004417-01 (A.D.G.), 1R01NS065317-01 (A.D.G.), P01 AG-09215 (N.M.B.), AG-10124 (J.Q.T., V.M.V.D.) and AG-17586, (V.M.-Y.L., V.M.V.D.). A.D.G. is a Pew Scholar in the Biomedical Sciences, supported by The Pew Charitable Trusts. A.S.C.-P. is supported by a Burroughs Wellcome Fund Career Award and NIH K08 AG-033101-01. N.M.B. is an Investigator of the Howard Hughes Medical Institute. U.R. has support from the Deutsche Heredo-Ataxie Gesellschaft (DHAG) and Autosomal Dominant Cerebellar Ataxia (ADCA) Vereniging Nederland, G.A. from the European Integrated Project on Spinocerebellar Ataxias (EuroSCA) and the Deutsche Forschungsgemeinschaft (DFG) (AU96/11-1). We acknowledge W. den Dunnen and E. Brunt for autopsy tissue and M. Babl for technical assistance. We thank J. Epstein, J. Shorter, A. Cashmore and members of the Gitler laboratory for comments on the manuscript and discussions. We are grateful for the dedication of the patients and their families and for their invaluable contributions to this research.	Al-Ramahi I, 2007, PLOS GENET, V3, P2551, DOI 10.1371/journal.pgen.0030234; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Huynh DP, 2003, HUM MOL GENET, V12, P1485, DOI 10.1093/hmg/ddg175; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; Infante J, 2004, MOVEMENT DISORD, V19, P848, DOI 10.1002/mds.20090; Jackson M, 2002, EXPERT OPIN INV DRUG, V11, P1343, DOI 10.1517/13543784.11.10.1343; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Lessing D, 2008, PLOS BIOL, V6, P266, DOI 10.1371/journal.pbio.0060029; Li LB, 2008, NATURE, V453, P1107, DOI 10.1038/nature06909; Lorenzetti D, 1997, NEUROLOGY, V49, P1009, DOI 10.1212/WNL.49.4.1009; Mangus DA, 1998, MOL CELL BIOL, V18, P7383, DOI 10.1128/MCB.18.12.7383; Nanetti L, 2009, J NEUROL, V256, P1926, DOI 10.1007/s00415-009-5237-9; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Pesiridis GS, 2009, HUM MOL GENET, V18, pR156, DOI 10.1093/hmg/ddp303; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; Valentine JS, 2003, P NATL ACAD SCI USA, V100, P3617, DOI 10.1073/pnas.0730423100; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200	33	825	847	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2010	466	7310					1069	U77		10.1038/nature09320	http://dx.doi.org/10.1038/nature09320			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20740007	Green Accepted			2022-12-01	WOS:000281203600032
J	Shackleton, M				Shackleton, Mark			Moving Targets That Drive Cancer Progression	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CELLS		[Shackleton, Mark] Peter MacCallum Canc Ctr, Melanoma Res Lab, Melbourne, Australia; [Shackleton, Mark] Peter MacCallum Canc Ctr, Dept Hematol & Med Oncol, Melbourne, Australia; [Shackleton, Mark] Univ Melbourne, Dept Pathol, Fac Med Dent & Hlth Sci, Parkville, Vic 3052, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne	Shackleton, M (corresponding author), Peter MacCallum Canc Ctr, Melanoma Res Lab, Melbourne, Australia.							Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027	5	13	13	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 26	2010	363	9					885	886		10.1056/NEJMcibr1006328	http://dx.doi.org/10.1056/NEJMcibr1006328			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642HG	20818851				2022-12-01	WOS:000281196600015
J	Clem, RL; Huganir, RL				Clem, Roger L.; Huganir, Richard L.			Calcium-Permeable AMPA Receptor Dynamics Mediate Fear Memory Erasure	SCIENCE			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; CONDITIONED FEAR; SPONTANEOUS-RECOVERY; IN-VIVO; EXTINCTION; AMYGDALA; PHOSPHORYLATION; RECONSOLIDATION; MECHANISMS	Traumatic fear memories can be inhibited by behavioral therapy for humans, or by extinction training in rodent models, but are prone to recur. Under some conditions, however, these treatments generate a permanent effect on behavior, which suggests that emotional memory erasure has occurred. The neural basis for such disparate outcomes is unknown. We found that a central component of extinction-induced erasure is the synaptic removal of calcium-permeable alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors (AMPARs) in the lateral amygdala. A transient up-regulation of this form of plasticity, which involves phosphorylation of the glutamate receptor 1 subunit of the AMPA receptor, defines a temporal window in which fear memory can be degraded by behavioral experience. These results reveal a molecular mechanism for fear erasure and the relative instability of recent memory.	[Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	rhuganir@jhmi.edu			NIH [R01NS036715, F32 MH087037-01]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH087037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036715] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by grants from NIH (R01NS036715) and the Howard Hughes Medical Institute. R. L. C. was supported by a postdoctoral fellowship from NIH (F32 MH087037-01). We thank G. Thomas, D. Linden, L. Volk, and A. Lade for helpful comments.	Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Clem RL, 2006, NEURON, V49, P663, DOI 10.1016/j.neuron.2006.01.019; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; He KW, 2009, P NATL ACAD SCI USA, V106, P20033, DOI 10.1073/pnas.0910338106; Herry C, 2010, EUR J NEUROSCI, V31, P599, DOI 10.1111/j.1460-9568.2010.07101.x; Ho MTW, 2007, J NEUROSCI, V27, P11651, DOI 10.1523/JNEUROSCI.2671-07.2007; Huff NC, 2009, BEHAV NEUROSCI, V123, P834, DOI 10.1037/a0016511; Humeau Y, 2007, J NEUROSCI, V27, P10947, DOI 10.1523/JNEUROSCI.2603-07.2007; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Mao SC, 2006, J NEUROSCI, V26, P8892, DOI 10.1523/JNEUROSCI.0365-06.2006; Maren S, 2006, P NATL ACAD SCI USA, V103, P18020, DOI 10.1073/pnas.0608398103; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; McNally RJ, 2007, CLIN PSYCHOL REV, V27, P750, DOI 10.1016/j.cpr.2007.01.003; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Rodrigues SM, 2004, NEURON, V44, P75, DOI 10.1016/j.neuron.2004.09.014; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sacco T, 2010, SCIENCE, V329, P649, DOI 10.1126/science.1183165; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Urcelay GP, 2009, LEARN BEHAV, V37, P60, DOI 10.3758/LB.37.1.60; Walker DL, 2002, J NEUROSCI, V22, P2343, DOI 10.1523/JNEUROSCI.22-06-02343.2002	30	359	364	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2010	330	6007					1108	1112		10.1126/science.1195298	http://dx.doi.org/10.1126/science.1195298			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	21030604	Green Accepted			2022-12-01	WOS:000284374700045
J	Hogg, JR; Goff, SP				Hogg, J. Robert; Goff, Stephen P.			Upf1 Senses 3 ' UTR Length to Potentiate mRNA Decay	CELL			English	Article							EXON JUNCTION COMPLEX; MURINE LEUKEMIA-VIRUS; GAG-POL JUNCTION; TERMINATION CODONS; MEDIATED DECAY; SACCHAROMYCES-CEREVISIAE; TRANSLATION TERMINATION; SURVEILLANCE MACHINERY; MAMMALIAN-CELLS; READ-THROUGH	The selective degradation of mRNAs by the nonsense-mediated decay pathway is a quality control process with important consequences for human disease. From initial studies using RNA hairpin-tagged mRNAs for purification of messenger ribonucleoproteins assembled on transcripts with HIV-1 3' untranslated region (3'UTR) sequences, we uncover a two-step mechanism for Upf1-dependent degradation of mRNAs with long 3'UTRs. We demonstrate that Upf1 associates with mRNAs in a 3'UTR length-dependent manner and is highly enriched on transcripts containing 3'UTRs known to elicit NMD. Surprisingly, Upf1 recruitment and subsequent RNA decay can be antagonized by retroviral RNA elements that promote translational readthrough. By modulating the efficiency of translation termination, recognition of long 3'UTRs by Upf1 is uncoupled from the initiation of decay. We propose a model for 3'UTR length surveillance in which equilibrium binding of Upf1 to mRNAs precedes a kinetically distinct commitment to RNA decay.	[Hogg, J. Robert; Goff, Stephen P.] Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Goff, Stephen P.] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA; [Hogg, J. Robert; Goff, Stephen P.] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Hogg, JR (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	jh2721@columbia.edu; spg1@columbia.edu	Hogg, J. Robert/AAE-6539-2021; Hogg, J. Robert/O-2327-2018; Goff, Stephen P/K-6337-2014	Hogg, J. Robert/0000-0001-5729-5135; Goff, Stephen P/0000-0003-0693-5547	NRSA [1F32GM087737]; NATIONAL CANCER INSTITUTE [R37CA030488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM087737] Funding Source: NIH RePORTER	NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jens Lykke-Andersen and Brian Houck-Loomis for generously providing reagents and Kathleen Collins, Lisa Postow, and Jason Rodriguez for critical reading of the manuscript. Mass spectrometry was performed by Mary Ann Gawinowicz in the Columbia University Medical Center protein core facility. J.R.H. is supported by NRSA postdoctoral fellowship 1F32GM087737. S.P.G. is an investigator of the Howard Hughes Medical Institute.	Allamand V, 2008, J GENE MED, V10, P217, DOI 10.1002/jgm.1140; Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Bedwell DM, 1997, NAT MED, V3, P1280, DOI 10.1038/nm1197-1280; Behm-Ansmant I, 2007, EMBO J, V26, P1591, DOI 10.1038/sj.emboj.7601588; Bhattacharya A, 2000, RNA, V6, P1226, DOI 10.1017/S1355838200000546; Bolinger C, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-8; Buhler M, 2006, NAT STRUCT MOL BIOL, V13, P462, DOI 10.1038/nsmb1081; Chamieh H, 2008, NAT STRUCT MOL BIOL, V15, P85, DOI 10.1038/nsmb1330; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cho H, 2009, MOL CELL, V33, P75, DOI 10.1016/j.molcel.2008.11.022; Eberle AB, 2008, PLOS BIOL, V6, P849, DOI 10.1371/journal.pbio.0060092; FELSENSTEIN KM, 1992, J VIROL, V66, P6601, DOI 10.1128/JVI.66.11.6601-6608.1992; FENG YX, 1990, P NATL ACAD SCI USA, V87, P8860, DOI 10.1073/pnas.87.22.8860; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; Hogg JR, 2007, GENE DEV, V21, P3067, DOI 10.1101/gad.1603907; Hogg JR, 2007, RNA, V13, P868, DOI 10.1261/rna.565207; Hosoda N, 2005, NAT STRUCT MOL BIOL, V12, P893, DOI 10.1038/nsmb995; Hwang J, 2010, MOL CELL, V39, P396, DOI 10.1016/j.molcel.2010.07.004; Isken O, 2008, CELL, V133, P314, DOI 10.1016/j.cell.2008.02.030; Ivanov PV, 2008, EMBO J, V27, P736, DOI 10.1038/emboj.2008.17; Johansson MJO, 2007, P NATL ACAD SCI USA, V104, P20872, DOI 10.1073/pnas.0709257105; Johns L, 2007, MOL CELL BIOL, V27, P5630, DOI 10.1128/MCB.00410-07; JORGENSEN F, 1993, J MOL BIOL, V230, P41, DOI 10.1006/jmbi.1993.1124; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Keeling KM, 2004, RNA, V10, P691, DOI 10.1261/rna.5147804; Kim VN, 2001, SCIENCE, V293, P1832, DOI 10.1126/science.1062829; Kuzmiak HA, 2006, TRENDS MOL MED, V12, P306, DOI 10.1016/j.molmed.2006.05.005; LEHI, 2001, EMBO J, V20, P4987; LEHI, 2000, EMBO J, V19, P6860; Lim F, 2002, NUCLEIC ACIDS RES, V30, P4138, DOI 10.1093/nar/gkf552; Lykke-Andersen J, 2001, SCIENCE, V293, P1836, DOI 10.1126/science.1062786; Maderazo AB, 2003, MOL CELL BIOL, V23, P842, DOI 10.1128/MCB.23.3.842-851.2003; Maquat LE, 2010, CELL, V142, P368, DOI 10.1016/j.cell.2010.07.022; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mehta A, 2004, J BIOL CHEM, V279, P37852, DOI 10.1074/jbc.M404639200; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Moriarty PM, 1998, MOL CELL BIOL, V18, P2932, DOI 10.1128/MCB.18.5.2932; Muhlemann O, 2008, BIOCHEM SOC T, V36, P497, DOI 10.1042/BST0360497; Nicholson P, 2010, CELL MOL LIFE SCI, V67, P677, DOI 10.1007/s00018-009-0177-1; Oeffinger M, 2007, NAT METHODS, V4, P951, DOI 10.1038/NMETH1101; Pal M, 2001, RNA, V7, P5, DOI 10.1017/S1355838201000127; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; Rehwinkel A, 2005, RNA, V11, P1530, DOI 10.1261/rna.2160905; Salvatori F, 2009, AM J HEMATOL, V84, P720, DOI 10.1002/ajh.21539; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Silva AL, 2008, RNA, V14, P563, DOI 10.1261/rna.815108; Singh G, 2008, PLOS BIOL, V6, P860, DOI 10.1371/journal.pbio.0060111; Sun XL, 1998, P NATL ACAD SCI USA, V95, P10009, DOI 10.1073/pnas.95.17.10009; Valente ST, 2006, MOL CELL, V23, P597, DOI 10.1016/j.molcel.2006.07.021; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Weischenfeldt J, 2008, GENE DEV, V22, P1381, DOI 10.1101/gad.468808; Weiss SL, 1998, RNA, V4, P816, DOI 10.1017/S1355838298971990; Weng YM, 1998, RNA, V4, P205; Weng YM, 1996, MOL CELL BIOL, V16, P5491, DOI 10.1128/mcb.16.10.5491; Weng YM, 1996, MOL CELL BIOL, V16, P5477; WILLS NM, 1991, P NATL ACAD SCI USA, V88, P6991, DOI 10.1073/pnas.88.16.6991; WILLS NM, 1994, EMBO J, V13, P4137, DOI 10.1002/j.1460-2075.1994.tb06731.x; Wittmann J, 2006, MOL CELL BIOL, V26, P1272, DOI 10.1128/MCB.26.4.1272-1287.2006; Zhang SA, 1997, RNA, V3, P234	59	232	235	2	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 29	2010	143	3					379	389		10.1016/j.cell.2010.10.005	http://dx.doi.org/10.1016/j.cell.2010.10.005			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672RF	21029861	Bronze, Green Accepted			2022-12-01	WOS:000283603900012
J	Filion, GJ; van Bemmel, JG; Braunschweig, U; Talhout, W; Kind, J; Ward, LD; Brugman, W; de Castro, IJ; Kerkhoven, RM; Bussemaker, HJ; van Steensel, B				Filion, Guillaume J.; van Bemmel, Joke G.; Braunschweig, Ulrich; Talhout, Wendy; Kind, Jop; Ward, Lucas D.; Brugman, Wim; de Castro, Ines J.; Kerkhoven, Ron M.; Bussemaker, Harmen J.; van Steensel, Bas			Systematic Protein Location Mapping Reveals Five Principal Chromatin Types in Drosophila Cells	CELL			English	Article							B-TYPE LAMIN; HISTONE H3; DOSAGE COMPENSATION; MELANOGASTER GENOME; GENE-EXPRESSION; LINKER HISTONE; NUCLEAR LAMINA; TRANSCRIPTION; COMPLEX; HETEROCHROMATIN	Chromatin is important for the regulation of transcription and other functions, yet the diversity of chromatin composition and the distribution along chromosomes are still poorly characterized. By integrative analysis of genome-wide binding maps of 53 broadly selected chromatin components in Drosophila cells, we show that the genome is segmented into five principal chromatin types that are defined by unique yet overlapping combinations of proteins and form domains that can extend over > 100 kb. We identify a repressive chromatin type that covers about half of the genome and lacks classic heterochromatin markers. Furthermore, transcriptionally active euchromatin consists of two types that differ in molecular organization and H3K36 methylation and regulate distinct classes of genes. Finally, we provide evidence that the different chromatin types help to target DNA-binding factors to specific genomic regions. These results provide a global view of chromatin diversity and domain organization in a metazoan cell.	[Filion, Guillaume J.; van Bemmel, Joke G.; Braunschweig, Ulrich; Talhout, Wendy; Kind, Jop; de Castro, Ines J.; van Steensel, Bas] Netherlands Canc Inst, Div Gene Regulat, NL-1066 CX Amsterdam, Netherlands; [Brugman, Wim; Kerkhoven, Ron M.] Netherlands Canc Inst, Cent Microarray Facil, NL-1066 CX Amsterdam, Netherlands; [Ward, Lucas D.; Bussemaker, Harmen J.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Ward, Lucas D.; Bussemaker, Harmen J.] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA	Netherlands Cancer Institute; Netherlands Cancer Institute; Columbia University; Columbia University	van Steensel, B (corresponding author), Netherlands Canc Inst, Div Gene Regulat, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	b.v.steensel@nki.nl	Filion, Guillaume/G-9619-2015; Braunschweig, Ulrich/I-1070-2019	Filion, Guillaume/0000-0002-3473-1632; Braunschweig, Ulrich/0000-0001-6653-0926; Ward, Lucas/0000-0002-8017-809X; de Castro, Ines/0000-0001-8710-3667	EMBO; National Institutes of Health [T32GM082797, R01HG003008, U54CA121852]; Netherlands Genomics Initiative; NWO-ALW VICI; EURYI; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM082797] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Genomics Initiative; NWO-ALW VICI(Netherlands Organization for Scientific Research (NWO)); EURYI(European Science Foundation (ESF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Francesco Russo for help with vector cloning; Marja Nieuwland and Arno Velds for help with RNA tag sequencing; Dirk Schubeler's laboratory for sharing H3K36 methylation data prior to publication; and Reuven Agami, Fred van Leeuwen, Wouter Meuleman, Ludo Pagie, and Aleksey Pindyurin for helpful suggestions. Supported by an EMBO long-term fellowship to J.K.; National Institutes of Health grants T32GM082797, R01HG003008, and U54CA121852 to L. D. W. and H. J.B.; and grants from the Netherlands Genomics Initiative, NWO-ALW VICI, and an EURYI Award to B. v. S.	Babenko VN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-318; Beato M, 1997, NUCLEIC ACIDS RES, V25, P3559, DOI 10.1093/nar/25.18.3559; Bell O, 2010, NAT STRUCT MOL BIOL, V17, P894, DOI 10.1038/nsmb.1825; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bianchi-Frias D, 2004, PLOS BIOL, V2, P975, DOI 10.1371/journal.pbio.0020178; Braunschweig U, 2009, EMBO J, V28, P3635, DOI 10.1038/emboj.2009.301; Cenci G, 1997, GENE DEV, V11, P863, DOI 10.1101/gad.11.7.863; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Collas P, 2009, METHODS MOL BIOL, V567, P1, DOI 10.1007/978-1-60327-414-2_1; Crevel G, 2001, J CELL SCI, V114, P37; Czermin B, 2001, EMBO REP, V2, P915, DOI 10.1093/embo-reports/kve210; de Wit E, 2007, PLOS GENET, V3, P346, DOI 10.1371/journal.pgen.0030038; Ebert A, 2006, CHROMOSOME RES, V14, P377, DOI 10.1007/s10577-006-1066-1; Engstrom PG, 2007, GENOME RES, V17, P1898, DOI 10.1101/gr.6669607; Fauvarque MO, 2001, GENET RES, V78, P137, DOI 10.1017/S0016672301005274; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; Gelbart ME, 2005, GENE DEV, V19, P942, DOI 10.1101/gad.1298905; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Gilbert DM, 2002, CURR OPIN CELL BIOL, V14, P377, DOI 10.1016/S0955-0674(02)00326-5; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Greil F, 2007, EMBO J, V26, P741, DOI 10.1038/sj.emboj.7601527; Handler AM, 1999, INSECT MOL BIOL, V8, P449, DOI 10.1046/j.1365-2583.1999.00139.x; Hediger F, 2006, CURR OPIN GENET DEV, V16, P143, DOI 10.1016/j.gde.2006.02.013; Kelley RL, 2003, GENETICS, V164, P565; Kind J, 2008, CELL, V133, P813, DOI 10.1016/j.cell.2008.04.036; LAYBOURN PJ, 1991, SCIENCE, V254, P238, DOI 10.1126/science.1718039; Lee JS, 2007, MUTAT RES-FUND MOL M, V618, P130, DOI 10.1016/j.mrfmmm.2006.08.014; LenzBohme B, 1997, J CELL BIOL, V137, P1001, DOI 10.1083/jcb.137.5.1001; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Liu ZQ, 2005, MOL CELL BIOL, V25, P2819, DOI 10.1128/MCB.25.7.2819-2831.2005; Lu XW, 2009, GENE DEV, V23, P452, DOI 10.1101/gad.1749309; MacAlpine HK, 2010, GENOME RES, V20, P201, DOI 10.1101/gr.097873.109; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Martinez-Balbas MA, 1998, P NATL ACAD SCI USA, V95, P132, DOI 10.1073/pnas.95.1.132; Moorman C, 2006, P NATL ACAD SCI USA, V103, P12027, DOI 10.1073/pnas.0605003103; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Pindyurin AV, 2007, J CELL SCI, V120, P2344, DOI 10.1242/jcs.006007; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Schmiedeberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004636; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schwaiger M, 2009, GENE DEV, V23, P589, DOI 10.1101/gad.511809; Shevelyov YY, 2009, P NATL ACAD SCI USA, V106, P3282, DOI 10.1073/pnas.0811933106; Singh RK, 2009, NAT CELL BIOL, V11, P925, DOI 10.1038/ncb1903; Smith MB, 2010, CHROMOSOMA, V119, P287, DOI 10.1007/s00412-010-0257-x; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Tie F, 2003, MOL CELL BIOL, V23, P3352, DOI 10.1128/MCB.23.9.3352-3362.2003; Tie F, 2001, DEVELOPMENT, V128, P275; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Towbin BD, 2009, CURR OPIN GENET DEV, V19, P180, DOI 10.1016/j.gde.2009.01.006; van Steensel B, 2001, NAT GENET, V27, P304, DOI 10.1038/85871; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wolffe AP, 1999, NUCLEIC ACIDS RES, V27, P711, DOI 10.1093/nar/27.3.711; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Zhang P, 2006, NUCLEIC ACIDS RES, V34, P6621, DOI 10.1093/nar/gkl989; Zhimulev IF, 2003, CHROMOSOMA, V111, P377, DOI 10.1007/s00412-002-0218-0	63	662	681	0	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					212	224		10.1016/j.cell.2010.09.009	http://dx.doi.org/10.1016/j.cell.2010.09.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20888037	Bronze, Green Accepted			2022-12-01	WOS:000283052200011
J	Kim, J; Woo, AJ; Chu, JL; Snow, JW; Fujiwara, Y; Kim, CG; Cantor, AB; Orkin, SH				Kim, Jonghwan; Woo, Andrew J.; Chu, Jianlin; Snow, Jonathan W.; Fujiwara, Yuko; Kim, Chul Geun; Cantor, Alan B.; Orkin, Stuart H.			A Myc Network Accounts for Similarities between Embryonic Stem and Cancer Cell Transcription Programs	CELL			English	Article							RNAI SCREEN; C-MYC; DEVELOPMENTAL REGULATORS; ESSENTIAL COFACTOR; SELF-RENEWAL; PLURIPOTENCY; COMPLEX; PROTEIN; GENES; TRRAP	c-Myc (Myc) is an important transcriptional regulator in embryonic stem (ES) cells, somatic cell reprogramming, and cancer. Here, we identify a Myc-centered regulatory network in ES cells by combining protein-protein and protein-DNA interaction studies and show that Myc interacts with the NuA4 complex, a regulator of ES cell identity. In combination with regulatory network information, we define three ES cell modules (Core, Polycomb, and Myc) and show that the modules are functionally separable, illustrating that the overall ES cell transcription program is composed of distinct units. With these modules as an analytical tool, we have reassessed the hypothesis linking an ES cell signature with cancer or cancer stem cells. We find that the Myc module, independent of the Core module, is active in various cancers and predicts cancer outcome. The apparent similarity of cancer and ES cell signatures reflects, in large part, the pervasive nature of Myc regulatory networks.	[Kim, Jonghwan; Woo, Andrew J.; Chu, Jianlin; Snow, Jonathan W.; Fujiwara, Yuko; Cantor, Alan B.; Orkin, Stuart H.] Childrens Hosp, Dept Pediat Oncol, Boston, MA 02115 USA; [Kim, Jonghwan; Woo, Andrew J.; Chu, Jianlin; Snow, Jonathan W.; Fujiwara, Yuko; Cantor, Alan B.; Orkin, Stuart H.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Kim, Jonghwan; Chu, Jianlin; Snow, Jonathan W.; Fujiwara, Yuko; Orkin, Stuart H.] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Kim, Jonghwan; Woo, Andrew J.; Chu, Jianlin; Snow, Jonathan W.; Fujiwara, Yuko; Cantor, Alan B.; Orkin, Stuart H.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Fujiwara, Yuko; Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Kim, Chul Geun] Hanyang Univ, Dept Life Sci, Seoul 133791, South Korea	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Hanyang University	Orkin, SH (corresponding author), Childrens Hosp, Dept Pediat Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu	Kim, Jonghwan/AAR-2815-2021	Kim, Jonghwan/0000-0002-9919-9843; Woo, Andrew/0000-0003-1198-6373; Cantor, Alan/0000-0002-5136-028X; Kim, Chul Geun/0000-0002-5848-3338	NIH/NIGMS [K99GM088384]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM088384] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jennifer Trowbridge for critical reading of the manuscript, the Taplin Biological Mass Spectrometry Facility at Harvard Medical School for mass-spectrometry and peptide identification, and the Microarray Core Facility at the Dana Farber Cancer Institute for ChIP sample processing. The project described is partially supported by Award Number K99GM088384 to J.K. from the NIH/NIGMS. S.H.O. is an investigator of the Howard Hughes Medical Institute.	Ard PG, 2002, MOL CELL BIOL, V22, P5650, DOI 10.1128/MCB.22.16.5650-5661.2002; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cai Y, 2003, J BIOL CHEM, V278, P42733, DOI 10.1074/jbc.C300389200; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Cole MD, 2006, SEMIN CANCER BIOL, V16, P241, DOI 10.1016/j.semcancer.2006.08.003; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Doyon Y, 2004, CURR OPIN GENET DEV, V14, P147, DOI 10.1016/j.gde.2004.02.009; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Fuchs M, 2001, CELL, V106, P297, DOI 10.1016/S0092-8674(01)00450-0; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Kang JS, 2009, TRENDS BIOCHEM SCI, V34, P491, DOI 10.1016/j.tibs.2009.06.003; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2009, NAT PROTOC, V4, P506, DOI 10.1038/nprot.2009.23; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Park IH, 2008, NATURE, V451, P141, DOI 10.1038/natureO6534; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schoenhals M, 2009, BIOCHEM BIOPH RES CO, V383, P157, DOI 10.1016/j.bbrc.2009.02.156; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wolfer A, 2010, P NATL ACAD SCI USA, V107, P3698, DOI 10.1073/pnas.0914203107; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wong DJ, 2008, CELL CYCLE, V7, P3622, DOI 10.4161/cc.7.23.7104; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	52	495	508	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					313	324		10.1016/j.cell.2010.09.010	http://dx.doi.org/10.1016/j.cell.2010.09.010			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946988	Bronze, Green Accepted			2022-12-01	WOS:000283052200019
J	Dang, SY; Sun, LF; Huang, YJ; Lu, FR; Liu, YF; Gong, HP; Wang, JW; Yan, NE				Dang, Shangyu; Sun, Linfeng; Huang, Yongjian; Lu, Feiran; Liu, Yufeng; Gong, Haipeng; Wang, Jiawei; Yan, Nieng			Structure of a fucose transporter in an outward-open conformation	NATURE			English	Article							H+ SYMPORT PROTEIN; LACTOSE PERMEASE; MECHANISM; BINDING; IDENTIFICATION; FUCP; SITE	The major facilitator superfamily (MFS) transporters are an ancient and widespread family of secondary active transporters(1). In Escherichia coli, the uptake of L-fucose, a source of carbon for microorganisms, is mediated by an MFS proton symporter, FucP(2,3). Despite intensive study of the MFS transporters, atomic structure information is only available on three proteins and the outward-open conformation has yet to be captured(4-6). Here we report the crystal structure of FucP at 3.1 angstrom resolution, which shows that it contains an outward-open, amphipathic cavity. The similarly folded amino and carboxyl domains of FucP have contrasting surface features along the transport path, with negative electrostatic potential on the N domain and hydrophobic surface on the C domain. FucP only contains two acidic residues along the transport path, Asp 46 and Glu 135, which can undergo cycles of protonation and deprotonation. Their essential role in active transport is supported by both in vivo and in vitro experiments. Structure-based biochemical analyses provide insights into energy coupling, substrate recognition and the transport mechanism of FucP.	[Wang, Jiawei] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; Tsinghua Univ, Sch Med, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Wang, JW (corresponding author), Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	jwwang@tsinghua.edu.cn; nyan@tsinghua.edu.cn	Wang, Jiawei/D-1144-2010; Huang, Yongjian/GPK-5986-2022	Wang, Jiawei/0000-0001-9893-8539; Huang, Yongjian/0000-0002-1168-6111; Liu, Yufeng/0000-0003-0848-5113; Lu, Feiran/0000-0002-1757-2895; Dang, Shangyu/0000-0001-9141-1865	Ministry of Science and Technology [2009CB918802]; Tsinghua University [985]; Yuyuan Foundation; Li Foundation	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Tsinghua University; Yuyuan Foundation; Li Foundation	We thank N. Shimizu and T. Kumasaka at Spring-8 beamline BL41XU in Japan, and J. He and S. Huang at the Shanghai Synchrotron Radiation Facility (SSRF) for on-site assistance. This work was supported by funds from the Ministry of Science and Technology (grant number 2009CB918802) and by Tsinghua University 985 Phase II funds. N.Y. acknowledges support from the Yuyuan Foundation and the Li Foundation.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; BRADLEY SA, 1987, BIOCHEM J, V248, P495, DOI 10.1042/bj2480495; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Christensen M, 2003, J BACTERIOL, V185, P6042, DOI 10.1128/JB.185.20.6042-6050.2003; COWTAN K, 1994, INT CCP4 ESF EACBM N, V31, P34; DeLano W.L., 2002, PYMOL MOL VIEWER; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRANCO PJ, 1994, J BIOL CHEM, V269, P7379; Guan L, 2004, P NATL ACAD SCI USA, V101, P12148, DOI 10.1073/pnas.0404936101; Guan L, 2007, P NATL ACAD SCI USA, V104, P15294, DOI 10.1073/pnas.0707688104; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; GUNN FJ, 1995, MOL MICROBIOL, V15, P771, DOI 10.1111/j.1365-2958.1995.tb02384.x; GUNN FJ, 1994, MOL MICROBIOL, V12, P799, DOI 10.1111/j.1365-2958.1994.tb01066.x; Horiba N, 2003, J BIOL CHEM, V278, P14669, DOI 10.1074/jbc.M212240200; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Kaback HR, 2001, NAT REV MOL CELL BIO, V2, P610, DOI 10.1038/35085077; Kaback HR, 2005, CR BIOL, V328, P557, DOI 10.1016/j.crvi.2005.03.008; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mirza O, 2006, EMBO J, V25, P1177, DOI 10.1038/sj.emboj.7601028; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Paulsen IT, 1998, J BACTERIOL, V180, P498, DOI 10.1128/JB.180.3.498-504.1998; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Psakis G, 2009, MOL MICROBIOL, V71, P391, DOI 10.1111/j.1365-2958.2008.06535.x; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Smirnova I, 2009, P NATL ACAD SCI USA, V106, P21561, DOI 10.1073/pnas.0911434106; Veenhoff LM, 1999, J BIOL CHEM, V274, P33244, DOI 10.1074/jbc.274.47.33244; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629	33	212	220	4	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2010	467	7316					734	U130		10.1038/nature09406	http://dx.doi.org/10.1038/nature09406			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659NE	20877283				2022-12-01	WOS:000282572500044
J	Krishnan, M; Mojarad, N; Kukura, P; Sandoghdar, V				Krishnan, Madhavi; Mojarad, Nassiredin; Kukura, Philipp; Sandoghdar, Vahid			Geometry-induced electrostatic trapping of nanometric objects in a fluid	NATURE			English	Article							OPTICAL MANIPULATION; BROWNIAN-MOTION; NANOPARTICLES; NANOSLIT; DNA; BIOMOLECULES; PRESSURE; DYNAMICS; FORCE	The ability to trap an object-whether a single atom or a macroscopic entity-affects fields as diverse as quantum optics(1), soft condensed-matter physics, biophysics and clinical medicine(2). Many sophisticated methodologies have been developed to counter the randomizing effect of Brownian motion in solution(3-10), but stable trapping of nanometre-sized objects remains challenging(8-10). Optical tweezers are widely used traps, but require sufficiently polarizable objects and thus are unable to manipulate small macromolecules. Confinement of single molecules has been achieved using electrokinetic feedback guided by tracking of a fluorescent label, but photophysical constraints limit the trap stiffness and lifetime(8). Here we show that a fluidic slit with appropriately tailored topography has a spatially modulated electrostatic potential that can trap and levitate charged objects in solution for up to several hours. We illustrate this principle with gold particles, polymer beads and lipid vesicles with diameters of tens of nanometres, which are all trapped without external intervention and independently of their mass and dielectric function. The stiffness and stability of our electrostatic trap is easily tuned by adjusting the system geometry and the ionic strength of the solution, and it lends itself to integration with other manipulation mechanisms. We anticipate that these features will allow its use for contact-free confinement of single proteins and macromolecules, and the sorting and fractionation of nanometre-sized objects or their assembly into high-density arrays.	[Krishnan, Madhavi; Mojarad, Nassiredin; Kukura, Philipp; Sandoghdar, Vahid] ETH, Phys Chem Lab, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Krishnan, M (corresponding author), ETH, Phys Chem Lab, CH-8093 Zurich, Switzerland.	mkrishnan@ethz.ch	Sandoghdar, Vahid/AAT-8856-2020; Krishnan, Madhavi/J-4217-2015	Sandoghdar, Vahid/0000-0003-2594-4801; Krishnan, Madhavi/0000-0003-1274-7155; Kukura, Philipp/0000-0003-0136-7704	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank A. Alt for expert assistance in electron-beam lithography and the staff of the Center for Micro-and Nanoscience (FIRST), ETH Zurich, for clean-room support; H. Ewers for assistance in producing lipid vesicles; M. Celebrano and A. Renn for experimental input; M. Agio for discussions; and E. Petrov and R. Klemm for reading the manuscript. M.K. acknowledges a Marie Curie Intra-European Fellowship for Career Development of the European Commission, and greatly appreciates the support of B. Eichler, I. Monch and P. Schwille in the early stages of the project.	Adamczyk Z, 1996, ADV COLLOID INTERFAC, V63, P41, DOI 10.1016/0001-8686(95)00281-2; ASHKIN A, 1970, PHYS REV LETT, V24, P156, DOI 10.1103/PhysRevLett.24.156; Behrens SH, 2001, J CHEM PHYS, V115, P6716, DOI 10.1063/1.1404988; Chiou PY, 2005, NATURE, V436, P370, DOI [10.1038/nature03831, 10.1038/nature0383l]; Chu S, 2002, NATURE, V416, P206, DOI 10.1038/416206a; Cohen AE, 2006, P NATL ACAD SCI USA, V103, P4362, DOI 10.1073/pnas.0509976103; Cordovez B, 2009, OPT EXPRESS, V17, P21134, DOI 10.1364/OE.17.021134; DUBOIS M, 1992, J CHEM PHYS, V96, P2278, DOI 10.1063/1.462078; Eichmann SL, 2008, LANGMUIR, V24, P714, DOI 10.1021/la702571z; Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5; Grier DG, 2003, NATURE, V424, P810, DOI 10.1038/nature01935; Hansen PM, 2005, NANO LETT, V5, P1937, DOI 10.1021/nl051289r; Israelachvili J., 1992, INTERMOLECULAR SURFA; Jacobsen V., 2007, NANOBIOPHOTONICS, V3, P143, DOI DOI 10.1016/S1574-0641(07)80014-3; Jamshidi A, 2008, NAT PHOTONICS, V2, P85, DOI 10.1038/nphoton.2007.277; Jo K, 2007, P NATL ACAD SCI USA, V104, P2673, DOI 10.1073/pnas.0611151104; Juan ML, 2009, NAT PHYS, V5, P915, DOI 10.1038/NPHYS1422; KAPLAN PD, 1994, PHYS REV LETT, V73, P2793, DOI 10.1103/PhysRevLett.73.2793; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Krishnan M, 2007, NANO LETT, V7, P1270, DOI 10.1021/nl0701861; Krishnan M, 2008, SMALL, V4, P1900, DOI 10.1002/smll.200800227; Kukura P, 2009, NAT METHODS, V6, P923, DOI 10.1038/nmeth.1395; Loeb A. L., 1961, ELECT DOUBLE LAYER S; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; MacDonald MP, 2003, NATURE, V426, P421, DOI 10.1038/nature02144; MAXWELL JC, 1954, TREATISE ELECT MAGNE, V1, P116; Polin M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.041406; Reisner W, 2009, P NATL ACAD SCI USA, V106, P79, DOI 10.1073/pnas.0811468106; Soyka F, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.208301; Stebe KJ, 2009, SCIENCE, V325, P159, DOI 10.1126/science.1174401; Tessier F, 2006, ELECTROPHORESIS, V27, P686, DOI 10.1002/elps.200500457; Yang AHJ, 2009, NATURE, V457, P71, DOI 10.1038/nature07593	32	178	183	1	186	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 7	2010	467	7316					692	U75		10.1038/nature09404	http://dx.doi.org/10.1038/nature09404			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659NE	20930840				2022-12-01	WOS:000282572500034
J	Kazatchkine, MD				Kazatchkine, Michel D.			Increased resources for the Global Fund, but pledges fall short of expected demand	LANCET			English	Editorial Material									Global Fund Fight AIDS TB & Malaria, CH-1214 Vernier, Switzerland		Kazatchkine, MD (corresponding author), Global Fund Fight AIDS TB & Malaria, CH-1214 Vernier, Switzerland.	michel.kazatchkine@theglobalfund.org						*GLOB FUND FIGHT A, RES SCEN 2011 2013; *GLOB FUND FIGHT A, 2010, GLOB FUND 3 VOL REPL; International Monetary Fund, 2010, WORLD EC OUTL DAT; MCNEIL DG, 2010, GLOBAL FIGHT AIDS FA	4	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT-NOV	2010	376	9751					1439	1440		10.1016/S0140-6736(10)61970-8	http://dx.doi.org/10.1016/S0140-6736(10)61970-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	680QC	21036260				2022-12-01	WOS:000284248500004
J	Ellershaw, J; Dewar, S; Murphy, D				Ellershaw, John; Dewar, Steve; Murphy, Deborah			Spotlight: Palliative Care Beyond Cancer Achieving a good death for all	BRITISH MEDICAL JOURNAL			English	Article									[Ellershaw, John; Murphy, Deborah] Univ Liverpool, Marie Curie Palliat Care Inst, Liverpool L69 3BX, England; [Dewar, Steve] Marie Curie Canc Care, London SE1 7TP, England; [Ellershaw, John; Murphy, Deborah] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, Liverpool L7 8XP, England	University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital	Ellershaw, J (corresponding author), Univ Liverpool, Marie Curie Palliat Care Inst, Liverpool L69 3BX, England.	j.e.ellershaw@liv.ac.uk		Ellershaw, John/0000-0001-9789-3180				Abel J, 2009, PALLIATIVE MED, V23, P616, DOI 10.1177/0269216309106460; Addicott R, 2008, IMPROVING CHOICE END; CANDY B, 2009, NONSTATUTORY PALLIAT; DAVIES E, 2004, WHO EUROPE BETTER PA; *DEP HLTH, 2008, ENGL END LIF CAR STR; Department of Health, 2009, END LIF CAR STRAT QU; Gambles M, 2006, INT J PALLIAT NURS, V12, P414, DOI 10.12968/ijpn.2006.12.9.21869; Gambles MA, 2009, INT J CARE COORD, V13, P51, DOI 10.1258/jicp.2009.009011; Gomes B, 2008, PALLIATIVE MED, V22, P33, DOI 10.1177/0269216307084606; Hockley J, 2005, J RES NURS, V10, P135, DOI 10.1177/174498710501000209; Jack Barbara A, 2003, Int J Palliat Nurs, V9, P375; *M CUR PALL CAR I, 2009, LCP GEN VERS 12 COR; *M CUR PALL CAR I, 2007, NAT CAR DYING AUD HO; Marie Curie Palliative Care Institute Liverpool and Clinical Standards Department of the Royal College of Physicians, 2009, NAT CAR DYING AUD HO; MAYLAND CR, 2009, EUR ASS PALL CAR 11; National Audit Office, 2008, END LIF CAR; National Institute for Health and Clinical Excellence, 2004, IMPR SUPP PALL CAR A; Office for National Statistics, MORT STAT DEATHS REG; ROBERTS A, 2007, PALLIATIVE NURSING I; Saunders C, 1989, TXB PAIN, P624; SMITH R, 2009, DAILY TELEGRAPH 1017; St John of God Health Care, 2019, OUR VIS; Veerbeek L, 2008, PALLIATIVE MED, V22, P145, DOI 10.1177/0269216307087164	23	14	15	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 16	2010	341								c4861	10.1136/bmj.c4861	http://dx.doi.org/10.1136/bmj.c4861			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653MO	20847021				2022-12-01	WOS:000282095800001
J	Grant, L; Murray, SA; Sheikh, A				Grant, Liz; Murray, Scott A.; Sheikh, Aziz			Spotlight: Palliative Care Beyond Cancer Spiritual dimensions of dying in pluralist societies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LUNG-CANCER; ILLNESS; PEOPLE; NEEDS; LIFE		Univ Edinburgh, Ctr Pop Hlth Sci, Primary Palliat Care Res Grp, Edinburgh, Scotland	University of Edinburgh	Sheikh, A (corresponding author), Univ Edinburgh, Ctr Pop Hlth Sci, Primary Palliat Care Res Grp, Edinburgh, Scotland.	aziz.sheikh@ed.ac.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056; Grant, Liz/0000-0001-7248-7792	COMPASS Collaborative; National Cancer Research Institute; Office of the Scottish Government	COMPASS Collaborative; National Cancer Research Institute; Office of the Scottish Government	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; AS and SM are grantholders on the COMPASS Collaborative, a programme grant for the development and evaluation of complex interventions in end of life care, which is supported by the National Cancer Research Institute; LG, SM, and AS had support from the Chief Scientist's Office of the Scottish Government, which has informed the submitted work; no other relationships or activities that could appear to have influenced the submitted work.	Breitbart William, 2009, Palliat Support Care, V7, P139, DOI 10.1017/S1478951509000182; Bryson Kenneth A, 2004, Palliat Support Care, V2, P321; CARPENITOMOYET L, 2008, HDB NURSING DIAGNOSI, P639; Chochinov HM, 1999, LANCET, V354, P816, DOI 10.1016/S0140-6736(99)80011-7; FOWLER M, 1997, J SUPERVISION TRAINI, V18, P46; Frankl V.E., 1984, MANS SEARCH MEANING; Gatrad AR, 2003, LANCET, V362, P748, DOI 10.1016/S0140-6736(03)14219-5; Gatrad AR, 2003, BRIT MED J, V327, P176, DOI 10.1136/bmj.327.7408.176; GATRAD AR, 2006, PALLIATIVE CARE S AS; *GEN MED COUNC, 2009, END LIF TREATM CAR G; Grant E, 2003, J PALLIATIVE CARE, V19, P159, DOI 10.1177/082585970301900303; Grant Elizabeth, 2004, Palliat Support Care, V2, P371; *I MED, 1997, APPR DEATH IMPR CAR; Kissane DW, 2001, J PALLIAT CARE, V17, P12, DOI 10.1177/082585970101700103; LLOYDWILLIAMS M, 2003, PSYCHOSOCIAL ISSUES; *M CUR CANC CAR, 1980, SPIR REL CAR COMP SP; McClain CS, 2003, LANCET, V361, P1603, DOI 10.1016/S0140-6736(03)13310-7; Meador Keith G, 2004, N C Med J, V65, P226; Murray SA, 2004, PALLIATIVE MED, V18, P39, DOI 10.1191/0269216304pm837oa; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; Murray SA, 2003, BRIT J GEN PRACT, V53, P957; Murray SA, 2007, J PAIN SYMPTOM MANAG, V34, P393, DOI 10.1016/j.jpainsymman.2006.12.009; Narayanasamy Aru, 2002, Br J Nurs, V11, P948; National Institute for Health and Clinical Excellence, 2004, IMPR SUPP PALL CAR A; Puchalski C, 2004, CRIT CARE CLIN, V20, P487, DOI 10.1016/j.ccc.2004.03.007; Sheikh A, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a273; Sloan RP, 1999, LANCET, V353, P664, DOI 10.1016/S0140-6736(98)07376-0; Sweeney K, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2862; WHO, WHO DEF PALL CAR; Worth A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b183	30	17	18	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2010	341								c4859	10.1136/bmj.c4859	http://dx.doi.org/10.1136/bmj.c4859			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653MO	20847019	Green Submitted			2022-12-01	WOS:000282095800012
J	Liu, H; Takeda, S; Kumar, R; Westergard, TD; Brown, EJ; Pandita, TK; Cheng, EHY; Hsieh, JJD				Liu, Han; Takeda, Shugaku; Kumar, Rakesh; Westergard, Todd D.; Brown, Eric J.; Pandita, Tej K.; Cheng, Emily H. -Y.; Hsieh, James J. -D.			Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint	NATURE			English	Article							CELL-CYCLE; DNA-DAMAGE; FUSION GENE; MAINTENANCE; PROTEINS; COMPLEX; ASSOCIATION; ACTIVATION; EXPRESSION; STABILITY	Cell cycle checkpoints are implemented to safeguard the genome, avoiding the accumulation of genetic errors(1,2). Checkpoint loss results in genomic instability and contributes to the evolution of cancer. Among G1-, S-, G2- and M-phase checkpoints, genetic studies indicate the role of an intact S-phase checkpoint in maintaining genome integrity(3,4). Although the basic framework of the S-phase checkpoint in multicellular organisms has been outlined, the mechanistic details remain to be elucidated. Human chromosome-11 band-q23 translocations disrupting the MLL gene lead to poor prognostic leukaemias(5-9). Here we assign MLL as a novel effector in the mammalian S-phase checkpoint network and identify checkpoint dysfunction as an underlying mechanism of MLL leukaemias. MLL is phosphorylated at serine 516 by ATR in response to genotoxic stress in the S phase, which disrupts its interaction with, and hence its degradation by, the SCFSkp2 E3 ligase, leading to its accumulation. Stabilized MLL protein accumulates on chromatin, methylates histone H3 lysine 4 at late replication origins and inhibits the loading of CDC45 to delay DNA replication. Cells deficient in MLL showed radioresistant DNA synthesis and chromatid-type genomic abnormalities, indicative of S-phase checkpoint dysfunction. Reconstitution of Mll(-/-) (Mll also known as Mll1) mouse embryonic fibroblasts with wild-type but not S516A or Delta SET mutant MLL rescues the S-phase checkpoint defects. Moreover, murine myeloid progenitor cells carrying an Mll-CBP knock-in allele that mimics human t(11;16) leukaemia show a severe radioresistant DNA synthesis phenotype. MLL fusions function as dominant negative mutants that abrogate the ATR-mediated phosphorylation/stabilization of wild-type MLL on damage to DNA, and thus compromise the S-phase checkpoint. Together, our results identify MLL as a key constituent of the mammalian DNA damage response pathway and show that deregulation of the S-phase checkpoint incurred by MLL translocations probably contributes to the pathogenesis of human MLL leukaemias.	[Liu, Han; Takeda, Shugaku; Westergard, Todd D.; Cheng, Emily H. -Y.; Hsieh, James J. -D.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Kumar, Rakesh; Pandita, Tej K.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Brown, Eric J.] Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA	Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania	Hsieh, JJD (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	jhsieh@dom.wustl.edu	Pandita, Tej K/AAM-9188-2020	Liu, Han/0000-0002-0022-1861; kumar, rakesh/0000-0002-0741-3663	American Society of Hematology [CA119008, CA129537/CA123232]; NATIONAL CANCER INSTITUTE [R01CA129537, R01CA123232, R01CA119008] Funding Source: NIH RePORTER	American Society of Hematology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Y. Wang and Z. You for discussions during the inception and the completion of this study, respectively. H.L. is supported by the Scholar award of the American Society of Hematology. The Mll<SUP>+1/ex7(stop)CBP</SUP> mice were provided by S. Armstrong and the late S. Korsmeyer. This study is supported by CA119008, the Scholar award of the American Society of Hematology, the Scholar award of the American Cancer Society, to J.J.-D.H., and CA129537/CA123232, to T.K.P.	Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Eguchi M, 2006, GENE CHROMOSOME CANC, V45, P754, DOI 10.1002/gcc.20338; Goren A, 2008, GENE DEV, V22, P1319, DOI 10.1101/gad.468308; Gupta A, 2008, MOL CELL BIOL, V28, P397, DOI 10.1128/MCB.01045-07; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Hsieh JJD, 2003, MOL CELL BIOL, V23, P186, DOI 10.1128/MCB.23.1.186-194.2003; Jude CD, 2007, CELL STEM CELL, V1, P324, DOI 10.1016/j.stem.2007.05.019; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Kumar AR, 2004, BLOOD, V103, P1823, DOI 10.1182/blood-2003-07-2582; Liedtke M, 2009, BLOOD, V113, P6061, DOI 10.1182/blood-2008-12-197061; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Liu H, 2007, GENE DEV, V21, P2385, DOI 10.1101/gad.1574507; Liu H, 2009, CANCER BIOL THER, V8, P1204, DOI 10.4161/cbt.8.13.8924; Liu K, 2006, EMBO J, V25, P4795, DOI 10.1038/sj.emboj.7601355; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Meyer C, 2009, LEUKEMIA, V23, P1490, DOI 10.1038/leu.2009.33; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Rodriguez-Perales S, 2008, INT J HEMATOL, V87, P3, DOI 10.1007/s12185-007-0001-3; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Taccioli GE, 1998, IMMUNITY, V9, P355, DOI 10.1016/S1074-7613(00)80618-4; Takeda S, 2006, GENE DEV, V20, P2397, DOI 10.1101/gad.1449406; Theunissen JWF, 2006, METHOD ENZYMOL, V409, P251, DOI 10.1016/S0076-6879(05)09015-4; Tu HC, 2009, P NATL ACAD SCI USA, V106, P1093, DOI 10.1073/pnas.0808173106; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Wang J, 2005, EMBO J, V24, P368, DOI 10.1038/sj.emboj.7600521; Xia ZB, 2005, P NATL ACAD SCI USA, V102, P14028, DOI 10.1073/pnas.0506464102; Yu BD, 1998, P NATL ACAD SCI USA, V95, P10632, DOI 10.1073/pnas.95.18.10632; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zinkel SS, 2005, CELL, V122, P579, DOI 10.1016/j.cell.2005.06.022	38	101	105	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2010	467	7313					343	U126		10.1038/nature09350	http://dx.doi.org/10.1038/nature09350			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650CF	20818375	Green Accepted			2022-12-01	WOS:000281824900042
J	Vickers, AJ; Cronin, AM; Bjork, T; Manjer, J; Nilsson, PM; Dahlin, A; Bjartell, A; Scardino, PT; Ulmert, D; Lilja, H				Vickers, Andrew J.; Cronin, Angel M.; Bjoerk, Thomas; Manjer, Jonas; Nilsson, Peter M.; Dahlin, Anders; Bjartell, Anders; Scardino, Peter T.; Ulmert, David; Lilja, Hans			Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK; DIAGNOSIS; SERUM; REPRODUCIBILITY; PREVALENCE; MORTALITY; REGISTER; BIOPSY; SWEDEN; PLASMA	Objective To determine the relation between concentrations of prostate specific antigen at age 60 and subsequent diagnosis of clinically relevant prostate cancer in an unscreened population to evaluate whether screening for prostate cancer and chemoprevention could be stratified by risk. Design Case-control study with 1: 3 matching nested within a highly representative population based cohort study. Setting General population of Sweden taking part in the Malmo Preventive Project. Cancer registry at the National Board of Health and Welfare. Participants 1167 men aged 60 who provided blood samples in 1981 and were followed up to age 85. Main outcome measures Metastasis or death from prostate cancer. Results The rate of screening during the course of the study was low. There were 43 cases of metastasis and 35 deaths from prostate cancer. Concentration of prostate specific antigen at age 60 was associated with prostate cancer metastasis (area under the curve 0.86, 95% confidence interval 0.79 to 0.92; P<0.001) and death from prostate cancer (0.90, 0.84 to 0.96; P<0.001). The greater the number for the area under the curve (values from 0 to 1) the better the test. Although only a minority of the men with concentrations in the top quarter (>2 ng/ml) develop fatal prostate cancer, 90% (78% to 100%) of deaths from prostate cancer occurred in these men. Conversely, men aged 60 with concentrations at the median or lower (<= 1 ng/ml) were unlikely to have clinically relevant prostate cancer (0.5% risk of metastasis by age 85 and 0.2% risk of death from prostate cancer). Conclusions The concentration of prostate specific antigen at age 60 predicts lifetime risk of metastasis and death from prostate cancer. Though men aged 60 with concentrations below the median (<= 1 ng/ml) might harbour prostate cancer, it is unlikely to become life threatening. Such men could be exempted from further screening, which should instead focus on men with higher concentrations.	[Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Clin Labs Surg & Med, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Lilja, H (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Clin Labs Surg & Med, New York, NY 10065 USA.	liljah@mskcc.org	Lilja, Hans/S-9703-2019	Lilja, Hans/0000-0001-5871-7846; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Vickers, Andrew/0000-0003-1525-6503	National Cancer Institute [R21-CA127768-01A1, P50-CA92629]; Swedish Cancer Society [3455]; Swedish Research Council (Medicine) [20095]; Sidney Kimmel Center for Prostate and Urologic Cancers; Prostate Cancer Foundation; Fundacion Federico SA; Memorial Sloan-Kettering Cancer Center; NATIONAL CANCER INSTITUTE [R33CA127768, P50CA092629, R21CA127768] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council (Medicine)(Swedish Research Council); Sidney Kimmel Center for Prostate and Urologic Cancers; Prostate Cancer Foundation; Fundacion Federico SA; Memorial Sloan-Kettering Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (grant numbers R21-CA127768-01A1, P50-CA92629); the Swedish Cancer Society (3455); the Swedish Research Council (Medicine) (20095); the Sidney Kimmel Center for Prostate and Urologic Cancers; David H Koch through the Prostate Cancer Foundation; and Fundacion Federico SA. The manuscript editing was paid for by internal funds at Memorial Sloan-Kettering Cancer Center. The study sponsors had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Adolfsson J, 2007, SCAND J UROL NEPHROL, V41, P456, DOI 10.1080/00365590701673625; Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Catalona WJ, 2009, NEW ENGL J MED, V361, P202, DOI 10.1056/NEJMc090849; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Cronin AM, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-75; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Draisma G, 2009, JNCI-J NATL CANCER I, V101, P374, DOI 10.1093/jnci/djp001; GANN PH, 1995, JAMA-J AM MED ASSOC, V273, P289, DOI 10.1001/jama.273.4.289; Goetzl MA, 2006, NAT CLIN PRACT UROL, V3, P422, DOI 10.1038/ncpuro0574; Greene KL, 2009, J UROLOGY, V182, P2232, DOI 10.1016/j.juro.2009.07.093; Haas GP, 2007, JNCI-J NATL CANCER I, V99, P1484, DOI 10.1093/jnci/djm153; Hernandez J, 2004, CANCER-AM CANCER SOC, V101, P894, DOI 10.1002/cncr.20480; Holmstrom B, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3537; Hsieh K, 2003, UROL CLIN N AM, V30, P669, DOI 10.1016/S0094-0143(03)00058-2; Kramer BS, 2009, J CLIN ONCOL, V27, P1502, DOI 10.1200/JCO.2008.16.9599; Lacher David A, 2006, Adv Data, P1; Lilja H, 2007, J CLIN ONCOL, V25, P431, DOI 10.1200/JCO.2006.06.9351; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; MITRUNEN K, 1995, CLIN CHEM, V41, P1115; Moskowitz CS, 2008, STAT MED, V27, P3191, DOI 10.1002/sim.3151; *NAT COMPR CANC NE, 2004, J NATL COMPR CANC NE, V2, P190; Ross LE, 2008, CANCER EPIDEM BIOMAR, V17, P636, DOI 10.1158/1055-9965.EPI-07-2709; Sandblom G, 2003, SCAND J UROL NEPHROL, V37, P112, DOI 10.1080/00365590310008839; Schroder F, 2008, EUR UROL, V54, P274, DOI 10.1016/j.eururo.2008.05.022; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; STENMAN UH, 1994, LANCET, V344, P1594, DOI 10.1016/S0140-6736(94)90405-7; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Thompson IM, 2006, J NATL CANCER I, V98, P529, DOI 10.1093/jnci/djj131; Ulmert D, 2006, CLIN CHEM, V52, P235, DOI 10.1373/clinchem.2005.050641; Ulmert D, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-6; Vickers A, 2010, J CLIN ONCOL, V28, P2493, DOI 10.1200/JCO.2009.24.1968; Welch HG, 2009, J NATL CANCER I, V101, P1325, DOI 10.1093/jnci/djp278	33	140	145	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2010	341								c4521	10.1136/bmj.c4521	http://dx.doi.org/10.1136/bmj.c4521			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653LK	20843935	hybrid, Green Published			2022-12-01	WOS:000282092600011
J	Carneiro, T; Khair, L; Reis, CC; Borges, V; Moser, BA; Nakamura, TM; Ferreira, MG				Carneiro, Tiago; Khair, Lyne; Reis, Clara C.; Borges, Vanessa; Moser, Bettina A.; Nakamura, Toru M.; Ferreira, Miguel Godinho			Telomeres avoid end detection by severing the checkpoint signal transduction pathway	NATURE			English	Article							FISSION YEAST; DNA-DAMAGE; CELL-CYCLE; DYSFUNCTIONAL TELOMERES; PROTEIN CRB2; RAP1; RECRUITMENT; METHYLATION; REPAIR; BREAKS	Telomeres protect the normal ends of chromosomes from being recognized as deleterious DNA double-strand breaks. Recent studies have uncovered an apparent paradox: although DNA repair is prevented, several proteins involved in DNA damage processing and checkpoint responses are recruited to telomeres in every cell cycle and are required for end protection(1). It is currently not understood how telomeres prevent DNA damage responses from causing permanent cell cycle arrest. Here we show that fission yeast (Schizosaccharomyces pombe) cells lacking Taz1, an orthologue of human TRF1 and TRF2 (ref. 2), recruit DNA repair proteins (Rad22(RAD52) and Rhp51(RAD51), where the superscript indicates the human orthologue) and checkpoint sensors (RPA, Rad9, Rad26(ATRIP) and Cut5/Rad4(TOPBP1)) to telomeres. Despite this, telomeres fail to accumulate the checkpoint mediator Crb2(53BP1) and, consequently, do not activate Chk1-dependent cell cycle arrest. Artificially recruiting Crb2(53BP1) to taz1D telomeres results in a full checkpoint response and cell cycle arrest. Stable association of Crb2(53BP1) to DNA double-strand breaks requires two independent histone modifications: H4 dimethylation at lysine 20 (H4K20me2) and H2A carboxy-terminal phosphorylation (gamma H2A)(3-5). Whereas cH2A can be readily detected, telomeres lack H4K20me2, in contrast to internal chromosome locations. Blocking checkpoint signal transduction at telomeres requires Pot1 and Ccq1, and loss of either Pot1 or Ccq1 from telomeres leads to Crb2(53BP1) foci formation, Chk1 activation and cell cycle arrest. Thus, telomeres constitute a chromatin-privileged region of the chromosomes that lack essential epigenetic markers for DNA damage response amplification and cell cycle arrest. Because the protein kinases ATM and ATR must associate with telomeres in each S phase to recruit telomerase(6), exclusion of Crb2(53BP1) has a critical role in preventing telomeres from triggering cell cycle arrest.	[Carneiro, Tiago; Reis, Clara C.; Borges, Vanessa; Ferreira, Miguel Godinho] Inst Gulbenkian Ciencias, P-2781901 Oeiras, Portugal; [Khair, Lyne; Moser, Bettina A.; Nakamura, Toru M.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	Instituto Gulbenkian de Ciencia; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Ferreira, MG (corresponding author), Inst Gulbenkian Ciencias, P-2781901 Oeiras, Portugal.	mgferreira@igc.gulbenkian.pt	Ferreira, Miguel Godinho/F-9290-2012; Nakamura, Toru M/B-2055-2008	Ferreira, Miguel Godinho/0000-0002-8363-7183; Nakamura, Toru M/0000-0001-5752-0814; Borges, Vanessa/0000-0003-0223-9085; Carneiro, Tiago/0000-0001-7909-4182	NIH [GM078253]; FCT [PTDC/BIA-BCM/67261/2006]; Association for International Cancer Research [06-396]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078253] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Association for International Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Cooper, K. Tomita and the rest of the Telomere Biology Laboratory (Cancer Research UK, London) for support at the start of this project. We thank J. Cooper, T. Wolkow, P. Russell and A. M. Carr for strains and plasmids. We thank W. Kaufman for her initial effort in the establishment of HO strains. We are grateful to S. Grewal for sharing unpublished results and to D. Lydall for insights on the quantitative analysis of checkpoint activation. We thank K. Labib, L. Jansen, K. Xavier, R. Martinho and S. Lopes for critically reading the manuscript. T. C. and C. C. R. are supported by Fundacao para a Ciencia e a Tecnologia (FCT) postdoctoral fellowships. T.M.N. was supported by the Sidney Kimmel Scholar Program and his laboratory is supported by NIH grant GM078253. This work was supported by the FCT (PTDC/BIA-BCM/67261/2006) and the Association for International Cancer Research (06-396).	Abdallah P, 2009, NAT CELL BIOL, V11, P988, DOI 10.1038/ncb1911; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Chikashige Y, 2001, CURR BIOL, V11, P1618, DOI 10.1016/S0960-9822(01)00457-2; Churikov D, 2008, NAT STRUCT MOL BIOL, V15, P79, DOI 10.1038/nsmb1331; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Du LL, 2006, GENE DEV, V20, P1583, DOI 10.1101/gad.1422606; Ferreira MG, 2004, GENE DEV, V18, P2249, DOI 10.1101/gad.315804; Ferreira MG, 2001, MOL CELL, V7, P55, DOI 10.1016/S1097-2765(01)00154-X; Goudsouzian LK, 2006, MOL CELL, V24, P603, DOI 10.1016/j.molcel.2006.10.005; Greeson NT, 2008, J BIOL CHEM, V283, P33168, DOI 10.1074/jbc.M806857200; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; Hirano Y, 2007, MOL BIOL CELL, V18, P2026, DOI 10.1091/mbc.E06-12-1074; Khair L, 2010, J BIOL CHEM, V285, P5327, DOI 10.1074/jbc.M109.078840; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Michelson RJ, 2005, GENE DEV, V19, P2546, DOI 10.1101/gad.1293805; Miller KM, 2006, NATURE, V440, P824, DOI 10.1038/nature04638; Miller KM, 2005, EMBO J, V24, P3128, DOI 10.1038/sj.emboj.7600779; Miyoshi T, 2008, SCIENCE, V320, P1341, DOI 10.1126/science.1154819; Mochida S, 2004, EMBO J, V23, P418, DOI 10.1038/sj.emboj.7600018; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moser BA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000622; Moser BA, 2009, EMBO J, V28, P810, DOI 10.1038/emboj.2009.31; Nakamura TM, 2004, MOL CELL BIOL, V24, P6215, DOI 10.1128/MCB.24.14.6215-6230.2004; Negrini S, 2007, GENE DEV, V21, P292, DOI 10.1101/gad.400907; Rog O, 2009, MOL CELL, V33, P559, DOI 10.1016/j.molcel.2009.01.027; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Tomita K, 2004, MOL CELL BIOL, V24, P9557, DOI 10.1128/MCB.24.21.9557-9567.2004; Tomita K, 2008, GENE DEV, V22, P3461, DOI 10.1101/gad.498608; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Wang Y, 2009, EPIGENETICS-US, V4, P273, DOI 10.4161/epi.4.5.9212	33	44	47	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2010	467	7312					228	U124		10.1038/nature09353	http://dx.doi.org/10.1038/nature09353			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647KB	20829797	Green Accepted			2022-12-01	WOS:000281616300039
J	Laiteerapong, N; Huang, ES				Laiteerapong, Neda; Huang, Elbert S.			Health Care Reform and Chronic Diseases Anticipating the Health Consequences	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							10-YEAR FOLLOW-UP; MEDICARE BENEFICIARIES; ACCESS; ADULTS		[Laiteerapong, Neda; Huang, Elbert S.] Univ Chicago, Gen Internal Med Sect, Dept Med, Chicago, IL 60637 USA	University of Chicago	Laiteerapong, N (corresponding author), Univ Chicago, Gen Internal Med Sect, Dept Med, 5841 S Maryland Ave,MC 2007, Chicago, IL 60637 USA.	nlaiteer@medicine.bsd.uchicago.edu	Laiteerapong, Neda/ABC-5566-2021; Laiteerapong, Neda/AAO-2596-2020	Laiteerapong, Neda/0000-0003-0124-4325; 	AHRQ HHS [T32HS000084] Funding Source: Medline; NIDDK NIH HHS [F32 DK089973, F32DK089973, P60 DK20595] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK089973, P60DK020595] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; HOFFMAN C, 2009, PUBLICATION HJ KAIS; Hoffman C, 2008, HEALTH AFFAIR, V27, pW340, DOI 10.1377/hlthaff.27.5.w340; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Paez KA, 2009, HEALTH AFFAIR, V28, P15, DOI 10.1377/hlthaff.28.1.15; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126; Thorpe KE, 2006, HEALTH AFFAIR, V25, pW378, DOI 10.1377/hlthaff.25.w378; Weissman JS, 2008, J HEALTH CARE POOR U, V19, P307, DOI 10.1353/hpu.2008.0021	9	9	9	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2010	304	8					899	900		10.1001/jama.2010.1209	http://dx.doi.org/10.1001/jama.2010.1209			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	644OY	20736475				2022-12-01	WOS:000281389900029
J	Larson, HJ; Brocard, P; Garnett, G				Larson, Heidi J.; Brocard, Pauline; Garnett, Geoffrey			The India HPV-vaccine suspension	LANCET			English	Editorial Material									[Larson, Heidi J.; Brocard, Pauline; Garnett, Geoffrey] Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth, London SW7 1NA, England	Imperial College London	Larson, HJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth, London SW7 1NA, England.	h.larson@imperial.ac.uk	Garnett, Geoffrey P/A-9312-2008; Larson, Heidi J./N-1018-2017	Larson, Heidi J./0000-0002-8477-7583				Agosti JM, 2007, NEW ENGL J MED, V356, P1908, DOI 10.1056/NEJMp078053; Cooper LZ, 2008, PEDIATRICS, V122, P149, DOI 10.1542/peds.2008-0987; Ramanathan Mala, 2010, Indian J Med Ethics, V7, P43; *SAH WOM RES CTR S, 2009, WOM ORG OPP HPV VACC; *SAM RES GROUP WOM, 2009, CONC HPV VACC MEM HL; *SAM RES GROUP WOM, 2010, MEM HLTH MIN WORLD H; SINHA K, 2010, TIMES INDIA     0409; THACKER T, 2010, MINISTRY ADMITS LAPS; 2010, UPDATE PATHS HPV VAC; 2010, TIMES INDIA     0422; 2010, GLAXOSMITHKLINE RESP	11	60	61	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 21	2010	376	9741					572	573		10.1016/S0140-6736(10)60881-1	http://dx.doi.org/10.1016/S0140-6736(10)60881-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	643PB	20728739				2022-12-01	WOS:000281309100007
J	Yoshida, Y; Kuroiwa, H; Misumi, O; Yoshida, M; Ohnuma, M; Fujiwara, T; Yagisawa, F; Hirooka, S; Imoto, Y; Matsushita, K; Kawano, S; Kuroiwa, T				Yoshida, Yamato; Kuroiwa, Haruko; Misumi, Osami; Yoshida, Masaki; Ohnuma, Mio; Fujiwara, Takayuki; Yagisawa, Fumi; Hirooka, Shunsuke; Imoto, Yuuta; Matsushita, Kazunobu; Kawano, Shigeyuki; Kuroiwa, Tsuneyoshi			Chloroplasts Divide by Contraction of a Bundle of Nanofilaments Consisting of Polyglucan	SCIENCE			English	Article							ALGA CYANIDIOSCHYZON-MEROLAE; PLASTID DIVISION; DYNAMIN; MACHINERY; MITOCHONDRIA; GLYCOGENIN; ORGANELLES; APPARATUS; MECHANISM; SEQUENCE	In chloroplast division, the plastid-dividing (PD) ring is a main structure of the PD machinery and is a universal structure in the plant kingdom. However, the components and formation of the PD ring have been enigmatic. By proteomic analysis of PD machineries isolated from Cyanidioschyzon merolae, we identified the glycosyltransferase protein plastid-dividing ring 1 (PDR1), which constructs the PD ring and is widely conserved from red alga to land plants. Electron microscopy showed that the PDR1 protein forms a ring with carbohydrates at the chloroplast-division site. Fluorometric saccharide ingredient analysis of purified PD ring filaments showed that only glucose was included, and down-regulation of PDR1 impaired chloroplast division. Thus, the chloroplasts are divided by the PD ring, which is a bundle of PDR1-mediated polyglucan filaments.	[Yoshida, Yamato; Kuroiwa, Haruko; Misumi, Osami; Yoshida, Masaki; Ohnuma, Mio; Fujiwara, Takayuki; Yagisawa, Fumi; Imoto, Yuuta; Kuroiwa, Tsuneyoshi] Rikkyo Univ, Cell Biol Lab, Dept Life Sci, Coll Sci,Res Informat Ctr Extremophile, Tokyo 1718501, Japan; [Hirooka, Shunsuke] Chiba Univ, Dept Nanobiol, Grad Sch Adv Integrat Sci, Chiba 2718510, Japan; [Matsushita, Kazunobu] Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi 7538515, Japan; [Kawano, Shigeyuki] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan	Rikkyo University; Chiba University; Yamaguchi University; University of Tokyo	Kuroiwa, T (corresponding author), Rikkyo Univ, Cell Biol Lab, Dept Life Sci, Coll Sci,Res Informat Ctr Extremophile, Tokyo 1718501, Japan.	tsune@rikkyo.ne.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan;  [22247007];  [22657061]; Grants-in-Aid for Scientific Research [22370024] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Y. Miyagishima and K. Nishida for thoughtful advice on the research. This work was supported by grants from the Scientific Research (22247007 and 22657061 to T. K.) and by the Frontier Project "Adaptation and Evolution of Extremophiles" from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Gao HB, 2003, P NATL ACAD SCI USA, V100, P4328, DOI 10.1073/pnas.0530206100; GILLHAM NW, 1994, ANNU REV GENET, V28, P71, DOI 10.1146/annurev.ge.28.120194.000443; Glynn JM, 2007, TRAFFIC, V8, P451, DOI 10.1111/j.1600-0854.2007.00545.x; Hirabaru C, 2010, PLANT CELL PHYSIOL, V51, P682, DOI 10.1093/pcp/pcq046; Kuroiwa H, 2002, PLANTA, V215, P185, DOI 10.1007/s00425-002-0734-4; Kuroiwa T, 2008, INT REV CEL MOL BIO, V271, P97, DOI 10.1016/S1937-6448(08)01203-3; Kuroiwa T, 1998, INT REV CYTOL, V181, P1, DOI 10.1016/S0074-7696(08)60415-5; Lomako J, 2004, BBA-GEN SUBJECTS, V1673, P45, DOI 10.1016/j.bbagen.2004.03.017; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Miyagishima S, 2003, PLANT CELL, V15, P655, DOI 10.1105/tpc.009373; Miyagishima SY, 2001, PLANT CELL, V13, P2257, DOI 10.1105/tpc.010185; Miyagishima SY, 2001, PLANT CELL, V13, P707; Nozaki H, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-28; Osteryoung KW, 2003, SCIENCE, V302, P1698, DOI 10.1126/science.1082192; OSTERYOUNG KW, 1995, NATURE, V376, P473, DOI 10.1038/376473b0; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pyke KA, 1999, PLANT CELL, V11, P549, DOI 10.1105/tpc.11.4.549; SMYTHE C, 1991, EUR J BIOCHEM, V200, P625, DOI 10.1111/j.1432-1033.1991.tb16225.x; Yoo SH, 2002, CARBOHYD RES, V337, P2195, DOI 10.1016/S0008-6215(02)00228-8; Yoshida Y, 2006, SCIENCE, V313, P1435, DOI 10.1126/science.1129689; Yoshida Y, 2009, CURR BIOL, V19, P1491, DOI 10.1016/j.cub.2009.07.035	22	63	66	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 20	2010	329	5994					949	953		10.1126/science.1190791	http://dx.doi.org/10.1126/science.1190791			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640WN	20724635				2022-12-01	WOS:000281084800036
J	Berne, O; Marcelino, N; Cernicharo, J				Berne, Olivier; Marcelino, Nuria; Cernicharo, Jose			Waves on the surface of the Orion molecular cloud	NATURE			English	Article							H-2 EMISSION; GAS; PHOTOEVAPORATION; REGION; STARS	Massive stars influence their parental molecular cloud, and it has long been suspected that the development of hydrodynamical instabilities can compress or fragment the cloud(1,2). Identifying such instabilities has proved difficult. It has been suggested that elongated structures (such as the 'pillars of creation'(3)) and other shapes arise because of instabilities(4,5), but alternative explanations are available(6,7). One key signature of an instability is a wave-like structure in the gas, which has hitherto not been seen. Here we report the presence of 'waves' at the surface of the Orion molecular cloud near where massive stars are forming. The waves seem to be a Kelvin-Helmholtz instability that arises during the expansion of the nebula as gas heated and ionized by massive stars is blown over pre-existing molecular gas.	[Berne, Olivier; Marcelino, Nuria; Cernicharo, Jose] CSIC INTA, Ctr Astrobiol, Torrejon De Ardoz 28850, Spain; [Berne, Olivier] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Leiden University; Leiden University - Excl LUMC	Berne, O (corresponding author), CSIC INTA, Ctr Astrobiol, Carretera Torrejon Ajalvir,Km 4, Torrejon De Ardoz 28850, Spain.	berne@strw.leidenuniv.nl	Marcelino, Nuria/H-4400-2017; Cernicharo, Jose/G-3059-2015	Marcelino, Nuria/0000-0001-7236-4047; Cernicharo, Jose/0000-0002-3518-2524	NASA	NASA(National Aeronautics & Space Administration (NASA))	We thank J. Bally and M. Pound for their comments, which contributed to the improvement of the manuscript. We also acknowledge B. Lefloc'h, J. Goicoechea and J. Martin-Pintado for discussions. D. Hochberg is acknowledged for his reading of the manuscript. O.B. acknowledges C. Joblin for support. This work is based in part on observations made with the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory, California Institute of Technology under a contract with NASA.	Bachiller R, 1996, ANNU REV ASTRON ASTR, V34, P111, DOI 10.1146/annurev.astro.34.1.111; Bally J, 2006, ASTRON J, V131, P473, DOI 10.1086/498265; Bally J, 2008, MONOGR ASTRON SOC PA, V4, P459; Berne O, 2009, ASTROPHYS J LETT, V706, pL160, DOI 10.1088/0004-637X/706/1/L160; CHANDRASEKHAR S, 1961, HYDRODYNAMIC HYDROMA, pCH11; GENZEL R, 1989, ANNU REV ASTRON ASTR, V27, P41, DOI 10.1146/annurev.aa.27.090189.000353; Gudel M, 2008, SCIENCE, V319, P309, DOI 10.1126/science.1149926; Hester JJ, 1996, ASTRON J, V111, P2349, DOI 10.1086/117968; Johnstone D, 1998, ASTROPHYS J, V499, P758, DOI 10.1086/305658; Kaufman MJ, 2006, ASTROPHYS J, V644, P283, DOI 10.1086/503596; Lefloch B, 2003, ASTROPHYS J, V590, pL41, DOI 10.1086/376673; Menten KM, 2007, ASTRON ASTROPHYS, V474, P515, DOI 10.1051/0004-6361:20078247; Neufeld DA, 2009, ASTROPHYS J, V706, P170, DOI 10.1088/0004-637X/706/1/170; Pound MW, 1998, ASTROPHYS J, V493, pL113, DOI 10.1086/311131; Pound MW, 2003, ASTRON J, V125, P2108, DOI 10.1086/368138; RODRIGUEZFRANCO A, 1992, ASTRON ASTROPHYS, V264, P592; Ryutov DD, 2007, ASTROPHYS SPACE SCI, V307, P173, DOI 10.1007/s10509-006-9233-6; Ryutov DD, 2003, PLASMA PHYS CONTR F, V45, P769, DOI 10.1088/0741-3335/45/5/319; Schuster KF, 2004, ASTRON ASTROPHYS, V423, P1171, DOI 10.1051/0004-6361:20034179; SPITZER L, 1978, PHYSICAL PROCESSES I, P223; Tappe A, 2008, ASTROPHYS J LETT, V680, pL117, DOI 10.1086/589998; TENORIOTAGLE G, 1988, ANNU REV ASTRON ASTR, V26, P145; TIELENS AGGM, 1993, SCIENCE, V262, P86, DOI 10.1126/science.262.5130.86; Weingartner JC, 2001, ASTROPHYS J, V548, P296, DOI 10.1086/318651; Wilms J, 2000, ASTROPHYS J, V542, P914, DOI 10.1086/317016; WOODWARD PR, 1976, ASTROPHYS J, V207, P484, DOI 10.1086/154516	26	32	32	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2010	466	7309					947	949		10.1038/nature09289	http://dx.doi.org/10.1038/nature09289			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640ED	20725034	Green Submitted			2022-12-01	WOS:000281030300028
J	Zhang, P; Wang, JW; Shi, YG				Zhang, Peng; Wang, Jiawei; Shi, Yigong			Structure and mechanism of the S component of a bacterial ECF transporter	NATURE			English	Article							ABC TRANSPORTERS; BINDING	The energy-coupling factor (ECF) transporters, responsible for vitamin uptake in prokaryotes, are a unique family of membrane transporters(1,2). Each ECF transporter contains a membrane-embedded, substrate-binding protein (known as the S component), an energy-coupling module that comprises two ATP-binding proteins (known as the A and A' components) and a transmembrane protein (known as the T component). The structure and transport mechanism of the ECF family remain unknown. Here we report the crystal structure of RibU, the S component of the ECF-type riboflavin transporter from Staphylococcus aureus at 3.6-angstrom resolution. RibU contains six transmembrane segments, adopts a previously unreported transporter fold and contains a riboflavin molecule bound to the L1 loop and the periplasmic portion of transmembrane segments 4-6. Structural analysis reveals the essential ligand-binding residues, identifies the putative transport path and, with sequence alignment, uncovers conserved structural features and suggests potential mechanisms of action among the ECF transporters. [GRAPHICS] .	[Shi, Yigong] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Minist Educ,Prot Sci Lab, Beijing 100084, Peoples R China; [Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Zhang, Peng] Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA; [Wang, Jiawei] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Wang, Jiawei] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Princeton University; Tsinghua University; Tsinghua University	Shi, YG (corresponding author), Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Minist Educ,Prot Sci Lab, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn	Wang, Jiawei/D-1144-2010	Wang, Jiawei/0000-0001-9893-8539; zhang, peng/0000-0003-0408-2923; Shi, Yigong/0000-0003-2030-168X	National Institutes of Health [R01 GM084964]; Ministry of Science and Technology of China [2009CB918801]; National Natural Science Foundation of China [30888001]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084964] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Yan for technical advice, A. Schmedel for administrative assistance and E. coli Genetic Resources at Yale Coli Genetic Stock Center for providing mutant E. coli strains. This work was supported by the National Institutes of Health (R01 GM084964), funds from the Ministry of Science and Technology of China (grant number 2009CB918801) and Project 30888001 supported by National Natural Science Foundation of China.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BANDRIN SV, 1983, GENETIKA+, V19, P1419; Burgess CM, 2006, J BACTERIOL, V188, P2752, DOI 10.1128/JB.188.8.2752-2760.2006; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Davidson AL, 2007, TRENDS MICROBIOL, V15, P448, DOI 10.1016/j.tim.2007.09.005; Dawson RJP, 2007, MOL MICROBIOL, V65, P250, DOI 10.1111/j.1365-2958.2007.05792.x; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Duurkens RH, 2007, J BIOL CHEM, V282, P10380, DOI 10.1074/jbc.M608583200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hakemian AS, 2008, BIOCHEMISTRY-US, V47, P6793, DOI 10.1021/bi800598h; Hebbeln P, 2007, P NATL ACAD SCI USA, V104, P2909, DOI 10.1073/pnas.0609905104; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Lieberman RL, 2005, NATURE, V434, P177, DOI 10.1038/nature03311; Linton KJ, 2007, PHYSIOLOGY, V22, P122, DOI 10.1152/physiol.00046.2006; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Neubauer O, 2009, J BACTERIOL, V191, P6482, DOI 10.1128/JB.00965-09; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rodionov DA, 2006, J BACTERIOL, V188, P317, DOI 10.1128/JB.188.1.317-327.2006; Rodionov DA, 2009, J BACTERIOL, V191, P42, DOI 10.1128/JB.01208-08; Vogl C, 2007, J BACTERIOL, V189, P7367, DOI 10.1128/JB.00590-07	25	71	74	4	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2010	468	7324					717	U148		10.1038/nature09488	http://dx.doi.org/10.1038/nature09488			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	20972419				2022-12-01	WOS:000284836700046
J	Wu, BL; Chien, EYT; Mol, CD; Fenalti, G; Liu, W; Katritch, V; Abagyan, R; Brooun, A; Wells, P; Bi, FC; Hamel, DJ; Kuhn, P; Handel, TM; Cherezov, V; Stevens, RC				Wu, Beili; Chien, Ellen Y. T.; Mol, Clifford D.; Fenalti, Gustavo; Liu, Wei; Katritch, Vsevolod; Abagyan, Ruben; Brooun, Alexei; Wells, Peter; Bi, F. Christopher; Hamel, Damon J.; Kuhn, Peter; Handel, Tracy M.; Cherezov, Vadim; Stevens, Raymond C.			Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists	SCIENCE			English	Article							ANTI-HIV ACTIVITY; CRYSTAL-STRUCTURE; RECEPTOR DIMERIZATION; LIGAND; GP120; REVEALS; IDENTIFICATION; MIGRATION; RESIDUES; CELLS	Chemokine receptors are critical regulators of cell migration in the context of immune surveillance, inflammation, and development. The G protein-coupled chemokine receptor CXCR4 is specifically implicated in cancer metastasis and HIV-1 infection. Here we report five independent crystal structures of CXCR4 bound to an antagonist small molecule IT1t and a cyclic peptide CVX15 at 2.5 to 3.2 angstrom resolution. All structures reveal a consistent homodimer with an interface including helices V and VI that may be involved in regulating signaling. The location and shape of the ligand-binding sites differ from other G protein-coupled receptors and are closer to the extracellular surface. These structures provide new clues about the interactions between CXCR4 and its natural ligand CXCL12, and with the HIV-1 glycoprotein gp120.	[Wu, Beili; Chien, Ellen Y. T.; Mol, Clifford D.; Fenalti, Gustavo; Liu, Wei; Kuhn, Peter; Cherezov, Vadim; Stevens, Raymond C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Katritch, Vsevolod; Abagyan, Ruben; Hamel, Damon J.; Handel, Tracy M.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Katritch, Vsevolod; Abagyan, Ruben; Hamel, Damon J.; Handel, Tracy M.] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; [Brooun, Alexei; Wells, Peter; Bi, F. Christopher] Pfizer Worldwide Res & Dev, San Diego, CA 92121 USA	Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Pfizer	Stevens, RC (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stevens@scripps.edu	Katritch, Vsevolod/Y-2721-2019; Liu, Wei/F-1820-2011; Katritch, Vsevolod/Q-8357-2016; Cherezov, Vadim/L-9812-2013; Stevens, Raymond/K-7272-2015	Katritch, Vsevolod/0000-0003-3883-4505; Cherezov, Vadim/0000-0002-5265-3914; Stevens, Raymond/0000-0002-4522-8725	Protein Structure Initiative [U54 GM074961]; NIH Roadmap Initiative [P50 GM073197]; NIH [R21 RR025336, R21 AI087189, R01 AI037113, R01 GM081763, GM075915]; Pfizer; NSF [IIS0308078]; Science Foundation Ireland [02-IN1-B266]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104];  [F32 GM083463];  [R01 GM071872]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087189, R01AI037113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075915, U54GM074961, P50GM073197, U54GM094618, R01GM071872, R01GM081763, R01GM089857, F32GM083463] Funding Source: NIH RePORTER	Protein Structure Initiative; NIH Roadmap Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); NSF(National Science Foundation (NSF)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Protein Structure Initiative grant U54 GM074961 for structure production, NIH Roadmap Initiative grant P50 GM073197 for technology development, NIH grants R21 RR025336 and R21 AI087189 to V. C., and Pfizer. T. M. H. acknowledges support from NIH R01 AI037113 and R01 GM081763, D.J.H. from F32 GM083463, and R. A. from R01 GM071872. The authors thank J. Velasquez for help on molecular biology, T. Trinh and K. Allin for help on baculovirus expression, I. Wilson and D. Burton for careful review and scientific feedback on the manuscript, W. Schief for electron microscopy models of gp120-gp41-CD4 complex, G. W. Han for evaluating the structure quality and preparation for PDB submission, and A. Walker for assistance with manuscript preparation. The authors acknowledge E. La Chapelle on chemistry tool compound synthesis; A. Rane on radiolabeling of [<SUP>3</SUP>H]BIMA; M. Cui for help developing [<SUP>3</SUP>H]BIMA binding assay; Y. Zheng, The Ohio State University, and M. Caffrey, Trinity College (Dublin, Ireland), for the generous loan of the in meso robot [built with support from the National Institutes of Health (GM075915), the NSF (IIS0308078), and Science Foundation Ireland (02-IN1-B266)]; and J. Smith, R. Fischetti, and N. Sanishvili at the General Medicine and Cancer Institutes Collaborative Access Team (GM/CA-CAT) beamline at the Advanced Photon Source for assistance in development and use of the minibeam and beamtime. The GM/CA-CAT beamline (23-ID) is supported by the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Sciences (Y1-GM-1104). R. C. S. is the founder and is a board member of Receptos, a biotech company focused on GPCR structure-based drug discovery. Transfer of IT1t, CVX15, and [3H] BIMA will require a Material Transfer Agreement (MTA) with Pfizer, and transfer of all other constructs and biological materials requires an MTA with the Scripps Research Institute. Atomic coordinates and structure factors have been deposited in the Protein Data Bank with identification codes 3ODU (CXCR4-2-IT1t, P21), 3OE0 (CXCR4-3-CVX15, C2), 3OE8 (CXCR4-2-IT1t, P1), 3OE9 (CXCR4-3-IT1t, P1), and 3OE6 (CXCR4-1-IT1t, I222).	Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; Appay V, 1999, J BIOL CHEM, V274, P27505, DOI 10.1074/jbc.274.39.27505; Babcock GJ, 2003, J BIOL CHEM, V278, P3378, DOI 10.1074/jbc.M210140200; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Balabanian K, 2005, BLOOD, V105, P2449, DOI 10.1182/blood-2004-06-2289; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Brelot A, 2000, J BIOL CHEM, V275, P23736, DOI 10.1074/jbc.M000776200; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; CLARKLEWIS I, 1995, J LEUKOCYTE BIOL, V57, P703, DOI 10.1002/jlb.57.5.703; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Czaplewski LG, 1999, J BIOL CHEM, V274, P16077, DOI 10.1074/jbc.274.23.16077; Dealwis C, 1998, P NATL ACAD SCI USA, V95, P6941, DOI 10.1073/pnas.95.12.6941; DeMarco SJ, 2006, BIOORGAN MED CHEM, V14, P8396, DOI 10.1016/j.bmc.2006.09.003; Diskin R, 2010, NAT STRUCT MOL BIOL, V17, P608, DOI 10.1038/nsmb.1796; Doranz BJ, 1999, J VIROL, V73, P2752, DOI 10.1128/JVI.73.4.2752-2761.1999; Fanelli F, 2006, J COMPUT AID MOL DES, V20, P449, DOI 10.1007/s10822-006-9064-0; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Filizola M, 2010, LIFE SCI, V86, P590, DOI 10.1016/j.lfs.2009.05.004; Fulton AM, 2009, CURR ONCOL REP, V11, P125, DOI 10.1007/s11912-009-0019-1; Gupta SK, 2001, IMMUNOL LETT, V78, P29, DOI 10.1016/S0165-2478(01)00228-0; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Isik N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003424; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kofuku Y, 2009, J BIOL CHEM, V284, P35240, DOI 10.1074/jbc.M109.024851; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lagane B, 2008, BLOOD, V112, P34, DOI 10.1182/blood-2007-07-102103; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Luker KE, 2009, FASEB J, V23, P823, DOI 10.1096/fj.08-116749; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298; Moncunill G, 2008, MOL PHARMACOL, V73, P1264, DOI 10.1124/mol.107.042911; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nemoto W, 2006, CURR PROTEIN PEPT SC, V7, P561, DOI 10.2174/138920306779025657; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Paavola CD, 1998, J BIOL CHEM, V273, P33157, DOI 10.1074/jbc.273.50.33157; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Pello OM, 2008, EUR J IMMUNOL, V38, P537, DOI 10.1002/eji.200737630; Percherancier Y, 2005, J BIOL CHEM, V280, P9895, DOI 10.1074/jbc.M411151200; Reggio PH, 2006, AAPS J, V8, pE322; Roth CB, 2008, J MOL BIOL, V376, P1305, DOI 10.1016/j.jmb.2007.12.028; Salanga CL, 2009, CELL MOL LIFE SCI, V66, P1370, DOI 10.1007/s00018-008-8666-1; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Sohy D, 2007, J BIOL CHEM, V282, P30062, DOI 10.1074/jbc.M705302200; Sohy D, 2009, J BIOL CHEM, V284, P31270, DOI 10.1074/jbc.M109.054809; Tamamura H, 2003, FEBS LETT, V550, P79, DOI 10.1016/S0014-5793(03)00824-X; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Thoma G, 2008, J MED CHEM, V51, P7915, DOI 10.1021/jm801065q; Tian SM, 2005, J VIROL, V79, P12667, DOI 10.1128/JVI.79.20.12667-12673.2005; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Vohra S, 2007, BIOCHEM SOC T, V35, P749, DOI 10.1042/BST0350749; Wang JH, 2008, DRUG DISCOV TODAY, V13, P625, DOI 10.1016/j.drudis.2008.04.004; Wang JH, 2006, MOL CANCER THER, V5, P2474, DOI 10.1158/1535-7163.MCT-05-0261; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wells TNC, 1996, J LEUKOCYTE BIOL, V59, P53, DOI 10.1002/jlb.59.1.53; Zhou HP, 2000, ARCH BIOCHEM BIOPHYS, V373, P211, DOI 10.1006/abbi.1999.1555; Zlotnik A, 2008, J PATHOL, V215, P211, DOI 10.1002/path.2350; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	65	1382	1434	9	385	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2010	330	6007					1066	1071		10.1126/science.1194396	http://dx.doi.org/10.1126/science.1194396			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	20929726	Green Accepted			2022-12-01	WOS:000284374700033
J	Lee, S; Yoon, BE; Berglund, K; Oh, SJ; Park, H; Shin, HS; Augustine, GJ; Lee, CJ				Lee, Soojung; Yoon, Bo-Eun; Berglund, Ken; Oh, Soo-Jin; Park, Hyungju; Shin, Hee-Sup; Augustine, George J.; Lee, C. Justin			Channel-Mediated Tonic GABA Release from Glia	SCIENCE			English	Article							CEREBELLAR GRANULE CELLS; SYNAPTIC INHIBITION; RAT CEREBELLUM; ACTIVATION; ASTROCYTES; NEURONS; RECEPTORS; CHLORIDE; BRAIN; DEGENERATION	Synaptic inhibition is based on both tonic and phasic release of the inhibitory transmitter gamma-aminobutyric acid (GABA). Although phasic GABA release arises from Ca2+-dependent exocytosis from neurons, the mechanism of tonic GABA release is unclear. Here we report that tonic inhibition in the cerebellum is due to GABA being released from glial cells by permeation through the Bestrophin 1 (Best1) anion channel. We demonstrate that GABA directly permeates through Best1 to yield GABA release and that tonic inhibition is eliminated by silencing of Best1. Glial cells express both GABA and Best1, and selective expression of Best1 in glial cells, after preventing general expression of Best1, fully rescues tonic inhibition. Our results identify a molecular mechanism for tonic inhibition and establish a role for interactions between glia and neurons in mediating tonic inhibition.	[Lee, Soojung; Yoon, Bo-Eun; Oh, Soo-Jin; Park, Hyungju; Shin, Hee-Sup; Lee, C. Justin] Korea Inst Sci & Technol, Ctr Neural Sci, Seoul, South Korea; [Yoon, Bo-Eun; Oh, Soo-Jin; Shin, Hee-Sup; Augustine, George J.; Lee, C. Justin] Korea Inst Sci & Technol, Ctr Funct Connect, Seoul, South Korea; [Berglund, Ken; Augustine, George J.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Augustine, George J.] Duke NUS Grad Med Sch, Program Neurosci & Behav Disorders, Singapore, Singapore; [Yoon, Bo-Eun; Lee, C. Justin] Univ Sci & Technol, Neurosci Program, Taejon, South Korea	Korea Institute of Science & Technology (KIST); Korea Institute of Science & Technology (KIST); Duke University; National University of Singapore	Lee, CJ (corresponding author), Korea Inst Sci & Technol, Ctr Neural Sci, Seoul, South Korea.	cjl@kist.re.kr	Park, Hyungju/C-4608-2016; Augustine, George James/J-9228-2013; Lee, C. Justin/AAC-1663-2019	Park, Hyungju/0000-0002-9010-9434; Lee, C Justin/0000-0002-3555-0980	KIST; International Cooperation Program; Korean national honor scientist grant; NIMH; World Class Institute	KIST(Korea Institute of Science & Technology Information (KISTI)); International Cooperation Program; Korean national honor scientist grant; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); World Class Institute	We thank J. Park for the ANO1 clone, J. Adelman for the human SK1 clone, K. Kunzelmann for mouse Best1 antibody, and J. Lee for image analysis. We specially thank K. McCarthy for his generous gift of hGFAP-CreERT2 transgenic mice. This study was supported by the KIST Core Competency Program and International Cooperation Program, by a Korean national honor scientist grant, an NIMH grant, and a World Class Institute grant to the Center for Functional Connectomics.	AMIN J, 1994, RECEPTOR CHANNEL, V2, P227; BARDAKDJIAN J, 1979, NEUROCHEM RES, V4, P517, DOI 10.1007/BF00964645; Bellamy TC, 2006, CEREBELLUM, V5, P116, DOI 10.1080/14734220600724569; Berglund K, 2008, BRAIN CELL BIOL, V36, P101, DOI 10.1007/s11068-008-9031-x; BLOMQVIST A, 1988, J NEUROCYTOL, V17, P629, DOI 10.1007/BF01260990; Bond CT, 2005, CURR OPIN NEUROBIOL, V15, P305, DOI 10.1016/j.conb.2005.05.001; BRENNER M, 1994, J NEUROSCI, V14, P1030, DOI 10.1523/JNEUROSCI.14-03-01030.1994; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Carland JE, 2004, NEUROPHARMACOLOGY, V46, P770, DOI 10.1016/j.neuropharm.2003.11.027; Cavelier P, 2005, PROG BIOPHYS MOL BIO, V87, P3, DOI 10.1016/j.pbiomolbio.2004.06.001; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; CHANPALAY V, 1972, Z ANAT ENTWICKLUNGS, V138, P1, DOI 10.1007/BF00519921; Chebib M, 2004, CLIN EXP PHARMACOL P, V31, P800, DOI 10.1111/j.1440-1681.2004.04083.x; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cope DW, 2009, NAT MED, V15, P1392, DOI 10.1038/nm.2058; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Gadea A, 2001, J NEUROSCI RES, V63, P461, DOI 10.1002/jnr.1040; Glykys J, 2007, NEURON, V56, P763, DOI 10.1016/j.neuron.2007.11.002; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; Jia F, 2005, J NEUROPHYSIOL, V94, P4491, DOI 10.1152/jn.00421.2005; Jones SM, 2009, J NEUROPHYSIOL, V102, P691, DOI 10.1152/jn.00285.2009; KANEDA M, 1995, J PHYSIOL-LONDON, V485, P419, DOI 10.1113/jphysiol.1995.sp020739; Kirischuk S, 1995, J NEUROSCI, V15, P7861; Kozlov AS, 2006, P NATL ACAD SCI USA, V103, P10058, DOI 10.1073/pnas.0603741103; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; Kunzelmann K, 2009, CELL CALCIUM, V46, P233, DOI 10.1016/j.ceca.2009.09.003; LANDIS DMD, 1983, DEV BRAIN RES, V8, P231, DOI 10.1016/0165-3806(83)90008-1; MARTINEZRODRIGUEZ R, 1993, CELL MOL BIOL, V39, P115; Muller T, 1995, INT REV NEUROBIOL, V38, P341, DOI 10.1016/S0074-7742(08)60530-9; O'Driscoll KE, 2009, BIOCHEM BIOPH RES CO, V384, P476, DOI 10.1016/j.bbrc.2009.05.008; OCHI S, 1993, GLIA, V9, P188, DOI 10.1002/glia.440090304; Olah S, 2009, NATURE, V461, P1278, DOI 10.1038/nature08503; OTIS TS, 1991, BRAIN RES, V545, P142, DOI 10.1016/0006-8993(91)91280-E; Park H, 2009, J NEUROSCI, V29, P13063, DOI 10.1523/JNEUROSCI.3193-09.2009; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Qu ZQ, 2008, AM J PHYSIOL-CELL PH, V294, pC1371, DOI 10.1152/ajpcell.00398.2007; Qu ZQ, 2006, J NEUROSCI, V26, P5411, DOI 10.1523/JNEUROSCI.5500-05.2006; Ribak CE, 1996, ANAT EMBRYOL, V194, P379; Rossi DJ, 2003, J PHYSIOL-LONDON, V548, P97, DOI 10.1113/jphysiol.2002.036459; Santhakumar V, 2006, J NEUROSCI, V26, P3357, DOI 10.1523/JNEUROSCI.4799-05.2006; Takayama K, 2008, NEUROSCI LETT, V443, P7, DOI 10.1016/j.neulet.2008.07.058; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; Yu K, 2007, INVEST OPHTH VIS SCI, V48, P4694, DOI 10.1167/iovs.07-0301	46	361	369	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 5	2010	330	6005					790	796		10.1126/science.1184334	http://dx.doi.org/10.1126/science.1184334			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675SY	20929730				2022-12-01	WOS:000283855700035
J	Smith, AK; Cenzer, IS; Knight, SJ; Puntillo, KA; Widera, E; Williams, BA; Boscardin, WJ; Covinsky, KE				Smith, Alexander K.; Cenzer, Irena Stijacic; Knight, Sara J.; Puntillo, Kathleen A.; Widera, Eric; Williams, Brie A.; Boscardin, W. John; Covinsky, Kenneth E.			The Epidemiology of Pain During the Last 2 Years of Life	ANNALS OF INTERNAL MEDICINE			English	Article							FAMILY-MEMBERS; OF-LIFE; CANCER; OLDER; AGE; PREVALENCE; MANAGEMENT; CARE; END; INTERFERENCE	Background: The epidemiology of pain during the last years of life has not been well described. Objective: To describe the prevalence and correlates of pain during the last 2 years of life. Design: Observational study. Data from participants who died while enrolled in the Health and Retirement Study were analyzed. The survey interview closest to death was used. Each participant or proxy was interviewed once in the last 24 months of life and was classified into 1 of 24 cohorts on the basis of the number of months between the interview and death. The relationship between time before death and pain was modeled and was adjusted for age, sex, race or ethnicity, education level, net worth, income, terminal diagnosis category, presence of arthritis, and proxy status. Setting: The Health and Retirement Study, a nationally representative survey of community-living older adults (1994 to 2006). Participants: Older adult decedents. Measurements: Clinically significant pain, as indicated by a report that the participant was "often troubled" by pain of at least moderate severity. Results: The sample included 4703 decedents. Mean age (SD) of participants was 75.7 years (SD, 10.8); 83.1% were white, 10.7% were black, 4.7% were Hispanic; and 52.3% were men. The adjusted prevalence of pain 24 months before death was 26% (95% CI, 23% to 30%). The prevalence remained flat until 4 months before death (28% [CI, 25% to 32%]), then it increased, reaching 46% (CI, 38% to 55%) in the last month of life. The prevalence of pain in the last month of life was 60% among patients with arthritis versus 26% among patients without arthritis (P < 0.001) and did not differ by terminal diagnosis category (cancer [45%], heart disease [48%], frailty [50%], sudden death [42%], or other causes [47%]; P = 0.195). Limitation: Data are cross-sectional; 19% of responses were from proxies; and information about cause, location, and treatment of pain was not available. Conclusion: Although the prevalence of pain increases in the last 4 months of life, pain is present in more than one quarter of elderly persons during the last 2 years of life. Arthritis is strongly associated with pain at the end of life.	[Smith, Alexander K.] Univ Calif San Francisco, Div Geriatr, Dept Med, San Francisco, CA 94121 USA; [Smith, Alexander K.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Smith, AK (corresponding author), Univ Calif San Francisco, Div Geriatr, Dept Med, 4150 Clement St 181G, San Francisco, CA 94121 USA.	aksmith@ucsf.edu	Knight, Sara/AAJ-3818-2020		National Institute on Aging [R01AG028481, K24AG029812]; National Center for Research Resources UCSF-CTSI [UL1 RR024131]; National Palliative Care Research Center; National Institute on Musculoskeletal and Skin Diseases [P60 AR053308]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR053308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG033102, K24AG029812, R01AG028481] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources UCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Palliative Care Research Center; National Institute on Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr. Smith is supported by a Research Supplement to Promote Diversity in Health Related Research from the National Institute on Aging (R01AG028481), the National Center for Research Resources UCSF-CTSI (UL1 RR024131), and the National Palliative Care Research Center. Dr. Covinsky is supported by a K-24 grant from the National Institute on Aging (K24AG029812) and a grant from the National Institute on Musculoskeletal and Skin Diseases (P60 AR053308).	ADDINGTONHALL J, 1995, PALLIATIVE MED, V9, P295, DOI 10.1177/026921639500900404; *AM GER SOC, AGS CLIN PRACT GUID; [Anonymous], 2009, J AM GERIATR SOC, V57, P1331, DOI 10.1111/j.1532-5415.2009.02376.x; Archer KJ, 2006, STATA J, V6, P97, DOI 10.1177/1536867X0600600106; BELLVILL.JW, 1971, J AMER MED ASSOC, V217, P1835, DOI 10.1001/jama.217.13.1835; Bernabei R, 1998, JAMA-J AM MED ASSOC, V279, P1877, DOI 10.1001/jama.279.23.1877; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Christakis NA., 2001, DEATH FORETOLD PROPH; CLEELAND CS, 1994, NEW ENGL J MED, V330, P592, DOI 10.1056/NEJM199403033300902; Conill C, 1997, J PAIN SYMPTOM MANAG, V14, P328, DOI 10.1016/S0885-3924(97)00263-7; David W, 2000, APPL LOGISTIC REGRES, P26, DOI 10.1002/0471722146; Desbiens NA, 1996, CRIT CARE MED, V24, P1953, DOI 10.1097/00003246-199612000-00005; Desbiens NA, 1997, J AM GERIATR SOC, V45, P1167, DOI 10.1111/j.1532-5415.1997.tb03765.x; DOBRATZ MC, 1991, CANCER NURS, V14, P20; Dominick Kelli L, 2004, Health Qual Life Outcomes, V2, P5; Du Pen SL, 1999, J CLIN ONCOL, V17, P361, DOI 10.1200/JCO.1999.17.1.361; Dunlop DD, 2001, ARTHRITIS RHEUM-US, V44, P212, DOI 10.1002/1529-0131(200101)44:1<212::AID-ANR28>3.0.CO;2-Q; Edwards RR, 2001, PSYCHOSOM MED, V63, P316, DOI 10.1097/00006842-200103000-00018; Glare P, 2003, BRIT MED J, V327, P195, DOI 10.1136/bmj.327.7408.195; HARKINS SW, 1976, PAIN, V2, P253, DOI 10.1016/0304-3959(76)90004-X; HARKINS SW, 1986, J GERONTOL, V41, P58, DOI 10.1093/geronj/41.1.58; Helme RD, 2001, CLIN GERIATR MED, V17, P417, DOI 10.1016/S0749-0690(05)70078-1; HIGGINSON I, 1994, SOC SCI MED, V38, P553, DOI 10.1016/0277-9536(94)90251-8; *HLTH RET STUD, SURV DES; Hogan C, 2001, HEALTH AFFAIR, V20, P188, DOI 10.1377/hlthaff.20.4.188; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Kutner JS, 2008, ANN INTERN MED, V149, P369, DOI 10.7326/0003-4819-149-6-200809160-00003; Lloyd-Williams M, 2004, PALLIATIVE MED, V18, P558, DOI 10.1191/0269216304pm923oa; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; Lunney JR, 2002, J AM GERIATR SOC, V50, P1108, DOI 10.1046/j.1532-5415.2002.50268.x; Lynn J, 1997, ANN INTERN MED, V126, P97, DOI 10.7326/0003-4819-126-2-199701150-00001; McPherson CJ, 2003, SOC SCI MED, V56, P95, DOI 10.1016/S0277-9536(02)00011-4; Mercadante S, 2000, J PAIN SYMPTOM MANAG, V20, P104, DOI 10.1016/S0885-3924(00)00160-3; Morrison RS, 2000, NEW ENGL J MED, V342, P1023, DOI 10.1056/NEJM200004063421406; National Comprehensive Cancer Network, NCCN CLIN PRACT GUID, pPA2019; Owens M R, 2001, Am J Hosp Palliat Care, V18, P124, DOI 10.1177/104990910101800211; PAPPAGALLO M, 2004, NEUROLOGIC BASIS PAI; Peat G, 2004, PAIN, V112, P397, DOI 10.1016/j.pain.2004.09.029; Reynolds KS, 2008, J PAIN SYMPTOM MANAG, V35, P388, DOI 10.1016/j.jpainsymman.2008.01.001; Scheetz J, 1988, Dimens Oncol Nurs, V2, P9; SCHLUDERMANN E, 1962, PERCEPT MOTOR SKILL, V14, P295; Silveira Maria J, 2005, J Palliat Med, V8, P827, DOI 10.1089/jpm.2005.8.827; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Stewart AL, 1999, J PAIN SYMPTOM MANAG, V17, P93, DOI 10.1016/S0885-3924(98)00131-6; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Thomas E, 2004, PAIN, V110, P361, DOI 10.1016/j.pain.2004.04.017; TURK DC, 1995, PAIN, V61, P93, DOI 10.1016/0304-3959(94)00167-D; Ventafridda V, 1990, J Palliat Care, V6, P7; Weiss SC, 2001, LANCET, V357, P1311, DOI 10.1016/S0140-6736(00)04515-3; WOODROW KM, 1972, PSYCHOSOM MED, V34, P548, DOI 10.1097/00006842-197211000-00007	50	100	101	1	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 2	2010	153	9					563	569		10.7326/0003-4819-153-9-201011020-00005	http://dx.doi.org/10.7326/0003-4819-153-9-201011020-00005			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	673MH	21041575	Green Accepted			2022-12-01	WOS:000283667000002
J	Annas, GJ				Annas, George J.			Resurrection of a Stem-Cell Funding Barrier - Dickey-Wicker in Court	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							POLITICS		Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				Annas GJ, 1996, NEW ENGL J MED, V334, P1329, DOI 10.1056/NEJM199605163342012; Annas GJ, 2004, NATURE, V431, P19, DOI 10.1038/431019a; FLANNERY EJ, 2000, COMMISSIONED PAPERS, V2, pD1; *NAT BIOETH ADV CO, 1999, ETH ISS HUM STEM CEL, V1	4	10	10	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 28	2010	363	18					1687	1689		10.1056/NEJMp1010466	http://dx.doi.org/10.1056/NEJMp1010466			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671XF	20979467				2022-12-01	WOS:000283546400002
J	Paige, DA; Siegler, MA; Zhang, JA; Hayne, PO; Foote, EJ; Bennett, KA; Vasavada, AR; Greenhagen, BT; Schofield, JT; McCleese, DJ; Foote, MC; DeJong, E; Bills, BG; Hartford, W; Murray, BC; Allen, CC; Snook, K; Soderblom, LA; Calcutt, S; Taylor, FW; Bowles, NE; Bandfield, JL; Elphic, R; Ghent, R; Glotch, TD; Wyatt, MB; Lucey, PG				Paige, David A.; Siegler, Matthew A.; Zhang, Jo Ann; Hayne, Paul O.; Foote, Emily J.; Bennett, Kristen A.; Vasavada, Ashwin R.; Greenhagen, Benjamin T.; Schofield, John T.; McCleese, Daniel J.; Foote, Marc C.; DeJong, Eric; Bills, Bruce G.; Hartford, Wayne; Murray, Bruce C.; Allen, Carlton C.; Snook, Kelly; Soderblom, Laurence A.; Calcutt, Simon; Taylor, Fredric W.; Bowles, Neil E.; Bandfield, Joshua L.; Elphic, Richard; Ghent, Rebecca; Glotch, Timothy D.; Wyatt, Michael B.; Lucey, Paul G.			Diviner Lunar Radiometer Observations of Cold Traps in the Moon's South Polar Region	SCIENCE			English	Article							WATER ICE; MERCURY; STABILITY; SURFACE; POLES	Diviner Lunar Radiometer Experiment surface-temperature maps reveal the existence of widespread surface and near-surface cryogenic regions that extend beyond the boundaries of persistent shadow. The Lunar Crater Observation and Sensing Satellite (LCROSS) struck one of the coldest of these regions, where subsurface temperatures are estimated to be 38 kelvin. Large areas of the lunar polar regions are currently cold enough to cold-trap water ice as well as a range of both more volatile and less volatile species. The diverse mixture of water and high-volatility compounds detected in the LCROSS ejecta plume is strong evidence for the impact delivery and cold-trapping of volatiles derived from primitive outer solar system bodies.	[Paige, David A.; Siegler, Matthew A.; Zhang, Jo Ann; Hayne, Paul O.; Foote, Emily J.; Bennett, Kristen A.] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; [Vasavada, Ashwin R.; Greenhagen, Benjamin T.; Schofield, John T.; McCleese, Daniel J.; Foote, Marc C.; DeJong, Eric; Bills, Bruce G.; Hartford, Wayne] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Murray, Bruce C.] CALTECH, Pasadena, CA 90025 USA; [Allen, Carlton C.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Snook, Kelly] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Soderblom, Laurence A.] US Geol Survey, Flagstaff, AZ 86001 USA; [Calcutt, Simon; Taylor, Fredric W.; Bowles, Neil E.] Univ Oxford, Oxford OX1 3PU, England; [Bandfield, Joshua L.] Univ Washington, Seattle, WA 98195 USA; [Elphic, Richard] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Ghent, Rebecca] Univ Toronto, Toronto, ON M5S 3B1, Canada; [Glotch, Timothy D.] SUNY Stony Brook, Stony Brook, NY 11794 USA; [Wyatt, Michael B.] Brown Univ, Providence, RI 02912 USA; [Lucey, Paul G.] Univ Hawaii, Honolulu, HI 96822 USA	University of California System; University of California Los Angeles; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; United States Department of the Interior; United States Geological Survey; University of Oxford; University of Washington; University of Washington Seattle; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Toronto; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Brown University; University of Hawaii System	Paige, DA (corresponding author), Univ Calif Los Angeles, Dept Earth & Space Sci, 595 Charles E Young Dr E, Los Angeles, CA 90095 USA.	dap@moon.ucla.edu	Greenhagen, Benjamin T/C-3760-2016	Greenhagen, Benjamin T/0000-0002-8252-9922; Hayne, Paul/0000-0003-4399-0449; Taylor, Fred/0000-0002-0675-9769; Bandfield, Joshua/0000-0003-3571-3716; Calcutt, Simon/0000-0002-0102-3170	National Aeronautics and Space Administration; Science and Technology Facilities Council [ST/H00243X/1] Funding Source: researchfish	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank the many people at the Jet Propulsion Laboratory and the Goddard Space Flight Center who contributed to the success of the Diviner instrument and the LRO project. We also thank the National Aeronautics and Space Administration for funding this investigation.	Araki H, 2009, SCIENCE, V323, P897, DOI 10.1126/science.1164146; Bills BG, 1999, GEOPHYS RES LETT, V26, P3045, DOI 10.1029/1999GL008348; Chin G, 2007, SPACE SCI REV, V129, P391, DOI 10.1007/s11214-007-9153-y; Colaprete A, 2010, SCIENCE, V330, P463, DOI 10.1126/science.1186986; Crider DH, 2003, ADV SPACE RES, V31, P2293, DOI 10.1016/S0273-1177(03)00530-1; Elphic RC, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029954; Feldman WC, 2001, J GEOPHYS RES-PLANET, V106, P23231, DOI 10.1029/2000JE001444; Gladstone GR, 2010, SCIENCE, V330, P472, DOI 10.1126/science.1186474; Hansen CJ, 1996, ICARUS, V120, P247, DOI 10.1006/icar.1996.0049; Harmon JK, 2007, SPACE SCI REV, V132, P307, DOI 10.1007/s11214-007-9234-y; Hayne PO, 2010, SCIENCE, V330, P477, DOI 10.1126/science.1197135; HODGES RR, 1980, LUN PLAN SCI C, V11, P2463; INGERSOLL AP, 1992, ICARUS, V100, P40, DOI 10.1016/0019-1035(92)90016-Z; LANGSETH MG, 1976, P LUNAR PLANET SCI C, V7, P3143; Lawrence DJ, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002637; MITROFANOV I, 2010, LUN PLAN SCI C, V41, P2250; MORGAN TH, 1991, J GEOPHYS RES-SPACE, V96, P1351, DOI 10.1029/90JA02127; Paige DA, 2010, SPACE SCI REV, V150, P125, DOI 10.1007/s11214-009-9529-2; PAIGE DA, 1992, SCIENCE, V258, P643, DOI 10.1126/science.258.5082.643; Schorghofer N, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002779; Schultz PH, 2010, SCIENCE, V330, P468, DOI 10.1126/science.1187454; TAYLOR GJ, 2004, P SPAC RES ROUNDT 6; Vasavada AR, 1999, ICARUS, V141, P179, DOI 10.1006/icar.1999.6175; WARD WR, 1975, SCIENCE, V189, P377, DOI 10.1126/science.189.4200.377; WATSON K, 1961, J GEOPHYS RES, V66, P3033, DOI 10.1029/JZ066i009p03033; Zhang JA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041806; Zhang JA, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038614	27	267	271	0	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 22	2010	330	6003					479	482		10.1126/science.1187726	http://dx.doi.org/10.1126/science.1187726			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966246				2022-12-01	WOS:000283329100032
J	Summers, DM; Johnson, RJ; Allen, J; Fuggle, SV; Collett, D; Watson, CJ; Bradley, JA				Summers, Dominic M.; Johnson, Rachel J.; Allen, Joanne; Fuggle, Susan V.; Collett, David; Watson, Christopher J.; Bradley, J. Andrew			Analysis of factors that affect outcome after transplantation of kidneys donated after cardiac death in the UK: a cohort study	LANCET			English	Article							DELAYED GRAFT FUNCTION; BEATING DONOR KIDNEYS; RENAL-TRANSPLANTATION; UNITED-KINGDOM; BRAIN-DEATH; HEART; REJECTION; SURVIVAL; ALLOCATION; EXPERIENCE	Background A third of all kidneys from deceased donors in the UK are donated after cardiac death, but concerns have been raised about the long-term outcome of such transplants. We aimed to establish these outcomes for kidneys donated after controlled cardiac death versus brain death, and to identify the factors that affect graft survival and function. Methods We used data from the UK transplant registry to select a cohort of deceased kidney donors and the corresponding transplant recipients (aged years) for transplantations done between Jan 1, 2000, and Dec 31, 2007. Kaplan-Meier estimates were used to assess graft survival, and multivariate analyses were used to identify factors associated with graft survival and with long-term renal function, which was measured from estimated glomerular filtration rate (eGFR). Findings 9134 kidney transplants were done in 23 centres; 8289 kidneys were donated after brain death and 845 after controlled cardiac death. First-time recipients of kidneys from cardiac-death donors (n=739) or brain-death donors (n=6759) showed no difference in graft survival up to 5 years (hazard ratio 1.01, 95% CI 0.83 to 1.19, p=0.97), or in eGFR at 1-5 years after transplantation (at 12 months -0.36 mL/min per 1.73 m(2), 95% CI -2.00 to 1.27, p=0.66). For recipients of kidneys from cardiac-death donors, increasing age of donor and recipient, repeat transplantation, and cold ischaemic time of more than 12 h were associated with worse graft survival; grafts from cardiac-death donors that were poorly matched for HLA had an association with inferior outcome that was not significant, and delayed graft function and warm ischaemic time had no effect on outcome. Interpretation Kidneys from controlled cardiac-death donors provide good graft survival and function up to 5 years in first-time recipients, and are equivalent to kidneys from brain-death donors. Allocation policy for kidneys from cardiac-death donors should reduce cold ischaemic time, avoid large age mismatches between donors and recipients, and restrict use of kidneys poorly matched for HLA in young recipients.	[Summers, Dominic M.; Watson, Christopher J.; Bradley, J. Andrew] Univ Cambridge, Sch Clin Med, Dept Surg, Cambridge, England; [Summers, Dominic M.; Watson, Christopher J.; Bradley, J. Andrew] Biomed Res Ctr, Cambridge Natl Inst Hlth Res, Cambridge, England; [Summers, Dominic M.; Johnson, Rachel J.; Allen, Joanne; Fuggle, Susan V.; Collett, David] Natl Hlth Serv Blood & Transplant, Bristol, Avon, England; [Fuggle, Susan V.] Univ Oxford, Nuffield Dept Surg, Oxford, England	University of Cambridge; University of Cambridge; NHS Blood & Transplant (NHSBT); University of Oxford	Bradley, JA (corresponding author), Addenbrookes Hosp, Univ Dept Surg, Box 202, Cambridge CB2 0QQ, England.	jab52@cam.ac.uk	Summers, D. M./H-8678-2019	Summers, D. M./0000-0003-3360-0726; Collett, David/0000-0003-4861-7627; Johnson, Rachel/0000-0001-9199-3455	Astellas; Novartis; Roche; Wyeth; Organ Recovery Systems; NHS Blood and Transplant; Cambridge NIHR Biomedical Research Centre	Astellas(Astellas Pharmaceuticals); Novartis(Novartis); Roche(Roche Holding); Wyeth(Wyeth); Organ Recovery Systems; NHS Blood and Transplant; Cambridge NIHR Biomedical Research Centre(National Institute for Health Research (NIHR))	JAB is a trustee of Roche Organ Transplant Foundation; his department has received grants from pharmaceutical companies which market immunosuppressive therapy, notably Astellas, Novartis, Roche, and Wyeth, and from machine preservation manufacturers Organ Recovery Systems; and he has received travel and accommodation costs from Astellas to attend a training course. CJW has received research grants and honoraria for travel, accommodation, and registration to transplant conferences from Astellas, Novartis, Roche, and Wyeth; and research grants from Organ Recovery Systems. All other authors declare that they have no conflicts of interest.; This study was supported by NHS Blood and Transplant, and Cambridge NIHR Biomedical Research Centre. DMS was supported by a grant from NHS Blood and Transplant.	Barlow AD, 2009, BRIT J SURG, V96, P685, DOI 10.1002/bjs.6607; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; *BRIT TRANSPL SOC, 2004, GUID REL SOL ORG TRA; Brook NR, 2003, AM J TRANSPLANT, V3, P614, DOI 10.1034/j.1600-6143.2003.00113.x; Cecka J Michael, 2008, Clin Transpl, P1; Chapman J, 2006, TRANSPL INT, V19, P715, DOI 10.1111/j.1432-2277.2006.00337.x; Cooper JT, 2004, AM J TRANSPLANT, V4, P1490, DOI 10.1111/j.1600-6143.2004.00531.x; De Fijter JW, 2001, J AM SOC NEPHROL, V12, P1538, DOI 10.1681/ASN.V1271538; Devey LR, 2007, TRANSPLANTATION, V84, P70, DOI 10.1097/01.tp.0000268072.04260.69; Doshi MD, 2007, AM J TRANSPLANT, V7, P122, DOI 10.1111/j.1600-6143.2006.01587.x; Johnson Rachel, 2008, Clin Transpl, P75; Johnson RJ, 2010, TRANSPLANTATION, V89, P387, DOI 10.1097/TP.0b013e3181c9029d; Johnson RJ, 2010, TRANSPLANTATION, V89, P379, DOI 10.1097/TP.0b013e3181c90287; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kokkinos C, 2007, TRANSPLANTATION, V83, P1193, DOI 10.1097/01.tp.0000261710.53848.51; KOOTSTRA G, 1995, TRANSPLANT P, V27, P2893; Lachmann N, 2009, TRANSPLANTATION, V87, P1505, DOI 10.1097/TP.0b013e3181a44206; LEVEY AS, 2000, J AM SOC NEPHROL, V11, P828; Locke JE, 2007, AM J TRANSPLANT, V7, P1797, DOI 10.1111/j.1600-6143.2007.01852.x; Moreso F, 1999, NEPHROL DIAL TRANSPL, V14, P930, DOI 10.1093/ndt/14.4.930; Morris PJ, 1999, LANCET, V354, P1147, DOI 10.1016/S0140-6736(99)01104-6; *NAT HLTH SERV BLO, TRANSPL ACT UK 2008; Novitzky D, 1997, TRANSPLANT P, V29, P3770, DOI 10.1016/S0041-1345(97)01149-4; OPELZ G, 1992, TRANSPLANT INT, V5, pS601; Pessione F, 2003, TRANSPLANTATION, V75, P361, DOI 10.1097/01.TP.0000044171.97375.61; Pratschke J, 1999, TRANSPLANTATION, V67, P343, DOI 10.1097/00007890-199902150-00001; Pratschke J, 2000, ANN SURG, V232, P263, DOI 10.1097/00000658-200008000-00017; Rao PS, 2009, TRANSPLANTATION, V88, P231, DOI 10.1097/TP.0b013e3181ac620b; Rudich SM, 2002, TRANSPLANTATION, V74, P1715, DOI 10.1097/01.TP.0000039165.58547.87; Shoskes DA, 1998, TRANSPLANTATION, V66, P1697, DOI 10.1097/00007890-199812270-00022; Taylor CJ, 2010, TRANSPLANTATION, V89, P185, DOI 10.1097/TP.0b013e3181c926f2; Wells AC, 2009, BRIT J SURG, V96, P299, DOI 10.1002/bjs.6485; Wolfe RA, 2009, AM J TRANSPLANT, V9, P869, DOI 10.1111/j.1600-6143.2009.02564.x	33	236	245	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 16	2010	376	9749					1303	1311		10.1016/S0140-6736(10)60827-6	http://dx.doi.org/10.1016/S0140-6736(10)60827-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671RX	20727576				2022-12-01	WOS:000283528600032
J	Goodwin, SS; Vale, RD				Goodwin, Sarah S.; Vale, Ronald D.			Patronin Regulates the Microtubule Network by Protecting Microtubule Minus Ends	CELL			English	Article							GAMMA-TUBULIN; DYNAMICS; CENTROSOME; LENGTH; NUCLEATION; DEPOLYMERIZATION; COOPERATE; KINESINS; COMPLEX; FAMILY	Tubulin assembles into microtubule polymers that have distinct plus and minus ends. Most microtubule plus ends in living cells are dynamic; the transitions between growth and shrinkage are regulated by assembly-promoting and destabilizing proteins. In contrast, minus ends are generally not dynamic, suggesting their stabilization by some unknown protein. Here, we have identified Patronin (also known as ssp4) as a protein that stabilizes microtubule minus ends in Drosophila S2 cells. In the absence of Patronin, minus ends lose subunits through the actions of the Kinesin-13 microtubule depolymerase, leading to a sparse interphase microtubule array and short, disorganized mitotic spindles. In vitro, the selective binding of purified Patronin to microtubule minus ends is sufficient to protect them against Kinesin-13-induced depolymerization. We propose that Patronin caps and stabilizes microtubule minus ends, an activity that serves a critical role in the organization of the microtubule cytoskeleton.	[Goodwin, Sarah S.; Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Goodwin, Sarah S.; Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	vale@cmp.ucsf.edu		Goodwin, Sarah/0000-0003-4686-0914	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038499] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R37 GM038499, R37 GM038499-22] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Baines AJ, 2009, MOL BIOL EVOL, V26, P2005, DOI 10.1093/molbev/msp115; Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Bouissou A, 2009, J CELL BIOL, V187, P327, DOI 10.1083/jcb.200905060; Cooper JR, 2010, NAT STRUCT MOL BIOL, V17, P77, DOI 10.1038/nsmb.1728; Dammermann A, 2003, CURR BIOL, V13, pR614, DOI 10.1016/S0960-9822(03)00530-X; Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Dumont S, 2009, CURR BIOL, V19, pR749, DOI 10.1016/j.cub.2009.07.028; Ehrhardt DW, 2008, CURR OPIN CELL BIOL, V20, P107, DOI 10.1016/j.ceb.2007.12.004; Fan J, 1996, J MOL BIOL, V259, P325, DOI 10.1006/jmbi.1996.0322; Goshima G, 2005, CURR BIOL, V15, P1979, DOI 10.1016/j.cub.2005.09.054; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; Keating TJ, 1997, P NATL ACAD SCI USA, V94, P5078, DOI 10.1073/pnas.94.10.5078; Kinoshita K, 2001, SCIENCE, V294, P1340, DOI 10.1126/science.1064629; Kwok BH, 2007, CURR OPIN CELL BIOL, V19, P36, DOI 10.1016/j.ceb.2006.12.003; Laycock JE, 2006, J CELL SCI, V119, P2354, DOI 10.1242/jcs.02957; Li KJ, 1996, CELL, V85, P585, DOI 10.1016/S0092-8674(00)81258-1; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Mennella V, 2005, NAT CELL BIOL, V7, P235, DOI 10.1038/ncb1222; Mitchison TJ, 2005, MOL BIOL CELL, V16, P3064, DOI 10.1091/mbc.E05-02-0174; MITCHISON TJ, 1993, SCIENCE, V261, P1044, DOI 10.1126/science.8102497; Moores CA, 2002, MOL CELL, V9, P903, DOI 10.1016/S1097-2765(02)00503-8; Moores CA, 2006, J CELL SCI, V119, P3905, DOI 10.1242/jcs.03224; MORITZ M, 1995, NATURE, V378, P638, DOI 10.1038/378638a0; Rath U, 2009, MOL BIOL CELL, V20, P4696, DOI 10.1091/mbc.E09-07-0557; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Rodionov V, 1999, P NATL ACAD SCI USA, V96, P115, DOI 10.1073/pnas.96.1.115; Rodionov VI, 1997, SCIENCE, V275, P215, DOI 10.1126/science.275.5297.215; Rogers GC, 2004, NATURE, V427, P364, DOI 10.1038/nature02256; Rogers GC, 2008, MOL BIOL CELL, V19, P3163, DOI 10.1091/mbc.E07-10-1069; Rusan NM, 2009, TRAFFIC, V10, P472, DOI 10.1111/j.1600-0854.2009.00880.x; Shaw SL, 2003, SCIENCE, V300, P1715, DOI 10.1126/science.1083529; Verollet C, 2006, J CELL BIOL, V172, P517, DOI 10.1083/jcb.200511071; Vorobjev IA, 1997, J CELL SCI, V110, P2635; Vorobjev IA, 1999, J CELL SCI, V112, P2277; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417; Wiese C, 2000, NAT CELL BIOL, V2, P358, DOI 10.1038/35014051; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Yvon AMC, 1997, J CELL SCI, V110, P2391; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0	47	163	167	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					263	274		10.1016/j.cell.2010.09.022	http://dx.doi.org/10.1016/j.cell.2010.09.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20946984	Bronze, Green Accepted, Green Submitted			2022-12-01	WOS:000283052200015
J	Shokrollahi, K; Whitaker, IS; Manning, SR; Mannasiev, D; Hiew, LY; Cooper, MACS				Shokrollahi, K.; Whitaker, I. S.; Manning, S. R.; Mannasiev, D.; Hiew, L. Y.; Cooper, M. A. C. S.			10-Minute Consultation Macromastia (large breasts): request for breast reduction	BRITISH MEDICAL JOURNAL			English	Editorial Material							MAMMAPLASTY; SURGERY		[Manning, S. R.] Sandwell Dist Gen Hosp, Lyndon B71 4NU, West Bromwich, England; [Shokrollahi, K.; Whitaker, I. S.; Hiew, L. Y.; Cooper, M. A. C. S.] Morriston Hosp, Welsh Ctr Burns & Plast Surg, Swansea SA6 6NL, W Glam, Wales; [Mannasiev, D.] Yardley Wood, Goodrest Croft Surg, Birmingham B14 4DU, England	Morriston Hospital	Manning, SR (corresponding author), Sandwell Dist Gen Hosp, Lyndon B71 4NU, West Bromwich, England.	stephen.manning@doctors.org.uk	Shokrollahi, Kayvan/V-4993-2019; Whitaker, Iain/O-5896-2019	Shokrollahi, Kayvan/0000-0003-1044-7781; Whitaker, Iain/0000-0002-3922-2079				Dafydd H, 2009, ANN PLAS SURG, V62, P244, DOI 10.1097/SAP.0b013e31817fe502; Greenbaum AR, 2003, BRIT J PLAST SURG, V56, P230, DOI 10.1016/S0007-1226(03)00122-X; Klassen A, 2000, ANN PLAS SURG, V45, P676; Klassen A, 1996, BMJ-BRIT MED J, V313, P454; Klassen A, 1996, BRIT J PLAST SURG, V49, P433, DOI 10.1016/S0007-1226(96)90025-9	5	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 13	2010	341								c5408	10.1136/bmj.c5408	http://dx.doi.org/10.1136/bmj.c5408			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	668FB	20943725	Green Accepted			2022-12-01	WOS:000283252900014
J	Fujii, T; Iwane, AH; Yanagida, T; Namba, K				Fujii, Takashi; Iwane, Atsuko H.; Yanagida, Toshio; Namba, Keiichi			Direct visualization of secondary structures of F-actin by electron cryomicroscopy	NATURE			English	Article							TOBACCO-MOSAIC-VIRUS; CRYO-EM STRUCTURE; ATOMIC MODEL; MICROSCOPY; RESOLUTION; FILAMENT; COMPLEX; RECONSTRUCTION; ARRANGEMENT; CHAPERONIN	F-actin is a helical assembly of actin, which is a component of muscle fibres essential for contraction and has a crucial role in numerous cellular processes, such as the formation of lamellipodia and filopodia(1,2), as the most abundant component and regulator of cytoskeletons by dynamic assembly and disassembly (from G-actin to F-actin and vice versa). Actin is a ubiquitous protein and is involved in important biological functions, but the definitive high-resolution structure of F-actin remains unknown. Although a recent atomic model well reproduced X-ray fibre diffraction intensity data from a highly oriented liquid-crystalline sol specimen(3), its refinement without experimental phase information has certain limitations. Direct visualization of the structure by electron cryomicroscopy, however, has been difficult because it is relatively thin and flexible. Here we report the F-actin structure at 6.6 angstrom resolution, made obtainable by recent advances in electron cryomicroscopy. The density map clearly resolves all the secondary structures of G-actin, such as alpha-helices, beta-structures and loops, and makes unambiguous modelling and refinement possible. Complex domain motions that open the nucleotide-binding pocket on F-actin formation, specific D-loop and terminal conformations, and relatively tight axial but markedly loose interprotofilament interactions hydrophilic in nature are revealed in the F-actin model, and all seem to be important for dynamic functions of actin.	[Fujii, Takashi; Iwane, Atsuko H.; Yanagida, Toshio; Namba, Keiichi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Osaka University	Namba, K (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	keiichi@fbs.osaka-u.ac.jp	Namba, Keiichi/A-9406-2016	Iwane, Atsuko/0000-0003-2641-2268	Ministry of Education, Culture, Sports, Science and Technology of Japan [16087207, 21227006]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank T. Kato for setting up and managing our cryoEM and computing facilities for high-throughput, high-resolution image analysis, and I. Tokita, M. Urabe and JEOL for maintaining the electron cryomicroscope in the best conditions. We also thank E. Egelman for his help in the use of the iterative helical real-space refinement method in the early stages of this study, and F. Oosawa, S. Asakura, H. Hotani and D. L. D. Caspar for their discussions, continuous support and encouragement. T. F. was a research fellow of the Japan Society for the Promotion of Science. This work was supported in part by Grants-in-Aid for Scientific Research to K. N. (16087207 and 21227006) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	BELA N, 1965, J AM CHEM SOC, V87, P2480; Carlier MF, 2007, J BIOL CHEM, V282, P23005, DOI 10.1074/jbc.R700020200; Cong Y, 2010, P NATL ACAD SCI USA, V107, P4967, DOI 10.1073/pnas.0913774107; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fujii T, 2009, STRUCTURE, V17, P1485, DOI 10.1016/j.str.2009.08.017; Fujiwara I, 2007, P NATL ACAD SCI USA, V104, P8827, DOI 10.1073/pnas.0702510104; Galkin VE, 2008, P NATL ACAD SCI USA, V105, P1494, DOI 10.1073/pnas.0708667105; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.3.CO;2-I; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Iwasa M, 2008, J BIOL CHEM, V283, P21045, DOI 10.1074/jbc.M800570200; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; NAMBA K, 1986, SCIENCE, V231, P1401, DOI 10.1126/science.3952490; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Sachse C, 2007, J MOL BIOL, V371, P812, DOI 10.1016/j.jmb.2007.05.088; Sander B, 2005, J STRUCT BIOL, V151, P92, DOI [10.1016/j.jsb.2005.04.004, 10.1016/j.jsb,2005.04.004]; Schmid MF, 2004, NATURE, V431, P104, DOI 10.1038/nature02881; SUTOH K, 1982, BIOCHEMISTRY-US, V21, P3654, DOI 10.1021/bi00258a020; Topf M, 2008, STRUCTURE, V16, P295, DOI 10.1016/j.str.2007.11.016; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830; Yonekura K, 2006, J STRUCT BIOL, V156, P524, DOI 10.1016/j.jsb.2006.07.016; Yu XK, 2008, NATURE, V453, P415, DOI 10.1038/nature06893; Zhang JJ, 2010, NATURE, V463, P379, DOI 10.1038/nature08701; Zhang X, 2008, P NATL ACAD SCI USA, V105, P1867, DOI 10.1073/pnas.0711623105; Zhang X, 2010, CELL, V141, P472, DOI 10.1016/j.cell.2010.03.041	35	268	272	0	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 7	2010	467	7316					724	U117		10.1038/nature09372	http://dx.doi.org/10.1038/nature09372			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659NE	20844487				2022-12-01	WOS:000282572500042
J	Arensburger, P; Megy, K; Waterhouse, RM; Abrudan, J; Amedeo, P; Antelo, B; Bartholomay, L; Bidwell, S; Caler, E; Camara, F; Campbell, CL; Campbell, KS; Casola, C; Castro, MT; Chandramouliswaran, I; Chapman, SB; Christley, S; Costas, J; Eisenstadt, E; Feschotte, C; Fraser-Liggett, C; Guigo, R; Haas, B; Hammond, M; Hansson, BS; Hemingway, J; Hill, SR; Howarth, C; Ignell, R; Kennedy, RC; Kodira, CD; Lobo, NF; Mao, CH; Mayhew, G; Michel, K; Mori, A; Liu, NN; Naveira, H; Nene, V; Nguyen, N; Pearson, MD; Pritham, EJ; Puiu, D; Qi, YM; Ranson, H; Ribeiro, JMC; Roberston, HM; Severson, DW; Shumway, M; Stanke, M; Strausberg, RL; Sun, C; Sutton, G; Tu, ZJ; Tubio, JMC; Unger, MF; Vanlandingham, DL; Vilella, AJ; White, O; White, JR; Wondji, CS; Wortman, J; Zdobnov, EM; Birren, B; Christensen, BM; Collins, FH; Cornel, A; Dimopoulos, G; Hannick, LI; Higgs, S; Lanzaro, GC; Lawson, D; Lee, NH; Muskavitch, MAT; Raikhel, AS; Atkinson, PW				Arensburger, Peter; Megy, Karine; Waterhouse, Robert M.; Abrudan, Jenica; Amedeo, Paolo; Antelo, Beatriz; Bartholomay, Lyric; Bidwell, Shelby; Caler, Elisabet; Camara, Francisco; Campbell, Corey L.; Campbell, Kathryn S.; Casola, Claudio; Castro, Marta T.; Chandramouliswaran, Ishwar; Chapman, Sinead B.; Christley, Scott; Costas, Javier; Eisenstadt, Eric; Feschotte, Cedric; Fraser-Liggett, Claire; Guigo, Roderic; Haas, Brian; Hammond, Martin; Hansson, Bill S.; Hemingway, Janet; Hill, Sharon R.; Howarth, Clint; Ignell, Rickard; Kennedy, Ryan C.; Kodira, Chinnappa D.; Lobo, Neil F.; Mao, Chunhong; Mayhew, George; Michel, Kristin; Mori, Akio; Liu, Nannan; Naveira, Horacio; Nene, Vishvanath; Nguyen, Nam; Pearson, Matthew D.; Pritham, Ellen J.; Puiu, Daniela; Qi, Yumin; Ranson, Hilary; Ribeiro, Jose M. C.; Roberston, Hugh M.; Severson, David W.; Shumway, Martin; Stanke, Mario; Strausberg, Robert L.; Sun, Cheng; Sutton, Granger; Tu, Zhijian (Jake); Tubio, Jose Manuel C.; Unger, Maria F.; Vanlandingham, Dana L.; Vilella, Albert J.; White, Owen; White, Jared R.; Wondji, Charles S.; Wortman, Jennifer; Zdobnov, Evgeny M.; Birren, Bruce; Christensen, Bruce M.; Collins, Frank H.; Cornel, Anthony; Dimopoulos, George; Hannick, Linda I.; Higgs, Stephen; Lanzaro, Gregory C.; Lawson, Daniel; Lee, Norman H.; Muskavitch, Marc A. T.; Raikhel, Alexander S.; Atkinson, Peter W.			Sequencing of Culex quinquefasciatus Establishes a Platform for Mosquito Comparative Genomics	SCIENCE			English	Article							AEDES-AEGYPTI; PIPIENS; VECTOR	Culex quinquefasciatus (the southern house mosquito) is an important mosquito vector of viruses such as West Nile virus and St. Louis encephalitis virus, as well as of nematodes that cause lymphatic filariasis. C. quinquefasciatus is one species within the Culex pipiens species complex and can be found throughout tropical and temperate climates of the world. The ability of C. quinquefasciatus to take blood meals from birds, livestock, and humans contributes to its ability to vector pathogens between species. Here, we describe the genomic sequence of C. quinquefasciatus: Its repertoire of 18,883 protein-coding genes is 22% larger than that of Aedes aegypti and 52% larger than that of Anopheles gambiae with multiple gene-family expansions, including olfactory and gustatory receptors, salivary gland genes, and genes associated with xenobiotic detoxification.	[Arensburger, Peter; Raikhel, Alexander S.; Atkinson, Peter W.] Univ Calif Riverside, Ctr Dis Vector Res, Riverside, CA 92521 USA; [Megy, Karine; Hammond, Martin; Vilella, Albert J.; Lawson, Daniel] European Bioinformat Inst EMBL EBI, Cambridge CB10 1SD, England; [Waterhouse, Robert M.; Zdobnov, Evgeny M.] Univ Geneva, Sch Med, CH-1211 Geneva, Switzerland; [Waterhouse, Robert M.] Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; [Abrudan, Jenica; Christley, Scott; Kennedy, Ryan C.; Lobo, Neil F.; Mori, Akio; Severson, David W.; Unger, Maria F.; Collins, Frank H.] Univ Notre Dame, Notre Dame, IN 46556 USA; [Amedeo, Paolo; Caler, Elisabet; Chandramouliswaran, Ishwar; Eisenstadt, Eric; Hannick, Linda I.] J Craig Venter Inst, Rockville, MD 20850 USA; [Tubio, Jose Manuel C.] Univ Santiago, Complexo Hosp, Santiago De Compostela 15706, Spain; [Bartholomay, Lyric] Iowa State Univ, Ames, IA 50011 USA; [Bidwell, Shelby; Camara, Francisco; Guigo, Roderic] Univ Pompeu Fabra, Ctr Gene Regulat, E-08003 Barcelona, Catalonia, Spain; [Campbell, Corey L.] Colorado State Univ, Ft Collins, CO 80523 USA; [Campbell, Kathryn S.] Harvard Univ, Cambridge, MA 02138 USA; [Casola, Claudio] Indiana Univ, Bloomington, IN 47405 USA; [Castro, Marta T.] Hosp Llobregat, Programa Epigenet & Biol Canc, Hosp Duran & Reynals, Barcelona 08907, Spain; [Chapman, Sinead B.; Haas, Brian; Howarth, Clint; Pearson, Matthew D.; White, Jared R.; Birren, Bruce; Muskavitch, Marc A. T.] Broad Inst, Cambridge, MA 02142 USA; [Costas, Javier] Fdn Publ Galega Med Xenomica Servizo Galego Saude, Santiago De Compostela 15706, Spain; [Feschotte, Cedric; Nguyen, Nam; Pritham, Ellen J.; Sun, Cheng] Univ Texas Arlington, Arlington, TX 76019 USA; [Fraser-Liggett, Claire; White, Owen; Wortman, Jennifer] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Hansson, Bill S.] Max Planck Inst Chem Ecol, D-07749 Jena, Germany; [Hemingway, Janet; Ranson, Hilary; Wondji, Charles S.] Univ Liverpool Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Hill, Sharon R.; Ignell, Rickard] Swedish Univ Agr Sci, S-23053 Alnarp, Sweden; [Kodira, Chinnappa D.] Roche Grp, Branford, CT 06405 USA; [Mao, Chunhong; Qi, Yumin; Tu, Zhijian (Jake)] Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA; [Mayhew, George; Christensen, Bruce M.] Univ Wisconsin, Madison, WI 53706 USA; [Michel, Kristin] Kansas State Univ, Manhattan, KS 66506 USA; [Liu, Nannan] Auburn Univ, Auburn, AL 36849 USA; [Naveira, Horacio] Univ A Coruna, Dept Bioloxia Celular & Mol, Coruna 15071 A, Spain; [Nene, Vishvanath] Int Livestock Res Inst, Nairobi, Kenya; [Puiu, Daniela] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Ribeiro, Jose M. C.; Shumway, Martin] Natl Inst Hlth, Bethesda, MD 20892 USA; [Roberston, Hugh M.] Univ Illinois, Urbana, IL 61801 USA; [Stanke, Mario] Univ Gottingen, D-37077 Gottingen, Germany; [Cornel, Anthony] Univ Texas Galveston, Med Branch, Galveston, TX 77555 USA; [Vanlandingham, Dana L.; Zdobnov, Evgeny M.; Higgs, Stephen] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Zdobnov, Evgeny M.; Lanzaro, Gregory C.] Univ Calif Davis, Parlier, CA 93648 USA; [Dimopoulos, George] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Lee, Norman H.] George Washington Univ, Med Ctr, Washington, DC 20037 USA; [Muskavitch, Marc A. T.] Boston Coll, Chestnut Hill, MA 02467 USA; [Muskavitch, Marc A. T.] Harvard Sch Publ Hlth, Boston, MA 02115 USA	University of California System; University of California Riverside; European Molecular Biology Laboratory (EMBL); University of Geneva; Swiss Institute of Bioinformatics; University of Notre Dame; J. Craig Venter Institute; Universidade de Santiago de Compostela; Iowa State University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Colorado State University; Harvard University; Indiana University System; Indiana University Bloomington; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; University of Barcelona; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Texas System; University of Texas Arlington; University System of Maryland; University of Maryland Baltimore; Max Planck Society; Liverpool School of Tropical Medicine; Swedish University of Agricultural Sciences; Roche Holding; Virginia Polytechnic Institute & State University; University of Wisconsin System; University of Wisconsin Madison; Kansas State University; Auburn University System; Auburn University; Universidade da Coruna; CGIAR; International Livestock Research Institute (ILRI); University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; University of Illinois System; University of Illinois Urbana-Champaign; University of Gottingen; University of Texas System; University of Texas Medical Branch Galveston; Imperial College London; University of California System; University of California Davis; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; George Washington University; Boston College; Harvard University; Harvard T.H. Chan School of Public Health	Arensburger, P (corresponding author), Univ Calif Riverside, Ctr Dis Vector Res, Riverside, CA 92521 USA.	arensburger@gmail.com	Hill, Sharon R/A-5121-2008; Naveira, Horacio/H-7249-2014; Feschotte, Cedric/C-4048-2011; Waterhouse, Robert M/A-1858-2010; Costas, Javier/B-5016-2008; Hansson, Bill S/G-2774-2013; Ferreira, Francisco Câmara/G-9841-2015; Mayhew, George F/B-4042-2016; Wondji, Charles/AAG-1510-2020; Zdobnov, Evgeny/AAB-2745-2022; Zdobnov, Evgeny M/K-1133-2012; Guigo, Roderic/D-1303-2010; Tubio, Jose M.C./H-5076-2015; Michel, Kristin/F-3400-2011; Sun, Cheng/AAW-7354-2021; Naveira, Horacio/I-7802-2019; Stanke, Mario/P-7876-2019; Tubio, Jose/AAG-7345-2019	Hill, Sharon R/0000-0002-6474-0214; Naveira, Horacio/0000-0002-3840-1569; Waterhouse, Robert M/0000-0003-4199-9052; Costas, Javier/0000-0003-0306-3990; Hansson, Bill S/0000-0002-4811-1223; Ferreira, Francisco Câmara/0000-0002-1971-5466; Mayhew, George F/0000-0003-0609-6018; Zdobnov, Evgeny/0000-0002-5178-1498; Guigo, Roderic/0000-0002-5738-4477; Tubio, Jose M.C./0000-0003-3540-2459; Sun, Cheng/0000-0001-7476-9224; Naveira, Horacio/0000-0002-3840-1569; Stanke, Mario/0000-0001-8696-0384; Tubio, Jose/0000-0003-3540-2459; Casola, Claudio/0000-0003-4853-1866; Wondji, Charles S./0000-0003-0791-3673; Wortman, Jennifer/0000-0002-8713-1227; Hannick, Linda/0000-0002-8018-8466; Vilella, Albert/0000-0002-2005-2516; Ranson, Hilary/0000-0003-2332-8247; Megy, Karyn/0000-0002-2826-3879; Dimopoulos, George/0000-0001-6755-8111; Hemingway, Janet/0000-0002-3200-7173; Fraser, Claire/0000-0003-1462-2428; Nene, Vishvanath/0000-0001-7066-4169; Campbell, Corey L./0000-0002-6384-1259; Lawson, Daniel/0000-0001-7765-983X; Ribeiro, Jose/0000-0002-9107-0818	NIH [HHSN266200400039C]; National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services [N01-AI-30071, HHSN266200400001C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000810] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant HHSN266200400039C and by the National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services under contract numbers N01-AI-30071 and HHSN266200400001C. The assembled genome was deposited in the GenBank database with accession number AAWU00000000.	Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P437; Benedict M, 2008, VECTOR-BORNE ZOONOT, V8, P127, DOI 10.1089/vbz.2007.0273; Cornel AJ, 2003, J MED ENTOMOL, V40, P36, DOI 10.1603/0022-2585-40.1.36; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Kasai S, 2000, INSECT BIOCHEM MOLEC, V30, P163, DOI 10.1016/S0965-1748(99)00114-9; Komagata O, 2010, INSECT BIOCHEM MOLEC, V40, P146, DOI 10.1016/j.ibmb.2010.01.006; Mori A, 1999, J HERED, V90, P160, DOI 10.1093/jhered/90.1.160; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Ribeiro JMC, 2009, ADV INSECT PHYSIOL, V37, P59, DOI 10.1016/S0065-2806(09)37002-2; Vinogradova E.B, 2000, CULEX PIPIENS PIPIEN	12	337	354	1	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2010	330	6000					86	88		10.1126/science.1191864	http://dx.doi.org/10.1126/science.1191864			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20929810	Green Accepted			2022-12-01	WOS:000282334500040
J	Bate, R; Attaran, A				Bate, Roger; Attaran, Amir			A counterfeit drug treaty: great idea, wrong implementation	LANCET			English	Editorial Material									[Attaran, Amir] Univ Ottawa, Fac Law, Ottawa, ON K1N 6N5, Canada; [Attaran, Amir] Univ Ottawa, Fac Med, Ottawa, ON K1N 6N5, Canada; [Bate, Roger] Amer Enterprise Inst Publ Policy Res, Washington, DC USA	University of Ottawa; University of Ottawa; American Enterprise Institute for Public Policy Research	Attaran, A (corresponding author), Univ Ottawa, Fac Law, Ottawa, ON K1N 6N5, Canada.	aattaran@uottawa.ca						ATTARAN A, WHY MAKE INT CRIME M; Cockburn R, 2005, PLOS MED, V2, P302, DOI 10.1371/journal.pmed.0020100; *COUNC EUR, 2010, MEDICRIME DRAFT COUN; Dondorp AM, 2004, TROP MED INT HEALTH, V9, P1241, DOI 10.1111/j.1365-3156.2004.01342.x; *ECCP COUNC EUR, 2008, 3 M APR 15; *EUR COMM CRIM PRO, 2009, DRAFT COUNC EUR CONV; Ludwig SP, 2005, DRUG DEV IND PHARM, V31, P215, DOI 10.1081/DDC-200047811; LYNN J, 2010, REUTERS         0512; Mullard A, 2010, LANCET, V375, P1335, DOI 10.1016/S0140-6736(10)60560-0; *US FDA, 2008, UPD QUEST ANSW HEP S; 1929, INT CONV SUPPR COUNT	11	13	13	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT-NOV	2010	376	9751					1446	1448		10.1016/S0140-6736(10)61416-X	http://dx.doi.org/10.1016/S0140-6736(10)61416-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	680QC	21036261				2022-12-01	WOS:000284248500008
J	Montessuit, S; Somasekharan, SP; Terrones, O; Lucken-Ardjomande, S; Herzig, S; Schwarzenbacher, R; Manstein, DJ; Bossy-Wetzel, E; Basanez, G; Meda, P; Martinou, JC				Montessuit, Sylvie; Somasekharan, Syam Prakash; Terrones, Oihana; Lucken-Ardjomande, Safa; Herzig, Sebastien; Schwarzenbacher, Robert; Manstein, Dietmar J.; Bossy-Wetzel, Ella; Basanez, Gorka; Meda, Paolo; Martinou, Jean-Claude			Membrane Remodeling Induced by the Dynamin-Related Protein Drp1 Stimulates Bax Oligomerization	CELL			English	Article							CYTOCHROME-C RELEASE; BCL-2 FAMILY-MEMBERS; MITOCHONDRIAL OUTER-MEMBRANE; CELL-DEATH; APOPTOTIC PROTEINS; FISSION; FUSION; PERMEABILIZATION; ACTIVATION; ASSOCIATION	In response to many apoptotic stimuli, oligomerization of Bax is essential for mitochondrial outer membrane permeabilization and the ensuing release of cytochrome c. These events are accompanied by mitochondrial fission that appears to require Drp1, a large GTPase of the dynamin superfamily. Loss of Drp1 leads to decreased cytochrome c release by a mechanism that is poorly understood. Here we show that Drp1 stimulates tBid-induced Bax oligomerization and cytochrome c release by promoting tethering and hemifusion of membranes in vitro. This function of Drp1 is independent of its GTPase activity and relies on arginine 247 and the presence of cardiolipin in membranes. In cells, overexpression of Drp1 R247A/E delays Bax oligomerization and cell death. Our findings uncover a function of Drp1 and provide insight into the mechanism of Bax oligomerization.	[Montessuit, Sylvie; Somasekharan, Syam Prakash; Terrones, Oihana; Lucken-Ardjomande, Safa; Herzig, Sebastien; Martinou, Jean-Claude] Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland; [Schwarzenbacher, Robert] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Manstein, Dietmar J.] Hannover Med Sch, Inst Biophys Chem, D-30625 Hannover, Germany; [Bossy-Wetzel, Ella] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Basanez, Gorka] Univ Pais Vasco Euskal Herriko Unibertsitatea, CSIC, Ctr Mixto, Unidad Biofis, Bilbao 48080, Spain; [Meda, Paolo] Ctr Med Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland	University of Geneva; Salzburg University; Hannover Medical School; State University System of Florida; University of Central Florida; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC-UPV - Unidad de Biofisica (UBF); University of Geneva	Martinou, JC (corresponding author), Univ Geneva, Dept Cell Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	jean-claude.martinou@unige.ch	Manstein, Dietmar J./AAG-2640-2019; Basanez, Gorka/L-9509-2014; Terrones, Oihana/AAA-8903-2019; Manstein, Dietmar J. J/M-1034-2013; Herzig, Sebastien/AAA-8853-2019; Terrones, Oihana/I-4023-2015	Manstein, Dietmar J./0000-0003-0763-0147; Basanez, Gorka/0000-0002-7475-7861; Manstein, Dietmar J. J/0000-0003-0763-0147; Herzig, Sebastien/0000-0002-9329-2860; Terrones, Oihana/0000-0001-7421-6486; martinou, Jean-claude/0000-0002-9847-2051; Somasekharan, Syam/0000-0002-9006-8206; Lucken Ardjomande Hasler, Safa/0000-0003-0845-3584	Swiss National Science Foundation [310000-109402]; Juvenile Diabetes Foundation International [1-2007-158]; European Union [222980]; DFG [MA 1081/7-2]; NATIONAL EYE INSTITUTE [R01EY016164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055193, R01NS047456] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Juvenile Diabetes Foundation International; European Union(European Commission); DFG(German Research Foundation (DFG)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank P. Chiesa and D. Caille for excellent technical assistance, Dr R. Cartoni for help with electron microscopy, Dr D. Tondera for some exploratory work on Bax oligomerization, Dr L. Chernomordik and Dr M. Schick for helpful discussions on the process of membrane hemifusion and fusion pore formation, Dr T. Halazonetis for help with the 3D structure of Drp1, and Dr. M. Koppen and Alexis Jourdain for careful reading of the manuscript. P. M. is supported by grants from the Swiss National Science Foundation (310000-109402), the Juvenile Diabetes Foundation International (1-2007-158), and the European Union (FP7 BETAIMAGE 222980). D.J.M. is supported by DFG grant MA 1081/7-2. E. B.-W. is supported by NIH grants RO1 EY016164, RO1 NS0474556, and RO1 NS055193 (E. B. W.) and EU grants MCEXT-033534 and MCIRG-046536 (R. S.). This work was funded by the Swiss National Science Foundation (subsidy 31003A-124968/1 to J.-C. M.), the European union (UE6-ONCODEATH-037278), OncoSuisse, and the Geneva	ARDAIL D, 1990, J BIOL CHEM, V265, P18797; Basanez G, 1996, BIOCHEMISTRY-US, V35, P7506, DOI 10.1021/bi953084a; Basanez G, 2002, J BIOL CHEM, V277, P49360, DOI 10.1074/jbc.M206069200; Bellot G, 2007, CELL DEATH DIFFER, V14, P785, DOI 10.1038/sj.cdd.4402055; Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; Brooks C, 2007, P NATL ACAD SCI USA, V104, P11649, DOI 10.1073/pnas.0703976104; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; CHERNOMORDIK LV, 1993, FEBS LETT, V318, P71, DOI 10.1016/0014-5793(93)81330-3; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098; ELLENS H, 1985, BIOCHEMISTRY-US, V24, P3099, DOI 10.1021/bi00334a005; Estaquier J, 2007, CELL DEATH DIFFER, V14, P1086, DOI 10.1038/sj.cdd.4402107; Etxebarria A, 2009, J BIOL CHEM, V284, P4200, DOI 10.1074/jbc.M808050200; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Gallenne T, 2009, J CELL BIOL, V185, P279, DOI 10.1083/jcb.200809153; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Germain M, 2005, EMBO J, V24, P1546, DOI 10.1038/sj.emboj.7600592; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Heymann JAW, 2009, J CELL SCI, V122, P3427, DOI 10.1242/jcs.051714; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Kawai C, 2005, J BIOL CHEM, V280, P34709, DOI 10.1074/jbc.M412532200; Kluck RM, 1999, J CELL BIOL, V147, P809, DOI 10.1083/jcb.147.4.809; Kozlovsky Y, 2003, BIOPHYS J, V85, P85, DOI 10.1016/S0006-3495(03)74457-9; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Lucken-Ardjomande S, 2008, CELL DEATH DIFFER, V15, P484, DOI 10.1038/sj.cdd.4402280; Lucken-Ardjomande S, 2005, J CELL SCI, V118, P473, DOI 10.1242/jcs.01654; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Ortiz A, 1999, BIOPHYS J, V77, P2003, DOI 10.1016/S0006-3495(99)77041-4; Ott M, 2007, J BIOL CHEM, V282, P27633, DOI 10.1074/jbc.M703155200; Parone PA, 2006, MOL CELL BIOL, V26, P7397, DOI 10.1128/MCB.02282-05; Roucou X, 2002, BIOCHEM J, V368, P915, DOI 10.1042/BJ20020972; Schinzel A, 2004, BBA-MOL CELL RES, V1644, P95, DOI 10.1016/j.bbamcr.2003.09.006; Sheridan C, 2008, MOL CELL, V31, P570, DOI 10.1016/j.molcel.2008.08.002; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Tan KO, 2005, P NATL ACAD SCI USA, V102, P14623, DOI 10.1073/pnas.0503524102; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200	51	309	319	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2010	142	6					889	901		10.1016/j.cell.2010.08.017	http://dx.doi.org/10.1016/j.cell.2010.08.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650NA	20850011	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000281855000012
J	Rodrigues, J; Brayner, FA; Alves, LC; Dixit, R; Barillas-Mury, C				Rodrigues, Janneth; Brayner, Fabio Andre; Alves, Luiz Carlos; Dixit, Rajnikant; Barillas-Mury, Carolina			Hemocyte Differentiation Mediates Innate Immune Memory in Anopheles gambiae Mosquitoes	SCIENCE			English	Article							RED FLOUR BEETLE; TRIBOLIUM-CASTANEUM; INSECT; DROSOPHILA; PARASITE; INVASION	Mosquito midgut invasion by ookinetes of the malaria parasite Plasmodium disrupts the barriers that normally prevent the gut microbiota from coming in direct contact with epithelial cells. This triggers a long-lived response characterized by increased abundance of granulocytes, a subpopulation of hemocytes that circulates in the insect's hemocoel, and enhanced immunity to bacteria that indirectly reduces survival of Plasmodium parasites upon reinfection. In mosquitoes, differentiation of hemocytes was necessary and sufficient to confer innate immune memory.	[Rodrigues, Janneth; Brayner, Fabio Andre; Alves, Luiz Carlos; Dixit, Rajnikant; Barillas-Mury, Carolina] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Barillas-Mury, C (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20892 USA.	cbarillas@niaid.nih.gov	Dixit, Rajnikant/D-2566-2009; Alves, Luiz/V-5314-2019	Dixit, Rajnikant/0000-0002-3536-8329; Rodrigues, Janneth/0000-0001-9693-1958	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH; Conselho Nacionale de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brazilian government agencies; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000947] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Conselho Nacionale de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brazilian government agencies; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH. We thank A. Laughinghouse and K. Lee for insectary support; C. Ortega for experimental support; L. Koo for confocal assistance; J. Ribeiro and J. Valenzuela for their comments and insight; and B. R. Marshall for editorial assistance. F. A. B. and L. C. A. were funded by the Conselho Nacionale de Desenvolvimento Cientifico e Tecnologico and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brazilian government agencies, respectively.	BEIER MS, 1994, J MED ENTOMOL, V31, P561, DOI 10.1093/jmedent/31.4.561; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Brown MJF, 2003, PARASITOLOGY, V126, P253, DOI 10.1017/S0031182002002755; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Eleftherianos I, 2006, INSECT BIOCHEM MOLEC, V36, P517, DOI 10.1016/j.ibmb.2006.04.001; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; HUBER M, 1991, P NATL ACAD SCI USA, V88, P2807, DOI 10.1073/pnas.88.7.2807; Little TJ, 2003, CURR BIOL, V13, P489, DOI 10.1016/S0960-9822(03)00163-5; Meister S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000542; Moret Y, 2003, P ROY SOC B-BIOL SCI, V270, P2475, DOI 10.1098/rspb.2003.2511; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Roth O, 2009, P ROY SOC B-BIOL SCI, V276, P145, DOI 10.1098/rspb.2008.1157; Roth O, 2010, J ANIM ECOL, V79, P403, DOI 10.1111/j.1365-2656.2009.01617.x; Sadd BM, 2006, CURR BIOL, V16, P1206, DOI 10.1016/j.cub.2006.04.047; Sadd BM, 2005, BIOL LETTERS, V1, P386, DOI 10.1098/rsbl.2005.0369; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044	18	311	318	2	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 10	2010	329	5997					1353	1355		10.1126/science.1190689	http://dx.doi.org/10.1126/science.1190689			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647YR	20829487	Green Accepted			2022-12-01	WOS:000281657300041
J	Cejka, P; Cannavo, E; Polaczek, P; Masuda-Sasa, T; Pokharel, S; Campbell, JL; Kowalczykowski, SC				Cejka, Petr; Cannavo, Elda; Polaczek, Piotr; Masuda-Sasa, Taro; Pokharel, Subhash; Campbell, Judith L.; Kowalczykowski, Stephen C.			DNA end resection by Dna2-Sgs1-RPA and its stimulation by Top3-Rmi1 and Mre11-Rad50-Xrs2	NATURE			English	Article							REPLICATION-PROTEIN-A; DOUBLE-STRAND BREAKS; RECOMBINATIONAL REPAIR; MRE11 NUCLEASE; RECQ HELICASE; RECBCD ENZYME; BLM HELICASE; IN-VIVO; SGS1; YEAST	The repair of DNA double-strand breaks (DSBs) by homologous recombination requires processing of broken ends. For repair to start, the DSB must first be resected to generate a 3'-single-stranded DNA (ssDNA) overhang, which becomes a substrate for the DNA strand exchange protein, Rad51 (ref. 1). Genetic studies have implicated a multitude of proteins in the process, including helicases, nucleases and topoisomerases(2-4). Here we biochemically reconstitute elements of the resection process and reveal that it requires the nuclease Dna2, the RecQ-family helicase Sgs1 and the ssDNA-binding protein replication protein-A (RPA). We establish that Dna2, Sgs1 and RPA constitute a minimal protein complex capable of DNA resection in vitro. Sgs1 helicase unwinds the DNA to produce an intermediate that is digested by Dna2, and RPA stimulates DNA unwinding by Sgs1 in a species-specific manner. Interestingly, RPA is also required both to direct Dna2 nucleolytic activity to the 5'-terminated strand of the DNA break and to inhibit 39 to 59 degradation by Dna2, actions that generate and protect the 3'-ssDNA overhang, respectively. In addition to this core machinery, we establish that both the topoisomerase 3 (Top3) and Rmi1 complex and the Mre11-Rad50-Xrs2 complex (MRX) have important roles as stimulatory components. Stimulation of end resection by the Top3-Rmi1 heterodimer and the MRX proteins is by complex formation with Sgs1 (refs 5, 6), which unexpectedly stimulates DNA unwinding. We suggest that Top3-Rmi1 and MRX are important for recruitment of the Sgs1-Dna2 complex to DSBs. Our experiments provide a mechanistic framework for understanding the initial steps of recombinational DNA repair in eukaryotes.	[Cejka, Petr; Cannavo, Elda; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Cejka, Petr; Cannavo, Elda; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Polaczek, Piotr; Masuda-Sasa, Taro; Pokharel, Subhash; Campbell, Judith L.] CALTECH, Div Biol, Pasadena, CA 91125 USA	University of California System; University of California Davis; University of California System; University of California Davis; California Institute of Technology	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA.	sckowalczykowski@ucdavis.edu	Cejka, Petr/B-4829-2009	Cejka, Petr/0000-0002-9087-032X	Swiss National Science Foundation; National Institutes of Health [GM-78666, GM-41347, GM-62653]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062653, R01GM062653, R01GM078666, R01GM041347] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J.-B. Boule, A. Nicolas, X. Veaute, B. Rad, J. L. Plank and P. Sung for purified proteins and DNA substrates, L. Symington for discussions, and W. D. Heyer and the members of the Kowalczykowski and Campbell laboratories for their comments on the manuscript. We are particularly grateful to P. Sung and colleagues for communicating their results to us before their publication. This work was supported by a Swiss National Science Foundation Fellowship (to P. C.), and National Institutes of Health grants GM-78666 (to J. L. C.), GM-41347 (to S. C. K.) and GM-62653 (to S.C.K.).	ALANI E, 1992, J MOL BIOL, V227, P54, DOI 10.1016/0022-2836(92)90681-9; Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Bae KH, 2003, NUCLEIC ACIDS RES, V31, P3006, DOI 10.1093/nar/gkg422; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Budd ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004267; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; CEJKA P, NAT STRUCT IN PRESS; Cejka Petr, 2010, J Biol Chem, V285, P8290, DOI 10.1074/jbc.M109.083196; Chang M, 2005, EMBO J, V24, P2024, DOI 10.1038/sj.emboj.7600684; Chiolo I, 2005, MOL CELL BIOL, V25, P5738, DOI 10.1128/MCB.25.13.5738-5751.2005; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Handa N, 2009, GENE DEV, V23, P1234, DOI 10.1101/gad.1780709; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; Hartsuiker E, 2009, MOL CELL, V33, P117, DOI 10.1016/j.molcel.2008.11.021; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; LEBOWITZ JH, 1985, THESIS J HOPKINS U; Li X, 2009, MOL CELL, V36, P704, DOI 10.1016/j.molcel.2009.09.036; Llorente B, 2004, MOL CELL BIOL, V24, P9682, DOI 10.1128/MCB.24.21.9682-9694.2004; Masuda-Sasa T, 2008, J BIOL CHEM, V283, P24359, DOI 10.1074/jbc.M802244200; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mullen JR, 2005, MOL CELL BIOL, V25, P4476, DOI 10.1128/MCB.25.11.4476-4487.2005; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; Solinger JA, 2001, J MOL BIOL, V307, P1207, DOI 10.1006/jmbi.2001.4555; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; SZANKASI P, 1995, SCIENCE, V267, P1166, DOI 10.1126/science.7855597; Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zierhut C, 2008, EMBO J, V27, P1875, DOI 10.1038/emboj.2008.111	35	331	339	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 2	2010	467	7311					112	U149		10.1038/nature09355	http://dx.doi.org/10.1038/nature09355			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645MB	20811461	Green Accepted, Green Submitted			2022-12-01	WOS:000281461200046
J	Niu, HY; Chung, WH; Zhu, Z; Kwon, Y; Zhao, WX; Chi, P; Prakash, R; Seong, CH; Liu, DQ; Lu, L; Ira, G; Sung, P				Niu, Hengyao; Chung, Woo-Hyun; Zhu, Zhu; Kwon, Youngho; Zhao, Weixing; Chi, Peter; Prakash, Rohit; Seong, Changhyun; Liu, Dongqing; Lu, Lucy; Ira, Grzegorz; Sung, Patrick			Mechanism of the ATP-dependent DNA end-resection machinery from Saccharomyces cerevisiae	NATURE			English	Article							REPLICATION-PROTEIN-A; HOMOLOGOUS RECOMBINATION; BREAK REPAIR; IN-VITRO; YEAST; HELICASE; MRE11; SGS1; RECOGNITION; MAINTENANCE	If not properly processed and repaired, DNA double-strand breaks (DSBs) can give rise to deleterious chromosome rearrangements, which could ultimately lead to the tumour phenotype(1,2). DSB ends are resected in a 5' to 3' fashion in cells, to yield single-stranded DNA (ssDNA) for the recruitment of factors critical for DNA damage checkpoint activation and repair by homologous recombination 2. The resection process involves redundant pathways consisting of nucleases, DNA helicases and associated proteins(3). Being guided by recent genetic studies(4-6), we have reconstituted the first eukaryotic ATP-dependent DNA end-resection machinery comprising the Saccharomyces cerevisiae Mre11-Rad50-Xrs2 (MRX) complex, the Sgs1-Top3-Rmi1 complex, Dna2 protein and the heterotrimeric ssDNA-binding protein RPA. Here we show that DNA strand separation during end resection is mediated by the Sgs1 helicase function, in a manner that is enhanced by Top3-Rmi1 and MRX. In congruence with genetic observations(6), although the Dna2 nuclease activity is critical for resection, the Mre11 nuclease activity is dispensable. By examining the top3 Y356F allele and its encoded protein, we provide evidence that the topoisomerase activity of Top3, although critical for the suppression of crossover recombination(2,7), is not needed for resection either in cells or in the reconstituted system. Our results also unveil a multifaceted role of RPA, in the sequestration of ssDNA generated by DNA unwinding, enhancement of 5' strand incision, and protection of the 3' strand. Our reconstituted system should serve as a useful model for delineating the mechanistic intricacy of the DNA break resection process in eukaryotes.	[Chung, Woo-Hyun; Zhu, Zhu; Ira, Grzegorz] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Niu, Hengyao; Kwon, Youngho; Zhao, Weixing; Chi, Peter; Prakash, Rohit; Seong, Changhyun; Liu, Dongqing; Lu, Lucy; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Baylor College of Medicine; Yale University	Ira, G (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.	gira@bcm.edu; patrick.sung@yale.edu	Chi, Peter/AAI-1580-2019; Niu, Hengyao/J-4593-2013; Niu, Hengyao/B-5026-2014; Huang, Wenchi/F-3981-2010; zhao, weixing/H-3154-2013; Niu, Hengyao/AAE-9269-2020; Classen, Scott/AAY-8176-2020	Chi, Peter/0000-0001-9229-8729; Huang, Wenchi/0000-0001-5556-1460; zhao, weixing/0000-0001-5746-3696	US National Institutes of Health; Susan G. Komen for the Cure Foundation; NATIONAL CANCER INSTITUTE [R01CA146940, P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007061, R01ES015252, R01ES015632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080600, R01GM057814] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Campbell, S. Brill and L. Symington for providing materials, X. Xue for the double Holliday junction substrate and S. Kowalczykowski for communicating results. This work was supported by grants from the US National Institutes of Health and by a postdoctoral fellowship from the Susan G. Komen for the Cure Foundation.	Bae KH, 2003, NUCLEIC ACIDS RES, V31, P3006, DOI 10.1093/nar/gkg422; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bressan DA, 1998, GENETICS, V150, P591; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Chen CF, 2007, J BIOL CHEM, V282, P28971, DOI 10.1074/jbc.M705427200; Chen L, 2001, MOL CELL, V8, P1105, DOI 10.1016/S1097-2765(01)00388-4; Chiolo I, 2005, MOL CELL BIOL, V25, P5738, DOI 10.1128/MCB.25.13.5738-5751.2005; Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; IVANOV EL, 1994, MOL CELL BIOL, V14, P3414, DOI 10.1128/MCB.14.5.3414; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Lu JA, 1996, NATURE, V383, P678, DOI 10.1038/383678a0; Masuda-Sasa T, 2008, J BIOL CHEM, V283, P24359, DOI 10.1074/jbc.M802244200; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2009, TRENDS BIOCHEM SCI, V34, P264, DOI 10.1016/j.tibs.2009.01.010; Moreau S, 1999, MOL CELL BIOL, V19, P556; Niu HY, 2009, GENE DEV, V23, P1481, DOI 10.1101/gad.1824209; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Trujillo KM, 2003, J BIOL CHEM, V278, P48957, DOI 10.1074/jbc.M309877200; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	29	276	279	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 2	2010	467	7311					108	U143		10.1038/nature09318	http://dx.doi.org/10.1038/nature09318			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645MB	20811460	Green Accepted			2022-12-01	WOS:000281461200045
J	Machlis, GE; McNutt, MK				Machlis, Gary E.; McNutt, Marcia K.			Scenario-Building for the Deepwater Horizon Oil Spill	SCIENCE			English	Editorial Material							CONSERVATION		[Machlis, Gary E.] US Dept Interior, Strateg Sci Working Grp, Washington, DC 20024 USA; [Machlis, Gary E.] Natl Pk Serv, Washington, DC 20024 USA; [McNutt, Marcia K.] US Geol Survey, Washington, DC 20024 USA	United States Department of the Interior; United States Department of the Interior; United States Department of the Interior; United States Geological Survey	Machlis, GE (corresponding author), US Dept Interior, Strateg Sci Working Grp, Washington, DC 20024 USA.	gary_machlis@nps.gov		McNutt, Marcia/0000-0003-0117-7716; Machlis, Gary/0000-0002-8915-5695				Burley D, 2007, ORGAN ENVIRON, V20, P347, DOI 10.1177/1086026607305739; CASTILLO S, 1996, J COAST CONSERV, V2, P13, DOI DOI 10.1007/BF02743033; Chermack T.J., 2001, FUTURES RES Q, V17, P7, DOI DOI 10.1016/j.futures.2005.12.010; Colten C.E., 2008, COMMUNITY RESILIENCE; *DEP INT, 2010, STRAT SCI WORK GROUP; Felder D. L., 2009, GULF MEXICO ORIGIN W, V1, P1; Haas J.E., 1977, RECONSTRUCTION FOLLO; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Kates RW, 2006, P NATL ACAD SCI USA, V103, P14653, DOI 10.1073/pnas.0605726103; KHAN H, 1965, THINKING UNTHINKABLE; Machlis GE, 1997, SOC NATUR RESOUR, V10, P347, DOI 10.1080/08941929709381034; MAGUIRE JJ, 2005, FISHERIES TOPICS ECO; Peterson GD, 2003, CONSERV BIOL, V17, P358, DOI 10.1046/j.1523-1739.2003.01491.x; Rabalais NN, 2001, J ENVIRON QUAL, V30, P320, DOI 10.2134/jeq2001.302320x; Robison BH, 2009, CONSERV BIOL, V23, P847, DOI 10.1111/j.1523-1739.2009.01219.x; Sheppard ES., 2004, SCALE GEOGRAPHIC INQ, DOI [10.1002/9780470999141, DOI 10.1002/9780470999141]; Tibbetts J, 2004, ENVIRON HEALTH PERSP, V112, pA282, DOI 10.1289/ehp.112-a282; *US DOI, DEEPW HOR RESP; Wang D, 2005, SCIENCE, V308, P1036, DOI 10.1126/science.1108791; [No title captured], DOI DOI 10.1093/LPR/2.1.25	20	32	32	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 27	2010	329	5995					1018	1019		10.1126/science.1195382	http://dx.doi.org/10.1126/science.1195382			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642WZ	20798302				2022-12-01	WOS:000281253500020
J	Lee, JH; Fang, L; Vlahos, E; Ke, XL; Jung, YW; Kourkoutis, LF; Kim, JW; Ryan, PJ; Heeg, T; Roeckerath, M; Goian, V; Bernhagen, M; Uecker, R; Hammel, PC; Rabe, KM; Kamba, S; Schubert, J; Freeland, JW; Muller, DA; Fennie, CJ; Schiffer, P; Gopalan, V; Johnston-Halperin, E; Schlom, DG				Lee, June Hyuk; Fang, Lei; Vlahos, Eftihia; Ke, Xianglin; Jung, Young Woo; Kourkoutis, Lena Fitting; Kim, Jong-Woo; Ryan, Philip J.; Heeg, Tassilo; Roeckerath, Martin; Goian, Veronica; Bernhagen, Margitta; Uecker, Reinhard; Hammel, P. Chris; Rabe, Karin M.; Kamba, Stanislav; Schubert, Juergen; Freeland, John W.; Muller, David A.; Fennie, Craig J.; Schiffer, Peter; Gopalan, Venkatraman; Johnston-Halperin, Ezekiel; Schlom, Darrell G.			A strong ferroelectric ferromagnet created by means of spin-lattice coupling	NATURE			English	Article							MAGNETIC-PROPERTIES; OXIDE; SYSTEM	Ferroelectric ferromagnets are exceedingly rare, fundamentally interesting multiferroic materials that could give rise to new technologies in which the low power and high speed of field-effect electronics are combined with the permanence and routability of voltage-controlled ferromagnetism(1,2). Furthermore, the properties of the few compounds that simultaneously exhibit these phenomena(1-5) are insignificant in comparison with those of useful ferroelectrics or ferromagnets: their spontaneous polarizations or magnetizations are smaller by a factor of 1,000 or more. The same holds for magnetic-or electric-field-induced multiferroics(6-8). Owing to the weak properties of single-phase multiferroics, composite and multilayer approaches involving strain-coupled piezoelectric and magnetostrictive components are the closest to application today(1,2). Recently, however, a new route to ferroelectric ferromagnets was proposed(9) by which magnetically ordered insulators that are neither ferroelectric nor ferromagnetic are transformed into ferroelectric ferromagnets using a single control parameter, strain. The system targeted, EuTiO3, was predicted to exhibit strong ferromagnetism (spontaneous magnetization, similar to 7 Bohr magnetons per Eu) and strong ferroelectricity (spontaneous polarization, similar to 10 mu C cm(-2)) simultaneously under large biaxial compressive strain(9). These values are orders of magnitude higher than those of any known ferroelectric ferromagnet and rival the best materials that are solely ferroelectric or ferromagnetic. Hindered by the absence of an appropriate substrate to provide the desired compression we turned to tensile strain. Here we show both experimentally and theoretically the emergence of a multiferroic state under biaxial tension with the unexpected benefit that even lower strains are required, thereby allowing thicker high-quality crystalline films. This realization of a strong ferromagnetic ferroelectric points the way to high-temperature manifestations of this spin-lattice coupling mechanism(10). Our work demonstrates that a single experimental parameter, strain, simultaneously controls multiple order parameters and is a viable alternative tuning parameter to composition(11) for creating multiferroics.	[Lee, June Hyuk; Heeg, Tassilo; Schlom, Darrell G.] Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA; [Lee, June Hyuk; Vlahos, Eftihia; Gopalan, Venkatraman] Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA; [Fang, Lei; Jung, Young Woo; Hammel, P. Chris; Johnston-Halperin, Ezekiel] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Ke, Xianglin; Schiffer, Peter] Penn State Univ, Dept Phys, University Pk, PA 16802 USA; [Ke, Xianglin; Schiffer, Peter] Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA; [Kourkoutis, Lena Fitting; Muller, David A.; Fennie, Craig J.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Kim, Jong-Woo; Ryan, Philip J.; Freeland, John W.] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; [Roeckerath, Martin] Forschungszentrum Julich, JARA Fundamentals Future Informat Technol, Inst Bio & Nanosyst, D-52425 Julich, Germany; [Goian, Veronica; Kamba, Stanislav] Acad Sci Czech Republ, Inst Phys, Prague 18221 8, Czech Republic; [Bernhagen, Margitta; Uecker, Reinhard] Leibniz Inst Crystal Growth, D-12489 Berlin, Germany; [Rabe, Karin M.] Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA; [Muller, David A.] Kavli Inst Cornell Nanoscale Sci, Ithaca, NY 14853 USA	Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Helmholtz Association; Research Center Julich; Czech Academy of Sciences; Institute of Physics of the Czech Academy of Sciences; Leibniz Institut fur Kristallzuchtung (IKZ); Rutgers State University New Brunswick	Schlom, DG (corresponding author), Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA.	schlom@cornell.edu	Schiffer, Peter/F-3227-2011; Kamba, Stanislav/G-5332-2014; Johnston-Halperin, Ezekiel/AAM-2564-2021; Muller, David/A-7745-2010; Goian, Veronica/G-6154-2014; Schubert, Jürgen/K-9543-2013; Schlom, Darrell G/J-2412-2013; Hammel, P Chris/O-4845-2014; Johnston-Halperin, Ezekiel/B-5902-2012; Kourkoutis, Lena/B-4229-2010	Kamba, Stanislav/0000-0003-4699-869X; Johnston-Halperin, Ezekiel/0000-0002-6240-3505; Muller, David/0000-0003-4129-0473; Goian, Veronica/0000-0002-7971-2224; Schubert, Jürgen/0000-0003-0185-6794; Schlom, Darrell G/0000-0003-2493-6113; Hammel, P Chris/0000-0002-4138-4798; Schiffer, Peter/0000-0002-6430-6549; Hammel, Pascal/0000-0002-4630-4996; Kim, Jong-Woo/0000-0001-9641-2947; Kourkoutis, Lena/0000-0002-1303-1362; Barnes, Eftihia/0000-0002-6075-6278	National Science Foundation [DMR-0507146]; National Science Foundation through MRSEC [DMR-0520404, DMR-0820404, DMR-0820414]; Czech Science Foundation [202/09/0682]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	National Science Foundation(National Science Foundation (NSF)); National Science Foundation through MRSEC; Czech Science Foundation(Grant Agency of the Czech Republic); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	The authors acknowledge discussions and interactions with M. D. Biegalski, D. H. A. Blank, C. B. Eom, M. B. Holcomb, M. Lezaic, J. Mannhart, L. W. Martin, D. V. Pelekhov, R. Ramesh, K. Z. Rushchanskii, N. Samarth, A. Schmehl, D. A. Tenne, J.-M. Triscone, D. Viehland and L. Yan. In addition, the financial support of the National Science Foundation through grant DMR-0507146 and the MRSEC program (DMR-0520404, DMR-0820404 and DMR-0820414), and of the Czech Science Foundation (project no. 202/09/0682), is gratefully acknowledged. Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357.	Anisimov VI, 1997, J PHYS-CONDENS MAT, V9, P767, DOI 10.1088/0953-8984/9/4/002; Bayrashev A, 2004, SENSOR ACTUAT A-PHYS, V114, P244, DOI 10.1016/j.sna.2004.01.007; BEACH RS, 1993, PHYS REV LETT, V70, P3502, DOI 10.1103/PhysRevLett.70.3502; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Bozovic I, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.107001; BROUS J, 1953, ACTA CRYSTALLOGR, V6, P67, DOI 10.1107/S0365110X53000156; Chae SC, 2009, J ELECTROCERAM, V22, P216, DOI 10.1007/s10832-008-9460-z; Choi KJ, 2004, SCIENCE, V306, P1005, DOI 10.1126/science.1103218; Chu MW, 2004, NAT MATER, V3, P87, DOI 10.1038/nmat1057; Das J, 2009, ADV MATER, V21, P2045, DOI 10.1002/adma.200803376; Eerenstein W, 2006, NATURE, V442, P759, DOI 10.1038/nature05023; Fennie CJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.267602; Fetisov YK, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2191950; Fong DD, 2004, SCIENCE, V304, P1650, DOI 10.1126/science.1098252; Fuchs D, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.014434; Fujita K, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3072598; Gajek M, 2007, NAT MATER, V6, P296, DOI 10.1038/nmat1860; Goto T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.257201; Haeni JH, 2004, NATURE, V430, P758, DOI 10.1038/nature02773; Hatabayashi K, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.100208; Hellwege KH, 1981, LANDOLTBORNSTEIN N A, V16, P59; Ikeda N, 2005, NATURE, V436, P1136, DOI 10.1038/nature04039; Junquera J, 2003, NATURE, V422, P506, DOI 10.1038/nature01501; Katsufuji T, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.054415; Ke X, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3117190; Kimura T, 2008, NAT MATER, V7, P291, DOI 10.1038/nmat2125; Kimura T, 2003, NATURE, V426, P55, DOI 10.1038/nature02018; Koster G, 1998, APPL PHYS LETT, V73, P2920, DOI 10.1063/1.122630; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kugimiya K, 2007, J MAGN MAGN MATER, V310, P2268, DOI 10.1016/j.jmmm.2006.10.839; Lee JH, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3133351; Lee JH, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.207204; Lottermoser T, 2004, NATURE, V430, P541, DOI 10.1038/nature02728; NGUYEN LD, 1992, IEEE T ELECTRON DEV, V39, P2007, DOI 10.1109/16.155871; Park JY, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2798597; Pertsev NA, 2000, PHYS REV B, V61, pR825, DOI 10.1103/PhysRevB.61.R825; Ramesh R, 2007, NAT MATER, V6, P21, DOI 10.1038/nmat1805; RIVERA JP, 1981, FERROELECTRICS, V36, P447, DOI 10.1080/00150198108218150; Schlom DG, 2007, ANNU REV MATER RES, V37, P589, DOI 10.1146/annurev.matsci.37.061206.113016; Shvartsman VV, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.064426; Steins M, 1997, Z KRIST-NEW CRYST ST, V212, P77, DOI 10.1524/ncrs.1997.212.1.77; Theis CD, 1996, J VAC SCI TECHNOL A, V14, P2677, DOI 10.1116/1.580185; Velickov B, 2007, Z KRISTALLOGR, V222, P466, DOI 10.1524/zkri.2007.222.9.466; Wang HH, 2004, J APPL PHYS, V96, P5324, DOI 10.1063/1.1794362; Zhai JY, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2172706	47	577	584	16	704	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2010	466	7309					954	U72		10.1038/nature09331	http://dx.doi.org/10.1038/nature09331			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640ED	20725036				2022-12-01	WOS:000281030300030
J	Sheard, LB; Tan, X; Mao, HB; Withers, J; Ben-Nissan, G; Hinds, TR; Kobayashi, Y; Hsu, FF; Sharon, M; Browse, J; He, SY; Rizo, J; Howe, GA; Zheng, N				Sheard, Laura B.; Tan, Xu; Mao, Haibin; Withers, John; Ben-Nissan, Gili; Hinds, Thomas R.; Kobayashi, Yuichi; Hsu, Fong-Fu; Sharon, Michal; Browse, John; He, Sheng Yang; Rizo, Josep; Howe, Gregg A.; Zheng, Ning			Jasmonate perception by inositol-phosphate-potentiated COI1-JAZ co-receptor	NATURE			English	Article							BOX PROTEIN TIR1; REGULATED DEFENSE; ISOLEUCINE; RECEPTOR; CORONATINE; MECHANISM; ACID; RECOGNITION; REPRESSION; SOFTWARE	Jasmonates are a family of plant hormones that regulate plant growth, development and responses to stress. The F-box protein CORONATINE INSENSITIVE 1 (COI1) mediates jasmonate signalling by promoting hormone-dependent ubiquitylation and degradation of transcriptional repressor JAZ proteins. Despite its importance, the mechanism of jasmonate perception remains unclear. Here we present structural and pharmacological data to show that the true Arabidopsis jasmonate receptor is a complex of both COI1 and JAZ. COI1 contains an open pocket that recognizes the bioactive hormone (3R, 7S)-jasmonoyl-L-isoleucine (JA-Ile) with high specificity. High-affinity hormone binding requires a bipartite JAZ degron sequence consisting of a conserved a-helix for COI1 docking and a loop region to trap the hormone in its binding pocket. In addition, we identify a third critical component of the jasmonate co-receptor complex, inositol pentakisphosphate, which interacts with both COI1 and JAZ adjacent to the ligand. Our results unravel the mechanism of jasmonate perception and highlight the ability of F-box proteins to evolve as multi-component signalling hubs.	[Sheard, Laura B.; Tan, Xu; Mao, Haibin; Hinds, Thomas R.; Zheng, Ning] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Withers, John; He, Sheng Yang; Howe, Gregg A.] Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA; [Withers, John; He, Sheng Yang] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Ben-Nissan, Gili; Sharon, Michal] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Kobayashi, Yuichi] Tokyo Inst Technol, Dept Biol Engn, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Hsu, Fong-Fu] Washington Univ, Sch Med, Dept Internal Med, Div Endocrinol Diabet Metab & Lipid Res, St Louis, MO 63110 USA; [Browse, John] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Howe, Gregg A.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Zheng, Ning] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Michigan State University; Michigan State University; Weizmann Institute of Science; Tokyo Institute of Technology; Washington University (WUSTL); Washington State University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Michigan State University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zheng, N (corresponding author), Univ Washington, Dept Pharmacol, Box 357280, Seattle, WA 98195 USA.	nzheng@u.washington.edu	Mao, Haibin/B-7609-2011; Tan, Xu/E-7170-2011; Howe, Gregg A/N-1887-2014	Tan, Xu/0000-0003-4861-4573; Howe, Gregg A/0000-0002-9218-979X; Hsu, Fong-Fu/0000-0001-5368-0183; Browse, John/0000-0002-2554-2821; He, Sheng Yang/0000-0003-1308-498X; Sharon, Michal/0000-0003-3933-0595	Howard Hughes Medical Institute; National Institutes of Health [R01 CA107134, T32 GM07270, R01GM57795, R01AI068718]; National Science Foundation [0929100]; US Department of Energy [DE-FG02-99ER20323, DE-FG02-91ER20021]; Michigan State University; Welch Foundation [I-1304]; European Research Council (ERC) under the European Community [239679]; NATIONAL CANCER INSTITUTE [R01CA107134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270, R01GM057795] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); US Department of Energy(United States Department of Energy (DOE)); Michigan State University; Welch Foundation(The Welch Foundation); European Research Council (ERC) under the European Community(European Research Council (ERC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the beamline staff of the Advanced Light Source at the University of California at Berkeley and the Advanced Photon Source at Argonne National Laboratory for help with data collection. We also thank P. Rajagopal and R. Klevit for <SUP>31</SUP>P NMR analysis, M. Sadilek for mass spectrometry analysis, L. Katsir, C. Hague and J. Lyssand for radioligand binding assay assistance, and C. Mecey and M. Melotto for initial cloning of coi1(sdm) mutants. We also thank members of the Zheng laboratory and W. Xu laboratory and R. Gardner for discussion and help. This work is supported by the Howard Hughes Medical Institute and grants from the National Institutes of Health (R01 CA107134 to N.Z., T32 GM07270 to L.B.S., R01GM57795 to G.A.H., R01AI068718 to S.Y.H.), National Science Foundation (0929100 to N.Z.), US Department of Energy (DE-FG02-99ER20323 to J.B. and DE-FG02-91ER20021 to G.A.H. and S.Y.H.), Michigan State University Plant Science Fellowship (J.W.), the Welch Foundation (I-1304 to J.R.) and the European Research Council (ERC) under the European Community's Seventh Framework Program (FP7/2007-2013)/ERC Grant agreement no. 239679 (G.B.-N. and M.S.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chung HS, 2010, PLANT J, V63, P613, DOI 10.1111/j.1365-313X.2010.04265.x; Chung HS, 2009, PLANT CELL, V21, P131, DOI 10.1105/tpc.108.064097; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Grunewald W, 2009, EMBO REP, V10, P923, DOI 10.1038/embor.2009.103; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Koo AJK, 2009, PLANT J, V59, P974, DOI 10.1111/j.1365-313X.2009.03924.x; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Melotto M, 2008, PLANT J, V55, P979, DOI 10.1111/j.1365-313X.2008.03566.x; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Murase K, 2008, NATURE, V456, P459, DOI 10.1038/nature07519; Nettleton EJ, 1998, J MOL BIOL, V281, P553, DOI 10.1006/jmbi.1998.1937; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Ogawa N, 2008, TETRAHEDRON LETT, V49, P7124, DOI 10.1016/j.tetlet.2008.09.144; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SADRZADEH SMH, 1993, J PHARMACOL TOXICOL, V30, P103, DOI 10.1016/1056-8719(93)90013-5; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Shimada A, 2008, NATURE, V456, P520, DOI 10.1038/nature07546; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; STEPHENS LR, 1991, BIOCHEM J, V275, P485, DOI 10.1042/bj2750485; Suza WP, 2008, PLANTA, V227, P1221, DOI 10.1007/s00425-008-0694-4; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Yan JB, 2009, PLANT CELL, V21, P2220, DOI 10.1105/tpc.109.065730; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708; Yin P, 2009, NAT STRUCT MOL BIOL, V16, P1230, DOI 10.1038/nsmb.1730	38	885	955	12	282	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 18	2010	468	7322					400	U301		10.1038/nature09430	http://dx.doi.org/10.1038/nature09430			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681KP	20927106	Green Accepted, Green Submitted			2022-12-01	WOS:000284313100035
J	Sauka-Spengler, T; Bronner, M				Sauka-Spengler, Tatjana; Bronner, Marianne			SnapShot: Neural Crest	CELL			English	Editorial Material									[Sauka-Spengler, Tatjana; Bronner, Marianne] CALTECH, Pasadena, CA 91125 USA	California Institute of Technology	Sauka-Spengler, T (corresponding author), CALTECH, Pasadena, CA 91125 USA.			Sauka-Spengler, Tatjana/0000-0001-9289-0263; Bronner, Marianne/0000-0003-4274-1862					0	20	20	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 29	2010	143	3					486	486	486.e1	10.1016/j.cell.2010.10.025	http://dx.doi.org/10.1016/j.cell.2010.10.025			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672RF	21029868	Bronze			2022-12-01	WOS:000283603900021
J	Perrings, C; Naeem, S; Ahrestani, F; Bunker, DE; Burkill, P; Canziani, G; Elmqvist, T; Ferrati, R; Fuhrman, JA; Jaksic, F; Kawabata, Z; Kinzig, A; Mace, GM; Milano, F; Mooney, H; Prieur-Richard, AH; Tschirhart, J; Weisser, W				Perrings, C.; Naeem, S.; Ahrestani, F.; Bunker, D. E.; Burkill, P.; Canziani, G.; Elmqvist, T.; Ferrati, R.; Fuhrman, J. A.; Jaksic, F.; Kawabata, Z.; Kinzig, A.; Mace, G. M.; Milano, F.; Mooney, H.; Prieur-Richard, A. -H.; Tschirhart, J.; Weisser, W.			Ecosystem Services for 2020	SCIENCE			English	Editorial Material							AGRICULTURAL SUSTAINABILITY; BIODIVERSITY INDICATORS; CHALLENGES; POLICY; SCIENCE		[Perrings, C.; Kinzig, A.] Arizona State Univ, Tempe, AZ 85287 USA; [Naeem, S.; Ahrestani, F.] Columbia Univ, New York, NY 10027 USA; [Bunker, D. E.] New Jersey Inst Technol, Newark, NJ 07102 USA; [Burkill, P.] Sir Alister Hardy Fdn Ocean Sci, Plymouth PL1 2PB, Devon, England; [Canziani, G.; Ferrati, R.; Milano, F.] Univ Nacl Ctr, Buenos Aires, DF, Argentina; [Elmqvist, T.] Stockholm Univ, SE-10691 Stockholm, Sweden; [Fuhrman, J. A.] Univ So Calif, Los Angeles, CA 90089 USA; [Jaksic, F.] Pontificia Univ Catolica Chile, Santiago, Chile; [Kawabata, Z.] Res Inst Humanity & Nat, Kyoto 6038047, Japan; [Mace, G. M.] Univ London Imperial Coll Sci Technol & Med, Ascot SL5 7PY, Berks, England; [Mooney, H.] Stanford Univ, Stanford, CA 94305 USA; [Prieur-Richard, A. -H.] Museum Natl Hist Nat, F-75231 Paris 05, France; [Tschirhart, J.] Univ Wyoming, Laramie, WY 82071 USA; [Weisser, W.] Univ Jena, D-07743 Jena, Germany	Arizona State University; Arizona State University-Tempe; Columbia University; New Jersey Institute of Technology; Comision Nacional de Energia Atomica (CNEA); Stockholm University; University of Southern California; Pontificia Universidad Catolica de Chile; Research Institute for Humanity & Nature (RIHN); Imperial College London; Stanford University; Museum National d'Histoire Naturelle (MNHN); University of Wyoming; Friedrich Schiller University of Jena	Perrings, C (corresponding author), Arizona State Univ, Tempe, AZ 85287 USA.	Charles.Perrings@asu.edu	Elmqvist, Thomas/AAY-6344-2021; Jaksic, Fabian M/G-1705-2014; Mace, Georgina M/I-3072-2016; Ahrestani, Farshid/B-4844-2012; Fuhrman, Jed A/C-6461-2013; Weisser, Wolfgang W/B-9718-2014	Elmqvist, Thomas/0000-0002-4617-6197; Jaksic, Fabian M/0000-0003-0098-0291; Mace, Georgina M/0000-0001-8965-5211; Ahrestani, Farshid/0000-0002-0979-4359; Fuhrman, Jed A/0000-0002-2361-1985; Weisser, Wolfgang W/0000-0002-2757-8959	NERC [SAH01001] Funding Source: UKRI; Natural Environment Research Council [SAH01001] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bracken MES, 2008, P NATL ACAD SCI USA, V105, P924, DOI 10.1073/pnas.0704103105; Bulling MT, 2010, PHILOS T R SOC B, V365, P2107, DOI 10.1098/rstb.2010.0022; Bunker DE, 2005, SCIENCE, V310, P1029, DOI 10.1126/science.1117682; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; CBD (Convention on Biological Diversity), 2010, REV UPD STRAT PLAN T; Godbold JA, 2009, MAR ECOL PROG SER, V396, P273, DOI 10.3354/meps08401; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Larigauderie A, 2010, CURR OPIN ENV SUST, V2, P9, DOI 10.1016/j.cosust.2010.02.006; Mace GM, 2007, CONSERV BIOL, V21, P1406, DOI 10.1111/j.1523-1739.2007.00830.x; Mace GM, 2010, CURR OPIN ENV SUST, V2, P3, DOI 10.1016/j.cosust.2010.03.003; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; McIntyre PB, 2007, P NATL ACAD SCI USA, V104, P4461, DOI 10.1073/pnas.0608148104; *MILL EC ASS, 2005, MILL EC ASS LIV OUR; Mooney H, 2009, SCIENCE, V325, P1474, DOI 10.1126/science.1180935; Pretty J, 2008, PHILOS T R SOC B, V363, P447, DOI 10.1098/rstb.2007.2163; Rands MRW, 2010, SCIENCE, V329, P1298, DOI 10.1126/science.1189138; Secretariat of the convention on biological diversity, 2020, GLOBAL BIODIVERSITY; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	21	129	149	6	250	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 15	2010	330	6002					323	324		10.1126/science.1196431	http://dx.doi.org/10.1126/science.1196431			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20947748				2022-12-01	WOS:000282986700022
J	Xue, G; Dong, Q; Chen, CS; Lu, ZL; Mumford, JA; Poldrack, RA				Xue, Gui; Dong, Qi; Chen, Chuansheng; Lu, Zhonglin; Mumford, Jeanette A.; Poldrack, Russell A.			Greater Neural Pattern Similarity Across Repetitions Is Associated with Better Memory	SCIENCE			English	Article							BRAIN ACTIVITY; ENCODING VARIABILITY; RETRIEVAL-PROCESSES; FREE-RECALL; REACTIVATION; HIPPOCAMPUS; CORTEX; REPLAY; FACES; TASK	Repeated study improves memory, but the underlying neural mechanisms of this improvement are not well understood. Using functional magnetic resonance imaging and representational similarity analysis of brain activity, we found that, compared with forgotten items, subsequently remembered faces and words showed greater similarity in neural activation across multiple study in many brain regions, including (but not limited to) the regions whose mean activities were correlated with subsequent memory. This result addresses a longstanding debate in the study of memory by showing that successful episodic memory encoding occurs when the same neural representations are more precisely reactivated across study episodes, rather than when patterns of activation are more variable across time.	[Xue, Gui; Dong, Qi] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Xue, Gui; Lu, Zhonglin] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Chen, Chuansheng] Univ Calif Irvine, Dept Psychol, Irvine, CA 92697 USA; [Chen, Chuansheng] Univ Calif Irvine, Dept Social Behav, Irvine, CA 92697 USA; [Mumford, Jeanette A.; Poldrack, Russell A.] Univ Texas Austin, Dept Psychol, Austin, TX 78759 USA; [Poldrack, Russell A.] Univ Texas Austin, Imaging Res Ctr, Austin, TX 78759 USA; [Poldrack, Russell A.] Univ Texas Austin, Dept Neurobiol, Austin, TX 78759 USA	Beijing Normal University; University of Southern California; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Dong, Q (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	dongqi@bnu.edu.cn; poldrack@mail.utexas.edu	Xue, Gui/A-1762-2009	Xue, Gui/0000-0001-7891-8151; Chen, Chuansheng/0000-0002-8224-1005; Poldrack, Russell/0000-0001-6755-0259	Program for New Century Excellent Talents in University; NSF [BCS 0823624, BCS 0823495]; NIH [HD057884-01A2]; 111 Project of China [B07008]; Direct For Social, Behav & Economic Scie [0823624] Funding Source: National Science Foundation; Division Of Behavioral and Cognitive Sci [0823495] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057884] Funding Source: NIH RePORTER	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 111 Project of China; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We wish to thank C. Stark for his suggestions in implementing Experiment 3; R. A. Bjork, D. M. Schnyer, and R. Raizada for their helpful comments on an earlier version of this report; and L. Mei, F. Xue, X. Lei, X. Xiao and M. Zhang for their help in data collection. This study was supported by the Program for New Century Excellent Talents in University, NSF (BCS 0823624 and BCS 0823495), NIH (HD057884-01A2), and the 111 Project of China (B07008).	Appleton-Knapp SL, 2005, J CONSUM RES, V32, P266, DOI 10.1086/432236; Bjork R., 1975, INFORM PROCESSING CO, P396; Bower GH., 1972, CODING PROCESS HUM, V3, P85; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Cepeda NJ, 2009, EXP PSYCHOL, V56, P236, DOI 10.1027/1618-3169.56.4.236; Ebbinghaus H. E., 1885, MEMORY CONTRIBUTION; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Gelbard-Sagiv H, 2008, SCIENCE, V322, P96, DOI 10.1126/science.1164685; Hintzman D. L., 1974, THEORIES COGNITIVE P, P77; HOERL AE, 1970, TECHNOMETRICS, V12, P69, DOI 10.2307/1267352; Howard MW, 2002, J MATH PSYCHOL, V46, P269, DOI 10.1006/jmps.2001.1388; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kahana MJ, 1996, MEM COGNITION, V24, P103, DOI 10.3758/BF03197276; Kahn I, 2004, J NEUROSCI, V24, P4172, DOI 10.1523/JNEUROSCI.0624-04.2004; Kriegeskorte N, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.004.2008; Kuhl BA, 2010, NAT NEUROSCI, V13, P501, DOI 10.1038/nn.2498; Kuskowski MA, 1999, NEUROIMAGE, V9, P599, DOI 10.1006/nimg.1999.0442; MARTIN E, 1968, PSYCHOL REV, V75, P421, DOI 10.1037/h0026301; Mei LL, 2010, NEUROIMAGE, V52, P371, DOI 10.1016/j.neuroimage.2010.03.067; MELTON AW, 1970, J VERB LEARN VERB BE, V9, P596, DOI 10.1016/S0022-5371(70)80107-4; Nyberg L, 2001, NEUROIMAGE, V14, P521, DOI 10.1006/nimg.2001.0801; Otten LJ, 2001, BRAIN, V124, P399, DOI 10.1093/brain/124.2.399; Polyn SM, 2005, SCIENCE, V310, P1963, DOI 10.1126/science.1117645; Prince SE, 2009, NEUROPSYCHOLOGIA, V47, P2282, DOI 10.1016/j.neuropsychologia.2009.01.021; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Schurger A, 2010, SCIENCE, V327, P97, DOI 10.1126/science.1180029; Smith APR, 2004, NEUROIMAGE, V22, P868, DOI 10.1016/j.neuroimage.2004.01.049; THIOS SJ, 1976, J VERB LEARN VERB BE, V15, P529, DOI 10.1016/0022-5371(76)90047-5; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wheeler ME, 2003, J NEUROSCI, V23, P3869; Wheeler ME, 2000, P NATL ACAD SCI USA, V97, P11125, DOI 10.1073/pnas.97.20.11125	31	206	213	9	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 1	2010	330	6000					97	101		10.1126/science.1193125	http://dx.doi.org/10.1126/science.1193125			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20829453	Green Accepted, Green Submitted			2022-12-01	WOS:000282334500044
J	Scheinberg, P; Cooper, JN; Sloand, EM; Wu, CO; Calado, RT; Young, NS				Scheinberg, Phillip; Cooper, James N.; Sloand, Elaine M.; Wu, Colin O.; Calado, Rodrigo T.; Young, Neal S.			Association of Telomere Length of Peripheral Blood Leukocytes With Hematopoietic Relapse, Malignant Transformation, and Survival in Severe Aplastic Anemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANTI-THYMOCYTE GLOBULIN; ANTITHYMOCYTE GLOBULIN; ULCERATIVE-COLITIS; CYCLOSPORINE; CANCER; DISEASE; INSTABILITY; PROGRESSION; MUTATIONS; CARCINOMA	Context Critically short telomeres produce apoptosis, cell senescence, and chromosomal instability in tissue culture and animal models. Variations in telomere length have been reported in severe aplastic anemia but their clinical significance is unknown. Objective To investigate the relationship between telomere length and clinical outcomes in severe aplastic anemia. Design, Setting, and Patients Single institution analysis of 183 patients with severe aplastic anemia who were treated in sequential prospective protocols at the National Institutes of Health from 2000 to 2008. The pretreatment leukocyte age-adjusted telomere length of patients with severe aplastic anemia consecutively enrolled in immunosuppression protocols with antithymocyte globulin plus cyclosporine for correlation with clinical outcomes were analyzed. Main Outcome Measures Hematologic response, relapse, clonal evolution, and survival. Results There was no relationship between hematologic response and telomere length with response rates of 56.5% of 46 patients in the first, 54.3% of 46 in the second, 60% of 45 in the third, and 56.5% of 46 in the fourth quartiles. Multivariate analysis demonstrated that telomere length was associated with relapse, clonal evolution, and mortality. Evaluated as a continuous variable, telomere length inversely correlated with the probability of hematologic relapse (hazard ratio [HR], 0.16; 95% confidence interval [CI], 0.03-0.69; P=.01). The probability of clonal evolution was higher in patients in the first quartile (24.5%; 95% CI, 8.7%-37.5%) than in quartiles 2 through 4 (8.4%; 95% CI, 3.2%-13.3%; P=.009), and evolution to monosomy 7 or complex cytogenetics was more common in the first quartile (18.8%; 95% CI, 3.5%-31.6%) than in quartiles 2 through 4 (4.5%; 95% CI, 0.5%-8.2%; P=.002). Survival between these 2 groups differed, with 66% (95% CI, 52.9%-82.5%) surviving 6 years in the first quartile compared with 83.8% (95% CI, 77.3%-90.9%) in quartiles 2 through 4 (P=.008). Conclusion In a cohort of patients with severe aplastic anemia receiving immunosuppressive therapy, telomere length was unrelated to response but was associated with risk of relapse, clonal evolution, and overall survival. JAMA. 2010; 304(12): 1358-1364	[Scheinberg, Phillip; Cooper, James N.; Sloand, Elaine M.; Calado, Rodrigo T.; Young, Neal S.] NHLBI, Hematol Branch, Bethesda, MD 20892 USA; [Wu, Colin O.] NHLBI, Off Biostat Res, Bethesda, MD 20892 USA; [Cooper, James N.] NIH, Clin Res Training Program, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; Pfizer	Scheinberg, P (corresponding author), NHLBI, Hematol Branch, 10 Ctr Dr,Bldg 10 CRC,Room 3-5140,MSC 1202, Bethesda, MD 20892 USA.	scheinbp@mail.nih.gov	Scheinberg, Phillip/H-5251-2012; Calado, Rodrigo T./G-2619-2011	Scheinberg, Phillip/0000-0002-9047-4538; Calado, Rodrigo T./0000-0002-7966-6029	National Institutes of Health; National Heart, Lung, and Blood Institute; Pfizer Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002315, ZIAHL006089] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Pfizer Inc(Pfizer); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the Intramural Research Program of the National Institutes of Health; the National Heart, Lung, and Blood Institute. Dr Cooper's research year was made possible through the Clinical Research Training Program (CRTP), a public-private partnership supported jointly by the National Institutes of Health and Pfizer Inc (via a grant to the Foundation for National Institutes of Health from Pfizer Inc).	Alter BP, 2009, BLOOD, V113, P6549, DOI 10.1182/blood-2008-12-192880; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Ball SE, 1998, BLOOD, V91, P3582; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Brummendorf TH, 2001, BLOOD, V97, P895, DOI 10.1182/blood.V97.4.895; Calado RT, 2008, BLOOD, V111, P4446, DOI 10.1182/blood-2007-08-019729; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Calado RT, 2009, BLOOD, V114, P2236, DOI 10.1182/blood-2008-09-178871; Calado RT, 2009, P NATL ACAD SCI USA, V106, P1187, DOI 10.1073/pnas.0807057106; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Engelhardt M, 1997, CLIN CANCER RES, V3, P1931; Feldser DM, 2007, CANCER CELL, V11, P461, DOI 10.1016/j.ccr.2007.02.026; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Maciejewski JP, 2002, BLOOD, V99, P3129, DOI 10.1182/blood.V99.9.3129; Meeker AK, 2002, CANCER RES, V62, P6405; Morrish TA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000357; O'Sullivan JN, 2002, NAT GENET, V32, P280, DOI 10.1038/ng989; Risques RA, 2008, GASTROENTEROLOGY, V135, P410, DOI 10.1053/j.gastro.2008.04.008; Risques RA, 2007, CANCER EPIDEM BIOMAR, V16, P2649, DOI 10.1158/1055-9965.EPI-07-0624; Rosenfeld S, 2003, JAMA-J AM MED ASSOC, V289, P1130, DOI 10.1001/jama.289.9.1130; Rossi D, 2009, LEUKEMIA, V23, P1062, DOI 10.1038/leu.2008.399; Scheinberg P, 2006, BRIT J HAEMATOL, V133, P622, DOI 10.1111/j.1365-2141.2006.06098.x; Scheinberg P, 2006, BRIT J HAEMATOL, V133, P606, DOI 10.1111/j.1365-2141.2006.06085.x; Scheinberg P, 2009, HAEMATOL-HEMATOL J, V94, P348, DOI 10.3324/haematol.13829; Scheinberg P, 2009, BRIT J HAEMATOL, V144, P206, DOI 10.1111/j.1365-2141.2008.07450.x; Svenson U, 2009, CANCER RES, V69, P2896, DOI 10.1158/0008-5472.CAN-08-3513; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Young NS, 2006, BLOOD, V108, P2509, DOI 10.1182/blood-2006-03-010777	31	147	170	1	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2010	304	12					1358	1364		10.1001/jama.2010.1376	http://dx.doi.org/10.1001/jama.2010.1376			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	652LK	20858879	Green Accepted			2022-12-01	WOS:000282007900019
J	Zagrosek, A; Messroghli, D; Schulz, O; Dietz, R; Schulz-Menger, J				Zagrosek, Anja; Messroghli, Daniel; Schulz, Olaf; Dietz, Rainer; Schulz-Menger, Jeanette			Effect of Binge Drinking on the Heart as Assessed by Cardiac Magnetic Resonance Imaging	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							MYOCARDITIS; ALCOHOL		[Zagrosek, Anja; Schulz-Menger, Jeanette] Humboldt Univ, Charite Campus Buch, HELIOS Clin, Clin Cardiol, D-1086 Berlin, Germany; [Messroghli, Daniel] Deutsch Herzzentrum Berlin, Dept Congenital Heart Defects & Pediat Cardiol, Berlin, Germany; [Schulz, Olaf] Intervent Kardiol Spandau, Berlin, Germany; [Dietz, Rainer] Humboldt Univ, Charite Campus Virchow, Dept Cardiol, D-1086 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Heart Center Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Zagrosek, A (corresponding author), Humboldt Univ, Charite Campus Buch, HELIOS Clin, Clin Cardiol, D-1086 Berlin, Germany.	anja.zagrosek@charite.de		Schulz-Menger, Jeanette/0000-0003-3100-1092				Goral J, 2008, ALCOHOL, V42, P237, DOI 10.1016/j.alcohol.2008.02.003; Jaffe A S, 2001, Cardiovasc Toxicol, V1, P87, DOI 10.1385/CT:1:2:087; Kim DJ, 2003, ALCOHOL, V31, P167, DOI 10.1016/j.alcohol.2003.09.003; Maron BJ, 2005, J AM COLL CARDIOL, V45, P1340, DOI 10.1016/j.jacc.2005.02.011; Urbano-Marquez A, 2004, MUSCLE NERVE, V30, P689, DOI 10.1002/mus.20168; Zagrosek A, 2009, JACC-CARDIOVASC IMAG, V2, P131, DOI 10.1016/j.jcmg.2008.09.014	6	32	33	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2010	304	12					1328	1330		10.1001/jama.2010.1343	http://dx.doi.org/10.1001/jama.2010.1343			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	652LK	20858877	Bronze			2022-12-01	WOS:000282007900014
J	Duce, JA; Tsatsanis, A; Cater, MA; James, SA; Robb, E; Wikhe, K; Leong, SL; Perez, K; Johanssen, T; Greenough, MA; Cho, HH; Galatis, D; Moir, RD; Masters, CL; McLean, C; Tanzi, RE; Cappai, R; Barnham, KJ; Ciccotosto, GD; Rogers, JT; Bush, AI				Duce, James A.; Tsatsanis, Andrew; Cater, Michael A.; James, Simon A.; Robb, Elysia; Wikhe, Krutika; Leong, Su Ling; Perez, Keyla; Johanssen, Timothy; Greenough, Mark A.; Cho, Hyun-Hee; Galatis, Denise; Moir, Robert D.; Masters, Colin L.; McLean, Catriona; Tanzi, Rudolph E.; Cappai, Roberto; Barnham, Kevin J.; Ciccotosto, Giuseppe D.; Rogers, Jack T.; Bush, Ashley I.			Iron-Export Ferroxidase Activity of beta-Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's Disease	CELL			English	Article							ISOFORM MESSENGER-RNAS; TARGETING A-BETA; SENILE PLAQUE; METAL-BINDING; BRAIN; CERULOPLASMIN; EXPRESSION; ACCUMULATION; AGE; OXIDATION	Alzheimer's Disease (AD) is complicated by pro-oxidant intraneuronal Fe2+ elevation as well as extracellular Zn2+ accumulation within amyloid plaque. We found that the AD beta-amyloid protein precursor (APP) possesses ferroxidase activity mediated by a conserved H-ferritin-like active site, which is inhibited specifically by Zn2+. Like ceruloplasmin, APP catalytically oxidizes Fe2+, loads Fe3+ into transferrin, and has a major interaction with ferroportin in HEK293T cells (that lack ceruloplasmin) and in human cortical tissue. Ablation of APP in HEK293T cells and primary neurons induces marked iron retention, whereas increasing APP695 promotes iron export. Unlike normal mice, APP(-/-) mice are vulnerable to dietary iron exposure, which causes Fe2+ accumulation and oxidative stress in cortical neurons. Paralleling iron accumulation, APP ferroxidase activity in AD postmortem neocortex is inhibited by endogenous Zn2+, which we demonstrate can originate from Zn2+-laden amyloid aggregates and correlates with A beta burden. Abnormal exchange of cortical zinc may link amyloid pathology with neuronal iron accumulation in AD.	[Leong, Su Ling; Perez, Keyla; Johanssen, Timothy; Cappai, Roberto; Barnham, Kevin J.; Ciccotosto, Giuseppe D.; Rogers, Jack T.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Greenough, Mark A.] Univ Melbourne, Dept Genet, Melbourne, Vic 3010, Australia; [Leong, Su Ling; Perez, Keyla; Galatis, Denise; Cappai, Roberto; Barnham, Kevin J.; Ciccotosto, Giuseppe D.; Bush, Ashley I.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Duce, James A.; Tsatsanis, Andrew; Cater, Michael A.; James, Simon A.; Robb, Elysia; Wikhe, Krutika; Perez, Keyla; Greenough, Mark A.; Masters, Colin L.; Barnham, Kevin J.; Ciccotosto, Giuseppe D.; Bush, Ashley I.] Univ Melbourne, Mental Hlth Res Inst, Parkville, Vic 3052, Australia; [Cho, Hyun-Hee; Rogers, Jack T.] Harvard Univ, Sch Med, Dept Psychiat, Neurochem Lab, Boston, MA 02129 USA; [Moir, Robert D.; Tanzi, Rudolph E.] Massachusetts Gen Hosp, Genet & Aging Res Unit, Boston, MA 02129 USA; [McLean, Catriona] Alfred Hosp, Dept Anat Pathol, Melbourne, Vic 3004, Australia	University of Melbourne; University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Florey Institute of Neuroscience & Mental Health	Rogers, JT (corresponding author), Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia.	jrogers@partners.org; abush@mhri.edu.au	Greenough, Mark/AAK-1615-2021; James, Simon/J-5320-2012; Bush, Ashley/Y-2457-2019; Moir, Robert D./M-7612-2017; Bush, Ashley I/A-1186-2007; Johanssen, Tim/G-6106-2014; Tanzi, Rudolph/AAE-9622-2019; James, Simon/ABA-8646-2020; Cappai, Roberto/B-3347-2010	James, Simon/0000-0001-9369-3288; Bush, Ashley/0000-0001-8259-9069; Moir, Robert D./0000-0001-5431-3553; Bush, Ashley I/0000-0001-8259-9069; Johanssen, Tim/0000-0001-6757-586X; Tanzi, Rudolph/0000-0002-7032-1454; Cappai, Roberto/0000-0002-9505-8496; Rogers, Jack/0000-0003-1262-8578; Duce, James/0000-0002-8762-2245; Greenough, Mark/0000-0001-6767-0584; McLean, Catriona/0000-0002-0302-5727	National Institute on Aging [1RO1AG12686]; Australian Research Council; Australian National Health & Medical Research Council (NHMRC); NATIONAL INSTITUTE ON AGING [R01AG012686] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Australian Research Council(Australian Research Council); Australian National Health & Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funds from the National Institute on Aging (1RO1AG12686), the Australian Research Council, the Australian National Health & Medical Research Council (NHMRC), Operational Infrastructure Support Victorian State Government, and the Alzheimer's Association. The Victorian Brain Bank Network is supported by The University of Melbourne, The Mental Health Research Institute, The Alfred Hospital, and the Victorian Forensic Institute of Medicine and funded by Neurosciences Australia and the NHMRC. We thank Gerd Multhaup for helpful comments and for providing APP reagents for pilot studies, Paul Adlard for human tissue samples, and Wilma Wasco for the APLP2 construct. C. L. M., R. E. T., K.J.B., and A. I. B. are shareholders, paid consultants, and advisory board members of Prana Biotechnology Ltd. A.I.B. is a shareholder of Cogstate Ltd and Eucalyptus Biosciences Pty Ltd. M. A. C. is a shareholder in Prana Biotechnology Ltd.	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; BAKKER GR, 1986, J BIOL CHEM, V261, P3182; Bartzokis G, 2000, CELL MOL BIOL, V46, P821; BARTZOKIS G, 1994, AM J NEURORADIOL, V15, P1129; BARTZOKIS G, 1994, BIOL PSYCHIAT, V35, P480, DOI 10.1016/0006-3223(94)90047-7; BODOVITZ S, 1995, J NEUROCHEM, V64, P307; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cherny RA, 1999, J BIOL CHEM, V274, P23223, DOI 10.1074/jbc.274.33.23223; Chinnery PF, 2007, BRAIN, V130, P110, DOI 10.1093/brain/awl319; CRAS P, 1991, P NATL ACAD SCI USA, V88, P7552, DOI 10.1073/pnas.88.17.7552; DE DOMENICO I, 2008, CELL METAB, V8, P146; DE DOMENICO I, 2007, EMBO J, V26, P2823; deSilva HAR, 1997, MOL BRAIN RES, V47, P147; Ding B, 2009, J MAGN RESON IMAGING, V29, P793, DOI 10.1002/jmri.21730; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; EL TAYARA NE, 2006, NEUROBIOL DIS, V22, P199; Falangola MF, 2005, NEUROCHEM RES, V30, P201, DOI 10.1007/s11064-004-2442-x; Faux NG, 2010, J ALZHEIMERS DIS, V20, P509, DOI 10.3233/JAD-2010-1390; Furukawa K, 1996, J NEUROCHEM, V67, P1882, DOI 10.1046/j.1471-4159.1996.67051882.x; Gonzalez-Cuyar LF, 2008, NEUROPATHOLOGY, V28, P466, DOI 10.1111/j.1440-1789.2008.00901.x; GRAY CW, 1993, NEUROREPORT, V4, P811, DOI 10.1097/00001756-199306000-00054; GRUNDKEIQBAL I, 1990, ACTA NEUROPATHOL, V81, P105, DOI 10.1007/BF00334497; Gutierrez JA, 1997, J CELL BIOL, V139, P895, DOI 10.1083/jcb.139.4.895; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Hao Q, 2005, J ALZHEIMERS DIS, V8, P161; HARRIS ZL, 1995, P NATL ACAD SCI USA, V92, P2539, DOI 10.1073/pnas.92.7.2539; Honda K, 2005, J BIOL CHEM, V280, P20978, DOI 10.1074/jbc.M500526200; Jack CR, 2005, J NEUROSCI, V25, P10041, DOI 10.1523/JNEUROSCI.2588-05.2005; Jeong SY, 2006, J NEUROSCI, V26, P9810, DOI 10.1523/JNEUROSCI.2922-06.2006; Jeong SY, 2003, J BIOL CHEM, V278, P27144, DOI 10.1074/jbc.M301988200; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; Klomp LWJ, 1996, J CLIN INVEST, V98, P207, DOI 10.1172/JCI118768; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; LAWSON DM, 1989, FEBS LETT, V254, P207, DOI 10.1016/0014-5793(89)81040-3; LAWSON DM, 1991, NATURE, V349, P541, DOI 10.1038/349541a0; Lee JY, 2002, P NATL ACAD SCI USA, V99, P7705, DOI 10.1073/pnas.092034699; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Mantovan MC, 2006, EUR J NEUROL, V13, P827, DOI 10.1111/j.1468-1331.2006.01363.x; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Maynard CJ, 2002, J BIOL CHEM, V277, P44670, DOI 10.1074/jbc.M204379200; Meloni G, 2008, NAT CHEM BIOL, V4, P366, DOI 10.1038/nchembio.89; Miller LM, 2006, J STRUCT BIOL, V155, P30, DOI 10.1016/j.jsb.2005.09.004; MITA S, 1989, AM J PATHOL, V134, P1253; NINOMIYA H, 1993, J CELL BIOL, V121, P879, DOI 10.1083/jcb.121.4.879; Opazo C, 2002, J BIOL CHEM, V277, P40302, DOI 10.1074/jbc.M206428200; OSAKI S, 1966, J BIOL CHEM, V241, P5053; Patel BN, 2002, J NEUROSCI, V22, P6578; Qian ZM, 2007, BBA-MOL BASIS DIS, V1772, P527, DOI 10.1016/j.bbadis.2007.02.006; Religa D, 2006, NEUROLOGY, V67, P69, DOI 10.1212/01.wnl.0000223644.08653.b5; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; ROBINSON SR, 1995, ALZ RES, V1, P191; Rogers JT, 2002, J BIOL CHEM, V277, P45518, DOI 10.1074/jbc.M207435200; Rossjohn J, 1999, NAT STRUCT BIOL, V6, P327; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; Suh SW, 2000, BRAIN RES, V852, P274, DOI 10.1016/S0006-8993(99)02096-X; Takahashi M, 2000, NEURON, V28, P461, DOI 10.1016/S0896-6273(00)00125-2; Toussaint L, 2007, J MOL BIOL, V365, P440, DOI 10.1016/j.jmb.2006.10.010; UCHIDA Y, 1991, NEURON, V7, P337, DOI 10.1016/0896-6273(91)90272-2; Visser CC, 2004, PHARM RES-DORDR, V21, P761, DOI 10.1023/B:PHAM.0000026425.69874.8e; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; Yamamoto A, 2002, J NEUROCHEM, V82, P1137; Yang XK, 1998, BIOCHEMISTRY-US, V37, P9743, DOI 10.1021/bi973128a; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537	64	473	491	2	84	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2010	142	6					857	867		10.1016/j.cell.2010.08.014	http://dx.doi.org/10.1016/j.cell.2010.08.014			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650NA	20817278	Green Accepted, Green Submitted, Bronze			2022-12-01	WOS:000281855000009
J	Singh, SK; Sabatinos, S; Forsburg, S; Bastia, D				Singh, Samarendra K.; Sabatinos, Sarah; Forsburg, Susan; Bastia, Deepak			Regulation of Replication Termination by Reb1 Protein-Mediated Action at a Distance	CELL			English	Article							SCHIZOSACCHAROMYCES-POMBE; ESCHERICHIA-COLI; DNA-REPLICATION; RIBOSOMAL DNA; POLAR ARREST; FORK ARREST; GENE; ORGANIZATION; CONTRAHELICASE; MECHANISM	DNA transactions driven by long-range protein-mediated inter-and intrachromosomal interactions have been reported to influence gene expression. Here, we report that site-specific replication termination in Schizosaccharomyces pombe is modulated by protein-mediated interactions between pairs of Ter sites located either on the same or on different chromosomes. The dimeric Reb1 protein catalyzes termination and mediates interaction between Ter sites. The Reb1-dependent interactions between two antiparallel Ter sites in cis caused looping out of the intervening DNA in vitro and enhancement of fork arrest in vivo. A Ter site on chromosome 2 interacted pairwise with two Ter sites located on chromosome 1 by chromosome kissing. Mutational inactivation of the major interacting Ter site on chromosome 1 significantly reduced fork arrest at the Ter site on chromosome 2, thereby revealing a cooperative mechanism of control of replication termination.	[Singh, Samarendra K.; Bastia, Deepak] Med Univ S Carolina, Dept Mol Biol & Biochem, Charleston, SC 29425 USA; [Sabatinos, Sarah; Forsburg, Susan] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA	Medical University of South Carolina; University of Southern California	Bastia, D (corresponding author), Med Univ S Carolina, Dept Mol Biol & Biochem, Charleston, SC 29425 USA.	bastia@musc.edu		Forsburg, Susan L/0000-0002-4895-8598	 [GM 049264];  [GM 049264-17S1]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049264, R01GM059321] Funding Source: NIH RePORTER	; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the grants GM 049264 and GM 049264-17S1 to D.B. We thank Louise Pape (University of Wisconsin) for strains and S. Biswas for technical help with one of the experiments. We also thank Carlos Escalante (VCU, Richmond, VA) for performing bioinformatics analysis of Reb1 and pointing out the presence of SANT-like domains within the myb-associated domain of Reb1, Tony Carr, Robert Schleif, and Fred Winston for useful comments on our manuscript, and Pablo Hernandez for allowing us to cite his work before its publication.	ARCANGIOLI B, 1991, EMBO J, V10, P3025, DOI 10.1002/j.1460-2075.1991.tb07853.x; Bastia D., 1996, DNA REPLICATION EUKA, P177; Bastia D, 2008, P NATL ACAD SCI USA, V105, P12831, DOI 10.1073/pnas.0805898105; Bastia Deepak, 2006, V47, P155; Biswas S, 2008, MOL CELL BIOL, V28, P6844, DOI 10.1128/MCB.01235-08; Blanco MA, 2000, EMBO J, V19, P3945, DOI 10.1093/emboj/19.15.3945; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; CHOY HE, 1992, P NATL ACAD SCI USA, V89, P11264, DOI 10.1073/pnas.89.23.11264; DE LAAT W, 2007, CURR OPIN CELL BIOL, V19, P317; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DUNN TM, 1984, P NATL ACAD SCI-BIOL, V81, P5017, DOI 10.1073/pnas.81.16.5017; Eydmann T, 2008, GENETICS, V180, P27, DOI 10.1534/genetics.108.089243; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Gondor A, 2008, NAT PROTOC, V3, P303, DOI 10.1038/nprot.2007.540; GRIMM C, 1988, MOL GEN GENET, V215, P81, DOI 10.1007/BF00331307; HOCHSCHILD A, 1986, CELL, V44, P681, DOI 10.1016/0092-8674(86)90833-0; HOCHSTRASSER M, 1987, J CELL BIOL, V104, P1471, DOI 10.1083/jcb.104.6.1471; Kaplan DL, 2009, MOL MICROBIOL, V72, P279, DOI 10.1111/j.1365-2958.2009.06656.x; KAUL S, 1994, P NATL ACAD SCI USA, V91, P11143, DOI 10.1073/pnas.91.23.11143; KHATRI GS, 1989, CELL, V59, P667, DOI 10.1016/0092-8674(89)90012-3; Kim SM, 2001, EMBO J, V20, P6115, DOI 10.1093/emboj/20.21.6115; Kitamura K, 1998, MOL BIOL CELL, V9, P1065, DOI 10.1091/mbc.9.5.1065; Krings G, 2005, J BIOL CHEM, V280, P39135, DOI 10.1074/jbc.M508996200; Krings G, 2004, P NATL ACAD SCI USA, V101, P14085, DOI 10.1073/pnas.0406037101; KRINGS G, 2007, THESIS MUSC CHARLEST; Krings G, 2006, MOL CELL BIOL, V26, P8061, DOI 10.1128/MCB.01102-06; LEE EH, 1989, P NATL ACAD SCI USA, V86, P9104, DOI 10.1073/pnas.86.23.9104; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Mejia-Ramirez E, 2005, MOL CELL BIOL, V25, P8755, DOI 10.1128/MCB.25.19.8755-8761.2005; MIRON A, 1992, EMBO J, V11, P1205, DOI 10.1002/j.1460-2075.1992.tb05161.x; MUKHERJEE S, 1988, CELL, V52, P375, DOI 10.1016/S0092-8674(88)80030-8; Mulugu S, 2001, P NATL ACAD SCI USA, V98, P9569, DOI 10.1073/pnas.171065898; Nemeth A, 2008, EMBO J, V27, P1255, DOI 10.1038/emboj.2008.57; Sanchez-Gorostiaga A, 2004, MOL CELL BIOL, V24, P398, DOI 10.1128/MCB.24.1.398-406.2004; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; Segurado M, 2003, EMBO REP, V4, P1048, DOI 10.1038/sj.embor.7400008; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Tan-Wong SM, 2009, GENE DEV, V23, P2610, DOI 10.1101/gad.1823209; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; WU JR, 1995, NUCLEIC ACIDS RES, V23, P3997, DOI 10.1093/nar/23.19.3997; Zhao A, 1997, NUCLEIC ACIDS RES, V25, P904, DOI 10.1093/nar/25.4.904; Zzaman S, 2005, MOL CELL, V20, P833, DOI 10.1016/j.molcel.2005.10.037	44	23	23	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2010	142	6					868	878		10.1016/j.cell.2010.08.013	http://dx.doi.org/10.1016/j.cell.2010.08.013			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650NA	20850009	Bronze, Green Accepted			2022-12-01	WOS:000281855000010
J	Worobey, M; Telfer, P; Souquiere, S; Hunter, M; Coleman, CA; Metzger, MJ; Reed, P; Makuwa, M; Hearn, G; Honarvar, S; Roques, P; Apetrei, C; Kazanji, M; Marx, PA				Worobey, Michael; Telfer, Paul; Souquiere, Sandrine; Hunter, Meredith; Coleman, Clint A.; Metzger, Michael J.; Reed, Patricia; Makuwa, Maria; Hearn, Gail; Honarvar, Shaya; Roques, Pierre; Apetrei, Cristian; Kazanji, Mirdad; Marx, Preston A.			Island Biogeography Reveals the Deep History of SIV	SCIENCE			English	Article							EVOLUTION		[Telfer, Paul; Hunter, Meredith; Coleman, Clint A.; Metzger, Michael J.; Reed, Patricia; Apetrei, Cristian; Marx, Preston A.] Tulane Natl Primate Res Ctr, Covington, LA 70433 USA; [Worobey, Michael] Univ Arizona, Tucson, AZ 85721 USA; [Telfer, Paul; Souquiere, Sandrine; Reed, Patricia; Makuwa, Maria; Roques, Pierre; Kazanji, Mirdad] Ctr Int Med Res, Franceville, Gabon; [Hearn, Gail; Honarvar, Shaya] Drexel Univ, Philadelphia, PA 19104 USA	Tulane University; University of Arizona; Drexel University	Marx, PA (corresponding author), Tulane Natl Primate Res Ctr, Covington, LA 70433 USA.	pmarx@tulane.edu	Metzger, Michael/AAA-3635-2022; Metzger, Michael/E-2242-2014; Roques, Pierre/M-2212-2013; Apetrei, Cristian/AAG-9032-2021	Metzger, Michael/0000-0001-7855-1388; Metzger, Michael/0000-0001-7855-1388; Roques, Pierre/0000-0003-1825-1054; Apetrei, Cristian/0000-0002-0322-7185	NIH [1RO1AI27698, 1RO1AI44596]; Tulane Phase II Enhancement Grant; ExxonMobil Foundation; David and Lucile Packard Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044596, R01AI027698] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane Phase II Enhancement Grant; ExxonMobil Foundation(Exxon Mobil Corporation); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. M. Butynski, J. M. Esara Echube, A. Lackner, and M. Sanderson for assistance and comments and acknowledge support from NIH grants 1RO1AI27698 and 1RO1AI44596, a Tulane Phase II Enhancement Grant, the ExxonMobil Foundation, and the David and Lucile Packard Foundation. Newly reported SIV sequences have been deposited in GenBank under accession numbers HM363406 to HM363427. P. Reed and P. T. are at the Wildlife Conservation Society, Bronx, NY, USA. P. Roques is at Commissariat a l'Energie Atomique-Life Science Division, Fontenay-aux-Roses, France. C. A. is at University of Pittsburgh, PA. M. J. M. is at University of Washington, Seattle, WA. M. K. is at Institut de Bangui, Bangui, Central African Republic.	de Sousa JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009936; Drucker E, 2001, LANCET, V358, P1989, DOI 10.1016/S0140-6736(01)06967-7; Gifford RJ, 2008, P NATL ACAD SCI USA, V105, P20362, DOI 10.1073/pnas.0807873105; JONES PJ, 1994, BIODIVERS CONSERV, V3, P772, DOI 10.1007/BF00129657; Sharp PM, 2000, BIOCHEM SOC T, V28, P275, DOI 10.1042/bst0280275; Wertheim JO, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000377	6	144	146	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2010	329	5998					1487	1487		10.1126/science.1193550	http://dx.doi.org/10.1126/science.1193550			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650RK	20847261				2022-12-01	WOS:000281869000031
J	Sanderson, WC; Scherbov, S				Sanderson, Warren C.; Scherbov, Sergei			Remeasuring Aging	SCIENCE			English	Editorial Material							LIFE EXPECTANCY; POPULATIONS; HEALTH		[Sanderson, Warren C.] SUNY Stony Brook, Stony Brook, NY 11794 USA; [Scherbov, Sergei] Vienna Inst Demog, A-1040 Vienna, Austria; [Sanderson, Warren C.; Scherbov, Sergei] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria	State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; International Institute for Applied Systems Analysis (IIASA)	Sanderson, WC (corresponding author), SUNY Stony Brook, Stony Brook, NY 11794 USA.	warren.sanderson@stonybrook.edu	Sanderson, Warren/R-3398-2019; Scherbov, Sergey/F-3158-2019	Scherbov, Sergey/0000-0001-5902-3790; Sanderson, Warren/0000-0002-2205-948X; Scherbov, Sergei/0000-0002-0881-1073				Bhattacharya J, 2004, NBER FR HLTH POL RES, P75; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; COTIS JP, 2003, 239 OECD; *EHEMU, 2009, DAT ACT LIM STAT INC; FUCHS VR, 1984, MILBANK FUND Q, V62, P143; *HUM MORT, HUM MORT DAT; JACOB S, 1993, GENERATION CHANGE PR; Lafortune G, 2007, OECD HLTH WORKING PA; Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516; Manton KG, 2006, P NATL ACAD SCI USA, V103, P18374, DOI 10.1073/pnas.0608483103; Manton KG, 2006, POPUL DEV REV, V32, P81, DOI 10.1111/j.1728-4457.2006.00106.x; MANTON KG, 1986, J AM STAT ASSOC, V81, P635, DOI 10.2307/2288991; *OECD, 2005, AG POP HIGH TIM ACT; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; PETERSON P, 1999, GRAY COMING AGE WAVE; RYDER NB, 1975, POPUL INDEX, V41, P3, DOI 10.2307/2734140; Sanderson W, 2008, CONVENTIONAL PROSPEC; SANDERSON W, 2008, POP B, V63, P4; Sanderson WC, 2007, DEMOGR RES, V16, P27, DOI 10.4054/DemRes.2007.16.2; Sanderson WC, 2005, NATURE, V435, P811, DOI 10.1038/nature03593; SCHULTZ G, 2008, PUTTING OUR HOUSE OR; *SOC SEC ADM, 2010, RETR BEN; *SOC SEC ADM, 2008, SOC SEC WORLD EUR; *UK, CAL YOUR STAT PENS A; *UN, 2001, WORL POP AG 1950 205; United Nations, 2009, WORLD POP AG 2009; United Nations, 2007, WORLD POP AG 2007; United Nations, 2009, WORLD POP PROSP 2008	28	166	170	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2010	329	5997					1287	1288		10.1126/science.1193647	http://dx.doi.org/10.1126/science.1193647			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	647YR	20829469				2022-12-01	WOS:000281657300018
J	Swartzendruber, A; Zenilman, JM				Swartzendruber, Andrea; Zenilman, Jonathan M.			A National Strategy to Improve Sexual Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Zenilman, Jonathan M.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21224 USA; [Swartzendruber, Andrea] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zenilman, JM (corresponding author), Johns Hopkins Univ, Sch Med, 4940 Eastern Ave, Baltimore, MD 21224 USA.	jzenilma@jhmi.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BERENSON A, 2005, NY TIMES        1204; Buller JL, 2007, MIL MED, V172, P511, DOI 10.7205/MILMED.172.5.511; Centers for Disease Control and Prevention, FREQ ASK QUEST HPV V; Centers for Disease Control and Prevention, HIV INC; DOUGLAS J, 2009, CHALL OPP STD PREV U; Lottes IL, 2002, J SEX RES, V39, P79, DOI 10.1080/00224490209552125; Medical Foundation for AIDS and Sexual Health, 2008, PROGR PRIOR WORK TOG; Satcher D., 2001, SURG GEN CALL ACTION; *WHIT HOUS, 2009, JOINT SESS C FEBR 24; WHO, GEND HUM RIGHTS	10	43	43	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 1	2010	304	9					1005	1006		10.1001/jama.2010.1252	http://dx.doi.org/10.1001/jama.2010.1252			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645AD	20810379				2022-12-01	WOS:000281422400028
J	Volpp, KG; Friedman, W; Romano, PS; Rosen, A; Silber, JH				Volpp, Kevin G.; Friedman, William; Romano, Patrick S.; Rosen, Amy; Silber, Jeffrey H.			Residency Training at a Crossroads: Duty-Hour Standards 2010	ANNALS OF INTERNAL MEDICINE			English	Article							MORTALITY; RISK; SLEEP; TIME	In 2003, the Accreditation Council for Graduate Medical Education (ACGME) implemented a single duty-hour standard nationwide. The evidence to date suggests that this neither improved nor worsened patient outcomes. In June 2010, the ACGME proposed a new set of duty-hour standards for implementation in July 2011. The main disadvantage of this approach is that there is no ability to determine whether different standards would have worked better to reduce resident fatigue while improving patient safety. Many unanswered questions remain about how to design duty-hour standards, but relatively little evidence exists. In addition, the same approach may not work in all specialties and all hospitals. A more flexible, dynamic policy that emphasizes ongoing testing and evaluation would be more likely to achieve improvements in clinical and educational outcomes.	[Silber, Jeffrey H.] Childrens Hosp Philadelphia, Ctr Outcomes Res, Philadelphia, PA 19104 USA; Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA; Univ Penn, Leonard Davis Inst Hlth Econ, Ctr Hlth Incent, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; Univ Florida, Gainesville, FL 32610 USA; Univ Calif Davis, Sch Med, Ctr Healthcare Policy & Res, Sacramento, CA 95817 USA; Vet Affairs Boston Healthcare Syst, Ctr Org Leadership & Management Res, Boston, MA USA; Boston Univ, Sch Publ Hlth, Boston, MA USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; State University System of Florida; University of Florida; University of California System; University of California Davis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University	Silber, JH (corresponding author), Childrens Hosp Philadelphia, Ctr Outcomes Res, 3535 Market St,Suite 1029, Philadelphia, PA 19104 USA.	silber@email.chop.edu	Romano, Patrick S/N-4225-2014; Friedman, William/GLR-1220-2022	Romano, Patrick S/0000-0001-6749-3979; Volpp, Kevin/0000-0003-1423-4599	National Heart, Lung, and Blood Institute [R01 HL082637]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082637] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By grant R01 HL082637 from the National Heart, Lung, and Blood Institute.	Antiel RM, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMp1008305; Arora VM, 2008, QUAL SAF HEALTH CARE, V17, P11, DOI 10.1136/qshc.2006.018952; Arora V, 2006, ANN INTERN MED, V144, P792, DOI 10.7326/0003-4819-144-11-200606060-00005; Arora VM, 2009, J HOSP MED, V4, P433, DOI 10.1002/jhm.573; Ayas NT, 2006, JAMA-J AM MED ASSOC, V296, P1055, DOI 10.1001/jama.296.9.1055; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; Ericsson KA, 2008, ACAD EMERG MED, V15, P988, DOI 10.1111/j.1553-2712.2008.00227.x; Kirch DG, 2010, COMMUNICATION   0809; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Nasca P., 2010, BASICS ZYNADDSUBFX; Nasca TJ, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMsb1005800; PETERSEN LA, 1994, ANN INTERN MED, V121, P866, DOI 10.7326/0003-4819-121-11-199412010-00008; Pollack R, 2010, COMMUNICATION   0806; Richardson GS, 1996, SLEEP, V19, P718; Rosen AK, 2009, MED CARE, V47, P723, DOI 10.1097/MLR.0b013e31819a588f; Shetty KD, 2007, ANN INTERN MED, V147, P73, DOI 10.7326/0003-4819-147-2-200707170-00161; Silber JH, 2009, MED CARE, V47, P1191, DOI 10.1097/MLR.0b013e3181adcbff; Ulmer C, 2009, RESIDENT DUTY HOURS: ENHANCING SLEEP, SUPERVISION, AND SAFETY, P1; Volpp KG, 2008, JAMA-J AM MED ASSOC, V300, P1197, DOI 10.1001/jama.300.10.1197; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P984, DOI 10.1001/jama.298.9.984; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975; Volpp KG, 2009, J GEN INTERN MED, V24, P1149, DOI 10.1007/s11606-009-1011-z	22	15	15	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 21	2010	153	12					826	+		10.7326/0003-4819-153-12-201012210-00287	http://dx.doi.org/10.7326/0003-4819-153-12-201012210-00287			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	696PL	20956679	Green Accepted			2022-12-01	WOS:000285453700006
J	Giorgi, C; Ito, K; Lin, HK; Santangelo, C; Wieckowski, MR; Lebiedzinska, M; Bononi, A; Bonora, M; Duszynski, J; Bernardi, R; Rizzuto, R; Tacchetti, C; Pinton, P; Pandolfi, PP				Giorgi, Carlotta; Ito, Keisuke; Lin, Hui-Kuan; Santangelo, Clara; Wieckowski, Mariusz R.; Lebiedzinska, Magdalena; Bononi, Angela; Bonora, Massimo; Duszynski, Jerzy; Bernardi, Rosa; Rizzuto, Rosario; Tacchetti, Carlo; Pinton, Paolo; Pandolfi, Pier Paolo			PML Regulates Apoptosis at Endoplasmic Reticulum by Modulating Calcium Release	SCIENCE			English	Article							CA2+ RELEASE; MITOCHONDRIA; BCL-2; CELLS	The promyelocytic leukemia (PML) tumor suppressor is a pleiotropic modulator of apoptosis. However, the molecular basis for such a diverse proapoptotic role is currently unknown. We show that extranuclear Pml was specifically enriched at the endoplasmic reticulum (ER) and at the mitochondria-associated membranes, signaling domains involved in ER-to-mitochondria calcium ion (Ca2+) transport and in induction of apoptosis. We found Pml in complexes of large molecular size with the inositol 1,4,5-trisphosphate receptor (IP3R), protein kinase Akt, and protein phosphatase 2a (PP2a). Pml was essential for Akt- and PP2a-dependent modulation of IP3R phosphorylation and in turn for IP3R-mediated Ca2+ release from ER. Our findings provide a mechanistic explanation for the pleiotropic role of Pml in apoptosis and identify a pharmacological target for the modulation of Ca2+ signals.	[Giorgi, Carlotta; Bononi, Angela; Bonora, Massimo; Pinton, Paolo] Univ Ferrara, Emilia Romagna Lab BioPharmaNet, Dept Expt & Diagnost Med, Sect Gen Pathol,ICSI, I-44100 Ferrara, Italy; [Giorgi, Carlotta; Bononi, Angela; Bonora, Massimo; Pinton, Paolo] Univ Ferrara, Lab Technol Adv Therapies, I-44100 Ferrara, Italy; [Giorgi, Carlotta] Univ Vita Salute San Raffaele, Ctr Excellence Cell Dev, Milan, Italy; [Giorgi, Carlotta] IIT Network, Res Unit Mol Neurosci, Milan, Italy; [Giorgi, Carlotta; Ito, Keisuke; Bernardi, Rosa; Pinton, Paolo; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr,Dept Med, Beth Israel Deaconess Canc Ctr,Canc Genet Program, Boston, MA 02215 USA; [Giorgi, Carlotta; Ito, Keisuke; Bernardi, Rosa; Pinton, Paolo; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr,Dept Pathol, Beth Israel Deaconess Canc Ctr,Canc Genet Program, Boston, MA 02215 USA; [Giorgi, Carlotta; Ito, Keisuke; Lin, Hui-Kuan; Bernardi, Rosa; Pinton, Paolo; Pandolfi, Pier Paolo] Mem Sloan Kettering Canc Ctr, Dept Pathol, Canc Biol & Genet Program, New York, NY 10065 USA; [Santangelo, Clara; Tacchetti, Carlo] Univ Genoa, Ctr Cell Oncol, IFOM FIRC Inst Mol Oncol Fdn, Genoa, Italy; [Santangelo, Clara; Tacchetti, Carlo] Univ Genoa, Dept Expt Med, Ultrastruct MicroSCoBiO Res Ctr, Genoa, Italy; [Wieckowski, Mariusz R.; Lebiedzinska, Magdalena; Duszynski, Jerzy] M Nencki Inst Expt Biol, PL-02093 Warsaw, Poland; [Bernardi, Rosa] San Raffaele Res Inst, Dept Mol Oncol, Milan, Italy; [Rizzuto, Rosario] Univ Padua, Dept Biomed Sci, Padua, Italy; [Tacchetti, Carlo] Ist Sci San Raffaele, Expt Imaging Ctr, I-20132 Milan, Italy	University of Ferrara; University of Ferrara; Vita-Salute San Raffaele University; Istituto Italiano di Tecnologia - IIT; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Memorial Sloan Kettering Cancer Center; IFOM - FIRC Institute of Molecular Oncology; University of Genoa; University of Genoa; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of Padua; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Pinton, P (corresponding author), Univ Ferrara, Emilia Romagna Lab BioPharmaNet, Dept Expt & Diagnost Med, Sect Gen Pathol,ICSI, I-44100 Ferrara, Italy.	pnp@unife.it; ppandolf@bidmc.harvard.edu	Pinton, Paolo/J-8025-2012; Giorgi, Carlotta/K-4649-2016; Lebiedzińska-Arciszewska, Magdalena/AAA-3279-2022; Bonora, Massimo/AAC-3609-2022; Lebiedzińska-Arciszewska, Magdalena/AAC-5956-2021; bernardi, rosa/B-1650-2013	Pinton, Paolo/0000-0001-7108-6508; Lebiedzińska-Arciszewska, Magdalena/0000-0002-2725-5551; Bonora, Massimo/0000-0002-5752-3318; bernardi, rosa/0000-0002-3607-6336; TACCHETTI, CARLO/0000-0003-4602-000X; Wieckowski, Mariusz/0000-0003-0789-4521; Pandolfi, Pier Paolo/0000-0002-5352-5295; Rizzuto, Rosario/0000-0001-7044-5097; Giorgi, Carlotta/0000-0002-2494-7405; Duszynski, Jerzy/0000-0003-2937-6725	National Cancer Institute; NIH; AIRC; FISM; Telethon; Ministry of Health; PRIN; FP7 "MyoAGE"; Cariparo Foundation; Ministry of Science and Higher Education in Poland; Polish Mitochondrial Network; NATIONAL CANCER INSTITUTE [K99CA139009, R01CA071692, R01CA142874, R01CA102142] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AIRC(Fondazione AIRC per la ricerca sul cancro); FISM(Fondazione Italiana Sclerosi Multipla (FISM)); Telethon(Fondazione Telethon); Ministry of Health; PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); FP7 "MyoAGE"; Cariparo Foundation(Fondazione Cariparo); Ministry of Science and Higher Education in Poland(Ministry of Science and Higher Education, Poland); Polish Mitochondrial Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the National Cancer Institute (to P. P. P.); by K99 NIH (to I. K.); by AIRC, FISM, Telethon, Ministry of Health, and PRIN (to P. P.); by FP7 "MyoAGE", NIH, Cariparo Foundation, and AIRC (to R. R.); and by grants from the Ministry of Science and Higher Education in Poland and the Polish Mitochondrial Network (to M. L., J.D., and M. R. W.). We thank S. Missiroli, F. Poletti, and C. Agnoletto for carrying out some experiments, and J. Meldolesi and members of the Pandolfi and Pinton lab for stimulating discussions.	Bernardi R, 2008, ONCOGENE, V27, P6299, DOI 10.1038/onc.2008.305; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Condemine W, 2006, CANCER RES, V66, P6192, DOI 10.1158/0008-5472.CAN-05-3792; Giorgi C, 2008, CURR MOL MED, V8, P119; Giorgi C, 2009, INT J BIOCHEM CELL B, V41, P1817, DOI 10.1016/j.biocel.2009.04.010; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Lin HK, 2004, NATURE, V431, P205, DOI 10.1038/nature02783; Marchi S, 2008, BIOCHEM BIOPH RES CO, V375, P501, DOI 10.1016/j.bbrc.2008.07.153; Mendes CCP, 2005, J BIOL CHEM, V280, P40892, DOI 10.1074/jbc.M506623200; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Pinton P, 2006, CELL DEATH DIFFER, V13, P1409, DOI 10.1038/sj.cdd.4401960; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Pinton P, 2007, METHOD CELL BIOL, V80, P297, DOI 10.1016/S0091-679X(06)80015-4; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Szado T, 2008, P NATL ACAD SCI USA, V105, P2427, DOI 10.1073/pnas.0711324105; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Yang M, 1997, J BIOL CHEM, V272, P1970, DOI 10.1074/jbc.272.3.1970	21	305	316	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 26	2010	330	6008					1247	1251		10.1126/science.1189157	http://dx.doi.org/10.1126/science.1189157			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	685FE	21030605	Green Accepted			2022-12-01	WOS:000284613700043
J	Waldo, GL; Ricks, TK; Hicks, SN; Cheever, ML; Kawano, T; Tsuboi, K; Wang, XY; Montell, C; Kozasa, T; Sondek, J; Harden, TK				Waldo, Gary L.; Ricks, Tiffany K.; Hicks, Stephanie N.; Cheever, Matthew L.; Kawano, Takeharu; Tsuboi, Kazuhito; Wang, Xiaoyue; Montell, Craig; Kozasa, Tohru; Sondek, John; Harden, T. Kendall			Kinetic Scaffolding Mediated by a Phospholipase C-beta and G(q) Signaling Complex	SCIENCE			English	Article							G-PROTEIN; RGS PROTEINS; ACTIVATION; RECEPTOR; DETERMINANTS; RECOGNITION; HYDROLYSIS; REGULATORS; SUBUNIT; BINDING	Transmembrane signals initiated by a broad range of extracellular stimuli converge on nodes that regulate phospholipase C (PLC)-dependent inositol lipid hydrolysis for signal propagation. We describe how heterotrimeric guanine nucleotide-binding proteins (G proteins) activate PLC-beta s and in turn are deactivated by these downstream effectors. The 2.7-angstrom structure of PLC-beta 3 bound to activated G alpha(q) reveals a conserved module found within PLC-beta s and other effectors optimized for rapid engagement of activated G proteins. The active site of PLC-beta 3 in the complex is occluded by an intramolecular plug that is likely removed upon G protein-dependent anchoring and orientation of the lipase at membrane surfaces. A second domain of PLC-beta 3 subsequently accelerates guanosine triphosphate hydrolysis by G alpha(q), causing the complex to dissociate and terminate signal propagation. Mutations within this domain dramatically delay signal termination in vitro and in vivo. Consequently, this work suggests a dynamic catch-and-release mechanism used to sharpen spatiotemporal signals mediated by diverse sensory inputs.	[Waldo, Gary L.; Ricks, Tiffany K.; Hicks, Stephanie N.; Cheever, Matthew L.; Sondek, John; Harden, T. Kendall] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Kawano, Takeharu; Tsuboi, Kazuhito; Kozasa, Tohru] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; [Wang, Xiaoyue; Montell, Craig] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Dept Biol Chem, Baltimore, MD 21205 USA; [Wang, Xiaoyue; Montell, Craig] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Dept Neurosci, Baltimore, MD 21205 USA; [Kozasa, Tohru] Univ Tokyo, Res Ctr Adv Sci & Technol, Lab Syst Biol & Med, Tokyo 1538904, Japan; [Sondek, John] Univ N Carolina, Sch Med, Dept Biochem, Chapel Hill, NC 27599 USA; [Sondek, John; Harden, T. Kendall] Univ N Carolina, Sch Med, Lineberger Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Johns Hopkins University; Johns Hopkins University; University of Tokyo; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Harden, TK (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA.	tkh@med.unc.edu	Wang, Xiaoyue/D-1046-2010; Montell, Craig/AAH-3357-2021	Montell, Craig/0000-0001-5637-1482; Sondek, John/0000-0002-1127-8310	NIH [GM38213, GM57391, GM61454, GM074001, EY010852]; Ruth L. Kirschstein National Service [F31]; United Negro College; Japan Society for the Promotion of Science; NATIONAL EYE INSTITUTE [R01EY010852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038213, R01GM061454, R01GM074001, R01GM057391, R01GM062299] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United Negro College; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NIH grants GM38213 and GM57391 (J.S. and T.K.H.), GM61454 and GM074001 (T.K.), and EY010852 (C.M.). T.K.R. was supported by a Ruth L. Kirschstein National Service Award F31 Predoctoral Fellowship and a United Negro College Fund Merck Graduate Science Research Dissertation Fellowship. K.T. was supported by a Postdoctoral Fellowship for Research Abroad from the Japan Society for the Promotion of Science. We acknowledge the outstanding help with structural analyses by B. Temple, L. Betts, J. Vanhooke, T. Charpentier, V. Arshavsky, and M. Kosloff; with analysis of linker-deleted PLC-beta 3 by N. Vincent Jordan; with SPR analyses by A. Kimple; with [gamma<SUP>32</SUP>P]GTP purification by E. Lazarowski and the insightful comments on the manuscript by H. Dohlman, R. Nicholas, E. Ross, and K. Slep. Coordinates and structure factors for Ga<INF>q</INF>center dot PLC-b3 have been deposited under the PDB accession code 3OHM.	Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Biddlecome GH, 1996, J BIOL CHEM, V271, P7999, DOI 10.1074/jbc.271.14.7999; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Chen Z, 2005, NAT STRUCT MOL BIOL, V12, P191, DOI 10.1038/nsmb888; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; Doupnik CA, 1997, P NATL ACAD SCI USA, V94, P10461, DOI 10.1073/pnas.94.19.10461; Harden TK, 2006, ANNU REV PHARMACOL, V46, P355, DOI 10.1146/annurev.pharmtox.46.120604.141223; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; MICHELL RH, 1975, BIOCHIM BIOPHYS ACTA, V415, P81, DOI 10.1016/0304-4157(75)90017-9; Mukhopadhyay S, 1999, P NATL ACAD SCI USA, V96, P9539, DOI 10.1073/pnas.96.17.9539; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; Nishiguchi KM, 2004, NATURE, V427, P75, DOI 10.1038/nature02170; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Rojas RJ, 2007, J BIOL CHEM, V282, P29201, DOI 10.1074/jbc.M703458200; Ross EM, 2008, CURR BIOL, V18, pR777, DOI 10.1016/j.cub.2008.07.035; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Shankaranarayanan A, 2008, J BIOL CHEM, V283, P34923, DOI 10.1074/jbc.M805860200; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Singer WD, 1997, ANNU REV BIOCHEM, V66, P475, DOI 10.1146/annurev.biochem.66.1.475; Skiba NP, 2000, J BIOL CHEM, V275, P32716, DOI 10.1074/jbc.C000413200; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; Slep KC, 2008, P NATL ACAD SCI USA, V105, P6243, DOI 10.1073/pnas.0801569105; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Turcotte M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000148; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Venkatakrishnan G, 1996, J BIOL CHEM, V271, P5066; WALDO GL, 1991, J BIOL CHEM, V266, P14217; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Xiao WB, 2009, CANCER CELL, V16, P161, DOI 10.1016/j.ccr.2009.05.018; Zhong HL, 2003, J BIOL CHEM, V278, P7278, DOI 10.1074/jbc.M208819200	39	140	143	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 12	2010	330	6006					974	980		10.1126/science.1193438	http://dx.doi.org/10.1126/science.1193438			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678XY	20966218	Green Accepted			2022-12-01	WOS:000284118000046
J	Leslie, WD; Morin, S; Lix, LM				Leslie, William D.; Morin, Suzanne; Lix, Lisa M.			A Before-and-After Study of Fracture Risk Reporting and Osteoporosis Treatment Initiation	ANNALS OF INTERNAL MEDICINE			English	Article							BONE-DENSITY PROGRAM; QUALITY-OF-LIFE; CLINICAL-PRACTICE; POSTMENOPAUSAL WOMEN; ASSESSMENT-TOOL; PHARMACOLOGICAL-TREATMENT; PRACTICE GUIDELINES; OLDER WOMEN; VALIDATION; DENSITOMETRY	Background: Several national organizations recommend that fracture risk assessment and osteoporotic treatment be based on estimated absolute 10-year fracture risk rather than bone mineral density (BMD) alone. Objective: To assess the changes in physician prescribing behavior after introduction of absolute 10-year fracture risk reporting. Design: Before-and-after study. Setting: Manitoba, Canada, which has an integrated BMD program in which tests are linkable to a population-based administrative health database repository. Patients: Women 50 years or older who were not receiving osteoporosis medication (2042 before and 3889 after intervention). Intervention: Introduction of a system reporting absolute 10-year fracture risk along with dual-energy x-ray absorptiometry results. Measurements: The proportion of untreated women who were prescribed osteoporosis medications in the year after baseline BMD measurement. Results: Absolute fracture risk reporting reclassified more women (32.7%) into lower-risk categories than into higher-risk categories (10%). This effect was more prominent in women younger than 65 years. Fewer women per physician were prescribed osteoporosis drugs after introduction of absolute fracture risk reporting. The absolute fracture risk reporting system was associated with an overall reduction in osteoporosis medications dispensed (adjusted absolute reduction, 9.0 percentage points [95% CI, 3.9 to 14.2 percentage points]; relative reduction, 21.3% [CI, 9.2% to 33.5%]; P < 0.001). The reduction was attributed to fewer drugs dispensed to women at low and moderate risk for fracture. No differences in fracture rates were observed. Limitations: This was a nonrandomized study. The risk assessment system studied differs slightly from other 10-year fracture risk assessment models. Conclusion: Change from a T-score-based fracture risk reporting system to a system based on absolute 10-year fracture risk was associated with appropriate, guideline-based changes in prescription of osteoporosis medications.	Univ Saskatchewan, Saskatoon, SK, Canada; McGill Univ, Montreal, PQ, Canada	University of Saskatchewan; McGill University	Leslie, WD (corresponding author), Univ Manitoba, Dept Med C5121, 409 Tache Ave, Winnipeg, MB R2H 2A6, Canada.	bleslie@sbgh.mb.ca		Morin, Suzanne/0000-0002-4317-492X; Leslie, William/0000-0002-1056-1691				Adachi JD, 2001, OSTEOPOROSIS INT, V12, P903, DOI 10.1007/s001980170017; Baltzan MA, 1999, LANCET, V353, P1327, DOI 10.1016/S0140-6736(98)04835-1; Binkley N, 2005, J BONE MINER RES, V20, P195, DOI 10.1359/JBMR.041115; Black DM, 2001, OSTEOPOROSIS INT, V12, P519, DOI 10.1007/s001980170072; Brown JP, 2002, CAN MED ASSOC J, V167, pS1; Browner WS, 1996, ARCH INTERN MED, V156, P1521, DOI 10.1001/archinte.156.14.1521; Cranney A, 2009, OSTEOPOROSIS INT, V20, P1621, DOI 10.1007/s00198-008-0823-8; Cummings SR, 2002, JAMA-J AM MED ASSOC, V288, P1889, DOI 10.1001/jama.288.15.1889; Dawson-Hughes B, 2008, OSTEOPOROSIS INT, V19, P449, DOI 10.1007/s00198-008-0559-5; Donaldson MG, 2009, J BONE MINER RES, V24, P675, DOI 10.1359/JBMR.081203; Fitzmaurice GM, 2004, APPL LONGITUDINAL AN; Fujiwara S, 2008, OSTEOPOROSIS INT, V19, P429, DOI 10.1007/s00198-007-0544-4; Hallberg I, 2004, OSTEOPOROSIS INT, V15, P834, DOI 10.1007/s00198-004-1622-5; Hannan EL, 2001, JAMA-J AM MED ASSOC, V285, P2736, DOI 10.1001/jama.285.21.2736; Hansen KE, 2005, J BONE MINER RES, V20, P501, DOI 10.1359/JBMR.041134; Hu FB, 1998, AM J EPIDEMIOL, V147, P694; Ioannidis G, 2007, CAN FAM PHYSICIAN, V53, P1694; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; Kanis JA, 2001, OSTEOPOROSIS INT, V12, P989, DOI 10.1007/s001980170006; Kozyrskyj AL, 1998, ANN PHARMACOTHER, V32, P1152, DOI 10.1345/aph.18117; Leslie WD, 2008, OSTEOPOROSIS INT, V19, P459, DOI 10.1007/s00198-008-0565-7; Leslie WD, 2006, BONE, V39, P361, DOI 10.1016/j.bone.2006.02.002; Leslie WD, 2005, J CLIN DENSITOM, V8, P25, DOI 10.1385/JCD:8:1:025; Leslie WD, 2003, OSTEOPOROSIS INT, V14, P334, DOI 10.1007/s00198-003-1375-6; Leslie WD, 2003, J CLIN DENSITOM, V6, P275, DOI 10.1385/JCD:6:3:275; Leslie WD, 2008, BONE, V43, P667, DOI 10.1016/j.bone.2008.06.001; Leslie WD, 2007, ARCH INTERN MED, V167, P1641, DOI 10.1001/archinte.167.15.1641; Leslie WD, 2009, J BONE MINER RES, V24, P353, DOI [10.1359/jbmr.081012, 10.1359/JBMR.081012]; Melton LJ, 2003, ENDOCRIN METAB CLIN, V32, P1, DOI 10.1016/S0889-8529(02)00061-0; Neuner JM, 2006, J AM GERIATR SOC, V54, P485, DOI 10.1111/j.1532-5415.2005.00622.x; Qaseem A, 2008, ANN INTERN MED, V149, P404, DOI 10.7326/0003-4819-149-6-200809160-00007; Richards JB, 2007, J BONE MINER RES, V22, P228, DOI 10.1359/JBMR.061109; Roos NP, 1999, MED CARE, V37, pJS10, DOI 10.1097/00005650-199906001-00005; Schousboe JT, 2005, ANN INTERN MED, V142, P734, DOI 10.7326/0003-4819-142-9-200505030-00008; Siminoski K, 2005, CAN ASSOC RADIOL J, V56, P178; Stock JL, 1998, ANN INTERN MED, V128, P996, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00006; Straus SE, 2009, CAN MED ASSOC J, V181, P165, DOI 10.1503/cmaj.081229; Watts NB, 2008, J CLIN DENSITOM, V11, P473, DOI 10.1016/j.jocd.2008.04.003; *WHO COLL CTR DRUG, 2005, GUID ATC CLASS DDD A	41	21	21	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 2	2010	153	9					580	586		10.7326/0003-4819-153-9-201011020-00007	http://dx.doi.org/10.7326/0003-4819-153-9-201011020-00007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	673MH	21041577				2022-12-01	WOS:000283667000004
J	Bai, JH; Hu, ZT; Dittman, JS; Pym, ECG; Kaplan, JM				Bai, Jihong; Hu, Zhitao; Dittman, Jeremy S.; Pym, Edward C. G.; Kaplan, Joshua M.			Endophilin Functions as a Membrane-Bending Molecule and Is Delivered to Endocytic Zones by Exocytosis	CELL			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; BAR; PROTEINS; CURVATURE; DOMAIN; TRANSMISSION; SYNAPTOJANIN; DOCKING; DYNAMIN; ACTIN	Two models have been proposed for endophilin function in synaptic vesicle (SV) endocytosis. The scaffolding model proposes that endophilin's SH3 domain recruits essential endocytic proteins, whereas the membrane-bending model proposes that the BAR domain induces positively curved membranes. We show that mutations disrupting the scaffolding function do not impair endocytosis, whereas those disrupting membrane bending cause significant defects. By anchoring endophilin to the plasma membrane, we show that endophilin acts prior to scission to promote endocytosis. Despite acting at the plasma membrane, the majority of endophilin is targeted to the SV pool. Photoactivation studies suggest that the soluble pool of endophilin at synapses is provided by unbinding from the adjacent SV pool and that the unbinding rate is regulated by exocytosis. Thus, endophilin participates in an association-dissociation cycle with SVs that parallels the cycle of exo- and endocytosis. This endophilin cycle may provide a mechanism for functionally coupling endocytosis and exocytosis.	[Bai, Jihong; Hu, Zhitao; Pym, Edward C. G.; Kaplan, Joshua M.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Bai, Jihong; Hu, Zhitao; Pym, Edward C. G.; Kaplan, Joshua M.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Dittman, Jeremy S.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Cornell University	Kaplan, JM (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	kaplan@molbio.mgh.harvard.edu	hu, zhitao/H-5626-2011	Dittman, Jeremy S./0000-0002-3850-9078; Hu, Zhitao/0000-0002-2948-3339	Jane Coffin Childs postdoctoral fellowship; NIH [GM54728, K99MH085039]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH085039] Funding Source: NIH RePORTER	Jane Coffin Childs postdoctoral fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the following for strains and reagents: Roger Tsien, Jennifer Lippincott-Schwartz, and the C. elegans Genetics Stock Center. We thank members of the Kaplan lab and Susana Garcia for critical comments. This work was supported by a Jane Coffin Childs postdoctoral fellowship (J.B.) and by NIH grants GM54728 (J.M.K.) and K99MH085039 (J.B.).	Ch'ng Q, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000283; Darcy KJ, 2006, NAT NEUROSCI, V9, P315, DOI 10.1038/nn1640; Dickman DK, 2005, CELL, V123, P521, DOI 10.1016/j.cell.2005.09.026; Dittman J, 2009, ANNU REV CELL DEV BI, V25, P133, DOI 10.1146/annurev.cellbio.042308.113302; Dittman JS, 2006, P NATL ACAD SCI USA, V103, P11399, DOI 10.1073/pnas.0600784103; Fabian-Fine R, 2003, J NEUROSCI, V23, P10732; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Jordan R, 2005, BIOPHYS J, V89, P2091, DOI 10.1529/biophysj.105.061663; Kohn RE, 2000, MOL BIOL CELL, V11, P3441, DOI 10.1091/mbc.11.10.3441; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Madison JM, 2005, CURR BIOL, V15, P2236, DOI 10.1016/j.cub.2005.10.049; Mahoney TR, 2006, MOL BIOL CELL, V17, P2617, DOI 10.1091/mbc.E05-12-1170; Mani M, 2007, NEURON, V56, P1004, DOI 10.1016/j.neuron.2007.10.032; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; McNew JA, 1999, MOL CELL, V4, P415, DOI 10.1016/S1097-2765(00)80343-3; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; Shupliakov O, 2009, NEUROSCIENCE, V158, P204, DOI 10.1016/j.neuroscience.2008.03.035; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118	33	87	95	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 29	2010	143	3					430	441		10.1016/j.cell.2010.09.024	http://dx.doi.org/10.1016/j.cell.2010.09.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	672RF	21029864	Bronze, Green Accepted			2022-12-01	WOS:000283603900016
J	Derdowski, A; Sindi, SS; Klaips, CL; DiSalvo, S; Serio, TR				Derdowski, Aaron; Sindi, Suzanne S.; Klaips, Courtney L.; DiSalvo, Susanne; Serio, Tricia R.			A Size Threshold Limits Prion Transmission and Establishes Phenotypic Diversity	SCIENCE			English	Article							PSI+ PRION; NEURODEGENERATIVE DISEASES; SACCHAROMYCES-CEREVISIAE; YEAST; PROTEIN; PROPAGATION; GENERATION; PARTICLES; PROPAGONS; AMYLOIDS	According to the prion hypothesis, atypical phenotypes arise when a prion protein adopts an alternative conformation and persist when that form assembles into self-replicating aggregates. Amyloid formation in vitro provides a model for this protein-misfolding pathway, but the mechanism by which this process interacts with the cellular environment to produce transmissible phenotypes is poorly understood. Using the yeast prion Sup35/[PSI+], we found that protein conformation determined the size distribution of aggregates through its interactions with a molecular chaperone. Shifts in this range created variations in aggregate abundance among cells because of a size threshold for transmission, and this heterogeneity, along with aggregate growth and fragmentation, induced age-dependent fluctuations in phenotype. Thus, prion conformations may specify phenotypes as population averages in a dynamic system.	[Derdowski, Aaron; Sindi, Suzanne S.; Klaips, Courtney L.; DiSalvo, Susanne; Serio, Tricia R.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Sindi, Suzanne S.] Brown Univ, Ctr Computat Mol Biol, Providence, RI 02912 USA	Brown University; Brown University	Sindi, SS (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, 185 Meeting St,POB G-L2, Providence, RI 02912 USA.	suzanne_sindi@brown.edu; tricia_serio@brown.edu	Serio, Tricia/GPP-7129-2022; DiSalvo, Susanne/AAR-9746-2020	Klaips, Courtney/0000-0002-4929-1641; Serio, Tricia/0000-0003-2687-7372	NIH [GM069802, GM085976, GM089049, AG034754, AG032818]; NSF [0548311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007601, F32GM089049, F32GM085976, R01GM069802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG034754, F31AG032818] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank N. Rhind, M. Duennwald, J. Sherley, and members of their groups for assistance with centrifugal elutriation, and the Center for Computation and Visualization, the Leduc Bioimaging Facility, and the Flow Cytometry and Sorting Facility at Brown University for instrumentation and the assistance of the respective support staffs. We thank J. Bender, J. Laney, M. Tuite, and members of the Serio and Laney labs for helpful discussions and comments on the manuscript. This research was supported by grants from NIH (GM069802 to T.R.S., GM085976 to A.D., GM089049 to S.S.S., AG034754 to C.K., and AG032818 to S.D.) and NSF/ADVANCE (0548311 to T.R.S.).	Allen KD, 2005, GENETICS, V169, P1227, DOI 10.1534/genetics.104.037168; Bagriantsev SN, 2006, METHOD ENZYMOL, V412, P33, DOI 10.1016/S0076-6879(06)12003-0; Benkemoun L, 2006, FUNGAL GENET BIOL, V43, P789, DOI 10.1016/j.fgb.2006.06.006; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Byrne LJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004670; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Cox B, 2003, GENETICS, V165, P23; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; Crapeau M, 2009, MOL BIOL CELL, V20, P2286, DOI 10.1091/mbc.E08-11-1097; Derkatch IL, 1996, GENETICS, V144, P1375; Edskes HK, 1999, P NATL ACAD SCI USA, V96, P1498, DOI 10.1073/pnas.96.4.1498; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Halfmann R, 2010, TRENDS CELL BIOL, V20, P125, DOI 10.1016/j.tcb.2009.12.003; Haslberger T, 2010, BIOCHEM CELL BIOL, V88, P63, DOI [10.1139/O09-118, 10.1139/o09-118]; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Kushnirov VV, 2007, PRION, V1, P179, DOI 10.4161/pri.1.3.4840; Lancaster AK, 2010, GENETICS, V184, P393, DOI 10.1534/genetics.109.110213; Ness F, 2002, MOL CELL BIOL, V22, P5593, DOI 10.1128/MCB.22.15.5593-5605.2002; Pezza JA, 2009, MOL BIOL CELL, V20, P1068, DOI 10.1091/mbc.E08-04-0436; Pezza JA, 2007, PRION, V1, P36, DOI 10.4161/pri.1.1.3992; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Rikhvanov EG, 2007, PRION, V1, P217, DOI 10.4161/pri.1.4.5058; Salnikova AB, 2005, J BIOL CHEM, V280, P8808, DOI 10.1074/jbc.M410150200; Satpute-Krishnan P, 2007, PLOS BIOL, V5, P251, DOI 10.1371/journal.pbio.0050024; Serio TR, 1999, ANNU REV CELL DEV BI, V15, P661, DOI 10.1146/annurev.cellbio.15.1.661; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Sindi SS, 2009, CURR OPIN MICROBIOL, V12, P623, DOI 10.1016/j.mib.2009.09.003; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Uptain SM, 2001, EMBO J, V20, P6236, DOI 10.1093/emboj/20.22.6236; Zhou P, 1999, EMBO J, V18, P1182, DOI 10.1093/emboj/18.5.1182	30	83	85	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 29	2010	330	6004					680	683		10.1126/science.1197785	http://dx.doi.org/10.1126/science.1197785			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672KB	21030659	Green Accepted			2022-12-01	WOS:000283580600051
J	Hayne, PO; Greenhagen, BT; Foote, MC; Siegler, MA; Vasavada, AR; Paige, DA				Hayne, Paul O.; Greenhagen, Benjamin T.; Foote, Marc C.; Siegler, Matthew A.; Vasavada, Ashwin R.; Paige, David A.			Diviner Lunar Radiometer Observations of the LCROSS Impact	SCIENCE			English	Article							SURFACE	The Lunar Reconnaissance Orbiter (LRO) Diviner instrument detected a thermal emission signature 90 seconds after the Lunar Crater Observation and Sensing Satellite (LCROSS) Centaur impact and on two subsequent orbits. The impact heated a region of 30 to 200 square meters to at least 950 kelvin, providing a sustained heat source for the sublimation of up to similar to 300 kilograms of water ice during the 4 minutes of LCROSS post-impact observations. Diviner visible observations constrain the mass of the sunlit ejecta column to be similar to 10(-6) to 10(-5) kilograms per square meter, which is consistent with LCROSS estimates used to derive the relative abundance of the ice within the regolith.	[Hayne, Paul O.; Siegler, Matthew A.; Paige, David A.] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; [Greenhagen, Benjamin T.; Foote, Marc C.; Vasavada, Ashwin R.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	University of California System; University of California Los Angeles; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Hayne, PO (corresponding author), Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA.	phayne@ucla.edu	Greenhagen, Benjamin T/C-3760-2016	Greenhagen, Benjamin T/0000-0002-8252-9922; Hayne, Paul/0000-0003-4399-0449				BELYAKOV GV, 1977, COMBUST EXPLO SHOCK+, V13, P524; BRASLAU D, 1970, J GEOPHYS RES, V75, P3987, DOI 10.1029/JB075i020p03987; Carrier W. D.  III, 1973, Moon, V6, P250, DOI 10.1007/BF00562206; Colaprete A, 2010, SCIENCE, V330, P463, DOI 10.1126/science.1186986; FANALE FP, 1984, ICARUS, V60, P476, DOI 10.1016/0019-1035(84)90157-X; FOOTE EJ, 2009, 40 LUN PLAN SCI C; Gladstone GR, 2010, SCIENCE, V330, P472, DOI 10.1126/science.1186474; Paige DA, 2010, SPACE SCI REV, V150, P125, DOI 10.1007/s11214-009-9529-2; Paige DA, 2010, SCIENCE, V330, P479, DOI 10.1126/science.1187726; Rehfuss D. E., 1974, Moon, V11, P19, DOI 10.1007/BF01877790; Schultz PH, 2010, SCIENCE, V330, P468, DOI 10.1126/science.1187454; Vasavada AR, 1999, ICARUS, V141, P179, DOI 10.1006/icar.1999.6175; WATSON K, 1961, J GEOPHYS RES, V66, P3033, DOI 10.1029/JZ066i009p03033; Zhang JA, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038614	14	50	54	2	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 22	2010	330	6003					477	479		10.1126/science.1197135	http://dx.doi.org/10.1126/science.1197135			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20966245				2022-12-01	WOS:000283329100031
J	Ghoreschi, K; Laurence, A; Yang, XP; Tato, CM; McGeachy, MJ; Konkel, JE; Ramos, HL; Wei, L; Davidson, TS; Bouladoux, N; Grainger, JR; Chen, QA; Kanno, Y; Watford, WT; Sun, HW; Eberl, G; Shevach, E; Belkaid, Y; Cua, DJ; Chen, WJ; O'Shea, JJ				Ghoreschi, Kamran; Laurence, Arian; Yang, Xiang-Ping; Tato, Cristina M.; McGeachy, Mandy J.; Konkel, Joanne E.; Ramos, Haydee L.; Wei, Lai; Davidson, Todd S.; Bouladoux, Nicolas; Grainger, John R.; Chen, Qian; Kanno, Yuka; Watford, Wendy T.; Sun, Hong-Wei; Eberl, GerRard; Shevach, EthanM.; Belkaid, Yasmine; Cua, Daniel J.; Chen, WanJun; O'Shea, John J.			Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling	NATURE			English	Article							REGULATORY T-CELLS; GROWTH-FACTOR-BETA; HELPER-CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; PROINFLAMMATORY IL-17(+); TH17 CELLS; IN-VIVO; DIFFERENTIATION; LINEAGE; INFLAMMATION	CD4(+) T-helper cells that selectively produce interleukin (IL)-17 (T(H)17), are critical for host defence and autoimmunity(1-4). Although crucial for T(H)17 cells in vivo(5,6), IL-23 has been thought to be incapable of driving initial differentiation. Rather, IL-6 and transforming growth factor (TGF)-beta 1 have been proposed to be the factors responsible for initiating specification(7-10). Here we show that T(H)17 differentiation can occur in the absence of TGF-beta signalling. Neither IL-6 nor IL-23 alone efficiently generated T(H)17 cells; however, these cytokines in combination with IL-1 beta effectively induced IL-17 production in naive precursors, independently of TGF-beta. Epigenetic modification of the Il17a, Il17f and Rorc promoters proceeded without TGF-beta 1, allowing the generation of cells that co-expressed ROR gamma t (encoded by Rorc) and T-bet. T-bet(+)ROR gamma t(+) T(H)17 cells are generated in vivo during experimental allergic encephalomyelitis, and adoptively transferred T(H)17 cells generated with IL-23 without TGF-beta 1 were pathogenic in this disease model. These data indicate an alternative mode for T(H)17 differentiation. Consistent with genetic data linking IL23R with autoimmunity, our findings re-emphasize the importance of IL-23 and therefore may have therapeutic implications.	[Ghoreschi, Kamran; Laurence, Arian; Yang, Xiang-Ping; Ramos, Haydee L.; Wei, Lai; Kanno, Yuka; Watford, Wendy T.; O'Shea, John J.] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Tato, Cristina M.; McGeachy, Mandy J.; Cua, Daniel J.] Merck Res Labs, Palo Alto, CA 94304 USA; [Konkel, Joanne E.; Chen, WanJun] Natl Inst Dent & Craniofacial Res, Mucosal Immunol Unit, Oral Infect & Immun Branch, NIH, Bethesda, MD 20892 USA; [Davidson, Todd S.; Chen, Qian; Shevach, EthanM.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Bouladoux, Nicolas; Grainger, John R.; Belkaid, Yasmine] NIAID, Mucosal Immunol Unit, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Sun, Hong-Wei] NIAMSD, Biodata Min & Discovery Sect, NIH, Bethesda, MD 20892 USA; [Eberl, GerRard] Inst Pasteur, Lymphoid Tissue Dev Unit, F-75724 Paris, France	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Merck & Company; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Ghoreschi, K (corresponding author), NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.	ghoreschik@mail.nih.gov; osheajo@mail.nih.gov	Eberl, Gerard/A-1160-2013; Wei, Lai/D-1088-2014; Yang, Xiangping/B-4833-2011; Laurence, Arian/A-8770-2009; Kanno, Yuka/B-5802-2013	Laurence, Arian/0000-0003-0942-8292; Kanno, Yuka/0000-0001-5668-9319; Grainger, John/0000-0002-4052-5923; Eberl, Gerard/0000-0002-1119-5638; Yang, Xiang-Ping/0000-0001-9003-1772; Watford, Wendy/0000-0003-4261-5399; Belkaid, Yasmine/0000-0001-9962-3571; Bouladoux, Nicolas/0000-0003-1593-671X; Ghoreschi, Kamran/0000-0002-5526-7517; Tato, Cristina M./0000-0002-0614-756X	NIAMS; NIDCR; NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000224, ZIAAI001132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIHAR041173, ZIAAR041159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000101] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank J. Simone, J. Lay (Flow Cytometry Section, NIAMS) and the NIAMS LACU staff for technical support. This work has been supported by the Intramural Research Programs of NIAMS, NIDCR and NIAID.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen Z, 2007, ARTHRITIS RHEUM-US, V56, P2936, DOI 10.1002/art.22866; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Das J, 2009, J EXP MED, V206, P2407, DOI 10.1084/jem.20082286; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; Gutcher I, 2006, NAT IMMUNOL, V7, P946, DOI 10.1038/ni1377; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Lord GM, 2005, BLOOD, V106, P3432, DOI 10.1182/blood-2005-04-1393; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084/jem.20090246; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yang YH, 2009, J EXP MED, V206, P1549, DOI 10.1084/jem.20082584; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	34	1011	1053	2	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 21	2010	467	7318					967	U144		10.1038/nature09447	http://dx.doi.org/10.1038/nature09447			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20962846	Green Accepted			2022-12-01	WOS:000283254700039
J	Keshavjee, S; Girard, F; Harrington, M; Farmer, PE				Keshavjee, Salmaan; Girard, Francoise; Harrington, Mark; Farmer, Paul E.			Time for a bold new vision at the Stop TB Partnership	LANCET			English	Editorial Material							MULTIDRUG-RESISTANT TUBERCULOSIS		[Keshavjee, Salmaan; Farmer, Paul E.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Program Infect Dis & Social Change, Boston, MA 02115 USA; [Keshavjee, Salmaan; Farmer, Paul E.] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; [Keshavjee, Salmaan; Farmer, Paul E.] Partners Hlth, Boston, MA USA; [Girard, Francoise] Open Soc Fdn, New York, NY USA; [Harrington, Mark] Treatment Act Grp, New York, NY USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Partners Healthcare System	Keshavjee, S (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Program Infect Dis & Social Change, Boston, MA 02115 USA.	salmaan_keshavjee@hms.harvard.edu		Keshavjee, Salmaan/0000-0002-6967-3305				Broekmans J., 2005, INVESTING STRATEGIES, P4; Keshavjee S, 2008, ANN NY ACAD SCI, V1136, P1, DOI 10.1196/annals.1425.009; Keshavjee S, 2010, INT J TUBERC LUNG D, V14, P1222; Keshavjee S, 2008, STEMMING TIDE MULTID; Lindert K., 2007, NUTS BOLTS BRAZILS B; *STOP TB PARTN, 2010, BAS FRAM PARTN STOP; Szreter S, 2002, AM J PUBLIC HEALTH, V92, P722, DOI 10.2105/AJPH.92.5.722; United Nations, 2010, MILL DEV GOALS REP 2; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; WHO, 2011, NEW WHO REP ANT DRUG	10	2	4	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 16	2010	376	9749					1283	1284		10.1016/S0140-6736(10)61887-9	http://dx.doi.org/10.1016/S0140-6736(10)61887-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	671RX	20951876				2022-12-01	WOS:000283528600008
J	Currie, TE; Greenhill, SJ; Gray, RD; Hasegawa, T; Mace, R				Currie, Thomas E.; Greenhill, Simon J.; Gray, Russell D.; Hasegawa, Toshikazu; Mace, Ruth			Rise and fall of political complexity in island South-East Asia and the Pacific	NATURE			English	Article							EVOLUTION	There is disagreement about whether human political evolution has proceeded through a sequence of incremental increases in complexity, or whether larger, non-sequential increases have occurred. The extent to which societies have decreased in complexity is also unclear. These debates have continued largely in the absence of rigorous, quantitative tests. We evaluated six competing models of political evolution in Austronesian-speaking societies using phylogenetic methods. Here we show that in the best-fitting model political complexity rises and falls in a sequence of small steps. This is closely followed by another model in which increases are sequential but decreases can be either sequential or in bigger drops. The results indicate that large, non-sequential jumps in political complexity have not occurred during the evolutionary history of these societies. This suggests that, despite the numerous contingent pathways of human history, there are regularities in cultural evolution that can be detected using computational phylogenetic methods.	[Currie, Thomas E.; Hasegawa, Toshikazu] Univ Tokyo, Grad Sch Arts & Sci, Evolutionary Cognit Sci Res Ctr, Tokyo 1538902, Japan; [Currie, Thomas E.; Mace, Ruth] UCL, Dept Anthropol, Human Evolutionary Ecol Grp, London WC1H 0BW, England; [Greenhill, Simon J.; Gray, Russell D.] Univ Auckland, Dept Psychol, Auckland 1142, New Zealand; [Greenhill, Simon J.] Univ Auckland, Computat Evolut Grp, Auckland 1142, New Zealand	University of Tokyo; University of London; University College London; University of Auckland; University of Auckland	Currie, TE (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Evolutionary Cognit Sci Res Ctr, Tokyo 1538902, Japan.	t.currie@ucl.ac.uk	Gray, Russell/H-2078-2015; Greenhill, Simon J/B-3114-2011; Greenhill, Simon/I-3554-2019	Gray, Russell/0000-0002-9858-0191; Greenhill, Simon J/0000-0001-7832-6156; Greenhill, Simon/0000-0001-7832-6156; Mace, Ruth/0000-0002-6137-7739	ESRC/NERC; Japan Society for the Promotion of Science; Royal Society of New Zealand; European Research Council	ESRC/NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)Economic & Social Research Council (ESRC)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Royal Society of New Zealand(Royal Society of New Zealand); European Research Council(European Research Council (ERC)European Commission)	We thank R. Green, who passed away recently, for his advice and support of phylogenetic studies of cultural evolution. We thank R. Foley and M. Dunn for their comments during an earlier stage of this research, and R. Blust and A. Pawley for comments on the manuscript. T.C. was supported by an ESRC/NERC Interdisciplinary Studentship and a Japan Society for the Promotion of Science Postdoctoral Fellowship. S.G. and R.G. were supported by the Royal Society of New Zealand Marsden Fund. R.M. was supported by a European Research Council grant.	[Anonymous], 1999, CHIEFDOMS PATHWAYS C, DOI DOI 10.1017/CBO9780511558238.002; BELLWOOD P, 1996, ORIGINS ANCESTRY ALL, P19; Bondarenko D. M., 2002, SOCIAL EVOLUTION HIS, V1, P54; Campbell RB, 2009, CURR ANTHROPOL, V50, P821, DOI 10.1086/648398; Carneiro Robert L., 2003, EVOLUTIONISM CULTURA; Currie TE, 2009, P NATL ACAD SCI USA, V106, P7339, DOI 10.1073/pnas.0804698106; Dennett DC., 1996, DARWINS DANGEROUS ID; Diamond J, 1997, GUNS GERMS STEEL; Flannery K.V., 1972, ANNU REV ECOL SYST, V3, P339, DOI DOI 10.1146/ANNUREV.ES.03.110172.002151; Glover I., 2004, SE ASIA PREHISTORY H; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Hage P., 1999, ASIAN PERSPECT, V38, P200; Hazen RM, 2010, ELEMENTS, V6, P43, DOI 10.2113/gselements.6.1.43; Johnson Allen., 2000, EVOLUTION HUMAN SOC; Jordan FM, 2009, P ROY SOC B-BIOL SCI, V276, P1957, DOI 10.1098/rspb.2009.0088; Kirch P.V., 2017, ROAD WINDS ARCHAEOLO; KIRCH PV, 2001, RC HAWAIKI ANCESTRAL; Mace R, 2005, TRENDS ECOL EVOL, V20, P116, DOI 10.1016/j.tree.2004.12.002; Marcos S, 2008, EUR PHYS J A, V37, P251, DOI 10.1140/epja/i2008-10619-1; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Richerson PJ, 2009, HUM BIOL, V81, P211, DOI 10.3378/027.081.0306; Richerson PJ., 2001, P BR ACAD, V110, P197; Service ElmanRogers., 1962, PRIMITIVE SOCIAL ORG; SPENCER CS, 1990, J ANTHROPOL ARCHAEOL, V9, P1, DOI 10.1016/0278-4165(90)90004-W; Tainter JA, 2006, ANNU REV ANTHROPOL, V35, P59, DOI 10.1146/annurev.anthro.35.081705.123136; Turchin P, 2009, SOC EVOL HIST, V8, P167; Wright HT, 2006, J ANTHROPOL RES, V62, P305, DOI 10.3998/jar.0521004.0062.301; Yoffee N., 1993, ARCHAEOLOGICAL THEOR, P60; Yoffee Norman, 2005, MYTHS ARCHAIC STATE	30	129	132	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 14	2010	467	7317					801	804		10.1038/nature09461	http://dx.doi.org/10.1038/nature09461			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	663PB	20944739				2022-12-01	WOS:000282898700057
J	Dillon, ME; Wang, G; Huey, RB				Dillon, Michael E.; Wang, George; Huey, Raymond B.			Global metabolic impacts of recent climate warming	NATURE			English	Article							TEMPERATURE; ECTOTHERMS; ANIMALS; ECOLOGY; PLANTS; SHIFT; SIZE; MASS	Documented shifts in geographical ranges(1,2), seasonal phenology(3,4), community interactions(5), genetics(3,6) and extinctions(7) have been attributed to recent global warming(8-10). Many such biotic shifts have been detected at mid-to high latitudes in the Northern Hemisphere(4,9,10)-a latitudinal pattern that is expected(4,8,10,11) because warming is fastest in these regions(8). In contrast, shifts in tropical regions are expected to be less marked(4,8,10,11) because warming is less pronounced there(8). However, biotic impacts of warming are mediated through physiology, and metabolic rate, which is a fundamental measure of physiological activity and ecological impact, increases exponentially rather than linearly with temperature in ectotherms(12). Therefore, tropical ectotherms (with warm baseline temperatures) should experience larger absolute shifts in metabolic rate than the magnitude of tropical temperature change itself would suggest, but the impact of climate warming on metabolic rate has never been quantified on a global scale. Here we show that estimated changes in terrestrial metabolic rates in the tropics are large, are equivalent in magnitude to those in the north temperate-zone regions, and are in fact far greater than those in the Arctic, even though tropical temperature change has been relatively small. Because of temperature's nonlinear effects on metabolism, tropical organisms, which constitute much of Earth's biodiversity, should be profoundly affected by recent and projected climate warming(2,13,14).	[Dillon, Michael E.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Wang, George; Huey, Raymond B.] Univ Washington, Dept Biol, Seattle, WA 98195 USA	University of Wyoming; University of Washington; University of Washington Seattle	Dillon, ME (corresponding author), Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.	Michael.Dillon@uwyo.edu	Huey, Raymond/F-1597-2010; Dillon, Michael/A-2564-2012	Dillon, Michael/0000-0002-7263-5537; Huey, Raymond/0000-0002-4962-8670	NSF [IOB-041684]	NSF(National Science Foundation (NSF))	We thank T. L. Daniel, C. Martinez del Rio, W. R. Rice and J. Tewksbury for discussion, and S. L. Chown for sharing his data on latitudinal variation in E. Research was funded in part by NSF IOB-041684 to R.B.H. and by an NSF Minority Postdoctoral Fellowship to M.E.D.	Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; Bradshaw WE, 2001, P NATL ACAD SCI USA, V98, P14509, DOI 10.1073/pnas.241391498; Clarke A, 2006, FUNCT ECOL, V20, P405, DOI 10.1111/j.1365-2435.2006.01109.x; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; del Rio CM, 2008, TRENDS ECOL EVOL, V23, P256, DOI 10.1016/j.tree.2008.01.010; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Downs CJ, 2008, FUNCT ECOL, V22, P239, DOI 10.1111/j.1365-2435.2007.01371.x; DUNHAM AE, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P95; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Hastings D.A., 1999, GLOBAL LAND ONE KILO; HERTZ PE, 1993, AM NAT, V142, P796, DOI 10.1086/285573; Irlich UM, 2009, AM NAT, V174, P819, DOI 10.1086/647904; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Lott N., 2001, FCC INTEGRATED SURFA; O'Connor MP, 2007, OIKOS, V116, P1058, DOI 10.1111/j.2006.0030-1299.15534.x; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Parry M.L., 2007, CONTRIBUTION WORKING; Portner HO, 2002, J EXP BIOL, V205, P2217; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Reich PB, 2006, NATURE, V439, P457, DOI 10.1038/nature04282; RICE WR, 1994, P NATL ACAD SCI USA, V91, P225, DOI 10.1073/pnas.91.1.225; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Ruel JJ, 1999, TRENDS ECOL EVOL, V14, P361, DOI 10.1016/S0169-5347(99)01664-X; Savage VM, 2004, J THEOR BIOL, V227, P525, DOI 10.1016/j.jtbi.2003.11.030; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Umina PA, 2005, SCIENCE, V308, P691, DOI 10.1126/science.1109523; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	32	579	596	12	567	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 7	2010	467	7316					704	U88		10.1038/nature09407	http://dx.doi.org/10.1038/nature09407			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659NE	20930843				2022-12-01	WOS:000282572500037
J	Bengtson, MH; Joazeiro, CAP				Bengtson, Mario H.; Joazeiro, Claudio A. P.			Role of a ribosome-associated E3 ubiquitin ligase in protein quality control	NATURE			English	Article							MESSENGER-RNA SURVEILLANCE; YEAST; TRANSLATION; IDENTIFICATION; PROTEASOME; ANTIBIOTICS; DEGRADATION; EXPRESSION; MECHANISM; REVEALS	Messenger RNA lacking stop codons ('non-stop mRNA') can arise from errors in gene expression, and encode aberrant proteins whose accumulation could be deleterious to cellular function(1,2). In bacteria, these 'non-stop proteins' become co-translationally tagged with a peptide encoded by ssrA/tmRNA (transfer-messenger RNA), which signals their degradation by energy-dependent proteases(1,3). How eukaryotic cells eliminate non-stop proteins has remained unknown. Here we show that the Saccharomyces cerevisiae Ltn1 RING-domain-type E3 ubiquitin ligase acts in the quality control of non-stop proteins, in a process that is mechanistically distinct but conceptually analogous to that performed by ssrA: Ltn1 is predominantly associated with ribosomes, and it marks nascent non-stop proteins with ubiquitin to signal their proteasomal degradation. Ltn1-mediated ubiquitylation of non-stop proteins seems to be triggered by their stalling in ribosomes on translation through the poly(A) tail. The biological relevance of this process is underscored by the finding that loss of Ltn1 function confers sensitivity to stress caused by increased non-stop protein production. We speculate that defective protein quality control may underlie the neurodegenerative phenotype that results from mutation of the mouse Ltn1 homologue Listerin.	[Bengtson, Mario H.; Joazeiro, Claudio A. P.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Joazeiro, CAP (corresponding author), Scripps Res Inst, Dept Cell Biol, CB168,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	joazeiro@scripps.edu			American Cancer Society [08-298-01-TBE]; National Institute of General Medical Sciences [R01GM083060]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083060] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. C. Sogayar for continued mentorship; I. Kwan for technical help; A. Bacconi for help with microscopy; T. Inada, A. van Hoof, S. Liebman and J. Frydman for reagents; the Williamson and Saez laboratories for help with sucrose-gradient fractionation and real-time PCR, respectively; E. Peters for mass spectrometry analyses; M. Smolka for help with yeast methods; and R. Deshaies, E. P. Geiduschek and T. Hunter for discussions. Work in the Joazeiro laboratory is supported by Research Scholar Grant 08-298-01-TBE from the American Cancer Society and grant R01GM083060 from the National Institute of General Medical Sciences.	Bradley ME, 2003, YEAST, V20, P625, DOI 10.1002/yea.985; Braun MA, 2007, MOL CELL BIOL, V27, P2800, DOI 10.1128/MCB.01947-06; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; Chu J, 2009, P NATL ACAD SCI USA, V106, P2097, DOI 10.1073/pnas.0812819106; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dimitrova LN, 2009, J BIOL CHEM, V284, P10343, DOI 10.1074/jbc.M808840200; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; Dulebohn D, 2007, BIOCHEMISTRY-US, V46, P4681, DOI 10.1021/bi6026055; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Inada T, 2005, EMBO J, V24, P1584, DOI 10.1038/sj.emboj.7600636; Ito-Harashima S, 2007, GENE DEV, V21, P519, DOI 10.1101/gad.1490207; Kirillov S, 1997, FEBS LETT, V406, P223, DOI 10.1016/S0014-5793(97)00261-5; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Lu JL, 2008, J MOL BIOL, V384, P73, DOI 10.1016/j.jmb.2008.08.089; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Rospert S, 2004, CURR BIOL, V14, pR386, DOI 10.1016/j.cub.2004.05.013; VAN HOOF A, 2002, SCIENCE, V295, P2262; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Wilson MA, 2007, GENETICS, V177, P773, DOI 10.1534/genetics.107.073205; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	23	305	309	2	39	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2010	467	7314					470	473		10.1038/nature09371	http://dx.doi.org/10.1038/nature09371			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KO	20835226	Green Accepted			2022-12-01	WOS:000282090200045
J	Polli, D; Altoe, P; Weingart, O; Spillane, KM; Manzoni, C; Brida, D; Tomasello, G; Orlandi, G; Kukura, P; Mathies, RA; Garavelli, M; Cerullo, G				Polli, Dario; Altoe, Piero; Weingart, Oliver; Spillane, Katelyn M.; Manzoni, Cristian; Brida, Daniele; Tomasello, Gaia; Orlandi, Giorgio; Kukura, Philipp; Mathies, Richard A.; Garavelli, Marco; Cerullo, Giulio			Conical intersection dynamics of the primary photoisomerization event in vision	NATURE			English	Article							INITIO MOLECULAR-DYNAMICS; EXCITED-STATE DYNAMICS; 1ST STEP; FEMTOSECOND ISOMERIZATION; PERTURBATION-THEORY; CHROMOPHORE MODELS; VISUAL PIGMENTS; ENERGY-STORAGE; RHODOPSIN; SPECTROSCOPY	Ever since the conversion of the 11-cis retinal chromophore to its all-trans form in rhodopsin was identified as the primary photochemical event in vision(1), experimentalists and theoreticians have tried to unravel the molecular details of this process. The high quantum yield of 0.65 (ref. 2), the production of the primary ground-state rhodopsin photoproduct within a mere 200 fs (refs 3-7), and the storage of considerable energy in the first stable bathorhodopsin intermediate(8) all suggest an unusually fast and efficient photoactivated one-way reaction(9). Rhodopsin's unique reactivity is generally attributed to a conical intersection between the potential energy surfaces of the ground and excited electronic states(10,11) enabling the efficient and ultrafast conversion of photon energy into chemical energy(12-16). But obtaining direct experimental evidence for the involvement of a conical intersection is challenging: the energy gap between the electronic states of the reacting molecule changes significantly over an ultrashort time-scale, which calls for observational methods that combine high temporal resolution with a broad spectral observation window. Here we show that ultrafast optical spectroscopy with sub-20-fs time resolution and spectral coverage from the visible to the near-infrared allows us to follow the dynamics leading to the conical intersection in rhodopsin isomerization. We track coherent wave-packet motion from the photoexcited Franck-Condon region to the photoproduct by monitoring the loss of reactant emission and the subsequent appearance of photoproduct absorption, and find excellent agreement between the experimental observations and molecular dynamics calculations that involve a true electronic state crossing. Taken together, these findings constitute the most compelling evidence to date for the existence and importance of conical intersections in visual photochemistry.	[Altoe, Piero; Tomasello, Gaia; Orlandi, Giorgio; Garavelli, Marco] Univ Bologna, Dipartimento Chim G Ciamician, I-40126 Bologna, Italy; [Polli, Dario; Manzoni, Cristian; Brida, Daniele; Cerullo, Giulio] Politecn Milan, IFN, CNR, Dipartimento Fis, I-20133 Milan, Italy; [Weingart, Oliver] Univ Duisburg Essen, Lehrstuhl Theoret Chem, D-45117 Essen, Germany; [Weingart, Oliver] Max Planck Inst Kohlenforsch, D-45470 Mulheim, Germany; [Spillane, Katelyn M.; Mathies, Richard A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Kukura, Philipp] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England	University of Bologna; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fotonica e Nanotecnologie (IFN-CNR); Polytechnic University of Milan; University of Duisburg Essen; Max Planck Society; University of California System; University of California Berkeley; University of Oxford	Garavelli, M (corresponding author), Univ Bologna, Dipartimento Chim G Ciamician, Via F Selmi 2, I-40126 Bologna, Italy.	marco.garavelli@unibo.it; giulio.cerullo@fisi.polimi.it	Manzoni, Cristian/ABF-1906-2020; Brida, Daniele/A-9301-2010; Manzoni, Cristian/GPX-1379-2022; GARAVELLI, MARCO/P-5510-2015; Weingart, Oliver/O-6470-2019; Brida, Daniele/AAT-6672-2020; Cerullo, Giulio/F-6534-2011; Manzoni, Cristian/F-6669-2011; Polli, Dario/B-4809-2011; Weingart, Oliver/P-9920-2017	Brida, Daniele/0000-0003-2060-5480; Manzoni, Cristian/0000-0002-4169-8869; GARAVELLI, MARCO/0000-0002-0796-289X; Weingart, Oliver/0000-0001-6033-3702; Brida, Daniele/0000-0003-2060-5480; Cerullo, Giulio/0000-0002-9534-2702; Manzoni, Cristian/0000-0002-4169-8869; Polli, Dario/0000-0002-6960-5708; Weingart, Oliver/0000-0001-6033-3702; Kukura, Philipp/0000-0003-0136-7704	DFG [FOR490]; PRIN programme [2008JKBBK4]; UK Engineering and Physical Sciences Research Council [EP/H003541/1]; Engineering and Physical Sciences Research Council [EP/H003541/1] Funding Source: researchfish; EPSRC [EP/H003541/1] Funding Source: UKRI	DFG(German Research Foundation (DFG)); PRIN programme(Ministry of Education, Universities and Research (MIUR)); UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	M.G., O.W., G.O., G. T. and P. A. thank E4-Computer Engineering S. p. A. for computational time and technical assistance. Part of this study was financially supported by the DFG (FOR490) and by the PRIN programme (2008JKBBK4). P. K. is supported by a Career Acceleration Fellowship awarded by the UK Engineering and Physical Sciences Research Council (EP/H003541/1).	Altoe P, 2007, THEOR CHEM ACC, V118, P219, DOI 10.1007/s00214-007-0275-9; ANDERSSON K, 1992, J CHEM PHYS, V96, P1218, DOI 10.1063/1.462209; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cembran A, 2004, J AM CHEM SOC, V126, P16018, DOI 10.1021/ja048782+; Chosrowjan H, 1998, J AM CHEM SOC, V120, P9706, DOI 10.1021/ja981659w; Forsberg N, 1997, CHEM PHYS LETT, V274, P196, DOI 10.1016/S0009-2614(97)00669-6; Frutos LM, 2007, P NATL ACAD SCI USA, V104, P7764, DOI 10.1073/pnas.0701732104; Garavelli M, 1997, J AM CHEM SOC, V119, P6891, DOI 10.1021/ja9610895; Gonzalez-Luque R, 2000, P NATL ACAD SCI USA, V97, P9379, DOI 10.1073/pnas.97.17.9379; Groenhof G, 2004, J AM CHEM SOC, V126, P4228, DOI 10.1021/ja039557f; Groenhof G, 2007, J AM CHEM SOC, V129, P6812, DOI 10.1021/ja069176c; Haran G, 1999, J PHYS CHEM A, V103, P2202, DOI 10.1021/jp9832847; Hayashi S, 2003, BIOPHYS J, V85, P1440, DOI 10.1016/S0006-3495(03)74576-7; Hayashi S, 2009, BIOPHYS J, V96, P403, DOI 10.1016/j.bpj.2008.09.049; Hudock HR, 2007, J PHYS CHEM A, V111, P8500, DOI 10.1021/jp0723665; Hudock HR, 2008, CHEMPHYSCHEM, V9, P2486, DOI 10.1002/cphc.200800649; Kandori H, 2001, CHEM PHYS LETT, V334, P271, DOI 10.1016/S0009-2614(00)01457-3; Karlstrom G, 2003, COMP MATER SCI, V28, P222, DOI 10.1016/S0927-0256(03)00109-5; Kim JE, 2001, BIOCHEMISTRY-US, V40, P13774, DOI 10.1021/bi0116137; KLESSINGER M, 1994, EXCITED STATES PHOTO; Kochendoerfer GG, 1996, J PHYS CHEM-US, V100, P14526, DOI 10.1021/jp960509+; Kukura P, 2005, SCIENCE, V310, P1006, DOI 10.1126/science.1118379; Levine BG, 2007, ANNU REV PHYS CHEM, V58, P613, DOI 10.1146/annurev.physchem.57.032905.104612; Lin H, 2007, THEOR CHEM ACC, V117, P185, DOI 10.1007/s00214-006-0143-z; Manzoni C, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2167128; Mathies R. A., 2000, HDB BIOL PHYSICS, P55, DOI DOI 10.1016/S1383-8121(00)80005-6; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Polli D, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2800778; Roos B. O., 2007, ADV CHEM PHYS, V69, P399, DOI DOI 10.1002/9780470142943.CH7; SCHICK GA, 1987, BIOCHEMISTRY-US, V26, P2556, DOI 10.1021/bi00383a022; SCHOENLEIN RW, 1991, SCIENCE, V254, P412, DOI 10.1126/science.1925597; SINGH UC, 1986, J COMPUT CHEM, V7, P718, DOI 10.1002/jcc.540070604; SLOANE CS, 1977, J CHEM PHYS, V66, P1523, DOI 10.1063/1.434116; Stenta M, 2008, J PHYS CHEM B, V112, P1057, DOI 10.1021/jp7104105; Tao HL, 2009, J PHYS CHEM A, V113, P13656, DOI 10.1021/jp9063565; Tomasello G, 2009, J AM CHEM SOC, V131, P5172, DOI 10.1021/ja808424b; VERLET L, 1967, PHYS REV, V159, P98, DOI 10.1103/PhysRev.159.98; WANG Q, 1994, SCIENCE, V266, P422, DOI 10.1126/science.7939680; WARSHEL A, 1982, J AM CHEM SOC, V104, P1469, DOI 10.1021/ja00370a003; WARSHEL A, 1976, NATURE, V260, P679, DOI 10.1038/260679a0; Weingart O, 2007, J AM CHEM SOC, V129, P10618, DOI 10.1021/ja071793t; Weingart O, 2007, J PHYS CHEM B, V111, P3782, DOI 10.1021/jp0683216; Werner H.-J., 2008, MOLPRO VERSION 2008; YOSHIZAWA T, 1963, NATURE, V197, P1279, DOI 10.1038/1971279a0	45	634	639	6	431	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2010	467	7314					440	U88		10.1038/nature09346	http://dx.doi.org/10.1038/nature09346			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KO	20864998				2022-12-01	WOS:000282090200038
J	Baudry, A; Mouillet-Richard, S; Schneider, B; Launay, JM; Kellermann, O				Baudry, Anne; Mouillet-Richard, Sophie; Schneider, Benoit; Launay, Jean-Marie; Kellermann, Odile			MiR-16 Targets the Serotonin Transporter: A New Facet for Adaptive Responses to Antidepressants	SCIENCE			English	Article							LOCUS-COERULEUS; RECOGNITION; RECEPTOR; CELLS; RAT	The serotonin transporter (SERT) ensures the recapture of serotonin and is the pharmacological target of selective serotonin reuptake inhibitor (SSRI) antidepressants. We show that SERT is a target of microRNA-16 (miR-16). miR-16 is expressed at higher levels in noradrenergic than in serotonergic cells; its reduction in noradrenergic neurons causes de novo SERT expression. In mice, chronic treatment with the SSRI fluoxetine (Prozac) increases miR-16 levels in serotonergic raphe nuclei, which reduces SERT expression. Further, raphe exposed to fluoxetine release the neurotrophic factor S100 beta, which acts on noradrenergic cells of the locus coeruleus. By decreasing miR-16, S100 beta turns on the expression of serotonergic functions in noradrenergic neurons. Based on pharmacological and behavioral data, we propose that miR-16 contributes to the therapeutic action of SSRI antidepressants in monoaminergic neurons.	[Launay, Jean-Marie] F Hoffmann La Roche, Pharma Res Dept, CH-4070 Basel, Switzerland; [Baudry, Anne; Mouillet-Richard, Sophie; Schneider, Benoit; Kellermann, Odile] Univ Paris 05, INSERM, U747, F-75006 Paris, France; [Launay, Jean-Marie] Hop Lariboisiere, INSERM, AP HP, U942,Serv Biochim,RTRS Sante Mentale, F-75475 Paris, France	Roche Holding; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Launay, JM (corresponding author), F Hoffmann La Roche, Pharma Res Dept, CH-4070 Basel, Switzerland.	jean-marie.launay@lrb.aphp.fr; odile.kellermann@parisdescartes.fr	Mouillet, Sophie/E-4960-2017; Schneider, Benoit/AAF-3850-2019; Baudry, Anne/O-2624-2017	Mouillet, Sophie/0000-0002-8950-1949; Baudry, Anne/0000-0002-7729-1753; Schneider, Benoit/0000-0002-1377-2670	CNRS; ANR; INSERM	CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	We thank P. Weil-Malherbe, V. Mutel, F. d'Agostini, G. Zurcher, E. Borroni, J. L. Moreau, F. Jenck, M. Buhler, and N. Pieron for skillful methodological assistance, and S. Blanquet, M. Briley, and L. Aggerbeck for critical reading of the manuscript. O.K. is a professor at Paris XI University. This work was funded by CNRS, ANR, and INSERM.	Azmitia EC, 2007, INT REV NEUROBIOL, V77, P31, DOI 10.1016/S0074-7742(06)77002-7; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benmansour S, 2002, J NEUROSCI, V22, P6766; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; FRAZER A, 1997, J CLIN PSYCHOPHARM S, V17, P25; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Kim MA, 2004, BRAIN RES, V1026, P56, DOI 10.1016/j.brainres.2004.08.022; Launay JM, 2006, FASEB J, V20, P1843, DOI 10.1096/fj.06-5724com; Manev R, 2001, EUR J PHARMACOL, V420, pR1, DOI 10.1016/S0014-2999(01)00989-X; Martello G, 2007, NATURE, V449, P183, DOI 10.1038/nature06100; Mouillet-Richard S, 2000, J BIOL CHEM, V275, P9186, DOI 10.1074/jbc.275.13.9186; Murphy DL, 2008, NEUROPHARMACOLOGY, V55, P932, DOI 10.1016/j.neuropharm.2008.08.034; Nestler EJ, 1999, BIOL PSYCHIAT, V46, P1131, DOI 10.1016/S0006-3223(99)00158-4; QIAN Y, 1995, J NEUROSCI, V15, P1261; Shanmugam N, 2008, J BIOL CHEM, V283, P36221, DOI 10.1074/jbc.M806322200; Surget A, 2009, NEUROPSYCHOPHARMACOL, V34, P1363, DOI 10.1038/npp.2008.76; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456	19	346	367	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2010	329	5998					1537	1541		10.1126/science.1193692	http://dx.doi.org/10.1126/science.1193692			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650RK	20847275				2022-12-01	WOS:000281869000046
J	Chou, YH; Zheng, XY; Beachy, PA; Luo, LQ				Chou, Ya-Hui; Zheng, Xiaoyan; Beachy, Philip A.; Luo, Liqun			Patterning Axon Targeting of Olfactory Receptor Neurons by Coupled Hedgehog Signaling at Two Distinct Steps	CELL			English	Article							DEPENDENT PROTEIN-KINASE; SONIC HEDGEHOG; PRONEURAL GENE; SENSE-ORGANS; DROSOPHILA; MAP; TRANSCRIPTION; SYSTEM; ORGANIZATION; SPECIFICITY	We present evidence for a coupled two-step action of Hedgehog signaling in patterning axon targeting of Drosophila olfactory receptor neurons (ORNs). In the first step, differential Hedgehog pathway activity in peripheral sensory organ precursors creates ORN populations with different levels of the Patched receptor. Different Patched levels in ORNs then determine axonal responsiveness to target-derived Hedgehog in the brain: only ORN axons that do not express high levels of Patched are responsive to and require a second step of Hedgehog signaling for target selection. Hedgehog signaling in the imaginal sensory organ precursors thus confers differential ORN responsiveness to Hedgehog-mediated axon targeting in the brain. This mechanism contributes to the spatial coordination of ORN cell bodies in the periphery and their glomerular targets in the brain. Such coupled two-step signaling may be more generally used to coordinate other spatially and temporally segregated developmental events.	[Chou, Ya-Hui; Zheng, Xiaoyan; Beachy, Philip A.; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Chou, Ya-Hui; Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Zheng, Xiaoyan; Beachy, Philip A.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Luo, LQ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	lluo@stanford.edu	Zheng, Xiaoyan/AAG-1251-2020; Chou, Ya-Hui/F-3775-2014	Zheng, Xiaoyan/0000-0003-4983-5503; Chou, Ya-Hui/0000-0001-6552-8728; Luo, Liqun/0000-0001-5467-9264	NIH [R01-DC005982]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005982] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank T. Clandinin, M. Scott, K. Shen, G. Struhl, and members of the Luo lab, in particular L. Sweeney, M. Spletter, D. Berdnik, K. Miyamichi, and T. Mosca for discussion and comments on the manuscript. We are grateful to D. Luginbuhl and S. Wheaton for assistance. We thank T. Tabata, I. Salecker, C. T. Chien, G. Struhl, Y.H. Sun, T. Lee, B. Dickson, R. Holmgren, N.E. Baker, J. Jiang, M. P. Scott, P. Therond, I. Guerrero, E. Sanchez-Herrero, R. Carthew, G. W. Davis, L. A. Raftery, K. Saigo, Bloomington Stock Center, Kyoto Stock Center, GETDB (NIG), and Developmental Studies Hybridoma Bank for reagents. Supported by an NIH grant (R01-DC005982 to L. L.). L. L. and P. A. B. are HHMI investigators.	Bourikas D, 2005, NAT NEUROSCI, V8, P297, DOI 10.1038/nn1396; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; CAPDEVILA J, 1994, EMBO J, V13, P71, DOI 10.1002/j.1460-2075.1994.tb06236.x; Casali A, 2004, NATURE, V431, P76, DOI 10.1038/nature02835; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Cho KO, 2000, CELL, V103, P331, DOI 10.1016/S0092-8674(00)00124-0; Chotard C, 2005, NEURON, V48, P237, DOI 10.1016/j.neuron.2005.09.019; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; EATON S, 1990, GENE DEV, V4, P1068, DOI 10.1101/gad.4.6.1068; Endo K, 2007, NAT NEUROSCI, V10, P153, DOI 10.1038/nn1832; Eugster C, 2007, DEV CELL, V13, P57, DOI 10.1016/j.devcel.2007.04.019; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Goulding SE, 2000, NEURON, V25, P69, DOI 10.1016/S0896-6273(00)80872-7; Gupta BP, 1998, DEV BIOL, V203, P400, DOI 10.1006/dbio.1998.9064; Gupta BP, 1997, GENES CELLS, V2, P225, DOI 10.1046/j.1365-2443.1997.d01-312.x; Han C, 2004, DEVELOPMENT, V131, P601, DOI 10.1242/dev.00958; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jhaveri D, 2000, DEV BIOL, V226, P73, DOI 10.1006/dbio.2000.9855; JIANG J, 1995, CELL, V80, P563, DOI 10.1016/0092-8674(95)90510-3; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LEPAGE T, 1995, NATURE, V373, P711, DOI 10.1038/373711a0; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Newsome TP, 2000, DEVELOPMENT, V127, P851; Ogden SK, 2008, NATURE, V456, P967, DOI 10.1038/nature07459; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; PAN DJ, 1995, CELL, V80, P543, DOI 10.1016/0092-8674(95)90508-1; Parra LM, 2010, NAT NEUROSCI, V13, P29, DOI 10.1038/nn.2457; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; SCHWARTZ C, 1995, DEVELOPMENT, V121, P1625; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; Stocker RF, 2001, MICROSC RES TECHNIQ, V55, P284, DOI 10.1002/jemt.1178; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Takeuchi H, 2010, CELL, V141, P1056, DOI 10.1016/j.cell.2010.04.041; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Yam PT, 2009, NEURON, V62, P349, DOI 10.1016/j.neuron.2009.03.022; Yao SQ, 2006, CELL, V125, P343, DOI 10.1016/j.cell.2006.02.040; Zheng XY, 2010, GENE DEV, V24, P57, DOI 10.1101/gad.1870310; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zhu HT, 2004, NEURON, V42, P63, DOI 10.1016/S0896-6273(04)00142-4	51	32	32	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2010	142	6					954	966		10.1016/j.cell.2010.08.015	http://dx.doi.org/10.1016/j.cell.2010.08.015			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650NA	20850015	Bronze, Green Accepted			2022-12-01	WOS:000281855000017
J	Seymour, JE; French, J; Richardson, E				Seymour, Jane E.; French, Jeff; Richardson, Eve			Spotlight: Palliative Care Beyond Cancer Dying matters: let's talk about it	BRITISH MEDICAL JOURNAL			English	Article							PHYSICIAN-ASSISTED SUICIDE; HOSPICE CARE; ATTITUDES; DEATH; LIFE; END		[Seymour, Jane E.] Univ Nottingham, Sch Nursing Midwif & Physiother, Nottingham NG7 2HA, England; [French, Jeff] Strateg Soc Marketing, Liphook, Guildford GU30 7QW, England; [Richardson, Eve] Natl Council Palliat Care, London N7 9AS, England	University of Nottingham	Seymour, JE (corresponding author), Univ Nottingham, Sch Nursing Midwif & Physiother, Nottingham NG7 2HA, England.	jane.seymour@nottingham.ac.uk	Seymour, Jane E/C-1610-2009	Seymour, Jane E/0000-0002-9384-2551	National Council for Palliative Care	National Council for Palliative Care	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: JS had support from the National Council for Palliative Care and the National End of Life Care Programme for the submitted work; JF is a consultant to the Dying Matters coalition; no other relationships or activities that could appear to have influenced the submitted work.	Arber S, 2008, J AGING STUD, V22, P366, DOI 10.1016/j.jaging.2008.05.009; Bauman Zygmunt, 1992, MORTALITY IMMORTALIT; Berger Peter Ludwig, 1973, SOCIAL REALITY RELIG; Born Wendi, 2004, J Palliat Med, V7, P247, DOI 10.1089/109662104773709369; Burdette AM, 2005, J SCI STUD RELIG, V44, P79, DOI 10.1111/j.1468-5906.2005.00266.x; Catt S, 2005, PALLIATIVE MED, V19, P402, DOI 10.1191/0269216305pm1037oa; CLARK DA, 2007, EUR J PALLIAT CARE S; Clery E, 2007, BRIT SOCIAL ATTITUDE; Department of Health, 2008, END LIF CAR STRAT PR; *DYING MATT COAL, 2009, NATCEN SURV ATT DYIN; Emanuel EJ, 2002, ARCH INTERN MED, V162, P142, DOI 10.1001/archinte.162.2.142; French J, 2009, SOCIAL MARKETING PUB; *HLTH CAR COMM, 2009, SPOTL COMPL REP 2 ST, V9; *ICM RES END UK, 2006, HAV GOOD HLTH GEN PU; Johnson KS, 2008, J AM GERIATR SOC, V56, P1953, DOI 10.1111/j.1532-5415.2008.01919.x; Kellehear A., 2008, Critical Public Health, V18, P111, DOI 10.1080/09581590701848960; Lloyd-Williams M, 2007, J PAIN SYMPTOM MANAG, V34, P60, DOI 10.1016/j.jpainsymman.2006.09.028; *M CUR CANC CAR, 2004, VIEWS DYING HOM SURV; *NAT COUNC PALL CA, 2010, DYING MATT LETS TALK; O'Neill C, 2003, SOC SCI MED, V57, P721, DOI 10.1016/S0277-9536(02)00421-5; Rietjens JAC, 2006, PALLIATIVE MED, V20, P685, DOI 10.1177/0269216306070241; Scottish Government, 2008, LIV DYING WELL NAT A; Seymour J., 2009, PUBLIC ATTITUDES DEA; WILLIAMS R, 1990, PROTESTANT LEGACY AT	24	22	23	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 16	2010	341								c4860	10.1136/bmj.c4860	http://dx.doi.org/10.1136/bmj.c4860			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	653MO	20847020				2022-12-01	WOS:000282095800003
J	Liberman, J; O'Brien, M; Hall, W; Hill, D				Liberman, Jonathan; O'Brien, Megan; Hall, Wayne; Hill, David			Ending inequities in access to effective pain relief?	LANCET			English	Editorial Material									[Liberman, Jonathan; O'Brien, Megan; Hill, David] Int Union Canc, Geneva, Switzerland; [Liberman, Jonathan] Canc Council Victoria, Canton S, Vic 3053, Australia; [O'Brien, Megan] Amer Canc Soc, Washington, DC USA; [Hall, Wayne] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia	Cancer Council Victoria; American Cancer Society; University of Queensland	Liberman, J (corresponding author), Int Union Canc, Geneva, Switzerland.	jonathan.liberman@cancervic.org.au	Hall, Wayne D/A-3283-2008	Hall, Wayne D/0000-0003-1984-0096				Amon J, 2009, LANCET, V374, P1676, DOI 10.1016/S0140-6736(09)61990-5; [Anonymous], 1961, SINGL CONV NARC DRUG; [Anonymous], 2008, REP INT NARC CONTR B; Barrett D, 2009, UN DRUG POLICY HUMAN; Cherny NI, 2010, ANN ONCOL, V21, P615, DOI 10.1093/annonc/mdp581; Taylor AL, 2007, J LAW MED ETHICS, V35, P556, DOI 10.1111/j.1748-720X.2007.00180.x; *UN EC SOC COUNC C, 2010, UN EC SOC COUNC COMM; United Nations, 2010, REP INT NARC CONTR B; United Nations, 1971, CONV PSYCH SUBST; WHO Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; World Health Organization, 2009, ACC CONTR MED PROGR	11	10	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 11	2010	376	9744					856	857		10.1016/S0140-6736(10)60880-X	http://dx.doi.org/10.1016/S0140-6736(10)60880-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	653DW	20833289				2022-12-01	WOS:000282069100010
J	Goel, H; Lusher, A; Boneh, A				Goel, Himanshu; Lusher, Allison; Boneh, Avihu			Pediatric Mortality Due to Inborn Errors of Metabolism in Victoria, Australia: A Population-Based Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Goel, Himanshu; Boneh, Avihu] Murdoch Childrens Res Inst, Metab Serv, Melbourne, Vic, Australia; [Lusher, Allison] Royal Childrens Hosp, Melbourne, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Goel, H (corresponding author), Murdoch Childrens Res Inst, Metab Serv, Melbourne, Vic, Australia.	avihu.boneh@ghsv.org.au						Applegarth DA, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.1.e10; Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00; Dionisi-Vici C, 2002, J PEDIATR-US, V140, P321, DOI 10.1067/mpd.2002.122394; Hutchesson ACJ, 1998, J MED GENET, V35, P366, DOI 10.1136/jmg.35.5.366; INTERACTIVE STAT CAL	5	5	6	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2010	304	10					1070	1072		10.1001/jama.2010.1259	http://dx.doi.org/10.1001/jama.2010.1259			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646RM	20823432				2022-12-01	WOS:000281559800016
J	Kirby, T				Kirby, Tony			Heather Zar-improving lung health for children in Africa	LANCET			English	Editorial Material												tony.kirby@lancet.com							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 4	2010	376	9743					763	763		10.1016/S0140-6736(10)61366-9	http://dx.doi.org/10.1016/S0140-6736(10)61366-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	650EC	20816534				2022-12-01	WOS:000281831000014
J	Alroy, J				Alroy, J.			The Shifting Balance of Diversity Among Major Marine Animal Groups	SCIENCE			English	Article							PHANEROZOIC TAXONOMIC DIVERSITY; FOSSIL RECORD; MASS EXTINCTIONS; KINETIC-MODEL; DIVERSIFICATION; PATTERNS; FAMILIES; HISTORY; TRENDS	The fossil record demonstrates that each major taxonomic group has a consistent net rate of diversification and a limit to its species richness. It has been thought that long-term changes in the dominance of major taxonomic groups can be predicted from these characteristics. However, new analyses show that diversity limits may rise or fall in response to adaptive radiations or extinctions. These changes are idiosyncratic and occur at different times in each taxa. For example, the end-Permian mass extinction permanently reduced the diversity of important, previously dominant groups such as brachiopods and crinoids. The current global crisis may therefore permanently alter the biosphere's taxonomic composition by changing the rules of evolution.	[Alroy, J.] Univ Calif Santa Barbara, Santa Barbara, CA 93101 USA	University of California System; University of California Santa Barbara	Alroy, J (corresponding author), Macquarie Univ, Fac Sci, Dept Biol Sci, Sydney, NSW 2109, Australia.		Alroy, John/B-4585-2009	Alroy, John/0000-0002-9882-2111				Alroy J, 2004, EVOL ECOL RES, V6, P1; Alroy J, 2008, P NATL ACAD SCI USA, V105, P11536, DOI 10.1073/pnas.0802597105; Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Bambach RK, 1999, GEOBIOS-LYON, V32, P131, DOI 10.1016/S0016-6995(99)80025-4; Bambach RK, 2002, P NATL ACAD SCI USA, V99, P6854, DOI 10.1073/pnas.092150999; BENTON MJ, 1995, SCIENCE, V268, P52, DOI 10.1126/science.7701342; GILINSKY NL, 1994, PALEOBIOLOGY, V20, P445, DOI 10.1017/S0094837300012926; HOFFMAN A, 1986, PALAEONTOLOGY, V29, P655; Kiessling W, 2008, NAT GEOSCI, V1, P527, DOI 10.1038/ngeo251; McKinney FK, 1998, SCIENCE, V281, P807, DOI 10.1126/science.281.5378.807; MILLER AI, 1988, PALEOBIOLOGY, V14, P364, DOI 10.1017/S0094837300012100; NEWELL NORMAN D., 1952, JOUR PALEONTOL, V26, P371; Peters SE, 2008, NATURE, V454, P626, DOI 10.1038/nature07032; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; SEPKOSKI JJ, 1978, PALEOBIOLOGY, V4, P223, DOI 10.1017/S0094837300005972; Sepkoski JJ, 1997, J PALEONTOL, V71, P533, DOI 10.1017/S0022336000040026; Sepkoski JJ, 2000, PALEOBIOLOGY, V26, P7, DOI 10.1666/0094-8373(2000)026<0007:CDAPPC>2.0.CO;2; SEPKOSKI JJ, 1984, PALEOBIOLOGY, V10, P246, DOI 10.1017/S0094837300008186; SEPKOSKI JJ, 1979, PALEOBIOLOGY, V5, P222, DOI 10.1017/S0094837300006539; SEPKOSKI JJ, 1981, PALEOBIOLOGY, V7, P36, DOI 10.1017/S0094837300003778; Stanley SM, 2007, PALEOBIOLOGY, V33, P1, DOI 10.1666/06020.1; VERMEIJ G J, 1977, Paleobiology, V3, P245; Wagner PJ, 2006, SCIENCE, V314, P1289, DOI 10.1126/science.1133795; Wagner PJ, 1995, PALEOBIOLOGY, V21, P410, DOI 10.1017/S0094837300013464	24	304	312	4	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 3	2010	329	5996					1191	1194		10.1126/science.1189910	http://dx.doi.org/10.1126/science.1189910			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645SG	20813951				2022-12-01	WOS:000281485600032
J	He, G; Luo, WJ; Li, P; Remmers, C; Netzer, WJ; Hendrick, J; Bettayeb, K; Flajolet, M; Gorelick, F; Wennogle, LP; Greengard, P				He, Gen; Luo, Wenjie; Li, Peng; Remmers, Christine; Netzer, William J.; Hendrick, Joseph; Bettayeb, Karima; Flajolet, Marc; Gorelick, Fred; Wennogle, Lawrence P.; Greengard, Paul			Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease	NATURE			English	Article							AMYLOID PRECURSOR PROTEIN; TERMINAL FRAGMENT; EPSILON; NOTCH; DIFFERENTIATION; PROTEOLYSIS; GENERATION; MUTATIONS; CLEAVAGE; GENES	Accumulation of neurotoxic amyloid-beta is a major hallmark of Alzheimer's disease(1). Formation of amyloid-beta is catalysed by gamma-secretase, a protease with numerous substrates(2,3). Little is known about the molecular mechanisms that confer substrate specificity on this potentially promiscuous enzyme. Knowledge of the mechanisms underlying its selectivity is critical for the development of clinically effective gamma-secretase inhibitors that can reduce amyloid-beta formation without impairing cleavage of other gamma-secretase substrates, especially Notch, which is essential for normal biological functions(3,4). Here we report the discovery of a novel gamma-secretase activating protein (GSAP) that drastically and selectively increases amyloid-beta production through a mechanism involving its interactions with both gamma-secretase and its substrate, the amyloid precursor protein carboxy-terminal fragment (APP-CTF). GSAP does not interact with Notch, nor does it affect its cleavage. Recombinant GSAP stimulates amyloid-beta production in vitro. Reducing GSAP concentrations in cell lines decreases amyloid-beta concentrations. Knockdown of GSAP in a mouse model of Alzheimer's disease reduces levels of amyloid-beta and plaque development. GSAP represents a type of gamma-secretase regulator that directs enzyme specificity by interacting with a specific substrate. We demonstrate that imatinib, an anticancer drug previously found to inhibit amyloid-beta formation without affecting Notch cleavage 5, achieves its amyloid-beta-lowering effect by preventing GSAP interaction with the gamma-secretase substrate, APP-CTF. Thus, GSAP can serve as an amyloid-beta-lowering therapeutic target without affecting other key functions of gamma-secretase.	[He, Gen; Luo, Wenjie; Remmers, Christine; Netzer, William J.; Bettayeb, Karima; Flajolet, Marc; Greengard, Paul] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10065 USA; [Li, Peng; Hendrick, Joseph; Wennogle, Lawrence P.] Intra Cellular Therapies Inc, New York, NY 10032 USA; [Gorelick, Fred] Yale Univ, Sch Med, Dept Internal Med & Cell Biol, New Haven, CT 06520 USA; [Gorelick, Fred] VA Connecticut Healthcare, New Haven, CT 06520 USA	Rockefeller University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Greengard, P (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, 1230 York Ave, New York, NY 10065 USA.	greengard@rockefeller.edu	Luo, Wenjie/ABF-8451-2020	Wennogle, Lawrence/0000-0002-3795-409X; Gorelick, Fred/0000-0001-8293-6803	NIH [AG09464]; DOD [W81XWH-09-1-0402]; Fisher Center for Alzheimer's Research Foundation; F. M. Kirby Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009464] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); Fisher Center for Alzheimer's Research Foundation; F. M. Kirby Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank E. Woo and B. Chait for their help with protein identification. We thank Y. M. Li for providing us with the biotinylated transition-state analogue. We thank B. Turner and S. Ku for their technical support. This work was supported by NIH grant AG09464 to P. G., DOD grant W81XWH-09-1-0402 to P. G., the Fisher Center for Alzheimer's Research Foundation and the F. M. Kirby Foundation.	Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Dai HQ, 2003, J PHARMACOL EXP THER, V304, P1085, DOI 10.1124/jpet.102.045260; Dougan DA, 2002, FEBS LETT, V529, P6, DOI 10.1016/S0014-5793(02)03179-4; Green RC, 2009, JAMA-J AM MED ASSOC, V302, P2557, DOI 10.1001/jama.2009.1866; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Kume H, 2006, BIOCHEM BIOPH RES CO, V349, P1356, DOI 10.1016/j.bbrc.2006.08.181; Lathia JD, 2008, J NEUROCHEM, V107, P1471, DOI 10.1111/j.1471-4159.2008.05715.x; Lefranc-Jullien S, 2006, J NEUROCHEM, V97, P807, DOI 10.1111/j.1471-4159.2006.03748.x; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Netzer WJ, 2003, P NATL ACAD SCI USA, V100, P12444, DOI 10.1073/pnas.1534745100; Placanica L, 2009, J BIOL CHEM, V284, P2967, DOI 10.1074/jbc.M807269200; Seibler J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm122; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Thathiah A, 2009, SCIENCE, V323, P946, DOI 10.1126/science.1160649; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wang H, 2004, J BIOL CHEM, V279, P40560, DOI 10.1074/jbc.M404345200; Wiley JC, 2005, J NEUROCHEM, V94, P1189, DOI 10.1111/j.1471-4159.2005.03266.x; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Xu HX, 1998, NAT MED, V4, P447, DOI 10.1038/nm0498-447	26	248	280	4	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 2	2010	467	7311					95	U129		10.1038/nature09325	http://dx.doi.org/10.1038/nature09325			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645MB	20811458	Green Accepted			2022-12-01	WOS:000281461200042
J	Mazon, G; Mimitou, EP; Symington, LS				Mazon, Gerard; Mimitou, Eleni P.; Symington, Lorraine S.			SnapShot: Homologous Recombination in DNA Double-Strand Break Repair	CELL			English	Editorial Material							MAINTAINS GENOMIC STABILITY		[Mazon, Gerard; Mimitou, Eleni P.; Symington, Lorraine S.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA	Columbia University	Mazon, G (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA.			Mazon Busquets, Gerard/0000-0002-9791-5666	NIH [GM041784]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041784] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W.K. Holloman and H.L. Klein for helpful comments. We are supported by NIH grant GM041784.	Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Dupaigne P, 2008, MOL CELL, V29, P243, DOI 10.1016/j.molcel.2007.11.033; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Li X, 2009, MOL CELL, V36, P704, DOI 10.1016/j.molcel.2009.09.036; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Prakash R, 2009, GENE DEV, V23, P67, DOI 10.1101/gad.1737809; Svendsen JM, 2010, GENE DEV, V24, P521, DOI 10.1101/gad.1903510; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253	10	39	40	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2010	142	4							648.e2	10.1016/j.cell.2010.08.006	http://dx.doi.org/10.1016/j.cell.2010.08.006			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	641HR	20723763	Bronze			2022-12-01	WOS:000281115900018
J	Vikanes, A; Skjaerven, R; Grjibovski, AM; Gunnes, N; Vangen, S; Magnus, P				Vikanes, Ase; Skjaerven, Rolv; Grjibovski, Andrej M.; Gunnes, Nina; Vangen, Siri; Magnus, Per			Recurrence of hyperemesis gravidarum across generations: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HELICOBACTER-PYLORI INFECTION; NAUSEA; PREGNANCY; RISK; COMPLICATIONS; TERMINATION; PREVALENCE; NORWAY; BIRTH; WOMEN	Objective To estimate the risk of hyperemesis gravidarum ( hyperemesis) according to whether the daughters and sons under study were born after pregnancies complicated by hyperemesis. Design Population based cohort study. Setting Registry data from Norway. Participants Linked generational data from the medical birth registry of Norway (1967-2006): 544 087 units of mother and childbearing daughter and 399 777 units of mother and child producing son. Main outcome measure Hyperemesis in daughters in mother and childbearing daughter units and hyperemesis in female partners of sons in mother and child producing son units. Results Daughters who were born after a pregnancy complicated by hyperemesis had a 3% risk of having hyperemesis in their own pregnancy, while women who were born after an unaffected pregnancy had a risk of 1.1% (unadjusted odds ratio 2.9, 95% confidence interval 2.4 to 3.6). Female partners of sons who were born after pregnancies complicated by hyperemesis had a risk of 1.2% (1.0, 0.7 to 1.6). Daughters born after a pregnancy not complicated by hyperemesis had an increased risk of the condition if the mother had hyperemesis in a previous or subsequent pregnancy (3.2 (1.6 to 6.4) if hyperemesis had occurred in one of the mother's previous pregnancies and 3.7 (1.5 to 9.1) if it had occurred in a later pregnancy). Adjustment for maternal age at childbirth, period of birth, and parity did not change the estimates. Restrictions to firstborns did not influence the results. Conclusions Hyperemesis gravidarum is more strongly influenced by the maternal genotype than the fetal genotype, though environmental influences along the maternal line cannot be excluded as contributing factors.	[Vikanes, Ase; Skjaerven, Rolv; Gunnes, Nina; Vangen, Siri; Magnus, Per] Norwegian Inst Publ Hlth, Div Epidemiol, N-0403 Oslo, Norway; [Skjaerven, Rolv] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, N-5020 Bergen, Norway; [Grjibovski, Andrej M.] Norwegian Inst Publ Hlth, Dept Infect Dis Epidemiol, N-0403 Oslo, Norway; [Grjibovski, Andrej M.] Univ Tromso, Inst Community Med, N-9001 Tromso, Norway; [Grjibovski, Andrej M.] No State Med Univ, Int Sch Publ Hlth, Arkhangelsk, Russia; [Vangen, Siri] Oslo Univ Hosp, Dept Obstet & Gynaecol, Natl Resource Ctr Womens Hlth, Oslo, Norway; [Magnus, Per] Univ Oslo, Inst Gen Practice & Community Med, N-0316 Oslo, Norway	Norwegian Institute of Public Health (NIPH); University of Bergen; Norwegian Institute of Public Health (NIPH); UiT The Arctic University of Tromso; Northern State Medical University; University of Oslo; University of Oslo	Vikanes, A (corresponding author), Norwegian Inst Publ Hlth, Div Epidemiol, POB 4404, N-0403 Oslo, Norway.	ase.vigdis.vikanes@fhi.no	Grjibovski, Andrej M/B-9815-2016	Grjibovski, Andrej M/0000-0002-5464-0498	Norwegian Research Council [166145/V50]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	The study was funded by the Norwegian Research Council (grant No 166145/V50).	ADAMS MM, 1994, OBSTET GYNECOL, V84, P35; Bailit JL, 2005, AM J OBSTET GYNECOL, V193, P811, DOI 10.1016/j.ajog.2005.02.132; Cedergren M, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.029; CHIN RKH, 1989, EUR J OBSTET GYN R B, V33, P215, DOI 10.1016/0028-2243(89)90132-9; COREY LA, 1992, OBSTET GYNECOL, V80, P989; DEPUE RH, 1987, AM J OBSTET GYNECOL, V156, P1137, DOI 10.1016/0002-9378(87)90126-8; Dodds L, 2006, OBSTET GYNECOL, V107, P285, DOI 10.1097/01.AOG.0000195060.22832.cd; Eliakim R, 2000, AM J PERINAT, V17, P207, DOI 10.1055/s-2000-9424; FAIRWEATHER DV, 1968, AM J OBSTET GYNECOL, V102, P135, DOI 10.1016/0002-9378(68)90445-6; Fejzo MS, 2008, EUR J OBSTET GYN R B, V141, P13, DOI 10.1016/j.ejogrb.2008.07.003; Fell DB, 2006, OBSTET GYNECOL, V107, P277, DOI 10.1097/01.AOG.0000195059.82029.74; GADSBY R, 1993, BRIT J GEN PRACT, V43, P245; Gazmararian JA, 2002, OBSTET GYNECOL, V100, P94, DOI 10.1016/S0029-7844(02)02024-0; Golberg D, 2007, OBSTET GYNECOL, V110, P695, DOI 10.1097/01.AOG.0000278571.93861.26; Grjibovski AM, 2008, ACTA OBSTET GYN SCAN, V87, P20, DOI 10.1080/00016340701709273; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Kallen B, 2003, ACTA OBSTET GYN SCAN, V82, P916, DOI 10.1034/j.1600-0412.2003.00307.x; Kim DR, 2009, ARCH WOMEN MENT HLTH, V12, P61, DOI 10.1007/s00737-009-0064-7; Mazzotta P, 2001, J PSYCHOSOM OBST GYN, V22, P7, DOI 10.3109/01674820109049946; Nordtveit TI, 2008, BRIT MED J, V336, P872, DOI 10.1136/bmj.39505.436539.BE; OBRIEN B, 1992, BIRTH-ISS PERINAT C, V19, P138, DOI 10.1111/j.1523-536X.1992.tb00671.x; Poursharif B, 2008, J PERINATOL, V28, P176, DOI 10.1038/sj.jp.7211906; Poursharif B, 2007, CONTRACEPTION, V76, P451, DOI 10.1016/j.contraception.2007.08.009; Sandven I, 2009, ACTA OBSTET GYN SCAN, V88, P1190, DOI 10.3109/00016340903284927; Signorello LB, 1998, EPIDEMIOLOGY, V9, P636, DOI 10.1097/00001648-199811000-00013; Skjaerven R, 2005, BRIT MED J, V331, P877, DOI 10.1136/bmj.38555.462685.8F; Trogstad LIS, 2005, BJOG-INT J OBSTET GY, V112, P1641, DOI 10.1111/j.1471-0528.2005.00765.x; VELLACOTT ID, 1988, INT J GYNECOL OBSTET, V27, P57, DOI 10.1016/0020-7292(88)90088-4; Verberg MFG, 2005, HUM REPROD UPDATE, V11, P527, DOI 10.1093/humupd/dmi021; Vikanes A, 2008, SCAND J PUBLIC HEALT, V36, P135, DOI 10.1177/1403494807085189; World Health Organization (WHO), 2009, INT CLASS DIS	31	36	36	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2010	340								c2050	10.1136/bmj.c2050	http://dx.doi.org/10.1136/bmj.c2050			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591PO	21030362				2022-12-01	WOS:000277314300003
J	de Galan, BE				de Galan, Bastiaan E.			Blood Pressure Control in Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	de Galan, BE (corresponding author), Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	b.degalan@aig.umcn.nl	de Galan, Bastiaan E/H-3161-2015; Wetzels, Jack F.M./A-1720-2014; Krüger, Bernd/F-5781-2011	de Galan, Bastiaan E/0000-0002-1255-7741; Wetzels, Jack F.M./0000-0002-0650-6921; 				de Galan BE, 2002, DIABETES, V51, P790, DOI 10.2337/diabetes.51.3.790; Messerli FH, 2006, ANN INTERN MED, V144, P884, DOI 10.7326/0003-4819-144-12-200606200-00005	2	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2010	363	7					695	696						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	636TN	20701534				2022-12-01	WOS:000280764600022
J	Schrier, RW				Schrier, Robert W.			Blood Pressure Control in Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									Univ Colorado Denver, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Schrier, RW (corresponding author), Univ Colorado Denver, Aurora, CO USA.	robert.schrier@ucdenver.edu	de Galan, Bastiaan E/H-3161-2015; Wetzels, Jack F.M./A-1720-2014; Krüger, Bernd/F-5781-2011	de Galan, Bastiaan E/0000-0002-1255-7741; Wetzels, Jack F.M./0000-0002-0650-6921; 				Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Schrier RW, 2007, NAT CLIN PRACT NEPHR, V3, P428, DOI 10.1038/ncpneph0559; Schrier RW, 2002, KIDNEY INT, V61, P1086, DOI 10.1046/j.1523-1755.2002.00213.x	3	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2010	363	7					696	697						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	636TN	20701534				2022-12-01	WOS:000280764600024
J	Benck, U; Kruger, B; Kramer, BK				Benck, Urs; Krueger, Bernd; Kraemer, Bernhard K.			Blood Pressure Control in Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Benck, Urs; Kraemer, Bernhard K.] Mannheim Univ Hosp, Mannheim, Germany; [Krueger, Bernd] Ruhr Univ Bochum, Bochum, Germany	Ruprecht Karls University Heidelberg; Ruhr University Bochum	Benck, U (corresponding author), Mannheim Univ Hosp, Mannheim, Germany.	bernhard.kraemer@umm.de	de Galan, Bastiaan E/H-3161-2015; Wetzels, Jack F.M./A-1720-2014; Krüger, Bernd/F-5781-2011	de Galan, Bastiaan E/0000-0002-1255-7741; Wetzels, Jack F.M./0000-0002-0650-6921; 					0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2010	363	7					696	696						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	636TN	20701534				2022-12-01	WOS:000280764600023
J	Wetzels, JFM				Wetzels, Jack F. M.			Blood Pressure Control in Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							DISEASE		Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Wetzels, JFM (corresponding author), Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	j.wetzels@nier.umcn.nl	de Galan, Bastiaan E/H-3161-2015; Wetzels, Jack F.M./A-1720-2014; Krüger, Bernd/F-5781-2011	de Galan, Bastiaan E/0000-0002-1255-7741; Wetzels, Jack F.M./0000-0002-0650-6921; 				Bavry AA, 2010, HYPERTENSION, V55, P48, DOI 10.1161/HYPERTENSIONAHA.109.142240; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Messerli FH, 2006, ANN INTERN MED, V144, P884, DOI 10.7326/0003-4819-144-12-200606200-00005; Protogerou AD, 2007, HYPERTENSION, V50, P172, DOI 10.1161/HYPERTENSIONAHA.107.089797	4	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2010	363	7					695	695						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	636TN	20701534				2022-12-01	WOS:000280764600021
